data_1rsf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rsf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.466 ' C ' HG13 ' A' ' 22' ' ' ILE . 74.4 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.009 0.433 . . . . 2.2599999999999998 110.631 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.508 HG23 ' HD2' ' A' ' 131' ' ' LYS . 4.6 mt -141.91 138.76 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 2.6299999999999999 110.928 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 21.5 p -93.6 147.86 22.62 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.339 0.59 . . . . 1.6499999999999999 110.714 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.12 82.88 0.22 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.04 -0.982 . . . . 1.26 111.8 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 48.3 Cg_endo -78.36 -73.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.706 2.937 . . . . 0.88 112.012 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.48 127.63 32.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.412 -0.959 . . . . 2.0600000000000001 108.412 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 133' ' ' ILE . 85.2 tt0 -143.77 158.34 43.75 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.015 1.117 . . . . 1.71 114.015 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.505 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.41 122.88 17.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.561 -1.199 . . . . 2.3999999999999999 109.031 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 mm -120.01 126.57 75.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.801 0.334 . . . . 1.1499999999999999 111.527 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 87.1 mt-10 -119.19 125.18 48.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.434 . . . . 1.1899999999999999 110.334 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HB2' HD12 ' A' ' 110' ' ' LEU . 74.8 mmtt -141.8 160.02 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 2.9300000000000002 111.309 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.33 137.56 39.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 1.1299999999999999 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.663 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 31.2 ttpt -46.59 139.95 4.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.7599999999999998 111.674 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.4 -23.2 7.51 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 116.059 -0.519 . . . . 0.32000000000000001 113.024 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.5 mt-10 -80.92 160.0 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.594 -0.521 . . . . 2.1099999999999999 109.594 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.79 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.7 m -84.49 130.22 34.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.104 -0.638 . . . . 1.0800000000000001 110.583 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -99.72 113.43 25.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 1.0700000000000001 110.441 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 40' ' ' PRO . 89.1 t80 -79.35 129.92 34.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 2.3199999999999998 112.24 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 104' ' ' SER . 14.3 mt -121.42 104.33 40.4 Favored Pre-proline 0 CA--C 1.528 0.121 0 N-CA-C 109.132 -0.692 . . . . 1.47 109.132 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 92.7 Cg_endo -84.25 134.03 5.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.546 2.164 . . . . 0.71999999999999997 114.889 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HA ' ' NZ ' ' A' ' 131' ' ' LYS . 57.3 m -141.59 112.55 7.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.171 -0.922 . . . . 1.03 109.911 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.509 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 8.2 tptt -118.69 109.12 15.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.889 0.376 . . . . 2.2400000000000002 110.663 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.583 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 39.9 p90 -93.82 141.79 28.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.673 -0.694 . . . . 2.1499999999999999 110.436 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 m -79.46 148.01 32.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 1.9299999999999999 111.238 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.36 144.33 39.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.477 -0.783 . . . . 2.5899999999999999 111.406 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 83.5 p -159.34 145.3 12.08 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.804 -0.634 . . . . 2.1299999999999999 110.08 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.3 Cg_exo -45.45 -21.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.495 2.13 . . . . 1.9299999999999999 113.107 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 52.6 tp10 -73.67 -38.26 65.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.617 -0.265 . . . . 2.1800000000000002 111.471 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 46' ' ' SER . 51.0 p-10 -65.79 73.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.641 0.734 . . . . 2.4100000000000001 110.753 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 76.8 mm-40 -90.79 -10.02 44.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.308 -0.86 . . . . 1.96 111.795 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -75.57 154.78 46.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.17 -1.014 . . . . 0.56000000000000005 112.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.63 149.0 25.78 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.205 1.937 . . . . 1.1899999999999999 111.578 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.52 131.05 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 2.4100000000000001 110.235 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.768 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 19.1 t0 -140.05 150.82 44.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.432 0.634 . . . . 1.78 111.417 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.747 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 51.0 mt -141.96 139.99 30.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.919 -1.037 . . . . 1.4099999999999999 109.747 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 85.9 tt0 -139.98 148.0 41.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.007 0.432 . . . . 1.6699999999999999 111.835 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.735 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 78.6 m95 -141.04 119.27 12.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.23999999999999999 111.004 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 83.5 mt -110.06 146.3 35.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 1.1200000000000001 109.192 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.9 tt -129.91 135.59 60.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.685 0.624 . . . . 1.3700000000000001 112.685 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 m -121.52 102.94 41.75 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.26 -0.882 . . . . 1.73 108.646 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 7.1 Cg_exo -78.09 114.09 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.518 2.145 . . . . 0.84999999999999998 112.619 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.98 87.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.101 -0.954 . . . . 1.0700000000000001 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.42 -40.05 62.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 1.8200000000000001 111.253 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -85.04 159.77 20.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.227 0.537 . . . . 2.3599999999999999 111.813 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.81 -16.39 63.77 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.343 -0.844 . . . . 1.95 111.576 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 93.8 mttt -69.6 151.73 45.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 2.2799999999999998 111.848 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.12 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-O 121.751 0.786 . . . . 1.4199999999999999 109.496 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 55.66 85.18 0.07 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.276 -1.329 . . . . 1.77 112.304 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -140.04 144.14 36.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.424 . . . . 2.54 111.124 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 73' ' ' LEU . 61.2 t -70.83 131.9 33.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.902 -0.59 . . . . 1.3899999999999999 111.33 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.71 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.1 pp -130.79 -41.38 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.187 0.44 . . . . 1.8200000000000001 112.187 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.833 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.4 129.89 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.373 0.606 . . . . 1.0800000000000001 110.064 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.724 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -140.41 160.97 38.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.255 -0.884 . . . . 1.8799999999999999 109.684 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.822 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 24.0 t80 -138.54 103.28 4.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.477 -0.564 . . . . 2.2000000000000002 109.477 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.426 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 18.2 t -143.65 153.66 42.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.502 -0.317 . . . . 1.4199999999999999 111.8 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' ASP . . . 58.43 29.49 63.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.624 -0.798 . . . . 0.56999999999999995 111.685 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 10.1 m-20 69.86 4.52 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.619 0.247 . . . . 1.46 111.088 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 97.3 mttt -99.98 112.68 24.95 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.611 -0.514 . . . . 2.96 109.611 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.822 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.28 116.47 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 108.057 -1.09 . . . . 2.27 108.057 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.803 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -100.33 126.28 46.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.439 -1.709 . . . . 2.1499999999999999 110.78 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.849 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.5 p-10 -165.98 -53.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.526 -1.286 . . . . 1.2 107.526 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' OD1' ' CD1' ' A' ' 83' ' ' TYR . 21.0 p-10 -82.93 -26.93 30.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.147 -0.933 . . . . 2.1699999999999999 109.749 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CD1' ' OD1' ' A' ' 82' ' ' ASP . 36.1 m-85 -75.57 -28.58 59.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.4 -1.333 . . . . 5.4100000000000001 107.4 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.567 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -83.16 113.19 44.4 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 114.158 -1.383 . . . . 2.21 110.329 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.7 -42.94 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.615 1.544 . . . . 1.1100000000000001 111.226 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 74.6 m-20 -67.99 104.6 1.78 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.012 -0.54 . . . . 1.3600000000000001 111.235 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.79 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 32.4 mt 71.27 24.4 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.306 -0.861 . . . . 2.2400000000000002 113.221 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.849 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.7 pttt -58.14 135.61 57.08 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.901 -0.499 . . . . 2.8700000000000001 111.63 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.35 11.31 75.64 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.536 -0.84 . . . . 0.48999999999999999 114.398 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.79 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.6 ptp180 -138.99 -50.97 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.678 1.362 . . . . 2.1099999999999999 114.678 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.833 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -78.96 81.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.847 1.308 . . . . 1.04 107.53 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.47 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.6 m80 -102.88 131.55 49.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.451 -2.159 . . . . 0.34000000000000002 112.401 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 82.6 m-85 -73.59 120.2 18.86 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 120.024 -0.67 . . . . 2.1600000000000001 109.312 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.0 p -70.09 -9.17 54.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.923 -1.035 . . . . 1.0900000000000001 110.807 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 5.3 m -88.32 118.53 28.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.941 -0.572 . . . . 1.71 110.887 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -90.09 0.18 57.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.244 0.545 . . . . 2.4700000000000002 110.168 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -146.41 67.19 1.18 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.487 -0.931 . . . . 2.1400000000000001 108.487 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 6.5 mp -57.77 -27.76 63.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.25 -0.886 . . . . 1.99 112.149 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -63.45 -5.04 3.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.187 0.518 . . . . 2.4900000000000002 112.115 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.6 p -89.85 -0.04 57.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.41 -0.814 . . . . 1.8999999999999999 110.975 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.21 0.6 38.26 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.645 -0.788 . . . . 0.40999999999999998 113.218 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.483 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 92.3 m-20 -99.94 118.65 36.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 111.002 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.571 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -118.5 10.39 12.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 1.1200000000000001 111.651 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.668 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -60.03 140.43 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.122 1.897 . . . . 1.46 116.122 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.82 134.61 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 114.543 -1.208 . . . . 1.0900000000000001 110.486 177.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.3 p-10 -108.88 151.08 26.75 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.673 -0.862 . . . . 1.5600000000000001 108.673 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.78 120.13 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.0 0.429 . . . . 1.0600000000000001 110.903 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.587 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -83.9 144.89 28.91 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.506 -0.77 . . . . 1.0700000000000001 111.094 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.82 61.77 3.04 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.963 -0.562 . . . . 1.9399999999999999 112.328 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 31' ' ' LYS . 9.4 mt -45.45 176.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.218 0.451 . . . . 1.21 112.218 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.663 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 62.3 tt0 -176.32 159.99 2.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 2.6699999999999999 110.616 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 95.0 mt -59.93 -40.07 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.525 . . . . 2.2400000000000002 112.416 -178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.3 m -74.56 -13.98 60.74 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.1 -0.24 . . . . 1.8300000000000001 111.372 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.62 -22.37 62.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 1.5800000000000001 109.271 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -46.53 144.9 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 115.641 -0.709 . . . . 1.1399999999999999 110.74 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.62 148.79 5.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.234 -0.984 . . . . 0.26000000000000001 113.268 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.1 m -59.07 135.89 57.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.431 . . . . 1.0700000000000001 111.771 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 31.5 m-85 -116.18 139.99 49.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 2.1400000000000001 109.867 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.735 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 54.7 tt0 -117.88 117.53 29.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.035 -0.357 . . . . 1.5900000000000001 110.035 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.538 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 18.0 t -100.0 109.62 21.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.101 -0.5 . . . . 1.03 110.687 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 54.4 mtpt -121.35 111.48 17.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 2.1899999999999999 111.895 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 t -96.28 110.16 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.483 -0.562 . . . . 1.8200000000000001 109.483 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 29.0 tttt -95.02 114.93 26.79 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.879 -0.728 . . . . 2.1899999999999999 112.767 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.99 102.66 3.67 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.262 -0.644 . . . . 3.2799999999999998 109.262 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.527 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.07 133.51 22.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 1.1799999999999999 112.29 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 58.6 Cg_endo -101.61 50.04 1.71 Allowed 'Cis proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.745 -0.939 . . . . 0.62 111.138 -0.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.98 103.06 0.29 Allowed Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.062 -1.066 . . . . 0.53000000000000003 113.29 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -88.41 119.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.203 -0.999 . . . . 1.8700000000000001 109.761 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -100.01 140.48 34.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.681 -0.236 . . . . 1.3200000000000001 111.601 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.402 ' H ' HD11 ' A' ' 22' ' ' ILE . 42.7 p-10 -146.07 131.72 18.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.483 -0.326 . . . . 2.0299999999999998 111.244 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.508 ' HD2' HG23 ' A' ' 22' ' ' ILE . 5.0 ptmt -145.25 158.5 43.81 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.344 -0.389 . . . . 3.46 110.676 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 96.7 mttt -102.79 140.02 37.61 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.065 0.765 . . . . 2.6699999999999999 113.065 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.58 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 2.4 mp -141.32 116.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.349 -0.841 . . . . 1.0600000000000001 108.895 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 54.0 m170 -101.44 120.04 39.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.70999999999999996 110.845 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -88.77 121.26 30.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 2.1000000000000001 111.623 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.8 t -120.0 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.763 -0.653 . . . . 1.0900000000000001 109.513 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.97 125.94 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 1.72 112.156 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.26 155.25 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.835 -0.62 . . . . 1.21 109.403 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 2.0899999999999999 111.654 -178.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.942 0.401 . . . . 2.2599999999999998 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.513 HG23 ' CB ' ' A' ' 129' ' ' ALA . 6.5 pt -99.18 144.89 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 2.6299999999999999 111.182 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.41 159.54 18.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.466 0.65 . . . . 1.6499999999999999 111.614 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.626 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER 41.75 83.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.724 -1.125 . . . . 1.26 111.899 -178.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.2 Cg_endo -78.72 -78.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.547 2.832 . . . . 0.88 112.867 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.1 mt-10 -78.96 128.6 33.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.871 -0.418 . . . . 2.0600000000000001 109.871 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.564 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 49.7 tt0 -144.45 159.96 41.87 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.212 1.19 . . . . 1.71 114.212 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.2 mtt -137.73 117.85 13.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.626 -1.17 . . . . 2.3999999999999999 108.847 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.528 HD13 ' HG2' ' A' ' 27' ' ' GLU . 3.6 mp -119.97 120.6 63.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.371 0.508 . . . . 1.1499999999999999 112.371 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 96.5 mt-10 -106.87 126.25 52.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.059 -0.519 . . . . 1.1899999999999999 109.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.452 ' CG ' HD13 ' A' ' 110' ' ' LEU . 27.7 tptt -141.79 150.07 41.23 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.795 -0.362 . . . . 2.9300000000000002 111.486 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.62 140.26 40.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 1.1299999999999999 112.134 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 97.6 mttt -44.98 153.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.654 0.613 . . . . 2.7599999999999998 112.654 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.09 -28.53 0.54 Allowed Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.139 -0.937 . . . . 0.32000000000000001 113.636 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 33' ' ' LYS . 99.4 mt-10 -79.62 160.07 26.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.236 -0.653 . . . . 2.1099999999999999 109.236 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.78 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 79.7 m -85.89 129.87 34.71 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.066 -0.654 . . . . 1.0800000000000001 110.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB1' HG22 ' A' ' 107' ' ' VAL . . . -98.83 117.8 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.509 . . . . 1.0700000000000001 110.243 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' HG23 ' A' ' 94' ' ' THR . 17.6 t80 -79.32 121.11 24.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.722 -0.672 . . . . 2.3199999999999998 112.631 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB3' HD11 ' A' ' 133' ' ' ILE . 22.9 mt -104.29 104.8 46.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.457 -0.942 . . . . 1.47 108.457 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.613 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 95.7 Cg_endo -82.95 129.72 5.48 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.235 1.957 . . . . 0.71999999999999997 114.202 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 3.8 t -140.64 134.4 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.183 -1.043 . . . . 1.03 108.183 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 43.8 mmtm -140.28 143.86 36.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.826 -0.35 . . . . 2.2400000000000002 111.349 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 47.3 p90 -140.56 140.71 35.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 2.1499999999999999 111.26 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -81.88 140.21 34.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.906 -0.588 . . . . 1.9299999999999999 111.899 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.61 141.97 33.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.762 -0.653 . . . . 2.5899999999999999 110.997 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 44.7 m -154.93 154.49 29.03 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 2.1299999999999999 110.242 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 11.7 Cg_endo -55.42 -21.33 29.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.603 2.202 . . . . 1.9299999999999999 112.909 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.3 tt0 -76.18 -41.49 49.44 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 120.942 -0.303 . . . . 2.1800000000000002 110.952 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.507 ' HB2' ' HG2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -71.48 74.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.357 -0.537 . . . . 2.4100000000000001 109.943 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 62.6 mm-40 -91.38 -8.02 49.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.801 . . . . 1.96 111.892 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.32 159.89 53.54 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.067 -1.064 . . . . 0.56000000000000005 112.259 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 144.04 59.56 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.132 1.888 . . . . 1.1899999999999999 111.348 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD22 ' CE1' ' A' ' 74' ' ' TYR . 9.7 tt -77.61 123.66 26.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 2.4100000000000001 110.663 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.2 m-20 -129.46 148.21 51.34 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.508 0.67 . . . . 1.78 111.223 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 24.3 mt -142.88 141.87 26.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.491 -1.232 . . . . 1.4099999999999999 109.248 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.778 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 40.9 mt-10 -139.97 151.41 45.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.015 -0.274 . . . . 1.6699999999999999 110.953 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.679 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 87.4 m95 -140.49 116.12 10.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.23999999999999999 110.588 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.3 mt -106.31 146.26 30.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 1.1200000000000001 109.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.062 0.458 . . . . 1.3700000000000001 111.923 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 28.4 t -115.64 102.88 54.24 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 108.916 -0.772 . . . . 1.73 108.916 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 72.4 Cg_endo -78.76 110.29 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.629 2.219 . . . . 0.84999999999999998 112.81 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.79 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.15 -0.932 . . . . 1.0700000000000001 110.901 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 20.1 p-10 -88.24 20.41 3.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 1.8200000000000001 111.642 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -151.46 160.02 43.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.245 0.545 . . . . 2.3599999999999999 111.858 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -68.4 -20.01 64.65 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.394 -0.821 . . . . 1.95 112.231 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.58 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 59.4 mttp -67.86 154.19 42.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 2.2799999999999998 110.945 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 135.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-O 122.751 1.262 . . . . 1.4199999999999999 110.78 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 39.98 46.31 1.74 Allowed 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.251 -2.25 . . . . 1.77 113.481 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.33 143.28 26.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.996 -0.282 . . . . 2.54 110.98 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.498 ' CG1' HD11 ' A' ' 73' ' ' LEU . 94.9 t -68.35 130.03 33.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 1.3899999999999999 110.525 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.891 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.3 pp -128.61 -37.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 1.8200000000000001 112.014 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.886 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.67 125.62 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.928 -0.767 . . . . 1.0800000000000001 108.928 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.74 158.29 44.18 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.556 -0.747 . . . . 1.8799999999999999 110.695 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.759 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 14.6 t80 -133.25 103.81 6.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.146 -0.687 . . . . 2.2000000000000002 109.146 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.444 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 23.5 m -142.74 159.11 42.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.784 0.326 . . . . 1.4199999999999999 111.666 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.19 27.55 23.85 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.797 -0.716 . . . . 0.56999999999999995 112.462 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 74.12 1.83 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.54 0.21 . . . . 1.46 110.989 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.9 mttm -100.01 114.1 27.17 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.954 -0.388 . . . . 2.96 109.954 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.684 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.24 126.87 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 C-N-CA 118.658 -1.217 . . . . 2.27 107.82 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.713 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -111.02 128.06 55.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.635 -1.62 . . . . 2.1499999999999999 110.631 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.7 p-10 -166.17 -56.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.081 -1.451 . . . . 1.2 107.081 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.9 t70 -83.09 -26.02 31.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.702 -1.135 . . . . 2.1699999999999999 109.188 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -75.87 -30.2 58.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.921 -1.14 . . . . 5.4100000000000001 107.921 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.55 110.58 22.82 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 114.402 -1.272 . . . . 2.21 110.166 178.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.73 -41.69 11.55 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.67 1.58 . . . . 1.1100000000000001 111.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 86.1 m-20 -68.06 104.2 1.71 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.83 -0.623 . . . . 1.3600000000000001 111.188 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.778 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.2 mt 71.74 20.75 4.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.21 0.819 . . . . 2.2400000000000002 113.21 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.8 pttt -56.23 131.99 49.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.883 -0.511 . . . . 2.8700000000000001 111.269 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 92.07 10.82 60.74 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.186 -1.007 . . . . 0.48999999999999999 114.247 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.778 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -142.02 -49.26 0.38 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 114.862 1.43 . . . . 2.1099999999999999 114.862 -178.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.891 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.3 p -79.61 81.45 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 CA-C-O 123.339 1.542 . . . . 1.04 107.128 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.6 m80 -102.05 128.9 48.31 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.044 -2.344 . . . . 0.34000000000000002 112.563 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.684 ' CD2' HG13 ' A' ' 79' ' ' ILE . 82.3 m-85 -72.34 124.74 25.74 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.752 -0.779 . . . . 2.1600000000000001 109.024 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.578 HG23 ' CE2' ' A' ' 38' ' ' TYR . 12.6 p -76.44 36.03 0.15 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.212 -0.903 . . . . 1.0900000000000001 112.062 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -148.68 133.33 17.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.91 0.386 . . . . 1.71 110.848 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -90.07 5.23 47.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 2.4700000000000002 110.2 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -146.16 65.74 1.2 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.704 -0.68 . . . . 2.1400000000000001 109.429 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.481 HD22 ' CD2' ' A' ' 93' ' ' PHE . 8.1 mp -57.32 -29.12 63.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 1.99 110.866 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.5 mttt -65.8 1.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.35 0.5 . . . . 2.4900000000000002 112.35 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 98' ' ' LEU . 11.1 m -89.99 -0.0 57.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.688 -0.687 . . . . 1.8999999999999999 111.244 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.606 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 110.51 -11.02 30.64 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.805 -0.712 . . . . 0.40999999999999998 113.022 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -100.09 112.69 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 111.135 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.559 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -109.65 12.75 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 1.1200000000000001 111.681 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 21.1 m -60.07 139.15 57.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.459 1.651 . . . . 1.46 115.459 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.38 130.03 65.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-N 114.347 -1.297 . . . . 1.0900000000000001 110.735 178.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.591 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.6 p-10 -104.4 146.62 28.58 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.672 -0.862 . . . . 1.5600000000000001 108.672 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.82 121.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.008 0.432 . . . . 1.0600000000000001 110.808 -178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.567 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -83.79 145.22 28.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.445 -0.798 . . . . 1.0700000000000001 111.176 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 54.12 63.73 2.07 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.081 -0.509 . . . . 1.9399999999999999 112.169 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD13 ' CG ' ' A' ' 31' ' ' LYS . 4.5 mt -45.03 175.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.198 0.523 . . . . 1.21 112.299 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.429 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 14.8 pt20 -177.02 156.83 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 2.6699999999999999 110.888 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.578 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 60.5 tp -60.04 -39.71 86.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 2.2400000000000002 112.11 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.478 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 4.8 t -72.46 -16.11 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.998 0.74 . . . . 1.8300000000000001 112.998 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 111' ' ' GLN . 3.2 p30 -74.38 -16.05 60.91 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.888 -0.725 . . . . 1.5800000000000001 109.791 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -45.17 141.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.094 -0.503 . . . . 1.1399999999999999 110.185 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.96 154.05 6.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 119.717 -1.23 . . . . 0.26000000000000001 113.88 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.88 137.73 57.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.933 -0.633 . . . . 1.0700000000000001 112.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.6 m-85 -119.97 139.7 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.324 -0.621 . . . . 2.1400000000000001 109.324 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.649 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.1 tt0 -128.39 121.89 30.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.706 0.288 . . . . 1.5900000000000001 110.893 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 56' ' ' GLU . 43.5 t -99.96 117.79 35.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.03 110.632 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.778 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 23.0 mttm -115.0 106.1 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.801 -0.359 . . . . 2.1899999999999999 110.56 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 34.3 t -94.87 105.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.649 -0.5 . . . . 1.8200000000000001 109.649 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.7 tttt -95.27 119.35 33.63 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.898 -0.721 . . . . 2.1899999999999999 112.603 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.507 ' HG2' ' HB2' ' A' ' 49' ' ' ASP . 6.6 ttpm? -146.25 102.98 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 3.2799999999999998 110.111 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.506 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.33 133.25 24.9 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 111.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 53.5 Cg_endo -100.68 47.26 2.19 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.742 -0.941 . . . . 0.62 111.434 -0.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.94 103.33 0.28 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.146 -1.026 . . . . 0.53000000000000003 113.579 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.73 151.46 3.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -0.811 . . . . 1.8700000000000001 108.887 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.513 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -141.44 151.32 43.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.412 0.523 . . . . 1.3200000000000001 112.412 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 129' ' ' ALA . 1.8 m120 -145.8 141.18 27.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.925 -0.58 . . . . 2.0299999999999998 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.626 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.26 156.31 43.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.689 -0.232 . . . . 3.46 110.645 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.3 mttm -101.34 140.53 35.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.631 0.975 . . . . 2.6699999999999999 113.631 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 33.3 mt -141.96 111.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 1.0600000000000001 109.233 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 117' ' ' THR . 41.7 m170 -100.04 118.71 37.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.727 -0.389 . . . . 0.70999999999999996 110.647 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 10.2 mt -92.94 125.39 37.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.267 0.556 . . . . 2.1000000000000001 112.035 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 57.8 t -115.64 123.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.314 -0.857 . . . . 1.0900000000000001 109.109 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 115' ' ' ILE . 21.6 t -94.6 120.03 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.062 0.458 . . . . 1.72 111.929 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.16 158.63 18.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 1.21 110.505 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.225 0.536 . . . . 2.0899999999999999 111.057 -179.796 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.2599999999999998 111.08 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 129' ' ' ALA . 14.9 tt -142.82 147.75 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.596 -0.729 . . . . 2.6299999999999999 110.986 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 53.6 p -88.86 146.3 25.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.28 0.562 . . . . 1.6499999999999999 110.998 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 40.28 82.52 0.22 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.868 -1.06 . . . . 1.26 111.384 -178.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.6 Cg_endo -78.15 -11.17 16.34 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 124.008 3.139 . . . . 0.88 113.127 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.56 121.8 13.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.592 -0.892 . . . . 2.0600000000000001 108.592 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 132' ' ' LYS . 85.1 tt0 -143.81 158.99 43.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.765 1.024 . . . . 1.71 113.765 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.3 ttm -138.52 135.05 34.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.692 -1.14 . . . . 2.3999999999999999 109.138 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.9 mm -133.79 139.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 1.1499999999999999 111.925 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.57 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.2 mt-10 -132.61 122.23 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 1.1899999999999999 109.544 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 11.6 tptm -142.1 161.52 37.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.74 -0.384 . . . . 2.9300000000000002 111.119 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.17 131.69 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 1.1299999999999999 111.573 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 138' ' ' LEU . 27.7 ttmt -44.89 132.04 6.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.767 -0.651 . . . . 2.7599999999999998 111.345 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.94 -16.56 56.65 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.056 -0.592 . . . . 0.32000000000000001 112.504 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 66.4 mm-40 -80.32 159.97 25.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.009 -0.737 . . . . 2.1099999999999999 109.009 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.898 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 10.1 m -90.84 121.69 32.91 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.001 -0.68 . . . . 1.0800000000000001 110.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' C ' ' OD1' ' A' ' 106' ' ' ASN . . . -99.53 119.73 38.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.146 0.498 . . . . 1.0700000000000001 111.451 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 80.7 t80 -79.24 116.38 19.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 2.3199999999999998 111.638 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.96 105.05 32.66 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.935 -0.765 . . . . 1.47 108.935 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.769 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.0 Cg_endo -82.31 124.92 4.37 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.424 2.083 . . . . 0.71999999999999997 114.09 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.9 t -141.16 132.71 27.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 1.03 109.473 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 22' ' ' ILE . 41.9 mttm -141.08 153.47 45.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.28 -0.418 . . . . 2.2400000000000002 110.538 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.541 ' CD1' HG11 ' A' ' 122' ' ' VAL . 36.3 p90 -140.41 153.02 46.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.145 -0.48 . . . . 2.1499999999999999 111.567 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -79.89 128.39 33.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 111.299 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 131.42 45.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.63 -0.713 . . . . 2.5899999999999999 110.725 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 m -152.24 139.91 13.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 110.223 -0.288 . . . . 2.1299999999999999 110.223 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.57 -25.69 5.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.398 2.065 . . . . 1.9299999999999999 112.344 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -39.97 67.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.345 -0.388 . . . . 2.1800000000000002 110.53 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.593 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -75.93 79.62 2.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.606 -0.887 . . . . 2.4100000000000001 108.606 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.95 -0.23 54.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.757 -0.656 . . . . 1.96 112.306 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -71.21 158.96 53.79 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.342 -0.932 . . . . 0.56000000000000005 112.719 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 123' ' ' LYS . 18.6 Cg_endo -59.93 132.5 45.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.472 2.115 . . . . 1.1899999999999999 111.376 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.2 104.67 8.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.444 -0.344 . . . . 2.4100000000000001 111.698 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.719 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.2 m-20 -118.3 103.56 9.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.53 0.681 . . . . 1.78 111.426 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 4.7 mm -89.56 104.44 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.774 -1.103 . . . . 1.4099999999999999 109.853 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HG3' HD13 ' A' ' 73' ' ' LEU . 85.9 tt0 -101.73 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.687 ' HB2' HG23 ' A' ' 72' ' ' ILE . 81.3 m95 -99.99 124.39 45.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.23999999999999999 110.303 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.2 mt -112.23 139.96 47.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.472 -0.566 . . . . 1.1200000000000001 109.472 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 117' ' ' THR . 3.7 tt -129.59 130.05 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.994 0.426 . . . . 1.3700000000000001 111.675 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.454 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 19.6 m -114.3 102.61 54.95 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 115.799 -0.637 . . . . 1.73 109.328 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.7 Cg_exo -78.67 113.79 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.707 2.272 . . . . 0.84999999999999998 112.255 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.98 87.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.29 -0.868 . . . . 1.0700000000000001 111.283 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.73 -40.01 61.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 1.8200000000000001 111.009 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 12.5 t-20 -82.91 159.96 22.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.3599999999999999 111.662 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.67 -17.49 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.419 -0.81 . . . . 1.95 111.408 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 60.8 mttp -69.76 152.66 44.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.592 -0.731 . . . . 2.2799999999999998 112.113 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -156.31 126.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-O 121.829 0.823 . . . . 1.4199999999999999 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 56.47 40.04 29.74 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 1.77 111.988 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -89.14 147.71 24.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.628 -0.26 . . . . 2.54 111.158 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 22.4 t -67.54 139.74 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.689 -0.486 . . . . 1.3899999999999999 109.689 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.688 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -134.06 -52.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.8200000000000001 112.912 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.729 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.21 127.04 31.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.076 -0.713 . . . . 1.0800000000000001 109.076 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD13 ' HG3' ' A' ' 56' ' ' GLU . 7.4 tt -140.13 160.63 39.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 1.8799999999999999 110.633 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.531 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 20.9 t80 -134.78 104.04 5.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.326 -0.397 . . . . 2.2000000000000002 110.619 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.467 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 35.6 t -143.61 159.82 41.76 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.475 0.546 . . . . 1.4199999999999999 112.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.14 31.89 8.91 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.862 -0.608 . . . . 0.56999999999999995 113.155 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t0 71.07 2.57 4.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.269 . . . . 1.46 111.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 92.2 mttt -100.18 113.4 26.03 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.979 -0.378 . . . . 2.96 109.979 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG22 ' CE2' ' A' ' 93' ' ' PHE . 3.1 mm -79.34 128.8 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.063 -1.458 . . . . 2.27 107.063 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.723 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -112.59 115.65 28.94 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.241 -0.89 . . . . 2.1499999999999999 110.328 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.853 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.7 p-10 -166.07 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 106.799 -1.556 . . . . 1.2 106.799 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -79.67 -25.72 41.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.585 -1.189 . . . . 2.1699999999999999 108.491 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -81.32 -28.26 34.64 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.849 -1.167 . . . . 5.4100000000000001 107.849 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' CB ' ' O ' ' A' ' 71' ' ' ILE . 2.7 m-85 -87.65 120.93 71.18 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 114.769 -1.105 . . . . 2.21 110.727 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 84' ' ' TYR . 7.7 Cg_exo -71.47 -28.67 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.033 1.822 . . . . 1.1100000000000001 112.951 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 28.7 t0 -49.22 -30.01 6.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.228 -0.589 . . . . 1.3600000000000001 112.06 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.759 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 29.9 mt -157.56 38.01 0.28 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.121 -0.945 . . . . 2.2400000000000002 110.504 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.853 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 23.9 pttm -55.81 134.09 51.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.877 -0.601 . . . . 2.8700000000000001 112.392 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.36 76.0 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.39 -0.823 . . . . 0.48999999999999999 114.461 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.5 ptp180 -145.27 -48.13 0.23 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.701 1.371 . . . . 2.1099999999999999 114.701 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 7.4 p -80.22 81.47 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-O 122.992 1.377 . . . . 1.04 108.064 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 106' ' ' ASN . 19.8 m80 -102.91 126.98 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.24 -2.254 . . . . 0.34000000000000002 112.343 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.905 ' CD1' HG21 ' A' ' 105' ' ' ILE . 80.5 m-85 -70.01 125.42 26.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 120.168 -0.613 . . . . 2.1600000000000001 109.701 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.472 HG21 ' CE1' ' A' ' 38' ' ' TYR . 2.4 p -76.14 32.94 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.204 -0.907 . . . . 1.0900000000000001 112.027 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.8 m -148.46 132.51 17.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 1.71 111.216 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -91.72 4.9 51.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 2.4700000000000002 110.585 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.04 66.29 1.2 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.135 -0.691 . . . . 2.1400000000000001 109.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 100' ' ' SER . 8.5 mp -57.72 -31.76 66.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.888 . . . . 1.99 111.425 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.99 2.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.291 0.478 . . . . 2.4900000000000002 112.291 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 98' ' ' LEU . 5.4 t -89.97 -0.03 57.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.761 -0.654 . . . . 1.8999999999999999 110.619 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.457 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.89 -14.01 41.28 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.055 -0.593 . . . . 0.40999999999999998 112.834 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.02 108.03 20.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 110.853 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -111.62 19.99 17.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.104 0.409 . . . . 1.1200000000000001 112.104 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.0 m -60.04 143.78 51.11 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.006 1.484 . . . . 1.46 115.006 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.905 HG21 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -129.67 133.26 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.735 -1.12 . . . . 1.0900000000000001 111.252 178.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.764 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 2.9 t-20 -102.84 157.33 17.04 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.022 -1.103 . . . . 1.5600000000000001 108.022 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.898 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -114.81 117.38 55.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.988 0.423 . . . . 1.0600000000000001 111.456 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.64 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.03 143.01 31.85 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.48 -0.782 . . . . 1.0700000000000001 110.556 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 8.7 t-20 48.88 58.31 5.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.958 -0.565 . . . . 1.9399999999999999 111.826 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.415 HD21 ' HB ' ' A' ' 107' ' ' VAL . 19.1 mt -47.27 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.754 1.02 . . . . 1.21 113.754 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.432 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 54.1 tt0 -56.58 145.57 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.983 -0.553 . . . . 2.6699999999999999 110.793 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 62.5 tp -60.03 -40.0 87.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 2.2400000000000002 111.127 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -73.51 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.939 -0.573 . . . . 1.8300000000000001 111.632 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.98 -18.08 63.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 1.5800000000000001 109.881 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.74 140.66 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.976 -0.556 . . . . 1.1399999999999999 110.235 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.8 159.14 7.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.9 -1.143 . . . . 0.26000000000000001 113.951 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.8 m -58.99 139.33 56.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.062 -0.569 . . . . 1.0700000000000001 112.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 29.9 m-85 -119.98 130.87 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.514 . . . . 2.1400000000000001 109.888 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -122.05 119.83 32.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.148 -0.221 . . . . 1.5900000000000001 110.662 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.546 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 39.5 t -100.15 120.01 39.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.468 -0.333 . . . . 1.03 110.76 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.5 mtpt -114.14 104.83 12.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.377 . . . . 2.1899999999999999 110.842 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.541 HG11 ' CD1' ' A' ' 43' ' ' PHE . 73.8 t -87.52 108.25 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.197 -1.038 . . . . 1.8200000000000001 108.197 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 83.4 tttt -97.78 110.87 23.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.423 0.897 . . . . 2.1899999999999999 113.423 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.593 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 34.8 tttp -145.61 101.56 3.58 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.545 -0.539 . . . . 3.2799999999999998 109.545 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -52.79 132.18 47.62 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 1.1799999999999999 112.332 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.552 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 60.7 Cg_endo -100.62 49.76 1.75 Allowed 'Cis proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.614 -0.994 . . . . 0.62 112.185 -0.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.99 103.3 0.29 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.303 -0.951 . . . . 0.53000000000000003 113.438 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.85 120.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.288 -0.956 . . . . 1.8700000000000001 110.203 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 22' ' ' ILE . . . -95.45 144.68 25.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 1.3200000000000001 111.359 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 1.4 m-80 -145.72 129.89 17.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.651 0.611 . . . . 2.0299999999999998 112.651 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.769 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.84 159.95 42.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.438 -0.346 . . . . 3.46 110.941 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.5 mttt -110.5 146.92 35.14 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.496 0.925 . . . . 2.6699999999999999 113.496 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 88.7 mt -143.39 118.97 4.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.266 -0.879 . . . . 1.0600000000000001 109.535 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.459 ' CD2' HG21 ' A' ' 117' ' ' THR . 64.2 m170 -100.9 113.22 25.98 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.91 -0.494 . . . . 0.70999999999999996 110.406 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.435 ' CB ' ' CE1' ' A' ' 118' ' ' TYR . 1.9 tm? -91.56 128.91 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.253 0.464 . . . . 2.1000000000000001 112.253 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.57 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.6 t -121.53 129.96 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.689 . . . . 1.0900000000000001 109.297 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.0 t -103.06 119.96 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.209 0.448 . . . . 1.72 112.209 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.2 mt -84.51 172.13 11.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 1.21 109.089 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.63 . . . . 2.0899999999999999 111.664 -178.498 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.812 0.339 . . . . 2.2599999999999998 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 42' ' ' LYS . 13.3 tt -130.01 129.93 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 2.6299999999999999 110.558 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -89.39 153.84 20.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.352 0.596 . . . . 1.6499999999999999 111.259 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.508 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 44.33 82.96 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.92 -1.037 . . . . 1.26 111.004 -177.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.1 Cg_endo -78.55 -86.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.619 2.879 . . . . 0.88 113.207 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.5 tt0 -77.85 123.09 26.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.222 -0.659 . . . . 2.0600000000000001 109.222 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.8 tp10 -143.91 159.96 41.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.446 0.906 . . . . 1.71 113.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 26.0 mtt -132.35 130.01 40.17 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.264 -0.88 . . . . 2.3999999999999999 109.918 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.2 mm -127.57 133.82 66.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.643 0.259 . . . . 1.1499999999999999 111.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.645 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.9 mt-10 -123.77 125.73 45.24 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.498 -0.319 . . . . 1.1899999999999999 110.842 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HB2' HD11 ' A' ' 110' ' ' LEU . 10.4 mmtp -142.35 160.01 41.1 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.408 . . . . 2.9300000000000002 111.713 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.82 139.23 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 1.1299999999999999 111.522 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 112' ' ' LEU . 85.5 tttt -49.24 134.87 17.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.858 0.361 . . . . 2.7599999999999998 111.356 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.52 -21.33 22.44 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.138 -0.553 . . . . 0.32000000000000001 112.776 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 80.7 mm-40 -79.98 159.83 26.13 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.32 -0.993 . . . . 2.1099999999999999 108.32 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.859 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.4 m -87.28 126.78 35.05 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.42 -0.912 . . . . 1.0800000000000001 110.484 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -98.74 117.62 33.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 1.0700000000000001 110.162 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.528 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 74.0 t80 -79.13 115.27 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 2.3199999999999998 112.038 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.45 104.76 32.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.961 -0.755 . . . . 1.47 108.961 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.657 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.6 Cg_endo -81.94 125.61 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.38 2.053 . . . . 0.71999999999999997 113.819 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.0 t -140.39 131.25 25.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.833 -1.173 . . . . 1.03 107.833 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 39.4 mttm -140.67 150.59 43.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 2.2400000000000002 111.183 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CE2' HD11 ' A' ' 53' ' ' LEU . 40.6 p90 -140.35 142.04 35.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.642 -0.708 . . . . 2.1499999999999999 111.133 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -82.3 135.48 35.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.989 -0.551 . . . . 1.9299999999999999 111.665 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 99' ' ' LYS . 83.8 mt -97.74 140.06 32.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 2.5899999999999999 111.762 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 t -159.19 143.21 11.07 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.835 -0.621 . . . . 2.1299999999999999 109.814 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -41.32 -26.72 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.735 2.29 . . . . 1.9299999999999999 113.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.82 -50.58 16.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.681 0.277 . . . . 2.1800000000000002 110.53 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB2' ' CG ' ' A' ' 124' ' ' LYS . 4.4 p-10 -74.59 64.25 1.18 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.174 0.512 . . . . 2.4100000000000001 110.047 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -102.46 2.59 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.479 -0.782 . . . . 1.96 112.556 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -73.34 169.53 53.11 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.231 -0.985 . . . . 0.56000000000000005 112.94 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.6 121.96 10.44 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.591 2.194 . . . . 1.1899999999999999 111.563 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.4 tt -78.29 120.62 23.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.151 -0.477 . . . . 2.4100000000000001 111.937 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.05 103.45 4.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.373 0.606 . . . . 1.78 111.484 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 67.8 mt -98.94 108.45 22.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 1.4099999999999999 111.103 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -100.62 121.17 41.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.765 0.654 . . . . 1.6699999999999999 112.765 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.678 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 76.5 m95 -95.33 126.57 40.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.23999999999999999 109.926 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 88.7 mt -112.9 141.81 46.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.702 -0.481 . . . . 1.1200000000000001 109.702 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.5 tt -129.99 129.95 65.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.036 0.446 . . . . 1.3700000000000001 111.793 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 14.3 m -120.23 102.01 46.35 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 109.015 -0.735 . . . . 1.73 109.015 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.4 Cg_exo -80.02 114.78 3.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.52 2.146 . . . . 0.84999999999999998 112.92 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.64 73.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 1.0700000000000001 110.714 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -86.29 17.2 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 1.8200000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.8 m-20 -149.86 163.66 37.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.265 0.555 . . . . 2.3599999999999999 111.68 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.49 -18.84 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.28 -0.873 . . . . 1.95 112.094 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 92.0 mttt -68.51 144.79 54.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.204 -0.453 . . . . 2.2799999999999998 111.798 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.67 127.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 121.837 0.827 . . . . 1.4199999999999999 109.636 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 52.88 39.93 29.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.089 -1.414 . . . . 1.77 112.046 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -91.09 145.61 24.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.521 -0.309 . . . . 2.54 110.961 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 84' ' ' TYR . 11.6 t -65.91 138.94 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 108.978 -0.749 . . . . 1.3899999999999999 108.978 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.806 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -132.97 -52.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 112.577 0.584 . . . . 1.8200000000000001 112.577 -176.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.784 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.99 129.95 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.646 -0.872 . . . . 1.0800000000000001 108.646 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 55' ' ' ILE . 7.7 tp -140.41 157.51 45.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.865 0.364 . . . . 1.8799999999999999 111.467 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.474 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 41.2 t80 -131.3 103.64 6.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 2.2000000000000002 110.165 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.49 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 41.4 t -144.12 159.78 42.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.661 0.615 . . . . 1.4199999999999999 112.661 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.13 33.46 5.45 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.838 -0.619 . . . . 0.56999999999999995 113.26 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t0 70.02 3.26 4.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.604 0.24 . . . . 1.46 111.095 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 21.4 mttm -100.46 116.54 32.65 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.108 -0.331 . . . . 2.96 110.108 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.414 HG22 ' CE2' ' A' ' 93' ' ' PHE . 3.2 mm -80.71 130.03 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.174 -1.417 . . . . 2.27 107.174 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.735 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -117.1 121.59 41.72 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.542 -0.754 . . . . 2.1499999999999999 110.822 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.859 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.5 p-10 -165.82 -52.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.324 -1.361 . . . . 1.2 107.324 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -81.38 -24.14 37.2 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.03 -0.986 . . . . 2.1699999999999999 109.31 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.93 -26.03 43.66 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.859 -1.064 . . . . 5.4100000000000001 108.139 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.654 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.8 m-85 -86.37 119.68 71.68 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 114.791 -1.095 . . . . 2.21 110.941 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.78 -41.96 52.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.365 1.377 . . . . 1.1100000000000001 109.93 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.696 ' O ' HG12 ' A' ' 71' ' ' ILE . 63.3 m-20 -67.58 105.6 1.92 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.844 -0.616 . . . . 1.3600000000000001 110.671 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.816 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.6 mt 68.4 26.79 6.59 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.448 0.907 . . . . 2.2400000000000002 113.448 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.859 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 129.88 43.97 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.78 -0.575 . . . . 2.8700000000000001 111.477 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.403 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.94 17.91 60.53 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.485 -0.864 . . . . 0.48999999999999999 114.108 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.7 ptp180 -143.96 -47.92 0.28 Allowed 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 114.448 1.277 . . . . 2.1099999999999999 114.448 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.806 HG11 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.8 81.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 123.109 1.433 . . . . 1.04 107.621 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.403 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 16.8 m80 -102.07 128.72 48.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 112.15 -2.295 . . . . 0.34000000000000002 112.363 -175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 68.0 m-85 -71.99 120.03 17.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.273 0.559 . . . . 2.1600000000000001 109.679 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 22.1 p -70.29 -9.97 57.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.21 -0.904 . . . . 1.0900000000000001 110.347 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.5 m -89.01 117.42 28.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.775 -0.648 . . . . 1.71 110.625 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -89.95 4.82 48.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.566 0.698 . . . . 2.4700000000000002 109.798 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' SER . 34.0 p-10 -146.28 66.46 1.19 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.979 -1.119 . . . . 2.1400000000000001 107.979 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 100' ' ' SER . 5.7 mp -59.49 -38.94 82.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.215 -0.902 . . . . 1.99 111.599 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 45' ' ' LEU . 60.5 mtpt -63.21 0.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.361 0.504 . . . . 2.4900000000000002 112.361 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' LEU . 29.3 m -92.97 -1.12 56.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.879 -0.6 . . . . 1.8999999999999999 110.845 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.496 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.51 -18.75 29.67 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.692 -0.766 . . . . 0.40999999999999998 113.725 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -99.21 107.95 20.4 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 117.37 0.585 . . . . 1.4399999999999999 109.829 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.76 23.37 12.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.457 0.91 . . . . 1.1200000000000001 113.457 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 80.1 p -60.41 147.84 39.43 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.736 1.384 . . . . 1.46 114.736 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -130.22 133.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 114.53 -1.213 . . . . 1.0900000000000001 111.015 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.5 p30 -109.21 144.36 37.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.437 -0.949 . . . . 1.5600000000000001 108.437 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.95 120.6 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.067 0.461 . . . . 1.0600000000000001 111.885 -177.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.62 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -81.09 144.43 31.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.316 -0.856 . . . . 1.0700000000000001 110.721 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.68 54.53 11.03 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.177 -0.465 . . . . 1.9399999999999999 111.627 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 31' ' ' LYS . 16.8 mt -42.86 90.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.968 1.099 . . . . 1.21 113.968 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.463 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 72.7 mt-30 -59.43 140.6 56.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.909 -0.587 . . . . 2.6699999999999999 110.829 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 60.1 tp -60.01 -34.09 72.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.021 -0.733 . . . . 2.2400000000000002 109.021 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.402 ' HB3' HD22 ' A' ' 64' ' ' ASN . 74.8 m -74.75 -12.43 60.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.271 -0.877 . . . . 1.8300000000000001 111.338 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 96.5 m-20 -73.43 -16.56 61.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.755 0.312 . . . . 1.5800000000000001 110.19 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.705 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.37 139.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 116.137 -0.483 . . . . 1.1399999999999999 110.314 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.13 162.22 9.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 119.982 -1.104 . . . . 0.26000000000000001 113.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 71.4 m -59.6 137.77 57.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.141 0.577 . . . . 1.0700000000000001 112.482 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 135' ' ' LEU . 21.0 m-85 -120.02 130.26 54.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.153 -0.684 . . . . 2.1400000000000001 109.153 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.6 tt0 -121.76 118.63 29.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 1.5900000000000001 111.29 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 26.5 t -102.4 110.8 22.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 1.03 110.562 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.5 mtpt -106.62 104.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.82 -0.352 . . . . 2.1899999999999999 110.23 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.633 ' HA ' HG12 ' A' ' 55' ' ' ILE . 62.8 t -88.07 109.92 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.637 -0.505 . . . . 1.8200000000000001 109.637 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.9 tttm -96.46 119.5 35.06 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.326 -0.55 . . . . 2.1899999999999999 112.064 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 49.2 tptt -145.59 101.42 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.648 -0.871 . . . . 3.2799999999999998 108.648 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.563 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -53.61 134.02 54.78 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 112.455 0.539 . . . . 1.1799999999999999 112.455 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.7 Cg_endo -99.61 50.47 1.65 Allowed 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.695 -0.96 . . . . 0.62 111.705 -0.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.87 103.2 0.28 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.284 -0.96 . . . . 0.53000000000000003 113.413 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.51 140.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.607 -0.797 . . . . 1.8700000000000001 109.802 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -130.09 149.94 51.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 1.3200000000000001 111.707 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 45.8 t30 -146.81 142.06 27.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.695 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.61 150.29 37.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 3.46 111.01 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -98.26 140.13 33.02 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.447 0.906 . . . . 2.6699999999999999 113.447 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.579 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.8 mt -143.58 113.57 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.266 -0.879 . . . . 1.0600000000000001 109.339 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 117' ' ' THR . 57.3 m170 -100.45 117.39 34.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.672 -0.411 . . . . 0.70999999999999996 110.554 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 12.8 mt -94.41 119.96 33.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.487 0.551 . . . . 2.1000000000000001 112.487 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.645 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 21.6 t -111.93 119.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.146 -1.057 . . . . 1.0900000000000001 108.146 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 59.5 t -100.47 122.99 53.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.187 0.518 . . . . 1.72 112.181 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.87 162.77 23.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.485 -0.78 . . . . 1.21 109.038 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 122.168 0.985 . . . . 2.0899999999999999 111.75 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.427 ' HB2' HG21 ' A' ' 44' ' ' THR . 53.7 m . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.251 0.548 . . . . 2.2599999999999998 111.468 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.93 133.39 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.833 . . . . 2.6299999999999999 109.596 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 79.6 p -88.81 150.3 22.99 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.733 0.778 . . . . 1.6499999999999999 111.914 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.07 82.99 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 114.524 -1.216 . . . . 1.26 111.983 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.1 Cg_endo -78.57 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.675 2.917 . . . . 0.88 112.107 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.32 127.46 32.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.352 -0.981 . . . . 2.0600000000000001 108.352 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 132' ' ' LYS . 83.6 tt0 -143.94 158.67 43.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.278 1.214 . . . . 1.71 114.278 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 42.0 mtt -139.95 121.86 15.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.5 -1.227 . . . . 2.3999999999999999 109.13 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.9 mm -120.0 122.08 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 1.1499999999999999 111.519 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.617 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 42.8 mt-10 -112.1 120.06 40.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.472 . . . . 1.1899999999999999 110.81 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 73.2 mmtt -141.23 150.45 42.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.824 0.345 . . . . 2.9300000000000002 111.744 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.02 143.74 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.311 -0.404 . . . . 1.1299999999999999 111.496 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.72 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 43.2 mtmt -42.88 156.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.255 0.55 . . . . 2.7599999999999998 112.396 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.09 -23.38 0.45 Allowed Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.287 -0.87 . . . . 0.32000000000000001 114.201 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 33' ' ' LYS . 99.3 mt-10 -79.96 156.2 27.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.544 -0.539 . . . . 2.1099999999999999 109.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.967 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -85.22 134.52 34.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.338 -0.545 . . . . 1.0800000000000001 109.582 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.762 ' CB ' HG13 ' A' ' 107' ' ' VAL . . . -100.21 110.83 23.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.347 -0.541 . . . . 1.0700000000000001 111.213 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 92.7 t80 -79.17 122.2 25.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 2.3199999999999998 111.618 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 104' ' ' SER . 25.3 mt -118.15 104.34 48.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.429 -0.582 . . . . 1.47 109.429 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.475 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.7 Cg_endo -82.99 133.03 6.47 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.587 2.191 . . . . 0.71999999999999997 114.778 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.419 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 55.8 m -141.42 104.03 4.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.374 -0.83 . . . . 1.03 110.105 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 10.6 mmtt -102.26 107.71 18.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.224 -0.288 . . . . 2.2400000000000002 110.224 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.541 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 42.5 p90 -93.78 142.72 27.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.355 . . . . 2.1499999999999999 110.785 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 21' ' ' SER . 9.0 t -79.98 174.24 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.419 0.628 . . . . 1.9299999999999999 111.627 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.2 mt -142.27 149.8 40.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.924 -1.034 . . . . 2.5899999999999999 109.96 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.8 t -158.69 147.02 13.92 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.763 0.316 . . . . 2.1299999999999999 110.886 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.0 Cg_exo -47.37 -26.67 6.14 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.419 2.079 . . . . 1.9299999999999999 112.188 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -77.59 -43.85 30.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.417 -0.356 . . . . 2.1800000000000002 110.694 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.586 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 67.6 m-20 -71.98 74.24 0.9 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.435 -0.58 . . . . 2.4100000000000001 109.435 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 55.5 mm-40 -94.04 -5.09 48.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.35 -0.841 . . . . 1.96 111.479 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.04 159.93 53.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.363 -0.923 . . . . 0.56000000000000005 112.136 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.43 149.1 31.34 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.526 2.151 . . . . 1.1899999999999999 112.081 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 43' ' ' PHE . 3.1 tt -77.81 133.47 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 2.4100000000000001 110.345 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 10.9 t70 -140.18 152.37 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.454 0.645 . . . . 1.78 112.012 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 31.5 mt -142.8 139.99 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.687 -1.142 . . . . 1.4099999999999999 109.515 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HA ' HD23 ' A' ' 73' ' ' LEU . 45.3 mt-10 -140.36 111.66 7.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.337 0.495 . . . . 1.6699999999999999 112.337 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.815 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 77.3 m95 -100.03 119.96 39.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.497 -0.319 . . . . 0.23999999999999999 111.026 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.736 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -106.05 124.33 49.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.597 -0.519 . . . . 1.1200000000000001 109.597 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.506 ' CG2' ' HB ' ' A' ' 71' ' ' ILE . 14.5 tt -109.88 126.34 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.892 0.701 . . . . 1.3700000000000001 112.892 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 50.2 m -119.98 102.04 46.96 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 108.711 -0.848 . . . . 1.73 108.711 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.607 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 96.0 Cg_endo -79.7 117.13 3.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.84 2.36 . . . . 0.84999999999999998 112.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.76 90.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.861 -0.609 . . . . 1.0700000000000001 111.496 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.29 -40.0 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.638 . . . . 1.8200000000000001 112.429 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.568 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 86.6 m-20 -81.59 161.14 23.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.3599999999999999 112.329 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -69.48 -18.36 63.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.936 -1.029 . . . . 1.95 111.295 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.8 mttp -69.29 151.75 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.741 -0.663 . . . . 2.2799999999999998 111.125 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -156.45 135.37 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.55 1.166 . . . . 1.4199999999999999 110.103 178.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 43.83 42.39 4.43 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.564 -2.107 . . . . 1.77 112.797 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -96.47 150.87 20.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.653 -0.249 . . . . 2.54 111.158 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.504 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 20.7 t -66.38 129.43 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 109.696 -0.483 . . . . 1.3899999999999999 109.696 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.872 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -116.9 -56.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 1.8200000000000001 112.58 -177.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.789 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.28 128.91 49.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.821 -0.807 . . . . 1.0800000000000001 108.821 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 56' ' ' GLU . 5.8 mt -134.96 160.0 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.468 0.651 . . . . 1.8799999999999999 111.701 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 41.3 t80 -135.25 103.33 5.48 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.567 -1.272 . . . . 2.2000000000000002 107.567 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.51 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 2.3 t -143.15 155.59 44.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.87 -0.604 . . . . 1.4199999999999999 111.854 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.95 29.47 6.41 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 113.044 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 73.54 2.94 4.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.508 0.194 . . . . 1.46 111.388 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 118.56 36.65 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.976 -0.379 . . . . 2.96 109.976 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 93' ' ' PHE . 2.8 mm -80.79 130.84 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.307 -1.368 . . . . 2.27 107.307 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -119.92 120.86 37.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.381 -0.827 . . . . 2.1499999999999999 110.288 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.828 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.8 p-10 -165.82 -48.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.663 -1.236 . . . . 1.2 107.663 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.61 -32.09 47.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.019 -0.991 . . . . 2.1699999999999999 109.185 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -76.18 -28.71 57.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.024 -0.989 . . . . 5.4100000000000001 108.647 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -81.01 117.39 67.88 Favored Pre-proline 0 CA--C 1.514 -0.431 0 CA-C-N 114.911 -1.041 . . . . 2.21 110.675 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.7 -40.06 56.41 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.508 1.472 . . . . 1.1100000000000001 110.117 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.675 ' O ' HG12 ' A' ' 71' ' ' ILE . 5.2 m-20 -67.01 106.37 1.92 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.093 -0.643 . . . . 1.3600000000000001 110.521 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.815 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.5 mt 65.81 28.44 10.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.597 0.962 . . . . 2.2400000000000002 113.597 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 17.8 pttt -56.58 131.32 48.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.395 -0.522 . . . . 2.8700000000000001 111.159 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 83.39 18.11 65.07 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.435 -0.888 . . . . 0.48999999999999999 114.501 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.815 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -145.96 -46.25 0.2 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 114.326 1.232 . . . . 2.1099999999999999 114.326 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.872 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.38 82.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 123.099 1.428 . . . . 1.04 107.274 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.4 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 15.5 m80 -103.38 129.83 50.55 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 112.426 -2.17 . . . . 0.34000000000000002 112.471 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' ' 104' ' ' SER . 63.3 m-85 -71.32 120.38 16.82 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.322 -0.622 . . . . 2.1600000000000001 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 16.6 p -73.03 36.76 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.042 -0.981 . . . . 1.0900000000000001 113.575 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -149.36 136.0 19.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.388 0.613 . . . . 1.71 111.404 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.04 6.74 46.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 2.4700000000000002 110.372 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -145.62 65.9 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.444 -0.947 . . . . 2.1400000000000001 108.444 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.528 HD11 ' CG ' ' A' ' 74' ' ' TYR . 8.2 tt -59.47 -38.44 80.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.632 -1.167 . . . . 1.99 111.641 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.5 1.47 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.391 0.515 . . . . 2.4900000000000002 112.391 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 98' ' ' LEU . 50.6 m -89.99 -0.01 57.34 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 1.8999999999999999 111.151 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.541 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 108.55 -1.91 32.46 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.844 -0.693 . . . . 0.40999999999999998 113.023 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 96.5 m-20 -100.26 108.7 20.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.729 0.299 . . . . 1.4399999999999999 110.672 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -108.78 5.95 25.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.132 -0.485 . . . . 1.1200000000000001 111.558 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 1.3 m -59.68 140.0 56.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.667 1.728 . . . . 1.46 115.667 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.24 135.16 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 114.0 -1.455 . . . . 1.0900000000000001 109.549 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 41.9 p-10 -113.46 148.95 34.98 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.951 -0.759 . . . . 1.5600000000000001 108.951 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.967 ' O ' ' HA ' ' A' ' 36' ' ' THR . 7.5 p -95.76 123.79 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 N-CA-C 113.455 0.909 . . . . 1.0600000000000001 113.455 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.645 ' HA ' HG23 ' A' ' 36' ' ' THR . 1.3 p -84.81 141.65 30.33 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.386 -1.734 . . . . 1.0700000000000001 111.372 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 53.12 60.56 3.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.486 -0.779 . . . . 1.9399999999999999 112.668 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.42 ' HG ' HG12 ' A' ' 107' ' ' VAL . 10.0 mt -46.19 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.041 0.448 . . . . 1.21 112.059 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.41 ' NE2' ' OG ' ' A' ' 113' ' ' SER . 12.0 pt20 -177.24 164.06 2.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.839 -0.618 . . . . 2.6699999999999999 110.347 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.72 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 79.4 mt -59.92 -36.73 77.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.806 0.336 . . . . 2.2400000000000002 111.531 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.41 ' OG ' ' NE2' ' A' ' 111' ' ' GLN . 70.5 p -73.29 -15.85 61.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.388 -0.369 . . . . 1.8300000000000001 111.97 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 89.1 m-20 -72.99 -20.07 61.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.622 -0.431 . . . . 1.5800000000000001 110.005 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -47.12 144.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.114 -0.494 . . . . 1.1399999999999999 110.947 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.84 150.73 5.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.564 -1.303 . . . . 0.26000000000000001 114.115 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.41 HG22 ' CD2' ' A' ' 134' ' ' HIS . 95.6 m -59.27 129.97 44.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.024 -0.588 . . . . 1.0700000000000001 111.965 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 22.9 m-85 -110.21 129.92 55.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.808 . . . . 2.1400000000000001 108.82 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.815 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -114.72 113.04 23.77 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.88 -0.415 . . . . 1.5900000000000001 109.88 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 7.3 t -100.01 109.36 21.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.965 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.523 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 45.0 mttt -120.4 109.97 15.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 2.1899999999999999 111.836 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 45.4 t -94.6 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.8200000000000001 109.448 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 43.2 tttm -98.67 122.88 42.45 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.994 -0.682 . . . . 2.1899999999999999 112.732 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 127' ' ' GLY . 28.5 tttp -144.63 102.36 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.314 -0.625 . . . . 3.2799999999999998 109.314 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -50.84 133.32 28.65 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 113.226 0.824 . . . . 1.1799999999999999 113.226 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.586 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 97.4 Cg_endo -98.43 36.87 6.58 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.439 -1.067 . . . . 0.62 111.753 -1.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -135.62 102.89 0.43 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-O 122.06 0.811 . . . . 0.53000000000000003 112.664 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.5 p -90.0 160.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.165 -1.017 . . . . 1.8700000000000001 109.984 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.459 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -139.36 149.32 44.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.336 . . . . 1.3200000000000001 111.673 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 37.9 p-10 -146.42 137.25 24.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.862 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.545 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.6 ptmt -145.96 155.11 42.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 3.46 110.636 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 24.1 mttt -103.45 140.07 37.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.148 0.796 . . . . 2.6699999999999999 113.148 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 87.2 mt -142.22 119.21 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.529 -0.76 . . . . 1.0600000000000001 109.225 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.41 ' CD2' HG22 ' A' ' 117' ' ' THR . 59.3 m170 -102.91 119.99 39.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.954 -0.299 . . . . 0.70999999999999996 110.547 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -89.82 120.03 30.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.428 -0.509 . . . . 2.1000000000000001 110.936 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.617 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 48.6 t -116.28 121.36 67.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.391 -0.822 . . . . 1.0900000000000001 109.27 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 14.8 p -94.92 128.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.885 0.374 . . . . 1.72 111.974 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 94.2 mt -83.53 152.8 24.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.525 -0.546 . . . . 1.21 109.525 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.778 0.799 . . . . 2.0899999999999999 112.038 -178.229 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.024 0.44 . . . . 2.2599999999999998 111.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 131' ' ' LYS . 2.4 pp -91.54 149.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 2.6299999999999999 111.144 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.17 158.22 19.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.326 0.584 . . . . 1.6499999999999999 110.892 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.464 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 44.89 83.82 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.018 -0.992 . . . . 1.26 111.098 -177.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 58.4 Cg_endo -78.19 -84.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.611 2.874 . . . . 0.88 113.498 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.1 tt0 -77.82 122.13 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.17 -0.612 . . . . 2.0600000000000001 109.362 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.9 tp10 -143.9 160.65 40.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.418 0.896 . . . . 1.71 113.418 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.427 ' HG3' ' HB2' ' A' ' 134' ' ' HIS . 54.1 ttm -134.56 134.33 41.24 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.067 -0.97 . . . . 2.3999999999999999 109.478 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 HG12 HG21 ' A' ' 133' ' ' ILE . 32.8 mm -129.94 129.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.949 -0.569 . . . . 1.1499999999999999 111.494 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.61 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 98.2 mt-10 -118.36 125.1 49.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.384 -0.371 . . . . 1.1899999999999999 110.695 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.626 ' HB2' HD11 ' A' ' 110' ' ' LEU . 61.0 mmtt -141.97 158.05 44.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.638 0.256 . . . . 2.9300000000000002 111.315 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.06 143.38 39.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.1299999999999999 111.69 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.812 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 39.6 ttmt -48.51 136.36 13.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 2.7599999999999998 111.609 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 82.46 -18.42 14.68 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.997 -0.62 . . . . 0.32000000000000001 113.119 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 80.9 mm-40 -79.99 158.97 26.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.712 -0.847 . . . . 2.1099999999999999 108.712 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 m -87.28 129.8 34.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.476 -0.89 . . . . 1.0800000000000001 109.982 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -100.04 114.92 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.807 0.337 . . . . 1.0700000000000001 110.504 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.504 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 40.8 t80 -79.35 120.77 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.849 -0.614 . . . . 2.3199999999999998 112.454 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB3' HD13 ' A' ' 133' ' ' ILE . 4.4 mp -115.28 104.76 53.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.619 -0.882 . . . . 1.47 108.619 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 88.8 Cg_endo -86.43 104.49 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.328 2.019 . . . . 0.71999999999999997 114.929 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.453 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -98.51 135.51 39.95 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 176.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 45.5 tptt -140.03 139.99 36.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.741 0.305 . . . . 2.2400000000000002 110.527 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.59 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -140.16 139.76 35.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 2.1499999999999999 111.413 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.14 126.39 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 1.9299999999999999 110.775 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.4 mt -89.09 149.95 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 2.5899999999999999 110.834 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.8 m -151.32 144.09 16.73 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.486 -0.324 . . . . 2.1299999999999999 110.133 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.18 -23.57 9.89 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.579 2.186 . . . . 1.9299999999999999 112.086 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 16.7 pt-20 -77.29 -43.66 32.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.194 -0.457 . . . . 2.1800000000000002 111.05 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -75.59 76.32 2.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.936 -0.705 . . . . 2.4100000000000001 109.287 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.51 -3.52 52.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.352 -0.84 . . . . 1.96 111.901 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.561 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.03 160.06 53.33 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.691 -0.766 . . . . 0.56000000000000005 113.024 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.61 136.56 76.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.632 2.222 . . . . 1.1899999999999999 111.675 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 6.6 mp -78.0 119.05 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.301 -0.409 . . . . 2.4100000000000001 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -133.01 102.17 5.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.535 0.683 . . . . 1.78 111.033 178.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.826 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.39 105.91 17.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.761 -1.109 . . . . 1.4099999999999999 110.874 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -100.93 117.66 35.41 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.62 0.6 . . . . 1.6699999999999999 112.62 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.682 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 72.3 m95 -94.06 120.01 33.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.133 -0.321 . . . . 0.23999999999999999 110.133 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.5 mt -105.91 146.86 29.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.866 -0.42 . . . . 1.1200000000000001 109.866 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.157 0.429 . . . . 1.3700000000000001 112.157 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.447 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 37.4 m -119.99 102.16 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.631 -0.877 . . . . 1.73 108.631 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 91.9 Cg_endo -78.96 114.97 3.48 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.775 2.317 . . . . 0.84999999999999998 113.533 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.18 82.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.352 -0.84 . . . . 1.0700000000000001 110.614 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -85.93 16.52 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.534 -0.757 . . . . 1.8200000000000001 112.078 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 81.0 m-20 -148.72 161.0 42.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.376 0.608 . . . . 2.3599999999999999 112.011 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.94 -19.76 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.058 -0.974 . . . . 1.95 112.507 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 43.6 mttt -69.1 153.05 44.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.825 0.345 . . . . 2.2799999999999998 111.536 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.36 128.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.716 0.77 . . . . 1.4199999999999999 109.468 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.17 45.18 27.94 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.346 -1.297 . . . . 1.77 112.088 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 136.4 33.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.677 0.275 . . . . 2.54 111.089 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG13 ' CE1' ' A' ' 84' ' ' TYR . 57.2 t -70.51 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 110.154 -0.313 . . . . 1.3899999999999999 110.154 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.756 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.5 pp -131.76 -38.85 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.808 0.67 . . . . 1.8200000000000001 112.808 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.838 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -141.31 123.85 14.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.175 0.512 . . . . 1.0800000000000001 110.092 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.5 tt -140.38 163.55 32.49 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 116.019 -0.537 . . . . 1.8799999999999999 109.799 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 23.3 t80 -135.31 109.94 8.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.206 0.527 . . . . 2.2000000000000002 110.477 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.3 t -142.61 159.99 41.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.249 -0.887 . . . . 1.4199999999999999 111.474 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.32 55.48 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.564 -0.827 . . . . 0.56999999999999995 112.152 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 74.14 2.83 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.845 -0.178 . . . . 1.46 111.241 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 6.0 mmtm -105.36 118.52 36.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.811 -0.441 . . . . 2.96 109.811 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.591 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.73 119.99 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.617 -1.253 . . . . 2.27 107.617 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.838 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -100.01 132.53 45.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.83 -1.077 . . . . 2.1499999999999999 110.728 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.8 p-10 -166.32 -58.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.796 -1.557 . . . . 1.2 106.796 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 33.6 p-10 -80.1 -22.01 42.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.565 -1.198 . . . . 2.1699999999999999 109.731 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.539 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -76.85 -29.8 56.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.85 -1.167 . . . . 5.4100000000000001 107.85 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -85.18 118.3 70.54 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 114.452 -1.249 . . . . 2.21 110.263 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -41.0 51.93 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.346 1.364 . . . . 1.1100000000000001 110.447 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 89.1 m-20 -68.19 104.87 1.92 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.771 -0.65 . . . . 1.3600000000000001 111.091 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 34.3 mt 70.4 22.37 5.31 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.295 0.85 . . . . 2.2400000000000002 113.295 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 21.6 pttp -58.17 136.9 57.34 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.843 -0.536 . . . . 2.8700000000000001 111.05 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.517 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 86.64 9.57 74.81 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.249 -0.977 . . . . 0.48999999999999999 114.176 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -137.99 -54.61 0.65 Allowed 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 114.754 1.39 . . . . 2.1099999999999999 114.754 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 71' ' ' ILE . 7.4 p -78.28 81.28 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 N-CA-C 107.088 -1.449 . . . . 1.04 107.088 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.517 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 6.7 m80 -100.06 129.43 46.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.163 -2.289 . . . . 0.34000000000000002 112.589 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.734 ' HA ' ' O ' ' A' ' 104' ' ' SER . 82.3 m-85 -70.37 121.17 17.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 120.231 -0.588 . . . . 2.1600000000000001 110.054 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.504 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 35.0 p -71.4 -10.67 60.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.93 . . . . 1.0900000000000001 110.099 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 58.1 m -95.15 120.0 34.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.726 -0.67 . . . . 1.71 110.683 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -91.34 6.08 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.927 -0.579 . . . . 2.4700000000000002 110.189 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -146.25 66.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.551 -0.907 . . . . 2.1400000000000001 108.551 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.3 -31.29 69.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 1.99 112.21 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -62.86 -4.08 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.142 0.496 . . . . 2.4900000000000002 111.91 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -89.65 -0.57 57.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.392 -0.822 . . . . 1.8999999999999999 110.89 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 110.07 -20.61 26.03 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.687 -0.768 . . . . 0.40999999999999998 113.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 82.8 m-20 -92.91 109.01 20.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.964 0.382 . . . . 1.4399999999999999 111.195 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.29 21.46 16.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 1.1200000000000001 111.102 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 82.5 p -59.98 145.89 44.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 116.03 1.863 . . . . 1.46 116.03 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.62 133.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 114.246 -1.343 . . . . 1.0900000000000001 111.27 178.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.1 p-10 -107.66 147.85 30.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.947 -1.131 . . . . 1.5600000000000001 107.947 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.75 123.9 52.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.958 0.408 . . . . 1.0600000000000001 111.79 -178.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.5 p -84.68 142.75 29.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.536 -0.756 . . . . 1.0700000000000001 110.935 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.9 m-20 49.98 55.69 9.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.996 -0.547 . . . . 1.9399999999999999 112.133 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 31' ' ' LYS . 19.8 mt -46.96 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.577 0.954 . . . . 1.21 113.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 63.7 tt0 -60.03 148.68 34.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 109.94 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.812 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 3.0 tm? -60.02 -39.99 87.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 2.2400000000000002 110.729 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.2 m -72.96 -10.04 59.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.663 . . . . 1.8300000000000001 111.611 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.434 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.95 -18.35 63.35 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.048 -0.352 . . . . 1.5800000000000001 110.048 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.7 145.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.026 0 CA-C-N 116.113 -0.494 . . . . 1.1399999999999999 110.397 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 155.79 6.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.984 -1.103 . . . . 0.26000000000000001 113.887 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 134' ' ' HIS . 95.2 m -59.36 139.01 57.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.94 0.496 . . . . 1.0700000000000001 111.808 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.0 m-85 -119.99 133.68 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.612 -0.514 . . . . 2.1400000000000001 109.612 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.618 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.3 tt0 -123.11 115.22 21.44 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.101 -0.24 . . . . 1.5900000000000001 110.843 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.3 t -99.96 112.15 24.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.011 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.826 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 98.4 mttt -110.49 106.51 15.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.627 -0.26 . . . . 2.1899999999999999 111.577 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.59 HG11 ' CG ' ' A' ' 43' ' ' PHE . 47.6 t -88.21 110.05 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.75 -0.833 . . . . 1.8200000000000001 108.75 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 61.1 tttp -96.06 120.3 36.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.869 0.692 . . . . 2.1899999999999999 112.869 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.457 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 11.0 mtmt -144.25 101.64 3.73 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.663 -0.495 . . . . 3.2799999999999998 109.663 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.561 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -53.22 132.32 51.64 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.45 -0.341 . . . . 1.1799999999999999 111.751 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 59.7 Cg_endo -100.37 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.808 -0.913 . . . . 0.62 112.366 -0.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 103.18 0.28 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.397 -0.906 . . . . 0.53000000000000003 113.141 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.4 m -87.06 142.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.221 -0.99 . . . . 1.8700000000000001 109.724 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.464 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . . . -136.03 148.11 48.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.979 -0.288 . . . . 1.3200000000000001 111.642 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 47.2 p-10 -146.61 151.67 37.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.466 0.543 . . . . 2.0299999999999998 112.466 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.29 153.51 41.36 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.154 -0.475 . . . . 3.46 110.958 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 25' ' ' PRO . 18.6 tttt -99.59 139.63 34.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.486 0.55 . . . . 2.6699999999999999 112.486 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 118' ' ' TYR . 95.2 mt -143.19 117.79 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 1.0600000000000001 109.641 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.532 ' CD2' HG22 ' A' ' 117' ' ' THR . 62.6 m170 -100.04 116.16 31.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.008 0.433 . . . . 0.70999999999999996 111.246 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 37' ' ' ALA . 1.8 tm? -89.17 125.18 34.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 2.1000000000000001 111.479 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.61 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 39.2 t -121.22 124.71 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 1.0900000000000001 109.939 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 115' ' ' ILE . 21.4 t -97.19 120.24 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 1.72 111.51 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.0 mt -80.45 160.02 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 1.21 109.686 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 2.0899999999999999 111.59 -178.732 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.944 0.402 . . . . 2.2599999999999998 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.512 ' CD1' ' HD2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 2.6299999999999999 110.719 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.643 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.0 p -93.44 156.22 16.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.575 0.702 . . . . 1.6499999999999999 111.958 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 43.06 82.41 0.23 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.698 -1.137 . . . . 1.26 112.013 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.645 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -79.3 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.775 2.983 . . . . 0.88 113.048 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 46.2 mt-10 -78.18 126.58 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.129 -0.693 . . . . 2.0600000000000001 109.129 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 132' ' ' LYS . 41.8 tt0 -144.11 159.25 42.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.405 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 16.5 mtm -140.12 116.43 10.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.629 -1.169 . . . . 2.3999999999999999 109.376 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 135' ' ' LEU . 39.2 mm -120.01 130.01 74.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 1.1499999999999999 111.553 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.63 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 35.8 mt-10 -120.59 128.06 52.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.572 -0.285 . . . . 1.1899999999999999 110.711 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 110' ' ' LEU . 51.3 tptt -142.82 158.48 43.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.687 -0.233 . . . . 2.9300000000000002 110.552 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.7 141.91 40.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.788 0.328 . . . . 1.1299999999999999 111.552 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 32.1 tttt -47.77 140.98 5.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.0 0.429 . . . . 2.7599999999999998 111.444 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 83.04 -21.95 7.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.734 -0.746 . . . . 0.32000000000000001 112.832 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.05 159.01 26.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.318 -0.993 . . . . 2.1099999999999999 108.318 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.873 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.0 m -88.13 130.0 35.15 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.546 -0.862 . . . . 1.0800000000000001 110.236 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -98.76 113.48 25.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 1.0700000000000001 110.617 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 40' ' ' PRO . 82.4 t80 -79.26 120.01 23.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.3199999999999998 112.402 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 4.5 mp -115.68 104.88 52.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 90.3 Cg_endo -85.48 104.65 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.47 2.114 . . . . 0.71999999999999997 115.914 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -102.25 131.51 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.467 -0.938 . . . . 1.03 108.467 176.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.643 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 23.0 tptm -140.69 105.08 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.042 0.449 . . . . 2.2400000000000002 110.393 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 38.6 p90 -90.95 141.89 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 2.1499999999999999 111.647 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -79.8 164.14 23.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 1.9299999999999999 110.483 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.4 mt -138.79 149.95 45.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 2.5899999999999999 111.44 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 m -157.73 148.57 16.28 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.544 -0.753 . . . . 2.1299999999999999 109.885 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.04 -23.61 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.889 2.392 . . . . 1.9299999999999999 112.979 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 85.6 tt0 -74.64 -25.92 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.518 -0.31 . . . . 2.1800000000000002 111.73 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 46' ' ' SER . 55.8 p-10 -63.54 82.69 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 121.534 0.683 . . . . 2.4100000000000001 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' GLU . 95.1 mt-30 -94.24 0.02 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 1.96 111.822 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -92.91 170.22 31.75 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.126 -1.035 . . . . 0.56000000000000005 113.087 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.02 153.03 63.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.913 2.409 . . . . 1.1899999999999999 111.86 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 tt -78.14 123.99 27.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.306 -0.406 . . . . 2.4100000000000001 110.613 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 15.3 m-20 -136.34 150.64 48.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.508 0.671 . . . . 1.78 111.494 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 25.1 mt -142.65 139.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.633 -1.167 . . . . 1.4099999999999999 109.174 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 99.2 mt-10 -140.68 116.24 10.16 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.613 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 79.2 m95 -101.79 122.85 44.73 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 121.102 -0.239 . . . . 0.23999999999999999 110.751 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.8 mt -109.19 139.87 43.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.145 -0.687 . . . . 1.1200000000000001 109.145 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 tt -130.04 130.0 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.196 0.522 . . . . 1.3700000000000001 112.245 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -120.47 102.82 44.9 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.461 -0.79 . . . . 1.73 109.11 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 97.8 Cg_endo -79.11 114.59 3.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.591 2.194 . . . . 0.84999999999999998 113.28 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.79 80.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.365 -0.834 . . . . 1.0700000000000001 110.828 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -86.15 20.69 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 1.8200000000000001 111.919 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.436 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 35.1 m120 -151.28 161.98 41.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.288 0.566 . . . . 2.3599999999999999 111.873 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.32 -19.83 64.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.287 -0.869 . . . . 1.95 112.32 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.626 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 90.8 mttt -68.51 146.4 53.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.257 -0.429 . . . . 2.2799999999999998 111.008 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -155.4 127.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 CA-C-O 121.971 0.891 . . . . 1.4199999999999999 109.994 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 54.15 39.97 31.22 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.841 -1.527 . . . . 1.77 112.582 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 66' ' ' LYS . 26.8 mt-30 -94.2 146.81 23.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 2.54 111.137 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' A' ' 73' ' ' LEU . 44.6 t -66.58 137.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.905 -0.405 . . . . 1.3899999999999999 109.905 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.819 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.39 -52.41 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 1.8200000000000001 112.73 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.949 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.52 130.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 107.982 -1.118 . . . . 1.0800000000000001 107.982 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 159.97 41.02 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 120.833 -0.347 . . . . 1.8799999999999999 111.704 -176.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.716 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.6 t80 -135.81 103.82 5.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.195 -0.669 . . . . 2.2000000000000002 109.195 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.449 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 20.2 m -142.6 159.99 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.751 0.31 . . . . 1.4199999999999999 111.582 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.11 25.93 18.95 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.602 -0.809 . . . . 0.56999999999999995 112.272 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 74.75 1.62 3.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.512 0.196 . . . . 1.46 111.091 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.9 mttt -100.01 115.08 28.89 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 110.034 -0.358 . . . . 2.96 110.034 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.709 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.55 128.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.575 -1.269 . . . . 2.27 107.575 177.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.6 m-85 -113.13 129.33 56.54 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.874 -1.512 . . . . 2.1499999999999999 110.256 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.771 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 21.9 p-10 -166.16 -54.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.654 -1.239 . . . . 1.2 107.654 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -80.13 -20.05 45.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.025 -0.989 . . . . 2.1699999999999999 109.202 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.43 -26.25 35.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.216 -0.902 . . . . 5.4100000000000001 108.904 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.5 m-85 -85.3 111.81 39.25 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.073 -0.967 . . . . 2.21 111.057 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.5 -41.9 10.83 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.427 1.418 . . . . 1.1100000000000001 109.939 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.697 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 60.3 t0 -67.89 105.46 1.99 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.64 -0.709 . . . . 1.3600000000000001 110.266 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.865 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 5.6 mt 68.66 20.03 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.012 1.116 . . . . 2.2400000000000002 114.012 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 12.2 pttm -54.78 127.06 26.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.336 -0.852 . . . . 2.8700000000000001 110.84 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.77 12.94 48.75 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.212 -0.994 . . . . 0.48999999999999999 114.213 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.865 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.5 ptp180 -143.81 -47.6 0.28 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 114.619 1.34 . . . . 2.1099999999999999 114.619 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.949 HG13 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.58 81.15 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.275 1.512 . . . . 1.04 107.544 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -101.58 127.83 48.12 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.044 -2.344 . . . . 0.34000000000000002 111.856 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.709 ' CD2' HG13 ' A' ' 79' ' ' ILE . 88.1 m-85 -69.59 125.9 28.12 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 119.918 -0.713 . . . . 2.1600000000000001 110.246 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 p -73.49 29.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 1.0900000000000001 111.747 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 93' ' ' PHE . 5.4 m -148.76 127.49 12.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.038 0.447 . . . . 1.71 110.359 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.02 8.17 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.773 -0.649 . . . . 2.4700000000000002 110.308 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.2 66.2 1.2 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.778 -0.823 . . . . 2.1400000000000001 108.778 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD21 ' CG ' ' A' ' 93' ' ' PHE . 6.3 mp -58.36 -23.56 57.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 1.99 111.616 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.54 -3.41 2.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.162 0.506 . . . . 2.4900000000000002 112.098 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -89.99 10.01 25.7 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.466 -0.788 . . . . 1.8999999999999999 111.048 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 96.54 -10.39 66.86 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.913 -0.66 . . . . 0.40999999999999998 113.079 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -95.25 110.12 22.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 1.4399999999999999 111.602 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.22 16.06 21.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 1.1200000000000001 110.569 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.5 m -59.94 140.38 56.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.229 1.566 . . . . 1.46 115.229 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.28 136.59 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-N 114.853 -1.067 . . . . 1.0900000000000001 111.002 178.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.606 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.5 p-10 -112.86 142.98 44.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.33 -0.989 . . . . 1.5600000000000001 108.33 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.42 120.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.107 0.48 . . . . 1.0600000000000001 111.512 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -84.57 141.9 30.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.344 -0.844 . . . . 1.0700000000000001 110.659 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.497 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 33.8 m120 53.82 52.77 12.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.9399999999999999 111.346 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 31' ' ' LYS . 16.0 mt -43.08 87.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.558 1.318 . . . . 1.21 114.558 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' ASN . 57.4 mt-30 -58.2 141.93 49.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.055 -0.521 . . . . 2.6699999999999999 110.593 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 87.0 mt -59.93 -33.1 71.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.885 0.374 . . . . 2.2400000000000002 110.487 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.4 m -75.06 -13.13 60.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 1.8300000000000001 111.213 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.58 -18.59 62.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.87 -0.419 . . . . 1.5800000000000001 109.87 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.49 141.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 116.044 -0.525 . . . . 1.1399999999999999 110.535 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.83 162.21 9.01 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.225 -0.988 . . . . 0.26000000000000001 113.514 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.51 135.77 57.77 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.414 0.524 . . . . 1.0700000000000001 112.414 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 41.3 m-85 -120.05 129.67 54.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.988 -0.551 . . . . 2.1400000000000001 109.72 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -121.35 119.97 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.186 -0.206 . . . . 1.5900000000000001 111.206 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.5 t -99.94 117.42 34.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.096 -0.335 . . . . 1.03 110.096 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 37.3 mtpt -118.07 107.87 14.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 2.1899999999999999 110.82 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 7.2 p -92.27 106.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.026 -0.361 . . . . 1.8200000000000001 110.026 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.6 tttm -93.89 115.18 27.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.04 -0.664 . . . . 2.1899999999999999 112.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -145.86 102.07 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.1 -0.704 . . . . 3.2799999999999998 109.1 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.581 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.06 134.31 39.73 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 112.369 0.507 . . . . 1.1799999999999999 112.369 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 77.0 Cg_endo -100.05 46.82 2.29 Favored 'Cis proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.642 -0.982 . . . . 0.62 111.208 -0.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.81 102.93 0.31 Allowed Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.086 -1.054 . . . . 0.53000000000000003 113.683 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 m -93.21 138.21 20.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 113.861 -1.17 . . . . 1.8700000000000001 109.233 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' ' HB ' ' A' ' 22' ' ' ILE . . . -140.76 144.47 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.979 0.363 . . . . 1.3200000000000001 111.979 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.5 p-10 -146.77 151.45 37.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.482 0.549 . . . . 2.0299999999999998 112.482 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.645 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.0 160.03 41.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 3.46 111.15 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 61.0 mttp -102.53 139.81 37.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 112.422 0.527 . . . . 2.6699999999999999 112.422 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 118' ' ' TYR . 84.9 mt -142.12 114.55 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.959 -0.756 . . . . 1.0600000000000001 108.959 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.405 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 48.7 m170 -99.97 115.55 29.96 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.481 -0.488 . . . . 0.70999999999999996 110.398 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 46.5 mt -93.68 120.05 33.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.609 0.596 . . . . 2.1000000000000001 112.609 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.63 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 17.6 t -115.25 120.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.306 -0.998 . . . . 1.0900000000000001 108.306 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 25.4 t -96.26 125.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.814 0.672 . . . . 1.72 112.814 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.85 160.02 22.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 1.21 109.896 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.987 0.899 . . . . 2.0899999999999999 112.935 -178.48 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.083 0.468 . . . . 2.2599999999999998 111.555 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 129' ' ' ALA . 1.1 pp -104.54 136.13 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.666 -0.697 . . . . 2.6299999999999999 110.401 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -87.15 148.96 24.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.059 0.457 . . . . 1.6499999999999999 110.344 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 43.35 83.81 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.393 -0.822 . . . . 1.26 110.549 -177.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.69 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.8 Cg_endo -77.34 -11.04 17.55 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 123.913 3.076 . . . . 0.88 113.864 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 49.2 mp0 -141.36 126.23 18.16 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.182 -0.673 . . . . 2.0600000000000001 109.182 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 85.5 tt0 -144.09 161.19 39.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 53.6 ttm -137.11 137.32 39.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.876 -1.057 . . . . 2.3999999999999999 109.415 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 mm -132.71 139.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.978 -0.555 . . . . 1.1499999999999999 111.597 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.58 123.07 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 1.1899999999999999 110.523 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.76 158.91 43.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.9300000000000002 112.119 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.03 138.6 39.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 1.1299999999999999 112.021 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.734 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 34.2 mtmt -47.52 144.2 3.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.163 0.506 . . . . 2.7599999999999998 111.773 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.4 -25.45 3.27 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.32000000000000001 112.743 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 81.8 mm-40 -80.02 159.97 26.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.148 -0.686 . . . . 2.1099999999999999 109.148 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 m -84.54 129.31 34.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.078 -0.649 . . . . 1.0800000000000001 110.639 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -100.03 114.1 27.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.068 0.461 . . . . 1.0700000000000001 110.921 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -79.53 121.28 25.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.803 -0.635 . . . . 2.3199999999999998 112.569 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' HB2' HD11 ' A' ' 105' ' ' ILE . 20.3 mt -110.05 105.27 57.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 108.913 -0.773 . . . . 1.47 108.913 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.06 128.68 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.51 2.14 . . . . 0.71999999999999997 114.219 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.848 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 17.2 t -140.87 131.48 25.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.838 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.48 146.6 38.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.261 -0.427 . . . . 2.2400000000000002 110.744 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.504 ' CE2' HD22 ' A' ' 53' ' ' LEU . 44.1 p90 -140.79 141.05 34.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 2.1499999999999999 111.908 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.3 p -88.02 143.74 26.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 1.9299999999999999 110.759 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.4 HD21 ' HE3' ' A' ' 124' ' ' LYS . 74.6 mt -94.18 113.32 25.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.692 -0.231 . . . . 2.5899999999999999 110.564 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.8 m -83.97 140.33 40.14 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 110.004 -0.369 . . . . 2.1299999999999999 110.004 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.76 -34.24 27.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.731 1.621 . . . . 1.9299999999999999 110.559 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -79.49 -35.48 40.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.313 -0.858 . . . . 2.1800000000000002 111.383 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 78.7 m-20 -71.24 73.66 0.68 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.282 0.563 . . . . 2.4100000000000001 109.952 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -95.51 -1.21 51.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.301 -0.863 . . . . 1.96 111.427 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.05 161.42 53.11 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.485 -0.864 . . . . 0.56000000000000005 112.259 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.55 144.42 41.71 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.144 1.896 . . . . 1.1899999999999999 111.488 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.509 ' CD2' ' HD3' ' A' ' 124' ' ' LYS . 6.8 mt -77.82 129.96 36.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.907 0.384 . . . . 2.4100000000000001 111.277 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 70.8 m-20 -136.85 153.96 50.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.734 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 2.0 mp -143.34 140.36 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 1.4099999999999999 110.067 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.886 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.5 tt0 -137.35 115.58 11.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.021 0.439 . . . . 1.6699999999999999 111.79 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 83.2 m95 -98.43 119.5 37.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.965 -0.561 . . . . 0.23999999999999999 110.826 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.86 120.64 42.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.406 -0.59 . . . . 1.1200000000000001 109.406 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 71' ' ' ILE . 8.6 tt -108.83 125.84 65.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.305 0.483 . . . . 1.3700000000000001 112.305 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -112.97 103.26 55.63 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.83 -0.804 . . . . 1.73 108.83 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.8 Cg_exo -78.62 116.75 3.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.83 2.353 . . . . 0.84999999999999998 112.536 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.49 92.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 1.0700000000000001 111.23 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.91 -40.01 61.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.753 -0.658 . . . . 1.8200000000000001 111.566 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -82.83 158.48 22.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.31 0.576 . . . . 2.3599999999999999 111.671 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -69.12 -18.02 63.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.294 -0.867 . . . . 1.95 111.872 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 70.7 mttt -69.46 152.43 44.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.939 -0.573 . . . . 2.2799999999999998 111.853 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.51 127.89 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-O 121.781 0.801 . . . . 1.4199999999999999 109.229 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.74 40.01 26.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.288 -1.324 . . . . 1.77 111.431 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.59 143.9 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.442 -0.345 . . . . 2.54 111.089 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.537 HG13 ' CD1' ' A' ' 73' ' ' LEU . 46.5 t -66.79 138.87 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.841 -0.8 . . . . 1.3899999999999999 108.841 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -134.27 -54.66 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.741 0.645 . . . . 1.8200000000000001 112.741 -177.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -135.92 130.73 49.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.283 -0.636 . . . . 1.0800000000000001 109.283 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.886 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 2.9 mp -139.77 163.81 31.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.8799999999999999 111.48 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 34.5 t80 -139.36 103.02 4.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.461 -0.79 . . . . 2.2000000000000002 109.413 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -144.42 159.82 42.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.072 -0.513 . . . . 1.4199999999999999 111.954 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.49 28.43 6.61 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.047 -0.597 . . . . 0.56999999999999995 112.851 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 73.91 1.32 3.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.557 0.206 . . . . 1.46 111.557 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 27.3 mttt -99.87 119.46 38.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 110.004 -0.369 . . . . 2.96 110.004 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.47 HG21 ' CE2' ' A' ' 93' ' ' PHE . 2.8 mm -81.23 130.21 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.004 -1.48 . . . . 2.27 107.004 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.664 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -115.39 117.83 31.52 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.552 -0.749 . . . . 2.1499999999999999 110.538 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.857 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -166.28 -48.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 1.2 107.345 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.443 ' OD1' ' HA2' ' A' ' 89' ' ' GLY . 10.3 m-20 -77.38 -33.57 55.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 114.72 -1.127 . . . . 2.1699999999999999 109.024 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -76.61 -28.77 56.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.739 -1.118 . . . . 5.4100000000000001 108.762 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.519 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -81.93 117.65 69.13 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 114.946 -1.024 . . . . 2.21 110.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.11 -40.33 59.94 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.64 1.56 . . . . 1.1100000000000001 110.267 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.708 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.7 m-20 -67.82 106.45 2.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.078 -0.649 . . . . 1.3600000000000001 110.22 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.8 mp 67.7 29.0 7.11 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.307 0.855 . . . . 2.2400000000000002 113.307 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.857 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 41.7 pttt -58.03 131.33 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.903 -0.498 . . . . 2.8700000000000001 111.409 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 82' ' ' ASP . . . 80.61 19.41 68.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.642 -0.789 . . . . 0.48999999999999999 114.142 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.3 ptp180 -145.78 -47.4 0.21 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 114.295 1.22 . . . . 2.1099999999999999 114.295 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.679 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.2 p -79.53 82.09 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 122.914 1.34 . . . . 1.04 107.624 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.408 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 16.4 m80 -103.4 131.38 50.54 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 112.287 -2.233 . . . . 0.34000000000000002 112.25 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.67 ' HA ' ' O ' ' A' ' 104' ' ' SER . 68.7 m-85 -73.45 124.51 25.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.251 -0.58 . . . . 2.1600000000000001 110.393 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 p -75.72 34.17 0.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.568 -0.742 . . . . 1.0900000000000001 111.428 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 93' ' ' PHE . 1.7 m -149.03 122.57 9.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.052 0.453 . . . . 1.71 110.87 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -91.48 11.61 23.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 2.4700000000000002 110.207 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -145.56 65.16 1.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.557 -0.905 . . . . 2.1400000000000001 108.557 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -55.66 -28.03 53.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.835 -1.075 . . . . 1.99 111.249 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.416 ' HG2' HD12 ' A' ' 53' ' ' LEU . 96.2 mttt -66.21 0.48 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.099 0.476 . . . . 2.4900000000000002 112.067 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 98' ' ' LEU . 82.5 p -89.98 -0.02 57.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 1.8999999999999999 111.255 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 98.36 -4.55 60.29 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.673 -0.775 . . . . 0.40999999999999998 113.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' HD12 ' A' ' 98' ' ' LEU . 95.9 m-20 -105.42 108.81 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.146 0.473 . . . . 1.4399999999999999 110.532 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -108.22 19.44 19.9 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 112.101 0.408 . . . . 1.1200000000000001 112.101 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.67 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 9.3 m -60.36 140.84 56.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.02 1.489 . . . . 1.46 115.02 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.51 130.44 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 114.831 -1.077 . . . . 1.0900000000000001 110.849 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -105.65 147.71 28.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.892 -0.781 . . . . 1.5600000000000001 108.892 177.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.68 120.02 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 1.0600000000000001 111.26 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.604 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.18 144.89 29.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.285 -0.87 . . . . 1.0700000000000001 110.787 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m120 53.21 60.18 3.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.059 -0.519 . . . . 1.9399999999999999 112.176 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 9.4 mt -45.28 176.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.255 0.55 . . . . 1.21 112.452 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -177.86 164.16 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.504 -0.771 . . . . 2.6699999999999999 110.073 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.734 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 88.0 mt -60.08 -36.22 76.9 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.749 0.278 . . . . 2.2400000000000002 111.749 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.5 p -73.68 -10.03 59.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.602 0.239 . . . . 1.8300000000000001 111.389 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.92 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.593 -0.521 . . . . 1.5800000000000001 109.593 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -47.07 142.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 CA-C-N 115.748 -0.66 . . . . 1.1399999999999999 111.221 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 148.38 5.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.755 -1.212 . . . . 0.26000000000000001 114.181 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.7 m -59.12 130.01 44.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.025 -0.588 . . . . 1.0700000000000001 111.772 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 45.3 m-85 -112.02 122.58 48.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.268 -0.424 . . . . 2.1400000000000001 110.017 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.0 tt0 -119.96 118.41 30.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.621 -0.263 . . . . 1.5900000000000001 110.71 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.538 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 29.7 p -101.52 119.65 39.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 1.03 110.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.589 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 83.3 mttt -110.65 110.19 20.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 2.1899999999999999 110.2 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 59.8 t -89.99 106.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.8200000000000001 109.646 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 7.4 ttpm? -91.15 117.35 29.55 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.365 0.506 . . . . 2.1899999999999999 112.365 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 7.1 ttpm? -145.3 101.92 3.66 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.502 -0.555 . . . . 3.2799999999999998 109.502 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.7 129.8 36.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 113.534 0.938 . . . . 1.1799999999999999 113.534 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 64.3 Cg_endo -101.95 48.84 1.89 Allowed 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 125.026 -0.823 . . . . 0.62 111.988 -0.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -142.01 103.7 0.34 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.577 -0.82 . . . . 0.53000000000000003 113.634 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.437 HG13 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -96.88 132.04 42.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.045 -1.078 . . . . 1.8700000000000001 109.888 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 22' ' ' ILE . . . -144.82 147.01 32.37 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.282 0.475 . . . . 1.3200000000000001 112.282 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.589 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 52.8 p-10 -147.51 161.7 40.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.866 0.691 . . . . 2.0299999999999998 112.866 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.848 ' HE3' ' HA ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -145.27 160.65 41.17 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 3.46 109.929 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -97.19 145.02 26.45 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.731 1.382 . . . . 2.6699999999999999 114.731 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 93.1 mt -143.59 115.11 2.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 114.55 -1.204 . . . . 1.0600000000000001 108.624 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 117' ' ' THR . 52.7 m170 -100.02 120.05 39.22 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.033 -0.417 . . . . 0.70999999999999996 111.124 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.465 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 1.1 tm? -89.48 128.33 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 2.1000000000000001 111.846 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.435 ' N ' HD11 ' A' ' 135' ' ' LEU . 62.4 t -116.93 130.0 72.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.524 -0.762 . . . . 1.0900000000000001 109.818 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 HG12 ' HG3' ' A' ' 33' ' ' LYS . 16.4 t -95.26 121.22 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.156 0.428 . . . . 1.72 112.156 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.797 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 64.3 mt -88.57 167.17 13.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.052 -0.522 . . . . 1.21 109.811 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 121.405 0.622 . . . . 2.0899999999999999 111.784 -178.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.051 0.453 . . . . 2.2599999999999998 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.96 136.0 33.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.744 -0.662 . . . . 2.6299999999999999 110.304 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -94.94 146.9 23.92 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.57 0.7 . . . . 1.6499999999999999 111.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.92 83.07 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 114.755 -1.112 . . . . 1.26 111.352 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.04 -85.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.701 2.934 . . . . 0.88 112.676 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 99.2 mt-10 -78.41 120.26 22.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.023 -0.732 . . . . 2.0600000000000001 109.023 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 132' ' ' LYS . 83.2 tt0 -144.36 160.5 40.93 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.376 1.25 . . . . 1.71 114.376 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 93.9 mtp -133.49 129.84 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.939 -1.028 . . . . 2.3999999999999999 109.74 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.9 mm -122.07 130.69 74.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 1.1499999999999999 111.416 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.692 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 72.7 mt-10 -124.39 129.42 50.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.542 -0.299 . . . . 1.1899999999999999 110.802 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 36' ' ' THR . 54.4 tptt -141.79 160.04 40.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.767 0.317 . . . . 2.9300000000000002 111.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 31' ' ' LYS . . . -76.15 138.26 40.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.032 0.444 . . . . 1.1299999999999999 111.74 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 46.3 tttp -47.59 136.47 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.777 -0.647 . . . . 2.7599999999999998 112.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.79 -21.89 10.35 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.647 -0.706 . . . . 0.32000000000000001 113.515 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.786 ' O ' HD13 ' A' ' 110' ' ' LEU . 79.5 mm-40 -77.69 -147.57 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.795 -1.187 . . . . 2.1099999999999999 107.795 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.66 ' HA ' ' CD1' ' A' ' 110' ' ' LEU . 81.6 m -139.07 133.68 31.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.01 0.433 . . . . 1.0800000000000001 110.441 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.532 ' H ' HD12 ' A' ' 110' ' ' LEU . . . -99.83 117.56 34.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 1.0700000000000001 110.73 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 94' ' ' THR . 64.7 t80 -79.25 120.29 23.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 2.3199999999999998 112.195 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 105' ' ' ILE . 21.1 mt -105.42 106.2 55.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.748 -0.834 . . . . 1.47 108.748 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.0 Cg_exo -79.54 123.54 5.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.669 2.246 . . . . 0.71999999999999997 113.832 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.499 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 49.6 t -141.83 123.96 15.48 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.504 -0.771 . . . . 1.03 109.579 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 87.6 mttt -141.56 149.1 40.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.463 -0.79 . . . . 2.2400000000000002 110.144 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' HG23 ' A' ' 122' ' ' VAL . 34.4 p90 -140.06 140.04 36.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.624 0.601 . . . . 2.1499999999999999 112.624 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 140.05 29.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.254 -0.885 . . . . 1.9299999999999999 110.195 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mp -95.99 117.41 30.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 2.5899999999999999 111.174 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.24 150.37 70.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 2.1299999999999999 109.822 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.65 -41.88 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.126 1.884 . . . . 1.9299999999999999 111.06 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -74.7 -36.96 62.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.517 -0.765 . . . . 2.1800000000000002 110.473 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.641 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 33.6 t0 -70.21 72.51 0.45 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.4100000000000001 110.47 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -99.75 0.03 40.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 1.96 111.061 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.03 159.96 53.34 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.94 -0.648 . . . . 0.56000000000000005 112.912 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.42 139.26 55.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.777 2.318 . . . . 1.1899999999999999 111.97 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.22 130.1 35.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.484 . . . . 2.4100000000000001 111.394 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.698 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.5 m-20 -134.88 159.98 39.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.613 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.4 mt -141.99 140.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.417 -0.81 . . . . 1.4099999999999999 110.412 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HA ' HD23 ' A' ' 73' ' ' LEU . 48.7 mt-10 -139.98 107.46 5.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.779 -0.368 . . . . 1.6699999999999999 111.394 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.682 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 81.4 m95 -95.12 126.09 40.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.23999999999999999 111.521 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -118.12 140.19 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.149 -0.686 . . . . 1.1200000000000001 109.149 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.4 tt -130.0 135.57 60.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 1.3700000000000001 112.335 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.1 m -114.11 104.05 54.95 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.168 -0.924 . . . . 1.73 108.998 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.9 Cg_exo -78.47 120.43 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.499 2.133 . . . . 0.84999999999999998 111.907 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.01 83.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 111.215 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -75.28 -39.96 59.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 1.8200000000000001 111.459 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.599 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 39.5 m-20 -85.41 158.02 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.608 . . . . 2.3599999999999999 112.186 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.82 -14.59 62.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.103 -0.953 . . . . 1.95 111.265 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.61 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 32.8 mttt -66.23 149.21 50.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.441 -0.799 . . . . 2.2799999999999998 112.303 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 66' ' ' LYS . 2.6 m -153.63 127.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 121.796 0.808 . . . . 1.4199999999999999 109.151 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.84 41.5 30.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.28 -1.327 . . . . 1.77 112.186 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -88.12 139.96 29.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 2.54 111.404 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 84' ' ' TYR . 65.3 t -69.98 133.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.224 -0.444 . . . . 1.3899999999999999 110.372 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.703 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.3 pp -134.75 -39.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.815 0.672 . . . . 1.8200000000000001 112.815 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.772 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -140.24 128.17 24.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.378 -0.601 . . . . 1.0800000000000001 109.378 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 56' ' ' GLU . 6.9 mt -137.98 162.29 34.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 1.8799999999999999 111.277 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.532 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 35.4 t80 -133.48 102.68 5.61 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.298 -1.371 . . . . 2.2000000000000002 107.298 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.476 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 5.9 t -143.96 157.53 44.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.638 -0.71 . . . . 1.4199999999999999 111.731 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.99 29.79 3.49 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.256 -0.497 . . . . 0.56999999999999995 113.405 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.3 t0 73.83 1.0 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.739 0.274 . . . . 1.46 111.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -100.08 118.58 36.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 110.003 -0.369 . . . . 2.96 110.003 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.451 HG22 ' CE2' ' A' ' 93' ' ' PHE . 2.2 mm -80.02 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 107.214 -1.402 . . . . 2.27 107.214 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.772 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.7 m-85 -120.81 123.83 43.58 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.48 -0.782 . . . . 2.1499999999999999 110.982 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.823 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.2 p-10 -165.96 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.818 -1.549 . . . . 1.2 106.818 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -79.8 -31.88 40.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.406 -1.27 . . . . 2.1699999999999999 109.519 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -72.95 -29.65 63.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.501 -1.296 . . . . 5.4100000000000001 107.501 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.594 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.12 118.72 73.03 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 114.346 -1.297 . . . . 2.21 109.979 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.0 Cg_endo -50.78 -43.2 47.77 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.428 1.418 . . . . 1.1100000000000001 110.602 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.563 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 86.4 m-20 -68.42 106.28 2.47 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.047 -0.524 . . . . 1.3600000000000001 111.145 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.757 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.1 mp 72.33 24.53 3.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.391 0.886 . . . . 2.2400000000000002 113.391 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 14.2 pttm -59.17 134.74 57.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.909 -0.494 . . . . 2.8700000000000001 111.51 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 80.42 16.6 75.61 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.659 -0.781 . . . . 0.48999999999999999 113.993 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -143.02 -51.02 0.35 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 114.38 1.252 . . . . 2.1099999999999999 114.38 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.769 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.09 81.99 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 123.08 1.419 . . . . 1.04 107.421 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.448 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 12.1 m80 -102.17 127.92 48.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.066 -2.333 . . . . 0.34000000000000002 112.62 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.69 ' HA ' ' O ' ' A' ' 104' ' ' SER . 67.7 m-85 -71.61 122.75 21.09 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 120.163 -0.615 . . . . 2.1600000000000001 109.601 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.438 HG22 ' CE2' ' A' ' 38' ' ' TYR . 2.3 p -75.04 35.89 0.11 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 1.0900000000000001 111.214 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 93' ' ' PHE . 48.1 m -149.09 125.78 11.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.953 0.406 . . . . 1.71 110.396 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.11 6.81 40.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.937 -0.574 . . . . 2.4700000000000002 110.383 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -145.92 65.12 1.22 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.583 -0.735 . . . . 2.1400000000000001 109.06 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.622 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.2 mp -59.06 -27.16 65.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.173 -0.921 . . . . 1.99 111.958 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -63.46 1.54 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 2.4900000000000002 112.078 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 98' ' ' LEU . 18.4 t -90.02 0.03 57.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.586 -0.734 . . . . 1.8999999999999999 110.671 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.25 -8.46 48.8 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.964 -0.636 . . . . 0.40999999999999998 113.001 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -94.77 114.13 25.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.125 0.488 . . . . 1.4399999999999999 110.594 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -109.55 13.32 24.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.661 -0.699 . . . . 1.1200000000000001 111.965 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 51.0 m -59.95 139.57 57.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 115.563 1.69 . . . . 1.46 115.563 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.41 129.7 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 114.343 -1.299 . . . . 1.0900000000000001 110.294 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.4 p-10 -105.7 146.31 29.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.542 -0.91 . . . . 1.5600000000000001 108.542 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.631 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -95.37 122.8 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.118 0.485 . . . . 1.0600000000000001 110.746 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -91.08 145.16 24.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.638 -0.71 . . . . 1.0700000000000001 110.84 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 66.7 57.06 0.69 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 1.9399999999999999 111.466 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -53.95 165.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 1.21 112.095 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 10.7 pt20 -177.14 167.87 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.664 -0.698 . . . . 2.6699999999999999 110.996 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 89.2 mt -59.99 -37.37 79.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.757 -0.656 . . . . 2.2400000000000002 111.852 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.6 p -73.24 -17.11 61.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.528 -0.305 . . . . 1.8300000000000001 111.687 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 92.2 m-20 -71.25 -20.01 62.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.723 -0.391 . . . . 1.5800000000000001 109.974 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -46.51 144.08 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.044 0 CA-C-N 116.179 -0.464 . . . . 1.1399999999999999 111.055 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 143.89 4.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.904 -1.141 . . . . 0.26000000000000001 113.834 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 m -59.05 130.6 47.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.143 -0.529 . . . . 1.0700000000000001 112.009 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.557 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 28.9 m-85 -110.3 137.08 48.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 2.1400000000000001 109.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.8 tt0 -126.87 122.17 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.638 -0.255 . . . . 1.5900000000000001 110.579 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.6 t -99.88 119.76 38.71 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.575 0.226 . . . . 1.03 110.679 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 58.0 mttm -115.25 108.69 16.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 2.1899999999999999 110.849 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 40.9 t -91.3 108.35 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.619 -0.511 . . . . 1.8200000000000001 109.619 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 72.8 tttt -93.71 112.32 24.17 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.659 0.614 . . . . 2.1899999999999999 112.659 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 12.3 pttm -145.74 103.24 3.76 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 109.831 -0.433 . . . . 3.2799999999999998 109.831 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.59 129.73 13.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 113.158 0.799 . . . . 1.1799999999999999 113.158 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.641 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 83.0 Cg_endo -102.67 39.93 4.0 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 C-N-CA 125.109 -0.788 . . . . 0.62 111.423 -0.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.66 102.87 0.52 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-O 122.365 0.98 . . . . 0.53000000000000003 113.478 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.3 m -96.67 135.05 32.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 113.505 -1.347 . . . . 1.8700000000000001 108.76 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -132.05 154.19 49.65 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.763 -0.375 . . . . 1.3200000000000001 111.837 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 49.1 p-10 -146.09 149.31 33.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 111.519 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.35 165.57 28.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 3.46 111.396 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -104.82 140.05 38.69 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 113.028 0.751 . . . . 2.6699999999999999 113.028 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 78.5 mt -145.2 112.18 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.375 -0.972 . . . . 1.0600000000000001 108.375 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 26.8 m170 -94.69 121.1 35.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.592 -0.443 . . . . 0.70999999999999996 111.254 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.422 HD23 ' CE1' ' A' ' 118' ' ' TYR . 58.5 tp -89.07 120.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.127 0.489 . . . . 2.1000000000000001 111.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.692 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.7 t -122.26 129.11 75.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.258 -0.883 . . . . 1.0900000000000001 109.089 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.98 129.34 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.063 0.459 . . . . 1.72 112.052 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.61 160.06 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.739 -0.664 . . . . 1.21 109.504 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.372 0.606 . . . . 2.0899999999999999 110.949 -179.362 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.805 0.336 . . . . 2.2599999999999998 110.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 129' ' ' ALA . 1.1 pt -112.11 141.43 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.318 -0.401 . . . . 2.6299999999999999 111.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -93.17 155.05 17.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.64 0.733 . . . . 1.6499999999999999 111.724 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 45.87 83.14 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 114.574 -1.193 . . . . 1.26 111.981 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.561 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 56.9 Cg_endo -78.55 -82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.745 2.964 . . . . 0.88 112.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.48 129.42 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.68 -0.859 . . . . 2.0600000000000001 108.68 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.6 tp10 -143.76 159.62 42.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.812 1.042 . . . . 1.71 113.812 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mtm -139.91 123.77 17.51 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.826 -1.079 . . . . 2.3999999999999999 109.376 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.6 mm -120.02 130.04 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 1.1499999999999999 111.75 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.693 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.1 mt-10 -127.57 121.83 31.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.395 -0.366 . . . . 1.1899999999999999 110.413 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 48.0 mmtm -142.23 161.31 38.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.791 0.329 . . . . 2.9300000000000002 111.44 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.4 136.55 39.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 1.1299999999999999 111.189 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 52.4 tttp -44.51 132.67 6.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 2.7599999999999998 111.329 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 90.12 -18.94 45.56 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.867 -0.606 . . . . 0.32000000000000001 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.03 158.63 26.46 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.582 -0.896 . . . . 2.1099999999999999 108.582 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 35.0 m -89.08 125.42 35.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.747 -0.781 . . . . 1.0800000000000001 110.35 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.57 ' HB3' HD23 ' A' ' 110' ' ' LEU . . . -97.12 116.31 29.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.89 0.376 . . . . 1.0700000000000001 110.264 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.488 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 74.5 t80 -79.18 114.97 18.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.795 -0.639 . . . . 2.3199999999999998 112.088 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -99.13 108.63 50.72 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.811 -0.811 . . . . 1.47 108.811 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.62 122.78 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.555 2.17 . . . . 0.71999999999999997 113.907 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' HE3' ' A' ' 131' ' ' LYS . 4.3 t -141.0 125.19 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.062 -0.972 . . . . 1.03 109.016 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 83.2 mttt -141.08 148.4 40.09 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.25 0.548 . . . . 2.2400000000000002 111.706 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 53' ' ' LEU . 40.8 p90 -140.8 142.62 34.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 2.1499999999999999 111.076 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 139.63 30.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.904 0.383 . . . . 1.9299999999999999 110.549 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.03 150.01 22.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 2.5899999999999999 111.756 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.9 m -150.33 139.88 13.47 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 109.698 -0.482 . . . . 2.1299999999999999 109.698 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -48.55 -25.4 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.544 2.163 . . . . 1.9299999999999999 112.144 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.63 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 17.5 pt-20 -78.49 -40.22 35.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.354 -0.384 . . . . 2.1800000000000002 111.473 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.1 m-20 -72.27 71.54 0.89 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.171 -0.612 . . . . 2.4100000000000001 109.68 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -97.37 -4.92 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.712 -0.676 . . . . 1.96 112.366 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.02 159.97 53.33 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.492 -0.861 . . . . 0.56000000000000005 112.805 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.43 123.77 12.81 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.363 2.042 . . . . 1.1899999999999999 111.693 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 43' ' ' PHE . 6.4 tt -78.17 110.2 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 2.4100000000000001 111.297 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 93.4 m-20 -127.83 103.78 7.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.391 0.615 . . . . 1.78 111.877 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.782 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 9.4 mt -91.68 113.31 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.974 -1.012 . . . . 1.4099999999999999 110.04 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.852 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -107.39 120.55 42.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.249 0.833 . . . . 1.6699999999999999 113.249 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.604 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 78.3 m95 -97.0 119.99 36.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.23999999999999999 109.924 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.0 mt -105.69 140.12 39.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.526 -0.546 . . . . 1.1200000000000001 109.526 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.1 tt -130.04 130.03 65.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.137 0.494 . . . . 1.3700000000000001 112.306 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.4 t -119.31 101.89 48.83 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 108.67 -0.863 . . . . 1.73 108.67 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.0 Cg_exo -79.97 111.57 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.603 2.202 . . . . 0.84999999999999998 112.725 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.61 75.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.395 -0.82 . . . . 1.0700000000000001 110.864 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -85.6 17.88 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 1.8200000000000001 112.004 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 79.3 m-20 -149.64 163.07 38.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.328 0.585 . . . . 2.3599999999999999 111.677 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.96 -18.89 64.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.209 -0.905 . . . . 1.95 111.868 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 78.9 mttt -69.31 150.38 47.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.114 -0.494 . . . . 2.2799999999999998 111.46 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.7 135.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.636 1.208 . . . . 1.4199999999999999 110.047 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 43.63 39.38 2.36 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 112.536 -2.12 . . . . 1.77 112.08 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 2.54 110.869 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' CG1' HD12 ' A' ' 73' ' ' LEU . 20.0 t -66.27 139.28 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.331 -0.618 . . . . 1.3899999999999999 109.331 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.832 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.17 -53.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.422 0.527 . . . . 1.8200000000000001 112.422 -177.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.778 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.76 130.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.857 -0.794 . . . . 1.0800000000000001 108.857 178.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.852 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.0 159.99 40.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.045 0.45 . . . . 1.8799999999999999 111.487 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 47.3 t80 -134.09 103.61 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 2.2000000000000002 110.03 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.466 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 47.5 t -143.54 156.15 44.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.555 0.576 . . . . 1.4199999999999999 112.555 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.02 32.99 9.6 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.953 -0.567 . . . . 0.56999999999999995 113.074 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 t0 70.13 4.3 4.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.573 0.225 . . . . 1.46 111.248 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.3 mttt -100.01 114.01 27.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.809 -0.441 . . . . 2.96 109.809 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.449 HG21 HD12 ' A' ' 79' ' ' ILE . 2.8 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.83 -1.544 . . . . 2.27 106.83 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.694 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -116.61 121.52 41.97 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.45 -0.795 . . . . 2.1499999999999999 110.625 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.895 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.5 p-10 -165.7 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.747 -1.205 . . . . 1.2 107.747 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -78.9 -31.08 45.24 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.158 -0.928 . . . . 2.1699999999999999 109.376 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -75.78 -28.3 58.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.185 -1.043 . . . . 5.4100000000000001 108.185 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -81.59 117.83 69.77 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-N 114.777 -1.101 . . . . 2.21 110.554 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.46 -42.8 40.75 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.602 1.535 . . . . 1.1100000000000001 110.352 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 71' ' ' ILE . 11.6 m-20 -67.28 106.18 1.97 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.105 -0.638 . . . . 1.3600000000000001 110.695 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.796 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 68.08 26.96 7.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.575 0.954 . . . . 2.2400000000000002 113.575 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.895 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 2.7 pttt -57.14 128.03 34.92 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.73 -0.606 . . . . 2.8700000000000001 111.616 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.05 18.59 57.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.589 -0.815 . . . . 0.48999999999999999 114.225 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.796 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.6 ptp180 -145.6 -46.27 0.21 Allowed 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 114.336 1.235 . . . . 2.1099999999999999 114.336 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.832 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.99 82.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 123.102 1.429 . . . . 1.04 107.555 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -102.67 128.44 49.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.235 -2.257 . . . . 0.34000000000000002 112.331 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.689 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 70.2 m-85 -72.25 124.07 24.3 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.338 -0.545 . . . . 2.1600000000000001 110.075 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.488 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 10.8 p -75.13 34.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.4 -0.818 . . . . 1.0900000000000001 111.116 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 93' ' ' PHE . 6.9 m -149.07 123.51 9.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.017 0.437 . . . . 1.71 110.856 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -90.95 10.89 24.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.784 -0.643 . . . . 2.4700000000000002 110.05 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -145.52 65.79 1.23 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.1400000000000001 108.416 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -56.24 -31.75 63.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 1.99 111.606 -178.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.23 1.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.4900000000000002 111.979 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.3 p -89.45 -0.01 57.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.862 -0.608 . . . . 1.8999999999999999 111.023 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 100.85 -5.68 56.65 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.783 -0.722 . . . . 0.40999999999999998 113.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' O ' HD21 ' A' ' 98' ' ' LEU . 95.9 m-20 -101.9 107.18 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.067 0.434 . . . . 1.4399999999999999 110.427 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.592 ' HA ' HD21 ' A' ' 98' ' ' LEU . . . -104.63 11.68 33.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.8 0.667 . . . . 1.1200000000000001 112.8 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 89.8 p -60.03 140.02 57.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.685 1.735 . . . . 1.46 115.685 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.689 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -131.23 130.02 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 114.197 -1.365 . . . . 1.0900000000000001 110.507 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.4 p-10 -104.62 146.23 29.21 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.918 -0.771 . . . . 1.5600000000000001 108.918 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.14 120.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.021 0.439 . . . . 1.0600000000000001 111.543 -178.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.603 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.7 p -82.26 142.77 31.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.39 -0.823 . . . . 1.0700000000000001 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 27.9 m120 49.98 55.51 9.32 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.062 -0.517 . . . . 1.9399999999999999 111.605 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 37' ' ' ALA . 24.2 mt -44.55 89.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.566 1.321 . . . . 1.21 114.566 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.435 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 64.1 tt0 -60.09 145.38 46.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.708 -0.678 . . . . 2.6699999999999999 109.896 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -59.98 -40.04 87.74 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.188 0.518 . . . . 2.2400000000000002 111.223 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.434 ' HB3' HD22 ' A' ' 64' ' ' ASN . 53.1 m -72.24 -9.98 59.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.505 -0.771 . . . . 1.8300000000000001 111.642 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.99 -19.95 63.32 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.149 -0.315 . . . . 1.5800000000000001 110.149 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.1 mt -43.33 145.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.134 -0.484 . . . . 1.1399999999999999 110.353 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.488 ' N ' HG21 ' A' ' 115' ' ' ILE . . . 140.86 155.08 6.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 0.26000000000000001 112.808 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.19 138.38 57.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.198 0.444 . . . . 1.0700000000000001 112.198 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 21.6 m-85 -119.3 135.1 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.58 . . . . 2.1400000000000001 109.886 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 53.4 tt0 -127.61 119.94 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.184 -0.302 . . . . 1.5900000000000001 110.184 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.528 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 39.1 t -99.98 118.98 37.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.416 . . . . 1.03 110.065 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.782 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 82.2 mttt -116.62 104.75 11.71 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 120.982 -0.287 . . . . 2.1899999999999999 111.418 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 22.1 t -87.71 108.66 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.092 -0.707 . . . . 1.8200000000000001 109.092 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 39.3 ttpt -99.93 113.09 25.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.174 0.805 . . . . 2.1899999999999999 113.174 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG2' ' HB3' ' A' ' 49' ' ' ASP . 6.7 ttpt -145.51 101.9 3.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.477 -0.564 . . . . 3.2799999999999998 109.477 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -52.22 133.13 41.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.683 -0.69 . . . . 1.1799999999999999 112.714 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 40.0 Cg_endo -97.84 39.82 4.79 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 124.275 -1.135 . . . . 0.62 112.966 -0.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.31 101.96 0.45 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.922 -1.133 . . . . 0.53000000000000003 113.496 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.82 140.02 18.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.576 -1.312 . . . . 1.8700000000000001 109.301 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' A' ' 22' ' ' ILE . . . -145.07 152.0 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.3200000000000001 112.41 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.516 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 35.8 p-10 -146.59 151.7 37.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.248 0.462 . . . . 2.0299999999999998 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.08 160.0 42.08 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.904 -0.589 . . . . 3.46 110.779 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.7 mttt -102.34 141.13 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.633 0.975 . . . . 2.6699999999999999 113.633 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 97.7 mt -141.75 116.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 1.0600000000000001 108.605 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -100.32 117.91 35.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.463 -0.495 . . . . 0.70999999999999996 110.752 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.43 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 63.5 tp -89.38 122.89 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.227 0.537 . . . . 2.1000000000000001 112.411 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.693 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 47.7 t -120.02 126.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.423 -0.954 . . . . 1.0900000000000001 108.423 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.95 125.66 67.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 112.223 0.453 . . . . 1.72 112.223 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.5 mt -83.4 163.95 20.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 1.21 109.614 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.854 0.835 . . . . 2.0899999999999999 112.124 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.915 0.388 . . . . 2.2599999999999998 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.462 ' CG2' ' HD3' ' A' ' 131' ' ' LYS . 70.8 mt -143.38 129.1 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 2.6299999999999999 110.77 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 69.2 p -94.29 153.63 17.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.399 0.618 . . . . 1.6499999999999999 111.125 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 41.37 82.27 0.23 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 114.782 -1.099 . . . . 1.26 112.347 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 59.9 Cg_endo -79.02 -84.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.83 3.02 . . . . 0.88 112.269 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.0 mt-10 -78.12 129.12 34.8 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.063 -1.088 . . . . 2.0600000000000001 108.063 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.6 tp10 -144.09 159.21 43.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.414 1.265 . . . . 1.71 114.414 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.6 mtp -140.01 121.7 15.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.303 -1.317 . . . . 2.3999999999999999 108.913 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.404 ' HA ' HD11 ' A' ' 29' ' ' ILE . 37.3 mm -119.77 129.98 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.611 -0.268 . . . . 1.1499999999999999 111.252 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.8 pt-20 -129.82 126.76 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.355 . . . . 1.1899999999999999 110.891 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -142.13 162.05 36.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 2.9300000000000002 110.858 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.853 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.08 40.59 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.197 0.444 . . . . 1.1299999999999999 112.197 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 138' ' ' LEU . 87.2 mttt -43.85 141.53 1.57 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.208 -0.451 . . . . 2.7599999999999998 112.031 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.43 -24.99 4.58 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.749 -0.659 . . . . 0.32000000000000001 113.003 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.4 mt-10 -80.07 160.58 25.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.214 -0.661 . . . . 2.1099999999999999 109.214 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 27.4 m -83.79 133.29 34.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.957 -0.697 . . . . 1.0800000000000001 110.449 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -95.45 118.43 32.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.989 0.423 . . . . 1.0700000000000001 110.773 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.478 ' HE1' ' CG2' ' A' ' 94' ' ' THR . 65.9 t80 -79.33 131.12 36.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.715 -0.675 . . . . 2.3199999999999998 112.66 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.7 mt -128.32 104.32 19.95 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 108.991 -0.744 . . . . 1.47 108.991 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 95.8 Cg_endo -86.06 126.98 2.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.657 2.238 . . . . 0.71999999999999997 114.762 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' SG ' ' CE ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -141.93 126.1 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.288 -0.869 . . . . 1.03 109.588 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 27.8 mttp -141.04 117.0 10.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.399 0.619 . . . . 2.2400000000000002 110.983 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 29.0 p90 -92.84 139.84 30.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.935 -1.03 . . . . 2.1499999999999999 111.031 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 143.3 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.415 . . . . 1.9299999999999999 110.91 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.2 mt -100.38 139.76 35.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 2.5899999999999999 111.525 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.43 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 5.3 m -158.93 147.13 13.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.583 . . . . 2.1299999999999999 109.899 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.28 -23.73 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.44 2.094 . . . . 1.9299999999999999 113.082 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -74.47 -43.24 56.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 120.563 0.221 . . . . 2.1800000000000002 111.014 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.673 ' HB2' ' HB3' ' A' ' 124' ' ' LYS . 1.2 p-10 -73.65 74.51 1.52 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.124 -0.63 . . . . 2.4100000000000001 109.503 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -90.64 -12.73 35.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 1.96 112.106 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -73.66 159.95 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.292 -0.956 . . . . 0.56000000000000005 112.912 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 140.93 97.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.487 2.125 . . . . 1.1899999999999999 111.385 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.09 104.09 8.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.793 0.33 . . . . 2.4100000000000001 111.287 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 96.0 m-20 -114.92 103.29 10.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.64 0.734 . . . . 1.78 110.996 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.789 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.3 mt -95.07 126.53 47.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.046 -0.979 . . . . 1.4099999999999999 110.709 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 96.5 mt-10 -120.54 117.57 27.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.486 0.55 . . . . 1.6699999999999999 112.486 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.753 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 76.0 m95 -96.44 120.04 36.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.072 -0.344 . . . . 0.23999999999999999 110.072 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 83.1 mt -108.76 140.25 42.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.36 -0.608 . . . . 1.1200000000000001 109.36 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 117' ' ' THR . 9.4 tt -129.91 130.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 1.3700000000000001 112.289 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.6 m -119.99 103.35 45.49 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.01 -0.995 . . . . 1.73 109.142 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 86.2 Cg_endo -78.31 119.11 4.47 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.655 2.237 . . . . 0.84999999999999998 112.367 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.05 87.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 1.0700000000000001 111.55 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD2' ' CD1' ' A' ' 112' ' ' LEU . 81.2 m-20 -76.56 -39.98 51.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.021 -0.536 . . . . 1.8200000000000001 112.138 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -84.43 160.01 20.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.348 0.594 . . . . 2.3599999999999999 112.214 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -69.84 -17.6 63.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.182 -0.917 . . . . 1.95 111.798 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.7 mttp -65.9 147.14 53.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.849 -0.614 . . . . 2.2799999999999998 111.02 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.83 127.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 CA-C-O 121.883 0.849 . . . . 1.4199999999999999 110.187 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 40.02 26.12 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.98 -1.464 . . . . 1.77 112.694 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.4 mt-30 -94.3 143.22 26.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.104 -0.238 . . . . 2.54 111.444 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.475 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 21.1 t -66.46 132.1 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 108.855 -0.795 . . . . 1.3899999999999999 108.855 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.885 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -123.48 -51.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.352 0.871 . . . . 1.8200000000000001 113.352 -176.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.863 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.81 105.3 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.699 0.761 . . . . 1.0800000000000001 108.949 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -109.72 155.09 21.99 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.136 -0.938 . . . . 1.8799999999999999 111.078 -177.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.904 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 22.0 t80 -135.11 104.79 6.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 2.2000000000000002 110.439 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.439 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 45.2 m -142.57 158.41 43.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.132 0.419 . . . . 1.4199999999999999 112.132 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.66 30.23 42.62 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.078 -0.582 . . . . 0.56999999999999995 112.729 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t0 72.62 2.28 4.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.612 0.244 . . . . 1.46 110.903 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.0 mttt -99.99 114.8 28.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.634 -0.506 . . . . 2.96 109.634 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.904 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.07 116.99 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.114 -1.069 . . . . 2.27 108.114 178.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.71 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -100.09 125.93 46.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.914 -1.494 . . . . 2.1499999999999999 110.46 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.859 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -164.43 -52.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.98 -21.43 43.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.214 -0.903 . . . . 2.1699999999999999 109.025 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -80.74 -27.42 36.86 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.15 -1.056 . . . . 5.4100000000000001 108.15 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.6 m-85 -86.24 116.67 66.71 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.086 . . . . 2.21 110.648 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.1 Cg_endo -47.98 -40.99 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.439 1.426 . . . . 1.1100000000000001 110.234 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' O ' HG12 ' A' ' 71' ' ' ILE . 65.5 m-20 -66.97 105.71 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.237 -0.585 . . . . 1.3600000000000001 110.825 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.776 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.7 mt 66.88 24.82 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.608 0.966 . . . . 2.2400000000000002 113.608 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.859 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 65.3 pttt -57.25 132.93 54.48 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.988 -0.685 . . . . 2.8700000000000001 111.141 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 87.79 14.83 62.41 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.417 -0.897 . . . . 0.48999999999999999 114.015 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.776 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -142.95 -50.85 0.35 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.826 1.417 . . . . 2.1099999999999999 114.826 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.885 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.2 p -79.18 81.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 123.319 1.533 . . . . 1.04 107.363 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.405 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 13.5 m80 -100.22 131.55 46.1 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 111.806 -2.452 . . . . 0.34000000000000002 111.756 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 74' ' ' TYR . 75.1 m-85 -70.78 120.03 15.78 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 121.696 0.76 . . . . 2.1600000000000001 110.719 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.478 ' CG2' ' HE1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -70.01 -8.11 46.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.438 -1.255 . . . . 1.0900000000000001 110.608 179.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 67.9 m -87.09 116.23 25.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.316 -0.402 . . . . 1.71 111.13 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.81 0.07 57.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.225 0.536 . . . . 2.4700000000000002 109.965 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -146.2 65.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.596 -0.89 . . . . 2.1400000000000001 108.596 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 74' ' ' TYR . 6.8 tt -58.15 -32.73 68.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.245 -0.889 . . . . 1.99 111.52 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.52 -8.65 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.293 0.568 . . . . 2.4900000000000002 111.717 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.6 m -88.52 -0.04 56.81 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.187 -0.915 . . . . 1.8999999999999999 110.813 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 103.24 -12.32 55.2 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.734 . . . . 0.40999999999999998 113.749 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 64.9 m-20 -95.06 109.96 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.159 0.48 . . . . 1.4399999999999999 110.432 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.62 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -117.79 24.75 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.653 0.612 . . . . 1.1200000000000001 112.653 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 10.0 m -61.42 154.6 23.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.27 1.211 . . . . 1.46 114.27 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -136.45 146.06 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.0900000000000001 111.719 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 90' ' ' ARG . 22.6 p30 -121.73 142.55 50.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.877 -1.157 . . . . 1.5600000000000001 107.877 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -97.43 121.84 48.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.065 0.459 . . . . 1.0600000000000001 111.205 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 145.75 28.71 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.297 -0.865 . . . . 1.0700000000000001 111.911 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.11 60.92 3.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.877 0.695 . . . . 1.9399999999999999 112.877 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 31' ' ' LYS . 10.2 mt -47.01 172.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.286 0.565 . . . . 1.21 112.397 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -176.6 160.01 1.94 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.997 -1.001 . . . . 2.6699999999999999 109.601 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.442 ' CD1' ' OD2' ' A' ' 63' ' ' ASP . 1.2 tm? -59.06 -34.13 71.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.454 0.538 . . . . 2.2400000000000002 112.454 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.38 -12.03 60.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.809 0.3 . . . . 1.8300000000000001 111.809 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.34 -20.95 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.5800000000000001 109.896 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.3 143.25 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 116.089 -0.505 . . . . 1.1399999999999999 111.072 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 141.05 147.36 4.91 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.722 -1.227 . . . . 0.26000000000000001 113.922 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 96.2 m -59.34 130.03 44.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.059 -0.57 . . . . 1.0700000000000001 111.83 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 30.5 m-85 -109.81 132.56 54.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.921 -0.581 . . . . 2.1400000000000001 109.584 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 61.8 tt0 -120.86 110.28 16.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 1.5900000000000001 110.027 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.505 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 1.5 t -100.18 119.68 38.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.87 -0.604 . . . . 1.03 110.066 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.789 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.9 mtpt -122.52 112.97 18.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 2.1899999999999999 111.172 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 20.6 t -93.83 113.15 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.274 -0.639 . . . . 1.8200000000000001 109.274 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 46.3 mttp -91.54 127.43 36.99 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.201 1.186 . . . . 2.1899999999999999 114.201 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 49' ' ' ASP . 9.5 mtmp? -145.98 101.88 3.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 3.2799999999999998 109.326 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.547 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.75 132.29 47.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.26 0.467 . . . . 1.1799999999999999 112.26 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -101.44 49.53 1.79 Allowed 'Cis proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.892 -0.879 . . . . 0.62 111.707 -0.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.83 103.84 0.29 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.699 -0.762 . . . . 0.53000000000000003 112.926 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 123' ' ' LYS . 26.9 m -83.38 127.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.742 -0.729 . . . . 1.8700000000000001 110.217 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -99.46 141.22 32.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.401 0.143 . . . . 1.3200000000000001 111.239 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.449 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.6 p-10 -145.76 136.47 24.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.985 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.582 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.33 157.16 44.1 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.724 -0.671 . . . . 3.46 110.361 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 27' ' ' GLU . 96.8 mttt -104.57 140.08 38.52 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 113.329 0.863 . . . . 2.6699999999999999 113.329 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.596 HD12 ' CH2' ' A' ' 57' ' ' TRP . 3.2 mt -140.97 120.0 11.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.317 -0.856 . . . . 1.0600000000000001 109.339 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -102.58 120.53 40.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.70999999999999996 110.897 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.458 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 3.3 tm? -87.92 120.0 28.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.066 0.46 . . . . 2.1000000000000001 111.124 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 59.1 t -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.373 -0.831 . . . . 1.0900000000000001 109.316 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' CG1' ' HG3' ' A' ' 33' ' ' LYS . 18.0 t -100.7 134.08 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.444 0.535 . . . . 1.72 112.444 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.853 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 58.7 mt -83.05 150.01 26.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.983 -0.747 . . . . 1.21 108.983 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 122.063 0.935 . . . . 2.0899999999999999 112.836 -177.836 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.495 ' H ' ' HB ' ' A' ' 44' ' ' THR . 79.4 p . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.105 0.479 . . . . 2.2599999999999998 111.154 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.564 HG22 ' HD2' ' A' ' 131' ' ' LYS . 73.1 mt -100.14 117.68 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.382 -0.826 . . . . 2.6299999999999999 111.189 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' CE ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -92.25 131.41 37.48 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.373 0.606 . . . . 1.6499999999999999 110.02 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 82.0 0.25 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 122.124 0.964 . . . . 1.26 110.292 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.6 Cg_endo -77.79 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.329 -0.488 0 C-N-CA 123.882 3.055 . . . . 0.88 112.966 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.5 mt-10 -78.48 125.31 29.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 2.0600000000000001 108.661 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 81.5 tt0 -143.96 160.02 41.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.855 1.057 . . . . 1.71 113.855 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.0 ttp -136.74 135.57 38.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.805 -1.089 . . . . 2.3999999999999999 109.471 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.6 mm -130.03 136.42 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.969 -0.559 . . . . 1.1499999999999999 111.436 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.634 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 83.8 mt-10 -129.86 123.51 31.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.647 0.26 . . . . 1.1899999999999999 110.925 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 26.4 mmtt -141.93 153.22 44.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.726 0.298 . . . . 2.9300000000000002 111.429 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.0 142.35 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 1.1299999999999999 111.228 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 94.8 mttt -41.28 159.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.373 0.606 . . . . 2.7599999999999998 112.178 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.63 -24.22 0.13 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.278 -0.874 . . . . 0.32000000000000001 113.879 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 33' ' ' LYS . 98.9 mt-10 -80.06 160.03 25.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.416 -0.587 . . . . 2.1099999999999999 109.416 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.81 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 40.8 m -86.51 128.93 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.24 -0.584 . . . . 1.0800000000000001 110.831 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -100.0 118.28 36.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.189 0.519 . . . . 1.0700000000000001 110.254 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CE2' HG22 ' A' ' 94' ' ' THR . 29.4 t80 -79.19 122.92 26.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.726 -0.67 . . . . 2.3199999999999998 112.338 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 57' ' ' TRP . 30.8 mt -110.03 104.67 56.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.39 -0.967 . . . . 1.47 108.39 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 86.9 Cg_endo -82.12 133.11 7.51 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.508 2.139 . . . . 0.71999999999999997 115.262 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.93 126.6 19.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.301 -1.318 . . . . 1.03 107.519 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.12 112.32 7.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.329 0.585 . . . . 2.2400000000000002 111.609 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.647 ' HB3' HG13 ' A' ' 122' ' ' VAL . 41.8 p90 -100.04 139.01 36.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.05 -0.977 . . . . 2.1499999999999999 111.205 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.495 ' HB ' ' H ' ' A' ' 21' ' ' SER . 19.5 m -79.93 165.98 22.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.683 -0.488 . . . . 1.9299999999999999 109.683 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD22 ' HE2' ' A' ' 43' ' ' PHE . 98.0 mt -132.27 148.12 52.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.446 0.641 . . . . 2.5899999999999999 112.417 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.5 t -160.16 147.92 12.91 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.965 -1.016 . . . . 2.1299999999999999 109.542 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.57 -21.57 5.44 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.438 2.092 . . . . 1.9299999999999999 113.236 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -76.38 -41.16 48.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 121.177 -0.209 . . . . 2.1800000000000002 111.194 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -73.03 79.21 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.294 -0.632 . . . . 2.4100000000000001 109.294 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -100.01 4.99 45.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 1.96 112.076 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -79.77 168.87 52.84 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.379 -0.915 . . . . 0.56000000000000005 113.383 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.0 131.28 23.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.743 2.296 . . . . 1.1899999999999999 111.562 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.0 tp -78.51 110.03 13.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 2.4100000000000001 111.856 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -126.94 103.5 7.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.415 0.626 . . . . 1.78 110.49 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.816 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.4 120.06 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.06 -0.973 . . . . 1.4099999999999999 111.065 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.905 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 97.6 mt-10 -109.75 119.97 41.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.187 0.44 . . . . 1.6699999999999999 112.187 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.701 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 69.6 m95 -95.36 119.98 34.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.856 -0.338 . . . . 0.23999999999999999 110.155 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.98 138.95 40.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.138 -0.69 . . . . 1.1200000000000001 109.138 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -130.02 130.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.13 0.49 . . . . 1.3700000000000001 112.264 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.1 m -122.74 102.75 38.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.555 -0.748 . . . . 1.73 109.331 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.58 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 93.8 Cg_endo -79.04 116.0 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.519 2.146 . . . . 0.84999999999999998 111.902 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.98 87.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 1.0700000000000001 111.588 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.61 -40.01 57.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.191 -0.459 . . . . 1.8200000000000001 111.636 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.3 m120 -84.23 160.04 20.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.293 0.568 . . . . 2.3599999999999999 112.137 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.72 -18.66 64.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.32 -0.855 . . . . 1.95 111.7 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.58 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 68.0 mttm -67.13 149.03 51.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.022 -0.535 . . . . 2.2799999999999998 111.186 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.61 127.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-O 121.902 0.858 . . . . 1.4199999999999999 109.99 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.25 39.96 31.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.58 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.05 144.05 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.553 -0.166 . . . . 2.54 110.553 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 23.6 t -66.01 130.0 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.657 -0.417 . . . . 1.3899999999999999 109.895 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -117.15 -54.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.753 0.649 . . . . 1.8200000000000001 112.753 -177.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.713 ' HB ' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -136.29 131.26 48.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.444 -0.947 . . . . 1.0800000000000001 108.444 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.905 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.01 158.5 43.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.235 -0.439 . . . . 1.8799999999999999 111.228 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 38.1 t80 -135.58 103.31 5.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 2.2000000000000002 109.823 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 21.3 t -144.58 160.04 41.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.765 -0.652 . . . . 1.4199999999999999 112.352 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.95 31.34 5.57 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 113.017 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 3.14 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.535 0.207 . . . . 1.46 111.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -99.95 115.66 30.2 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.429 -0.582 . . . . 2.96 109.429 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 HG23 ' CD2' ' A' ' 93' ' ' PHE . 3.1 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 107.219 -1.4 . . . . 2.27 107.219 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.678 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 2.8 m-85 -114.92 117.77 31.6 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.397 -0.82 . . . . 2.1499999999999999 110.065 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.856 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 9.7 p-10 -165.94 -49.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.127 -1.434 . . . . 1.2 107.127 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD1' ' CE1' ' A' ' 83' ' ' TYR . 12.1 p-10 -80.13 -26.98 39.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.575 -1.193 . . . . 2.1699999999999999 108.749 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 36.3 m-85 -80.84 -29.54 35.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.021 -1.103 . . . . 5.4100000000000001 108.021 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.521 ' CZ ' HG13 ' A' ' 70' ' ' VAL . 1.8 m-85 -82.33 110.32 20.74 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 115.014 -0.994 . . . . 2.21 109.794 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 25.9 Cg_exo -63.1 -28.56 74.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.086 1.857 . . . . 1.1100000000000001 113.119 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 87' ' ' LEU . 20.1 m-20 -48.71 -33.32 9.93 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.213 -0.595 . . . . 1.3600000000000001 112.045 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.788 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.3 mp -153.06 32.44 0.48 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.03 -0.986 . . . . 2.2400000000000002 110.186 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.856 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 56.1 pttt -53.38 127.63 25.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.475 0.546 . . . . 2.8700000000000001 112.475 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.52 15.91 57.73 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.487 -0.779 . . . . 0.48999999999999999 114.639 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.788 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.4 ptp180 -145.87 -45.31 0.21 Allowed 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 114.594 1.331 . . . . 2.1099999999999999 114.594 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.758 HG13 HD13 ' A' ' 71' ' ' ILE . 7.7 p -79.91 81.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.868 1.318 . . . . 1.04 107.782 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -102.62 128.88 49.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.654 -2.067 . . . . 0.34000000000000002 112.684 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 60.8 m-85 -70.7 122.77 20.43 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 121.227 0.537 . . . . 2.1600000000000001 110.016 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.523 HG22 ' CE2' ' A' ' 38' ' ' TYR . 30.3 p -77.58 34.84 0.18 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.518 -0.765 . . . . 1.0900000000000001 111.395 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 93' ' ' PHE . 11.7 m -149.05 125.14 10.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.939 0.4 . . . . 1.71 110.275 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -90.0 8.47 32.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.94 -0.573 . . . . 2.4700000000000002 110.303 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.2 66.53 1.19 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.668 -0.864 . . . . 2.1400000000000001 108.668 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 100' ' ' SER . 6.9 mp -58.45 -33.11 69.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.107 -0.951 . . . . 1.99 111.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.27 0.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 2.4900000000000002 112.166 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 98' ' ' LEU . 52.6 m -89.95 0.02 57.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.625 -0.716 . . . . 1.8999999999999999 111.18 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.574 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 107.88 -14.59 37.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.69 -0.767 . . . . 0.40999999999999998 113.295 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.955 0.377 . . . . 1.4399999999999999 110.735 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.24 20.01 16.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.387 . . . . 1.1200000000000001 111.998 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.65 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.2 p -60.11 144.73 49.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.939 1.459 . . . . 1.46 114.939 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.04 131.84 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 114.588 -1.187 . . . . 1.0900000000000001 110.581 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.0 p-10 -105.51 150.09 25.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.734 -0.839 . . . . 1.5600000000000001 108.734 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.46 119.84 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.923 0.392 . . . . 1.0600000000000001 110.652 -179.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.541 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -84.96 144.66 28.18 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.583 -0.735 . . . . 1.0700000000000001 111.049 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 54.42 59.98 3.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 1.9399999999999999 112.121 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.443 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 8.6 mt -45.52 177.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.271 0.558 . . . . 1.21 112.395 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -177.24 166.7 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.485 -0.78 . . . . 2.6699999999999999 110.291 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.589 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 58.8 tp -60.04 -39.93 87.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 2.2400000000000002 111.577 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.2 m -73.22 -10.03 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.393 . . . . 1.8300000000000001 112.062 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' A' ' 110' ' ' LEU . 90.7 m-20 -71.85 -22.35 61.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.528 -0.469 . . . . 1.5800000000000001 109.735 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -47.97 142.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.05 -0.523 . . . . 1.1399999999999999 110.186 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 150.87 5.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.2 -1.0 . . . . 0.26000000000000001 113.7 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.29 130.64 47.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.137 -0.532 . . . . 1.0700000000000001 112.375 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 43.8 m-85 -114.49 124.55 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.444 -0.576 . . . . 2.1400000000000001 109.444 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.0 tt0 -123.37 119.22 29.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.117 -0.233 . . . . 1.5900000000000001 110.765 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 15.5 p -105.05 119.91 40.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 1.03 110.362 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.816 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 41.2 mtmt -111.77 107.81 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 2.1899999999999999 110.659 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 43' ' ' PHE . 5.7 p -88.0 113.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 1.8200000000000001 110.033 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.8 tttt -96.55 116.35 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.372 0.508 . . . . 2.1899999999999999 112.372 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 25.7 tttp -145.65 102.48 3.69 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.402 -0.519 . . . . 3.2799999999999998 109.849 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -51.68 134.0 36.15 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.918 -0.583 . . . . 1.1799999999999999 111.878 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -100.02 49.9 1.73 Allowed 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.627 -0.989 . . . . 0.62 111.606 -0.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -146.34 103.26 0.27 Allowed Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.147 -1.025 . . . . 0.53000000000000003 113.939 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.86 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 1.8700000000000001 108.804 176.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -140.96 146.86 37.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.309 0.485 . . . . 1.3200000000000001 112.309 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.453 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 53.7 p30 -146.73 150.93 36.33 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.198 -0.455 . . . . 2.0299999999999998 111.374 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.564 ' HD2' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -145.64 159.99 42.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.166 -0.47 . . . . 3.46 110.763 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 66.9 mttm -100.25 140.11 34.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.841 1.052 . . . . 2.6699999999999999 113.841 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 86.7 mt -140.6 113.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.946 -1.025 . . . . 1.0600000000000001 108.289 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -99.95 119.54 38.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.405 -0.518 . . . . 0.70999999999999996 110.995 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.6 tp -91.31 122.52 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 2.1000000000000001 111.945 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.634 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 59.7 t -120.01 127.18 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.826 -0.805 . . . . 1.0900000000000001 108.826 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.507 HG13 ' HG2' ' A' ' 33' ' ' LYS . 33.5 t -98.9 131.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.46 0.541 . . . . 1.72 112.46 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 85.8 mt -82.36 151.3 26.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.824 -0.625 . . . . 1.21 109.824 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 121.678 0.751 . . . . 2.0899999999999999 112.387 -178.39 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' CG2' ' A' ' 44' ' ' THR . 16.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.904 0.383 . . . . 2.2599999999999998 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -142.86 132.81 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 2.6299999999999999 110.321 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.21 150.3 22.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.676 0.75 . . . . 1.6499999999999999 111.725 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.515 HG22 ' HG3' ' A' ' 27' ' ' GLU . 0.3 OUTLIER 52.68 81.64 0.26 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.526 -1.215 . . . . 1.26 112.464 -178.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.631 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -78.93 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.656 2.904 . . . . 0.88 111.857 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.57 126.85 31.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 2.0600000000000001 108.521 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HG3' HG22 ' A' ' 24' ' ' THR . 2.4 mm-40 -143.61 159.99 41.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.864 1.061 . . . . 1.71 113.864 -176.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.5 ttp -138.93 132.26 30.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.55 -1.205 . . . . 2.3999999999999999 108.98 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 133' ' ' ILE . 4.3 mp -130.0 139.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.943 -0.571 . . . . 1.1499999999999999 111.405 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.0 pt-20 -135.13 127.29 29.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.1899999999999999 111.134 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 56.0 tptt -141.9 157.52 44.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 2.9300000000000002 110.742 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.5 144.34 39.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.934 0.397 . . . . 1.1299999999999999 111.746 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HG2' HG22 ' A' ' 137' ' ' VAL . 60.7 mttp -47.2 143.05 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.767 0.655 . . . . 2.7599999999999998 112.767 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 79.67 -21.8 4.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 114.858 -1.065 . . . . 0.32000000000000001 113.307 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HB3' ' CE ' ' A' ' 31' ' ' LYS . 80.7 mm-40 -81.39 160.65 24.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.708 -0.479 . . . . 2.1099999999999999 109.708 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.3 m -84.43 129.96 34.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.034 -0.667 . . . . 1.0800000000000001 110.679 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -100.39 117.43 34.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 1.0700000000000001 110.628 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.45 ' CE1' HG23 ' A' ' 94' ' ' THR . 80.0 t80 -79.61 119.85 23.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.67 0.619 . . . . 2.3199999999999998 112.67 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 37.3 mt -106.31 111.58 64.17 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.502 -0.925 . . . . 1.47 108.502 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 85.7 Cg_endo -85.26 131.71 4.26 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.385 2.056 . . . . 0.71999999999999997 115.648 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.9 t -141.36 130.0 22.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.461 -1.245 . . . . 1.03 108.254 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 33.0 mmtp -141.16 139.99 33.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.394 . . . . 2.2400000000000002 111.063 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 53.5 p90 -140.0 140.83 36.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 2.1499999999999999 110.75 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.406 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 4.7 p -82.04 138.64 34.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 1.9299999999999999 111.967 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.24 139.97 33.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 2.5899999999999999 110.275 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 p -152.49 151.1 26.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.843 0.354 . . . . 2.1299999999999999 110.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.34 -25.85 25.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.809 2.339 . . . . 1.9299999999999999 112.39 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 13.4 pt-20 -74.17 -39.99 62.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.494 -0.321 . . . . 2.1800000000000002 110.251 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.612 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -71.9 75.28 0.89 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.234 -0.654 . . . . 2.4100000000000001 109.234 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -91.98 -9.51 42.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.405 -0.816 . . . . 1.96 111.691 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.475 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.0 160.0 53.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.324 -0.941 . . . . 0.56000000000000005 112.317 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.24 148.56 59.77 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.423 2.082 . . . . 1.1899999999999999 111.619 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 99' ' ' LYS . 61.5 tp -77.69 131.6 37.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 2.4100000000000001 110.691 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.732 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 26.6 t0 -137.13 146.46 45.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.548 0.69 . . . . 1.78 110.951 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 40.9 mt -142.44 140.01 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.53 -1.214 . . . . 1.4099999999999999 109.121 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.832 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 96.0 mt-10 -140.02 148.81 42.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.944 -0.302 . . . . 1.6699999999999999 111.187 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.685 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 79.0 m95 -140.48 119.16 12.4 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.23999999999999999 110.828 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.5 mt -109.86 146.33 35.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.314 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.0 136.17 59.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.19 0.519 . . . . 1.3700000000000001 112.267 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 70.1 m -119.66 103.84 45.7 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 1.73 108.854 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 85.1 Cg_endo -78.31 112.07 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.84999999999999998 112.613 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.75 87.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.177 -0.92 . . . . 1.0700000000000001 110.922 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -73.96 -40.48 62.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 1.8200000000000001 111.416 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 94.3 m-20 -85.12 159.99 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 2.3599999999999999 111.652 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -69.17 -19.88 64.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.95 111.173 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 57.7 mttt -70.0 150.63 46.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 2.2799999999999998 111.298 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.65 127.83 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-O 121.732 0.777 . . . . 1.4199999999999999 109.249 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 61.14 88.12 0.09 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.366 -1.288 . . . . 1.77 111.969 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.44 141.84 35.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.794 0.331 . . . . 2.54 111.219 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG13 HD11 ' A' ' 73' ' ' LEU . 61.7 t -71.74 129.38 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 1.3899999999999999 110.18 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.73 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.4 pp -130.3 -38.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.347 0.499 . . . . 1.8200000000000001 112.347 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.784 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 126.3 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.258 -0.645 . . . . 1.0800000000000001 109.258 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.602 ' HB3' ' HD2' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -140.8 159.98 41.03 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.487 -0.779 . . . . 1.8799999999999999 110.715 -178.048 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.742 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.2 t80 -134.86 103.75 5.73 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.997 -0.742 . . . . 2.2000000000000002 108.997 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.452 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 13.0 t -142.7 160.01 41.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 1.4199999999999999 111.45 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.52 13.75 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.691 -0.766 . . . . 0.56999999999999995 112.356 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.29 0.34 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.457 0.17 . . . . 1.46 111.307 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -100.05 114.27 27.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.739 -0.467 . . . . 2.96 109.739 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -79.4 134.02 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.107 -1.442 . . . . 2.27 107.107 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.73 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -118.8 127.72 53.8 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 2.1499999999999999 110.208 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.836 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.6 p-10 -165.82 -55.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.15 -1.426 . . . . 1.2 107.15 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 51.8 t0 -82.84 -27.54 30.75 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.785 -1.098 . . . . 2.1699999999999999 109.0 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.42 -30.04 61.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.7 -1.222 . . . . 5.4100000000000001 107.7 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.78 110.94 25.63 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.275 -1.33 . . . . 2.21 110.373 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.22 -43.12 13.29 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.843 1.695 . . . . 1.1100000000000001 111.505 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 95.9 m-20 -67.95 103.75 1.56 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.181 -0.463 . . . . 1.3600000000000001 111.274 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.735 ' HB3' ' NE ' ' A' ' 90' ' ' ARG . 40.4 mt 73.58 21.48 2.85 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.965 0.728 . . . . 2.2400000000000002 112.965 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.836 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.8 pttt -56.78 132.24 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.97 -0.456 . . . . 2.8700000000000001 111.44 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 90.27 10.74 63.7 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.289 -0.958 . . . . 0.48999999999999999 114.389 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.75 ' HG3' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -139.56 -49.73 0.49 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 114.781 1.4 . . . . 2.1099999999999999 114.781 -178.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.784 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.79 81.56 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.981 1.372 . . . . 1.04 107.462 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.451 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.8 m80 -102.71 129.25 49.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.342 -2.208 . . . . 0.34000000000000002 112.475 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.687 ' HA ' ' O ' ' A' ' 104' ' ' SER . 75.3 m-85 -70.34 126.25 29.12 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.084 -0.646 . . . . 2.1600000000000001 109.577 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.45 HG23 ' CE1' ' A' ' 38' ' ' TYR . 2.6 p -74.39 33.41 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.327 -0.851 . . . . 1.0900000000000001 112.693 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.9 t -149.16 140.03 22.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.1 0.476 . . . . 1.71 111.332 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -91.54 0.07 57.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.4700000000000002 110.648 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.61 67.45 1.17 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.294 0.568 . . . . 2.1400000000000001 109.506 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD22 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -56.99 -25.88 59.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 1.99 111.229 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HA ' HD21 ' A' ' 53' ' ' LEU . 63.6 mttt -64.93 1.28 0.95 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.165 0.507 . . . . 2.4900000000000002 112.297 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.7 p -89.99 0.06 57.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.561 -0.745 . . . . 1.8999999999999999 110.714 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.45 -8.75 32.72 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.40999999999999998 112.845 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -98.15 111.91 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.329 . . . . 1.4399999999999999 110.988 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.516 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -110.04 13.02 23.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.31 -0.404 . . . . 1.1200000000000001 111.424 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 54.5 m -59.98 140.0 57.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.389 1.625 . . . . 1.46 115.389 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.96 129.99 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.753 -1.112 . . . . 1.0900000000000001 110.511 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.5 p30 -106.52 154.91 20.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.243 -0.651 . . . . 1.5600000000000001 109.243 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -98.35 124.31 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 120.966 0.413 . . . . 1.0600000000000001 111.364 -178.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -88.01 143.59 27.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.702 -0.681 . . . . 1.0700000000000001 110.92 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.2 m120 50.66 60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 1.9399999999999999 111.888 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 31' ' ' LYS . 9.9 mt -45.37 176.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.445 0.64 . . . . 1.21 112.464 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -176.69 163.84 2.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.141 -0.936 . . . . 2.6699999999999999 110.082 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 115' ' ' ILE . 2.0 tm? -60.03 -36.42 77.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 2.2400000000000002 111.937 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -73.81 -14.43 61.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.056 0.391 . . . . 1.8300000000000001 112.056 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -71.18 -22.02 62.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.408 -0.517 . . . . 1.5800000000000001 109.698 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -46.52 142.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.988 -0.551 . . . . 1.1399999999999999 110.91 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.05 150.92 5.47 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.704 -1.236 . . . . 0.26000000000000001 114.218 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.0 m -59.78 135.86 57.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.768 -0.716 . . . . 1.0700000000000001 111.936 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 51.8 m-85 -120.0 139.68 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 2.1400000000000001 110.105 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 58.4 tt0 -127.0 120.16 28.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 1.5900000000000001 109.982 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 48.7 t -98.4 118.21 34.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.055 -0.258 . . . . 1.03 110.684 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.832 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 57.4 mttt -115.81 105.22 12.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 2.1899999999999999 111.008 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 89.5 t -95.34 108.18 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.41 -0.589 . . . . 1.8200000000000001 109.41 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 61.0 tttm -98.7 115.33 28.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.718 -0.793 . . . . 2.1899999999999999 112.118 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 50.0 tttm -145.65 102.35 3.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.483 -0.562 . . . . 3.2799999999999998 109.483 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.475 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -49.89 131.99 21.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 113.162 0.801 . . . . 1.1799999999999999 113.162 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.612 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 47.2 Cg_endo -100.07 37.59 5.91 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.625 -0.99 . . . . 0.62 111.627 -0.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.67 102.41 0.53 Allowed Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.313 -0.946 . . . . 0.53000000000000003 113.345 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.75 141.22 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 113.56 -1.32 . . . . 1.8700000000000001 109.357 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 22' ' ' ILE . . . -138.13 144.02 40.62 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.385 0.513 . . . . 1.3200000000000001 112.385 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 39.6 p-10 -146.26 140.41 26.49 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.587 . . . . 2.0299999999999998 110.783 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.9 164.13 32.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.582 -0.281 . . . . 3.46 111.517 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.2 mttt -99.75 140.12 34.41 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.667 0.988 . . . . 2.6699999999999999 113.667 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 2.6 mp -140.57 111.91 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.926 -1.034 . . . . 1.0600000000000001 109.072 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -101.03 120.02 39.58 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.596 -0.442 . . . . 0.70999999999999996 111.235 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 59.5 tp -91.02 123.5 34.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.017 -0.538 . . . . 2.1000000000000001 111.884 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -119.95 121.45 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 1.0900000000000001 109.464 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 33' ' ' LYS . 12.1 p -93.9 131.3 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 1.72 111.92 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.5 mt -86.55 149.98 24.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 1.21 109.722 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.773 0.797 . . . . 2.0899999999999999 111.709 -179.02 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.223 0.535 . . . . 2.2599999999999998 111.658 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -140.01 140.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.369 -0.832 . . . . 2.6299999999999999 109.987 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.35 149.52 22.27 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.541 0.686 . . . . 1.6499999999999999 111.365 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.5 83.12 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-N 114.657 -1.156 . . . . 1.26 111.232 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 56.1 Cg_endo -78.21 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.645 2.897 . . . . 0.88 112.278 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.41 127.59 32.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.555 -0.906 . . . . 2.0600000000000001 108.555 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' LYS . 83.4 tt0 -143.85 160.0 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.098 1.147 . . . . 1.71 114.098 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtt -139.73 122.8 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.586 -1.188 . . . . 2.3999999999999999 109.311 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.01 123.5 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 1.1499999999999999 111.607 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.58 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.2 mt-10 -113.79 123.78 50.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.339 -0.391 . . . . 1.1899999999999999 110.421 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.4 mmtt -141.56 154.61 45.56 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.087 0.403 . . . . 2.9300000000000002 112.087 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.2 143.25 39.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 1.1299999999999999 112.219 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 54.9 mtpt -48.81 143.22 5.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.295 0.569 . . . . 2.7599999999999998 112.422 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 -23.86 3.34 Favored Glycine 0 CA--C 1.516 0.13 0 CA-C-N 115.185 -0.916 . . . . 0.32000000000000001 113.545 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 7.2 mm-40 -80.01 160.09 25.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.403 -0.592 . . . . 2.1099999999999999 109.403 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.1 m -85.72 129.99 34.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.965 -0.694 . . . . 1.0800000000000001 109.991 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -97.73 118.78 35.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 1.0700000000000001 110.983 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.563 ' HE1' HG22 ' A' ' 94' ' ' THR . 83.0 t80 -79.53 129.98 34.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.49 -0.777 . . . . 2.3199999999999998 112.223 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.6 104.5 30.91 Favored Pre-proline 0 C--N 1.333 -0.138 0 N-CA-C 108.903 -0.777 . . . . 1.47 108.903 178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 91.7 Cg_endo -79.76 129.61 8.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.495 2.13 . . . . 0.71999999999999997 114.658 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 11.6 t -141.37 125.24 17.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.712 -1.131 . . . . 1.03 108.963 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -140.65 144.78 35.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.771 -0.65 . . . . 2.2400000000000002 109.838 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.2 p90 -140.03 141.24 36.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.794 -0.639 . . . . 2.1499999999999999 112.21 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -88.91 139.86 30.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.654 . . . . 1.9299999999999999 110.481 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -96.84 110.0 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.621 -0.263 . . . . 2.5899999999999999 110.744 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -84.52 137.74 38.83 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.843 -0.429 . . . . 2.1299999999999999 109.843 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -44.89 -34.21 8.38 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.755 1.637 . . . . 1.9299999999999999 111.035 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.06 -40.03 47.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.403 -0.817 . . . . 2.1800000000000002 111.014 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 91.7 m-20 -72.76 73.8 1.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.304 -0.558 . . . . 2.4100000000000001 109.587 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.23 -0.02 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.889 -0.596 . . . . 1.96 112.235 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.07 161.92 52.99 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.56000000000000005 113.159 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.87 137.86 60.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.695 2.264 . . . . 1.1899999999999999 112.21 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.507 ' HG ' ' CD ' ' A' ' 124' ' ' LYS . 2.3 mt -78.59 106.8 10.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 2.4100000000000001 112.137 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.5 m-20 -119.36 102.41 8.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.519 0.676 . . . . 1.78 110.921 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.847 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 6.7 mt -99.04 111.39 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.873 -1.058 . . . . 1.4099999999999999 111.029 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' HD13 ' A' ' 73' ' ' LEU . 84.8 tt0 -107.43 120.69 42.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.278 0.844 . . . . 1.6699999999999999 113.278 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.664 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 76.0 m95 -94.82 119.99 34.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.352 -0.385 . . . . 0.23999999999999999 110.127 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.0 mt -103.82 141.11 36.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.529 -0.545 . . . . 1.1200000000000001 109.529 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.6 tt -130.01 138.06 54.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.072 0.767 . . . . 1.3700000000000001 113.072 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -132.02 102.96 14.37 Favored Pre-proline 0 N--CA 1.455 -0.195 0 CA-C-N 115.199 -0.909 . . . . 1.73 109.503 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 6.3 Cg_exo -80.17 122.06 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.587 2.191 . . . . 0.84999999999999998 112.38 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.73 73.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.207 0.527 . . . . 1.0700000000000001 110.45 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.76 13.12 7.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.405 -0.816 . . . . 1.8200000000000001 112.066 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 81.9 m-20 -145.67 160.01 42.32 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.385 0.612 . . . . 2.3599999999999999 112.04 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -68.96 -19.47 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.008 -0.996 . . . . 1.95 112.316 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.615 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.8 mtpt -67.71 140.03 56.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.042 0.448 . . . . 2.2799999999999998 111.531 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.73 129.08 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 CA-C-O 121.935 0.874 . . . . 1.4199999999999999 109.546 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 34.71 21.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.031 -1.44 . . . . 1.77 111.858 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.76 142.16 27.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.492 -0.322 . . . . 2.54 110.56 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 6.1 t -66.25 131.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.731 -0.47 . . . . 1.3899999999999999 109.731 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.825 ' CD1' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -124.24 -50.58 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.64 0.607 . . . . 1.8200000000000001 112.64 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.042 ' HB ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.04 125.79 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.792 -0.818 . . . . 1.0800000000000001 108.792 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.06 159.97 40.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 116.172 -0.467 . . . . 1.8799999999999999 110.211 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 16.4 t80 -136.34 109.15 7.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 2.2000000000000002 110.328 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 8.6 p -142.86 160.05 41.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.631 -0.713 . . . . 1.4199999999999999 111.561 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.56 39.22 53.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.728 -0.749 . . . . 0.56999999999999995 112.477 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.9 t0 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.026 0.441 . . . . 1.46 110.515 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 89.7 mttt -131.33 108.94 10.0 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.96 110.631 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.601 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -79.89 118.51 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 107.125 -1.435 . . . . 2.27 107.125 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.752 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.3 m-85 -100.79 136.11 41.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.795 -1.093 . . . . 2.1499999999999999 110.612 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.786 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 13.9 p-10 -166.37 -55.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.854 -1.165 . . . . 1.2 107.854 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 12.5 t70 -79.26 -18.66 52.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.101 -0.954 . . . . 2.1699999999999999 109.209 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.35 -28.26 34.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.55 -0.907 . . . . 5.4100000000000001 108.55 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -85.8 114.28 55.99 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 114.949 -1.023 . . . . 2.21 111.161 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.28 -42.36 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.611 1.541 . . . . 1.1100000000000001 110.595 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.692 ' O ' HG12 ' A' ' 71' ' ' ILE . 3.4 m-20 -66.99 104.88 1.48 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.252 -0.579 . . . . 1.3600000000000001 110.639 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.783 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 25.9 mt 67.43 23.29 9.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.826 1.047 . . . . 2.2400000000000002 113.826 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -54.84 128.63 33.97 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.601 -0.687 . . . . 2.8700000000000001 111.127 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.79 10.59 56.37 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.159 -1.02 . . . . 0.48999999999999999 114.502 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.783 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -142.1 -46.43 0.35 Allowed 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 114.55 1.315 . . . . 2.1099999999999999 114.55 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.042 HG12 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -79.95 80.89 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-O 123.251 1.501 . . . . 1.04 107.173 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -98.78 132.06 44.43 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.258 -2.246 . . . . 0.34000000000000002 111.615 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 66.6 m-85 -72.41 121.07 18.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.895 0.855 . . . . 2.1600000000000001 111.222 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.563 HG22 ' HE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -69.48 -11.69 61.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.069 -1.423 . . . . 1.0900000000000001 109.914 178.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.8 m -95.22 120.01 34.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.025 -0.534 . . . . 1.71 110.929 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -90.64 4.82 50.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 110.422 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -146.19 67.02 1.19 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.802 -0.814 . . . . 2.1400000000000001 108.802 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.1 mp -59.05 -35.04 72.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.216 -0.902 . . . . 1.99 111.886 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.93 -5.35 4.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 2.4900000000000002 111.843 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -90.04 0.03 57.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.349 -0.841 . . . . 1.8999999999999999 110.963 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.01 -20.02 34.17 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.682 -0.771 . . . . 0.40999999999999998 113.737 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.5 m-20 -96.04 109.34 21.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.361 0.58 . . . . 1.4399999999999999 110.414 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -114.86 25.58 10.83 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.816 0.673 . . . . 1.1200000000000001 112.816 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 43.4 t -59.95 146.15 43.47 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.27 1.582 . . . . 1.46 115.27 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.53 139.97 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 114.217 -1.356 . . . . 1.0900000000000001 110.788 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.559 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -118.18 148.51 42.29 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.302 -0.999 . . . . 1.5600000000000001 108.302 177.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.88 121.56 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 120.967 0.413 . . . . 1.0600000000000001 111.26 -178.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -84.06 145.7 28.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.514 -0.767 . . . . 1.0700000000000001 111.298 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.64 61.78 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.978 -0.555 . . . . 1.9399999999999999 112.424 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 31' ' ' LYS . 9.7 mt -46.86 173.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.322 0.582 . . . . 1.21 112.336 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -177.38 163.55 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 2.6699999999999999 110.137 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.06 -38.29 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.277 -0.419 . . . . 2.2400000000000002 111.99 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.7 t -73.11 -14.21 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.11 0.411 . . . . 1.8300000000000001 112.11 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -72.83 -20.09 61.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.699 -0.4 . . . . 1.5800000000000001 110.183 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.45 146.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.202 -0.454 . . . . 1.1399999999999999 110.953 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.36 147.0 4.92 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 119.923 -1.132 . . . . 0.26000000000000001 113.788 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 47.2 m -59.27 138.3 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.378 -0.411 . . . . 1.0700000000000001 111.755 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.6 m-85 -119.95 131.08 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 2.1400000000000001 109.792 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -121.56 119.88 33.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.048 -0.261 . . . . 1.5900000000000001 110.383 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.454 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.7 t -99.51 111.17 23.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.578 -0.283 . . . . 1.03 110.455 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.847 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 74.3 mttt -106.61 104.74 14.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 2.1899999999999999 110.812 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 43' ' ' PHE . 24.0 t -89.3 110.12 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 109.212 -0.662 . . . . 1.8200000000000001 109.212 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.667 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 87.8 tttt -95.79 122.92 39.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.309 0.855 . . . . 2.1899999999999999 113.309 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 3.9 mmtt -141.6 101.43 3.98 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.892 -0.781 . . . . 3.2799999999999998 108.892 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.543 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -54.34 132.61 61.87 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 112.507 0.558 . . . . 1.1799999999999999 112.507 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.524 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 81.0 Cg_endo -100.0 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.646 -0.981 . . . . 0.62 112.667 -0.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.3 103.38 0.29 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.696 -0.764 . . . . 0.53000000000000003 112.971 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 151.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.623 -0.788 . . . . 1.8700000000000001 110.087 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.86 152.13 43.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.218 . . . . 1.3200000000000001 111.535 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.484 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 17.6 p30 -146.49 151.9 38.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.05 0.389 . . . . 2.0299999999999998 112.05 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.15 161.23 40.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.106 -0.497 . . . . 3.46 111.191 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 39.4 mttp -102.82 140.01 37.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.625 0.972 . . . . 2.6699999999999999 113.625 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 87.7 mt -143.83 110.66 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.372 -0.973 . . . . 1.0600000000000001 108.372 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -98.46 120.01 38.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.70999999999999996 111.391 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -86.87 124.26 32.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 2.1000000000000001 111.225 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.58 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.3 t -119.29 126.93 75.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.582 -0.735 . . . . 1.0900000000000001 109.433 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 33' ' ' LYS . 18.2 t -96.33 126.76 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.72 112.054 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.2 mt -87.7 145.7 26.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.078 -0.712 . . . . 1.21 109.078 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 122.249 1.023 . . . . 2.0899999999999999 112.872 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.072 0.463 . . . . 2.2599999999999998 111.562 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 42' ' ' LYS . 19.2 tt -139.51 134.99 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 2.6299999999999999 110.399 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.43 156.91 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.515 0.674 . . . . 1.6499999999999999 111.706 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.54 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.31 83.25 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.576 -1.193 . . . . 1.26 111.695 -178.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.692 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 59.3 Cg_endo -78.26 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.404 2.736 . . . . 0.88 112.6 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.59 125.55 29.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.072 -0.714 . . . . 2.0600000000000001 109.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB3' HG12 ' A' ' 133' ' ' ILE . 83.7 tt0 -144.33 163.95 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.846 1.054 . . . . 1.71 113.846 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.4 ttm -138.72 139.4 38.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.72 -1.127 . . . . 2.3999999999999999 109.117 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 135' ' ' LEU . 34.3 mm -132.72 139.37 49.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.214 0.449 . . . . 1.1499999999999999 112.214 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 21.9 pt-20 -140.23 124.63 17.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 1.1899999999999999 110.567 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.5 mmtt -142.3 163.41 32.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.522 -0.308 . . . . 2.9300000000000002 111.597 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.62 139.57 40.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 1.1299999999999999 111.467 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.35 130.35 16.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 2.7599999999999998 111.762 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.79 -19.15 47.02 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.32000000000000001 112.695 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 99.2 mt-10 -79.99 160.01 26.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.37 -0.974 . . . . 2.1099999999999999 108.37 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.861 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 42.0 m -88.43 128.51 35.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.566 -0.853 . . . . 1.0800000000000001 110.352 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.451 ' N ' HD13 ' A' ' 110' ' ' LEU . . . -99.8 113.92 26.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 1.0700000000000001 110.522 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.501 ' CE2' HG22 ' A' ' 94' ' ' THR . 29.0 t80 -79.53 129.89 34.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.908 -0.587 . . . . 2.3199999999999998 112.387 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 4.1 mp -120.17 107.64 39.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.424 -0.954 . . . . 1.47 108.424 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.528 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.0 Cg_endo -82.8 104.66 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.451 2.101 . . . . 0.71999999999999997 115.944 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -105.58 126.12 51.77 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.165 -1.05 . . . . 1.03 108.165 175.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mttm -140.72 139.37 34.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.176 0.512 . . . . 2.2400000000000002 110.992 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 40.8 p90 -141.11 150.04 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.415 -0.811 . . . . 2.1499999999999999 111.028 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 t -80.1 170.74 16.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.9299999999999999 111.177 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.19 141.19 40.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 2.5899999999999999 111.03 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 79.5 p -159.99 158.63 26.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.847 -0.615 . . . . 2.1299999999999999 110.212 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 13.1 Cg_endo -56.24 -17.64 21.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.433 2.089 . . . . 1.9299999999999999 112.88 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -73.33 -43.72 60.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.685 0.278 . . . . 2.1800000000000002 110.534 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.46 76.63 1.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.069 -0.715 . . . . 2.4100000000000001 109.069 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.13 -11.54 43.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 1.96 111.773 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -72.6 157.59 52.73 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.222 -0.989 . . . . 0.56000000000000005 112.29 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.81 150.9 27.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.334 2.022 . . . . 1.1899999999999999 111.321 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 4.1 mp -77.61 133.06 38.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.893 0.377 . . . . 2.4100000000000001 110.845 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.74 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 21.9 t0 -140.24 146.84 39.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.361 0.6 . . . . 1.78 111.753 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.711 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 6.6 mt -143.79 135.0 22.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.774 -1.103 . . . . 1.4099999999999999 109.422 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -140.61 119.9 12.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.668 0.667 . . . . 1.6699999999999999 112.667 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.712 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 83.0 m95 -100.2 124.85 46.12 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.174 -0.466 . . . . 0.23999999999999999 111.377 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.0 mt -106.87 120.34 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.843 -0.429 . . . . 1.1200000000000001 109.843 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 117' ' ' THR . 10.3 tt -104.06 124.42 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.506 0.558 . . . . 1.3700000000000001 112.506 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.8 m -118.33 101.9 50.8 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.302 -0.999 . . . . 1.73 108.302 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.621 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 98.9 Cg_endo -79.56 115.52 3.41 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.597 2.198 . . . . 0.84999999999999998 112.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 1.0700000000000001 110.944 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.94 -39.96 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 1.8200000000000001 111.8 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.538 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.4 m120 -85.43 161.87 19.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.39 0.614 . . . . 2.3599999999999999 112.28 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.63 -18.48 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.091 -0.958 . . . . 1.95 111.741 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -68.49 150.91 47.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.906 -0.588 . . . . 2.2799999999999998 111.333 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.59 127.69 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.113 0 CA-C-O 121.893 0.854 . . . . 1.4199999999999999 109.988 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 55.89 40.05 30.57 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 114.074 -1.421 . . . . 1.77 112.727 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.3 mt-30 -94.32 145.05 25.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.192 -0.203 . . . . 2.54 110.75 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.539 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 18.4 t -66.68 125.95 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.064 0.459 . . . . 1.3899999999999999 109.883 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -116.21 -53.72 4.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 1.8200000000000001 111.923 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.707 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.73 124.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.2 -1.037 . . . . 1.0800000000000001 108.2 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 6.1 tt -135.32 157.09 47.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.806 -0.633 . . . . 1.8799999999999999 109.772 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.882 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 12.1 t80 -136.91 104.08 5.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.758 -0.46 . . . . 2.2000000000000002 109.758 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -143.15 158.26 43.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 1.4199999999999999 111.678 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.58 28.58 45.8 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.732 -0.747 . . . . 0.56999999999999995 112.472 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.53 2.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.545 0.212 . . . . 1.46 111.107 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 68.2 mttm -100.01 113.24 25.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 110.08 -0.341 . . . . 2.96 110.08 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.882 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.87 116.52 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.879 -1.156 . . . . 2.27 107.879 177.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.2 m-85 -100.03 128.19 46.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.819 -1.537 . . . . 2.1499999999999999 110.908 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.739 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.2 p-10 -166.14 -53.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.222 -1.029 . . . . 1.2 108.222 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.8 t70 -80.17 -24.33 40.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.09 -0.959 . . . . 2.1699999999999999 109.371 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.25 -29.1 42.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.118 -0.946 . . . . 5.4100000000000001 108.5 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -82.35 115.9 60.57 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-N 114.795 -1.093 . . . . 2.21 110.552 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.2 Cg_endo -46.81 -40.99 25.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.729 1.619 . . . . 1.1100000000000001 110.373 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.712 ' O ' HG12 ' A' ' 71' ' ' ILE . 67.1 m-20 -66.98 105.22 1.57 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.824 -0.626 . . . . 1.3600000000000001 110.653 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.829 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.2 mt 68.02 24.56 7.82 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.862 1.06 . . . . 2.2400000000000002 113.862 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttt -55.61 127.5 30.18 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.627 -0.671 . . . . 2.8700000000000001 111.219 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.63 15.12 54.03 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.385 -0.912 . . . . 0.48999999999999999 114.451 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.829 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp180 -144.14 -48.03 0.27 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 114.483 1.29 . . . . 2.1099999999999999 114.483 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.23 81.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.864 1.316 . . . . 1.04 107.725 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -102.93 129.14 49.55 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.474 -2.148 . . . . 0.34000000000000002 112.326 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 77.0 m-85 -70.97 120.77 17.03 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 109.097 -0.705 . . . . 2.1600000000000001 109.097 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 38' ' ' TYR . 24.6 p -70.43 -10.01 57.97 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.22 -0.9 . . . . 1.0900000000000001 110.455 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.2 m -93.16 121.46 34.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.848 -0.615 . . . . 1.71 110.259 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.11 2.48 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.1 0.476 . . . . 2.4700000000000002 110.344 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -146.07 66.81 1.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.849 -0.797 . . . . 2.1400000000000001 108.849 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' A' ' 74' ' ' TYR . 5.9 mp -56.74 -28.98 62.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 1.99 111.466 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -62.81 -6.23 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 2.4900000000000002 111.809 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -87.55 -3.11 59.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.309 -0.86 . . . . 1.8999999999999999 110.733 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.64 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.57 -12.97 32.93 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.779 -0.724 . . . . 0.40999999999999998 113.702 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -95.09 110.03 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.192 0.496 . . . . 1.4399999999999999 110.429 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -108.83 16.38 22.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.294 -0.412 . . . . 1.1200000000000001 111.916 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 6.0 m -60.16 140.02 57.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 116.104 1.891 . . . . 1.46 116.104 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.82 135.53 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.291 -1.322 . . . . 1.0900000000000001 110.587 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.59 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.0 p-10 -111.95 145.05 40.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.326 -0.99 . . . . 1.5600000000000001 108.326 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.861 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.03 120.02 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.063 0.459 . . . . 1.0600000000000001 111.443 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -83.15 143.96 30.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.369 -0.832 . . . . 1.0700000000000001 110.64 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 81.3 m-20 49.92 56.52 7.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.156 0.503 . . . . 1.9399999999999999 111.359 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 31' ' ' LYS . 21.4 mt -46.38 90.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.986 1.106 . . . . 1.21 113.986 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 47.5 mt-30 -56.58 149.03 18.27 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.948 -0.569 . . . . 2.6699999999999999 110.468 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.96 -37.05 78.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.28 -0.637 . . . . 2.2400000000000002 109.28 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.55 -5.63 43.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 1.8300000000000001 111.542 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 90.0 m-20 -70.08 -19.18 63.28 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.615 -0.513 . . . . 1.5800000000000001 109.615 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -43.14 137.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 116.001 -0.545 . . . . 1.1399999999999999 110.452 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.04 158.8 7.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.893 -1.146 . . . . 0.26000000000000001 114.145 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.4 m -60.48 140.0 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.751 -0.724 . . . . 1.0700000000000001 112.709 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 32.8 m-85 -125.12 125.38 43.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.023 -0.732 . . . . 2.1400000000000001 109.023 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 24.6 tt0 -120.01 118.96 32.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.943 -0.303 . . . . 1.5900000000000001 110.727 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.464 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.2 t -97.81 118.58 34.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.999 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 31.9 mttm -114.07 106.38 14.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 2.1899999999999999 110.858 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 48.9 t -92.18 104.67 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.229 -0.656 . . . . 1.8200000000000001 109.229 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 85.5 tttt -96.99 120.12 36.75 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.009 -0.676 . . . . 2.1899999999999999 112.65 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 10.3 mtmp? -141.81 102.87 4.25 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.693 -0.484 . . . . 3.2799999999999998 109.693 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.491 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.01 131.96 22.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 1.1799999999999999 111.654 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 44.1 Cg_endo -101.89 46.83 2.26 Favored 'Cis proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.986 -0.839 . . . . 0.62 111.69 -0.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.07 103.56 0.28 Allowed Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.328 -0.939 . . . . 0.53000000000000003 113.679 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.33 149.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.691 -0.754 . . . . 1.8700000000000001 109.666 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -141.79 144.62 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.587 0.232 . . . . 1.3200000000000001 111.47 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 44.7 p-10 -146.72 148.6 32.16 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.316 0.487 . . . . 2.0299999999999998 112.316 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.692 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.31 160.72 41.09 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.018 -0.537 . . . . 3.46 110.698 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 99.1 mttt -103.22 136.14 43.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.282 0.845 . . . . 2.6699999999999999 113.282 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.758 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 91.1 mt -145.24 113.47 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 108.708 -0.849 . . . . 1.0600000000000001 108.708 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 175.4 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.076 -0.65 . . . . 0.70999999999999996 109.907 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 54.5 tp -144.07 133.05 22.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 112.255 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.4 t -129.98 129.99 65.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.383 -0.826 . . . . 1.0900000000000001 109.515 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 33.4 t -97.09 124.84 50.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.915 0.388 . . . . 1.72 111.67 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.8 mt -80.87 157.72 25.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.433 -0.58 . . . . 1.21 109.433 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 2.0899999999999999 111.106 -179.173 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.938 0.399 . . . . 2.2599999999999998 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -144.56 144.08 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 2.6299999999999999 110.991 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.455 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -99.48 139.95 34.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.744 0.783 . . . . 1.6499999999999999 112.025 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.95 81.11 0.27 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.344 -1.298 . . . . 1.26 112.109 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 76.1 Cg_endo -79.62 -11.03 14.33 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 124.344 3.363 . . . . 0.88 113.338 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -140.67 125.26 17.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.546 -0.909 . . . . 2.0600000000000001 108.546 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 83.4 tt0 -144.28 162.87 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 114.595 1.332 . . . . 1.71 114.595 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 54.8 ttm -137.92 137.12 37.7 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.491 -1.232 . . . . 2.3999999999999999 109.197 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.0 mm -134.5 139.99 46.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.269 -0.423 . . . . 1.1499999999999999 111.688 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 39.4 mt-10 -137.6 119.28 15.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.368 -0.378 . . . . 1.1899999999999999 110.295 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 31.0 tptt -142.07 158.64 43.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.665 -0.243 . . . . 2.9300000000000002 110.978 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.89 143.95 39.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.136 0.493 . . . . 1.1299999999999999 112.242 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 35.2 ttpt -48.93 131.18 18.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.799 -0.637 . . . . 2.7599999999999998 111.864 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.77 -19.84 38.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.32000000000000001 112.488 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.7 mt-10 -79.9 158.43 26.68 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.239 -1.023 . . . . 2.1099999999999999 108.239 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.81 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.0 m -88.4 128.92 35.53 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.511 -0.876 . . . . 1.0800000000000001 110.976 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 110' ' ' LEU . . . -99.98 117.7 34.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 1.0700000000000001 110.531 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CE2' ' CG2' ' A' ' 94' ' ' THR . 31.4 t80 -79.42 112.82 17.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.937 -0.574 . . . . 2.3199999999999998 111.712 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 40.6 mt -99.09 107.59 44.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.436 -0.95 . . . . 1.47 108.436 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 95.4 Cg_endo -82.69 134.52 7.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.213 1.942 . . . . 0.71999999999999997 114.4 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.52 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 1.8 t -140.42 130.07 24.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.477 -1.238 . . . . 1.03 107.841 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 22' ' ' ILE . 30.3 mmtp -140.42 137.05 33.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.979 0.418 . . . . 2.2400000000000002 110.94 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 53.2 p90 -140.28 154.25 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 2.1499999999999999 110.976 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -80.02 169.96 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 1.9299999999999999 111.835 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.0 tp -139.98 132.78 29.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.378 -0.828 . . . . 2.5899999999999999 110.625 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -157.18 156.09 28.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.1299999999999999 110.498 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.96 -19.21 31.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.442 2.094 . . . . 1.9299999999999999 112.529 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 12.6 pt-20 -75.44 -40.61 57.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.718 -0.219 . . . . 2.1800000000000002 110.84 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.4 OUTLIER -72.29 75.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.238 -0.585 . . . . 2.4100000000000001 109.452 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -91.65 -4.47 55.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 1.96 112.292 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -82.71 146.65 24.6 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 119.814 -1.184 . . . . 0.56000000000000005 112.292 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.1 131.08 44.25 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.153 1.902 . . . . 1.1899999999999999 111.393 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.735 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 1.1 pt? -77.64 133.77 38.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 2.4100000000000001 111.532 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 76.7 m-20 -134.38 102.38 5.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.819 0.819 . . . . 1.78 110.556 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.735 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 4.7 mt -92.36 108.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.225 -1.352 . . . . 1.4099999999999999 110.564 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' HG3' HD13 ' A' ' 73' ' ' LEU . 85.6 tt0 -106.52 117.56 34.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.409 0.522 . . . . 1.6699999999999999 112.409 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.691 ' HB2' HG21 ' A' ' 72' ' ' ILE . 74.3 m95 -94.66 119.95 34.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.226 -0.287 . . . . 0.23999999999999999 110.226 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.6 mt -107.69 143.88 35.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.958 -0.386 . . . . 1.1200000000000001 109.958 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 114' ' ' ASP . 11.1 tt -129.99 130.0 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 1.3700000000000001 112.05 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.448 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.1 m -117.57 102.82 51.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.888 -0.782 . . . . 1.73 108.888 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.652 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 72.0 Cg_endo -78.37 107.68 2.34 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.349 2.032 . . . . 0.84999999999999998 112.979 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.19 70.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.956 -1.02 . . . . 1.0700000000000001 110.365 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 5.7 p-10 -87.42 17.27 4.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.644 -0.707 . . . . 1.8200000000000001 111.204 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -152.86 162.61 41.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.208 0.528 . . . . 2.3599999999999999 111.837 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -67.19 -19.92 65.64 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.372 -0.831 . . . . 1.95 112.258 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.652 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 62.8 mttp -70.06 152.09 44.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.263 -0.426 . . . . 2.2799999999999998 111.321 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.8 128.67 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 CA-C-O 121.773 0.797 . . . . 1.4199999999999999 109.614 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.95 44.74 25.18 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.339 -1.301 . . . . 1.77 112.289 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' O ' HG23 ' A' ' 59' ' ' ILE . 90.6 mm-40 -87.29 134.54 33.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 2.54 111.036 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 84' ' ' TYR . 65.6 t -70.8 130.05 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.524 -0.307 . . . . 1.3899999999999999 110.682 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.719 HD12 ' CG2' ' A' ' 72' ' ' ILE . 1.4 pp -130.15 -37.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.836 0.68 . . . . 1.8200000000000001 112.836 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -141.12 122.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.698 -0.482 . . . . 1.0800000000000001 109.698 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.26 161.71 37.02 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.045 -0.525 . . . . 1.8799999999999999 110.221 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.611 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 47.1 t80 -132.46 111.02 10.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.884 0.373 . . . . 2.2000000000000002 110.615 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 15.2 t -142.34 158.05 44.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.788 -0.642 . . . . 1.4199999999999999 111.576 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.69 33.53 42.09 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.827 -0.701 . . . . 0.56999999999999995 112.324 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER 70.01 10.16 7.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.711 0.291 . . . . 1.46 110.866 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 58.5 mttm -108.84 111.65 23.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.37 -0.377 . . . . 2.96 111.181 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.611 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.05 117.84 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.752 -1.574 . . . . 2.27 106.752 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.798 ' O ' HG12 ' A' ' 72' ' ' ILE . 7.2 m-85 -100.05 130.12 46.17 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.839 -1.073 . . . . 2.1499999999999999 110.648 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.795 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.2 p-10 -165.99 -56.81 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.358 -1.719 . . . . 1.2 106.358 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -78.43 -24.52 46.08 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 114.416 -1.266 . . . . 2.1699999999999999 108.894 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.523 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -76.99 -29.97 55.73 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.396 -1.335 . . . . 5.4100000000000001 107.396 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 1.2 m-85 -86.24 113.31 51.5 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 114.423 -1.262 . . . . 2.21 109.919 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.04 -36.2 90.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.902 1.735 . . . . 1.1100000000000001 112.948 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 58.2 m-20 -49.99 -29.99 9.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.298 0.851 . . . . 1.3600000000000001 113.298 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.857 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 2.0 mp -151.74 30.19 0.59 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.874 -0.603 . . . . 2.2400000000000002 111.467 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 40.5 pttt -58.96 137.75 57.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.996 -0.682 . . . . 2.8700000000000001 111.899 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 81.15 13.83 80.2 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.598 -0.728 . . . . 0.48999999999999999 114.175 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.857 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.4 ptm85 -142.23 -56.65 0.45 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 114.922 1.453 . . . . 2.1099999999999999 114.922 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.747 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -78.21 80.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 123.059 1.409 . . . . 1.04 107.358 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.461 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 8.0 m80 -98.89 127.07 44.72 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.161 -2.29 . . . . 0.34000000000000002 112.797 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 71.6 m-85 -68.66 125.53 26.83 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 120.1 -0.64 . . . . 2.1600000000000001 109.298 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.533 ' CG2' ' CE2' ' A' ' 38' ' ' TYR . 6.6 p -74.15 28.24 0.08 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.514 -0.766 . . . . 1.0900000000000001 112.644 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 93' ' ' PHE . 4.9 t -148.7 137.64 21.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.13 0.491 . . . . 1.71 110.948 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -92.73 3.72 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.569 -0.741 . . . . 2.4700000000000002 110.73 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -146.49 66.95 1.17 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.95 -0.759 . . . . 2.1400000000000001 108.95 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' A' ' 93' ' ' PHE . 9.3 mp -57.87 -24.66 58.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.114 -0.948 . . . . 1.99 111.637 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -64.16 0.59 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.224 0.453 . . . . 2.4900000000000002 112.224 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -90.02 -0.03 57.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.682 -0.69 . . . . 1.8999999999999999 110.832 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.73 -13.7 42.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.40999999999999998 112.557 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -96.14 108.39 20.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.115 -0.328 . . . . 1.4399999999999999 110.115 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -112.54 15.53 20.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.18 0.437 . . . . 1.1200000000000001 112.18 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 27.9 p -61.31 147.77 43.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.354 1.613 . . . . 1.46 115.354 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -134.47 130.33 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.291 -1.322 . . . . 1.0900000000000001 111.211 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -103.37 143.58 32.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.602 -0.888 . . . . 1.5600000000000001 108.602 177.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.68 124.45 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 120.891 0.377 . . . . 1.0600000000000001 111.637 -178.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.617 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.8 p -85.67 145.14 27.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 1.0700000000000001 110.874 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 98.5 m-20 50.57 57.28 6.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.063 0.459 . . . . 1.9399999999999999 111.878 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 25.1 mt -45.66 85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.727 1.38 . . . . 1.21 114.727 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.47 ' H ' HH22 ' A' ' 90' ' ' ARG . 63.9 tt0 -59.98 147.89 37.27 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.668 -0.696 . . . . 2.6699999999999999 110.416 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.61 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 94.1 mt -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.054 0.39 . . . . 2.2400000000000002 112.054 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.403 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 23.3 t -70.82 -14.96 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 1.8300000000000001 111.567 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.551 ' O ' HD13 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -70.16 -19.15 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.384 -0.599 . . . . 1.5800000000000001 109.384 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 30.2 mt -45.68 138.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.1399999999999999 110.057 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.77 163.68 9.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 119.95 -1.119 . . . . 0.26000000000000001 113.876 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.487 HG22 ' CD2' ' A' ' 134' ' ' HIS . 87.5 m -59.41 130.02 44.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.599 0.592 . . . . 1.0700000000000001 112.599 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 31.2 m-85 -112.43 130.94 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 2.1400000000000001 109.687 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -123.24 118.22 27.08 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.057 -0.257 . . . . 1.5900000000000001 111.027 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 41.9 t -100.54 118.57 36.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 1.03 110.153 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.735 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 44.2 mtpt -117.89 106.17 12.7 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.822 -0.351 . . . . 2.1899999999999999 111.493 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 43' ' ' PHE . 29.9 t -90.04 109.27 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.229 -0.656 . . . . 1.8200000000000001 109.229 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.735 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.7 tttp -100.32 111.77 24.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 2.1899999999999999 112.327 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 48.6 tttt -142.41 102.84 4.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.3 -0.56 . . . . 3.2799999999999998 110.189 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.487 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.26 134.01 24.02 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.643 -0.708 . . . . 1.1799999999999999 112.09 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 65.5 Cg_endo -99.26 47.87 2.08 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.414 -1.078 . . . . 0.62 111.785 -0.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.97 102.95 0.27 Allowed Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.89 -1.147 . . . . 0.53000000000000003 113.822 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.61 151.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.534 -0.833 . . . . 1.8700000000000001 109.689 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.49 144.47 34.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.387 0.514 . . . . 1.3200000000000001 112.387 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.421 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 43.7 p-10 -146.78 139.8 25.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 111.61 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.634 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.18 161.99 38.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.548 -0.296 . . . . 3.46 111.073 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.4 mttt -106.66 143.44 34.76 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.888 1.07 . . . . 2.6699999999999999 113.888 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 86.3 mt -143.86 114.81 2.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 114.982 -1.008 . . . . 1.0600000000000001 108.879 176.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.487 ' CD2' HG22 ' A' ' 117' ' ' THR . 58.8 m170 -99.44 112.79 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.481 -0.488 . . . . 0.70999999999999996 110.911 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 118' ' ' TYR . 54.6 tp -88.25 131.01 34.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.697 -0.683 . . . . 2.1000000000000001 112.425 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.544 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.0 t -126.42 125.83 68.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 1.0900000000000001 109.729 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 27.6 t -99.33 123.09 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.72 111.412 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.6 mt -81.82 157.21 24.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.701 -0.481 . . . . 1.21 109.701 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.53 0.681 . . . . 2.0899999999999999 111.629 -178.926 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.971 0.415 . . . . 2.2599999999999998 110.371 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.464 HG23 ' HZ2' ' A' ' 131' ' ' LYS . 42.5 mm -118.73 129.99 74.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 2.6299999999999999 111.003 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 51.1 p -85.9 146.56 26.66 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.32 0.581 . . . . 1.6499999999999999 110.598 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.27 83.27 0.21 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.146 -0.934 . . . . 1.26 111.333 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.4 Cg_endo -77.72 -77.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.568 2.845 . . . . 0.88 112.193 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 45.4 mp0 -78.64 123.22 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 2.0600000000000001 108.958 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 29' ' ' ILE . 77.8 tt0 -143.81 159.99 41.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.077 1.14 . . . . 1.71 114.077 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 57.5 ttm -134.6 130.01 35.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.536 -1.211 . . . . 2.3999999999999999 108.284 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.538 HD13 HG22 ' A' ' 133' ' ' ILE . 3.6 mp -131.22 138.48 53.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.03 -0.532 . . . . 1.1499999999999999 112.335 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.742 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 92.2 mt-10 -128.81 126.34 39.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.211 -0.45 . . . . 1.1899999999999999 110.252 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.624 ' HB2' HD12 ' A' ' 110' ' ' LEU . 60.3 mmtt -142.09 156.87 45.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.892 0.377 . . . . 2.9300000000000002 111.846 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -77.29 140.18 39.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.887 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HD2' ' HB2' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -45.73 141.89 2.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.09 -0.505 . . . . 2.7599999999999998 111.872 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 79.3 -21.66 4.17 Favored Glycine 0 C--N 1.328 0.132 0 C-N-CA 121.168 -0.539 . . . . 0.32000000000000001 113.759 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 98.9 mt-10 -78.48 155.25 29.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.2 m -88.67 121.69 31.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.818 -0.753 . . . . 1.0800000000000001 110.544 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.584 ' HB3' HG21 ' A' ' 107' ' ' VAL . . . -95.93 116.1 28.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.275 0.559 . . . . 1.0700000000000001 110.072 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.467 ' CE2' HG22 ' A' ' 94' ' ' THR . 6.5 t80 -79.15 116.22 19.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.558 -0.746 . . . . 2.3199999999999998 111.632 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD11 ' CZ3' ' A' ' 57' ' ' TRP . 29.1 mt -104.37 104.19 43.28 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.383 -0.969 . . . . 1.47 108.383 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 83.1 Cg_endo -83.26 135.58 7.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.685 2.257 . . . . 0.71999999999999997 114.712 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.556 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 86.9 m -141.03 103.32 4.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.273 -0.876 . . . . 1.03 109.831 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 58.2 tptt -100.9 133.86 44.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.962 -0.563 . . . . 2.2400000000000002 109.53 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.725 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 21.2 p90 -138.31 138.15 38.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.272 0.558 . . . . 2.1499999999999999 111.395 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -91.5 139.64 30.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.289 -0.869 . . . . 1.9299999999999999 110.438 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' CE ' ' A' ' 124' ' ' LYS . 86.0 mt -94.63 109.75 21.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.144 -0.317 . . . . 2.5899999999999999 110.144 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 m -81.04 139.49 49.44 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 109.942 -0.392 . . . . 2.1299999999999999 109.942 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.89 -31.27 10.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.558 1.505 . . . . 1.9299999999999999 110.707 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 82.7 tt0 -75.54 -40.03 57.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.207 -0.906 . . . . 2.1800000000000002 110.827 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 80.0 m-20 -67.79 79.05 0.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.245 0.545 . . . . 2.4100000000000001 109.549 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.85 -8.74 33.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.419 -0.81 . . . . 1.96 111.428 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.04 160.02 53.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.611 -0.804 . . . . 0.56000000000000005 112.335 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.18 148.82 47.61 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.255 1.97 . . . . 1.1899999999999999 111.785 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.737 HD21 ' HD2' ' A' ' 124' ' ' LYS . 8.2 mt -78.02 131.1 37.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 2.4100000000000001 111.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.716 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 83.1 m-20 -131.72 149.77 52.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.954 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.481 ' O ' HD13 ' A' ' 73' ' ' LEU . 23.5 mt -143.57 104.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.226 -0.897 . . . . 1.4099999999999999 109.538 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 86.4 tt0 -104.48 111.04 23.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.491 0.552 . . . . 1.6699999999999999 112.491 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.579 ' HB2' HG21 ' A' ' 72' ' ' ILE . 73.8 m95 -92.98 132.93 36.64 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.923 -0.311 . . . . 0.23999999999999999 110.437 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.3 mt -119.55 139.99 51.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.465 -0.569 . . . . 1.1200000000000001 109.465 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.719 HG21 ' HB ' ' A' ' 71' ' ' ILE . 8.8 tt -129.97 130.74 66.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.752 0.649 . . . . 1.3700000000000001 112.752 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.9 m -125.51 101.39 30.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.306 -0.998 . . . . 1.73 108.306 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.679 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 3.0 Cg_exo -79.76 118.25 3.77 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.534 2.156 . . . . 0.84999999999999998 112.902 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.75 -39.95 86.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.561 -0.745 . . . . 1.0700000000000001 110.604 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.847 -0.615 . . . . 1.8200000000000001 111.749 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 33.7 m120 -85.98 160.51 19.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.365 0.602 . . . . 2.3599999999999999 112.181 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -69.48 -15.87 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.103 -0.953 . . . . 1.95 111.327 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 48.7 mttt -67.0 151.47 47.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 2.2799999999999998 111.821 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.02 135.58 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.585 1.183 . . . . 1.4199999999999999 110.149 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 45.46 40.0 5.19 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 112.609 -2.087 . . . . 1.77 112.858 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.9 145.44 24.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.518 0.199 . . . . 2.54 110.826 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 21.7 t -67.12 130.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.814 0.34 . . . . 1.3899999999999999 110.124 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.785 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -109.68 -65.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.908 0.707 . . . . 1.8200000000000001 112.908 -177.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.762 HG12 ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -134.06 107.4 9.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.434 -0.95 . . . . 1.0800000000000001 108.434 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 74' ' ' TYR . 8.0 tp -112.94 157.4 21.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.8799999999999999 111.042 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 18.1 t80 -132.58 104.72 6.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 2.2000000000000002 109.921 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.522 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 14.6 t -143.12 159.77 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.427 0.528 . . . . 1.4199999999999999 112.427 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.45 31.71 14.27 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.875 -0.602 . . . . 0.56999999999999995 112.73 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t0 70.51 3.3 4.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.666 0.269 . . . . 1.46 111.013 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 50.1 mtpt -100.52 116.5 32.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.876 -0.416 . . . . 2.96 109.876 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.54 HG23 ' HD2' ' A' ' 93' ' ' PHE . 2.8 mm -80.11 129.44 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 107.543 -1.28 . . . . 2.27 107.543 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.666 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -113.62 121.11 43.17 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.25 -0.886 . . . . 2.1499999999999999 110.49 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.762 ' HB3' HG12 ' A' ' 72' ' ' ILE . 16.2 p-10 -165.58 -51.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.634 -1.247 . . . . 1.2 107.634 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 50.3 t0 -77.18 -21.73 53.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.157 -0.929 . . . . 2.1699999999999999 108.88 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.81 -26.46 27.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.925 -1.034 . . . . 5.4100000000000001 109.268 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.867 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -89.05 111.32 44.19 Favored Pre-proline 0 CA--C 1.512 -0.485 0 CA-C-N 115.25 -0.886 . . . . 2.21 112.155 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.5 -38.72 28.24 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.415 1.41 . . . . 1.1100000000000001 110.473 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.6 m-20 -64.46 106.07 1.07 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.977 -0.556 . . . . 1.3600000000000001 111.251 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 4.7 mt 59.95 23.08 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.711 1.004 . . . . 2.2400000000000002 113.711 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.867 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 23.2 pttm -58.34 149.01 25.71 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.179 -1.008 . . . . 2.8700000000000001 111.379 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.83 6.72 88.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.498 -0.858 . . . . 0.48999999999999999 113.024 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.54 -40.47 0.34 Allowed 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 113.737 1.014 . . . . 2.1099999999999999 113.737 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.785 ' CG2' HD13 ' A' ' 71' ' ' ILE . 1.6 t -85.29 87.97 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 123.221 1.486 . . . . 1.04 107.525 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -113.16 132.92 55.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 111.258 -2.701 . . . . 0.34000000000000002 111.86 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.653 ' HA ' ' O ' ' A' ' 104' ' ' SER . 82.2 m-85 -75.26 123.96 26.24 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 119.988 -0.685 . . . . 2.1600000000000001 109.75 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' CE2' ' A' ' 38' ' ' TYR . 23.2 p -74.69 -4.68 38.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 1.0900000000000001 110.916 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . 15.9 p -84.43 113.66 21.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.206 -0.452 . . . . 1.71 110.949 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -88.19 0.01 56.57 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.514 0.673 . . . . 2.4700000000000002 109.505 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -146.52 68.72 1.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.524 -1.288 . . . . 2.1400000000000001 107.524 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 74' ' ' TYR . 9.3 tt -56.11 -38.23 70.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.499 -1.228 . . . . 1.99 112.029 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -63.59 -2.7 1.76 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.137 0.494 . . . . 2.4900000000000002 112.119 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 98' ' ' LEU . 7.2 t -89.62 -0.03 57.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.585 -0.734 . . . . 1.8999999999999999 111.204 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.725 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.47 -0.18 34.79 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.521 -0.847 . . . . 0.40999999999999998 113.887 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 95.5 m-20 -99.48 119.95 38.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.005 0.402 . . . . 1.4399999999999999 110.986 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -118.5 3.7 11.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.21 -0.45 . . . . 1.1200000000000001 112.087 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 29.9 p -59.99 145.19 47.13 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.508 2.04 . . . . 1.46 116.508 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.93 130.07 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 114.034 -1.439 . . . . 1.0900000000000001 109.809 177.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 90' ' ' ARG . 53.2 p-10 -100.77 142.38 32.33 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.578 -1.267 . . . . 1.5600000000000001 107.578 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.91 117.83 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 120.746 -0.381 . . . . 1.0600000000000001 110.716 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.568 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -84.55 143.3 29.41 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.743 -0.662 . . . . 1.0700000000000001 110.759 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 80.8 m-20 49.89 58.55 5.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.256 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 31' ' ' LYS . 22.1 mt -46.19 90.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.642 0.979 . . . . 1.21 113.642 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 53.8 tt0 -59.64 143.92 49.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.712 -0.676 . . . . 2.6699999999999999 110.338 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.509 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 2.4 tt -60.0 -38.52 82.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.188 0.518 . . . . 2.2400000000000002 110.67 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.3 p -74.12 -6.52 48.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.8300000000000001 111.42 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.99 -19.47 63.34 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.346 -0.613 . . . . 1.5800000000000001 109.346 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -43.08 139.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.632 -0.713 . . . . 1.1399999999999999 110.256 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.78 162.34 9.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.098 -1.049 . . . . 0.26000000000000001 113.331 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.4 m -59.71 135.23 57.62 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 1.0700000000000001 112.408 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 19.6 m-85 -119.99 132.1 55.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 2.1400000000000001 109.618 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.572 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.9 mt-30 -120.16 117.5 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.613 0.244 . . . . 1.5900000000000001 110.401 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.518 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 10.2 t -101.15 106.37 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.92 -0.4 . . . . 1.03 109.92 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 77.7 mttt -113.26 112.5 23.84 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.522 -0.308 . . . . 2.1899999999999999 111.501 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 37.8 t -92.96 108.24 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.765 -0.458 . . . . 1.8200000000000001 109.765 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.716 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 82.2 tttt -97.0 119.17 34.97 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.783 0.66 . . . . 2.1899999999999999 112.783 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.737 ' HD2' HD21 ' A' ' 53' ' ' LEU . 18.9 tttt -145.82 102.79 3.7 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.646 -0.502 . . . . 3.2799999999999998 109.646 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -49.78 131.59 21.02 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.286 0.847 . . . . 1.1799999999999999 113.286 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.55 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 63.7 Cg_endo -100.35 40.66 4.13 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.675 -0.969 . . . . 0.62 111.979 -1.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.67 102.27 0.48 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.26 -0.972 . . . . 0.53000000000000003 113.225 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.96 141.76 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 113.629 -1.286 . . . . 1.8700000000000001 109.879 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.411 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . . . -139.87 152.18 46.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.992 -0.283 . . . . 1.3200000000000001 111.706 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 41.2 p-10 -146.35 149.64 34.18 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.419 0.526 . . . . 2.0299999999999998 112.419 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.556 ' HZ3' ' HA ' ' A' ' 41' ' ' CYS . 10.6 ptmt -144.44 157.77 44.08 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.895 -0.593 . . . . 3.46 110.81 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 5.6 ttmm -100.98 139.97 35.93 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.78 0.659 . . . . 2.6699999999999999 112.78 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.595 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 89.2 mt -142.06 113.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.479 -0.782 . . . . 1.0600000000000001 109.689 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -100.13 114.75 28.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.728 -0.471 . . . . 0.70999999999999996 109.728 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.535 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 53.8 tp -94.73 123.0 37.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.609 0.596 . . . . 2.1000000000000001 112.609 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.742 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.8 t -119.93 122.18 67.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.032 -0.729 . . . . 1.0900000000000001 109.032 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 16.4 t -100.27 127.16 53.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.952 0.406 . . . . 1.72 111.988 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 91.0 mt -80.65 159.42 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 1.21 109.705 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.461 0.648 . . . . 2.0899999999999999 111.333 -179.136 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.038 0.447 . . . . 2.2599999999999998 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' LYS . 10.9 tt -141.67 144.23 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.776 -0.647 . . . . 2.6299999999999999 110.482 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.6 p -88.12 152.73 21.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.414 0.626 . . . . 1.6499999999999999 111.574 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.683 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 37.91 84.75 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.743 -1.117 . . . . 1.26 111.212 -178.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.682 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.2 Cg_endo -76.8 -11.6 18.26 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 123.417 2.745 . . . . 0.88 112.777 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.9 126.6 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.544 -0.91 . . . . 2.0600000000000001 108.544 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' ILE . 81.0 tt0 -143.93 159.41 42.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.25 1.204 . . . . 1.71 114.25 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 77.9 mtp -139.96 123.89 17.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.678 -1.146 . . . . 2.3999999999999999 109.781 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.47 129.46 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.649 0.261 . . . . 1.1499999999999999 111.288 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.588 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.3 mt-10 -119.95 124.21 45.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.499 -0.319 . . . . 1.1899999999999999 110.554 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 110' ' ' LEU . 23.6 mmtt -142.22 162.22 36.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 2.9300000000000002 111.639 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.56 137.93 39.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 111.76 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -48.33 129.99 16.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.208 -0.451 . . . . 2.7599999999999998 111.083 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.0 -18.96 45.01 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.118 -0.563 . . . . 0.32000000000000001 112.349 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 82.0 mm-40 -80.09 160.0 25.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.246 -1.02 . . . . 2.1099999999999999 108.246 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.841 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 82.8 m -88.18 128.31 35.45 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.568 -0.853 . . . . 1.0800000000000001 110.814 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HB1' ' CD1' ' A' ' 110' ' ' LEU . . . -98.95 119.98 38.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 1.0700000000000001 110.394 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.571 ' CE2' HG21 ' A' ' 94' ' ' THR . 30.5 t80 -79.51 113.89 18.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.803 -0.635 . . . . 2.3199999999999998 111.427 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 47.1 mt -100.96 106.3 43.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.442 -0.948 . . . . 1.47 108.442 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.667 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 4.4 Cg_endo -84.92 126.23 3.3 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.401 2.068 . . . . 0.71999999999999997 113.361 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.488 ' HA ' ' NZ ' ' A' ' 131' ' ' LYS . 19.7 t -140.59 125.92 18.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.6 -0.889 . . . . 1.03 108.6 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.518 ' O ' HG13 ' A' ' 22' ' ' ILE . 8.4 mtpm? -140.82 148.55 40.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.943 -0.571 . . . . 2.2400000000000002 111.473 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.576 ' CE2' HD21 ' A' ' 53' ' ' LEU . 50.3 p90 -139.99 143.1 36.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.027 -0.988 . . . . 2.1499999999999999 111.613 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.1 p -83.3 159.96 21.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.814 -0.63 . . . . 1.9299999999999999 111.093 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.58 122.88 36.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 2.5899999999999999 110.458 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 15.8 m -76.06 155.97 84.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.599 -0.273 . . . . 2.1299999999999999 110.404 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.41 -20.1 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.562 2.175 . . . . 1.9299999999999999 112.399 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 79.5 tt0 -148.19 34.55 0.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.607 -0.27 . . . . 2.1800000000000002 111.267 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 46' ' ' SER . 34.0 p-10 -69.92 69.94 0.33 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.022 0.439 . . . . 2.4100000000000001 110.447 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -96.42 -1.4 47.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 1.96 111.679 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.84 153.95 49.33 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.206 -0.997 . . . . 0.56000000000000005 112.165 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.68 126.8 23.45 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.235 1.957 . . . . 1.1899999999999999 111.152 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' HB3' ' A' ' 124' ' ' LYS . 1.3 mt -77.94 104.55 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.448 -0.342 . . . . 2.4100000000000001 111.23 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -116.98 103.42 10.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.535 0.683 . . . . 1.78 110.728 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.776 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.1 mt -97.57 121.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 1.4099999999999999 110.782 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.912 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -115.41 126.37 54.3 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.34 0.496 . . . . 1.6699999999999999 112.34 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.663 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 74.0 m95 -100.52 124.24 45.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.23999999999999999 110.16 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.1 mt -109.52 140.52 43.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.499 -0.556 . . . . 1.1200000000000001 109.499 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.0 tt -127.77 130.03 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.485 . . . . 1.3700000000000001 112.259 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.8 m -120.18 102.41 46.08 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.892 -0.781 . . . . 1.73 108.892 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.728 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.3 Cg_exo -79.4 118.08 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.514 2.143 . . . . 0.84999999999999998 112.628 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.98 87.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.721 -0.672 . . . . 1.0700000000000001 110.542 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -75.69 -40.01 56.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 1.8200000000000001 111.425 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 15.6 t-20 -82.61 158.15 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 2.3599999999999999 111.731 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -69.18 -20.02 64.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 1.95 111.895 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.728 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 18.5 mtpt -70.59 151.73 44.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 2.2799999999999998 111.907 -178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 66' ' ' LYS . 1.2 m -153.94 129.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.799 0.809 . . . . 1.4199999999999999 109.106 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 59.5 39.18 22.05 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.231 -1.35 . . . . 1.77 111.785 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.411 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 96.0 mm-40 -92.09 153.56 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.356 -0.384 . . . . 2.54 111.415 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.614 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 4.2 p -64.34 150.55 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.427 -0.582 . . . . 1.3899999999999999 109.427 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.868 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -144.21 -57.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.179 -0.608 . . . . 1.8200000000000001 112.504 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.035 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.56 135.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.626 -0.509 . . . . 1.0800000000000001 109.626 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.912 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 4.0 mp -140.73 164.06 31.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 1.8799999999999999 112.207 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.573 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 45.3 t80 -137.2 103.27 5.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.337 -0.847 . . . . 2.2000000000000002 109.195 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.454 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 12.8 t -144.1 159.58 42.39 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.083 -0.508 . . . . 1.4199999999999999 112.256 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.33 31.02 4.53 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.058 -0.519 . . . . 0.56999999999999995 113.353 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 72.03 1.95 4.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.446 0.165 . . . . 1.46 111.419 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 87.4 mttt -100.01 117.77 34.99 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.657 -0.497 . . . . 2.96 109.657 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.464 HD11 ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm -80.02 130.31 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.436 -1.32 . . . . 2.27 107.436 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.738 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.3 m-85 -117.45 125.17 50.47 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.325 -0.852 . . . . 2.1499999999999999 110.655 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.867 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.8 p-10 -165.93 -55.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.975 -1.491 . . . . 1.2 106.975 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.64 -21.51 41.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.864 -1.062 . . . . 2.1699999999999999 109.047 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.579 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -81.56 -25.91 35.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.371 -0.974 . . . . 5.4100000000000001 108.371 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -87.11 120.71 71.56 Favored Pre-proline 0 CA--C 1.509 -0.604 0 CA-C-N 115.273 -0.876 . . . . 2.21 110.555 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.9 Cg_endo -48.56 -43.78 32.39 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.391 1.394 . . . . 1.1100000000000001 110.443 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 71' ' ' ILE . 2.8 m-20 -68.72 107.22 2.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.297 -0.961 . . . . 1.3600000000000001 111.328 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.9 mt 68.75 25.9 6.24 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.642 0.979 . . . . 2.2400000000000002 113.642 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.867 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.2 pttt -56.62 127.53 31.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.025 -0.67 . . . . 2.8700000000000001 111.431 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.66 16.3 52.48 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.48999999999999999 114.135 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -144.32 -47.68 0.26 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.707 1.373 . . . . 2.1099999999999999 114.707 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.035 HG13 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -80.85 82.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 123.038 1.399 . . . . 1.04 108.119 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -101.29 130.18 47.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.639 -2.073 . . . . 0.34000000000000002 111.997 -176.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 71.1 m-85 -74.09 121.55 21.31 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.551 0.691 . . . . 2.1600000000000001 109.704 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.571 HG21 ' CE2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -69.98 -11.17 60.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.65 -1.159 . . . . 1.0900000000000001 110.096 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.7 m -93.49 120.02 33.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.971 -0.559 . . . . 1.71 110.738 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -89.56 0.03 57.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.071 0.462 . . . . 2.4700000000000002 110.26 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -146.19 67.24 1.19 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.764 -0.828 . . . . 2.1400000000000001 108.764 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.419 HD22 ' CG ' ' A' ' 74' ' ' TYR . 5.2 mp -54.61 -23.58 17.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.141 -0.936 . . . . 1.99 111.655 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.26 -4.59 3.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.216 0.532 . . . . 2.4900000000000002 111.759 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.7 p -88.53 0.02 56.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.305 -0.861 . . . . 1.8999999999999999 111.072 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 102.86 -14.18 56.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.744 -0.741 . . . . 0.40999999999999998 113.151 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.18 108.95 21.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.911 0.355 . . . . 1.4399999999999999 110.69 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.05 16.69 21.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.36 0.504 . . . . 1.1200000000000001 112.36 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m -60.03 145.78 45.14 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 115.793 1.775 . . . . 1.46 115.793 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.41 136.02 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.082 -1.417 . . . . 1.0900000000000001 110.783 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 90' ' ' ARG . 49.2 p-10 -107.11 143.52 35.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.528 -0.915 . . . . 1.5600000000000001 108.528 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.841 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.71 120.7 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.063 0.459 . . . . 1.0600000000000001 111.655 -178.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 144.54 29.43 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.333 -0.849 . . . . 1.0700000000000001 111.012 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 29.0 m120 49.84 55.89 8.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.281 -0.418 . . . . 1.9399999999999999 111.811 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 31' ' ' LYS . 21.7 mt -45.45 89.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.699 1.0 . . . . 1.21 113.699 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 52.3 tt0 -60.05 143.82 51.0 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.582 -0.525 . . . . 2.6699999999999999 109.582 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.96 -40.04 87.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 2.2400000000000002 110.892 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -73.3 -10.01 59.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.8300000000000001 111.613 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.2 m-20 -70.56 -17.24 62.92 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.892 -0.41 . . . . 1.5800000000000001 109.892 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.61 143.76 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 110.381 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.75 157.09 7.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.155 -1.021 . . . . 0.26000000000000001 113.201 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.6 m -59.34 138.95 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.339 0.496 . . . . 1.0700000000000001 112.339 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 9.6 m-85 -120.09 130.91 54.87 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.432 -0.581 . . . . 2.1400000000000001 109.432 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 66.7 tt0 -127.47 119.96 27.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.957 -0.297 . . . . 1.5900000000000001 111.015 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.541 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 21.6 p -102.71 119.95 39.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.76 0.314 . . . . 1.03 110.554 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.776 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 97.5 mttt -112.75 104.9 12.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 2.1899999999999999 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.5 ' CG2' HG12 ' A' ' 55' ' ' ILE . 21.8 t -88.42 117.31 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.325 -0.62 . . . . 1.8200000000000001 109.325 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 75.8 mttt -113.76 118.31 33.93 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.91 1.078 . . . . 2.1899999999999999 113.91 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 21.1 pttm -146.94 103.8 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.639 -0.71 . . . . 3.2799999999999998 110.809 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.34 129.11 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.92 -0.582 . . . . 1.1799999999999999 111.835 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -104.11 53.79 1.21 Allowed 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 125.207 -0.747 . . . . 0.62 111.802 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 102.98 0.27 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.95 -1.119 . . . . 0.53000000000000003 113.871 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.432 ' CG1' ' HG2' ' A' ' 123' ' ' LYS . 17.1 m -94.24 134.27 32.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.394 -0.903 . . . . 1.8700000000000001 109.845 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' A' ' 22' ' ' ILE . . . -143.55 136.6 27.72 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.13 0.418 . . . . 1.3200000000000001 112.13 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.448 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.9 p-10 -146.79 150.24 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.219 0.452 . . . . 2.0299999999999998 112.219 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.683 ' HE3' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.55 163.52 34.51 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 3.46 110.567 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.0 mttt -101.3 145.05 29.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 114.25 1.204 . . . . 2.6699999999999999 114.25 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.542 ' HA ' ' HB3' ' A' ' 27' ' ' GLU . 85.6 mt -140.53 119.36 11.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.63 -1.168 . . . . 1.0600000000000001 108.654 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.473 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 52.4 m170 -100.43 119.75 38.95 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.564 -0.455 . . . . 0.70999999999999996 110.741 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 1.5 tm? -89.58 120.04 30.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 2.1000000000000001 111.384 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.588 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.1 t -117.3 120.0 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.653 . . . . 1.0900000000000001 109.551 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.66 125.34 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.016 0.436 . . . . 1.72 112.035 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 92.9 mt -84.85 170.01 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 1.21 109.368 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 2.0899999999999999 111.69 -178.643 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.938 0.399 . . . . 2.2599999999999998 110.998 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.431 ' CD1' ' CB ' ' A' ' 129' ' ' ALA . 85.6 mt -110.0 129.96 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 2.6299999999999999 110.558 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 38.1 p -91.44 148.34 22.38 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.191 0.519 . . . . 1.6499999999999999 110.792 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.623 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 41.38 82.69 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.089 -0.96 . . . . 1.26 111.117 -177.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.46 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 123.971 3.114 . . . . 0.88 112.926 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.27 126.3 30.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.504 -0.925 . . . . 2.0600000000000001 108.504 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 132' ' ' LYS . 86.0 tt0 -143.74 160.02 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.893 1.071 . . . . 1.71 113.893 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 57.7 ttm -137.16 137.21 38.95 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 114.881 -1.054 . . . . 2.3999999999999999 109.281 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.2 mm -134.16 140.02 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.296 0.48 . . . . 1.1499999999999999 112.296 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt-10 -130.14 123.96 31.54 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.431 -0.581 . . . . 1.1899999999999999 109.431 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HB3' HD11 ' A' ' 110' ' ' LEU . 49.3 tptt -142.07 157.22 45.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.981 -0.287 . . . . 2.9300000000000002 111.31 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.8 141.66 40.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 1.1299999999999999 112.067 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 59.5 tttp -48.67 131.48 17.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.884 -0.598 . . . . 2.7599999999999998 111.872 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.38 -17.36 43.92 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.13 -0.557 . . . . 0.32000000000000001 113.267 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.535 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 99.1 mt-10 -80.01 159.77 26.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.628 -0.879 . . . . 2.1099999999999999 108.628 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.4 m -89.37 128.5 35.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.652 -0.819 . . . . 1.0800000000000001 110.367 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -99.0 112.12 24.33 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.888 0.375 . . . . 1.0700000000000001 110.343 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.448 ' CD1' HG22 ' A' ' 94' ' ' THR . 77.4 t80 -79.15 117.89 20.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 2.3199999999999998 111.616 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 39.9 mt -105.97 104.73 50.71 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.249 -0.649 . . . . 1.47 109.249 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.449 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 83.6 Cg_endo -83.37 127.19 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.448 2.099 . . . . 0.71999999999999997 113.497 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -140.31 130.18 24.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.359 -0.837 . . . . 1.03 109.616 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 8.9 mptt -140.03 140.34 36.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.053 -0.521 . . . . 2.2400000000000002 110.003 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.487 ' CE2' ' HD2' ' A' ' 124' ' ' LYS . 50.0 p90 -140.23 139.81 35.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 2.1499999999999999 111.704 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 p -88.91 147.42 24.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.612 -0.722 . . . . 1.9299999999999999 111.441 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.453 ' HA ' ' NZ ' ' A' ' 124' ' ' LYS . 24.5 tp -99.48 114.38 27.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 2.5899999999999999 110.903 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -81.87 145.46 53.75 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 110.028 -0.36 . . . . 2.1299999999999999 110.028 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -49.62 -34.15 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.782 1.654 . . . . 1.9299999999999999 110.536 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -75.64 -40.02 56.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.282 -0.872 . . . . 2.1800000000000002 110.641 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.7 m-20 -69.51 73.58 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.134 0.493 . . . . 2.4100000000000001 109.759 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -94.29 -4.84 48.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.754 . . . . 1.96 111.621 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.99 157.33 53.51 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.413 -0.899 . . . . 0.56000000000000005 112.536 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.45 148.88 10.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.477 2.118 . . . . 1.1899999999999999 111.858 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 5.6 mp -78.16 135.76 37.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 2.4100000000000001 111.503 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 9.2 t70 -140.73 153.59 45.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 1.78 111.876 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.556 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 21.5 mt -142.49 139.93 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.007 -0.997 . . . . 1.4099999999999999 109.667 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 98.0 mt-10 -140.23 111.71 7.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.026 0.375 . . . . 1.6699999999999999 111.748 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.833 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 74.3 m95 -97.68 119.9 37.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.867 -0.333 . . . . 0.23999999999999999 110.929 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 119' ' ' GLN . 89.2 mt -104.9 138.84 40.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.014 -0.736 . . . . 1.1200000000000001 109.014 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.9 tt -129.97 129.98 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.321 0.489 . . . . 1.3700000000000001 112.321 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.8 m -121.44 102.45 42.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 1.73 109.153 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.8 Cg_exo -81.46 116.19 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.645 2.23 . . . . 0.84999999999999998 112.716 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -33.25 71.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.71 . . . . 1.0700000000000001 110.886 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -85.29 12.89 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 1.8200000000000001 112.148 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 93.9 m-20 -146.99 163.19 37.02 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.37 0.605 . . . . 2.3599999999999999 111.873 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.06 -18.06 65.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.065 -0.97 . . . . 1.95 111.912 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.647 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 96.2 mttt -67.16 140.01 57.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.117 0.484 . . . . 2.2799999999999998 111.827 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 66' ' ' LYS . 2.5 m -153.0 127.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.852 0.834 . . . . 1.4199999999999999 109.012 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.82 39.33 29.64 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.098 -1.41 . . . . 1.77 111.796 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -94.72 140.01 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 2.54 110.816 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.505 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 43.0 t -69.86 127.1 31.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.987 0.422 . . . . 1.3899999999999999 110.276 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -112.04 -51.38 5.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.925 -0.58 . . . . 1.8200000000000001 112.124 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.721 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -136.92 130.13 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.593 -0.891 . . . . 1.0800000000000001 108.593 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 3.3 tt -140.1 157.03 46.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 1.8799999999999999 111.271 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 36.8 t80 -135.45 104.33 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.345 -0.388 . . . . 2.2000000000000002 110.076 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 t -144.24 157.26 44.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.416 0.524 . . . . 1.4199999999999999 112.416 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.22 12.57 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.214 -0.517 . . . . 0.56999999999999995 113.075 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t0 72.12 3.27 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.497 0.184 . . . . 1.46 111.497 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 114.85 28.46 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.568 -0.53 . . . . 2.96 109.568 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.531 HG22 ' HD2' ' A' ' 93' ' ' PHE . 2.9 mm -79.81 129.81 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 107.313 -1.366 . . . . 2.27 107.313 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.721 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -115.55 119.2 35.38 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.095 -0.957 . . . . 2.1499999999999999 110.197 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.788 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 10.0 p-10 -166.19 -51.74 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.695 -1.595 . . . . 1.2 106.695 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -80.04 -23.92 41.1 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.352 -1.295 . . . . 2.1699999999999999 108.49 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.525 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -80.82 -27.05 36.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.057 -1.09 . . . . 5.4100000000000001 108.057 177.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 2.6 m-85 -86.57 108.86 19.75 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-N 115.154 -0.93 . . . . 2.21 110.014 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 30.7 Cg_exo -61.47 -28.64 83.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.729 1.619 . . . . 1.1100000000000001 112.065 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 53.2 t0 -44.32 -36.34 2.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.347 0.594 . . . . 1.3600000000000001 111.762 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.857 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 1.5 mm? -156.48 33.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.751 -1.113 . . . . 2.2400000000000002 110.56 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.788 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 63.3 pttt -52.9 129.98 31.94 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.435 -0.506 . . . . 2.8700000000000001 111.902 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.14 57.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.506 -0.854 . . . . 0.48999999999999999 114.818 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.857 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -142.88 -46.6 0.31 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 115.009 1.485 . . . . 2.1099999999999999 115.009 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 71' ' ' ILE . 8.0 p -80.22 81.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.748 1.261 . . . . 1.04 108.235 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -103.13 129.69 50.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.892 -1.958 . . . . 0.34000000000000002 112.521 -175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.68 ' HA ' ' O ' ' A' ' 104' ' ' SER . 75.4 m-85 -73.17 122.79 22.44 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 120.002 -0.679 . . . . 2.1600000000000001 109.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.448 HG22 ' CD1' ' A' ' 38' ' ' TYR . 17.9 p -72.16 -9.93 59.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.148 -0.933 . . . . 1.0900000000000001 110.274 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 1.4 m -89.13 122.05 32.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.658 -0.701 . . . . 1.71 110.5 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -91.34 4.45 52.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.218 0.532 . . . . 2.4700000000000002 110.396 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -146.57 66.71 1.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.424 -0.807 . . . . 2.1400000000000001 108.903 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 7.9 mp -57.92 -35.04 70.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.254 -0.885 . . . . 1.99 111.434 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HA ' HD21 ' A' ' 53' ' ' LEU . 19.1 pttt -60.05 -13.78 13.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.701 0.762 . . . . 2.4900000000000002 111.801 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 t -82.99 0.04 46.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.386 -1.279 . . . . 1.8999999999999999 110.99 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.86 -2.51 38.65 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.543 -0.836 . . . . 0.40999999999999998 113.742 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.55 112.65 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.172 0.486 . . . . 1.4399999999999999 110.976 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -109.83 10.53 24.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.388 0.514 . . . . 1.1200000000000001 112.388 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 p -60.06 137.08 58.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.825 1.787 . . . . 1.46 115.825 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 114.247 -1.342 . . . . 1.0900000000000001 110.698 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -105.21 145.33 30.77 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.527 -0.546 . . . . 1.5600000000000001 109.527 177.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.849 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.49 118.72 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.142 0.496 . . . . 1.0600000000000001 111.351 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.19 143.7 30.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.297 -0.865 . . . . 1.0700000000000001 110.757 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.0 m120 49.95 55.16 9.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.083 0.468 . . . . 1.9399999999999999 111.508 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 31' ' ' LYS . 23.9 mt -45.26 88.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.225 1.194 . . . . 1.21 114.225 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.66 151.45 24.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 2.6699999999999999 109.756 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.489 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.5 mt -60.12 -28.39 67.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 2.2400000000000002 110.863 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.3 m -73.93 -5.95 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 1.8300000000000001 111.424 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -69.92 -23.63 63.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.616 -0.513 . . . . 1.5800000000000001 109.616 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.87 133.47 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.116 -0.493 . . . . 1.1399999999999999 110.091 178.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.65 158.71 7.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.034 -1.079 . . . . 0.26000000000000001 113.386 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.9 m -59.35 133.89 56.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.569 0.581 . . . . 1.0700000000000001 112.569 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.494 ' N ' ' O ' ' A' ' 133' ' ' ILE . 25.9 m-85 -118.4 132.83 56.24 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.035 -0.53 . . . . 2.1400000000000001 109.692 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.833 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.5 mt-30 -120.01 119.98 34.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.627 -0.261 . . . . 1.5900000000000001 111.666 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.578 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 42.7 t -100.04 107.3 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.214 -0.662 . . . . 1.03 109.214 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 8.9 mtpm? -114.19 109.31 18.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.418 -0.355 . . . . 2.1899999999999999 111.492 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 53.2 t -91.85 108.36 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.652 -0.499 . . . . 1.8200000000000001 109.652 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 64.7 tttm -93.63 120.37 33.82 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.246 -0.582 . . . . 2.1899999999999999 112.206 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.691 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 4.6 mtpt -144.38 102.2 3.8 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.821 -0.436 . . . . 3.2799999999999998 109.821 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.04 130.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 113.44 0.904 . . . . 1.1799999999999999 113.44 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.541 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 88.5 Cg_endo -101.64 42.16 3.3 Favored 'Cis proline' 0 C--N 1.354 0.866 0 C-N-CA 125.094 -0.794 . . . . 0.62 111.811 -1.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -135.95 103.59 0.46 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 122.006 0.781 . . . . 0.53000000000000003 112.723 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -82.93 155.73 3.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.086 -1.057 . . . . 1.8700000000000001 110.433 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.56 0.219 . . . . 1.3200000000000001 111.397 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -146.59 134.59 21.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.121 0.415 . . . . 2.0299999999999998 112.121 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.68 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -142.22 158.87 43.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.55 -0.537 . . . . 3.46 109.55 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 43.5 mmtm -109.98 146.68 34.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.659 1.355 . . . . 2.6699999999999999 114.659 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 118' ' ' TYR . 98.9 mt -144.17 122.57 6.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 114.586 -1.188 . . . . 1.0600000000000001 109.335 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.09 111.6 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.591 -0.443 . . . . 0.70999999999999996 110.063 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 51.6 tp -87.83 135.53 33.35 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.524 0.564 . . . . 2.1000000000000001 112.524 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.525 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 63.0 t -129.99 130.03 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.491 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.429 ' HB ' HD12 ' A' ' 115' ' ' ILE . 20.4 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.363 . . . . 1.72 111.859 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 87.9 mt -83.81 167.86 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.045 -0.525 . . . . 1.21 109.609 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.381 0.61 . . . . 2.0899999999999999 111.208 -178.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.897 0.38 . . . . 2.2599999999999998 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.569 HD11 ' HD3' ' A' ' 131' ' ' LYS . 1.9 pt -142.28 143.86 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.0 -0.546 . . . . 2.6299999999999999 110.869 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 27.5 p -88.58 162.43 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.793 0.806 . . . . 1.6499999999999999 112.325 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.12 82.78 0.22 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.264 -1.335 . . . . 1.26 112.712 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 63.3 Cg_endo -79.12 -86.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.775 2.984 . . . . 0.88 112.421 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 6.2 pm0 -78.0 122.02 24.99 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.711 -0.848 . . . . 2.0600000000000001 108.711 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 132' ' ' LYS . 51.3 tp10 -144.22 159.99 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.715 1.006 . . . . 1.71 113.715 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.414 ' HG3' ' HB2' ' A' ' 134' ' ' HIS . 57.7 ttm -137.9 133.01 33.3 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.829 -1.078 . . . . 2.3999999999999999 109.091 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 mm -130.05 140.04 49.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.853 -0.612 . . . . 1.1499999999999999 111.358 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.1 pt-20 -136.85 127.3 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.455 -0.338 . . . . 1.1899999999999999 110.687 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 18.3 mmtp -142.31 164.18 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.309 -0.405 . . . . 2.9300000000000002 111.03 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.35 137.33 39.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.1299999999999999 111.269 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 112' ' ' LEU . 21.0 ttpt -45.79 130.34 9.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 2.7599999999999998 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 92.23 -18.02 55.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.005 -0.617 . . . . 0.32000000000000001 112.746 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 98.9 mt-10 -79.99 156.0 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.704 -0.85 . . . . 2.1099999999999999 108.704 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.888 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 62.6 m -87.98 127.83 35.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.666 -0.814 . . . . 1.0800000000000001 110.67 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' HD12 ' A' ' 110' ' ' LEU . . . -99.9 115.1 28.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 1.0700000000000001 110.787 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CE2' HG23 ' A' ' 94' ' ' THR . 25.1 t80 -79.37 120.06 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.036 -0.529 . . . . 2.3199999999999998 111.491 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.475 HD13 ' CZ3' ' A' ' 57' ' ' TRP . 18.3 mt -109.48 104.78 56.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.093 -0.706 . . . . 1.47 109.093 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 88.3 Cg_endo -84.76 131.16 4.46 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.818 2.345 . . . . 0.71999999999999997 115.082 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.415 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 62.6 m -141.34 104.01 4.52 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.623 -0.717 . . . . 1.03 110.251 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 4.4 mptp? -102.96 140.04 37.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 2.2400000000000002 110.662 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 50.4 p90 -140.55 146.68 38.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 2.1499999999999999 110.826 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.429 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 82.4 p -80.02 167.1 20.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.86 -0.609 . . . . 1.9299999999999999 111.65 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.96 142.88 36.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 2.5899999999999999 111.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 82.0 p -160.02 159.69 27.01 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.474 -0.784 . . . . 2.1299999999999999 110.003 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 16.4 Cg_endo -57.77 -16.65 26.12 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.197 1.931 . . . . 1.9299999999999999 112.772 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.0 tt0 -72.21 -41.54 66.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.654 0.264 . . . . 2.1800000000000002 110.303 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.434 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.79 80.4 0.87 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.815 -0.809 . . . . 2.4100000000000001 108.815 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.61 -11.24 49.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.238 -0.892 . . . . 1.96 111.686 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -78.3 156.82 43.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.217 -0.992 . . . . 0.56000000000000005 111.916 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.84 148.81 81.97 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.226 1.951 . . . . 1.1899999999999999 111.435 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -77.5 131.7 38.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.806 0.336 . . . . 2.4100000000000001 110.288 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -133.83 152.34 51.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.245 0.545 . . . . 1.78 111.093 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.2 mt -143.57 107.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.923 -1.035 . . . . 1.4099999999999999 109.711 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.659 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 97.6 mt-10 -110.25 115.01 28.93 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.191 0.441 . . . . 1.6699999999999999 112.191 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.64 ' HB2' HG23 ' A' ' 72' ' ' ILE . 76.9 m95 -99.17 120.89 40.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.23999999999999999 110.612 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 87.7 mt -105.21 140.77 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 1.1200000000000001 109.45 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.3 tt -130.0 130.02 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.274 0.559 . . . . 1.3700000000000001 112.165 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.1 p -119.17 103.06 48.04 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.816 -0.809 . . . . 1.73 108.816 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.3 Cg_endo -79.07 114.65 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.51 2.14 . . . . 0.84999999999999998 113.208 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.03 87.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 1.0700000000000001 111.006 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.99 -40.03 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.62 . . . . 1.8200000000000001 111.437 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.567 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.85 160.87 21.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 2.3599999999999999 111.661 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.0 -22.0 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.349 -0.841 . . . . 1.95 112.313 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.585 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -72.64 156.73 38.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.765 0.317 . . . . 2.2799999999999998 111.789 -178.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.35 128.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.906 0.86 . . . . 1.4199999999999999 109.954 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 39.98 19.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.979 -1.464 . . . . 1.77 112.47 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -88.86 146.84 24.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.666 -0.243 . . . . 2.54 110.578 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 17.2 t -68.87 124.3 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.676 -0.49 . . . . 1.3899999999999999 109.676 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.867 ' CD1' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -112.04 -52.14 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.055 0.761 . . . . 1.8200000000000001 113.055 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.969 ' HB ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.06 124.64 26.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.537 -0.912 . . . . 1.0800000000000001 108.537 179.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' CD1' ' HG2' ' A' ' 56' ' ' GLU . 3.8 tt -132.24 156.48 46.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 1.8799999999999999 110.586 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.871 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 15.6 t80 -135.14 104.98 6.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.249 -0.432 . . . . 2.2000000000000002 109.94 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 7.7 t -142.11 158.84 43.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.822 0.344 . . . . 1.4199999999999999 111.802 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.4 28.7 36.57 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.843 -0.694 . . . . 0.56999999999999995 112.217 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.6 t0 72.2 3.28 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.24 . . . . 1.46 110.871 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 20.9 mmtp -100.03 112.29 24.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.269 -0.641 . . . . 2.96 109.269 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.871 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.84 116.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.171 -1.048 . . . . 2.27 108.171 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.744 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.1 m-85 -99.43 130.55 45.7 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.816 -1.538 . . . . 2.1499999999999999 110.659 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.9 p-10 -165.9 -53.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.743 -1.206 . . . . 1.2 107.743 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -79.92 -20.09 46.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.291 -0.868 . . . . 2.1699999999999999 109.171 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.434 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.2 t80 -80.82 -27.0 36.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.352 -0.981 . . . . 5.4100000000000001 108.352 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.7 m-85 -86.1 113.3 51.2 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.945 -1.025 . . . . 2.21 110.777 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.4 -41.37 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.36 1.373 . . . . 1.1100000000000001 109.951 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 71' ' ' ILE . 46.7 m-20 -67.29 105.16 1.67 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.574 -0.739 . . . . 1.3600000000000001 110.668 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.854 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.0 mt 67.35 23.41 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.735 1.013 . . . . 2.2400000000000002 113.735 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttm -56.08 129.26 39.22 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.517 -0.739 . . . . 2.8700000000000001 111.08 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.65 15.56 54.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.352 -0.928 . . . . 0.48999999999999999 114.216 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.854 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.4 ptp180 -144.25 -48.93 0.27 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 114.645 1.35 . . . . 2.1099999999999999 114.645 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.969 HG12 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -79.89 81.9 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 123.157 1.456 . . . . 1.04 107.604 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -103.21 129.45 50.14 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.151 -2.295 . . . . 0.34000000000000002 112.399 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 84.7 m-85 -70.81 125.04 25.73 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.907 -0.717 . . . . 2.1600000000000001 109.788 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.507 HG23 ' CE2' ' A' ' 38' ' ' TYR . 14.3 p -77.06 36.94 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.923 -1.035 . . . . 1.0900000000000001 112.931 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.419 ' O ' HD11 ' A' ' 98' ' ' LEU . 38.0 m -147.75 136.3 21.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 1.71 111.257 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.85 0.77 57.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.663 . . . . 2.4700000000000002 110.632 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -146.69 67.81 1.17 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.448 -0.575 . . . . 2.1400000000000001 109.448 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.422 ' CD2' ' CD2' ' A' ' 74' ' ' TYR . 7.9 mp -57.15 -27.73 62.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.302 -0.863 . . . . 1.99 111.044 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -64.29 -2.93 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 2.4900000000000002 112.062 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -87.24 0.01 56.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.524 -0.762 . . . . 1.8999999999999999 110.964 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 109.93 -7.14 31.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.40999999999999998 113.234 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.35 119.4 35.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.968 0.413 . . . . 1.4399999999999999 110.813 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.57 6.48 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.891 -0.595 . . . . 1.1200000000000001 111.571 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -59.95 140.08 56.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 116.203 1.927 . . . . 1.46 116.203 -177.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -129.13 131.94 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.147 -1.388 . . . . 1.0900000000000001 110.788 177.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -104.08 142.84 33.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.054 -1.091 . . . . 1.5600000000000001 108.054 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.51 120.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.024 0.44 . . . . 1.0600000000000001 111.439 -178.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.2 p -84.29 143.86 29.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.444 -0.798 . . . . 1.0700000000000001 110.851 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 31.0 m120 49.97 55.13 9.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.072 -0.513 . . . . 1.9399999999999999 111.916 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 27.9 mt -44.19 93.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.456 0.91 . . . . 1.21 113.456 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 56.2 tt0 -59.64 144.47 47.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.7 -0.682 . . . . 2.6699999999999999 110.136 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.507 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 63.9 tp -59.97 -40.07 87.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.193 0.52 . . . . 2.2400000000000002 110.792 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -73.24 -5.56 40.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.739 -0.664 . . . . 1.8300000000000001 111.517 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.96 -19.02 63.38 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.082 -0.34 . . . . 1.5800000000000001 110.082 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 139.63 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 116.145 -0.479 . . . . 1.1399999999999999 110.206 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 141.04 159.73 8.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.958 -1.115 . . . . 0.26000000000000001 113.414 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 63.7 m -59.44 130.69 48.12 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.838 0.681 . . . . 1.0700000000000001 112.838 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 13.3 m-85 -114.27 129.64 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.174 -0.676 . . . . 2.1400000000000001 109.174 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 12.1 tt0 -120.9 118.61 30.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 1.5900000000000001 110.276 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.62 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 9.7 t -101.01 118.29 36.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 1.03 110.57 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 97.4 mttt -123.66 112.32 17.25 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 116.475 -0.33 . . . . 2.1899999999999999 111.774 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 61.9 t -92.05 106.46 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.235 -0.654 . . . . 1.8200000000000001 109.235 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.673 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 25.7 ttpp -95.42 117.34 30.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.006 -0.678 . . . . 2.1899999999999999 112.691 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 44' ' ' THR . 2.7 pttm -146.29 103.14 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.51 -0.476 . . . . 3.2799999999999998 110.12 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.463 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -49.92 133.91 21.61 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.691 -0.686 . . . . 1.1799999999999999 112.055 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.434 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.7 Cg_endo -100.03 46.52 2.37 Favored 'Cis proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.769 -0.929 . . . . 0.62 111.209 -0.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 103.62 0.29 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.257 -0.973 . . . . 0.53000000000000003 113.674 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.47 153.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.712 -0.744 . . . . 1.8700000000000001 109.322 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -139.51 144.92 38.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.279 -0.168 . . . . 1.3200000000000001 111.269 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.519 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 40.0 p-10 -146.57 142.22 27.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.895 0.702 . . . . 2.0299999999999998 112.895 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.58 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.01 157.78 44.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.784 -0.644 . . . . 3.46 110.39 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 41.2 tttt -101.84 139.98 36.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.216 0.821 . . . . 2.6699999999999999 113.216 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 70.9 mt -142.23 119.86 7.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.883 -0.599 . . . . 1.0600000000000001 109.953 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.414 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 14.8 m170 -100.22 118.37 36.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 0.70999999999999996 110.381 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.421 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 57.0 tp -91.89 123.2 35.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.217 0.451 . . . . 2.1000000000000001 112.217 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -120.03 119.99 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 1.0900000000000001 109.424 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.95 121.71 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.72 111.794 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.2 mt -81.56 164.5 21.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.337 -0.616 . . . . 1.21 109.337 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.399 0.619 . . . . 2.0899999999999999 111.261 -178.831 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.807 0.337 . . . . 2.2599999999999998 110.944 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG21 ' HB1' ' A' ' 129' ' ' ALA . 1.1 pt -144.29 151.34 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 116.169 -0.469 . . . . 2.6299999999999999 111.413 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 82.6 p -92.39 161.73 14.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.544 0.687 . . . . 1.6499999999999999 111.618 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.18 83.55 0.2 Allowed Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.566 -1.197 . . . . 1.26 112.091 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.653 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 65.4 Cg_endo -78.44 -91.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.586 2.857 . . . . 0.88 111.876 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.75 126.93 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.704 -0.85 . . . . 2.0600000000000001 108.704 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 133' ' ' ILE . 55.3 tt0 -143.69 153.66 42.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.842 1.052 . . . . 1.71 113.842 -176.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.472 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 58.5 mtp -135.45 116.45 14.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.62 -1.173 . . . . 2.3999999999999999 108.511 176.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.552 HD12 HG22 ' A' ' 133' ' ' ILE . 3.7 mp -120.0 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.004 0.431 . . . . 1.1499999999999999 111.809 -178.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.665 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 43.9 mt-10 -106.86 126.15 51.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 1.1899999999999999 110.203 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.532 ' HB3' HD11 ' A' ' 110' ' ' LEU . 49.9 tptt -141.7 157.3 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 2.9300000000000002 111.081 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.68 40.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 1.1299999999999999 112.018 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.3 134.02 18.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.995 -0.548 . . . . 2.7599999999999998 111.546 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.63 -20.39 27.83 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.874 -0.603 . . . . 0.32000000000000001 112.578 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 79.5 mm-40 -79.94 160.0 26.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 178.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.829 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.1 m -89.46 129.97 35.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.658 -0.817 . . . . 1.0800000000000001 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -99.92 115.8 30.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.861 0.362 . . . . 1.0700000000000001 110.217 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.503 ' CE2' HG23 ' A' ' 94' ' ' THR . 32.6 t80 -79.25 116.42 19.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.027 -0.533 . . . . 2.3199999999999998 111.875 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 15.5 mt -101.5 107.62 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 177.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.67 122.76 3.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.13 . . . . 0.71999999999999997 113.972 -178.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.3 t -141.46 126.34 18.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.744 -0.662 . . . . 1.03 110.211 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.5 mttm -140.91 149.93 42.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.922 -0.581 . . . . 2.2400000000000002 109.993 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 36.3 p90 -140.87 139.98 34.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 2.1499999999999999 112.012 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.43 139.64 30.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.743 . . . . 1.9299999999999999 110.373 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.415 HD22 ' CE ' ' A' ' 124' ' ' LYS . 90.0 mt -92.22 107.6 19.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 2.5899999999999999 110.884 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ASP . 30.4 t -83.54 133.58 46.66 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.529 -0.545 . . . . 2.1299999999999999 109.529 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -43.0 -33.2 3.11 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.691 1.594 . . . . 1.9299999999999999 111.04 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 83.4 tt0 -76.72 -39.98 50.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.358 -0.837 . . . . 2.1800000000000002 111.074 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.486 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 77.0 m-20 -68.5 79.19 0.27 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.41 -0.516 . . . . 2.4100000000000001 109.659 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.99 -5.08 28.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 1.96 111.925 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.687 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.04 160.81 53.25 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.894 -0.669 . . . . 0.56000000000000005 112.689 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.36 138.27 85.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.422 2.082 . . . . 1.1899999999999999 112.384 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 124' ' ' LYS . 11.3 mt -78.17 120.08 22.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 2.4100000000000001 111.596 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -133.51 103.05 5.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.548 0.69 . . . . 1.78 111.419 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.7 mp -91.34 122.35 42.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.745 -1.116 . . . . 1.4099999999999999 110.162 179.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.904 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.3 mt-10 -119.08 114.08 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.449 0.537 . . . . 1.6699999999999999 112.449 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.591 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 76.3 m95 -91.7 120.02 32.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 110.078 -0.341 . . . . 0.23999999999999999 110.078 178.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.9 mt -108.69 143.85 37.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.392 . . . . 1.1200000000000001 109.94 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 117' ' ' THR . 10.3 tt -130.01 132.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.293 0.479 . . . . 1.3700000000000001 112.293 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.405 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.9 m -123.28 101.85 37.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.0 -0.741 . . . . 1.73 109.0 177.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 88.5 Cg_endo -79.86 116.92 3.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.714 2.276 . . . . 0.84999999999999998 113.435 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.96 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.61 -0.723 . . . . 1.0700000000000001 110.632 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -87.42 17.28 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 1.8200000000000001 112.182 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 42.7 m-20 -148.99 160.02 43.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.41 0.624 . . . . 2.3599999999999999 112.213 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.08 -18.64 64.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.052 -0.976 . . . . 1.95 111.92 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.635 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 61.1 mttp -66.82 150.82 48.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 2.2799999999999998 111.017 -178.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.77 130.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-O 122.409 1.099 . . . . 1.4199999999999999 110.299 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 49.66 39.99 18.77 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 112.932 -1.94 . . . . 1.77 112.542 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -90.24 140.02 30.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 2.54 111.095 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 89.7 t -69.65 130.04 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.923 0.392 . . . . 1.3899999999999999 111.048 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.702 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -124.25 -37.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.008 -0.542 . . . . 1.8200000000000001 111.473 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.749 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 124.58 18.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.685 -0.857 . . . . 1.0800000000000001 108.685 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.904 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -140.27 157.61 45.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.64 -0.709 . . . . 1.8799999999999999 110.344 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 60.5 t80 -133.75 103.56 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.018 -0.364 . . . . 2.2000000000000002 110.018 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.424 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 40.0 t -143.03 155.98 44.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.879 0.371 . . . . 1.4199999999999999 111.925 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.84 30.15 28.43 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 112.899 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t0 71.72 1.6 3.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.481 0.182 . . . . 1.46 111.118 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.2 mmtt -99.95 107.03 18.9 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.787 -0.82 . . . . 2.96 108.787 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.76 118.32 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.601 1.191 . . . . 2.27 108.748 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -100.28 124.9 46.3 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.527 -2.124 . . . . 2.1499999999999999 111.563 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.809 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.8 p-10 -166.31 -53.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.01 -1.478 . . . . 1.2 107.01 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 55.2 t0 -81.34 -32.59 32.91 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.538 -1.21 . . . . 2.1699999999999999 109.117 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 46.9 m-85 -71.55 -31.82 67.42 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.332 -1.358 . . . . 5.4100000000000001 107.332 178.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -82.49 109.97 19.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.338 -1.301 . . . . 2.21 109.256 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 26.7 Cg_exo -62.96 -31.05 77.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.018 1.812 . . . . 1.1100000000000001 113.031 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 83.7 m-20 -49.99 -29.95 9.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 1.3600000000000001 112.564 -178.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 2.0 mp -152.2 27.66 0.59 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.474 -0.785 . . . . 2.2400000000000002 111.198 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.809 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 24.8 pttm -55.63 138.15 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.156 0.503 . . . . 2.8700000000000001 111.839 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.85 82.89 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.617 -0.801 . . . . 0.48999999999999999 114.41 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -143.35 -52.42 0.36 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 115.07 1.507 . . . . 2.1099999999999999 115.07 -178.545 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.749 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.3 81.33 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.939 1.352 . . . . 1.04 107.861 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -100.64 127.87 46.89 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 112.442 -2.163 . . . . 0.34000000000000002 112.418 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.736 ' CD2' HG13 ' A' ' 79' ' ' ILE . 78.8 m-85 -72.14 120.57 17.92 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.12 -0.696 . . . . 2.1600000000000001 109.12 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.503 HG23 ' CE2' ' A' ' 38' ' ' TYR . 28.4 p -71.34 -9.93 58.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.336 -0.847 . . . . 1.0900000000000001 109.957 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 p -86.94 122.62 31.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.6 -0.727 . . . . 1.71 109.55 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.95 4.66 49.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.144 0.497 . . . . 2.4700000000000002 110.307 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -146.66 69.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.742 -0.836 . . . . 2.1400000000000001 108.742 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -56.13 -39.59 72.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.085 -0.961 . . . . 1.99 111.363 -178.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -64.77 -3.07 2.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.118 0.485 . . . . 2.4900000000000002 112.111 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.7 t -89.56 -0.01 57.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.626 -0.715 . . . . 1.8999999999999999 111.029 179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.517 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.34 -16.16 35.23 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.722 -0.751 . . . . 0.40999999999999998 113.698 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -97.3 108.82 21.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.203 0.502 . . . . 1.4399999999999999 110.45 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.558 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.45 19.94 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 1.1200000000000001 112.667 -179.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.2 m -61.53 140.0 58.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.857 1.429 . . . . 1.46 114.857 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.15 133.27 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.061 -0.972 . . . . 1.0900000000000001 111.25 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.58 ' O ' ' O ' ' A' ' 90' ' ' ARG . 53.4 p-10 -106.66 145.5 31.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.829 -0.804 . . . . 1.5600000000000001 108.829 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.5 122.09 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 1.0600000000000001 111.63 -178.354 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -84.86 144.13 28.61 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.52 -0.764 . . . . 1.0700000000000001 111.169 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 96.8 m-20 49.96 57.66 6.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 1.9399999999999999 111.354 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 31' ' ' LYS . 35.6 mt -47.57 92.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.126 1.158 . . . . 1.21 114.126 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 35.0 mt-30 -58.64 142.4 49.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.069 -0.514 . . . . 2.6699999999999999 110.413 176.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.04 -36.86 78.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.094 0.473 . . . . 2.2400000000000002 110.185 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 t -74.31 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.646 . . . . 1.8300000000000001 111.358 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.74 -15.55 62.69 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.009 -0.367 . . . . 1.5800000000000001 110.009 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 141.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-N 116.238 -0.437 . . . . 1.1399999999999999 110.096 178.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.79 155.2 6.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.879 -1.153 . . . . 0.26000000000000001 113.759 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.5 m -59.18 129.99 44.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.483 0.549 . . . . 1.0700000000000001 112.483 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.2 m-85 -111.2 130.2 55.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.291 -0.633 . . . . 2.1400000000000001 109.291 177.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 62.4 tt0 -121.79 120.05 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.811 -0.356 . . . . 1.5900000000000001 111.022 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 40.7 t -100.04 123.14 43.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.036 -0.529 . . . . 1.03 109.923 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.783 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 96.0 mttt -123.87 105.45 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.69 -0.404 . . . . 2.1899999999999999 111.978 -179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 25.0 t -89.44 111.98 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.476 -0.935 . . . . 1.8200000000000001 108.476 177.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 77.7 tttt -99.45 120.06 39.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.411 0.893 . . . . 2.1899999999999999 113.411 -177.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 14.0 tttp -145.72 102.5 3.68 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.725 -0.472 . . . . 3.2799999999999998 109.725 176.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -50.97 131.36 30.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.548 -0.751 . . . . 1.1799999999999999 112.934 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 46.2 Cg_endo -100.76 48.04 2.04 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.696 -0.96 . . . . 0.62 112.527 -0.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.85 102.64 0.31 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.139 -1.029 . . . . 0.53000000000000003 112.982 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 ' CG1' ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -88.82 132.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.207 -0.997 . . . . 1.8700000000000001 109.629 177.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -121.13 139.05 53.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.773 0.286 . . . . 1.3200000000000001 111.773 -179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.464 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 52.4 p30 -146.33 146.14 30.58 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.252 0.464 . . . . 2.0299999999999998 112.252 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.52 160.11 42.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 3.46 110.652 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 44.0 mttp -99.96 140.78 33.68 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.298 0.851 . . . . 2.6699999999999999 113.298 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.61 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 3.5 mp -139.26 109.13 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.824 -1.08 . . . . 1.0600000000000001 108.459 176.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.472 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 54.0 m170 -97.28 118.02 32.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.353 -0.539 . . . . 0.70999999999999996 110.748 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 118' ' ' TYR . 61.2 tp -92.41 123.3 35.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.883 -0.598 . . . . 2.1000000000000001 111.669 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.665 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 45.3 t -119.93 120.9 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.723 -0.671 . . . . 1.0900000000000001 109.328 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.1 t -95.49 121.97 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.376 0.51 . . . . 1.72 112.376 -178.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 89.6 mt -84.05 163.77 19.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.717 -0.674 . . . . 1.21 109.224 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.401 0.62 . . . . 2.0899999999999999 111.429 -178.912 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.081 0.467 . . . . 2.2599999999999998 111.361 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -149.72 149.81 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 110.934 -179.577 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.15 155.13 17.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 1.6499999999999999 112.21 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 38.79 82.69 0.22 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.358 -1.292 . . . . 1.26 112.652 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.713 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 53.6 Cg_endo -79.26 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.449 2.766 . . . . 0.88 112.738 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 85.9 tt0 -78.54 127.88 32.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.11 -0.7 . . . . 2.0600000000000001 109.11 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 28' ' ' MET . 44.3 tp10 -143.74 157.02 44.68 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.785 1.032 . . . . 1.71 113.785 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.406 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 54.0 ttp -136.92 125.34 23.42 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.665 -1.152 . . . . 2.3999999999999999 107.934 176.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.619 HD11 HG21 ' A' ' 133' ' ' ILE . 4.1 mp -130.24 137.52 56.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.703 -0.681 . . . . 1.1499999999999999 112.362 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 74.9 mt-10 -133.77 127.74 33.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.156 -0.475 . . . . 1.1899999999999999 110.154 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 10.9 tptm -142.71 161.35 38.32 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.511 0.196 . . . . 2.9300000000000002 110.754 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.07 140.59 41.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 1.1299999999999999 112.228 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -47.25 132.3 12.77 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.819 -0.628 . . . . 2.7599999999999998 111.421 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.64 -20.11 36.91 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.049 -0.596 . . . . 0.32000000000000001 112.686 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.3 mt-10 -80.04 157.67 26.68 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.767 -0.827 . . . . 2.1099999999999999 108.767 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.831 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.5 m -87.6 126.97 35.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.985 -0.686 . . . . 1.0800000000000001 110.733 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.498 ' HB1' HD22 ' A' ' 110' ' ' LEU . . . -99.56 115.17 28.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.831 0.348 . . . . 1.0700000000000001 110.367 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 71.6 t80 -79.46 115.14 18.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 2.3199999999999998 112.383 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 20.8 mt -100.22 109.83 57.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 108.593 -0.891 . . . . 1.47 108.593 177.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.46 125.35 2.91 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.353 2.035 . . . . 0.71999999999999997 114.97 -177.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -141.51 122.26 14.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.819 -1.082 . . . . 1.03 108.495 177.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -141.32 115.89 9.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 2.2400000000000002 111.513 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.586 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 25.6 p90 -94.48 139.97 30.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.006 -0.997 . . . . 2.1499999999999999 111.025 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 141.92 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 1.9299999999999999 111.042 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 98.6 mt -97.73 139.54 33.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.599 . . . . 2.5899999999999999 111.527 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.447 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 86.2 p -159.89 145.99 11.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 2.1299999999999999 109.942 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.62 -21.54 3.54 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.318 2.012 . . . . 1.9299999999999999 113.084 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.589 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.75 -40.06 66.36 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.769 -0.196 . . . . 2.1800000000000002 111.329 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.52 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 3.1 p30 -69.91 79.14 0.47 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.035 -0.666 . . . . 2.4100000000000001 110.115 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.38 -10.06 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.225 -0.898 . . . . 1.96 111.837 -178.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -79.54 154.26 38.01 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.304 -0.951 . . . . 0.56000000000000005 112.981 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.99 153.71 19.72 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.498 2.132 . . . . 1.1899999999999999 111.696 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.47 HD12 ' CE2' ' A' ' 43' ' ' PHE . 47.7 tp -78.08 131.56 37.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 2.4100000000000001 111.337 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -139.5 149.08 43.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.36 0.6 . . . . 1.78 110.722 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.751 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 30.5 mt -142.75 135.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.845 -1.07 . . . . 1.4099999999999999 109.087 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.631 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 40.2 mt-10 -140.13 108.28 5.77 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.278 0.474 . . . . 1.6699999999999999 112.278 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.834 ' HB2' HG22 ' A' ' 72' ' ' ILE . 78.5 m95 -94.51 126.34 39.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.382 -0.372 . . . . 0.23999999999999999 110.918 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.8 mt -108.87 141.18 41.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.877 -0.786 . . . . 1.1200000000000001 108.877 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 117' ' ' THR . 11.5 tt -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.52 0.563 . . . . 1.3700000000000001 112.52 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 t -120.36 102.95 45.05 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.228 -0.896 . . . . 1.73 108.932 177.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.1 Cg_endo -78.24 115.63 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.527 2.151 . . . . 0.84999999999999998 113.028 -178.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.86 -34.47 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.356 -0.838 . . . . 1.0700000000000001 110.679 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.18 11.53 7.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.637 -0.71 . . . . 1.8200000000000001 111.818 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.451 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -148.93 160.37 43.33 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.279 0.561 . . . . 2.3599999999999999 111.76 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.75 -18.47 64.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.284 -0.871 . . . . 1.95 112.694 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.682 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.3 mttt -65.79 144.05 57.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.253 -0.431 . . . . 2.2799999999999998 111.216 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 m -156.39 129.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-O 121.929 0.871 . . . . 1.4199999999999999 110.019 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.02 40.0 19.23 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.97 -1.468 . . . . 1.77 112.827 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 96.9 mt-30 -95.26 141.1 29.25 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.367 -0.235 . . . . 2.54 110.367 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 16.5 t -65.86 120.0 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.3899999999999999 109.977 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.779 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -105.97 -51.97 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.4 -0.818 . . . . 1.8200000000000001 112.045 -178.135 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.834 HG22 ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -138.81 122.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.949 -1.13 . . . . 1.0800000000000001 107.949 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 1.1 tt -130.98 154.88 47.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.778 -0.646 . . . . 1.8799999999999999 110.895 -176.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.846 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 25.9 t80 -133.01 104.54 6.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.309 -0.256 . . . . 2.2000000000000002 110.309 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.453 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 10.0 t -142.64 156.82 45.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.882 0.372 . . . . 1.4199999999999999 111.98 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.57 29.7 40.55 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.924 -0.655 . . . . 0.56999999999999995 112.43 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.56 3.14 4.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.583 0.23 . . . . 1.46 110.915 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 34.3 mttm -100.03 112.56 24.85 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.749 -0.463 . . . . 2.96 109.749 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.846 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -83.85 116.98 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.941 -1.133 . . . . 2.27 107.941 178.136 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.743 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.5 m-85 -99.95 127.74 46.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.282 -1.781 . . . . 2.1499999999999999 110.589 -178.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.797 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.0 p-10 -166.01 -52.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.426 -1.324 . . . . 1.2 107.426 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -80.2 -23.2 41.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.988 -1.006 . . . . 2.1699999999999999 109.31 177.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -78.68 -28.0 45.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.588 -0.893 . . . . 5.4100000000000001 108.588 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.521 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 m-85 -84.71 119.85 73.28 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 114.942 -1.027 . . . . 2.21 110.668 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.69 -41.75 44.98 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.261 1.307 . . . . 1.1100000000000001 109.237 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 71' ' ' ILE . 39.1 m-20 -66.98 104.66 1.43 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.365 -0.834 . . . . 1.3600000000000001 110.657 178.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.9 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.0 mp 68.8 27.35 5.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.101 1.148 . . . . 2.2400000000000002 114.101 178.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.797 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.3 pttt -57.58 129.56 42.41 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.659 -0.65 . . . . 2.8700000000000001 111.23 177.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.37 19.35 58.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.711 -0.757 . . . . 0.48999999999999999 114.31 178.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.9 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.7 ptm180 -145.89 -48.26 0.21 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.379 1.252 . . . . 2.1099999999999999 114.379 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.817 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -78.86 81.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.071 -1.455 . . . . 1.04 107.071 -178.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 15.7 m80 -102.8 128.62 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.262 -2.245 . . . . 0.34000000000000002 112.789 -175.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 73.3 m-85 -70.26 123.76 22.46 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 120.152 -0.619 . . . . 2.1600000000000001 109.61 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.484 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 15.9 p -73.52 33.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.426 -0.807 . . . . 1.0900000000000001 111.839 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -149.63 128.81 12.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.71 110.097 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -92.64 7.56 42.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.986 -0.552 . . . . 2.4700000000000002 110.377 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -146.35 65.72 1.19 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 109.116 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 74' ' ' TYR . 9.6 mp -56.7 -24.72 51.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.391 -0.822 . . . . 1.99 111.432 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.3 -3.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 2.4900000000000002 111.996 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 98' ' ' LEU . 22.7 t -88.73 0.03 56.86 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.48 -0.782 . . . . 1.8999999999999999 110.94 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 104.31 -9.94 50.12 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.731 -0.747 . . . . 0.40999999999999998 113.647 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.11 110.04 21.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.963 0.381 . . . . 1.4399999999999999 111.198 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -107.77 9.48 28.99 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.508 0.559 . . . . 1.1200000000000001 112.508 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.7 p -59.98 143.45 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.67 1.73 . . . . 1.46 115.67 -178.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.37 132.33 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 114.422 -1.263 . . . . 1.0900000000000001 110.78 178.17 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.559 ' O ' ' O ' ' A' ' 90' ' ' ARG . 53.2 p30 -106.41 146.37 30.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.631 -0.878 . . . . 1.5600000000000001 108.631 177.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.831 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 120.02 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 120.826 0.346 . . . . 1.0600000000000001 111.152 -178.257 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.611 HG22 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.92 143.7 30.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.824 -0.625 . . . . 1.0700000000000001 110.928 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 26.4 m120 47.88 58.89 4.6 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.186 -0.461 . . . . 1.9399999999999999 111.675 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.582 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 18.8 mt -44.44 88.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.082 1.142 . . . . 1.21 114.082 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.459 ' O ' ' OD2' ' A' ' 114' ' ' ASP . 51.7 tt0 -58.53 147.26 32.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.548 -0.538 . . . . 2.6699999999999999 109.548 176.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.03 -37.03 78.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.43 . . . . 2.2400000000000002 111.036 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.8 m -72.03 -9.66 58.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 1.8300000000000001 112.39 -178.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 111' ' ' GLN . 3.0 p30 -70.47 -18.57 62.98 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.378 -0.529 . . . . 1.5800000000000001 110.085 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 137.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 CA-C-N 115.988 -0.551 . . . . 1.1399999999999999 110.265 179.112 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.99 160.51 8.32 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 119.844 -1.17 . . . . 0.26000000000000001 113.853 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -60.04 137.09 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.125 -0.537 . . . . 1.0700000000000001 112.128 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 25.0 m-85 -120.04 132.15 55.36 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.445 -0.576 . . . . 2.1400000000000001 109.445 177.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.715 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 49.0 tp60 -120.0 115.06 22.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.073 -0.251 . . . . 1.5900000000000001 110.708 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.503 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 53.0 t -98.35 116.82 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 1.03 110.295 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 88.2 mttt -119.1 106.41 12.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 2.1899999999999999 111.066 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.4 t -91.34 105.5 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.566 -0.531 . . . . 1.8200000000000001 109.566 179.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.638 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 52.2 tttp -90.48 116.11 28.15 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.039 -0.665 . . . . 2.1899999999999999 111.474 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.52 ' HE2' ' CB ' ' A' ' 49' ' ' ASP . 7.2 ttpm? -146.08 102.35 3.62 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.457 -0.571 . . . . 3.2799999999999998 109.457 178.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -51.42 134.39 33.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 1.1799999999999999 112.002 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.9 Cg_endo -100.13 48.69 1.92 Allowed 'Cis proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.698 -0.959 . . . . 0.62 111.297 -0.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 103.31 0.28 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.188 -1.006 . . . . 0.53000000000000003 113.591 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.404 ' CG1' ' HG3' ' A' ' 123' ' ' LYS . 3.5 m -87.4 120.0 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.552 -0.824 . . . . 1.8700000000000001 109.956 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -101.53 144.77 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.867 0.321 . . . . 1.3200000000000001 111.867 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.44 ' C ' ' HG3' ' A' ' 131' ' ' LYS . 46.1 t30 -146.28 132.11 19.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 2.0299999999999998 111.114 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.713 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 4.7 mttp -142.58 160.33 40.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.841 0.353 . . . . 3.46 111.773 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 64.5 mttt -101.77 141.67 34.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.441 0.904 . . . . 2.6699999999999999 113.441 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.619 HG21 HD11 ' A' ' 29' ' ' ILE . 3.1 mp -142.58 112.59 2.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.041 -0.982 . . . . 1.0600000000000001 109.347 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -101.1 114.4 28.3 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.9 -0.5 . . . . 0.70999999999999996 110.58 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 14.9 mt -96.2 135.58 37.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.698 0.629 . . . . 2.1000000000000001 112.698 -179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 60.7 t -129.96 130.0 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.355 -0.838 . . . . 1.0900000000000001 109.198 178.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.9 t -100.46 121.32 51.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.872 0.368 . . . . 1.72 111.96 -179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.7 mt -80.77 163.7 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.353 -0.61 . . . . 1.21 109.353 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.462 0.649 . . . . 2.0899999999999999 111.681 -178.522 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.781 0.324 . . . . 2.2599999999999998 110.666 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 43' ' ' PHE . 45.1 mm -140.02 138.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 110.884 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -86.89 144.91 26.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.6499999999999999 110.292 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.48 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 45.28 82.61 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 115.179 -0.919 . . . . 1.26 110.39 -177.33 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 57.3 Cg_endo -77.94 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.649 2.899 . . . . 0.88 113.095 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.28 120.66 23.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.571 -0.529 . . . . 2.0600000000000001 109.571 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -143.82 160.02 41.51 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.604 0.964 . . . . 1.71 113.604 -177.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 53.6 ttm -130.95 130.95 44.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.867 -1.06 . . . . 2.3999999999999999 108.724 177.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.513 HD12 HG22 ' A' ' 133' ' ' ILE . 3.5 mp -129.71 131.9 66.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.62 . . . . 1.1499999999999999 112.122 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.651 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 89.7 mt-10 -122.63 127.18 49.04 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.281 -0.418 . . . . 1.1899999999999999 110.737 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 110' ' ' LEU . 47.0 mmtm -142.33 160.03 41.07 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.563 0.221 . . . . 2.9300000000000002 110.998 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.723 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.79 137.0 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 1.1299999999999999 112.157 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HA ' ' CG1' ' A' ' 137' ' ' VAL . 60.0 tttt -46.22 129.97 10.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.895 -0.593 . . . . 2.7599999999999998 110.964 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.74 -19.12 43.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.32000000000000001 112.275 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 68.1 mm-40 -80.05 160.03 25.97 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.438 -0.949 . . . . 2.1099999999999999 108.438 178.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.856 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.6 m -88.82 129.73 35.52 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.608 -0.837 . . . . 1.0800000000000001 110.685 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -99.99 120.0 39.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.895 0.379 . . . . 1.0700000000000001 110.449 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.479 ' HE1' ' CG2' ' A' ' 94' ' ' THR . 70.1 t80 -79.1 117.42 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 2.3199999999999998 111.714 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 20.4 mt -109.98 104.4 55.48 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.838 -0.801 . . . . 1.47 108.838 178.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.637 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 89.8 Cg_endo -86.92 128.92 2.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.352 2.035 . . . . 0.71999999999999997 114.019 -178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 1.8 t -140.8 128.89 22.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.402 -0.817 . . . . 1.03 108.8 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.537 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.6 ttpt -140.86 118.62 11.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.241 0.543 . . . . 2.2400000000000002 110.961 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.575 ' HA ' HD13 ' A' ' 22' ' ' ILE . 43.9 p90 -101.87 137.63 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.667 -1.151 . . . . 2.1499999999999999 112.399 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -89.26 140.01 29.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 1.9299999999999999 109.785 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.7 mt -94.46 109.7 21.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.964 -0.294 . . . . 2.5899999999999999 111.327 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.1 m -83.75 140.0 40.69 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 109.467 -0.568 . . . . 2.1299999999999999 109.467 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.88 -34.08 21.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.801 1.668 . . . . 1.9299999999999999 110.775 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.4 pt-20 -81.52 -33.97 31.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.441 -0.799 . . . . 2.1800000000000002 111.798 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.499 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 78.9 m-20 -69.14 77.62 0.35 Allowed 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 120.271 -0.572 . . . . 2.4100000000000001 110.143 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -101.82 -0.76 33.67 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.502 -0.772 . . . . 1.96 111.548 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -74.08 162.86 54.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.01 -0.614 . . . . 0.56000000000000005 113.4 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.12 131.42 44.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.809 2.339 . . . . 1.1899999999999999 112.168 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 13.6 tp -78.12 126.38 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 2.4100000000000001 111.337 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 123' ' ' LYS . 6.1 m-20 -139.36 103.09 4.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.564 0.697 . . . . 1.78 111.646 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.9 mt -95.69 118.28 41.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.745 -1.116 . . . . 1.4099999999999999 110.322 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.1 tt0 -115.64 120.32 39.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.453 0.538 . . . . 1.6699999999999999 112.453 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.659 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 82.6 m95 -94.18 119.94 33.73 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.194 -0.299 . . . . 0.23999999999999999 110.194 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.2 mt -108.13 142.45 38.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 1.1200000000000001 110.185 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.6 tt -130.0 132.33 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 1.3700000000000001 112.043 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 48.7 m -117.71 102.12 51.77 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 108.471 -0.937 . . . . 1.73 108.471 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.616 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 85.4 Cg_endo -79.38 113.49 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.807 2.338 . . . . 0.84999999999999998 113.031 -178.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.99 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 1.0700000000000001 111.257 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.63 -40.08 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 1.8200000000000001 111.556 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 33.9 m120 -84.58 160.04 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 2.3599999999999999 111.957 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.81 -18.0 64.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.303 -0.862 . . . . 1.95 111.245 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.616 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 42.9 mttt -69.49 154.63 41.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.579 -0.737 . . . . 2.2799999999999998 111.681 -178.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.72 128.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-O 121.637 0.732 . . . . 1.4199999999999999 109.072 178.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 57.82 41.82 24.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.631 -1.168 . . . . 1.77 111.724 179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 59' ' ' ILE . 96.1 mm-40 -87.07 135.09 33.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.797 0.332 . . . . 2.54 111.59 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 84' ' ' TYR . 57.7 t -71.82 132.02 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 1.3899999999999999 110.261 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.77 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.3 pp -129.84 -39.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.631 0.604 . . . . 1.8200000000000001 112.631 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -140.43 123.6 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.415 0.626 . . . . 1.0800000000000001 109.637 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 7.3 tt -140.58 160.54 39.78 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.576 -0.738 . . . . 1.8799999999999999 109.477 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.597 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 23.9 t80 -134.32 109.15 8.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.218 0.532 . . . . 2.2000000000000002 110.283 178.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.534 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 32.7 t -142.37 160.01 41.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.353 -0.839 . . . . 1.4199999999999999 111.394 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.31 36.82 53.91 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.822 -0.704 . . . . 0.56999999999999995 112.608 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 60.63 25.22 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.609 0.242 . . . . 1.46 111.378 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.563 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.3 mttp -128.15 111.14 13.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.191 -0.67 . . . . 2.96 109.191 177.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.597 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -76.81 119.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.964 -1.124 . . . . 2.27 107.964 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.796 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -99.97 133.51 44.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.72 -1.127 . . . . 2.1499999999999999 110.62 -178.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.3 p-10 -166.46 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.977 -1.49 . . . . 1.2 106.977 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' CA ' ' A' ' 88' ' ' LYS . 50.9 t0 -80.03 -20.19 45.9 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 114.556 -1.202 . . . . 2.1699999999999999 109.315 177.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.7 t80 -78.78 -29.81 45.21 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.25 -1.018 . . . . 5.4100000000000001 108.25 178.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -84.34 112.61 42.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-N 114.436 -1.257 . . . . 2.21 110.872 179.717 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 85.7 Cg_exo -44.09 -42.98 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.501 1.467 . . . . 1.1100000000000001 110.548 178.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.582 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.0 m-20 -68.31 104.92 1.98 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.685 -0.688 . . . . 1.3600000000000001 110.739 178.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.855 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.4 mp 72.71 18.91 4.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.499 0.926 . . . . 2.2400000000000002 113.499 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.445 -0.784 . . . . 2.8700000000000001 110.763 178.022 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.44 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 91.56 11.67 60.46 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.273 -0.965 . . . . 0.48999999999999999 113.917 178.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.855 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.5 ptp180 -141.27 -53.79 0.47 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 114.574 1.324 . . . . 2.1099999999999999 114.574 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.77 HG12 ' CD1' ' A' ' 71' ' ' ILE . 7.3 p -78.73 80.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.11 -1.441 . . . . 1.04 107.11 -178.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.44 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.3 m80 -97.52 128.82 44.57 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.084 -2.326 . . . . 0.34000000000000002 111.849 -176.148 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 60.5 m-85 -69.4 121.66 17.39 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.685 0.755 . . . . 2.1600000000000001 110.684 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.479 ' CG2' ' HE1' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -73.71 34.85 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.471 -1.24 . . . . 1.0900000000000001 111.732 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -148.81 136.39 20.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.076 0.465 . . . . 1.71 111.683 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.23 0.02 56.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.779 -0.646 . . . . 2.4700000000000002 110.737 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -146.45 66.76 1.18 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.294 0.569 . . . . 2.1400000000000001 109.517 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 7.2 mp -59.14 -31.64 69.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.403 -0.817 . . . . 1.99 111.939 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.52 -3.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.152 0.501 . . . . 2.4900000000000002 112.319 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 98' ' ' LEU . 33.8 m -88.5 -0.09 56.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.54 -0.754 . . . . 1.8999999999999999 111.137 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 111.34 -19.88 23.95 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.748 -0.739 . . . . 0.40999999999999998 112.915 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.0 m-20 -97.01 107.47 20.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.694 0.283 . . . . 1.4399999999999999 110.633 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -116.75 24.23 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.891 0.33 . . . . 1.1200000000000001 111.891 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.4 m -60.92 151.6 29.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 114.425 1.268 . . . . 1.46 114.425 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -137.03 140.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.682 -1.145 . . . . 1.0900000000000001 111.545 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.0 p-10 -113.46 142.81 45.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.263 -1.014 . . . . 1.5600000000000001 108.263 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.856 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 122.36 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 120.991 0.424 . . . . 1.0600000000000001 111.868 -177.866 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.67 143.89 28.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 1.0700000000000001 111.16 178.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.9 OUTLIER 50.82 54.35 11.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.08 -0.509 . . . . 1.9399999999999999 112.304 178.537 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 31' ' ' LYS . 34.5 mt -45.9 89.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.441 1.274 . . . . 1.21 114.441 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 60.1 tp60 -59.4 147.72 35.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.767 -0.651 . . . . 2.6699999999999999 110.399 176.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' CE ' ' A' ' 33' ' ' LYS . 85.4 mt -59.98 -37.35 79.37 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.875 0.369 . . . . 2.2400000000000002 111.144 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.3 p -72.57 -9.47 58.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.052 -0.522 . . . . 1.8300000000000001 111.333 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 96.0 m-20 -70.0 -19.95 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.91 -0.404 . . . . 1.5800000000000001 109.91 179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 142.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 115.922 -0.581 . . . . 1.1399999999999999 110.455 178.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.45 155.93 6.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.824 -1.179 . . . . 0.26000000000000001 113.828 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.6 m -59.33 128.59 37.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.236 0.458 . . . . 1.0700000000000001 112.236 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 18.6 m-85 -108.84 130.76 55.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 2.1400000000000001 109.649 177.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -125.76 119.29 27.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.034 -0.266 . . . . 1.5900000000000001 110.765 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.479 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 20.0 t -99.96 115.82 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.03 110.126 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 52.3 mtpt -112.53 105.52 13.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.878 -0.329 . . . . 2.1899999999999999 111.456 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 15.3 t -89.75 110.58 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.747 -0.834 . . . . 1.8200000000000001 108.747 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 tttm -99.86 120.22 39.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.264 0.839 . . . . 2.1899999999999999 113.264 -177.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 35.5 tttp -145.09 102.15 3.71 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.388 -0.597 . . . . 3.2799999999999998 109.388 177.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -52.36 133.65 43.01 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.331 -0.85 . . . . 1.1799999999999999 113.013 -179.106 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.494 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 55.0 Cg_endo -98.82 47.68 2.11 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.383 -1.09 . . . . 0.62 112.264 -0.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.16 103.13 0.28 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.2 -1.0 . . . . 0.53000000000000003 113.142 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 150.2 3.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.36 -0.92 . . . . 1.8700000000000001 109.587 177.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 22' ' ' ILE . . . -142.98 151.54 40.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.975 -0.29 . . . . 1.3200000000000001 111.683 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.489 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 42.5 p-10 -146.41 153.14 40.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.411 -0.359 . . . . 2.0299999999999998 111.777 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.637 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.35 155.45 43.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.471 -0.331 . . . . 3.46 110.465 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 12.4 tttt -99.99 141.09 33.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.866 1.062 . . . . 2.6699999999999999 113.866 -177.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 68.0 mt -143.81 112.03 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 114.805 -1.089 . . . . 1.0600000000000001 109.397 177.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -97.06 114.38 26.02 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.70999999999999996 110.284 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.47 HD23 ' CE1' ' A' ' 118' ' ' TYR . 52.3 tp -93.02 122.53 35.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.477 0.547 . . . . 2.1000000000000001 112.477 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.651 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.1 t -119.99 121.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.762 -0.829 . . . . 1.0900000000000001 108.762 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 33' ' ' LYS . 11.7 t -98.52 127.03 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 112.656 0.613 . . . . 1.72 112.656 -177.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.723 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 81.3 mt -84.51 173.59 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 1.21 109.443 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.358 0.599 . . . . 2.0899999999999999 112.04 -178.639 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.961 0.41 . . . . 2.2599999999999998 111.026 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.67 141.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 2.6299999999999999 110.798 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.2 p -86.58 157.22 19.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.41 0.624 . . . . 1.6499999999999999 111.399 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.549 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.13 83.21 0.21 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.75 -1.113 . . . . 1.26 111.489 -178.206 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.6 Cg_endo -78.39 -79.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.277 2.651 . . . . 0.88 112.354 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -78.58 128.14 33.1 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.607 -0.886 . . . . 2.0600000000000001 108.607 178.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' LYS . 84.0 tt0 -144.03 159.45 42.57 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.038 1.125 . . . . 1.71 114.038 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.407 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 27.4 mtt -139.97 118.93 12.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.802 -1.09 . . . . 2.3999999999999999 109.584 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.9 mm -120.02 130.93 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.509 -0.314 . . . . 1.1499999999999999 111.428 -179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 19.5 pt-20 -128.56 127.8 43.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 1.1899999999999999 110.775 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HB2' HD13 ' A' ' 110' ' ' LEU . 42.4 mmtm -142.28 164.86 29.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.439 . . . . 2.9300000000000002 110.953 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.52 135.24 39.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.286 -0.416 . . . . 1.1299999999999999 111.283 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -45.84 130.71 9.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.346 -0.388 . . . . 2.7599999999999998 111.24 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.77 -19.91 45.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 0.32000000000000001 112.372 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.2 mt-10 -80.03 160.01 26.0 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.551 -0.907 . . . . 2.1099999999999999 108.551 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 31.3 m -88.68 127.34 35.58 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.789 -0.764 . . . . 1.0800000000000001 110.762 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -100.04 119.97 39.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 1.0700000000000001 110.829 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CE2' HG22 ' A' ' 94' ' ' THR . 41.4 t80 -79.37 119.35 22.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 2.3199999999999998 111.907 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -103.8 105.42 47.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.87 -0.789 . . . . 1.47 108.87 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.489 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 90.7 Cg_endo -84.6 122.66 2.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.449 2.099 . . . . 0.71999999999999997 114.589 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.416 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.73 127.26 20.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.355 -0.979 . . . . 1.03 108.355 177.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.8 ttpt -140.69 116.56 10.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.393 0.616 . . . . 2.2400000000000002 110.697 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.701 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 33.2 p90 -93.62 141.43 28.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 2.1499999999999999 111.885 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 m -80.94 150.48 28.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 110.774 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.79 141.62 39.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.841 -0.618 . . . . 2.5899999999999999 111.313 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 m -156.25 153.59 25.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 2.1299999999999999 110.162 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.4 -20.69 26.82 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.431 2.087 . . . . 1.9299999999999999 112.467 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.678 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 mt-10 -75.76 -41.42 53.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 111.942 0.349 . . . . 2.1800000000000002 111.942 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -69.2 74.64 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.836 -0.745 . . . . 2.4100000000000001 110.244 -179.43 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' GLU . 93.0 mt-30 -90.42 -16.44 29.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.085 -0.961 . . . . 1.96 111.02 -179.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.487 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.05 155.8 53.25 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.133 -1.032 . . . . 0.56000000000000005 112.096 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.23 151.13 9.75 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.125 1.883 . . . . 1.1899999999999999 111.551 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.701 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -77.67 132.62 38.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.854 0.359 . . . . 2.4100000000000001 110.946 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 36.1 t0 -140.26 150.5 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.392 0.615 . . . . 1.78 111.895 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 50.4 mt -142.23 137.78 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.682 -1.145 . . . . 1.4099999999999999 109.619 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 73' ' ' LEU . 37.0 mt-10 -140.22 111.86 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.79 0.328 . . . . 1.6699999999999999 111.825 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.621 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 80.6 m95 -98.67 119.99 38.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 110.908 178.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.55 146.15 37.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.492 . . . . 1.1200000000000001 109.67 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.3 tt -132.5 140.01 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.775 0.657 . . . . 1.3700000000000001 112.775 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -122.37 102.98 39.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.628 -0.879 . . . . 1.73 108.628 177.149 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.7 Cg_exo -79.08 115.23 3.49 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.725 2.283 . . . . 0.84999999999999998 113.22 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.32 69.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 1.0700000000000001 110.243 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.68 10.22 7.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.614 -0.721 . . . . 1.8200000000000001 111.491 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 32.7 m120 -145.77 156.01 43.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.061 0.458 . . . . 2.3599999999999999 111.361 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.91 -22.87 64.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.652 -0.703 . . . . 1.95 111.716 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.68 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 5.6 mttt -73.79 151.23 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 2.2799999999999998 110.71 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.3 m -152.41 136.29 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 122.502 1.144 . . . . 1.4199999999999999 110.764 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 61.23 45.05 9.23 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.758 -2.019 . . . . 1.77 112.566 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -87.12 149.72 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.728 0.299 . . . . 2.54 110.538 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.712 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.9 p -68.26 139.99 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.427 -0.351 . . . . 1.3899999999999999 110.09 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.744 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.1 pp -136.51 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.538 -0.465 . . . . 1.8200000000000001 111.552 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.837 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.19 133.14 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.009 0.433 . . . . 1.0800000000000001 109.848 179.384 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.615 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 1.6 mp -140.83 158.57 43.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 1.8799999999999999 111.024 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 51.8 t80 -133.68 104.47 6.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.578 -0.527 . . . . 2.2000000000000002 109.578 176.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.498 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.1 t -144.02 159.78 42.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.413 0.523 . . . . 1.4199999999999999 112.413 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.57 30.02 6.05 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.988 -0.551 . . . . 0.56999999999999995 113.182 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 t0 71.9 3.07 4.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 1.46 111.4 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 22.8 mtpp -100.03 118.05 35.6 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.1 -0.704 . . . . 2.96 109.1 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.443 HD13 ' CE1' ' A' ' 74' ' ' TYR . 2.3 mm -79.86 130.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.87 -1.159 . . . . 2.27 107.87 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.77 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.1 m-85 -118.56 125.79 50.59 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.096 -0.956 . . . . 2.1499999999999999 110.289 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.823 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.0 p-10 -166.09 -55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.486 -1.672 . . . . 1.2 106.486 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 34.0 p-10 -82.18 -22.08 36.19 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.311 -1.313 . . . . 2.1699999999999999 109.202 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -80.83 -26.52 36.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.736 -1.12 . . . . 5.4100000000000001 108.556 178.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 1.8 m-85 -85.25 118.3 70.51 Favored Pre-proline 0 CA--C 1.51 -0.58 0 CA-C-N 115.374 -0.83 . . . . 2.21 109.868 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.6 Cg_endo -47.04 -43.6 24.54 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.421 1.414 . . . . 1.1100000000000001 110.49 179.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 71.5 m-20 -69.59 106.25 2.96 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.627 -0.829 . . . . 1.3600000000000001 111.512 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.818 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.7 mp 73.12 20.13 3.46 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.186 -0.916 . . . . 2.2400000000000002 113.453 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 60.2 pttt -54.66 126.07 22.42 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.903 -0.719 . . . . 2.8700000000000001 111.332 178.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 14.28 45.09 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.323 -0.941 . . . . 0.48999999999999999 114.402 178.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.7 -47.2 0.24 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 114.656 1.354 . . . . 2.1099999999999999 114.656 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.837 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.24 81.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.676 1.227 . . . . 1.04 108.109 -178.285 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 106' ' ' ASN . 21.8 m80 -102.73 130.2 49.6 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.081 -1.872 . . . . 0.34000000000000002 112.313 -176.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 68.9 m-85 -72.82 121.22 19.57 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.177 -0.675 . . . . 2.1600000000000001 109.177 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.552 HG21 ' OD1' ' A' ' 106' ' ' ASN . 38.1 p -70.15 -9.78 56.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.188 -0.914 . . . . 1.0900000000000001 110.805 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.5 m -91.09 119.95 31.65 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.987 -0.551 . . . . 1.71 110.449 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.59 4.07 50.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.268 0.556 . . . . 2.4700000000000002 110.142 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -145.99 67.6 1.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.262 -1.014 . . . . 2.1400000000000001 108.262 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 100' ' ' SER . 6.8 mp -55.73 -33.41 64.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.975 -1.011 . . . . 1.99 111.72 -178.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -61.28 -3.59 0.95 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.152 0.501 . . . . 2.4900000000000002 112.21 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -88.68 0.07 56.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.546 -0.752 . . . . 1.8999999999999999 111.187 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.81 -12.31 45.9 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.618 -0.801 . . . . 0.40999999999999998 113.673 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.75 113.76 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.472 . . . . 1.4399999999999999 111.418 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.532 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -109.36 12.17 24.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.637 . . . . 1.1200000000000001 111.918 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 72.5 p -60.03 140.05 57.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.64 1.718 . . . . 1.46 115.64 -178.002 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.07 135.51 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-N 114.104 -1.407 . . . . 1.0900000000000001 110.871 178.547 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.591 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -105.03 148.21 27.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.039 -0.726 . . . . 1.5600000000000001 109.039 177.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -101.42 118.89 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.005 0.431 . . . . 1.0600000000000001 110.999 -179.561 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.584 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.1 p -83.26 144.44 29.74 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.537 -0.756 . . . . 1.0700000000000001 110.53 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 50.58 57.52 6.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.037 0.446 . . . . 1.9399999999999999 111.549 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 31' ' ' LYS . 23.5 mt -46.92 90.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.95 1.092 . . . . 1.21 113.95 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 33.7 mt-30 -59.22 141.47 54.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.864 -0.607 . . . . 2.6699999999999999 110.702 176.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.06 -37.02 78.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 2.2400000000000002 110.215 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.58 -9.97 59.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.8300000000000001 111.48 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' O ' HD11 ' A' ' 59' ' ' ILE . 92.4 m-20 -72.47 -17.07 61.79 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.938 -0.393 . . . . 1.5800000000000001 109.938 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.46 141.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 116.198 -0.455 . . . . 1.1399999999999999 110.346 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.11 158.97 7.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.218 -0.991 . . . . 0.26000000000000001 113.352 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -59.55 131.04 49.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.685 0.624 . . . . 1.0700000000000001 112.685 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' CE1' HD23 ' A' ' 135' ' ' LEU . 20.7 m-85 -111.26 135.38 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.294 -0.632 . . . . 2.1400000000000001 109.294 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 59.2 tt0 -127.06 121.5 31.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.971 -0.291 . . . . 1.5900000000000001 110.717 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 26.0 t -99.98 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.456 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' GLU . 90.8 mttt -119.81 106.22 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.1899999999999999 111.188 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 50.1 t -93.72 109.92 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.695 -0.483 . . . . 1.8200000000000001 109.695 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 72.6 tttt -94.13 120.01 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.969 -0.693 . . . . 2.1899999999999999 112.308 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.574 ' HE2' ' CD2' ' A' ' 43' ' ' PHE . 5.6 mtmp? -143.73 101.99 3.84 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.202 -0.666 . . . . 3.2799999999999998 109.202 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.487 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.03 131.02 40.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 113.016 0.747 . . . . 1.1799999999999999 113.016 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 21.2 Cg_endo -102.03 51.92 1.44 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.788 -0.922 . . . . 0.62 111.505 -0.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.49 103.44 0.29 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.183 -1.008 . . . . 0.53000000000000003 113.993 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.2 m -89.52 139.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.193 -1.004 . . . . 1.8700000000000001 109.396 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -136.73 149.34 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.193 -0.317 . . . . 1.3200000000000001 111.81 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.6 p-10 -146.41 151.22 37.09 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.381 0.511 . . . . 2.0299999999999998 112.381 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.549 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.65 155.27 42.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.915 -0.584 . . . . 3.46 110.37 178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.5 mttt -101.25 140.02 36.12 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.504 0.927 . . . . 2.6699999999999999 113.504 -178.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 118' ' ' TYR . 85.6 mt -140.23 119.97 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 1.0600000000000001 109.026 176.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.424 ' CD2' HG23 ' A' ' 117' ' ' THR . 35.3 m170 -100.25 116.79 33.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.609 -0.436 . . . . 0.70999999999999996 110.44 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.53 HD23 ' CE1' ' A' ' 118' ' ' TYR . 58.8 tp -89.86 120.1 30.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.451 . . . . 2.1000000000000001 111.657 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 57.7 t -118.14 119.95 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 1.0900000000000001 109.418 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.78 125.81 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.038 0.447 . . . . 1.72 112.174 -178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 97.8 mt -83.92 170.0 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.734 -0.667 . . . . 1.21 109.545 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 2.0899999999999999 111.55 -178.813 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.823 0.344 . . . . 2.2599999999999998 111.066 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 42' ' ' LYS . 15.6 tt -142.18 131.3 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 2.6299999999999999 110.793 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.432 ' HG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -92.73 151.75 19.88 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.546 0.689 . . . . 1.6499999999999999 111.65 -179.479 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.59 82.96 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.673 -1.149 . . . . 1.26 111.491 -178.287 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.574 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.9 Cg_endo -78.6 -83.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.557 2.838 . . . . 0.88 112.989 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.4 tt0 -77.97 120.22 22.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.221 -0.659 . . . . 2.0600000000000001 109.221 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 132' ' ' LYS . 86.1 tt0 -144.02 161.03 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.472 0.916 . . . . 1.71 113.472 -176.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.4 ' N ' ' HG2' ' A' ' 27' ' ' GLU . 53.8 ttm -131.91 139.42 48.74 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.255 -0.884 . . . . 2.3999999999999999 109.807 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -134.24 140.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.202 -0.454 . . . . 1.1499999999999999 111.465 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.406 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.5 pt-20 -137.84 129.21 27.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.773 0.32 . . . . 1.1899999999999999 111.086 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB2' HD12 ' A' ' 110' ' ' LEU . 56.8 mmtt -142.33 159.98 41.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.327 -0.397 . . . . 2.9300000000000002 111.534 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.755 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.51 142.51 40.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.089 -0.505 . . . . 1.1299999999999999 111.844 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.75 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 66.4 mttt -46.66 144.13 2.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.888 -0.597 . . . . 2.7599999999999998 111.933 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.97 -22.81 2.8 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.328 -0.851 . . . . 0.32000000000000001 113.334 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.99 160.03 26.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.435 -0.58 . . . . 2.1099999999999999 109.435 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 60.5 m -87.09 129.1 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.182 -0.607 . . . . 1.0800000000000001 110.712 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.474 ' HB1' HG22 ' A' ' 107' ' ' VAL . . . -100.0 115.34 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.044 0.45 . . . . 1.0700000000000001 110.631 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.471 ' CD1' HG23 ' A' ' 94' ' ' THR . 70.6 t80 -79.38 120.05 23.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.117 -0.492 . . . . 2.3199999999999998 112.315 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 39' ' ' LEU . 23.8 mt -104.73 104.86 48.13 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.05 -0.722 . . . . 1.47 109.05 177.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.8 Cg_exo -80.23 130.78 8.36 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.535 2.157 . . . . 0.71999999999999997 114.257 -177.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.572 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 1.9 t -141.17 130.96 24.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.125 -0.943 . . . . 1.03 108.766 177.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HB2' ' HG1' ' A' ' 23' ' ' THR . 6.4 mmtp -140.24 137.54 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.473 -0.33 . . . . 2.2400000000000002 110.649 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.577 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.3 p90 -140.92 139.97 34.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.461 . . . . 2.1499999999999999 111.488 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 1.9299999999999999 110.567 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.67 108.04 20.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.421 -0.354 . . . . 2.5899999999999999 110.871 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 t -84.3 136.87 39.96 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.879 -0.415 . . . . 2.1299999999999999 109.879 179.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.55 -30.73 4.17 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.842 1.694 . . . . 1.9299999999999999 111.194 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.94 -38.6 45.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.565 -0.743 . . . . 2.1800000000000002 111.018 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 78.0 m-20 -70.13 73.78 0.47 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.518 -0.473 . . . . 2.4100000000000001 109.741 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -98.55 0.05 44.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.677 -0.692 . . . . 1.96 111.912 -178.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -69.4 171.73 39.75 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.811 -0.709 . . . . 0.56000000000000005 113.183 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.66 138.69 65.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.816 2.344 . . . . 1.1899999999999999 112.365 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.556 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 2.0 mt -78.54 111.82 14.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 2.4100000000000001 111.557 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.761 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 89.0 m-20 -127.57 102.75 6.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.613 0.721 . . . . 1.78 111.429 178.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.3 mt -94.01 123.55 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.61 -1.177 . . . . 1.4099999999999999 109.96 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 95.0 mt-10 -120.01 111.87 18.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.831 0.678 . . . . 1.6699999999999999 112.831 -178.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.802 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 69.9 m95 -94.33 119.96 33.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.772 -0.371 . . . . 0.23999999999999999 110.088 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 86.1 mt -105.59 122.67 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.665 0.269 . . . . 1.1200000000000001 110.329 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG2' ' HB ' ' A' ' 71' ' ' ILE . 7.3 tt -108.11 131.52 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.459 0.54 . . . . 1.3700000000000001 112.459 -179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -126.1 102.19 27.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.909 -0.774 . . . . 1.73 108.909 177.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.5 Cg_exo -79.77 118.35 3.79 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.735 2.29 . . . . 0.84999999999999998 112.389 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.06 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 1.0700000000000001 111.024 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.0 -40.03 60.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.869 -0.605 . . . . 1.8200000000000001 111.845 -179.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.33 159.95 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.329 0.585 . . . . 2.3599999999999999 111.988 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -69.36 -16.76 63.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.121 -0.945 . . . . 1.95 111.199 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.65 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.7 mttm -69.15 149.14 48.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.629 -0.714 . . . . 2.2799999999999998 111.651 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.73 127.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-O 121.942 0.877 . . . . 1.4199999999999999 109.887 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.65 39.98 27.0 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.51 178.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.04 143.85 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.367 0.127 . . . . 2.54 110.719 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 26.5 t -67.9 119.79 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.108 0.48 . . . . 1.3899999999999999 110.004 179.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.711 HG12 ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.23 -55.45 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.622 -0.717 . . . . 1.8200000000000001 112.328 -178.203 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.73 HG12 ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -135.8 124.47 38.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.145 -1.058 . . . . 1.0800000000000001 108.145 179.119 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 5.6 tt -137.71 156.17 48.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.928 -0.578 . . . . 1.8799999999999999 110.786 -176.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' N ' HD22 ' A' ' 73' ' ' LEU . 25.2 t80 -132.81 103.71 6.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.198 -0.456 . . . . 2.2000000000000002 109.879 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.407 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 29.7 t -143.99 156.61 44.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.244 0.461 . . . . 1.4199999999999999 112.244 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.24 29.3 21.81 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.02 -0.609 . . . . 0.56999999999999995 112.795 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.6 t0 73.47 2.85 4.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.494 0.188 . . . . 1.46 111.28 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 80.2 mttt -100.01 115.17 29.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 110.148 -0.316 . . . . 2.96 110.148 178.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.463 HG22 ' CE2' ' A' ' 93' ' ' PHE . 2.4 mm -80.34 128.33 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 106.927 -1.509 . . . . 2.27 106.927 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.64 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.6 m-85 -112.43 117.31 32.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.215 -0.902 . . . . 2.1499999999999999 110.38 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.833 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.4 p-10 -166.14 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.845 -1.539 . . . . 1.2 106.845 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -76.63 -34.66 58.33 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.37 -1.286 . . . . 2.1699999999999999 108.563 177.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 37.5 m-85 -74.52 -29.98 61.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.765 -1.198 . . . . 5.4100000000000001 107.765 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.542 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 m-85 -83.47 110.83 27.01 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 114.833 -1.076 . . . . 2.21 109.938 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 23.0 Cg_exo -64.77 -28.14 59.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.063 1.842 . . . . 1.1100000000000001 112.456 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' LEU . 61.1 m-20 -50.05 -32.77 16.31 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.356 -0.538 . . . . 1.3600000000000001 111.843 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.812 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.6 mp -151.42 35.27 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.092 -0.958 . . . . 2.2400000000000002 110.424 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.8 pttp -57.26 134.86 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.134 0.492 . . . . 2.8700000000000001 112.011 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.419 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 75.54 19.84 78.96 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.513 -0.767 . . . . 0.48999999999999999 113.947 178.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -146.78 -48.71 0.19 Allowed 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.394 1.257 . . . . 2.1099999999999999 114.394 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG12 HD11 ' A' ' 71' ' ' ILE . 8.2 p -80.0 81.48 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.979 1.371 . . . . 1.04 107.721 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.419 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 15.6 m80 -101.81 127.68 48.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.355 -2.202 . . . . 0.34000000000000002 112.366 -175.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.683 ' HA ' ' O ' ' A' ' 104' ' ' SER . 58.6 m-85 -71.86 124.02 23.94 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 120.219 -0.592 . . . . 2.1600000000000001 109.406 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.471 HG23 ' CD1' ' A' ' 38' ' ' TYR . 30.6 p -73.9 33.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.587 -0.733 . . . . 1.0900000000000001 112.517 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 m -148.91 136.25 20.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.968 0.413 . . . . 1.71 111.338 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.8 1.01 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 2.4700000000000002 110.735 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -146.35 65.53 1.19 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.347 0.594 . . . . 2.1400000000000001 109.583 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 9.5 mp -57.67 -30.04 65.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 1.99 111.114 -179.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -60.01 -10.96 4.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.619 0.723 . . . . 2.4900000000000002 112.238 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -83.45 0.05 47.95 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.489 -1.232 . . . . 1.8999999999999999 111.121 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.448 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 112.87 -9.38 25.47 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.627 -0.797 . . . . 0.40999999999999998 113.433 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.59 116.58 29.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.931 0.366 . . . . 1.4399999999999999 110.61 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' HB1' ' HB3' ' A' ' 41' ' ' CYS . . . -115.75 10.03 15.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.491 -0.322 . . . . 1.1200000000000001 111.627 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 50.4 m -60.01 139.76 57.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 115.335 1.605 . . . . 1.46 115.335 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -134.71 127.87 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 114.419 -1.264 . . . . 1.0900000000000001 110.45 178.375 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.635 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.8 OUTLIER -103.65 150.46 23.98 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.506 -0.553 . . . . 1.5600000000000001 109.506 178.119 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -101.14 119.98 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.101 0.477 . . . . 1.0600000000000001 111.114 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -85.56 144.12 28.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.313 -0.858 . . . . 1.0700000000000001 110.64 178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.15 59.99 3.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.629 0.603 . . . . 1.9399999999999999 112.629 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 31' ' ' LYS . 8.9 mt -46.0 178.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.13 0.49 . . . . 1.21 112.274 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 112' ' ' LEU . 64.1 tt0 -177.55 161.44 1.71 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.817 -0.629 . . . . 2.6699999999999999 110.25 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.75 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 59.0 tp -59.96 -40.03 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.842 0.353 . . . . 2.2400000000000002 111.376 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -72.2 -12.33 61.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.127 -0.488 . . . . 1.8300000000000001 111.683 -178.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.14 -21.31 61.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.791 -0.448 . . . . 1.5800000000000001 109.791 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.94 145.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.877 -0.601 . . . . 1.1399999999999999 111.06 179.066 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.68 149.91 5.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.768 -1.206 . . . . 0.26000000000000001 114.229 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.8 m -59.81 136.8 58.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.802 -0.699 . . . . 1.0700000000000001 111.813 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.2 m-85 -120.0 132.57 55.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.704 -0.48 . . . . 2.1400000000000001 109.704 177.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.802 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.7 tt0 -120.29 116.4 25.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.589 -0.278 . . . . 1.5900000000000001 110.631 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.503 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 53.3 t -100.02 115.57 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 1.03 110.545 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 29.7 mtpp -119.46 105.7 11.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 2.1899999999999999 111.125 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.577 HG11 ' CG ' ' A' ' 43' ' ' PHE . 42.9 t -90.03 117.14 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.349 -0.611 . . . . 1.8200000000000001 109.349 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.761 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 62.9 tttp -98.58 120.29 38.75 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.515 0.931 . . . . 2.1899999999999999 113.515 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.556 ' HD3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -143.17 101.04 3.74 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.105 -0.702 . . . . 3.2799999999999998 109.105 176.44 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -54.68 132.56 65.0 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.722 -0.672 . . . . 1.1799999999999999 112.71 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 51.6 Cg_endo -99.53 48.37 1.98 Allowed 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.68 -0.967 . . . . 0.62 112.432 -0.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.37 103.56 0.29 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.864 -0.684 . . . . 0.53000000000000003 112.823 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.03 152.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.575 -0.812 . . . . 1.8700000000000001 110.099 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -131.66 147.46 52.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.485 0.183 . . . . 1.3200000000000001 111.198 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -146.69 138.59 24.64 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.871 0.322 . . . . 2.0299999999999998 111.871 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.574 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.42 151.7 38.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.49 -0.323 . . . . 3.46 110.824 178.865 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' PRO . 3.4 tttt -97.98 139.94 33.07 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 113.188 0.81 . . . . 2.6699999999999999 113.188 -177.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 90.1 mt -145.1 113.7 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 115.662 -0.699 . . . . 1.0600000000000001 109.76 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -102.95 120.0 39.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.70999999999999996 111.273 -179.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 mt -91.09 127.23 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 2.1000000000000001 112.634 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 30' ' ' GLU . 62.7 t -113.27 127.48 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.098 -0.955 . . . . 1.0900000000000001 108.939 178.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.88 120.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.579 0.585 . . . . 1.72 112.579 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.755 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 78.4 mt -83.57 160.85 21.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.899 -0.592 . . . . 1.21 109.765 178.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.384 0.612 . . . . 2.0899999999999999 112.204 -178.5 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 2.2599999999999998 111.092 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 42' ' ' LYS . 17.1 tt -139.98 139.37 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 2.6299999999999999 110.324 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 7.9 p -92.09 153.03 19.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.49 0.662 . . . . 1.6499999999999999 111.734 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.508 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.41 83.75 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 114.554 -1.203 . . . . 1.26 111.502 -178.358 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.4 Cg_endo -77.84 -80.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.334 2.689 . . . . 0.88 112.704 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 14.7 pt-20 -78.49 128.11 33.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 179.163 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.8 tp10 -144.14 160.01 41.66 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.247 1.203 . . . . 1.71 114.247 -176.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.457 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 11.2 mtm -140.26 118.27 11.87 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.464 -1.244 . . . . 2.3999999999999999 109.126 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.7 mm -120.03 128.65 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.906 0.384 . . . . 1.1499999999999999 111.561 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.4 mt-10 -120.01 125.35 48.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.1899999999999999 109.916 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HB2' HD12 ' A' ' 110' ' ' LEU . 74.5 mmtt -141.9 160.02 41.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 2.9300000000000002 111.428 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.77 134.37 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.143 -0.48 . . . . 1.1299999999999999 111.742 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 84.8 tttt -46.92 134.38 10.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.934 -0.575 . . . . 2.7599999999999998 111.273 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.72 -25.16 14.24 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.992 -0.623 . . . . 0.32000000000000001 112.66 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 98.9 mt-10 -80.0 160.0 26.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.124 -1.065 . . . . 2.1099999999999999 108.124 178.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.827 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 59.1 m -87.98 127.04 35.38 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.491 -0.884 . . . . 1.0800000000000001 110.609 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -97.52 116.65 30.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.905 0.383 . . . . 1.0700000000000001 110.169 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CE1' HG23 ' A' ' 94' ' ' THR . 74.5 t80 -79.11 118.54 21.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.873 -0.603 . . . . 2.3199999999999998 112.259 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' HD13 ' A' ' 133' ' ' ILE . 38.7 mt -102.9 107.94 56.64 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.142 -0.688 . . . . 1.47 109.142 178.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.32 120.63 3.3 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.078 . . . . 0.71999999999999997 114.312 -178.106 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.485 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 2.6 t -141.01 123.93 16.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.777 -0.823 . . . . 1.03 108.777 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.641 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 17.1 mttp -141.09 153.77 45.61 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.283 -0.417 . . . . 2.2400000000000002 110.758 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 101' ' ' GLY . 33.1 p90 -139.74 145.71 38.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.631 . . . . 2.1499999999999999 111.479 -178.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.07 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.456 -0.793 . . . . 1.9299999999999999 111.631 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.53 147.46 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.904 -0.589 . . . . 2.5899999999999999 110.943 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 19.5 p -157.35 139.98 10.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 2.1299999999999999 110.29 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.27 -27.05 2.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.801 2.334 . . . . 1.9299999999999999 112.804 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.616 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.08 -28.65 54.69 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.025 0.38 . . . . 2.1800000000000002 112.025 -179.518 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 44.1 p-10 -67.74 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.453 0.644 . . . . 2.4100000000000001 111.22 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' GLU . 65.8 mt-30 -96.98 -6.81 34.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.678 . . . . 1.96 111.763 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -73.85 158.24 52.08 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.207 -0.997 . . . . 0.56000000000000005 113.056 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.83 130.33 39.79 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 1.1899999999999999 111.209 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.687 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.3 tt -77.81 119.96 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.39 . . . . 2.4100000000000001 110.981 -179.04 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 75' ' ' SER . 0.4 OUTLIER -136.67 102.76 5.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.648 0.737 . . . . 1.78 111.83 179.727 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.8 mt -96.71 111.4 26.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.802 -1.09 . . . . 1.4099999999999999 110.37 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.2 mt-10 -108.91 117.67 34.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.389 0.515 . . . . 1.6699999999999999 112.389 -179.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.651 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 73.9 m95 -95.43 118.52 32.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.771 -0.455 . . . . 0.23999999999999999 109.771 177.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.6 mt -109.96 140.02 44.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.599 -0.273 . . . . 1.1200000000000001 110.294 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.6 tt -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.086 0.402 . . . . 1.3700000000000001 112.086 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.8 m -114.63 102.53 54.88 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 108.515 -0.92 . . . . 1.73 108.515 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 81.4 Cg_endo -78.85 111.06 2.91 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.475 2.117 . . . . 0.84999999999999998 113.151 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.99 72.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 111.009 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 7.4 p-10 -87.6 17.21 4.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.242 -0.435 . . . . 1.8200000000000001 111.369 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.517 HD22 ' HB2' ' A' ' 113' ' ' SER . 91.8 m-20 -148.34 162.98 38.44 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.408 0.623 . . . . 2.3599999999999999 111.96 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.3 -19.84 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.946 . . . . 1.95 111.64 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.622 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 57.4 mttt -69.68 151.74 45.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.073 -0.512 . . . . 2.2799999999999998 111.344 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.98 127.93 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-O 121.752 0.787 . . . . 1.4199999999999999 109.483 178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.48 41.26 31.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.312 -1.313 . . . . 1.77 112.227 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.38 134.89 33.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 2.54 110.919 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.475 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 91.3 t -70.5 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.619 -0.264 . . . . 1.3899999999999999 110.872 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.663 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 1.5 pp -127.11 -36.7 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.269 0.47 . . . . 1.8200000000000001 112.269 -179.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.758 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 123.4 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.53 0.681 . . . . 1.0800000000000001 109.385 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 5.2 tt -140.36 155.61 46.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.491 -0.777 . . . . 1.8799999999999999 109.592 -178.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 62.7 t80 -132.45 104.29 6.63 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.658 0.266 . . . . 2.2000000000000002 110.318 179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.43 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 17.9 t -142.46 157.05 45.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.9 0.381 . . . . 1.4199999999999999 111.875 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.39 29.45 38.5 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.002 -0.618 . . . . 0.56999999999999995 112.684 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 71.9 2.43 4.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.601 0.239 . . . . 1.46 110.933 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.0 mttm -100.05 107.36 19.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.991 -0.744 . . . . 2.96 108.991 177.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.751 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.95 118.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 122.511 1.148 . . . . 2.27 108.562 178.674 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.69 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -100.19 125.7 46.37 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.767 -2.015 . . . . 2.1499999999999999 111.663 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.816 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 20.8 p-10 -166.39 -54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.906 -1.516 . . . . 1.2 106.906 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 54.3 t0 -81.7 -30.77 32.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.52 -1.218 . . . . 2.1699999999999999 108.848 177.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -72.48 -31.24 65.23 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 5.4100000000000001 107.317 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.533 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.6 OUTLIER -82.6 111.04 25.71 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.32 -1.309 . . . . 2.21 109.399 178.165 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -34.2 92.91 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.292 1.994 . . . . 1.1100000000000001 113.581 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 51.8 m-20 -49.72 -29.84 8.26 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.129 0.789 . . . . 1.3600000000000001 113.129 -177.423 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.716 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.9 mt -153.8 30.29 0.46 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.808 -0.633 . . . . 2.2400000000000002 111.316 178.024 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 13.5 pttm -55.54 133.41 50.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.309 -0.556 . . . . 2.8700000000000001 111.847 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.88 11.97 67.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.515 -0.85 . . . . 0.48999999999999999 114.673 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptp180 -142.57 -51.02 0.37 Allowed 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 114.977 1.473 . . . . 2.1099999999999999 114.977 -178.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.758 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.08 80.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-O 122.988 1.375 . . . . 1.04 107.667 -177.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 106' ' ' ASN . 12.5 m80 -101.2 126.15 47.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 112.248 -2.251 . . . . 0.34000000000000002 112.388 -175.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.751 ' CD2' HG13 ' A' ' 79' ' ' ILE . 83.3 m-85 -70.76 124.58 24.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 120.036 -0.666 . . . . 2.1600000000000001 109.715 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.463 HG23 ' CE1' ' A' ' 38' ' ' TYR . 1.7 p -76.18 36.08 0.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.283 -0.871 . . . . 1.0900000000000001 110.966 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 98' ' ' LEU . 2.9 m -148.93 127.1 12.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.96 0.409 . . . . 1.71 110.127 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.62 8.24 37.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.998 -0.546 . . . . 2.4700000000000002 110.313 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.53 67.62 1.18 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.518 -0.764 . . . . 2.1400000000000001 108.998 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.49 HD23 ' CG ' ' A' ' 93' ' ' PHE . 6.2 mp -57.96 -36.21 72.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.299 -0.864 . . . . 1.99 111.747 -178.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.97 2.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.561 0.578 . . . . 2.4900000000000002 112.561 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 98' ' ' LEU . 15.7 m -90.53 -0.23 57.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.913 -0.585 . . . . 1.8999999999999999 110.591 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 108.13 -12.61 37.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.049 -0.596 . . . . 0.40999999999999998 113.393 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -98.07 110.83 23.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.111 0.456 . . . . 1.4399999999999999 110.801 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -109.51 15.43 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 1.1200000000000001 112.241 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 23.5 m -60.01 139.98 57.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.338 1.607 . . . . 1.46 115.338 -178.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -132.97 130.1 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 114.844 -1.071 . . . . 1.0900000000000001 111.078 178.356 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 90' ' ' ARG . 50.8 p30 -105.54 147.88 27.88 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.122 -0.696 . . . . 1.5600000000000001 109.122 177.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.39 121.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.964 0.411 . . . . 1.0600000000000001 111.409 -178.268 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.595 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -83.06 144.71 29.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.549 -0.751 . . . . 1.0700000000000001 110.33 178.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 50.98 58.68 5.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.93 0.395 . . . . 1.9399999999999999 111.139 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 31' ' ' LYS . 20.1 mt -46.25 88.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.494 0.924 . . . . 1.21 113.494 -178.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 pt20 -59.51 147.42 36.87 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.896 -0.593 . . . . 2.6699999999999999 110.441 177.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.94 -35.37 74.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.276 0.56 . . . . 2.2400000000000002 110.428 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.517 ' HB2' HD22 ' A' ' 64' ' ' ASN . 24.3 p -72.21 -9.42 58.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.794 . . . . 1.8300000000000001 111.887 -179.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 6.5 m-20 -70.54 -18.99 62.93 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.682 -0.407 . . . . 1.5800000000000001 110.209 179.149 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 27.2 mt -44.6 134.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.767 -0.457 . . . . 1.1399999999999999 109.767 178.233 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.89 156.54 6.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.073 -1.06 . . . . 0.26000000000000001 113.522 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 85.9 m -59.39 134.67 57.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.797 0.666 . . . . 1.0700000000000001 112.797 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 14.6 m-85 -113.49 137.88 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 2.1400000000000001 109.754 177.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 32.1 tt0 -129.13 118.14 21.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.666 0.27 . . . . 1.5900000000000001 110.762 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 13.0 t -104.13 118.79 37.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.4 . . . . 1.03 110.34 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.75 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.0 mtpm? -119.97 107.01 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.538 -0.301 . . . . 2.1899999999999999 111.283 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 18.3 t -90.82 110.25 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.311 -0.625 . . . . 1.8200000000000001 109.311 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 74.3 mttt -96.72 116.53 29.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.942 1.09 . . . . 2.1899999999999999 113.942 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 49' ' ' ASP . 63.9 tttt -147.21 102.13 3.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 3.2799999999999998 109.453 176.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.73 133.17 46.92 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 112.27 0.47 . . . . 1.1799999999999999 112.27 -179.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.6 Cg_endo -100.42 51.56 1.5 Allowed 'Cis proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.716 -0.952 . . . . 0.62 111.9 -0.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.11 102.83 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.107 -1.044 . . . . 0.53000000000000003 113.34 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 123' ' ' LYS . 6.0 m -90.01 119.97 38.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.27 -0.965 . . . . 1.8700000000000001 110.029 178.202 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -99.68 140.01 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.598 0.222 . . . . 1.3200000000000001 111.598 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -146.59 133.57 20.27 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.539 -0.301 . . . . 2.0299999999999998 111.525 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.54 152.64 40.06 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.571 -0.286 . . . . 3.46 111.239 179.152 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 81.9 mttt -102.16 141.16 35.43 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.282 0.845 . . . . 2.6699999999999999 113.282 -178.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 84.1 mt -139.98 120.02 13.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 CA-C-N 115.5 -0.773 . . . . 1.0600000000000001 109.417 176.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 15.9 m170 -100.01 114.26 27.43 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.468 -0.493 . . . . 0.70999999999999996 110.274 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.6 tp -90.45 125.02 35.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 2.1000000000000001 112.35 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 40.7 t -120.88 123.84 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 1.0900000000000001 109.634 178.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.87 119.95 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.173 0.434 . . . . 1.72 112.173 -178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.749 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.3 mt -84.46 170.64 13.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.808 -0.633 . . . . 1.21 109.342 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.352 0.596 . . . . 2.0899999999999999 111.538 -178.817 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 29.7 t . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.071 0.462 . . . . 2.2599999999999998 111.323 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.587 HG12 ' CB ' ' A' ' 129' ' ' ALA . 3.8 mt -130.01 129.97 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.671 -0.695 . . . . 2.6299999999999999 110.407 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.71 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -89.09 140.04 29.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.581 . . . . 1.6499999999999999 110.225 179.072 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 46.04 81.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.039 -0.982 . . . . 1.26 111.096 -177.189 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.667 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.0 Cg_endo -78.99 -14.15 13.76 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.854 3.036 . . . . 0.88 113.377 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.8 mt-10 -141.36 126.28 18.21 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.272 -0.64 . . . . 2.0600000000000001 109.272 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 132' ' ' LYS . 2.1 tt0 -144.06 155.66 44.07 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.534 1.309 . . . . 1.71 114.534 -177.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 29.1 mtm -140.38 113.99 8.73 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.639 -1.164 . . . . 2.3999999999999999 109.455 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.489 HD11 ' CG2' ' A' ' 133' ' ' ILE . 5.3 mp -119.97 120.69 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.646 0.609 . . . . 1.1499999999999999 112.646 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.6 mt-10 -101.59 126.91 48.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.806 -0.634 . . . . 1.1899999999999999 109.888 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HB3' HD12 ' A' ' 110' ' ' LEU . 16.7 tptt -142.02 156.0 45.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 121.021 -0.272 . . . . 2.9300000000000002 111.1 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.93 143.69 39.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.855 0.36 . . . . 1.1299999999999999 111.919 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' CD ' ' HG ' ' A' ' 112' ' ' LEU . 80.8 tttt -48.98 132.47 18.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.283 -0.417 . . . . 2.7599999999999998 111.621 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 86.98 -15.78 51.21 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.155 -0.545 . . . . 0.32000000000000001 112.923 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 99.4 mt-10 -79.98 158.76 26.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.95 -0.759 . . . . 2.1099999999999999 108.95 178.719 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.786 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.7 m -88.77 128.42 35.63 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.058 -0.657 . . . . 1.0800000000000001 111.033 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 110' ' ' LEU . . . -99.98 118.88 37.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 1.0700000000000001 110.648 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 40' ' ' PRO . 62.8 t80 -79.51 119.13 22.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.037 -0.529 . . . . 2.3199999999999998 112.062 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 12.0 mt -109.96 104.79 56.28 Favored Pre-proline 0 C--N 1.333 -0.132 0 N-CA-C 108.315 -0.994 . . . . 1.47 108.315 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 96.9 Cg_endo -91.02 104.0 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.218 1.945 . . . . 0.71999999999999997 115.987 -176.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.584 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -100.14 128.7 46.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.438 -1.319 . . . . 1.03 107.438 175.411 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.71 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 41.1 mmtm -140.58 107.26 5.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.183 0.516 . . . . 2.2400000000000002 110.738 -178.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.597 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 47.4 p90 -99.3 140.09 33.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.005 -0.998 . . . . 2.1499999999999999 111.735 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 21' ' ' SER . 0.3 OUTLIER -79.99 139.13 37.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 1.9299999999999999 110.62 179.492 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.7 mt -96.23 141.47 29.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 2.5899999999999999 111.67 -179.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.6 m -150.66 135.86 10.13 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 2.1299999999999999 109.303 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -46.81 -25.66 3.96 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.471 2.114 . . . . 1.9299999999999999 112.238 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.98 -39.99 60.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.373 -0.376 . . . . 2.1800000000000002 111.199 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 73.7 m-20 -73.27 74.97 1.33 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.017 -0.673 . . . . 2.4100000000000001 109.638 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.85 -5.31 41.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.423 -0.808 . . . . 1.96 112.148 -178.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -69.96 166.24 50.02 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.56000000000000005 112.584 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.22 130.05 29.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.359 2.039 . . . . 1.1899999999999999 111.756 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 8.7 tp -77.98 117.29 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.446 -0.343 . . . . 2.4100000000000001 110.904 -179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -129.37 103.17 6.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.484 0.659 . . . . 1.78 111.682 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.734 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -95.56 109.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.922 -1.035 . . . . 1.4099999999999999 110.879 179.108 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HA ' HD11 ' A' ' 73' ' ' LEU . 18.0 mt-10 -104.7 116.61 32.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.6699999999999999 111.721 -179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.641 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 70.5 m95 -91.28 116.66 29.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 109.954 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 mt -105.75 138.76 41.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.643 -0.503 . . . . 1.1200000000000001 109.643 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 117' ' ' THR . 9.0 tt -129.97 132.76 65.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.615 0.598 . . . . 1.3700000000000001 112.615 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.08 102.33 40.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 1.73 109.571 177.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.71 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 84.6 Cg_endo -79.52 114.9 3.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.566 2.177 . . . . 0.84999999999999998 113.043 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -29.03 68.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 1.0700000000000001 110.373 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.72 10.24 9.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.713 -0.676 . . . . 1.8200000000000001 111.742 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.496 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 67.3 t30 -152.24 160.05 43.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.203 0.525 . . . . 2.3599999999999999 111.849 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -65.85 -19.01 65.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.386 -0.824 . . . . 1.95 111.941 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.0 ttmt -65.89 142.08 58.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 2.2799999999999998 111.418 -178.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.79 128.0 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-O 122.015 0.912 . . . . 1.4199999999999999 110.173 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.53 39.68 21.34 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 113.809 -1.541 . . . . 1.77 112.904 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.484 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 93.9 mm-40 -93.37 136.52 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 2.54 110.807 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 99.2 t -69.38 130.15 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 1.3899999999999999 110.615 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.735 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.4 pp -126.97 -38.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.23 -0.441 . . . . 1.8200000000000001 111.658 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.766 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -140.26 120.85 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.089 -0.708 . . . . 1.0800000000000001 109.089 179.25 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 80' ' ' TYR . 2.4 tp -140.52 161.12 38.48 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.699 -0.682 . . . . 1.8799999999999999 109.543 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 21.0 t80 -134.66 110.43 9.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.107 0.479 . . . . 2.2000000000000002 110.307 178.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.533 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.9 t -142.37 160.02 41.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.125 -0.943 . . . . 1.4199999999999999 111.639 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.65 37.8 42.76 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.805 -0.712 . . . . 0.56999999999999995 112.137 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t0 59.92 30.04 19.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.075 0.464 . . . . 1.46 110.348 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 44.5 mtmt -129.27 110.82 12.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.704 -0.68 . . . . 2.96 110.344 178.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.564 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.3 117.49 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.581 -1.266 . . . . 2.27 107.581 177.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.766 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -99.98 132.17 45.5 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.693 -1.139 . . . . 2.1499999999999999 110.641 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.721 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 14.2 p-10 -166.11 -56.34 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.418 -1.327 . . . . 1.2 107.418 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 74.0 m-20 -80.23 -27.41 38.75 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.796 -1.093 . . . . 2.1699999999999999 109.238 177.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.89 -31.65 61.63 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.226 -1.027 . . . . 5.4100000000000001 108.226 178.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.49 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -81.18 112.73 35.46 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 114.512 -1.222 . . . . 2.21 110.102 179.201 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.25 -42.71 16.98 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.653 1.569 . . . . 1.1100000000000001 111.208 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 96.2 m-20 -67.73 104.12 1.57 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.028 -0.533 . . . . 1.3600000000000001 111.095 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.908 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 13.6 mt 73.88 19.91 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.799 1.037 . . . . 2.2400000000000002 113.799 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.5 pttt -57.19 130.08 44.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.572 -0.705 . . . . 2.8700000000000001 110.555 177.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 94.21 11.35 57.51 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.165 -1.017 . . . . 0.48999999999999999 114.186 178.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.908 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 12.4 ptp180 -141.96 -52.36 0.42 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 114.24 1.2 . . . . 2.1099999999999999 114.24 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.735 HG12 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.24 81.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-O 122.991 1.377 . . . . 1.04 107.322 -178.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.424 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.4 m80 -99.0 128.81 45.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.193 -2.276 . . . . 0.34000000000000002 112.184 -175.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.709 ' HA ' ' O ' ' A' ' 104' ' ' SER . 66.1 m-85 -70.53 123.25 21.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.201 0.524 . . . . 2.1600000000000001 110.79 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.7 p -76.21 28.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.412 -0.813 . . . . 1.0900000000000001 111.926 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.1 m -147.45 129.71 15.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.094 0.473 . . . . 1.71 111.566 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.64 5.73 46.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 2.4700000000000002 110.361 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -145.77 66.11 1.22 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 2.1400000000000001 108.959 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.8 mp -59.92 -37.43 79.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.097 -0.956 . . . . 1.99 112.101 -178.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -62.52 3.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.521 0.563 . . . . 2.4900000000000002 112.521 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.3 m -90.03 -3.58 57.89 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.813 -0.63 . . . . 1.8999999999999999 110.259 178.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.566 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 116.96 -20.51 11.56 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.142 -0.552 . . . . 0.40999999999999998 113.005 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 3.6 m-20 -100.98 107.81 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.4399999999999999 111.122 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.91 23.79 13.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.169 -0.468 . . . . 1.1200000000000001 110.978 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -59.61 147.08 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.881 1.808 . . . . 1.46 115.881 -178.089 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -135.66 132.0 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 114.455 -1.248 . . . . 1.0900000000000001 111.016 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.601 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.8 OUTLIER -105.35 145.79 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.673 -0.862 . . . . 1.5600000000000001 108.673 177.216 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.04 122.21 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.87 0.367 . . . . 1.0600000000000001 111.185 -178.845 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.562 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -86.06 143.35 28.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.821 -0.627 . . . . 1.0700000000000001 110.892 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.7 m-20 49.98 58.17 5.75 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.098 -0.501 . . . . 1.9399999999999999 111.669 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 31' ' ' LYS . 20.7 mt -46.53 89.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.557 0.947 . . . . 1.21 113.557 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.97 145.68 45.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.881 -0.599 . . . . 2.6699999999999999 109.898 177.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.441 ' HG ' ' CD ' ' A' ' 33' ' ' LYS . 83.8 mt -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.773 0.321 . . . . 2.2400000000000002 111.618 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.6 p -73.36 -11.19 60.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.8300000000000001 111.606 -179.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.7 -17.29 62.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 1.5800000000000001 109.904 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.4 mt -43.5 141.43 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.85 -0.614 . . . . 1.1399999999999999 110.594 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.86 164.71 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.39 -0.91 . . . . 0.26000000000000001 113.34 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.0 m -59.55 129.99 44.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.625 0.602 . . . . 1.0700000000000001 112.625 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 26.9 m-85 -113.89 121.81 45.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.625 -0.88 . . . . 2.1400000000000001 108.625 177.058 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.0 tt0 -124.34 125.22 43.97 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.778 -0.369 . . . . 1.5900000000000001 111.021 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 16.1 p -108.34 119.97 41.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 1.03 110.861 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.2 mttm -113.6 104.09 11.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.157 -0.474 . . . . 2.1899999999999999 110.935 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 5.6 p -90.02 112.0 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.084 -0.71 . . . . 1.8200000000000001 109.084 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.3 tttm -102.61 120.06 39.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.724 1.009 . . . . 2.1899999999999999 113.724 -177.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 6.6 ttpp -143.9 102.4 3.89 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.169 0.509 . . . . 3.2799999999999998 109.756 176.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.0 131.98 30.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 1.1799999999999999 113.051 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.4 Cg_endo -99.96 45.55 2.61 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.686 -0.964 . . . . 0.62 112.198 -0.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.29 103.57 0.32 Allowed Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.422 -0.894 . . . . 0.53000000000000003 113.044 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.2 p -89.07 158.66 2.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.435 -0.882 . . . . 1.8700000000000001 109.519 177.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' CB ' HG12 ' A' ' 22' ' ' ILE . . . -144.74 135.64 24.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.376 -0.374 . . . . 1.3200000000000001 111.554 -179.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.519 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 19.2 p30 -146.71 139.36 25.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.676 0.621 . . . . 2.0299999999999998 112.676 -179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.667 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -145.68 161.61 39.46 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.359 -0.382 . . . . 3.46 111.228 178.832 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 68.8 mttm -100.47 143.31 30.79 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.715 1.006 . . . . 2.6699999999999999 113.715 -178.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 96.5 mt -141.32 113.05 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 114.961 -1.018 . . . . 1.0600000000000001 108.305 176.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.439 ' CD2' HG23 ' A' ' 117' ' ' THR . 7.7 m170 -98.8 117.75 33.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.435 -0.506 . . . . 0.70999999999999996 110.885 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -93.7 118.5 31.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.099 -0.5 . . . . 2.1000000000000001 111.946 -179.311 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.56 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 58.6 t -111.75 120.01 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.674 -0.862 . . . . 1.0900000000000001 108.674 178.065 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 24.4 t -101.48 122.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.498 0.555 . . . . 1.72 112.498 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.1 mt -84.07 169.27 15.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.971 -0.751 . . . . 1.21 108.971 178.36 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.416 0.627 . . . . 2.0899999999999999 111.496 -178.884 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.018 0.437 . . . . 2.2599999999999998 111.406 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 129' ' ' ALA . 19.5 tt -133.65 140.02 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 2.6299999999999999 110.45 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.748 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.1 p -88.68 154.47 20.27 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.505 0.669 . . . . 1.6499999999999999 111.867 -179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.517 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 38.39 82.16 0.23 Allowed Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 114.487 -1.233 . . . . 1.26 111.953 -178.55 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.64 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 77.8 Cg_endo -79.43 -8.62 14.99 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 123.891 3.06 . . . . 0.88 113.032 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -141.3 122.46 14.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.144 -0.687 . . . . 2.0600000000000001 109.144 178.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' LYS . 86.0 tt0 -144.24 156.63 44.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.981 1.104 . . . . 1.71 113.981 -176.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.49 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 47.7 mtp -138.82 122.3 17.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.847 -1.07 . . . . 2.3999999999999999 109.442 177.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.442 HD13 ' CG ' ' A' ' 27' ' ' GLU . 27.1 mm -126.48 134.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 1.1499999999999999 111.513 -179.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 20.4 pt-20 -130.72 127.3 38.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 1.1899999999999999 110.652 179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 13.3 tptt -142.43 163.48 32.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.39 -0.368 . . . . 2.9300000000000002 110.945 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.12 140.29 41.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 1.1299999999999999 111.704 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 76.6 tttt -47.43 139.71 6.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.095 -0.502 . . . . 2.7599999999999998 111.715 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 82.5 -20.17 9.55 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.793 -0.639 . . . . 0.32000000000000001 113.032 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.555 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 80.7 mm-40 -80.07 159.98 25.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.513 -0.921 . . . . 2.1099999999999999 108.513 178.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.9 m -90.68 127.34 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.785 -0.766 . . . . 1.0800000000000001 111.222 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' HB1' HD23 ' A' ' 110' ' ' LEU . . . -100.01 119.88 38.96 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.794 0.331 . . . . 1.0700000000000001 110.529 179.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 65.6 t80 -79.64 116.77 20.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.329 -0.396 . . . . 2.3199999999999998 111.842 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 mt -100.91 106.15 42.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.999 -0.741 . . . . 1.47 108.999 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 97.0 Cg_endo -81.98 129.3 6.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.71999999999999997 114.509 -177.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -140.91 130.28 23.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.21 -0.905 . . . . 1.03 109.195 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.748 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 57.2 tptt -140.02 141.44 36.31 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 2.2400000000000002 109.514 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.515 ' CG ' HG12 ' A' ' 122' ' ' VAL . 53.1 p90 -139.94 144.82 37.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.242 0.544 . . . . 2.1499999999999999 112.05 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -80.85 158.37 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.36 -0.836 . . . . 1.9299999999999999 110.513 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.468 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 63.7 tp -140.0 99.98 3.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 2.5899999999999999 111.422 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.9 t -82.1 142.3 47.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.576 -0.527 . . . . 2.1299999999999999 109.576 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.34 -29.35 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.931 1.754 . . . . 1.9299999999999999 111.821 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.89 -33.64 51.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.984 -0.553 . . . . 2.1800000000000002 111.389 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.24 79.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.087 -0.645 . . . . 2.4100000000000001 109.625 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -102.3 7.24 40.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 1.96 112.284 -178.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.617 ' O ' ' HD2' ' A' ' 124' ' ' LYS . . . -69.94 164.22 51.77 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.56000000000000005 112.809 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.57 134.72 59.76 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.3 2.0 . . . . 1.1899999999999999 111.731 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.584 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 18.7 mt -78.19 104.73 8.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 2.4100000000000001 111.375 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.1 m-20 -119.55 102.61 8.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.64 0.733 . . . . 1.78 110.905 178.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.804 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 8.9 mt -101.38 130.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.765 -1.107 . . . . 1.4099999999999999 110.004 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HA ' HD22 ' A' ' 73' ' ' LEU . 99.3 mt-10 -130.05 125.68 35.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.274 0.842 . . . . 1.6699999999999999 113.274 -178.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.683 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 80.8 m95 -97.86 119.95 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.935 -0.575 . . . . 0.23999999999999999 109.514 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.0 mt -105.54 139.98 39.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.372 -0.603 . . . . 1.1200000000000001 109.372 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.9 tt -128.63 129.56 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.171 0.51 . . . . 1.3700000000000001 111.46 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 p -119.91 103.03 46.14 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.954 -0.758 . . . . 1.73 108.954 178.211 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 95.2 Cg_endo -78.78 113.52 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.424 2.082 . . . . 0.84999999999999998 112.892 -178.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.277 -0.874 . . . . 1.0700000000000001 111.066 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.73 -40.02 63.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.928 -0.578 . . . . 1.8200000000000001 111.329 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 97.8 m-20 -84.61 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.156 0.503 . . . . 2.3599999999999999 111.628 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.44 -20.01 63.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.456 -0.793 . . . . 1.95 111.222 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 77.6 mttt -70.3 150.02 46.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 2.2799999999999998 111.233 -178.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 66' ' ' LYS . 2.3 m -154.89 128.46 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 121.925 0.869 . . . . 1.4199999999999999 110.081 178.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.96 40.19 19.23 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 113.94 -1.482 . . . . 1.77 113.229 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.59 144.89 25.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.683 0.277 . . . . 2.54 111.217 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG13 ' CD2' ' A' ' 73' ' ' LEU . 31.0 t -66.01 136.56 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.599 -0.889 . . . . 1.3899999999999999 108.599 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.815 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.72 -51.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.839 0.681 . . . . 1.8200000000000001 112.839 -176.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.986 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.42 126.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.309 -0.626 . . . . 1.0800000000000001 109.309 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.672 HD22 ' H ' ' A' ' 57' ' ' TRP . 3.1 mt -138.09 175.73 9.32 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.412 0.625 . . . . 1.8799999999999999 111.534 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.555 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 45.7 t80 -140.3 104.39 4.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.203 -1.362 . . . . 2.2000000000000002 107.427 175.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.527 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.9 t -141.54 157.11 45.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.998 -0.546 . . . . 1.4199999999999999 111.067 -178.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.27 39.25 42.57 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.525 -0.845 . . . . 0.56999999999999995 112.013 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.01 30.29 19.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 1.46 110.433 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 67.5 mttm -130.8 110.5 11.36 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.768 -0.651 . . . . 2.96 111.231 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -79.98 112.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.253 -1.388 . . . . 2.27 107.253 176.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.717 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -100.11 141.5 32.85 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.922 . . . . 2.1499999999999999 111.198 -178.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.4 p-10 -166.83 -54.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.653 -1.24 . . . . 1.2 107.653 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.457 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 33.9 m-20 -80.01 -19.9 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.0 -1.0 . . . . 2.1699999999999999 109.873 177.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.47 -28.72 46.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.746 -0.835 . . . . 5.4100000000000001 108.746 178.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.673 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.4 m-85 -85.41 119.92 72.7 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 114.931 -1.031 . . . . 2.21 111.189 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 7.5 Cg_endo -48.55 -42.84 34.83 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.388 1.392 . . . . 1.1100000000000001 109.933 178.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.766 ' O ' HG12 ' A' ' 71' ' ' ILE . 41.3 m-20 -66.31 106.05 1.6 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.747 -0.66 . . . . 1.3600000000000001 110.702 178.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.874 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.7 mt 66.76 21.29 10.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.278 1.214 . . . . 2.2400000000000002 114.278 178.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 55.6 pttt -56.23 129.95 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.457 -0.897 . . . . 2.8700000000000001 110.666 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.61 14.26 53.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.263 -0.97 . . . . 0.48999999999999999 113.875 178.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.874 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.2 ptp180 -145.16 -48.96 0.24 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.815 1.413 . . . . 2.1099999999999999 114.815 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.986 HG13 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -81.1 81.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-O 123.274 1.511 . . . . 1.04 107.019 -178.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.457 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 12.9 m80 -99.03 129.21 45.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.145 -2.298 . . . . 0.34000000000000002 112.74 -175.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.709 ' HA ' ' O ' ' A' ' 104' ' ' SER . 86.1 m-85 -72.31 120.14 17.5 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 120.272 -0.571 . . . . 2.1600000000000001 109.519 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.442 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 18.8 p -73.37 -7.13 50.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.367 -0.833 . . . . 1.0900000000000001 110.482 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 17.7 m -86.35 118.77 26.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.939 -0.573 . . . . 1.71 110.895 -179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -90.03 1.38 56.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.858 -0.61 . . . . 2.4700000000000002 110.014 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -145.99 67.65 1.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.335 -0.987 . . . . 2.1400000000000001 108.335 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.475 ' CD2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 tt -58.27 -36.33 73.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.897 -1.047 . . . . 1.99 112.07 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -62.26 -1.08 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 2.4900000000000002 112.254 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 70.5 m -89.64 0.04 57.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 1.8999999999999999 110.795 178.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 107.13 -15.11 39.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.968 -0.634 . . . . 0.40999999999999998 113.069 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.508 ' OD1' ' HD3' ' A' ' 42' ' ' LYS . 86.6 m-20 -92.26 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.873 0.337 . . . . 1.4399999999999999 111.355 -179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.09 19.85 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.1200000000000001 111.632 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 5.2 p -60.1 141.2 56.21 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.678 1.733 . . . . 1.46 115.678 -178.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -133.3 130.84 57.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 114.416 -1.266 . . . . 1.0900000000000001 111.292 178.713 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.2 p30 -102.98 144.98 30.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.396 -0.964 . . . . 1.5600000000000001 108.396 177.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.887 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.87 120.76 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 120.911 0.386 . . . . 1.0600000000000001 111.971 -177.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.61 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -84.44 143.13 29.61 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.516 -0.765 . . . . 1.0700000000000001 110.832 178.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 26.2 m120 49.96 57.84 6.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.142 0.496 . . . . 1.9399999999999999 111.668 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.537 HD23 ' HB1' ' A' ' 37' ' ' ALA . 31.3 mt -46.63 90.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.009 1.114 . . . . 1.21 114.009 -179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.406 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 38.9 mt-30 -59.3 141.56 54.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.922 -0.581 . . . . 2.6699999999999999 110.924 176.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -60.04 -35.37 74.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.113 0.483 . . . . 2.2400000000000002 109.995 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.2 p -74.47 -11.63 60.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.698 -0.683 . . . . 1.8300000000000001 111.435 -179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.406 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 99.1 m-20 -71.7 -18.45 62.16 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.033 -0.358 . . . . 1.5800000000000001 110.033 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.36 139.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.202 -0.454 . . . . 1.1399999999999999 110.22 179.09 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 164.06 9.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.111 -1.042 . . . . 0.26000000000000001 113.39 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.6 m -59.29 130.22 45.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.012 0.745 . . . . 1.0700000000000001 113.012 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 15.5 m-85 -114.87 128.87 56.55 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.774 -0.824 . . . . 2.1400000000000001 108.774 176.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.5 tt0 -127.45 119.03 25.19 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.568 -0.453 . . . . 1.5900000000000001 111.314 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 57' ' ' TRP . 35.4 t -100.01 119.4 38.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 1.03 110.611 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.804 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.3 mttt -116.57 106.27 13.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.005 -0.278 . . . . 2.1899999999999999 110.915 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG12 ' CG ' ' A' ' 43' ' ' PHE . 43.8 t -90.53 112.46 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.363 -0.606 . . . . 1.8200000000000001 109.363 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 85.9 tttt -99.57 121.88 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.041 0.756 . . . . 2.1899999999999999 113.041 -178.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 53.9 tptt -145.16 101.39 3.61 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.448 -0.575 . . . . 3.2799999999999998 109.448 177.111 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -54.76 135.83 64.85 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 1.1799999999999999 112.335 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.557 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 53.0 Cg_endo -96.94 46.2 2.4 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.336 -1.11 . . . . 0.62 111.631 -0.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.28 103.64 0.29 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.434 -0.889 . . . . 0.53000000000000003 113.399 -179.332 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.64 153.1 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.342 -0.929 . . . . 1.8700000000000001 109.897 178.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.464 ' CB ' ' HB ' ' A' ' 22' ' ' ILE . . . -138.01 140.4 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.575 0.213 . . . . 1.3200000000000001 111.575 -179.254 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -146.74 143.61 28.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.21 0.448 . . . . 2.0299999999999998 112.21 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.06 159.98 42.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.19 -0.459 . . . . 3.46 110.864 179.056 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 72.1 mmtt -105.61 140.39 38.76 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 112.776 0.658 . . . . 2.6699999999999999 112.776 -178.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 64.7 mt -139.97 119.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.558 -0.746 . . . . 1.0600000000000001 109.17 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 35.2 m170 -102.72 117.35 34.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.70999999999999996 110.616 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 40.6 tp -89.35 124.94 34.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 2.1000000000000001 111.601 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 45.0 t -119.97 120.01 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.797 -0.638 . . . . 1.0900000000000001 109.293 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.3 122.69 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.316 0.487 . . . . 1.72 112.316 -178.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.5 mt -84.86 164.95 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.727 -0.67 . . . . 1.21 109.717 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 2.0899999999999999 111.514 -179.117 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.14 0.495 . . . . 2.2599999999999998 111.457 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 129' ' ' ALA . 1.8 pp -95.33 143.98 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.478 -0.783 . . . . 2.6299999999999999 111.5 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -91.12 155.12 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 110.361 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.4 OUTLIER 39.44 83.41 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.612 0.72 . . . . 1.26 111.258 -178.069 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.693 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 61.2 Cg_endo -78.24 -8.11 16.27 Favored 'Trans proline' 0 C--N 1.327 -0.582 0 C-N-CA 123.753 2.969 . . . . 0.88 113.477 -178.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.16 121.31 13.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.0600000000000001 108.893 178.113 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 132' ' ' LYS . 3.3 tt0 -144.48 160.48 41.03 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.86 1.43 . . . . 1.71 114.86 -176.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 39.6 mtm -139.98 121.38 15.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.582 -1.19 . . . . 2.3999999999999999 109.632 177.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.02 126.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.756 0.312 . . . . 1.1499999999999999 111.659 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 86.3 mt-10 -116.26 125.53 52.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.376 -0.375 . . . . 1.1899999999999999 110.325 179.166 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 34.5 mmtm -142.07 156.8 45.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.784 0.326 . . . . 2.9300000000000002 111.502 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.98 137.83 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 1.1299999999999999 112.184 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 8.0 ttpt -45.17 142.16 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.854 -0.612 . . . . 2.7599999999999998 111.707 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.12 -26.9 4.15 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.909 -0.587 . . . . 0.32000000000000001 112.981 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -80.03 160.02 25.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.889 -0.782 . . . . 2.1099999999999999 108.889 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 91.6 m -85.49 130.11 34.66 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.018 -0.673 . . . . 1.0800000000000001 110.737 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -97.2 117.25 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.126 0.488 . . . . 1.0700000000000001 110.327 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 89.1 t80 -79.05 120.01 23.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.8 0.667 . . . . 2.3199999999999998 112.8 -178.397 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.08 105.67 56.23 Favored Pre-proline 0 CA--C 1.528 0.108 0 N-CA-C 108.533 -0.914 . . . . 1.47 108.533 177.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.455 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 87.6 Cg_endo -83.0 128.88 5.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.45 2.1 . . . . 0.71999999999999997 115.066 -177.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.6 ' HA ' ' HZ1' ' A' ' 131' ' ' LYS . 9.9 t -141.5 129.89 22.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.043 -0.98 . . . . 1.03 109.637 177.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 1.0 OUTLIER -140.31 150.74 44.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.966 -0.561 . . . . 2.2400000000000002 109.995 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CZ ' HD13 ' A' ' 53' ' ' LEU . 49.7 p90 -140.13 153.26 46.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 2.1499999999999999 111.021 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 m -79.74 162.81 24.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 1.9299999999999999 111.047 -179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.6 tp -139.83 130.32 25.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.5899999999999999 110.871 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.01 158.01 25.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 2.1299999999999999 110.445 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.81 -20.71 23.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 1.9299999999999999 112.888 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.57 -45.37 59.53 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 110.014 -0.365 . . . . 2.1800000000000002 110.014 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.532 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -71.88 83.34 0.93 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.595 -0.891 . . . . 2.4100000000000001 108.595 178.588 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -95.9 -4.36 43.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.56 -0.745 . . . . 1.96 112.361 -177.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -83.15 152.84 30.05 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.169 -1.015 . . . . 0.56000000000000005 112.779 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.16 139.01 88.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.313 2.009 . . . . 1.1899999999999999 111.493 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' ' HD2' ' A' ' 124' ' ' LYS . 6.5 mt -78.33 104.33 8.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.447 -0.342 . . . . 2.4100000000000001 111.767 -179.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 96.6 m-20 -114.31 102.59 10.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.532 0.682 . . . . 1.78 110.06 178.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 47.1 mt -95.38 139.83 18.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.97 -1.014 . . . . 1.4099999999999999 110.008 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.611 ' HA ' HD23 ' A' ' 73' ' ' LEU . 98.9 mt-10 -137.6 117.15 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 1.6699999999999999 112.741 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.687 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 83.6 m95 -91.25 121.88 33.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.428 -0.351 . . . . 0.23999999999999999 110.469 178.173 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -107.29 140.02 40.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.555 -0.906 . . . . 1.1200000000000001 108.555 178.278 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -128.83 133.06 66.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.352 0.596 . . . . 1.3700000000000001 112.473 -178.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -119.85 103.59 45.53 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.112 -0.949 . . . . 1.73 109.216 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.9 Cg_exo -79.33 122.52 5.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.503 2.135 . . . . 0.84999999999999998 112.075 -179.109 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.98 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 1.0700000000000001 110.872 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -74.97 -40.03 60.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 1.8200000000000001 111.542 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 30.6 m120 -83.64 154.45 23.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.288 0.566 . . . . 2.3599999999999999 111.912 -179.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.72 -16.92 63.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.233 -0.894 . . . . 1.95 111.131 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 33.2 mttp -68.89 150.02 48.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.484 -0.78 . . . . 2.2799999999999998 111.449 -178.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.44 128.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-O 121.984 0.897 . . . . 1.4199999999999999 110.14 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.78 39.96 20.13 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.835 -1.53 . . . . 1.77 112.863 178.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -91.14 146.93 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.603 0.239 . . . . 2.54 110.906 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.445 HG13 ' CD2' ' A' ' 73' ' ' LEU . 15.8 t -65.84 130.01 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.013 -0.736 . . . . 1.3899999999999999 109.013 178.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.826 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -124.81 -53.21 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.671 0.619 . . . . 1.8200000000000001 112.671 -177.028 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.943 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.02 129.37 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.163 -0.68 . . . . 1.0800000000000001 109.163 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.663 ' HG ' ' CE2' ' A' ' 84' ' ' TYR . 3.9 mt -138.76 175.45 9.55 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.57 0.7 . . . . 1.8799999999999999 111.373 -179.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.6 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 39.2 t80 -141.36 103.61 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.095 -1.411 . . . . 2.2000000000000002 107.648 176.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.493 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.8 t -141.6 153.99 45.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.385 -0.371 . . . . 1.4199999999999999 111.005 -178.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.87 30.1 52.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.527 -0.844 . . . . 0.56999999999999995 112.146 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.91 3.99 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.618 0.247 . . . . 1.46 110.872 -178.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 65.1 mttm -105.34 110.79 23.28 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.575 -0.284 . . . . 2.96 111.306 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 79' ' ' ILE . 1.2 pp -79.87 113.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.465 -1.68 . . . . 2.27 106.465 176.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.75 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -99.92 140.02 34.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.426 -0.807 . . . . 2.1499999999999999 111.177 -177.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.2 p-10 -166.55 -52.39 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.864 -1.162 . . . . 1.2 107.864 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.409 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 54.5 m-20 -79.92 -25.57 40.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.122 -0.945 . . . . 2.1699999999999999 109.632 178.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.77 -30.47 56.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.546 -0.909 . . . . 5.4100000000000001 108.546 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.663 ' CE2' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -82.19 114.05 48.22 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 114.952 -1.022 . . . . 2.21 110.679 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.86 -42.17 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.73 1.62 . . . . 1.1100000000000001 110.31 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 71' ' ' ILE . 58.5 m-20 -67.09 105.24 1.62 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.678 -0.692 . . . . 1.3600000000000001 110.584 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.759 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 mp 68.98 24.18 6.37 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.892 1.071 . . . . 2.2400000000000002 113.892 178.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 51.1 pttt -57.02 129.83 43.46 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.571 -0.706 . . . . 2.8700000000000001 111.016 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 89.45 15.46 58.52 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.515 -0.85 . . . . 0.48999999999999999 114.119 178.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp85 -143.37 -48.54 0.31 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.383 1.253 . . . . 2.1099999999999999 114.383 -178.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.943 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.01 81.28 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 123.132 1.444 . . . . 1.04 107.274 -178.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 106' ' ' ASN . 11.3 m80 -98.29 127.84 44.42 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.248 -2.251 . . . . 0.34000000000000002 112.325 -175.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 67.2 m-85 -70.88 121.82 18.79 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.166 0.508 . . . . 2.1600000000000001 110.434 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.436 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 5.8 p -77.79 36.0 0.21 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.527 -0.76 . . . . 1.0900000000000001 111.839 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.1 m -148.32 127.55 12.96 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.128 0.489 . . . . 1.71 111.639 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -90.62 6.16 44.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.593 -0.73 . . . . 2.4700000000000002 110.211 178.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -145.91 66.03 1.21 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.103 -0.702 . . . . 2.1400000000000001 109.103 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 93' ' ' PHE . 4.8 mp -60.08 -39.27 85.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.15 -0.932 . . . . 1.99 111.333 -178.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HE2' ' OH ' ' A' ' 74' ' ' TYR . 25.8 mttm -59.52 -6.73 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.511 . . . . 2.4900000000000002 112.224 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.9 m -81.94 -7.09 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.522 -0.763 . . . . 1.8999999999999999 110.535 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 115.35 -20.02 14.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.852 -0.689 . . . . 0.40999999999999998 113.227 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -99.91 106.03 17.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.03 0.415 . . . . 1.4399999999999999 110.516 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.598 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.03 22.59 14.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.466 0.543 . . . . 1.1200000000000001 112.466 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 13.9 m -60.02 151.02 27.45 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.963 1.468 . . . . 1.46 114.963 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -135.11 134.21 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 114.639 -1.164 . . . . 1.0900000000000001 111.447 179.301 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.8 p-10 -107.95 148.37 29.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.832 -0.803 . . . . 1.5600000000000001 108.832 177.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.31 123.46 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.943 0.401 . . . . 1.0600000000000001 111.058 -178.774 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -86.27 144.9 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 111.262 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.11 61.0 2.92 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.01 -0.541 . . . . 1.9399999999999999 112.224 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 6.6 mt -45.99 169.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 1.21 111.904 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 11.8 pt20 -177.43 161.22 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.701 -0.681 . . . . 2.6699999999999999 110.572 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.463 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 5.1 mp -60.06 -33.01 71.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 2.2400000000000002 111.465 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -73.74 -19.93 60.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.984 -0.286 . . . . 1.8300000000000001 111.629 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 95.5 m-20 -72.27 -19.72 61.64 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.923 -0.399 . . . . 1.5800000000000001 109.923 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -46.03 142.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 116.111 -0.495 . . . . 1.1399999999999999 111.171 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.46 150.4 5.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.689 -1.243 . . . . 0.26000000000000001 114.298 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 98.1 m -59.47 139.95 56.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -0.662 . . . . 1.0700000000000001 112.135 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CZ ' HD13 ' A' ' 59' ' ' ILE . 27.8 m-85 -119.98 135.08 55.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 2.1400000000000001 109.9 178.136 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.8 tt0 -126.77 117.13 22.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.612 -0.267 . . . . 1.5900000000000001 111.145 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 50.8 t -99.99 114.73 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 1.03 110.288 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.785 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.0 mtpt -109.45 104.77 13.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.574 -0.284 . . . . 2.1899999999999999 110.801 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 42.8 t -90.05 110.69 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.578 -0.527 . . . . 1.8200000000000001 109.578 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 26.8 tttp -98.9 115.89 29.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.479 0.548 . . . . 2.1899999999999999 112.479 -178.758 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 36.1 tttp -145.77 102.63 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.316 -0.554 . . . . 3.2799999999999998 109.784 177.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.519 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.56 132.1 26.8 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.919 -0.582 . . . . 1.1799999999999999 111.903 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 63.1 Cg_endo -101.29 51.94 1.44 Allowed 'Cis proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.771 -0.929 . . . . 0.62 111.94 -0.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 102.59 0.26 Allowed Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.855 -1.164 . . . . 0.53000000000000003 113.866 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.83 135.78 27.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.391 -0.905 . . . . 1.8700000000000001 109.293 177.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . . . -144.44 152.51 40.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.599 -0.44 . . . . 1.3200000000000001 112.068 -179.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 23.6 p-10 -146.42 157.91 43.82 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.217 0.451 . . . . 2.0299999999999998 112.217 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.693 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.99 166.61 25.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.193 -0.458 . . . . 3.46 111.083 179.009 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' GLU . 68.3 mttm -111.17 140.25 45.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 112.6 0.593 . . . . 2.6699999999999999 112.6 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 96.8 mt -141.55 112.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.543 -0.91 . . . . 1.0600000000000001 108.543 176.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.418 ' CD2' HG22 ' A' ' 117' ' ' THR . 49.5 m170 -96.89 118.77 34.04 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.425 -0.51 . . . . 0.70999999999999996 110.984 -178.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 3.2 tm? -88.44 120.0 29.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 2.1000000000000001 111.69 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.609 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 42.3 t -118.96 120.3 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.197 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.91 133.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.312 0.486 . . . . 1.72 112.312 -178.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 66.6 mt -80.1 158.18 26.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.944 -0.762 . . . . 1.21 108.944 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 122.134 0.968 . . . . 2.0899999999999999 113.439 -177.185 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.706 0.288 . . . . 2.2599999999999998 110.856 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 129' ' ' ALA . 1.6 pp -91.96 143.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 2.6299999999999999 111.264 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -89.11 157.75 18.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.775 -0.648 . . . . 1.6499999999999999 109.891 178.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 45.1 85.42 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 121.716 0.769 . . . . 1.26 109.809 -176.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.714 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.0 Cg_endo -76.4 -83.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.246 2.631 . . . . 0.88 113.215 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.3 mt-10 -78.54 128.14 33.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.894 -0.722 . . . . 2.0600000000000001 109.501 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -143.6 156.18 44.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.91 1.078 . . . . 1.71 113.91 -177.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.444 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 45.0 mtm -137.26 118.24 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.285 -1.325 . . . . 2.3999999999999999 107.865 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.587 HD12 ' CG2' ' A' ' 133' ' ' ILE . 5.2 mp -120.03 120.05 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 1.1499999999999999 111.894 -177.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.623 ' HG3' ' HB ' ' A' ' 136' ' ' VAL . 51.7 mp0 -105.72 128.53 53.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.821 -0.627 . . . . 1.1899999999999999 110.939 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HE2' ' OE1' ' A' ' 35' ' ' GLU . 20.9 tptm -141.45 154.73 45.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.854 0.359 . . . . 2.9300000000000002 111.151 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.605 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.65 143.63 40.01 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.615 0.598 . . . . 1.1299999999999999 112.615 -179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.475 ' HE2' ' HG ' ' A' ' 112' ' ' LEU . 75.0 mttt -47.86 143.76 3.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.593 -0.731 . . . . 2.7599999999999998 112.604 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.36 -23.64 1.48 Allowed Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.32000000000000001 113.719 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' OE1' ' HE2' ' A' ' 31' ' ' LYS . 98.7 mt-10 -79.99 159.97 26.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.338 -0.616 . . . . 2.1099999999999999 109.338 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 55.9 m -86.91 126.31 34.6 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.12 -0.632 . . . . 1.0800000000000001 110.984 -179.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 107' ' ' VAL . . . -96.74 118.54 33.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.185 0.516 . . . . 1.0700000000000001 110.307 179.144 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CE2' HG21 ' A' ' 94' ' ' THR . 9.9 t80 -79.17 120.53 23.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.887 -0.597 . . . . 2.3199999999999998 111.932 -178.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 35.7 mt -105.75 104.77 50.34 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 108.428 -0.952 . . . . 1.47 108.428 177.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.468 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.8 Cg_endo -82.31 127.49 5.21 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.363 2.042 . . . . 0.71999999999999997 114.345 -177.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.0 t -141.2 129.98 22.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.072 -0.967 . . . . 1.03 108.859 178.011 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HD3' ' OD1' ' A' ' 102' ' ' ASP . 33.3 ttpt -140.73 150.12 43.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.708 -0.678 . . . . 2.2400000000000002 110.634 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.461 ' CD1' HG12 ' A' ' 122' ' ' VAL . 47.0 p90 -139.95 140.42 36.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 2.1499999999999999 111.897 -178.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 138.31 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.694 -0.684 . . . . 1.9299999999999999 110.507 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.0 107.84 19.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 2.5899999999999999 111.34 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -83.34 148.23 55.24 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 109.355 -0.609 . . . . 2.1299999999999999 109.355 178.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -42.36 -46.75 7.57 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 121.984 1.789 . . . . 1.9299999999999999 111.594 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 85.6 tt0 -75.94 -38.49 57.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.652 -0.704 . . . . 2.1800000000000002 110.971 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 13.9 t0 -70.96 80.03 0.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.303 0.573 . . . . 2.4100000000000001 110.441 -179.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -137.25 33.75 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.19 -0.914 . . . . 1.96 111.022 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.12 -171.32 33.8 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.541 -0.838 . . . . 0.56000000000000005 112.717 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.66 113.03 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.644 2.229 . . . . 1.1899999999999999 111.861 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 47.9 tp -78.7 118.54 20.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 2.4100000000000001 111.566 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -134.55 102.95 5.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.524 0.678 . . . . 1.78 111.371 179.08 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.825 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 3.7 mt -96.06 110.01 23.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.011 -0.995 . . . . 1.4099999999999999 110.809 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -102.56 117.99 35.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.129 0.788 . . . . 1.6699999999999999 113.129 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.656 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 74.3 m95 -93.88 121.7 35.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.23999999999999999 109.882 176.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.1 mt -106.65 129.94 54.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.035 -0.357 . . . . 1.1200000000000001 110.035 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 67' ' ' VAL . 3.9 tt -119.96 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.203 0.816 . . . . 1.3700000000000001 113.203 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 67' ' ' VAL . 5.4 t -108.11 104.5 53.82 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 108.842 -0.799 . . . . 1.73 108.842 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.679 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 80.6 Cg_endo -78.85 112.74 3.16 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.304 2.003 . . . . 0.84999999999999998 111.952 -179.107 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.01 87.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.435 -0.802 . . . . 1.0700000000000001 111.082 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.78 -39.99 63.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.84 -0.618 . . . . 1.8200000000000001 111.555 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -85.28 162.84 18.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.18 0.514 . . . . 2.3599999999999999 111.942 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.18 -18.05 63.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.4 -0.818 . . . . 1.95 111.942 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -69.46 170.03 11.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.877 -0.601 . . . . 2.2799999999999998 111.967 -177.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 59' ' ' ILE . 1.3 t -133.47 -154.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 107.753 -1.203 . . . . 1.4199999999999999 107.753 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' HB2' ' A' ' 60' ' ' SER . 78.4 m-20 -67.54 64.54 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.73 0.776 . . . . 1.77 111.564 -177.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -85.76 157.19 20.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.425 -1.261 . . . . 2.54 109.508 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 11.5 t -66.27 131.4 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.398 -0.521 . . . . 1.3899999999999999 109.652 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -126.56 -50.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.652 0.612 . . . . 1.8200000000000001 112.652 -176.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.973 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.01 123.1 17.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.067 -0.716 . . . . 1.0800000000000001 109.067 179.642 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 80' ' ' TYR . 7.9 tt -140.0 160.99 38.68 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.793 -0.639 . . . . 1.8799999999999999 110.156 -177.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.58 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 10.2 t80 -135.61 111.64 9.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.997 0.427 . . . . 2.2000000000000002 110.155 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 6.7 t -142.46 159.98 41.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 1.4199999999999999 111.441 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.17 36.2 51.61 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.63 -0.795 . . . . 0.56999999999999995 111.941 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t0 62.94 22.35 13.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.956 0.408 . . . . 1.46 110.397 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 22.5 mttm -120.68 110.3 16.24 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.922 -0.581 . . . . 2.96 110.677 178.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -80.13 117.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.1 -1.444 . . . . 2.27 107.1 177.313 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.719 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.3 m-85 -99.96 136.47 39.83 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.976 -1.011 . . . . 2.1499999999999999 110.526 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.728 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.3 p-10 -166.26 -56.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.402 -0.962 . . . . 1.2 108.402 -179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' OD1' ' CD2' ' A' ' 83' ' ' TYR . 25.6 p-10 -78.77 -24.01 44.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 2.1699999999999999 109.787 177.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CD2' ' OD1' ' A' ' 82' ' ' ASP . 16.4 m-85 -77.19 -29.17 54.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.285 -1.006 . . . . 5.4100000000000001 108.285 178.378 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.536 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.18 115.9 60.38 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-N 114.985 -1.007 . . . . 2.21 110.644 179.368 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.3 -43.95 16.51 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.739 1.626 . . . . 1.1100000000000001 111.046 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.754 ' O ' HG12 ' A' ' 71' ' ' ILE . 16.6 m-20 -66.93 106.7 1.99 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.106 -0.638 . . . . 1.3600000000000001 110.808 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.813 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 67.64 22.4 9.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.926 1.084 . . . . 2.2400000000000002 113.926 178.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 42.6 pttt -54.81 128.75 34.41 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.81 -0.756 . . . . 2.8700000000000001 111.089 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.35 13.61 55.46 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.344 -0.931 . . . . 0.48999999999999999 114.422 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.7 ptp85 -143.63 -48.98 0.3 Allowed 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 114.584 1.327 . . . . 2.1099999999999999 114.584 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.973 HG11 ' HB ' ' A' ' 72' ' ' ILE . 5.7 p -80.76 81.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 107.232 -1.395 . . . . 1.04 107.232 -178.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.411 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 12.6 m80 -100.6 132.89 45.75 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.277 -2.238 . . . . 0.34000000000000002 112.191 -175.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 74.6 m-85 -73.8 120.01 18.81 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-O 121.254 0.55 . . . . 2.1600000000000001 109.884 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 38' ' ' TYR . 32.3 p -74.8 -6.14 47.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 1.0900000000000001 110.428 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.3 m -90.4 120.17 31.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 1.71 110.754 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -89.93 1.58 56.07 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 110.299 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -146.16 68.51 1.19 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 4.3 mp -59.66 -38.38 81.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.962 -1.017 . . . . 1.99 111.696 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -61.62 -6.23 2.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.204 0.526 . . . . 2.4900000000000002 112.071 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 98' ' ' LEU . 53.0 m -86.63 -4.64 59.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.393 -0.821 . . . . 1.8999999999999999 110.643 178.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.404 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 113.55 -22.7 14.63 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.771 -0.728 . . . . 0.40999999999999998 113.254 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.4 m-20 -93.7 107.19 19.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.132 0.466 . . . . 1.4399999999999999 110.489 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.9 22.11 14.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.657 0.614 . . . . 1.1200000000000001 112.657 -178.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.1 m -59.99 148.18 36.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.521 1.675 . . . . 1.46 115.521 -178.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -132.28 134.31 59.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 114.494 -1.23 . . . . 1.0900000000000001 111.108 179.199 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -107.06 150.37 26.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.766 -0.828 . . . . 1.5600000000000001 108.766 177.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.35 121.59 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 120.902 0.382 . . . . 1.0600000000000001 110.915 -178.938 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.48 144.36 28.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.703 -0.681 . . . . 1.0700000000000001 111.432 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 54.17 60.32 3.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.825 -0.625 . . . . 1.9399999999999999 112.638 178.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 31' ' ' LYS . 12.2 mt -46.17 169.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.039 0.447 . . . . 1.21 111.887 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.441 ' HG2' ' N ' ' A' ' 112' ' ' LEU . 64.0 tt0 -177.99 166.44 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 2.6699999999999999 109.909 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.571 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 87.0 mt -59.97 -33.26 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.903 0.335 . . . . 2.2400000000000002 111.903 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.9 m -73.36 -19.42 61.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.986 -0.285 . . . . 1.8300000000000001 111.509 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.44 -20.77 62.06 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.571 -0.529 . . . . 1.5800000000000001 109.571 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -49.98 140.33 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-N 115.704 -0.68 . . . . 1.1399999999999999 111.067 178.796 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.01 153.21 5.91 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 119.71 -1.234 . . . . 0.26000000000000001 113.705 179.137 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 84.2 m -59.42 135.71 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.298 0.481 . . . . 1.0700000000000001 112.298 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.611 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.9 m-85 -121.17 131.5 54.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.9 tt0 -128.85 120.0 25.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.78 -0.368 . . . . 1.5900000000000001 110.238 179.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 131' ' ' LYS . 16.6 p -102.81 119.59 39.1 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.546 -0.462 . . . . 1.03 110.911 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.825 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.0 mttt -111.21 104.53 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 2.1899999999999999 110.441 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 21.8 t -88.45 107.44 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.86 -0.422 . . . . 1.8200000000000001 109.86 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 33.8 mttm -100.1 120.7 40.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.823 1.046 . . . . 2.1899999999999999 113.823 -178.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 19.1 tttt -145.83 103.32 3.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.211 0.529 . . . . 3.2799999999999998 109.874 177.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.95 130.6 11.89 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.322 -0.853 . . . . 1.1799999999999999 113.274 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.569 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.9 Cg_endo -102.73 48.72 1.91 Allowed 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 125.008 -0.83 . . . . 0.62 111.621 -0.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 103.5 0.3 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.214 -0.993 . . . . 0.53000000000000003 113.138 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.56 ' HB ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -92.93 151.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.338 -0.931 . . . . 1.8700000000000001 109.995 177.918 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB3' ' CG2' ' A' ' 22' ' ' ILE . . . -145.63 144.08 30.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.182 -0.463 . . . . 1.3200000000000001 111.867 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.551 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 50.5 p-10 -147.16 146.66 29.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.559 0.577 . . . . 2.0299999999999998 112.559 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -144.5 164.67 30.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.395 -0.366 . . . . 3.46 111.299 179.483 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 94.5 mttt -99.68 140.0 34.52 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 113.031 0.752 . . . . 2.6699999999999999 113.031 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 71.9 mt -141.08 110.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.939 -1.028 . . . . 1.0600000000000001 109.248 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 53.3 m170 -100.02 119.98 39.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.70999999999999996 111.052 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.478 ' CB ' ' CE1' ' A' ' 118' ' ' TYR . 3.3 tm? -89.53 125.54 35.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.933 -0.576 . . . . 2.1000000000000001 111.42 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 46.9 t -119.95 130.0 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 1.0900000000000001 109.496 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.412 ' CG1' ' CG ' ' A' ' 33' ' ' LYS . 25.3 t -100.22 122.88 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.156 0.428 . . . . 1.72 112.156 -178.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 72.7 mt -83.5 159.99 21.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.982 -0.554 . . . . 1.21 109.614 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 2.0899999999999999 111.939 -178.626 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.462 -0.255 . . . . 3.6600000000000001 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -79.97 169.99 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 2.8100000000000001 110.91 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.466 ' C ' HG13 ' A' ' 22' ' ' ILE . 74.4 m -153.82 116.03 4.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.009 0.433 . . . . 2.2599999999999998 110.631 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.508 HG23 ' HD2' ' A' ' 131' ' ' LYS . 4.6 mt -141.91 138.76 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 2.6299999999999999 110.928 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 21.5 p -93.6 147.86 22.62 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.339 0.59 . . . . 1.6499999999999999 110.714 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.12 82.88 0.22 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.04 -0.982 . . . . 1.26 111.8 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 48.3 Cg_endo -78.36 -73.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.706 2.937 . . . . 0.88 112.012 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.48 127.63 32.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.412 -0.959 . . . . 2.0600000000000001 108.412 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 133' ' ' ILE . 85.2 tt0 -143.77 158.34 43.75 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.015 1.117 . . . . 1.71 114.015 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.505 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.41 122.88 17.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.561 -1.199 . . . . 2.3999999999999999 109.031 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 mm -120.01 126.57 75.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.801 0.334 . . . . 1.1499999999999999 111.527 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 87.1 mt-10 -119.19 125.18 48.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.434 . . . . 1.1899999999999999 110.334 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HB2' HD12 ' A' ' 110' ' ' LEU . 74.8 mmtt -141.8 160.02 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 2.9300000000000002 111.309 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.33 137.56 39.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 1.1299999999999999 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.663 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 31.2 ttpt -46.59 139.95 4.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.7599999999999998 111.674 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.4 -23.2 7.51 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 116.059 -0.519 . . . . 0.32000000000000001 113.024 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.5 mt-10 -80.92 160.0 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.594 -0.521 . . . . 2.1099999999999999 109.594 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.79 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.7 m -84.49 130.22 34.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.104 -0.638 . . . . 1.0800000000000001 110.583 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -99.72 113.43 25.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 1.0700000000000001 110.441 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 40' ' ' PRO . 89.1 t80 -79.35 129.92 34.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 2.3199999999999998 112.24 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 104' ' ' SER . 14.3 mt -121.42 104.33 40.4 Favored Pre-proline 0 CA--C 1.528 0.121 0 N-CA-C 109.132 -0.692 . . . . 1.47 109.132 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 92.7 Cg_endo -84.25 134.03 5.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.546 2.164 . . . . 0.71999999999999997 114.889 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HA ' ' NZ ' ' A' ' 131' ' ' LYS . 57.3 m -141.59 112.55 7.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.171 -0.922 . . . . 1.03 109.911 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.509 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 8.2 tptt -118.69 109.12 15.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.889 0.376 . . . . 2.2400000000000002 110.663 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.583 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 39.9 p90 -93.82 141.79 28.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.673 -0.694 . . . . 2.1499999999999999 110.436 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 m -79.46 148.01 32.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 1.9299999999999999 111.238 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.36 144.33 39.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.477 -0.783 . . . . 2.5899999999999999 111.406 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 83.5 p -159.34 145.3 12.08 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.804 -0.634 . . . . 2.1299999999999999 110.08 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.3 Cg_exo -45.45 -21.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.495 2.13 . . . . 1.9299999999999999 113.107 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 52.6 tp10 -73.67 -38.26 65.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.617 -0.265 . . . . 2.1800000000000002 111.471 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 46' ' ' SER . 51.0 p-10 -65.79 73.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.641 0.734 . . . . 2.4100000000000001 110.753 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 76.8 mm-40 -90.79 -10.02 44.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.308 -0.86 . . . . 1.96 111.795 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -75.57 154.78 46.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.17 -1.014 . . . . 0.56000000000000005 112.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.63 149.0 25.78 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.205 1.937 . . . . 1.1899999999999999 111.578 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.52 131.05 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 2.4100000000000001 110.235 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.768 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 19.1 t0 -140.05 150.82 44.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.432 0.634 . . . . 1.78 111.417 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.747 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 51.0 mt -141.96 139.99 30.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.919 -1.037 . . . . 1.4099999999999999 109.747 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 85.9 tt0 -139.98 148.0 41.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.007 0.432 . . . . 1.6699999999999999 111.835 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.735 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 78.6 m95 -141.04 119.27 12.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.23999999999999999 111.004 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 83.5 mt -110.06 146.3 35.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 1.1200000000000001 109.192 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.9 tt -129.91 135.59 60.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.685 0.624 . . . . 1.3700000000000001 112.685 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 m -121.52 102.94 41.75 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.26 -0.882 . . . . 1.73 108.646 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 7.1 Cg_exo -78.09 114.09 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.518 2.145 . . . . 0.84999999999999998 112.619 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.98 87.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.101 -0.954 . . . . 1.0700000000000001 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.42 -40.05 62.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 1.8200000000000001 111.253 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -85.04 159.77 20.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.227 0.537 . . . . 2.3599999999999999 111.813 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.81 -16.39 63.77 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.343 -0.844 . . . . 1.95 111.576 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 93.8 mttt -69.6 151.73 45.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 2.2799999999999998 111.848 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.12 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-O 121.751 0.786 . . . . 1.4199999999999999 109.496 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 55.66 85.18 0.07 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.276 -1.329 . . . . 1.77 112.304 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -140.04 144.14 36.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.424 . . . . 2.54 111.124 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 73' ' ' LEU . 61.2 t -70.83 131.9 33.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.902 -0.59 . . . . 1.3899999999999999 111.33 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.71 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.1 pp -130.79 -41.38 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.187 0.44 . . . . 1.8200000000000001 112.187 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.833 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.4 129.89 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.373 0.606 . . . . 1.0800000000000001 110.064 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.724 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -140.41 160.97 38.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.255 -0.884 . . . . 1.8799999999999999 109.684 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.822 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 24.0 t80 -138.54 103.28 4.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.477 -0.564 . . . . 2.2000000000000002 109.477 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.426 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 18.2 t -143.65 153.66 42.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.502 -0.317 . . . . 1.4199999999999999 111.8 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' ASP . . . 58.43 29.49 63.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.624 -0.798 . . . . 0.56999999999999995 111.685 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 10.1 m-20 69.86 4.52 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.619 0.247 . . . . 1.46 111.088 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 97.3 mttt -99.98 112.68 24.95 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.611 -0.514 . . . . 2.96 109.611 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.822 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.28 116.47 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 108.057 -1.09 . . . . 2.27 108.057 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.803 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -100.33 126.28 46.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.439 -1.709 . . . . 2.1499999999999999 110.78 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.849 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.5 p-10 -165.98 -53.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.526 -1.286 . . . . 1.2 107.526 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' OD1' ' CD1' ' A' ' 83' ' ' TYR . 21.0 p-10 -82.93 -26.93 30.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.147 -0.933 . . . . 2.1699999999999999 109.749 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CD1' ' OD1' ' A' ' 82' ' ' ASP . 36.1 m-85 -75.57 -28.58 59.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.4 -1.333 . . . . 5.4100000000000001 107.4 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.567 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -83.16 113.19 44.4 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 114.158 -1.383 . . . . 2.21 110.329 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.7 -42.94 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.615 1.544 . . . . 1.1100000000000001 111.226 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 74.6 m-20 -67.99 104.6 1.78 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.012 -0.54 . . . . 1.3600000000000001 111.235 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.79 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 32.4 mt 71.27 24.4 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.306 -0.861 . . . . 2.2400000000000002 113.221 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.849 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.7 pttt -58.14 135.61 57.08 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.901 -0.499 . . . . 2.8700000000000001 111.63 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.35 11.31 75.64 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.536 -0.84 . . . . 0.48999999999999999 114.398 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.79 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.6 ptp180 -138.99 -50.97 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.678 1.362 . . . . 2.1099999999999999 114.678 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.833 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -78.96 81.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.847 1.308 . . . . 1.04 107.53 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.47 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.6 m80 -102.88 131.55 49.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.451 -2.159 . . . . 0.34000000000000002 112.401 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 82.6 m-85 -73.59 120.2 18.86 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 120.024 -0.67 . . . . 2.1600000000000001 109.312 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.0 p -70.09 -9.17 54.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.923 -1.035 . . . . 1.0900000000000001 110.807 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.483 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 5.3 m -88.32 118.53 28.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.941 -0.572 . . . . 1.71 110.887 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -90.09 0.18 57.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.244 0.545 . . . . 2.4700000000000002 110.168 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -146.41 67.19 1.18 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.487 -0.931 . . . . 2.1400000000000001 108.487 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 6.5 mp -57.77 -27.76 63.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.25 -0.886 . . . . 1.99 112.149 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -63.45 -5.04 3.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.187 0.518 . . . . 2.4900000000000002 112.115 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.6 p -89.85 -0.04 57.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.41 -0.814 . . . . 1.8999999999999999 110.975 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.21 0.6 38.26 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.645 -0.788 . . . . 0.40999999999999998 113.218 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 92.3 m-20 -99.94 118.65 36.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 111.002 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.571 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -118.5 10.39 12.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 1.1200000000000001 111.651 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.668 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -60.03 140.43 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.122 1.897 . . . . 1.46 116.122 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.82 134.61 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 114.543 -1.208 . . . . 1.0900000000000001 110.486 177.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.3 p-10 -108.88 151.08 26.75 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.673 -0.862 . . . . 1.5600000000000001 108.673 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.78 120.13 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.0 0.429 . . . . 1.0600000000000001 110.903 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.587 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -83.9 144.89 28.91 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.506 -0.77 . . . . 1.0700000000000001 111.094 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.416 ' HB3' ' OXT' ' A' ' 144' ' ' ALA . 98.6 m-20 51.82 61.77 3.04 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.963 -0.562 . . . . 1.9399999999999999 112.328 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 31' ' ' LYS . 9.4 mt -45.45 176.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.218 0.451 . . . . 1.21 112.218 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.663 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 62.3 tt0 -176.32 159.99 2.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 2.6699999999999999 110.616 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 95.0 mt -59.93 -40.07 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.525 . . . . 2.2400000000000002 112.416 -178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.3 m -74.56 -13.98 60.74 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.1 -0.24 . . . . 1.8300000000000001 111.372 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.62 -22.37 62.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 1.5800000000000001 109.271 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -46.53 144.9 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 115.641 -0.709 . . . . 1.1399999999999999 110.74 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.62 148.79 5.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.234 -0.984 . . . . 0.26000000000000001 113.268 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.1 m -59.07 135.89 57.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.431 . . . . 1.0700000000000001 111.771 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 31.5 m-85 -116.18 139.99 49.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 2.1400000000000001 109.867 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.735 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 54.7 tt0 -117.88 117.53 29.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.035 -0.357 . . . . 1.5900000000000001 110.035 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.538 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 18.0 t -100.0 109.62 21.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.101 -0.5 . . . . 1.03 110.687 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 54.4 mtpt -121.35 111.48 17.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 2.1899999999999999 111.895 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 t -96.28 110.16 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.483 -0.562 . . . . 1.8200000000000001 109.483 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 29.0 tttt -95.02 114.93 26.79 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.879 -0.728 . . . . 2.1899999999999999 112.767 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.99 102.66 3.67 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.262 -0.644 . . . . 3.2799999999999998 109.262 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.527 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.07 133.51 22.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 1.1799999999999999 112.29 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 58.6 Cg_endo -101.61 50.04 1.71 Allowed 'Cis proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.745 -0.939 . . . . 0.62 111.138 -0.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.98 103.06 0.29 Allowed Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.062 -1.066 . . . . 0.53000000000000003 113.29 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -88.41 119.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.203 -0.999 . . . . 1.8700000000000001 109.761 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -100.01 140.48 34.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.681 -0.236 . . . . 1.3200000000000001 111.601 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.402 ' H ' HD11 ' A' ' 22' ' ' ILE . 42.7 p-10 -146.07 131.72 18.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.483 -0.326 . . . . 2.0299999999999998 111.244 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.508 ' HD2' HG23 ' A' ' 22' ' ' ILE . 5.0 ptmt -145.25 158.5 43.81 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.344 -0.389 . . . . 3.46 110.676 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 96.7 mttt -102.79 140.02 37.61 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.065 0.765 . . . . 2.6699999999999999 113.065 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.58 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 2.4 mp -141.32 116.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.349 -0.841 . . . . 1.0600000000000001 108.895 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 54.0 m170 -101.44 120.04 39.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.70999999999999996 110.845 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -88.77 121.26 30.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 2.1000000000000001 111.623 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.8 t -120.0 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.763 -0.653 . . . . 1.0900000000000001 109.513 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.97 125.94 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 1.72 112.156 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.26 155.25 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.835 -0.62 . . . . 1.21 109.403 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.9 134.73 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 2.0899999999999999 111.654 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.736 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.14 173.57 3.64 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.431 -1.259 . . . . 2.7599999999999998 108.953 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 5.4 Cg_endo -46.85 164.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.876 1.717 . . . . 1.4199999999999999 111.583 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 144' ' ' ALA . 0.4 OUTLIER -35.62 -79.59 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.348 0.499 . . . . 2.6899999999999999 112.348 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.19 -66.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.215 -0.448 . . . . 2.8799999999999999 112.956 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.449 -0.786 . . . . 2.6000000000000001 111.789 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.51 -0.236 . . . . 3.6600000000000001 112.51 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -80.04 138.69 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 2.8100000000000001 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -157.25 134.29 10.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 2.2599999999999998 111.06 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.513 HG23 ' CB ' ' A' ' 129' ' ' ALA . 6.5 pt -99.18 144.89 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 2.6299999999999999 111.182 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.41 159.54 18.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.466 0.65 . . . . 1.6499999999999999 111.614 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.626 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER 41.75 83.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.724 -1.125 . . . . 1.26 111.899 -178.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.2 Cg_endo -78.72 -78.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.547 2.832 . . . . 0.88 112.867 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.1 mt-10 -78.96 128.6 33.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.871 -0.418 . . . . 2.0600000000000001 109.871 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.564 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 49.7 tt0 -144.45 159.96 41.87 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.212 1.19 . . . . 1.71 114.212 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.2 mtt -137.73 117.85 13.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.626 -1.17 . . . . 2.3999999999999999 108.847 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.528 HD13 ' HG2' ' A' ' 27' ' ' GLU . 3.6 mp -119.97 120.6 63.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.371 0.508 . . . . 1.1499999999999999 112.371 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 96.5 mt-10 -106.87 126.25 52.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.059 -0.519 . . . . 1.1899999999999999 109.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.452 ' CG ' HD13 ' A' ' 110' ' ' LEU . 27.7 tptt -141.79 150.07 41.23 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.795 -0.362 . . . . 2.9300000000000002 111.486 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.62 140.26 40.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 1.1299999999999999 112.134 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' CG ' ' A' ' 140' ' ' LYS . 97.6 mttt -44.98 153.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.654 0.613 . . . . 2.7599999999999998 112.654 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.09 -28.53 0.54 Allowed Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.139 -0.937 . . . . 0.32000000000000001 113.636 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 33' ' ' LYS . 99.4 mt-10 -79.62 160.07 26.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.236 -0.653 . . . . 2.1099999999999999 109.236 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.78 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 79.7 m -85.89 129.87 34.71 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.066 -0.654 . . . . 1.0800000000000001 110.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB1' HG22 ' A' ' 107' ' ' VAL . . . -98.83 117.8 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.509 . . . . 1.0700000000000001 110.243 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' HG23 ' A' ' 94' ' ' THR . 17.6 t80 -79.32 121.11 24.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.722 -0.672 . . . . 2.3199999999999998 112.631 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB3' HD11 ' A' ' 133' ' ' ILE . 22.9 mt -104.29 104.8 46.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.457 -0.942 . . . . 1.47 108.457 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.613 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 95.7 Cg_endo -82.95 129.72 5.48 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.235 1.957 . . . . 0.71999999999999997 114.202 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 3.8 t -140.64 134.4 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.183 -1.043 . . . . 1.03 108.183 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 43.8 mmtm -140.28 143.86 36.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.826 -0.35 . . . . 2.2400000000000002 111.349 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 47.3 p90 -140.56 140.71 35.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 2.1499999999999999 111.26 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -81.88 140.21 34.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.906 -0.588 . . . . 1.9299999999999999 111.899 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.61 141.97 33.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.762 -0.653 . . . . 2.5899999999999999 110.997 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 44.7 m -154.93 154.49 29.03 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 2.1299999999999999 110.242 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 11.7 Cg_endo -55.42 -21.33 29.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.603 2.202 . . . . 1.9299999999999999 112.909 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.3 tt0 -76.18 -41.49 49.44 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 120.942 -0.303 . . . . 2.1800000000000002 110.952 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.507 ' HB2' ' HG2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -71.48 74.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.357 -0.537 . . . . 2.4100000000000001 109.943 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 62.6 mm-40 -91.38 -8.02 49.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.801 . . . . 1.96 111.892 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.32 159.89 53.54 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.067 -1.064 . . . . 0.56000000000000005 112.259 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 144.04 59.56 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.132 1.888 . . . . 1.1899999999999999 111.348 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD22 ' CE1' ' A' ' 74' ' ' TYR . 9.7 tt -77.61 123.66 26.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 2.4100000000000001 110.663 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.2 m-20 -129.46 148.21 51.34 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.508 0.67 . . . . 1.78 111.223 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 24.3 mt -142.88 141.87 26.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.491 -1.232 . . . . 1.4099999999999999 109.248 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.778 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 40.9 mt-10 -139.97 151.41 45.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.015 -0.274 . . . . 1.6699999999999999 110.953 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.679 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 87.4 m95 -140.49 116.12 10.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.23999999999999999 110.588 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.3 mt -106.31 146.26 30.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 1.1200000000000001 109.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.062 0.458 . . . . 1.3700000000000001 111.923 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 28.4 t -115.64 102.88 54.24 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 108.916 -0.772 . . . . 1.73 108.916 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 72.4 Cg_endo -78.76 110.29 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.629 2.219 . . . . 0.84999999999999998 112.81 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.79 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.15 -0.932 . . . . 1.0700000000000001 110.901 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 20.1 p-10 -88.24 20.41 3.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 1.8200000000000001 111.642 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -151.46 160.02 43.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.245 0.545 . . . . 2.3599999999999999 111.858 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -68.4 -20.01 64.65 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.394 -0.821 . . . . 1.95 112.231 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.58 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 59.4 mttp -67.86 154.19 42.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 2.2799999999999998 110.945 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 135.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-O 122.751 1.262 . . . . 1.4199999999999999 110.78 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 39.98 46.31 1.74 Allowed 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.251 -2.25 . . . . 1.77 113.481 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.33 143.28 26.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.996 -0.282 . . . . 2.54 110.98 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.498 ' CG1' HD11 ' A' ' 73' ' ' LEU . 94.9 t -68.35 130.03 33.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 1.3899999999999999 110.525 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.891 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.3 pp -128.61 -37.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 1.8200000000000001 112.014 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.886 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.67 125.62 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.928 -0.767 . . . . 1.0800000000000001 108.928 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.74 158.29 44.18 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.556 -0.747 . . . . 1.8799999999999999 110.695 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.759 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 14.6 t80 -133.25 103.81 6.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.146 -0.687 . . . . 2.2000000000000002 109.146 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.444 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 23.5 m -142.74 159.11 42.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.784 0.326 . . . . 1.4199999999999999 111.666 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.19 27.55 23.85 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.797 -0.716 . . . . 0.56999999999999995 112.462 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 74.12 1.83 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.54 0.21 . . . . 1.46 110.989 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.9 mttm -100.01 114.1 27.17 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.954 -0.388 . . . . 2.96 109.954 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.684 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.24 126.87 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 C-N-CA 118.658 -1.217 . . . . 2.27 107.82 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.713 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -111.02 128.06 55.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.635 -1.62 . . . . 2.1499999999999999 110.631 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.7 p-10 -166.17 -56.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.081 -1.451 . . . . 1.2 107.081 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.9 t70 -83.09 -26.02 31.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.702 -1.135 . . . . 2.1699999999999999 109.188 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -75.87 -30.2 58.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.921 -1.14 . . . . 5.4100000000000001 107.921 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.55 110.58 22.82 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 114.402 -1.272 . . . . 2.21 110.166 178.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.73 -41.69 11.55 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.67 1.58 . . . . 1.1100000000000001 111.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 86.1 m-20 -68.06 104.2 1.71 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.83 -0.623 . . . . 1.3600000000000001 111.188 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.778 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.2 mt 71.74 20.75 4.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.21 0.819 . . . . 2.2400000000000002 113.21 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.8 pttt -56.23 131.99 49.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.883 -0.511 . . . . 2.8700000000000001 111.269 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 92.07 10.82 60.74 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.186 -1.007 . . . . 0.48999999999999999 114.247 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.778 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -142.02 -49.26 0.38 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 114.862 1.43 . . . . 2.1099999999999999 114.862 -178.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.891 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.3 p -79.61 81.45 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 CA-C-O 123.339 1.542 . . . . 1.04 107.128 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.6 m80 -102.05 128.9 48.31 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.044 -2.344 . . . . 0.34000000000000002 112.563 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.684 ' CD2' HG13 ' A' ' 79' ' ' ILE . 82.3 m-85 -72.34 124.74 25.74 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.752 -0.779 . . . . 2.1600000000000001 109.024 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.578 HG23 ' CE2' ' A' ' 38' ' ' TYR . 12.6 p -76.44 36.03 0.15 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.212 -0.903 . . . . 1.0900000000000001 112.062 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -148.68 133.33 17.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.91 0.386 . . . . 1.71 110.848 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -90.07 5.23 47.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 2.4700000000000002 110.2 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -146.16 65.74 1.2 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.704 -0.68 . . . . 2.1400000000000001 109.429 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.481 HD22 ' CD2' ' A' ' 93' ' ' PHE . 8.1 mp -57.32 -29.12 63.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 1.99 110.866 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.5 mttt -65.8 1.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.35 0.5 . . . . 2.4900000000000002 112.35 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 98' ' ' LEU . 11.1 m -89.99 -0.0 57.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.688 -0.687 . . . . 1.8999999999999999 111.244 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.606 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 110.51 -11.02 30.64 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.805 -0.712 . . . . 0.40999999999999998 113.022 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -100.09 112.69 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 111.135 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.559 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -109.65 12.75 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 1.1200000000000001 111.681 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 21.1 m -60.07 139.15 57.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.459 1.651 . . . . 1.46 115.459 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.38 130.03 65.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-N 114.347 -1.297 . . . . 1.0900000000000001 110.735 178.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.591 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.6 p-10 -104.4 146.62 28.58 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.672 -0.862 . . . . 1.5600000000000001 108.672 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.78 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.82 121.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.008 0.432 . . . . 1.0600000000000001 110.808 -178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.567 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -83.79 145.22 28.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.445 -0.798 . . . . 1.0700000000000001 111.176 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 54.12 63.73 2.07 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.081 -0.509 . . . . 1.9399999999999999 112.169 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD13 ' CG ' ' A' ' 31' ' ' LYS . 4.5 mt -45.03 175.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.198 0.523 . . . . 1.21 112.299 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 144' ' ' ALA . 14.8 pt20 -177.02 156.83 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 2.6699999999999999 110.888 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.578 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 60.5 tp -60.04 -39.71 86.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 2.2400000000000002 112.11 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.478 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 4.8 t -72.46 -16.11 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.998 0.74 . . . . 1.8300000000000001 112.998 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 111' ' ' GLN . 3.2 p30 -74.38 -16.05 60.91 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.888 -0.725 . . . . 1.5800000000000001 109.791 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -45.17 141.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.094 -0.503 . . . . 1.1399999999999999 110.185 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.423 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.96 154.05 6.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 119.717 -1.23 . . . . 0.26000000000000001 113.88 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.88 137.73 57.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.933 -0.633 . . . . 1.0700000000000001 112.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.6 m-85 -119.97 139.7 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.324 -0.621 . . . . 2.1400000000000001 109.324 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.649 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.1 tt0 -128.39 121.89 30.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.706 0.288 . . . . 1.5900000000000001 110.893 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 56' ' ' GLU . 43.5 t -99.96 117.79 35.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.03 110.632 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.778 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 23.0 mttm -115.0 106.1 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.801 -0.359 . . . . 2.1899999999999999 110.56 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 34.3 t -94.87 105.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.649 -0.5 . . . . 1.8200000000000001 109.649 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.7 tttt -95.27 119.35 33.63 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.898 -0.721 . . . . 2.1899999999999999 112.603 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.507 ' HG2' ' HB2' ' A' ' 49' ' ' ASP . 6.6 ttpm? -146.25 102.98 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 3.2799999999999998 110.111 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.506 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.33 133.25 24.9 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 111.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 53.5 Cg_endo -100.68 47.26 2.19 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.742 -0.941 . . . . 0.62 111.434 -0.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.94 103.33 0.28 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.146 -1.026 . . . . 0.53000000000000003 113.579 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.73 151.46 3.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -0.811 . . . . 1.8700000000000001 108.887 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.513 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -141.44 151.32 43.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.412 0.523 . . . . 1.3200000000000001 112.412 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 129' ' ' ALA . 1.8 m120 -145.8 141.18 27.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.925 -0.58 . . . . 2.0299999999999998 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.626 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.26 156.31 43.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.689 -0.232 . . . . 3.46 110.645 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.3 mttm -101.34 140.53 35.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.631 0.975 . . . . 2.6699999999999999 113.631 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 33.3 mt -141.96 111.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 1.0600000000000001 109.233 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CD2' HG22 ' A' ' 117' ' ' THR . 41.7 m170 -100.04 118.71 37.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.727 -0.389 . . . . 0.70999999999999996 110.647 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 10.2 mt -92.94 125.39 37.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.267 0.556 . . . . 2.1000000000000001 112.035 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 57.8 t -115.64 123.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.314 -0.857 . . . . 1.0900000000000001 109.109 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 115' ' ' ILE . 21.6 t -94.6 120.03 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.062 0.458 . . . . 1.72 111.929 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.16 158.63 18.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 1.21 110.505 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.1 142.02 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.225 0.536 . . . . 2.0899999999999999 111.057 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.847 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -159.63 175.89 2.93 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.47 -0.786 . . . . 2.7599999999999998 110.031 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 72.2 Cg_exo -14.72 -140.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.545 4.163 . . . . 1.4199999999999999 115.769 179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 141' ' ' PRO . 7.5 t -22.77 -51.87 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.193 0.812 . . . . 2.6899999999999999 113.193 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 144' ' ' ALA . . . 113.83 56.05 0.41 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.163 -1.018 . . . . 2.8799999999999999 113.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 143' ' ' GLY . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.292 -0.861 . . . . 2.6000000000000001 110.977 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.492 -0.243 . . . . 3.6600000000000001 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.409 ' HB3' ' HA2' ' A' ' 127' ' ' GLY . 78.9 p -78.65 158.55 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 2.8100000000000001 110.934 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 m -159.9 149.24 17.86 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 2.2599999999999998 111.08 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 129' ' ' ALA . 14.9 tt -142.82 147.75 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.596 -0.729 . . . . 2.6299999999999999 110.986 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.503 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 53.6 p -88.86 146.3 25.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.28 0.562 . . . . 1.6499999999999999 110.998 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 40.28 82.52 0.22 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.868 -1.06 . . . . 1.26 111.384 -178.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.6 Cg_endo -78.15 -11.17 16.34 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 124.008 3.139 . . . . 0.88 113.127 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.56 121.8 13.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.592 -0.892 . . . . 2.0600000000000001 108.592 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 132' ' ' LYS . 85.1 tt0 -143.81 158.99 43.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.765 1.024 . . . . 1.71 113.765 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.3 ttm -138.52 135.05 34.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.692 -1.14 . . . . 2.3999999999999999 109.138 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.9 mm -133.79 139.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 1.1499999999999999 111.925 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.57 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.2 mt-10 -132.61 122.23 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 1.1899999999999999 109.544 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 11.6 tptm -142.1 161.52 37.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.74 -0.384 . . . . 2.9300000000000002 111.119 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.604 ' CB ' ' HG3' ' A' ' 140' ' ' LYS . . . -76.17 131.69 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 1.1299999999999999 111.573 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 27.7 ttmt -44.89 132.04 6.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.767 -0.651 . . . . 2.7599999999999998 111.345 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.94 -16.56 56.65 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.056 -0.592 . . . . 0.32000000000000001 112.504 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 66.4 mm-40 -80.32 159.97 25.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.009 -0.737 . . . . 2.1099999999999999 109.009 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.898 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 10.1 m -90.84 121.69 32.91 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.001 -0.68 . . . . 1.0800000000000001 110.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' C ' ' OD1' ' A' ' 106' ' ' ASN . . . -99.53 119.73 38.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.146 0.498 . . . . 1.0700000000000001 111.451 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 80.7 t80 -79.24 116.38 19.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 2.3199999999999998 111.638 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.96 105.05 32.66 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.935 -0.765 . . . . 1.47 108.935 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.769 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.0 Cg_endo -82.31 124.92 4.37 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.424 2.083 . . . . 0.71999999999999997 114.09 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.9 t -141.16 132.71 27.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 1.03 109.473 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 22' ' ' ILE . 41.9 mttm -141.08 153.47 45.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.28 -0.418 . . . . 2.2400000000000002 110.538 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.541 ' CD1' HG11 ' A' ' 122' ' ' VAL . 36.3 p90 -140.41 153.02 46.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.145 -0.48 . . . . 2.1499999999999999 111.567 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -79.89 128.39 33.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 1.9299999999999999 111.299 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -99.75 131.42 45.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.63 -0.713 . . . . 2.5899999999999999 110.725 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 m -152.24 139.91 13.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 110.223 -0.288 . . . . 2.1299999999999999 110.223 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.57 -25.69 5.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.398 2.065 . . . . 1.9299999999999999 112.344 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -39.97 67.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.345 -0.388 . . . . 2.1800000000000002 110.53 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.593 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -75.93 79.62 2.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.606 -0.887 . . . . 2.4100000000000001 108.606 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.95 -0.23 54.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.757 -0.656 . . . . 1.96 112.306 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -71.21 158.96 53.79 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.342 -0.932 . . . . 0.56000000000000005 112.719 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 123' ' ' LYS . 18.6 Cg_endo -59.93 132.5 45.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.472 2.115 . . . . 1.1899999999999999 111.376 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.2 104.67 8.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.444 -0.344 . . . . 2.4100000000000001 111.698 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.719 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.2 m-20 -118.3 103.56 9.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.53 0.681 . . . . 1.78 111.426 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 4.7 mm -89.56 104.44 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.774 -1.103 . . . . 1.4099999999999999 109.853 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HG3' HD13 ' A' ' 73' ' ' LEU . 85.9 tt0 -101.73 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.687 ' HB2' HG23 ' A' ' 72' ' ' ILE . 81.3 m95 -99.99 124.39 45.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.23999999999999999 110.303 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.2 mt -112.23 139.96 47.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.472 -0.566 . . . . 1.1200000000000001 109.472 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 117' ' ' THR . 3.7 tt -129.59 130.05 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.994 0.426 . . . . 1.3700000000000001 111.675 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.454 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 19.6 m -114.3 102.61 54.95 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 115.799 -0.637 . . . . 1.73 109.328 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.7 Cg_exo -78.67 113.79 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.707 2.272 . . . . 0.84999999999999998 112.255 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.98 87.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.29 -0.868 . . . . 1.0700000000000001 111.283 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.73 -40.01 61.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 1.8200000000000001 111.009 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 12.5 t-20 -82.91 159.96 22.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.3599999999999999 111.662 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.67 -17.49 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.419 -0.81 . . . . 1.95 111.408 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 60.8 mttp -69.76 152.66 44.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.592 -0.731 . . . . 2.2799999999999998 112.113 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -156.31 126.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-O 121.829 0.823 . . . . 1.4199999999999999 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 56.47 40.04 29.74 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 1.77 111.988 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -89.14 147.71 24.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.628 -0.26 . . . . 2.54 111.158 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 22.4 t -67.54 139.74 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.689 -0.486 . . . . 1.3899999999999999 109.689 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.688 HD12 HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -134.06 -52.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.8200000000000001 112.912 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.729 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.21 127.04 31.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.076 -0.713 . . . . 1.0800000000000001 109.076 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD13 ' HG3' ' A' ' 56' ' ' GLU . 7.4 tt -140.13 160.63 39.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 1.8799999999999999 110.633 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 20.9 t80 -134.78 104.04 5.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.326 -0.397 . . . . 2.2000000000000002 110.619 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.467 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 35.6 t -143.61 159.82 41.76 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.475 0.546 . . . . 1.4199999999999999 112.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.14 31.89 8.91 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.862 -0.608 . . . . 0.56999999999999995 113.155 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t0 71.07 2.57 4.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.269 . . . . 1.46 111.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 92.2 mttt -100.18 113.4 26.03 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.979 -0.378 . . . . 2.96 109.979 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG22 ' CE2' ' A' ' 93' ' ' PHE . 3.1 mm -79.34 128.8 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.063 -1.458 . . . . 2.27 107.063 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.723 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -112.59 115.65 28.94 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.241 -0.89 . . . . 2.1499999999999999 110.328 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.853 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.7 p-10 -166.07 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 106.799 -1.556 . . . . 1.2 106.799 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -79.67 -25.72 41.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.585 -1.189 . . . . 2.1699999999999999 108.491 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -81.32 -28.26 34.64 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.849 -1.167 . . . . 5.4100000000000001 107.849 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 2.7 m-85 -87.65 120.93 71.18 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 114.769 -1.105 . . . . 2.21 110.727 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 84' ' ' TYR . 7.7 Cg_exo -71.47 -28.67 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.033 1.822 . . . . 1.1100000000000001 112.951 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 28.7 t0 -49.22 -30.01 6.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.228 -0.589 . . . . 1.3600000000000001 112.06 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.759 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 29.9 mt -157.56 38.01 0.28 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.121 -0.945 . . . . 2.2400000000000002 110.504 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.853 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 23.9 pttm -55.81 134.09 51.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.877 -0.601 . . . . 2.8700000000000001 112.392 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.36 76.0 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.39 -0.823 . . . . 0.48999999999999999 114.461 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.5 ptp180 -145.27 -48.13 0.23 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.701 1.371 . . . . 2.1099999999999999 114.701 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 7.4 p -80.22 81.47 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-O 122.992 1.377 . . . . 1.04 108.064 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 106' ' ' ASN . 19.8 m80 -102.91 126.98 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.24 -2.254 . . . . 0.34000000000000002 112.343 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.905 ' CD1' HG21 ' A' ' 105' ' ' ILE . 80.5 m-85 -70.01 125.42 26.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 120.168 -0.613 . . . . 2.1600000000000001 109.701 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.472 HG21 ' CE1' ' A' ' 38' ' ' TYR . 2.4 p -76.14 32.94 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.204 -0.907 . . . . 1.0900000000000001 112.027 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.8 m -148.46 132.51 17.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 1.71 111.216 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -91.72 4.9 51.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 2.4700000000000002 110.585 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.04 66.29 1.2 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.135 -0.691 . . . . 2.1400000000000001 109.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 100' ' ' SER . 8.5 mp -57.72 -31.76 66.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.888 . . . . 1.99 111.425 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.99 2.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.291 0.478 . . . . 2.4900000000000002 112.291 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 98' ' ' LEU . 5.4 t -89.97 -0.03 57.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.761 -0.654 . . . . 1.8999999999999999 110.619 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.457 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.89 -14.01 41.28 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.055 -0.593 . . . . 0.40999999999999998 112.834 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.02 108.03 20.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 110.853 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -111.62 19.99 17.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.104 0.409 . . . . 1.1200000000000001 112.104 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.0 m -60.04 143.78 51.11 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.006 1.484 . . . . 1.46 115.006 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.905 HG21 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -129.67 133.26 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.735 -1.12 . . . . 1.0900000000000001 111.252 178.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.764 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 2.9 t-20 -102.84 157.33 17.04 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.022 -1.103 . . . . 1.5600000000000001 108.022 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.898 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -114.81 117.38 55.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.988 0.423 . . . . 1.0600000000000001 111.456 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.64 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.03 143.01 31.85 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.48 -0.782 . . . . 1.0700000000000001 110.556 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 8.7 t-20 48.88 58.31 5.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.958 -0.565 . . . . 1.9399999999999999 111.826 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.415 HD21 ' HB ' ' A' ' 107' ' ' VAL . 19.1 mt -47.27 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.754 1.02 . . . . 1.21 113.754 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HB2' ' CB ' ' A' ' 144' ' ' ALA . 54.1 tt0 -56.58 145.57 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.983 -0.553 . . . . 2.6699999999999999 110.793 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.426 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 62.5 tp -60.03 -40.0 87.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 2.2400000000000002 111.127 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -73.51 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.939 -0.573 . . . . 1.8300000000000001 111.632 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.98 -18.08 63.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 1.5800000000000001 109.881 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.74 140.66 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.976 -0.556 . . . . 1.1399999999999999 110.235 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.8 159.14 7.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.9 -1.143 . . . . 0.26000000000000001 113.951 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.8 m -58.99 139.33 56.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.062 -0.569 . . . . 1.0700000000000001 112.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 29.9 m-85 -119.98 130.87 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.514 . . . . 2.1400000000000001 109.888 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -122.05 119.83 32.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.148 -0.221 . . . . 1.5900000000000001 110.662 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.546 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 39.5 t -100.15 120.01 39.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.468 -0.333 . . . . 1.03 110.76 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.5 mtpt -114.14 104.83 12.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.377 . . . . 2.1899999999999999 110.842 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.541 HG11 ' CD1' ' A' ' 43' ' ' PHE . 73.8 t -87.52 108.25 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.197 -1.038 . . . . 1.8200000000000001 108.197 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 83.4 tttt -97.78 110.87 23.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.423 0.897 . . . . 2.1899999999999999 113.423 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.593 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 34.8 tttp -145.61 101.56 3.58 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.545 -0.539 . . . . 3.2799999999999998 109.545 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -52.79 132.18 47.62 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 1.1799999999999999 112.332 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 60.7 Cg_endo -100.62 49.76 1.75 Allowed 'Cis proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.614 -0.994 . . . . 0.62 112.185 -0.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 20' ' ' SER . . . -144.99 103.3 0.29 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.303 -0.951 . . . . 0.53000000000000003 113.438 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.85 120.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.288 -0.956 . . . . 1.8700000000000001 110.203 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 22' ' ' ILE . . . -95.45 144.68 25.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 1.3200000000000001 111.359 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 1.4 m-80 -145.72 129.89 17.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.651 0.611 . . . . 2.0299999999999998 112.651 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.769 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.84 159.95 42.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.438 -0.346 . . . . 3.46 110.941 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.5 mttt -110.5 146.92 35.14 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.496 0.925 . . . . 2.6699999999999999 113.496 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 88.7 mt -143.39 118.97 4.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.266 -0.879 . . . . 1.0600000000000001 109.535 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.459 ' CD2' HG21 ' A' ' 117' ' ' THR . 64.2 m170 -100.9 113.22 25.98 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.91 -0.494 . . . . 0.70999999999999996 110.406 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.435 ' CB ' ' CE1' ' A' ' 118' ' ' TYR . 1.9 tm? -91.56 128.91 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.253 0.464 . . . . 2.1000000000000001 112.253 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.57 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.6 t -121.53 129.96 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.689 . . . . 1.0900000000000001 109.297 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.0 t -103.06 119.96 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.209 0.448 . . . . 1.72 112.209 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.2 mt -84.51 172.13 11.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 1.21 109.089 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.87 139.24 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.63 . . . . 2.0899999999999999 111.664 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.604 ' HG3' ' CB ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -162.69 172.56 5.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.017 -0.992 . . . . 2.7599999999999998 110.708 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.9 Cg_endo -51.52 -142.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.071 2.514 . . . . 1.4199999999999999 112.39 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.479 ' H ' ' HB2' ' A' ' 141' ' ' PRO . 10.7 t -34.16 -49.87 0.38 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.757 0.313 . . . . 2.6899999999999999 111.82 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 33' ' ' LYS . . . 53.18 55.91 21.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.789 . . . . 2.8799999999999999 113.261 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 2.6000000000000001 111.247 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.481 -0.248 . . . . 3.6600000000000001 112.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.7 p -79.88 140.06 36.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.357 . . . . 2.8100000000000001 110.859 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -160.05 160.43 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 2.2599999999999998 110.843 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 42' ' ' LYS . 13.3 tt -130.01 129.93 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 2.6299999999999999 110.558 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -89.39 153.84 20.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.352 0.596 . . . . 1.6499999999999999 111.259 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.508 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 44.33 82.96 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.92 -1.037 . . . . 1.26 111.004 -177.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.1 Cg_endo -78.55 -86.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.619 2.879 . . . . 0.88 113.207 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.5 tt0 -77.85 123.09 26.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.222 -0.659 . . . . 2.0600000000000001 109.222 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.8 tp10 -143.91 159.96 41.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.446 0.906 . . . . 1.71 113.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 26.0 mtt -132.35 130.01 40.17 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.264 -0.88 . . . . 2.3999999999999999 109.918 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.2 mm -127.57 133.82 66.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.643 0.259 . . . . 1.1499999999999999 111.524 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.645 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.9 mt-10 -123.77 125.73 45.24 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.498 -0.319 . . . . 1.1899999999999999 110.842 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HB2' HD11 ' A' ' 110' ' ' LEU . 10.4 mmtp -142.35 160.01 41.1 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.408 . . . . 2.9300000000000002 111.713 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.82 139.23 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 1.1299999999999999 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 85.5 tttt -49.24 134.87 17.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.858 0.361 . . . . 2.7599999999999998 111.356 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.52 -21.33 22.44 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.138 -0.553 . . . . 0.32000000000000001 112.776 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 80.7 mm-40 -79.98 159.83 26.13 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.32 -0.993 . . . . 2.1099999999999999 108.32 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.859 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.4 m -87.28 126.78 35.05 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.42 -0.912 . . . . 1.0800000000000001 110.484 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -98.74 117.62 33.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 1.0700000000000001 110.162 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.528 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 74.0 t80 -79.13 115.27 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 2.3199999999999998 112.038 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.45 104.76 32.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.961 -0.755 . . . . 1.47 108.961 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.657 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.6 Cg_endo -81.94 125.61 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.38 2.053 . . . . 0.71999999999999997 113.819 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.0 t -140.39 131.25 25.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.833 -1.173 . . . . 1.03 107.833 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 39.4 mttm -140.67 150.59 43.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 2.2400000000000002 111.183 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CE2' HD11 ' A' ' 53' ' ' LEU . 40.6 p90 -140.35 142.04 35.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.642 -0.708 . . . . 2.1499999999999999 111.133 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -82.3 135.48 35.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.989 -0.551 . . . . 1.9299999999999999 111.665 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 99' ' ' LYS . 83.8 mt -97.74 140.06 32.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 2.5899999999999999 111.762 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 t -159.19 143.21 11.07 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.835 -0.621 . . . . 2.1299999999999999 109.814 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -41.32 -26.72 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.735 2.29 . . . . 1.9299999999999999 113.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.82 -50.58 16.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.681 0.277 . . . . 2.1800000000000002 110.53 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB2' ' CG ' ' A' ' 124' ' ' LYS . 4.4 p-10 -74.59 64.25 1.18 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.174 0.512 . . . . 2.4100000000000001 110.047 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -102.46 2.59 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.479 -0.782 . . . . 1.96 112.556 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -73.34 169.53 53.11 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.231 -0.985 . . . . 0.56000000000000005 112.94 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.6 121.96 10.44 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.591 2.194 . . . . 1.1899999999999999 111.563 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.4 tt -78.29 120.62 23.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.151 -0.477 . . . . 2.4100000000000001 111.937 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -138.05 103.45 4.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.373 0.606 . . . . 1.78 111.484 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 67.8 mt -98.94 108.45 22.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 1.4099999999999999 111.103 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -100.62 121.17 41.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.765 0.654 . . . . 1.6699999999999999 112.765 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.678 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 76.5 m95 -95.33 126.57 40.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.23999999999999999 109.926 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 88.7 mt -112.9 141.81 46.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.702 -0.481 . . . . 1.1200000000000001 109.702 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.5 tt -129.99 129.95 65.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.036 0.446 . . . . 1.3700000000000001 111.793 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 14.3 m -120.23 102.01 46.35 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 109.015 -0.735 . . . . 1.73 109.015 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.4 Cg_exo -80.02 114.78 3.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.52 2.146 . . . . 0.84999999999999998 112.92 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.64 73.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 1.0700000000000001 110.714 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -86.29 17.2 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 1.8200000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.8 m-20 -149.86 163.66 37.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.265 0.555 . . . . 2.3599999999999999 111.68 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.49 -18.84 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.28 -0.873 . . . . 1.95 112.094 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 92.0 mttt -68.51 144.79 54.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.204 -0.453 . . . . 2.2799999999999998 111.798 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.67 127.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 121.837 0.827 . . . . 1.4199999999999999 109.636 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 52.88 39.93 29.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.089 -1.414 . . . . 1.77 112.046 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -91.09 145.61 24.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.521 -0.309 . . . . 2.54 110.961 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 84' ' ' TYR . 11.6 t -65.91 138.94 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 108.978 -0.749 . . . . 1.3899999999999999 108.978 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.806 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -132.97 -52.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 112.577 0.584 . . . . 1.8200000000000001 112.577 -176.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.784 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.99 129.95 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.646 -0.872 . . . . 1.0800000000000001 108.646 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 55' ' ' ILE . 7.7 tp -140.41 157.51 45.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.865 0.364 . . . . 1.8799999999999999 111.467 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.474 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 41.2 t80 -131.3 103.64 6.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 2.2000000000000002 110.165 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.49 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 41.4 t -144.12 159.78 42.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.661 0.615 . . . . 1.4199999999999999 112.661 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.13 33.46 5.45 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.838 -0.619 . . . . 0.56999999999999995 113.26 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t0 70.02 3.26 4.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.604 0.24 . . . . 1.46 111.095 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 21.4 mttm -100.46 116.54 32.65 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.108 -0.331 . . . . 2.96 110.108 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.414 HG22 ' CE2' ' A' ' 93' ' ' PHE . 3.2 mm -80.71 130.03 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.174 -1.417 . . . . 2.27 107.174 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.735 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -117.1 121.59 41.72 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.542 -0.754 . . . . 2.1499999999999999 110.822 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.859 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.5 p-10 -165.82 -52.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.324 -1.361 . . . . 1.2 107.324 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -81.38 -24.14 37.2 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.03 -0.986 . . . . 2.1699999999999999 109.31 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.93 -26.03 43.66 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.859 -1.064 . . . . 5.4100000000000001 108.139 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.654 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.8 m-85 -86.37 119.68 71.68 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 114.791 -1.095 . . . . 2.21 110.941 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.78 -41.96 52.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.365 1.377 . . . . 1.1100000000000001 109.93 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.696 ' O ' HG12 ' A' ' 71' ' ' ILE . 63.3 m-20 -67.58 105.6 1.92 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.844 -0.616 . . . . 1.3600000000000001 110.671 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.816 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.6 mt 68.4 26.79 6.59 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.448 0.907 . . . . 2.2400000000000002 113.448 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.859 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 129.88 43.97 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.78 -0.575 . . . . 2.8700000000000001 111.477 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.403 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.94 17.91 60.53 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.485 -0.864 . . . . 0.48999999999999999 114.108 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.7 ptp180 -143.96 -47.92 0.28 Allowed 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 114.448 1.277 . . . . 2.1099999999999999 114.448 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.806 HG11 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.8 81.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 123.109 1.433 . . . . 1.04 107.621 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 16.8 m80 -102.07 128.72 48.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 112.15 -2.295 . . . . 0.34000000000000002 112.363 -175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 68.0 m-85 -71.99 120.03 17.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.273 0.559 . . . . 2.1600000000000001 109.679 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.528 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 22.1 p -70.29 -9.97 57.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.21 -0.904 . . . . 1.0900000000000001 110.347 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.5 m -89.01 117.42 28.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.775 -0.648 . . . . 1.71 110.625 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -89.95 4.82 48.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.566 0.698 . . . . 2.4700000000000002 109.798 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' SER . 34.0 p-10 -146.28 66.46 1.19 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.979 -1.119 . . . . 2.1400000000000001 107.979 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 100' ' ' SER . 5.7 mp -59.49 -38.94 82.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.215 -0.902 . . . . 1.99 111.599 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' O ' HD12 ' A' ' 45' ' ' LEU . 60.5 mtpt -63.21 0.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.361 0.504 . . . . 2.4900000000000002 112.361 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' LEU . 29.3 m -92.97 -1.12 56.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.879 -0.6 . . . . 1.8999999999999999 110.845 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.496 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.51 -18.75 29.67 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.692 -0.766 . . . . 0.40999999999999998 113.725 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -99.21 107.95 20.4 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 117.37 0.585 . . . . 1.4399999999999999 109.829 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.76 23.37 12.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.457 0.91 . . . . 1.1200000000000001 113.457 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 80.1 p -60.41 147.84 39.43 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.736 1.384 . . . . 1.46 114.736 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -130.22 133.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 114.53 -1.213 . . . . 1.0900000000000001 111.015 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.5 p30 -109.21 144.36 37.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.437 -0.949 . . . . 1.5600000000000001 108.437 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.95 120.6 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.067 0.461 . . . . 1.0600000000000001 111.885 -177.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.62 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -81.09 144.43 31.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.316 -0.856 . . . . 1.0700000000000001 110.721 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.68 54.53 11.03 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.177 -0.465 . . . . 1.9399999999999999 111.627 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 31' ' ' LYS . 16.8 mt -42.86 90.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.968 1.099 . . . . 1.21 113.968 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.463 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 72.7 mt-30 -59.43 140.6 56.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.909 -0.587 . . . . 2.6699999999999999 110.829 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 60.1 tp -60.01 -34.09 72.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.021 -0.733 . . . . 2.2400000000000002 109.021 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.402 ' HB3' HD22 ' A' ' 64' ' ' ASN . 74.8 m -74.75 -12.43 60.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.271 -0.877 . . . . 1.8300000000000001 111.338 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 96.5 m-20 -73.43 -16.56 61.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.755 0.312 . . . . 1.5800000000000001 110.19 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.705 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.37 139.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 116.137 -0.483 . . . . 1.1399999999999999 110.314 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.13 162.22 9.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 119.982 -1.104 . . . . 0.26000000000000001 113.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 71.4 m -59.6 137.77 57.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.141 0.577 . . . . 1.0700000000000001 112.482 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 135' ' ' LEU . 21.0 m-85 -120.02 130.26 54.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.153 -0.684 . . . . 2.1400000000000001 109.153 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.6 tt0 -121.76 118.63 29.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 1.5900000000000001 111.29 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 26.5 t -102.4 110.8 22.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 1.03 110.562 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.5 mtpt -106.62 104.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.82 -0.352 . . . . 2.1899999999999999 110.23 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.633 ' HA ' HG12 ' A' ' 55' ' ' ILE . 62.8 t -88.07 109.92 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.637 -0.505 . . . . 1.8200000000000001 109.637 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.9 tttm -96.46 119.5 35.06 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.326 -0.55 . . . . 2.1899999999999999 112.064 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 49.2 tptt -145.59 101.42 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.648 -0.871 . . . . 3.2799999999999998 108.648 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.563 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -53.61 134.02 54.78 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 112.455 0.539 . . . . 1.1799999999999999 112.455 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.7 Cg_endo -99.61 50.47 1.65 Allowed 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.695 -0.96 . . . . 0.62 111.705 -0.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.87 103.2 0.28 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.284 -0.96 . . . . 0.53000000000000003 113.413 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.51 140.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.607 -0.797 . . . . 1.8700000000000001 109.802 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -130.09 149.94 51.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 1.3200000000000001 111.707 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 45.8 t30 -146.81 142.06 27.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.695 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -144.61 150.29 37.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 3.46 111.01 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -98.26 140.13 33.02 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.447 0.906 . . . . 2.6699999999999999 113.447 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.579 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 73.8 mt -143.58 113.57 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.266 -0.879 . . . . 1.0600000000000001 109.339 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.47 ' CD2' HG23 ' A' ' 117' ' ' THR . 57.3 m170 -100.45 117.39 34.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.672 -0.411 . . . . 0.70999999999999996 110.554 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 12.8 mt -94.41 119.96 33.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.487 0.551 . . . . 2.1000000000000001 112.487 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.645 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 21.6 t -111.93 119.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.146 -1.057 . . . . 1.0900000000000001 108.146 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 59.5 t -100.47 122.99 53.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.187 0.518 . . . . 1.72 112.181 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.87 162.77 23.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.485 -0.78 . . . . 1.21 109.038 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.65 134.27 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 122.168 0.985 . . . . 2.0899999999999999 111.75 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 4.5 mmmt -162.27 174.48 3.63 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 113.404 -1.725 . . . . 2.7599999999999998 109.659 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.0 Cg_endo -51.52 144.22 33.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.112 1.875 . . . . 1.4199999999999999 112.15 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.425 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 67.4 m -39.91 -75.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 112.058 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.97 -60.03 0.76 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.839 -0.696 . . . . 2.8799999999999999 112.696 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.207 -0.902 . . . . 2.6000000000000001 111.164 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.484 -0.246 . . . . 3.6600000000000001 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -79.16 131.5 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 2.8100000000000001 110.86 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.427 ' HB2' HG21 ' A' ' 44' ' ' THR . 53.7 m -75.83 130.04 37.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.251 0.548 . . . . 2.2599999999999998 111.468 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.93 133.39 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.833 . . . . 2.6299999999999999 109.596 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 79.6 p -88.81 150.3 22.99 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.733 0.778 . . . . 1.6499999999999999 111.914 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.07 82.99 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 114.524 -1.216 . . . . 1.26 111.983 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.1 Cg_endo -78.57 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.675 2.917 . . . . 0.88 112.107 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.32 127.46 32.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.352 -0.981 . . . . 2.0600000000000001 108.352 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 132' ' ' LYS . 83.6 tt0 -143.94 158.67 43.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.278 1.214 . . . . 1.71 114.278 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 42.0 mtt -139.95 121.86 15.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.5 -1.227 . . . . 2.3999999999999999 109.13 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.9 mm -120.0 122.08 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 1.1499999999999999 111.519 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.617 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 42.8 mt-10 -112.1 120.06 40.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.472 . . . . 1.1899999999999999 110.81 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 73.2 mmtt -141.23 150.45 42.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.824 0.345 . . . . 2.9300000000000002 111.744 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.02 143.74 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.311 -0.404 . . . . 1.1299999999999999 111.496 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.72 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 43.2 mtmt -42.88 156.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.255 0.55 . . . . 2.7599999999999998 112.396 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.09 -23.38 0.45 Allowed Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.287 -0.87 . . . . 0.32000000000000001 114.201 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 33' ' ' LYS . 99.3 mt-10 -79.96 156.2 27.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.544 -0.539 . . . . 2.1099999999999999 109.544 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.967 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -85.22 134.52 34.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.338 -0.545 . . . . 1.0800000000000001 109.582 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.762 ' CB ' HG13 ' A' ' 107' ' ' VAL . . . -100.21 110.83 23.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.347 -0.541 . . . . 1.0700000000000001 111.213 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 92.7 t80 -79.17 122.2 25.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 2.3199999999999998 111.618 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 104' ' ' SER . 25.3 mt -118.15 104.34 48.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.429 -0.582 . . . . 1.47 109.429 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.475 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.7 Cg_endo -82.99 133.03 6.47 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.587 2.191 . . . . 0.71999999999999997 114.778 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.419 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 55.8 m -141.42 104.03 4.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.374 -0.83 . . . . 1.03 110.105 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 10.6 mmtt -102.26 107.71 18.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.224 -0.288 . . . . 2.2400000000000002 110.224 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.541 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 42.5 p90 -93.78 142.72 27.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.355 . . . . 2.1499999999999999 110.785 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 21' ' ' SER . 9.0 t -79.98 174.24 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.419 0.628 . . . . 1.9299999999999999 111.627 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.2 mt -142.27 149.8 40.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.924 -1.034 . . . . 2.5899999999999999 109.96 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.8 t -158.69 147.02 13.92 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.763 0.316 . . . . 2.1299999999999999 110.886 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.0 Cg_exo -47.37 -26.67 6.14 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.419 2.079 . . . . 1.9299999999999999 112.188 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -77.59 -43.85 30.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.417 -0.356 . . . . 2.1800000000000002 110.694 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.586 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 67.6 m-20 -71.98 74.24 0.9 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.435 -0.58 . . . . 2.4100000000000001 109.435 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 55.5 mm-40 -94.04 -5.09 48.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.35 -0.841 . . . . 1.96 111.479 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.04 159.93 53.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.363 -0.923 . . . . 0.56000000000000005 112.136 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.43 149.1 31.34 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.526 2.151 . . . . 1.1899999999999999 112.081 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 43' ' ' PHE . 3.1 tt -77.81 133.47 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 2.4100000000000001 110.345 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 10.9 t70 -140.18 152.37 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.454 0.645 . . . . 1.78 112.012 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 31.5 mt -142.8 139.99 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.687 -1.142 . . . . 1.4099999999999999 109.515 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HA ' HD23 ' A' ' 73' ' ' LEU . 45.3 mt-10 -140.36 111.66 7.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.337 0.495 . . . . 1.6699999999999999 112.337 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.815 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 77.3 m95 -100.03 119.96 39.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.497 -0.319 . . . . 0.23999999999999999 111.026 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.736 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -106.05 124.33 49.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.597 -0.519 . . . . 1.1200000000000001 109.597 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.506 ' CG2' ' HB ' ' A' ' 71' ' ' ILE . 14.5 tt -109.88 126.34 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.892 0.701 . . . . 1.3700000000000001 112.892 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 50.2 m -119.98 102.04 46.96 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 108.711 -0.848 . . . . 1.73 108.711 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.607 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 96.0 Cg_endo -79.7 117.13 3.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.84 2.36 . . . . 0.84999999999999998 112.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.76 90.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.861 -0.609 . . . . 1.0700000000000001 111.496 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.29 -40.0 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.638 . . . . 1.8200000000000001 112.429 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.568 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 86.6 m-20 -81.59 161.14 23.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.3599999999999999 112.329 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -69.48 -18.36 63.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.936 -1.029 . . . . 1.95 111.295 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.8 mttp -69.29 151.75 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.741 -0.663 . . . . 2.2799999999999998 111.125 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -156.45 135.37 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.55 1.166 . . . . 1.4199999999999999 110.103 178.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 43.83 42.39 4.43 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.564 -2.107 . . . . 1.77 112.797 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -96.47 150.87 20.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.653 -0.249 . . . . 2.54 111.158 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.504 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 20.7 t -66.38 129.43 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 109.696 -0.483 . . . . 1.3899999999999999 109.696 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.872 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -116.9 -56.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 1.8200000000000001 112.58 -177.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.789 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.28 128.91 49.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.821 -0.807 . . . . 1.0800000000000001 108.821 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 56' ' ' GLU . 5.8 mt -134.96 160.0 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.468 0.651 . . . . 1.8799999999999999 111.701 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 41.3 t80 -135.25 103.33 5.48 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.567 -1.272 . . . . 2.2000000000000002 107.567 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.51 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 2.3 t -143.15 155.59 44.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.87 -0.604 . . . . 1.4199999999999999 111.854 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.95 29.47 6.41 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 113.044 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 73.54 2.94 4.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.508 0.194 . . . . 1.46 111.388 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 118.56 36.65 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.976 -0.379 . . . . 2.96 109.976 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 93' ' ' PHE . 2.8 mm -80.79 130.84 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.307 -1.368 . . . . 2.27 107.307 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -119.92 120.86 37.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.381 -0.827 . . . . 2.1499999999999999 110.288 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.828 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.8 p-10 -165.82 -48.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.663 -1.236 . . . . 1.2 107.663 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.61 -32.09 47.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.019 -0.991 . . . . 2.1699999999999999 109.185 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -76.18 -28.71 57.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.024 -0.989 . . . . 5.4100000000000001 108.647 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -81.01 117.39 67.88 Favored Pre-proline 0 CA--C 1.514 -0.431 0 CA-C-N 114.911 -1.041 . . . . 2.21 110.675 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.7 -40.06 56.41 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.508 1.472 . . . . 1.1100000000000001 110.117 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.675 ' O ' HG12 ' A' ' 71' ' ' ILE . 5.2 m-20 -67.01 106.37 1.92 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.093 -0.643 . . . . 1.3600000000000001 110.521 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.815 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.5 mt 65.81 28.44 10.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.597 0.962 . . . . 2.2400000000000002 113.597 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 17.8 pttt -56.58 131.32 48.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.395 -0.522 . . . . 2.8700000000000001 111.159 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 83.39 18.11 65.07 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.435 -0.888 . . . . 0.48999999999999999 114.501 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.815 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -145.96 -46.25 0.2 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 114.326 1.232 . . . . 2.1099999999999999 114.326 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.872 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.38 82.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 123.099 1.428 . . . . 1.04 107.274 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.4 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 15.5 m80 -103.38 129.83 50.55 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 112.426 -2.17 . . . . 0.34000000000000002 112.471 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.682 ' HA ' ' O ' ' A' ' 104' ' ' SER . 63.3 m-85 -71.32 120.38 16.82 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.322 -0.622 . . . . 2.1600000000000001 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.411 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 16.6 p -73.03 36.76 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.042 -0.981 . . . . 1.0900000000000001 113.575 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -149.36 136.0 19.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.388 0.613 . . . . 1.71 111.404 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.04 6.74 46.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 2.4700000000000002 110.372 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -145.62 65.9 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.444 -0.947 . . . . 2.1400000000000001 108.444 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.528 HD11 ' CG ' ' A' ' 74' ' ' TYR . 8.2 tt -59.47 -38.44 80.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.632 -1.167 . . . . 1.99 111.641 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.5 1.47 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.391 0.515 . . . . 2.4900000000000002 112.391 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 98' ' ' LEU . 50.6 m -89.99 -0.01 57.34 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 1.8999999999999999 111.151 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.541 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 108.55 -1.91 32.46 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.844 -0.693 . . . . 0.40999999999999998 113.023 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 96.5 m-20 -100.26 108.7 20.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.729 0.299 . . . . 1.4399999999999999 110.672 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -108.78 5.95 25.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.132 -0.485 . . . . 1.1200000000000001 111.558 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 1.3 m -59.68 140.0 56.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.667 1.728 . . . . 1.46 115.667 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.24 135.16 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 114.0 -1.455 . . . . 1.0900000000000001 109.549 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.636 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 41.9 p-10 -113.46 148.95 34.98 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.951 -0.759 . . . . 1.5600000000000001 108.951 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.967 ' O ' ' HA ' ' A' ' 36' ' ' THR . 7.5 p -95.76 123.79 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 N-CA-C 113.455 0.909 . . . . 1.0600000000000001 113.455 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.645 ' HA ' HG23 ' A' ' 36' ' ' THR . 1.3 p -84.81 141.65 30.33 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.386 -1.734 . . . . 1.0700000000000001 111.372 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 53.12 60.56 3.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.486 -0.779 . . . . 1.9399999999999999 112.668 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.42 ' HG ' HG12 ' A' ' 107' ' ' VAL . 10.0 mt -46.19 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.041 0.448 . . . . 1.21 112.059 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 12.0 pt20 -177.24 164.06 2.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.839 -0.618 . . . . 2.6699999999999999 110.347 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.72 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 79.4 mt -59.92 -36.73 77.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.806 0.336 . . . . 2.2400000000000002 111.531 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.41 ' OG ' ' NE2' ' A' ' 111' ' ' GLN . 70.5 p -73.29 -15.85 61.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.388 -0.369 . . . . 1.8300000000000001 111.97 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 89.1 m-20 -72.99 -20.07 61.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.622 -0.431 . . . . 1.5800000000000001 110.005 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -47.12 144.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.114 -0.494 . . . . 1.1399999999999999 110.947 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.84 150.73 5.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.564 -1.303 . . . . 0.26000000000000001 114.115 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.41 HG22 ' CD2' ' A' ' 134' ' ' HIS . 95.6 m -59.27 129.97 44.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.024 -0.588 . . . . 1.0700000000000001 111.965 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 22.9 m-85 -110.21 129.92 55.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.808 . . . . 2.1400000000000001 108.82 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.815 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -114.72 113.04 23.77 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.88 -0.415 . . . . 1.5900000000000001 109.88 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 7.3 t -100.01 109.36 21.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.965 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.523 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 45.0 mttt -120.4 109.97 15.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 2.1899999999999999 111.836 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 45.4 t -94.6 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.8200000000000001 109.448 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 43.2 tttm -98.67 122.88 42.45 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.994 -0.682 . . . . 2.1899999999999999 112.732 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 127' ' ' GLY . 28.5 tttp -144.63 102.36 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.314 -0.625 . . . . 3.2799999999999998 109.314 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -50.84 133.32 28.65 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 113.226 0.824 . . . . 1.1799999999999999 113.226 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.586 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 97.4 Cg_endo -98.43 36.87 6.58 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.439 -1.067 . . . . 0.62 111.753 -1.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -135.62 102.89 0.43 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-O 122.06 0.811 . . . . 0.53000000000000003 112.664 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.5 p -90.0 160.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.165 -1.017 . . . . 1.8700000000000001 109.984 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.459 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -139.36 149.32 44.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.336 . . . . 1.3200000000000001 111.673 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 37.9 p-10 -146.42 137.25 24.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.862 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.545 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.6 ptmt -145.96 155.11 42.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 3.46 110.636 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 24.1 mttt -103.45 140.07 37.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.148 0.796 . . . . 2.6699999999999999 113.148 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 87.2 mt -142.22 119.21 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.529 -0.76 . . . . 1.0600000000000001 109.225 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.41 ' CD2' HG22 ' A' ' 117' ' ' THR . 59.3 m170 -102.91 119.99 39.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.954 -0.299 . . . . 0.70999999999999996 110.547 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -89.82 120.03 30.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.428 -0.509 . . . . 2.1000000000000001 110.936 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.617 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 48.6 t -116.28 121.36 67.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.391 -0.822 . . . . 1.0900000000000001 109.27 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 14.8 p -94.92 128.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.885 0.374 . . . . 1.72 111.974 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 94.2 mt -83.53 152.8 24.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.525 -0.546 . . . . 1.21 109.525 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.57 134.54 28.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.778 0.799 . . . . 2.0899999999999999 112.038 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.77 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -165.22 174.86 2.77 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.26 -1.336 . . . . 2.7599999999999998 108.832 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 5.9 Cg_endo -48.1 -177.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.924 1.749 . . . . 1.4199999999999999 111.833 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 141' ' ' PRO . 62.3 m -31.53 -79.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.232 0.456 . . . . 2.6899999999999999 112.232 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.482 ' HA3' ' CE ' ' A' ' 140' ' ' LYS . . . 43.66 23.52 0.35 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.328 -0.463 . . . . 2.8799999999999999 113.64 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.294 -0.86 . . . . 2.6000000000000001 110.99 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' HA3' ' OE2' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.46 -0.256 . . . . 3.6600000000000001 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -158.92 155.13 27.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.659 0.266 . . . . 2.8100000000000001 110.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t -159.87 150.5 19.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 2.2599999999999998 111.537 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 131' ' ' LYS . 2.4 pp -91.54 149.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 2.6299999999999999 111.144 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.17 158.22 19.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.326 0.584 . . . . 1.6499999999999999 110.892 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.464 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 44.89 83.82 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.018 -0.992 . . . . 1.26 111.098 -177.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 58.4 Cg_endo -78.19 -84.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.611 2.874 . . . . 0.88 113.498 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.1 tt0 -77.82 122.13 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.17 -0.612 . . . . 2.0600000000000001 109.362 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.9 tp10 -143.9 160.65 40.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.418 0.896 . . . . 1.71 113.418 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.427 ' HG3' ' HB2' ' A' ' 134' ' ' HIS . 54.1 ttm -134.56 134.33 41.24 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.067 -0.97 . . . . 2.3999999999999999 109.478 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 HG12 HG21 ' A' ' 133' ' ' ILE . 32.8 mm -129.94 129.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.949 -0.569 . . . . 1.1499999999999999 111.494 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.61 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 98.2 mt-10 -118.36 125.1 49.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.384 -0.371 . . . . 1.1899999999999999 110.695 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.626 ' HB2' HD11 ' A' ' 110' ' ' LEU . 61.0 mmtt -141.97 158.05 44.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.638 0.256 . . . . 2.9300000000000002 111.315 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.06 143.38 39.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.1299999999999999 111.69 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.812 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 39.6 ttmt -48.51 136.36 13.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 2.7599999999999998 111.609 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 82.46 -18.42 14.68 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.997 -0.62 . . . . 0.32000000000000001 113.119 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 80.9 mm-40 -79.99 158.97 26.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.712 -0.847 . . . . 2.1099999999999999 108.712 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 m -87.28 129.8 34.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.476 -0.89 . . . . 1.0800000000000001 109.982 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -100.04 114.92 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.807 0.337 . . . . 1.0700000000000001 110.504 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.504 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 40.8 t80 -79.35 120.77 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.849 -0.614 . . . . 2.3199999999999998 112.454 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB3' HD13 ' A' ' 133' ' ' ILE . 4.4 mp -115.28 104.76 53.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.619 -0.882 . . . . 1.47 108.619 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 88.8 Cg_endo -86.43 104.49 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.328 2.019 . . . . 0.71999999999999997 114.929 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.453 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -98.51 135.51 39.95 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 176.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 45.5 tptt -140.03 139.99 36.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.741 0.305 . . . . 2.2400000000000002 110.527 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.59 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -140.16 139.76 35.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 2.1499999999999999 111.413 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.14 126.39 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 1.9299999999999999 110.775 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.4 mt -89.09 149.95 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 2.5899999999999999 110.834 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.8 m -151.32 144.09 16.73 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.486 -0.324 . . . . 2.1299999999999999 110.133 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.18 -23.57 9.89 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.579 2.186 . . . . 1.9299999999999999 112.086 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 16.7 pt-20 -77.29 -43.66 32.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.194 -0.457 . . . . 2.1800000000000002 111.05 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -75.59 76.32 2.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.936 -0.705 . . . . 2.4100000000000001 109.287 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.51 -3.52 52.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.352 -0.84 . . . . 1.96 111.901 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.561 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.03 160.06 53.33 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.691 -0.766 . . . . 0.56000000000000005 113.024 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.61 136.56 76.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.632 2.222 . . . . 1.1899999999999999 111.675 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 6.6 mp -78.0 119.05 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.301 -0.409 . . . . 2.4100000000000001 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -133.01 102.17 5.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.535 0.683 . . . . 1.78 111.033 178.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.826 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.39 105.91 17.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.761 -1.109 . . . . 1.4099999999999999 110.874 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -100.93 117.66 35.41 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.62 0.6 . . . . 1.6699999999999999 112.62 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.682 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 72.3 m95 -94.06 120.01 33.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.133 -0.321 . . . . 0.23999999999999999 110.133 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.5 mt -105.91 146.86 29.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.866 -0.42 . . . . 1.1200000000000001 109.866 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.157 0.429 . . . . 1.3700000000000001 112.157 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.447 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 37.4 m -119.99 102.16 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.631 -0.877 . . . . 1.73 108.631 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 91.9 Cg_endo -78.96 114.97 3.48 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.775 2.317 . . . . 0.84999999999999998 113.533 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.18 82.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.352 -0.84 . . . . 1.0700000000000001 110.614 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -85.93 16.52 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.534 -0.757 . . . . 1.8200000000000001 112.078 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 81.0 m-20 -148.72 161.0 42.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.376 0.608 . . . . 2.3599999999999999 112.011 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.94 -19.76 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.058 -0.974 . . . . 1.95 112.507 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 43.6 mttt -69.1 153.05 44.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.825 0.345 . . . . 2.2799999999999998 111.536 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.36 128.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.716 0.77 . . . . 1.4199999999999999 109.468 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.17 45.18 27.94 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.346 -1.297 . . . . 1.77 112.088 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 136.4 33.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.677 0.275 . . . . 2.54 111.089 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG13 ' CE1' ' A' ' 84' ' ' TYR . 57.2 t -70.51 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 110.154 -0.313 . . . . 1.3899999999999999 110.154 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.756 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.5 pp -131.76 -38.85 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.808 0.67 . . . . 1.8200000000000001 112.808 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.838 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -141.31 123.85 14.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.175 0.512 . . . . 1.0800000000000001 110.092 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.5 tt -140.38 163.55 32.49 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 116.019 -0.537 . . . . 1.8799999999999999 109.799 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.591 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 23.3 t80 -135.31 109.94 8.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.206 0.527 . . . . 2.2000000000000002 110.477 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.3 t -142.61 159.99 41.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.249 -0.887 . . . . 1.4199999999999999 111.474 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.32 55.48 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.564 -0.827 . . . . 0.56999999999999995 112.152 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 74.14 2.83 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.845 -0.178 . . . . 1.46 111.241 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 6.0 mmtm -105.36 118.52 36.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.811 -0.441 . . . . 2.96 109.811 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.591 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.73 119.99 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.617 -1.253 . . . . 2.27 107.617 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.838 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -100.01 132.53 45.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.83 -1.077 . . . . 2.1499999999999999 110.728 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.8 p-10 -166.32 -58.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.796 -1.557 . . . . 1.2 106.796 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 33.6 p-10 -80.1 -22.01 42.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.565 -1.198 . . . . 2.1699999999999999 109.731 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.539 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -76.85 -29.8 56.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.85 -1.167 . . . . 5.4100000000000001 107.85 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -85.18 118.3 70.54 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 114.452 -1.249 . . . . 2.21 110.263 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -41.0 51.93 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.346 1.364 . . . . 1.1100000000000001 110.447 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 89.1 m-20 -68.19 104.87 1.92 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.771 -0.65 . . . . 1.3600000000000001 111.091 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 34.3 mt 70.4 22.37 5.31 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.295 0.85 . . . . 2.2400000000000002 113.295 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 21.6 pttp -58.17 136.9 57.34 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.843 -0.536 . . . . 2.8700000000000001 111.05 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.517 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 86.64 9.57 74.81 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.249 -0.977 . . . . 0.48999999999999999 114.176 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.726 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -137.99 -54.61 0.65 Allowed 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 114.754 1.39 . . . . 2.1099999999999999 114.754 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 71' ' ' ILE . 7.4 p -78.28 81.28 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 N-CA-C 107.088 -1.449 . . . . 1.04 107.088 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.517 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 6.7 m80 -100.06 129.43 46.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.163 -2.289 . . . . 0.34000000000000002 112.589 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.734 ' HA ' ' O ' ' A' ' 104' ' ' SER . 82.3 m-85 -70.37 121.17 17.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 120.231 -0.588 . . . . 2.1600000000000001 110.054 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.504 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 35.0 p -71.4 -10.67 60.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.93 . . . . 1.0900000000000001 110.099 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 58.1 m -95.15 120.0 34.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.726 -0.67 . . . . 1.71 110.683 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -91.34 6.08 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.927 -0.579 . . . . 2.4700000000000002 110.189 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -146.25 66.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.551 -0.907 . . . . 2.1400000000000001 108.551 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.3 -31.29 69.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 1.99 112.21 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -62.86 -4.08 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.142 0.496 . . . . 2.4900000000000002 111.91 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -89.65 -0.57 57.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.392 -0.822 . . . . 1.8999999999999999 110.89 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 110.07 -20.61 26.03 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.687 -0.768 . . . . 0.40999999999999998 113.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 82.8 m-20 -92.91 109.01 20.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.964 0.382 . . . . 1.4399999999999999 111.195 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.29 21.46 16.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 1.1200000000000001 111.102 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 82.5 p -59.98 145.89 44.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 116.03 1.863 . . . . 1.46 116.03 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.62 133.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 114.246 -1.343 . . . . 1.0900000000000001 111.27 178.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.1 p-10 -107.66 147.85 30.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.947 -1.131 . . . . 1.5600000000000001 107.947 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.75 123.9 52.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.958 0.408 . . . . 1.0600000000000001 111.79 -178.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.5 p -84.68 142.75 29.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.536 -0.756 . . . . 1.0700000000000001 110.935 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.9 m-20 49.98 55.69 9.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.996 -0.547 . . . . 1.9399999999999999 112.133 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 31' ' ' LYS . 19.8 mt -46.96 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.577 0.954 . . . . 1.21 113.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 63.7 tt0 -60.03 148.68 34.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 109.94 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.812 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 3.0 tm? -60.02 -39.99 87.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 2.2400000000000002 110.729 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.2 m -72.96 -10.04 59.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.663 . . . . 1.8300000000000001 111.611 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.434 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.95 -18.35 63.35 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.048 -0.352 . . . . 1.5800000000000001 110.048 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.7 145.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.026 0 CA-C-N 116.113 -0.494 . . . . 1.1399999999999999 110.397 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 155.79 6.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.984 -1.103 . . . . 0.26000000000000001 113.887 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 134' ' ' HIS . 95.2 m -59.36 139.01 57.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.94 0.496 . . . . 1.0700000000000001 111.808 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.0 m-85 -119.99 133.68 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.612 -0.514 . . . . 2.1400000000000001 109.612 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.618 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.3 tt0 -123.11 115.22 21.44 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.101 -0.24 . . . . 1.5900000000000001 110.843 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.3 t -99.96 112.15 24.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.011 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.826 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 98.4 mttt -110.49 106.51 15.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.627 -0.26 . . . . 2.1899999999999999 111.577 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.59 HG11 ' CG ' ' A' ' 43' ' ' PHE . 47.6 t -88.21 110.05 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.75 -0.833 . . . . 1.8200000000000001 108.75 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 61.1 tttp -96.06 120.3 36.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.869 0.692 . . . . 2.1899999999999999 112.869 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.457 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 11.0 mtmt -144.25 101.64 3.73 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.663 -0.495 . . . . 3.2799999999999998 109.663 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.561 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -53.22 132.32 51.64 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.45 -0.341 . . . . 1.1799999999999999 111.751 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 59.7 Cg_endo -100.37 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.808 -0.913 . . . . 0.62 112.366 -0.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 103.18 0.28 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.397 -0.906 . . . . 0.53000000000000003 113.141 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.4 m -87.06 142.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.221 -0.99 . . . . 1.8700000000000001 109.724 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.464 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . . . -136.03 148.11 48.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.979 -0.288 . . . . 1.3200000000000001 111.642 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 47.2 p-10 -146.61 151.67 37.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.466 0.543 . . . . 2.0299999999999998 112.466 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.29 153.51 41.36 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.154 -0.475 . . . . 3.46 110.958 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 25' ' ' PRO . 18.6 tttt -99.59 139.63 34.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.486 0.55 . . . . 2.6699999999999999 112.486 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 118' ' ' TYR . 95.2 mt -143.19 117.79 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 1.0600000000000001 109.641 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.532 ' CD2' HG22 ' A' ' 117' ' ' THR . 62.6 m170 -100.04 116.16 31.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.008 0.433 . . . . 0.70999999999999996 111.246 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 37' ' ' ALA . 1.8 tm? -89.17 125.18 34.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 2.1000000000000001 111.479 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.61 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 39.2 t -121.22 124.71 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 1.0900000000000001 109.939 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 115' ' ' ILE . 21.4 t -97.19 120.24 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 1.72 111.51 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.0 mt -80.45 160.02 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 1.21 109.686 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -77.03 137.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 2.0899999999999999 111.59 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -164.93 179.47 1.13 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 114.633 -1.167 . . . . 2.7599999999999998 109.308 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.768 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 10.7 Cg_endo -53.58 -159.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.062 1.841 . . . . 1.4199999999999999 112.407 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 141' ' ' PRO . 35.7 t -32.08 -78.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.414 -0.357 . . . . 2.6899999999999999 111.879 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.454 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 77.49 -43.76 2.13 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.994 -0.622 . . . . 2.8799999999999999 113.709 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.22 -0.895 . . . . 2.6000000000000001 111.114 -179.706 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.646 -0.181 . . . . 3.6600000000000001 112.646 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.9 t -159.67 151.31 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 2.8100000000000001 110.894 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -160.01 150.01 18.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.2599999999999998 111.024 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' CD1' ' HD2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 2.6299999999999999 110.719 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.643 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.0 p -93.44 156.22 16.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.575 0.702 . . . . 1.6499999999999999 111.958 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 43.06 82.41 0.23 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.698 -1.137 . . . . 1.26 112.013 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.645 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -79.3 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.775 2.983 . . . . 0.88 113.048 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 46.2 mt-10 -78.18 126.58 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.129 -0.693 . . . . 2.0600000000000001 109.129 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 132' ' ' LYS . 41.8 tt0 -144.11 159.25 42.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.405 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 16.5 mtm -140.12 116.43 10.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.629 -1.169 . . . . 2.3999999999999999 109.376 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 135' ' ' LEU . 39.2 mm -120.01 130.01 74.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 1.1499999999999999 111.553 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.63 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 35.8 mt-10 -120.59 128.06 52.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.572 -0.285 . . . . 1.1899999999999999 110.711 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HB3' HD11 ' A' ' 110' ' ' LEU . 51.3 tptt -142.82 158.48 43.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.687 -0.233 . . . . 2.9300000000000002 110.552 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.7 141.91 40.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.788 0.328 . . . . 1.1299999999999999 111.552 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 32.1 tttt -47.77 140.98 5.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.0 0.429 . . . . 2.7599999999999998 111.444 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 83.04 -21.95 7.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.734 -0.746 . . . . 0.32000000000000001 112.832 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.05 159.01 26.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.318 -0.993 . . . . 2.1099999999999999 108.318 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.873 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.0 m -88.13 130.0 35.15 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.546 -0.862 . . . . 1.0800000000000001 110.236 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -98.76 113.48 25.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 1.0700000000000001 110.617 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 40' ' ' PRO . 82.4 t80 -79.26 120.01 23.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.3199999999999998 112.402 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 4.5 mp -115.68 104.88 52.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 90.3 Cg_endo -85.48 104.65 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.47 2.114 . . . . 0.71999999999999997 115.914 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -102.25 131.51 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.467 -0.938 . . . . 1.03 108.467 176.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.643 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 23.0 tptm -140.69 105.08 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.042 0.449 . . . . 2.2400000000000002 110.393 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 38.6 p90 -90.95 141.89 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 2.1499999999999999 111.647 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -79.8 164.14 23.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 1.9299999999999999 110.483 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.4 mt -138.79 149.95 45.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 2.5899999999999999 111.44 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 m -157.73 148.57 16.28 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.544 -0.753 . . . . 2.1299999999999999 109.885 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.04 -23.61 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.889 2.392 . . . . 1.9299999999999999 112.979 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 85.6 tt0 -74.64 -25.92 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.518 -0.31 . . . . 2.1800000000000002 111.73 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 46' ' ' SER . 55.8 p-10 -63.54 82.69 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 121.534 0.683 . . . . 2.4100000000000001 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' GLU . 95.1 mt-30 -94.24 0.02 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 1.96 111.822 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -92.91 170.22 31.75 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.126 -1.035 . . . . 0.56000000000000005 113.087 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.02 153.03 63.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.913 2.409 . . . . 1.1899999999999999 111.86 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 tt -78.14 123.99 27.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.306 -0.406 . . . . 2.4100000000000001 110.613 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 15.3 m-20 -136.34 150.64 48.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.508 0.671 . . . . 1.78 111.494 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.716 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 25.1 mt -142.65 139.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.633 -1.167 . . . . 1.4099999999999999 109.174 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 99.2 mt-10 -140.68 116.24 10.16 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.613 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 79.2 m95 -101.79 122.85 44.73 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 121.102 -0.239 . . . . 0.23999999999999999 110.751 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.8 mt -109.19 139.87 43.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.145 -0.687 . . . . 1.1200000000000001 109.145 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 tt -130.04 130.0 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.196 0.522 . . . . 1.3700000000000001 112.245 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.5 m -120.47 102.82 44.9 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.461 -0.79 . . . . 1.73 109.11 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 97.8 Cg_endo -79.11 114.59 3.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.591 2.194 . . . . 0.84999999999999998 113.28 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.79 80.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.365 -0.834 . . . . 1.0700000000000001 110.828 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -86.15 20.69 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 1.8200000000000001 111.919 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.436 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 35.1 m120 -151.28 161.98 41.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.288 0.566 . . . . 2.3599999999999999 111.873 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.32 -19.83 64.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.287 -0.869 . . . . 1.95 112.32 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.626 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 90.8 mttt -68.51 146.4 53.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.257 -0.429 . . . . 2.2799999999999998 111.008 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -155.4 127.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 CA-C-O 121.971 0.891 . . . . 1.4199999999999999 109.994 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 54.15 39.97 31.22 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.841 -1.527 . . . . 1.77 112.582 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 66' ' ' LYS . 26.8 mt-30 -94.2 146.81 23.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 2.54 111.137 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' A' ' 73' ' ' LEU . 44.6 t -66.58 137.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.905 -0.405 . . . . 1.3899999999999999 109.905 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.819 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.39 -52.41 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 1.8200000000000001 112.73 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.949 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.52 130.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 107.982 -1.118 . . . . 1.0800000000000001 107.982 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 159.97 41.02 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 120.833 -0.347 . . . . 1.8799999999999999 111.704 -176.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.716 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.6 t80 -135.81 103.82 5.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.195 -0.669 . . . . 2.2000000000000002 109.195 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.449 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 20.2 m -142.6 159.99 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.751 0.31 . . . . 1.4199999999999999 111.582 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.11 25.93 18.95 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.602 -0.809 . . . . 0.56999999999999995 112.272 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 74.75 1.62 3.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.512 0.196 . . . . 1.46 111.091 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.9 mttt -100.01 115.08 28.89 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 110.034 -0.358 . . . . 2.96 110.034 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.709 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.55 128.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.575 -1.269 . . . . 2.27 107.575 177.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.6 m-85 -113.13 129.33 56.54 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.874 -1.512 . . . . 2.1499999999999999 110.256 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.771 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 21.9 p-10 -166.16 -54.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.654 -1.239 . . . . 1.2 107.654 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -80.13 -20.05 45.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.025 -0.989 . . . . 2.1699999999999999 109.202 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.43 -26.25 35.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.216 -0.902 . . . . 5.4100000000000001 108.904 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.5 m-85 -85.3 111.81 39.25 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.073 -0.967 . . . . 2.21 111.057 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.5 -41.9 10.83 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.427 1.418 . . . . 1.1100000000000001 109.939 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.697 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 60.3 t0 -67.89 105.46 1.99 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.64 -0.709 . . . . 1.3600000000000001 110.266 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.865 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 5.6 mt 68.66 20.03 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.012 1.116 . . . . 2.2400000000000002 114.012 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 12.2 pttm -54.78 127.06 26.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.336 -0.852 . . . . 2.8700000000000001 110.84 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.77 12.94 48.75 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.212 -0.994 . . . . 0.48999999999999999 114.213 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.865 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.5 ptp180 -143.81 -47.6 0.28 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 114.619 1.34 . . . . 2.1099999999999999 114.619 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.949 HG13 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.58 81.15 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.275 1.512 . . . . 1.04 107.544 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -101.58 127.83 48.12 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.044 -2.344 . . . . 0.34000000000000002 111.856 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.709 ' CD2' HG13 ' A' ' 79' ' ' ILE . 88.1 m-85 -69.59 125.9 28.12 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 119.918 -0.713 . . . . 2.1600000000000001 110.246 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.9 p -73.49 29.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 1.0900000000000001 111.747 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 93' ' ' PHE . 5.4 m -148.76 127.49 12.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.038 0.447 . . . . 1.71 110.359 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.02 8.17 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.773 -0.649 . . . . 2.4700000000000002 110.308 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.2 66.2 1.2 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.778 -0.823 . . . . 2.1400000000000001 108.778 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD21 ' CG ' ' A' ' 93' ' ' PHE . 6.3 mp -58.36 -23.56 57.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 1.99 111.616 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.54 -3.41 2.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.162 0.506 . . . . 2.4900000000000002 112.098 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -89.99 10.01 25.7 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.466 -0.788 . . . . 1.8999999999999999 111.048 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 96.54 -10.39 66.86 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.913 -0.66 . . . . 0.40999999999999998 113.079 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -95.25 110.12 22.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 1.4399999999999999 111.602 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.22 16.06 21.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 1.1200000000000001 110.569 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.5 m -59.94 140.38 56.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.229 1.566 . . . . 1.46 115.229 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.28 136.59 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-N 114.853 -1.067 . . . . 1.0900000000000001 111.002 178.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.606 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.5 p-10 -112.86 142.98 44.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.33 -0.989 . . . . 1.5600000000000001 108.33 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.42 120.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.107 0.48 . . . . 1.0600000000000001 111.512 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -84.57 141.9 30.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.344 -0.844 . . . . 1.0700000000000001 110.659 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.497 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 33.8 m120 53.82 52.77 12.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.9399999999999999 111.346 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 31' ' ' LYS . 16.0 mt -43.08 87.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.558 1.318 . . . . 1.21 114.558 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' ASN . 57.4 mt-30 -58.2 141.93 49.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.055 -0.521 . . . . 2.6699999999999999 110.593 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 87.0 mt -59.93 -33.1 71.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.885 0.374 . . . . 2.2400000000000002 110.487 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.4 m -75.06 -13.13 60.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 1.8300000000000001 111.213 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.58 -18.59 62.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.87 -0.419 . . . . 1.5800000000000001 109.87 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.49 141.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 116.044 -0.525 . . . . 1.1399999999999999 110.535 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.83 162.21 9.01 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.225 -0.988 . . . . 0.26000000000000001 113.514 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.51 135.77 57.77 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.414 0.524 . . . . 1.0700000000000001 112.414 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 41.3 m-85 -120.05 129.67 54.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.988 -0.551 . . . . 2.1400000000000001 109.72 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -121.35 119.97 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.186 -0.206 . . . . 1.5900000000000001 111.206 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.5 t -99.94 117.42 34.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.096 -0.335 . . . . 1.03 110.096 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 37.3 mtpt -118.07 107.87 14.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 2.1899999999999999 110.82 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 7.2 p -92.27 106.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.026 -0.361 . . . . 1.8200000000000001 110.026 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.6 tttm -93.89 115.18 27.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.04 -0.664 . . . . 2.1899999999999999 112.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -145.86 102.07 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.1 -0.704 . . . . 3.2799999999999998 109.1 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.581 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.06 134.31 39.73 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 112.369 0.507 . . . . 1.1799999999999999 112.369 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 77.0 Cg_endo -100.05 46.82 2.29 Favored 'Cis proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.642 -0.982 . . . . 0.62 111.208 -0.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.81 102.93 0.31 Allowed Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.086 -1.054 . . . . 0.53000000000000003 113.683 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 m -93.21 138.21 20.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 113.861 -1.17 . . . . 1.8700000000000001 109.233 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' ' HB ' ' A' ' 22' ' ' ILE . . . -140.76 144.47 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.979 0.363 . . . . 1.3200000000000001 111.979 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.5 p-10 -146.77 151.45 37.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.482 0.549 . . . . 2.0299999999999998 112.482 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.645 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.0 160.03 41.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 3.46 111.15 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 61.0 mttp -102.53 139.81 37.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 112.422 0.527 . . . . 2.6699999999999999 112.422 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 118' ' ' TYR . 84.9 mt -142.12 114.55 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.959 -0.756 . . . . 1.0600000000000001 108.959 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.405 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 48.7 m170 -99.97 115.55 29.96 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.481 -0.488 . . . . 0.70999999999999996 110.398 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 46.5 mt -93.68 120.05 33.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.609 0.596 . . . . 2.1000000000000001 112.609 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.63 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 17.6 t -115.25 120.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.306 -0.998 . . . . 1.0900000000000001 108.306 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 25.4 t -96.26 125.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.814 0.672 . . . . 1.72 112.814 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.85 160.02 22.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 1.21 109.896 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -77.88 142.59 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.987 0.899 . . . . 2.0899999999999999 112.935 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.616 ' HG3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -162.85 178.83 1.4 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 113.863 -1.517 . . . . 2.7599999999999998 109.511 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.533 ' CD ' ' HB2' ' A' ' 140' ' ' LYS . 59.9 Cg_exo -53.07 -145.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.486 2.124 . . . . 1.4199999999999999 112.699 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.0 m -39.56 -69.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.905 0.383 . . . . 2.6899999999999999 111.736 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 59.29 49.89 73.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 2.8799999999999999 113.355 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.194 -0.908 . . . . 2.6000000000000001 111.063 179.731 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.541 -0.224 . . . . 3.6600000000000001 112.541 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 1.9 m -78.5 125.24 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.797 0.332 . . . . 2.8100000000000001 110.709 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 t -82.58 140.06 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 2.2599999999999998 111.555 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 129' ' ' ALA . 1.1 pp -104.54 136.13 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.666 -0.697 . . . . 2.6299999999999999 110.401 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -87.15 148.96 24.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.059 0.457 . . . . 1.6499999999999999 110.344 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 43.35 83.81 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.393 -0.822 . . . . 1.26 110.549 -177.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.69 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.8 Cg_endo -77.34 -11.04 17.55 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 123.913 3.076 . . . . 0.88 113.864 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 49.2 mp0 -141.36 126.23 18.16 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.182 -0.673 . . . . 2.0600000000000001 109.182 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 85.5 tt0 -144.09 161.19 39.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 53.6 ttm -137.11 137.32 39.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.876 -1.057 . . . . 2.3999999999999999 109.415 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 mm -132.71 139.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.978 -0.555 . . . . 1.1499999999999999 111.597 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.58 123.07 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 1.1899999999999999 110.523 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.76 158.91 43.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.9300000000000002 112.119 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.03 138.6 39.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 1.1299999999999999 112.021 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.768 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 34.2 mtmt -47.52 144.2 3.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.163 0.506 . . . . 2.7599999999999998 111.773 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.4 -25.45 3.27 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.32000000000000001 112.743 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 81.8 mm-40 -80.02 159.97 26.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.148 -0.686 . . . . 2.1099999999999999 109.148 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 m -84.54 129.31 34.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.078 -0.649 . . . . 1.0800000000000001 110.639 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -100.03 114.1 27.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.068 0.461 . . . . 1.0700000000000001 110.921 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -79.53 121.28 25.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.803 -0.635 . . . . 2.3199999999999998 112.569 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' HB2' HD11 ' A' ' 105' ' ' ILE . 20.3 mt -110.05 105.27 57.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 108.913 -0.773 . . . . 1.47 108.913 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.06 128.68 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.51 2.14 . . . . 0.71999999999999997 114.219 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.848 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 17.2 t -140.87 131.48 25.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.838 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.48 146.6 38.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.261 -0.427 . . . . 2.2400000000000002 110.744 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.504 ' CE2' HD22 ' A' ' 53' ' ' LEU . 44.1 p90 -140.79 141.05 34.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 2.1499999999999999 111.908 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.3 p -88.02 143.74 26.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 1.9299999999999999 110.759 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.4 HD21 ' HE3' ' A' ' 124' ' ' LYS . 74.6 mt -94.18 113.32 25.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.692 -0.231 . . . . 2.5899999999999999 110.564 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.8 m -83.97 140.33 40.14 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 110.004 -0.369 . . . . 2.1299999999999999 110.004 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.76 -34.24 27.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.731 1.621 . . . . 1.9299999999999999 110.559 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -79.49 -35.48 40.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.313 -0.858 . . . . 2.1800000000000002 111.383 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 78.7 m-20 -71.24 73.66 0.68 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.282 0.563 . . . . 2.4100000000000001 109.952 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -95.51 -1.21 51.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.301 -0.863 . . . . 1.96 111.427 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.05 161.42 53.11 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.485 -0.864 . . . . 0.56000000000000005 112.259 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.55 144.42 41.71 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.144 1.896 . . . . 1.1899999999999999 111.488 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 ' CD2' ' HD3' ' A' ' 124' ' ' LYS . 6.8 mt -77.82 129.96 36.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.907 0.384 . . . . 2.4100000000000001 111.277 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 70.8 m-20 -136.85 153.96 50.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.734 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 2.0 mp -143.34 140.36 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 1.4099999999999999 110.067 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.886 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.5 tt0 -137.35 115.58 11.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.021 0.439 . . . . 1.6699999999999999 111.79 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.594 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 83.2 m95 -98.43 119.5 37.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.965 -0.561 . . . . 0.23999999999999999 110.826 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.86 120.64 42.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.406 -0.59 . . . . 1.1200000000000001 109.406 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 71' ' ' ILE . 8.6 tt -108.83 125.84 65.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.305 0.483 . . . . 1.3700000000000001 112.305 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -112.97 103.26 55.63 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.83 -0.804 . . . . 1.73 108.83 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.8 Cg_exo -78.62 116.75 3.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.83 2.353 . . . . 0.84999999999999998 112.536 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.49 92.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 1.0700000000000001 111.23 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.91 -40.01 61.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.753 -0.658 . . . . 1.8200000000000001 111.566 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -82.83 158.48 22.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.31 0.576 . . . . 2.3599999999999999 111.671 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -69.12 -18.02 63.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.294 -0.867 . . . . 1.95 111.872 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 70.7 mttt -69.46 152.43 44.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.939 -0.573 . . . . 2.2799999999999998 111.853 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.51 127.89 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-O 121.781 0.801 . . . . 1.4199999999999999 109.229 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.74 40.01 26.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.288 -1.324 . . . . 1.77 111.431 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.59 143.9 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.442 -0.345 . . . . 2.54 111.089 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.537 HG13 ' CD1' ' A' ' 73' ' ' LEU . 46.5 t -66.79 138.87 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.841 -0.8 . . . . 1.3899999999999999 108.841 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -134.27 -54.66 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.741 0.645 . . . . 1.8200000000000001 112.741 -177.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -135.92 130.73 49.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.283 -0.636 . . . . 1.0800000000000001 109.283 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.886 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 2.9 mp -139.77 163.81 31.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.8799999999999999 111.48 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 34.5 t80 -139.36 103.02 4.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.461 -0.79 . . . . 2.2000000000000002 109.413 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -144.42 159.82 42.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.072 -0.513 . . . . 1.4199999999999999 111.954 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.49 28.43 6.61 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.047 -0.597 . . . . 0.56999999999999995 112.851 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 73.91 1.32 3.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.557 0.206 . . . . 1.46 111.557 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 27.3 mttt -99.87 119.46 38.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 110.004 -0.369 . . . . 2.96 110.004 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.47 HG21 ' CE2' ' A' ' 93' ' ' PHE . 2.8 mm -81.23 130.21 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.004 -1.48 . . . . 2.27 107.004 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.664 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -115.39 117.83 31.52 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.552 -0.749 . . . . 2.1499999999999999 110.538 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.857 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -166.28 -48.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 1.2 107.345 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.443 ' OD1' ' HA2' ' A' ' 89' ' ' GLY . 10.3 m-20 -77.38 -33.57 55.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 114.72 -1.127 . . . . 2.1699999999999999 109.024 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -76.61 -28.77 56.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.739 -1.118 . . . . 5.4100000000000001 108.762 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.519 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -81.93 117.65 69.13 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 114.946 -1.024 . . . . 2.21 110.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.11 -40.33 59.94 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.64 1.56 . . . . 1.1100000000000001 110.267 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.708 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.7 m-20 -67.82 106.45 2.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.078 -0.649 . . . . 1.3600000000000001 110.22 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.734 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.8 mp 67.7 29.0 7.11 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.307 0.855 . . . . 2.2400000000000002 113.307 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.857 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 41.7 pttt -58.03 131.33 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.903 -0.498 . . . . 2.8700000000000001 111.409 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 82' ' ' ASP . . . 80.61 19.41 68.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.642 -0.789 . . . . 0.48999999999999999 114.142 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.734 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.3 ptp180 -145.78 -47.4 0.21 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 114.295 1.22 . . . . 2.1099999999999999 114.295 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.679 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.2 p -79.53 82.09 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 122.914 1.34 . . . . 1.04 107.624 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.408 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 16.4 m80 -103.4 131.38 50.54 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 112.287 -2.233 . . . . 0.34000000000000002 112.25 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.67 ' HA ' ' O ' ' A' ' 104' ' ' SER . 68.7 m-85 -73.45 124.51 25.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.251 -0.58 . . . . 2.1600000000000001 110.393 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 p -75.72 34.17 0.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.568 -0.742 . . . . 1.0900000000000001 111.428 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 93' ' ' PHE . 1.7 m -149.03 122.57 9.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.052 0.453 . . . . 1.71 110.87 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -91.48 11.61 23.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 2.4700000000000002 110.207 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -145.56 65.16 1.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.557 -0.905 . . . . 2.1400000000000001 108.557 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -55.66 -28.03 53.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.835 -1.075 . . . . 1.99 111.249 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.416 ' HG2' HD12 ' A' ' 53' ' ' LEU . 96.2 mttt -66.21 0.48 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.099 0.476 . . . . 2.4900000000000002 112.067 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 98' ' ' LEU . 82.5 p -89.98 -0.02 57.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 1.8999999999999999 111.255 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 98.36 -4.55 60.29 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.673 -0.775 . . . . 0.40999999999999998 113.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' HD12 ' A' ' 98' ' ' LEU . 95.9 m-20 -105.42 108.81 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.146 0.473 . . . . 1.4399999999999999 110.532 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -108.22 19.44 19.9 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 112.101 0.408 . . . . 1.1200000000000001 112.101 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.67 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 9.3 m -60.36 140.84 56.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.02 1.489 . . . . 1.46 115.02 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.51 130.44 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 114.831 -1.077 . . . . 1.0900000000000001 110.849 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.595 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -105.65 147.71 28.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.892 -0.781 . . . . 1.5600000000000001 108.892 177.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.68 120.02 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 1.0600000000000001 111.26 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.604 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.18 144.89 29.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.285 -0.87 . . . . 1.0700000000000001 110.787 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m120 53.21 60.18 3.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.059 -0.519 . . . . 1.9399999999999999 112.176 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 9.4 mt -45.28 176.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.255 0.55 . . . . 1.21 112.452 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -177.86 164.16 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.504 -0.771 . . . . 2.6699999999999999 110.073 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.734 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 88.0 mt -60.08 -36.22 76.9 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.749 0.278 . . . . 2.2400000000000002 111.749 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.5 p -73.68 -10.03 59.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.602 0.239 . . . . 1.8300000000000001 111.389 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.92 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.593 -0.521 . . . . 1.5800000000000001 109.593 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -47.07 142.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 CA-C-N 115.748 -0.66 . . . . 1.1399999999999999 111.221 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 148.38 5.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.755 -1.212 . . . . 0.26000000000000001 114.181 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.7 m -59.12 130.01 44.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.025 -0.588 . . . . 1.0700000000000001 111.772 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 45.3 m-85 -112.02 122.58 48.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.268 -0.424 . . . . 2.1400000000000001 110.017 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.0 tt0 -119.96 118.41 30.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.621 -0.263 . . . . 1.5900000000000001 110.71 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.538 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 29.7 p -101.52 119.65 39.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 1.03 110.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.589 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 83.3 mttt -110.65 110.19 20.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 2.1899999999999999 110.2 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 59.8 t -89.99 106.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.8200000000000001 109.646 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 7.4 ttpm? -91.15 117.35 29.55 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.365 0.506 . . . . 2.1899999999999999 112.365 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 7.1 ttpm? -145.3 101.92 3.66 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.502 -0.555 . . . . 3.2799999999999998 109.502 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.7 129.8 36.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 113.534 0.938 . . . . 1.1799999999999999 113.534 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 64.3 Cg_endo -101.95 48.84 1.89 Allowed 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 125.026 -0.823 . . . . 0.62 111.988 -0.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -142.01 103.7 0.34 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.577 -0.82 . . . . 0.53000000000000003 113.634 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.437 HG13 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -96.88 132.04 42.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.045 -1.078 . . . . 1.8700000000000001 109.888 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 22' ' ' ILE . . . -144.82 147.01 32.37 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.282 0.475 . . . . 1.3200000000000001 112.282 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.589 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 52.8 p-10 -147.51 161.7 40.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.866 0.691 . . . . 2.0299999999999998 112.866 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.848 ' HE3' ' HA ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -145.27 160.65 41.17 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 3.46 109.929 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -97.19 145.02 26.45 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.731 1.382 . . . . 2.6699999999999999 114.731 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 93.1 mt -143.59 115.11 2.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 114.55 -1.204 . . . . 1.0600000000000001 108.624 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 117' ' ' THR . 52.7 m170 -100.02 120.05 39.22 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.033 -0.417 . . . . 0.70999999999999996 111.124 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.465 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 1.1 tm? -89.48 128.33 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 2.1000000000000001 111.846 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.435 ' N ' HD11 ' A' ' 135' ' ' LEU . 62.4 t -116.93 130.0 72.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.524 -0.762 . . . . 1.0900000000000001 109.818 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 HG12 ' HG3' ' A' ' 33' ' ' LYS . 16.4 t -95.26 121.22 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.156 0.428 . . . . 1.72 112.156 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.797 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 64.3 mt -88.57 167.17 13.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.052 -0.522 . . . . 1.21 109.811 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.64 140.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.405 0.622 . . . . 2.0899999999999999 111.784 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.768 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -164.3 175.34 2.7 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.09 -0.959 . . . . 2.7599999999999998 110.455 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 9.5 Cg_endo -50.68 -142.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.164 2.576 . . . . 1.4199999999999999 113.127 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.1 m -31.77 -38.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.413 0.523 . . . . 2.6899999999999999 112.413 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 33' ' ' LYS . . . 102.53 22.68 9.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.453 -0.88 . . . . 2.8799999999999999 113.513 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 2.6000000000000001 111.144 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.52 -0.232 . . . . 3.6600000000000001 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 t -78.61 140.0 38.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 2.8100000000000001 110.89 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -76.33 150.06 36.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 2.2599999999999998 111.159 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.96 136.0 33.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.744 -0.662 . . . . 2.6299999999999999 110.304 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -94.94 146.9 23.92 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.57 0.7 . . . . 1.6499999999999999 111.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.92 83.07 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 114.755 -1.112 . . . . 1.26 111.352 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.04 -85.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.701 2.934 . . . . 0.88 112.676 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 99.2 mt-10 -78.41 120.26 22.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.023 -0.732 . . . . 2.0600000000000001 109.023 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 132' ' ' LYS . 83.2 tt0 -144.36 160.5 40.93 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.376 1.25 . . . . 1.71 114.376 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 93.9 mtp -133.49 129.84 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.939 -1.028 . . . . 2.3999999999999999 109.74 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.9 mm -122.07 130.69 74.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 1.1499999999999999 111.416 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.692 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 72.7 mt-10 -124.39 129.42 50.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.542 -0.299 . . . . 1.1899999999999999 110.802 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 36' ' ' THR . 54.4 tptt -141.79 160.04 40.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.767 0.317 . . . . 2.9300000000000002 111.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 31' ' ' LYS . . . -76.15 138.26 40.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.032 0.444 . . . . 1.1299999999999999 111.74 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 tttp -47.59 136.47 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.777 -0.647 . . . . 2.7599999999999998 112.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.79 -21.89 10.35 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.647 -0.706 . . . . 0.32000000000000001 113.515 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.786 ' O ' HD13 ' A' ' 110' ' ' LEU . 79.5 mm-40 -77.69 -147.57 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.795 -1.187 . . . . 2.1099999999999999 107.795 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.66 ' HA ' ' CD1' ' A' ' 110' ' ' LEU . 81.6 m -139.07 133.68 31.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.01 0.433 . . . . 1.0800000000000001 110.441 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' H ' HD12 ' A' ' 110' ' ' LEU . . . -99.83 117.56 34.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 1.0700000000000001 110.73 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 94' ' ' THR . 64.7 t80 -79.25 120.29 23.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 2.3199999999999998 112.195 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 105' ' ' ILE . 21.1 mt -105.42 106.2 55.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.748 -0.834 . . . . 1.47 108.748 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.0 Cg_exo -79.54 123.54 5.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.669 2.246 . . . . 0.71999999999999997 113.832 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.499 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 49.6 t -141.83 123.96 15.48 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.504 -0.771 . . . . 1.03 109.579 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 87.6 mttt -141.56 149.1 40.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.463 -0.79 . . . . 2.2400000000000002 110.144 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' HG23 ' A' ' 122' ' ' VAL . 34.4 p90 -140.06 140.04 36.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.624 0.601 . . . . 2.1499999999999999 112.624 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 140.05 29.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.254 -0.885 . . . . 1.9299999999999999 110.195 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mp -95.99 117.41 30.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 2.5899999999999999 111.174 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.24 150.37 70.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 2.1299999999999999 109.822 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.65 -41.88 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.126 1.884 . . . . 1.9299999999999999 111.06 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -74.7 -36.96 62.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.517 -0.765 . . . . 2.1800000000000002 110.473 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.641 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 33.6 t0 -70.21 72.51 0.45 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.4100000000000001 110.47 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -99.75 0.03 40.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 1.96 111.061 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.03 159.96 53.34 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.94 -0.648 . . . . 0.56000000000000005 112.912 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.42 139.26 55.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.777 2.318 . . . . 1.1899999999999999 111.97 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.22 130.1 35.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.484 . . . . 2.4100000000000001 111.394 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.698 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.5 m-20 -134.88 159.98 39.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.613 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.4 mt -141.99 140.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.417 -0.81 . . . . 1.4099999999999999 110.412 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HA ' HD23 ' A' ' 73' ' ' LEU . 48.7 mt-10 -139.98 107.46 5.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.779 -0.368 . . . . 1.6699999999999999 111.394 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.682 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 81.4 m95 -95.12 126.09 40.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.23999999999999999 111.521 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.8 mt -118.12 140.19 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.149 -0.686 . . . . 1.1200000000000001 109.149 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.4 tt -130.0 135.57 60.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 1.3700000000000001 112.335 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.1 m -114.11 104.05 54.95 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.168 -0.924 . . . . 1.73 108.998 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.9 Cg_exo -78.47 120.43 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.499 2.133 . . . . 0.84999999999999998 111.907 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.01 83.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 111.215 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -75.28 -39.96 59.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 1.8200000000000001 111.459 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.599 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 39.5 m-20 -85.41 158.02 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.608 . . . . 2.3599999999999999 112.186 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.82 -14.59 62.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.103 -0.953 . . . . 1.95 111.265 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.61 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 32.8 mttt -66.23 149.21 50.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.441 -0.799 . . . . 2.2799999999999998 112.303 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 66' ' ' LYS . 2.6 m -153.63 127.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 121.796 0.808 . . . . 1.4199999999999999 109.151 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.84 41.5 30.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.28 -1.327 . . . . 1.77 112.186 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -88.12 139.96 29.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 2.54 111.404 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 84' ' ' TYR . 65.3 t -69.98 133.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.224 -0.444 . . . . 1.3899999999999999 110.372 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.703 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.3 pp -134.75 -39.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.815 0.672 . . . . 1.8200000000000001 112.815 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.772 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -140.24 128.17 24.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.378 -0.601 . . . . 1.0800000000000001 109.378 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 56' ' ' GLU . 6.9 mt -137.98 162.29 34.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 1.8799999999999999 111.277 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 35.4 t80 -133.48 102.68 5.61 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.298 -1.371 . . . . 2.2000000000000002 107.298 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.476 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 5.9 t -143.96 157.53 44.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.638 -0.71 . . . . 1.4199999999999999 111.731 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.99 29.79 3.49 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.256 -0.497 . . . . 0.56999999999999995 113.405 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.3 t0 73.83 1.0 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.739 0.274 . . . . 1.46 111.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -100.08 118.58 36.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 110.003 -0.369 . . . . 2.96 110.003 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.451 HG22 ' CE2' ' A' ' 93' ' ' PHE . 2.2 mm -80.02 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 107.214 -1.402 . . . . 2.27 107.214 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.772 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.7 m-85 -120.81 123.83 43.58 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.48 -0.782 . . . . 2.1499999999999999 110.982 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.823 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.2 p-10 -165.96 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.818 -1.549 . . . . 1.2 106.818 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -79.8 -31.88 40.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.406 -1.27 . . . . 2.1699999999999999 109.519 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -72.95 -29.65 63.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.501 -1.296 . . . . 5.4100000000000001 107.501 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.594 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.12 118.72 73.03 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 114.346 -1.297 . . . . 2.21 109.979 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.0 Cg_endo -50.78 -43.2 47.77 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.428 1.418 . . . . 1.1100000000000001 110.602 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 86.4 m-20 -68.42 106.28 2.47 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.047 -0.524 . . . . 1.3600000000000001 111.145 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.757 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.1 mp 72.33 24.53 3.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.391 0.886 . . . . 2.2400000000000002 113.391 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 14.2 pttm -59.17 134.74 57.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.909 -0.494 . . . . 2.8700000000000001 111.51 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 80.42 16.6 75.61 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.659 -0.781 . . . . 0.48999999999999999 113.993 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -143.02 -51.02 0.35 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 114.38 1.252 . . . . 2.1099999999999999 114.38 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.769 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.09 81.99 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 123.08 1.419 . . . . 1.04 107.421 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.448 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 12.1 m80 -102.17 127.92 48.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.066 -2.333 . . . . 0.34000000000000002 112.62 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.69 ' HA ' ' O ' ' A' ' 104' ' ' SER . 67.7 m-85 -71.61 122.75 21.09 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 120.163 -0.615 . . . . 2.1600000000000001 109.601 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.438 HG22 ' CE2' ' A' ' 38' ' ' TYR . 2.3 p -75.04 35.89 0.11 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 1.0900000000000001 111.214 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 93' ' ' PHE . 48.1 m -149.09 125.78 11.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.953 0.406 . . . . 1.71 110.396 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.11 6.81 40.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.937 -0.574 . . . . 2.4700000000000002 110.383 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -145.92 65.12 1.22 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.583 -0.735 . . . . 2.1400000000000001 109.06 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.622 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.2 mp -59.06 -27.16 65.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.173 -0.921 . . . . 1.99 111.958 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -63.46 1.54 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 2.4900000000000002 112.078 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 98' ' ' LEU . 18.4 t -90.02 0.03 57.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.586 -0.734 . . . . 1.8999999999999999 110.671 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.25 -8.46 48.8 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.964 -0.636 . . . . 0.40999999999999998 113.001 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -94.77 114.13 25.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.125 0.488 . . . . 1.4399999999999999 110.594 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -109.55 13.32 24.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.661 -0.699 . . . . 1.1200000000000001 111.965 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 51.0 m -59.95 139.57 57.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 115.563 1.69 . . . . 1.46 115.563 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.41 129.7 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 114.343 -1.299 . . . . 1.0900000000000001 110.294 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.4 p-10 -105.7 146.31 29.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.542 -0.91 . . . . 1.5600000000000001 108.542 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.631 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -95.37 122.8 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.118 0.485 . . . . 1.0600000000000001 110.746 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -91.08 145.16 24.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.638 -0.71 . . . . 1.0700000000000001 110.84 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 66.7 57.06 0.69 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 1.9399999999999999 111.466 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -53.95 165.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 1.21 112.095 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 10.7 pt20 -177.14 167.87 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.664 -0.698 . . . . 2.6699999999999999 110.996 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 89.2 mt -59.99 -37.37 79.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.757 -0.656 . . . . 2.2400000000000002 111.852 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.6 p -73.24 -17.11 61.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.528 -0.305 . . . . 1.8300000000000001 111.687 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 92.2 m-20 -71.25 -20.01 62.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.723 -0.391 . . . . 1.5800000000000001 109.974 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -46.51 144.08 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.044 0 CA-C-N 116.179 -0.464 . . . . 1.1399999999999999 111.055 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 143.89 4.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.904 -1.141 . . . . 0.26000000000000001 113.834 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 m -59.05 130.6 47.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.143 -0.529 . . . . 1.0700000000000001 112.009 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.557 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 28.9 m-85 -110.3 137.08 48.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 2.1400000000000001 109.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.8 tt0 -126.87 122.17 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.638 -0.255 . . . . 1.5900000000000001 110.579 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.6 t -99.88 119.76 38.71 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.575 0.226 . . . . 1.03 110.679 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 58.0 mttm -115.25 108.69 16.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 2.1899999999999999 110.849 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 40.9 t -91.3 108.35 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.619 -0.511 . . . . 1.8200000000000001 109.619 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 72.8 tttt -93.71 112.32 24.17 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.659 0.614 . . . . 2.1899999999999999 112.659 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 12.3 pttm -145.74 103.24 3.76 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 109.831 -0.433 . . . . 3.2799999999999998 109.831 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.59 129.73 13.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 113.158 0.799 . . . . 1.1799999999999999 113.158 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.641 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 83.0 Cg_endo -102.67 39.93 4.0 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 C-N-CA 125.109 -0.788 . . . . 0.62 111.423 -0.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.66 102.87 0.52 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-O 122.365 0.98 . . . . 0.53000000000000003 113.478 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.3 m -96.67 135.05 32.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 113.505 -1.347 . . . . 1.8700000000000001 108.76 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -132.05 154.19 49.65 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.763 -0.375 . . . . 1.3200000000000001 111.837 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 49.1 p-10 -146.09 149.31 33.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 111.519 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.35 165.57 28.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 3.46 111.396 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -104.82 140.05 38.69 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 113.028 0.751 . . . . 2.6699999999999999 113.028 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 78.5 mt -145.2 112.18 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.375 -0.972 . . . . 1.0600000000000001 108.375 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 26.8 m170 -94.69 121.1 35.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.592 -0.443 . . . . 0.70999999999999996 111.254 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.422 HD23 ' CE1' ' A' ' 118' ' ' TYR . 58.5 tp -89.07 120.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.127 0.489 . . . . 2.1000000000000001 111.024 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.692 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.7 t -122.26 129.11 75.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.258 -0.883 . . . . 1.0900000000000001 109.089 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.98 129.34 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.063 0.459 . . . . 1.72 112.052 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.61 160.06 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.739 -0.664 . . . . 1.21 109.504 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.1 t -76.61 134.99 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.372 0.606 . . . . 2.0899999999999999 110.949 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -162.47 170.59 7.57 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.855 -1.066 . . . . 2.7599999999999998 109.792 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 4.3 Cg_endo -45.89 171.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.339 2.026 . . . . 1.4199999999999999 111.879 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 144' ' ' ALA . 6.4 p -35.54 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.907 0.336 . . . . 2.6899999999999999 111.907 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.72 -65.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.295 -0.411 . . . . 2.8799999999999999 113.419 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.153 -0.927 . . . . 2.6000000000000001 111.426 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.487 -0.245 . . . . 3.6600000000000001 112.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -78.34 154.41 30.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 2.8100000000000001 111.08 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 153.51 22.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.671 -0.695 . . . . 2.2599999999999998 110.38 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 129' ' ' ALA . 1.1 pt -112.11 141.43 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.318 -0.401 . . . . 2.6299999999999999 111.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -93.17 155.05 17.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.64 0.733 . . . . 1.6499999999999999 111.724 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 45.87 83.14 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 114.574 -1.193 . . . . 1.26 111.981 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.561 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 56.9 Cg_endo -78.55 -82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.745 2.964 . . . . 0.88 112.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.48 129.42 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.68 -0.859 . . . . 2.0600000000000001 108.68 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.6 tp10 -143.76 159.62 42.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.812 1.042 . . . . 1.71 113.812 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mtm -139.91 123.77 17.51 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.826 -1.079 . . . . 2.3999999999999999 109.376 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.6 mm -120.02 130.04 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 1.1499999999999999 111.75 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.693 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.1 mt-10 -127.57 121.83 31.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.395 -0.366 . . . . 1.1899999999999999 110.413 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 48.0 mmtm -142.23 161.31 38.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.791 0.329 . . . . 2.9300000000000002 111.44 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.4 136.55 39.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 1.1299999999999999 111.189 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.894 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 52.4 tttp -44.51 132.67 6.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 2.7599999999999998 111.329 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 90.12 -18.94 45.56 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.867 -0.606 . . . . 0.32000000000000001 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.03 158.63 26.46 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.582 -0.896 . . . . 2.1099999999999999 108.582 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 35.0 m -89.08 125.42 35.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.747 -0.781 . . . . 1.0800000000000001 110.35 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.57 ' HB3' HD23 ' A' ' 110' ' ' LEU . . . -97.12 116.31 29.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.89 0.376 . . . . 1.0700000000000001 110.264 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.488 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 74.5 t80 -79.18 114.97 18.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.795 -0.639 . . . . 2.3199999999999998 112.088 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.6 mt -99.13 108.63 50.72 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.811 -0.811 . . . . 1.47 108.811 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.62 122.78 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.555 2.17 . . . . 0.71999999999999997 113.907 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' HE3' ' A' ' 131' ' ' LYS . 4.3 t -141.0 125.19 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.062 -0.972 . . . . 1.03 109.016 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 83.2 mttt -141.08 148.4 40.09 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.25 0.548 . . . . 2.2400000000000002 111.706 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 53' ' ' LEU . 40.8 p90 -140.8 142.62 34.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 2.1499999999999999 111.076 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 139.63 30.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.904 0.383 . . . . 1.9299999999999999 110.549 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.03 150.01 22.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 2.5899999999999999 111.756 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.9 m -150.33 139.88 13.47 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 109.698 -0.482 . . . . 2.1299999999999999 109.698 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -48.55 -25.4 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.544 2.163 . . . . 1.9299999999999999 112.144 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.63 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 17.5 pt-20 -78.49 -40.22 35.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.354 -0.384 . . . . 2.1800000000000002 111.473 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.1 m-20 -72.27 71.54 0.89 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.171 -0.612 . . . . 2.4100000000000001 109.68 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -97.37 -4.92 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.712 -0.676 . . . . 1.96 112.366 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.02 159.97 53.33 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.492 -0.861 . . . . 0.56000000000000005 112.805 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.43 123.77 12.81 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.363 2.042 . . . . 1.1899999999999999 111.693 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 43' ' ' PHE . 6.4 tt -78.17 110.2 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 2.4100000000000001 111.297 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 93.4 m-20 -127.83 103.78 7.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.391 0.615 . . . . 1.78 111.877 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.782 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 9.4 mt -91.68 113.31 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.974 -1.012 . . . . 1.4099999999999999 110.04 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.852 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -107.39 120.55 42.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.249 0.833 . . . . 1.6699999999999999 113.249 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.604 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 78.3 m95 -97.0 119.99 36.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.23999999999999999 109.924 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.0 mt -105.69 140.12 39.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.526 -0.546 . . . . 1.1200000000000001 109.526 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.1 tt -130.04 130.03 65.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.137 0.494 . . . . 1.3700000000000001 112.306 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.4 t -119.31 101.89 48.83 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 108.67 -0.863 . . . . 1.73 108.67 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.0 Cg_exo -79.97 111.57 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.603 2.202 . . . . 0.84999999999999998 112.725 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.61 75.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.395 -0.82 . . . . 1.0700000000000001 110.864 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -85.6 17.88 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 1.8200000000000001 112.004 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 79.3 m-20 -149.64 163.07 38.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.328 0.585 . . . . 2.3599999999999999 111.677 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.96 -18.89 64.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.209 -0.905 . . . . 1.95 111.868 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 78.9 mttt -69.31 150.38 47.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.114 -0.494 . . . . 2.2799999999999998 111.46 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.7 135.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.636 1.208 . . . . 1.4199999999999999 110.047 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 43.63 39.38 2.36 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 112.536 -2.12 . . . . 1.77 112.08 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 2.54 110.869 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' CG1' HD12 ' A' ' 73' ' ' LEU . 20.0 t -66.27 139.28 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.331 -0.618 . . . . 1.3899999999999999 109.331 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.832 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.17 -53.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.422 0.527 . . . . 1.8200000000000001 112.422 -177.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.778 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.76 130.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.857 -0.794 . . . . 1.0800000000000001 108.857 178.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.852 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.0 159.99 40.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.045 0.45 . . . . 1.8799999999999999 111.487 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 47.3 t80 -134.09 103.61 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 2.2000000000000002 110.03 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.466 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 47.5 t -143.54 156.15 44.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.555 0.576 . . . . 1.4199999999999999 112.555 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.02 32.99 9.6 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.953 -0.567 . . . . 0.56999999999999995 113.074 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 t0 70.13 4.3 4.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.573 0.225 . . . . 1.46 111.248 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.3 mttt -100.01 114.01 27.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.809 -0.441 . . . . 2.96 109.809 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.449 HG21 HD12 ' A' ' 79' ' ' ILE . 2.8 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.83 -1.544 . . . . 2.27 106.83 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.694 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -116.61 121.52 41.97 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.45 -0.795 . . . . 2.1499999999999999 110.625 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.895 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.5 p-10 -165.7 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.747 -1.205 . . . . 1.2 107.747 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -78.9 -31.08 45.24 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.158 -0.928 . . . . 2.1699999999999999 109.376 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -75.78 -28.3 58.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.185 -1.043 . . . . 5.4100000000000001 108.185 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -81.59 117.83 69.77 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-N 114.777 -1.101 . . . . 2.21 110.554 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.46 -42.8 40.75 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.602 1.535 . . . . 1.1100000000000001 110.352 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 71' ' ' ILE . 11.6 m-20 -67.28 106.18 1.97 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.105 -0.638 . . . . 1.3600000000000001 110.695 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.796 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 68.08 26.96 7.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.575 0.954 . . . . 2.2400000000000002 113.575 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.895 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 2.7 pttt -57.14 128.03 34.92 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.73 -0.606 . . . . 2.8700000000000001 111.616 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.05 18.59 57.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.589 -0.815 . . . . 0.48999999999999999 114.225 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.796 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.6 ptp180 -145.6 -46.27 0.21 Allowed 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 114.336 1.235 . . . . 2.1099999999999999 114.336 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.832 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.99 82.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 123.102 1.429 . . . . 1.04 107.555 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -102.67 128.44 49.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.235 -2.257 . . . . 0.34000000000000002 112.331 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.689 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 70.2 m-85 -72.25 124.07 24.3 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.338 -0.545 . . . . 2.1600000000000001 110.075 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.488 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 10.8 p -75.13 34.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.4 -0.818 . . . . 1.0900000000000001 111.116 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 93' ' ' PHE . 6.9 m -149.07 123.51 9.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.017 0.437 . . . . 1.71 110.856 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -90.95 10.89 24.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.784 -0.643 . . . . 2.4700000000000002 110.05 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -145.52 65.79 1.23 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.1400000000000001 108.416 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.592 HD21 ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -56.24 -31.75 63.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 1.99 111.606 -178.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -66.23 1.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.4900000000000002 111.979 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.3 p -89.45 -0.01 57.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.862 -0.608 . . . . 1.8999999999999999 111.023 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 100.85 -5.68 56.65 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.783 -0.722 . . . . 0.40999999999999998 113.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' O ' HD21 ' A' ' 98' ' ' LEU . 95.9 m-20 -101.9 107.18 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.067 0.434 . . . . 1.4399999999999999 110.427 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.592 ' HA ' HD21 ' A' ' 98' ' ' LEU . . . -104.63 11.68 33.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.8 0.667 . . . . 1.1200000000000001 112.8 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 89.8 p -60.03 140.02 57.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.685 1.735 . . . . 1.46 115.685 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.689 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -131.23 130.02 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 114.197 -1.365 . . . . 1.0900000000000001 110.507 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.4 p-10 -104.62 146.23 29.21 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.918 -0.771 . . . . 1.5600000000000001 108.918 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.14 120.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.021 0.439 . . . . 1.0600000000000001 111.543 -178.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.603 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.7 p -82.26 142.77 31.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.39 -0.823 . . . . 1.0700000000000001 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 27.9 m120 49.98 55.51 9.32 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.062 -0.517 . . . . 1.9399999999999999 111.605 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 37' ' ' ALA . 24.2 mt -44.55 89.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.566 1.321 . . . . 1.21 114.566 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.435 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 64.1 tt0 -60.09 145.38 46.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.708 -0.678 . . . . 2.6699999999999999 109.896 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -59.98 -40.04 87.74 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.188 0.518 . . . . 2.2400000000000002 111.223 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.434 ' HB3' HD22 ' A' ' 64' ' ' ASN . 53.1 m -72.24 -9.98 59.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.505 -0.771 . . . . 1.8300000000000001 111.642 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.99 -19.95 63.32 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.149 -0.315 . . . . 1.5800000000000001 110.149 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.1 mt -43.33 145.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.134 -0.484 . . . . 1.1399999999999999 110.353 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.488 ' N ' HG21 ' A' ' 115' ' ' ILE . . . 140.86 155.08 6.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 0.26000000000000001 112.808 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.19 138.38 57.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.198 0.444 . . . . 1.0700000000000001 112.198 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 21.6 m-85 -119.3 135.1 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.58 . . . . 2.1400000000000001 109.886 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 53.4 tt0 -127.61 119.94 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.184 -0.302 . . . . 1.5900000000000001 110.184 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.528 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 39.1 t -99.98 118.98 37.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.416 . . . . 1.03 110.065 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.782 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 82.2 mttt -116.62 104.75 11.71 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 120.982 -0.287 . . . . 2.1899999999999999 111.418 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 22.1 t -87.71 108.66 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.092 -0.707 . . . . 1.8200000000000001 109.092 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 39.3 ttpt -99.93 113.09 25.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.174 0.805 . . . . 2.1899999999999999 113.174 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG2' ' HB3' ' A' ' 49' ' ' ASP . 6.7 ttpt -145.51 101.9 3.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.477 -0.564 . . . . 3.2799999999999998 109.477 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -52.22 133.13 41.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.683 -0.69 . . . . 1.1799999999999999 112.714 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 40.0 Cg_endo -97.84 39.82 4.79 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 124.275 -1.135 . . . . 0.62 112.966 -0.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.31 101.96 0.45 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.922 -1.133 . . . . 0.53000000000000003 113.496 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.82 140.02 18.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.576 -1.312 . . . . 1.8700000000000001 109.301 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' A' ' 22' ' ' ILE . . . -145.07 152.0 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 1.3200000000000001 112.41 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.516 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 35.8 p-10 -146.59 151.7 37.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.248 0.462 . . . . 2.0299999999999998 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.08 160.0 42.08 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.904 -0.589 . . . . 3.46 110.779 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.7 mttt -102.34 141.13 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.633 0.975 . . . . 2.6699999999999999 113.633 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 97.7 mt -141.75 116.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 1.0600000000000001 108.605 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -100.32 117.91 35.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.463 -0.495 . . . . 0.70999999999999996 110.752 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.43 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 63.5 tp -89.38 122.89 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.227 0.537 . . . . 2.1000000000000001 112.411 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.693 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 47.7 t -120.02 126.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.423 -0.954 . . . . 1.0900000000000001 108.423 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.95 125.66 67.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 112.223 0.453 . . . . 1.72 112.223 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.5 mt -83.4 163.95 20.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 1.21 109.614 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.538 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -75.0 139.67 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.854 0.835 . . . . 2.0899999999999999 112.124 -178.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.894 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 10.1 mmtp -159.83 175.65 3.06 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 113.875 -1.512 . . . . 2.7599999999999998 109.863 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 140' ' ' LYS . 45.2 Cg_exo -57.62 -147.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.644 2.229 . . . . 1.4199999999999999 113.061 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.55 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 50.4 m -41.61 -40.01 1.79 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.006 0.373 . . . . 2.6899999999999999 112.006 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 64.55 -65.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.193 -0.527 . . . . 2.8799999999999999 113.621 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.248 -0.882 . . . . 2.6000000000000001 111.117 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.564 -0.214 . . . . 3.6600000000000001 112.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.5 p -78.16 155.51 30.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 2.8100000000000001 110.904 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.1 t -79.68 157.12 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 2.2599999999999998 111.058 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.462 ' CG2' ' HD3' ' A' ' 131' ' ' LYS . 70.8 mt -143.38 129.1 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 2.6299999999999999 110.77 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 69.2 p -94.29 153.63 17.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.399 0.618 . . . . 1.6499999999999999 111.125 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 41.37 82.27 0.23 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 114.782 -1.099 . . . . 1.26 112.347 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 59.9 Cg_endo -79.02 -84.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.83 3.02 . . . . 0.88 112.269 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.0 mt-10 -78.12 129.12 34.8 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.063 -1.088 . . . . 2.0600000000000001 108.063 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.6 tp10 -144.09 159.21 43.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.414 1.265 . . . . 1.71 114.414 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.6 mtp -140.01 121.7 15.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.303 -1.317 . . . . 2.3999999999999999 108.913 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.404 ' HA ' HD11 ' A' ' 29' ' ' ILE . 37.3 mm -119.77 129.98 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.611 -0.268 . . . . 1.1499999999999999 111.252 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.8 pt-20 -129.82 126.76 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.355 . . . . 1.1899999999999999 110.891 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -142.13 162.05 36.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 2.9300000000000002 110.858 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.853 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.08 40.59 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.197 0.444 . . . . 1.1299999999999999 112.197 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 87.2 mttt -43.85 141.53 1.57 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.208 -0.451 . . . . 2.7599999999999998 112.031 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' OXT' ' A' ' 144' ' ' ALA . . . 82.43 -24.99 4.58 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.749 -0.659 . . . . 0.32000000000000001 113.003 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.4 mt-10 -80.07 160.58 25.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.214 -0.661 . . . . 2.1099999999999999 109.214 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 27.4 m -83.79 133.29 34.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.957 -0.697 . . . . 1.0800000000000001 110.449 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -95.45 118.43 32.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.989 0.423 . . . . 1.0700000000000001 110.773 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.478 ' HE1' ' CG2' ' A' ' 94' ' ' THR . 65.9 t80 -79.33 131.12 36.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.715 -0.675 . . . . 2.3199999999999998 112.66 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.7 mt -128.32 104.32 19.95 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 108.991 -0.744 . . . . 1.47 108.991 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 95.8 Cg_endo -86.06 126.98 2.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.657 2.238 . . . . 0.71999999999999997 114.762 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' SG ' ' CE ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -141.93 126.1 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.288 -0.869 . . . . 1.03 109.588 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 27.8 mttp -141.04 117.0 10.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.399 0.619 . . . . 2.2400000000000002 110.983 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 29.0 p90 -92.84 139.84 30.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.935 -1.03 . . . . 2.1499999999999999 111.031 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 143.3 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.415 . . . . 1.9299999999999999 110.91 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.2 mt -100.38 139.76 35.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 2.5899999999999999 111.525 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.43 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 5.3 m -158.93 147.13 13.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.583 . . . . 2.1299999999999999 109.899 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.28 -23.73 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.44 2.094 . . . . 1.9299999999999999 113.082 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -74.47 -43.24 56.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 120.563 0.221 . . . . 2.1800000000000002 111.014 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.673 ' HB2' ' HB3' ' A' ' 124' ' ' LYS . 1.2 p-10 -73.65 74.51 1.52 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.124 -0.63 . . . . 2.4100000000000001 109.503 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -90.64 -12.73 35.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 1.96 112.106 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -73.66 159.95 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.292 -0.956 . . . . 0.56000000000000005 112.912 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 140.93 97.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.487 2.125 . . . . 1.1899999999999999 111.385 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.09 104.09 8.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.793 0.33 . . . . 2.4100000000000001 111.287 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 96.0 m-20 -114.92 103.29 10.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.64 0.734 . . . . 1.78 110.996 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.789 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.3 mt -95.07 126.53 47.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.046 -0.979 . . . . 1.4099999999999999 110.709 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 96.5 mt-10 -120.54 117.57 27.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.486 0.55 . . . . 1.6699999999999999 112.486 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.753 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 76.0 m95 -96.44 120.04 36.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.072 -0.344 . . . . 0.23999999999999999 110.072 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 83.1 mt -108.76 140.25 42.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.36 -0.608 . . . . 1.1200000000000001 109.36 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 117' ' ' THR . 9.4 tt -129.91 130.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 1.3700000000000001 112.289 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.6 m -119.99 103.35 45.49 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.01 -0.995 . . . . 1.73 109.142 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 86.2 Cg_endo -78.31 119.11 4.47 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.655 2.237 . . . . 0.84999999999999998 112.367 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.05 87.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 1.0700000000000001 111.55 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD2' ' CD1' ' A' ' 112' ' ' LEU . 81.2 m-20 -76.56 -39.98 51.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.021 -0.536 . . . . 1.8200000000000001 112.138 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -84.43 160.01 20.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.348 0.594 . . . . 2.3599999999999999 112.214 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -69.84 -17.6 63.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.182 -0.917 . . . . 1.95 111.798 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.7 mttp -65.9 147.14 53.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.849 -0.614 . . . . 2.2799999999999998 111.02 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.83 127.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 CA-C-O 121.883 0.849 . . . . 1.4199999999999999 110.187 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 40.02 26.12 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.98 -1.464 . . . . 1.77 112.694 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.4 mt-30 -94.3 143.22 26.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.104 -0.238 . . . . 2.54 111.444 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.475 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 21.1 t -66.46 132.1 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 108.855 -0.795 . . . . 1.3899999999999999 108.855 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.885 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -123.48 -51.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.352 0.871 . . . . 1.8200000000000001 113.352 -176.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.863 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.81 105.3 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.699 0.761 . . . . 1.0800000000000001 108.949 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -109.72 155.09 21.99 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.136 -0.938 . . . . 1.8799999999999999 111.078 -177.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.904 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 22.0 t80 -135.11 104.79 6.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 2.2000000000000002 110.439 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.439 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 45.2 m -142.57 158.41 43.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.132 0.419 . . . . 1.4199999999999999 112.132 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.66 30.23 42.62 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.078 -0.582 . . . . 0.56999999999999995 112.729 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t0 72.62 2.28 4.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.612 0.244 . . . . 1.46 110.903 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.0 mttt -99.99 114.8 28.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.634 -0.506 . . . . 2.96 109.634 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.904 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.07 116.99 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.114 -1.069 . . . . 2.27 108.114 178.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.71 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -100.09 125.93 46.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.914 -1.494 . . . . 2.1499999999999999 110.46 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.859 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -164.43 -52.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.98 -21.43 43.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.214 -0.903 . . . . 2.1699999999999999 109.025 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -80.74 -27.42 36.86 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.15 -1.056 . . . . 5.4100000000000001 108.15 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.6 m-85 -86.24 116.67 66.71 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.086 . . . . 2.21 110.648 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.1 Cg_endo -47.98 -40.99 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.439 1.426 . . . . 1.1100000000000001 110.234 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' O ' HG12 ' A' ' 71' ' ' ILE . 65.5 m-20 -66.97 105.71 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.237 -0.585 . . . . 1.3600000000000001 110.825 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.776 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.7 mt 66.88 24.82 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.608 0.966 . . . . 2.2400000000000002 113.608 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.859 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 65.3 pttt -57.25 132.93 54.48 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.988 -0.685 . . . . 2.8700000000000001 111.141 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 87.79 14.83 62.41 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.417 -0.897 . . . . 0.48999999999999999 114.015 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.776 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -142.95 -50.85 0.35 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.826 1.417 . . . . 2.1099999999999999 114.826 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.885 HG13 ' CD1' ' A' ' 71' ' ' ILE . 7.2 p -79.18 81.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 123.319 1.533 . . . . 1.04 107.363 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.405 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 13.5 m80 -100.22 131.55 46.1 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 111.806 -2.452 . . . . 0.34000000000000002 111.756 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 74' ' ' TYR . 75.1 m-85 -70.78 120.03 15.78 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 121.696 0.76 . . . . 2.1600000000000001 110.719 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.478 ' CG2' ' HE1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -70.01 -8.11 46.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.438 -1.255 . . . . 1.0900000000000001 110.608 179.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 67.9 m -87.09 116.23 25.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.316 -0.402 . . . . 1.71 111.13 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.81 0.07 57.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.225 0.536 . . . . 2.4700000000000002 109.965 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -146.2 65.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.596 -0.89 . . . . 2.1400000000000001 108.596 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 74' ' ' TYR . 6.8 tt -58.15 -32.73 68.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.245 -0.889 . . . . 1.99 111.52 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.52 -8.65 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.293 0.568 . . . . 2.4900000000000002 111.717 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.6 m -88.52 -0.04 56.81 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.187 -0.915 . . . . 1.8999999999999999 110.813 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 103.24 -12.32 55.2 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.734 . . . . 0.40999999999999998 113.749 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 64.9 m-20 -95.06 109.96 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.159 0.48 . . . . 1.4399999999999999 110.432 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.62 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -117.79 24.75 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.653 0.612 . . . . 1.1200000000000001 112.653 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 10.0 m -61.42 154.6 23.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.27 1.211 . . . . 1.46 114.27 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -136.45 146.06 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.81 -1.086 . . . . 1.0900000000000001 111.719 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.517 ' O ' ' O ' ' A' ' 90' ' ' ARG . 22.6 p30 -121.73 142.55 50.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.877 -1.157 . . . . 1.5600000000000001 107.877 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -97.43 121.84 48.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.065 0.459 . . . . 1.0600000000000001 111.205 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 145.75 28.71 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.297 -0.865 . . . . 1.0700000000000001 111.911 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.11 60.92 3.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.877 0.695 . . . . 1.9399999999999999 112.877 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 31' ' ' LYS . 10.2 mt -47.01 172.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.286 0.565 . . . . 1.21 112.397 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' HA ' ' C ' ' A' ' 144' ' ' ALA . 13.7 pt20 -176.6 160.01 1.94 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.997 -1.001 . . . . 2.6699999999999999 109.601 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 ' CD1' ' OD2' ' A' ' 63' ' ' ASP . 1.2 tm? -59.06 -34.13 71.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.454 0.538 . . . . 2.2400000000000002 112.454 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.38 -12.03 60.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.809 0.3 . . . . 1.8300000000000001 111.809 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.34 -20.95 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.5800000000000001 109.896 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.3 143.25 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 116.089 -0.505 . . . . 1.1399999999999999 111.072 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 141.05 147.36 4.91 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.722 -1.227 . . . . 0.26000000000000001 113.922 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 96.2 m -59.34 130.03 44.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.059 -0.57 . . . . 1.0700000000000001 111.83 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 30.5 m-85 -109.81 132.56 54.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.921 -0.581 . . . . 2.1400000000000001 109.584 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 61.8 tt0 -120.86 110.28 16.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 1.5900000000000001 110.027 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.505 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 1.5 t -100.18 119.68 38.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.87 -0.604 . . . . 1.03 110.066 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.789 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.9 mtpt -122.52 112.97 18.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 2.1899999999999999 111.172 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 20.6 t -93.83 113.15 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.274 -0.639 . . . . 1.8200000000000001 109.274 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 46.3 mttp -91.54 127.43 36.99 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.201 1.186 . . . . 2.1899999999999999 114.201 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 49' ' ' ASP . 9.5 mtmp? -145.98 101.88 3.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 3.2799999999999998 109.326 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.547 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.75 132.29 47.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.26 0.467 . . . . 1.1799999999999999 112.26 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -101.44 49.53 1.79 Allowed 'Cis proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.892 -0.879 . . . . 0.62 111.707 -0.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.83 103.84 0.29 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.699 -0.762 . . . . 0.53000000000000003 112.926 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 123' ' ' LYS . 26.9 m -83.38 127.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.742 -0.729 . . . . 1.8700000000000001 110.217 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -99.46 141.22 32.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.401 0.143 . . . . 1.3200000000000001 111.239 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.449 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.6 p-10 -145.76 136.47 24.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.985 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.582 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.33 157.16 44.1 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.724 -0.671 . . . . 3.46 110.361 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 27' ' ' GLU . 96.8 mttt -104.57 140.08 38.52 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 113.329 0.863 . . . . 2.6699999999999999 113.329 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.596 HD12 ' CH2' ' A' ' 57' ' ' TRP . 3.2 mt -140.97 120.0 11.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.317 -0.856 . . . . 1.0600000000000001 109.339 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -102.58 120.53 40.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.70999999999999996 110.897 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.458 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 3.3 tm? -87.92 120.0 28.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.066 0.46 . . . . 2.1000000000000001 111.124 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 59.1 t -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.373 -0.831 . . . . 1.0900000000000001 109.316 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' CG1' ' HG3' ' A' ' 33' ' ' LYS . 18.0 t -100.7 134.08 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.444 0.535 . . . . 1.72 112.444 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.853 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 58.7 mt -83.05 150.01 26.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.983 -0.747 . . . . 1.21 108.983 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.36 136.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 122.063 0.935 . . . . 2.0899999999999999 112.836 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -165.2 172.2 4.67 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 113.855 -1.52 . . . . 2.7599999999999998 108.669 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 2.3 Cg_endo -40.12 128.94 2.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.089 1.859 . . . . 1.4199999999999999 110.84 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.789 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.7 m -33.71 -81.76 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.326 0.491 . . . . 2.6899999999999999 112.326 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 26.06 -67.37 0.0 OUTLIER Glycine 0 N--CA 1.468 0.782 0 N-CA-C 114.687 0.635 . . . . 2.8799999999999999 114.687 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.789 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.091 -0.957 . . . . 2.6000000000000001 109.396 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.473 -0.251 . . . . 3.6600000000000001 112.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' A' ' 44' ' ' THR . 38.0 t -77.29 144.24 38.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.29 . . . . 2.8100000000000001 110.588 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.495 ' H ' ' HB ' ' A' ' 44' ' ' THR . 79.4 p -160.01 159.56 32.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.479 . . . . 2.2599999999999998 111.154 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.564 HG22 ' HD2' ' A' ' 131' ' ' LYS . 73.1 mt -100.14 117.68 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.382 -0.826 . . . . 2.6299999999999999 111.189 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' CE ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -92.25 131.41 37.48 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.373 0.606 . . . . 1.6499999999999999 110.02 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 82.0 0.25 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 122.124 0.964 . . . . 1.26 110.292 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.6 Cg_endo -77.79 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.329 -0.488 0 C-N-CA 123.882 3.055 . . . . 0.88 112.966 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.5 mt-10 -78.48 125.31 29.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 2.0600000000000001 108.661 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 81.5 tt0 -143.96 160.02 41.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.855 1.057 . . . . 1.71 113.855 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.0 ttp -136.74 135.57 38.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.805 -1.089 . . . . 2.3999999999999999 109.471 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.6 mm -130.03 136.42 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.969 -0.559 . . . . 1.1499999999999999 111.436 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.634 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 83.8 mt-10 -129.86 123.51 31.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.647 0.26 . . . . 1.1899999999999999 110.925 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 26.4 mmtt -141.93 153.22 44.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.726 0.298 . . . . 2.9300000000000002 111.429 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.0 142.35 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 1.1299999999999999 111.228 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 94.8 mttt -41.28 159.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.373 0.606 . . . . 2.7599999999999998 112.178 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.63 -24.22 0.13 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.278 -0.874 . . . . 0.32000000000000001 113.879 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 33' ' ' LYS . 98.9 mt-10 -80.06 160.03 25.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.416 -0.587 . . . . 2.1099999999999999 109.416 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.81 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 40.8 m -86.51 128.93 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.24 -0.584 . . . . 1.0800000000000001 110.831 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -100.0 118.28 36.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.189 0.519 . . . . 1.0700000000000001 110.254 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.523 ' CE2' HG22 ' A' ' 94' ' ' THR . 29.4 t80 -79.19 122.92 26.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.726 -0.67 . . . . 2.3199999999999998 112.338 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 57' ' ' TRP . 30.8 mt -110.03 104.67 56.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.39 -0.967 . . . . 1.47 108.39 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 86.9 Cg_endo -82.12 133.11 7.51 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.508 2.139 . . . . 0.71999999999999997 115.262 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.93 126.6 19.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.301 -1.318 . . . . 1.03 107.519 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.12 112.32 7.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.329 0.585 . . . . 2.2400000000000002 111.609 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.647 ' HB3' HG13 ' A' ' 122' ' ' VAL . 41.8 p90 -100.04 139.01 36.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.05 -0.977 . . . . 2.1499999999999999 111.205 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.495 ' HB ' ' H ' ' A' ' 21' ' ' SER . 19.5 m -79.93 165.98 22.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.683 -0.488 . . . . 1.9299999999999999 109.683 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD22 ' HE2' ' A' ' 43' ' ' PHE . 98.0 mt -132.27 148.12 52.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.446 0.641 . . . . 2.5899999999999999 112.417 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.5 t -160.16 147.92 12.91 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.965 -1.016 . . . . 2.1299999999999999 109.542 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.57 -21.57 5.44 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.438 2.092 . . . . 1.9299999999999999 113.236 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -76.38 -41.16 48.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 121.177 -0.209 . . . . 2.1800000000000002 111.194 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -73.03 79.21 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.294 -0.632 . . . . 2.4100000000000001 109.294 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -100.01 4.99 45.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 1.96 112.076 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -79.77 168.87 52.84 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.379 -0.915 . . . . 0.56000000000000005 113.383 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.0 131.28 23.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.743 2.296 . . . . 1.1899999999999999 111.562 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.0 tp -78.51 110.03 13.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 2.4100000000000001 111.856 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -126.94 103.5 7.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.415 0.626 . . . . 1.78 110.49 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.816 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.4 120.06 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.06 -0.973 . . . . 1.4099999999999999 111.065 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.905 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 97.6 mt-10 -109.75 119.97 41.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.187 0.44 . . . . 1.6699999999999999 112.187 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.701 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 69.6 m95 -95.36 119.98 34.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.856 -0.338 . . . . 0.23999999999999999 110.155 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.98 138.95 40.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.138 -0.69 . . . . 1.1200000000000001 109.138 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -130.02 130.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.13 0.49 . . . . 1.3700000000000001 112.264 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.1 m -122.74 102.75 38.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.555 -0.748 . . . . 1.73 109.331 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.58 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 93.8 Cg_endo -79.04 116.0 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.519 2.146 . . . . 0.84999999999999998 111.902 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.98 87.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 1.0700000000000001 111.588 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.61 -40.01 57.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.191 -0.459 . . . . 1.8200000000000001 111.636 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.3 m120 -84.23 160.04 20.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.293 0.568 . . . . 2.3599999999999999 112.137 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.72 -18.66 64.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.32 -0.855 . . . . 1.95 111.7 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.58 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 68.0 mttm -67.13 149.03 51.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.022 -0.535 . . . . 2.2799999999999998 111.186 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.61 127.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-O 121.902 0.858 . . . . 1.4199999999999999 109.99 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.25 39.96 31.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.58 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.05 144.05 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.553 -0.166 . . . . 2.54 110.553 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 23.6 t -66.01 130.0 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.657 -0.417 . . . . 1.3899999999999999 109.895 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -117.15 -54.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.753 0.649 . . . . 1.8200000000000001 112.753 -177.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.713 ' HB ' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -136.29 131.26 48.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.444 -0.947 . . . . 1.0800000000000001 108.444 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.905 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.01 158.5 43.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.235 -0.439 . . . . 1.8799999999999999 111.228 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 38.1 t80 -135.58 103.31 5.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 2.2000000000000002 109.823 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 21.3 t -144.58 160.04 41.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.765 -0.652 . . . . 1.4199999999999999 112.352 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.95 31.34 5.57 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 113.017 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 3.14 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.535 0.207 . . . . 1.46 111.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -99.95 115.66 30.2 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.429 -0.582 . . . . 2.96 109.429 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 HG23 ' CD2' ' A' ' 93' ' ' PHE . 3.1 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 107.219 -1.4 . . . . 2.27 107.219 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.678 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 2.8 m-85 -114.92 117.77 31.6 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.397 -0.82 . . . . 2.1499999999999999 110.065 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.856 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 9.7 p-10 -165.94 -49.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.127 -1.434 . . . . 1.2 107.127 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD1' ' CE1' ' A' ' 83' ' ' TYR . 12.1 p-10 -80.13 -26.98 39.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.575 -1.193 . . . . 2.1699999999999999 108.749 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 36.3 m-85 -80.84 -29.54 35.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.021 -1.103 . . . . 5.4100000000000001 108.021 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.521 ' CZ ' HG13 ' A' ' 70' ' ' VAL . 1.8 m-85 -82.33 110.32 20.74 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 115.014 -0.994 . . . . 2.21 109.794 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 25.9 Cg_exo -63.1 -28.56 74.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.086 1.857 . . . . 1.1100000000000001 113.119 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 87' ' ' LEU . 20.1 m-20 -48.71 -33.32 9.93 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.213 -0.595 . . . . 1.3600000000000001 112.045 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.788 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.3 mp -153.06 32.44 0.48 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.03 -0.986 . . . . 2.2400000000000002 110.186 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.856 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 56.1 pttt -53.38 127.63 25.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.475 0.546 . . . . 2.8700000000000001 112.475 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.52 15.91 57.73 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.487 -0.779 . . . . 0.48999999999999999 114.639 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.788 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.4 ptp180 -145.87 -45.31 0.21 Allowed 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 114.594 1.331 . . . . 2.1099999999999999 114.594 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.758 HG13 HD13 ' A' ' 71' ' ' ILE . 7.7 p -79.91 81.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.868 1.318 . . . . 1.04 107.782 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -102.62 128.88 49.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.654 -2.067 . . . . 0.34000000000000002 112.684 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 60.8 m-85 -70.7 122.77 20.43 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 121.227 0.537 . . . . 2.1600000000000001 110.016 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.523 HG22 ' CE2' ' A' ' 38' ' ' TYR . 30.3 p -77.58 34.84 0.18 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.518 -0.765 . . . . 1.0900000000000001 111.395 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 93' ' ' PHE . 11.7 m -149.05 125.14 10.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.939 0.4 . . . . 1.71 110.275 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -90.0 8.47 32.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.94 -0.573 . . . . 2.4700000000000002 110.303 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.2 66.53 1.19 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.668 -0.864 . . . . 2.1400000000000001 108.668 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 100' ' ' SER . 6.9 mp -58.45 -33.11 69.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.107 -0.951 . . . . 1.99 111.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.27 0.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 2.4900000000000002 112.166 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 98' ' ' LEU . 52.6 m -89.95 0.02 57.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.625 -0.716 . . . . 1.8999999999999999 111.18 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.574 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 107.88 -14.59 37.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.69 -0.767 . . . . 0.40999999999999998 113.295 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.955 0.377 . . . . 1.4399999999999999 110.735 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.24 20.01 16.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.387 . . . . 1.1200000000000001 111.998 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.65 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.2 p -60.11 144.73 49.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.939 1.459 . . . . 1.46 114.939 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.04 131.84 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 114.588 -1.187 . . . . 1.0900000000000001 110.581 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.0 p-10 -105.51 150.09 25.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.734 -0.839 . . . . 1.5600000000000001 108.734 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.46 119.84 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.923 0.392 . . . . 1.0600000000000001 110.652 -179.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.541 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -84.96 144.66 28.18 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.583 -0.735 . . . . 1.0700000000000001 111.049 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 54.42 59.98 3.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 1.9399999999999999 112.121 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.443 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 8.6 mt -45.52 177.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.271 0.558 . . . . 1.21 112.395 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 11.5 pt20 -177.24 166.7 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.485 -0.78 . . . . 2.6699999999999999 110.291 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.589 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 58.8 tp -60.04 -39.93 87.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 2.2400000000000002 111.577 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.2 m -73.22 -10.03 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.393 . . . . 1.8300000000000001 112.062 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' A' ' 110' ' ' LEU . 90.7 m-20 -71.85 -22.35 61.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.528 -0.469 . . . . 1.5800000000000001 109.735 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -47.97 142.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.05 -0.523 . . . . 1.1399999999999999 110.186 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 150.87 5.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.2 -1.0 . . . . 0.26000000000000001 113.7 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.29 130.64 47.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.137 -0.532 . . . . 1.0700000000000001 112.375 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 43.8 m-85 -114.49 124.55 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.444 -0.576 . . . . 2.1400000000000001 109.444 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.0 tt0 -123.37 119.22 29.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.117 -0.233 . . . . 1.5900000000000001 110.765 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 15.5 p -105.05 119.91 40.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 1.03 110.362 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.816 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 41.2 mtmt -111.77 107.81 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 2.1899999999999999 110.659 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 43' ' ' PHE . 5.7 p -88.0 113.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 1.8200000000000001 110.033 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.8 tttt -96.55 116.35 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.372 0.508 . . . . 2.1899999999999999 112.372 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 25.7 tttp -145.65 102.48 3.69 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.402 -0.519 . . . . 3.2799999999999998 109.849 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -51.68 134.0 36.15 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.918 -0.583 . . . . 1.1799999999999999 111.878 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -100.02 49.9 1.73 Allowed 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.627 -0.989 . . . . 0.62 111.606 -0.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -146.34 103.26 0.27 Allowed Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.147 -1.025 . . . . 0.53000000000000003 113.939 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.86 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 1.8700000000000001 108.804 176.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -140.96 146.86 37.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.309 0.485 . . . . 1.3200000000000001 112.309 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.453 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 53.7 p30 -146.73 150.93 36.33 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.198 -0.455 . . . . 2.0299999999999998 111.374 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.564 ' HD2' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -145.64 159.99 42.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.166 -0.47 . . . . 3.46 110.763 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 66.9 mttm -100.25 140.11 34.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.841 1.052 . . . . 2.6699999999999999 113.841 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 86.7 mt -140.6 113.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.946 -1.025 . . . . 1.0600000000000001 108.289 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -99.95 119.54 38.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.405 -0.518 . . . . 0.70999999999999996 110.995 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.6 tp -91.31 122.52 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 2.1000000000000001 111.945 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.634 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 59.7 t -120.01 127.18 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.826 -0.805 . . . . 1.0900000000000001 108.826 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.507 HG13 ' HG2' ' A' ' 33' ' ' LYS . 33.5 t -98.9 131.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.46 0.541 . . . . 1.72 112.46 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 85.8 mt -82.36 151.3 26.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.824 -0.625 . . . . 1.21 109.824 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.04 139.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.678 0.751 . . . . 2.0899999999999999 112.387 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.607 ' HB2' ' CD ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -164.74 -173.75 0.36 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.517 -1.22 . . . . 2.7599999999999998 109.036 179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 140' ' ' LYS . 50.9 Cg_exo -55.24 -143.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.185 1.923 . . . . 1.4199999999999999 112.244 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 t -38.86 -71.8 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.784 0.326 . . . . 2.6899999999999999 111.265 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 33' ' ' LYS . . . 68.0 -59.74 0.37 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.957 -0.639 . . . . 2.8799999999999999 113.59 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.265 -0.874 . . . . 2.6000000000000001 111.186 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.543 -0.223 . . . . 3.6600000000000001 112.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 m -77.67 135.55 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 2.8100000000000001 110.89 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' CG2' ' A' ' 44' ' ' THR . 16.5 m -157.11 150.86 24.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 2.2599999999999998 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -142.86 132.81 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 2.6299999999999999 110.321 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.21 150.3 22.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.676 0.75 . . . . 1.6499999999999999 111.725 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.515 HG22 ' HG3' ' A' ' 27' ' ' GLU . 0.3 OUTLIER 52.68 81.64 0.26 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.526 -1.215 . . . . 1.26 112.464 -178.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.631 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -78.93 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.656 2.904 . . . . 0.88 111.857 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.57 126.85 31.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 2.0600000000000001 108.521 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HG3' HG22 ' A' ' 24' ' ' THR . 2.4 mm-40 -143.61 159.99 41.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.864 1.061 . . . . 1.71 113.864 -176.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.5 ttp -138.93 132.26 30.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.55 -1.205 . . . . 2.3999999999999999 108.98 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 133' ' ' ILE . 4.3 mp -130.0 139.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.943 -0.571 . . . . 1.1499999999999999 111.405 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.0 pt-20 -135.13 127.29 29.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.1899999999999999 111.134 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 56.0 tptt -141.9 157.52 44.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 2.9300000000000002 110.742 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.5 144.34 39.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.934 0.397 . . . . 1.1299999999999999 111.746 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HB2' ' HG3' ' A' ' 140' ' ' LYS . 60.7 mttp -47.2 143.05 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.767 0.655 . . . . 2.7599999999999998 112.767 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 79.67 -21.8 4.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 114.858 -1.065 . . . . 0.32000000000000001 113.307 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HB3' ' CE ' ' A' ' 31' ' ' LYS . 80.7 mm-40 -81.39 160.65 24.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.708 -0.479 . . . . 2.1099999999999999 109.708 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.3 m -84.43 129.96 34.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.034 -0.667 . . . . 1.0800000000000001 110.679 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -100.39 117.43 34.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 1.0700000000000001 110.628 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.45 ' CE1' HG23 ' A' ' 94' ' ' THR . 80.0 t80 -79.61 119.85 23.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.67 0.619 . . . . 2.3199999999999998 112.67 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 37.3 mt -106.31 111.58 64.17 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.502 -0.925 . . . . 1.47 108.502 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 85.7 Cg_endo -85.26 131.71 4.26 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.385 2.056 . . . . 0.71999999999999997 115.648 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.9 t -141.36 130.0 22.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.461 -1.245 . . . . 1.03 108.254 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 33.0 mmtp -141.16 139.99 33.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.394 . . . . 2.2400000000000002 111.063 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 53.5 p90 -140.0 140.83 36.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 2.1499999999999999 110.75 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.406 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 4.7 p -82.04 138.64 34.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 1.9299999999999999 111.967 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.24 139.97 33.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 2.5899999999999999 110.275 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 p -152.49 151.1 26.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.843 0.354 . . . . 2.1299999999999999 110.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.34 -25.85 25.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.809 2.339 . . . . 1.9299999999999999 112.39 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 13.4 pt-20 -74.17 -39.99 62.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.494 -0.321 . . . . 2.1800000000000002 110.251 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.612 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -71.9 75.28 0.89 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.234 -0.654 . . . . 2.4100000000000001 109.234 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -91.98 -9.51 42.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.405 -0.816 . . . . 1.96 111.691 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.475 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.0 160.0 53.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.324 -0.941 . . . . 0.56000000000000005 112.317 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.24 148.56 59.77 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.423 2.082 . . . . 1.1899999999999999 111.619 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 99' ' ' LYS . 61.5 tp -77.69 131.6 37.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 2.4100000000000001 110.691 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.732 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 26.6 t0 -137.13 146.46 45.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.548 0.69 . . . . 1.78 110.951 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 40.9 mt -142.44 140.01 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.53 -1.214 . . . . 1.4099999999999999 109.121 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.832 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 96.0 mt-10 -140.02 148.81 42.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.944 -0.302 . . . . 1.6699999999999999 111.187 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.685 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 79.0 m95 -140.48 119.16 12.4 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.23999999999999999 110.828 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.5 mt -109.86 146.33 35.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.728 -0.669 . . . . 1.1200000000000001 109.314 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.0 136.17 59.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.19 0.519 . . . . 1.3700000000000001 112.267 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 70.1 m -119.66 103.84 45.7 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 1.73 108.854 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 85.1 Cg_endo -78.31 112.07 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.84999999999999998 112.613 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.75 87.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.177 -0.92 . . . . 1.0700000000000001 110.922 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -73.96 -40.48 62.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 1.8200000000000001 111.416 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 94.3 m-20 -85.12 159.99 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 2.3599999999999999 111.652 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -69.17 -19.88 64.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.95 111.173 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 57.7 mttt -70.0 150.63 46.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 2.2799999999999998 111.298 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.65 127.83 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-O 121.732 0.777 . . . . 1.4199999999999999 109.249 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 61.14 88.12 0.09 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.366 -1.288 . . . . 1.77 111.969 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.44 141.84 35.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.794 0.331 . . . . 2.54 111.219 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG13 HD11 ' A' ' 73' ' ' LEU . 61.7 t -71.74 129.38 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 1.3899999999999999 110.18 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.73 ' CD1' HG13 ' A' ' 91' ' ' VAL . 1.4 pp -130.3 -38.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.347 0.499 . . . . 1.8200000000000001 112.347 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.784 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 126.3 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.258 -0.645 . . . . 1.0800000000000001 109.258 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.602 ' HB3' ' HD2' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -140.8 159.98 41.03 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.487 -0.779 . . . . 1.8799999999999999 110.715 -178.048 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.742 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.2 t80 -134.86 103.75 5.73 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.997 -0.742 . . . . 2.2000000000000002 108.997 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.452 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 13.0 t -142.7 160.01 41.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 1.4199999999999999 111.45 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.52 13.75 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.691 -0.766 . . . . 0.56999999999999995 112.356 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.29 0.34 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.457 0.17 . . . . 1.46 111.307 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -100.05 114.27 27.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.739 -0.467 . . . . 2.96 109.739 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.604 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -79.4 134.02 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.107 -1.442 . . . . 2.27 107.107 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.73 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -118.8 127.72 53.8 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 2.1499999999999999 110.208 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.836 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.6 p-10 -165.82 -55.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.15 -1.426 . . . . 1.2 107.15 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 51.8 t0 -82.84 -27.54 30.75 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.785 -1.098 . . . . 2.1699999999999999 109.0 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.42 -30.04 61.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.7 -1.222 . . . . 5.4100000000000001 107.7 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.78 110.94 25.63 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.275 -1.33 . . . . 2.21 110.373 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.22 -43.12 13.29 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.843 1.695 . . . . 1.1100000000000001 111.505 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 95.9 m-20 -67.95 103.75 1.56 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.181 -0.463 . . . . 1.3600000000000001 111.274 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.735 ' HB3' ' NE ' ' A' ' 90' ' ' ARG . 40.4 mt 73.58 21.48 2.85 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.965 0.728 . . . . 2.2400000000000002 112.965 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.836 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.8 pttt -56.78 132.24 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.97 -0.456 . . . . 2.8700000000000001 111.44 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 90.27 10.74 63.7 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.289 -0.958 . . . . 0.48999999999999999 114.389 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.75 ' HG3' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -139.56 -49.73 0.49 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 114.781 1.4 . . . . 2.1099999999999999 114.781 -178.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.784 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.79 81.56 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.981 1.372 . . . . 1.04 107.462 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.451 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.8 m80 -102.71 129.25 49.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.342 -2.208 . . . . 0.34000000000000002 112.475 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.687 ' HA ' ' O ' ' A' ' 104' ' ' SER . 75.3 m-85 -70.34 126.25 29.12 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.084 -0.646 . . . . 2.1600000000000001 109.577 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.45 HG23 ' CE1' ' A' ' 38' ' ' TYR . 2.6 p -74.39 33.41 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.327 -0.851 . . . . 1.0900000000000001 112.693 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.9 t -149.16 140.03 22.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.1 0.476 . . . . 1.71 111.332 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -91.54 0.07 57.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.4700000000000002 110.648 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.61 67.45 1.17 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.294 0.568 . . . . 2.1400000000000001 109.506 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD22 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -56.99 -25.88 59.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 1.99 111.229 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HA ' HD21 ' A' ' 53' ' ' LEU . 63.6 mttt -64.93 1.28 0.95 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.165 0.507 . . . . 2.4900000000000002 112.297 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.7 p -89.99 0.06 57.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.561 -0.745 . . . . 1.8999999999999999 110.714 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.45 -8.75 32.72 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.40999999999999998 112.845 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -98.15 111.91 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.329 . . . . 1.4399999999999999 110.988 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.516 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -110.04 13.02 23.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.31 -0.404 . . . . 1.1200000000000001 111.424 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 54.5 m -59.98 140.0 57.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.389 1.625 . . . . 1.46 115.389 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.96 129.99 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.753 -1.112 . . . . 1.0900000000000001 110.511 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.5 p30 -106.52 154.91 20.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.243 -0.651 . . . . 1.5600000000000001 109.243 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -98.35 124.31 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 120.966 0.413 . . . . 1.0600000000000001 111.364 -178.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -88.01 143.59 27.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.702 -0.681 . . . . 1.0700000000000001 110.92 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.2 m120 50.66 60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 1.9399999999999999 111.888 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 31' ' ' LYS . 9.9 mt -45.37 176.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.445 0.64 . . . . 1.21 112.464 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -176.69 163.84 2.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.141 -0.936 . . . . 2.6699999999999999 110.082 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 115' ' ' ILE . 2.0 tm? -60.03 -36.42 77.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 2.2400000000000002 111.937 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -73.81 -14.43 61.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.056 0.391 . . . . 1.8300000000000001 112.056 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -71.18 -22.02 62.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.408 -0.517 . . . . 1.5800000000000001 109.698 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -46.52 142.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.988 -0.551 . . . . 1.1399999999999999 110.91 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.05 150.92 5.47 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.704 -1.236 . . . . 0.26000000000000001 114.218 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.0 m -59.78 135.86 57.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.768 -0.716 . . . . 1.0700000000000001 111.936 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 51.8 m-85 -120.0 139.68 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 2.1400000000000001 110.105 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 58.4 tt0 -127.0 120.16 28.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 1.5900000000000001 109.982 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 48.7 t -98.4 118.21 34.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.055 -0.258 . . . . 1.03 110.684 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.832 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 57.4 mttt -115.81 105.22 12.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 2.1899999999999999 111.008 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 89.5 t -95.34 108.18 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.41 -0.589 . . . . 1.8200000000000001 109.41 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 61.0 tttm -98.7 115.33 28.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.718 -0.793 . . . . 2.1899999999999999 112.118 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 50.0 tttm -145.65 102.35 3.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.483 -0.562 . . . . 3.2799999999999998 109.483 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.475 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -49.89 131.99 21.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 113.162 0.801 . . . . 1.1799999999999999 113.162 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.612 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 47.2 Cg_endo -100.07 37.59 5.91 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.625 -0.99 . . . . 0.62 111.627 -0.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.67 102.41 0.53 Allowed Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.313 -0.946 . . . . 0.53000000000000003 113.345 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.75 141.22 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 113.56 -1.32 . . . . 1.8700000000000001 109.357 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 22' ' ' ILE . . . -138.13 144.02 40.62 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.385 0.513 . . . . 1.3200000000000001 112.385 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 39.6 p-10 -146.26 140.41 26.49 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.587 . . . . 2.0299999999999998 110.783 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.9 164.13 32.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.582 -0.281 . . . . 3.46 111.517 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.2 mttt -99.75 140.12 34.41 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.667 0.988 . . . . 2.6699999999999999 113.667 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 2.6 mp -140.57 111.91 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.926 -1.034 . . . . 1.0600000000000001 109.072 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -101.03 120.02 39.58 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.596 -0.442 . . . . 0.70999999999999996 111.235 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 59.5 tp -91.02 123.5 34.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.017 -0.538 . . . . 2.1000000000000001 111.884 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -119.95 121.45 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 1.0900000000000001 109.464 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 33' ' ' LYS . 12.1 p -93.9 131.3 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 1.72 111.92 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.5 mt -86.55 149.98 24.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 1.21 109.722 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -78.18 134.82 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.773 0.797 . . . . 2.0899999999999999 111.709 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.819 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.21 176.55 1.99 Allowed Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.26 -1.336 . . . . 2.7599999999999998 108.713 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.819 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 7.9 Cg_endo -49.38 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.21 1.94 . . . . 1.4199999999999999 112.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 141' ' ' PRO . 49.1 m -26.89 -76.22 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.993 0.368 . . . . 2.6899999999999999 111.993 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.514 ' HA3' ' HD2' ' A' ' 140' ' ' LYS . . . 53.93 55.56 25.21 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.846 -0.692 . . . . 2.8799999999999999 113.757 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.208 -0.901 . . . . 2.6000000000000001 111.038 179.821 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.644 -0.182 . . . . 3.6600000000000001 112.644 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 66.8 m -76.84 149.96 36.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 2.8100000000000001 111.024 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.6 m -77.72 133.66 38.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.223 0.535 . . . . 2.2599999999999998 111.658 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -140.01 140.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.369 -0.832 . . . . 2.6299999999999999 109.987 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.35 149.52 22.27 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.541 0.686 . . . . 1.6499999999999999 111.365 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.5 83.12 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-N 114.657 -1.156 . . . . 1.26 111.232 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 56.1 Cg_endo -78.21 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.645 2.897 . . . . 0.88 112.278 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.41 127.59 32.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.555 -0.906 . . . . 2.0600000000000001 108.555 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' LYS . 83.4 tt0 -143.85 160.0 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.098 1.147 . . . . 1.71 114.098 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.0 mtt -139.73 122.8 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.586 -1.188 . . . . 2.3999999999999999 109.311 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.01 123.5 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 1.1499999999999999 111.607 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.58 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.2 mt-10 -113.79 123.78 50.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.339 -0.391 . . . . 1.1899999999999999 110.421 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.4 mmtt -141.56 154.61 45.56 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.087 0.403 . . . . 2.9300000000000002 112.087 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.2 143.25 39.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 1.1299999999999999 112.219 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 140' ' ' LYS . 54.9 mtpt -48.81 143.22 5.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.295 0.569 . . . . 2.7599999999999998 112.422 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 144' ' ' ALA . . . 79.53 -23.86 3.34 Favored Glycine 0 CA--C 1.516 0.13 0 CA-C-N 115.185 -0.916 . . . . 0.32000000000000001 113.545 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 7.2 mm-40 -80.01 160.09 25.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.403 -0.592 . . . . 2.1099999999999999 109.403 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.1 m -85.72 129.99 34.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.965 -0.694 . . . . 1.0800000000000001 109.991 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -97.73 118.78 35.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 1.0700000000000001 110.983 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.563 ' HE1' HG22 ' A' ' 94' ' ' THR . 83.0 t80 -79.53 129.98 34.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.49 -0.777 . . . . 2.3199999999999998 112.223 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.6 104.5 30.91 Favored Pre-proline 0 C--N 1.333 -0.138 0 N-CA-C 108.903 -0.777 . . . . 1.47 108.903 178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 91.7 Cg_endo -79.76 129.61 8.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.495 2.13 . . . . 0.71999999999999997 114.658 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 11.6 t -141.37 125.24 17.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.712 -1.131 . . . . 1.03 108.963 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -140.65 144.78 35.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.771 -0.65 . . . . 2.2400000000000002 109.838 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.2 p90 -140.03 141.24 36.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.794 -0.639 . . . . 2.1499999999999999 112.21 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -88.91 139.86 30.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.654 . . . . 1.9299999999999999 110.481 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -96.84 110.0 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.621 -0.263 . . . . 2.5899999999999999 110.744 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -84.52 137.74 38.83 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.843 -0.429 . . . . 2.1299999999999999 109.843 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -44.89 -34.21 8.38 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.755 1.637 . . . . 1.9299999999999999 111.035 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.06 -40.03 47.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.403 -0.817 . . . . 2.1800000000000002 111.014 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 91.7 m-20 -72.76 73.8 1.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.304 -0.558 . . . . 2.4100000000000001 109.587 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.23 -0.02 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.889 -0.596 . . . . 1.96 112.235 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.07 161.92 52.99 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.56000000000000005 113.159 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.87 137.86 60.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.695 2.264 . . . . 1.1899999999999999 112.21 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.507 ' HG ' ' CD ' ' A' ' 124' ' ' LYS . 2.3 mt -78.59 106.8 10.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 2.4100000000000001 112.137 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.667 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.5 m-20 -119.36 102.41 8.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.519 0.676 . . . . 1.78 110.921 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.847 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 6.7 mt -99.04 111.39 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.873 -1.058 . . . . 1.4099999999999999 111.029 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' HD13 ' A' ' 73' ' ' LEU . 84.8 tt0 -107.43 120.69 42.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.278 0.844 . . . . 1.6699999999999999 113.278 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.664 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 76.0 m95 -94.82 119.99 34.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.352 -0.385 . . . . 0.23999999999999999 110.127 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.0 mt -103.82 141.11 36.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.529 -0.545 . . . . 1.1200000000000001 109.529 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.6 tt -130.01 138.06 54.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.072 0.767 . . . . 1.3700000000000001 113.072 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -132.02 102.96 14.37 Favored Pre-proline 0 N--CA 1.455 -0.195 0 CA-C-N 115.199 -0.909 . . . . 1.73 109.503 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 6.3 Cg_exo -80.17 122.06 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.587 2.191 . . . . 0.84999999999999998 112.38 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.73 73.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.207 0.527 . . . . 1.0700000000000001 110.45 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.76 13.12 7.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.405 -0.816 . . . . 1.8200000000000001 112.066 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 81.9 m-20 -145.67 160.01 42.32 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.385 0.612 . . . . 2.3599999999999999 112.04 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -68.96 -19.47 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.008 -0.996 . . . . 1.95 112.316 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.615 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.8 mtpt -67.71 140.03 56.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.042 0.448 . . . . 2.2799999999999998 111.531 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.73 129.08 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 CA-C-O 121.935 0.874 . . . . 1.4199999999999999 109.546 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 34.71 21.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.031 -1.44 . . . . 1.77 111.858 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.76 142.16 27.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.492 -0.322 . . . . 2.54 110.56 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 6.1 t -66.25 131.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.731 -0.47 . . . . 1.3899999999999999 109.731 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.825 ' CD1' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -124.24 -50.58 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.64 0.607 . . . . 1.8200000000000001 112.64 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.042 ' HB ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.04 125.79 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.792 -0.818 . . . . 1.0800000000000001 108.792 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.06 159.97 40.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 116.172 -0.467 . . . . 1.8799999999999999 110.211 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 16.4 t80 -136.34 109.15 7.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 2.2000000000000002 110.328 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 8.6 p -142.86 160.05 41.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.631 -0.713 . . . . 1.4199999999999999 111.561 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.56 39.22 53.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.728 -0.749 . . . . 0.56999999999999995 112.477 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.9 t0 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.026 0.441 . . . . 1.46 110.515 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 89.7 mttt -131.33 108.94 10.0 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.96 110.631 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.601 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -79.89 118.51 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 107.125 -1.435 . . . . 2.27 107.125 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.752 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.3 m-85 -100.79 136.11 41.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.795 -1.093 . . . . 2.1499999999999999 110.612 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.786 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 13.9 p-10 -166.37 -55.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.854 -1.165 . . . . 1.2 107.854 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 12.5 t70 -79.26 -18.66 52.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.101 -0.954 . . . . 2.1699999999999999 109.209 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.35 -28.26 34.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.55 -0.907 . . . . 5.4100000000000001 108.55 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -85.8 114.28 55.99 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 114.949 -1.023 . . . . 2.21 111.161 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.28 -42.36 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.611 1.541 . . . . 1.1100000000000001 110.595 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.692 ' O ' HG12 ' A' ' 71' ' ' ILE . 3.4 m-20 -66.99 104.88 1.48 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.252 -0.579 . . . . 1.3600000000000001 110.639 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.783 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 25.9 mt 67.43 23.29 9.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.826 1.047 . . . . 2.2400000000000002 113.826 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -54.84 128.63 33.97 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.601 -0.687 . . . . 2.8700000000000001 111.127 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.79 10.59 56.37 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.159 -1.02 . . . . 0.48999999999999999 114.502 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.783 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -142.1 -46.43 0.35 Allowed 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 114.55 1.315 . . . . 2.1099999999999999 114.55 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.042 HG12 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -79.95 80.89 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-O 123.251 1.501 . . . . 1.04 107.173 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -98.78 132.06 44.43 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.258 -2.246 . . . . 0.34000000000000002 111.615 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 66.6 m-85 -72.41 121.07 18.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.895 0.855 . . . . 2.1600000000000001 111.222 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.563 HG22 ' HE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -69.48 -11.69 61.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.069 -1.423 . . . . 1.0900000000000001 109.914 178.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.8 m -95.22 120.01 34.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.025 -0.534 . . . . 1.71 110.929 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -90.64 4.82 50.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 110.422 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -146.19 67.02 1.19 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.802 -0.814 . . . . 2.1400000000000001 108.802 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.1 mp -59.05 -35.04 72.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.216 -0.902 . . . . 1.99 111.886 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.93 -5.35 4.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 2.4900000000000002 111.843 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -90.04 0.03 57.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.349 -0.841 . . . . 1.8999999999999999 110.963 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.01 -20.02 34.17 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.682 -0.771 . . . . 0.40999999999999998 113.737 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.5 m-20 -96.04 109.34 21.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.361 0.58 . . . . 1.4399999999999999 110.414 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -114.86 25.58 10.83 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.816 0.673 . . . . 1.1200000000000001 112.816 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 43.4 t -59.95 146.15 43.47 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.27 1.582 . . . . 1.46 115.27 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.53 139.97 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 114.217 -1.356 . . . . 1.0900000000000001 110.788 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.559 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -118.18 148.51 42.29 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.302 -0.999 . . . . 1.5600000000000001 108.302 177.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.88 121.56 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 120.967 0.413 . . . . 1.0600000000000001 111.26 -178.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -84.06 145.7 28.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.514 -0.767 . . . . 1.0700000000000001 111.298 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.64 61.78 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.978 -0.555 . . . . 1.9399999999999999 112.424 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 31' ' ' LYS . 9.7 mt -46.86 173.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.322 0.582 . . . . 1.21 112.336 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -177.38 163.55 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 2.6699999999999999 110.137 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.06 -38.29 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.277 -0.419 . . . . 2.2400000000000002 111.99 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.7 t -73.11 -14.21 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.11 0.411 . . . . 1.8300000000000001 112.11 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -72.83 -20.09 61.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.699 -0.4 . . . . 1.5800000000000001 110.183 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.45 146.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.202 -0.454 . . . . 1.1399999999999999 110.953 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.36 147.0 4.92 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 119.923 -1.132 . . . . 0.26000000000000001 113.788 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 47.2 m -59.27 138.3 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.378 -0.411 . . . . 1.0700000000000001 111.755 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.6 m-85 -119.95 131.08 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 2.1400000000000001 109.792 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -121.56 119.88 33.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.048 -0.261 . . . . 1.5900000000000001 110.383 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.454 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.7 t -99.51 111.17 23.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.578 -0.283 . . . . 1.03 110.455 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.847 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 74.3 mttt -106.61 104.74 14.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 2.1899999999999999 110.812 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 43' ' ' PHE . 24.0 t -89.3 110.12 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 109.212 -0.662 . . . . 1.8200000000000001 109.212 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.667 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 87.8 tttt -95.79 122.92 39.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.309 0.855 . . . . 2.1899999999999999 113.309 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 3.9 mmtt -141.6 101.43 3.98 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.892 -0.781 . . . . 3.2799999999999998 108.892 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -54.34 132.61 61.87 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 112.507 0.558 . . . . 1.1799999999999999 112.507 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.524 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 81.0 Cg_endo -100.0 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.646 -0.981 . . . . 0.62 112.667 -0.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.3 103.38 0.29 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.696 -0.764 . . . . 0.53000000000000003 112.971 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 151.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.623 -0.788 . . . . 1.8700000000000001 110.087 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.86 152.13 43.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.218 . . . . 1.3200000000000001 111.535 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.484 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 17.6 p30 -146.49 151.9 38.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.05 0.389 . . . . 2.0299999999999998 112.05 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.15 161.23 40.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.106 -0.497 . . . . 3.46 111.191 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 39.4 mttp -102.82 140.01 37.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.625 0.972 . . . . 2.6699999999999999 113.625 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 87.7 mt -143.83 110.66 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.372 -0.973 . . . . 1.0600000000000001 108.372 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -98.46 120.01 38.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.70999999999999996 111.391 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -86.87 124.26 32.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 2.1000000000000001 111.225 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.58 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.3 t -119.29 126.93 75.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.582 -0.735 . . . . 1.0900000000000001 109.433 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 33' ' ' LYS . 18.2 t -96.33 126.76 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.72 112.054 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.2 mt -87.7 145.7 26.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.078 -0.712 . . . . 1.21 109.078 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.43 134.82 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.249 1.023 . . . . 2.0899999999999999 112.872 -178.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.702 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.03 169.97 6.9 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.295 -1.775 . . . . 2.7599999999999998 109.174 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 2.2 Cg_endo -40.27 167.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.847 2.365 . . . . 1.4199999999999999 112.535 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 144' ' ' ALA . 0.4 OUTLIER -33.08 -79.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.175 0.435 . . . . 2.6899999999999999 112.175 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.58 -66.49 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.091 -0.504 . . . . 2.8799999999999999 113.538 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.407 -0.806 . . . . 2.6000000000000001 111.812 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.582 -0.207 . . . . 3.6600000000000001 112.582 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -159.51 150.02 19.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 2.8100000000000001 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t -76.98 152.39 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.2599999999999998 111.562 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 42' ' ' LYS . 19.2 tt -139.51 134.99 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 2.6299999999999999 110.399 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.43 156.91 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.515 0.674 . . . . 1.6499999999999999 111.706 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.54 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.31 83.25 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.576 -1.193 . . . . 1.26 111.695 -178.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.692 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 59.3 Cg_endo -78.26 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.404 2.736 . . . . 0.88 112.6 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.59 125.55 29.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.072 -0.714 . . . . 2.0600000000000001 109.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB3' HG12 ' A' ' 133' ' ' ILE . 83.7 tt0 -144.33 163.95 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.846 1.054 . . . . 1.71 113.846 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.4 ttm -138.72 139.4 38.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.72 -1.127 . . . . 2.3999999999999999 109.117 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 135' ' ' LEU . 34.3 mm -132.72 139.37 49.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.214 0.449 . . . . 1.1499999999999999 112.214 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 21.9 pt-20 -140.23 124.63 17.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 1.1899999999999999 110.567 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.5 mmtt -142.3 163.41 32.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.522 -0.308 . . . . 2.9300000000000002 111.597 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.62 139.57 40.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 1.1299999999999999 111.467 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 86.9 tttt -48.35 130.35 16.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 2.7599999999999998 111.762 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.79 -19.15 47.02 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.32000000000000001 112.695 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 99.2 mt-10 -79.99 160.01 26.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.37 -0.974 . . . . 2.1099999999999999 108.37 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.861 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 42.0 m -88.43 128.51 35.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.566 -0.853 . . . . 1.0800000000000001 110.352 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.451 ' N ' HD13 ' A' ' 110' ' ' LEU . . . -99.8 113.92 26.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 1.0700000000000001 110.522 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.501 ' CE2' HG22 ' A' ' 94' ' ' THR . 29.0 t80 -79.53 129.89 34.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.908 -0.587 . . . . 2.3199999999999998 112.387 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 4.1 mp -120.17 107.64 39.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.424 -0.954 . . . . 1.47 108.424 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.528 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.0 Cg_endo -82.8 104.66 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.451 2.101 . . . . 0.71999999999999997 115.944 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -105.58 126.12 51.77 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.165 -1.05 . . . . 1.03 108.165 175.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mttm -140.72 139.37 34.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.176 0.512 . . . . 2.2400000000000002 110.992 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 40.8 p90 -141.11 150.04 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.415 -0.811 . . . . 2.1499999999999999 111.028 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 t -80.1 170.74 16.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.9299999999999999 111.177 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.19 141.19 40.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 2.5899999999999999 111.03 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 79.5 p -159.99 158.63 26.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.847 -0.615 . . . . 2.1299999999999999 110.212 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 13.1 Cg_endo -56.24 -17.64 21.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.433 2.089 . . . . 1.9299999999999999 112.88 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -73.33 -43.72 60.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.685 0.278 . . . . 2.1800000000000002 110.534 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.46 76.63 1.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.069 -0.715 . . . . 2.4100000000000001 109.069 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.13 -11.54 43.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 1.96 111.773 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -72.6 157.59 52.73 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.222 -0.989 . . . . 0.56000000000000005 112.29 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.81 150.9 27.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.334 2.022 . . . . 1.1899999999999999 111.321 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.731 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 4.1 mp -77.61 133.06 38.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.893 0.377 . . . . 2.4100000000000001 110.845 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.74 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 21.9 t0 -140.24 146.84 39.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.361 0.6 . . . . 1.78 111.753 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.711 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 6.6 mt -143.79 135.0 22.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.774 -1.103 . . . . 1.4099999999999999 109.422 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -140.61 119.9 12.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.668 0.667 . . . . 1.6699999999999999 112.667 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.712 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 83.0 m95 -100.2 124.85 46.12 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.174 -0.466 . . . . 0.23999999999999999 111.377 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.0 mt -106.87 120.34 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.843 -0.429 . . . . 1.1200000000000001 109.843 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 117' ' ' THR . 10.3 tt -104.06 124.42 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.506 0.558 . . . . 1.3700000000000001 112.506 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.8 m -118.33 101.9 50.8 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.302 -0.999 . . . . 1.73 108.302 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.621 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 98.9 Cg_endo -79.56 115.52 3.41 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.597 2.198 . . . . 0.84999999999999998 112.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 1.0700000000000001 110.944 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.94 -39.96 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 1.8200000000000001 111.8 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.538 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.4 m120 -85.43 161.87 19.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.39 0.614 . . . . 2.3599999999999999 112.28 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.63 -18.48 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.091 -0.958 . . . . 1.95 111.741 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.621 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -68.49 150.91 47.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.906 -0.588 . . . . 2.2799999999999998 111.333 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.59 127.69 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.113 0 CA-C-O 121.893 0.854 . . . . 1.4199999999999999 109.988 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 55.89 40.05 30.57 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 114.074 -1.421 . . . . 1.77 112.727 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.411 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.3 mt-30 -94.32 145.05 25.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.192 -0.203 . . . . 2.54 110.75 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.539 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 18.4 t -66.68 125.95 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.064 0.459 . . . . 1.3899999999999999 109.883 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -116.21 -53.72 4.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 1.8200000000000001 111.923 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.707 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.73 124.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.2 -1.037 . . . . 1.0800000000000001 108.2 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 6.1 tt -135.32 157.09 47.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.806 -0.633 . . . . 1.8799999999999999 109.772 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.882 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 12.1 t80 -136.91 104.08 5.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.758 -0.46 . . . . 2.2000000000000002 109.758 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -143.15 158.26 43.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 1.4199999999999999 111.678 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.58 28.58 45.8 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.732 -0.747 . . . . 0.56999999999999995 112.472 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.53 2.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.545 0.212 . . . . 1.46 111.107 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 68.2 mttm -100.01 113.24 25.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 110.08 -0.341 . . . . 2.96 110.08 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.882 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.87 116.52 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.879 -1.156 . . . . 2.27 107.879 177.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.2 m-85 -100.03 128.19 46.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.819 -1.537 . . . . 2.1499999999999999 110.908 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.739 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.2 p-10 -166.14 -53.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.222 -1.029 . . . . 1.2 108.222 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.8 t70 -80.17 -24.33 40.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.09 -0.959 . . . . 2.1699999999999999 109.371 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.25 -29.1 42.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.118 -0.946 . . . . 5.4100000000000001 108.5 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.539 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -82.35 115.9 60.57 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-N 114.795 -1.093 . . . . 2.21 110.552 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.2 Cg_endo -46.81 -40.99 25.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.729 1.619 . . . . 1.1100000000000001 110.373 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.712 ' O ' HG12 ' A' ' 71' ' ' ILE . 67.1 m-20 -66.98 105.22 1.57 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.824 -0.626 . . . . 1.3600000000000001 110.653 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.829 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.2 mt 68.02 24.56 7.82 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.862 1.06 . . . . 2.2400000000000002 113.862 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttt -55.61 127.5 30.18 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.627 -0.671 . . . . 2.8700000000000001 111.219 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.63 15.12 54.03 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.385 -0.912 . . . . 0.48999999999999999 114.451 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.829 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp180 -144.14 -48.03 0.27 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 114.483 1.29 . . . . 2.1099999999999999 114.483 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.23 81.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.864 1.316 . . . . 1.04 107.725 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -102.93 129.14 49.55 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.474 -2.148 . . . . 0.34000000000000002 112.326 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 77.0 m-85 -70.97 120.77 17.03 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 109.097 -0.705 . . . . 2.1600000000000001 109.097 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 38' ' ' TYR . 24.6 p -70.43 -10.01 57.97 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.22 -0.9 . . . . 1.0900000000000001 110.455 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.2 m -93.16 121.46 34.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.848 -0.615 . . . . 1.71 110.259 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.11 2.48 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.1 0.476 . . . . 2.4700000000000002 110.344 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -146.07 66.81 1.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.849 -0.797 . . . . 2.1400000000000001 108.849 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' A' ' 74' ' ' TYR . 5.9 mp -56.74 -28.98 62.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 1.99 111.466 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -62.81 -6.23 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 2.4900000000000002 111.809 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -87.55 -3.11 59.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.309 -0.86 . . . . 1.8999999999999999 110.733 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.64 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.57 -12.97 32.93 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.779 -0.724 . . . . 0.40999999999999998 113.702 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -95.09 110.03 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.192 0.496 . . . . 1.4399999999999999 110.429 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -108.83 16.38 22.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.294 -0.412 . . . . 1.1200000000000001 111.916 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 6.0 m -60.16 140.02 57.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 116.104 1.891 . . . . 1.46 116.104 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.82 135.53 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.291 -1.322 . . . . 1.0900000000000001 110.587 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.59 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.0 p-10 -111.95 145.05 40.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.326 -0.99 . . . . 1.5600000000000001 108.326 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.861 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.03 120.02 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.063 0.459 . . . . 1.0600000000000001 111.443 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -83.15 143.96 30.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.369 -0.832 . . . . 1.0700000000000001 110.64 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 81.3 m-20 49.92 56.52 7.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.156 0.503 . . . . 1.9399999999999999 111.359 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 31' ' ' LYS . 21.4 mt -46.38 90.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.986 1.106 . . . . 1.21 113.986 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 47.5 mt-30 -56.58 149.03 18.27 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.948 -0.569 . . . . 2.6699999999999999 110.468 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.96 -37.05 78.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.28 -0.637 . . . . 2.2400000000000002 109.28 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.55 -5.63 43.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 1.8300000000000001 111.542 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 90.0 m-20 -70.08 -19.18 63.28 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.615 -0.513 . . . . 1.5800000000000001 109.615 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -43.14 137.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 116.001 -0.545 . . . . 1.1399999999999999 110.452 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.04 158.8 7.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.893 -1.146 . . . . 0.26000000000000001 114.145 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.4 m -60.48 140.0 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.751 -0.724 . . . . 1.0700000000000001 112.709 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 32.8 m-85 -125.12 125.38 43.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.023 -0.732 . . . . 2.1400000000000001 109.023 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 24.6 tt0 -120.01 118.96 32.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.943 -0.303 . . . . 1.5900000000000001 110.727 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.464 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.2 t -97.81 118.58 34.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.999 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 31.9 mttm -114.07 106.38 14.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 2.1899999999999999 110.858 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 48.9 t -92.18 104.67 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.229 -0.656 . . . . 1.8200000000000001 109.229 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 85.5 tttt -96.99 120.12 36.75 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.009 -0.676 . . . . 2.1899999999999999 112.65 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 10.3 mtmp? -141.81 102.87 4.25 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.693 -0.484 . . . . 3.2799999999999998 109.693 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.491 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.01 131.96 22.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 1.1799999999999999 111.654 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 44.1 Cg_endo -101.89 46.83 2.26 Favored 'Cis proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.986 -0.839 . . . . 0.62 111.69 -0.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.07 103.56 0.28 Allowed Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.328 -0.939 . . . . 0.53000000000000003 113.679 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.33 149.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.691 -0.754 . . . . 1.8700000000000001 109.666 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -141.79 144.62 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.587 0.232 . . . . 1.3200000000000001 111.47 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 44.7 p-10 -146.72 148.6 32.16 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.316 0.487 . . . . 2.0299999999999998 112.316 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.692 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.31 160.72 41.09 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.018 -0.537 . . . . 3.46 110.698 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 99.1 mttt -103.22 136.14 43.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.282 0.845 . . . . 2.6699999999999999 113.282 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.758 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 91.1 mt -145.24 113.47 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 108.708 -0.849 . . . . 1.0600000000000001 108.708 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.4 175.4 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.076 -0.65 . . . . 0.70999999999999996 109.907 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 54.5 tp -144.07 133.05 22.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 112.255 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.4 t -129.98 129.99 65.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.383 -0.826 . . . . 1.0900000000000001 109.515 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 33.4 t -97.09 124.84 50.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.915 0.388 . . . . 1.72 111.67 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.8 mt -80.87 157.72 25.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.433 -0.58 . . . . 1.21 109.433 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.64 130.53 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 2.0899999999999999 111.106 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.747 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 10.0 ptmt -165.5 176.96 1.76 Allowed Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 114.691 -1.14 . . . . 2.7599999999999998 109.418 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.747 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 4.3 Cg_endo -46.66 174.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.094 1.863 . . . . 1.4199999999999999 112.103 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 p -34.59 -79.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.043 0.386 . . . . 2.6899999999999999 112.043 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.38 -5.64 2.89 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.027 -0.606 . . . . 2.8799999999999999 113.748 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.235 -0.888 . . . . 2.6000000000000001 111.156 -179.846 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.768 -0.133 . . . . 3.6600000000000001 112.768 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -78.45 138.07 38.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 2.8100000000000001 111.036 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -74.13 149.98 40.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 2.2599999999999998 110.926 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -144.56 144.08 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 2.6299999999999999 110.991 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.455 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -99.48 139.95 34.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.744 0.783 . . . . 1.6499999999999999 112.025 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.95 81.11 0.27 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.344 -1.298 . . . . 1.26 112.109 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 76.1 Cg_endo -79.62 -11.03 14.33 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 124.344 3.363 . . . . 0.88 113.338 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -140.67 125.26 17.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.546 -0.909 . . . . 2.0600000000000001 108.546 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 83.4 tt0 -144.28 162.87 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 114.595 1.332 . . . . 1.71 114.595 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 54.8 ttm -137.92 137.12 37.7 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.491 -1.232 . . . . 2.3999999999999999 109.197 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.0 mm -134.5 139.99 46.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.269 -0.423 . . . . 1.1499999999999999 111.688 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 39.4 mt-10 -137.6 119.28 15.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.368 -0.378 . . . . 1.1899999999999999 110.295 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 31.0 tptt -142.07 158.64 43.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.665 -0.243 . . . . 2.9300000000000002 110.978 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -76.89 143.95 39.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.136 0.493 . . . . 1.1299999999999999 112.242 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 35.2 ttpt -48.93 131.18 18.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.799 -0.637 . . . . 2.7599999999999998 111.864 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.77 -19.84 38.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.32000000000000001 112.488 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.7 mt-10 -79.9 158.43 26.68 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.239 -1.023 . . . . 2.1099999999999999 108.239 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.81 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.0 m -88.4 128.92 35.53 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.511 -0.876 . . . . 1.0800000000000001 110.976 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 110' ' ' LEU . . . -99.98 117.7 34.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 1.0700000000000001 110.531 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CE2' ' CG2' ' A' ' 94' ' ' THR . 31.4 t80 -79.42 112.82 17.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.937 -0.574 . . . . 2.3199999999999998 111.712 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 40.6 mt -99.09 107.59 44.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.436 -0.95 . . . . 1.47 108.436 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 95.4 Cg_endo -82.69 134.52 7.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.213 1.942 . . . . 0.71999999999999997 114.4 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.52 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 1.8 t -140.42 130.07 24.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.477 -1.238 . . . . 1.03 107.841 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 22' ' ' ILE . 30.3 mmtp -140.42 137.05 33.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.979 0.418 . . . . 2.2400000000000002 110.94 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 53.2 p90 -140.28 154.25 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 2.1499999999999999 110.976 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -80.02 169.96 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 1.9299999999999999 111.835 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.0 tp -139.98 132.78 29.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.378 -0.828 . . . . 2.5899999999999999 110.625 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -157.18 156.09 28.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 2.1299999999999999 110.498 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.96 -19.21 31.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.442 2.094 . . . . 1.9299999999999999 112.529 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 12.6 pt-20 -75.44 -40.61 57.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.718 -0.219 . . . . 2.1800000000000002 110.84 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.4 OUTLIER -72.29 75.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.238 -0.585 . . . . 2.4100000000000001 109.452 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -91.65 -4.47 55.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 1.96 112.292 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -82.71 146.65 24.6 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 119.814 -1.184 . . . . 0.56000000000000005 112.292 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.1 131.08 44.25 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.153 1.902 . . . . 1.1899999999999999 111.393 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.735 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 1.1 pt? -77.64 133.77 38.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 2.4100000000000001 111.532 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 76.7 m-20 -134.38 102.38 5.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.819 0.819 . . . . 1.78 110.556 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.735 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 4.7 mt -92.36 108.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.225 -1.352 . . . . 1.4099999999999999 110.564 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' HG3' HD13 ' A' ' 73' ' ' LEU . 85.6 tt0 -106.52 117.56 34.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.409 0.522 . . . . 1.6699999999999999 112.409 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.691 ' HB2' HG21 ' A' ' 72' ' ' ILE . 74.3 m95 -94.66 119.95 34.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.226 -0.287 . . . . 0.23999999999999999 110.226 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.6 mt -107.69 143.88 35.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.958 -0.386 . . . . 1.1200000000000001 109.958 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 114' ' ' ASP . 11.1 tt -129.99 130.0 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 1.3700000000000001 112.05 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.448 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.1 m -117.57 102.82 51.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.888 -0.782 . . . . 1.73 108.888 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.652 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 72.0 Cg_endo -78.37 107.68 2.34 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.349 2.032 . . . . 0.84999999999999998 112.979 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.19 70.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.956 -1.02 . . . . 1.0700000000000001 110.365 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 5.7 p-10 -87.42 17.27 4.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.644 -0.707 . . . . 1.8200000000000001 111.204 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -152.86 162.61 41.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.208 0.528 . . . . 2.3599999999999999 111.837 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -67.19 -19.92 65.64 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.372 -0.831 . . . . 1.95 112.258 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.652 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 62.8 mttp -70.06 152.09 44.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.263 -0.426 . . . . 2.2799999999999998 111.321 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.8 128.67 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 CA-C-O 121.773 0.797 . . . . 1.4199999999999999 109.614 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.95 44.74 25.18 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.339 -1.301 . . . . 1.77 112.289 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' O ' HG23 ' A' ' 59' ' ' ILE . 90.6 mm-40 -87.29 134.54 33.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 2.54 111.036 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 84' ' ' TYR . 65.6 t -70.8 130.05 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.524 -0.307 . . . . 1.3899999999999999 110.682 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.719 HD12 ' CG2' ' A' ' 72' ' ' ILE . 1.4 pp -130.15 -37.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.836 0.68 . . . . 1.8200000000000001 112.836 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -141.12 122.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.698 -0.482 . . . . 1.0800000000000001 109.698 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.26 161.71 37.02 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.045 -0.525 . . . . 1.8799999999999999 110.221 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.611 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 47.1 t80 -132.46 111.02 10.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.884 0.373 . . . . 2.2000000000000002 110.615 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 15.2 t -142.34 158.05 44.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.788 -0.642 . . . . 1.4199999999999999 111.576 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.69 33.53 42.09 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.827 -0.701 . . . . 0.56999999999999995 112.324 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER 70.01 10.16 7.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.711 0.291 . . . . 1.46 110.866 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 58.5 mttm -108.84 111.65 23.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.37 -0.377 . . . . 2.96 111.181 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.611 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.05 117.84 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.752 -1.574 . . . . 2.27 106.752 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.798 ' O ' HG12 ' A' ' 72' ' ' ILE . 7.2 m-85 -100.05 130.12 46.17 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.839 -1.073 . . . . 2.1499999999999999 110.648 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.795 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.2 p-10 -165.99 -56.81 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.358 -1.719 . . . . 1.2 106.358 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -78.43 -24.52 46.08 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 114.416 -1.266 . . . . 2.1699999999999999 108.894 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.523 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -76.99 -29.97 55.73 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.396 -1.335 . . . . 5.4100000000000001 107.396 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 1.2 m-85 -86.24 113.31 51.5 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 114.423 -1.262 . . . . 2.21 109.919 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.04 -36.2 90.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.902 1.735 . . . . 1.1100000000000001 112.948 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 58.2 m-20 -49.99 -29.99 9.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.298 0.851 . . . . 1.3600000000000001 113.298 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.857 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 2.0 mp -151.74 30.19 0.59 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.874 -0.603 . . . . 2.2400000000000002 111.467 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.795 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 40.5 pttt -58.96 137.75 57.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.996 -0.682 . . . . 2.8700000000000001 111.899 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 81.15 13.83 80.2 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.598 -0.728 . . . . 0.48999999999999999 114.175 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.857 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.4 ptm85 -142.23 -56.65 0.45 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 114.922 1.453 . . . . 2.1099999999999999 114.922 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.747 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -78.21 80.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 123.059 1.409 . . . . 1.04 107.358 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.461 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 8.0 m80 -98.89 127.07 44.72 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.161 -2.29 . . . . 0.34000000000000002 112.797 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 71.6 m-85 -68.66 125.53 26.83 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 120.1 -0.64 . . . . 2.1600000000000001 109.298 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.533 ' CG2' ' CE2' ' A' ' 38' ' ' TYR . 6.6 p -74.15 28.24 0.08 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.514 -0.766 . . . . 1.0900000000000001 112.644 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 93' ' ' PHE . 4.9 t -148.7 137.64 21.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.13 0.491 . . . . 1.71 110.948 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -92.73 3.72 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.569 -0.741 . . . . 2.4700000000000002 110.73 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -146.49 66.95 1.17 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.95 -0.759 . . . . 2.1400000000000001 108.95 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' A' ' 93' ' ' PHE . 9.3 mp -57.87 -24.66 58.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.114 -0.948 . . . . 1.99 111.637 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -64.16 0.59 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.224 0.453 . . . . 2.4900000000000002 112.224 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -90.02 -0.03 57.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.682 -0.69 . . . . 1.8999999999999999 110.832 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.73 -13.7 42.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.40999999999999998 112.557 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -96.14 108.39 20.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.115 -0.328 . . . . 1.4399999999999999 110.115 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -112.54 15.53 20.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.18 0.437 . . . . 1.1200000000000001 112.18 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 27.9 p -61.31 147.77 43.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.354 1.613 . . . . 1.46 115.354 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -134.47 130.33 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.291 -1.322 . . . . 1.0900000000000001 111.211 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.539 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -103.37 143.58 32.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.602 -0.888 . . . . 1.5600000000000001 108.602 177.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.81 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.68 124.45 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 120.891 0.377 . . . . 1.0600000000000001 111.637 -178.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.617 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.8 p -85.67 145.14 27.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 1.0700000000000001 110.874 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 98.5 m-20 50.57 57.28 6.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.063 0.459 . . . . 1.9399999999999999 111.878 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 25.1 mt -45.66 85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.727 1.38 . . . . 1.21 114.727 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.47 ' H ' HH22 ' A' ' 90' ' ' ARG . 63.9 tt0 -59.98 147.89 37.27 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.668 -0.696 . . . . 2.6699999999999999 110.416 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.61 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 94.1 mt -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.054 0.39 . . . . 2.2400000000000002 112.054 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.403 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 23.3 t -70.82 -14.96 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 1.8300000000000001 111.567 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.551 ' O ' HD13 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -70.16 -19.15 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.384 -0.599 . . . . 1.5800000000000001 109.384 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 30.2 mt -45.68 138.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.1399999999999999 110.057 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.77 163.68 9.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 119.95 -1.119 . . . . 0.26000000000000001 113.876 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.487 HG22 ' CD2' ' A' ' 134' ' ' HIS . 87.5 m -59.41 130.02 44.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.599 0.592 . . . . 1.0700000000000001 112.599 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 31.2 m-85 -112.43 130.94 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 2.1400000000000001 109.687 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -123.24 118.22 27.08 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.057 -0.257 . . . . 1.5900000000000001 111.027 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 41.9 t -100.54 118.57 36.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 1.03 110.153 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.735 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 44.2 mtpt -117.89 106.17 12.7 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.822 -0.351 . . . . 2.1899999999999999 111.493 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 43' ' ' PHE . 29.9 t -90.04 109.27 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.229 -0.656 . . . . 1.8200000000000001 109.229 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.735 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.7 tttp -100.32 111.77 24.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 2.1899999999999999 112.327 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 48.6 tttt -142.41 102.84 4.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.3 -0.56 . . . . 3.2799999999999998 110.189 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.487 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.26 134.01 24.02 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.643 -0.708 . . . . 1.1799999999999999 112.09 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 65.5 Cg_endo -99.26 47.87 2.08 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.414 -1.078 . . . . 0.62 111.785 -0.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.97 102.95 0.27 Allowed Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.89 -1.147 . . . . 0.53000000000000003 113.822 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.61 151.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.534 -0.833 . . . . 1.8700000000000001 109.689 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.49 144.47 34.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.387 0.514 . . . . 1.3200000000000001 112.387 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.421 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 43.7 p-10 -146.78 139.8 25.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 111.61 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.634 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.18 161.99 38.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.548 -0.296 . . . . 3.46 111.073 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.4 mttt -106.66 143.44 34.76 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.888 1.07 . . . . 2.6699999999999999 113.888 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 86.3 mt -143.86 114.81 2.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 114.982 -1.008 . . . . 1.0600000000000001 108.879 176.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.487 ' CD2' HG22 ' A' ' 117' ' ' THR . 58.8 m170 -99.44 112.79 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.481 -0.488 . . . . 0.70999999999999996 110.911 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 118' ' ' TYR . 54.6 tp -88.25 131.01 34.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.697 -0.683 . . . . 2.1000000000000001 112.425 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.544 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.0 t -126.42 125.83 68.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 1.0900000000000001 109.729 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 27.6 t -99.33 123.09 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.72 111.412 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.6 mt -81.82 157.21 24.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.701 -0.481 . . . . 1.21 109.701 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.65 135.86 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.53 0.681 . . . . 2.0899999999999999 111.629 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.792 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.1 177.6 1.62 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 114.79 -1.096 . . . . 2.7599999999999998 109.352 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.792 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 9.6 Cg_endo -54.1 -163.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 121.925 1.75 . . . . 1.4199999999999999 112.83 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.509 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -30.64 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.981 -0.554 . . . . 2.6899999999999999 112.492 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.53 -63.23 0.17 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.802 -0.713 . . . . 2.8799999999999999 113.043 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 2.6000000000000001 111.139 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.756 -0.138 . . . . 3.6600000000000001 112.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 t -77.64 129.99 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.599 0.238 . . . . 2.8100000000000001 110.534 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.8 m -74.82 130.01 38.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 2.2599999999999998 110.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.464 HG23 ' HZ2' ' A' ' 131' ' ' LYS . 42.5 mm -118.73 129.99 74.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 2.6299999999999999 111.003 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 51.1 p -85.9 146.56 26.66 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.32 0.581 . . . . 1.6499999999999999 110.598 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.27 83.27 0.21 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.146 -0.934 . . . . 1.26 111.333 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.4 Cg_endo -77.72 -77.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.568 2.845 . . . . 0.88 112.193 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 45.4 mp0 -78.64 123.22 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 2.0600000000000001 108.958 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 29' ' ' ILE . 77.8 tt0 -143.81 159.99 41.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.077 1.14 . . . . 1.71 114.077 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 57.5 ttm -134.6 130.01 35.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.536 -1.211 . . . . 2.3999999999999999 108.284 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.538 HD13 HG22 ' A' ' 133' ' ' ILE . 3.6 mp -131.22 138.48 53.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.03 -0.532 . . . . 1.1499999999999999 112.335 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.742 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 92.2 mt-10 -128.81 126.34 39.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.211 -0.45 . . . . 1.1899999999999999 110.252 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.624 ' HB2' HD12 ' A' ' 110' ' ' LEU . 60.3 mmtt -142.09 156.87 45.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.892 0.377 . . . . 2.9300000000000002 111.846 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 35' ' ' GLU . . . -77.29 140.18 39.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.887 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HD2' ' HB2' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -45.73 141.89 2.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.09 -0.505 . . . . 2.7599999999999998 111.872 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 79.3 -21.66 4.17 Favored Glycine 0 C--N 1.328 0.132 0 C-N-CA 121.168 -0.539 . . . . 0.32000000000000001 113.759 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 98.9 mt-10 -78.48 155.25 29.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.2 m -88.67 121.69 31.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.818 -0.753 . . . . 1.0800000000000001 110.544 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.584 ' HB3' HG21 ' A' ' 107' ' ' VAL . . . -95.93 116.1 28.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.275 0.559 . . . . 1.0700000000000001 110.072 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.467 ' CE2' HG22 ' A' ' 94' ' ' THR . 6.5 t80 -79.15 116.22 19.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.558 -0.746 . . . . 2.3199999999999998 111.632 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD11 ' CZ3' ' A' ' 57' ' ' TRP . 29.1 mt -104.37 104.19 43.28 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.383 -0.969 . . . . 1.47 108.383 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 83.1 Cg_endo -83.26 135.58 7.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.685 2.257 . . . . 0.71999999999999997 114.712 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.556 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 86.9 m -141.03 103.32 4.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.273 -0.876 . . . . 1.03 109.831 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 58.2 tptt -100.9 133.86 44.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.962 -0.563 . . . . 2.2400000000000002 109.53 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.725 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 21.2 p90 -138.31 138.15 38.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.272 0.558 . . . . 2.1499999999999999 111.395 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -91.5 139.64 30.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.289 -0.869 . . . . 1.9299999999999999 110.438 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' CE ' ' A' ' 124' ' ' LYS . 86.0 mt -94.63 109.75 21.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.144 -0.317 . . . . 2.5899999999999999 110.144 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 m -81.04 139.49 49.44 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 109.942 -0.392 . . . . 2.1299999999999999 109.942 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.89 -31.27 10.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.558 1.505 . . . . 1.9299999999999999 110.707 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 82.7 tt0 -75.54 -40.03 57.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.207 -0.906 . . . . 2.1800000000000002 110.827 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 80.0 m-20 -67.79 79.05 0.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.245 0.545 . . . . 2.4100000000000001 109.549 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.85 -8.74 33.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.419 -0.81 . . . . 1.96 111.428 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.04 160.02 53.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.611 -0.804 . . . . 0.56000000000000005 112.335 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.18 148.82 47.61 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.255 1.97 . . . . 1.1899999999999999 111.785 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.737 HD21 ' HD2' ' A' ' 124' ' ' LYS . 8.2 mt -78.02 131.1 37.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 2.4100000000000001 111.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.716 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 83.1 m-20 -131.72 149.77 52.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.954 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.481 ' O ' HD13 ' A' ' 73' ' ' LEU . 23.5 mt -143.57 104.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.226 -0.897 . . . . 1.4099999999999999 109.538 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 86.4 tt0 -104.48 111.04 23.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.491 0.552 . . . . 1.6699999999999999 112.491 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.579 ' HB2' HG21 ' A' ' 72' ' ' ILE . 73.8 m95 -92.98 132.93 36.64 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.923 -0.311 . . . . 0.23999999999999999 110.437 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.3 mt -119.55 139.99 51.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.465 -0.569 . . . . 1.1200000000000001 109.465 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.719 HG21 ' HB ' ' A' ' 71' ' ' ILE . 8.8 tt -129.97 130.74 66.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.752 0.649 . . . . 1.3700000000000001 112.752 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.9 m -125.51 101.39 30.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.306 -0.998 . . . . 1.73 108.306 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.679 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 3.0 Cg_exo -79.76 118.25 3.77 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.534 2.156 . . . . 0.84999999999999998 112.902 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.75 -39.95 86.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.561 -0.745 . . . . 1.0700000000000001 110.604 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.847 -0.615 . . . . 1.8200000000000001 111.749 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 33.7 m120 -85.98 160.51 19.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.365 0.602 . . . . 2.3599999999999999 112.181 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -69.48 -15.87 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.103 -0.953 . . . . 1.95 111.327 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 48.7 mttt -67.0 151.47 47.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 2.2799999999999998 111.821 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.02 135.58 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.585 1.183 . . . . 1.4199999999999999 110.149 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 45.46 40.0 5.19 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 112.609 -2.087 . . . . 1.77 112.858 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.9 145.44 24.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.518 0.199 . . . . 2.54 110.826 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 21.7 t -67.12 130.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.814 0.34 . . . . 1.3899999999999999 110.124 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.785 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -109.68 -65.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.908 0.707 . . . . 1.8200000000000001 112.908 -177.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.762 HG12 ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -134.06 107.4 9.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.434 -0.95 . . . . 1.0800000000000001 108.434 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 74' ' ' TYR . 8.0 tp -112.94 157.4 21.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.8799999999999999 111.042 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' ASP . 18.1 t80 -132.58 104.72 6.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 2.2000000000000002 109.921 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.522 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 14.6 t -143.12 159.77 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.427 0.528 . . . . 1.4199999999999999 112.427 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.45 31.71 14.27 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.875 -0.602 . . . . 0.56999999999999995 112.73 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t0 70.51 3.3 4.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.666 0.269 . . . . 1.46 111.013 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 50.1 mtpt -100.52 116.5 32.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.876 -0.416 . . . . 2.96 109.876 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.54 HG23 ' HD2' ' A' ' 93' ' ' PHE . 2.8 mm -80.11 129.44 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 107.543 -1.28 . . . . 2.27 107.543 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.666 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -113.62 121.11 43.17 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.25 -0.886 . . . . 2.1499999999999999 110.49 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.762 ' HB3' HG12 ' A' ' 72' ' ' ILE . 16.2 p-10 -165.58 -51.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.634 -1.247 . . . . 1.2 107.634 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 50.3 t0 -77.18 -21.73 53.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.157 -0.929 . . . . 2.1699999999999999 108.88 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.81 -26.46 27.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.925 -1.034 . . . . 5.4100000000000001 109.268 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.867 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -89.05 111.32 44.19 Favored Pre-proline 0 CA--C 1.512 -0.485 0 CA-C-N 115.25 -0.886 . . . . 2.21 112.155 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.5 -38.72 28.24 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.415 1.41 . . . . 1.1100000000000001 110.473 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.6 m-20 -64.46 106.07 1.07 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.977 -0.556 . . . . 1.3600000000000001 111.251 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 4.7 mt 59.95 23.08 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.711 1.004 . . . . 2.2400000000000002 113.711 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.867 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 23.2 pttm -58.34 149.01 25.71 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.179 -1.008 . . . . 2.8700000000000001 111.379 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.83 6.72 88.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.498 -0.858 . . . . 0.48999999999999999 113.024 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -142.54 -40.47 0.34 Allowed 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 113.737 1.014 . . . . 2.1099999999999999 113.737 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.785 ' CG2' HD13 ' A' ' 71' ' ' ILE . 1.6 t -85.29 87.97 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 123.221 1.486 . . . . 1.04 107.525 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -113.16 132.92 55.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 111.258 -2.701 . . . . 0.34000000000000002 111.86 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.653 ' HA ' ' O ' ' A' ' 104' ' ' SER . 82.2 m-85 -75.26 123.96 26.24 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 119.988 -0.685 . . . . 2.1600000000000001 109.75 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' CE2' ' A' ' 38' ' ' TYR . 23.2 p -74.69 -4.68 38.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 1.0900000000000001 110.916 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . 15.9 p -84.43 113.66 21.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.206 -0.452 . . . . 1.71 110.949 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -88.19 0.01 56.57 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.514 0.673 . . . . 2.4700000000000002 109.505 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -146.52 68.72 1.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.524 -1.288 . . . . 2.1400000000000001 107.524 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 74' ' ' TYR . 9.3 tt -56.11 -38.23 70.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.499 -1.228 . . . . 1.99 112.029 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -63.59 -2.7 1.76 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.137 0.494 . . . . 2.4900000000000002 112.119 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 98' ' ' LEU . 7.2 t -89.62 -0.03 57.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.585 -0.734 . . . . 1.8999999999999999 111.204 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.725 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.47 -0.18 34.79 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.521 -0.847 . . . . 0.40999999999999998 113.887 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 95.5 m-20 -99.48 119.95 38.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.005 0.402 . . . . 1.4399999999999999 110.986 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -118.5 3.7 11.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.21 -0.45 . . . . 1.1200000000000001 112.087 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 29.9 p -59.99 145.19 47.13 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.508 2.04 . . . . 1.46 116.508 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.93 130.07 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 114.034 -1.439 . . . . 1.0900000000000001 109.809 177.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 90' ' ' ARG . 53.2 p-10 -100.77 142.38 32.33 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.578 -1.267 . . . . 1.5600000000000001 107.578 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.91 117.83 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 120.746 -0.381 . . . . 1.0600000000000001 110.716 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.568 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -84.55 143.3 29.41 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.743 -0.662 . . . . 1.0700000000000001 110.759 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 80.8 m-20 49.89 58.55 5.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.256 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 31' ' ' LYS . 22.1 mt -46.19 90.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.642 0.979 . . . . 1.21 113.642 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 53.8 tt0 -59.64 143.92 49.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.712 -0.676 . . . . 2.6699999999999999 110.338 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.509 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 2.4 tt -60.0 -38.52 82.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.188 0.518 . . . . 2.2400000000000002 110.67 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.3 p -74.12 -6.52 48.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.8300000000000001 111.42 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.99 -19.47 63.34 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.346 -0.613 . . . . 1.5800000000000001 109.346 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -43.08 139.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.632 -0.713 . . . . 1.1399999999999999 110.256 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.78 162.34 9.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.098 -1.049 . . . . 0.26000000000000001 113.331 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.4 m -59.71 135.23 57.62 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 1.0700000000000001 112.408 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 19.6 m-85 -119.99 132.1 55.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 2.1400000000000001 109.618 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.572 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.9 mt-30 -120.16 117.5 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.613 0.244 . . . . 1.5900000000000001 110.401 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.518 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 10.2 t -101.15 106.37 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.92 -0.4 . . . . 1.03 109.92 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 77.7 mttt -113.26 112.5 23.84 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.522 -0.308 . . . . 2.1899999999999999 111.501 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 37.8 t -92.96 108.24 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.765 -0.458 . . . . 1.8200000000000001 109.765 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.716 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 82.2 tttt -97.0 119.17 34.97 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.783 0.66 . . . . 2.1899999999999999 112.783 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.737 ' HD2' HD21 ' A' ' 53' ' ' LEU . 18.9 tttt -145.82 102.79 3.7 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.646 -0.502 . . . . 3.2799999999999998 109.646 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -49.78 131.59 21.02 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.286 0.847 . . . . 1.1799999999999999 113.286 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.55 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 63.7 Cg_endo -100.35 40.66 4.13 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.675 -0.969 . . . . 0.62 111.979 -1.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.67 102.27 0.48 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.26 -0.972 . . . . 0.53000000000000003 113.225 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.96 141.76 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 113.629 -1.286 . . . . 1.8700000000000001 109.879 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.411 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . . . -139.87 152.18 46.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.992 -0.283 . . . . 1.3200000000000001 111.706 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 41.2 p-10 -146.35 149.64 34.18 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.419 0.526 . . . . 2.0299999999999998 112.419 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.556 ' HZ3' ' HA ' ' A' ' 41' ' ' CYS . 10.6 ptmt -144.44 157.77 44.08 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.895 -0.593 . . . . 3.46 110.81 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 5.6 ttmm -100.98 139.97 35.93 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.78 0.659 . . . . 2.6699999999999999 112.78 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.595 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 89.2 mt -142.06 113.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.479 -0.782 . . . . 1.0600000000000001 109.689 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -100.13 114.75 28.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.728 -0.471 . . . . 0.70999999999999996 109.728 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.535 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 53.8 tp -94.73 123.0 37.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.609 0.596 . . . . 2.1000000000000001 112.609 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.742 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.8 t -119.93 122.18 67.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.032 -0.729 . . . . 1.0900000000000001 109.032 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 16.4 t -100.27 127.16 53.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.952 0.406 . . . . 1.72 111.988 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 91.0 mt -80.65 159.42 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 1.21 109.705 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.51 136.32 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.461 0.648 . . . . 2.0899999999999999 111.333 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.508 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.05 177.14 1.76 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.868 -1.06 . . . . 2.7599999999999998 109.718 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 66.7 Cg_exo -51.28 -173.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.995 1.797 . . . . 1.4199999999999999 111.689 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 p -35.63 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.748 0.309 . . . . 2.6899999999999999 111.792 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.21 -29.64 1.64 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.99 -0.624 . . . . 2.8799999999999999 113.59 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.233 -0.889 . . . . 2.6000000000000001 111.292 -179.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.72 -0.152 . . . . 3.6600000000000001 112.72 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -77.4 160.0 29.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 2.8100000000000001 111.151 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -159.22 150.36 20.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.488 . . . . 2.2599999999999998 110.986 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' LYS . 10.9 tt -141.67 144.23 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.776 -0.647 . . . . 2.6299999999999999 110.482 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.6 p -88.12 152.73 21.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.414 0.626 . . . . 1.6499999999999999 111.574 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.683 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 37.91 84.75 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.743 -1.117 . . . . 1.26 111.212 -178.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.682 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.2 Cg_endo -76.8 -11.6 18.26 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 123.417 2.745 . . . . 0.88 112.777 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.9 126.6 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.544 -0.91 . . . . 2.0600000000000001 108.544 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' ILE . 81.0 tt0 -143.93 159.41 42.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.25 1.204 . . . . 1.71 114.25 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 77.9 mtp -139.96 123.89 17.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.678 -1.146 . . . . 2.3999999999999999 109.781 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.47 129.46 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.649 0.261 . . . . 1.1499999999999999 111.288 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.588 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.3 mt-10 -119.95 124.21 45.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.499 -0.319 . . . . 1.1899999999999999 110.554 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 110' ' ' LEU . 23.6 mmtt -142.22 162.22 36.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 2.9300000000000002 111.639 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.56 137.93 39.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 111.76 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 53.9 tttt -48.33 129.99 16.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.208 -0.451 . . . . 2.7599999999999998 111.083 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.0 -18.96 45.01 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.118 -0.563 . . . . 0.32000000000000001 112.349 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 82.0 mm-40 -80.09 160.0 25.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.246 -1.02 . . . . 2.1099999999999999 108.246 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.841 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 82.8 m -88.18 128.31 35.45 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.568 -0.853 . . . . 1.0800000000000001 110.814 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HB1' ' CD1' ' A' ' 110' ' ' LEU . . . -98.95 119.98 38.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 1.0700000000000001 110.394 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.571 ' CE2' HG21 ' A' ' 94' ' ' THR . 30.5 t80 -79.51 113.89 18.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.803 -0.635 . . . . 2.3199999999999998 111.427 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 47.1 mt -100.96 106.3 43.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.442 -0.948 . . . . 1.47 108.442 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.667 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 4.4 Cg_endo -84.92 126.23 3.3 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.401 2.068 . . . . 0.71999999999999997 113.361 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.488 ' HA ' ' NZ ' ' A' ' 131' ' ' LYS . 19.7 t -140.59 125.92 18.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.6 -0.889 . . . . 1.03 108.6 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.518 ' O ' HG13 ' A' ' 22' ' ' ILE . 8.4 mtpm? -140.82 148.55 40.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.943 -0.571 . . . . 2.2400000000000002 111.473 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.576 ' CE2' HD21 ' A' ' 53' ' ' LEU . 50.3 p90 -139.99 143.1 36.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.027 -0.988 . . . . 2.1499999999999999 111.613 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.1 p -83.3 159.96 21.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.814 -0.63 . . . . 1.9299999999999999 111.093 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.58 122.88 36.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 2.5899999999999999 110.458 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 15.8 m -76.06 155.97 84.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.599 -0.273 . . . . 2.1299999999999999 110.404 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.41 -20.1 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.562 2.175 . . . . 1.9299999999999999 112.399 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 79.5 tt0 -148.19 34.55 0.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.607 -0.27 . . . . 2.1800000000000002 111.267 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 46' ' ' SER . 34.0 p-10 -69.92 69.94 0.33 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.022 0.439 . . . . 2.4100000000000001 110.447 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -96.42 -1.4 47.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 1.96 111.679 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.84 153.95 49.33 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.206 -0.997 . . . . 0.56000000000000005 112.165 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.68 126.8 23.45 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.235 1.957 . . . . 1.1899999999999999 111.152 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' HB3' ' A' ' 124' ' ' LYS . 1.3 mt -77.94 104.55 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.448 -0.342 . . . . 2.4100000000000001 111.23 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -116.98 103.42 10.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.535 0.683 . . . . 1.78 110.728 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.776 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.1 mt -97.57 121.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 1.4099999999999999 110.782 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.912 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -115.41 126.37 54.3 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.34 0.496 . . . . 1.6699999999999999 112.34 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.663 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 74.0 m95 -100.52 124.24 45.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.23999999999999999 110.16 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.1 mt -109.52 140.52 43.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.499 -0.556 . . . . 1.1200000000000001 109.499 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.0 tt -127.77 130.03 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.485 . . . . 1.3700000000000001 112.259 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.8 m -120.18 102.41 46.08 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.892 -0.781 . . . . 1.73 108.892 177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.728 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.3 Cg_exo -79.4 118.08 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.514 2.143 . . . . 0.84999999999999998 112.628 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.98 87.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.721 -0.672 . . . . 1.0700000000000001 110.542 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -75.69 -40.01 56.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 1.8200000000000001 111.425 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 15.6 t-20 -82.61 158.15 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 2.3599999999999999 111.731 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -69.18 -20.02 64.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 1.95 111.895 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.728 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 18.5 mtpt -70.59 151.73 44.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 2.2799999999999998 111.907 -178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 66' ' ' LYS . 1.2 m -153.94 129.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.799 0.809 . . . . 1.4199999999999999 109.106 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 59.5 39.18 22.05 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.231 -1.35 . . . . 1.77 111.785 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.411 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 96.0 mm-40 -92.09 153.56 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.356 -0.384 . . . . 2.54 111.415 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.614 ' CG2' ' CE1' ' A' ' 84' ' ' TYR . 4.2 p -64.34 150.55 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.427 -0.582 . . . . 1.3899999999999999 109.427 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.868 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -144.21 -57.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.179 -0.608 . . . . 1.8200000000000001 112.504 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.035 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.56 135.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.626 -0.509 . . . . 1.0800000000000001 109.626 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.912 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 4.0 mp -140.73 164.06 31.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 1.8799999999999999 112.207 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 45.3 t80 -137.2 103.27 5.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.337 -0.847 . . . . 2.2000000000000002 109.195 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.454 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 12.8 t -144.1 159.58 42.39 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.083 -0.508 . . . . 1.4199999999999999 112.256 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.33 31.02 4.53 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.058 -0.519 . . . . 0.56999999999999995 113.353 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 72.03 1.95 4.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.446 0.165 . . . . 1.46 111.419 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 87.4 mttt -100.01 117.77 34.99 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.657 -0.497 . . . . 2.96 109.657 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.464 HD11 ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm -80.02 130.31 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.436 -1.32 . . . . 2.27 107.436 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.738 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.3 m-85 -117.45 125.17 50.47 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.325 -0.852 . . . . 2.1499999999999999 110.655 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.867 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.8 p-10 -165.93 -55.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.975 -1.491 . . . . 1.2 106.975 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -80.64 -21.51 41.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.864 -1.062 . . . . 2.1699999999999999 109.047 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.579 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -81.56 -25.91 35.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.371 -0.974 . . . . 5.4100000000000001 108.371 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -87.11 120.71 71.56 Favored Pre-proline 0 CA--C 1.509 -0.604 0 CA-C-N 115.273 -0.876 . . . . 2.21 110.555 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.9 Cg_endo -48.56 -43.78 32.39 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.391 1.394 . . . . 1.1100000000000001 110.443 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 71' ' ' ILE . 2.8 m-20 -68.72 107.22 2.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.297 -0.961 . . . . 1.3600000000000001 111.328 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.9 mt 68.75 25.9 6.24 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.642 0.979 . . . . 2.2400000000000002 113.642 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.867 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.2 pttt -56.62 127.53 31.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.025 -0.67 . . . . 2.8700000000000001 111.431 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.66 16.3 52.48 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.48999999999999999 114.135 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -144.32 -47.68 0.26 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.707 1.373 . . . . 2.1099999999999999 114.707 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.035 HG13 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -80.85 82.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 123.038 1.399 . . . . 1.04 108.119 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -101.29 130.18 47.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.639 -2.073 . . . . 0.34000000000000002 111.997 -176.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 71.1 m-85 -74.09 121.55 21.31 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.551 0.691 . . . . 2.1600000000000001 109.704 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.571 HG21 ' CE2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -69.98 -11.17 60.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.65 -1.159 . . . . 1.0900000000000001 110.096 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.7 m -93.49 120.02 33.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.971 -0.559 . . . . 1.71 110.738 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -89.56 0.03 57.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.071 0.462 . . . . 2.4700000000000002 110.26 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -146.19 67.24 1.19 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.764 -0.828 . . . . 2.1400000000000001 108.764 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.419 HD22 ' CG ' ' A' ' 74' ' ' TYR . 5.2 mp -54.61 -23.58 17.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.141 -0.936 . . . . 1.99 111.655 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.26 -4.59 3.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.216 0.532 . . . . 2.4900000000000002 111.759 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.7 p -88.53 0.02 56.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.305 -0.861 . . . . 1.8999999999999999 111.072 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 102.86 -14.18 56.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.744 -0.741 . . . . 0.40999999999999998 113.151 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.18 108.95 21.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.911 0.355 . . . . 1.4399999999999999 110.69 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.05 16.69 21.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.36 0.504 . . . . 1.1200000000000001 112.36 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m -60.03 145.78 45.14 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 115.793 1.775 . . . . 1.46 115.793 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.41 136.02 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.082 -1.417 . . . . 1.0900000000000001 110.783 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 90' ' ' ARG . 49.2 p-10 -107.11 143.52 35.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.528 -0.915 . . . . 1.5600000000000001 108.528 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.841 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.71 120.7 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.063 0.459 . . . . 1.0600000000000001 111.655 -178.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.573 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 144.54 29.43 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.333 -0.849 . . . . 1.0700000000000001 111.012 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 29.0 m120 49.84 55.89 8.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.281 -0.418 . . . . 1.9399999999999999 111.811 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 31' ' ' LYS . 21.7 mt -45.45 89.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.699 1.0 . . . . 1.21 113.699 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 52.3 tt0 -60.05 143.82 51.0 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.582 -0.525 . . . . 2.6699999999999999 109.582 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.96 -40.04 87.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 2.2400000000000002 110.892 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -73.3 -10.01 59.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.8300000000000001 111.613 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.2 m-20 -70.56 -17.24 62.92 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.892 -0.41 . . . . 1.5800000000000001 109.892 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.61 143.76 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 110.381 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.75 157.09 7.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.155 -1.021 . . . . 0.26000000000000001 113.201 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.6 m -59.34 138.95 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.339 0.496 . . . . 1.0700000000000001 112.339 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 9.6 m-85 -120.09 130.91 54.87 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.432 -0.581 . . . . 2.1400000000000001 109.432 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 66.7 tt0 -127.47 119.96 27.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.957 -0.297 . . . . 1.5900000000000001 111.015 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.541 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 21.6 p -102.71 119.95 39.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.76 0.314 . . . . 1.03 110.554 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.776 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 97.5 mttt -112.75 104.9 12.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 2.1899999999999999 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.5 ' CG2' HG12 ' A' ' 55' ' ' ILE . 21.8 t -88.42 117.31 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.325 -0.62 . . . . 1.8200000000000001 109.325 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 75.8 mttt -113.76 118.31 33.93 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.91 1.078 . . . . 2.1899999999999999 113.91 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.61 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 21.1 pttm -146.94 103.8 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.639 -0.71 . . . . 3.2799999999999998 110.809 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.34 129.11 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.92 -0.582 . . . . 1.1799999999999999 111.835 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -104.11 53.79 1.21 Allowed 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 125.207 -0.747 . . . . 0.62 111.802 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 102.98 0.27 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.95 -1.119 . . . . 0.53000000000000003 113.871 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.432 ' CG1' ' HG2' ' A' ' 123' ' ' LYS . 17.1 m -94.24 134.27 32.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.394 -0.903 . . . . 1.8700000000000001 109.845 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' A' ' 22' ' ' ILE . . . -143.55 136.6 27.72 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.13 0.418 . . . . 1.3200000000000001 112.13 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.448 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.9 p-10 -146.79 150.24 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.219 0.452 . . . . 2.0299999999999998 112.219 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.683 ' HE3' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.55 163.52 34.51 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 3.46 110.567 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.0 mttt -101.3 145.05 29.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 114.25 1.204 . . . . 2.6699999999999999 114.25 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.542 ' HA ' ' HB3' ' A' ' 27' ' ' GLU . 85.6 mt -140.53 119.36 11.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.63 -1.168 . . . . 1.0600000000000001 108.654 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.473 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 52.4 m170 -100.43 119.75 38.95 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.564 -0.455 . . . . 0.70999999999999996 110.741 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 1.5 tm? -89.58 120.04 30.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 2.1000000000000001 111.384 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.588 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.1 t -117.3 120.0 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.653 . . . . 1.0900000000000001 109.551 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.66 125.34 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.016 0.436 . . . . 1.72 112.035 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 92.9 mt -84.85 170.01 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 1.21 109.368 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.43 135.18 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 2.0899999999999999 111.69 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 5.8 mttt -165.05 176.47 2.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.717 -1.129 . . . . 2.7599999999999998 110.015 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' HD2' ' HD3' ' A' ' 140' ' ' LYS . 44.6 Cg_exo -56.87 155.5 27.4 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.302 2.002 . . . . 1.4199999999999999 112.251 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' ALA . 1.1 m -40.05 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.15 -0.477 . . . . 2.6899999999999999 111.948 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.24 -65.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.99 -0.624 . . . . 2.8799999999999999 112.854 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.282 -0.866 . . . . 2.6000000000000001 111.258 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.498 -0.241 . . . . 3.6600000000000001 112.498 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -78.28 159.96 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 2.8100000000000001 110.827 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.8 m -157.84 133.9 9.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.2599999999999998 110.998 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.431 ' CD1' ' CB ' ' A' ' 129' ' ' ALA . 85.6 mt -110.0 129.96 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 2.6299999999999999 110.558 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 38.1 p -91.44 148.34 22.38 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.191 0.519 . . . . 1.6499999999999999 110.792 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.623 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 41.38 82.69 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.089 -0.96 . . . . 1.26 111.117 -177.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.46 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 123.971 3.114 . . . . 0.88 112.926 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.27 126.3 30.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.504 -0.925 . . . . 2.0600000000000001 108.504 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 132' ' ' LYS . 86.0 tt0 -143.74 160.02 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.893 1.071 . . . . 1.71 113.893 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 57.7 ttm -137.16 137.21 38.95 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 114.881 -1.054 . . . . 2.3999999999999999 109.281 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.2 mm -134.16 140.02 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.296 0.48 . . . . 1.1499999999999999 112.296 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt-10 -130.14 123.96 31.54 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.431 -0.581 . . . . 1.1899999999999999 109.431 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HB3' HD11 ' A' ' 110' ' ' LEU . 49.3 tptt -142.07 157.22 45.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.981 -0.287 . . . . 2.9300000000000002 111.31 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.8 141.66 40.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 1.1299999999999999 112.067 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 142' ' ' SER . 59.5 tttp -48.67 131.48 17.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.884 -0.598 . . . . 2.7599999999999998 111.872 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.538 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 87.38 -17.36 43.92 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.13 -0.557 . . . . 0.32000000000000001 113.267 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.535 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 99.1 mt-10 -80.01 159.77 26.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.628 -0.879 . . . . 2.1099999999999999 108.628 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.4 m -89.37 128.5 35.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.652 -0.819 . . . . 1.0800000000000001 110.367 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -99.0 112.12 24.33 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.888 0.375 . . . . 1.0700000000000001 110.343 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.448 ' CD1' HG22 ' A' ' 94' ' ' THR . 77.4 t80 -79.15 117.89 20.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 2.3199999999999998 111.616 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 39.9 mt -105.97 104.73 50.71 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.249 -0.649 . . . . 1.47 109.249 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 83.6 Cg_endo -83.37 127.19 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.448 2.099 . . . . 0.71999999999999997 113.497 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -140.31 130.18 24.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.359 -0.837 . . . . 1.03 109.616 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 8.9 mptt -140.03 140.34 36.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.053 -0.521 . . . . 2.2400000000000002 110.003 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.487 ' CE2' ' HD2' ' A' ' 124' ' ' LYS . 50.0 p90 -140.23 139.81 35.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 2.1499999999999999 111.704 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 p -88.91 147.42 24.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.612 -0.722 . . . . 1.9299999999999999 111.441 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.453 ' HA ' ' NZ ' ' A' ' 124' ' ' LYS . 24.5 tp -99.48 114.38 27.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 2.5899999999999999 110.903 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -81.87 145.46 53.75 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 110.028 -0.36 . . . . 2.1299999999999999 110.028 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -49.62 -34.15 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.782 1.654 . . . . 1.9299999999999999 110.536 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -75.64 -40.02 56.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.282 -0.872 . . . . 2.1800000000000002 110.641 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.7 m-20 -69.51 73.58 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.134 0.493 . . . . 2.4100000000000001 109.759 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -94.29 -4.84 48.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.754 . . . . 1.96 111.621 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.99 157.33 53.51 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.413 -0.899 . . . . 0.56000000000000005 112.536 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.45 148.88 10.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.477 2.118 . . . . 1.1899999999999999 111.858 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.691 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 5.6 mp -78.16 135.76 37.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 2.4100000000000001 111.503 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 9.2 t70 -140.73 153.59 45.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 1.78 111.876 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 21.5 mt -142.49 139.93 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.007 -0.997 . . . . 1.4099999999999999 109.667 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 98.0 mt-10 -140.23 111.71 7.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.026 0.375 . . . . 1.6699999999999999 111.748 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.833 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 74.3 m95 -97.68 119.9 37.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.867 -0.333 . . . . 0.23999999999999999 110.929 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 119' ' ' GLN . 89.2 mt -104.9 138.84 40.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.014 -0.736 . . . . 1.1200000000000001 109.014 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.9 tt -129.97 129.98 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.321 0.489 . . . . 1.3700000000000001 112.321 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.8 m -121.44 102.45 42.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 1.73 109.153 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.8 Cg_exo -81.46 116.19 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.645 2.23 . . . . 0.84999999999999998 112.716 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -33.25 71.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.71 . . . . 1.0700000000000001 110.886 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -85.29 12.89 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 1.8200000000000001 112.148 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 93.9 m-20 -146.99 163.19 37.02 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.37 0.605 . . . . 2.3599999999999999 111.873 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.06 -18.06 65.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.065 -0.97 . . . . 1.95 111.912 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.647 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 96.2 mttt -67.16 140.01 57.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.117 0.484 . . . . 2.2799999999999998 111.827 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 66' ' ' LYS . 2.5 m -153.0 127.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.852 0.834 . . . . 1.4199999999999999 109.012 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.82 39.33 29.64 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.098 -1.41 . . . . 1.77 111.796 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -94.72 140.01 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 2.54 110.816 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.505 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 43.0 t -69.86 127.1 31.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.987 0.422 . . . . 1.3899999999999999 110.276 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -112.04 -51.38 5.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.925 -0.58 . . . . 1.8200000000000001 112.124 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.721 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -136.92 130.13 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.593 -0.891 . . . . 1.0800000000000001 108.593 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 3.3 tt -140.1 157.03 46.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 1.8799999999999999 111.271 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 36.8 t80 -135.45 104.33 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.345 -0.388 . . . . 2.2000000000000002 110.076 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 t -144.24 157.26 44.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.416 0.524 . . . . 1.4199999999999999 112.416 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.22 12.57 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.214 -0.517 . . . . 0.56999999999999995 113.075 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t0 72.12 3.27 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.497 0.184 . . . . 1.46 111.497 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 114.85 28.46 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.568 -0.53 . . . . 2.96 109.568 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.531 HG22 ' HD2' ' A' ' 93' ' ' PHE . 2.9 mm -79.81 129.81 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 107.313 -1.366 . . . . 2.27 107.313 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.721 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -115.55 119.2 35.38 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.095 -0.957 . . . . 2.1499999999999999 110.197 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.788 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 10.0 p-10 -166.19 -51.74 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.695 -1.595 . . . . 1.2 106.695 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -80.04 -23.92 41.1 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.352 -1.295 . . . . 2.1699999999999999 108.49 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.525 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -80.82 -27.05 36.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.057 -1.09 . . . . 5.4100000000000001 108.057 177.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 2.6 m-85 -86.57 108.86 19.75 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-N 115.154 -0.93 . . . . 2.21 110.014 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 30.7 Cg_exo -61.47 -28.64 83.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.729 1.619 . . . . 1.1100000000000001 112.065 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 53.2 t0 -44.32 -36.34 2.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.347 0.594 . . . . 1.3600000000000001 111.762 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.857 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 1.5 mm? -156.48 33.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.751 -1.113 . . . . 2.2400000000000002 110.56 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.788 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 63.3 pttt -52.9 129.98 31.94 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.435 -0.506 . . . . 2.8700000000000001 111.902 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.14 57.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.506 -0.854 . . . . 0.48999999999999999 114.818 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.857 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -142.88 -46.6 0.31 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 115.009 1.485 . . . . 2.1099999999999999 115.009 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 71' ' ' ILE . 8.0 p -80.22 81.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.748 1.261 . . . . 1.04 108.235 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -103.13 129.69 50.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.892 -1.958 . . . . 0.34000000000000002 112.521 -175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.68 ' HA ' ' O ' ' A' ' 104' ' ' SER . 75.4 m-85 -73.17 122.79 22.44 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 120.002 -0.679 . . . . 2.1600000000000001 109.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.448 HG22 ' CD1' ' A' ' 38' ' ' TYR . 17.9 p -72.16 -9.93 59.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.148 -0.933 . . . . 1.0900000000000001 110.274 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 1.4 m -89.13 122.05 32.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.658 -0.701 . . . . 1.71 110.5 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -91.34 4.45 52.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.218 0.532 . . . . 2.4700000000000002 110.396 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -146.57 66.71 1.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.424 -0.807 . . . . 2.1400000000000001 108.903 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 7.9 mp -57.92 -35.04 70.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.254 -0.885 . . . . 1.99 111.434 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HA ' HD21 ' A' ' 53' ' ' LEU . 19.1 pttt -60.05 -13.78 13.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.701 0.762 . . . . 2.4900000000000002 111.801 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 t -82.99 0.04 46.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.386 -1.279 . . . . 1.8999999999999999 110.99 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.86 -2.51 38.65 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.543 -0.836 . . . . 0.40999999999999998 113.742 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.55 112.65 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.172 0.486 . . . . 1.4399999999999999 110.976 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -109.83 10.53 24.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.388 0.514 . . . . 1.1200000000000001 112.388 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 p -60.06 137.08 58.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.825 1.787 . . . . 1.46 115.825 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 114.247 -1.342 . . . . 1.0900000000000001 110.698 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.629 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -105.21 145.33 30.77 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.527 -0.546 . . . . 1.5600000000000001 109.527 177.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.849 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.49 118.72 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.142 0.496 . . . . 1.0600000000000001 111.351 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.19 143.7 30.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.297 -0.865 . . . . 1.0700000000000001 110.757 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.0 m120 49.95 55.16 9.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.083 0.468 . . . . 1.9399999999999999 111.508 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 31' ' ' LYS . 23.9 mt -45.26 88.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.225 1.194 . . . . 1.21 114.225 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -59.66 151.45 24.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 2.6699999999999999 109.756 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.489 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.5 mt -60.12 -28.39 67.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 2.2400000000000002 110.863 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.3 m -73.93 -5.95 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 1.8300000000000001 111.424 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -69.92 -23.63 63.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.616 -0.513 . . . . 1.5800000000000001 109.616 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.87 133.47 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.116 -0.493 . . . . 1.1399999999999999 110.091 178.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.65 158.71 7.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.034 -1.079 . . . . 0.26000000000000001 113.386 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.9 m -59.35 133.89 56.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.569 0.581 . . . . 1.0700000000000001 112.569 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.494 ' N ' ' O ' ' A' ' 133' ' ' ILE . 25.9 m-85 -118.4 132.83 56.24 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.035 -0.53 . . . . 2.1400000000000001 109.692 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.833 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.5 mt-30 -120.01 119.98 34.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.627 -0.261 . . . . 1.5900000000000001 111.666 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.578 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 42.7 t -100.04 107.3 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.214 -0.662 . . . . 1.03 109.214 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 8.9 mtpm? -114.19 109.31 18.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.418 -0.355 . . . . 2.1899999999999999 111.492 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 53.2 t -91.85 108.36 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.652 -0.499 . . . . 1.8200000000000001 109.652 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 64.7 tttm -93.63 120.37 33.82 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.246 -0.582 . . . . 2.1899999999999999 112.206 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.691 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 4.6 mtpt -144.38 102.2 3.8 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.821 -0.436 . . . . 3.2799999999999998 109.821 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.04 130.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 113.44 0.904 . . . . 1.1799999999999999 113.44 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.541 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 88.5 Cg_endo -101.64 42.16 3.3 Favored 'Cis proline' 0 C--N 1.354 0.866 0 C-N-CA 125.094 -0.794 . . . . 0.62 111.811 -1.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -135.95 103.59 0.46 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 122.006 0.781 . . . . 0.53000000000000003 112.723 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -82.93 155.73 3.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.086 -1.057 . . . . 1.8700000000000001 110.433 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.56 0.219 . . . . 1.3200000000000001 111.397 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -146.59 134.59 21.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.121 0.415 . . . . 2.0299999999999998 112.121 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.68 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -142.22 158.87 43.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.55 -0.537 . . . . 3.46 109.55 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 43.5 mmtm -109.98 146.68 34.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.659 1.355 . . . . 2.6699999999999999 114.659 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 118' ' ' TYR . 98.9 mt -144.17 122.57 6.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 114.586 -1.188 . . . . 1.0600000000000001 109.335 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.09 111.6 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.591 -0.443 . . . . 0.70999999999999996 110.063 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 51.6 tp -87.83 135.53 33.35 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.524 0.564 . . . . 2.1000000000000001 112.524 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.525 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 63.0 t -129.99 130.03 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.491 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.429 ' HB ' HD12 ' A' ' 115' ' ' ILE . 20.4 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.363 . . . . 1.72 111.859 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 87.9 mt -83.81 167.86 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.045 -0.525 . . . . 1.21 109.609 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.89 138.16 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.381 0.61 . . . . 2.0899999999999999 111.208 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 5.3 mttt -163.6 170.49 7.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.175 -0.92 . . . . 2.7599999999999998 110.823 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.2 Cg_endo -50.95 -158.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.98 2.454 . . . . 1.4199999999999999 112.827 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 68.3 m -36.78 -40.74 0.28 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.35 -0.387 . . . . 2.6899999999999999 111.721 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.538 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 34.59 47.35 0.62 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.779 -0.646 . . . . 2.8799999999999999 114.139 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.212 -0.899 . . . . 2.6000000000000001 111.083 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.711 -0.156 . . . . 3.6600000000000001 112.711 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 m -158.93 159.15 34.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.348 . . . . 2.8100000000000001 110.763 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.55 149.95 19.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 2.2599999999999998 110.738 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.569 HD11 ' HD3' ' A' ' 131' ' ' LYS . 1.9 pt -142.28 143.86 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.0 -0.546 . . . . 2.6299999999999999 110.869 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 27.5 p -88.58 162.43 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.793 0.806 . . . . 1.6499999999999999 112.325 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.12 82.78 0.22 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.264 -1.335 . . . . 1.26 112.712 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 63.3 Cg_endo -79.12 -86.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.775 2.984 . . . . 0.88 112.421 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 6.2 pm0 -78.0 122.02 24.99 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.711 -0.848 . . . . 2.0600000000000001 108.711 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 132' ' ' LYS . 51.3 tp10 -144.22 159.99 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.715 1.006 . . . . 1.71 113.715 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.414 ' HG3' ' HB2' ' A' ' 134' ' ' HIS . 57.7 ttm -137.9 133.01 33.3 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.829 -1.078 . . . . 2.3999999999999999 109.091 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 mm -130.05 140.04 49.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.853 -0.612 . . . . 1.1499999999999999 111.358 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.1 pt-20 -136.85 127.3 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.455 -0.338 . . . . 1.1899999999999999 110.687 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 18.3 mmtp -142.31 164.18 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.309 -0.405 . . . . 2.9300000000000002 111.03 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.35 137.33 39.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.1299999999999999 111.269 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 21.0 ttpt -45.79 130.34 9.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 2.7599999999999998 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 92.23 -18.02 55.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.005 -0.617 . . . . 0.32000000000000001 112.746 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 98.9 mt-10 -79.99 156.0 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.704 -0.85 . . . . 2.1099999999999999 108.704 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.888 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 62.6 m -87.98 127.83 35.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.666 -0.814 . . . . 1.0800000000000001 110.67 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' HD12 ' A' ' 110' ' ' LEU . . . -99.9 115.1 28.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 1.0700000000000001 110.787 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CE2' HG23 ' A' ' 94' ' ' THR . 25.1 t80 -79.37 120.06 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.036 -0.529 . . . . 2.3199999999999998 111.491 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.475 HD13 ' CZ3' ' A' ' 57' ' ' TRP . 18.3 mt -109.48 104.78 56.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.093 -0.706 . . . . 1.47 109.093 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 88.3 Cg_endo -84.76 131.16 4.46 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.818 2.345 . . . . 0.71999999999999997 115.082 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.415 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 62.6 m -141.34 104.01 4.52 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.623 -0.717 . . . . 1.03 110.251 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 4.4 mptp? -102.96 140.04 37.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 2.2400000000000002 110.662 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 50.4 p90 -140.55 146.68 38.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 2.1499999999999999 110.826 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.429 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 82.4 p -80.02 167.1 20.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.86 -0.609 . . . . 1.9299999999999999 111.65 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.96 142.88 36.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 2.5899999999999999 111.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 82.0 p -160.02 159.69 27.01 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.474 -0.784 . . . . 2.1299999999999999 110.003 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 16.4 Cg_endo -57.77 -16.65 26.12 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.197 1.931 . . . . 1.9299999999999999 112.772 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.0 tt0 -72.21 -41.54 66.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.654 0.264 . . . . 2.1800000000000002 110.303 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.434 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.79 80.4 0.87 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.815 -0.809 . . . . 2.4100000000000001 108.815 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.61 -11.24 49.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.238 -0.892 . . . . 1.96 111.686 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -78.3 156.82 43.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.217 -0.992 . . . . 0.56000000000000005 111.916 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.84 148.81 81.97 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.226 1.951 . . . . 1.1899999999999999 111.435 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -77.5 131.7 38.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.806 0.336 . . . . 2.4100000000000001 110.288 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -133.83 152.34 51.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.245 0.545 . . . . 1.78 111.093 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.2 mt -143.57 107.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.923 -1.035 . . . . 1.4099999999999999 109.711 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.659 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 97.6 mt-10 -110.25 115.01 28.93 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.191 0.441 . . . . 1.6699999999999999 112.191 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.64 ' HB2' HG23 ' A' ' 72' ' ' ILE . 76.9 m95 -99.17 120.89 40.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.23999999999999999 110.612 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 87.7 mt -105.21 140.77 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 1.1200000000000001 109.45 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.3 tt -130.0 130.02 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.274 0.559 . . . . 1.3700000000000001 112.165 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.1 p -119.17 103.06 48.04 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.816 -0.809 . . . . 1.73 108.816 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.3 Cg_endo -79.07 114.65 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.51 2.14 . . . . 0.84999999999999998 113.208 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.03 87.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 1.0700000000000001 111.006 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.99 -40.03 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.62 . . . . 1.8200000000000001 111.437 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.567 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.85 160.87 21.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 2.3599999999999999 111.661 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.0 -22.0 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.349 -0.841 . . . . 1.95 112.313 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.585 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -72.64 156.73 38.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.765 0.317 . . . . 2.2799999999999998 111.789 -178.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.35 128.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.906 0.86 . . . . 1.4199999999999999 109.954 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 39.98 19.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.979 -1.464 . . . . 1.77 112.47 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -88.86 146.84 24.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.666 -0.243 . . . . 2.54 110.578 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 17.2 t -68.87 124.3 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.676 -0.49 . . . . 1.3899999999999999 109.676 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.867 ' CD1' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -112.04 -52.14 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.055 0.761 . . . . 1.8200000000000001 113.055 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.969 ' HB ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.06 124.64 26.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.537 -0.912 . . . . 1.0800000000000001 108.537 179.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' CD1' ' HG2' ' A' ' 56' ' ' GLU . 3.8 tt -132.24 156.48 46.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 1.8799999999999999 110.586 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.871 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 15.6 t80 -135.14 104.98 6.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.249 -0.432 . . . . 2.2000000000000002 109.94 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 7.7 t -142.11 158.84 43.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.822 0.344 . . . . 1.4199999999999999 111.802 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.4 28.7 36.57 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.843 -0.694 . . . . 0.56999999999999995 112.217 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.6 t0 72.2 3.28 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.24 . . . . 1.46 110.871 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 20.9 mmtp -100.03 112.29 24.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.269 -0.641 . . . . 2.96 109.269 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.871 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.84 116.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.171 -1.048 . . . . 2.27 108.171 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.744 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.1 m-85 -99.43 130.55 45.7 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.816 -1.538 . . . . 2.1499999999999999 110.659 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.9 p-10 -165.9 -53.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.743 -1.206 . . . . 1.2 107.743 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -79.92 -20.09 46.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.291 -0.868 . . . . 2.1699999999999999 109.171 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.434 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.2 t80 -80.82 -27.0 36.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.352 -0.981 . . . . 5.4100000000000001 108.352 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.54 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.7 m-85 -86.1 113.3 51.2 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.945 -1.025 . . . . 2.21 110.777 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.4 -41.37 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.36 1.373 . . . . 1.1100000000000001 109.951 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 71' ' ' ILE . 46.7 m-20 -67.29 105.16 1.67 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.574 -0.739 . . . . 1.3600000000000001 110.668 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.854 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.0 mt 67.35 23.41 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.735 1.013 . . . . 2.2400000000000002 113.735 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttm -56.08 129.26 39.22 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.517 -0.739 . . . . 2.8700000000000001 111.08 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.65 15.56 54.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.352 -0.928 . . . . 0.48999999999999999 114.216 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.854 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.4 ptp180 -144.25 -48.93 0.27 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 114.645 1.35 . . . . 2.1099999999999999 114.645 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.969 HG12 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -79.89 81.9 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 123.157 1.456 . . . . 1.04 107.604 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -103.21 129.45 50.14 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.151 -2.295 . . . . 0.34000000000000002 112.399 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 84.7 m-85 -70.81 125.04 25.73 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.907 -0.717 . . . . 2.1600000000000001 109.788 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.507 HG23 ' CE2' ' A' ' 38' ' ' TYR . 14.3 p -77.06 36.94 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.923 -1.035 . . . . 1.0900000000000001 112.931 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.419 ' O ' HD11 ' A' ' 98' ' ' LEU . 38.0 m -147.75 136.3 21.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 1.71 111.257 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.85 0.77 57.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.663 . . . . 2.4700000000000002 110.632 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -146.69 67.81 1.17 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.448 -0.575 . . . . 2.1400000000000001 109.448 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.422 ' CD2' ' CD2' ' A' ' 74' ' ' TYR . 7.9 mp -57.15 -27.73 62.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.302 -0.863 . . . . 1.99 111.044 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -64.29 -2.93 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 2.4900000000000002 112.062 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -87.24 0.01 56.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.524 -0.762 . . . . 1.8999999999999999 110.964 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 109.93 -7.14 31.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.40999999999999998 113.234 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.35 119.4 35.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.968 0.413 . . . . 1.4399999999999999 110.813 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.57 6.48 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.891 -0.595 . . . . 1.1200000000000001 111.571 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -59.95 140.08 56.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 116.203 1.927 . . . . 1.46 116.203 -177.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -129.13 131.94 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.147 -1.388 . . . . 1.0900000000000001 110.788 177.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -104.08 142.84 33.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.054 -1.091 . . . . 1.5600000000000001 108.054 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.51 120.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.024 0.44 . . . . 1.0600000000000001 111.439 -178.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.2 p -84.29 143.86 29.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.444 -0.798 . . . . 1.0700000000000001 110.851 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 31.0 m120 49.97 55.13 9.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.072 -0.513 . . . . 1.9399999999999999 111.916 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 27.9 mt -44.19 93.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.456 0.91 . . . . 1.21 113.456 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 56.2 tt0 -59.64 144.47 47.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.7 -0.682 . . . . 2.6699999999999999 110.136 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.507 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 63.9 tp -59.97 -40.07 87.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.193 0.52 . . . . 2.2400000000000002 110.792 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -73.24 -5.56 40.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.739 -0.664 . . . . 1.8300000000000001 111.517 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.96 -19.02 63.38 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.082 -0.34 . . . . 1.5800000000000001 110.082 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 139.63 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 116.145 -0.479 . . . . 1.1399999999999999 110.206 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 141.04 159.73 8.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.958 -1.115 . . . . 0.26000000000000001 113.414 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 63.7 m -59.44 130.69 48.12 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.838 0.681 . . . . 1.0700000000000001 112.838 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 13.3 m-85 -114.27 129.64 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.174 -0.676 . . . . 2.1400000000000001 109.174 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 12.1 tt0 -120.9 118.61 30.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 1.5900000000000001 110.276 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.62 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 9.7 t -101.01 118.29 36.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 1.03 110.57 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 97.4 mttt -123.66 112.32 17.25 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 116.475 -0.33 . . . . 2.1899999999999999 111.774 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 61.9 t -92.05 106.46 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.235 -0.654 . . . . 1.8200000000000001 109.235 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.673 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 25.7 ttpp -95.42 117.34 30.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.006 -0.678 . . . . 2.1899999999999999 112.691 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 44' ' ' THR . 2.7 pttm -146.29 103.14 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.51 -0.476 . . . . 3.2799999999999998 110.12 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.463 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -49.92 133.91 21.61 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.691 -0.686 . . . . 1.1799999999999999 112.055 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.7 Cg_endo -100.03 46.52 2.37 Favored 'Cis proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.769 -0.929 . . . . 0.62 111.209 -0.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 103.62 0.29 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.257 -0.973 . . . . 0.53000000000000003 113.674 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.47 153.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.712 -0.744 . . . . 1.8700000000000001 109.322 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -139.51 144.92 38.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.279 -0.168 . . . . 1.3200000000000001 111.269 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.519 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 40.0 p-10 -146.57 142.22 27.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.895 0.702 . . . . 2.0299999999999998 112.895 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.58 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.01 157.78 44.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.784 -0.644 . . . . 3.46 110.39 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 41.2 tttt -101.84 139.98 36.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.216 0.821 . . . . 2.6699999999999999 113.216 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 70.9 mt -142.23 119.86 7.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.883 -0.599 . . . . 1.0600000000000001 109.953 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.414 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 14.8 m170 -100.22 118.37 36.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 0.70999999999999996 110.381 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.421 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 57.0 tp -91.89 123.2 35.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.217 0.451 . . . . 2.1000000000000001 112.217 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -120.03 119.99 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 1.0900000000000001 109.424 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.95 121.71 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.72 111.794 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.2 mt -81.56 164.5 21.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.337 -0.616 . . . . 1.21 109.337 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.1 139.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.399 0.619 . . . . 2.0899999999999999 111.261 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.54 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -162.25 172.53 5.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.056 -0.975 . . . . 2.7599999999999998 110.294 -179.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 9.5 Cg_endo -51.91 -157.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.593 2.195 . . . . 1.4199999999999999 112.363 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -35.12 -59.23 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.972 0.415 . . . . 2.6899999999999999 111.817 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.421 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 69.44 -62.12 0.62 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.062 -0.59 . . . . 2.8799999999999999 113.127 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.229 -0.891 . . . . 2.6000000000000001 111.105 -179.826 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.645 -0.182 . . . . 3.6600000000000001 112.645 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -79.92 168.07 19.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 2.8100000000000001 110.787 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -158.63 151.06 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 2.2599999999999998 110.944 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG21 ' HB1' ' A' ' 129' ' ' ALA . 1.1 pt -144.29 151.34 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 116.169 -0.469 . . . . 2.6299999999999999 111.413 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 82.6 p -92.39 161.73 14.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.544 0.687 . . . . 1.6499999999999999 111.618 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.18 83.55 0.2 Allowed Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.566 -1.197 . . . . 1.26 112.091 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.653 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 65.4 Cg_endo -78.44 -91.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.586 2.857 . . . . 0.88 111.876 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.75 126.93 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.704 -0.85 . . . . 2.0600000000000001 108.704 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 133' ' ' ILE . 55.3 tt0 -143.69 153.66 42.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.842 1.052 . . . . 1.71 113.842 -176.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.472 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 58.5 mtp -135.45 116.45 14.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.62 -1.173 . . . . 2.3999999999999999 108.511 176.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.552 HD12 HG22 ' A' ' 133' ' ' ILE . 3.7 mp -120.0 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.004 0.431 . . . . 1.1499999999999999 111.809 -178.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.665 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 43.9 mt-10 -106.86 126.15 51.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 1.1899999999999999 110.203 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.532 ' HB3' HD11 ' A' ' 110' ' ' LEU . 49.9 tptt -141.7 157.3 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 2.9300000000000002 111.081 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . . . -76.54 139.68 40.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 1.1299999999999999 112.018 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.3 134.02 18.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.995 -0.548 . . . . 2.7599999999999998 111.546 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.63 -20.39 27.83 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.874 -0.603 . . . . 0.32000000000000001 112.578 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 79.5 mm-40 -79.94 160.0 26.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 178.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.829 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.1 m -89.46 129.97 35.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.658 -0.817 . . . . 1.0800000000000001 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -99.92 115.8 30.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.861 0.362 . . . . 1.0700000000000001 110.217 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.503 ' CE2' HG23 ' A' ' 94' ' ' THR . 32.6 t80 -79.25 116.42 19.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.027 -0.533 . . . . 2.3199999999999998 111.875 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 15.5 mt -101.5 107.62 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 177.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.67 122.76 3.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.13 . . . . 0.71999999999999997 113.972 -178.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.3 t -141.46 126.34 18.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.744 -0.662 . . . . 1.03 110.211 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.5 mttm -140.91 149.93 42.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.922 -0.581 . . . . 2.2400000000000002 109.993 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 36.3 p90 -140.87 139.98 34.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 2.1499999999999999 112.012 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.43 139.64 30.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.743 . . . . 1.9299999999999999 110.373 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.415 HD22 ' CE ' ' A' ' 124' ' ' LYS . 90.0 mt -92.22 107.6 19.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 2.5899999999999999 110.884 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ASP . 30.4 t -83.54 133.58 46.66 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.529 -0.545 . . . . 2.1299999999999999 109.529 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -43.0 -33.2 3.11 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.691 1.594 . . . . 1.9299999999999999 111.04 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 83.4 tt0 -76.72 -39.98 50.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.358 -0.837 . . . . 2.1800000000000002 111.074 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.486 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 77.0 m-20 -68.5 79.19 0.27 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.41 -0.516 . . . . 2.4100000000000001 109.659 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.99 -5.08 28.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 1.96 111.925 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.687 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.04 160.81 53.25 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.894 -0.669 . . . . 0.56000000000000005 112.689 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.36 138.27 85.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.422 2.082 . . . . 1.1899999999999999 112.384 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 124' ' ' LYS . 11.3 mt -78.17 120.08 22.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 2.4100000000000001 111.596 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -133.51 103.05 5.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.548 0.69 . . . . 1.78 111.419 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.7 mp -91.34 122.35 42.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.745 -1.116 . . . . 1.4099999999999999 110.162 179.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.904 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.3 mt-10 -119.08 114.08 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.449 0.537 . . . . 1.6699999999999999 112.449 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.591 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 76.3 m95 -91.7 120.02 32.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 110.078 -0.341 . . . . 0.23999999999999999 110.078 178.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.9 mt -108.69 143.85 37.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.392 . . . . 1.1200000000000001 109.94 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 117' ' ' THR . 10.3 tt -130.01 132.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.293 0.479 . . . . 1.3700000000000001 112.293 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.405 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.9 m -123.28 101.85 37.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.0 -0.741 . . . . 1.73 109.0 177.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 88.5 Cg_endo -79.86 116.92 3.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.714 2.276 . . . . 0.84999999999999998 113.435 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.96 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.61 -0.723 . . . . 1.0700000000000001 110.632 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -87.42 17.28 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 1.8200000000000001 112.182 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 42.7 m-20 -148.99 160.02 43.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.41 0.624 . . . . 2.3599999999999999 112.213 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.08 -18.64 64.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.052 -0.976 . . . . 1.95 111.92 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.635 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 61.1 mttp -66.82 150.82 48.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 2.2799999999999998 111.017 -178.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.77 130.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-O 122.409 1.099 . . . . 1.4199999999999999 110.299 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 49.66 39.99 18.77 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 112.932 -1.94 . . . . 1.77 112.542 177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -90.24 140.02 30.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 2.54 111.095 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 89.7 t -69.65 130.04 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.923 0.392 . . . . 1.3899999999999999 111.048 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.702 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -124.25 -37.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.008 -0.542 . . . . 1.8200000000000001 111.473 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.749 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 124.58 18.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.685 -0.857 . . . . 1.0800000000000001 108.685 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.904 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -140.27 157.61 45.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.64 -0.709 . . . . 1.8799999999999999 110.344 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 60.5 t80 -133.75 103.56 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.018 -0.364 . . . . 2.2000000000000002 110.018 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.424 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 40.0 t -143.03 155.98 44.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.879 0.371 . . . . 1.4199999999999999 111.925 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.84 30.15 28.43 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 112.899 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t0 71.72 1.6 3.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.481 0.182 . . . . 1.46 111.118 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.2 mmtt -99.95 107.03 18.9 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.787 -0.82 . . . . 2.96 108.787 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.76 118.32 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.601 1.191 . . . . 2.27 108.748 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -100.28 124.9 46.3 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.527 -2.124 . . . . 2.1499999999999999 111.563 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.809 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.8 p-10 -166.31 -53.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.01 -1.478 . . . . 1.2 107.01 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 55.2 t0 -81.34 -32.59 32.91 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.538 -1.21 . . . . 2.1699999999999999 109.117 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 46.9 m-85 -71.55 -31.82 67.42 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.332 -1.358 . . . . 5.4100000000000001 107.332 178.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -82.49 109.97 19.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.338 -1.301 . . . . 2.21 109.256 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 26.7 Cg_exo -62.96 -31.05 77.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.018 1.812 . . . . 1.1100000000000001 113.031 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 83.7 m-20 -49.99 -29.95 9.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 1.3600000000000001 112.564 -178.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 2.0 mp -152.2 27.66 0.59 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.474 -0.785 . . . . 2.2400000000000002 111.198 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.809 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 24.8 pttm -55.63 138.15 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.156 0.503 . . . . 2.8700000000000001 111.839 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.85 82.89 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.617 -0.801 . . . . 0.48999999999999999 114.41 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.58 ' O ' ' O ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -143.35 -52.42 0.36 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 115.07 1.507 . . . . 2.1099999999999999 115.07 -178.545 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.749 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.3 81.33 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.939 1.352 . . . . 1.04 107.861 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -100.64 127.87 46.89 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 112.442 -2.163 . . . . 0.34000000000000002 112.418 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.736 ' CD2' HG13 ' A' ' 79' ' ' ILE . 78.8 m-85 -72.14 120.57 17.92 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.12 -0.696 . . . . 2.1600000000000001 109.12 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.503 HG23 ' CE2' ' A' ' 38' ' ' TYR . 28.4 p -71.34 -9.93 58.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.336 -0.847 . . . . 1.0900000000000001 109.957 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 p -86.94 122.62 31.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.6 -0.727 . . . . 1.71 109.55 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.95 4.66 49.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.144 0.497 . . . . 2.4700000000000002 110.307 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -146.66 69.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.742 -0.836 . . . . 2.1400000000000001 108.742 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -56.13 -39.59 72.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.085 -0.961 . . . . 1.99 111.363 -178.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -64.77 -3.07 2.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.118 0.485 . . . . 2.4900000000000002 112.111 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.7 t -89.56 -0.01 57.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.626 -0.715 . . . . 1.8999999999999999 111.029 179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.517 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.34 -16.16 35.23 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.722 -0.751 . . . . 0.40999999999999998 113.698 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -97.3 108.82 21.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.203 0.502 . . . . 1.4399999999999999 110.45 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.558 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.45 19.94 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 1.1200000000000001 112.667 -179.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.2 m -61.53 140.0 58.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.857 1.429 . . . . 1.46 114.857 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.15 133.27 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.061 -0.972 . . . . 1.0900000000000001 111.25 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.58 ' O ' ' O ' ' A' ' 90' ' ' ARG . 53.4 p-10 -106.66 145.5 31.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.829 -0.804 . . . . 1.5600000000000001 108.829 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.5 122.09 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 1.0600000000000001 111.63 -178.354 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -84.86 144.13 28.61 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.52 -0.764 . . . . 1.0700000000000001 111.169 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 96.8 m-20 49.96 57.66 6.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 1.9399999999999999 111.354 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 31' ' ' LYS . 35.6 mt -47.57 92.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.126 1.158 . . . . 1.21 114.126 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 35.0 mt-30 -58.64 142.4 49.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.069 -0.514 . . . . 2.6699999999999999 110.413 176.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.04 -36.86 78.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.094 0.473 . . . . 2.2400000000000002 110.185 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 t -74.31 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.646 . . . . 1.8300000000000001 111.358 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.74 -15.55 62.69 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.009 -0.367 . . . . 1.5800000000000001 110.009 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 141.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-N 116.238 -0.437 . . . . 1.1399999999999999 110.096 178.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.79 155.2 6.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.879 -1.153 . . . . 0.26000000000000001 113.759 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.5 m -59.18 129.99 44.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.483 0.549 . . . . 1.0700000000000001 112.483 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.2 m-85 -111.2 130.2 55.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.291 -0.633 . . . . 2.1400000000000001 109.291 177.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 62.4 tt0 -121.79 120.05 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.811 -0.356 . . . . 1.5900000000000001 111.022 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 40.7 t -100.04 123.14 43.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.036 -0.529 . . . . 1.03 109.923 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.783 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 96.0 mttt -123.87 105.45 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.69 -0.404 . . . . 2.1899999999999999 111.978 -179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 25.0 t -89.44 111.98 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.476 -0.935 . . . . 1.8200000000000001 108.476 177.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 77.7 tttt -99.45 120.06 39.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.411 0.893 . . . . 2.1899999999999999 113.411 -177.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 14.0 tttp -145.72 102.5 3.68 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.725 -0.472 . . . . 3.2799999999999998 109.725 176.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -50.97 131.36 30.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.548 -0.751 . . . . 1.1799999999999999 112.934 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 46.2 Cg_endo -100.76 48.04 2.04 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.696 -0.96 . . . . 0.62 112.527 -0.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.85 102.64 0.31 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.139 -1.029 . . . . 0.53000000000000003 112.982 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 ' CG1' ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -88.82 132.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.207 -0.997 . . . . 1.8700000000000001 109.629 177.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -121.13 139.05 53.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.773 0.286 . . . . 1.3200000000000001 111.773 -179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.464 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 52.4 p30 -146.33 146.14 30.58 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.252 0.464 . . . . 2.0299999999999998 112.252 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.52 160.11 42.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 3.46 110.652 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 44.0 mttp -99.96 140.78 33.68 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.298 0.851 . . . . 2.6699999999999999 113.298 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.61 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 3.5 mp -139.26 109.13 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.824 -1.08 . . . . 1.0600000000000001 108.459 176.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.472 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 54.0 m170 -97.28 118.02 32.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.353 -0.539 . . . . 0.70999999999999996 110.748 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 118' ' ' TYR . 61.2 tp -92.41 123.3 35.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.883 -0.598 . . . . 2.1000000000000001 111.669 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.665 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 45.3 t -119.93 120.9 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.723 -0.671 . . . . 1.0900000000000001 109.328 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.1 t -95.49 121.97 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.376 0.51 . . . . 1.72 112.376 -178.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 89.6 mt -84.05 163.77 19.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.717 -0.674 . . . . 1.21 109.224 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.1 t -77.04 133.21 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.401 0.62 . . . . 2.0899999999999999 111.429 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.571 ' HD2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.08 177.07 1.78 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.797 -1.092 . . . . 2.7599999999999998 109.675 179.694 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.571 ' HD2' ' HD2' ' A' ' 140' ' ' LYS . 75.3 Cg_exo -51.1 145.28 26.14 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.073 1.849 . . . . 1.4199999999999999 112.107 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -37.44 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.025 -0.534 . . . . 2.6899999999999999 112.251 -179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.84 -63.23 0.91 Allowed Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.767 -0.73 . . . . 2.8799999999999999 112.355 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.408 -0.806 . . . . 2.6000000000000001 111.474 179.698 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.583 ' HA3' ' HA2' ' A' ' 127' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 120.418 -0.101 . . . . 3.6600000000000001 113.092 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -155.19 157.08 36.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.715 0.293 . . . . 2.8100000000000001 110.473 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 99.5 p -77.37 147.41 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 2.2599999999999998 111.361 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -149.72 149.81 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 110.934 -179.577 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.15 155.13 17.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 1.6499999999999999 112.21 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 38.79 82.69 0.22 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.358 -1.292 . . . . 1.26 112.652 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.713 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 53.6 Cg_endo -79.26 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.449 2.766 . . . . 0.88 112.738 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 85.9 tt0 -78.54 127.88 32.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.11 -0.7 . . . . 2.0600000000000001 109.11 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 28' ' ' MET . 44.3 tp10 -143.74 157.02 44.68 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.785 1.032 . . . . 1.71 113.785 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.406 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 54.0 ttp -136.92 125.34 23.42 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.665 -1.152 . . . . 2.3999999999999999 107.934 176.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.619 HD11 HG21 ' A' ' 133' ' ' ILE . 4.1 mp -130.24 137.52 56.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.703 -0.681 . . . . 1.1499999999999999 112.362 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 74.9 mt-10 -133.77 127.74 33.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.156 -0.475 . . . . 1.1899999999999999 110.154 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 10.9 tptm -142.71 161.35 38.32 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.511 0.196 . . . . 2.9300000000000002 110.754 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.07 140.59 41.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 1.1299999999999999 112.228 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 142' ' ' SER . 56.5 tttm -47.25 132.3 12.77 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.819 -0.628 . . . . 2.7599999999999998 111.421 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.64 -20.11 36.91 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.049 -0.596 . . . . 0.32000000000000001 112.686 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.3 mt-10 -80.04 157.67 26.68 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.767 -0.827 . . . . 2.1099999999999999 108.767 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.831 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.5 m -87.6 126.97 35.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.985 -0.686 . . . . 1.0800000000000001 110.733 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.498 ' HB1' HD22 ' A' ' 110' ' ' LEU . . . -99.56 115.17 28.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.831 0.348 . . . . 1.0700000000000001 110.367 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HE1' ' OG1' ' A' ' 94' ' ' THR . 71.6 t80 -79.46 115.14 18.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 2.3199999999999998 112.383 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 20.8 mt -100.22 109.83 57.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 108.593 -0.891 . . . . 1.47 108.593 177.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.46 125.35 2.91 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.353 2.035 . . . . 0.71999999999999997 114.97 -177.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -141.51 122.26 14.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.819 -1.082 . . . . 1.03 108.495 177.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -141.32 115.89 9.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 2.2400000000000002 111.513 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.586 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 25.6 p90 -94.48 139.97 30.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.006 -0.997 . . . . 2.1499999999999999 111.025 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 141.92 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 1.9299999999999999 111.042 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 98.6 mt -97.73 139.54 33.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.599 . . . . 2.5899999999999999 111.527 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.447 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 86.2 p -159.89 145.99 11.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 2.1299999999999999 109.942 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.62 -21.54 3.54 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.318 2.012 . . . . 1.9299999999999999 113.084 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.589 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.75 -40.06 66.36 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.769 -0.196 . . . . 2.1800000000000002 111.329 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 3.1 p30 -69.91 79.14 0.47 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.035 -0.666 . . . . 2.4100000000000001 110.115 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.38 -10.06 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.225 -0.898 . . . . 1.96 111.837 -178.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -79.54 154.26 38.01 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.304 -0.951 . . . . 0.56000000000000005 112.981 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.99 153.71 19.72 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.498 2.132 . . . . 1.1899999999999999 111.696 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.47 HD12 ' CE2' ' A' ' 43' ' ' PHE . 47.7 tp -78.08 131.56 37.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 2.4100000000000001 111.337 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -139.5 149.08 43.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.36 0.6 . . . . 1.78 110.722 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.751 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 30.5 mt -142.75 135.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.845 -1.07 . . . . 1.4099999999999999 109.087 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.631 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 40.2 mt-10 -140.13 108.28 5.77 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.278 0.474 . . . . 1.6699999999999999 112.278 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.834 ' HB2' HG22 ' A' ' 72' ' ' ILE . 78.5 m95 -94.51 126.34 39.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.382 -0.372 . . . . 0.23999999999999999 110.918 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.8 mt -108.87 141.18 41.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.877 -0.786 . . . . 1.1200000000000001 108.877 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 117' ' ' THR . 11.5 tt -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.52 0.563 . . . . 1.3700000000000001 112.52 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 t -120.36 102.95 45.05 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.228 -0.896 . . . . 1.73 108.932 177.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.1 Cg_endo -78.24 115.63 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.527 2.151 . . . . 0.84999999999999998 113.028 -178.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.86 -34.47 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.356 -0.838 . . . . 1.0700000000000001 110.679 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.18 11.53 7.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.637 -0.71 . . . . 1.8200000000000001 111.818 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.451 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -148.93 160.37 43.33 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.279 0.561 . . . . 2.3599999999999999 111.76 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.75 -18.47 64.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.284 -0.871 . . . . 1.95 112.694 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.682 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.3 mttt -65.79 144.05 57.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.253 -0.431 . . . . 2.2799999999999998 111.216 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 m -156.39 129.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-O 121.929 0.871 . . . . 1.4199999999999999 110.019 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.02 40.0 19.23 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.97 -1.468 . . . . 1.77 112.827 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 96.9 mt-30 -95.26 141.1 29.25 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.367 -0.235 . . . . 2.54 110.367 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 16.5 t -65.86 120.0 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.175 0.512 . . . . 1.3899999999999999 109.977 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.779 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -105.97 -51.97 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.4 -0.818 . . . . 1.8200000000000001 112.045 -178.135 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.834 HG22 ' HB2' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -138.81 122.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.949 -1.13 . . . . 1.0800000000000001 107.949 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 1.1 tt -130.98 154.88 47.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.778 -0.646 . . . . 1.8799999999999999 110.895 -176.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.846 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 25.9 t80 -133.01 104.54 6.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.309 -0.256 . . . . 2.2000000000000002 110.309 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.453 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 10.0 t -142.64 156.82 45.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.882 0.372 . . . . 1.4199999999999999 111.98 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.57 29.7 40.55 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.924 -0.655 . . . . 0.56999999999999995 112.43 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.56 3.14 4.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.583 0.23 . . . . 1.46 110.915 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 34.3 mttm -100.03 112.56 24.85 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.749 -0.463 . . . . 2.96 109.749 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.846 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -83.85 116.98 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.941 -1.133 . . . . 2.27 107.941 178.136 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.743 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.5 m-85 -99.95 127.74 46.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.282 -1.781 . . . . 2.1499999999999999 110.589 -178.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.797 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.0 p-10 -166.01 -52.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.426 -1.324 . . . . 1.2 107.426 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -80.2 -23.2 41.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.988 -1.006 . . . . 2.1699999999999999 109.31 177.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -78.68 -28.0 45.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.588 -0.893 . . . . 5.4100000000000001 108.588 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.521 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 m-85 -84.71 119.85 73.28 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 114.942 -1.027 . . . . 2.21 110.668 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.69 -41.75 44.98 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.261 1.307 . . . . 1.1100000000000001 109.237 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 71' ' ' ILE . 39.1 m-20 -66.98 104.66 1.43 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.365 -0.834 . . . . 1.3600000000000001 110.657 178.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.9 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.0 mp 68.8 27.35 5.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.101 1.148 . . . . 2.2400000000000002 114.101 178.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.797 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.3 pttt -57.58 129.56 42.41 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.659 -0.65 . . . . 2.8700000000000001 111.23 177.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.37 19.35 58.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.711 -0.757 . . . . 0.48999999999999999 114.31 178.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.9 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.7 ptm180 -145.89 -48.26 0.21 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.379 1.252 . . . . 2.1099999999999999 114.379 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.817 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -78.86 81.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.071 -1.455 . . . . 1.04 107.071 -178.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 15.7 m80 -102.8 128.62 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.262 -2.245 . . . . 0.34000000000000002 112.789 -175.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 73.3 m-85 -70.26 123.76 22.46 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 120.152 -0.619 . . . . 2.1600000000000001 109.61 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.484 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 15.9 p -73.52 33.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.426 -0.807 . . . . 1.0900000000000001 111.839 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -149.63 128.81 12.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.71 110.097 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -92.64 7.56 42.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.986 -0.552 . . . . 2.4700000000000002 110.377 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -146.35 65.72 1.19 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 109.116 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 74' ' ' TYR . 9.6 mp -56.7 -24.72 51.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.391 -0.822 . . . . 1.99 111.432 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.3 -3.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 2.4900000000000002 111.996 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 98' ' ' LEU . 22.7 t -88.73 0.03 56.86 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.48 -0.782 . . . . 1.8999999999999999 110.94 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 104.31 -9.94 50.12 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.731 -0.747 . . . . 0.40999999999999998 113.647 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.11 110.04 21.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.963 0.381 . . . . 1.4399999999999999 111.198 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -107.77 9.48 28.99 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.508 0.559 . . . . 1.1200000000000001 112.508 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.7 p -59.98 143.45 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.67 1.73 . . . . 1.46 115.67 -178.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.37 132.33 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 114.422 -1.263 . . . . 1.0900000000000001 110.78 178.17 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.559 ' O ' ' O ' ' A' ' 90' ' ' ARG . 53.2 p30 -106.41 146.37 30.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.631 -0.878 . . . . 1.5600000000000001 108.631 177.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.831 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 120.02 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 120.826 0.346 . . . . 1.0600000000000001 111.152 -178.257 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.611 HG22 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.92 143.7 30.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.824 -0.625 . . . . 1.0700000000000001 110.928 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 26.4 m120 47.88 58.89 4.6 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.186 -0.461 . . . . 1.9399999999999999 111.675 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.582 ' HA ' ' NH2' ' A' ' 90' ' ' ARG . 18.8 mt -44.44 88.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.082 1.142 . . . . 1.21 114.082 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.459 ' O ' ' OD2' ' A' ' 114' ' ' ASP . 51.7 tt0 -58.53 147.26 32.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.548 -0.538 . . . . 2.6699999999999999 109.548 176.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.03 -37.03 78.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.43 . . . . 2.2400000000000002 111.036 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.8 m -72.03 -9.66 58.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 1.8300000000000001 112.39 -178.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 111' ' ' GLN . 3.0 p30 -70.47 -18.57 62.98 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.378 -0.529 . . . . 1.5800000000000001 110.085 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 137.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 CA-C-N 115.988 -0.551 . . . . 1.1399999999999999 110.265 179.112 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.99 160.51 8.32 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 119.844 -1.17 . . . . 0.26000000000000001 113.853 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -60.04 137.09 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.125 -0.537 . . . . 1.0700000000000001 112.128 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 25.0 m-85 -120.04 132.15 55.36 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.445 -0.576 . . . . 2.1400000000000001 109.445 177.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.715 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 49.0 tp60 -120.0 115.06 22.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.073 -0.251 . . . . 1.5900000000000001 110.708 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.503 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 53.0 t -98.35 116.82 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 1.03 110.295 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 88.2 mttt -119.1 106.41 12.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 2.1899999999999999 111.066 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.4 t -91.34 105.5 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.566 -0.531 . . . . 1.8200000000000001 109.566 179.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.638 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 52.2 tttp -90.48 116.11 28.15 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.039 -0.665 . . . . 2.1899999999999999 111.474 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.52 ' HE2' ' CB ' ' A' ' 49' ' ' ASP . 7.2 ttpm? -146.08 102.35 3.62 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.457 -0.571 . . . . 3.2799999999999998 109.457 178.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -51.42 134.39 33.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 1.1799999999999999 112.002 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.9 Cg_endo -100.13 48.69 1.92 Allowed 'Cis proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.698 -0.959 . . . . 0.62 111.297 -0.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.583 ' HA2' ' HA3' ' A' ' 19' ' ' GLY . . . -145.8 103.31 0.28 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.188 -1.006 . . . . 0.53000000000000003 113.591 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.404 ' CG1' ' HG3' ' A' ' 123' ' ' LYS . 3.5 m -87.4 120.0 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.552 -0.824 . . . . 1.8700000000000001 109.956 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -101.53 144.77 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.867 0.321 . . . . 1.3200000000000001 111.867 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.44 ' C ' ' HG3' ' A' ' 131' ' ' LYS . 46.1 t30 -146.28 132.11 19.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 2.0299999999999998 111.114 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.713 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 4.7 mttp -142.58 160.33 40.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.841 0.353 . . . . 3.46 111.773 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 64.5 mttt -101.77 141.67 34.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.441 0.904 . . . . 2.6699999999999999 113.441 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.619 HG21 HD11 ' A' ' 29' ' ' ILE . 3.1 mp -142.58 112.59 2.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.041 -0.982 . . . . 1.0600000000000001 109.347 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -101.1 114.4 28.3 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.9 -0.5 . . . . 0.70999999999999996 110.58 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 14.9 mt -96.2 135.58 37.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.698 0.629 . . . . 2.1000000000000001 112.698 -179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 60.7 t -129.96 130.0 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.355 -0.838 . . . . 1.0900000000000001 109.198 178.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.9 t -100.46 121.32 51.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.872 0.368 . . . . 1.72 111.96 -179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.7 mt -80.77 163.7 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.353 -0.61 . . . . 1.21 109.353 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.88 136.98 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.462 0.649 . . . . 2.0899999999999999 111.681 -178.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -163.56 173.74 3.96 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 2.7599999999999998 110.088 179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 46.1 Cg_exo -56.4 -162.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.27 1.98 . . . . 1.4199999999999999 111.965 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.421 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 43.1 p -38.5 -79.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.785 0.326 . . . . 2.6899999999999999 111.611 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.97 15.2 6.36 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.943 -0.646 . . . . 2.8799999999999999 113.418 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.242 -0.885 . . . . 2.6000000000000001 111.132 -179.843 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.557 -0.217 . . . . 3.6600000000000001 112.557 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 m -80.17 112.83 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 2.8100000000000001 111.102 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.02 167.61 20.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 2.2599999999999998 110.666 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 43' ' ' PHE . 45.1 mm -140.02 138.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 110.884 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -86.89 144.91 26.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.6499999999999999 110.292 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.48 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 45.28 82.61 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 115.179 -0.919 . . . . 1.26 110.39 -177.33 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 57.3 Cg_endo -77.94 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.649 2.899 . . . . 0.88 113.095 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.28 120.66 23.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.571 -0.529 . . . . 2.0600000000000001 109.571 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -143.82 160.02 41.51 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.604 0.964 . . . . 1.71 113.604 -177.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 53.6 ttm -130.95 130.95 44.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.867 -1.06 . . . . 2.3999999999999999 108.724 177.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.513 HD12 HG22 ' A' ' 133' ' ' ILE . 3.5 mp -129.71 131.9 66.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.62 . . . . 1.1499999999999999 112.122 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.651 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 89.7 mt-10 -122.63 127.18 49.04 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.281 -0.418 . . . . 1.1899999999999999 110.737 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB2' HD11 ' A' ' 110' ' ' LEU . 47.0 mmtm -142.33 160.03 41.07 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.563 0.221 . . . . 2.9300000000000002 110.998 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.723 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.79 137.0 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 1.1299999999999999 112.157 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 60.0 tttt -46.22 129.97 10.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.895 -0.593 . . . . 2.7599999999999998 110.964 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.74 -19.12 43.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.32000000000000001 112.275 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 68.1 mm-40 -80.05 160.03 25.97 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.438 -0.949 . . . . 2.1099999999999999 108.438 178.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.856 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.6 m -88.82 129.73 35.52 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.608 -0.837 . . . . 1.0800000000000001 110.685 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -99.99 120.0 39.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.895 0.379 . . . . 1.0700000000000001 110.449 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.479 ' HE1' ' CG2' ' A' ' 94' ' ' THR . 70.1 t80 -79.1 117.42 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 2.3199999999999998 111.714 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 20.4 mt -109.98 104.4 55.48 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.838 -0.801 . . . . 1.47 108.838 178.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.637 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 89.8 Cg_endo -86.92 128.92 2.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.352 2.035 . . . . 0.71999999999999997 114.019 -178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 1.8 t -140.8 128.89 22.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.402 -0.817 . . . . 1.03 108.8 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.537 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.6 ttpt -140.86 118.62 11.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.241 0.543 . . . . 2.2400000000000002 110.961 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.575 ' HA ' HD13 ' A' ' 22' ' ' ILE . 43.9 p90 -101.87 137.63 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.667 -1.151 . . . . 2.1499999999999999 112.399 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -89.26 140.01 29.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 1.9299999999999999 109.785 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.7 mt -94.46 109.7 21.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.964 -0.294 . . . . 2.5899999999999999 111.327 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.1 m -83.75 140.0 40.69 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 109.467 -0.568 . . . . 2.1299999999999999 109.467 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.88 -34.08 21.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.801 1.668 . . . . 1.9299999999999999 110.775 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.4 pt-20 -81.52 -33.97 31.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.441 -0.799 . . . . 2.1800000000000002 111.798 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.499 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 78.9 m-20 -69.14 77.62 0.35 Allowed 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 120.271 -0.572 . . . . 2.4100000000000001 110.143 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -101.82 -0.76 33.67 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.502 -0.772 . . . . 1.96 111.548 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -74.08 162.86 54.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.01 -0.614 . . . . 0.56000000000000005 113.4 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.12 131.42 44.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.809 2.339 . . . . 1.1899999999999999 112.168 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 13.6 tp -78.12 126.38 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 2.4100000000000001 111.337 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 6.1 m-20 -139.36 103.09 4.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.564 0.697 . . . . 1.78 111.646 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.9 mt -95.69 118.28 41.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.745 -1.116 . . . . 1.4099999999999999 110.322 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.1 tt0 -115.64 120.32 39.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.453 0.538 . . . . 1.6699999999999999 112.453 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.659 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 82.6 m95 -94.18 119.94 33.73 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.194 -0.299 . . . . 0.23999999999999999 110.194 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.2 mt -108.13 142.45 38.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 1.1200000000000001 110.185 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.6 tt -130.0 132.33 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 1.3700000000000001 112.043 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 48.7 m -117.71 102.12 51.77 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 108.471 -0.937 . . . . 1.73 108.471 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.616 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 85.4 Cg_endo -79.38 113.49 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.807 2.338 . . . . 0.84999999999999998 113.031 -178.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.99 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 1.0700000000000001 111.257 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.63 -40.08 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 1.8200000000000001 111.556 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 33.9 m120 -84.58 160.04 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 2.3599999999999999 111.957 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.81 -18.0 64.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.303 -0.862 . . . . 1.95 111.245 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.616 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 42.9 mttt -69.49 154.63 41.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.579 -0.737 . . . . 2.2799999999999998 111.681 -178.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.72 128.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-O 121.637 0.732 . . . . 1.4199999999999999 109.072 178.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 57.82 41.82 24.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.631 -1.168 . . . . 1.77 111.724 179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 59' ' ' ILE . 96.1 mm-40 -87.07 135.09 33.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.797 0.332 . . . . 2.54 111.59 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 84' ' ' TYR . 57.7 t -71.82 132.02 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 1.3899999999999999 110.261 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.77 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.3 pp -129.84 -39.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.631 0.604 . . . . 1.8200000000000001 112.631 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -140.43 123.6 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.415 0.626 . . . . 1.0800000000000001 109.637 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 7.3 tt -140.58 160.54 39.78 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.576 -0.738 . . . . 1.8799999999999999 109.477 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.597 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 23.9 t80 -134.32 109.15 8.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.218 0.532 . . . . 2.2000000000000002 110.283 178.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.534 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 32.7 t -142.37 160.01 41.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.353 -0.839 . . . . 1.4199999999999999 111.394 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.31 36.82 53.91 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.822 -0.704 . . . . 0.56999999999999995 112.608 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 60.63 25.22 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.609 0.242 . . . . 1.46 111.378 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.563 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.3 mttp -128.15 111.14 13.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.191 -0.67 . . . . 2.96 109.191 177.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.597 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -76.81 119.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.964 -1.124 . . . . 2.27 107.964 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.796 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -99.97 133.51 44.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.72 -1.127 . . . . 2.1499999999999999 110.62 -178.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.3 p-10 -166.46 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.977 -1.49 . . . . 1.2 106.977 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' CA ' ' A' ' 88' ' ' LYS . 50.9 t0 -80.03 -20.19 45.9 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 114.556 -1.202 . . . . 2.1699999999999999 109.315 177.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.7 t80 -78.78 -29.81 45.21 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.25 -1.018 . . . . 5.4100000000000001 108.25 178.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -84.34 112.61 42.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-N 114.436 -1.257 . . . . 2.21 110.872 179.717 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 85.7 Cg_exo -44.09 -42.98 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.501 1.467 . . . . 1.1100000000000001 110.548 178.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.582 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.0 m-20 -68.31 104.92 1.98 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.685 -0.688 . . . . 1.3600000000000001 110.739 178.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.855 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.4 mp 72.71 18.91 4.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.499 0.926 . . . . 2.2400000000000002 113.499 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.445 -0.784 . . . . 2.8700000000000001 110.763 178.022 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.44 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 91.56 11.67 60.46 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.273 -0.965 . . . . 0.48999999999999999 113.917 178.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.855 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.5 ptp180 -141.27 -53.79 0.47 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 114.574 1.324 . . . . 2.1099999999999999 114.574 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.77 HG12 ' CD1' ' A' ' 71' ' ' ILE . 7.3 p -78.73 80.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.11 -1.441 . . . . 1.04 107.11 -178.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.44 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.3 m80 -97.52 128.82 44.57 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.084 -2.326 . . . . 0.34000000000000002 111.849 -176.148 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 60.5 m-85 -69.4 121.66 17.39 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.685 0.755 . . . . 2.1600000000000001 110.684 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.479 ' CG2' ' HE1' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -73.71 34.85 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.471 -1.24 . . . . 1.0900000000000001 111.732 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -148.81 136.39 20.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.076 0.465 . . . . 1.71 111.683 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.23 0.02 56.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.779 -0.646 . . . . 2.4700000000000002 110.737 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -146.45 66.76 1.18 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.294 0.569 . . . . 2.1400000000000001 109.517 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 7.2 mp -59.14 -31.64 69.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.403 -0.817 . . . . 1.99 111.939 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.52 -3.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.152 0.501 . . . . 2.4900000000000002 112.319 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 98' ' ' LEU . 33.8 m -88.5 -0.09 56.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.54 -0.754 . . . . 1.8999999999999999 111.137 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 111.34 -19.88 23.95 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.748 -0.739 . . . . 0.40999999999999998 112.915 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.0 m-20 -97.01 107.47 20.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.694 0.283 . . . . 1.4399999999999999 110.633 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -116.75 24.23 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.891 0.33 . . . . 1.1200000000000001 111.891 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.4 m -60.92 151.6 29.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 114.425 1.268 . . . . 1.46 114.425 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -137.03 140.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.682 -1.145 . . . . 1.0900000000000001 111.545 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.0 p-10 -113.46 142.81 45.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.263 -1.014 . . . . 1.5600000000000001 108.263 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.856 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 122.36 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 120.991 0.424 . . . . 1.0600000000000001 111.868 -177.866 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.67 143.89 28.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 1.0700000000000001 111.16 178.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.9 OUTLIER 50.82 54.35 11.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.08 -0.509 . . . . 1.9399999999999999 112.304 178.537 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 31' ' ' LYS . 34.5 mt -45.9 89.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.441 1.274 . . . . 1.21 114.441 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 60.1 tp60 -59.4 147.72 35.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.767 -0.651 . . . . 2.6699999999999999 110.399 176.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HG ' ' CE ' ' A' ' 33' ' ' LYS . 85.4 mt -59.98 -37.35 79.37 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.875 0.369 . . . . 2.2400000000000002 111.144 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.3 p -72.57 -9.47 58.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.052 -0.522 . . . . 1.8300000000000001 111.333 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 96.0 m-20 -70.0 -19.95 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.91 -0.404 . . . . 1.5800000000000001 109.91 179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 142.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 115.922 -0.581 . . . . 1.1399999999999999 110.455 178.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.45 155.93 6.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.824 -1.179 . . . . 0.26000000000000001 113.828 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.6 m -59.33 128.59 37.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.236 0.458 . . . . 1.0700000000000001 112.236 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.602 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 18.6 m-85 -108.84 130.76 55.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 2.1400000000000001 109.649 177.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -125.76 119.29 27.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.034 -0.266 . . . . 1.5900000000000001 110.765 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.479 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 20.0 t -99.96 115.82 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.03 110.126 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.806 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 52.3 mtpt -112.53 105.52 13.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.878 -0.329 . . . . 2.1899999999999999 111.456 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 15.3 t -89.75 110.58 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.747 -0.834 . . . . 1.8200000000000001 108.747 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 tttm -99.86 120.22 39.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.264 0.839 . . . . 2.1899999999999999 113.264 -177.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 35.5 tttp -145.09 102.15 3.71 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.388 -0.597 . . . . 3.2799999999999998 109.388 177.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -52.36 133.65 43.01 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.331 -0.85 . . . . 1.1799999999999999 113.013 -179.106 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.494 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 55.0 Cg_endo -98.82 47.68 2.11 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.383 -1.09 . . . . 0.62 112.264 -0.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.16 103.13 0.28 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.2 -1.0 . . . . 0.53000000000000003 113.142 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 150.2 3.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.36 -0.92 . . . . 1.8700000000000001 109.587 177.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 22' ' ' ILE . . . -142.98 151.54 40.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.975 -0.29 . . . . 1.3200000000000001 111.683 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.489 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 42.5 p-10 -146.41 153.14 40.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.411 -0.359 . . . . 2.0299999999999998 111.777 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.637 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.35 155.45 43.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.471 -0.331 . . . . 3.46 110.465 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 12.4 tttt -99.99 141.09 33.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.866 1.062 . . . . 2.6699999999999999 113.866 -177.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 68.0 mt -143.81 112.03 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 114.805 -1.089 . . . . 1.0600000000000001 109.397 177.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -97.06 114.38 26.02 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.70999999999999996 110.284 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.47 HD23 ' CE1' ' A' ' 118' ' ' TYR . 52.3 tp -93.02 122.53 35.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.477 0.547 . . . . 2.1000000000000001 112.477 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.651 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.1 t -119.99 121.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.762 -0.829 . . . . 1.0900000000000001 108.762 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 33' ' ' LYS . 11.7 t -98.52 127.03 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 112.656 0.613 . . . . 1.72 112.656 -177.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.723 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 81.3 mt -84.51 173.59 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 1.21 109.443 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -76.52 138.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.358 0.599 . . . . 2.0899999999999999 112.04 -178.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.907 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 7.4 mmmt -159.87 178.91 1.49 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.897 -1.047 . . . . 2.7599999999999998 109.605 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.907 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 20.5 Cg_exo -31.59 146.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 123.058 2.505 . . . . 1.4199999999999999 114.133 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.72 42.57 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.008 1.484 . . . . 2.6899999999999999 115.008 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 141' ' ' PRO . . . 149.72 55.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.386 -1.388 . . . . 2.8799999999999999 114.329 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.659 ' H ' ' HE2' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.104 -0.951 . . . . 2.6000000000000001 111.197 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.551 -0.22 . . . . 3.6600000000000001 112.551 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -157.22 157.0 33.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 2.8100000000000001 110.758 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.2 m -158.86 163.68 36.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 2.2599999999999998 111.026 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.67 141.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 2.6299999999999999 110.798 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.2 p -86.58 157.22 19.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.41 0.624 . . . . 1.6499999999999999 111.399 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.549 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.13 83.21 0.21 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.75 -1.113 . . . . 1.26 111.489 -178.206 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.6 Cg_endo -78.39 -79.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.277 2.651 . . . . 0.88 112.354 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -78.58 128.14 33.1 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.607 -0.886 . . . . 2.0600000000000001 108.607 178.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' LYS . 84.0 tt0 -144.03 159.45 42.57 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.038 1.125 . . . . 1.71 114.038 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.407 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 27.4 mtt -139.97 118.93 12.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.802 -1.09 . . . . 2.3999999999999999 109.584 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.9 mm -120.02 130.93 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.509 -0.314 . . . . 1.1499999999999999 111.428 -179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 19.5 pt-20 -128.56 127.8 43.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 1.1899999999999999 110.775 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HB2' HD13 ' A' ' 110' ' ' LEU . 42.4 mmtm -142.28 164.86 29.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.439 . . . . 2.9300000000000002 110.953 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' CB ' ' HG3' ' A' ' 140' ' ' LYS . . . -76.52 135.24 39.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.286 -0.416 . . . . 1.1299999999999999 111.283 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 71.3 tttt -45.84 130.71 9.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.346 -0.388 . . . . 2.7599999999999998 111.24 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.77 -19.91 45.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 0.32000000000000001 112.372 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 99.2 mt-10 -80.03 160.01 26.0 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.551 -0.907 . . . . 2.1099999999999999 108.551 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 31.3 m -88.68 127.34 35.58 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.789 -0.764 . . . . 1.0800000000000001 110.762 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 110' ' ' LEU . . . -100.04 119.97 39.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 1.0700000000000001 110.829 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CE2' HG22 ' A' ' 94' ' ' THR . 41.4 t80 -79.37 119.35 22.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 2.3199999999999998 111.907 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -103.8 105.42 47.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.87 -0.789 . . . . 1.47 108.87 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.489 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 90.7 Cg_endo -84.6 122.66 2.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.449 2.099 . . . . 0.71999999999999997 114.589 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.416 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.73 127.26 20.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.355 -0.979 . . . . 1.03 108.355 177.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.8 ttpt -140.69 116.56 10.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.393 0.616 . . . . 2.2400000000000002 110.697 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.701 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 33.2 p90 -93.62 141.43 28.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 2.1499999999999999 111.885 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 m -80.94 150.48 28.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 110.774 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.79 141.62 39.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.841 -0.618 . . . . 2.5899999999999999 111.313 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 m -156.25 153.59 25.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 2.1299999999999999 110.162 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.4 -20.69 26.82 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.431 2.087 . . . . 1.9299999999999999 112.467 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.678 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 mt-10 -75.76 -41.42 53.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 111.942 0.349 . . . . 2.1800000000000002 111.942 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -69.2 74.64 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.836 -0.745 . . . . 2.4100000000000001 110.244 -179.43 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' GLU . 93.0 mt-30 -90.42 -16.44 29.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.085 -0.961 . . . . 1.96 111.02 -179.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.487 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -70.05 155.8 53.25 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.133 -1.032 . . . . 0.56000000000000005 112.096 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.23 151.13 9.75 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.125 1.883 . . . . 1.1899999999999999 111.551 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.701 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -77.67 132.62 38.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.854 0.359 . . . . 2.4100000000000001 110.946 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 36.1 t0 -140.26 150.5 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.392 0.615 . . . . 1.78 111.895 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 50.4 mt -142.23 137.78 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.682 -1.145 . . . . 1.4099999999999999 109.619 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 73' ' ' LEU . 37.0 mt-10 -140.22 111.86 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.79 0.328 . . . . 1.6699999999999999 111.825 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.621 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 80.6 m95 -98.67 119.99 38.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 110.908 178.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.55 146.15 37.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.492 . . . . 1.1200000000000001 109.67 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.3 tt -132.5 140.01 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.775 0.657 . . . . 1.3700000000000001 112.775 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -122.37 102.98 39.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.628 -0.879 . . . . 1.73 108.628 177.149 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.7 Cg_exo -79.08 115.23 3.49 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.725 2.283 . . . . 0.84999999999999998 113.22 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.32 69.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 1.0700000000000001 110.243 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.68 10.22 7.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.614 -0.721 . . . . 1.8200000000000001 111.491 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 32.7 m120 -145.77 156.01 43.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.061 0.458 . . . . 2.3599999999999999 111.361 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.91 -22.87 64.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.652 -0.703 . . . . 1.95 111.716 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.68 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 5.6 mttt -73.79 151.23 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 2.2799999999999998 110.71 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.3 m -152.41 136.29 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 122.502 1.144 . . . . 1.4199999999999999 110.764 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 61.23 45.05 9.23 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.758 -2.019 . . . . 1.77 112.566 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -87.12 149.72 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.728 0.299 . . . . 2.54 110.538 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.712 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.9 p -68.26 139.99 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.427 -0.351 . . . . 1.3899999999999999 110.09 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.744 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.1 pp -136.51 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.538 -0.465 . . . . 1.8200000000000001 111.552 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.837 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.19 133.14 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.009 0.433 . . . . 1.0800000000000001 109.848 179.384 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.615 ' HB2' ' CE2' ' A' ' 84' ' ' TYR . 1.6 mp -140.83 158.57 43.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 1.8799999999999999 111.024 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 51.8 t80 -133.68 104.47 6.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.578 -0.527 . . . . 2.2000000000000002 109.578 176.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.498 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.1 t -144.02 159.78 42.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.413 0.523 . . . . 1.4199999999999999 112.413 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.57 30.02 6.05 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.988 -0.551 . . . . 0.56999999999999995 113.182 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 t0 71.9 3.07 4.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 1.46 111.4 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 22.8 mtpp -100.03 118.05 35.6 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.1 -0.704 . . . . 2.96 109.1 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.443 HD13 ' CE1' ' A' ' 74' ' ' TYR . 2.3 mm -79.86 130.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.87 -1.159 . . . . 2.27 107.87 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.77 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.1 m-85 -118.56 125.79 50.59 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.096 -0.956 . . . . 2.1499999999999999 110.289 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.823 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.0 p-10 -166.09 -55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.486 -1.672 . . . . 1.2 106.486 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 34.0 p-10 -82.18 -22.08 36.19 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.311 -1.313 . . . . 2.1699999999999999 109.202 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -80.83 -26.52 36.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.736 -1.12 . . . . 5.4100000000000001 108.556 178.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 1.8 m-85 -85.25 118.3 70.51 Favored Pre-proline 0 CA--C 1.51 -0.58 0 CA-C-N 115.374 -0.83 . . . . 2.21 109.868 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.6 Cg_endo -47.04 -43.6 24.54 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.421 1.414 . . . . 1.1100000000000001 110.49 179.125 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 71.5 m-20 -69.59 106.25 2.96 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.627 -0.829 . . . . 1.3600000000000001 111.512 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.818 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.7 mp 73.12 20.13 3.46 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.186 -0.916 . . . . 2.2400000000000002 113.453 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 60.2 pttt -54.66 126.07 22.42 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.903 -0.719 . . . . 2.8700000000000001 111.332 178.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 14.28 45.09 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.323 -0.941 . . . . 0.48999999999999999 114.402 178.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.818 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.7 -47.2 0.24 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 114.656 1.354 . . . . 2.1099999999999999 114.656 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.837 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.24 81.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.676 1.227 . . . . 1.04 108.109 -178.285 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 106' ' ' ASN . 21.8 m80 -102.73 130.2 49.6 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.081 -1.872 . . . . 0.34000000000000002 112.313 -176.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 68.9 m-85 -72.82 121.22 19.57 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.177 -0.675 . . . . 2.1600000000000001 109.177 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.552 HG21 ' OD1' ' A' ' 106' ' ' ASN . 38.1 p -70.15 -9.78 56.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.188 -0.914 . . . . 1.0900000000000001 110.805 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.5 m -91.09 119.95 31.65 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.987 -0.551 . . . . 1.71 110.449 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.59 4.07 50.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.268 0.556 . . . . 2.4700000000000002 110.142 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -145.99 67.6 1.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.262 -1.014 . . . . 2.1400000000000001 108.262 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 100' ' ' SER . 6.8 mp -55.73 -33.41 64.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.975 -1.011 . . . . 1.99 111.72 -178.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -61.28 -3.59 0.95 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.152 0.501 . . . . 2.4900000000000002 112.21 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -88.68 0.07 56.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.546 -0.752 . . . . 1.8999999999999999 111.187 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.81 -12.31 45.9 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.618 -0.801 . . . . 0.40999999999999998 113.673 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.75 113.76 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.472 . . . . 1.4399999999999999 111.418 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.532 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -109.36 12.17 24.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.637 . . . . 1.1200000000000001 111.918 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 72.5 p -60.03 140.05 57.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.64 1.718 . . . . 1.46 115.64 -178.002 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.07 135.51 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-N 114.104 -1.407 . . . . 1.0900000000000001 110.871 178.547 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.591 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -105.03 148.21 27.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.039 -0.726 . . . . 1.5600000000000001 109.039 177.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -101.42 118.89 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.005 0.431 . . . . 1.0600000000000001 110.999 -179.561 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.584 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.1 p -83.26 144.44 29.74 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.537 -0.756 . . . . 1.0700000000000001 110.53 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 50.58 57.52 6.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.037 0.446 . . . . 1.9399999999999999 111.549 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 31' ' ' LYS . 23.5 mt -46.92 90.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.95 1.092 . . . . 1.21 113.95 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 33.7 mt-30 -59.22 141.47 54.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.864 -0.607 . . . . 2.6699999999999999 110.702 176.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.06 -37.02 78.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 2.2400000000000002 110.215 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.58 -9.97 59.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.8300000000000001 111.48 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' O ' HD11 ' A' ' 59' ' ' ILE . 92.4 m-20 -72.47 -17.07 61.79 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.938 -0.393 . . . . 1.5800000000000001 109.938 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.46 141.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 116.198 -0.455 . . . . 1.1399999999999999 110.346 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.11 158.97 7.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.218 -0.991 . . . . 0.26000000000000001 113.352 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -59.55 131.04 49.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.685 0.624 . . . . 1.0700000000000001 112.685 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' CE1' HD23 ' A' ' 135' ' ' LEU . 20.7 m-85 -111.26 135.38 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.294 -0.632 . . . . 2.1400000000000001 109.294 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 59.2 tt0 -127.06 121.5 31.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.971 -0.291 . . . . 1.5900000000000001 110.717 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 26.0 t -99.98 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.456 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' GLU . 90.8 mttt -119.81 106.22 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.1899999999999999 111.188 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 50.1 t -93.72 109.92 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.695 -0.483 . . . . 1.8200000000000001 109.695 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 72.6 tttt -94.13 120.01 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.969 -0.693 . . . . 2.1899999999999999 112.308 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.574 ' HE2' ' CD2' ' A' ' 43' ' ' PHE . 5.6 mtmp? -143.73 101.99 3.84 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.202 -0.666 . . . . 3.2799999999999998 109.202 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.487 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.03 131.02 40.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 113.016 0.747 . . . . 1.1799999999999999 113.016 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 21.2 Cg_endo -102.03 51.92 1.44 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.788 -0.922 . . . . 0.62 111.505 -0.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.49 103.44 0.29 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.183 -1.008 . . . . 0.53000000000000003 113.993 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.2 m -89.52 139.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.193 -1.004 . . . . 1.8700000000000001 109.396 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -136.73 149.34 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.193 -0.317 . . . . 1.3200000000000001 111.81 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.6 p-10 -146.41 151.22 37.09 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.381 0.511 . . . . 2.0299999999999998 112.381 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.549 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.65 155.27 42.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.915 -0.584 . . . . 3.46 110.37 178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.5 mttt -101.25 140.02 36.12 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.504 0.927 . . . . 2.6699999999999999 113.504 -178.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 118' ' ' TYR . 85.6 mt -140.23 119.97 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 1.0600000000000001 109.026 176.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.424 ' CD2' HG23 ' A' ' 117' ' ' THR . 35.3 m170 -100.25 116.79 33.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.609 -0.436 . . . . 0.70999999999999996 110.44 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.53 HD23 ' CE1' ' A' ' 118' ' ' TYR . 58.8 tp -89.86 120.1 30.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.451 . . . . 2.1000000000000001 111.657 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 57.7 t -118.14 119.95 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 1.0900000000000001 109.418 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.1 t -99.78 125.81 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.038 0.447 . . . . 1.72 112.174 -178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 97.8 mt -83.92 170.0 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.734 -0.667 . . . . 1.21 109.545 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.3 t -75.97 138.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 2.0899999999999999 111.55 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 4.4 mmtt -160.85 171.19 7.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.872 -1.058 . . . . 2.7599999999999998 109.89 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 11.1 Cg_endo -53.74 -154.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.542 2.161 . . . . 1.4199999999999999 112.131 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.1 t -36.33 -49.95 0.73 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.916 0.389 . . . . 2.6899999999999999 111.723 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 73.32 -60.01 1.91 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.919 -0.657 . . . . 2.8799999999999999 113.279 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.246 -0.883 . . . . 2.6000000000000001 111.152 -179.724 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.619 -0.192 . . . . 3.6600000000000001 112.619 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 159.32 28.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 2.8100000000000001 110.848 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 142.6 36.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 2.2599999999999998 111.066 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 42' ' ' LYS . 15.6 tt -142.18 131.3 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 2.6299999999999999 110.793 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.432 ' HG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -92.73 151.75 19.88 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.546 0.689 . . . . 1.6499999999999999 111.65 -179.479 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.59 82.96 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.673 -1.149 . . . . 1.26 111.491 -178.287 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.574 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.9 Cg_endo -78.6 -83.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.557 2.838 . . . . 0.88 112.989 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.4 tt0 -77.97 120.22 22.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.221 -0.659 . . . . 2.0600000000000001 109.221 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 132' ' ' LYS . 86.1 tt0 -144.02 161.03 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.472 0.916 . . . . 1.71 113.472 -176.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.4 ' N ' ' HG2' ' A' ' 27' ' ' GLU . 53.8 ttm -131.91 139.42 48.74 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.255 -0.884 . . . . 2.3999999999999999 109.807 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -134.24 140.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.202 -0.454 . . . . 1.1499999999999999 111.465 -179.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.406 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.5 pt-20 -137.84 129.21 27.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.773 0.32 . . . . 1.1899999999999999 111.086 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HB2' HD12 ' A' ' 110' ' ' LEU . 56.8 mmtt -142.33 159.98 41.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.327 -0.397 . . . . 2.9300000000000002 111.534 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.755 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.51 142.51 40.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.089 -0.505 . . . . 1.1299999999999999 111.844 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 66.4 mttt -46.66 144.13 2.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.888 -0.597 . . . . 2.7599999999999998 111.933 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.97 -22.81 2.8 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.328 -0.851 . . . . 0.32000000000000001 113.334 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.99 160.03 26.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.435 -0.58 . . . . 2.1099999999999999 109.435 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 60.5 m -87.09 129.1 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.182 -0.607 . . . . 1.0800000000000001 110.712 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.474 ' HB1' HG22 ' A' ' 107' ' ' VAL . . . -100.0 115.34 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.044 0.45 . . . . 1.0700000000000001 110.631 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.471 ' CD1' HG23 ' A' ' 94' ' ' THR . 70.6 t80 -79.38 120.05 23.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.117 -0.492 . . . . 2.3199999999999998 112.315 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 39' ' ' LEU . 23.8 mt -104.73 104.86 48.13 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.05 -0.722 . . . . 1.47 109.05 177.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.8 Cg_exo -80.23 130.78 8.36 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.535 2.157 . . . . 0.71999999999999997 114.257 -177.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.572 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 1.9 t -141.17 130.96 24.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.125 -0.943 . . . . 1.03 108.766 177.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HB2' ' HG1' ' A' ' 23' ' ' THR . 6.4 mmtp -140.24 137.54 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.473 -0.33 . . . . 2.2400000000000002 110.649 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.577 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.3 p90 -140.92 139.97 34.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.461 . . . . 2.1499999999999999 111.488 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 1.9299999999999999 110.567 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.67 108.04 20.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.421 -0.354 . . . . 2.5899999999999999 110.871 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 t -84.3 136.87 39.96 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.879 -0.415 . . . . 2.1299999999999999 109.879 179.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.55 -30.73 4.17 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.842 1.694 . . . . 1.9299999999999999 111.194 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.94 -38.6 45.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.565 -0.743 . . . . 2.1800000000000002 111.018 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 78.0 m-20 -70.13 73.78 0.47 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.518 -0.473 . . . . 2.4100000000000001 109.741 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -98.55 0.05 44.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.677 -0.692 . . . . 1.96 111.912 -178.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -69.4 171.73 39.75 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.811 -0.709 . . . . 0.56000000000000005 113.183 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.66 138.69 65.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.816 2.344 . . . . 1.1899999999999999 112.365 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.556 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 2.0 mt -78.54 111.82 14.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 2.4100000000000001 111.557 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.761 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 89.0 m-20 -127.57 102.75 6.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.613 0.721 . . . . 1.78 111.429 178.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.3 mt -94.01 123.55 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.61 -1.177 . . . . 1.4099999999999999 109.96 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 95.0 mt-10 -120.01 111.87 18.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.831 0.678 . . . . 1.6699999999999999 112.831 -178.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.802 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 69.9 m95 -94.33 119.96 33.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.772 -0.371 . . . . 0.23999999999999999 110.088 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 86.1 mt -105.59 122.67 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.665 0.269 . . . . 1.1200000000000001 110.329 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG2' ' HB ' ' A' ' 71' ' ' ILE . 7.3 tt -108.11 131.52 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.459 0.54 . . . . 1.3700000000000001 112.459 -179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -126.1 102.19 27.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.909 -0.774 . . . . 1.73 108.909 177.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.5 Cg_exo -79.77 118.35 3.79 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.735 2.29 . . . . 0.84999999999999998 112.389 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.06 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 1.0700000000000001 111.024 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.0 -40.03 60.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.869 -0.605 . . . . 1.8200000000000001 111.845 -179.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.33 159.95 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.329 0.585 . . . . 2.3599999999999999 111.988 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -69.36 -16.76 63.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.121 -0.945 . . . . 1.95 111.199 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.65 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.7 mttm -69.15 149.14 48.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.629 -0.714 . . . . 2.2799999999999998 111.651 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.73 127.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-O 121.942 0.877 . . . . 1.4199999999999999 109.887 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.65 39.98 27.0 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.51 178.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.04 143.85 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.367 0.127 . . . . 2.54 110.719 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 26.5 t -67.9 119.79 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.108 0.48 . . . . 1.3899999999999999 110.004 179.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.711 HG12 ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.23 -55.45 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.622 -0.717 . . . . 1.8200000000000001 112.328 -178.203 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.73 HG12 ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -135.8 124.47 38.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.145 -1.058 . . . . 1.0800000000000001 108.145 179.119 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 5.6 tt -137.71 156.17 48.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.928 -0.578 . . . . 1.8799999999999999 110.786 -176.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' N ' HD22 ' A' ' 73' ' ' LEU . 25.2 t80 -132.81 103.71 6.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.198 -0.456 . . . . 2.2000000000000002 109.879 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.407 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 29.7 t -143.99 156.61 44.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.244 0.461 . . . . 1.4199999999999999 112.244 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.24 29.3 21.81 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.02 -0.609 . . . . 0.56999999999999995 112.795 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.6 t0 73.47 2.85 4.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.494 0.188 . . . . 1.46 111.28 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 80.2 mttt -100.01 115.17 29.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 110.148 -0.316 . . . . 2.96 110.148 178.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 HG22 ' CE2' ' A' ' 93' ' ' PHE . 2.4 mm -80.34 128.33 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 106.927 -1.509 . . . . 2.27 106.927 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.64 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.6 m-85 -112.43 117.31 32.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.215 -0.902 . . . . 2.1499999999999999 110.38 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.833 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.4 p-10 -166.14 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.845 -1.539 . . . . 1.2 106.845 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -76.63 -34.66 58.33 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.37 -1.286 . . . . 2.1699999999999999 108.563 177.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 37.5 m-85 -74.52 -29.98 61.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.765 -1.198 . . . . 5.4100000000000001 107.765 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.542 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 m-85 -83.47 110.83 27.01 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 114.833 -1.076 . . . . 2.21 109.938 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 23.0 Cg_exo -64.77 -28.14 59.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.063 1.842 . . . . 1.1100000000000001 112.456 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' LEU . 61.1 m-20 -50.05 -32.77 16.31 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.356 -0.538 . . . . 1.3600000000000001 111.843 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.812 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.6 mp -151.42 35.27 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.092 -0.958 . . . . 2.2400000000000002 110.424 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.8 pttp -57.26 134.86 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.134 0.492 . . . . 2.8700000000000001 112.011 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 75.54 19.84 78.96 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.513 -0.767 . . . . 0.48999999999999999 113.947 178.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -146.78 -48.71 0.19 Allowed 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.394 1.257 . . . . 2.1099999999999999 114.394 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG12 HD11 ' A' ' 71' ' ' ILE . 8.2 p -80.0 81.48 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.979 1.371 . . . . 1.04 107.721 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.419 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 15.6 m80 -101.81 127.68 48.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.355 -2.202 . . . . 0.34000000000000002 112.366 -175.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.683 ' HA ' ' O ' ' A' ' 104' ' ' SER . 58.6 m-85 -71.86 124.02 23.94 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 120.219 -0.592 . . . . 2.1600000000000001 109.406 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.471 HG23 ' CD1' ' A' ' 38' ' ' TYR . 30.6 p -73.9 33.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.587 -0.733 . . . . 1.0900000000000001 112.517 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 m -148.91 136.25 20.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.968 0.413 . . . . 1.71 111.338 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.8 1.01 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 2.4700000000000002 110.735 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -146.35 65.53 1.19 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.347 0.594 . . . . 2.1400000000000001 109.583 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 9.5 mp -57.67 -30.04 65.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 1.99 111.114 -179.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -60.01 -10.96 4.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.619 0.723 . . . . 2.4900000000000002 112.238 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -83.45 0.05 47.95 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.489 -1.232 . . . . 1.8999999999999999 111.121 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.448 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 112.87 -9.38 25.47 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.627 -0.797 . . . . 0.40999999999999998 113.433 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.59 116.58 29.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.931 0.366 . . . . 1.4399999999999999 110.61 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' HB1' ' HB3' ' A' ' 41' ' ' CYS . . . -115.75 10.03 15.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.491 -0.322 . . . . 1.1200000000000001 111.627 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 50.4 m -60.01 139.76 57.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 115.335 1.605 . . . . 1.46 115.335 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -134.71 127.87 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 114.419 -1.264 . . . . 1.0900000000000001 110.45 178.375 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.635 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.8 OUTLIER -103.65 150.46 23.98 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.506 -0.553 . . . . 1.5600000000000001 109.506 178.119 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -101.14 119.98 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.101 0.477 . . . . 1.0600000000000001 111.114 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -85.56 144.12 28.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.313 -0.858 . . . . 1.0700000000000001 110.64 178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.15 59.99 3.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.629 0.603 . . . . 1.9399999999999999 112.629 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 31' ' ' LYS . 8.9 mt -46.0 178.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.13 0.49 . . . . 1.21 112.274 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 112' ' ' LEU . 64.1 tt0 -177.55 161.44 1.71 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.817 -0.629 . . . . 2.6699999999999999 110.25 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.75 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 59.0 tp -59.96 -40.03 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.842 0.353 . . . . 2.2400000000000002 111.376 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -72.2 -12.33 61.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.127 -0.488 . . . . 1.8300000000000001 111.683 -178.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.14 -21.31 61.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.791 -0.448 . . . . 1.5800000000000001 109.791 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.94 145.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.877 -0.601 . . . . 1.1399999999999999 111.06 179.066 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.68 149.91 5.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.768 -1.206 . . . . 0.26000000000000001 114.229 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.8 m -59.81 136.8 58.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.802 -0.699 . . . . 1.0700000000000001 111.813 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.2 m-85 -120.0 132.57 55.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.704 -0.48 . . . . 2.1400000000000001 109.704 177.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.802 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.7 tt0 -120.29 116.4 25.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.589 -0.278 . . . . 1.5900000000000001 110.631 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.503 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 53.3 t -100.02 115.57 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 1.03 110.545 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 29.7 mtpp -119.46 105.7 11.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 2.1899999999999999 111.125 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.577 HG11 ' CG ' ' A' ' 43' ' ' PHE . 42.9 t -90.03 117.14 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.349 -0.611 . . . . 1.8200000000000001 109.349 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.761 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 62.9 tttp -98.58 120.29 38.75 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.515 0.931 . . . . 2.1899999999999999 113.515 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.556 ' HD3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -143.17 101.04 3.74 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.105 -0.702 . . . . 3.2799999999999998 109.105 176.44 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -54.68 132.56 65.0 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.722 -0.672 . . . . 1.1799999999999999 112.71 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 51.6 Cg_endo -99.53 48.37 1.98 Allowed 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.68 -0.967 . . . . 0.62 112.432 -0.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.37 103.56 0.29 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.864 -0.684 . . . . 0.53000000000000003 112.823 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.03 152.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.575 -0.812 . . . . 1.8700000000000001 110.099 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -131.66 147.46 52.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.485 0.183 . . . . 1.3200000000000001 111.198 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -146.69 138.59 24.64 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.871 0.322 . . . . 2.0299999999999998 111.871 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.574 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.42 151.7 38.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.49 -0.323 . . . . 3.46 110.824 178.865 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' PRO . 3.4 tttt -97.98 139.94 33.07 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 113.188 0.81 . . . . 2.6699999999999999 113.188 -177.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 90.1 mt -145.1 113.7 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 115.662 -0.699 . . . . 1.0600000000000001 109.76 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -102.95 120.0 39.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.70999999999999996 111.273 -179.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 13.8 mt -91.09 127.23 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 2.1000000000000001 112.634 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 30' ' ' GLU . 62.7 t -113.27 127.48 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.098 -0.955 . . . . 1.0900000000000001 108.939 178.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.88 120.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.579 0.585 . . . . 1.72 112.579 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.755 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 78.4 mt -83.57 160.85 21.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.899 -0.592 . . . . 1.21 109.765 178.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -76.05 139.98 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.384 0.612 . . . . 2.0899999999999999 112.204 -178.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.81 179.81 1.28 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 114.759 -1.11 . . . . 2.7599999999999998 109.197 -179.874 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 88.4 Cg_exo -49.13 -141.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.684 2.256 . . . . 1.4199999999999999 113.42 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.4 m -34.58 -41.2 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.454 0.539 . . . . 2.6899999999999999 112.454 -178.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 33' ' ' LYS . . . 123.08 -52.57 0.77 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.454 -0.879 . . . . 2.8799999999999999 113.331 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.258 -0.877 . . . . 2.6000000000000001 111.068 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.478 -0.249 . . . . 3.6600000000000001 112.478 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -78.71 140.4 38.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 2.8100000000000001 110.742 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -157.79 163.58 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 2.2599999999999998 111.092 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 42' ' ' LYS . 17.1 tt -139.98 139.37 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 2.6299999999999999 110.324 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 7.9 p -92.09 153.03 19.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.49 0.662 . . . . 1.6499999999999999 111.734 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.508 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.41 83.75 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 114.554 -1.203 . . . . 1.26 111.502 -178.358 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.4 Cg_endo -77.84 -80.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.334 2.689 . . . . 0.88 112.704 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 14.7 pt-20 -78.49 128.11 33.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 179.163 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.8 tp10 -144.14 160.01 41.66 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.247 1.203 . . . . 1.71 114.247 -176.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.457 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 11.2 mtm -140.26 118.27 11.87 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.464 -1.244 . . . . 2.3999999999999999 109.126 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.7 mm -120.03 128.65 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.906 0.384 . . . . 1.1499999999999999 111.561 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.4 mt-10 -120.01 125.35 48.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.1899999999999999 109.916 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HB2' HD12 ' A' ' 110' ' ' LEU . 74.5 mmtt -141.9 160.02 41.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 2.9300000000000002 111.428 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.77 134.37 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.143 -0.48 . . . . 1.1299999999999999 111.742 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 84.8 tttt -46.92 134.38 10.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.934 -0.575 . . . . 2.7599999999999998 111.273 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.47 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 90.72 -25.16 14.24 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.992 -0.623 . . . . 0.32000000000000001 112.66 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 98.9 mt-10 -80.0 160.0 26.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.124 -1.065 . . . . 2.1099999999999999 108.124 178.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.827 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 59.1 m -87.98 127.04 35.38 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.491 -0.884 . . . . 1.0800000000000001 110.609 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 106' ' ' ASN . . . -97.52 116.65 30.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.905 0.383 . . . . 1.0700000000000001 110.169 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CE1' HG23 ' A' ' 94' ' ' THR . 74.5 t80 -79.11 118.54 21.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.873 -0.603 . . . . 2.3199999999999998 112.259 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' HD13 ' A' ' 133' ' ' ILE . 38.7 mt -102.9 107.94 56.64 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.142 -0.688 . . . . 1.47 109.142 178.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.32 120.63 3.3 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.078 . . . . 0.71999999999999997 114.312 -178.106 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.485 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 2.6 t -141.01 123.93 16.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.777 -0.823 . . . . 1.03 108.777 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.641 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 17.1 mttp -141.09 153.77 45.61 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.283 -0.417 . . . . 2.2400000000000002 110.758 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 101' ' ' GLY . 33.1 p90 -139.74 145.71 38.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.631 . . . . 2.1499999999999999 111.479 -178.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.07 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.456 -0.793 . . . . 1.9299999999999999 111.631 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.53 147.46 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.904 -0.589 . . . . 2.5899999999999999 110.943 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 19.5 p -157.35 139.98 10.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 2.1299999999999999 110.29 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.27 -27.05 2.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.801 2.334 . . . . 1.9299999999999999 112.804 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.616 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.08 -28.65 54.69 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.025 0.38 . . . . 2.1800000000000002 112.025 -179.518 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 44.1 p-10 -67.74 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.453 0.644 . . . . 2.4100000000000001 111.22 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 48' ' ' GLU . 65.8 mt-30 -96.98 -6.81 34.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.678 . . . . 1.96 111.763 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -73.85 158.24 52.08 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.207 -0.997 . . . . 0.56000000000000005 113.056 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.83 130.33 39.79 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 1.1899999999999999 111.209 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.687 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.3 tt -77.81 119.96 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.39 . . . . 2.4100000000000001 110.981 -179.04 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 75' ' ' SER . 0.4 OUTLIER -136.67 102.76 5.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.648 0.737 . . . . 1.78 111.83 179.727 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.8 mt -96.71 111.4 26.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.802 -1.09 . . . . 1.4099999999999999 110.37 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.2 mt-10 -108.91 117.67 34.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.389 0.515 . . . . 1.6699999999999999 112.389 -179.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.651 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 73.9 m95 -95.43 118.52 32.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.771 -0.455 . . . . 0.23999999999999999 109.771 177.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.6 mt -109.96 140.02 44.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.599 -0.273 . . . . 1.1200000000000001 110.294 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.6 tt -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.086 0.402 . . . . 1.3700000000000001 112.086 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.8 m -114.63 102.53 54.88 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 108.515 -0.92 . . . . 1.73 108.515 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 81.4 Cg_endo -78.85 111.06 2.91 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.475 2.117 . . . . 0.84999999999999998 113.151 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.99 72.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 111.009 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 7.4 p-10 -87.6 17.21 4.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.242 -0.435 . . . . 1.8200000000000001 111.369 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.517 HD22 ' HB2' ' A' ' 113' ' ' SER . 91.8 m-20 -148.34 162.98 38.44 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.408 0.623 . . . . 2.3599999999999999 111.96 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.3 -19.84 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.946 . . . . 1.95 111.64 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.622 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 57.4 mttt -69.68 151.74 45.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.073 -0.512 . . . . 2.2799999999999998 111.344 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.98 127.93 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-O 121.752 0.787 . . . . 1.4199999999999999 109.483 178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.48 41.26 31.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.312 -1.313 . . . . 1.77 112.227 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.38 134.89 33.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 2.54 110.919 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.475 HG13 ' CZ ' ' A' ' 84' ' ' TYR . 91.3 t -70.5 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.619 -0.264 . . . . 1.3899999999999999 110.872 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.663 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 1.5 pp -127.11 -36.7 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.269 0.47 . . . . 1.8200000000000001 112.269 -179.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.758 ' HB ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 123.4 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.53 0.681 . . . . 1.0800000000000001 109.385 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 5.2 tt -140.36 155.61 46.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.491 -0.777 . . . . 1.8799999999999999 109.592 -178.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 62.7 t80 -132.45 104.29 6.63 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.658 0.266 . . . . 2.2000000000000002 110.318 179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.43 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 17.9 t -142.46 157.05 45.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.9 0.381 . . . . 1.4199999999999999 111.875 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.39 29.45 38.5 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.002 -0.618 . . . . 0.56999999999999995 112.684 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 71.9 2.43 4.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.601 0.239 . . . . 1.46 110.933 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.0 mttm -100.05 107.36 19.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.991 -0.744 . . . . 2.96 108.991 177.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.751 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.95 118.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 122.511 1.148 . . . . 2.27 108.562 178.674 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.69 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -100.19 125.7 46.37 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.767 -2.015 . . . . 2.1499999999999999 111.663 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.816 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 20.8 p-10 -166.39 -54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.906 -1.516 . . . . 1.2 106.906 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 54.3 t0 -81.7 -30.77 32.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.52 -1.218 . . . . 2.1699999999999999 108.848 177.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -72.48 -31.24 65.23 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 5.4100000000000001 107.317 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.533 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.6 OUTLIER -82.6 111.04 25.71 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.32 -1.309 . . . . 2.21 109.399 178.165 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -34.2 92.91 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.292 1.994 . . . . 1.1100000000000001 113.581 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 51.8 m-20 -49.72 -29.84 8.26 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.129 0.789 . . . . 1.3600000000000001 113.129 -177.423 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.716 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.9 mt -153.8 30.29 0.46 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.808 -0.633 . . . . 2.2400000000000002 111.316 178.024 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 13.5 pttm -55.54 133.41 50.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.309 -0.556 . . . . 2.8700000000000001 111.847 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.88 11.97 67.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.515 -0.85 . . . . 0.48999999999999999 114.673 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptp180 -142.57 -51.02 0.37 Allowed 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 114.977 1.473 . . . . 2.1099999999999999 114.977 -178.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.758 ' CG1' ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.08 80.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-O 122.988 1.375 . . . . 1.04 107.667 -177.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 106' ' ' ASN . 12.5 m80 -101.2 126.15 47.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 112.248 -2.251 . . . . 0.34000000000000002 112.388 -175.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.751 ' CD2' HG13 ' A' ' 79' ' ' ILE . 83.3 m-85 -70.76 124.58 24.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 120.036 -0.666 . . . . 2.1600000000000001 109.715 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.463 HG23 ' CE1' ' A' ' 38' ' ' TYR . 1.7 p -76.18 36.08 0.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.283 -0.871 . . . . 1.0900000000000001 110.966 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 98' ' ' LEU . 2.9 m -148.93 127.1 12.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.96 0.409 . . . . 1.71 110.127 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.62 8.24 37.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.998 -0.546 . . . . 2.4700000000000002 110.313 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.53 67.62 1.18 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.518 -0.764 . . . . 2.1400000000000001 108.998 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.49 HD23 ' CG ' ' A' ' 93' ' ' PHE . 6.2 mp -57.96 -36.21 72.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.299 -0.864 . . . . 1.99 111.747 -178.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.97 2.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.561 0.578 . . . . 2.4900000000000002 112.561 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 98' ' ' LEU . 15.7 m -90.53 -0.23 57.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.913 -0.585 . . . . 1.8999999999999999 110.591 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 108.13 -12.61 37.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.049 -0.596 . . . . 0.40999999999999998 113.393 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -98.07 110.83 23.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.111 0.456 . . . . 1.4399999999999999 110.801 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -109.51 15.43 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 1.1200000000000001 112.241 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 23.5 m -60.01 139.98 57.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.338 1.607 . . . . 1.46 115.338 -178.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -132.97 130.1 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 114.844 -1.071 . . . . 1.0900000000000001 111.078 178.356 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 90' ' ' ARG . 50.8 p30 -105.54 147.88 27.88 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.122 -0.696 . . . . 1.5600000000000001 109.122 177.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.39 121.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.964 0.411 . . . . 1.0600000000000001 111.409 -178.268 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.595 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -83.06 144.71 29.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.549 -0.751 . . . . 1.0700000000000001 110.33 178.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 50.98 58.68 5.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.93 0.395 . . . . 1.9399999999999999 111.139 179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 31' ' ' LYS . 20.1 mt -46.25 88.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.494 0.924 . . . . 1.21 113.494 -178.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 pt20 -59.51 147.42 36.87 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.896 -0.593 . . . . 2.6699999999999999 110.441 177.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.94 -35.37 74.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.276 0.56 . . . . 2.2400000000000002 110.428 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.517 ' HB2' HD22 ' A' ' 64' ' ' ASN . 24.3 p -72.21 -9.42 58.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.794 . . . . 1.8300000000000001 111.887 -179.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 6.5 m-20 -70.54 -18.99 62.93 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.682 -0.407 . . . . 1.5800000000000001 110.209 179.149 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 27.2 mt -44.6 134.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.767 -0.457 . . . . 1.1399999999999999 109.767 178.233 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.89 156.54 6.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.073 -1.06 . . . . 0.26000000000000001 113.522 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 85.9 m -59.39 134.67 57.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.797 0.666 . . . . 1.0700000000000001 112.797 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 14.6 m-85 -113.49 137.88 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 2.1400000000000001 109.754 177.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 32.1 tt0 -129.13 118.14 21.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.666 0.27 . . . . 1.5900000000000001 110.762 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 13.0 t -104.13 118.79 37.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.4 . . . . 1.03 110.34 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.75 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.0 mtpm? -119.97 107.01 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.538 -0.301 . . . . 2.1899999999999999 111.283 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 18.3 t -90.82 110.25 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.311 -0.625 . . . . 1.8200000000000001 109.311 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 74.3 mttt -96.72 116.53 29.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.942 1.09 . . . . 2.1899999999999999 113.942 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 49' ' ' ASP . 63.9 tttt -147.21 102.13 3.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 3.2799999999999998 109.453 176.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -52.73 133.17 46.92 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 112.27 0.47 . . . . 1.1799999999999999 112.27 -179.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.6 Cg_endo -100.42 51.56 1.5 Allowed 'Cis proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.716 -0.952 . . . . 0.62 111.9 -0.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.11 102.83 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.107 -1.044 . . . . 0.53000000000000003 113.34 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 123' ' ' LYS . 6.0 m -90.01 119.97 38.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.27 -0.965 . . . . 1.8700000000000001 110.029 178.202 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -99.68 140.01 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.598 0.222 . . . . 1.3200000000000001 111.598 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -146.59 133.57 20.27 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.539 -0.301 . . . . 2.0299999999999998 111.525 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.54 152.64 40.06 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.571 -0.286 . . . . 3.46 111.239 179.152 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 81.9 mttt -102.16 141.16 35.43 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.282 0.845 . . . . 2.6699999999999999 113.282 -178.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 84.1 mt -139.98 120.02 13.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 CA-C-N 115.5 -0.773 . . . . 1.0600000000000001 109.417 176.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 15.9 m170 -100.01 114.26 27.43 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.468 -0.493 . . . . 0.70999999999999996 110.274 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.6 tp -90.45 125.02 35.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 2.1000000000000001 112.35 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 40.7 t -120.88 123.84 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 1.0900000000000001 109.634 178.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.87 119.95 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.173 0.434 . . . . 1.72 112.173 -178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.749 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.3 mt -84.46 170.64 13.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.808 -0.633 . . . . 1.21 109.342 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -75.15 138.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.352 0.596 . . . . 2.0899999999999999 111.538 -178.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.615 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 18.7 mmtm -160.26 173.93 4.4 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.816 -1.084 . . . . 2.7599999999999998 109.817 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 16.4 Cg_endo -56.88 -153.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.376 2.051 . . . . 1.4199999999999999 111.924 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.7 m -36.49 -49.99 0.76 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.969 0.414 . . . . 2.6899999999999999 111.734 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.47 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 72.22 -61.87 1.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.976 -0.63 . . . . 2.8799999999999999 113.207 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.191 -0.909 . . . . 2.6000000000000001 111.151 -179.748 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.556 -0.218 . . . . 3.6600000000000001 112.556 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -78.21 155.95 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 2.8100000000000001 110.862 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 29.7 t -78.1 151.72 33.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.071 0.462 . . . . 2.2599999999999998 111.323 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.587 HG12 ' CB ' ' A' ' 129' ' ' ALA . 3.8 mt -130.01 129.97 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.671 -0.695 . . . . 2.6299999999999999 110.407 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.71 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -89.09 140.04 29.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.581 . . . . 1.6499999999999999 110.225 179.072 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 46.04 81.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.039 -0.982 . . . . 1.26 111.096 -177.189 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.667 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.0 Cg_endo -78.99 -14.15 13.76 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.854 3.036 . . . . 0.88 113.377 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.8 mt-10 -141.36 126.28 18.21 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.272 -0.64 . . . . 2.0600000000000001 109.272 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 132' ' ' LYS . 2.1 tt0 -144.06 155.66 44.07 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.534 1.309 . . . . 1.71 114.534 -177.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 29.1 mtm -140.38 113.99 8.73 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.639 -1.164 . . . . 2.3999999999999999 109.455 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.489 HD11 ' CG2' ' A' ' 133' ' ' ILE . 5.3 mp -119.97 120.69 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.646 0.609 . . . . 1.1499999999999999 112.646 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.6 mt-10 -101.59 126.91 48.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.806 -0.634 . . . . 1.1899999999999999 109.888 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HB3' HD12 ' A' ' 110' ' ' LEU . 16.7 tptt -142.02 156.0 45.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 121.021 -0.272 . . . . 2.9300000000000002 111.1 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.93 143.69 39.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.855 0.36 . . . . 1.1299999999999999 111.919 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 80.8 tttt -48.98 132.47 18.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.283 -0.417 . . . . 2.7599999999999998 111.621 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 86.98 -15.78 51.21 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.155 -0.545 . . . . 0.32000000000000001 112.923 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 99.4 mt-10 -79.98 158.76 26.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.95 -0.759 . . . . 2.1099999999999999 108.95 178.719 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.786 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.7 m -88.77 128.42 35.63 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.058 -0.657 . . . . 1.0800000000000001 111.033 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 110' ' ' LEU . . . -99.98 118.88 37.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 1.0700000000000001 110.648 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 40' ' ' PRO . 62.8 t80 -79.51 119.13 22.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.037 -0.529 . . . . 2.3199999999999998 112.062 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB3' ' CH2' ' A' ' 57' ' ' TRP . 12.0 mt -109.96 104.79 56.28 Favored Pre-proline 0 C--N 1.333 -0.132 0 N-CA-C 108.315 -0.994 . . . . 1.47 108.315 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 96.9 Cg_endo -91.02 104.0 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.218 1.945 . . . . 0.71999999999999997 115.987 -176.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.584 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -100.14 128.7 46.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.438 -1.319 . . . . 1.03 107.438 175.411 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.71 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 41.1 mmtm -140.58 107.26 5.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.183 0.516 . . . . 2.2400000000000002 110.738 -178.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.597 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 47.4 p90 -99.3 140.09 33.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.005 -0.998 . . . . 2.1499999999999999 111.735 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 21' ' ' SER . 0.3 OUTLIER -79.99 139.13 37.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 1.9299999999999999 110.62 179.492 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.7 mt -96.23 141.47 29.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 2.5899999999999999 111.67 -179.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.6 m -150.66 135.86 10.13 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 2.1299999999999999 109.303 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -46.81 -25.66 3.96 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.471 2.114 . . . . 1.9299999999999999 112.238 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.98 -39.99 60.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.373 -0.376 . . . . 2.1800000000000002 111.199 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.463 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 73.7 m-20 -73.27 74.97 1.33 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.017 -0.673 . . . . 2.4100000000000001 109.638 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.85 -5.31 41.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.423 -0.808 . . . . 1.96 112.148 -178.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -69.96 166.24 50.02 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.56000000000000005 112.584 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.22 130.05 29.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.359 2.039 . . . . 1.1899999999999999 111.756 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 8.7 tp -77.98 117.29 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.446 -0.343 . . . . 2.4100000000000001 110.904 -179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -129.37 103.17 6.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.484 0.659 . . . . 1.78 111.682 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.734 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -95.56 109.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.922 -1.035 . . . . 1.4099999999999999 110.879 179.108 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HA ' HD11 ' A' ' 73' ' ' LEU . 18.0 mt-10 -104.7 116.61 32.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.6699999999999999 111.721 -179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.641 ' HB2' ' CG2' ' A' ' 72' ' ' ILE . 70.5 m95 -91.28 116.66 29.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 109.954 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.0 mt -105.75 138.76 41.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.643 -0.503 . . . . 1.1200000000000001 109.643 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 117' ' ' THR . 9.0 tt -129.97 132.76 65.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.615 0.598 . . . . 1.3700000000000001 112.615 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.08 102.33 40.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 1.73 109.571 177.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.71 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 84.6 Cg_endo -79.52 114.9 3.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.566 2.177 . . . . 0.84999999999999998 113.043 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -29.03 68.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 1.0700000000000001 110.373 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.72 10.24 9.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.713 -0.676 . . . . 1.8200000000000001 111.742 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.496 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 67.3 t30 -152.24 160.05 43.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.203 0.525 . . . . 2.3599999999999999 111.849 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -65.85 -19.01 65.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.386 -0.824 . . . . 1.95 111.941 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.0 ttmt -65.89 142.08 58.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 2.2799999999999998 111.418 -178.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.79 128.0 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-O 122.015 0.912 . . . . 1.4199999999999999 110.173 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.53 39.68 21.34 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 113.809 -1.541 . . . . 1.77 112.904 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.484 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 93.9 mm-40 -93.37 136.52 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 2.54 110.807 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 99.2 t -69.38 130.15 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 1.3899999999999999 110.615 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.735 ' CD1' HG12 ' A' ' 91' ' ' VAL . 1.4 pp -126.97 -38.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.23 -0.441 . . . . 1.8200000000000001 111.658 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.766 HG12 ' O ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -140.26 120.85 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.089 -0.708 . . . . 1.0800000000000001 109.089 179.25 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 80' ' ' TYR . 2.4 tp -140.52 161.12 38.48 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.699 -0.682 . . . . 1.8799999999999999 109.543 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 21.0 t80 -134.66 110.43 9.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.107 0.479 . . . . 2.2000000000000002 110.307 178.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.533 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.9 t -142.37 160.02 41.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.125 -0.943 . . . . 1.4199999999999999 111.639 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.65 37.8 42.76 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.805 -0.712 . . . . 0.56999999999999995 112.137 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t0 59.92 30.04 19.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.075 0.464 . . . . 1.46 110.348 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 44.5 mtmt -129.27 110.82 12.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.704 -0.68 . . . . 2.96 110.344 178.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.564 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.3 117.49 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.581 -1.266 . . . . 2.27 107.581 177.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.766 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -99.98 132.17 45.5 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.693 -1.139 . . . . 2.1499999999999999 110.641 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.721 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 14.2 p-10 -166.11 -56.34 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.418 -1.327 . . . . 1.2 107.418 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 74.0 m-20 -80.23 -27.41 38.75 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.796 -1.093 . . . . 2.1699999999999999 109.238 177.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.89 -31.65 61.63 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.226 -1.027 . . . . 5.4100000000000001 108.226 178.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -81.18 112.73 35.46 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 114.512 -1.222 . . . . 2.21 110.102 179.201 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.25 -42.71 16.98 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.653 1.569 . . . . 1.1100000000000001 111.208 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' HB2' ' HA ' ' A' ' 71' ' ' ILE . 96.2 m-20 -67.73 104.12 1.57 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.028 -0.533 . . . . 1.3600000000000001 111.095 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.908 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 13.6 mt 73.88 19.91 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.799 1.037 . . . . 2.2400000000000002 113.799 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.5 pttt -57.19 130.08 44.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.572 -0.705 . . . . 2.8700000000000001 110.555 177.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 94.21 11.35 57.51 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.165 -1.017 . . . . 0.48999999999999999 114.186 178.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.908 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 12.4 ptp180 -141.96 -52.36 0.42 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 114.24 1.2 . . . . 2.1099999999999999 114.24 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.735 HG12 ' CD1' ' A' ' 71' ' ' ILE . 7.1 p -79.24 81.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-O 122.991 1.377 . . . . 1.04 107.322 -178.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.424 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.4 m80 -99.0 128.81 45.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.193 -2.276 . . . . 0.34000000000000002 112.184 -175.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.709 ' HA ' ' O ' ' A' ' 104' ' ' SER . 66.1 m-85 -70.53 123.25 21.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.201 0.524 . . . . 2.1600000000000001 110.79 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.7 p -76.21 28.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.412 -0.813 . . . . 1.0900000000000001 111.926 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.1 m -147.45 129.71 15.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.094 0.473 . . . . 1.71 111.566 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.64 5.73 46.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 2.4700000000000002 110.361 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -145.77 66.11 1.22 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 2.1400000000000001 108.959 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.8 mp -59.92 -37.43 79.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.097 -0.956 . . . . 1.99 112.101 -178.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -62.52 3.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.521 0.563 . . . . 2.4900000000000002 112.521 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.3 m -90.03 -3.58 57.89 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.813 -0.63 . . . . 1.8999999999999999 110.259 178.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.566 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 116.96 -20.51 11.56 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.142 -0.552 . . . . 0.40999999999999998 113.005 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 3.6 m-20 -100.98 107.81 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.4399999999999999 111.122 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.91 23.79 13.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.169 -0.468 . . . . 1.1200000000000001 110.978 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -59.61 147.08 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.881 1.808 . . . . 1.46 115.881 -178.089 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -135.66 132.0 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 114.455 -1.248 . . . . 1.0900000000000001 111.016 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' O ' ' O ' ' A' ' 90' ' ' ARG . 0.8 OUTLIER -105.35 145.79 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.673 -0.862 . . . . 1.5600000000000001 108.673 177.216 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.04 122.21 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.87 0.367 . . . . 1.0600000000000001 111.185 -178.845 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.562 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -86.06 143.35 28.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.821 -0.627 . . . . 1.0700000000000001 110.892 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.7 m-20 49.98 58.17 5.75 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.098 -0.501 . . . . 1.9399999999999999 111.669 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 31' ' ' LYS . 20.7 mt -46.53 89.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.557 0.947 . . . . 1.21 113.557 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.97 145.68 45.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.881 -0.599 . . . . 2.6699999999999999 109.898 177.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.441 ' HG ' ' CD ' ' A' ' 33' ' ' LYS . 83.8 mt -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.773 0.321 . . . . 2.2400000000000002 111.618 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.6 p -73.36 -11.19 60.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.8300000000000001 111.606 -179.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.7 -17.29 62.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 1.5800000000000001 109.904 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.4 mt -43.5 141.43 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.85 -0.614 . . . . 1.1399999999999999 110.594 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.86 164.71 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.39 -0.91 . . . . 0.26000000000000001 113.34 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.0 m -59.55 129.99 44.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.625 0.602 . . . . 1.0700000000000001 112.625 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 26.9 m-85 -113.89 121.81 45.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.625 -0.88 . . . . 2.1400000000000001 108.625 177.058 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.0 tt0 -124.34 125.22 43.97 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.778 -0.369 . . . . 1.5900000000000001 111.021 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 16.1 p -108.34 119.97 41.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 1.03 110.861 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.2 mttm -113.6 104.09 11.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.157 -0.474 . . . . 2.1899999999999999 110.935 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 43' ' ' PHE . 5.6 p -90.02 112.0 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.084 -0.71 . . . . 1.8200000000000001 109.084 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.3 tttm -102.61 120.06 39.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.724 1.009 . . . . 2.1899999999999999 113.724 -177.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 6.6 ttpp -143.9 102.4 3.89 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.169 0.509 . . . . 3.2799999999999998 109.756 176.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -51.0 131.98 30.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 1.1799999999999999 113.051 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.4 Cg_endo -99.96 45.55 2.61 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.686 -0.964 . . . . 0.62 112.198 -0.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.29 103.57 0.32 Allowed Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.422 -0.894 . . . . 0.53000000000000003 113.044 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.2 p -89.07 158.66 2.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.435 -0.882 . . . . 1.8700000000000001 109.519 177.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' CB ' HG12 ' A' ' 22' ' ' ILE . . . -144.74 135.64 24.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.376 -0.374 . . . . 1.3200000000000001 111.554 -179.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.519 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 19.2 p30 -146.71 139.36 25.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.676 0.621 . . . . 2.0299999999999998 112.676 -179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.667 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -145.68 161.61 39.46 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.359 -0.382 . . . . 3.46 111.228 178.832 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 68.8 mttm -100.47 143.31 30.79 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.715 1.006 . . . . 2.6699999999999999 113.715 -178.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 96.5 mt -141.32 113.05 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 114.961 -1.018 . . . . 1.0600000000000001 108.305 176.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.439 ' CD2' HG23 ' A' ' 117' ' ' THR . 7.7 m170 -98.8 117.75 33.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.435 -0.506 . . . . 0.70999999999999996 110.885 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -93.7 118.5 31.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.099 -0.5 . . . . 2.1000000000000001 111.946 -179.311 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.56 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 58.6 t -111.75 120.01 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.674 -0.862 . . . . 1.0900000000000001 108.674 178.065 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 24.4 t -101.48 122.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.498 0.555 . . . . 1.72 112.498 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.1 mt -84.07 169.27 15.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.971 -0.751 . . . . 1.21 108.971 178.36 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.8 136.7 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.416 0.627 . . . . 2.0899999999999999 111.496 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -164.26 173.68 3.82 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.985 -1.007 . . . . 2.7599999999999998 110.326 179.746 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 71.5 Cg_exo -50.02 169.64 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.455 2.103 . . . . 1.4199999999999999 112.641 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.456 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 19.4 m -40.1 -69.94 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.945 -0.57 . . . . 2.6899999999999999 112.348 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.75 -64.98 0.31 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.826 -0.702 . . . . 2.8799999999999999 112.509 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.208 -0.901 . . . . 2.6000000000000001 111.442 179.774 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.488 -0.245 . . . . 3.6600000000000001 112.488 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.476 ' OG ' ' HA3' ' A' ' 127' ' ' GLY . 13.2 m -80.09 132.22 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 2.8100000000000001 110.814 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t -159.95 160.04 32.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 2.2599999999999998 111.406 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.464 ' HB ' ' CB ' ' A' ' 129' ' ' ALA . 19.5 tt -133.65 140.02 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 2.6299999999999999 110.45 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.748 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.1 p -88.68 154.47 20.27 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.505 0.669 . . . . 1.6499999999999999 111.867 -179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.517 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 38.39 82.16 0.23 Allowed Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 114.487 -1.233 . . . . 1.26 111.953 -178.55 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.64 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 77.8 Cg_endo -79.43 -8.62 14.99 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 123.891 3.06 . . . . 0.88 113.032 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -141.3 122.46 14.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.144 -0.687 . . . . 2.0600000000000001 109.144 178.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' LYS . 86.0 tt0 -144.24 156.63 44.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.981 1.104 . . . . 1.71 113.981 -176.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.49 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 47.7 mtp -138.82 122.3 17.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.847 -1.07 . . . . 2.3999999999999999 109.442 177.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.442 HD13 ' CG ' ' A' ' 27' ' ' GLU . 27.1 mm -126.48 134.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 1.1499999999999999 111.513 -179.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 20.4 pt-20 -130.72 127.3 38.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 1.1899999999999999 110.652 179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 13.3 tptt -142.43 163.48 32.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.39 -0.368 . . . . 2.9300000000000002 110.945 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.12 140.29 41.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 1.1299999999999999 111.704 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 76.6 tttt -47.43 139.71 6.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.095 -0.502 . . . . 2.7599999999999998 111.715 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 82.5 -20.17 9.55 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.793 -0.639 . . . . 0.32000000000000001 113.032 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.555 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 80.7 mm-40 -80.07 159.98 25.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.513 -0.921 . . . . 2.1099999999999999 108.513 178.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.9 m -90.68 127.34 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.785 -0.766 . . . . 1.0800000000000001 111.222 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' HB1' HD23 ' A' ' 110' ' ' LEU . . . -100.01 119.88 38.96 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.794 0.331 . . . . 1.0700000000000001 110.529 179.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 65.6 t80 -79.64 116.77 20.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.329 -0.396 . . . . 2.3199999999999998 111.842 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.9 mt -100.91 106.15 42.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.999 -0.741 . . . . 1.47 108.999 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 97.0 Cg_endo -81.98 129.3 6.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.71999999999999997 114.509 -177.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 t -140.91 130.28 23.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.21 -0.905 . . . . 1.03 109.195 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.748 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 57.2 tptt -140.02 141.44 36.31 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 2.2400000000000002 109.514 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.515 ' CG ' HG12 ' A' ' 122' ' ' VAL . 53.1 p90 -139.94 144.82 37.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.242 0.544 . . . . 2.1499999999999999 112.05 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -80.85 158.37 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.36 -0.836 . . . . 1.9299999999999999 110.513 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.468 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 63.7 tp -140.0 99.98 3.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 2.5899999999999999 111.422 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.9 t -82.1 142.3 47.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.576 -0.527 . . . . 2.1299999999999999 109.576 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.34 -29.35 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.931 1.754 . . . . 1.9299999999999999 111.821 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.89 -33.64 51.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.984 -0.553 . . . . 2.1800000000000002 111.389 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.24 79.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.087 -0.645 . . . . 2.4100000000000001 109.625 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -102.3 7.24 40.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 1.96 112.284 -178.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.617 ' O ' ' HD2' ' A' ' 124' ' ' LYS . . . -69.94 164.22 51.77 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.56000000000000005 112.809 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.57 134.72 59.76 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.3 2.0 . . . . 1.1899999999999999 111.731 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 18.7 mt -78.19 104.73 8.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 2.4100000000000001 111.375 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.1 m-20 -119.55 102.61 8.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.64 0.733 . . . . 1.78 110.905 178.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.804 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 8.9 mt -101.38 130.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.765 -1.107 . . . . 1.4099999999999999 110.004 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HA ' HD22 ' A' ' 73' ' ' LEU . 99.3 mt-10 -130.05 125.68 35.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.274 0.842 . . . . 1.6699999999999999 113.274 -178.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.683 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 80.8 m95 -97.86 119.95 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.935 -0.575 . . . . 0.23999999999999999 109.514 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.0 mt -105.54 139.98 39.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.372 -0.603 . . . . 1.1200000000000001 109.372 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.9 tt -128.63 129.56 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.171 0.51 . . . . 1.3700000000000001 111.46 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.479 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 p -119.91 103.03 46.14 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.954 -0.758 . . . . 1.73 108.954 178.211 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 95.2 Cg_endo -78.78 113.52 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.424 2.082 . . . . 0.84999999999999998 112.892 -178.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.277 -0.874 . . . . 1.0700000000000001 111.066 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.73 -40.02 63.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.928 -0.578 . . . . 1.8200000000000001 111.329 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 97.8 m-20 -84.61 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.156 0.503 . . . . 2.3599999999999999 111.628 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.44 -20.01 63.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.456 -0.793 . . . . 1.95 111.222 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 77.6 mttt -70.3 150.02 46.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 2.2799999999999998 111.233 -178.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 66' ' ' LYS . 2.3 m -154.89 128.46 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 121.925 0.869 . . . . 1.4199999999999999 110.081 178.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.96 40.19 19.23 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 113.94 -1.482 . . . . 1.77 113.229 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.59 144.89 25.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.683 0.277 . . . . 2.54 111.217 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG13 ' CD2' ' A' ' 73' ' ' LEU . 31.0 t -66.01 136.56 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.599 -0.889 . . . . 1.3899999999999999 108.599 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.815 ' CD1' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.72 -51.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.839 0.681 . . . . 1.8200000000000001 112.839 -176.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.986 ' HB ' HG13 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.42 126.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.309 -0.626 . . . . 1.0800000000000001 109.309 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.672 HD22 ' H ' ' A' ' 57' ' ' TRP . 3.1 mt -138.09 175.73 9.32 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.412 0.625 . . . . 1.8799999999999999 111.534 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.555 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 45.7 t80 -140.3 104.39 4.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.203 -1.362 . . . . 2.2000000000000002 107.427 175.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.527 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.9 t -141.54 157.11 45.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.998 -0.546 . . . . 1.4199999999999999 111.067 -178.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.27 39.25 42.57 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.525 -0.845 . . . . 0.56999999999999995 112.013 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.01 30.29 19.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 1.46 110.433 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 67.5 mttm -130.8 110.5 11.36 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.768 -0.651 . . . . 2.96 111.231 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 79' ' ' ILE . 1.3 pp -79.98 112.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.253 -1.388 . . . . 2.27 107.253 176.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.717 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -100.11 141.5 32.85 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.922 . . . . 2.1499999999999999 111.198 -178.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.794 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.4 p-10 -166.83 -54.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.653 -1.24 . . . . 1.2 107.653 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.457 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 33.9 m-20 -80.01 -19.9 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.0 -1.0 . . . . 2.1699999999999999 109.873 177.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.47 -28.72 46.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.746 -0.835 . . . . 5.4100000000000001 108.746 178.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.673 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.4 m-85 -85.41 119.92 72.7 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 114.931 -1.031 . . . . 2.21 111.189 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 7.5 Cg_endo -48.55 -42.84 34.83 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.388 1.392 . . . . 1.1100000000000001 109.933 178.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.766 ' O ' HG12 ' A' ' 71' ' ' ILE . 41.3 m-20 -66.31 106.05 1.6 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.747 -0.66 . . . . 1.3600000000000001 110.702 178.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.874 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.7 mt 66.76 21.29 10.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.278 1.214 . . . . 2.2400000000000002 114.278 178.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 55.6 pttt -56.23 129.95 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.457 -0.897 . . . . 2.8700000000000001 110.666 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.61 14.26 53.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.263 -0.97 . . . . 0.48999999999999999 113.875 178.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.874 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.2 ptp180 -145.16 -48.96 0.24 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.815 1.413 . . . . 2.1099999999999999 114.815 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.986 HG13 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -81.1 81.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-O 123.274 1.511 . . . . 1.04 107.019 -178.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.457 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 12.9 m80 -99.03 129.21 45.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.145 -2.298 . . . . 0.34000000000000002 112.74 -175.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.709 ' HA ' ' O ' ' A' ' 104' ' ' SER . 86.1 m-85 -72.31 120.14 17.5 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 120.272 -0.571 . . . . 2.1600000000000001 109.519 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.442 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 18.8 p -73.37 -7.13 50.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.367 -0.833 . . . . 1.0900000000000001 110.482 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 17.7 m -86.35 118.77 26.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.939 -0.573 . . . . 1.71 110.895 -179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -90.03 1.38 56.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.858 -0.61 . . . . 2.4700000000000002 110.014 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -145.99 67.65 1.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.335 -0.987 . . . . 2.1400000000000001 108.335 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.475 ' CD2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 tt -58.27 -36.33 73.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.897 -1.047 . . . . 1.99 112.07 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -62.26 -1.08 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 2.4900000000000002 112.254 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 70.5 m -89.64 0.04 57.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 1.8999999999999999 110.795 178.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 107.13 -15.11 39.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.968 -0.634 . . . . 0.40999999999999998 113.069 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.508 ' OD1' ' HD3' ' A' ' 42' ' ' LYS . 86.6 m-20 -92.26 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.873 0.337 . . . . 1.4399999999999999 111.355 -179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.09 19.85 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.1200000000000001 111.632 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 5.2 p -60.1 141.2 56.21 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.678 1.733 . . . . 1.46 115.678 -178.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -133.3 130.84 57.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 114.416 -1.266 . . . . 1.0900000000000001 111.292 178.713 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.2 p30 -102.98 144.98 30.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.396 -0.964 . . . . 1.5600000000000001 108.396 177.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.887 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.87 120.76 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 120.911 0.386 . . . . 1.0600000000000001 111.971 -177.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.61 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -84.44 143.13 29.61 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.516 -0.765 . . . . 1.0700000000000001 110.832 178.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 26.2 m120 49.96 57.84 6.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.142 0.496 . . . . 1.9399999999999999 111.668 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.537 HD23 ' HB1' ' A' ' 37' ' ' ALA . 31.3 mt -46.63 90.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.009 1.114 . . . . 1.21 114.009 -179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.406 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 38.9 mt-30 -59.3 141.56 54.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.922 -0.581 . . . . 2.6699999999999999 110.924 176.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -60.04 -35.37 74.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.113 0.483 . . . . 2.2400000000000002 109.995 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.2 p -74.47 -11.63 60.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.698 -0.683 . . . . 1.8300000000000001 111.435 -179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.406 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 99.1 m-20 -71.7 -18.45 62.16 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.033 -0.358 . . . . 1.5800000000000001 110.033 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.36 139.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.202 -0.454 . . . . 1.1399999999999999 110.22 179.09 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 164.06 9.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.111 -1.042 . . . . 0.26000000000000001 113.39 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.6 m -59.29 130.22 45.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.012 0.745 . . . . 1.0700000000000001 113.012 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 15.5 m-85 -114.87 128.87 56.55 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.774 -0.824 . . . . 2.1400000000000001 108.774 176.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.5 tt0 -127.45 119.03 25.19 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.568 -0.453 . . . . 1.5900000000000001 111.314 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 57' ' ' TRP . 35.4 t -100.01 119.4 38.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 1.03 110.611 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.804 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.3 mttt -116.57 106.27 13.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.005 -0.278 . . . . 2.1899999999999999 110.915 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.515 HG12 ' CG ' ' A' ' 43' ' ' PHE . 43.8 t -90.53 112.46 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.363 -0.606 . . . . 1.8200000000000001 109.363 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 85.9 tttt -99.57 121.88 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.041 0.756 . . . . 2.1899999999999999 113.041 -178.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.617 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 53.9 tptt -145.16 101.39 3.61 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.448 -0.575 . . . . 3.2799999999999998 109.448 177.111 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -54.76 135.83 64.85 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 1.1799999999999999 112.335 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.557 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 53.0 Cg_endo -96.94 46.2 2.4 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.336 -1.11 . . . . 0.62 111.631 -0.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.476 ' HA3' ' OG ' ' A' ' 20' ' ' SER . . . -145.28 103.64 0.29 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.434 -0.889 . . . . 0.53000000000000003 113.399 -179.332 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.64 153.1 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.342 -0.929 . . . . 1.8700000000000001 109.897 178.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.464 ' CB ' ' HB ' ' A' ' 22' ' ' ILE . . . -138.01 140.4 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.575 0.213 . . . . 1.3200000000000001 111.575 -179.254 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -146.74 143.61 28.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.21 0.448 . . . . 2.0299999999999998 112.21 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.06 159.98 42.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.19 -0.459 . . . . 3.46 110.864 179.056 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 72.1 mmtt -105.61 140.39 38.76 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 112.776 0.658 . . . . 2.6699999999999999 112.776 -178.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 64.7 mt -139.97 119.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.558 -0.746 . . . . 1.0600000000000001 109.17 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 35.2 m170 -102.72 117.35 34.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.70999999999999996 110.616 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 40.6 tp -89.35 124.94 34.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 2.1000000000000001 111.601 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 45.0 t -119.97 120.01 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.797 -0.638 . . . . 1.0900000000000001 109.293 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.3 122.69 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.316 0.487 . . . . 1.72 112.316 -178.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.5 mt -84.86 164.95 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.727 -0.67 . . . . 1.21 109.717 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -77.72 138.42 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 2.0899999999999999 111.514 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 1.7 mmtt -159.96 175.22 3.32 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.864 -1.062 . . . . 2.7599999999999998 109.249 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 18.5 Cg_endo -59.32 -153.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.864 1.709 . . . . 1.4199999999999999 111.581 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.8 m -34.96 -71.86 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.847 0.356 . . . . 2.6899999999999999 111.685 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 69.69 -58.68 0.71 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.995 -0.621 . . . . 2.8799999999999999 113.082 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.194 -0.907 . . . . 2.6000000000000001 111.157 -179.718 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.54 -0.224 . . . . 3.6600000000000001 112.54 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -158.97 159.06 34.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 2.8100000000000001 110.642 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.2 t -158.22 144.73 17.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.14 0.495 . . . . 2.2599999999999998 111.457 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 129' ' ' ALA . 1.8 pp -95.33 143.98 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.478 -0.783 . . . . 2.6299999999999999 111.5 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -91.12 155.12 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 110.361 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.4 OUTLIER 39.44 83.41 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.612 0.72 . . . . 1.26 111.258 -178.069 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.693 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 61.2 Cg_endo -78.24 -8.11 16.27 Favored 'Trans proline' 0 C--N 1.327 -0.582 0 C-N-CA 123.753 2.969 . . . . 0.88 113.477 -178.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.16 121.31 13.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.0600000000000001 108.893 178.113 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 132' ' ' LYS . 3.3 tt0 -144.48 160.48 41.03 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.86 1.43 . . . . 1.71 114.86 -176.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 39.6 mtm -139.98 121.38 15.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.582 -1.19 . . . . 2.3999999999999999 109.632 177.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.02 126.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.756 0.312 . . . . 1.1499999999999999 111.659 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 86.3 mt-10 -116.26 125.53 52.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.376 -0.375 . . . . 1.1899999999999999 110.325 179.166 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 34.5 mmtm -142.07 156.8 45.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.784 0.326 . . . . 2.9300000000000002 111.502 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.98 137.83 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 1.1299999999999999 112.184 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.707 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 8.0 ttpt -45.17 142.16 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.854 -0.612 . . . . 2.7599999999999998 111.707 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.12 -26.9 4.15 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.909 -0.587 . . . . 0.32000000000000001 112.981 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -80.03 160.02 25.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.889 -0.782 . . . . 2.1099999999999999 108.889 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.794 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 91.6 m -85.49 130.11 34.66 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.018 -0.673 . . . . 1.0800000000000001 110.737 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . . . -97.2 117.25 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.126 0.488 . . . . 1.0700000000000001 110.327 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 89.1 t80 -79.05 120.01 23.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.8 0.667 . . . . 2.3199999999999998 112.8 -178.397 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.08 105.67 56.23 Favored Pre-proline 0 CA--C 1.528 0.108 0 N-CA-C 108.533 -0.914 . . . . 1.47 108.533 177.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.455 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 87.6 Cg_endo -83.0 128.88 5.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.45 2.1 . . . . 0.71999999999999997 115.066 -177.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.6 ' HA ' ' HZ1' ' A' ' 131' ' ' LYS . 9.9 t -141.5 129.89 22.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.043 -0.98 . . . . 1.03 109.637 177.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 1.0 OUTLIER -140.31 150.74 44.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.966 -0.561 . . . . 2.2400000000000002 109.995 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CZ ' HD13 ' A' ' 53' ' ' LEU . 49.7 p90 -140.13 153.26 46.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 2.1499999999999999 111.021 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 m -79.74 162.81 24.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 1.9299999999999999 111.047 -179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.6 tp -139.83 130.32 25.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.5899999999999999 110.871 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.01 158.01 25.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 2.1299999999999999 110.445 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.81 -20.71 23.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 1.9299999999999999 112.888 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.57 -45.37 59.53 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 110.014 -0.365 . . . . 2.1800000000000002 110.014 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -71.88 83.34 0.93 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.595 -0.891 . . . . 2.4100000000000001 108.595 178.588 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -95.9 -4.36 43.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.56 -0.745 . . . . 1.96 112.361 -177.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA3' ' CB ' ' A' ' 125' ' ' ALA . . . -83.15 152.84 30.05 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.169 -1.015 . . . . 0.56000000000000005 112.779 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.16 139.01 88.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.313 2.009 . . . . 1.1899999999999999 111.493 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' ' HD2' ' A' ' 124' ' ' LYS . 6.5 mt -78.33 104.33 8.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.447 -0.342 . . . . 2.4100000000000001 111.767 -179.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 96.6 m-20 -114.31 102.59 10.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.532 0.682 . . . . 1.78 110.06 178.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 47.1 mt -95.38 139.83 18.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.97 -1.014 . . . . 1.4099999999999999 110.008 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.611 ' HA ' HD23 ' A' ' 73' ' ' LEU . 98.9 mt-10 -137.6 117.15 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 1.6699999999999999 112.741 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.687 ' HA ' ' O ' ' A' ' 119' ' ' GLN . 83.6 m95 -91.25 121.88 33.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.428 -0.351 . . . . 0.23999999999999999 110.469 178.173 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -107.29 140.02 40.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.555 -0.906 . . . . 1.1200000000000001 108.555 178.278 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -128.83 133.06 66.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.352 0.596 . . . . 1.3700000000000001 112.473 -178.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -119.85 103.59 45.53 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.112 -0.949 . . . . 1.73 109.216 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.9 Cg_exo -79.33 122.52 5.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.503 2.135 . . . . 0.84999999999999998 112.075 -179.109 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.98 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 1.0700000000000001 110.872 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -74.97 -40.03 60.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 1.8200000000000001 111.542 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 30.6 m120 -83.64 154.45 23.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.288 0.566 . . . . 2.3599999999999999 111.912 -179.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.72 -16.92 63.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.233 -0.894 . . . . 1.95 111.131 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 33.2 mttp -68.89 150.02 48.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.484 -0.78 . . . . 2.2799999999999998 111.449 -178.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.44 128.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-O 121.984 0.897 . . . . 1.4199999999999999 110.14 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.78 39.96 20.13 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.835 -1.53 . . . . 1.77 112.863 178.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -91.14 146.93 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.603 0.239 . . . . 2.54 110.906 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.445 HG13 ' CD2' ' A' ' 73' ' ' LEU . 15.8 t -65.84 130.01 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.013 -0.736 . . . . 1.3899999999999999 109.013 178.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.826 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -124.81 -53.21 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.671 0.619 . . . . 1.8200000000000001 112.671 -177.028 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.943 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.02 129.37 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.163 -0.68 . . . . 1.0800000000000001 109.163 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.663 ' HG ' ' CE2' ' A' ' 84' ' ' TYR . 3.9 mt -138.76 175.45 9.55 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.57 0.7 . . . . 1.8799999999999999 111.373 -179.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.6 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 39.2 t80 -141.36 103.61 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.095 -1.411 . . . . 2.2000000000000002 107.648 176.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.493 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.8 t -141.6 153.99 45.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.385 -0.371 . . . . 1.4199999999999999 111.005 -178.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.87 30.1 52.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.527 -0.844 . . . . 0.56999999999999995 112.146 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.91 3.99 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.618 0.247 . . . . 1.46 110.872 -178.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 65.1 mttm -105.34 110.79 23.28 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.575 -0.284 . . . . 2.96 111.306 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 79' ' ' ILE . 1.2 pp -79.87 113.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.465 -1.68 . . . . 2.27 106.465 176.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.75 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -99.92 140.02 34.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.426 -0.807 . . . . 2.1499999999999999 111.177 -177.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.2 p-10 -166.55 -52.39 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.864 -1.162 . . . . 1.2 107.864 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.409 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 54.5 m-20 -79.92 -25.57 40.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.122 -0.945 . . . . 2.1699999999999999 109.632 178.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.77 -30.47 56.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.546 -0.909 . . . . 5.4100000000000001 108.546 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.663 ' CE2' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -82.19 114.05 48.22 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 114.952 -1.022 . . . . 2.21 110.679 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.86 -42.17 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.73 1.62 . . . . 1.1100000000000001 110.31 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.616 ' O ' HG12 ' A' ' 71' ' ' ILE . 58.5 m-20 -67.09 105.24 1.62 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.678 -0.692 . . . . 1.3600000000000001 110.584 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.759 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 mp 68.98 24.18 6.37 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.892 1.071 . . . . 2.2400000000000002 113.892 178.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 51.1 pttt -57.02 129.83 43.46 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.571 -0.706 . . . . 2.8700000000000001 111.016 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 89.45 15.46 58.52 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.515 -0.85 . . . . 0.48999999999999999 114.119 178.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.759 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp85 -143.37 -48.54 0.31 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.383 1.253 . . . . 2.1099999999999999 114.383 -178.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.943 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.01 81.28 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 123.132 1.444 . . . . 1.04 107.274 -178.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 106' ' ' ASN . 11.3 m80 -98.29 127.84 44.42 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.248 -2.251 . . . . 0.34000000000000002 112.325 -175.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 67.2 m-85 -70.88 121.82 18.79 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.166 0.508 . . . . 2.1600000000000001 110.434 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.436 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 5.8 p -77.79 36.0 0.21 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.527 -0.76 . . . . 1.0900000000000001 111.839 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.1 m -148.32 127.55 12.96 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.128 0.489 . . . . 1.71 111.639 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -90.62 6.16 44.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.593 -0.73 . . . . 2.4700000000000002 110.211 178.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -145.91 66.03 1.21 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.103 -0.702 . . . . 2.1400000000000001 109.103 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 93' ' ' PHE . 4.8 mp -60.08 -39.27 85.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.15 -0.932 . . . . 1.99 111.333 -178.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HE2' ' OH ' ' A' ' 74' ' ' TYR . 25.8 mttm -59.52 -6.73 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.511 . . . . 2.4900000000000002 112.224 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.9 m -81.94 -7.09 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.522 -0.763 . . . . 1.8999999999999999 110.535 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 115.35 -20.02 14.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.852 -0.689 . . . . 0.40999999999999998 113.227 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -99.91 106.03 17.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.03 0.415 . . . . 1.4399999999999999 110.516 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.598 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.03 22.59 14.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.466 0.543 . . . . 1.1200000000000001 112.466 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 13.9 m -60.02 151.02 27.45 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.963 1.468 . . . . 1.46 114.963 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -135.11 134.21 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 114.639 -1.164 . . . . 1.0900000000000001 111.447 179.301 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.8 p-10 -107.95 148.37 29.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.832 -0.803 . . . . 1.5600000000000001 108.832 177.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.31 123.46 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.943 0.401 . . . . 1.0600000000000001 111.058 -178.774 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -86.27 144.9 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 111.262 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.11 61.0 2.92 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.01 -0.541 . . . . 1.9399999999999999 112.224 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 31' ' ' LYS . 6.6 mt -45.99 169.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 1.21 111.904 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 11.8 pt20 -177.43 161.22 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.701 -0.681 . . . . 2.6699999999999999 110.572 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.463 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 5.1 mp -60.06 -33.01 71.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 2.2400000000000002 111.465 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -73.74 -19.93 60.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.984 -0.286 . . . . 1.8300000000000001 111.629 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 95.5 m-20 -72.27 -19.72 61.64 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.923 -0.399 . . . . 1.5800000000000001 109.923 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -46.03 142.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 116.111 -0.495 . . . . 1.1399999999999999 111.171 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.46 150.4 5.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.689 -1.243 . . . . 0.26000000000000001 114.298 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 98.1 m -59.47 139.95 56.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -0.662 . . . . 1.0700000000000001 112.135 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CZ ' HD13 ' A' ' 59' ' ' ILE . 27.8 m-85 -119.98 135.08 55.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 2.1400000000000001 109.9 178.136 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.8 tt0 -126.77 117.13 22.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.612 -0.267 . . . . 1.5900000000000001 111.145 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 50.8 t -99.99 114.73 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 1.03 110.288 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.785 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.0 mtpt -109.45 104.77 13.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.574 -0.284 . . . . 2.1899999999999999 110.801 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 42.8 t -90.05 110.69 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.578 -0.527 . . . . 1.8200000000000001 109.578 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 26.8 tttp -98.9 115.89 29.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.479 0.548 . . . . 2.1899999999999999 112.479 -178.758 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 36.1 tttp -145.77 102.63 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.316 -0.554 . . . . 3.2799999999999998 109.784 177.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.519 ' CB ' ' HA3' ' A' ' 51' ' ' GLY . . . -50.56 132.1 26.8 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.919 -0.582 . . . . 1.1799999999999999 111.903 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 63.1 Cg_endo -101.29 51.94 1.44 Allowed 'Cis proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.771 -0.929 . . . . 0.62 111.94 -0.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 102.59 0.26 Allowed Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.855 -1.164 . . . . 0.53000000000000003 113.866 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.83 135.78 27.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.391 -0.905 . . . . 1.8700000000000001 109.293 177.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . . . -144.44 152.51 40.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.599 -0.44 . . . . 1.3200000000000001 112.068 -179.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 23.6 p-10 -146.42 157.91 43.82 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.217 0.451 . . . . 2.0299999999999998 112.217 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.693 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.99 166.61 25.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.193 -0.458 . . . . 3.46 111.083 179.009 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' GLU . 68.3 mttm -111.17 140.25 45.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 112.6 0.593 . . . . 2.6699999999999999 112.6 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 96.8 mt -141.55 112.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.543 -0.91 . . . . 1.0600000000000001 108.543 176.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' CD2' HG22 ' A' ' 117' ' ' THR . 49.5 m170 -96.89 118.77 34.04 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.425 -0.51 . . . . 0.70999999999999996 110.984 -178.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 118' ' ' TYR . 3.2 tm? -88.44 120.0 29.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 2.1000000000000001 111.69 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.609 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 42.3 t -118.96 120.3 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.197 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.91 133.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.312 0.486 . . . . 1.72 112.312 -178.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 66.6 mt -80.1 158.18 26.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.944 -0.762 . . . . 1.21 108.944 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' A' ' 140' ' ' LYS . 3.0 p -69.07 150.55 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 122.134 0.968 . . . . 2.0899999999999999 113.439 -177.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.707 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 1.3 mttm -164.24 -174.28 0.39 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 113.538 -1.665 . . . . 2.7599999999999998 110.303 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 85.8 Cg_exo -49.93 -142.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.85 2.367 . . . . 1.4199999999999999 113.903 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.0 p -30.42 -59.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.227 0.825 . . . . 2.6899999999999999 113.227 -178.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.458 ' CA ' ' HD2' ' A' ' 33' ' ' LYS . . . 142.97 27.32 0.15 Allowed Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.333 -0.937 . . . . 2.8799999999999999 113.342 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.292 -0.861 . . . . 2.6000000000000001 111.015 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.582 -0.207 . . . . 3.6600000000000001 112.582 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -79.53 137.57 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.336 . . . . 2.8100000000000001 111.063 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -159.96 158.19 30.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 2.2599999999999998 110.856 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 129' ' ' ALA . 1.6 pp -91.96 143.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 2.6299999999999999 111.264 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -89.11 157.75 18.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.775 -0.648 . . . . 1.6499999999999999 109.891 178.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 45.1 85.42 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 121.716 0.769 . . . . 1.26 109.809 -176.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.714 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.0 Cg_endo -76.4 -83.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.246 2.631 . . . . 0.88 113.215 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.3 mt-10 -78.54 128.14 33.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.894 -0.722 . . . . 2.0600000000000001 109.501 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -143.6 156.18 44.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.91 1.078 . . . . 1.71 113.91 -177.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.444 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 45.0 mtm -137.26 118.24 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.285 -1.325 . . . . 2.3999999999999999 107.865 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.587 HD12 ' CG2' ' A' ' 133' ' ' ILE . 5.2 mp -120.03 120.05 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 1.1499999999999999 111.894 -177.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.623 ' HG3' ' HB ' ' A' ' 136' ' ' VAL . 51.7 mp0 -105.72 128.53 53.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.821 -0.627 . . . . 1.1899999999999999 110.939 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HE2' ' OE1' ' A' ' 35' ' ' GLU . 20.9 tptm -141.45 154.73 45.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.854 0.359 . . . . 2.9300000000000002 111.151 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.605 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.65 143.63 40.01 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.615 0.598 . . . . 1.1299999999999999 112.615 -179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.859 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 75.0 mttt -47.86 143.76 3.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.593 -0.731 . . . . 2.7599999999999998 112.604 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.36 -23.64 1.48 Allowed Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.32000000000000001 113.719 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' OE1' ' HE2' ' A' ' 31' ' ' LYS . 98.7 mt-10 -79.99 159.97 26.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.338 -0.616 . . . . 2.1099999999999999 109.338 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 55.9 m -86.91 126.31 34.6 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.12 -0.632 . . . . 1.0800000000000001 110.984 -179.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 107' ' ' VAL . . . -96.74 118.54 33.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.185 0.516 . . . . 1.0700000000000001 110.307 179.144 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CE2' HG21 ' A' ' 94' ' ' THR . 9.9 t80 -79.17 120.53 23.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.887 -0.597 . . . . 2.3199999999999998 111.932 -178.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 105' ' ' ILE . 35.7 mt -105.75 104.77 50.34 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 108.428 -0.952 . . . . 1.47 108.428 177.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.468 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.8 Cg_endo -82.31 127.49 5.21 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.363 2.042 . . . . 0.71999999999999997 114.345 -177.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.0 t -141.2 129.98 22.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.072 -0.967 . . . . 1.03 108.859 178.011 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.432 ' HD3' ' OD1' ' A' ' 102' ' ' ASP . 33.3 ttpt -140.73 150.12 43.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.708 -0.678 . . . . 2.2400000000000002 110.634 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.461 ' CD1' HG12 ' A' ' 122' ' ' VAL . 47.0 p90 -139.95 140.42 36.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 2.1499999999999999 111.897 -178.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 138.31 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.694 -0.684 . . . . 1.9299999999999999 110.507 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.0 107.84 19.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 2.5899999999999999 111.34 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -83.34 148.23 55.24 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 109.355 -0.609 . . . . 2.1299999999999999 109.355 178.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -42.36 -46.75 7.57 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 121.984 1.789 . . . . 1.9299999999999999 111.594 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 85.6 tt0 -75.94 -38.49 57.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.652 -0.704 . . . . 2.1800000000000002 110.971 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 13.9 t0 -70.96 80.03 0.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.303 0.573 . . . . 2.4100000000000001 110.441 -179.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -137.25 33.75 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.19 -0.914 . . . . 1.96 111.022 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.12 -171.32 33.8 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.541 -0.838 . . . . 0.56000000000000005 112.717 -179.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.66 113.03 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.644 2.229 . . . . 1.1899999999999999 111.861 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 47.9 tp -78.7 118.54 20.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 2.4100000000000001 111.566 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -134.55 102.95 5.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.524 0.678 . . . . 1.78 111.371 179.08 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.825 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 3.7 mt -96.06 110.01 23.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.011 -0.995 . . . . 1.4099999999999999 110.809 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -102.56 117.99 35.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.129 0.788 . . . . 1.6699999999999999 113.129 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.656 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 74.3 m95 -93.88 121.7 35.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.23999999999999999 109.882 176.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.1 mt -106.65 129.94 54.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.035 -0.357 . . . . 1.1200000000000001 110.035 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 67' ' ' VAL . 3.9 tt -119.96 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.203 0.816 . . . . 1.3700000000000001 113.203 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 67' ' ' VAL . 5.4 t -108.11 104.5 53.82 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 108.842 -0.799 . . . . 1.73 108.842 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.679 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 80.6 Cg_endo -78.85 112.74 3.16 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.304 2.003 . . . . 0.84999999999999998 111.952 -179.107 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.01 87.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.435 -0.802 . . . . 1.0700000000000001 111.082 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.78 -39.99 63.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.84 -0.618 . . . . 1.8200000000000001 111.555 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -85.28 162.84 18.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.18 0.514 . . . . 2.3599999999999999 111.942 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.18 -18.05 63.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.4 -0.818 . . . . 1.95 111.942 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -69.46 170.03 11.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.877 -0.601 . . . . 2.2799999999999998 111.967 -177.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 59' ' ' ILE . 1.3 t -133.47 -154.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 107.753 -1.203 . . . . 1.4199999999999999 107.753 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' N ' ' HB2' ' A' ' 60' ' ' SER . 78.4 m-20 -67.54 64.54 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.73 0.776 . . . . 1.77 111.564 -177.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -85.76 157.19 20.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.425 -1.261 . . . . 2.54 109.508 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 84' ' ' TYR . 11.5 t -66.27 131.4 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.398 -0.521 . . . . 1.3899999999999999 109.652 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -126.56 -50.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.652 0.612 . . . . 1.8200000000000001 112.652 -176.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.973 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.01 123.1 17.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.067 -0.716 . . . . 1.0800000000000001 109.067 179.642 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 80' ' ' TYR . 7.9 tt -140.0 160.99 38.68 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.793 -0.639 . . . . 1.8799999999999999 110.156 -177.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.58 ' CD1' ' CG2' ' A' ' 79' ' ' ILE . 10.2 t80 -135.61 111.64 9.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.997 0.427 . . . . 2.2000000000000002 110.155 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 6.7 t -142.46 159.98 41.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 1.4199999999999999 111.441 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.17 36.2 51.61 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.63 -0.795 . . . . 0.56999999999999995 111.941 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t0 62.94 22.35 13.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.956 0.408 . . . . 1.46 110.397 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 22.5 mttm -120.68 110.3 16.24 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.922 -0.581 . . . . 2.96 110.677 178.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -80.13 117.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.1 -1.444 . . . . 2.27 107.1 177.313 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.719 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.3 m-85 -99.96 136.47 39.83 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.976 -1.011 . . . . 2.1499999999999999 110.526 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.728 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.3 p-10 -166.26 -56.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.402 -0.962 . . . . 1.2 108.402 -179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' OD1' ' CD2' ' A' ' 83' ' ' TYR . 25.6 p-10 -78.77 -24.01 44.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 2.1699999999999999 109.787 177.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CD2' ' OD1' ' A' ' 82' ' ' ASP . 16.4 m-85 -77.19 -29.17 54.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.285 -1.006 . . . . 5.4100000000000001 108.285 178.378 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.536 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.18 115.9 60.38 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-N 114.985 -1.007 . . . . 2.21 110.644 179.368 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.3 -43.95 16.51 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.739 1.626 . . . . 1.1100000000000001 111.046 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.754 ' O ' HG12 ' A' ' 71' ' ' ILE . 16.6 m-20 -66.93 106.7 1.99 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.106 -0.638 . . . . 1.3600000000000001 110.808 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.813 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 67.64 22.4 9.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.926 1.084 . . . . 2.2400000000000002 113.926 178.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 42.6 pttt -54.81 128.75 34.41 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.81 -0.756 . . . . 2.8700000000000001 111.089 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.35 13.61 55.46 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.344 -0.931 . . . . 0.48999999999999999 114.422 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.7 ptp85 -143.63 -48.98 0.3 Allowed 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 114.584 1.327 . . . . 2.1099999999999999 114.584 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.973 HG11 ' HB ' ' A' ' 72' ' ' ILE . 5.7 p -80.76 81.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 107.232 -1.395 . . . . 1.04 107.232 -178.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.411 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 12.6 m80 -100.6 132.89 45.75 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.277 -2.238 . . . . 0.34000000000000002 112.191 -175.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . 74.6 m-85 -73.8 120.01 18.81 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-O 121.254 0.55 . . . . 2.1600000000000001 109.884 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.453 HG21 ' CE2' ' A' ' 38' ' ' TYR . 32.3 p -74.8 -6.14 47.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 1.0900000000000001 110.428 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.3 m -90.4 120.17 31.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 1.71 110.754 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -89.93 1.58 56.07 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 110.299 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -146.16 68.51 1.19 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 4.3 mp -59.66 -38.38 81.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.962 -1.017 . . . . 1.99 111.696 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -61.62 -6.23 2.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.204 0.526 . . . . 2.4900000000000002 112.071 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 98' ' ' LEU . 53.0 m -86.63 -4.64 59.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.393 -0.821 . . . . 1.8999999999999999 110.643 178.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.404 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 113.55 -22.7 14.63 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.771 -0.728 . . . . 0.40999999999999998 113.254 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.4 m-20 -93.7 107.19 19.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.132 0.466 . . . . 1.4399999999999999 110.489 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.583 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.9 22.11 14.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.657 0.614 . . . . 1.1200000000000001 112.657 -178.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.1 m -59.99 148.18 36.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.521 1.675 . . . . 1.46 115.521 -178.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -132.28 134.31 59.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 114.494 -1.23 . . . . 1.0900000000000001 111.108 179.199 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.57 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -107.06 150.37 26.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.766 -0.828 . . . . 1.5600000000000001 108.766 177.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.35 121.59 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 120.902 0.382 . . . . 1.0600000000000001 110.915 -178.938 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.48 144.36 28.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.703 -0.681 . . . . 1.0700000000000001 111.432 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 54.17 60.32 3.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.825 -0.625 . . . . 1.9399999999999999 112.638 178.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 31' ' ' LYS . 12.2 mt -46.17 169.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.039 0.447 . . . . 1.21 111.887 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.441 ' HG2' ' N ' ' A' ' 112' ' ' LEU . 64.0 tt0 -177.99 166.44 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 2.6699999999999999 109.909 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.571 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 87.0 mt -59.97 -33.26 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.903 0.335 . . . . 2.2400000000000002 111.903 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.9 m -73.36 -19.42 61.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.986 -0.285 . . . . 1.8300000000000001 111.509 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.44 -20.77 62.06 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.571 -0.529 . . . . 1.5800000000000001 109.571 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -49.98 140.33 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-N 115.704 -0.68 . . . . 1.1399999999999999 111.067 178.796 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.01 153.21 5.91 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 119.71 -1.234 . . . . 0.26000000000000001 113.705 179.137 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 84.2 m -59.42 135.71 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.298 0.481 . . . . 1.0700000000000001 112.298 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.611 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.9 m-85 -121.17 131.5 54.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.9 tt0 -128.85 120.0 25.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.78 -0.368 . . . . 1.5900000000000001 110.238 179.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 131' ' ' LYS . 16.6 p -102.81 119.59 39.1 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.546 -0.462 . . . . 1.03 110.911 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.825 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.0 mttt -111.21 104.53 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 2.1899999999999999 110.441 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 21.8 t -88.45 107.44 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.86 -0.422 . . . . 1.8200000000000001 109.86 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 33.8 mttm -100.1 120.7 40.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.823 1.046 . . . . 2.1899999999999999 113.823 -178.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 19.1 tttt -145.83 103.32 3.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.211 0.529 . . . . 3.2799999999999998 109.874 177.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.95 130.6 11.89 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.322 -0.853 . . . . 1.1799999999999999 113.274 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.569 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.9 Cg_endo -102.73 48.72 1.91 Allowed 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 125.008 -0.83 . . . . 0.62 111.621 -0.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 103.5 0.3 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.214 -0.993 . . . . 0.53000000000000003 113.138 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.56 ' HB ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -92.93 151.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.338 -0.931 . . . . 1.8700000000000001 109.995 177.918 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB3' ' CG2' ' A' ' 22' ' ' ILE . . . -145.63 144.08 30.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.182 -0.463 . . . . 1.3200000000000001 111.867 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.551 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 50.5 p-10 -147.16 146.66 29.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.559 0.577 . . . . 2.0299999999999998 112.559 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -144.5 164.67 30.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.395 -0.366 . . . . 3.46 111.299 179.483 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 94.5 mttt -99.68 140.0 34.52 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 113.031 0.752 . . . . 2.6699999999999999 113.031 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 71.9 mt -141.08 110.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.939 -1.028 . . . . 1.0600000000000001 109.248 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 53.3 m170 -100.02 119.98 39.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.70999999999999996 111.052 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.478 ' CB ' ' CE1' ' A' ' 118' ' ' TYR . 3.3 tm? -89.53 125.54 35.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.933 -0.576 . . . . 2.1000000000000001 111.42 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 46.9 t -119.95 130.0 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 1.0900000000000001 109.496 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.412 ' CG1' ' CG ' ' A' ' 33' ' ' LYS . 25.3 t -100.22 122.88 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.156 0.428 . . . . 1.72 112.156 -178.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 72.7 mt -83.5 159.99 21.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.982 -0.554 . . . . 1.21 109.614 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t -72.98 140.77 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 2.0899999999999999 111.939 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.859 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 4.0 mmtt -161.31 175.88 2.82 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.67 -1.15 . . . . 2.7599999999999998 109.783 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.64 ' O ' ' O ' ' A' ' 140' ' ' LYS . 4.2 Cg_endo -44.86 -144.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.252 2.635 . . . . 1.4199999999999999 113.173 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 141' ' ' PRO . 66.5 m -31.8 -44.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.52 0.563 . . . . 2.6899999999999999 112.52 -179.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 33' ' ' LYS . . . 125.14 -57.42 0.68 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.402 -0.904 . . . . 2.8799999999999999 113.555 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.262 -0.875 . . . . 2.6000000000000001 110.989 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 22' ' ' ILE . 74.4 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.009 0.433 . . . . 1.84 110.631 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 ' HB1' ' A' ' 129' ' ' ALA . 4.6 mt -141.91 138.76 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 2.15 110.928 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 21.5 p -93.6 147.86 22.62 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.339 0.59 . . . . 1.12 110.714 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.12 82.88 0.22 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.04 -0.982 . . . . 0.65 111.8 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 48.3 Cg_endo -78.36 -73.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.706 2.937 . . . . 0.88 112.012 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.48 127.63 32.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.412 -0.959 . . . . 2.06 108.412 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.947 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.2 tt0 -143.77 158.34 43.75 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.015 1.117 . . . . 1.71 114.015 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.533 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.41 122.88 17.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.561 -1.199 . . . . 1.86 109.031 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.947 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.8 mm -120.01 126.57 75.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.39 111.527 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.73 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 87.1 mt-10 -119.19 125.18 48.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.434 . . . . 1.19 110.334 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.8 mmtt -141.8 160.02 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 2.52 111.309 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.33 137.56 39.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.39 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.68 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 31.2 ttpt -46.59 139.95 4.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.35 111.674 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.4 -23.2 7.51 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 116.059 -0.519 . . . . 0.31 113.024 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.581 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.5 mt-10 -80.92 160.0 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.594 -0.521 . . . . 2.11 109.594 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.7 m -84.49 130.22 34.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.104 -0.638 . . . . 0.33 110.583 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -99.72 113.43 25.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.26 110.441 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.35 129.92 34.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 1.43 112.24 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.705 HD22 HG21 ' A' ' 133' ' ' ILE . 14.3 mt -121.42 104.33 40.4 Favored Pre-proline 0 CA--C 1.528 0.121 0 N-CA-C 109.132 -0.692 . . . . 0.8 109.132 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 92.7 Cg_endo -84.25 134.03 5.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.546 2.164 . . . . 0.42 114.889 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.676 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 57.3 m -141.59 112.55 7.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.171 -0.922 . . . . 1.03 109.911 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 8.2 tptt -118.69 109.12 15.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.889 0.376 . . . . 1.66 110.663 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.591 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 39.9 p90 -93.82 141.79 28.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.673 -0.694 . . . . 1.26 110.436 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 m -79.46 148.01 32.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 1.33 111.238 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.36 144.33 39.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.477 -0.783 . . . . 2.12 111.406 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 83.5 p -159.34 145.3 12.08 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.804 -0.634 . . . . 1.75 110.08 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.3 Cg_exo -45.45 -21.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.495 2.13 . . . . 1.61 113.107 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 52.6 tp10 -73.67 -38.26 65.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.617 -0.265 . . . . 2.18 111.471 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 46' ' ' SER . 51.0 p-10 -65.79 73.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.641 0.734 . . . . 2.41 110.753 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 76.8 mm-40 -90.79 -10.02 44.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.308 -0.86 . . . . 1.64 111.795 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.941 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -75.57 154.78 46.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.17 -1.014 . . . . 0.55 112.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.63 149.0 25.78 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.205 1.937 . . . . 0.85 111.578 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.52 131.05 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 1.9 110.235 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 19.1 t0 -140.05 150.82 44.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.432 0.634 . . . . 1.78 111.417 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 51.0 mt -141.96 139.99 30.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.919 -1.037 . . . . 0.75 109.747 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.744 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 85.9 tt0 -139.98 148.0 41.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.007 0.432 . . . . 1.67 111.835 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.953 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.6 m95 -141.04 119.27 12.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.22 111.004 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.591 HD21 HG22 ' A' ' 70' ' ' VAL . 83.5 mt -110.06 146.3 35.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.41 109.192 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.753 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 6.9 tt -129.91 135.59 60.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.685 0.624 . . . . 0.78 112.685 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 m -121.52 102.94 41.75 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.26 -0.882 . . . . 1.25 108.646 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 7.1 Cg_exo -78.09 114.09 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.518 2.145 . . . . 0.53 112.619 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.98 87.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.101 -0.954 . . . . 0.41 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.42 -40.05 62.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 1.82 111.253 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 1.4 t-20 -85.04 159.77 20.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.227 0.537 . . . . 1.94 111.813 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.81 -16.39 63.77 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.343 -0.844 . . . . 1.66 111.576 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 93.8 mttt -69.6 151.73 45.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 1.74 111.848 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.12 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-O 121.751 0.786 . . . . 0.97 109.496 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 55.66 85.18 0.07 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.276 -1.329 . . . . 1.77 112.304 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -140.04 144.14 36.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.424 . . . . 1.96 111.124 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD21 ' A' ' 58' ' ' LEU . 61.2 t -70.83 131.9 33.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.902 -0.59 . . . . 0.77 111.33 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.896 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -130.79 -41.38 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.187 0.44 . . . . 1.15 112.187 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.884 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.4 129.89 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.373 0.606 . . . . 0.29 110.064 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 160.97 38.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.255 -0.884 . . . . 1.3 109.684 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 24.0 t80 -138.54 103.28 4.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -143.65 153.66 42.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.502 -0.317 . . . . 0.89 111.8 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' ASP . . . 58.43 29.49 63.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.624 -0.798 . . . . 0.57 111.685 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 10.1 m-20 69.86 4.52 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.619 0.247 . . . . 1.46 111.088 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 97.3 mttt -99.98 112.68 24.95 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.611 -0.514 . . . . 2.41 109.611 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -84.28 116.47 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 108.057 -1.09 . . . . 1.66 108.057 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.7 m-85 -100.33 126.28 46.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.439 -1.709 . . . . 1.25 110.78 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.87 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.5 p-10 -165.98 -53.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.526 -1.286 . . . . 1.2 107.526 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.0 p-10 -82.93 -26.93 30.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.147 -0.933 . . . . 2.17 109.749 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CD1' ' OD1' ' A' ' 82' ' ' ASP . 36.1 m-85 -75.57 -28.58 59.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.4 -1.333 . . . . 5.05 107.4 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -83.16 113.19 44.4 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 114.158 -1.383 . . . . 1.29 110.329 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.7 -42.94 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.615 1.544 . . . . 0.79 111.226 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.811 ' HB3' HG22 ' A' ' 71' ' ' ILE . 74.6 m-20 -67.99 104.6 1.78 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.012 -0.54 . . . . 1.36 111.235 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 32.4 mt 71.27 24.4 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.306 -0.861 . . . . 1.62 113.221 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.7 pttt -58.14 135.61 57.08 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.901 -0.499 . . . . 2.39 111.63 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.35 11.31 75.64 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.536 -0.84 . . . . 0.37 114.398 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.6 ptp180 -138.99 -50.97 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.678 1.362 . . . . 1.59 114.678 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.896 HG11 ' CD1' ' A' ' 71' ' ' ILE . 7.6 p -78.96 81.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.847 1.308 . . . . 0.2 107.53 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 11.2 m-70 -102.88 131.55 49.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.451 -2.159 . . . . 0.29 112.401 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.142 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.6 m-85 -73.59 120.2 18.86 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 120.024 -0.67 . . . . 1.23 109.312 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 38' ' ' TYR . 18.0 p -70.09 -9.17 54.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.923 -1.035 . . . . 0.46 110.807 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 5.3 m -88.32 118.53 28.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.941 -0.572 . . . . 1.2 110.887 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -90.09 0.18 57.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.244 0.545 . . . . 2.22 110.168 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -146.41 67.19 1.18 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.487 -0.931 . . . . 2.14 108.487 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.594 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.5 mp -57.77 -27.76 63.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.25 -0.886 . . . . 1.49 112.149 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -63.45 -5.04 3.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.187 0.518 . . . . 2.04 112.115 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.6 p -89.85 -0.04 57.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.41 -0.814 . . . . 1.4 110.975 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.591 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.21 0.6 38.26 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.645 -0.788 . . . . 0.38 113.218 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.512 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 92.3 m-20 -99.94 118.65 36.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 1.44 111.002 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -118.5 10.39 12.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.43 111.651 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -60.03 140.43 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.122 1.897 . . . . 1.04 116.122 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.142 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.82 134.61 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 114.543 -1.208 . . . . 0.31 110.486 177.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.3 p-10 -108.88 151.08 26.75 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.673 -0.862 . . . . 1.15 108.673 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.78 120.13 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.0 0.429 . . . . 0.27 110.903 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -83.9 144.89 28.91 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.506 -0.77 . . . . 0.29 111.094 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.82 61.77 3.04 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.963 -0.562 . . . . 1.52 112.328 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.45 176.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.218 0.451 . . . . 1.02 112.218 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.745 ' O ' HG21 ' A' ' 137' ' ' VAL . 62.3 tt0 -176.32 159.99 2.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 2.13 110.616 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 95.0 mt -59.93 -40.07 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.525 . . . . 1.7 112.416 -178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.3 m -74.56 -13.98 60.74 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.1 -0.24 . . . . 1.32 111.372 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.62 -22.37 62.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 1.58 109.271 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.58 HG13 HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.53 144.9 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 115.641 -0.709 . . . . 0.42 110.74 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.62 148.79 5.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.234 -0.984 . . . . 0.24 113.268 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.887 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.1 m -59.07 135.89 57.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.431 . . . . 0.31 111.771 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.753 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.5 m-85 -116.18 139.99 49.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 1.24 109.867 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.753 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 54.7 tt0 -117.88 117.53 29.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.035 -0.357 . . . . 1.16 110.035 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.545 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 18.0 t -100.0 109.62 21.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.101 -0.5 . . . . 1.03 110.687 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 54.4 mtpt -121.35 111.48 17.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 1.76 111.895 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 t -96.28 110.16 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.483 -0.562 . . . . 1.18 109.483 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 29.0 tttt -95.02 114.93 26.79 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.879 -0.728 . . . . 1.62 112.767 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.99 102.66 3.67 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.262 -0.644 . . . . 2.84 109.262 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.941 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.07 133.51 22.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.44 112.29 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 58.6 Cg_endo -101.61 50.04 1.71 Allowed 'Cis proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.745 -0.939 . . . . 0.56 111.138 -0.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.98 103.06 0.29 Allowed Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.062 -1.066 . . . . 0.48 113.29 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -88.41 119.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.203 -0.999 . . . . 1.22 109.761 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -100.01 140.48 34.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.681 -0.236 . . . . 0.57 111.601 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -146.07 131.72 18.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.483 -0.326 . . . . 2.03 111.244 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.676 ' HZ3' ' HA ' ' A' ' 41' ' ' CYS . 5.0 ptmt -145.25 158.5 43.81 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.344 -0.389 . . . . 2.95 110.676 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.578 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 96.7 mttt -102.79 140.02 37.61 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.065 0.765 . . . . 2.26 113.065 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.831 HD13 ' CH2' ' A' ' 57' ' ' TRP . 2.4 mp -141.32 116.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.349 -0.841 . . . . 0.28 108.895 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.887 ' CD2' HG23 ' A' ' 117' ' ' THR . 54.0 m170 -101.44 120.04 39.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.55 110.845 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.425 HD21 ' CD2' ' A' ' 110' ' ' LEU . 60.8 tp -88.77 121.26 30.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 1.52 111.623 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.8 t -120.0 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.763 -0.653 . . . . 0.32 109.513 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG21 ' O ' ' A' ' 111' ' ' GLN . 25.9 t -100.97 125.94 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 1.08 112.156 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.26 155.25 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.835 -0.62 . . . . 0.52 109.403 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 1.48 111.654 -178.744 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.942 0.401 . . . . 1.84 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.587 HD13 ' HB1' ' A' ' 129' ' ' ALA . 6.5 pt -99.18 144.89 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 2.15 111.182 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.41 159.54 18.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.466 0.65 . . . . 1.12 111.614 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.638 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER 41.75 83.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.724 -1.125 . . . . 0.65 111.899 -178.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.2 Cg_endo -78.72 -78.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.547 2.832 . . . . 0.88 112.867 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.1 mt-10 -78.96 128.6 33.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.871 -0.418 . . . . 2.06 109.871 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.583 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 49.7 tt0 -144.45 159.96 41.87 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.212 1.19 . . . . 1.71 114.212 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' ILE . 31.2 mtt -137.73 117.85 13.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.626 -1.17 . . . . 1.86 108.847 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.988 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -119.97 120.6 63.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.371 0.508 . . . . 0.39 112.371 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 96.5 mt-10 -106.87 126.25 52.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.059 -0.519 . . . . 1.19 109.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 110' ' ' LEU . 27.7 tptt -141.79 150.07 41.23 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.795 -0.362 . . . . 2.52 111.486 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.62 140.26 40.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.39 112.134 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 97.6 mttt -44.98 153.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.654 0.613 . . . . 2.35 112.654 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.09 -28.53 0.54 Allowed Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.139 -0.937 . . . . 0.31 113.636 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.62 160.07 26.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.236 -0.653 . . . . 2.11 109.236 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 79.7 m -85.89 129.87 34.71 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.066 -0.654 . . . . 0.33 110.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.83 117.8 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.509 . . . . 0.26 110.243 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 94' ' ' THR . 17.6 t80 -79.32 121.11 24.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.722 -0.672 . . . . 1.43 112.631 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.843 ' HB2' HD12 ' A' ' 105' ' ' ILE . 22.9 mt -104.29 104.8 46.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.457 -0.942 . . . . 0.8 108.457 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.624 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 95.7 Cg_endo -82.95 129.72 5.48 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.235 1.957 . . . . 0.42 114.202 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 3.8 t -140.64 134.4 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.183 -1.043 . . . . 1.03 108.183 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' O ' HG22 ' A' ' 22' ' ' ILE . 43.8 mmtm -140.28 143.86 36.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.826 -0.35 . . . . 1.66 111.349 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.766 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 47.3 p90 -140.56 140.71 35.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.26 111.26 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -81.88 140.21 34.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.906 -0.588 . . . . 1.33 111.899 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.589 HD21 ' HE2' ' A' ' 43' ' ' PHE . 86.1 mt -101.61 141.97 33.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.762 -0.653 . . . . 2.12 110.997 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 44.7 m -154.93 154.49 29.03 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 1.75 110.242 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.42 -21.33 29.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.603 2.202 . . . . 1.61 112.909 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.3 tt0 -76.18 -41.49 49.44 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 120.942 -0.303 . . . . 2.18 110.952 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -71.48 74.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.357 -0.537 . . . . 2.41 109.943 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -91.38 -8.02 49.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.801 . . . . 1.64 111.892 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.938 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.32 159.89 53.54 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.067 -1.064 . . . . 0.55 112.259 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 144.04 59.56 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.132 1.888 . . . . 0.85 111.348 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.766 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 9.7 tt -77.61 123.66 26.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 1.9 110.663 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.2 m-20 -129.46 148.21 51.34 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.508 0.67 . . . . 1.78 111.223 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.807 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 24.3 mt -142.88 141.87 26.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.491 -1.232 . . . . 0.75 109.248 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 40.9 mt-10 -139.97 151.41 45.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.015 -0.274 . . . . 1.67 110.953 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.979 ' CD2' HD11 ' A' ' 105' ' ' ILE . 87.4 m95 -140.49 116.12 10.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.22 110.588 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.3 mt -106.31 146.26 30.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.41 109.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.568 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.062 0.458 . . . . 0.78 111.923 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.454 ' OG ' HG12 ' A' ' 67' ' ' VAL . 28.4 t -115.64 102.88 54.24 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 108.916 -0.772 . . . . 1.25 108.916 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 66' ' ' LYS . 72.4 Cg_endo -78.76 110.29 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.629 2.219 . . . . 0.53 112.81 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.79 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.15 -0.932 . . . . 0.41 110.901 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 20.1 p-10 -88.24 20.41 3.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 1.82 111.642 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -151.46 160.02 43.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.245 0.545 . . . . 1.94 111.858 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -68.4 -20.01 64.65 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.394 -0.821 . . . . 1.66 112.231 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.609 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 59.4 mttp -67.86 154.19 42.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.945 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.454 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.78 135.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-O 122.751 1.262 . . . . 0.97 110.78 178.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 39.98 46.31 1.74 Allowed 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.251 -2.25 . . . . 1.77 113.481 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -91.33 143.28 26.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.996 -0.282 . . . . 1.96 110.98 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 HD21 ' A' ' 58' ' ' LEU . 94.9 t -68.35 130.03 33.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.77 110.525 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.905 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -128.61 -37.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 1.15 112.014 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.98 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.67 125.62 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.928 -0.767 . . . . 0.29 108.928 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.74 158.29 44.18 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.556 -0.747 . . . . 1.3 110.695 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 14.6 t80 -133.25 103.81 6.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.146 -0.687 . . . . 1.3 109.146 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.444 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 23.5 m -142.74 159.11 42.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.784 0.326 . . . . 0.89 111.666 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.19 27.55 23.85 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.797 -0.716 . . . . 0.57 112.462 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 74.12 1.83 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.54 0.21 . . . . 1.46 110.989 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.9 mttm -100.01 114.1 27.17 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.954 -0.388 . . . . 2.41 109.954 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.24 126.87 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 C-N-CA 118.658 -1.217 . . . . 1.66 107.82 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.703 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -111.02 128.06 55.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.635 -1.62 . . . . 1.25 110.631 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.868 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.7 p-10 -166.17 -56.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.081 -1.451 . . . . 1.2 107.081 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.9 t70 -83.09 -26.02 31.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.702 -1.135 . . . . 2.17 109.188 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -75.87 -30.2 58.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.921 -1.14 . . . . 5.05 107.921 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.55 110.58 22.82 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 114.402 -1.272 . . . . 1.29 110.166 178.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.73 -41.69 11.55 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.67 1.58 . . . . 0.79 111.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.818 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.1 m-20 -68.06 104.2 1.71 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.83 -0.623 . . . . 1.36 111.188 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.816 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.2 mt 71.74 20.75 4.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.21 0.819 . . . . 1.62 113.21 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.868 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.8 pttt -56.23 131.99 49.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.883 -0.511 . . . . 2.39 111.269 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.07 10.82 60.74 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.186 -1.007 . . . . 0.37 114.247 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -142.02 -49.26 0.38 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 114.862 1.43 . . . . 1.59 114.862 -178.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.98 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.61 81.45 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 CA-C-O 123.339 1.542 . . . . 0.2 107.128 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.498 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.2 m-70 -102.05 128.9 48.31 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.044 -2.344 . . . . 0.29 112.563 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.109 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -72.34 124.74 25.74 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.752 -0.779 . . . . 1.23 109.024 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.464 HG21 ' CD2' ' A' ' 38' ' ' TYR . 12.6 p -76.44 36.03 0.15 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.212 -0.903 . . . . 0.46 112.062 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -148.68 133.33 17.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.91 0.386 . . . . 1.2 110.848 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -90.07 5.23 47.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 2.22 110.2 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -146.16 65.74 1.2 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.704 -0.68 . . . . 2.14 109.429 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.849 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.1 mp -57.32 -29.12 63.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 1.49 110.866 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.5 mttt -65.8 1.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.35 0.5 . . . . 2.04 112.35 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 m -89.99 -0.0 57.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.688 -0.687 . . . . 1.4 111.244 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 110.51 -11.02 30.64 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.805 -0.712 . . . . 0.38 113.022 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -100.09 112.69 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 1.44 111.135 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -109.65 12.75 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.43 111.681 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 21.1 m -60.07 139.15 57.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.459 1.651 . . . . 1.04 115.459 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.109 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.38 130.03 65.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-N 114.347 -1.297 . . . . 0.31 110.735 178.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.629 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.6 p-10 -104.4 146.62 28.58 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.672 -0.862 . . . . 1.15 108.672 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.82 121.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.008 0.432 . . . . 0.27 110.808 -178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -83.79 145.22 28.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.445 -0.798 . . . . 0.29 111.176 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 54.12 63.73 2.07 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.081 -0.509 . . . . 1.52 112.169 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 31' ' ' LYS . 4.5 mt -45.03 175.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.198 0.523 . . . . 1.02 112.299 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.748 ' O ' HG21 ' A' ' 137' ' ' VAL . 14.8 pt20 -177.02 156.83 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 2.13 110.888 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 60.5 tp -60.04 -39.71 86.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 1.7 112.11 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.487 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 4.8 t -72.46 -16.11 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.998 0.74 . . . . 1.32 112.998 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.2 p30 -74.38 -16.05 60.91 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.888 -0.725 . . . . 1.58 109.791 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.839 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -45.17 141.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.42 110.185 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 154.05 6.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 119.717 -1.23 . . . . 0.24 113.88 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.533 HG23 ' ND1' ' A' ' 134' ' ' HIS . 94.4 m -59.88 137.73 57.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.933 -0.633 . . . . 0.31 112.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.6 m-85 -119.97 139.7 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.324 -0.621 . . . . 1.24 109.324 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.1 tt0 -128.39 121.89 30.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.706 0.288 . . . . 1.16 110.893 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 56' ' ' GLU . 43.5 t -99.96 117.79 35.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.03 110.632 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 23.0 mttm -115.0 106.1 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.801 -0.359 . . . . 1.76 110.56 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 34.3 t -94.87 105.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.649 -0.5 . . . . 1.18 109.649 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.7 tttt -95.27 119.35 33.63 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.898 -0.721 . . . . 1.62 112.603 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.526 ' HG2' ' HB2' ' A' ' 49' ' ' ASP . 6.6 ttpm? -146.25 102.98 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 2.84 110.111 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.938 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.33 133.25 24.9 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 53.5 Cg_endo -100.68 47.26 2.19 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.742 -0.941 . . . . 0.56 111.434 -0.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.94 103.33 0.28 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.146 -1.026 . . . . 0.48 113.579 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.73 151.46 3.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -0.811 . . . . 1.22 108.887 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -141.44 151.32 43.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.412 0.523 . . . . 0.57 112.412 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 3.7 m-20 -145.8 141.18 27.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.925 -0.58 . . . . 2.03 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.638 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.26 156.31 43.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.689 -0.232 . . . . 2.95 110.645 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.3 mttm -101.34 140.53 35.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.631 0.975 . . . . 2.26 113.631 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.988 HG23 HD13 ' A' ' 29' ' ' ILE . 33.3 mt -141.96 111.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.28 109.233 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.533 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.6 m-70 -100.04 118.71 37.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.727 -0.389 . . . . 0.55 110.647 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.658 HD11 HD21 ' A' ' 39' ' ' LEU . 10.2 mt -92.94 125.39 37.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.267 0.556 . . . . 1.52 112.035 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.669 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 57.8 t -115.64 123.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.314 -0.857 . . . . 0.32 109.109 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.839 HG23 HG13 ' A' ' 115' ' ' ILE . 21.6 t -94.6 120.03 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.062 0.458 . . . . 1.08 111.929 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.16 158.63 18.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.52 110.505 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.225 0.536 . . . . 1.48 111.057 -179.796 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 1.84 111.08 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.87 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 14.9 tt -142.82 147.75 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.596 -0.729 . . . . 2.15 110.986 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 53.6 p -88.86 146.3 25.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.28 0.562 . . . . 1.12 110.998 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 40.28 82.52 0.22 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.868 -1.06 . . . . 0.65 111.384 -178.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.6 Cg_endo -78.15 -11.17 16.34 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 124.008 3.139 . . . . 0.88 113.127 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.56 121.8 13.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.592 -0.892 . . . . 2.06 108.592 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.899 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.1 tt0 -143.81 158.99 43.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.765 1.024 . . . . 1.71 113.765 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 29' ' ' ILE . 56.3 ttm -138.52 135.05 34.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.692 -1.14 . . . . 1.86 109.138 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.899 HD11 ' OE2' ' A' ' 27' ' ' GLU . 31.9 mm -133.79 139.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.39 111.925 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.2 mt-10 -132.61 122.23 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 1.19 109.544 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 11.6 tptm -142.1 161.52 37.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.74 -0.384 . . . . 2.52 111.119 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.17 131.69 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.39 111.573 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 137' ' ' VAL . 27.7 ttmt -44.89 132.04 6.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.767 -0.651 . . . . 2.35 111.345 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.94 -16.56 56.65 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.056 -0.592 . . . . 0.31 112.504 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 66.4 mm-40 -80.32 159.97 25.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.009 -0.737 . . . . 2.11 109.009 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.979 HG22 ' OD1' ' A' ' 106' ' ' ASN . 10.1 m -90.84 121.69 32.91 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.001 -0.68 . . . . 0.33 110.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.53 119.73 38.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.146 0.498 . . . . 0.26 111.451 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.7 t80 -79.24 116.38 19.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 1.43 111.638 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.721 HD12 HD12 ' A' ' 105' ' ' ILE . 15.4 mt -99.96 105.05 32.66 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.935 -0.765 . . . . 0.8 108.935 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.786 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.0 Cg_endo -82.31 124.92 4.37 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.424 2.083 . . . . 0.42 114.09 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.9 t -141.16 132.71 27.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 1.03 109.473 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.579 ' O ' HG13 ' A' ' 22' ' ' ILE . 41.9 mttm -141.08 153.47 45.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.28 -0.418 . . . . 1.66 110.538 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.919 ' CE2' HD11 ' A' ' 53' ' ' LEU . 36.3 p90 -140.41 153.02 46.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.567 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -79.89 128.39 33.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 1.33 111.299 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.574 ' C ' HD13 ' A' ' 45' ' ' LEU . 3.0 tm? -99.75 131.42 45.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.63 -0.713 . . . . 2.12 110.725 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 45' ' ' LEU . 46.0 m -152.24 139.91 13.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 110.223 -0.288 . . . . 1.75 110.223 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.57 -25.69 5.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.398 2.065 . . . . 1.61 112.344 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -39.97 67.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.345 -0.388 . . . . 2.18 110.53 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -75.93 79.62 2.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.606 -0.887 . . . . 2.41 108.606 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.95 -0.23 54.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.757 -0.656 . . . . 1.64 112.306 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -71.21 158.96 53.79 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.342 -0.932 . . . . 0.55 112.719 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 123' ' ' LYS . 18.6 Cg_endo -59.93 132.5 45.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.472 2.115 . . . . 0.85 111.376 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.919 HD11 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -78.2 104.67 8.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.444 -0.344 . . . . 1.9 111.698 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.2 m-20 -118.3 103.56 9.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.53 0.681 . . . . 1.78 111.426 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.743 ' CD1' HG13 ' A' ' 122' ' ' VAL . 4.7 mm -89.56 104.44 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.853 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 73' ' ' LEU . 85.9 tt0 -101.73 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.185 0.439 . . . . 1.67 112.185 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.3 m95 -99.99 124.39 45.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.22 110.303 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.618 HD12 ' OE1' ' A' ' 119' ' ' GLN . 92.2 mt -112.23 139.96 47.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.472 -0.566 . . . . 0.41 109.472 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.628 HD11 ' O ' ' A' ' 114' ' ' ASP . 3.7 tt -129.59 130.05 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.994 0.426 . . . . 0.78 111.675 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 19.6 m -114.3 102.61 54.95 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 115.799 -0.637 . . . . 1.25 109.328 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.7 Cg_exo -78.67 113.79 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.707 2.272 . . . . 0.53 112.255 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.98 87.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.29 -0.868 . . . . 0.41 111.283 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.73 -40.01 61.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 1.82 111.009 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 12.5 t-20 -82.91 159.96 22.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 1.94 111.662 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.67 -17.49 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.419 -0.81 . . . . 1.66 111.408 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 60.8 mttp -69.76 152.66 44.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.592 -0.731 . . . . 1.74 112.113 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -156.31 126.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-O 121.829 0.823 . . . . 0.97 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 56.47 40.04 29.74 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 1.77 111.988 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -89.14 147.71 24.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.628 -0.26 . . . . 1.96 111.158 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG11 ' OH ' ' A' ' 84' ' ' TYR . 22.4 t -67.54 139.74 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.689 -0.486 . . . . 0.77 109.689 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 -52.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.15 112.912 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.911 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.21 127.04 31.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.076 -0.713 . . . . 0.29 109.076 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' HG3' ' A' ' 56' ' ' GLU . 7.4 tt -140.13 160.63 39.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 1.3 110.633 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.925 ' CD1' HD13 ' A' ' 79' ' ' ILE . 20.9 t80 -134.78 104.04 5.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.619 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.473 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 35.6 t -143.61 159.82 41.76 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.475 0.546 . . . . 0.89 112.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.14 31.89 8.91 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.862 -0.608 . . . . 0.57 113.155 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t0 71.07 2.57 4.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.269 . . . . 1.46 111.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 92.2 mttt -100.18 113.4 26.03 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.979 -0.378 . . . . 2.41 109.979 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.925 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.34 128.8 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.063 -1.458 . . . . 1.66 107.063 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.725 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -112.59 115.65 28.94 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.241 -0.89 . . . . 1.25 110.328 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.872 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.7 p-10 -166.07 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 106.799 -1.556 . . . . 1.2 106.799 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -79.67 -25.72 41.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.585 -1.189 . . . . 2.17 108.491 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -81.32 -28.26 34.64 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.849 -1.167 . . . . 5.05 107.849 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 2.7 m-85 -87.65 120.93 71.18 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 114.769 -1.105 . . . . 1.29 110.727 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 84' ' ' TYR . 7.7 Cg_exo -71.47 -28.67 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.033 1.822 . . . . 0.79 112.951 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' HD23 ' A' ' 87' ' ' LEU . 28.7 t0 -49.22 -30.01 6.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.228 -0.589 . . . . 1.36 112.06 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.946 HD22 ' HD2' ' A' ' 90' ' ' ARG . 29.9 mt -157.56 38.01 0.28 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.121 -0.945 . . . . 1.62 110.504 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 23.9 pttm -55.81 134.09 51.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.877 -0.601 . . . . 2.39 112.392 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.36 76.0 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.39 -0.823 . . . . 0.37 114.461 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.946 ' HD2' HD22 ' A' ' 87' ' ' LEU . 3.5 ptp180 -145.27 -48.13 0.23 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.701 1.371 . . . . 1.59 114.701 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.911 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.22 81.47 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-O 122.992 1.377 . . . . 0.2 108.064 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 106' ' ' ASN . 19.8 m80 -102.91 126.98 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.24 -2.254 . . . . 0.29 112.343 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.941 ' CD1' HG23 ' A' ' 105' ' ' ILE . 80.5 m-85 -70.01 125.42 26.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 120.168 -0.613 . . . . 1.23 109.701 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.631 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.4 p -76.14 32.94 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.204 -0.907 . . . . 0.46 112.027 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.8 m -148.46 132.51 17.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 1.2 111.216 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -91.72 4.9 51.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 2.22 110.585 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.04 66.29 1.2 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.135 -0.691 . . . . 2.14 109.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.558 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -57.72 -31.76 66.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.888 . . . . 1.49 111.425 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.99 2.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.291 0.478 . . . . 2.04 112.291 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 5.4 t -89.97 -0.03 57.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.761 -0.654 . . . . 1.4 110.619 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.89 -14.01 41.28 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.055 -0.593 . . . . 0.38 112.834 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -100.02 108.03 20.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 1.44 110.853 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -111.62 19.99 17.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.104 0.409 . . . . 0.43 112.104 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.0 m -60.04 143.78 51.11 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.006 1.484 . . . . 1.04 115.006 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.941 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -129.67 133.26 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.735 -1.12 . . . . 0.31 111.252 178.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.979 ' OD1' HG22 ' A' ' 36' ' ' THR . 2.9 t-20 -102.84 157.33 17.04 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.022 -1.103 . . . . 1.15 108.022 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.917 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -114.81 117.38 55.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.988 0.423 . . . . 0.27 111.456 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.832 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.03 143.01 31.85 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.48 -0.782 . . . . 0.29 110.556 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 8.7 t-20 48.88 58.31 5.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.958 -0.565 . . . . 1.52 111.826 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.1 mt -47.27 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.754 1.02 . . . . 1.02 113.754 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.448 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 54.1 tt0 -56.58 145.57 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.983 -0.553 . . . . 2.13 110.793 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.584 HD13 ' HE2' ' A' ' 33' ' ' LYS . 62.5 tp -60.03 -40.0 87.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 1.7 111.127 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -73.51 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.939 -0.573 . . . . 1.32 111.632 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.628 ' O ' HD11 ' A' ' 59' ' ' ILE . 95.8 m-20 -69.98 -18.08 63.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 1.58 109.881 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.74 140.66 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.976 -0.556 . . . . 0.42 110.235 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.8 159.14 7.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.9 -1.143 . . . . 0.24 113.951 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.8 m -58.99 139.33 56.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.062 -0.569 . . . . 0.31 112.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 29.9 m-85 -119.98 130.87 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.514 . . . . 1.24 109.888 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.618 ' OE1' HD12 ' A' ' 58' ' ' LEU . 57.8 tt0 -122.05 119.83 32.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.148 -0.221 . . . . 1.16 110.662 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.557 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 39.5 t -100.15 120.01 39.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.468 -0.333 . . . . 1.03 110.76 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.5 mtpt -114.14 104.83 12.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.377 . . . . 1.76 110.842 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 73.8 t -87.52 108.25 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.197 -1.038 . . . . 1.18 108.197 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 83.4 tttt -97.78 110.87 23.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.423 0.897 . . . . 1.62 113.423 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.748 ' HD2' HD12 ' A' ' 53' ' ' LEU . 34.8 tttp -145.61 101.56 3.58 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.545 -0.539 . . . . 2.84 109.545 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.779 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.79 132.18 47.62 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.44 112.332 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.576 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 60.7 Cg_endo -100.62 49.76 1.75 Allowed 'Cis proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.614 -0.994 . . . . 0.56 112.185 -0.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.99 103.3 0.29 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.303 -0.951 . . . . 0.48 113.438 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.85 120.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.288 -0.956 . . . . 1.22 110.203 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.006 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -95.45 144.68 25.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 0.57 111.359 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 1.4 m-80 -145.72 129.89 17.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.651 0.611 . . . . 2.03 112.651 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.786 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.84 159.95 42.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.438 -0.346 . . . . 2.95 110.941 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.5 mttt -110.5 146.92 35.14 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.496 0.925 . . . . 2.26 113.496 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.748 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 88.7 mt -143.39 118.97 4.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.266 -0.879 . . . . 0.28 109.535 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -100.9 113.22 25.98 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.91 -0.494 . . . . 0.55 110.406 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 110' ' ' LEU . 1.9 tm? -91.56 128.91 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.253 0.464 . . . . 1.52 112.253 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.6 t -121.53 129.96 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.689 . . . . 0.32 109.297 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 33' ' ' LYS . 26.0 t -103.06 119.96 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.209 0.448 . . . . 1.08 112.209 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.2 mt -84.51 172.13 11.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.52 109.089 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.63 . . . . 1.48 111.664 -178.498 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.812 0.339 . . . . 1.84 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 13.3 tt -130.01 129.93 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 2.15 110.558 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -89.39 153.84 20.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.352 0.596 . . . . 1.12 111.259 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 44.33 82.96 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.92 -1.037 . . . . 0.65 111.004 -177.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.663 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.1 Cg_endo -78.55 -86.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.619 2.879 . . . . 0.88 113.207 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.5 tt0 -77.85 123.09 26.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.222 -0.659 . . . . 2.06 109.222 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.8 tp10 -143.91 159.96 41.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.446 0.906 . . . . 1.71 113.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.497 ' O ' HD13 ' A' ' 29' ' ' ILE . 26.0 mtt -132.35 130.01 40.17 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.264 -0.88 . . . . 1.86 109.918 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.606 ' HB ' HD23 ' A' ' 135' ' ' LEU . 33.2 mm -127.57 133.82 66.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.643 0.259 . . . . 0.39 111.524 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.9 mt-10 -123.77 125.73 45.24 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.498 -0.319 . . . . 1.19 110.842 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 110' ' ' LEU . 10.4 mmtp -142.35 160.01 41.1 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.408 . . . . 2.52 111.713 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.82 139.23 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.39 111.522 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 112' ' ' LEU . 85.5 tttt -49.24 134.87 17.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.858 0.361 . . . . 2.35 111.356 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.52 -21.33 22.44 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.138 -0.553 . . . . 0.31 112.776 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -79.98 159.83 26.13 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.32 -0.993 . . . . 2.11 108.32 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.4 m -87.28 126.78 35.05 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.42 -0.912 . . . . 0.33 110.484 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.018 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.74 117.62 33.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.26 110.162 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.946 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 74.0 t80 -79.13 115.27 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 1.43 112.038 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.776 HD21 HD11 ' A' ' 135' ' ' LEU . 33.9 mt -100.45 104.76 32.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.961 -0.755 . . . . 0.8 108.961 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.683 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.6 Cg_endo -81.94 125.61 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.38 2.053 . . . . 0.42 113.819 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.0 t -140.39 131.25 25.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.833 -1.173 . . . . 1.03 107.833 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 39.4 mttm -140.67 150.59 43.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 1.66 111.183 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 40.6 p90 -140.35 142.04 35.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.642 -0.708 . . . . 1.26 111.133 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -82.3 135.48 35.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.989 -0.551 . . . . 1.33 111.665 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -97.74 140.06 32.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 2.12 111.762 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 2.8 t -159.19 143.21 11.07 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.835 -0.621 . . . . 1.75 109.814 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -41.32 -26.72 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.735 2.29 . . . . 1.61 113.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.82 -50.58 16.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.681 0.277 . . . . 2.18 110.53 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' CG ' ' A' ' 124' ' ' LYS . 4.4 p-10 -74.59 64.25 1.18 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.174 0.512 . . . . 2.41 110.047 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -102.46 2.59 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.479 -0.782 . . . . 1.64 112.556 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.34 169.53 53.11 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.231 -0.985 . . . . 0.55 112.94 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.6 121.96 10.44 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.591 2.194 . . . . 0.85 111.563 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.4 tt -78.29 120.62 23.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.151 -0.477 . . . . 1.9 111.937 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 5.7 m-20 -138.05 103.45 4.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.373 0.606 . . . . 1.78 111.484 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 67.8 mt -98.94 108.45 22.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.103 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' OE2' HD21 ' A' ' 58' ' ' LEU . 85.9 tt0 -100.62 121.17 41.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.765 0.654 . . . . 1.67 112.765 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.901 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.5 m95 -95.33 126.57 40.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.22 109.926 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 88.7 mt -112.9 141.81 46.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.702 -0.481 . . . . 0.41 109.702 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.5 tt -129.99 129.95 65.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.036 0.446 . . . . 0.78 111.793 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.432 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 14.3 m -120.23 102.01 46.35 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 109.015 -0.735 . . . . 1.25 109.015 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.4 Cg_exo -80.02 114.78 3.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.52 2.146 . . . . 0.53 112.92 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.64 73.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.41 110.714 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 86.6 m-20 -86.29 17.2 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 1.82 111.992 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 28.1 m120 -149.86 163.66 37.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.265 0.555 . . . . 1.94 111.68 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.49 -18.84 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.28 -0.873 . . . . 1.66 112.094 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 92.0 mttt -68.51 144.79 54.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.204 -0.453 . . . . 1.74 111.798 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.67 127.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 121.837 0.827 . . . . 0.97 109.636 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 52.88 39.93 29.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.089 -1.414 . . . . 1.77 112.046 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -91.09 145.61 24.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.521 -0.309 . . . . 1.96 110.961 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.6 t -65.91 138.94 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 108.978 -0.749 . . . . 0.77 108.978 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -132.97 -52.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 112.577 0.584 . . . . 1.15 112.577 -176.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.96 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.99 129.95 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.646 -0.872 . . . . 0.29 108.646 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 55' ' ' ILE . 7.7 tp -140.41 157.51 45.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.865 0.364 . . . . 1.3 111.467 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.802 ' CD1' HD13 ' A' ' 79' ' ' ILE . 41.2 t80 -131.3 103.64 6.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 1.3 110.165 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.49 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 41.4 t -144.12 159.78 42.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.661 0.615 . . . . 0.89 112.661 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.13 33.46 5.45 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.838 -0.619 . . . . 0.57 113.26 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t0 70.02 3.26 4.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.604 0.24 . . . . 1.46 111.095 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 21.4 mttm -100.46 116.54 32.65 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.108 -0.331 . . . . 2.41 110.108 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.2 mm -80.71 130.03 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.174 -1.417 . . . . 1.66 107.174 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -117.1 121.59 41.72 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.542 -0.754 . . . . 1.25 110.822 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.5 p-10 -165.82 -52.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.324 -1.361 . . . . 1.2 107.324 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -81.38 -24.14 37.2 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.03 -0.986 . . . . 2.17 109.31 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.93 -26.03 43.66 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.859 -1.064 . . . . 5.05 108.139 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.672 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.8 m-85 -86.37 119.68 71.68 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 114.791 -1.095 . . . . 1.29 110.941 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.2 Cg_endo -50.78 -41.96 52.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.365 1.377 . . . . 0.79 109.93 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' ILE . 63.3 m-20 -67.58 105.6 1.92 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.844 -0.616 . . . . 1.36 110.671 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.862 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.6 mt 68.4 26.79 6.59 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.448 0.907 . . . . 1.62 113.448 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 129.88 43.97 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.78 -0.575 . . . . 2.39 111.477 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.94 17.91 60.53 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.485 -0.864 . . . . 0.37 114.108 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.862 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.7 ptp180 -143.96 -47.92 0.28 Allowed 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 114.448 1.277 . . . . 1.59 114.448 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.96 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.8 81.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 123.109 1.433 . . . . 0.2 107.621 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.526 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.8 m80 -102.07 128.72 48.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 112.15 -2.295 . . . . 0.29 112.363 -175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.112 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.0 m-85 -71.99 120.03 17.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.273 0.559 . . . . 1.23 109.679 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.946 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 22.1 p -70.29 -9.97 57.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.21 -0.904 . . . . 0.46 110.347 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.5 m -89.01 117.42 28.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.775 -0.648 . . . . 1.2 110.625 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -89.95 4.82 48.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.566 0.698 . . . . 2.22 109.798 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' SER . 34.0 p-10 -146.28 66.46 1.19 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.979 -1.119 . . . . 2.14 107.979 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.49 -38.94 82.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.215 -0.902 . . . . 1.49 111.599 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -63.21 0.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.361 0.504 . . . . 2.04 112.361 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 29.3 m -92.97 -1.12 56.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.879 -0.6 . . . . 1.4 110.845 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.497 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.51 -18.75 29.67 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.692 -0.766 . . . . 0.38 113.725 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -99.21 107.95 20.4 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 117.37 0.585 . . . . 1.44 109.829 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.76 23.37 12.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.457 0.91 . . . . 0.43 113.457 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 80.1 p -60.41 147.84 39.43 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.736 1.384 . . . . 1.04 114.736 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.112 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -130.22 133.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 114.53 -1.213 . . . . 0.31 111.015 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.7 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p30 -109.21 144.36 37.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.437 -0.949 . . . . 1.15 108.437 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.95 120.6 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.067 0.461 . . . . 0.27 111.885 -177.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.788 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -81.09 144.43 31.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.316 -0.856 . . . . 0.29 110.721 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.68 54.53 11.03 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.177 -0.465 . . . . 1.52 111.627 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.018 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.8 mt -42.86 90.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.968 1.099 . . . . 1.02 113.968 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.483 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 72.7 mt-30 -59.43 140.6 56.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.909 -0.587 . . . . 2.13 110.829 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.473 HD12 HD12 ' A' ' 115' ' ' ILE . 60.1 tp -60.01 -34.09 72.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.021 -0.733 . . . . 1.7 109.021 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -74.75 -12.43 60.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.271 -0.877 . . . . 1.32 111.338 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.483 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 96.5 m-20 -73.43 -16.56 61.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.755 0.312 . . . . 1.58 110.19 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.37 139.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.314 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.13 162.22 9.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 119.982 -1.104 . . . . 0.24 113.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 71.4 m -59.6 137.77 57.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.141 0.577 . . . . 0.31 112.482 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.678 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 21.0 m-85 -120.02 130.26 54.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.153 -0.684 . . . . 1.24 109.153 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.3 tt0 -121.76 118.63 29.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 1.16 111.29 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 26.5 t -102.4 110.8 22.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 1.03 110.562 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.818 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.5 mtpt -106.62 104.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.82 -0.352 . . . . 1.76 110.23 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.681 ' HA ' HG12 ' A' ' 55' ' ' ILE . 62.8 t -88.07 109.92 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.637 -0.505 . . . . 1.18 109.637 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.9 tttm -96.46 119.5 35.06 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.326 -0.55 . . . . 1.62 112.064 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 49.2 tptt -145.59 101.42 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.648 -0.871 . . . . 2.84 108.648 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 1.033 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.61 134.02 54.78 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 112.455 0.539 . . . . 0.44 112.455 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.7 Cg_endo -99.61 50.47 1.65 Allowed 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.695 -0.96 . . . . 0.56 111.705 -0.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.87 103.2 0.28 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.284 -0.96 . . . . 0.48 113.413 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.4 m -84.51 140.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.607 -0.797 . . . . 1.22 109.802 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -130.09 149.94 51.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.57 111.707 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 45.8 t30 -146.81 142.06 27.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.286 -0.416 . . . . 2.03 111.695 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.761 ' HG2' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -144.61 150.29 37.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 2.95 111.01 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -98.26 140.13 33.02 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.447 0.906 . . . . 2.26 113.447 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.692 HD12 ' CH2' ' A' ' 57' ' ' TRP . 73.8 mt -143.58 113.57 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.266 -0.879 . . . . 0.28 109.339 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 117' ' ' THR . 57.3 m170 -100.45 117.39 34.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.672 -0.411 . . . . 0.55 110.554 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.776 HD11 HD21 ' A' ' 39' ' ' LEU . 12.8 mt -94.41 119.96 33.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.487 0.551 . . . . 1.52 112.487 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 21.6 t -111.93 119.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.146 -1.057 . . . . 0.32 108.146 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 59.5 t -100.47 122.99 53.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.187 0.518 . . . . 1.08 112.181 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.87 162.77 23.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.485 -0.78 . . . . 0.52 109.038 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 122.168 0.985 . . . . 1.48 111.75 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 44' ' ' THR . 53.7 m . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.251 0.548 . . . . 1.84 111.468 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.618 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.93 133.39 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.833 . . . . 2.15 109.596 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 79.6 p -88.81 150.3 22.99 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.733 0.778 . . . . 1.12 111.914 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.07 82.99 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 114.524 -1.216 . . . . 0.65 111.983 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.1 Cg_endo -78.57 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.675 2.917 . . . . 0.88 112.107 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.32 127.46 32.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.352 -0.981 . . . . 2.06 108.352 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.946 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.6 tt0 -143.94 158.67 43.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.278 1.214 . . . . 1.71 114.278 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 42.0 mtt -139.95 121.86 15.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.5 -1.227 . . . . 1.86 109.13 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.946 HD11 ' OE2' ' A' ' 27' ' ' GLU . 38.9 mm -120.0 122.08 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.39 111.519 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 42.8 mt-10 -112.1 120.06 40.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.472 . . . . 1.19 110.81 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 73.2 mmtt -141.23 150.45 42.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.824 0.345 . . . . 2.52 111.744 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.02 143.74 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.311 -0.404 . . . . 0.39 111.496 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.742 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 43.2 mtmt -42.88 156.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.255 0.55 . . . . 2.35 112.396 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.09 -23.38 0.45 Allowed Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.287 -0.87 . . . . 0.31 114.201 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -79.96 156.2 27.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.544 -0.539 . . . . 2.11 109.544 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.996 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -85.22 134.52 34.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.338 -0.545 . . . . 0.33 109.582 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB3' HG12 ' A' ' 107' ' ' VAL . . . -100.21 110.83 23.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.347 -0.541 . . . . 0.26 111.213 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 94' ' ' THR . 92.7 t80 -79.17 122.2 25.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 1.43 111.618 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.735 HD22 HG21 ' A' ' 133' ' ' ILE . 25.3 mt -118.15 104.34 48.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.429 -0.582 . . . . 0.8 109.429 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.511 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.7 Cg_endo -82.99 133.03 6.47 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.587 2.191 . . . . 0.42 114.778 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.419 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 55.8 m -141.42 104.03 4.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.374 -0.83 . . . . 1.03 110.105 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 10.6 mmtt -102.26 107.71 18.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.224 -0.288 . . . . 1.66 110.224 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 42.5 p90 -93.78 142.72 27.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.355 . . . . 1.26 110.785 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 21' ' ' SER . 9.0 t -79.98 174.24 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.419 0.628 . . . . 1.33 111.627 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 44' ' ' THR . 87.2 mt -142.27 149.8 40.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.924 -1.034 . . . . 2.12 109.96 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.8 t -158.69 147.02 13.92 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.763 0.316 . . . . 1.75 110.886 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.37 -26.67 6.14 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.419 2.079 . . . . 1.61 112.188 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -77.59 -43.85 30.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.417 -0.356 . . . . 2.18 110.694 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 67.6 m-20 -71.98 74.24 0.9 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.435 -0.58 . . . . 2.41 109.435 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -94.04 -5.09 48.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.35 -0.841 . . . . 1.64 111.479 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 159.93 53.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.363 -0.923 . . . . 0.55 112.136 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.43 149.1 31.34 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.526 2.151 . . . . 0.85 112.081 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.949 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.1 tt -77.81 133.47 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 1.9 110.345 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.627 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 10.9 t70 -140.18 152.37 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.454 0.645 . . . . 1.78 112.012 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.71 HD13 ' HB1' ' A' ' 103' ' ' ALA . 31.5 mt -142.8 139.99 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.687 -1.142 . . . . 0.75 109.515 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 1.085 ' HA ' HD22 ' A' ' 73' ' ' LEU . 45.3 mt-10 -140.36 111.66 7.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.337 0.495 . . . . 1.67 112.337 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.9 ' CD2' HD11 ' A' ' 105' ' ' ILE . 77.3 m95 -100.03 119.96 39.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.497 -0.319 . . . . 0.22 111.026 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -106.05 124.33 49.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.597 -0.519 . . . . 0.41 109.597 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.692 HD12 HD11 ' A' ' 87' ' ' LEU . 14.5 tt -109.88 126.34 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.892 0.701 . . . . 0.78 112.892 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 50.2 m -119.98 102.04 46.96 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 108.711 -0.848 . . . . 1.25 108.711 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 96.0 Cg_endo -79.7 117.13 3.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.84 2.36 . . . . 0.53 112.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.76 90.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.861 -0.609 . . . . 0.41 111.496 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.29 -40.0 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.638 . . . . 1.82 112.429 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 13.6 m120 -81.59 161.14 23.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 1.94 112.329 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -69.48 -18.36 63.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.936 -1.029 . . . . 1.66 111.295 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.8 mttp -69.29 151.75 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.741 -0.663 . . . . 1.74 111.125 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.45 135.37 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.55 1.166 . . . . 0.97 110.103 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 43.83 42.39 4.43 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.564 -2.107 . . . . 1.77 112.797 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -96.47 150.87 20.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.653 -0.249 . . . . 1.96 111.158 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 73' ' ' LEU . 20.7 t -66.38 129.43 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 109.696 -0.483 . . . . 0.77 109.696 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.879 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -116.9 -56.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 1.15 112.58 -177.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.963 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.28 128.91 49.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.821 -0.807 . . . . 0.29 108.821 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' GLU . 5.8 mt -134.96 160.0 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.468 0.651 . . . . 1.3 111.701 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.861 ' HD1' HD13 ' A' ' 79' ' ' ILE . 41.3 t80 -135.25 103.33 5.48 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.567 -1.272 . . . . 1.3 107.567 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.523 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 2.3 t -143.15 155.59 44.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.87 -0.604 . . . . 0.89 111.854 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.95 29.47 6.41 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.135 -0.555 . . . . 0.57 113.044 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 73.54 2.94 4.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.508 0.194 . . . . 1.46 111.388 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 118.56 36.65 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.976 -0.379 . . . . 2.41 109.976 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.861 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.79 130.84 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.307 -1.368 . . . . 1.66 107.307 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.632 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -119.92 120.86 37.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.381 -0.827 . . . . 1.25 110.288 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.8 p-10 -165.82 -48.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.663 -1.236 . . . . 1.2 107.663 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.61 -32.09 47.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.019 -0.991 . . . . 2.17 109.185 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -76.18 -28.71 57.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.024 -0.989 . . . . 5.05 108.647 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.3 m-85 -81.01 117.39 67.88 Favored Pre-proline 0 CA--C 1.514 -0.431 0 CA-C-N 114.911 -1.041 . . . . 1.29 110.675 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.7 -40.06 56.41 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.508 1.472 . . . . 0.79 110.117 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.682 ' O ' HG12 ' A' ' 71' ' ' ILE . 5.2 m-20 -67.01 106.37 1.92 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.093 -0.643 . . . . 1.36 110.521 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.5 mt 65.81 28.44 10.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.597 0.962 . . . . 1.62 113.597 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 17.8 pttt -56.58 131.32 48.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.395 -0.522 . . . . 2.39 111.159 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.11 65.07 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.435 -0.888 . . . . 0.37 114.501 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -145.96 -46.25 0.2 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 114.326 1.232 . . . . 1.59 114.326 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.963 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.38 82.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 123.099 1.428 . . . . 0.2 107.274 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.565 ' C ' HG22 ' A' ' 105' ' ' ILE . 7.5 m-70 -103.38 129.83 50.55 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 112.426 -2.17 . . . . 0.29 112.471 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 63.3 m-85 -71.32 120.38 16.82 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.322 -0.622 . . . . 1.23 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.594 HG21 ' HD1' ' A' ' 38' ' ' TYR . 16.6 p -73.03 36.76 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.042 -0.981 . . . . 0.46 113.575 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -149.36 136.0 19.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.388 0.613 . . . . 1.2 111.404 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.04 6.74 46.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 2.22 110.372 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -145.62 65.9 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.444 -0.947 . . . . 2.14 108.444 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 55' ' ' ILE . 8.2 tt -59.47 -38.44 80.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.632 -1.167 . . . . 1.49 111.641 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.5 1.47 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.391 0.515 . . . . 2.04 112.391 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' LEU . 50.6 m -89.99 -0.01 57.34 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 1.4 111.151 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.546 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 108.55 -1.91 32.46 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.844 -0.693 . . . . 0.38 113.023 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 96.5 m-20 -100.26 108.7 20.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.729 0.299 . . . . 1.44 110.672 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.71 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -108.78 5.95 25.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.43 111.558 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 1.3 m -59.68 140.0 56.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.667 1.728 . . . . 1.04 115.667 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.24 135.16 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 114.0 -1.455 . . . . 0.31 109.549 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 41.9 p-10 -113.46 148.95 34.98 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.951 -0.759 . . . . 1.15 108.951 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.03 HG12 ' HB3' ' A' ' 37' ' ' ALA . 7.5 p -95.76 123.79 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 N-CA-C 113.455 0.909 . . . . 0.27 113.455 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.766 ' HA ' HG23 ' A' ' 36' ' ' THR . 1.3 p -84.81 141.65 30.33 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.386 -1.734 . . . . 0.29 111.372 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 53.12 60.56 3.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.486 -0.779 . . . . 1.52 112.668 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 135' ' ' LEU . 10.0 mt -46.19 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.041 0.448 . . . . 1.02 112.059 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HG2' ' OD2' ' A' ' 114' ' ' ASP . 2.9 pt20 -177.24 164.06 2.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.839 -0.618 . . . . 2.13 110.347 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.851 ' HA ' HG11 ' A' ' 137' ' ' VAL . 79.4 mt -59.92 -36.73 77.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.806 0.336 . . . . 1.7 111.531 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.5 p -73.29 -15.85 61.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.388 -0.369 . . . . 1.32 111.97 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 89.1 m-20 -72.99 -20.07 61.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.622 -0.431 . . . . 1.58 110.005 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.903 HD12 HG12 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -47.12 144.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.114 -0.494 . . . . 0.42 110.947 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.84 150.73 5.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.564 -1.303 . . . . 0.24 114.115 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.453 HG23 ' CE1' ' A' ' 134' ' ' HIS . 95.6 m -59.27 129.97 44.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.024 -0.588 . . . . 0.31 111.965 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 87' ' ' LEU . 22.9 m-85 -110.21 129.92 55.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.808 . . . . 1.24 108.82 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.835 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.5 tt0 -114.72 113.04 23.77 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.88 -0.415 . . . . 1.16 109.88 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 7.3 t -100.01 109.36 21.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.965 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 45.0 mttt -120.4 109.97 15.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 1.76 111.836 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 43' ' ' PHE . 45.4 t -94.6 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.18 109.448 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 43.2 tttm -98.67 122.88 42.45 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.994 -0.682 . . . . 1.62 112.732 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 28.5 tttp -144.63 102.36 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.314 -0.625 . . . . 2.84 109.314 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.84 133.32 28.65 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 113.226 0.824 . . . . 0.44 113.226 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.594 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 97.4 Cg_endo -98.43 36.87 6.58 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.439 -1.067 . . . . 0.56 111.753 -1.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.62 102.89 0.43 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-O 122.06 0.811 . . . . 0.48 112.664 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.5 p -90.0 160.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.165 -1.017 . . . . 1.22 109.984 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -139.36 149.32 44.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.336 . . . . 0.57 111.673 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.542 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 37.9 p-10 -146.42 137.25 24.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.286 -0.416 . . . . 2.03 111.862 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.6 ptmt -145.96 155.11 42.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 2.95 110.636 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 24.1 mttt -103.45 140.07 37.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.148 0.796 . . . . 2.26 113.148 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.735 HG21 HD22 ' A' ' 39' ' ' LEU . 87.2 mt -142.22 119.21 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.529 -0.76 . . . . 0.28 109.225 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.453 ' CE1' HG23 ' A' ' 117' ' ' THR . 3.0 m-70 -102.91 119.99 39.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.954 -0.299 . . . . 0.55 110.547 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 110' ' ' LEU . 58.8 tp -89.82 120.03 30.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.428 -0.509 . . . . 1.52 110.936 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 48.6 t -116.28 121.36 67.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.391 -0.822 . . . . 0.32 109.27 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.903 HG12 HD12 ' A' ' 115' ' ' ILE . 14.8 p -94.92 128.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.885 0.374 . . . . 1.08 111.974 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 94.2 mt -83.53 152.8 24.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.525 -0.546 . . . . 0.52 109.525 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.778 0.799 . . . . 1.48 112.038 -178.229 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.024 0.44 . . . . 1.84 111.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.684 HD12 ' O ' ' A' ' 22' ' ' ILE . 2.4 pp -91.54 149.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 2.15 111.144 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.17 158.22 19.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.326 0.584 . . . . 1.12 110.892 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.468 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 44.89 83.82 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.018 -0.992 . . . . 0.65 111.098 -177.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.4 Cg_endo -78.19 -84.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.611 2.874 . . . . 0.88 113.498 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.1 tt0 -77.82 122.13 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.17 -0.612 . . . . 2.06 109.362 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.9 tp10 -143.9 160.65 40.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.418 0.896 . . . . 1.71 113.418 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.1 ttm -134.56 134.33 41.24 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.067 -0.97 . . . . 1.86 109.478 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 28' ' ' MET . 32.8 mm -129.94 129.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.949 -0.569 . . . . 0.39 111.494 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.637 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 98.2 mt-10 -118.36 125.1 49.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.384 -0.371 . . . . 1.19 110.695 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' A' ' 110' ' ' LEU . 61.0 mmtt -141.97 158.05 44.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.638 0.256 . . . . 2.52 111.315 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -77.06 143.38 39.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 0.39 111.69 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 39.6 ttmt -48.51 136.36 13.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 2.35 111.609 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 82.46 -18.42 14.68 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.997 -0.62 . . . . 0.31 113.119 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.9 mm-40 -79.99 158.97 26.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.712 -0.847 . . . . 2.11 108.712 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 m -87.28 129.8 34.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.476 -0.89 . . . . 0.33 109.982 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 114.92 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.807 0.337 . . . . 0.26 110.504 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 94' ' ' THR . 40.8 t80 -79.35 120.77 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.849 -0.614 . . . . 1.43 112.454 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 133' ' ' ILE . 4.4 mp -115.28 104.76 53.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.619 -0.882 . . . . 0.8 108.619 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 88.8 Cg_endo -86.43 104.49 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.328 2.019 . . . . 0.42 114.929 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -98.51 135.51 39.95 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 176.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' HD3' ' OD1' ' A' ' 102' ' ' ASP . 45.5 tptt -140.03 139.99 36.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.741 0.305 . . . . 1.66 110.527 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -140.16 139.76 35.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 1.26 111.413 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.14 126.39 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 1.33 110.775 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD21 ' HE1' ' A' ' 43' ' ' PHE . 84.4 mt -89.09 149.95 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 2.12 110.834 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.8 m -151.32 144.09 16.73 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.486 -0.324 . . . . 1.75 110.133 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.18 -23.57 9.89 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.579 2.186 . . . . 1.61 112.086 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 16.7 pt-20 -77.29 -43.66 32.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.194 -0.457 . . . . 2.18 111.05 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -75.59 76.32 2.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.936 -0.705 . . . . 2.41 109.287 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.51 -3.52 52.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.352 -0.84 . . . . 1.64 111.901 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.03 160.06 53.33 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.691 -0.766 . . . . 0.55 113.024 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.61 136.56 76.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.632 2.222 . . . . 0.85 111.675 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 6.6 mp -78.0 119.05 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.301 -0.409 . . . . 1.9 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -133.01 102.17 5.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.535 0.683 . . . . 1.78 111.033 178.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.881 HG12 HG22 ' A' ' 122' ' ' VAL . 2.6 mp -96.39 105.91 17.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.761 -1.109 . . . . 0.75 110.874 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.646 ' OE2' HD21 ' A' ' 58' ' ' LEU . 86.5 tt0 -100.93 117.66 35.41 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.62 0.6 . . . . 1.67 112.62 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.819 ' CD2' HD11 ' A' ' 105' ' ' ILE . 72.3 m95 -94.06 120.01 33.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.133 -0.321 . . . . 0.22 110.133 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.646 HD21 ' OE2' ' A' ' 56' ' ' GLU . 89.5 mt -105.91 146.86 29.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.866 -0.42 . . . . 0.41 109.866 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 87' ' ' LEU . 12.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.157 0.429 . . . . 0.78 112.157 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.447 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 37.4 m -119.99 102.16 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.631 -0.877 . . . . 1.25 108.631 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.617 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 91.9 Cg_endo -78.96 114.97 3.48 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.775 2.317 . . . . 0.53 113.533 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.18 82.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.352 -0.84 . . . . 0.41 110.614 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 94.4 m-20 -85.93 16.52 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.534 -0.757 . . . . 1.82 112.078 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 28.0 m120 -148.72 161.0 42.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.376 0.608 . . . . 1.94 112.011 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.94 -19.76 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.058 -0.974 . . . . 1.66 112.507 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 43.6 mttt -69.1 153.05 44.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.825 0.345 . . . . 1.74 111.536 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.36 128.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.716 0.77 . . . . 0.97 109.468 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.17 45.18 27.94 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.346 -1.297 . . . . 1.77 112.088 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 136.4 33.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.96 111.089 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.51 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 110.154 -0.313 . . . . 0.77 110.154 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.891 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.5 pp -131.76 -38.85 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.808 0.67 . . . . 1.15 112.808 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.905 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.31 123.85 14.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.175 0.512 . . . . 0.29 110.092 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 8.5 tt -140.38 163.55 32.49 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 116.019 -0.537 . . . . 1.3 109.799 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' ILE . 23.3 t80 -135.31 109.94 8.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.206 0.527 . . . . 1.3 110.477 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.3 t -142.61 159.99 41.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.249 -0.887 . . . . 0.89 111.474 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.32 55.48 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.564 -0.827 . . . . 0.57 112.152 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 74.14 2.83 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.845 -0.178 . . . . 1.46 111.241 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 6.0 mmtm -105.36 118.52 36.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.811 -0.441 . . . . 2.41 109.811 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.73 119.99 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.617 -1.253 . . . . 1.66 107.617 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.839 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -100.01 132.53 45.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.83 -1.077 . . . . 1.25 110.728 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.815 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.8 p-10 -166.32 -58.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.796 -1.557 . . . . 1.2 106.796 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 33.6 p-10 -80.1 -22.01 42.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.565 -1.198 . . . . 2.17 109.731 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.555 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -76.85 -29.8 56.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.85 -1.167 . . . . 5.05 107.85 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.739 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -85.18 118.3 70.54 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 114.452 -1.249 . . . . 1.29 110.263 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -41.0 51.93 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.346 1.364 . . . . 0.79 110.447 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.867 ' HB3' HG22 ' A' ' 71' ' ' ILE . 89.1 m-20 -68.19 104.87 1.92 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.771 -0.65 . . . . 1.36 111.091 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.764 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 34.3 mt 70.4 22.37 5.31 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.295 0.85 . . . . 1.62 113.295 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 21.6 pttp -58.17 136.9 57.34 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.843 -0.536 . . . . 2.39 111.05 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.57 74.81 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.249 -0.977 . . . . 0.37 114.176 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -137.99 -54.61 0.65 Allowed 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 114.754 1.39 . . . . 1.59 114.754 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.905 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -78.28 81.28 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 N-CA-C 107.088 -1.449 . . . . 0.2 107.088 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.501 ' C ' HG22 ' A' ' 105' ' ' ILE . 5.9 m-70 -100.06 129.43 46.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.163 -2.289 . . . . 0.29 112.589 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.093 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -70.37 121.17 17.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 120.231 -0.588 . . . . 1.23 110.054 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.588 HG21 ' CD1' ' A' ' 38' ' ' TYR . 35.0 p -71.4 -10.67 60.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.93 . . . . 0.46 110.099 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 58.1 m -95.15 120.0 34.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.726 -0.67 . . . . 1.2 110.683 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -91.34 6.08 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.927 -0.579 . . . . 2.22 110.189 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -146.25 66.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.551 -0.907 . . . . 2.14 108.551 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.3 -31.29 69.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 1.49 112.21 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -62.86 -4.08 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.142 0.496 . . . . 2.04 111.91 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -0.57 57.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.392 -0.822 . . . . 1.4 110.89 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.507 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 110.07 -20.61 26.03 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.687 -0.768 . . . . 0.38 113.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 82.8 m-20 -92.91 109.01 20.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.964 0.382 . . . . 1.44 111.195 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.29 21.46 16.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.43 111.102 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.728 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 82.5 p -59.98 145.89 44.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 116.03 1.863 . . . . 1.04 116.03 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.093 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.62 133.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 114.246 -1.343 . . . . 0.31 111.27 178.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.678 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.1 p-10 -107.66 147.85 30.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.947 -1.131 . . . . 1.15 107.947 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.75 123.9 52.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.958 0.408 . . . . 0.27 111.79 -178.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.5 p -84.68 142.75 29.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.536 -0.756 . . . . 0.29 110.935 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.9 m-20 49.98 55.69 9.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.996 -0.547 . . . . 1.52 112.133 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.8 mt -46.96 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.577 0.954 . . . . 1.02 113.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 63.7 tt0 -60.03 148.68 34.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.154 -0.475 . . . . 2.13 109.94 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 3.0 tm? -60.02 -39.99 87.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 1.7 110.729 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 74.2 m -72.96 -10.04 59.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.663 . . . . 1.32 111.611 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.95 -18.35 63.35 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.048 -0.352 . . . . 1.58 110.048 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.7 145.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.026 0 CA-C-N 116.113 -0.494 . . . . 0.42 110.397 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 155.79 6.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.984 -1.103 . . . . 0.24 113.887 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.2 m -59.36 139.01 57.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.94 0.496 . . . . 0.31 111.808 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.0 m-85 -119.99 133.68 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.612 -0.514 . . . . 1.24 109.612 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.3 tt0 -123.11 115.22 21.44 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.101 -0.24 . . . . 1.16 110.843 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.485 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.3 t -99.96 112.15 24.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.011 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.847 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 98.4 mttt -110.49 106.51 15.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.627 -0.26 . . . . 1.76 111.577 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.881 HG22 HG12 ' A' ' 55' ' ' ILE . 47.6 t -88.21 110.05 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.75 -0.833 . . . . 1.18 108.75 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.708 ' HG3' HG12 ' A' ' 128' ' ' VAL . 61.1 tttp -96.06 120.3 36.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.869 0.692 . . . . 1.62 112.869 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 11.0 mtmt -144.25 101.64 3.73 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.663 -0.495 . . . . 2.84 109.663 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.22 132.32 51.64 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.45 -0.341 . . . . 0.44 111.751 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 59.7 Cg_endo -100.37 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.808 -0.913 . . . . 0.56 112.366 -0.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 103.18 0.28 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.397 -0.906 . . . . 0.48 113.141 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.708 HG12 ' HG3' ' A' ' 123' ' ' LYS . 13.4 m -87.06 142.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.221 -0.99 . . . . 1.22 109.724 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -136.03 148.11 48.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.979 -0.288 . . . . 0.57 111.642 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.628 ' O ' HD11 ' A' ' 22' ' ' ILE . 47.2 p-10 -146.61 151.67 37.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.466 0.543 . . . . 2.03 112.466 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.916 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.29 153.51 41.36 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.154 -0.475 . . . . 2.95 110.958 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 18.6 tttt -99.59 139.63 34.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.486 0.55 . . . . 2.26 112.486 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.947 HG21 HD23 ' A' ' 39' ' ' LEU . 95.2 mt -143.19 117.79 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.28 109.641 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 117' ' ' THR . 62.6 m170 -100.04 116.16 31.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.008 0.433 . . . . 0.55 111.246 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.889 HD11 HD22 ' A' ' 110' ' ' LEU . 1.8 tm? -89.17 125.18 34.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 1.52 111.479 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 39.2 t -121.22 124.71 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.32 109.939 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.4 t -97.19 120.24 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 1.08 111.51 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.0 mt -80.45 160.02 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.52 109.686 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 1.48 111.59 -178.732 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.944 0.402 . . . . 1.84 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.815 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 2.15 110.719 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.688 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.0 p -93.44 156.22 16.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.575 0.702 . . . . 1.12 111.958 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 43.06 82.41 0.23 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.698 -1.137 . . . . 0.65 112.013 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -79.3 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.775 2.983 . . . . 0.88 113.048 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 46.2 mt-10 -78.18 126.58 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.129 -0.693 . . . . 2.06 109.129 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 132' ' ' LYS . 41.8 tt0 -144.11 159.25 42.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 16.5 mtm -140.12 116.43 10.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.629 -1.169 . . . . 1.86 109.376 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.619 ' HB ' HD23 ' A' ' 135' ' ' LEU . 39.2 mm -120.01 130.01 74.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.39 111.553 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.65 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 35.8 mt-10 -120.59 128.06 52.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.572 -0.285 . . . . 1.19 110.711 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 51.3 tptt -142.82 158.48 43.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.687 -0.233 . . . . 2.52 110.552 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.767 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.7 141.91 40.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.788 0.328 . . . . 0.39 111.552 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 32.1 tttt -47.77 140.98 5.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.0 0.429 . . . . 2.35 111.444 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 83.04 -21.95 7.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.832 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.767 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.05 159.01 26.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.318 -0.993 . . . . 2.11 108.318 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.0 m -88.13 130.0 35.15 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.546 -0.862 . . . . 0.33 110.236 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.933 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.76 113.48 25.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.26 110.617 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.4 t80 -79.26 120.01 23.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 1.43 112.402 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.863 HD23 HG21 ' A' ' 133' ' ' ILE . 4.5 mp -115.68 104.88 52.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.476 -0.935 . . . . 0.8 108.476 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 90.3 Cg_endo -85.48 104.65 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.47 2.114 . . . . 0.42 115.914 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -102.25 131.51 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.467 -0.938 . . . . 1.03 108.467 176.24 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 23.0 tptm -140.69 105.08 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.042 0.449 . . . . 1.66 110.393 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.895 ' HB3' HG11 ' A' ' 122' ' ' VAL . 38.6 p90 -90.95 141.89 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 1.26 111.647 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 45' ' ' LEU . 25.1 m -79.8 164.14 23.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 1.33 110.483 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' N ' HG22 ' A' ' 44' ' ' THR . 77.4 mt -138.79 149.95 45.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 2.12 111.44 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 m -157.73 148.57 16.28 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.544 -0.753 . . . . 1.75 109.885 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.04 -23.61 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.889 2.392 . . . . 1.61 112.979 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 85.6 tt0 -74.64 -25.92 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.518 -0.31 . . . . 2.18 111.73 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 46' ' ' SER . 55.8 p-10 -63.54 82.69 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 121.534 0.683 . . . . 2.41 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' GLU . 95.1 mt-30 -94.24 0.02 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 1.64 111.822 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.971 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -92.91 170.22 31.75 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.126 -1.035 . . . . 0.55 113.087 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.02 153.03 63.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.913 2.409 . . . . 0.85 111.86 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.681 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.0 tt -78.14 123.99 27.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.306 -0.406 . . . . 1.9 110.613 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 15.3 m-20 -136.34 150.64 48.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.508 0.671 . . . . 1.78 111.494 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 25.1 mt -142.65 139.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.75 109.174 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 99.2 mt-10 -140.68 116.24 10.16 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.185 0.439 . . . . 1.67 112.185 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.843 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.2 m95 -101.79 122.85 44.73 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 121.102 -0.239 . . . . 0.22 110.751 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.8 mt -109.19 139.87 43.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.145 -0.687 . . . . 0.41 109.145 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 tt -130.04 130.0 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.196 0.522 . . . . 0.78 112.245 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.5 m -120.47 102.82 44.9 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.461 -0.79 . . . . 1.25 109.11 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 97.8 Cg_endo -79.11 114.59 3.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.591 2.194 . . . . 0.53 113.28 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.79 80.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.365 -0.834 . . . . 0.41 110.828 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -86.15 20.69 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 1.82 111.919 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 35.1 m120 -151.28 161.98 41.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.288 0.566 . . . . 1.94 111.873 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.32 -19.83 64.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.287 -0.869 . . . . 1.66 112.32 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 90.8 mttt -68.51 146.4 53.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.257 -0.429 . . . . 1.74 111.008 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -155.4 127.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 CA-C-O 121.971 0.891 . . . . 0.97 109.994 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 54.15 39.97 31.22 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.841 -1.527 . . . . 1.77 112.582 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.2 146.81 23.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 1.96 111.137 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 ' OH ' ' A' ' 84' ' ' TYR . 44.6 t -66.58 137.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.905 -0.405 . . . . 0.77 109.905 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.894 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -129.39 -52.41 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 1.15 112.73 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.972 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.52 130.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 107.982 -1.118 . . . . 0.29 107.982 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 159.97 41.02 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 120.833 -0.347 . . . . 1.3 111.704 -176.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.6 t80 -135.81 103.82 5.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.195 -0.669 . . . . 1.3 109.195 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.449 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 20.2 m -142.6 159.99 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.751 0.31 . . . . 0.89 111.582 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.11 25.93 18.95 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.602 -0.809 . . . . 0.57 112.272 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 74.75 1.62 3.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.512 0.196 . . . . 1.46 111.091 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.9 mttt -100.01 115.08 28.89 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 110.034 -0.358 . . . . 2.41 110.034 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.725 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.55 128.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.575 -1.269 . . . . 1.66 107.575 177.024 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.6 m-85 -113.13 129.33 56.54 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.874 -1.512 . . . . 1.25 110.256 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 21.9 p-10 -166.16 -54.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.654 -1.239 . . . . 1.2 107.654 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -80.13 -20.05 45.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.025 -0.989 . . . . 2.17 109.202 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.43 -26.25 35.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.216 -0.902 . . . . 5.05 108.904 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.532 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -85.3 111.81 39.25 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.073 -0.967 . . . . 1.29 111.057 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.5 -41.9 10.83 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.427 1.418 . . . . 0.79 109.939 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 60.3 t0 -67.89 105.46 1.99 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.64 -0.709 . . . . 1.36 110.266 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.904 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 5.6 mt 68.66 20.03 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.012 1.116 . . . . 1.62 114.012 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 12.2 pttm -54.78 127.06 26.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.336 -0.852 . . . . 2.39 110.84 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.77 12.94 48.75 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.212 -0.994 . . . . 0.37 114.213 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.904 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.5 ptp180 -143.81 -47.6 0.28 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 114.619 1.34 . . . . 1.59 114.619 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.972 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.58 81.15 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.275 1.512 . . . . 0.2 107.544 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -101.58 127.83 48.12 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.044 -2.344 . . . . 0.29 111.856 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.1 ' CD1' HG23 ' A' ' 105' ' ' ILE . 88.1 m-85 -69.59 125.9 28.12 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 119.918 -0.713 . . . . 1.23 110.246 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.713 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.9 p -73.49 29.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.46 111.747 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 93' ' ' PHE . 5.4 m -148.76 127.49 12.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.038 0.447 . . . . 1.2 110.359 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.02 8.17 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.773 -0.649 . . . . 2.22 110.308 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.2 66.2 1.2 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.778 -0.823 . . . . 2.14 108.778 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.618 HD21 ' CG ' ' A' ' 93' ' ' PHE . 6.3 mp -58.36 -23.56 57.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 1.49 111.616 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.54 -3.41 2.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.162 0.506 . . . . 2.04 112.098 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 10.01 25.7 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.466 -0.788 . . . . 1.4 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.577 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 96.54 -10.39 66.86 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.913 -0.66 . . . . 0.38 113.079 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -95.25 110.12 22.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 1.44 111.602 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -110.22 16.06 21.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.43 110.569 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.5 m -59.94 140.38 56.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.229 1.566 . . . . 1.04 115.229 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.1 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.28 136.59 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-N 114.853 -1.067 . . . . 0.31 111.002 178.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.717 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p-10 -112.86 142.98 44.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.33 -0.989 . . . . 1.15 108.33 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.887 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.42 120.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.107 0.48 . . . . 0.27 111.512 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -84.57 141.9 30.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.344 -0.844 . . . . 0.29 110.659 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.514 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 33.8 m120 53.82 52.77 12.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.52 111.346 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.933 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.0 mt -43.08 87.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.558 1.318 . . . . 1.02 114.558 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' ASN . 57.4 mt-30 -58.2 141.93 49.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.055 -0.521 . . . . 2.13 110.593 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.554 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 87.0 mt -59.93 -33.1 71.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.885 0.374 . . . . 1.7 110.487 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.4 m -75.06 -13.13 60.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 1.32 111.213 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.58 -18.59 62.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.87 -0.419 . . . . 1.58 109.87 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.49 141.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 116.044 -0.525 . . . . 0.42 110.535 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.83 162.21 9.01 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.225 -0.988 . . . . 0.24 113.514 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.51 135.77 57.77 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.414 0.524 . . . . 0.31 112.414 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.915 ' CE1' HD12 ' A' ' 135' ' ' LEU . 41.3 m-85 -120.05 129.67 54.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.988 -0.551 . . . . 1.24 109.72 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -121.35 119.97 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.186 -0.206 . . . . 1.16 111.206 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.5 t -99.94 117.42 34.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.096 -0.335 . . . . 1.03 110.096 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 37.3 mtpt -118.07 107.87 14.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 1.76 110.82 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.895 HG11 ' HB3' ' A' ' 43' ' ' PHE . 7.2 p -92.27 106.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.026 -0.361 . . . . 1.18 110.026 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.6 tttm -93.89 115.18 27.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.04 -0.664 . . . . 1.62 112.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -145.86 102.07 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.1 -0.704 . . . . 2.84 109.1 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.971 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.06 134.31 39.73 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 112.369 0.507 . . . . 0.44 112.369 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 77.0 Cg_endo -100.05 46.82 2.29 Favored 'Cis proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.642 -0.982 . . . . 0.56 111.208 -0.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.81 102.93 0.31 Allowed Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.086 -1.054 . . . . 0.48 113.683 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.4 m -93.21 138.21 20.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 113.861 -1.17 . . . . 1.22 109.233 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.815 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -140.76 144.47 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.979 0.363 . . . . 0.57 111.979 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.5 p-10 -146.77 151.45 37.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.482 0.549 . . . . 2.03 112.482 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.0 160.03 41.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 2.95 111.15 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 61.0 mttp -102.53 139.81 37.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 112.422 0.527 . . . . 2.26 112.422 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.863 HG21 HD23 ' A' ' 39' ' ' LEU . 84.9 mt -142.12 114.55 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.959 -0.756 . . . . 0.28 108.959 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.526 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.4 m-70 -99.97 115.55 29.96 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.481 -0.488 . . . . 0.55 110.398 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.915 HD12 ' CE1' ' A' ' 118' ' ' TYR . 46.5 mt -93.68 120.05 33.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.65 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 17.6 t -115.25 120.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.306 -0.998 . . . . 0.32 108.306 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 115' ' ' ILE . 25.4 t -96.26 125.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.814 0.672 . . . . 1.08 112.814 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.85 160.02 22.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.52 109.896 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 139' ' ' VAL . 1.2 p . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.987 0.899 . . . . 1.48 112.935 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.083 0.468 . . . . 1.84 111.555 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pp -104.54 136.13 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.666 -0.697 . . . . 2.15 110.401 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -87.15 148.96 24.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.059 0.457 . . . . 1.12 110.344 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.549 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 43.35 83.81 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.393 -0.822 . . . . 0.65 110.549 -177.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.771 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.8 Cg_endo -77.34 -11.04 17.55 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 123.913 3.076 . . . . 0.88 113.864 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 49.2 mp0 -141.36 126.23 18.16 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.182 -0.673 . . . . 2.06 109.182 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.901 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.5 tt0 -144.09 161.19 39.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.731 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.6 ttm -137.11 137.32 39.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.876 -1.057 . . . . 1.86 109.415 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.901 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.1 mm -132.71 139.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.978 -0.555 . . . . 0.39 111.597 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.58 123.07 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 1.19 110.523 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.76 158.91 43.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.52 112.119 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.03 138.6 39.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 0.39 112.021 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.757 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 34.2 mtmt -47.52 144.2 3.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.163 0.506 . . . . 2.35 111.773 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.4 -25.45 3.27 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.31 112.743 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 81.8 mm-40 -80.02 159.97 26.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.148 -0.686 . . . . 2.11 109.148 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 m -84.54 129.31 34.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.078 -0.649 . . . . 0.33 110.639 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.03 114.1 27.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.068 0.461 . . . . 0.26 110.921 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.0 t80 -79.53 121.28 25.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.803 -0.635 . . . . 1.43 112.569 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 105' ' ' ILE . 20.3 mt -110.05 105.27 57.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 108.913 -0.773 . . . . 0.8 108.913 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.772 ' O ' HD11 ' A' ' 133' ' ' ILE . 2.4 Cg_endo -81.06 128.68 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.51 2.14 . . . . 0.42 114.219 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 17.2 t -140.87 131.48 25.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.838 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.48 146.6 38.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.261 -0.427 . . . . 1.66 110.744 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CG ' HG11 ' A' ' 122' ' ' VAL . 44.1 p90 -140.79 141.05 34.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 1.26 111.908 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.3 p -88.02 143.74 26.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 1.33 110.759 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -94.18 113.32 25.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.692 -0.231 . . . . 2.12 110.564 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.8 m -83.97 140.33 40.14 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 110.004 -0.369 . . . . 1.75 110.004 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.76 -34.24 27.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.731 1.621 . . . . 1.61 110.559 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 21.2 pt-20 -79.49 -35.48 40.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.313 -0.858 . . . . 2.18 111.383 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 78.7 m-20 -71.24 73.66 0.68 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.282 0.563 . . . . 2.41 109.952 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -95.51 -1.21 51.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.301 -0.863 . . . . 1.64 111.427 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.05 161.42 53.11 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.485 -0.864 . . . . 0.55 112.259 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.55 144.42 41.71 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.144 1.896 . . . . 0.85 111.488 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.579 HD23 ' HD3' ' A' ' 124' ' ' LYS . 6.8 mt -77.82 129.96 36.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.907 0.384 . . . . 1.9 111.277 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 70.8 m-20 -136.85 153.96 50.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.734 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.617 HG13 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -143.34 140.36 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.75 110.067 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.898 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.5 tt0 -137.35 115.58 11.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.021 0.439 . . . . 1.67 111.79 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.671 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.2 m95 -98.43 119.5 37.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.965 -0.561 . . . . 0.22 110.826 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.86 120.64 42.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.406 -0.59 . . . . 0.41 109.406 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 8.6 tt -108.83 125.84 65.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.305 0.483 . . . . 0.78 112.305 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -112.97 103.26 55.63 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.83 -0.804 . . . . 1.25 108.83 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.8 Cg_exo -78.62 116.75 3.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.83 2.353 . . . . 0.53 112.536 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.49 92.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.41 111.23 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.91 -40.01 61.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.753 -0.658 . . . . 1.82 111.566 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -82.83 158.48 22.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.31 0.576 . . . . 1.94 111.671 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -69.12 -18.02 63.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.294 -0.867 . . . . 1.66 111.872 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 70.7 mttt -69.46 152.43 44.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.939 -0.573 . . . . 1.74 111.853 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.51 127.89 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-O 121.781 0.801 . . . . 0.97 109.229 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.74 40.01 26.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.288 -1.324 . . . . 1.77 111.431 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.59 143.9 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.442 -0.345 . . . . 1.96 111.089 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 73' ' ' LEU . 46.5 t -66.79 138.87 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.841 -0.8 . . . . 0.77 108.841 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -134.27 -54.66 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.741 0.645 . . . . 1.15 112.741 -177.019 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.827 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.92 130.73 49.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.283 -0.636 . . . . 0.29 109.283 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.898 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 2.9 mp -139.77 163.81 31.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.3 111.48 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.89 ' HD1' HD13 ' A' ' 79' ' ' ILE . 34.5 t80 -139.36 103.02 4.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.461 -0.79 . . . . 1.3 109.413 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -144.42 159.82 42.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.072 -0.513 . . . . 0.89 111.954 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.49 28.43 6.61 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.047 -0.597 . . . . 0.57 112.851 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 73.91 1.32 3.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.557 0.206 . . . . 1.46 111.557 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 27.3 mttt -99.87 119.46 38.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 110.004 -0.369 . . . . 2.41 110.004 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.89 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -81.23 130.21 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.004 -1.48 . . . . 1.66 107.004 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.663 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -115.39 117.83 31.52 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.552 -0.749 . . . . 1.25 110.538 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.881 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -166.28 -48.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 1.2 107.345 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD1' ' HA2' ' A' ' 89' ' ' GLY . 10.3 m-20 -77.38 -33.57 55.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 114.72 -1.127 . . . . 2.17 109.024 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -76.61 -28.77 56.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.739 -1.118 . . . . 5.05 108.762 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.536 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -81.93 117.65 69.13 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 114.946 -1.024 . . . . 1.29 110.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.11 -40.33 59.94 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.64 1.56 . . . . 0.79 110.267 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.72 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.7 m-20 -67.82 106.45 2.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.078 -0.649 . . . . 1.36 110.22 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.8 mp 67.7 29.0 7.11 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.307 0.855 . . . . 1.62 113.307 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.881 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 41.7 pttt -58.03 131.33 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.903 -0.498 . . . . 2.39 111.409 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 82' ' ' ASP . . . 80.61 19.41 68.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.642 -0.789 . . . . 0.37 114.142 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.3 ptp180 -145.78 -47.4 0.21 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 114.295 1.22 . . . . 1.59 114.295 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 71' ' ' ILE . 7.2 p -79.53 82.09 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 122.914 1.34 . . . . 0.2 107.624 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.547 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.4 m80 -103.4 131.38 50.54 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 112.287 -2.233 . . . . 0.29 112.25 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.13 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.7 m-85 -73.45 124.51 25.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.251 -0.58 . . . . 1.23 110.393 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.57 HG22 ' ND2' ' A' ' 106' ' ' ASN . 17.3 p -75.72 34.17 0.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.568 -0.742 . . . . 0.46 111.428 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.7 m -149.03 122.57 9.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.052 0.453 . . . . 1.2 110.87 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -91.48 11.61 23.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 2.22 110.207 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -145.56 65.16 1.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.557 -0.905 . . . . 2.14 108.557 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -55.66 -28.03 53.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.835 -1.075 . . . . 1.49 111.249 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.2 mttt -66.21 0.48 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.099 0.476 . . . . 2.04 112.067 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.5 p -89.98 -0.02 57.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 1.4 111.255 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 98.36 -4.55 60.29 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.673 -0.775 . . . . 0.38 113.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -105.42 108.81 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.146 0.473 . . . . 1.44 110.532 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -108.22 19.44 19.9 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 112.101 0.408 . . . . 0.43 112.101 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 9.3 m -60.36 140.84 56.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.02 1.489 . . . . 1.04 115.02 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.13 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.51 130.44 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 114.831 -1.077 . . . . 0.31 110.849 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.698 ' HB2' HG22 ' A' ' 36' ' ' THR . 30.1 p30 -105.65 147.71 28.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.892 -0.781 . . . . 1.15 108.892 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.68 120.02 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.27 111.26 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.18 144.89 29.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.285 -0.87 . . . . 0.29 110.787 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m120 53.21 60.18 3.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.059 -0.519 . . . . 1.52 112.176 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.28 176.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.255 0.55 . . . . 1.02 112.452 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -177.86 164.16 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.504 -0.771 . . . . 2.13 110.073 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.757 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 88.0 mt -60.08 -36.22 76.9 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.749 0.278 . . . . 1.7 111.749 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.5 p -73.68 -10.03 59.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.602 0.239 . . . . 1.32 111.389 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD2' HG11 ' A' ' 107' ' ' VAL . 11.0 t70 -72.92 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.593 -0.521 . . . . 1.58 109.593 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -47.07 142.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 CA-C-N 115.748 -0.66 . . . . 0.42 111.221 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 148.38 5.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.755 -1.212 . . . . 0.24 114.181 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.561 HG23 ' ND1' ' A' ' 134' ' ' HIS . 94.7 m -59.12 130.01 44.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.025 -0.588 . . . . 0.31 111.772 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.676 ' OH ' HD21 ' A' ' 87' ' ' LEU . 45.3 m-85 -112.02 122.58 48.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.268 -0.424 . . . . 1.24 110.017 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.0 tt0 -119.96 118.41 30.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.621 -0.263 . . . . 1.16 110.71 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 29.7 p -101.52 119.65 39.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 1.03 110.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 83.3 mttt -110.65 110.19 20.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 1.76 110.2 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG13 ' A' ' 55' ' ' ILE . 59.8 t -89.99 106.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.18 109.646 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 7.4 ttpm? -91.15 117.35 29.55 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.365 0.506 . . . . 1.62 112.365 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HD3' HD23 ' A' ' 53' ' ' LEU . 7.1 ttpm? -145.3 101.92 3.66 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.502 -0.555 . . . . 2.84 109.502 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.7 129.8 36.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 113.534 0.938 . . . . 0.44 113.534 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 64.3 Cg_endo -101.95 48.84 1.89 Allowed 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 125.026 -0.823 . . . . 0.56 111.988 -0.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -142.01 103.7 0.34 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.577 -0.82 . . . . 0.48 113.634 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -96.88 132.04 42.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.045 -1.078 . . . . 1.22 109.888 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.523 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.82 147.01 32.37 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.282 0.475 . . . . 0.57 112.282 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.616 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 52.8 p-10 -147.51 161.7 40.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.866 0.691 . . . . 2.03 112.866 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.88 ' HE3' ' HA ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -145.27 160.65 41.17 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 2.95 109.929 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -97.19 145.02 26.45 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.731 1.382 . . . . 2.26 114.731 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.772 HD11 ' O ' ' A' ' 40' ' ' PRO . 93.1 mt -143.59 115.11 2.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 114.55 -1.204 . . . . 0.28 108.624 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.561 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.2 m-70 -100.02 120.05 39.22 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.033 -0.417 . . . . 0.55 111.124 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.807 HD21 ' HB1' ' A' ' 37' ' ' ALA . 1.1 tm? -89.48 128.33 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 1.52 111.846 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 135' ' ' LEU . 62.4 t -116.93 130.0 72.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.32 109.818 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 33' ' ' LYS . 16.4 t -95.26 121.22 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.156 0.428 . . . . 1.08 112.156 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.802 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 64.3 mt -88.57 167.17 13.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.052 -0.522 . . . . 0.52 109.811 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 121.405 0.622 . . . . 1.48 111.784 -178.943 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.051 0.453 . . . . 1.84 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -140.96 136.0 33.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.744 -0.662 . . . . 2.15 110.304 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -94.94 146.9 23.92 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.57 0.7 . . . . 1.12 111.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.92 83.07 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 114.755 -1.112 . . . . 0.65 111.352 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.04 -85.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.701 2.934 . . . . 0.88 112.676 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 99.2 mt-10 -78.41 120.26 22.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.023 -0.732 . . . . 2.06 109.023 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.485 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.2 tt0 -144.36 160.5 40.93 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.376 1.25 . . . . 1.71 114.376 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.701 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 93.9 mtp -133.49 129.84 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.939 -1.028 . . . . 1.86 109.74 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.485 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.9 mm -122.07 130.69 74.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.39 111.416 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.714 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 72.7 mt-10 -124.39 129.42 50.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.542 -0.299 . . . . 1.19 110.802 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 36' ' ' THR . 54.4 tptt -141.79 160.04 40.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.767 0.317 . . . . 2.52 111.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.15 138.26 40.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.032 0.444 . . . . 0.39 111.74 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 46.3 tttp -47.59 136.47 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.777 -0.647 . . . . 2.35 112.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.79 -21.89 10.35 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.647 -0.706 . . . . 0.31 113.515 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.737 ' O ' HD13 ' A' ' 110' ' ' LEU . 79.5 mm-40 -77.69 -147.57 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.795 -1.187 . . . . 2.11 107.795 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 107' ' ' VAL . 81.6 m -139.07 133.68 31.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.01 0.433 . . . . 0.33 110.441 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.556 ' H ' HD11 ' A' ' 110' ' ' LEU . . . -99.83 117.56 34.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 0.26 110.73 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.666 ' CD2' HG21 ' A' ' 94' ' ' THR . 64.7 t80 -79.25 120.29 23.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 1.43 112.195 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 105' ' ' ILE . 21.1 mt -105.42 106.2 55.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.748 -0.834 . . . . 0.8 108.748 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.0 Cg_exo -79.54 123.54 5.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.669 2.246 . . . . 0.42 113.832 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 49.6 t -141.83 123.96 15.48 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.504 -0.771 . . . . 1.03 109.579 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 87.6 mttt -141.56 149.1 40.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.463 -0.79 . . . . 1.66 110.144 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CG ' HG11 ' A' ' 122' ' ' VAL . 34.4 p90 -140.06 140.04 36.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.624 0.601 . . . . 1.26 112.624 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 140.05 29.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.254 -0.885 . . . . 1.33 110.195 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.475 HD21 HD21 ' A' ' 53' ' ' LEU . 9.6 mp -95.99 117.41 30.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 2.12 111.174 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.24 150.37 70.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 1.75 109.822 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.65 -41.88 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.126 1.884 . . . . 1.61 111.06 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -74.7 -36.96 62.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.517 -0.765 . . . . 2.18 110.473 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.646 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 33.6 t0 -70.21 72.51 0.45 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.41 110.47 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -99.75 0.03 40.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 1.64 111.061 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.03 159.96 53.34 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.94 -0.648 . . . . 0.55 112.912 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.42 139.26 55.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.777 2.318 . . . . 0.85 111.97 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 43' ' ' PHE . 86.9 mt -78.22 130.1 35.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.484 . . . . 1.9 111.394 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.5 m-20 -134.88 159.98 39.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.613 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.667 HD13 ' HB1' ' A' ' 103' ' ' ALA . 27.4 mt -141.99 140.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.417 -0.81 . . . . 0.75 110.412 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 1.026 ' HA ' HD22 ' A' ' 73' ' ' LEU . 48.7 mt-10 -139.98 107.46 5.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.779 -0.368 . . . . 1.67 111.394 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.4 m95 -95.12 126.09 40.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.22 111.521 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.581 HD21 HG22 ' A' ' 70' ' ' VAL . 89.8 mt -118.12 140.19 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.149 -0.686 . . . . 0.41 109.149 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.876 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 2.4 tt -130.0 135.57 60.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.78 112.335 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.1 m -114.11 104.05 54.95 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.168 -0.924 . . . . 1.25 108.998 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.9 Cg_exo -78.47 120.43 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.499 2.133 . . . . 0.53 111.907 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.01 83.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.62 -0.718 . . . . 0.41 111.215 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -75.28 -39.96 59.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 1.82 111.459 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 39.5 m-20 -85.41 158.02 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.608 . . . . 1.94 112.186 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.82 -14.59 62.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.103 -0.953 . . . . 1.66 111.265 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 32.8 mttt -66.23 149.21 50.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.441 -0.799 . . . . 1.74 112.303 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -153.63 127.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 121.796 0.808 . . . . 0.97 109.151 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.84 41.5 30.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.28 -1.327 . . . . 1.77 112.186 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -88.12 139.96 29.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 1.96 111.404 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.673 HG13 HD21 ' A' ' 73' ' ' LEU . 65.3 t -69.98 133.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.77 110.372 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 86' ' ' ASP . 1.3 pp -134.75 -39.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.815 0.672 . . . . 1.15 112.815 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 128.17 24.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.378 -0.601 . . . . 0.29 109.378 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.026 HD22 ' HA ' ' A' ' 56' ' ' GLU . 6.9 mt -137.98 162.29 34.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 1.3 111.277 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.704 ' CD1' HD13 ' A' ' 79' ' ' ILE . 35.4 t80 -133.48 102.68 5.61 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.298 -1.371 . . . . 1.3 107.298 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 5.9 t -143.96 157.53 44.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.638 -0.71 . . . . 0.89 111.731 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.99 29.79 3.49 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.256 -0.497 . . . . 0.57 113.405 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.3 t0 73.83 1.0 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.739 0.274 . . . . 1.46 111.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -100.08 118.58 36.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 110.003 -0.369 . . . . 2.41 110.003 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.2 mm -80.02 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 107.214 -1.402 . . . . 1.66 107.214 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.771 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.7 m-85 -120.81 123.83 43.58 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.48 -0.782 . . . . 1.25 110.982 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.851 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.2 p-10 -165.96 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.818 -1.549 . . . . 1.2 106.818 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -79.8 -31.88 40.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.406 -1.27 . . . . 2.17 109.519 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -72.95 -29.65 63.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.501 -1.296 . . . . 5.05 107.501 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.604 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.12 118.72 73.03 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 114.346 -1.297 . . . . 1.29 109.979 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.0 Cg_endo -50.78 -43.2 47.77 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.428 1.418 . . . . 0.79 110.602 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.877 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.4 m-20 -68.42 106.28 2.47 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.047 -0.524 . . . . 1.36 111.145 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.8 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.1 mp 72.33 24.53 3.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.391 0.886 . . . . 1.62 113.391 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.851 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 14.2 pttm -59.17 134.74 57.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.909 -0.494 . . . . 2.39 111.51 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.6 75.61 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.659 -0.781 . . . . 0.37 113.993 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -143.02 -51.02 0.35 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 114.38 1.252 . . . . 1.59 114.38 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.09 81.99 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 123.08 1.419 . . . . 0.2 107.421 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.546 ' C ' HG22 ' A' ' 105' ' ' ILE . 8.8 m-70 -102.17 127.92 48.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.066 -2.333 . . . . 0.29 112.62 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.129 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.7 m-85 -71.61 122.75 21.09 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 120.163 -0.615 . . . . 1.23 109.601 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.666 HG21 ' CD2' ' A' ' 38' ' ' TYR . 2.3 p -75.04 35.89 0.11 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.46 111.214 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 48.1 m -149.09 125.78 11.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.953 0.406 . . . . 1.2 110.396 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.11 6.81 40.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.937 -0.574 . . . . 2.22 110.383 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -145.92 65.12 1.22 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.583 -0.735 . . . . 2.14 109.06 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.2 mp -59.06 -27.16 65.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.173 -0.921 . . . . 1.49 111.958 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -63.46 1.54 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 2.04 112.078 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 98' ' ' LEU . 18.4 t -90.02 0.03 57.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.586 -0.734 . . . . 1.4 110.671 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.25 -8.46 48.8 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.964 -0.636 . . . . 0.38 113.001 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -94.77 114.13 25.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.125 0.488 . . . . 1.44 110.594 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.667 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.55 13.32 24.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.661 -0.699 . . . . 0.43 111.965 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 51.0 m -59.95 139.57 57.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 115.563 1.69 . . . . 1.04 115.563 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.129 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.41 129.7 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 114.343 -1.299 . . . . 0.31 110.294 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.4 p-10 -105.7 146.31 29.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.542 -0.91 . . . . 1.15 108.542 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -95.37 122.8 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.118 0.485 . . . . 0.27 110.746 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -91.08 145.16 24.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.638 -0.71 . . . . 0.29 110.84 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 66.7 57.06 0.69 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 1.52 111.466 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -53.95 165.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 1.02 112.095 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.653 ' O ' HG21 ' A' ' 137' ' ' VAL . 10.7 pt20 -177.14 167.87 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.664 -0.698 . . . . 2.13 110.996 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.436 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 89.2 mt -59.99 -37.37 79.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.852 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.6 p -73.24 -17.11 61.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.528 -0.305 . . . . 1.32 111.687 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 92.2 m-20 -71.25 -20.01 62.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.723 -0.391 . . . . 1.58 109.974 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -46.51 144.08 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.044 0 CA-C-N 116.179 -0.464 . . . . 0.42 111.055 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 143.89 4.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.904 -1.141 . . . . 0.24 113.834 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 m -59.05 130.6 47.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.143 -0.529 . . . . 0.31 112.009 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.876 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 28.9 m-85 -110.3 137.08 48.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 1.24 109.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.3 tt0 -126.87 122.17 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.638 -0.255 . . . . 1.16 110.579 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.6 t -99.88 119.76 38.71 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.575 0.226 . . . . 1.03 110.679 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 58.0 mttm -115.25 108.69 16.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 1.76 110.849 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.784 HG11 ' CG ' ' A' ' 43' ' ' PHE . 40.9 t -91.3 108.35 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.619 -0.511 . . . . 1.18 109.619 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 72.8 tttt -93.71 112.32 24.17 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.659 0.614 . . . . 1.62 112.659 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.588 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 12.3 pttm -145.74 103.24 3.76 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 109.831 -0.433 . . . . 2.84 109.831 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.59 129.73 13.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 113.158 0.799 . . . . 0.44 113.158 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.646 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 83.0 Cg_endo -102.67 39.93 4.0 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 C-N-CA 125.109 -0.788 . . . . 0.56 111.423 -0.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -131.66 102.87 0.52 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-O 122.365 0.98 . . . . 0.48 113.478 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 123' ' ' LYS . 1.3 m -96.67 135.05 32.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 113.505 -1.347 . . . . 1.22 108.76 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -132.05 154.19 49.65 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.763 -0.375 . . . . 0.57 111.837 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 49.1 p-10 -146.09 149.31 33.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.174 -0.466 . . . . 2.03 111.519 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.35 165.57 28.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 2.95 111.396 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -104.82 140.05 38.69 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 113.028 0.751 . . . . 2.26 113.028 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.7 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 78.5 mt -145.2 112.18 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.375 -0.972 . . . . 0.28 108.375 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.701 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 26.8 m170 -94.69 121.1 35.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.592 -0.443 . . . . 0.55 111.254 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.07 120.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.127 0.489 . . . . 1.52 111.024 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.7 t -122.26 129.11 75.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.258 -0.883 . . . . 0.32 109.089 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 111' ' ' GLN . 47.4 t -109.98 129.34 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.063 0.459 . . . . 1.08 112.052 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.61 160.06 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.739 -0.664 . . . . 0.52 109.504 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.372 0.606 . . . . 1.48 110.949 -179.362 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.805 0.336 . . . . 1.84 110.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.722 HG21 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 pt -112.11 141.43 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.318 -0.401 . . . . 2.15 111.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -93.17 155.05 17.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.64 0.733 . . . . 1.12 111.724 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 45.87 83.14 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 114.574 -1.193 . . . . 0.65 111.981 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 56.9 Cg_endo -78.55 -82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.745 2.964 . . . . 0.88 112.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.48 129.42 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.68 -0.859 . . . . 2.06 108.68 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HB3' HG12 ' A' ' 133' ' ' ILE . 50.6 tp10 -143.76 159.62 42.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.812 1.042 . . . . 1.71 113.812 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 25.5 mtm -139.91 123.77 17.51 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.826 -1.079 . . . . 1.86 109.376 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 133' ' ' ILE . 34.6 mm -120.02 130.04 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.39 111.75 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.717 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.1 mt-10 -127.57 121.83 31.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.395 -0.366 . . . . 1.19 110.413 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 48.0 mmtm -142.23 161.31 38.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.791 0.329 . . . . 2.52 111.44 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.4 136.55 39.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.39 111.189 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 52.4 tttp -44.51 132.67 6.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 2.35 111.329 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 90.12 -18.94 45.56 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.867 -0.606 . . . . 0.31 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.709 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.03 158.63 26.46 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.582 -0.896 . . . . 2.11 108.582 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 35.0 m -89.08 125.42 35.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.747 -0.781 . . . . 0.33 110.35 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.12 116.31 29.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.26 110.264 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.18 114.97 18.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.795 -0.639 . . . . 1.43 112.088 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 133' ' ' ILE . 31.6 mt -99.13 108.63 50.72 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.811 -0.811 . . . . 0.8 108.811 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.62 122.78 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.555 2.17 . . . . 0.42 113.907 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' HE3' ' A' ' 131' ' ' LYS . 4.3 t -141.0 125.19 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.062 -0.972 . . . . 1.03 109.016 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 83.2 mttt -141.08 148.4 40.09 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.25 0.548 . . . . 1.66 111.706 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 53' ' ' LEU . 40.8 p90 -140.8 142.62 34.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 1.26 111.076 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 139.63 30.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.904 0.383 . . . . 1.33 110.549 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.635 HD23 ' NZ ' ' A' ' 124' ' ' LYS . 32.4 mt -89.03 150.01 22.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 2.12 111.756 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.9 m -150.33 139.88 13.47 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 109.698 -0.482 . . . . 1.75 109.698 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 5.7 Cg_endo -48.55 -25.4 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.544 2.163 . . . . 1.61 112.144 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.667 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 17.5 pt-20 -78.49 -40.22 35.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.354 -0.384 . . . . 2.18 111.473 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.528 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.1 m-20 -72.27 71.54 0.89 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.171 -0.612 . . . . 2.41 109.68 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 47' ' ' PRO . 87.1 mt-30 -97.37 -4.92 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.712 -0.676 . . . . 1.64 112.366 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.864 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.02 159.97 53.33 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.492 -0.861 . . . . 0.55 112.805 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.43 123.77 12.81 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.363 2.042 . . . . 0.85 111.693 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 43' ' ' PHE . 6.4 tt -78.17 110.2 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 1.9 111.297 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 93.4 m-20 -127.83 103.78 7.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.391 0.615 . . . . 1.78 111.877 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 9.4 mt -91.68 113.31 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.974 -1.012 . . . . 0.75 110.04 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.866 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -107.39 120.55 42.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.249 0.833 . . . . 1.67 113.249 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.918 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.3 m95 -97.0 119.99 36.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.22 109.924 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' OE2' ' A' ' 56' ' ' GLU . 92.0 mt -105.69 140.12 39.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.526 -0.546 . . . . 0.41 109.526 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.1 tt -130.04 130.03 65.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.137 0.494 . . . . 0.78 112.306 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 68' ' ' ASP . 26.4 t -119.31 101.89 48.83 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 108.67 -0.863 . . . . 1.25 108.67 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.0 Cg_exo -79.97 111.57 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.603 2.202 . . . . 0.53 112.725 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.61 75.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.395 -0.82 . . . . 0.41 110.864 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 15.9 t0 -85.6 17.88 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 1.82 112.004 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 26.9 m120 -149.64 163.07 38.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.328 0.585 . . . . 1.94 111.677 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.96 -18.89 64.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.209 -0.905 . . . . 1.66 111.868 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 78.9 mttt -69.31 150.38 47.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.114 -0.494 . . . . 1.74 111.46 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.7 135.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.636 1.208 . . . . 0.97 110.047 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 60' ' ' SER . 1.5 p-10 43.63 39.38 2.36 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 112.536 -2.12 . . . . 1.77 112.08 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 1.96 110.869 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 73' ' ' LEU . 20.0 t -66.27 139.28 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.331 -0.618 . . . . 0.77 109.331 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.895 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.17 -53.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.422 0.527 . . . . 1.15 112.422 -177.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.95 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.76 130.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.857 -0.794 . . . . 0.29 108.857 178.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.866 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.0 159.99 40.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.045 0.45 . . . . 1.3 111.487 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.892 ' HD1' HD13 ' A' ' 79' ' ' ILE . 47.3 t80 -134.09 103.61 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.3 110.03 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 47.5 t -143.54 156.15 44.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.555 0.576 . . . . 0.89 112.555 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.02 32.99 9.6 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.953 -0.567 . . . . 0.57 113.074 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 t0 70.13 4.3 4.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.573 0.225 . . . . 1.46 111.248 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.3 mttt -100.01 114.01 27.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.809 -0.441 . . . . 2.41 109.809 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.892 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.83 -1.544 . . . . 1.66 106.83 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -116.61 121.52 41.97 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.45 -0.795 . . . . 1.25 110.625 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.909 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.5 p-10 -165.7 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.747 -1.205 . . . . 1.2 107.747 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -78.9 -31.08 45.24 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.158 -0.928 . . . . 2.17 109.376 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -75.78 -28.3 58.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.185 -1.043 . . . . 5.05 108.185 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.609 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.1 m-85 -81.59 117.83 69.77 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-N 114.777 -1.101 . . . . 1.29 110.554 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.46 -42.8 40.75 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.602 1.535 . . . . 0.79 110.352 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' O ' HG12 ' A' ' 71' ' ' ILE . 11.6 m-20 -67.28 106.18 1.97 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.105 -0.638 . . . . 1.36 110.695 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.838 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 68.08 26.96 7.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.575 0.954 . . . . 1.62 113.575 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.909 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 2.7 pttt -57.14 128.03 34.92 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.73 -0.606 . . . . 2.39 111.616 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.05 18.59 57.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.589 -0.815 . . . . 0.37 114.225 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.6 ptp180 -145.6 -46.27 0.21 Allowed 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 114.336 1.235 . . . . 1.59 114.336 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.99 82.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 123.102 1.429 . . . . 0.2 107.555 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.56 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.6 m80 -102.67 128.44 49.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.235 -2.257 . . . . 0.29 112.331 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.094 ' CD1' HG23 ' A' ' 105' ' ' ILE . 70.2 m-85 -72.25 124.07 24.3 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.338 -0.545 . . . . 1.23 110.075 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.6 HG21 ' CD1' ' A' ' 38' ' ' TYR . 10.8 p -75.13 34.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.4 -0.818 . . . . 0.46 111.116 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 6.9 m -149.07 123.51 9.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.017 0.437 . . . . 1.2 110.856 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -90.95 10.89 24.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.784 -0.643 . . . . 2.22 110.05 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -145.52 65.79 1.23 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.14 108.416 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -56.24 -31.75 63.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 1.49 111.606 -178.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' HD11 ' A' ' 45' ' ' LEU . 71.9 mttt -66.23 1.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.04 111.979 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -89.45 -0.01 57.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.862 -0.608 . . . . 1.4 111.023 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 100.85 -5.68 56.65 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.783 -0.722 . . . . 0.38 113.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 98' ' ' LEU . 95.9 m-20 -101.9 107.18 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.067 0.434 . . . . 1.44 110.427 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -104.63 11.68 33.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.8 0.667 . . . . 0.43 112.8 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 89.8 p -60.03 140.02 57.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.685 1.735 . . . . 1.04 115.685 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.094 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -131.23 130.02 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 114.197 -1.365 . . . . 0.31 110.507 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.703 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.4 p-10 -104.62 146.23 29.21 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.918 -0.771 . . . . 1.15 108.918 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.14 120.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.021 0.439 . . . . 0.27 111.543 -178.212 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.754 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.7 p -82.26 142.77 31.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.39 -0.823 . . . . 0.29 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.431 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 27.9 m120 49.98 55.51 9.32 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.062 -0.517 . . . . 1.52 111.605 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 24.2 mt -44.55 89.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.566 1.321 . . . . 1.02 114.566 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.486 ' HG2' ' H ' ' A' ' 113' ' ' SER . 64.1 tt0 -60.09 145.38 46.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.708 -0.678 . . . . 2.13 109.896 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.555 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -59.98 -40.04 87.74 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.188 0.518 . . . . 1.7 111.223 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 53.1 m -72.24 -9.98 59.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.505 -0.771 . . . . 1.32 111.642 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.99 -19.95 63.32 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.149 -0.315 . . . . 1.58 110.149 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.561 HG13 HG23 ' A' ' 137' ' ' VAL . 2.1 mt -43.33 145.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.42 110.353 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.86 155.08 6.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 0.24 112.808 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.19 138.38 57.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.198 0.444 . . . . 0.31 112.198 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.601 ' OH ' HD11 ' A' ' 87' ' ' LEU . 21.6 m-85 -119.3 135.1 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.58 . . . . 1.24 109.886 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 53.4 tt0 -127.61 119.94 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.184 -0.302 . . . . 1.16 110.184 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 39.1 t -99.98 118.98 37.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.416 . . . . 1.03 110.065 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 82.2 mttt -116.62 104.75 11.71 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 120.982 -0.287 . . . . 1.76 111.418 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 55' ' ' ILE . 22.1 t -87.71 108.66 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.092 -0.707 . . . . 1.18 109.092 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.592 ' HG3' HG12 ' A' ' 128' ' ' VAL . 39.3 ttpt -99.93 113.09 25.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.174 0.805 . . . . 1.62 113.174 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.635 ' NZ ' HD23 ' A' ' 45' ' ' LEU . 6.7 ttpt -145.51 101.9 3.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.477 -0.564 . . . . 2.84 109.477 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.864 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.22 133.13 41.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.683 -0.69 . . . . 0.44 112.714 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 40.0 Cg_endo -97.84 39.82 4.79 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 124.275 -1.135 . . . . 0.56 112.966 -0.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.31 101.96 0.45 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.922 -1.133 . . . . 0.48 113.496 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.7 m -96.82 140.02 18.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.576 -1.312 . . . . 1.22 109.301 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.07 152.0 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 0.57 112.41 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.552 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 35.8 p-10 -146.59 151.7 37.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.248 0.462 . . . . 2.03 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.722 ' NZ ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.08 160.0 42.08 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.904 -0.589 . . . . 2.95 110.779 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.7 mttt -102.34 141.13 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.633 0.975 . . . . 2.26 113.633 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.797 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 97.7 mt -141.75 116.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.28 108.605 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.437 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 2.2 m-70 -100.32 117.91 35.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.463 -0.495 . . . . 0.55 110.752 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 63.5 tp -89.38 122.89 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.227 0.537 . . . . 1.52 112.411 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.717 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 47.7 t -120.02 126.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.423 -0.954 . . . . 0.32 108.423 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 115' ' ' ILE . 46.2 t -109.95 125.66 67.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 112.223 0.453 . . . . 1.08 112.223 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.5 mt -83.4 163.95 20.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.52 109.614 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 139' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.854 0.835 . . . . 1.48 112.124 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.915 0.388 . . . . 1.84 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 129' ' ' ALA . 70.8 mt -143.38 129.1 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 2.15 110.77 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 69.2 p -94.29 153.63 17.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.399 0.618 . . . . 1.12 111.125 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 41.37 82.27 0.23 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 114.782 -1.099 . . . . 0.65 112.347 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 59.9 Cg_endo -79.02 -84.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.83 3.02 . . . . 0.88 112.269 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.0 mt-10 -78.12 129.12 34.8 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.063 -1.088 . . . . 2.06 108.063 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HB3' HG13 ' A' ' 133' ' ' ILE . 50.6 tp10 -144.09 159.21 43.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.414 1.265 . . . . 1.71 114.414 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.6 mtp -140.01 121.7 15.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.303 -1.317 . . . . 1.86 108.913 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 HG12 HG23 ' A' ' 133' ' ' ILE . 37.3 mm -119.77 129.98 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.611 -0.268 . . . . 0.39 111.252 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.8 pt-20 -129.82 126.76 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.355 . . . . 1.19 110.891 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -142.13 162.05 36.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 2.52 110.858 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.08 40.59 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.197 0.444 . . . . 0.39 112.197 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.629 ' HG3' HG12 ' A' ' 137' ' ' VAL . 87.2 mttt -43.85 141.53 1.57 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.208 -0.451 . . . . 2.35 112.031 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.43 -24.99 4.58 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.749 -0.659 . . . . 0.31 113.003 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -80.07 160.58 25.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.214 -0.661 . . . . 2.11 109.214 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.836 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 27.4 m -83.79 133.29 34.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.957 -0.697 . . . . 0.33 110.449 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -95.45 118.43 32.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.989 0.423 . . . . 0.26 110.773 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.991 ' HE1' HG21 ' A' ' 94' ' ' THR . 65.9 t80 -79.33 131.12 36.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.715 -0.675 . . . . 1.43 112.66 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.816 HD12 HD12 ' A' ' 105' ' ' ILE . 15.7 mt -128.32 104.32 19.95 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 108.991 -0.744 . . . . 0.8 108.991 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 95.8 Cg_endo -86.06 126.98 2.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.657 2.238 . . . . 0.42 114.762 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' SG ' ' CE ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -141.93 126.1 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.288 -0.869 . . . . 1.03 109.588 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 27.8 mttp -141.04 117.0 10.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.399 0.619 . . . . 1.66 110.983 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.791 ' CG ' HG11 ' A' ' 122' ' ' VAL . 29.0 p90 -92.84 139.84 30.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.935 -1.03 . . . . 1.26 111.031 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 143.3 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.415 . . . . 1.33 110.91 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.2 mt -100.38 139.76 35.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 2.12 111.525 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.423 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 5.3 m -158.93 147.13 13.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.583 . . . . 1.75 109.899 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.28 -23.73 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.44 2.094 . . . . 1.61 113.082 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -74.47 -43.24 56.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 120.563 0.221 . . . . 2.18 111.014 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 124' ' ' LYS . 1.2 p-10 -73.65 74.51 1.52 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.124 -0.63 . . . . 2.41 109.503 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -90.64 -12.73 35.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 1.64 112.106 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.66 159.95 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.292 -0.956 . . . . 0.55 112.912 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 140.93 97.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.487 2.125 . . . . 0.85 111.385 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.09 104.09 8.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.793 0.33 . . . . 1.9 111.287 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 96.0 m-20 -114.92 103.29 10.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.64 0.734 . . . . 1.78 110.996 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.3 mt -95.07 126.53 47.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.046 -0.979 . . . . 0.75 110.709 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 73' ' ' LEU . 96.5 mt-10 -120.54 117.57 27.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.486 0.55 . . . . 1.67 112.486 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.799 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -96.44 120.04 36.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.072 -0.344 . . . . 0.22 110.072 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.808 HD12 ' OE1' ' A' ' 119' ' ' GLN . 83.1 mt -108.76 140.25 42.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.36 -0.608 . . . . 0.41 109.36 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.651 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.4 tt -129.91 130.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 0.78 112.289 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.6 m -119.99 103.35 45.49 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.01 -0.995 . . . . 1.25 109.142 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 86.2 Cg_endo -78.31 119.11 4.47 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.655 2.237 . . . . 0.53 112.367 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.05 87.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.41 111.55 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD2' ' CD1' ' A' ' 112' ' ' LEU . 81.2 m-20 -76.56 -39.98 51.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.021 -0.536 . . . . 1.82 112.138 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 28.1 m120 -84.43 160.01 20.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.348 0.594 . . . . 1.94 112.214 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -69.84 -17.6 63.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.182 -0.917 . . . . 1.66 111.798 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.7 mttp -65.9 147.14 53.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.849 -0.614 . . . . 1.74 111.02 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.83 127.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 CA-C-O 121.883 0.849 . . . . 0.97 110.187 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 40.02 26.12 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.98 -1.464 . . . . 1.77 112.694 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.4 mt-30 -94.3 143.22 26.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.104 -0.238 . . . . 1.96 111.444 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.584 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.1 t -66.46 132.1 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 108.855 -0.795 . . . . 0.77 108.855 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.939 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -123.48 -51.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.352 0.871 . . . . 1.15 113.352 -176.508 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.032 HG21 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.81 105.3 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.699 0.761 . . . . 0.29 108.949 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -109.72 155.09 21.99 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.136 -0.938 . . . . 1.3 111.078 -177.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.916 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 22.0 t80 -135.11 104.79 6.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 1.3 110.439 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.439 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 45.2 m -142.57 158.41 43.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.132 0.419 . . . . 0.89 112.132 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.66 30.23 42.62 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.078 -0.582 . . . . 0.57 112.729 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t0 72.62 2.28 4.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.612 0.244 . . . . 1.46 110.903 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 88.0 mttt -99.99 114.8 28.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.634 -0.506 . . . . 2.41 109.634 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.916 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.07 116.99 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.114 -1.069 . . . . 1.66 108.114 178.152 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.715 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 m-85 -100.09 125.93 46.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.914 -1.494 . . . . 1.25 110.46 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.884 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -164.43 -52.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.98 -21.43 43.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.214 -0.903 . . . . 2.17 109.025 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -80.74 -27.42 36.86 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.15 -1.056 . . . . 5.05 108.15 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.65 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.6 m-85 -86.24 116.67 66.71 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.086 . . . . 1.29 110.648 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.1 Cg_endo -47.98 -40.99 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.439 1.426 . . . . 0.79 110.234 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' ILE . 65.5 m-20 -66.97 105.71 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.237 -0.585 . . . . 1.36 110.825 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.821 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.7 mt 66.88 24.82 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.608 0.966 . . . . 1.62 113.608 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 65.3 pttt -57.25 132.93 54.48 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.988 -0.685 . . . . 2.39 111.141 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.79 14.83 62.41 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.417 -0.897 . . . . 0.37 114.015 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.821 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -142.95 -50.85 0.35 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.826 1.417 . . . . 1.59 114.826 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 HG21 ' A' ' 72' ' ' ILE . 7.2 p -79.18 81.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 123.319 1.533 . . . . 0.2 107.363 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.613 ' C ' HG22 ' A' ' 105' ' ' ILE . 8.9 m-70 -100.22 131.55 46.1 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 111.806 -2.452 . . . . 0.29 111.756 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.081 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.1 m-85 -70.78 120.03 15.78 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 121.696 0.76 . . . . 1.23 110.719 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.991 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -70.01 -8.11 46.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.46 110.608 179.34 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 67.9 m -87.09 116.23 25.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.316 -0.402 . . . . 1.2 111.13 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.81 0.07 57.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.225 0.536 . . . . 2.22 109.965 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -146.2 65.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.596 -0.89 . . . . 2.14 108.596 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.702 HD22 ' CE1' ' A' ' 74' ' ' TYR . 6.8 tt -58.15 -32.73 68.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.245 -0.889 . . . . 1.49 111.52 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.52 -8.65 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.293 0.568 . . . . 2.04 111.717 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.6 m -88.52 -0.04 56.81 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.187 -0.915 . . . . 1.4 110.813 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 103.24 -12.32 55.2 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.734 . . . . 0.38 113.749 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 64.9 m-20 -95.06 109.96 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.159 0.48 . . . . 1.44 110.432 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -117.79 24.75 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.653 0.612 . . . . 0.43 112.653 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 10.0 m -61.42 154.6 23.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.27 1.211 . . . . 1.04 114.27 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.081 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -136.45 146.06 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.81 -1.086 . . . . 0.31 111.719 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.617 ' HB2' HG22 ' A' ' 36' ' ' THR . 22.6 p30 -121.73 142.55 50.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.877 -1.157 . . . . 1.15 107.877 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.836 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -97.43 121.84 48.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.065 0.459 . . . . 0.27 111.205 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 145.75 28.71 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.297 -0.865 . . . . 0.29 111.911 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.11 60.92 3.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.877 0.695 . . . . 1.52 112.877 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 31' ' ' LYS . 10.2 mt -47.01 172.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.286 0.565 . . . . 1.02 112.397 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -176.6 160.01 1.94 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.997 -1.001 . . . . 2.13 109.601 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 112' ' ' LEU . 1.2 tm? -59.06 -34.13 71.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.454 0.538 . . . . 1.7 112.454 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.38 -12.03 60.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.809 0.3 . . . . 1.32 111.809 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 98.5 m-20 -72.34 -20.95 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.58 109.896 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.3 143.25 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 116.089 -0.505 . . . . 0.42 111.072 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 141.05 147.36 4.91 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.722 -1.227 . . . . 0.24 113.922 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.583 HG23 ' CD2' ' A' ' 134' ' ' HIS . 96.2 m -59.34 130.03 44.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.059 -0.57 . . . . 0.31 111.83 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.651 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 30.5 m-85 -109.81 132.56 54.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.921 -0.581 . . . . 1.24 109.584 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.808 ' OE1' HD12 ' A' ' 58' ' ' LEU . 61.8 tt0 -120.86 110.28 16.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 1.16 110.027 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CE3' ' A' ' 57' ' ' TRP . 1.5 t -100.18 119.68 38.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.87 -0.604 . . . . 1.03 110.066 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.808 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.9 mtpt -122.52 112.97 18.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 1.76 111.172 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 43' ' ' PHE . 20.6 t -93.83 113.15 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.274 -0.639 . . . . 1.18 109.274 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.764 ' HG2' HG12 ' A' ' 128' ' ' VAL . 46.3 mttp -91.54 127.43 36.99 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.201 1.186 . . . . 1.62 114.201 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.718 ' HB3' ' HB2' ' A' ' 49' ' ' ASP . 9.5 mtmp? -145.98 101.88 3.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 2.84 109.326 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.75 132.29 47.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.26 0.467 . . . . 0.44 112.26 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 54.3 Cg_endo -101.44 49.53 1.79 Allowed 'Cis proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.892 -0.879 . . . . 0.56 111.707 -0.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.83 103.84 0.29 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.699 -0.762 . . . . 0.48 112.926 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.764 HG12 ' HG2' ' A' ' 123' ' ' LYS . 26.9 m -83.38 127.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.742 -0.729 . . . . 1.22 110.217 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 22' ' ' ILE . . . -99.46 141.22 32.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.401 0.143 . . . . 0.57 111.239 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.463 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.6 p-10 -145.76 136.47 24.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.068 0.461 . . . . 2.03 111.985 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.639 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.33 157.16 44.1 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.724 -0.671 . . . . 2.95 110.361 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 27' ' ' GLU . 96.8 mttt -104.57 140.08 38.52 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 113.329 0.863 . . . . 2.26 113.329 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.624 HD13 ' CH2' ' A' ' 57' ' ' TRP . 3.2 mt -140.97 120.0 11.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.317 -0.856 . . . . 0.28 109.339 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.583 ' CD2' HG23 ' A' ' 117' ' ' THR . 14.6 m170 -102.58 120.53 40.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.55 110.897 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.517 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -87.92 120.0 28.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.066 0.46 . . . . 1.52 111.124 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 59.1 t -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.373 -0.831 . . . . 0.32 109.316 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 33' ' ' LYS . 18.0 t -100.7 134.08 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.444 0.535 . . . . 1.08 112.444 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 58.7 mt -83.05 150.01 26.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.983 -0.747 . . . . 0.52 108.983 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 122.063 0.935 . . . . 1.48 112.836 -177.836 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.105 0.479 . . . . 1.84 111.154 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.914 HG12 ' HB1' ' A' ' 129' ' ' ALA . 73.1 mt -100.14 117.68 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.382 -0.826 . . . . 2.15 111.189 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' CE ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -92.25 131.41 37.48 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.373 0.606 . . . . 1.12 110.02 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 82.0 0.25 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 122.124 0.964 . . . . 0.65 110.292 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.6 Cg_endo -77.79 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.329 -0.488 0 C-N-CA 123.882 3.055 . . . . 0.88 112.966 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.5 mt-10 -78.48 125.31 29.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 2.06 108.661 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.5 tt0 -143.96 160.02 41.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.855 1.057 . . . . 1.71 113.855 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 29' ' ' ILE . 49.0 ttp -136.74 135.57 38.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.805 -1.089 . . . . 1.86 109.471 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.6 mm -130.03 136.42 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.969 -0.559 . . . . 0.39 111.436 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 83.8 mt-10 -129.86 123.51 31.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.647 0.26 . . . . 1.19 110.925 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' HD11 ' A' ' 110' ' ' LEU . 26.4 mmtt -141.93 153.22 44.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.726 0.298 . . . . 2.52 111.429 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.0 142.35 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 0.39 111.228 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 94.8 mttt -41.28 159.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.373 0.606 . . . . 2.35 112.178 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.63 -24.22 0.13 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.278 -0.874 . . . . 0.31 113.879 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 33' ' ' LYS . 98.9 mt-10 -80.06 160.03 25.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.416 -0.587 . . . . 2.11 109.416 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 40.8 m -86.51 128.93 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.24 -0.584 . . . . 0.33 110.831 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 118.28 36.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.189 0.519 . . . . 0.26 110.254 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.4 t80 -79.19 122.92 26.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.726 -0.67 . . . . 1.43 112.338 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.716 ' HB2' HD12 ' A' ' 105' ' ' ILE . 30.8 mt -110.03 104.67 56.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.39 -0.967 . . . . 0.8 108.39 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' O ' HD11 ' A' ' 133' ' ' ILE . 86.9 Cg_endo -82.12 133.11 7.51 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.508 2.139 . . . . 0.42 115.262 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.93 126.6 19.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.301 -1.318 . . . . 1.03 107.519 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.12 112.32 7.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.329 0.585 . . . . 1.66 111.609 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.715 ' HB3' HG11 ' A' ' 122' ' ' VAL . 41.8 p90 -100.04 139.01 36.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.05 -0.977 . . . . 1.26 111.205 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 45' ' ' LEU . 19.5 m -79.93 165.98 22.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.683 -0.488 . . . . 1.33 109.683 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 43' ' ' PHE . 98.0 mt -132.27 148.12 52.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.446 0.641 . . . . 2.12 112.417 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.5 t -160.16 147.92 12.91 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.965 -1.016 . . . . 1.75 109.542 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.57 -21.57 5.44 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.438 2.092 . . . . 1.61 113.236 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.3 pt-20 -76.38 -41.16 48.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 121.177 -0.209 . . . . 2.18 111.194 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -73.03 79.21 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.294 -0.632 . . . . 2.41 109.294 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -100.01 4.99 45.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 1.64 112.076 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.904 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.77 168.87 52.84 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.379 -0.915 . . . . 0.55 113.383 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.0 131.28 23.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.743 2.296 . . . . 0.85 111.562 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 124' ' ' LYS . 7.0 tp -78.51 110.03 13.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 1.9 111.856 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -126.94 103.5 7.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.415 0.626 . . . . 1.78 110.49 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.4 120.06 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.06 -0.973 . . . . 0.75 111.065 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.913 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 97.6 mt-10 -109.75 119.97 41.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.187 0.44 . . . . 1.67 112.187 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.996 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.6 m95 -95.36 119.98 34.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.856 -0.338 . . . . 0.22 110.155 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.98 138.95 40.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.138 -0.69 . . . . 0.41 109.138 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -130.02 130.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.13 0.49 . . . . 0.78 112.264 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.1 m -122.74 102.75 38.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.555 -0.748 . . . . 1.25 109.331 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.602 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 93.8 Cg_endo -79.04 116.0 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.519 2.146 . . . . 0.53 111.902 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.98 87.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.41 111.588 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.61 -40.01 57.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.191 -0.459 . . . . 1.82 111.636 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.3 m120 -84.23 160.04 20.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.293 0.568 . . . . 1.94 112.137 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.72 -18.66 64.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.32 -0.855 . . . . 1.66 111.7 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.602 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 68.0 mttm -67.13 149.03 51.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.022 -0.535 . . . . 1.74 111.186 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.61 127.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-O 121.902 0.858 . . . . 0.97 109.99 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.25 39.96 31.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.58 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.05 144.05 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.553 -0.166 . . . . 1.96 110.553 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' CG1' HD12 ' A' ' 73' ' ' LEU . 23.6 t -66.01 130.0 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.657 -0.417 . . . . 0.77 109.895 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.922 ' CG1' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -117.15 -54.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.753 0.649 . . . . 1.15 112.753 -177.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.861 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.29 131.26 48.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.444 -0.947 . . . . 0.29 108.444 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.913 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.01 158.5 43.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.228 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 79' ' ' ILE . 38.1 t80 -135.58 103.31 5.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 1.3 109.823 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 21.3 t -144.58 160.04 41.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.765 -0.652 . . . . 0.89 112.352 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.95 31.34 5.57 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.093 -0.503 . . . . 0.57 113.017 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 3.14 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.535 0.207 . . . . 1.46 111.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -99.95 115.66 30.2 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.429 -0.582 . . . . 2.41 109.429 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.927 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 107.219 -1.4 . . . . 1.66 107.219 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.722 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 2.8 m-85 -114.92 117.77 31.6 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.397 -0.82 . . . . 1.25 110.065 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 9.7 p-10 -165.94 -49.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.127 -1.434 . . . . 1.2 107.127 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD1' ' CE1' ' A' ' 83' ' ' TYR . 12.1 p-10 -80.13 -26.98 39.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.575 -1.193 . . . . 2.17 108.749 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 36.3 m-85 -80.84 -29.54 35.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.021 -1.103 . . . . 5.05 108.021 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.8 m-85 -82.33 110.32 20.74 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 115.014 -0.994 . . . . 1.29 109.794 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 25.9 Cg_exo -63.1 -28.56 74.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.086 1.857 . . . . 0.79 113.119 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.972 ' O ' HD12 ' A' ' 87' ' ' LEU . 20.1 m-20 -48.71 -33.32 9.93 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.213 -0.595 . . . . 1.36 112.045 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.3 mp -153.06 32.44 0.48 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.03 -0.986 . . . . 1.62 110.186 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 56.1 pttt -53.38 127.63 25.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.475 0.546 . . . . 2.39 112.475 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.52 15.91 57.73 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.487 -0.779 . . . . 0.37 114.639 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.4 ptp180 -145.87 -45.31 0.21 Allowed 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 114.594 1.331 . . . . 1.59 114.594 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.861 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.7 p -79.91 81.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.868 1.318 . . . . 0.2 107.782 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.537 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.0 m80 -102.62 128.88 49.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.654 -2.067 . . . . 0.29 112.684 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.8 m-85 -70.7 122.77 20.43 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 121.227 0.537 . . . . 1.23 110.016 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 38' ' ' TYR . 30.3 p -77.58 34.84 0.18 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.518 -0.765 . . . . 0.46 111.395 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 m -149.05 125.14 10.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.939 0.4 . . . . 1.2 110.275 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -90.0 8.47 32.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.94 -0.573 . . . . 2.22 110.303 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.2 66.53 1.19 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.668 -0.864 . . . . 2.14 108.668 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.62 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.9 mp -58.45 -33.11 69.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.107 -0.951 . . . . 1.49 111.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.27 0.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 2.04 112.166 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 98' ' ' LEU . 52.6 m -89.95 0.02 57.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.625 -0.716 . . . . 1.4 111.18 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.578 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 107.88 -14.59 37.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.69 -0.767 . . . . 0.38 113.295 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.955 0.377 . . . . 1.44 110.735 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.24 20.01 16.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.387 . . . . 0.43 111.998 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.2 p -60.11 144.73 49.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.939 1.459 . . . . 1.04 114.939 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.04 131.84 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 114.588 -1.187 . . . . 0.31 110.581 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -105.51 150.09 25.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.734 -0.839 . . . . 1.15 108.734 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.46 119.84 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.923 0.392 . . . . 0.27 110.652 -179.067 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -84.96 144.66 28.18 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.583 -0.735 . . . . 0.29 111.049 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 54.42 59.98 3.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 1.52 112.121 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.6 mt -45.52 177.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.271 0.558 . . . . 1.02 112.395 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.708 ' O ' HG21 ' A' ' 137' ' ' VAL . 11.5 pt20 -177.24 166.7 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.485 -0.78 . . . . 2.13 110.291 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.61 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 58.8 tp -60.04 -39.93 87.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 1.7 111.577 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 70.2 m -73.22 -10.03 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.393 . . . . 1.32 112.062 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 110' ' ' LEU . 90.7 m-20 -71.85 -22.35 61.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.528 -0.469 . . . . 1.58 109.735 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 142.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.05 -0.523 . . . . 0.42 110.186 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 150.87 5.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.2 -1.0 . . . . 0.24 113.7 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.29 130.64 47.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.137 -0.532 . . . . 0.31 112.375 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 43.8 m-85 -114.49 124.55 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.444 -0.576 . . . . 1.24 109.444 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.0 tt0 -123.37 119.22 29.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.117 -0.233 . . . . 1.16 110.765 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.546 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 15.5 p -105.05 119.91 40.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 1.03 110.362 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 41.2 mtmt -111.77 107.81 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 1.76 110.659 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.7 p -88.0 113.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 1.18 110.033 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.8 tttt -96.55 116.35 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.372 0.508 . . . . 1.62 112.372 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.714 ' HB2' HD12 ' A' ' 53' ' ' LEU . 25.7 tttp -145.65 102.48 3.69 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.402 -0.519 . . . . 2.84 109.849 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.904 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.68 134.0 36.15 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.918 -0.583 . . . . 0.44 111.878 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 93.3 Cg_endo -100.02 49.9 1.73 Allowed 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.627 -0.989 . . . . 0.56 111.606 -0.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.34 103.26 0.27 Allowed Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.147 -1.025 . . . . 0.48 113.939 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.443 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -87.86 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 1.22 108.804 176.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.914 ' HB1' HG12 ' A' ' 22' ' ' ILE . . . -140.96 146.86 37.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.309 0.485 . . . . 0.57 112.309 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.457 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 53.7 p30 -146.73 150.93 36.33 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.198 -0.455 . . . . 2.03 111.374 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.614 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -145.64 159.99 42.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.166 -0.47 . . . . 2.95 110.763 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 66.9 mttm -100.25 140.11 34.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.841 1.052 . . . . 2.26 113.841 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.64 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.7 mt -140.6 113.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.946 -1.025 . . . . 0.28 108.289 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -99.95 119.54 38.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.405 -0.518 . . . . 0.55 110.995 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 110' ' ' LEU . 60.6 tp -91.31 122.52 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.945 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 59.7 t -120.01 127.18 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.826 -0.805 . . . . 0.32 108.826 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.708 HG21 ' O ' ' A' ' 111' ' ' GLN . 33.5 t -98.9 131.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.46 0.541 . . . . 1.08 112.46 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 85.8 mt -82.36 151.3 26.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.824 -0.625 . . . . 0.52 109.824 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 121.678 0.751 . . . . 1.48 112.387 -178.39 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB2' HG21 ' A' ' 44' ' ' THR . 16.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.904 0.383 . . . . 1.84 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -142.86 132.81 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 2.15 110.321 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.21 150.3 22.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.676 0.75 . . . . 1.12 111.725 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER 52.68 81.64 0.26 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.526 -1.215 . . . . 0.65 112.464 -178.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.647 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -78.93 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.656 2.904 . . . . 0.88 111.857 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.57 126.85 31.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 2.06 108.521 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 24' ' ' THR . 2.4 mm-40 -143.61 159.99 41.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.864 1.061 . . . . 1.71 113.864 -176.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.559 ' C ' HD12 ' A' ' 29' ' ' ILE . 49.5 ttp -138.93 132.26 30.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.55 -1.205 . . . . 1.86 108.98 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.116 HD13 HG23 ' A' ' 133' ' ' ILE . 4.3 mp -130.0 139.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.943 -0.571 . . . . 0.39 111.405 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.0 pt-20 -135.13 127.29 29.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.19 111.134 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 56.0 tptt -141.9 157.52 44.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 2.52 110.742 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.5 144.34 39.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.934 0.397 . . . . 0.39 111.746 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HG2' HG21 ' A' ' 137' ' ' VAL . 60.7 mttp -47.2 143.05 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.767 0.655 . . . . 2.35 112.767 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 79.67 -21.8 4.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 114.858 -1.065 . . . . 0.31 113.307 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -81.39 160.65 24.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.708 -0.479 . . . . 2.11 109.708 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.3 m -84.43 129.96 34.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.034 -0.667 . . . . 0.33 110.679 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.899 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.39 117.43 34.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.26 110.628 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.731 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.0 t80 -79.61 119.85 23.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.67 0.619 . . . . 1.43 112.67 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.751 ' HB2' HD12 ' A' ' 105' ' ' ILE . 37.3 mt -106.31 111.58 64.17 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.502 -0.925 . . . . 0.8 108.502 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 85.7 Cg_endo -85.26 131.71 4.26 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.385 2.056 . . . . 0.42 115.648 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.9 t -141.36 130.0 22.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.461 -1.245 . . . . 1.03 108.254 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 33.0 mmtp -141.16 139.99 33.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.394 . . . . 1.66 111.063 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 53.5 p90 -140.0 140.83 36.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 110.75 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 21' ' ' SER . 4.7 p -82.04 138.64 34.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 1.33 111.967 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.24 139.97 33.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 2.12 110.275 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 p -152.49 151.1 26.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.843 0.354 . . . . 1.75 110.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.34 -25.85 25.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.809 2.339 . . . . 1.61 112.39 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 13.4 pt-20 -74.17 -39.99 62.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.494 -0.321 . . . . 2.18 110.251 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.619 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -71.9 75.28 0.89 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.234 -0.654 . . . . 2.41 109.234 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -91.98 -9.51 42.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.405 -0.816 . . . . 1.64 111.691 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.948 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.0 160.0 53.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.324 -0.941 . . . . 0.55 112.317 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.24 148.56 59.77 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.423 2.082 . . . . 0.85 111.619 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 61.5 tp -77.69 131.6 37.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 1.9 110.691 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 26.6 t0 -137.13 146.46 45.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.548 0.69 . . . . 1.78 110.951 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 40.9 mt -142.44 140.01 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.53 -1.214 . . . . 0.75 109.121 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 96.0 mt-10 -140.02 148.81 42.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.944 -0.302 . . . . 1.67 111.187 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.944 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.0 m95 -140.48 119.16 12.4 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.22 110.828 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 70' ' ' VAL . 86.5 mt -109.86 146.33 35.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.728 -0.669 . . . . 0.41 109.314 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.0 136.17 59.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.19 0.519 . . . . 0.78 112.267 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 70.1 m -119.66 103.84 45.7 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 1.25 108.854 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 85.1 Cg_endo -78.31 112.07 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.53 112.613 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.75 87.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.177 -0.92 . . . . 0.41 110.922 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -73.96 -40.48 62.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 1.82 111.416 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 94.3 m-20 -85.12 159.99 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 1.94 111.652 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -69.17 -19.88 64.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.66 111.173 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.542 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 57.7 mttt -70.0 150.63 46.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 1.74 111.298 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.65 127.83 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-O 121.732 0.777 . . . . 0.97 109.249 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 61.14 88.12 0.09 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.366 -1.288 . . . . 1.77 111.969 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' ILE . 11.8 pt20 -140.44 141.84 35.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.794 0.331 . . . . 1.96 111.219 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 58' ' ' LEU . 61.7 t -71.74 129.38 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.77 110.18 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CG1' HD12 ' A' ' 87' ' ' LEU . 1.4 pp -130.3 -38.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.347 0.499 . . . . 1.15 112.347 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.907 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 126.3 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.258 -0.645 . . . . 0.29 109.258 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -140.8 159.98 41.03 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.487 -0.779 . . . . 1.3 110.715 -178.048 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.79 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.2 t80 -134.86 103.75 5.73 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.997 -0.742 . . . . 1.3 108.997 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.452 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 13.0 t -142.7 160.01 41.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.89 111.45 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.52 13.75 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.691 -0.766 . . . . 0.57 112.356 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.29 0.34 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.457 0.17 . . . . 1.46 111.307 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -100.05 114.27 27.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.739 -0.467 . . . . 2.41 109.739 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.61 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -79.4 134.02 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.107 -1.442 . . . . 1.66 107.107 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.722 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -118.8 127.72 53.8 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 1.25 110.208 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.858 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.6 p-10 -165.82 -55.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.15 -1.426 . . . . 1.2 107.15 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 51.8 t0 -82.84 -27.54 30.75 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.785 -1.098 . . . . 2.17 109.0 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.42 -30.04 61.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.7 -1.222 . . . . 5.05 107.7 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.78 110.94 25.63 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.275 -1.33 . . . . 1.29 110.373 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.22 -43.12 13.29 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.843 1.695 . . . . 0.79 111.505 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 71' ' ' ILE . 95.9 m-20 -67.95 103.75 1.56 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.181 -0.463 . . . . 1.36 111.274 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.078 HD13 ' NH2' ' A' ' 90' ' ' ARG . 40.4 mt 73.58 21.48 2.85 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.965 0.728 . . . . 1.62 112.965 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.858 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.8 pttt -56.78 132.24 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.97 -0.456 . . . . 2.39 111.44 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.27 10.74 63.7 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.289 -0.958 . . . . 0.37 114.389 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 1.078 ' NH2' HD13 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -139.56 -49.73 0.49 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 114.781 1.4 . . . . 1.59 114.781 -178.051 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.907 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.79 81.56 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.981 1.372 . . . . 0.2 107.462 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.422 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.3 m-70 -102.71 129.25 49.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.342 -2.208 . . . . 0.29 112.475 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.3 m-85 -70.34 126.25 29.12 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.084 -0.646 . . . . 1.23 109.577 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.731 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.6 p -74.39 33.41 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.46 112.693 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 t -149.16 140.03 22.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.1 0.476 . . . . 1.2 111.332 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -91.54 0.07 57.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.22 110.648 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.61 67.45 1.17 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.294 0.568 . . . . 2.14 109.506 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.91 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -56.99 -25.88 59.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 1.49 111.229 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HA ' HD22 ' A' ' 53' ' ' LEU . 63.6 mttt -64.93 1.28 0.95 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.165 0.507 . . . . 2.04 112.297 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.7 p -89.99 0.06 57.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.561 -0.745 . . . . 1.4 110.714 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.45 -8.75 32.72 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.38 112.845 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -98.15 111.91 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.329 . . . . 1.44 110.988 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.516 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -110.04 13.02 23.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.31 -0.404 . . . . 0.43 111.424 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 54.5 m -59.98 140.0 57.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.389 1.625 . . . . 1.04 115.389 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.96 129.99 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.753 -1.112 . . . . 0.31 110.511 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.644 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.5 p30 -106.52 154.91 20.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.243 -0.651 . . . . 1.15 109.243 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -98.35 124.31 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 120.966 0.413 . . . . 0.27 111.364 -178.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -88.01 143.59 27.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.702 -0.681 . . . . 0.29 110.92 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.2 m120 50.66 60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 1.52 111.888 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.9 mt -45.37 176.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.445 0.64 . . . . 1.02 112.464 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.405 ' HG2' ' OD2' ' A' ' 114' ' ' ASP . 13.3 pt20 -176.69 163.84 2.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.141 -0.936 . . . . 2.13 110.082 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.775 ' HA ' HG11 ' A' ' 137' ' ' VAL . 2.0 tm? -60.03 -36.42 77.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 1.7 111.937 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -73.81 -14.43 61.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.056 0.391 . . . . 1.32 112.056 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 96.4 m-20 -71.18 -22.02 62.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.408 -0.517 . . . . 1.58 109.698 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.855 ' CD1' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.52 142.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.988 -0.551 . . . . 0.42 110.91 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.05 150.92 5.47 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.704 -1.236 . . . . 0.24 114.218 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.55 HG23 ' CE1' ' A' ' 134' ' ' HIS . 92.0 m -59.78 135.86 57.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.768 -0.716 . . . . 0.31 111.936 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 51.8 m-85 -120.0 139.68 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.24 110.105 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 58.4 tt0 -127.0 120.16 28.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 1.16 109.982 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 48.7 t -98.4 118.21 34.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.055 -0.258 . . . . 1.03 110.684 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 57.4 mttt -115.81 105.22 12.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 1.76 111.008 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 89.5 t -95.34 108.18 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.41 -0.589 . . . . 1.18 109.41 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 61.0 tttm -98.7 115.33 28.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.718 -0.793 . . . . 1.62 112.118 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 50.0 tttm -145.65 102.35 3.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.483 -0.562 . . . . 2.84 109.483 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.948 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.89 131.99 21.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 113.162 0.801 . . . . 0.44 113.162 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.619 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 47.2 Cg_endo -100.07 37.59 5.91 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.625 -0.99 . . . . 0.56 111.627 -0.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.67 102.41 0.53 Allowed Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.313 -0.946 . . . . 0.48 113.345 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.7 m -91.75 141.22 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 113.56 -1.32 . . . . 1.22 109.357 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -138.13 144.02 40.62 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.385 0.513 . . . . 0.57 112.385 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 39.6 p-10 -146.26 140.41 26.49 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.587 . . . . 2.03 110.783 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.9 164.13 32.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.582 -0.281 . . . . 2.95 111.517 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.2 mttt -99.75 140.12 34.41 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.667 0.988 . . . . 2.26 113.667 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.116 HG23 HD13 ' A' ' 29' ' ' ILE . 2.6 mp -140.57 111.91 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.926 -1.034 . . . . 0.28 109.072 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.55 ' CE1' HG23 ' A' ' 117' ' ' THR . 4.6 m-70 -101.03 120.02 39.58 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.596 -0.442 . . . . 0.55 111.235 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 59.5 tp -91.02 123.5 34.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.017 -0.538 . . . . 1.52 111.884 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -119.95 121.45 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.32 109.464 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.855 HG12 ' CD1' ' A' ' 115' ' ' ILE . 12.1 p -93.9 131.3 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 1.08 111.92 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.5 mt -86.55 149.98 24.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.52 109.722 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.773 0.797 . . . . 1.48 111.709 -179.02 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 70.6 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.223 0.535 . . . . 1.84 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -140.01 140.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.369 -0.832 . . . . 2.15 109.987 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -90.35 149.52 22.27 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.541 0.686 . . . . 1.12 111.365 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.5 83.12 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-N 114.657 -1.156 . . . . 0.65 111.232 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 56.1 Cg_endo -78.21 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.645 2.897 . . . . 0.88 112.278 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.41 127.59 32.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.555 -0.906 . . . . 2.06 108.555 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.911 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -143.85 160.0 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.098 1.147 . . . . 1.71 114.098 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.73 122.8 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.586 -1.188 . . . . 1.86 109.311 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.911 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.4 mm -120.01 123.5 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 0.39 111.607 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.2 mt-10 -113.79 123.78 50.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.339 -0.391 . . . . 1.19 110.421 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.56 154.61 45.56 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.087 0.403 . . . . 2.52 112.087 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.2 143.25 39.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.39 112.219 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 137' ' ' VAL . 54.9 mtpt -48.81 143.22 5.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.295 0.569 . . . . 2.35 112.422 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 -23.86 3.34 Favored Glycine 0 CA--C 1.516 0.13 0 CA-C-N 115.185 -0.916 . . . . 0.31 113.545 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.2 mm-40 -80.01 160.09 25.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.403 -0.592 . . . . 2.11 109.403 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.1 m -85.72 129.99 34.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.965 -0.694 . . . . 0.33 109.991 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.751 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.73 118.78 35.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.26 110.983 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.986 ' HE1' HG21 ' A' ' 94' ' ' THR . 83.0 t80 -79.53 129.98 34.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.49 -0.777 . . . . 1.43 112.223 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 105' ' ' ILE . 23.5 mt -124.6 104.5 30.91 Favored Pre-proline 0 C--N 1.333 -0.138 0 N-CA-C 108.903 -0.777 . . . . 0.8 108.903 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.76 129.61 8.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.495 2.13 . . . . 0.42 114.658 -177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.544 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 11.6 t -141.37 125.24 17.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.712 -1.131 . . . . 1.03 108.963 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 9.1 mtmm -140.65 144.78 35.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.771 -0.65 . . . . 1.66 109.838 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.916 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.2 p90 -140.03 141.24 36.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.794 -0.639 . . . . 1.26 112.21 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 21' ' ' SER . 1.3 p -88.91 139.86 30.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.654 . . . . 1.33 110.481 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -96.84 110.0 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.621 -0.263 . . . . 2.12 110.744 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -84.52 137.74 38.83 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.843 -0.429 . . . . 1.75 109.843 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -44.89 -34.21 8.38 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.755 1.637 . . . . 1.61 111.035 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.06 -40.03 47.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.403 -0.817 . . . . 2.18 111.014 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 91.7 m-20 -72.76 73.8 1.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.304 -0.558 . . . . 2.41 109.587 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.23 -0.02 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.889 -0.596 . . . . 1.64 112.235 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.07 161.92 52.99 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.55 113.159 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.87 137.86 60.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.695 2.264 . . . . 0.85 112.21 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 43' ' ' PHE . 2.3 mt -78.59 106.8 10.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.9 112.137 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.5 m-20 -119.36 102.41 8.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.519 0.676 . . . . 1.78 110.921 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.868 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 6.7 mt -99.04 111.39 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.873 -1.058 . . . . 0.75 111.029 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 73' ' ' LEU . 84.8 tt0 -107.43 120.69 42.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.278 0.844 . . . . 1.67 113.278 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.946 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -94.82 119.99 34.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.352 -0.385 . . . . 0.22 110.127 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.0 mt -103.82 141.11 36.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.529 -0.545 . . . . 0.41 109.529 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -130.01 138.06 54.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.072 0.767 . . . . 0.78 113.072 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -132.02 102.96 14.37 Favored Pre-proline 0 N--CA 1.455 -0.195 0 CA-C-N 115.199 -0.909 . . . . 1.25 109.503 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 6.3 Cg_exo -80.17 122.06 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.587 2.191 . . . . 0.53 112.38 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.73 73.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.41 110.45 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.76 13.12 7.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.405 -0.816 . . . . 1.82 112.066 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 81.9 m-20 -145.67 160.01 42.32 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.385 0.612 . . . . 1.94 112.04 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -68.96 -19.47 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.008 -0.996 . . . . 1.66 112.316 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.8 mtpt -67.71 140.03 56.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.042 0.448 . . . . 1.74 111.531 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.73 129.08 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 CA-C-O 121.935 0.874 . . . . 0.97 109.546 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 34.71 21.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.031 -1.44 . . . . 1.77 111.858 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.76 142.16 27.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.492 -0.322 . . . . 1.96 110.56 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 6.1 t -66.25 131.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.731 -0.47 . . . . 0.77 109.731 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.903 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.24 -50.58 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.64 0.607 . . . . 1.15 112.64 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.976 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.04 125.79 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.792 -0.818 . . . . 0.29 108.792 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 74' ' ' TYR . 8.6 tt -140.06 159.97 40.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 116.172 -0.467 . . . . 1.3 110.211 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.639 ' CD1' HG23 ' A' ' 79' ' ' ILE . 16.4 t80 -136.34 109.15 7.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 1.3 110.328 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.476 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.6 p -142.86 160.05 41.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.631 -0.713 . . . . 0.89 111.561 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.56 39.22 53.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.728 -0.749 . . . . 0.57 112.477 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.9 t0 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.026 0.441 . . . . 1.46 110.515 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 89.7 mttt -131.33 108.94 10.0 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.41 110.631 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -79.89 118.51 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 107.125 -1.435 . . . . 1.66 107.125 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.747 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.3 m-85 -100.79 136.11 41.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.795 -1.093 . . . . 1.25 110.612 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.81 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 13.9 p-10 -166.37 -55.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.854 -1.165 . . . . 1.2 107.854 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 12.5 t70 -79.26 -18.66 52.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.101 -0.954 . . . . 2.17 109.209 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.35 -28.26 34.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.55 -0.907 . . . . 5.05 108.55 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.571 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -85.8 114.28 55.99 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 114.949 -1.023 . . . . 1.29 111.161 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 88.8 Cg_exo -44.28 -42.36 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.611 1.541 . . . . 0.79 110.595 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.694 ' O ' HG12 ' A' ' 71' ' ' ILE . 3.4 m-20 -66.99 104.88 1.48 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.252 -0.579 . . . . 1.36 110.639 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.819 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 25.9 mt 67.43 23.29 9.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.826 1.047 . . . . 1.62 113.826 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -54.84 128.63 33.97 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.601 -0.687 . . . . 2.39 111.127 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.79 10.59 56.37 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.159 -1.02 . . . . 0.37 114.502 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.819 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -142.1 -46.43 0.35 Allowed 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 114.55 1.315 . . . . 1.59 114.55 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.976 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -79.95 80.89 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-O 123.251 1.501 . . . . 0.2 107.173 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.49 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.5 m80 -98.78 132.06 44.43 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.258 -2.246 . . . . 0.29 111.615 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.103 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.6 m-85 -72.41 121.07 18.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.895 0.855 . . . . 1.23 111.222 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.986 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -69.48 -11.69 61.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.069 -1.423 . . . . 0.46 109.914 178.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.8 m -95.22 120.01 34.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.025 -0.534 . . . . 1.2 110.929 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -90.64 4.82 50.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.422 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -146.19 67.02 1.19 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.802 -0.814 . . . . 2.14 108.802 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.1 mp -59.05 -35.04 72.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.216 -0.902 . . . . 1.49 111.886 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.93 -5.35 4.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 2.04 111.843 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -90.04 0.03 57.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.349 -0.841 . . . . 1.4 110.963 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.01 -20.02 34.17 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.737 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.5 m-20 -96.04 109.34 21.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.361 0.58 . . . . 1.44 110.414 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -114.86 25.58 10.83 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.816 0.673 . . . . 0.43 112.816 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 43.4 t -59.95 146.15 43.47 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.27 1.582 . . . . 1.04 115.27 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.103 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.53 139.97 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 114.217 -1.356 . . . . 0.31 110.788 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.701 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.9 OUTLIER -118.18 148.51 42.29 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.302 -0.999 . . . . 1.15 108.302 177.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.88 121.56 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 120.967 0.413 . . . . 0.27 111.26 -178.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -84.06 145.7 28.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.514 -0.767 . . . . 0.29 111.298 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.64 61.78 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.978 -0.555 . . . . 1.52 112.424 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.7 mt -46.86 173.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.322 0.582 . . . . 1.02 112.336 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.602 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -177.38 163.55 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 2.13 110.137 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.06 -38.29 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.277 -0.419 . . . . 1.7 111.99 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.7 t -73.11 -14.21 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.11 0.411 . . . . 1.32 112.11 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -72.83 -20.09 61.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.699 -0.4 . . . . 1.58 110.183 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.45 146.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.202 -0.454 . . . . 0.42 110.953 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.36 147.0 4.92 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 119.923 -1.132 . . . . 0.24 113.788 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.552 HG23 ' ND1' ' A' ' 134' ' ' HIS . 47.2 m -59.27 138.3 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.378 -0.411 . . . . 0.31 111.755 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.6 m-85 -119.95 131.08 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 1.24 109.792 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.648 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -121.56 119.88 33.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.048 -0.261 . . . . 1.16 110.383 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.458 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.7 t -99.51 111.17 23.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.578 -0.283 . . . . 1.03 110.455 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.868 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 74.3 mttt -106.61 104.74 14.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 1.76 110.812 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 43' ' ' PHE . 24.0 t -89.3 110.12 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 109.212 -0.662 . . . . 1.18 109.212 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 87.8 tttt -95.79 122.92 39.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.309 0.855 . . . . 1.62 113.309 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 3.9 mmtt -141.6 101.43 3.98 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.892 -0.781 . . . . 2.84 108.892 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 1.0 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.34 132.61 61.87 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 112.507 0.558 . . . . 0.44 112.507 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.53 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 81.0 Cg_endo -100.0 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.646 -0.981 . . . . 0.56 112.667 -0.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.3 103.38 0.29 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.696 -0.764 . . . . 0.48 112.971 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 123' ' ' LYS . 2.0 t -90.16 151.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.623 -0.788 . . . . 1.22 110.087 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.86 152.13 43.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.218 . . . . 0.57 111.535 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.517 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 17.6 p30 -146.49 151.9 38.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.05 0.389 . . . . 2.03 112.05 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.15 161.23 40.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.106 -0.497 . . . . 2.95 111.191 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 39.4 mttp -102.82 140.01 37.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.625 0.972 . . . . 2.26 113.625 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.729 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 87.7 mt -143.83 110.66 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.372 -0.973 . . . . 0.28 108.372 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.552 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.7 m-70 -98.46 120.01 38.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.55 111.391 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.415 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.1 tm? -86.87 124.26 32.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 1.52 111.225 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.3 t -119.29 126.93 75.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.582 -0.735 . . . . 0.32 109.433 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 111' ' ' GLN . 18.2 t -96.33 126.76 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.08 112.054 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.2 mt -87.7 145.7 26.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.52 109.078 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 122.249 1.023 . . . . 1.48 112.872 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 44' ' ' THR . 46.8 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.072 0.463 . . . . 1.84 111.562 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 131' ' ' LYS . 19.2 tt -139.51 134.99 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 2.15 110.399 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.43 156.91 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.515 0.674 . . . . 1.12 111.706 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.31 83.25 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.576 -1.193 . . . . 0.65 111.695 -178.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 59.3 Cg_endo -78.26 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.404 2.736 . . . . 0.88 112.6 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.59 125.55 29.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.072 -0.714 . . . . 2.06 109.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.7 tt0 -144.33 163.95 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.846 1.054 . . . . 1.71 113.846 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.687 ' O ' HD13 ' A' ' 29' ' ' ILE . 55.4 ttm -138.72 139.4 38.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.72 -1.127 . . . . 1.86 109.117 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.3 mm -132.72 139.37 49.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.214 0.449 . . . . 0.39 112.214 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 21.9 pt-20 -140.23 124.63 17.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 1.19 110.567 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -142.3 163.41 32.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.522 -0.308 . . . . 2.52 111.597 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.731 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.62 139.57 40.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.39 111.467 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.35 130.35 16.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 2.35 111.762 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.79 -19.15 47.02 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.31 112.695 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.731 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -79.99 160.01 26.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 42.0 m -88.43 128.51 35.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.566 -0.853 . . . . 0.33 110.352 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.987 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.8 113.92 26.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.26 110.522 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.635 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.0 t80 -79.53 129.89 34.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.908 -0.587 . . . . 1.43 112.387 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 133' ' ' ILE . 4.1 mp -120.17 107.64 39.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.424 -0.954 . . . . 0.8 108.424 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.0 Cg_endo -82.8 104.66 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.451 2.101 . . . . 0.42 115.944 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -105.58 126.12 51.77 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.165 -1.05 . . . . 1.03 108.165 175.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mttm -140.72 139.37 34.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.176 0.512 . . . . 1.66 110.992 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.645 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 40.8 p90 -141.11 150.04 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.415 -0.811 . . . . 1.26 111.028 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' SER . 1.7 t -80.1 170.74 16.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.33 111.177 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD21 ' HE2' ' A' ' 43' ' ' PHE . 91.7 mt -138.19 141.19 40.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 2.12 111.03 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 79.5 p -159.99 158.63 26.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.847 -0.615 . . . . 1.75 110.212 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 13.1 Cg_endo -56.24 -17.64 21.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.433 2.089 . . . . 1.61 112.88 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -73.33 -43.72 60.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.685 0.278 . . . . 2.18 110.534 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.46 76.63 1.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.069 -0.715 . . . . 2.41 109.069 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.13 -11.54 43.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 1.64 111.773 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.6 157.59 52.73 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.222 -0.989 . . . . 0.55 112.29 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.81 150.9 27.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.334 2.022 . . . . 0.85 111.321 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.765 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 4.1 mp -77.61 133.06 38.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.893 0.377 . . . . 1.9 110.845 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 21.9 t0 -140.24 146.84 39.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.361 0.6 . . . . 1.78 111.753 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 6.6 mt -143.79 135.0 22.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.422 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.739 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.3 tt0 -140.61 119.9 12.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.668 0.667 . . . . 1.67 112.667 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.889 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.0 m95 -100.2 124.85 46.12 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.174 -0.466 . . . . 0.22 111.377 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -106.87 120.34 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.843 -0.429 . . . . 0.41 109.843 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' A' ' 71' ' ' ILE . 10.3 tt -104.06 124.42 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.506 0.558 . . . . 0.78 112.506 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.8 m -118.33 101.9 50.8 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 98.9 Cg_endo -79.56 115.52 3.41 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.597 2.198 . . . . 0.53 112.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.41 110.944 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.94 -39.96 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 1.82 111.8 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.561 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.4 m120 -85.43 161.87 19.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.39 0.614 . . . . 1.94 112.28 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.63 -18.48 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.091 -0.958 . . . . 1.66 111.741 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -68.49 150.91 47.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.906 -0.588 . . . . 1.74 111.333 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.59 127.69 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.113 0 CA-C-O 121.893 0.854 . . . . 0.97 109.988 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 55.89 40.05 30.57 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 114.074 -1.421 . . . . 1.77 112.727 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.3 mt-30 -94.32 145.05 25.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.192 -0.203 . . . . 1.96 110.75 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG11 ' OH ' ' A' ' 84' ' ' TYR . 18.4 t -66.68 125.95 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.064 0.459 . . . . 0.77 109.883 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -116.21 -53.72 4.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 1.15 111.923 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.73 124.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.2 -1.037 . . . . 0.29 108.2 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.852 HD23 ' N ' ' A' ' 74' ' ' TYR . 6.1 tt -135.32 157.09 47.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.806 -0.633 . . . . 1.3 109.772 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.901 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 12.1 t80 -136.91 104.08 5.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.758 -0.46 . . . . 1.3 109.758 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -143.15 158.26 43.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.89 111.678 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.58 28.58 45.8 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.732 -0.747 . . . . 0.57 112.472 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.53 2.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.545 0.212 . . . . 1.46 111.107 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 68.2 mttm -100.01 113.24 25.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 110.08 -0.341 . . . . 2.41 110.08 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.901 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.87 116.52 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.879 -1.156 . . . . 1.66 107.879 177.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.718 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.2 m-85 -100.03 128.19 46.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.819 -1.537 . . . . 1.25 110.908 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.758 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.2 p-10 -166.14 -53.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.222 -1.029 . . . . 1.2 108.222 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.8 t70 -80.17 -24.33 40.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.09 -0.959 . . . . 2.17 109.371 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.25 -29.1 42.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.118 -0.946 . . . . 5.05 108.5 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -82.35 115.9 60.57 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-N 114.795 -1.093 . . . . 1.29 110.552 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.2 Cg_endo -46.81 -40.99 25.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.729 1.619 . . . . 0.79 110.373 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.721 ' O ' HG12 ' A' ' 71' ' ' ILE . 67.1 m-20 -66.98 105.22 1.57 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.824 -0.626 . . . . 1.36 110.653 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.859 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.2 mt 68.02 24.56 7.82 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.862 1.06 . . . . 1.62 113.862 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttt -55.61 127.5 30.18 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.627 -0.671 . . . . 2.39 111.219 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.63 15.12 54.03 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.385 -0.912 . . . . 0.37 114.451 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.859 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp180 -144.14 -48.03 0.27 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 114.483 1.29 . . . . 1.59 114.483 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.23 81.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.864 1.316 . . . . 0.2 107.725 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.472 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.5 m80 -102.93 129.14 49.55 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.474 -2.148 . . . . 0.29 112.326 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.117 ' CD1' HG23 ' A' ' 105' ' ' ILE . 77.0 m-85 -70.97 120.77 17.03 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 109.097 -0.705 . . . . 1.23 109.097 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.635 HG21 ' CE2' ' A' ' 38' ' ' TYR . 24.6 p -70.43 -10.01 57.97 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.22 -0.9 . . . . 0.46 110.455 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 67.2 m -93.16 121.46 34.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.848 -0.615 . . . . 1.2 110.259 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.11 2.48 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.1 0.476 . . . . 2.22 110.344 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -146.07 66.81 1.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.849 -0.797 . . . . 2.14 108.849 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.598 HD22 ' CD2' ' A' ' 74' ' ' TYR . 5.9 mp -56.74 -28.98 62.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 1.49 111.466 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 55.6 mtmt -62.81 -6.23 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 2.04 111.809 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -87.55 -3.11 59.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.309 -0.86 . . . . 1.4 110.733 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.645 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.57 -12.97 32.93 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.779 -0.724 . . . . 0.38 113.702 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -95.09 110.03 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.192 0.496 . . . . 1.44 110.429 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -108.83 16.38 22.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.294 -0.412 . . . . 0.43 111.916 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 6.0 m -60.16 140.02 57.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 116.104 1.891 . . . . 1.04 116.104 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.117 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.82 135.53 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.291 -1.322 . . . . 0.31 110.587 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.63 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -111.95 145.05 40.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.326 -0.99 . . . . 1.15 108.326 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.03 120.02 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.063 0.459 . . . . 0.27 111.443 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.774 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -83.15 143.96 30.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.369 -0.832 . . . . 0.29 110.64 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 81.3 m-20 49.92 56.52 7.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.156 0.503 . . . . 1.52 111.359 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.987 HD11 ' HB2' ' A' ' 37' ' ' ALA . 21.4 mt -46.38 90.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.986 1.106 . . . . 1.02 113.986 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 47.5 mt-30 -56.58 149.03 18.27 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.948 -0.569 . . . . 2.13 110.468 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.96 -37.05 78.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.28 -0.637 . . . . 1.7 109.28 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.55 -5.63 43.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 1.32 111.542 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 90.0 m-20 -70.08 -19.18 63.28 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.615 -0.513 . . . . 1.58 109.615 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -43.14 137.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 116.001 -0.545 . . . . 0.42 110.452 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 141.04 158.8 7.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.893 -1.146 . . . . 0.24 114.145 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.4 m -60.48 140.0 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.751 -0.724 . . . . 0.31 112.709 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.771 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 32.8 m-85 -125.12 125.38 43.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.023 -0.732 . . . . 1.24 109.023 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.73 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.0 tt0 -120.01 118.96 32.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.943 -0.303 . . . . 1.16 110.727 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.2 t -97.81 118.58 34.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.999 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 31.9 mttm -114.07 106.38 14.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.76 110.858 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 48.9 t -92.18 104.67 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.229 -0.656 . . . . 1.18 109.229 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 85.5 tttt -96.99 120.12 36.75 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.009 -0.676 . . . . 1.62 112.65 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.765 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 10.3 mtmp? -141.81 102.87 4.25 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.693 -0.484 . . . . 2.84 109.693 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.924 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.01 131.96 22.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 0.44 111.654 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 44.1 Cg_endo -101.89 46.83 2.26 Favored 'Cis proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.986 -0.839 . . . . 0.56 111.69 -0.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.07 103.56 0.28 Allowed Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.328 -0.939 . . . . 0.48 113.679 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.33 149.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.691 -0.754 . . . . 1.22 109.666 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -141.79 144.62 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.587 0.232 . . . . 0.57 111.47 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 44.7 p-10 -146.72 148.6 32.16 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.316 0.487 . . . . 2.03 112.316 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.804 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.31 160.72 41.09 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.018 -0.537 . . . . 2.95 110.698 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 99.1 mttt -103.22 136.14 43.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.282 0.845 . . . . 2.26 113.282 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 91.1 mt -145.24 113.47 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 108.708 -0.849 . . . . 0.28 108.708 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -95.4 175.4 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.076 -0.65 . . . . 0.55 109.907 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 110' ' ' LEU . 54.5 tp -144.07 133.05 22.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.864 -0.607 . . . . 1.52 112.255 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.4 t -129.98 129.99 65.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.383 -0.826 . . . . 0.32 109.515 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 33.4 t -97.09 124.84 50.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.915 0.388 . . . . 1.08 111.67 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.87 157.72 25.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.433 -0.58 . . . . 0.52 109.433 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 1.48 111.106 -179.173 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.938 0.399 . . . . 1.84 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.56 144.08 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 2.15 110.991 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.48 139.95 34.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.744 0.783 . . . . 1.12 112.025 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.95 81.11 0.27 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.344 -1.298 . . . . 0.65 112.109 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.704 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 76.1 Cg_endo -79.62 -11.03 14.33 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 124.344 3.363 . . . . 0.88 113.338 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -140.67 125.26 17.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.546 -0.909 . . . . 2.06 108.546 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.762 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -144.28 162.87 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 114.595 1.332 . . . . 1.71 114.595 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.713 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.8 ttm -137.92 137.12 37.7 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.491 -1.232 . . . . 1.86 109.197 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.762 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.0 mm -134.5 139.99 46.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.269 -0.423 . . . . 0.39 111.688 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 39.4 mt-10 -137.6 119.28 15.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.368 -0.378 . . . . 1.19 110.295 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 110' ' ' LEU . 31.0 tptt -142.07 158.64 43.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.665 -0.243 . . . . 2.52 110.978 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.89 143.95 39.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.136 0.493 . . . . 0.39 112.242 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 35.2 ttpt -48.93 131.18 18.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.799 -0.637 . . . . 2.35 111.864 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.77 -19.84 38.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.488 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.726 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.7 mt-10 -79.9 158.43 26.68 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.239 -1.023 . . . . 2.11 108.239 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.823 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.0 m -88.4 128.92 35.53 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.511 -0.876 . . . . 0.33 110.976 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 117.7 34.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.26 110.531 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 94' ' ' THR . 31.4 t80 -79.42 112.82 17.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.937 -0.574 . . . . 1.43 111.712 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB2' HD12 ' A' ' 105' ' ' ILE . 40.6 mt -99.09 107.59 44.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.436 -0.95 . . . . 0.8 108.436 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 95.4 Cg_endo -82.69 134.52 7.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.213 1.942 . . . . 0.42 114.4 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 1.8 t -140.42 130.07 24.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.477 -1.238 . . . . 1.03 107.841 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.571 ' O ' HG22 ' A' ' 22' ' ' ILE . 30.3 mmtp -140.42 137.05 33.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.979 0.418 . . . . 1.66 110.94 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HE1' ' HB2' ' A' ' 103' ' ' ALA . 53.2 p90 -140.28 154.25 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 1.26 110.976 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -80.02 169.96 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 1.33 111.835 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.525 HD12 ' OD2' ' A' ' 49' ' ' ASP . 69.0 tp -139.98 132.78 29.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.378 -0.828 . . . . 2.12 110.625 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -157.18 156.09 28.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.75 110.498 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.96 -19.21 31.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.442 2.094 . . . . 1.61 112.529 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 12.6 pt-20 -75.44 -40.61 57.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.718 -0.219 . . . . 2.18 110.84 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' OD2' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -72.29 75.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.238 -0.585 . . . . 2.41 109.452 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -91.65 -4.47 55.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 1.64 112.292 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.919 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -82.71 146.65 24.6 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 119.814 -1.184 . . . . 0.55 112.292 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.1 131.08 44.25 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.153 1.902 . . . . 0.85 111.393 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.748 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 1.1 pt? -77.64 133.77 38.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 1.9 111.532 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 76.7 m-20 -134.38 102.38 5.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.819 0.819 . . . . 1.78 110.556 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.875 HG12 HG22 ' A' ' 122' ' ' VAL . 4.7 mt -92.36 108.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.225 -1.352 . . . . 0.75 110.564 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' CB ' HD12 ' A' ' 73' ' ' LEU . 85.6 tt0 -106.52 117.56 34.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.409 0.522 . . . . 1.67 112.409 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.935 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -94.66 119.95 34.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.226 -0.287 . . . . 0.22 110.226 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.6 mt -107.69 143.88 35.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.958 -0.386 . . . . 0.41 109.958 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 114' ' ' ASP . 11.1 tt -129.99 130.0 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 0.78 112.05 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.1 m -117.57 102.82 51.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.888 -0.782 . . . . 1.25 108.888 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.677 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 72.0 Cg_endo -78.37 107.68 2.34 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.349 2.032 . . . . 0.53 112.979 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.19 70.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.956 -1.02 . . . . 0.41 110.365 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 5.7 p-10 -87.42 17.27 4.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.644 -0.707 . . . . 1.82 111.204 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -152.86 162.61 41.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.208 0.528 . . . . 1.94 111.837 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -67.19 -19.92 65.64 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.372 -0.831 . . . . 1.66 112.258 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 62.8 mttp -70.06 152.09 44.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.263 -0.426 . . . . 1.74 111.321 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.8 128.67 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 CA-C-O 121.773 0.797 . . . . 0.97 109.614 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.95 44.74 25.18 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.339 -1.301 . . . . 1.77 112.289 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' O ' HG22 ' A' ' 59' ' ' ILE . 90.6 mm-40 -87.29 134.54 33.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 1.96 111.036 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 58' ' ' LEU . 65.6 t -70.8 130.05 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.524 -0.307 . . . . 0.77 110.682 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.843 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -130.15 -37.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.836 0.68 . . . . 1.15 112.836 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.12 122.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.698 -0.482 . . . . 0.29 109.698 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.26 161.71 37.02 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.045 -0.525 . . . . 1.3 110.221 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.659 ' CD1' HG23 ' A' ' 79' ' ' ILE . 47.1 t80 -132.46 111.02 10.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.884 0.373 . . . . 1.3 110.615 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 15.2 t -142.34 158.05 44.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.788 -0.642 . . . . 0.89 111.576 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.69 33.53 42.09 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.827 -0.701 . . . . 0.57 112.324 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER 70.01 10.16 7.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.711 0.291 . . . . 1.46 110.866 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 58.5 mttm -108.84 111.65 23.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.37 -0.377 . . . . 2.41 111.181 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.05 117.84 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.752 -1.574 . . . . 1.66 106.752 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.795 ' O ' HG12 ' A' ' 72' ' ' ILE . 7.2 m-85 -100.05 130.12 46.17 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.839 -1.073 . . . . 1.25 110.648 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.2 p-10 -165.99 -56.81 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.358 -1.719 . . . . 1.2 106.358 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -78.43 -24.52 46.08 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 114.416 -1.266 . . . . 2.17 108.894 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -76.99 -29.97 55.73 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.396 -1.335 . . . . 5.05 107.396 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.619 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 1.2 m-85 -86.24 113.31 51.5 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 114.423 -1.262 . . . . 1.29 109.919 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.04 -36.2 90.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.902 1.735 . . . . 0.79 112.948 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 87' ' ' LEU . 58.2 m-20 -49.99 -29.99 9.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.298 0.851 . . . . 1.36 113.298 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 2.0 mp -151.74 30.19 0.59 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.874 -0.603 . . . . 1.62 111.467 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 40.5 pttt -58.96 137.75 57.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.996 -0.682 . . . . 2.39 111.899 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 13.83 80.2 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.598 -0.728 . . . . 0.37 114.175 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.4 ptm85 -142.23 -56.65 0.45 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 114.922 1.453 . . . . 1.59 114.922 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -78.21 80.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 123.059 1.409 . . . . 0.2 107.358 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.438 ' C ' HG22 ' A' ' 105' ' ' ILE . 7.9 m-70 -98.89 127.07 44.72 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.161 -2.29 . . . . 0.29 112.797 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.113 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.6 m-85 -68.66 125.53 26.83 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 120.1 -0.64 . . . . 1.23 109.298 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.963 HG21 ' CE2' ' A' ' 38' ' ' TYR . 6.6 p -74.15 28.24 0.08 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.514 -0.766 . . . . 0.46 112.644 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 t -148.7 137.64 21.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.13 0.491 . . . . 1.2 110.948 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -92.73 3.72 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.569 -0.741 . . . . 2.22 110.73 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -146.49 66.95 1.17 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.95 -0.759 . . . . 2.14 108.95 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.3 mp -57.87 -24.66 58.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.114 -0.948 . . . . 1.49 111.637 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -64.16 0.59 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.224 0.453 . . . . 2.04 112.224 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -90.02 -0.03 57.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.682 -0.69 . . . . 1.4 110.832 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.73 -13.7 42.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.38 112.557 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -96.14 108.39 20.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.115 -0.328 . . . . 1.44 110.115 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -112.54 15.53 20.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.18 0.437 . . . . 0.43 112.18 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 27.9 p -61.31 147.77 43.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.354 1.613 . . . . 1.04 115.354 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.113 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -134.47 130.33 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.291 -1.322 . . . . 0.31 111.211 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.881 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.3 OUTLIER -103.37 143.58 32.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.602 -0.888 . . . . 1.15 108.602 177.353 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.68 124.45 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 120.891 0.377 . . . . 0.27 111.637 -178.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.723 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.8 p -85.67 145.14 27.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.29 110.874 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 98.5 m-20 50.57 57.28 6.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.063 0.459 . . . . 1.52 111.878 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 37' ' ' ALA . 25.1 mt -45.66 85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.727 1.38 . . . . 1.02 114.727 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 63.9 tt0 -59.98 147.89 37.27 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.668 -0.696 . . . . 2.13 110.416 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.647 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 94.1 mt -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.054 0.39 . . . . 1.7 112.054 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 23.3 t -70.82 -14.96 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 1.32 111.567 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.726 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -70.16 -19.15 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.384 -0.599 . . . . 1.58 109.384 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 30.2 mt -45.68 138.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.947 -0.57 . . . . 0.42 110.057 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.77 163.68 9.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 119.95 -1.119 . . . . 0.24 113.876 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 87.5 m -59.41 130.02 44.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.599 0.592 . . . . 0.31 112.599 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.596 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.2 m-85 -112.43 130.94 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 1.24 109.687 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -123.24 118.22 27.08 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.057 -0.257 . . . . 1.16 111.027 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 41.9 t -100.54 118.57 36.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 1.03 110.153 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 44.2 mtpt -117.89 106.17 12.7 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.822 -0.351 . . . . 1.76 111.493 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 55' ' ' ILE . 29.9 t -90.04 109.27 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.229 -0.656 . . . . 1.18 109.229 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.7 tttp -100.32 111.77 24.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 1.62 112.327 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 48.6 tttt -142.41 102.84 4.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.3 -0.56 . . . . 2.84 110.189 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.919 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.26 134.01 24.02 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.643 -0.708 . . . . 0.44 112.09 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 65.5 Cg_endo -99.26 47.87 2.08 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.414 -1.078 . . . . 0.56 111.785 -0.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.97 102.95 0.27 Allowed Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.89 -1.147 . . . . 0.48 113.822 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.61 151.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.534 -0.833 . . . . 1.22 109.689 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.49 144.47 34.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.387 0.514 . . . . 0.57 112.387 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.44 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 43.7 p-10 -146.78 139.8 25.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.241 -0.436 . . . . 2.03 111.61 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.704 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.18 161.99 38.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.548 -0.296 . . . . 2.95 111.073 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.4 mttt -106.66 143.44 34.76 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.888 1.07 . . . . 2.26 113.888 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.737 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.3 mt -143.86 114.81 2.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 114.982 -1.008 . . . . 0.28 108.879 176.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -99.44 112.79 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.481 -0.488 . . . . 0.55 110.911 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.7 HD21 HD22 ' A' ' 110' ' ' LEU . 54.6 tp -88.25 131.01 34.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.697 -0.683 . . . . 1.52 112.425 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.0 t -126.42 125.83 68.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.32 109.729 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 27.6 t -99.33 123.09 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.08 111.412 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.6 mt -81.82 157.21 24.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.701 -0.481 . . . . 0.52 109.701 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.53 0.681 . . . . 1.48 111.629 -178.926 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.971 0.415 . . . . 1.84 110.371 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.748 HG13 ' HB1' ' A' ' 129' ' ' ALA . 42.5 mm -118.73 129.99 74.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 2.15 111.003 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 51.1 p -85.9 146.56 26.66 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.32 0.581 . . . . 1.12 110.598 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.27 83.27 0.21 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.146 -0.934 . . . . 0.65 111.333 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.4 Cg_endo -77.72 -77.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.568 2.845 . . . . 0.88 112.193 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 45.4 mp0 -78.64 123.22 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 2.06 108.958 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 28' ' ' MET . 77.8 tt0 -143.81 159.99 41.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.077 1.14 . . . . 1.71 114.077 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.502 ' C ' HD12 ' A' ' 29' ' ' ILE . 57.5 ttm -134.6 130.01 35.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.536 -1.211 . . . . 1.86 108.284 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.047 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -131.22 138.48 53.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.03 -0.532 . . . . 0.39 112.335 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.764 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 92.2 mt-10 -128.81 126.34 39.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.211 -0.45 . . . . 1.19 110.252 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HB2' HD13 ' A' ' 110' ' ' LEU . 60.3 mmtt -142.09 156.87 45.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.892 0.377 . . . . 2.52 111.846 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -77.29 140.18 39.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.39 111.887 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HD2' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -45.73 141.89 2.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.09 -0.505 . . . . 2.35 111.872 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 79.3 -21.66 4.17 Favored Glycine 0 C--N 1.328 0.132 0 C-N-CA 121.168 -0.539 . . . . 0.31 113.759 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -78.48 155.25 29.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.768 -0.827 . . . . 2.11 108.768 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.835 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.2 m -88.67 121.69 31.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.818 -0.753 . . . . 0.33 110.544 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -95.93 116.1 28.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.275 0.559 . . . . 0.26 110.072 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -79.15 116.22 19.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.558 -0.746 . . . . 1.43 111.632 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 105' ' ' ILE . 29.1 mt -104.37 104.19 43.28 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.383 -0.969 . . . . 0.8 108.383 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 83.1 Cg_endo -83.26 135.58 7.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.685 2.257 . . . . 0.42 114.712 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 86.9 m -141.03 103.32 4.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.273 -0.876 . . . . 1.03 109.831 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 58.2 tptt -100.9 133.86 44.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.962 -0.563 . . . . 1.66 109.53 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.731 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 21.2 p90 -138.31 138.15 38.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.272 0.558 . . . . 1.26 111.395 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -91.5 139.64 30.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.289 -0.869 . . . . 1.33 110.438 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' NZ ' ' A' ' 124' ' ' LYS . 86.0 mt -94.63 109.75 21.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.144 -0.317 . . . . 2.12 110.144 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 m -81.04 139.49 49.44 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 109.942 -0.392 . . . . 1.75 109.942 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.89 -31.27 10.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.558 1.505 . . . . 1.61 110.707 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 82.7 tt0 -75.54 -40.03 57.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.207 -0.906 . . . . 2.18 110.827 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 80.0 m-20 -67.79 79.05 0.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.245 0.545 . . . . 2.41 109.549 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.85 -8.74 33.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.419 -0.81 . . . . 1.64 111.428 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.02 53.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.611 -0.804 . . . . 0.55 112.335 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.18 148.82 47.61 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.255 1.97 . . . . 0.85 111.785 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 45' ' ' LEU . 8.2 mt -78.02 131.1 37.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 1.9 111.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 83.1 m-20 -131.72 149.77 52.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.954 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.696 ' CD1' HD11 ' A' ' 98' ' ' LEU . 23.5 mt -143.57 104.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.226 -0.897 . . . . 0.75 109.538 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 73' ' ' LEU . 86.4 tt0 -104.48 111.04 23.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.491 0.552 . . . . 1.67 112.491 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.693 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.8 m95 -92.98 132.93 36.64 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.923 -0.311 . . . . 0.22 110.437 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.3 mt -119.55 139.99 51.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.465 -0.569 . . . . 0.41 109.465 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 87' ' ' LEU . 8.8 tt -129.97 130.74 66.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.752 0.649 . . . . 0.78 112.752 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.431 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.9 m -125.51 101.39 30.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.306 -0.998 . . . . 1.25 108.306 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.0 Cg_exo -79.76 118.25 3.77 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.534 2.156 . . . . 0.53 112.902 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.75 -39.95 86.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.561 -0.745 . . . . 0.41 110.604 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.847 -0.615 . . . . 1.82 111.749 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 33.7 m120 -85.98 160.51 19.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.365 0.602 . . . . 1.94 112.181 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -69.48 -15.87 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.103 -0.953 . . . . 1.66 111.327 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 48.7 mttt -67.0 151.47 47.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 1.74 111.821 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.02 135.58 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.585 1.183 . . . . 0.97 110.149 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 45.46 40.0 5.19 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 112.609 -2.087 . . . . 1.77 112.858 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.9 145.44 24.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.518 0.199 . . . . 1.96 110.826 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.7 t -67.12 130.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.814 0.34 . . . . 0.77 110.124 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.899 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -109.68 -65.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.908 0.707 . . . . 1.15 112.908 -177.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.824 HG22 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 107.4 9.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.434 -0.95 . . . . 0.29 108.434 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 55' ' ' ILE . 8.0 tp -112.94 157.4 21.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.3 111.042 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.843 ' CD1' HD13 ' A' ' 79' ' ' ILE . 18.1 t80 -132.58 104.72 6.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 1.3 109.921 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.522 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 14.6 t -143.12 159.77 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.427 0.528 . . . . 0.89 112.427 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.45 31.71 14.27 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.875 -0.602 . . . . 0.57 112.73 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t0 70.51 3.3 4.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.666 0.269 . . . . 1.46 111.013 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 50.1 mtpt -100.52 116.5 32.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.876 -0.416 . . . . 2.41 109.876 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.843 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.11 129.44 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 107.543 -1.28 . . . . 1.66 107.543 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.657 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -113.62 121.11 43.17 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.25 -0.886 . . . . 1.25 110.49 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.804 ' HB3' HG12 ' A' ' 72' ' ' ILE . 16.2 p-10 -165.58 -51.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.634 -1.247 . . . . 1.2 107.634 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 50.3 t0 -77.18 -21.73 53.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.157 -0.929 . . . . 2.17 108.88 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.81 -26.46 27.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.925 -1.034 . . . . 5.05 109.268 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.884 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -89.05 111.32 44.19 Favored Pre-proline 0 CA--C 1.512 -0.485 0 CA-C-N 115.25 -0.886 . . . . 1.29 112.155 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.5 -38.72 28.24 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.415 1.41 . . . . 0.79 110.473 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.6 m-20 -64.46 106.07 1.07 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.977 -0.556 . . . . 1.36 111.251 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 59' ' ' ILE . 4.7 mt 59.95 23.08 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.711 1.004 . . . . 1.62 113.711 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 23.2 pttm -58.34 149.01 25.71 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.179 -1.008 . . . . 2.39 111.379 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.83 6.72 88.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.498 -0.858 . . . . 0.37 113.024 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.791 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -142.54 -40.47 0.34 Allowed 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 113.737 1.014 . . . . 1.59 113.737 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.923 ' CG1' HD13 ' A' ' 105' ' ' ILE . 1.6 t -85.29 87.97 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 123.221 1.486 . . . . 0.2 107.525 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 30.2 m-70 -113.16 132.92 55.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 111.258 -2.701 . . . . 0.29 111.86 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.077 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.2 m-85 -75.26 123.96 26.24 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 119.988 -0.685 . . . . 1.23 109.75 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 p -74.69 -4.68 38.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.46 110.916 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . 15.9 p -84.43 113.66 21.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.206 -0.452 . . . . 1.2 110.949 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -88.19 0.01 56.57 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.514 0.673 . . . . 2.22 109.505 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -146.52 68.72 1.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.524 -1.288 . . . . 2.14 107.524 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.696 HD11 ' CD1' ' A' ' 55' ' ' ILE . 9.3 tt -56.11 -38.23 70.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.499 -1.228 . . . . 1.49 112.029 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -63.59 -2.7 1.76 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.137 0.494 . . . . 2.04 112.119 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.2 t -89.62 -0.03 57.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.585 -0.734 . . . . 1.4 111.204 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.731 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.47 -0.18 34.79 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.521 -0.847 . . . . 0.38 113.887 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 95.5 m-20 -99.48 119.95 38.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.005 0.402 . . . . 1.44 110.986 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -118.5 3.7 11.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.21 -0.45 . . . . 0.43 112.087 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 29.9 p -59.99 145.19 47.13 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.508 2.04 . . . . 1.04 116.508 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.93 130.07 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 114.034 -1.439 . . . . 0.31 109.809 177.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p-10 -100.77 142.38 32.33 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.578 -1.267 . . . . 1.15 107.578 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.91 117.83 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 120.746 -0.381 . . . . 0.27 110.716 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -84.55 143.3 29.41 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.743 -0.662 . . . . 0.29 110.759 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 80.8 m-20 49.89 58.55 5.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.52 111.256 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 37' ' ' ALA . 22.1 mt -46.19 90.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.642 0.979 . . . . 1.02 113.642 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.486 HE21 ' NH2' ' A' ' 90' ' ' ARG . 7.1 tt0 -59.64 143.92 49.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.712 -0.676 . . . . 2.13 110.338 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.573 HD12 ' HD2' ' A' ' 33' ' ' LYS . 2.4 tt -60.0 -38.52 82.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.188 0.518 . . . . 1.7 110.67 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 79.3 p -74.12 -6.52 48.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.32 111.42 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 87' ' ' LEU . 95.8 m-20 -69.99 -19.47 63.34 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.346 -0.613 . . . . 1.58 109.346 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -43.08 139.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.632 -0.713 . . . . 0.42 110.256 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.78 162.34 9.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.098 -1.049 . . . . 0.24 113.331 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.4 m -59.71 135.23 57.62 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.31 112.408 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.606 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 19.6 m-85 -119.99 132.1 55.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 1.24 109.618 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.9 mt-30 -120.16 117.5 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.613 0.244 . . . . 1.16 110.401 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.526 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 10.2 t -101.15 106.37 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.92 -0.4 . . . . 1.03 109.92 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.579 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 77.7 mttt -113.26 112.5 23.84 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.522 -0.308 . . . . 1.76 111.501 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 37.8 t -92.96 108.24 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.765 -0.458 . . . . 1.18 109.765 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 82.2 tttt -97.0 119.17 34.97 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.783 0.66 . . . . 1.62 112.783 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.9 tttt -145.82 102.79 3.7 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.646 -0.502 . . . . 2.84 109.646 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.627 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.78 131.59 21.02 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.286 0.847 . . . . 0.44 113.286 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.558 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 63.7 Cg_endo -100.35 40.66 4.13 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.675 -0.969 . . . . 0.56 111.979 -1.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.67 102.27 0.48 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.26 -0.972 . . . . 0.48 113.225 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -91.96 141.76 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 113.629 -1.286 . . . . 1.22 109.879 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -139.87 152.18 46.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.992 -0.283 . . . . 0.57 111.706 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.579 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 41.2 p-10 -146.35 149.64 34.18 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.419 0.526 . . . . 2.03 112.419 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 10.6 ptmt -144.44 157.77 44.08 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.895 -0.593 . . . . 2.95 110.81 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 5.6 ttmm -100.98 139.97 35.93 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.78 0.659 . . . . 2.26 112.78 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.047 HG23 HD13 ' A' ' 29' ' ' ILE . 89.2 mt -142.06 113.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.479 -0.782 . . . . 0.28 109.689 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -100.13 114.75 28.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.728 -0.471 . . . . 0.55 109.728 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 53.8 tp -94.73 123.0 37.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.764 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.8 t -119.93 122.18 67.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.032 -0.729 . . . . 0.32 109.032 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 16.4 t -100.27 127.16 53.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.952 0.406 . . . . 1.08 111.988 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.65 159.42 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.52 109.705 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.461 0.648 . . . . 1.48 111.333 -179.136 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.038 0.447 . . . . 1.84 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.933 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 10.9 tt -141.67 144.23 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.776 -0.647 . . . . 2.15 110.482 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.6 p -88.12 152.73 21.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.414 0.626 . . . . 1.12 111.574 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.687 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 37.91 84.75 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.743 -1.117 . . . . 0.65 111.212 -178.185 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.2 Cg_endo -76.8 -11.6 18.26 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 123.417 2.745 . . . . 0.88 112.777 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.9 126.6 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.544 -0.91 . . . . 2.06 108.544 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.0 tt0 -143.93 159.41 42.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.25 1.204 . . . . 1.71 114.25 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 77.9 mtp -139.96 123.89 17.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.678 -1.146 . . . . 1.86 109.781 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.769 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.3 mm -122.47 129.46 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.649 0.261 . . . . 0.39 111.288 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.613 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.3 mt-10 -119.95 124.21 45.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.499 -0.319 . . . . 1.19 110.554 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' A' ' 110' ' ' LEU . 23.6 mmtt -142.22 162.22 36.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 2.52 111.639 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -76.56 137.93 39.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.125 -0.489 . . . . 0.39 111.76 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -48.33 129.99 16.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.208 -0.451 . . . . 2.35 111.083 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.0 -18.96 45.01 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.118 -0.563 . . . . 0.31 112.349 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 110' ' ' LEU . 82.0 mm-40 -80.09 160.0 25.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.246 -1.02 . . . . 2.11 108.246 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 82.8 m -88.18 128.31 35.45 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.568 -0.853 . . . . 0.33 110.814 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.95 119.98 38.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.26 110.394 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 94' ' ' THR . 30.5 t80 -79.51 113.89 18.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.803 -0.635 . . . . 1.43 111.427 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.766 ' HB2' HD12 ' A' ' 105' ' ' ILE . 47.1 mt -100.96 106.3 43.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.442 -0.948 . . . . 0.8 108.442 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.669 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 4.4 Cg_endo -84.92 126.23 3.3 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.401 2.068 . . . . 0.42 113.361 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 19.7 t -140.59 125.92 18.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.6 -0.889 . . . . 1.03 108.6 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 22' ' ' ILE . 8.4 mtpm? -140.82 148.55 40.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.943 -0.571 . . . . 1.66 111.473 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' CD1' HG11 ' A' ' 122' ' ' VAL . 50.3 p90 -139.99 143.1 36.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.027 -0.988 . . . . 1.26 111.613 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.1 p -83.3 159.96 21.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.814 -0.63 . . . . 1.33 111.093 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.58 122.88 36.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 2.12 110.458 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 15.8 m -76.06 155.97 84.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.599 -0.273 . . . . 1.75 110.404 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.41 -20.1 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.562 2.175 . . . . 1.61 112.399 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 79.5 tt0 -148.19 34.55 0.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.607 -0.27 . . . . 2.18 111.267 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 46' ' ' SER . 34.0 p-10 -69.92 69.94 0.33 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.022 0.439 . . . . 2.41 110.447 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -96.42 -1.4 47.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 1.64 111.679 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.671 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.84 153.95 49.33 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.206 -0.997 . . . . 0.55 112.165 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.68 126.8 23.45 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.235 1.957 . . . . 0.85 111.152 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.874 HD21 ' HD3' ' A' ' 124' ' ' LYS . 1.3 mt -77.94 104.55 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.448 -0.342 . . . . 1.9 111.23 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -116.98 103.42 10.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.535 0.683 . . . . 1.78 110.728 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.1 mt -97.57 121.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.75 110.782 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.932 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -115.41 126.37 54.3 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.34 0.496 . . . . 1.67 112.34 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.732 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.0 m95 -100.52 124.24 45.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.22 110.16 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.513 HD21 ' OE2' ' A' ' 56' ' ' GLU . 86.1 mt -109.52 140.52 43.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.499 -0.556 . . . . 0.41 109.499 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.0 tt -127.77 130.03 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.485 . . . . 0.78 112.259 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 17.8 m -120.18 102.41 46.08 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.892 -0.781 . . . . 1.25 108.892 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.3 Cg_exo -79.4 118.08 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.514 2.143 . . . . 0.53 112.628 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.98 87.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.721 -0.672 . . . . 0.41 110.542 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -75.69 -40.01 56.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 1.82 111.425 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 15.6 t-20 -82.61 158.15 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 1.94 111.731 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -69.18 -20.02 64.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 1.66 111.895 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.75 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 18.5 mtpt -70.59 151.73 44.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 1.74 111.907 -178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.2 m -153.94 129.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.799 0.809 . . . . 0.97 109.106 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 59.5 39.18 22.05 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.231 -1.35 . . . . 1.77 111.785 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 96.0 mm-40 -92.09 153.56 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.356 -0.384 . . . . 1.96 111.415 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.711 HG21 ' CE1' ' A' ' 84' ' ' TYR . 4.2 p -64.34 150.55 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.427 -0.582 . . . . 0.77 109.427 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.914 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -144.21 -57.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.179 -0.608 . . . . 1.15 112.504 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.975 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.56 135.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.626 -0.509 . . . . 0.29 109.626 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.932 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 4.0 mp -140.73 164.06 31.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 1.3 112.207 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.888 ' CD1' HD13 ' A' ' 79' ' ' ILE . 45.3 t80 -137.2 103.27 5.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.337 -0.847 . . . . 1.3 109.195 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.454 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 12.8 t -144.1 159.58 42.39 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.083 -0.508 . . . . 0.89 112.256 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.33 31.02 4.53 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.058 -0.519 . . . . 0.57 113.353 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 72.03 1.95 4.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.446 0.165 . . . . 1.46 111.419 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 87.4 mttt -100.01 117.77 34.99 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.657 -0.497 . . . . 2.41 109.657 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.888 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.4 mm -80.02 130.31 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.436 -1.32 . . . . 1.66 107.436 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.732 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.3 m-85 -117.45 125.17 50.47 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.325 -0.852 . . . . 1.25 110.655 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.885 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.8 p-10 -165.93 -55.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.975 -1.491 . . . . 1.2 106.975 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' N ' ' A' ' 89' ' ' GLY . 51.1 t0 -80.64 -21.51 41.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.864 -1.062 . . . . 2.17 109.047 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -81.56 -25.91 35.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.371 -0.974 . . . . 5.05 108.371 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.729 ' CZ ' HD13 ' A' ' 73' ' ' LEU . 2.2 m-85 -87.11 120.71 71.56 Favored Pre-proline 0 CA--C 1.509 -0.604 0 CA-C-N 115.273 -0.876 . . . . 1.29 110.555 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.9 Cg_endo -48.56 -43.78 32.39 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.391 1.394 . . . . 0.79 110.443 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 71' ' ' ILE . 2.8 m-20 -68.72 107.22 2.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.297 -0.961 . . . . 1.36 111.328 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.813 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.9 mt 68.75 25.9 6.24 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.642 0.979 . . . . 1.62 113.642 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.885 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.2 pttt -56.62 127.53 31.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.025 -0.67 . . . . 2.39 111.431 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 82' ' ' ASP . . . 91.66 16.3 52.48 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.37 114.135 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -144.32 -47.68 0.26 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.707 1.373 . . . . 1.59 114.707 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -80.85 82.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 123.038 1.399 . . . . 0.2 108.119 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.698 ' C ' HG22 ' A' ' 105' ' ' ILE . 20.3 m80 -101.29 130.18 47.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.639 -2.073 . . . . 0.29 111.997 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.1 m-85 -74.09 121.55 21.31 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.551 0.691 . . . . 1.23 109.704 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -69.98 -11.17 60.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.65 -1.159 . . . . 0.46 110.096 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.7 m -93.49 120.02 33.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.971 -0.559 . . . . 1.2 110.738 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -89.56 0.03 57.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.071 0.462 . . . . 2.22 110.26 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -146.19 67.24 1.19 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.764 -0.828 . . . . 2.14 108.764 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 74' ' ' TYR . 5.2 mp -54.61 -23.58 17.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.141 -0.936 . . . . 1.49 111.655 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.26 -4.59 3.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.216 0.532 . . . . 2.04 111.759 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.7 p -88.53 0.02 56.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.305 -0.861 . . . . 1.4 111.072 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 102.86 -14.18 56.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.744 -0.741 . . . . 0.38 113.151 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.18 108.95 21.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.911 0.355 . . . . 1.44 110.69 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.05 16.69 21.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.36 0.504 . . . . 0.43 112.36 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m -60.03 145.78 45.14 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 115.793 1.775 . . . . 1.04 115.793 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.41 136.02 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.082 -1.417 . . . . 0.31 110.783 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 90' ' ' ARG . 49.2 p-10 -107.11 143.52 35.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.528 -0.915 . . . . 1.15 108.528 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.85 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.71 120.7 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.063 0.459 . . . . 0.27 111.655 -178.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 144.54 29.43 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.333 -0.849 . . . . 0.29 111.012 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 29.0 m120 49.84 55.89 8.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.281 -0.418 . . . . 1.52 111.811 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.891 HD22 HD11 ' A' ' 135' ' ' LEU . 21.7 mt -45.45 89.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.699 1.0 . . . . 1.02 113.699 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 52.3 tt0 -60.05 143.82 51.0 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.582 -0.525 . . . . 2.13 109.582 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.96 -40.04 87.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 1.7 110.892 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -73.3 -10.01 59.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.32 111.613 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.2 m-20 -70.56 -17.24 62.92 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.892 -0.41 . . . . 1.58 109.892 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.61 143.76 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 CA-C-N 115.862 -0.608 . . . . 0.42 110.381 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.75 157.09 7.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.155 -1.021 . . . . 0.24 113.201 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.6 m -59.34 138.95 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.339 0.496 . . . . 0.31 112.339 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.552 ' OH ' HD11 ' A' ' 87' ' ' LEU . 9.6 m-85 -120.09 130.91 54.87 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.432 -0.581 . . . . 1.24 109.432 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.6 tt0 -127.47 119.96 27.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.957 -0.297 . . . . 1.16 111.015 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 21.6 p -102.71 119.95 39.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.76 0.314 . . . . 1.03 110.554 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 97.5 mttt -112.75 104.9 12.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 1.76 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.764 HG22 HG12 ' A' ' 55' ' ' ILE . 21.8 t -88.42 117.31 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.325 -0.62 . . . . 1.18 109.325 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.848 ' HG2' HG12 ' A' ' 128' ' ' VAL . 75.8 mttt -113.76 118.31 33.93 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.91 1.078 . . . . 1.62 113.91 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.874 ' HD3' HD21 ' A' ' 53' ' ' LEU . 21.1 pttm -146.94 103.8 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.639 -0.71 . . . . 2.84 110.809 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.671 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -48.34 129.11 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.92 -0.582 . . . . 0.44 111.835 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -104.11 53.79 1.21 Allowed 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 125.207 -0.747 . . . . 0.56 111.802 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 102.98 0.27 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.95 -1.119 . . . . 0.48 113.871 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 123' ' ' LYS . 17.1 m -94.24 134.27 32.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.394 -0.903 . . . . 1.22 109.845 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.933 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -143.55 136.6 27.72 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.13 0.418 . . . . 0.57 112.13 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.605 ' C ' HD13 ' A' ' 22' ' ' ILE . 45.9 p-10 -146.79 150.24 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.219 0.452 . . . . 2.03 112.219 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.758 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.55 163.52 34.51 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 2.95 110.567 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.0 mttt -101.3 145.05 29.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 114.25 1.204 . . . . 2.26 114.25 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.673 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.53 119.36 11.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.63 -1.168 . . . . 0.28 108.654 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.504 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 5.3 m-70 -100.43 119.75 38.95 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.564 -0.455 . . . . 0.55 110.741 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.891 HD11 HD22 ' A' ' 110' ' ' LEU . 1.5 tm? -89.58 120.04 30.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 1.52 111.384 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.613 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.1 t -117.3 120.0 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.653 . . . . 0.32 109.551 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.66 125.34 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.016 0.436 . . . . 1.08 112.035 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 92.9 mt -84.85 170.01 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.52 109.368 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 1.48 111.69 -178.643 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.938 0.399 . . . . 1.84 110.998 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.784 ' CD1' ' HB1' ' A' ' 129' ' ' ALA . 85.6 mt -110.0 129.96 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 2.15 110.558 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 38.1 p -91.44 148.34 22.38 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.191 0.519 . . . . 1.12 110.792 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.62 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 41.38 82.69 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.089 -0.96 . . . . 0.65 111.117 -177.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.46 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 123.971 3.114 . . . . 0.88 112.926 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.27 126.3 30.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.504 -0.925 . . . . 2.06 108.504 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.934 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -143.74 160.02 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.893 1.071 . . . . 1.71 113.893 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.793 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.16 137.21 38.95 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 114.881 -1.054 . . . . 1.86 109.281 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.934 HD11 ' OE2' ' A' ' 27' ' ' GLU . 32.2 mm -134.16 140.02 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.296 0.48 . . . . 0.39 112.296 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt-10 -130.14 123.96 31.54 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.431 -0.581 . . . . 1.19 109.431 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.606 ' HB3' HD13 ' A' ' 110' ' ' LEU . 49.3 tptt -142.07 157.22 45.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.981 -0.287 . . . . 2.52 111.31 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.8 141.66 40.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.39 112.067 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 59.5 tttp -48.67 131.48 17.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.884 -0.598 . . . . 2.35 111.872 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.38 -17.36 43.92 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.13 -0.557 . . . . 0.31 113.267 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.771 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.1 mt-10 -80.01 159.77 26.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.628 -0.879 . . . . 2.11 108.628 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.863 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.4 m -89.37 128.5 35.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.652 -0.819 . . . . 0.33 110.367 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.966 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.0 112.12 24.33 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.26 110.343 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CD1' HG21 ' A' ' 94' ' ' THR . 77.4 t80 -79.15 117.89 20.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 1.43 111.616 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.831 HD22 HG21 ' A' ' 133' ' ' ILE . 39.9 mt -105.97 104.73 50.71 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.8 109.249 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.37 127.19 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.448 2.099 . . . . 0.42 113.497 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -140.31 130.18 24.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.359 -0.837 . . . . 1.03 109.616 179.02 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 8.9 mptt -140.03 140.34 36.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.053 -0.521 . . . . 1.66 110.003 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CG ' HG11 ' A' ' 122' ' ' VAL . 50.0 p90 -140.23 139.81 35.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.26 111.704 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 p -88.91 147.42 24.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.612 -0.722 . . . . 1.33 111.441 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 124' ' ' LYS . 24.5 tp -99.48 114.38 27.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 2.12 110.903 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -81.87 145.46 53.75 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 110.028 -0.36 . . . . 1.75 110.028 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -49.62 -34.15 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.782 1.654 . . . . 1.61 110.536 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -75.64 -40.02 56.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.282 -0.872 . . . . 2.18 110.641 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.548 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.7 m-20 -69.51 73.58 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.134 0.493 . . . . 2.41 109.759 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -94.29 -4.84 48.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.754 . . . . 1.64 111.621 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.666 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.99 157.33 53.51 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.413 -0.899 . . . . 0.55 112.536 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.45 148.88 10.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.477 2.118 . . . . 0.85 111.858 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.985 HD22 ' HA ' ' A' ' 99' ' ' LYS . 5.6 mp -78.16 135.76 37.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 1.9 111.503 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 9.2 t70 -140.73 153.59 45.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 1.78 111.876 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 21.5 mt -142.49 139.93 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.007 -0.997 . . . . 0.75 109.667 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.621 ' HG2' HD11 ' A' ' 73' ' ' LEU . 98.0 mt-10 -140.23 111.71 7.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.026 0.375 . . . . 1.67 111.748 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.965 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -97.68 119.9 37.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.867 -0.333 . . . . 0.22 110.929 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 119' ' ' GLN . 89.2 mt -104.9 138.84 40.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.014 -0.736 . . . . 0.41 109.014 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.9 tt -129.97 129.98 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.321 0.489 . . . . 0.78 112.321 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.8 m -121.44 102.45 42.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 1.25 109.153 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.8 Cg_exo -81.46 116.19 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.645 2.23 . . . . 0.53 112.716 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -33.25 71.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.71 . . . . 0.41 110.886 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -85.29 12.89 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 1.82 112.148 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 93.9 m-20 -146.99 163.19 37.02 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.37 0.605 . . . . 1.94 111.873 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.06 -18.06 65.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.065 -0.97 . . . . 1.66 111.912 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.676 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 96.2 mttt -67.16 140.01 57.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.117 0.484 . . . . 1.74 111.827 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.0 127.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.852 0.834 . . . . 0.97 109.012 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.82 39.33 29.64 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.098 -1.41 . . . . 1.77 111.796 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -94.72 140.01 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 1.96 110.816 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 43.0 t -69.86 127.1 31.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.987 0.422 . . . . 0.77 110.276 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.925 HG13 HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -112.04 -51.38 5.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.925 -0.58 . . . . 1.15 112.124 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.866 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.92 130.13 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.593 -0.891 . . . . 0.29 108.593 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 74' ' ' TYR . 3.3 tt -140.1 157.03 46.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 1.3 111.271 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 79' ' ' ILE . 36.8 t80 -135.45 104.33 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.345 -0.388 . . . . 1.3 110.076 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 t -144.24 157.26 44.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.416 0.524 . . . . 0.89 112.416 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.22 12.57 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.214 -0.517 . . . . 0.57 113.075 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t0 72.12 3.27 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.497 0.184 . . . . 1.46 111.497 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 114.85 28.46 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.568 -0.53 . . . . 2.41 109.568 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.9 mm -79.81 129.81 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 107.313 -1.366 . . . . 1.66 107.313 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.717 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -115.55 119.2 35.38 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.095 -0.957 . . . . 1.25 110.197 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 10.0 p-10 -166.19 -51.74 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.695 -1.595 . . . . 1.2 106.695 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -80.04 -23.92 41.1 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.352 -1.295 . . . . 2.17 108.49 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -80.82 -27.05 36.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.057 -1.09 . . . . 5.05 108.057 177.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.528 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.6 m-85 -86.57 108.86 19.75 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-N 115.154 -0.93 . . . . 1.29 110.014 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 30.7 Cg_exo -61.47 -28.64 83.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.729 1.619 . . . . 0.79 112.065 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.797 ' O ' HD22 ' A' ' 87' ' ' LEU . 53.2 t0 -44.32 -36.34 2.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.347 0.594 . . . . 1.36 111.762 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.925 HD23 HG13 ' A' ' 71' ' ' ILE . 1.5 mm? -156.48 33.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.751 -1.113 . . . . 1.62 110.56 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 63.3 pttt -52.9 129.98 31.94 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.435 -0.506 . . . . 2.39 111.902 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.14 57.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.506 -0.854 . . . . 0.37 114.818 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.889 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -142.88 -46.6 0.31 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 115.009 1.485 . . . . 1.59 115.009 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.866 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.0 p -80.22 81.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.748 1.261 . . . . 0.2 108.235 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.483 ' C ' HG22 ' A' ' 105' ' ' ILE . 22.3 m80 -103.13 129.69 50.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.892 -1.958 . . . . 0.29 112.521 -175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.115 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.4 m-85 -73.17 122.79 22.44 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 120.002 -0.679 . . . . 1.23 109.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 38' ' ' TYR . 17.9 p -72.16 -9.93 59.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.148 -0.933 . . . . 0.46 110.274 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 1.4 m -89.13 122.05 32.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.658 -0.701 . . . . 1.2 110.5 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -91.34 4.45 52.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.218 0.532 . . . . 2.22 110.396 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -146.57 66.71 1.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.424 -0.807 . . . . 2.14 108.903 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 93' ' ' PHE . 7.9 mp -57.92 -35.04 70.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.254 -0.885 . . . . 1.49 111.434 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.985 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.1 pttt -60.05 -13.78 13.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.701 0.762 . . . . 2.04 111.801 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 t -82.99 0.04 46.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.386 -1.279 . . . . 1.4 110.99 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.86 -2.51 38.65 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.543 -0.836 . . . . 0.38 113.742 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.55 112.65 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.172 0.486 . . . . 1.44 110.976 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -109.83 10.53 24.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.388 0.514 . . . . 0.43 112.388 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.668 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 p -60.06 137.08 58.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.825 1.787 . . . . 1.04 115.825 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.115 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 114.247 -1.342 . . . . 0.31 110.698 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.719 ' OD1' HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -105.21 145.33 30.77 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.527 -0.546 . . . . 1.15 109.527 177.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.863 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.49 118.72 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.142 0.496 . . . . 0.27 111.351 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.19 143.7 30.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.297 -0.865 . . . . 0.29 110.757 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.0 m120 49.95 55.16 9.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.083 0.468 . . . . 1.52 111.508 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.9 mt -45.26 88.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.225 1.194 . . . . 1.02 114.225 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' CG ' ' A' ' 114' ' ' ASP . 14.7 pt20 -59.66 151.45 24.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 2.13 109.756 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.478 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.5 mt -60.12 -28.39 67.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 1.7 110.863 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.3 m -73.93 -5.95 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 1.32 111.424 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.527 ' HB3' HD23 ' A' ' 135' ' ' LEU . 87.9 m-20 -69.92 -23.63 63.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.616 -0.513 . . . . 1.58 109.616 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.87 133.47 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.116 -0.493 . . . . 0.42 110.091 178.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.65 158.71 7.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.034 -1.079 . . . . 0.24 113.386 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.9 m -59.35 133.89 56.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.569 0.581 . . . . 0.31 112.569 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.641 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 25.9 m-85 -118.4 132.83 56.24 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.035 -0.53 . . . . 1.24 109.692 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.5 mt-30 -120.01 119.98 34.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.627 -0.261 . . . . 1.16 111.666 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.574 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 42.7 t -100.04 107.3 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.214 -0.662 . . . . 1.03 109.214 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 8.9 mtpm? -114.19 109.31 18.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.418 -0.355 . . . . 1.76 111.492 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.765 HG11 ' CG ' ' A' ' 43' ' ' PHE . 53.2 t -91.85 108.36 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.652 -0.499 . . . . 1.18 109.652 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 64.7 tttm -93.63 120.37 33.82 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.246 -0.582 . . . . 1.62 112.206 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 4.6 mtpt -144.38 102.2 3.8 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.821 -0.436 . . . . 2.84 109.821 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.666 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.04 130.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 113.44 0.904 . . . . 0.44 113.44 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 88.5 Cg_endo -101.64 42.16 3.3 Favored 'Cis proline' 0 C--N 1.354 0.866 0 C-N-CA 125.094 -0.794 . . . . 0.56 111.811 -1.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.95 103.59 0.46 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 122.006 0.781 . . . . 0.48 112.723 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.584 HG12 ' HG3' ' A' ' 123' ' ' LYS . 23.0 m -82.93 155.73 3.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.086 -1.057 . . . . 1.22 110.433 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.56 0.219 . . . . 0.57 111.397 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 47.9 t30 -146.59 134.59 21.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.121 0.415 . . . . 2.03 112.121 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.684 ' CE ' HD11 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -142.22 158.87 43.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.55 -0.537 . . . . 2.95 109.55 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 43.5 mmtm -109.98 146.68 34.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.659 1.355 . . . . 2.26 114.659 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.831 HG21 HD22 ' A' ' 39' ' ' LEU . 98.9 mt -144.17 122.57 6.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 114.586 -1.188 . . . . 0.28 109.335 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.09 111.6 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.591 -0.443 . . . . 0.55 110.063 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 110' ' ' LEU . 51.6 tp -87.83 135.53 33.35 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.524 0.564 . . . . 1.52 112.524 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.549 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 63.0 t -129.99 130.03 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 0.32 109.491 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 20.4 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.363 . . . . 1.08 111.859 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 87.9 mt -83.81 167.86 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.045 -0.525 . . . . 0.52 109.609 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.381 0.61 . . . . 1.48 111.208 -178.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.897 0.38 . . . . 1.84 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 42' ' ' LYS . 1.9 pt -142.28 143.86 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.0 -0.546 . . . . 2.15 110.869 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 27.5 p -88.58 162.43 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.793 0.806 . . . . 1.12 112.325 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.12 82.78 0.22 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.264 -1.335 . . . . 0.65 112.712 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 63.3 Cg_endo -79.12 -86.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.775 2.984 . . . . 0.88 112.421 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 6.2 pm0 -78.0 122.02 24.99 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.711 -0.848 . . . . 2.06 108.711 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 132' ' ' LYS . 51.3 tp10 -144.22 159.99 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.715 1.006 . . . . 1.71 113.715 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.9 133.01 33.3 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.829 -1.078 . . . . 1.86 109.091 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 28' ' ' MET . 32.0 mm -130.05 140.04 49.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.853 -0.612 . . . . 0.39 111.358 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.1 pt-20 -136.85 127.3 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.455 -0.338 . . . . 1.19 110.687 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 18.3 mmtp -142.31 164.18 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.309 -0.405 . . . . 2.52 111.03 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.7 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.35 137.33 39.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.39 111.269 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 112' ' ' LEU . 21.0 ttpt -45.79 130.34 9.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 2.35 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 92.23 -18.02 55.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.005 -0.617 . . . . 0.31 112.746 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.7 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 98.9 mt-10 -79.99 156.0 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.704 -0.85 . . . . 2.11 108.704 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 62.6 m -87.98 127.83 35.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.666 -0.814 . . . . 0.33 110.67 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.942 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.9 115.1 28.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.26 110.787 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.702 ' CE2' HG21 ' A' ' 94' ' ' THR . 25.1 t80 -79.37 120.06 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.036 -0.529 . . . . 1.43 111.491 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 105' ' ' ILE . 18.3 mt -109.48 104.78 56.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.093 -0.706 . . . . 0.8 109.093 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.492 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 88.3 Cg_endo -84.76 131.16 4.46 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.818 2.345 . . . . 0.42 115.082 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.415 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 62.6 m -141.34 104.01 4.52 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.623 -0.717 . . . . 1.03 110.251 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 4.4 mptp? -102.96 140.04 37.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 1.66 110.662 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.585 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 50.4 p90 -140.55 146.68 38.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 1.26 110.826 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 82.4 p -80.02 167.1 20.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.86 -0.609 . . . . 1.33 111.65 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.96 142.88 36.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 2.12 111.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 82.0 p -160.02 159.69 27.01 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.474 -0.784 . . . . 1.75 110.003 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 16.4 Cg_endo -57.77 -16.65 26.12 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.197 1.931 . . . . 1.61 112.772 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.0 tt0 -72.21 -41.54 66.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.654 0.264 . . . . 2.18 110.303 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.79 80.4 0.87 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.815 -0.809 . . . . 2.41 108.815 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.61 -11.24 49.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.238 -0.892 . . . . 1.64 111.686 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -78.3 156.82 43.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.217 -0.992 . . . . 0.55 111.916 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.84 148.81 81.97 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.226 1.951 . . . . 0.85 111.435 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 99' ' ' LYS . 92.7 mt -77.5 131.7 38.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.806 0.336 . . . . 1.9 110.288 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -133.83 152.34 51.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.245 0.545 . . . . 1.78 111.093 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.2 mt -143.57 107.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.923 -1.035 . . . . 0.75 109.711 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.745 ' HG2' HD11 ' A' ' 73' ' ' LEU . 97.6 mt-10 -110.25 115.01 28.93 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.191 0.441 . . . . 1.67 112.191 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.828 ' CE2' HD11 ' A' ' 105' ' ' ILE . 76.9 m95 -99.17 120.89 40.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.22 110.612 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 87.7 mt -105.21 140.77 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.41 109.45 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.3 tt -130.0 130.02 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.274 0.559 . . . . 0.78 112.165 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.1 p -119.17 103.06 48.04 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.585 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 88.3 Cg_endo -79.07 114.65 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.51 2.14 . . . . 0.53 113.208 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.03 87.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.41 111.006 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.99 -40.03 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.62 . . . . 1.82 111.437 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.585 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 27.8 m120 -83.85 160.87 21.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 1.94 111.661 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.0 -22.0 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.349 -0.841 . . . . 1.66 112.313 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.575 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -72.64 156.73 38.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.765 0.317 . . . . 1.74 111.789 -178.282 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.35 128.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.906 0.86 . . . . 0.97 109.954 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 39.98 19.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.979 -1.464 . . . . 1.77 112.47 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -88.86 146.84 24.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.666 -0.243 . . . . 1.96 110.578 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.564 HG11 ' OH ' ' A' ' 84' ' ' TYR . 17.2 t -68.87 124.3 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.676 -0.49 . . . . 0.77 109.676 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -112.04 -52.14 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.055 0.761 . . . . 1.15 113.055 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.0 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.06 124.64 26.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.537 -0.912 . . . . 0.29 108.537 179.07 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.745 HD11 ' HG2' ' A' ' 56' ' ' GLU . 3.8 tt -132.24 156.48 46.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 1.3 110.586 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.875 ' CD2' HD22 ' A' ' 98' ' ' LEU . 15.6 t80 -135.14 104.98 6.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.249 -0.432 . . . . 1.3 109.94 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 7.7 t -142.11 158.84 43.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.822 0.344 . . . . 0.89 111.802 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.4 28.7 36.57 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.843 -0.694 . . . . 0.57 112.217 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.6 t0 72.2 3.28 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.24 . . . . 1.46 110.871 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 20.9 mmtp -100.03 112.29 24.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.269 -0.641 . . . . 2.41 109.269 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.84 116.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.171 -1.048 . . . . 1.66 108.171 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.744 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.1 m-85 -99.43 130.55 45.7 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.816 -1.538 . . . . 1.25 110.659 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.864 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.9 p-10 -165.9 -53.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.743 -1.206 . . . . 1.2 107.743 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -79.92 -20.09 46.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.291 -0.868 . . . . 2.17 109.171 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.2 t80 -80.82 -27.0 36.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.352 -0.981 . . . . 5.05 108.352 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.7 m-85 -86.1 113.3 51.2 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.945 -1.025 . . . . 1.29 110.777 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.4 -41.37 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.36 1.373 . . . . 0.79 109.951 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' O ' HG12 ' A' ' 71' ' ' ILE . 46.7 m-20 -67.29 105.16 1.67 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.574 -0.739 . . . . 1.36 110.668 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.886 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.0 mt 67.35 23.41 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.735 1.013 . . . . 1.62 113.735 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.864 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttm -56.08 129.26 39.22 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.517 -0.739 . . . . 2.39 111.08 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.65 15.56 54.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.352 -0.928 . . . . 0.37 114.216 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.886 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.4 ptp180 -144.25 -48.93 0.27 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 114.645 1.35 . . . . 1.59 114.645 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.0 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -79.89 81.9 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 123.157 1.456 . . . . 0.2 107.604 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.491 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.9 m-70 -103.21 129.45 50.14 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.151 -2.295 . . . . 0.29 112.399 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 84.7 m-85 -70.81 125.04 25.73 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.907 -0.717 . . . . 1.23 109.788 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.702 HG21 ' CE2' ' A' ' 38' ' ' TYR . 14.3 p -77.06 36.94 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.923 -1.035 . . . . 0.46 112.931 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.0 m -147.75 136.3 21.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 1.2 111.257 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.85 0.77 57.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.663 . . . . 2.22 110.632 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -146.69 67.81 1.17 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.448 -0.575 . . . . 2.14 109.448 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.875 HD22 ' CD2' ' A' ' 74' ' ' TYR . 7.9 mp -57.15 -27.73 62.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.302 -0.863 . . . . 1.49 111.044 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.73 ' HG2' HD12 ' A' ' 53' ' ' LEU . 37.0 mtmm -64.29 -2.93 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 2.04 112.062 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 0.01 56.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.524 -0.762 . . . . 1.4 110.964 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.585 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 109.93 -7.14 31.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.38 113.234 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.35 119.4 35.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.968 0.413 . . . . 1.44 110.813 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.57 6.48 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.891 -0.595 . . . . 0.43 111.571 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -59.95 140.08 56.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 116.203 1.927 . . . . 1.04 116.203 -177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -129.13 131.94 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.147 -1.388 . . . . 0.31 110.788 177.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -104.08 142.84 33.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.054 -1.091 . . . . 1.15 108.054 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.51 120.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.024 0.44 . . . . 0.27 111.439 -178.067 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.2 p -84.29 143.86 29.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.444 -0.798 . . . . 0.29 110.851 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 31.0 m120 49.97 55.13 9.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.072 -0.513 . . . . 1.52 111.916 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.942 HD11 ' HB2' ' A' ' 37' ' ' ALA . 27.9 mt -44.19 93.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.456 0.91 . . . . 1.02 113.456 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 56.2 tt0 -59.64 144.47 47.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.7 -0.682 . . . . 2.13 110.136 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 63.9 tp -59.97 -40.07 87.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.193 0.52 . . . . 1.7 110.792 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -73.24 -5.56 40.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.739 -0.664 . . . . 1.32 111.517 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.489 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.96 -19.02 63.38 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.082 -0.34 . . . . 1.58 110.082 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 139.63 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 116.145 -0.479 . . . . 0.42 110.206 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 141.04 159.73 8.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.958 -1.115 . . . . 0.24 113.414 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 63.7 m -59.44 130.69 48.12 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.838 0.681 . . . . 0.31 112.838 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 87' ' ' LEU . 13.3 m-85 -114.27 129.64 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.174 -0.676 . . . . 1.24 109.174 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.61 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 21.1 tt0 -120.9 118.61 30.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 1.16 110.276 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 57' ' ' TRP . 9.7 t -101.01 118.29 36.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 1.03 110.57 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 97.4 mttt -123.66 112.32 17.25 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 116.475 -0.33 . . . . 1.76 111.774 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 61.9 t -92.05 106.46 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.235 -0.654 . . . . 1.18 109.235 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 25.7 ttpp -95.42 117.34 30.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.006 -0.678 . . . . 1.62 112.691 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 44' ' ' THR . 2.7 pttm -146.29 103.14 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.51 -0.476 . . . . 2.84 110.12 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.93 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.92 133.91 21.61 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.44 112.055 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.7 Cg_endo -100.03 46.52 2.37 Favored 'Cis proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.769 -0.929 . . . . 0.56 111.209 -0.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 103.62 0.29 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.257 -0.973 . . . . 0.48 113.674 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.47 153.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.712 -0.744 . . . . 1.22 109.322 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -139.51 144.92 38.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.279 -0.168 . . . . 0.57 111.269 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.538 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 40.0 p-10 -146.57 142.22 27.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.895 0.702 . . . . 2.03 112.895 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.642 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.01 157.78 44.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.784 -0.644 . . . . 2.95 110.39 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 41.2 tttt -101.84 139.98 36.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.216 0.821 . . . . 2.26 113.216 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.697 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 70.9 mt -142.23 119.86 7.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.883 -0.599 . . . . 0.28 109.953 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.443 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 14.8 m170 -100.22 118.37 36.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 0.55 110.381 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 57.0 tp -91.89 123.2 35.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.217 0.451 . . . . 1.52 112.217 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -120.03 119.99 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.32 109.424 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.95 121.71 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.08 111.794 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.2 mt -81.56 164.5 21.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.337 -0.616 . . . . 0.52 109.337 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.399 0.619 . . . . 1.48 111.261 -178.831 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.807 0.337 . . . . 1.84 110.944 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pt -144.29 151.34 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 116.169 -0.469 . . . . 2.15 111.413 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 82.6 p -92.39 161.73 14.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.544 0.687 . . . . 1.12 111.618 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.18 83.55 0.2 Allowed Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.566 -1.197 . . . . 0.65 112.091 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.717 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 65.4 Cg_endo -78.44 -91.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.586 2.857 . . . . 0.88 111.876 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.75 126.93 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.704 -0.85 . . . . 2.06 108.704 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' CG ' HD11 ' A' ' 29' ' ' ILE . 55.3 tt0 -143.69 153.66 42.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.842 1.052 . . . . 1.71 113.842 -176.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 58.5 mtp -135.45 116.45 14.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.62 -1.173 . . . . 1.86 108.511 176.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.065 HD13 HG23 ' A' ' 133' ' ' ILE . 3.7 mp -120.0 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.004 0.431 . . . . 0.39 111.809 -178.076 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 43.9 mt-10 -106.86 126.15 51.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 1.19 110.203 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 49.9 tptt -141.7 157.3 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 2.52 111.081 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -76.54 139.68 40.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.39 112.018 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.3 134.02 18.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.995 -0.548 . . . . 2.35 111.546 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.63 -20.39 27.83 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.874 -0.603 . . . . 0.31 112.578 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 79.5 mm-40 -79.94 160.0 26.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.359 -0.978 . . . . 2.11 108.359 178.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.838 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.1 m -89.46 129.97 35.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.658 -0.817 . . . . 0.33 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.851 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.92 115.8 30.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.26 110.217 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 94' ' ' THR . 32.6 t80 -79.25 116.42 19.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.027 -0.533 . . . . 1.43 111.875 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.793 HD12 ' CD1' ' A' ' 105' ' ' ILE . 15.5 mt -101.5 107.62 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.796 -0.816 . . . . 0.8 108.796 177.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.2 Cg_endo -82.67 122.76 3.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.13 . . . . 0.42 113.972 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.3 t -141.46 126.34 18.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.744 -0.662 . . . . 1.03 110.211 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.5 mttm -140.91 149.93 42.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.922 -0.581 . . . . 1.66 109.993 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.803 ' CG ' HG11 ' A' ' 122' ' ' VAL . 36.3 p90 -140.87 139.98 34.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 1.26 112.012 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.43 139.64 30.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.743 . . . . 1.33 110.373 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' CE ' ' A' ' 124' ' ' LYS . 90.0 mt -92.22 107.6 19.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 2.12 110.884 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ASP . 30.4 t -83.54 133.58 46.66 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.529 -0.545 . . . . 1.75 109.529 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -43.0 -33.2 3.11 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.691 1.594 . . . . 1.61 111.04 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 83.4 tt0 -76.72 -39.98 50.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.358 -0.837 . . . . 2.18 111.074 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 77.0 m-20 -68.5 79.19 0.27 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.41 -0.516 . . . . 2.41 109.659 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.99 -5.08 28.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 1.64 111.925 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.757 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.81 53.25 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.894 -0.669 . . . . 0.55 112.689 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.36 138.27 85.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.422 2.082 . . . . 0.85 112.384 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 43' ' ' PHE . 11.3 mt -78.17 120.08 22.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 1.9 111.596 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -133.51 103.05 5.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.548 0.69 . . . . 1.78 111.419 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.849 HG12 HG22 ' A' ' 122' ' ' VAL . 2.7 mp -91.34 122.35 42.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.162 179.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.908 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.3 mt-10 -119.08 114.08 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.449 0.537 . . . . 1.67 112.449 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.92 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.3 m95 -91.7 120.02 32.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 110.078 -0.341 . . . . 0.22 110.078 178.019 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.9 mt -108.69 143.85 37.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.392 . . . . 0.41 109.94 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.611 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 10.3 tt -130.01 132.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.293 0.479 . . . . 0.78 112.293 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.419 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 52.9 m -123.28 101.85 37.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.0 -0.741 . . . . 1.25 109.0 177.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.5 Cg_endo -79.86 116.92 3.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.714 2.276 . . . . 0.53 113.435 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.96 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.61 -0.723 . . . . 0.41 110.632 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -87.42 17.28 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 1.82 112.182 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 42.7 m-20 -148.99 160.02 43.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.41 0.624 . . . . 1.94 112.213 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.08 -18.64 64.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.052 -0.976 . . . . 1.66 111.92 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 61.1 mttp -66.82 150.82 48.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 1.74 111.017 -178.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.77 130.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-O 122.409 1.099 . . . . 0.97 110.299 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.516 ' OD2' HD13 ' A' ' 58' ' ' LEU . 4.9 t0 49.66 39.99 18.77 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 112.932 -1.94 . . . . 1.77 112.542 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -90.24 140.02 30.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 1.96 111.095 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 73' ' ' LEU . 89.7 t -69.65 130.04 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.923 0.392 . . . . 0.77 111.048 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.828 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.3 pp -124.25 -37.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.008 -0.542 . . . . 1.15 111.473 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.918 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 124.58 18.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.685 -0.857 . . . . 0.29 108.685 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.908 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -140.27 157.61 45.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.64 -0.709 . . . . 1.3 110.344 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.494 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 60.5 t80 -133.75 103.56 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.018 -0.364 . . . . 1.3 110.018 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 40.0 t -143.03 155.98 44.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.879 0.371 . . . . 0.89 111.925 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.84 30.15 28.43 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.135 -0.555 . . . . 0.57 112.899 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t0 71.72 1.6 3.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.481 0.182 . . . . 1.46 111.118 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.2 mmtt -99.95 107.03 18.9 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.787 -0.82 . . . . 2.41 108.787 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.77 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.76 118.32 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.601 1.191 . . . . 1.66 108.748 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.658 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 1.6 m-85 -100.28 124.9 46.3 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.527 -2.124 . . . . 1.25 111.563 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.833 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.8 p-10 -166.31 -53.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.01 -1.478 . . . . 1.2 107.01 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 55.2 t0 -81.34 -32.59 32.91 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.538 -1.21 . . . . 2.17 109.117 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -71.55 -31.82 67.42 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.332 -1.358 . . . . 5.05 107.332 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -82.49 109.97 19.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.338 -1.301 . . . . 1.29 109.256 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.96 -31.05 77.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.018 1.812 . . . . 0.79 113.031 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.805 ' O ' HD12 ' A' ' 87' ' ' LEU . 83.7 m-20 -49.99 -29.95 9.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 1.36 112.564 -178.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 86' ' ' ASP . 2.0 mp -152.2 27.66 0.59 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.474 -0.785 . . . . 1.62 111.198 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 24.8 pttm -55.63 138.15 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.156 0.503 . . . . 2.39 111.839 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.85 82.89 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.617 -0.801 . . . . 0.37 114.41 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.72 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.35 -52.42 0.36 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 115.07 1.507 . . . . 1.59 115.07 -178.545 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.918 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.3 81.33 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.939 1.352 . . . . 0.2 107.861 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 105' ' ' ILE . 13.8 m-70 -100.64 127.87 46.89 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 112.442 -2.163 . . . . 0.29 112.418 -176.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 78.8 m-85 -72.14 120.57 17.92 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.12 -0.696 . . . . 1.23 109.12 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.615 HG21 ' CE2' ' A' ' 38' ' ' TYR . 28.4 p -71.34 -9.93 58.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.336 -0.847 . . . . 0.46 109.957 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 p -86.94 122.62 31.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.6 -0.727 . . . . 1.2 109.55 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.95 4.66 49.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.144 0.497 . . . . 2.22 110.307 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -146.66 69.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.742 -0.836 . . . . 2.14 108.742 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -56.13 -39.59 72.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.085 -0.961 . . . . 1.49 111.363 -178.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HG3' ' OH ' ' A' ' 74' ' ' TYR . 31.7 mtmm -64.77 -3.07 2.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.118 0.485 . . . . 2.04 112.111 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.7 t -89.56 -0.01 57.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.626 -0.715 . . . . 1.4 111.029 179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.34 -16.16 35.23 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.722 -0.751 . . . . 0.38 113.698 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -97.3 108.82 21.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.203 0.502 . . . . 1.44 110.45 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.902 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.45 19.94 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.43 112.667 -179.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.2 m -61.53 140.0 58.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.857 1.429 . . . . 1.04 114.857 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.15 133.27 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.061 -0.972 . . . . 0.31 111.25 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.4 p-10 -106.66 145.5 31.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.829 -0.804 . . . . 1.15 108.829 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.5 122.09 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.27 111.63 -178.354 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -84.86 144.13 28.61 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.52 -0.764 . . . . 0.29 111.169 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 96.8 m-20 49.96 57.66 6.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 1.52 111.354 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 37' ' ' ALA . 35.6 mt -47.57 92.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.126 1.158 . . . . 1.02 114.126 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 35.0 mt-30 -58.64 142.4 49.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.069 -0.514 . . . . 2.13 110.413 176.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.04 -36.86 78.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.094 0.473 . . . . 1.7 110.185 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 t -74.31 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.646 . . . . 1.32 111.358 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.74 -15.55 62.69 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.009 -0.367 . . . . 1.58 110.009 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 141.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-N 116.238 -0.437 . . . . 0.42 110.096 178.781 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.79 155.2 6.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.879 -1.153 . . . . 0.24 113.759 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.5 m -59.18 129.99 44.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.483 0.549 . . . . 0.31 112.483 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.2 m-85 -111.2 130.2 55.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.291 -0.633 . . . . 1.24 109.291 177.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 62.4 tt0 -121.79 120.05 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.811 -0.356 . . . . 1.16 111.022 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 40.7 t -100.04 123.14 43.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.036 -0.529 . . . . 1.03 109.923 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 96.0 mttt -123.87 105.45 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.69 -0.404 . . . . 1.76 111.978 -179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 55' ' ' ILE . 25.0 t -89.44 111.98 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.476 -0.935 . . . . 1.18 108.476 177.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.709 ' HG3' HG12 ' A' ' 128' ' ' VAL . 77.7 tttt -99.45 120.06 39.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.411 0.893 . . . . 1.62 113.411 -177.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.712 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 14.0 tttp -145.72 102.5 3.68 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.725 -0.472 . . . . 2.84 109.725 176.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.757 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.97 131.36 30.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.548 -0.751 . . . . 0.44 112.934 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.492 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 46.2 Cg_endo -100.76 48.04 2.04 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.696 -0.96 . . . . 0.56 112.527 -0.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.85 102.64 0.31 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.139 -1.029 . . . . 0.48 112.982 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.709 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -88.82 132.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.207 -0.997 . . . . 1.22 109.629 177.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 22' ' ' ILE . . . -121.13 139.05 53.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.773 0.286 . . . . 0.57 111.773 -179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.481 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 52.4 p30 -146.33 146.14 30.58 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.252 0.464 . . . . 2.03 112.252 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.52 160.11 42.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 2.95 110.652 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 44.0 mttp -99.96 140.78 33.68 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.298 0.851 . . . . 2.26 113.298 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.065 HG23 HD13 ' A' ' 29' ' ' ILE . 3.5 mp -139.26 109.13 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.824 -1.08 . . . . 0.28 108.459 176.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.512 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 5.4 m-70 -97.28 118.02 32.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.353 -0.539 . . . . 0.55 110.748 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 110' ' ' LEU . 61.2 tp -92.41 123.3 35.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.883 -0.598 . . . . 1.52 111.669 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 45.3 t -119.93 120.9 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.723 -0.671 . . . . 0.32 109.328 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HB ' HD12 ' A' ' 115' ' ' ILE . 22.1 t -95.49 121.97 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.376 0.51 . . . . 1.08 112.376 -178.287 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 89.6 mt -84.05 163.77 19.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.717 -0.674 . . . . 0.52 109.224 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.401 0.62 . . . . 1.48 111.429 -178.912 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.081 0.467 . . . . 1.84 111.361 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.665 HD13 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -149.72 149.81 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.711 -0.677 . . . . 2.15 110.934 -179.577 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.15 155.13 17.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 1.12 112.21 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 38.79 82.69 0.22 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.358 -1.292 . . . . 0.65 112.652 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.777 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 53.6 Cg_endo -79.26 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.449 2.766 . . . . 0.88 112.738 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 85.9 tt0 -78.54 127.88 32.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.11 -0.7 . . . . 2.06 109.11 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.641 ' CG ' HD11 ' A' ' 29' ' ' ILE . 44.3 tp10 -143.74 157.02 44.68 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.785 1.032 . . . . 1.71 113.785 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 54.0 ttp -136.92 125.34 23.42 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.665 -1.152 . . . . 1.86 107.934 176.525 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 133' ' ' ILE . 4.1 mp -130.24 137.52 56.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.703 -0.681 . . . . 0.39 112.362 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 74.9 mt-10 -133.77 127.74 33.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.156 -0.475 . . . . 1.19 110.154 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 10.9 tptm -142.71 161.35 38.32 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.511 0.196 . . . . 2.52 110.754 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.07 140.59 41.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.39 112.228 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 112' ' ' LEU . 56.5 tttm -47.25 132.3 12.77 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.819 -0.628 . . . . 2.35 111.421 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.64 -20.11 36.91 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.049 -0.596 . . . . 0.31 112.686 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.3 mt-10 -80.04 157.67 26.68 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.767 -0.827 . . . . 2.11 108.767 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.5 m -87.6 126.97 35.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.985 -0.686 . . . . 0.33 110.733 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.56 115.17 28.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.831 0.348 . . . . 0.26 110.367 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.795 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 71.6 t80 -79.46 115.14 18.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 1.43 112.383 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD22 HG21 ' A' ' 133' ' ' ILE . 20.8 mt -100.22 109.83 57.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 108.593 -0.891 . . . . 0.8 108.593 177.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.46 125.35 2.91 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.353 2.035 . . . . 0.42 114.97 -177.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -141.51 122.26 14.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.819 -1.082 . . . . 1.03 108.495 177.591 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -141.32 115.89 9.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 1.66 111.513 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.592 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 25.6 p90 -94.48 139.97 30.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.006 -0.997 . . . . 1.26 111.025 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 141.92 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 1.33 111.042 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 98.6 mt -97.73 139.54 33.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.599 . . . . 2.12 111.527 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.447 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 86.2 p -159.89 145.99 11.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 1.75 109.942 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.62 -21.54 3.54 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.318 2.012 . . . . 1.61 113.084 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.75 -40.06 66.36 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.769 -0.196 . . . . 2.18 111.329 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 3.1 p30 -69.91 79.14 0.47 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.035 -0.666 . . . . 2.41 110.115 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.38 -10.06 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.225 -0.898 . . . . 1.64 111.837 -178.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.981 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.54 154.26 38.01 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.304 -0.951 . . . . 0.55 112.981 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.99 153.71 19.72 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.498 2.132 . . . . 0.85 111.696 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 47.7 tp -78.08 131.56 37.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 1.9 111.337 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -139.5 149.08 43.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.36 0.6 . . . . 1.78 110.722 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 30.5 mt -142.75 135.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.845 -1.07 . . . . 0.75 109.087 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.637 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 40.2 mt-10 -140.13 108.28 5.77 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.278 0.474 . . . . 1.67 112.278 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.974 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.5 m95 -94.51 126.34 39.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.382 -0.372 . . . . 0.22 110.918 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.8 mt -108.87 141.18 41.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.877 -0.786 . . . . 0.41 108.877 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 11.5 tt -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.52 0.563 . . . . 0.78 112.52 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 t -120.36 102.95 45.05 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.228 -0.896 . . . . 1.25 108.932 177.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.1 Cg_endo -78.24 115.63 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.527 2.151 . . . . 0.53 113.028 -178.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.86 -34.47 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.356 -0.838 . . . . 0.41 110.679 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.18 11.53 7.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.637 -0.71 . . . . 1.82 111.818 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 80.8 m-20 -148.93 160.37 43.33 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.279 0.561 . . . . 1.94 111.76 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.75 -18.47 64.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.284 -0.871 . . . . 1.66 112.694 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.68 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.3 mttt -65.79 144.05 57.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.253 -0.431 . . . . 1.74 111.216 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 m -156.39 129.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-O 121.929 0.871 . . . . 0.97 110.019 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.02 40.0 19.23 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.97 -1.468 . . . . 1.77 112.827 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 96.9 mt-30 -95.26 141.1 29.25 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.367 -0.235 . . . . 1.96 110.367 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 84' ' ' TYR . 16.5 t -65.86 120.0 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.175 0.512 . . . . 0.77 109.977 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.901 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.97 -51.97 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.4 -0.818 . . . . 1.15 112.045 -178.135 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.983 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.81 122.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.949 -1.13 . . . . 0.29 107.949 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 1.1 tt -130.98 154.88 47.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.778 -0.646 . . . . 1.3 110.895 -176.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.872 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 25.9 t80 -133.01 104.54 6.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.309 -0.256 . . . . 1.3 110.309 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.453 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 10.0 t -142.64 156.82 45.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.882 0.372 . . . . 0.89 111.98 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.57 29.7 40.55 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.924 -0.655 . . . . 0.57 112.43 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.56 3.14 4.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.583 0.23 . . . . 1.46 110.915 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 34.3 mttm -100.03 112.56 24.85 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.749 -0.463 . . . . 2.41 109.749 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.896 HD13 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -83.85 116.98 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.941 -1.133 . . . . 1.66 107.941 178.136 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.821 ' N ' HD12 ' A' ' 79' ' ' ILE . 4.5 m-85 -99.95 127.74 46.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.282 -1.781 . . . . 1.25 110.589 -178.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.0 p-10 -166.01 -52.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.426 -1.324 . . . . 1.2 107.426 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -80.2 -23.2 41.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.988 -1.006 . . . . 2.17 109.31 177.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -78.68 -28.0 45.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.588 -0.893 . . . . 5.05 108.588 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.549 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.0 m-85 -84.71 119.85 73.28 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 114.942 -1.027 . . . . 1.29 110.668 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.69 -41.75 44.98 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.261 1.307 . . . . 0.79 109.237 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 71' ' ' ILE . 39.1 m-20 -66.98 104.66 1.43 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.365 -0.834 . . . . 1.36 110.657 178.294 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.935 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.0 mp 68.8 27.35 5.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.101 1.148 . . . . 1.62 114.101 178.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.3 pttt -57.58 129.56 42.41 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.659 -0.65 . . . . 2.39 111.23 177.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.35 58.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.711 -0.757 . . . . 0.37 114.31 178.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.935 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.7 ptm180 -145.89 -48.26 0.21 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.379 1.252 . . . . 1.59 114.379 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.983 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -78.86 81.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.071 -1.455 . . . . 0.2 107.071 -178.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.535 ' C ' HG22 ' A' ' 105' ' ' ILE . 8.4 m-70 -102.8 128.62 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.262 -2.245 . . . . 0.29 112.789 -175.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.12 ' CD1' HG23 ' A' ' 105' ' ' ILE . 73.3 m-85 -70.26 123.76 22.46 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 120.152 -0.619 . . . . 1.23 109.61 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.795 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 15.9 p -73.52 33.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.426 -0.807 . . . . 0.46 111.839 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -149.63 128.81 12.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.2 110.097 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -92.64 7.56 42.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.986 -0.552 . . . . 2.22 110.377 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -146.35 65.72 1.19 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.573 -0.74 . . . . 2.14 109.116 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 74' ' ' TYR . 9.6 mp -56.7 -24.72 51.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.391 -0.822 . . . . 1.49 111.432 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.3 -3.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 2.04 111.996 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -88.73 0.03 56.86 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.48 -0.782 . . . . 1.4 110.94 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 104.31 -9.94 50.12 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.731 -0.747 . . . . 0.38 113.647 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.11 110.04 21.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.963 0.381 . . . . 1.44 111.198 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -107.77 9.48 28.99 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.508 0.559 . . . . 0.43 112.508 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.7 p -59.98 143.45 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.67 1.73 . . . . 1.04 115.67 -178.297 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.12 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.37 132.33 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 114.422 -1.263 . . . . 0.31 110.78 178.17 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p30 -106.41 146.37 30.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.631 -0.878 . . . . 1.15 108.631 177.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 120.02 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 120.826 0.346 . . . . 0.27 111.152 -178.257 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.92 143.7 30.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.824 -0.625 . . . . 0.29 110.928 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 26.4 m120 47.88 58.89 4.6 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.186 -0.461 . . . . 1.52 111.675 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 37' ' ' ALA . 18.8 mt -44.44 88.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.082 1.142 . . . . 1.02 114.082 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.459 ' O ' ' OD2' ' A' ' 114' ' ' ASP . 51.7 tt0 -58.53 147.26 32.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.548 -0.538 . . . . 2.13 109.548 176.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.403 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 58.9 tp -60.03 -37.03 78.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.43 . . . . 1.7 111.036 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.8 m -72.03 -9.66 58.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 1.32 112.39 -178.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 111' ' ' GLN . 3.0 p30 -70.47 -18.57 62.98 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.378 -0.529 . . . . 1.58 110.085 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 137.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 CA-C-N 115.988 -0.551 . . . . 0.42 110.265 179.112 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.99 160.51 8.32 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 119.844 -1.17 . . . . 0.24 113.853 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 134' ' ' HIS . 90.9 m -60.04 137.09 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.125 -0.537 . . . . 0.31 112.128 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 25.0 m-85 -120.04 132.15 55.36 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.445 -0.576 . . . . 1.24 109.445 177.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.725 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 49.0 tp60 -120.0 115.06 22.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.073 -0.251 . . . . 1.16 110.708 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 53.0 t -98.35 116.82 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 1.03 110.295 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 88.2 mttt -119.1 106.41 12.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 1.76 111.066 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.4 t -91.34 105.5 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.566 -0.531 . . . . 1.18 109.566 179.01 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.766 ' HG3' HG12 ' A' ' 128' ' ' VAL . 52.2 tttp -90.48 116.11 28.15 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.039 -0.665 . . . . 1.62 111.474 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' CB ' ' A' ' 49' ' ' ASP . 7.2 ttpm? -146.08 102.35 3.62 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.457 -0.571 . . . . 2.84 109.457 178.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.981 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.42 134.39 33.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.44 112.002 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.9 Cg_endo -100.13 48.69 1.92 Allowed 'Cis proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.698 -0.959 . . . . 0.56 111.297 -0.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 103.31 0.28 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.188 -1.006 . . . . 0.48 113.591 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.766 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.5 m -87.4 120.0 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.552 -0.824 . . . . 1.22 109.956 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.665 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -101.53 144.77 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.867 0.321 . . . . 0.57 111.867 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.452 ' C ' ' HG3' ' A' ' 131' ' ' LYS . 46.1 t30 -146.28 132.11 19.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 2.03 111.114 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.777 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 4.7 mttp -142.58 160.33 40.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.841 0.353 . . . . 2.95 111.773 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 64.5 mttt -101.77 141.67 34.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.441 0.904 . . . . 2.26 113.441 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 29' ' ' ILE . 3.1 mp -142.58 112.59 2.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.041 -0.982 . . . . 0.28 109.347 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 117' ' ' THR . 60.5 m170 -101.1 114.4 28.3 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.9 -0.5 . . . . 0.55 110.58 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 14.9 mt -96.2 135.58 37.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.698 0.629 . . . . 1.52 112.698 -179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 60.7 t -129.96 130.0 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.355 -0.838 . . . . 0.32 109.198 178.032 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.417 ' H ' HD11 ' A' ' 115' ' ' ILE . 18.9 t -100.46 121.32 51.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.872 0.368 . . . . 1.08 111.96 -179.042 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.7 mt -80.77 163.7 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.353 -0.61 . . . . 0.52 109.353 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.462 0.649 . . . . 1.48 111.681 -178.522 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HD13 ' A' ' 22' ' ' ILE . 43.2 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.781 0.324 . . . . 1.84 110.666 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.725 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 45.1 mm -140.02 138.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 2.15 110.884 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -86.89 144.91 26.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.12 110.292 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.484 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 45.28 82.61 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 115.179 -0.919 . . . . 0.65 110.39 -177.33 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 57.3 Cg_endo -77.94 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.649 2.899 . . . . 0.88 113.095 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.28 120.66 23.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.571 -0.529 . . . . 2.06 109.571 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 28' ' ' MET . 80.0 tt0 -143.82 160.02 41.51 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.604 0.964 . . . . 1.71 113.604 -177.29 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.556 ' C ' HD12 ' A' ' 29' ' ' ILE . 53.6 ttm -130.95 130.95 44.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.867 -1.06 . . . . 1.86 108.724 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 133' ' ' ILE . 3.5 mp -129.71 131.9 66.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.62 . . . . 0.39 112.122 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 89.7 mt-10 -122.63 127.18 49.04 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.281 -0.418 . . . . 1.19 110.737 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' A' ' 110' ' ' LEU . 47.0 mmtm -142.33 160.03 41.07 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.563 0.221 . . . . 2.52 110.998 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.79 137.0 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.39 112.157 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' CE ' ' HG ' ' A' ' 112' ' ' LEU . 60.0 tttt -46.22 129.97 10.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.895 -0.593 . . . . 2.35 110.964 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.74 -19.12 43.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.31 112.275 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 68.1 mm-40 -80.05 160.03 25.97 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.438 -0.949 . . . . 2.11 108.438 178.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.6 m -88.82 129.73 35.52 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.608 -0.837 . . . . 0.33 110.685 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.99 120.0 39.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.895 0.379 . . . . 0.26 110.449 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.955 ' HE1' HG21 ' A' ' 94' ' ' THR . 70.1 t80 -79.1 117.42 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 1.43 111.714 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 133' ' ' ILE . 20.4 mt -109.98 104.4 55.48 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.838 -0.801 . . . . 0.8 108.838 178.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.642 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 89.8 Cg_endo -86.92 128.92 2.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.352 2.035 . . . . 0.42 114.019 -178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 1.8 t -140.8 128.89 22.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.402 -0.817 . . . . 1.03 108.8 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.6 ttpt -140.86 118.62 11.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.241 0.543 . . . . 1.66 110.961 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CG ' HG11 ' A' ' 122' ' ' VAL . 43.9 p90 -101.87 137.63 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.667 -1.151 . . . . 1.26 112.399 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -89.26 140.01 29.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 1.33 109.785 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.812 HD22 ' HE2' ' A' ' 124' ' ' LYS . 90.7 mt -94.46 109.7 21.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.964 -0.294 . . . . 2.12 111.327 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.1 m -83.75 140.0 40.69 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 109.467 -0.568 . . . . 1.75 109.467 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.88 -34.08 21.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.801 1.668 . . . . 1.61 110.775 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.4 pt-20 -81.52 -33.97 31.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.441 -0.799 . . . . 2.18 111.798 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 78.9 m-20 -69.14 77.62 0.35 Allowed 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 120.271 -0.572 . . . . 2.41 110.143 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -101.82 -0.76 33.67 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.502 -0.772 . . . . 1.64 111.548 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.884 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -74.08 162.86 54.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.01 -0.614 . . . . 0.55 113.4 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.12 131.42 44.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.809 2.339 . . . . 0.85 112.168 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 122' ' ' VAL . 13.6 tp -78.12 126.38 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 1.9 111.337 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 6.1 m-20 -139.36 103.09 4.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.564 0.697 . . . . 1.78 111.646 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.9 mt -95.69 118.28 41.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.322 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.561 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.1 tt0 -115.64 120.32 39.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.453 0.538 . . . . 1.67 112.453 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.921 ' CD2' HD11 ' A' ' 105' ' ' ILE . 82.6 m95 -94.18 119.94 33.73 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.194 -0.299 . . . . 0.22 110.194 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.2 mt -108.13 142.45 38.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 0.41 110.185 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 114' ' ' ASP . 5.6 tt -130.0 132.33 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.78 112.043 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 48.7 m -117.71 102.12 51.77 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 108.471 -0.937 . . . . 1.25 108.471 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.639 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 85.4 Cg_endo -79.38 113.49 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.807 2.338 . . . . 0.53 113.031 -178.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.99 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.41 111.257 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.63 -40.08 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 1.82 111.556 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 33.9 m120 -84.58 160.04 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 1.94 111.957 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.81 -18.0 64.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.303 -0.862 . . . . 1.66 111.245 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 42.9 mttt -69.49 154.63 41.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.579 -0.737 . . . . 1.74 111.681 -178.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.72 128.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-O 121.637 0.732 . . . . 0.97 109.072 178.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 57.82 41.82 24.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.631 -1.168 . . . . 1.77 111.724 179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 96.1 mm-40 -87.07 135.09 33.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.797 0.332 . . . . 1.96 111.59 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 58' ' ' LEU . 57.7 t -71.82 132.02 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.77 110.261 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -129.84 -39.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.631 0.604 . . . . 1.15 112.631 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.954 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.43 123.6 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.415 0.626 . . . . 0.29 109.637 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 74' ' ' TYR . 7.3 tt -140.58 160.54 39.78 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.576 -0.738 . . . . 1.3 109.477 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.91 ' N ' HD23 ' A' ' 73' ' ' LEU . 23.9 t80 -134.32 109.15 8.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.218 0.532 . . . . 1.3 110.283 178.264 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.534 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 32.7 t -142.37 160.01 41.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.353 -0.839 . . . . 0.89 111.394 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.31 36.82 53.91 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.822 -0.704 . . . . 0.57 112.608 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 60.63 25.22 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.609 0.242 . . . . 1.46 111.378 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.3 mttp -128.15 111.14 13.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.191 -0.67 . . . . 2.41 109.191 177.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.627 ' CG2' HD22 ' A' ' 98' ' ' LEU . 1.4 pp -76.81 119.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.964 -1.124 . . . . 1.66 107.964 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.796 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -99.97 133.51 44.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.72 -1.127 . . . . 1.25 110.62 -178.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.3 p-10 -166.46 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.977 -1.49 . . . . 1.2 106.977 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HA ' ' CA ' ' A' ' 88' ' ' LYS . 50.9 t0 -80.03 -20.19 45.9 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 114.556 -1.202 . . . . 2.17 109.315 177.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.7 t80 -78.78 -29.81 45.21 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.25 -1.018 . . . . 5.05 108.25 178.019 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -84.34 112.61 42.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-N 114.436 -1.257 . . . . 1.29 110.872 179.717 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 85.7 Cg_exo -44.09 -42.98 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.501 1.467 . . . . 0.79 110.548 178.471 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.0 m-20 -68.31 104.92 1.98 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.685 -0.688 . . . . 1.36 110.739 178.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.894 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.4 mp 72.71 18.91 4.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.499 0.926 . . . . 1.62 113.499 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.445 -0.784 . . . . 2.39 110.763 178.022 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.67 60.46 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.273 -0.965 . . . . 0.37 113.917 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.894 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.5 ptp180 -141.27 -53.79 0.47 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 114.574 1.324 . . . . 1.59 114.574 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.954 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -78.73 80.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.11 -1.441 . . . . 0.2 107.11 -178.157 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.636 ' C ' HG22 ' A' ' 105' ' ' ILE . 7.3 m-70 -97.52 128.82 44.57 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.084 -2.326 . . . . 0.29 111.849 -176.148 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.5 m-85 -69.4 121.66 17.39 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.685 0.755 . . . . 1.23 110.684 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.955 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -73.71 34.85 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.471 -1.24 . . . . 0.46 111.732 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -148.81 136.39 20.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.076 0.465 . . . . 1.2 111.683 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.23 0.02 56.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.779 -0.646 . . . . 2.22 110.737 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -146.45 66.76 1.18 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.294 0.569 . . . . 2.14 109.517 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.714 HD21 ' CG ' ' A' ' 93' ' ' PHE . 7.2 mp -59.14 -31.64 69.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.403 -0.817 . . . . 1.49 111.939 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.52 -3.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.152 0.501 . . . . 2.04 112.319 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.8 m -88.5 -0.09 56.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.54 -0.754 . . . . 1.4 111.137 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 111.34 -19.88 23.95 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.748 -0.739 . . . . 0.38 112.915 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.0 m-20 -97.01 107.47 20.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.694 0.283 . . . . 1.44 110.633 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -116.75 24.23 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.891 0.33 . . . . 0.43 111.891 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.4 m -60.92 151.6 29.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 114.425 1.268 . . . . 1.04 114.425 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.035 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -137.03 140.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.682 -1.145 . . . . 0.31 111.545 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.0 p-10 -113.46 142.81 45.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.263 -1.014 . . . . 1.15 108.263 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 122.36 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 120.991 0.424 . . . . 0.27 111.868 -177.866 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.67 143.89 28.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.29 111.16 178.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.482 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 4.0 m-20 50.82 54.35 11.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.08 -0.509 . . . . 1.52 112.304 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 37' ' ' ALA . 34.5 mt -45.9 89.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.441 1.274 . . . . 1.02 114.441 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 60.1 tp60 -59.4 147.72 35.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.767 -0.651 . . . . 2.13 110.399 176.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' CE ' ' A' ' 33' ' ' LYS . 85.4 mt -59.98 -37.35 79.37 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.875 0.369 . . . . 1.7 111.144 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.3 p -72.57 -9.47 58.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.052 -0.522 . . . . 1.32 111.333 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.689 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.0 m-20 -70.0 -19.95 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.91 -0.404 . . . . 1.58 109.91 179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 142.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 115.922 -0.581 . . . . 0.42 110.455 178.999 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.45 155.93 6.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.824 -1.179 . . . . 0.24 113.828 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.6 m -59.33 128.59 37.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 18.6 m-85 -108.84 130.76 55.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 1.24 109.649 177.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.2 tt0 -125.76 119.29 27.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.034 -0.266 . . . . 1.16 110.765 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 20.0 t -99.96 115.82 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.03 110.126 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.82 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 52.3 mtpt -112.53 105.52 13.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.878 -0.329 . . . . 1.76 111.456 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.83 HG11 ' CG ' ' A' ' 43' ' ' PHE . 15.3 t -89.75 110.58 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.747 -0.834 . . . . 1.18 108.747 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 tttm -99.86 120.22 39.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.264 0.839 . . . . 1.62 113.264 -177.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.812 ' HE2' HD22 ' A' ' 45' ' ' LEU . 35.5 tttp -145.09 102.15 3.71 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.388 -0.597 . . . . 2.84 109.388 177.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.884 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.36 133.65 43.01 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.331 -0.85 . . . . 0.44 113.013 -179.106 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 55.0 Cg_endo -98.82 47.68 2.11 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.383 -1.09 . . . . 0.56 112.264 -0.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.16 103.13 0.28 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.2 -1.0 . . . . 0.48 113.142 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 150.2 3.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.36 -0.92 . . . . 1.22 109.587 177.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -142.98 151.54 40.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.975 -0.29 . . . . 0.57 111.683 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 42.5 p-10 -146.41 153.14 40.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.411 -0.359 . . . . 2.03 111.777 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.674 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.35 155.45 43.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.471 -0.331 . . . . 2.95 110.465 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 12.4 tttt -99.99 141.09 33.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.866 1.062 . . . . 2.26 113.866 -177.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.035 HG23 HD13 ' A' ' 29' ' ' ILE . 68.0 mt -143.81 112.03 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.28 109.397 177.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.438 ' CD2' HG23 ' A' ' 117' ' ' THR . 8.3 m170 -97.06 114.38 26.02 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.55 110.284 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.642 HD21 HD22 ' A' ' 110' ' ' LEU . 52.3 tp -93.02 122.53 35.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.477 0.547 . . . . 1.52 112.477 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.1 t -119.99 121.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.762 -0.829 . . . . 0.32 108.762 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 33' ' ' LYS . 11.7 t -98.52 127.03 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 112.656 0.613 . . . . 1.08 112.656 -177.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 81.3 mt -84.51 173.59 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.52 109.443 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.358 0.599 . . . . 1.48 112.04 -178.639 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.961 0.41 . . . . 1.84 111.026 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.67 141.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 2.15 110.798 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.2 p -86.58 157.22 19.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.41 0.624 . . . . 1.12 111.399 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.551 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.13 83.21 0.21 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.75 -1.113 . . . . 0.65 111.489 -178.206 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.6 Cg_endo -78.39 -79.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.277 2.651 . . . . 0.88 112.354 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -78.58 128.14 33.1 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.607 -0.886 . . . . 2.06 108.607 178.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.897 ' OE2' HD11 ' A' ' 29' ' ' ILE . 84.0 tt0 -144.03 159.45 42.57 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.038 1.125 . . . . 1.71 114.038 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.45 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 27.4 mtt -139.97 118.93 12.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.802 -1.09 . . . . 1.86 109.584 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.9 mm -120.02 130.93 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.509 -0.314 . . . . 0.39 111.428 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 19.5 pt-20 -128.56 127.8 43.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 1.19 110.775 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 42.4 mmtm -142.28 164.86 29.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.439 . . . . 2.52 110.953 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.832 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.52 135.24 39.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.286 -0.416 . . . . 0.39 111.283 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -45.84 130.71 9.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.346 -0.388 . . . . 2.35 111.24 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.77 -19.91 45.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 0.31 112.372 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.832 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -80.03 160.01 26.0 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.551 -0.907 . . . . 2.11 108.551 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 31.3 m -88.68 127.34 35.58 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.789 -0.764 . . . . 0.33 110.762 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.008 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 119.97 39.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 0.26 110.829 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 94' ' ' THR . 41.4 t80 -79.37 119.35 22.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 1.43 111.907 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 105' ' ' ILE . 13.1 mt -103.8 105.42 47.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.87 -0.789 . . . . 0.8 108.87 177.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 90.7 Cg_endo -84.6 122.66 2.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.449 2.099 . . . . 0.42 114.589 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.73 127.26 20.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.355 -0.979 . . . . 1.03 108.355 177.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.8 ttpt -140.69 116.56 10.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.393 0.616 . . . . 1.66 110.697 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.754 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 33.2 p90 -93.62 141.43 28.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 1.26 111.885 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 m -80.94 150.48 28.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 1.33 110.774 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.79 141.62 39.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.841 -0.618 . . . . 2.12 111.313 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 m -156.25 153.59 25.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 1.75 110.162 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.4 -20.69 26.82 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.431 2.087 . . . . 1.61 112.467 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.715 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 mt-10 -75.76 -41.42 53.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 111.942 0.349 . . . . 2.18 111.942 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -69.2 74.64 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.836 -0.745 . . . . 2.41 110.244 -179.43 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' GLU . 93.0 mt-30 -90.42 -16.44 29.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.085 -0.961 . . . . 1.64 111.02 -179.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.05 155.8 53.25 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.133 -1.032 . . . . 0.55 112.096 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.23 151.13 9.75 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.125 1.883 . . . . 0.85 111.551 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.754 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -77.67 132.62 38.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.854 0.359 . . . . 1.9 110.946 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 36.1 t0 -140.26 150.5 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.392 0.615 . . . . 1.78 111.895 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.711 HD13 ' HB1' ' A' ' 103' ' ' ALA . 50.4 mt -142.23 137.78 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.682 -1.145 . . . . 0.75 109.619 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.734 ' HG2' HD21 ' A' ' 73' ' ' LEU . 37.0 mt-10 -140.22 111.86 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.79 0.328 . . . . 1.67 111.825 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.6 m95 -98.67 119.99 38.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.22 110.908 178.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.55 146.15 37.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.492 . . . . 0.41 109.67 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.787 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.3 tt -132.5 140.01 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.775 0.657 . . . . 0.78 112.775 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -122.37 102.98 39.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.628 -0.879 . . . . 1.25 108.628 177.149 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.7 Cg_exo -79.08 115.23 3.49 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.725 2.283 . . . . 0.53 113.22 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.32 69.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.41 110.243 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.68 10.22 7.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.614 -0.721 . . . . 1.82 111.491 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 32.7 m120 -145.77 156.01 43.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.061 0.458 . . . . 1.94 111.361 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.91 -22.87 64.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.652 -0.703 . . . . 1.66 111.716 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.707 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 5.6 mttt -73.79 151.23 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 1.74 110.71 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.3 m -152.41 136.29 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 122.502 1.144 . . . . 0.97 110.764 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 61.23 45.05 9.23 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.758 -2.019 . . . . 1.77 112.566 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.12 149.72 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.728 0.299 . . . . 1.96 110.538 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.734 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.9 p -68.26 139.99 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.77 110.09 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.86 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -136.51 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.538 -0.465 . . . . 1.15 111.552 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.946 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.19 133.14 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.009 0.433 . . . . 0.29 109.848 179.384 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HG2' ' A' ' 56' ' ' GLU . 1.6 mp -140.83 158.57 43.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.024 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.867 ' CD1' HD13 ' A' ' 79' ' ' ILE . 51.8 t80 -133.68 104.47 6.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.578 -0.527 . . . . 1.3 109.578 176.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.498 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.1 t -144.02 159.78 42.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.413 0.523 . . . . 0.89 112.413 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.57 30.02 6.05 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.988 -0.551 . . . . 0.57 113.182 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 t0 71.9 3.07 4.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 1.46 111.4 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 22.8 mtpp -100.03 118.05 35.6 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.1 -0.704 . . . . 2.41 109.1 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.867 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.3 mm -79.86 130.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.87 -1.159 . . . . 1.66 107.87 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.77 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.1 m-85 -118.56 125.79 50.59 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.096 -0.956 . . . . 1.25 110.289 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.0 p-10 -166.09 -55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.486 -1.672 . . . . 1.2 106.486 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 34.0 p-10 -82.18 -22.08 36.19 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.311 -1.313 . . . . 2.17 109.202 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.615 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -80.83 -26.52 36.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.736 -1.12 . . . . 5.05 108.556 178.496 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 1.8 m-85 -85.25 118.3 70.51 Favored Pre-proline 0 CA--C 1.51 -0.58 0 CA-C-N 115.374 -0.83 . . . . 1.29 109.868 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.6 Cg_endo -47.04 -43.6 24.54 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.421 1.414 . . . . 0.79 110.49 179.125 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.775 ' HB3' HG22 ' A' ' 71' ' ' ILE . 71.5 m-20 -69.59 106.25 2.96 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.627 -0.829 . . . . 1.36 111.512 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.7 mp 73.12 20.13 3.46 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.186 -0.916 . . . . 1.62 113.453 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 60.2 pttt -54.66 126.07 22.42 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.903 -0.719 . . . . 2.39 111.332 178.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 14.28 45.09 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.323 -0.941 . . . . 0.37 114.402 178.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.7 -47.2 0.24 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 114.656 1.354 . . . . 1.59 114.656 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.946 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.24 81.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.676 1.227 . . . . 0.2 108.109 -178.285 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.595 ' C ' HG22 ' A' ' 105' ' ' ILE . 21.8 m80 -102.73 130.2 49.6 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.081 -1.872 . . . . 0.29 112.313 -176.073 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.119 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.9 m-85 -72.82 121.22 19.57 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.177 -0.675 . . . . 1.23 109.177 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.573 HG22 ' OD1' ' A' ' 106' ' ' ASN . 38.1 p -70.15 -9.78 56.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.188 -0.914 . . . . 0.46 110.805 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 70.5 m -91.09 119.95 31.65 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.987 -0.551 . . . . 1.2 110.449 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.59 4.07 50.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.268 0.556 . . . . 2.22 110.142 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -145.99 67.6 1.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.262 -1.014 . . . . 2.14 108.262 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.466 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.8 mp -55.73 -33.41 64.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.975 -1.011 . . . . 1.49 111.72 -178.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -61.28 -3.59 0.95 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.152 0.501 . . . . 2.04 112.21 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.68 0.07 56.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.546 -0.752 . . . . 1.4 111.187 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.81 -12.31 45.9 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.618 -0.801 . . . . 0.38 113.673 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 96.1 m-20 -94.75 113.76 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.472 . . . . 1.44 111.418 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.36 12.17 24.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.637 . . . . 0.43 111.918 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 72.5 p -60.03 140.05 57.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.64 1.718 . . . . 1.04 115.64 -178.002 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.119 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.07 135.51 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-N 114.104 -1.407 . . . . 0.31 110.871 178.547 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.633 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.7 OUTLIER -105.03 148.21 27.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.039 -0.726 . . . . 1.15 109.039 177.832 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.816 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -101.42 118.89 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.005 0.431 . . . . 0.27 110.999 -179.561 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.1 p -83.26 144.44 29.74 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.537 -0.756 . . . . 0.29 110.53 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 50.58 57.52 6.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.037 0.446 . . . . 1.52 111.549 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.5 mt -46.92 90.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.95 1.092 . . . . 1.02 113.95 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 mt-30 -59.22 141.47 54.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.864 -0.607 . . . . 2.13 110.702 176.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.06 -37.02 78.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 1.7 110.215 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.58 -9.97 59.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.32 111.48 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.581 ' O ' HD11 ' A' ' 59' ' ' ILE . 92.4 m-20 -72.47 -17.07 61.79 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.938 -0.393 . . . . 1.58 109.938 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.46 141.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 116.198 -0.455 . . . . 0.42 110.346 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.11 158.97 7.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.218 -0.991 . . . . 0.24 113.352 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -59.55 131.04 49.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.685 0.624 . . . . 0.31 112.685 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 20.7 m-85 -111.26 135.38 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.294 -0.632 . . . . 1.24 109.294 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.3 tt0 -127.06 121.5 31.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.971 -0.291 . . . . 1.16 110.717 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 26.0 t -99.98 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.456 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 90.8 mttt -119.81 106.22 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 1.76 111.188 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 50.1 t -93.72 109.92 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.695 -0.483 . . . . 1.18 109.695 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 72.6 tttt -94.13 120.01 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.969 -0.693 . . . . 1.62 112.308 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 5.6 mtmp? -143.73 101.99 3.84 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.202 -0.666 . . . . 2.84 109.202 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.03 131.02 40.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 113.016 0.747 . . . . 0.44 113.016 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 21.2 Cg_endo -102.03 51.92 1.44 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.788 -0.922 . . . . 0.56 111.505 -0.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.49 103.44 0.29 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.183 -1.008 . . . . 0.48 113.993 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.2 m -89.52 139.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.193 -1.004 . . . . 1.22 109.396 177.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -136.73 149.34 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.193 -0.317 . . . . 0.57 111.81 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.6 p-10 -146.41 151.22 37.09 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.381 0.511 . . . . 2.03 112.381 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.625 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.65 155.27 42.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.915 -0.584 . . . . 2.95 110.37 178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.5 mttt -101.25 140.02 36.12 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.504 0.927 . . . . 2.26 113.504 -178.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.8 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.23 119.97 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.28 109.026 176.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 117' ' ' THR . 35.3 m170 -100.25 116.79 33.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.609 -0.436 . . . . 0.55 110.44 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 110' ' ' LEU . 58.8 tp -89.86 120.1 30.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.451 . . . . 1.52 111.657 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 57.7 t -118.14 119.95 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.32 109.418 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 115' ' ' ILE . 39.1 t -99.78 125.81 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.038 0.447 . . . . 1.08 112.174 -178.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 97.8 mt -83.92 170.0 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.734 -0.667 . . . . 0.52 109.545 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 1.48 111.55 -178.813 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.823 0.344 . . . . 1.84 111.066 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.605 HD12 ' HB1' ' A' ' 129' ' ' ALA . 15.6 tt -142.18 131.3 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 2.15 110.793 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.73 151.75 19.88 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.546 0.689 . . . . 1.12 111.65 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.59 82.96 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.673 -1.149 . . . . 0.65 111.491 -178.287 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.635 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.9 Cg_endo -78.6 -83.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.557 2.838 . . . . 0.88 112.989 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.4 tt0 -77.97 120.22 22.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.221 -0.659 . . . . 2.06 109.221 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.884 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.1 tt0 -144.02 161.03 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.472 0.916 . . . . 1.71 113.472 -176.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.732 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.8 ttm -131.91 139.42 48.74 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.255 -0.884 . . . . 1.86 109.807 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.884 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.5 mm -134.24 140.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.202 -0.454 . . . . 0.39 111.465 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.5 pt-20 -137.84 129.21 27.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.773 0.32 . . . . 1.19 111.086 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 56.8 mmtt -142.33 159.98 41.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.327 -0.397 . . . . 2.52 111.534 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.51 142.51 40.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.089 -0.505 . . . . 0.39 111.844 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.791 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 66.4 mttt -46.66 144.13 2.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.888 -0.597 . . . . 2.35 111.933 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.97 -22.81 2.8 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.328 -0.851 . . . . 0.31 113.334 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.99 160.03 26.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.435 -0.58 . . . . 2.11 109.435 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 60.5 m -87.09 129.1 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.182 -0.607 . . . . 0.33 110.712 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 115.34 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.044 0.45 . . . . 0.26 110.631 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.38 120.05 23.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.117 -0.492 . . . . 1.43 112.315 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 105' ' ' ILE . 23.8 mt -104.73 104.86 48.13 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.05 -0.722 . . . . 0.8 109.05 177.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.8 Cg_exo -80.23 130.78 8.36 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.535 2.157 . . . . 0.42 114.257 -177.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.9 t -141.17 130.96 24.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.125 -0.943 . . . . 1.03 108.766 177.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.4 mmtp -140.24 137.54 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.473 -0.33 . . . . 1.66 110.649 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 122' ' ' VAL . 51.3 p90 -140.92 139.97 34.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.488 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 1.33 110.567 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.503 ' O ' HD23 ' A' ' 45' ' ' LEU . 9.6 tt -97.67 108.04 20.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.421 -0.354 . . . . 2.12 110.871 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 t -84.3 136.87 39.96 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.879 -0.415 . . . . 1.75 109.879 179.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.55 -30.73 4.17 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.842 1.694 . . . . 1.61 111.194 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.94 -38.6 45.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.565 -0.743 . . . . 2.18 111.018 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 78.0 m-20 -70.13 73.78 0.47 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.518 -0.473 . . . . 2.41 109.741 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -98.55 0.05 44.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.677 -0.692 . . . . 1.64 111.912 -178.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.908 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.4 171.73 39.75 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.811 -0.709 . . . . 0.55 113.183 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.66 138.69 65.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.816 2.344 . . . . 0.85 112.365 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 2.0 mt -78.54 111.82 14.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 1.9 111.557 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 89.0 m-20 -127.57 102.75 6.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.613 0.721 . . . . 1.78 111.429 178.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.768 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.3 mt -94.01 123.55 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.61 -1.177 . . . . 0.75 109.96 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.682 ' HG2' HD11 ' A' ' 73' ' ' LEU . 95.0 mt-10 -120.01 111.87 18.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.831 0.678 . . . . 1.67 112.831 -178.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.9 m95 -94.33 119.96 33.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.772 -0.371 . . . . 0.22 110.088 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.512 HD12 ' OE1' ' A' ' 119' ' ' GLN . 86.1 mt -105.59 122.67 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.665 0.269 . . . . 0.41 110.329 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.634 ' HB ' HG21 ' A' ' 71' ' ' ILE . 7.3 tt -108.11 131.52 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.459 0.54 . . . . 0.78 112.459 -179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -126.1 102.19 27.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.909 -0.774 . . . . 1.25 108.909 177.191 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.5 Cg_exo -79.77 118.35 3.79 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.735 2.29 . . . . 0.53 112.389 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.06 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.41 111.024 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.0 -40.03 60.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.869 -0.605 . . . . 1.82 111.845 -179.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 27.5 m120 -83.33 159.95 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.329 0.585 . . . . 1.94 111.988 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -69.36 -16.76 63.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.121 -0.945 . . . . 1.66 111.199 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.67 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.7 mttm -69.15 149.14 48.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.629 -0.714 . . . . 1.74 111.651 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.73 127.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-O 121.942 0.877 . . . . 0.97 109.887 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.65 39.98 27.0 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.51 178.268 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.04 143.85 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.367 0.127 . . . . 1.96 110.719 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 26.5 t -67.9 119.79 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.77 110.004 179.466 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.23 -55.45 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.622 -0.717 . . . . 1.15 112.328 -178.203 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.825 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.8 124.47 38.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.145 -1.058 . . . . 0.29 108.145 179.119 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.6 tt -137.71 156.17 48.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.928 -0.578 . . . . 1.3 110.786 -176.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.837 ' CD1' HD13 ' A' ' 79' ' ' ILE . 25.2 t80 -132.81 103.71 6.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.198 -0.456 . . . . 1.3 109.879 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.438 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 29.7 t -143.99 156.61 44.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.244 0.461 . . . . 0.89 112.244 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.24 29.3 21.81 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.02 -0.609 . . . . 0.57 112.795 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.6 t0 73.47 2.85 4.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.494 0.188 . . . . 1.46 111.28 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 80.2 mttt -100.01 115.17 29.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 110.148 -0.316 . . . . 2.41 110.148 178.239 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.837 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.4 mm -80.34 128.33 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 106.927 -1.509 . . . . 1.66 106.927 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.6 m-85 -112.43 117.31 32.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.215 -0.902 . . . . 1.25 110.38 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.855 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.4 p-10 -166.14 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.845 -1.539 . . . . 1.2 106.845 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -76.63 -34.66 58.33 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.37 -1.286 . . . . 2.17 108.563 177.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.52 -29.98 61.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.765 -1.198 . . . . 5.05 107.765 177.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.542 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 m-85 -83.47 110.83 27.01 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 114.833 -1.076 . . . . 1.29 109.938 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.77 -28.14 59.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.063 1.842 . . . . 0.79 112.456 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 1.058 ' O ' HD12 ' A' ' 87' ' ' LEU . 61.1 m-20 -50.05 -32.77 16.31 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.356 -0.538 . . . . 1.36 111.843 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.6 mp -151.42 35.27 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.092 -0.958 . . . . 1.62 110.424 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.855 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.8 pttp -57.26 134.86 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.134 0.492 . . . . 2.39 112.011 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.84 78.96 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.513 -0.767 . . . . 0.37 113.947 178.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -146.78 -48.71 0.19 Allowed 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.394 1.257 . . . . 1.59 114.394 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.825 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.2 p -80.0 81.48 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.979 1.371 . . . . 0.2 107.721 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.43 ' C ' HG22 ' A' ' 105' ' ' ILE . 11.8 m-70 -101.81 127.68 48.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.355 -2.202 . . . . 0.29 112.366 -175.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.104 ' CD1' HG23 ' A' ' 105' ' ' ILE . 58.6 m-85 -71.86 124.02 23.94 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 120.219 -0.592 . . . . 1.23 109.406 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.669 HG22 ' OD1' ' A' ' 106' ' ' ASN . 30.6 p -73.9 33.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.587 -0.733 . . . . 0.46 112.517 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 m -148.91 136.25 20.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.968 0.413 . . . . 1.2 111.338 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.8 1.01 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 2.22 110.735 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -146.35 65.53 1.19 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.347 0.594 . . . . 2.14 109.583 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.914 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.5 mp -57.67 -30.04 65.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 1.49 111.114 -179.018 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -60.01 -10.96 4.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.619 0.723 . . . . 2.04 112.238 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -83.45 0.05 47.95 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.489 -1.232 . . . . 1.4 111.121 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 112.87 -9.38 25.47 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.627 -0.797 . . . . 0.38 113.433 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.59 116.58 29.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.931 0.366 . . . . 1.44 110.61 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.674 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.75 10.03 15.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.491 -0.322 . . . . 0.43 111.627 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 50.4 m -60.01 139.76 57.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 115.335 1.605 . . . . 1.04 115.335 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.104 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -134.71 127.87 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 114.419 -1.264 . . . . 0.31 110.45 178.375 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.669 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -103.65 150.46 23.98 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.506 -0.553 . . . . 1.15 109.506 178.119 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -101.14 119.98 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.101 0.477 . . . . 0.27 111.114 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -85.56 144.12 28.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.313 -0.858 . . . . 0.29 110.64 178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.15 59.99 3.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.629 0.603 . . . . 1.52 112.629 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.9 mt -46.0 178.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.13 0.49 . . . . 1.02 112.274 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.604 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.1 tt0 -177.55 161.44 1.71 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.817 -0.629 . . . . 2.13 110.25 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.791 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 59.0 tp -59.96 -40.03 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.842 0.353 . . . . 1.7 111.376 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -72.2 -12.33 61.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.127 -0.488 . . . . 1.32 111.683 -178.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.14 -21.31 61.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.791 -0.448 . . . . 1.58 109.791 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -44.94 145.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.877 -0.601 . . . . 0.42 111.06 179.066 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.68 149.91 5.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.768 -1.206 . . . . 0.24 114.229 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.841 HG23 ' CD2' ' A' ' 134' ' ' HIS . 93.8 m -59.81 136.8 58.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.802 -0.699 . . . . 0.31 111.813 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.937 ' CE1' HD12 ' A' ' 135' ' ' LEU . 47.2 m-85 -120.0 132.57 55.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.704 -0.48 . . . . 1.24 109.704 177.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.812 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.7 tt0 -120.29 116.4 25.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.589 -0.278 . . . . 1.16 110.631 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.519 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 53.3 t -100.02 115.57 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 1.03 110.545 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 29.7 mtpp -119.46 105.7 11.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.76 111.125 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.684 HG22 HG12 ' A' ' 55' ' ' ILE . 42.9 t -90.03 117.14 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.349 -0.611 . . . . 1.18 109.349 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 62.9 tttp -98.58 120.29 38.75 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.515 0.931 . . . . 1.62 113.515 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HD3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -143.17 101.04 3.74 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.105 -0.702 . . . . 2.84 109.105 176.44 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.908 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.68 132.56 65.0 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.722 -0.672 . . . . 0.44 112.71 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 51.6 Cg_endo -99.53 48.37 1.98 Allowed 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.68 -0.967 . . . . 0.56 112.432 -0.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.37 103.56 0.29 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.864 -0.684 . . . . 0.48 112.823 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.03 152.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.575 -0.812 . . . . 1.22 110.099 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -131.66 147.46 52.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.485 0.183 . . . . 0.57 111.198 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 49.5 t-20 -146.69 138.59 24.64 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.871 0.322 . . . . 2.03 111.871 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.42 151.7 38.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.49 -0.323 . . . . 2.95 110.824 178.865 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 3.4 tttt -97.98 139.94 33.07 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 113.188 0.81 . . . . 2.26 113.188 -177.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.799 HD11 ' HE2' ' A' ' 131' ' ' LYS . 90.1 mt -145.1 113.7 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.28 109.76 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.841 ' CD2' HG23 ' A' ' 117' ' ' THR . 53.4 m170 -102.95 120.0 39.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.55 111.273 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.937 HD12 ' CE1' ' A' ' 118' ' ' TYR . 13.8 mt -91.09 127.23 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 1.52 112.634 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.417 ' HB ' ' CB ' ' A' ' 30' ' ' GLU . 62.7 t -113.27 127.48 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.098 -0.955 . . . . 0.32 108.939 178.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.857 HG23 HG13 ' A' ' 115' ' ' ILE . 20.7 t -97.88 120.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.579 0.585 . . . . 1.08 112.579 -178.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.763 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 78.4 mt -83.57 160.85 21.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.899 -0.592 . . . . 0.52 109.765 178.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.384 0.612 . . . . 1.48 112.204 -178.5 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 1.84 111.092 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 129' ' ' ALA . 17.1 tt -139.98 139.37 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 2.15 110.324 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 7.9 p -92.09 153.03 19.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.49 0.662 . . . . 1.12 111.734 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.513 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.41 83.75 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 114.554 -1.203 . . . . 0.65 111.502 -178.358 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.616 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.4 Cg_endo -77.84 -80.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.334 2.689 . . . . 0.88 112.704 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 14.7 pt-20 -78.49 128.11 33.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 2.06 108.783 179.163 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.8 tp10 -144.14 160.01 41.66 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.247 1.203 . . . . 1.71 114.247 -176.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 11.2 mtm -140.26 118.27 11.87 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.464 -1.244 . . . . 1.86 109.126 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.422 HG12 HG23 ' A' ' 133' ' ' ILE . 36.7 mm -120.03 128.65 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.906 0.384 . . . . 0.39 111.561 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.4 mt-10 -120.01 125.35 48.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.19 109.916 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -141.9 160.02 41.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 2.52 111.428 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.77 134.37 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.143 -0.48 . . . . 0.39 111.742 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 84.8 tttt -46.92 134.38 10.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.934 -0.575 . . . . 2.35 111.273 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.72 -25.16 14.24 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.992 -0.623 . . . . 0.31 112.66 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -80.0 160.0 26.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.124 -1.065 . . . . 2.11 108.124 178.315 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 59.1 m -87.98 127.04 35.38 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.491 -0.884 . . . . 0.33 110.609 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.52 116.65 30.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.905 0.383 . . . . 0.26 110.169 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.71 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.11 118.54 21.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.873 -0.603 . . . . 1.43 112.259 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 133' ' ' ILE . 38.7 mt -102.9 107.94 56.64 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.142 -0.688 . . . . 0.8 109.142 178.253 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.32 120.63 3.3 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.078 . . . . 0.42 114.312 -178.106 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 2.6 t -141.01 123.93 16.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.777 -0.823 . . . . 1.03 108.777 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 17.1 mttp -141.09 153.77 45.61 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.283 -0.417 . . . . 1.66 110.758 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.494 ' CD1' HG11 ' A' ' 122' ' ' VAL . 33.1 p90 -139.74 145.71 38.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.631 . . . . 1.26 111.479 -178.332 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.07 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.456 -0.793 . . . . 1.33 111.631 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.53 147.46 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.904 -0.589 . . . . 2.12 110.943 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 19.5 p -157.35 139.98 10.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 1.75 110.29 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.27 -27.05 2.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.801 2.334 . . . . 1.61 112.804 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.647 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.08 -28.65 54.69 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.025 0.38 . . . . 2.18 112.025 -179.518 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 44.1 p-10 -67.74 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.453 0.644 . . . . 2.41 111.22 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 65.8 mt-30 -96.98 -6.81 34.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.678 . . . . 1.64 111.763 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.873 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.85 158.24 52.08 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.207 -0.997 . . . . 0.55 113.056 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.83 130.33 39.79 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.85 111.209 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HE2' ' A' ' 74' ' ' TYR . 7.3 tt -77.81 119.96 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.39 . . . . 1.9 110.981 -179.04 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -136.67 102.76 5.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.648 0.737 . . . . 1.78 111.83 179.727 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.8 mt -96.71 111.4 26.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.802 -1.09 . . . . 0.75 110.37 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.762 ' HG2' HD11 ' A' ' 73' ' ' LEU . 79.2 mt-10 -108.91 117.67 34.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.389 0.515 . . . . 1.67 112.389 -179.045 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.947 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.9 m95 -95.43 118.52 32.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.771 -0.455 . . . . 0.22 109.771 177.6 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' CD2' HG22 ' A' ' 70' ' ' VAL . 85.6 mt -109.96 140.02 44.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.599 -0.273 . . . . 0.41 110.294 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.6 tt -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.086 0.402 . . . . 0.78 112.086 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.423 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.8 m -114.63 102.53 54.88 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 108.515 -0.92 . . . . 1.25 108.515 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 81.4 Cg_endo -78.85 111.06 2.91 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.475 2.117 . . . . 0.53 113.151 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.99 72.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.994 -1.003 . . . . 0.41 111.009 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 7.4 p-10 -87.6 17.21 4.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.242 -0.435 . . . . 1.82 111.369 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 63' ' ' ASP . 15.6 m120 -148.34 162.98 38.44 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.408 0.623 . . . . 1.94 111.96 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.3 -19.84 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.946 . . . . 1.66 111.64 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 57.4 mttt -69.68 151.74 45.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.073 -0.512 . . . . 1.74 111.344 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.98 127.93 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-O 121.752 0.787 . . . . 0.97 109.483 178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.48 41.26 31.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.312 -1.313 . . . . 1.77 112.227 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.38 134.89 33.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.96 110.919 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.572 HG22 ' CD2' ' A' ' 58' ' ' LEU . 91.3 t -70.5 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.619 -0.264 . . . . 0.77 110.872 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.5 pp -127.11 -36.7 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.269 0.47 . . . . 1.15 112.269 -179.368 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 123.4 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.29 109.385 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.847 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.2 tt -140.36 155.61 46.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.592 -178.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.847 ' N ' HD23 ' A' ' 73' ' ' LEU . 62.7 t80 -132.45 104.29 6.63 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.658 0.266 . . . . 1.3 110.318 179.15 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.43 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 17.9 t -142.46 157.05 45.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.9 0.381 . . . . 0.89 111.875 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.39 29.45 38.5 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.002 -0.618 . . . . 0.57 112.684 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 71.9 2.43 4.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.601 0.239 . . . . 1.46 110.933 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.0 mttm -100.05 107.36 19.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.991 -0.744 . . . . 2.41 108.991 177.645 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.786 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.95 118.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 122.511 1.148 . . . . 1.66 108.562 178.674 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.68 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -100.19 125.7 46.37 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.767 -2.015 . . . . 1.25 111.663 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.838 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 20.8 p-10 -166.39 -54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.906 -1.516 . . . . 1.2 106.906 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 54.3 t0 -81.7 -30.77 32.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.52 -1.218 . . . . 2.17 108.848 177.23 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -72.48 -31.24 65.23 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 5.05 107.317 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.6 OUTLIER -82.6 111.04 25.71 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.32 -1.309 . . . . 1.29 109.399 178.165 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -34.2 92.91 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.292 1.994 . . . . 0.79 113.581 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 87' ' ' LEU . 51.8 m-20 -49.72 -29.84 8.26 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.129 0.789 . . . . 1.36 113.129 -177.423 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.833 HD22 ' HD2' ' A' ' 90' ' ' ARG . 17.9 mt -153.8 30.29 0.46 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.808 -0.633 . . . . 1.62 111.316 178.024 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 13.5 pttm -55.54 133.41 50.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.309 -0.556 . . . . 2.39 111.847 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.88 11.97 67.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.673 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.833 ' HD2' HD22 ' A' ' 87' ' ' LEU . 6.1 ptp180 -142.57 -51.02 0.37 Allowed 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 114.977 1.473 . . . . 1.59 114.977 -178.353 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.08 80.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-O 122.988 1.375 . . . . 0.2 107.667 -177.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.428 ' C ' HG22 ' A' ' 105' ' ' ILE . 13.4 m-70 -101.2 126.15 47.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 112.248 -2.251 . . . . 0.29 112.388 -175.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.134 ' CD1' HG23 ' A' ' 105' ' ' ILE . 83.3 m-85 -70.76 124.58 24.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 120.036 -0.666 . . . . 1.23 109.715 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 ' CD1' ' A' ' 38' ' ' TYR . 1.7 p -76.18 36.08 0.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.283 -0.871 . . . . 0.46 110.966 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 93' ' ' PHE . 2.9 m -148.93 127.1 12.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.96 0.409 . . . . 1.2 110.127 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.62 8.24 37.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.998 -0.546 . . . . 2.22 110.313 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.53 67.62 1.18 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.518 -0.764 . . . . 2.14 108.998 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.2 mp -57.96 -36.21 72.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.299 -0.864 . . . . 1.49 111.747 -178.591 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.97 2.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.561 0.578 . . . . 2.04 112.561 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 98' ' ' LEU . 15.7 m -90.53 -0.23 57.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.913 -0.585 . . . . 1.4 110.591 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.13 -12.61 37.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.049 -0.596 . . . . 0.38 113.393 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -98.07 110.83 23.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.111 0.456 . . . . 1.44 110.801 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.51 15.43 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.43 112.241 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 23.5 m -60.01 139.98 57.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.338 1.607 . . . . 1.04 115.338 -178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.134 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -132.97 130.1 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 114.844 -1.071 . . . . 0.31 111.078 178.356 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.689 ' HB2' HG22 ' A' ' 36' ' ' THR . 50.8 p30 -105.54 147.88 27.88 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.122 -0.696 . . . . 1.15 109.122 177.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.39 121.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.964 0.411 . . . . 0.27 111.409 -178.268 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -83.06 144.71 29.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.549 -0.751 . . . . 0.29 110.33 178.702 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.98 58.68 5.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.93 0.395 . . . . 1.52 111.139 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.1 mt -46.25 88.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.494 0.924 . . . . 1.02 113.494 -178.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 pt20 -59.51 147.42 36.87 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.896 -0.593 . . . . 2.13 110.441 177.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.94 -35.37 74.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.276 0.56 . . . . 1.7 110.428 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.419 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 24.3 p -72.21 -9.42 58.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.794 . . . . 1.32 111.887 -179.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 6.5 m-20 -70.54 -18.99 62.93 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.682 -0.407 . . . . 1.58 110.209 179.149 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 27.2 mt -44.6 134.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.767 -0.457 . . . . 0.42 109.767 178.233 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.89 156.54 6.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.073 -1.06 . . . . 0.24 113.522 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 85.9 m -59.39 134.67 57.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.797 0.666 . . . . 0.31 112.797 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 14.6 m-85 -113.49 137.88 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 1.24 109.754 177.649 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 32.1 tt0 -129.13 118.14 21.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.666 0.27 . . . . 1.16 110.762 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 13.0 t -104.13 118.79 37.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.4 . . . . 1.03 110.34 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.0 mtpm? -119.97 107.01 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.538 -0.301 . . . . 1.76 111.283 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 t -90.82 110.25 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.311 -0.625 . . . . 1.18 109.311 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.879 ' HG2' HG12 ' A' ' 128' ' ' VAL . 74.3 mttt -96.72 116.53 29.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.942 1.09 . . . . 1.62 113.942 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 49' ' ' ASP . 63.9 tttt -147.21 102.13 3.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 2.84 109.453 176.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.873 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.73 133.17 46.92 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 112.27 0.47 . . . . 0.44 112.27 -179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.6 Cg_endo -100.42 51.56 1.5 Allowed 'Cis proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.716 -0.952 . . . . 0.56 111.9 -0.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 102.83 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.107 -1.044 . . . . 0.48 113.34 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.879 HG12 ' HG2' ' A' ' 123' ' ' LYS . 6.0 m -90.01 119.97 38.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.27 -0.965 . . . . 1.22 110.029 178.202 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -99.68 140.01 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.598 0.222 . . . . 0.57 111.598 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -146.59 133.57 20.27 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.539 -0.301 . . . . 2.03 111.525 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.658 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.54 152.64 40.06 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.571 -0.286 . . . . 2.95 111.239 179.152 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 81.9 mttt -102.16 141.16 35.43 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.282 0.845 . . . . 2.26 113.282 -178.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.774 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 84.1 mt -139.98 120.02 13.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.28 109.417 176.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 15.9 m170 -100.01 114.26 27.43 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.468 -0.493 . . . . 0.55 110.274 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 55.6 tp -90.45 125.02 35.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 1.52 112.35 -178.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 40.7 t -120.88 123.84 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.32 109.634 178.357 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 115' ' ' ILE . 38.2 t -96.87 119.95 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.173 0.434 . . . . 1.08 112.173 -178.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.3 mt -84.46 170.64 13.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.808 -0.633 . . . . 0.52 109.342 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.352 0.596 . . . . 1.48 111.538 -178.817 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 29.7 t . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.071 0.462 . . . . 1.84 111.323 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.888 HG12 ' HB1' ' A' ' 129' ' ' ALA . 3.8 mt -130.01 129.97 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.671 -0.695 . . . . 2.15 110.407 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.738 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -89.09 140.04 29.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.581 . . . . 1.12 110.225 179.072 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 46.04 81.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.039 -0.982 . . . . 0.65 111.096 -177.189 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.0 Cg_endo -78.99 -14.15 13.76 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.854 3.036 . . . . 0.88 113.377 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.8 mt-10 -141.36 126.28 18.21 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.272 -0.64 . . . . 2.06 109.272 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 132' ' ' LYS . 2.1 tt0 -144.06 155.66 44.07 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.534 1.309 . . . . 1.71 114.534 -177.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.458 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 29.1 mtm -140.38 113.99 8.73 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.639 -1.164 . . . . 1.86 109.455 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.885 HD13 HG23 ' A' ' 133' ' ' ILE . 5.3 mp -119.97 120.69 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.646 0.609 . . . . 0.39 112.646 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.6 mt-10 -101.59 126.91 48.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.806 -0.634 . . . . 1.19 109.888 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HB3' HD13 ' A' ' 110' ' ' LEU . 16.7 tptt -142.02 156.0 45.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 121.021 -0.272 . . . . 2.52 111.1 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.826 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.93 143.69 39.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.855 0.36 . . . . 0.39 111.919 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' CD ' ' HG ' ' A' ' 112' ' ' LEU . 80.8 tttt -48.98 132.47 18.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.283 -0.417 . . . . 2.35 111.621 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 86.98 -15.78 51.21 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.155 -0.545 . . . . 0.31 112.923 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.826 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -79.98 158.76 26.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.95 -0.759 . . . . 2.11 108.95 178.719 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.793 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.7 m -88.77 128.42 35.63 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.058 -0.657 . . . . 0.33 111.033 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 118.88 37.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.26 110.648 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD1' HG21 ' A' ' 94' ' ' THR . 62.8 t80 -79.51 119.13 22.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.037 -0.529 . . . . 1.43 112.062 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.783 HD12 ' CD1' ' A' ' 105' ' ' ILE . 12.0 mt -109.96 104.79 56.28 Favored Pre-proline 0 C--N 1.333 -0.132 0 N-CA-C 108.315 -0.994 . . . . 0.8 108.315 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 96.9 Cg_endo -91.02 104.0 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.218 1.945 . . . . 0.42 115.987 -176.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -100.14 128.7 46.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.438 -1.319 . . . . 1.03 107.438 175.411 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 41.1 mmtm -140.58 107.26 5.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.183 0.516 . . . . 1.66 110.738 -178.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.077 ' HB3' HG11 ' A' ' 122' ' ' VAL . 47.4 p90 -99.3 140.09 33.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.005 -0.998 . . . . 1.26 111.735 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 21' ' ' SER . 0.3 OUTLIER -79.99 139.13 37.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 1.33 110.62 179.492 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 43' ' ' PHE . 97.7 mt -96.23 141.47 29.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 2.12 111.67 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.6 m -150.66 135.86 10.13 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.75 109.303 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -46.81 -25.66 3.96 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.471 2.114 . . . . 1.61 112.238 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.98 -39.99 60.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.373 -0.376 . . . . 2.18 111.199 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 73.7 m-20 -73.27 74.97 1.33 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.017 -0.673 . . . . 2.41 109.638 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.85 -5.31 41.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.423 -0.808 . . . . 1.64 112.148 -178.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.96 166.24 50.02 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.55 112.584 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.22 130.05 29.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.359 2.039 . . . . 0.85 111.756 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 124' ' ' LYS . 8.7 tp -77.98 117.29 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.446 -0.343 . . . . 1.9 110.904 -179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -129.37 103.17 6.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.484 0.659 . . . . 1.78 111.682 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.836 ' O ' HD12 ' A' ' 73' ' ' LEU . 2.6 mp -95.56 109.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.922 -1.035 . . . . 0.75 110.879 179.108 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.921 ' HG2' HD13 ' A' ' 73' ' ' LEU . 18.0 mt-10 -104.7 116.61 32.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.67 111.721 -179.592 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.914 ' CD2' HD11 ' A' ' 105' ' ' ILE . 70.5 m95 -91.28 116.66 29.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.587 -0.445 . . . . 0.22 109.954 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 70' ' ' VAL . 63.0 mt -105.75 138.76 41.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.643 -0.503 . . . . 0.41 109.643 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.628 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.0 tt -129.97 132.76 65.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.615 0.598 . . . . 0.78 112.615 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.08 102.33 40.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 1.25 109.571 177.638 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.71 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 84.6 Cg_endo -79.52 114.9 3.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.566 2.177 . . . . 0.53 113.043 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -29.03 68.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.41 110.373 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.72 10.24 9.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.713 -0.676 . . . . 1.82 111.742 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 67.3 t30 -152.24 160.05 43.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.203 0.525 . . . . 1.94 111.849 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -65.85 -19.01 65.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.386 -0.824 . . . . 1.66 111.941 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.0 ttmt -65.89 142.08 58.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 1.74 111.418 -178.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.79 128.0 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-O 122.015 0.912 . . . . 0.97 110.173 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.53 39.68 21.34 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 113.809 -1.541 . . . . 1.77 112.904 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 93.9 mm-40 -93.37 136.52 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 1.96 110.807 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 58' ' ' LEU . 99.2 t -69.38 130.15 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.77 110.615 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.836 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -126.97 -38.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.23 -0.441 . . . . 1.15 111.658 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.26 120.85 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.089 -0.708 . . . . 0.29 109.089 179.25 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.921 HD13 ' HG2' ' A' ' 56' ' ' GLU . 2.4 tp -140.52 161.12 38.48 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.699 -0.682 . . . . 1.3 109.543 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 79' ' ' ILE . 21.0 t80 -134.66 110.43 9.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.107 0.479 . . . . 1.3 110.307 178.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.533 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.9 t -142.37 160.02 41.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.125 -0.943 . . . . 0.89 111.639 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.65 37.8 42.76 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.805 -0.712 . . . . 0.57 112.137 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t0 59.92 30.04 19.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.075 0.464 . . . . 1.46 110.348 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 44.5 mtmt -129.27 110.82 12.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.704 -0.68 . . . . 2.41 110.344 178.717 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.3 117.49 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.581 -1.266 . . . . 1.66 107.581 177.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.759 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -99.98 132.17 45.5 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.693 -1.139 . . . . 1.25 110.641 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 14.2 p-10 -166.11 -56.34 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.418 -1.327 . . . . 1.2 107.418 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 74.0 m-20 -80.23 -27.41 38.75 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.796 -1.093 . . . . 2.17 109.238 177.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.89 -31.65 61.63 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.226 -1.027 . . . . 5.05 108.226 178.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -81.18 112.73 35.46 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 114.512 -1.222 . . . . 1.29 110.102 179.201 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.25 -42.71 16.98 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.653 1.569 . . . . 0.79 111.208 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.2 m-20 -67.73 104.12 1.57 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.028 -0.533 . . . . 1.36 111.095 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 13.6 mt 73.88 19.91 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.799 1.037 . . . . 1.62 113.799 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.5 pttt -57.19 130.08 44.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.572 -0.705 . . . . 2.39 110.555 177.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 94.21 11.35 57.51 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.165 -1.017 . . . . 0.37 114.186 178.773 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.943 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 12.4 ptp180 -141.96 -52.36 0.42 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 114.24 1.2 . . . . 1.59 114.24 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.24 81.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-O 122.991 1.377 . . . . 0.2 107.322 -178.06 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.434 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.4 m80 -99.0 128.81 45.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.193 -2.276 . . . . 0.29 112.184 -175.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.08 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.1 m-85 -70.53 123.25 21.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.201 0.524 . . . . 1.23 110.79 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -76.21 28.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.412 -0.813 . . . . 0.46 111.926 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.1 m -147.45 129.71 15.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.094 0.473 . . . . 1.2 111.566 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.64 5.73 46.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 2.22 110.361 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -145.77 66.11 1.22 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 2.14 108.959 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.587 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.8 mp -59.92 -37.43 79.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.097 -0.956 . . . . 1.49 112.101 -178.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -62.52 3.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.521 0.563 . . . . 2.04 112.521 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.3 m -90.03 -3.58 57.89 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.813 -0.63 . . . . 1.4 110.259 178.198 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 116.96 -20.51 11.56 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.142 -0.552 . . . . 0.38 113.005 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 3.6 m-20 -100.98 107.81 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.44 111.122 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.91 23.79 13.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.169 -0.468 . . . . 0.43 110.978 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -59.61 147.08 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.881 1.808 . . . . 1.04 115.881 -178.089 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.08 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -135.66 132.0 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 114.455 -1.248 . . . . 0.31 111.016 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -105.35 145.79 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.673 -0.862 . . . . 1.15 108.673 177.216 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.04 122.21 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.87 0.367 . . . . 0.27 111.185 -178.845 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -86.06 143.35 28.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.821 -0.627 . . . . 0.29 110.892 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.7 m-20 49.98 58.17 5.75 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.098 -0.501 . . . . 1.52 111.669 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.7 mt -46.53 89.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.557 0.947 . . . . 1.02 113.557 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.45 ' HG2' ' H ' ' A' ' 113' ' ' SER . 7.5 tt0 -59.97 145.68 45.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.881 -0.599 . . . . 2.13 109.898 177.413 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.445 ' HG ' ' CD ' ' A' ' 33' ' ' LYS . 83.8 mt -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.773 0.321 . . . . 1.7 111.618 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.45 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 79.6 p -73.36 -11.19 60.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.32 111.606 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.3 m-20 -71.7 -17.29 62.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 1.58 109.904 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.4 mt -43.5 141.43 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.42 110.594 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.86 164.71 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.39 -0.91 . . . . 0.24 113.34 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.0 m -59.55 129.99 44.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.625 0.602 . . . . 0.31 112.625 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.628 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 26.9 m-85 -113.89 121.81 45.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.625 -0.88 . . . . 1.24 108.625 177.058 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.0 tt0 -124.34 125.22 43.97 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.778 -0.369 . . . . 1.16 111.021 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.543 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 16.1 p -108.34 119.97 41.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 1.03 110.861 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.2 mttm -113.6 104.09 11.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.157 -0.474 . . . . 1.76 110.935 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 1.077 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.6 p -90.02 112.0 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.084 -0.71 . . . . 1.18 109.084 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.3 tttm -102.61 120.06 39.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.724 1.009 . . . . 1.62 113.724 -177.448 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 53' ' ' LEU . 6.6 ttpp -143.9 102.4 3.89 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.169 0.509 . . . . 2.84 109.756 176.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.796 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.0 131.98 30.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.44 113.051 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.4 Cg_endo -99.96 45.55 2.61 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.686 -0.964 . . . . 0.56 112.198 -0.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.29 103.57 0.32 Allowed Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.422 -0.894 . . . . 0.48 113.044 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.2 p -89.07 158.66 2.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.435 -0.882 . . . . 1.22 109.519 177.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.983 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . . . -144.74 135.64 24.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.376 -0.374 . . . . 0.57 111.554 -179.471 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 19.2 p30 -146.71 139.36 25.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.676 0.621 . . . . 2.03 112.676 -179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.741 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -145.68 161.61 39.46 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.359 -0.382 . . . . 2.95 111.228 178.832 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 68.8 mttm -100.47 143.31 30.79 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.715 1.006 . . . . 2.26 113.715 -178.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 29' ' ' ILE . 96.5 mt -141.32 113.05 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 114.961 -1.018 . . . . 0.28 108.305 176.656 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 7.7 m170 -98.8 117.75 33.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.435 -0.506 . . . . 0.55 110.885 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.956 HD21 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -93.7 118.5 31.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.52 111.946 -179.311 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 58.6 t -111.75 120.01 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.674 -0.862 . . . . 0.32 108.674 178.065 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 115' ' ' ILE . 24.4 t -101.48 122.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.498 0.555 . . . . 1.08 112.498 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.1 mt -84.07 169.27 15.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.971 -0.751 . . . . 0.52 108.971 178.36 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.416 0.627 . . . . 1.48 111.496 -178.884 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.018 0.437 . . . . 1.84 111.406 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.959 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 19.5 tt -133.65 140.02 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 2.15 110.45 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.757 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.1 p -88.68 154.47 20.27 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.505 0.669 . . . . 1.12 111.867 -179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.52 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 38.39 82.16 0.23 Allowed Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.65 111.953 -178.55 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 77.8 Cg_endo -79.43 -8.62 14.99 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 123.891 3.06 . . . . 0.88 113.032 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -141.3 122.46 14.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.144 -0.687 . . . . 2.06 109.144 178.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.776 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -144.24 156.63 44.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.981 1.104 . . . . 1.71 113.981 -176.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HD13 ' A' ' 29' ' ' ILE . 47.7 mtp -138.82 122.3 17.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.847 -1.07 . . . . 1.86 109.442 177.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.776 HD11 ' OE2' ' A' ' 27' ' ' GLU . 27.1 mm -126.48 134.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 0.39 111.513 -179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 20.4 pt-20 -130.72 127.3 38.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 1.19 110.652 179.622 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 13.3 tptt -142.43 163.48 32.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.39 -0.368 . . . . 2.52 110.945 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.492 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.12 140.29 41.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 0.39 111.704 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CD ' ' HG ' ' A' ' 112' ' ' LEU . 76.6 tttt -47.43 139.71 6.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.095 -0.502 . . . . 2.35 111.715 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 82.5 -20.17 9.55 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.793 -0.639 . . . . 0.31 113.032 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.591 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 80.7 mm-40 -80.07 159.98 25.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.513 -0.921 . . . . 2.11 108.513 178.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.9 m -90.68 127.34 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.785 -0.766 . . . . 0.33 111.222 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.01 119.88 38.96 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.794 0.331 . . . . 0.26 110.529 179.181 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 65.6 t80 -79.64 116.77 20.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.329 -0.396 . . . . 1.43 111.842 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.752 ' HB2' HD12 ' A' ' 105' ' ' ILE . 39.9 mt -100.91 106.15 42.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.999 -0.741 . . . . 0.8 108.999 178.061 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 97.0 Cg_endo -81.98 129.3 6.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.42 114.509 -177.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.6 t -140.91 130.28 23.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.21 -0.905 . . . . 1.03 109.195 177.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.757 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 57.2 tptt -140.02 141.44 36.31 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 1.66 109.514 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.955 ' CG ' HG11 ' A' ' 122' ' ' VAL . 53.1 p90 -139.94 144.82 37.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.242 0.544 . . . . 1.26 112.05 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -80.85 158.37 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.36 -0.836 . . . . 1.33 110.513 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.598 HD11 ' HE2' ' A' ' 124' ' ' LYS . 63.7 tp -140.0 99.98 3.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 2.12 111.422 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.9 t -82.1 142.3 47.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.576 -0.527 . . . . 1.75 109.576 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.34 -29.35 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.931 1.754 . . . . 1.61 111.821 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.89 -33.64 51.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.984 -0.553 . . . . 2.18 111.389 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.585 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.24 79.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.087 -0.645 . . . . 2.41 109.625 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -102.3 7.24 40.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 1.64 112.284 -178.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.959 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.94 164.22 51.77 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.55 112.809 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.57 134.72 59.76 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.3 2.0 . . . . 0.85 111.731 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.611 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 18.7 mt -78.19 104.73 8.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 1.9 111.375 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.1 m-20 -119.55 102.61 8.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.64 0.733 . . . . 1.78 110.905 178.69 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.817 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 8.9 mt -101.38 130.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.765 -1.107 . . . . 0.75 110.004 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.901 ' HG2' HD13 ' A' ' 73' ' ' LEU . 99.3 mt-10 -130.05 125.68 35.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.274 0.842 . . . . 1.67 113.274 -178.605 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.847 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.8 m95 -97.86 119.95 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.935 -0.575 . . . . 0.22 109.514 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.0 mt -105.54 139.98 39.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.372 -0.603 . . . . 0.41 109.372 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.9 tt -128.63 129.56 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.171 0.51 . . . . 0.78 111.46 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.499 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 p -119.91 103.03 46.14 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.954 -0.758 . . . . 1.25 108.954 178.211 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 95.2 Cg_endo -78.78 113.52 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.424 2.082 . . . . 0.53 112.892 -178.629 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.277 -0.874 . . . . 0.41 111.066 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.73 -40.02 63.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.928 -0.578 . . . . 1.82 111.329 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 97.8 m-20 -84.61 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.156 0.503 . . . . 1.94 111.628 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.44 -20.01 63.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.456 -0.793 . . . . 1.66 111.222 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 77.6 mttt -70.3 150.02 46.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 1.74 111.233 -178.425 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.89 128.46 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 121.925 0.869 . . . . 0.97 110.081 178.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.96 40.19 19.23 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 113.94 -1.482 . . . . 1.77 113.229 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.59 144.89 25.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.683 0.277 . . . . 1.96 111.217 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.939 HG13 HD21 ' A' ' 73' ' ' LEU . 31.0 t -66.01 136.56 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.599 -0.889 . . . . 0.77 108.599 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.72 -51.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.839 0.681 . . . . 1.15 112.839 -176.867 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.969 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.42 126.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.309 -0.626 . . . . 0.29 109.309 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 70' ' ' VAL . 3.1 mt -138.09 175.73 9.32 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.412 0.625 . . . . 1.3 111.534 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.718 ' CD1' HG23 ' A' ' 79' ' ' ILE . 45.7 t80 -140.3 104.39 4.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.203 -1.362 . . . . 1.3 107.427 175.647 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.526 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.9 t -141.54 157.11 45.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.998 -0.546 . . . . 0.89 111.067 -178.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.27 39.25 42.57 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.525 -0.845 . . . . 0.57 112.013 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.01 30.29 19.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 1.46 110.433 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 67.5 mttm -130.8 110.5 11.36 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.768 -0.651 . . . . 2.41 111.231 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -79.98 112.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.253 -1.388 . . . . 1.66 107.253 176.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -100.11 141.5 32.85 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.922 . . . . 1.25 111.198 -178.454 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.4 p-10 -166.83 -54.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.653 -1.24 . . . . 1.2 107.653 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 33.9 m-20 -80.01 -19.9 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.0 -1.0 . . . . 2.17 109.873 177.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.411 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.47 -28.72 46.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.746 -0.835 . . . . 5.05 108.746 178.466 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.682 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.4 m-85 -85.41 119.92 72.7 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 114.931 -1.031 . . . . 1.29 111.189 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 7.5 Cg_endo -48.55 -42.84 34.83 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.388 1.392 . . . . 0.79 109.933 178.142 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.775 ' O ' HG12 ' A' ' 71' ' ' ILE . 41.3 m-20 -66.31 106.05 1.6 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.747 -0.66 . . . . 1.36 110.702 178.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.7 mt 66.76 21.29 10.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.278 1.214 . . . . 1.62 114.278 178.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 55.6 pttt -56.23 129.95 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.457 -0.897 . . . . 2.39 110.666 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 93.61 14.26 53.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.263 -0.97 . . . . 0.37 113.875 178.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.2 ptp180 -145.16 -48.96 0.24 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.815 1.413 . . . . 1.59 114.815 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.969 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -81.1 81.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-O 123.274 1.511 . . . . 0.2 107.019 -178.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.536 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.2 m-70 -99.03 129.21 45.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.145 -2.298 . . . . 0.29 112.74 -175.399 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.11 ' CD1' HG23 ' A' ' 105' ' ' ILE . 86.1 m-85 -72.31 120.14 17.5 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 120.272 -0.571 . . . . 1.23 109.519 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.448 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 18.8 p -73.37 -7.13 50.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.367 -0.833 . . . . 0.46 110.482 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 17.7 m -86.35 118.77 26.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.939 -0.573 . . . . 1.2 110.895 -179.173 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -90.03 1.38 56.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.858 -0.61 . . . . 2.22 110.014 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -145.99 67.65 1.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.335 -0.987 . . . . 2.14 108.335 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.646 HD22 ' CE2' ' A' ' 74' ' ' TYR . 10.0 tt -58.27 -36.33 73.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.897 -1.047 . . . . 1.49 112.07 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -62.26 -1.08 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 2.04 112.254 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 98' ' ' LEU . 70.5 m -89.64 0.04 57.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 1.4 110.795 178.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 107.13 -15.11 39.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.968 -0.634 . . . . 0.38 113.069 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 42' ' ' LYS . 86.6 m-20 -92.26 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.873 0.337 . . . . 1.44 111.355 -179.754 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.568 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.09 19.85 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.43 111.632 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 5.2 p -60.1 141.2 56.21 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.678 1.733 . . . . 1.04 115.678 -178.399 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.11 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -133.3 130.84 57.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 114.416 -1.266 . . . . 0.31 111.292 178.713 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.2 p30 -102.98 144.98 30.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.396 -0.964 . . . . 1.15 108.396 177.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.87 120.76 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 120.911 0.386 . . . . 0.27 111.971 -177.995 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.704 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -84.44 143.13 29.61 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.516 -0.765 . . . . 0.29 110.832 178.671 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 26.2 m120 49.96 57.84 6.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.142 0.496 . . . . 1.52 111.668 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 37' ' ' ALA . 31.3 mt -46.63 90.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.009 1.114 . . . . 1.02 114.009 -179.051 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 38.9 mt-30 -59.3 141.56 54.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.922 -0.581 . . . . 2.13 110.924 176.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.605 HD23 ' CG1' ' A' ' 137' ' ' VAL . 84.4 mt -60.04 -35.37 74.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.113 0.483 . . . . 1.7 109.995 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.2 p -74.47 -11.63 60.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.698 -0.683 . . . . 1.32 111.435 -179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 99.1 m-20 -71.7 -18.45 62.16 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.033 -0.358 . . . . 1.58 110.033 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -43.36 139.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.202 -0.454 . . . . 0.42 110.22 179.09 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 164.06 9.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.111 -1.042 . . . . 0.24 113.39 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.6 m -59.29 130.22 45.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.012 0.745 . . . . 0.31 113.012 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 15.5 m-85 -114.87 128.87 56.55 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.774 -0.824 . . . . 1.24 108.774 176.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.5 tt0 -127.45 119.03 25.19 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.568 -0.453 . . . . 1.16 111.314 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 35.4 t -100.01 119.4 38.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 1.03 110.611 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.3 mttt -116.57 106.27 13.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.005 -0.278 . . . . 1.76 110.915 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CG ' ' A' ' 43' ' ' PHE . 43.8 t -90.53 112.46 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.363 -0.606 . . . . 1.18 109.363 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 85.9 tttt -99.57 121.88 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.041 0.756 . . . . 1.62 113.041 -178.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 53.9 tptt -145.16 101.39 3.61 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.448 -0.575 . . . . 2.84 109.448 177.111 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.959 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.76 135.83 64.85 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.44 112.335 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.585 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 53.0 Cg_endo -96.94 46.2 2.4 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.336 -1.11 . . . . 0.56 111.631 -0.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.28 103.64 0.29 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.434 -0.889 . . . . 0.48 113.399 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.64 153.1 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.342 -0.929 . . . . 1.22 109.897 178.142 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.959 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -138.01 140.4 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.575 0.213 . . . . 0.57 111.575 -179.254 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.472 ' C ' HD13 ' A' ' 22' ' ' ILE . 49.9 p30 -146.74 143.61 28.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.21 0.448 . . . . 2.03 112.21 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.06 159.98 42.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.19 -0.459 . . . . 2.95 110.864 179.056 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 72.1 mmtt -105.61 140.39 38.76 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 112.776 0.658 . . . . 2.26 112.776 -178.647 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.828 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 64.7 mt -139.97 119.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.28 109.17 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 35.2 m170 -102.72 117.35 34.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.55 110.616 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 40.6 tp -89.35 124.94 34.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 1.52 111.601 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 45.0 t -119.97 120.01 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.797 -0.638 . . . . 0.32 109.293 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 115' ' ' ILE . 40.2 t -99.3 122.69 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.316 0.487 . . . . 1.08 112.316 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.5 mt -84.86 164.95 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.727 -0.67 . . . . 0.52 109.717 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 1.48 111.514 -179.117 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.14 0.495 . . . . 1.84 111.457 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.709 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.8 pp -95.33 143.98 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.478 -0.783 . . . . 2.15 111.5 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -91.12 155.12 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.12 110.361 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.4 OUTLIER 39.44 83.41 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.612 0.72 . . . . 0.65 111.258 -178.069 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.769 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 61.2 Cg_endo -78.24 -8.11 16.27 Favored 'Trans proline' 0 C--N 1.327 -0.582 0 C-N-CA 123.753 2.969 . . . . 0.88 113.477 -178.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.16 121.31 13.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.06 108.893 178.113 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 132' ' ' LYS . 3.3 tt0 -144.48 160.48 41.03 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.86 1.43 . . . . 1.71 114.86 -176.165 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 39.6 mtm -139.98 121.38 15.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.582 -1.19 . . . . 1.86 109.632 177.716 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.02 126.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.756 0.312 . . . . 0.39 111.659 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 86.3 mt-10 -116.26 125.53 52.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.376 -0.375 . . . . 1.19 110.325 179.166 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.627 ' HB2' HD11 ' A' ' 110' ' ' LEU . 34.5 mmtm -142.07 156.8 45.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.784 0.326 . . . . 2.52 111.502 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.98 137.83 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.39 112.184 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 8.0 ttpt -45.17 142.16 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.854 -0.612 . . . . 2.35 111.707 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.12 -26.9 4.15 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.909 -0.587 . . . . 0.31 112.981 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 110' ' ' LEU . 100.0 mt-10 -80.03 160.02 25.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.889 -0.782 . . . . 2.11 108.889 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 91.6 m -85.49 130.11 34.66 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.018 -0.673 . . . . 0.33 110.737 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.2 117.25 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.126 0.488 . . . . 0.26 110.327 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.545 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.05 120.01 23.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.8 0.667 . . . . 1.43 112.8 -178.397 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' A' ' 105' ' ' ILE . 11.7 mt -107.08 105.67 56.23 Favored Pre-proline 0 CA--C 1.528 0.108 0 N-CA-C 108.533 -0.914 . . . . 0.8 108.533 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.49 ' HD2' HD13 ' A' ' 133' ' ' ILE . 87.6 Cg_endo -83.0 128.88 5.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.45 2.1 . . . . 0.42 115.066 -177.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 9.9 t -141.5 129.89 22.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.043 -0.98 . . . . 1.03 109.637 177.402 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 1.0 OUTLIER -140.31 150.74 44.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.966 -0.561 . . . . 1.66 109.995 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 122' ' ' VAL . 49.7 p90 -140.13 153.26 46.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 1.26 111.021 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 45' ' ' LEU . 20.0 m -79.74 162.81 24.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 1.33 111.047 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 124' ' ' LYS . 47.6 tp -139.83 130.32 25.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.12 110.871 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.01 158.01 25.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.445 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.81 -20.71 23.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 1.61 112.888 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.57 -45.37 59.53 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 110.014 -0.365 . . . . 2.18 110.014 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.556 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -71.88 83.34 0.93 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.595 -0.891 . . . . 2.41 108.595 178.588 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -95.9 -4.36 43.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.56 -0.745 . . . . 1.64 112.361 -177.533 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.848 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -83.15 152.84 30.05 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.169 -1.015 . . . . 0.55 112.779 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.16 139.01 88.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.313 2.009 . . . . 0.85 111.493 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 124' ' ' LYS . 6.5 mt -78.33 104.33 8.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.447 -0.342 . . . . 1.9 111.767 -179.35 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 96.6 m-20 -114.31 102.59 10.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.532 0.682 . . . . 1.78 110.06 178.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 47.1 mt -95.38 139.83 18.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.97 -1.014 . . . . 0.75 110.008 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.91 ' HA ' HD22 ' A' ' 73' ' ' LEU . 98.9 mt-10 -137.6 117.15 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 1.67 112.741 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.961 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.6 m95 -91.25 121.88 33.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.469 178.173 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -107.29 140.02 40.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.555 -0.906 . . . . 0.41 108.555 178.278 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -128.83 133.06 66.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.352 0.596 . . . . 0.78 112.473 -178.426 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -119.85 103.59 45.53 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.112 -0.949 . . . . 1.25 109.216 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.9 Cg_exo -79.33 122.52 5.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.503 2.135 . . . . 0.53 112.075 -179.109 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.98 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.41 110.872 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -74.97 -40.03 60.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 1.82 111.542 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 30.6 m120 -83.64 154.45 23.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.288 0.566 . . . . 1.94 111.912 -179.44 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.72 -16.92 63.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.233 -0.894 . . . . 1.66 111.131 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.673 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 33.2 mttp -68.89 150.02 48.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.484 -0.78 . . . . 1.74 111.449 -178.07 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.44 128.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-O 121.984 0.897 . . . . 0.97 110.14 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.78 39.96 20.13 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.835 -1.53 . . . . 1.77 112.863 178.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -91.14 146.93 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.603 0.239 . . . . 1.96 110.906 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.918 HG13 HD21 ' A' ' 73' ' ' LEU . 15.8 t -65.84 130.01 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.013 -0.736 . . . . 0.77 109.013 178.824 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.9 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.81 -53.21 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.671 0.619 . . . . 1.15 112.671 -177.028 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.012 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.02 129.37 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.163 -0.68 . . . . 0.29 109.163 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 70' ' ' VAL . 3.9 mt -138.76 175.45 9.55 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.57 0.7 . . . . 1.3 111.373 -179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.775 ' CD1' HG23 ' A' ' 79' ' ' ILE . 39.2 t80 -141.36 103.61 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.095 -1.411 . . . . 1.3 107.648 176.141 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 1.8 t -141.6 153.99 45.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.385 -0.371 . . . . 0.89 111.005 -178.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.87 30.1 52.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.527 -0.844 . . . . 0.57 112.146 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.91 3.99 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.618 0.247 . . . . 1.46 110.872 -178.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 65.1 mttm -105.34 110.79 23.28 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.575 -0.284 . . . . 2.41 111.306 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.775 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.2 pp -79.87 113.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.465 -1.68 . . . . 1.66 106.465 176.392 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.742 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -99.92 140.02 34.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.426 -0.807 . . . . 1.25 111.177 -177.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.2 p-10 -166.55 -52.39 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.864 -1.162 . . . . 1.2 107.864 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 54.5 m-20 -79.92 -25.57 40.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.122 -0.945 . . . . 2.17 109.632 178.061 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.77 -30.47 56.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.546 -0.909 . . . . 5.05 108.546 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.656 ' CE2' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -82.19 114.05 48.22 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 114.952 -1.022 . . . . 1.29 110.679 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.86 -42.17 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.73 1.62 . . . . 0.79 110.31 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.619 ' O ' HG12 ' A' ' 71' ' ' ILE . 58.5 m-20 -67.09 105.24 1.62 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.678 -0.692 . . . . 1.36 110.584 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.797 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 mp 68.98 24.18 6.37 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.892 1.071 . . . . 1.62 113.892 178.805 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 51.1 pttt -57.02 129.83 43.46 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.571 -0.706 . . . . 2.39 111.016 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.45 15.46 58.52 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.119 178.642 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp85 -143.37 -48.54 0.31 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.383 1.253 . . . . 1.59 114.383 -178.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.012 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.01 81.28 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 123.132 1.444 . . . . 0.2 107.274 -178.54 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.641 ' C ' HG22 ' A' ' 105' ' ' ILE . 3.8 m-70 -98.29 127.84 44.42 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.248 -2.251 . . . . 0.29 112.325 -175.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.036 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.2 m-85 -70.88 121.82 18.79 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.166 0.508 . . . . 1.23 110.434 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 38' ' ' TYR . 5.8 p -77.79 36.0 0.21 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.527 -0.76 . . . . 0.46 111.839 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.1 m -148.32 127.55 12.96 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.128 0.489 . . . . 1.2 111.639 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -90.62 6.16 44.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.593 -0.73 . . . . 2.22 110.211 178.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -145.91 66.03 1.21 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.103 -0.702 . . . . 2.14 109.103 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.469 HD21 ' CG ' ' A' ' 93' ' ' PHE . 4.8 mp -60.08 -39.27 85.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.15 -0.932 . . . . 1.49 111.333 -178.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HE2' ' OH ' ' A' ' 74' ' ' TYR . 25.8 mttm -59.52 -6.73 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.511 . . . . 2.04 112.224 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -81.94 -7.09 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.522 -0.763 . . . . 1.4 110.535 179.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 115.35 -20.02 14.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.852 -0.689 . . . . 0.38 113.227 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -99.91 106.03 17.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.03 0.415 . . . . 1.44 110.516 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -113.03 22.59 14.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.466 0.543 . . . . 0.43 112.466 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 13.9 m -60.02 151.02 27.45 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.963 1.468 . . . . 1.04 114.963 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.036 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -135.11 134.21 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 114.639 -1.164 . . . . 0.31 111.447 179.301 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.658 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.8 p-10 -107.95 148.37 29.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.832 -0.803 . . . . 1.15 108.832 177.438 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.31 123.46 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.943 0.401 . . . . 0.27 111.058 -178.774 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -86.27 144.9 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.689 -0.687 . . . . 0.29 111.262 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.11 61.0 2.92 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.01 -0.541 . . . . 1.52 112.224 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 31' ' ' LYS . 6.6 mt -45.99 169.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 1.02 111.904 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 11.8 pt20 -177.43 161.22 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.701 -0.681 . . . . 2.13 110.572 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.813 ' HA ' HG11 ' A' ' 137' ' ' VAL . 5.1 mp -60.06 -33.01 71.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 1.7 111.465 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -73.74 -19.93 60.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.984 -0.286 . . . . 1.32 111.629 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 95.5 m-20 -72.27 -19.72 61.64 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.923 -0.399 . . . . 1.58 109.923 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -46.03 142.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 116.111 -0.495 . . . . 0.42 111.171 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.46 150.4 5.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.689 -1.243 . . . . 0.24 114.298 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.53 HG23 ' ND1' ' A' ' 134' ' ' HIS . 98.1 m -59.47 139.95 56.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -0.662 . . . . 0.31 112.135 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.8 m-85 -119.98 135.08 55.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 1.24 109.9 178.136 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.1 tt0 -126.77 117.13 22.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.612 -0.267 . . . . 1.16 111.145 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.461 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 50.8 t -99.99 114.73 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 1.03 110.288 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.0 mtpt -109.45 104.77 13.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.574 -0.284 . . . . 1.76 110.801 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 55' ' ' ILE . 42.8 t -90.05 110.69 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.578 -0.527 . . . . 1.18 109.578 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HG3' HG12 ' A' ' 128' ' ' VAL . 26.8 tttp -98.9 115.89 29.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.479 0.548 . . . . 1.62 112.479 -178.758 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.556 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 36.1 tttp -145.77 102.63 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.316 -0.554 . . . . 2.84 109.784 177.643 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.848 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.56 132.1 26.8 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.919 -0.582 . . . . 0.44 111.903 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 63.1 Cg_endo -101.29 51.94 1.44 Allowed 'Cis proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.771 -0.929 . . . . 0.56 111.94 -0.418 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 102.59 0.26 Allowed Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.855 -1.164 . . . . 0.48 113.866 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -93.83 135.78 27.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.391 -0.905 . . . . 1.22 109.293 177.306 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.709 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.44 152.51 40.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.599 -0.44 . . . . 0.57 112.068 -179.183 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 23.6 p-10 -146.42 157.91 43.82 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.217 0.451 . . . . 2.03 112.217 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.769 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.99 166.61 25.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.193 -0.458 . . . . 2.95 111.083 179.009 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' GLU . 68.3 mttm -111.17 140.25 45.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 112.6 0.593 . . . . 2.26 112.6 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.631 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 96.8 mt -141.55 112.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.543 -0.91 . . . . 0.28 108.543 176.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.53 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.7 m-70 -96.89 118.77 34.04 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.425 -0.51 . . . . 0.55 110.984 -178.478 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.2 tm? -88.44 120.0 29.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 1.52 111.69 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 42.3 t -118.96 120.3 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.32 109.197 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 112' ' ' LEU . 10.7 p -94.91 133.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.312 0.486 . . . . 1.08 112.312 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 66.6 mt -80.1 158.18 26.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.944 -0.762 . . . . 0.52 108.944 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 122.134 0.968 . . . . 1.48 113.439 -177.185 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.706 0.288 . . . . 1.84 110.856 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.766 HG13 ' HB1' ' A' ' 129' ' ' ALA . 1.6 pp -91.96 143.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 2.15 111.264 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -89.11 157.75 18.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.775 -0.648 . . . . 1.12 109.891 178.926 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 45.1 85.42 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 121.716 0.769 . . . . 0.65 109.809 -176.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.0 Cg_endo -76.4 -83.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.246 2.631 . . . . 0.88 113.215 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.3 mt-10 -78.54 128.14 33.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.894 -0.722 . . . . 2.06 109.501 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.502 ' CG ' HD11 ' A' ' 29' ' ' ILE . 39.4 tp10 -143.6 156.18 44.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.91 1.078 . . . . 1.71 113.91 -177.317 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 45.0 mtm -137.26 118.24 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.285 -1.325 . . . . 1.86 107.865 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.986 HD13 HG23 ' A' ' 133' ' ' ILE . 5.2 mp -120.03 120.05 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.39 111.894 -177.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 136' ' ' VAL . 51.7 mp0 -105.72 128.53 53.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.821 -0.627 . . . . 1.19 110.939 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB3' HD11 ' A' ' 110' ' ' LEU . 20.9 tptm -141.45 154.73 45.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.854 0.359 . . . . 2.52 111.151 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.681 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . . . -76.65 143.63 40.01 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.615 0.598 . . . . 0.39 112.615 -179.041 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.618 ' HG3' HG12 ' A' ' 137' ' ' VAL . 75.0 mttt -47.86 143.76 3.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.593 -0.731 . . . . 2.35 112.604 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.36 -23.64 1.48 Allowed Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.31 113.719 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 32' ' ' ALA . 98.7 mt-10 -79.99 159.97 26.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.338 -0.616 . . . . 2.11 109.338 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 55.9 m -86.91 126.31 34.6 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.12 -0.632 . . . . 0.33 110.984 -179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -96.74 118.54 33.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.185 0.516 . . . . 0.26 110.307 179.144 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 94' ' ' THR . 9.9 t80 -79.17 120.53 23.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.887 -0.597 . . . . 1.43 111.932 -178.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.722 ' HB2' HD12 ' A' ' 105' ' ' ILE . 35.7 mt -105.75 104.77 50.34 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 108.428 -0.952 . . . . 0.8 108.428 177.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.8 Cg_endo -82.31 127.49 5.21 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.363 2.042 . . . . 0.42 114.345 -177.67 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.0 t -141.2 129.98 22.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.072 -0.967 . . . . 1.03 108.859 178.011 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.61 ' O ' HG22 ' A' ' 22' ' ' ILE . 33.3 ttpt -140.73 150.12 43.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.708 -0.678 . . . . 1.66 110.634 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.837 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -139.95 140.42 36.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.897 -178.033 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 138.31 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.694 -0.684 . . . . 1.33 110.507 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.0 107.84 19.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 2.12 111.34 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 57.6 m -83.34 148.23 55.24 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 109.355 -0.609 . . . . 1.75 109.355 178.314 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -42.36 -46.75 7.57 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 121.984 1.789 . . . . 1.61 111.594 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 85.6 tt0 -75.94 -38.49 57.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.652 -0.704 . . . . 2.18 110.971 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 13.9 t0 -70.96 80.03 0.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.303 0.573 . . . . 2.41 110.441 -179.439 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.25 33.75 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.19 -0.914 . . . . 1.64 111.022 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -97.12 -171.32 33.8 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.541 -0.838 . . . . 0.55 112.717 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.66 113.03 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.644 2.229 . . . . 0.85 111.861 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 47.9 tp -78.7 118.54 20.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.9 111.566 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -134.55 102.95 5.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.524 0.678 . . . . 1.78 111.371 179.08 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.846 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 3.7 mt -96.06 110.01 23.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.75 110.809 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' CB ' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -102.56 117.99 35.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.129 0.788 . . . . 1.67 113.129 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.905 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -93.88 121.7 35.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.22 109.882 176.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.1 mt -106.65 129.94 54.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.035 -0.357 . . . . 0.41 110.035 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.786 HD12 HD11 ' A' ' 87' ' ' LEU . 3.9 tt -119.96 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.203 0.816 . . . . 0.78 113.203 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.538 ' HA ' ' C ' ' A' ' 67' ' ' VAL . 5.4 t -108.11 104.5 53.82 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 108.842 -0.799 . . . . 1.25 108.842 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.701 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 80.6 Cg_endo -78.85 112.74 3.16 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.304 2.003 . . . . 0.53 111.952 -179.107 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.01 87.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.435 -0.802 . . . . 0.41 111.082 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.78 -39.99 63.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.84 -0.618 . . . . 1.82 111.555 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 28.0 m120 -85.28 162.84 18.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.18 0.514 . . . . 1.94 111.942 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.18 -18.05 63.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.4 -0.818 . . . . 1.66 111.942 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -69.46 170.03 11.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.877 -0.601 . . . . 1.74 111.967 -177.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 59' ' ' ILE . 1.3 t -133.47 -154.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 107.753 -1.203 . . . . 0.97 107.753 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 67' ' ' VAL . 78.4 m-20 -67.54 64.54 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.73 0.776 . . . . 1.77 111.564 -177.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -85.76 157.19 20.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.425 -1.261 . . . . 1.96 109.508 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.5 t -66.27 131.4 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.398 -0.521 . . . . 0.77 109.652 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.077 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.56 -50.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.652 0.612 . . . . 1.15 112.652 -176.998 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.777 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.01 123.1 17.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.067 -0.716 . . . . 0.29 109.067 179.642 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' CB ' ' A' ' 56' ' ' GLU . 7.9 tt -140.0 160.99 38.68 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.793 -0.639 . . . . 1.3 110.156 -177.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.631 ' CD1' HG23 ' A' ' 79' ' ' ILE . 10.2 t80 -135.61 111.64 9.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.997 0.427 . . . . 1.3 110.155 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 6.7 t -142.46 159.98 41.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.89 111.441 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.17 36.2 51.61 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.63 -0.795 . . . . 0.57 111.941 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t0 62.94 22.35 13.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.956 0.408 . . . . 1.46 110.397 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 22.5 mttm -120.68 110.3 16.24 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.922 -0.581 . . . . 2.41 110.677 178.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -80.13 117.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.1 -1.444 . . . . 1.66 107.1 177.313 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.3 m-85 -99.96 136.47 39.83 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.976 -1.011 . . . . 1.25 110.526 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.3 p-10 -166.26 -56.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.402 -0.962 . . . . 1.2 108.402 -179.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' OD1' ' CD2' ' A' ' 83' ' ' TYR . 25.6 p-10 -78.77 -24.01 44.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 2.17 109.787 177.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 80' ' ' TYR . 16.4 m-85 -77.19 -29.17 54.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.285 -1.006 . . . . 5.05 108.285 178.378 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -82.18 115.9 60.38 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-N 114.985 -1.007 . . . . 1.29 110.644 179.368 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.3 -43.95 16.51 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.739 1.626 . . . . 0.79 111.046 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 71' ' ' ILE . 16.6 m-20 -66.93 106.7 1.99 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.106 -0.638 . . . . 1.36 110.808 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.846 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 67.64 22.4 9.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.926 1.084 . . . . 1.62 113.926 178.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 42.6 pttt -54.81 128.75 34.41 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.81 -0.756 . . . . 2.39 111.089 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.35 13.61 55.46 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.344 -0.931 . . . . 0.37 114.422 178.366 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.7 ptp85 -143.63 -48.98 0.3 Allowed 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 114.584 1.327 . . . . 1.59 114.584 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.077 HG11 HD11 ' A' ' 71' ' ' ILE . 5.7 p -80.76 81.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 107.232 -1.395 . . . . 0.2 107.232 -178.299 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.593 ' C ' HG22 ' A' ' 105' ' ' ILE . 6.9 m-70 -100.6 132.89 45.75 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.277 -2.238 . . . . 0.29 112.191 -175.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 1.118 ' CD1' HG23 ' A' ' 105' ' ' ILE . 74.6 m-85 -73.8 120.01 18.81 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-O 121.254 0.55 . . . . 1.23 109.884 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.467 HG21 ' CE2' ' A' ' 38' ' ' TYR . 32.3 p -74.8 -6.14 47.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.46 110.428 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.3 m -90.4 120.17 31.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 1.2 110.754 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -89.93 1.58 56.07 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.299 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -146.16 68.51 1.19 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.751 -0.833 . . . . 2.14 108.751 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 4.3 mp -59.66 -38.38 81.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.962 -1.017 . . . . 1.49 111.696 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -61.62 -6.23 2.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.204 0.526 . . . . 2.04 112.071 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m -86.63 -4.64 59.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.393 -0.821 . . . . 1.4 110.643 178.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.55 -22.7 14.63 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.771 -0.728 . . . . 0.38 113.254 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.4 m-20 -93.7 107.19 19.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.132 0.466 . . . . 1.44 110.489 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -113.9 22.11 14.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.657 0.614 . . . . 0.43 112.657 -178.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.1 m -59.99 148.18 36.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.521 1.675 . . . . 1.04 115.521 -178.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.118 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -132.28 134.31 59.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 114.494 -1.23 . . . . 0.31 111.108 179.199 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.2 p-10 -107.06 150.37 26.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.766 -0.828 . . . . 1.15 108.766 177.516 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.35 121.59 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 120.902 0.382 . . . . 0.27 110.915 -178.938 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.48 144.36 28.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.703 -0.681 . . . . 0.29 111.432 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 54.17 60.32 3.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.638 178.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 37' ' ' ALA . 12.2 mt -46.17 169.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.039 0.447 . . . . 1.02 111.887 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.785 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.0 tt0 -177.99 166.44 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 2.13 109.909 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 87.0 mt -59.97 -33.26 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.903 0.335 . . . . 1.7 111.903 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.9 m -73.36 -19.42 61.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.986 -0.285 . . . . 1.32 111.509 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.44 -20.77 62.06 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.571 -0.529 . . . . 1.58 109.571 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.804 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -49.98 140.33 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-N 115.704 -0.68 . . . . 0.42 111.067 178.796 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.01 153.21 5.91 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 119.71 -1.234 . . . . 0.24 113.705 179.137 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.548 HG23 ' ND1' ' A' ' 134' ' ' HIS . 84.2 m -59.42 135.71 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.298 0.481 . . . . 0.31 112.298 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.9 m-85 -121.17 131.5 54.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.186 -0.672 . . . . 1.24 109.186 177.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.9 tt0 -128.85 120.0 25.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.78 -0.368 . . . . 1.16 110.238 179.233 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.505 ' SG ' ' HG2' ' A' ' 131' ' ' LYS . 16.6 p -102.81 119.59 39.1 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.546 -0.462 . . . . 1.03 110.911 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.846 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.0 mttt -111.21 104.53 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 1.76 110.441 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.837 HG11 ' CG ' ' A' ' 43' ' ' PHE . 21.8 t -88.45 107.44 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.86 -0.422 . . . . 1.18 109.86 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 33.8 mttm -100.1 120.7 40.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.823 1.046 . . . . 1.62 113.823 -178.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 19.1 tttt -145.83 103.32 3.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.211 0.529 . . . . 2.84 109.874 177.171 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.496 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -47.95 130.6 11.89 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.322 -0.853 . . . . 0.44 113.274 -178.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.567 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.9 Cg_endo -102.73 48.72 1.91 Allowed 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 125.008 -0.83 . . . . 0.56 111.621 -0.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 103.5 0.3 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.214 -0.993 . . . . 0.48 113.138 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -92.93 151.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.338 -0.931 . . . . 1.22 109.995 177.918 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -145.63 144.08 30.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.182 -0.463 . . . . 0.57 111.867 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.569 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 50.5 p-10 -147.16 146.66 29.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.559 0.577 . . . . 2.03 112.559 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -144.5 164.67 30.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.395 -0.366 . . . . 2.95 111.299 179.483 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 94.5 mttt -99.68 140.0 34.52 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 113.031 0.752 . . . . 2.26 113.031 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.986 HG23 HD13 ' A' ' 29' ' ' ILE . 71.9 mt -141.08 110.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.939 -1.028 . . . . 0.28 109.248 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.548 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.2 m-70 -100.02 119.98 39.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.55 111.052 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.498 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -89.53 125.54 35.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.933 -0.576 . . . . 1.52 111.42 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 46.9 t -119.95 130.0 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.32 109.496 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.804 HG23 HG13 ' A' ' 115' ' ' ILE . 25.3 t -100.22 122.88 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.156 0.428 . . . . 1.08 112.156 -178.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 72.7 mt -83.5 159.99 21.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.982 -0.554 . . . . 0.52 109.614 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 1.48 111.939 -178.626 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.462 -0.255 . . . . 3.28 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -79.97 169.99 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 2.43 110.91 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 22' ' ' ILE . 74.4 m -153.82 116.03 4.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.009 0.433 . . . . 1.84 110.631 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 ' HB1' ' A' ' 129' ' ' ALA . 4.6 mt -141.91 138.76 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 2.15 110.928 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 21.5 p -93.6 147.86 22.62 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.339 0.59 . . . . 1.12 110.714 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.12 82.88 0.22 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.04 -0.982 . . . . 0.65 111.8 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 48.3 Cg_endo -78.36 -73.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.706 2.937 . . . . 0.88 112.012 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.48 127.63 32.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.412 -0.959 . . . . 2.06 108.412 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.947 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.2 tt0 -143.77 158.34 43.75 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.015 1.117 . . . . 1.71 114.015 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.533 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.41 122.88 17.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.561 -1.199 . . . . 1.86 109.031 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.947 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.8 mm -120.01 126.57 75.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.39 111.527 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.73 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 87.1 mt-10 -119.19 125.18 48.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.434 . . . . 1.19 110.334 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.8 mmtt -141.8 160.02 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 2.52 111.309 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.33 137.56 39.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.39 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.68 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 31.2 ttpt -46.59 139.95 4.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.35 111.674 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.4 -23.2 7.51 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 116.059 -0.519 . . . . 0.31 113.024 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.5 mt-10 -80.92 160.0 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.594 -0.521 . . . . 2.11 109.594 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.7 m -84.49 130.22 34.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.104 -0.638 . . . . 0.33 110.583 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -99.72 113.43 25.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.26 110.441 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.35 129.92 34.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 1.43 112.24 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.705 HD22 HG21 ' A' ' 133' ' ' ILE . 14.3 mt -121.42 104.33 40.4 Favored Pre-proline 0 CA--C 1.528 0.121 0 N-CA-C 109.132 -0.692 . . . . 0.8 109.132 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 92.7 Cg_endo -84.25 134.03 5.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.546 2.164 . . . . 0.42 114.889 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.676 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 57.3 m -141.59 112.55 7.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.171 -0.922 . . . . 1.03 109.911 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 8.2 tptt -118.69 109.12 15.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.889 0.376 . . . . 1.66 110.663 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.591 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 39.9 p90 -93.82 141.79 28.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.673 -0.694 . . . . 1.26 110.436 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 m -79.46 148.01 32.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 1.33 111.238 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.36 144.33 39.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.477 -0.783 . . . . 2.12 111.406 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 83.5 p -159.34 145.3 12.08 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.804 -0.634 . . . . 1.75 110.08 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.3 Cg_exo -45.45 -21.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.495 2.13 . . . . 1.61 113.107 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 52.6 tp10 -73.67 -38.26 65.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.617 -0.265 . . . . 2.18 111.471 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 46' ' ' SER . 51.0 p-10 -65.79 73.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.641 0.734 . . . . 2.41 110.753 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 76.8 mm-40 -90.79 -10.02 44.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.308 -0.86 . . . . 1.64 111.795 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.941 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -75.57 154.78 46.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.17 -1.014 . . . . 0.55 112.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.63 149.0 25.78 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.205 1.937 . . . . 0.85 111.578 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.52 131.05 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 1.9 110.235 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 19.1 t0 -140.05 150.82 44.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.432 0.634 . . . . 1.78 111.417 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 51.0 mt -141.96 139.99 30.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.919 -1.037 . . . . 0.75 109.747 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.744 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 85.9 tt0 -139.98 148.0 41.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.007 0.432 . . . . 1.67 111.835 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.953 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.6 m95 -141.04 119.27 12.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.22 111.004 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.591 HD21 HG22 ' A' ' 70' ' ' VAL . 83.5 mt -110.06 146.3 35.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.41 109.192 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.753 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 6.9 tt -129.91 135.59 60.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.685 0.624 . . . . 0.78 112.685 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 m -121.52 102.94 41.75 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.26 -0.882 . . . . 1.25 108.646 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 7.1 Cg_exo -78.09 114.09 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.518 2.145 . . . . 0.53 112.619 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.98 87.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.101 -0.954 . . . . 0.41 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.42 -40.05 62.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 1.82 111.253 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 1.4 t-20 -85.04 159.77 20.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.227 0.537 . . . . 1.94 111.813 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.81 -16.39 63.77 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.343 -0.844 . . . . 1.66 111.576 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 93.8 mttt -69.6 151.73 45.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 1.74 111.848 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.12 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-O 121.751 0.786 . . . . 0.97 109.496 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 55.66 85.18 0.07 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.276 -1.329 . . . . 1.77 112.304 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -140.04 144.14 36.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.424 . . . . 1.96 111.124 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD21 ' A' ' 58' ' ' LEU . 61.2 t -70.83 131.9 33.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.902 -0.59 . . . . 0.77 111.33 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.896 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -130.79 -41.38 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.187 0.44 . . . . 1.15 112.187 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.884 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.4 129.89 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.373 0.606 . . . . 0.29 110.064 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 160.97 38.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.255 -0.884 . . . . 1.3 109.684 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 24.0 t80 -138.54 103.28 4.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -143.65 153.66 42.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.502 -0.317 . . . . 0.89 111.8 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' ASP . . . 58.43 29.49 63.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.624 -0.798 . . . . 0.57 111.685 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 10.1 m-20 69.86 4.52 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.619 0.247 . . . . 1.46 111.088 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 97.3 mttt -99.98 112.68 24.95 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.611 -0.514 . . . . 2.41 109.611 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -84.28 116.47 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 108.057 -1.09 . . . . 1.66 108.057 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.7 m-85 -100.33 126.28 46.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.439 -1.709 . . . . 1.25 110.78 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.87 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.5 p-10 -165.98 -53.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.526 -1.286 . . . . 1.2 107.526 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.0 p-10 -82.93 -26.93 30.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.147 -0.933 . . . . 2.17 109.749 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CD1' ' OD1' ' A' ' 82' ' ' ASP . 36.1 m-85 -75.57 -28.58 59.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.4 -1.333 . . . . 5.05 107.4 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -83.16 113.19 44.4 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 114.158 -1.383 . . . . 1.29 110.329 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.7 -42.94 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.615 1.544 . . . . 0.79 111.226 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.811 ' HB3' HG22 ' A' ' 71' ' ' ILE . 74.6 m-20 -67.99 104.6 1.78 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.012 -0.54 . . . . 1.36 111.235 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 32.4 mt 71.27 24.4 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.306 -0.861 . . . . 1.62 113.221 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.7 pttt -58.14 135.61 57.08 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.901 -0.499 . . . . 2.39 111.63 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.35 11.31 75.64 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.536 -0.84 . . . . 0.37 114.398 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.6 ptp180 -138.99 -50.97 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.678 1.362 . . . . 1.59 114.678 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.896 HG11 ' CD1' ' A' ' 71' ' ' ILE . 7.6 p -78.96 81.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.847 1.308 . . . . 0.2 107.53 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 11.2 m-70 -102.88 131.55 49.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.451 -2.159 . . . . 0.29 112.401 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.142 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.6 m-85 -73.59 120.2 18.86 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 120.024 -0.67 . . . . 1.23 109.312 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 38' ' ' TYR . 18.0 p -70.09 -9.17 54.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.923 -1.035 . . . . 0.46 110.807 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 5.3 m -88.32 118.53 28.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.941 -0.572 . . . . 1.2 110.887 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -90.09 0.18 57.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.244 0.545 . . . . 2.22 110.168 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -146.41 67.19 1.18 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.487 -0.931 . . . . 2.14 108.487 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.594 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.5 mp -57.77 -27.76 63.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.25 -0.886 . . . . 1.49 112.149 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -63.45 -5.04 3.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.187 0.518 . . . . 2.04 112.115 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.6 p -89.85 -0.04 57.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.41 -0.814 . . . . 1.4 110.975 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.591 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.21 0.6 38.26 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.645 -0.788 . . . . 0.38 113.218 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.512 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 92.3 m-20 -99.94 118.65 36.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 1.44 111.002 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -118.5 10.39 12.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.43 111.651 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -60.03 140.43 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.122 1.897 . . . . 1.04 116.122 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.142 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.82 134.61 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 114.543 -1.208 . . . . 0.31 110.486 177.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.3 p-10 -108.88 151.08 26.75 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.673 -0.862 . . . . 1.15 108.673 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.78 120.13 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.0 0.429 . . . . 0.27 110.903 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -83.9 144.89 28.91 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.506 -0.77 . . . . 0.29 111.094 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.43 ' HB3' ' OXT' ' A' ' 144' ' ' ALA . 98.6 m-20 51.82 61.77 3.04 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.963 -0.562 . . . . 1.52 112.328 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.45 176.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.218 0.451 . . . . 1.02 112.218 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.745 ' O ' HG21 ' A' ' 137' ' ' VAL . 62.3 tt0 -176.32 159.99 2.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 2.13 110.616 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 95.0 mt -59.93 -40.07 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.525 . . . . 1.7 112.416 -178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.3 m -74.56 -13.98 60.74 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.1 -0.24 . . . . 1.32 111.372 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.62 -22.37 62.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 1.58 109.271 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.58 HG13 HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.53 144.9 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 115.641 -0.709 . . . . 0.42 110.74 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.62 148.79 5.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.234 -0.984 . . . . 0.24 113.268 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.887 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.1 m -59.07 135.89 57.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.431 . . . . 0.31 111.771 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.753 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.5 m-85 -116.18 139.99 49.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 1.24 109.867 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.753 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 54.7 tt0 -117.88 117.53 29.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.035 -0.357 . . . . 1.16 110.035 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.545 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 18.0 t -100.0 109.62 21.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.101 -0.5 . . . . 1.03 110.687 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 54.4 mtpt -121.35 111.48 17.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 1.76 111.895 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 t -96.28 110.16 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.483 -0.562 . . . . 1.18 109.483 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 29.0 tttt -95.02 114.93 26.79 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.879 -0.728 . . . . 1.62 112.767 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.99 102.66 3.67 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.262 -0.644 . . . . 2.84 109.262 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.941 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.07 133.51 22.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.44 112.29 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 58.6 Cg_endo -101.61 50.04 1.71 Allowed 'Cis proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.745 -0.939 . . . . 0.56 111.138 -0.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.98 103.06 0.29 Allowed Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.062 -1.066 . . . . 0.48 113.29 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -88.41 119.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.203 -0.999 . . . . 1.22 109.761 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -100.01 140.48 34.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.681 -0.236 . . . . 0.57 111.601 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -146.07 131.72 18.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.483 -0.326 . . . . 2.03 111.244 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.676 ' HZ3' ' HA ' ' A' ' 41' ' ' CYS . 5.0 ptmt -145.25 158.5 43.81 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.344 -0.389 . . . . 2.95 110.676 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.578 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 96.7 mttt -102.79 140.02 37.61 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.065 0.765 . . . . 2.26 113.065 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.831 HD13 ' CH2' ' A' ' 57' ' ' TRP . 2.4 mp -141.32 116.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.349 -0.841 . . . . 0.28 108.895 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.887 ' CD2' HG23 ' A' ' 117' ' ' THR . 54.0 m170 -101.44 120.04 39.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.55 110.845 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.425 HD21 ' CD2' ' A' ' 110' ' ' LEU . 60.8 tp -88.77 121.26 30.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 1.52 111.623 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.8 t -120.0 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.763 -0.653 . . . . 0.32 109.513 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG21 ' O ' ' A' ' 111' ' ' GLN . 25.9 t -100.97 125.94 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 1.08 112.156 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.26 155.25 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.835 -0.62 . . . . 0.52 109.403 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.9 134.73 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 1.48 111.654 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.749 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.14 173.57 3.64 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.431 -1.259 . . . . 2.2 108.953 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.749 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 5.4 Cg_endo -46.85 164.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.876 1.717 . . . . 1.31 111.583 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 144' ' ' ALA . 0.4 OUTLIER -35.62 -79.59 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.348 0.499 . . . . 2.31 112.348 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.19 -66.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.215 -0.448 . . . . 2.52 112.956 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.449 -0.786 . . . . 2.6 111.789 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.51 -0.236 . . . . 3.28 112.51 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -80.04 138.69 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 2.43 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -157.25 134.29 10.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 1.84 111.06 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.587 HD13 ' HB1' ' A' ' 129' ' ' ALA . 6.5 pt -99.18 144.89 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 2.15 111.182 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.41 159.54 18.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.466 0.65 . . . . 1.12 111.614 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.638 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER 41.75 83.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.724 -1.125 . . . . 0.65 111.899 -178.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.2 Cg_endo -78.72 -78.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.547 2.832 . . . . 0.88 112.867 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.1 mt-10 -78.96 128.6 33.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.871 -0.418 . . . . 2.06 109.871 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.583 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 49.7 tt0 -144.45 159.96 41.87 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.212 1.19 . . . . 1.71 114.212 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' ILE . 31.2 mtt -137.73 117.85 13.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.626 -1.17 . . . . 1.86 108.847 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.988 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -119.97 120.6 63.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.371 0.508 . . . . 0.39 112.371 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 96.5 mt-10 -106.87 126.25 52.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.059 -0.519 . . . . 1.19 109.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 110' ' ' LEU . 27.7 tptt -141.79 150.07 41.23 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.795 -0.362 . . . . 2.52 111.486 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.62 140.26 40.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.39 112.134 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.599 ' HB2' ' CG ' ' A' ' 140' ' ' LYS . 97.6 mttt -44.98 153.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.654 0.613 . . . . 2.35 112.654 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.09 -28.53 0.54 Allowed Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.139 -0.937 . . . . 0.31 113.636 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.62 160.07 26.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.236 -0.653 . . . . 2.11 109.236 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 79.7 m -85.89 129.87 34.71 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.066 -0.654 . . . . 0.33 110.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.83 117.8 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.509 . . . . 0.26 110.243 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 94' ' ' THR . 17.6 t80 -79.32 121.11 24.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.722 -0.672 . . . . 1.43 112.631 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.843 ' HB2' HD12 ' A' ' 105' ' ' ILE . 22.9 mt -104.29 104.8 46.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.457 -0.942 . . . . 0.8 108.457 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 95.7 Cg_endo -82.95 129.72 5.48 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.235 1.957 . . . . 0.42 114.202 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 3.8 t -140.64 134.4 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.183 -1.043 . . . . 1.03 108.183 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' O ' HG22 ' A' ' 22' ' ' ILE . 43.8 mmtm -140.28 143.86 36.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.826 -0.35 . . . . 1.66 111.349 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.766 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 47.3 p90 -140.56 140.71 35.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.26 111.26 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -81.88 140.21 34.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.906 -0.588 . . . . 1.33 111.899 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.589 HD21 ' HE2' ' A' ' 43' ' ' PHE . 86.1 mt -101.61 141.97 33.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.762 -0.653 . . . . 2.12 110.997 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 44.7 m -154.93 154.49 29.03 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 1.75 110.242 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.42 -21.33 29.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.603 2.202 . . . . 1.61 112.909 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.3 tt0 -76.18 -41.49 49.44 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 120.942 -0.303 . . . . 2.18 110.952 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -71.48 74.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.357 -0.537 . . . . 2.41 109.943 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -91.38 -8.02 49.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.801 . . . . 1.64 111.892 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.938 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.32 159.89 53.54 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.067 -1.064 . . . . 0.55 112.259 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 144.04 59.56 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.132 1.888 . . . . 0.85 111.348 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.766 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 9.7 tt -77.61 123.66 26.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 1.9 110.663 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.2 m-20 -129.46 148.21 51.34 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.508 0.67 . . . . 1.78 111.223 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.807 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 24.3 mt -142.88 141.87 26.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.491 -1.232 . . . . 0.75 109.248 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 40.9 mt-10 -139.97 151.41 45.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.015 -0.274 . . . . 1.67 110.953 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.979 ' CD2' HD11 ' A' ' 105' ' ' ILE . 87.4 m95 -140.49 116.12 10.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.22 110.588 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.3 mt -106.31 146.26 30.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.41 109.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.568 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.062 0.458 . . . . 0.78 111.923 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.454 ' OG ' HG12 ' A' ' 67' ' ' VAL . 28.4 t -115.64 102.88 54.24 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 108.916 -0.772 . . . . 1.25 108.916 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 66' ' ' LYS . 72.4 Cg_endo -78.76 110.29 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.629 2.219 . . . . 0.53 112.81 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.79 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.15 -0.932 . . . . 0.41 110.901 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 20.1 p-10 -88.24 20.41 3.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 1.82 111.642 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -151.46 160.02 43.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.245 0.545 . . . . 1.94 111.858 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -68.4 -20.01 64.65 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.394 -0.821 . . . . 1.66 112.231 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.609 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 59.4 mttp -67.86 154.19 42.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.945 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.454 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.78 135.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-O 122.751 1.262 . . . . 0.97 110.78 178.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 39.98 46.31 1.74 Allowed 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.251 -2.25 . . . . 1.77 113.481 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -91.33 143.28 26.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.996 -0.282 . . . . 1.96 110.98 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 HD21 ' A' ' 58' ' ' LEU . 94.9 t -68.35 130.03 33.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.77 110.525 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.905 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -128.61 -37.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 1.15 112.014 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.98 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.67 125.62 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.928 -0.767 . . . . 0.29 108.928 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.74 158.29 44.18 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.556 -0.747 . . . . 1.3 110.695 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 14.6 t80 -133.25 103.81 6.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.146 -0.687 . . . . 1.3 109.146 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.444 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 23.5 m -142.74 159.11 42.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.784 0.326 . . . . 0.89 111.666 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.19 27.55 23.85 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.797 -0.716 . . . . 0.57 112.462 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 74.12 1.83 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.54 0.21 . . . . 1.46 110.989 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.9 mttm -100.01 114.1 27.17 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.954 -0.388 . . . . 2.41 109.954 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.24 126.87 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 C-N-CA 118.658 -1.217 . . . . 1.66 107.82 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.703 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -111.02 128.06 55.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.635 -1.62 . . . . 1.25 110.631 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.868 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.7 p-10 -166.17 -56.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.081 -1.451 . . . . 1.2 107.081 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.9 t70 -83.09 -26.02 31.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.702 -1.135 . . . . 2.17 109.188 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -75.87 -30.2 58.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.921 -1.14 . . . . 5.05 107.921 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.55 110.58 22.82 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 114.402 -1.272 . . . . 1.29 110.166 178.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.73 -41.69 11.55 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.67 1.58 . . . . 0.79 111.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.818 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.1 m-20 -68.06 104.2 1.71 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.83 -0.623 . . . . 1.36 111.188 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.816 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.2 mt 71.74 20.75 4.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.21 0.819 . . . . 1.62 113.21 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.868 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.8 pttt -56.23 131.99 49.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.883 -0.511 . . . . 2.39 111.269 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.07 10.82 60.74 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.186 -1.007 . . . . 0.37 114.247 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -142.02 -49.26 0.38 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 114.862 1.43 . . . . 1.59 114.862 -178.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.98 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.61 81.45 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 CA-C-O 123.339 1.542 . . . . 0.2 107.128 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.498 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.2 m-70 -102.05 128.9 48.31 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.044 -2.344 . . . . 0.29 112.563 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.109 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -72.34 124.74 25.74 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.752 -0.779 . . . . 1.23 109.024 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.464 HG21 ' CD2' ' A' ' 38' ' ' TYR . 12.6 p -76.44 36.03 0.15 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.212 -0.903 . . . . 0.46 112.062 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -148.68 133.33 17.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.91 0.386 . . . . 1.2 110.848 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -90.07 5.23 47.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 2.22 110.2 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -146.16 65.74 1.2 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.704 -0.68 . . . . 2.14 109.429 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.849 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.1 mp -57.32 -29.12 63.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 1.49 110.866 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.5 mttt -65.8 1.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.35 0.5 . . . . 2.04 112.35 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 m -89.99 -0.0 57.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.688 -0.687 . . . . 1.4 111.244 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 110.51 -11.02 30.64 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.805 -0.712 . . . . 0.38 113.022 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -100.09 112.69 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 1.44 111.135 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -109.65 12.75 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.43 111.681 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 21.1 m -60.07 139.15 57.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.459 1.651 . . . . 1.04 115.459 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.109 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.38 130.03 65.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-N 114.347 -1.297 . . . . 0.31 110.735 178.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.629 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.6 p-10 -104.4 146.62 28.58 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.672 -0.862 . . . . 1.15 108.672 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.82 121.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.008 0.432 . . . . 0.27 110.808 -178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -83.79 145.22 28.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.445 -0.798 . . . . 0.29 111.176 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 54.12 63.73 2.07 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.081 -0.509 . . . . 1.52 112.169 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 31' ' ' LYS . 4.5 mt -45.03 175.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.198 0.523 . . . . 1.02 112.299 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.748 ' O ' HG21 ' A' ' 137' ' ' VAL . 14.8 pt20 -177.02 156.83 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 2.13 110.888 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 60.5 tp -60.04 -39.71 86.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 1.7 112.11 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.487 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 4.8 t -72.46 -16.11 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.998 0.74 . . . . 1.32 112.998 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.2 p30 -74.38 -16.05 60.91 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.888 -0.725 . . . . 1.58 109.791 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.839 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -45.17 141.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.42 110.185 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 154.05 6.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 119.717 -1.23 . . . . 0.24 113.88 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.533 HG23 ' ND1' ' A' ' 134' ' ' HIS . 94.4 m -59.88 137.73 57.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.933 -0.633 . . . . 0.31 112.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.6 m-85 -119.97 139.7 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.324 -0.621 . . . . 1.24 109.324 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.1 tt0 -128.39 121.89 30.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.706 0.288 . . . . 1.16 110.893 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 56' ' ' GLU . 43.5 t -99.96 117.79 35.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.03 110.632 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 23.0 mttm -115.0 106.1 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.801 -0.359 . . . . 1.76 110.56 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 34.3 t -94.87 105.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.649 -0.5 . . . . 1.18 109.649 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.7 tttt -95.27 119.35 33.63 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.898 -0.721 . . . . 1.62 112.603 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.526 ' HG2' ' HB2' ' A' ' 49' ' ' ASP . 6.6 ttpm? -146.25 102.98 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 2.84 110.111 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.938 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.33 133.25 24.9 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 53.5 Cg_endo -100.68 47.26 2.19 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.742 -0.941 . . . . 0.56 111.434 -0.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.94 103.33 0.28 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.146 -1.026 . . . . 0.48 113.579 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.73 151.46 3.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -0.811 . . . . 1.22 108.887 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -141.44 151.32 43.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.412 0.523 . . . . 0.57 112.412 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 3.7 m-20 -145.8 141.18 27.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.925 -0.58 . . . . 2.03 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.638 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.26 156.31 43.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.689 -0.232 . . . . 2.95 110.645 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.3 mttm -101.34 140.53 35.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.631 0.975 . . . . 2.26 113.631 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.988 HG23 HD13 ' A' ' 29' ' ' ILE . 33.3 mt -141.96 111.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.28 109.233 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.533 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.6 m-70 -100.04 118.71 37.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.727 -0.389 . . . . 0.55 110.647 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.658 HD11 HD21 ' A' ' 39' ' ' LEU . 10.2 mt -92.94 125.39 37.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.267 0.556 . . . . 1.52 112.035 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.669 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 57.8 t -115.64 123.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.314 -0.857 . . . . 0.32 109.109 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.839 HG23 HG13 ' A' ' 115' ' ' ILE . 21.6 t -94.6 120.03 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.062 0.458 . . . . 1.08 111.929 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.16 158.63 18.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.52 110.505 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.1 142.02 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.225 0.536 . . . . 1.48 111.057 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.873 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -159.63 175.89 2.93 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.47 -0.786 . . . . 2.2 110.031 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.873 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 72.2 Cg_exo -14.72 -140.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.545 4.163 . . . . 1.31 115.769 179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 141' ' ' PRO . 7.5 t -22.77 -51.87 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.193 0.812 . . . . 2.31 113.193 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 144' ' ' ALA . . . 113.83 56.05 0.41 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.163 -1.018 . . . . 2.52 113.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.495 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.292 -0.861 . . . . 2.6 110.977 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.492 -0.243 . . . . 3.28 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.451 ' HB3' ' HA2' ' A' ' 127' ' ' GLY . 78.9 p -78.65 158.55 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 2.43 110.934 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 m -159.9 149.24 17.86 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 1.84 111.08 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.87 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 14.9 tt -142.82 147.75 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.596 -0.729 . . . . 2.15 110.986 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 53.6 p -88.86 146.3 25.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.28 0.562 . . . . 1.12 110.998 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 40.28 82.52 0.22 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.868 -1.06 . . . . 0.65 111.384 -178.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.6 Cg_endo -78.15 -11.17 16.34 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 124.008 3.139 . . . . 0.88 113.127 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.56 121.8 13.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.592 -0.892 . . . . 2.06 108.592 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.899 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.1 tt0 -143.81 158.99 43.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.765 1.024 . . . . 1.71 113.765 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 29' ' ' ILE . 56.3 ttm -138.52 135.05 34.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.692 -1.14 . . . . 1.86 109.138 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.899 HD11 ' OE2' ' A' ' 27' ' ' GLU . 31.9 mm -133.79 139.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.39 111.925 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.2 mt-10 -132.61 122.23 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 1.19 109.544 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 11.6 tptm -142.1 161.52 37.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.74 -0.384 . . . . 2.52 111.119 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.003 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.17 131.69 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.39 111.573 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 137' ' ' VAL . 27.7 ttmt -44.89 132.04 6.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.767 -0.651 . . . . 2.35 111.345 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.94 -16.56 56.65 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.056 -0.592 . . . . 0.31 112.504 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 66.4 mm-40 -80.32 159.97 25.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.009 -0.737 . . . . 2.11 109.009 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.979 HG22 ' OD1' ' A' ' 106' ' ' ASN . 10.1 m -90.84 121.69 32.91 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.001 -0.68 . . . . 0.33 110.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.53 119.73 38.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.146 0.498 . . . . 0.26 111.451 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.7 t80 -79.24 116.38 19.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 1.43 111.638 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.721 HD12 HD12 ' A' ' 105' ' ' ILE . 15.4 mt -99.96 105.05 32.66 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.935 -0.765 . . . . 0.8 108.935 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.786 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.0 Cg_endo -82.31 124.92 4.37 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.424 2.083 . . . . 0.42 114.09 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.9 t -141.16 132.71 27.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 1.03 109.473 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.579 ' O ' HG13 ' A' ' 22' ' ' ILE . 41.9 mttm -141.08 153.47 45.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.28 -0.418 . . . . 1.66 110.538 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.919 ' CE2' HD11 ' A' ' 53' ' ' LEU . 36.3 p90 -140.41 153.02 46.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.567 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -79.89 128.39 33.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 1.33 111.299 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.574 ' C ' HD13 ' A' ' 45' ' ' LEU . 3.0 tm? -99.75 131.42 45.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.63 -0.713 . . . . 2.12 110.725 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 45' ' ' LEU . 46.0 m -152.24 139.91 13.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 110.223 -0.288 . . . . 1.75 110.223 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.57 -25.69 5.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.398 2.065 . . . . 1.61 112.344 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -39.97 67.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.345 -0.388 . . . . 2.18 110.53 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -75.93 79.62 2.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.606 -0.887 . . . . 2.41 108.606 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.95 -0.23 54.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.757 -0.656 . . . . 1.64 112.306 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -71.21 158.96 53.79 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.342 -0.932 . . . . 0.55 112.719 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 123' ' ' LYS . 18.6 Cg_endo -59.93 132.5 45.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.472 2.115 . . . . 0.85 111.376 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.919 HD11 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -78.2 104.67 8.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.444 -0.344 . . . . 1.9 111.698 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.2 m-20 -118.3 103.56 9.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.53 0.681 . . . . 1.78 111.426 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.743 ' CD1' HG13 ' A' ' 122' ' ' VAL . 4.7 mm -89.56 104.44 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.853 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 73' ' ' LEU . 85.9 tt0 -101.73 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.185 0.439 . . . . 1.67 112.185 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.3 m95 -99.99 124.39 45.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.22 110.303 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.618 HD12 ' OE1' ' A' ' 119' ' ' GLN . 92.2 mt -112.23 139.96 47.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.472 -0.566 . . . . 0.41 109.472 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.628 HD11 ' O ' ' A' ' 114' ' ' ASP . 3.7 tt -129.59 130.05 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.994 0.426 . . . . 0.78 111.675 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 19.6 m -114.3 102.61 54.95 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 115.799 -0.637 . . . . 1.25 109.328 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.7 Cg_exo -78.67 113.79 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.707 2.272 . . . . 0.53 112.255 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.98 87.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.29 -0.868 . . . . 0.41 111.283 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.73 -40.01 61.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 1.82 111.009 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 12.5 t-20 -82.91 159.96 22.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 1.94 111.662 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.67 -17.49 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.419 -0.81 . . . . 1.66 111.408 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 60.8 mttp -69.76 152.66 44.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.592 -0.731 . . . . 1.74 112.113 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -156.31 126.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-O 121.829 0.823 . . . . 0.97 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 56.47 40.04 29.74 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 1.77 111.988 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -89.14 147.71 24.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.628 -0.26 . . . . 1.96 111.158 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG11 ' OH ' ' A' ' 84' ' ' TYR . 22.4 t -67.54 139.74 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.689 -0.486 . . . . 0.77 109.689 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 -52.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.15 112.912 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.911 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.21 127.04 31.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.076 -0.713 . . . . 0.29 109.076 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' HG3' ' A' ' 56' ' ' GLU . 7.4 tt -140.13 160.63 39.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 1.3 110.633 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.925 ' CD1' HD13 ' A' ' 79' ' ' ILE . 20.9 t80 -134.78 104.04 5.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.619 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.473 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 35.6 t -143.61 159.82 41.76 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.475 0.546 . . . . 0.89 112.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.14 31.89 8.91 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.862 -0.608 . . . . 0.57 113.155 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t0 71.07 2.57 4.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.269 . . . . 1.46 111.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 92.2 mttt -100.18 113.4 26.03 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.979 -0.378 . . . . 2.41 109.979 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.925 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.34 128.8 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.063 -1.458 . . . . 1.66 107.063 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.725 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -112.59 115.65 28.94 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.241 -0.89 . . . . 1.25 110.328 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.872 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.7 p-10 -166.07 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 106.799 -1.556 . . . . 1.2 106.799 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -79.67 -25.72 41.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.585 -1.189 . . . . 2.17 108.491 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -81.32 -28.26 34.64 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.849 -1.167 . . . . 5.05 107.849 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 2.7 m-85 -87.65 120.93 71.18 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 114.769 -1.105 . . . . 1.29 110.727 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 84' ' ' TYR . 7.7 Cg_exo -71.47 -28.67 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.033 1.822 . . . . 0.79 112.951 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' HD23 ' A' ' 87' ' ' LEU . 28.7 t0 -49.22 -30.01 6.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.228 -0.589 . . . . 1.36 112.06 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.946 HD22 ' HD2' ' A' ' 90' ' ' ARG . 29.9 mt -157.56 38.01 0.28 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.121 -0.945 . . . . 1.62 110.504 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 23.9 pttm -55.81 134.09 51.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.877 -0.601 . . . . 2.39 112.392 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.36 76.0 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.39 -0.823 . . . . 0.37 114.461 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.946 ' HD2' HD22 ' A' ' 87' ' ' LEU . 3.5 ptp180 -145.27 -48.13 0.23 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.701 1.371 . . . . 1.59 114.701 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.911 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.22 81.47 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-O 122.992 1.377 . . . . 0.2 108.064 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 106' ' ' ASN . 19.8 m80 -102.91 126.98 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.24 -2.254 . . . . 0.29 112.343 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.941 ' CD1' HG23 ' A' ' 105' ' ' ILE . 80.5 m-85 -70.01 125.42 26.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 120.168 -0.613 . . . . 1.23 109.701 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.631 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.4 p -76.14 32.94 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.204 -0.907 . . . . 0.46 112.027 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.8 m -148.46 132.51 17.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 1.2 111.216 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -91.72 4.9 51.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 2.22 110.585 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.04 66.29 1.2 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.135 -0.691 . . . . 2.14 109.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.558 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -57.72 -31.76 66.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.888 . . . . 1.49 111.425 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.99 2.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.291 0.478 . . . . 2.04 112.291 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 5.4 t -89.97 -0.03 57.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.761 -0.654 . . . . 1.4 110.619 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.89 -14.01 41.28 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.055 -0.593 . . . . 0.38 112.834 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -100.02 108.03 20.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 1.44 110.853 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -111.62 19.99 17.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.104 0.409 . . . . 0.43 112.104 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.0 m -60.04 143.78 51.11 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.006 1.484 . . . . 1.04 115.006 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.941 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -129.67 133.26 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.735 -1.12 . . . . 0.31 111.252 178.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.979 ' OD1' HG22 ' A' ' 36' ' ' THR . 2.9 t-20 -102.84 157.33 17.04 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.022 -1.103 . . . . 1.15 108.022 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.917 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -114.81 117.38 55.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.988 0.423 . . . . 0.27 111.456 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.832 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.03 143.01 31.85 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.48 -0.782 . . . . 0.29 110.556 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.772 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 8.7 t-20 48.88 58.31 5.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.958 -0.565 . . . . 1.52 111.826 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.1 mt -47.27 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.754 1.02 . . . . 1.02 113.754 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.742 ' HA ' ' HB3' ' A' ' 144' ' ' ALA . 54.1 tt0 -56.58 145.57 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.983 -0.553 . . . . 2.13 110.793 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.584 HD13 ' HE2' ' A' ' 33' ' ' LYS . 62.5 tp -60.03 -40.0 87.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 1.7 111.127 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -73.51 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.939 -0.573 . . . . 1.32 111.632 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.628 ' O ' HD11 ' A' ' 59' ' ' ILE . 95.8 m-20 -69.98 -18.08 63.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 1.58 109.881 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.74 140.66 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.976 -0.556 . . . . 0.42 110.235 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.8 159.14 7.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.9 -1.143 . . . . 0.24 113.951 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.8 m -58.99 139.33 56.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.062 -0.569 . . . . 0.31 112.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 29.9 m-85 -119.98 130.87 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.514 . . . . 1.24 109.888 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.618 ' OE1' HD12 ' A' ' 58' ' ' LEU . 57.8 tt0 -122.05 119.83 32.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.148 -0.221 . . . . 1.16 110.662 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.557 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 39.5 t -100.15 120.01 39.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.468 -0.333 . . . . 1.03 110.76 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.5 mtpt -114.14 104.83 12.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.377 . . . . 1.76 110.842 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 73.8 t -87.52 108.25 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.197 -1.038 . . . . 1.18 108.197 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 83.4 tttt -97.78 110.87 23.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.423 0.897 . . . . 1.62 113.423 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.748 ' HD2' HD12 ' A' ' 53' ' ' LEU . 34.8 tttp -145.61 101.56 3.58 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.545 -0.539 . . . . 2.84 109.545 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.779 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.79 132.18 47.62 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.44 112.332 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.576 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 60.7 Cg_endo -100.62 49.76 1.75 Allowed 'Cis proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.614 -0.994 . . . . 0.56 112.185 -0.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 20' ' ' SER . . . -144.99 103.3 0.29 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.303 -0.951 . . . . 0.48 113.438 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.85 120.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.288 -0.956 . . . . 1.22 110.203 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.006 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -95.45 144.68 25.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 0.57 111.359 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 1.4 m-80 -145.72 129.89 17.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.651 0.611 . . . . 2.03 112.651 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.786 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.84 159.95 42.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.438 -0.346 . . . . 2.95 110.941 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.5 mttt -110.5 146.92 35.14 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.496 0.925 . . . . 2.26 113.496 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.748 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 88.7 mt -143.39 118.97 4.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.266 -0.879 . . . . 0.28 109.535 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -100.9 113.22 25.98 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.91 -0.494 . . . . 0.55 110.406 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 110' ' ' LEU . 1.9 tm? -91.56 128.91 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.253 0.464 . . . . 1.52 112.253 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.6 t -121.53 129.96 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.689 . . . . 0.32 109.297 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 33' ' ' LYS . 26.0 t -103.06 119.96 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.209 0.448 . . . . 1.08 112.209 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.2 mt -84.51 172.13 11.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.52 109.089 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.87 139.24 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.63 . . . . 1.48 111.664 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.003 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -162.69 172.56 5.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.017 -0.992 . . . . 2.2 110.708 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.9 Cg_endo -51.52 -142.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.071 2.514 . . . . 1.31 112.39 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 141' ' ' PRO . 10.7 t -34.16 -49.87 0.38 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.757 0.313 . . . . 2.31 111.82 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 144' ' ' ALA . . . 53.18 55.91 21.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.789 . . . . 2.52 113.261 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 109' ' ' ASN . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 2.6 111.247 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.481 -0.248 . . . . 3.28 112.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.7 p -79.88 140.06 36.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.357 . . . . 2.43 110.859 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -160.05 160.43 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.84 110.843 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 13.3 tt -130.01 129.93 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 2.15 110.558 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -89.39 153.84 20.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.352 0.596 . . . . 1.12 111.259 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 44.33 82.96 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.92 -1.037 . . . . 0.65 111.004 -177.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.663 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.1 Cg_endo -78.55 -86.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.619 2.879 . . . . 0.88 113.207 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.5 tt0 -77.85 123.09 26.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.222 -0.659 . . . . 2.06 109.222 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.8 tp10 -143.91 159.96 41.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.446 0.906 . . . . 1.71 113.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.497 ' O ' HD13 ' A' ' 29' ' ' ILE . 26.0 mtt -132.35 130.01 40.17 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.264 -0.88 . . . . 1.86 109.918 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.606 ' HB ' HD23 ' A' ' 135' ' ' LEU . 33.2 mm -127.57 133.82 66.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.643 0.259 . . . . 0.39 111.524 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.9 mt-10 -123.77 125.73 45.24 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.498 -0.319 . . . . 1.19 110.842 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 110' ' ' LEU . 10.4 mmtp -142.35 160.01 41.1 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.408 . . . . 2.52 111.713 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.824 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.82 139.23 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.39 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 85.5 tttt -49.24 134.87 17.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.858 0.361 . . . . 2.35 111.356 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.52 -21.33 22.44 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.138 -0.553 . . . . 0.31 112.776 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -79.98 159.83 26.13 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.32 -0.993 . . . . 2.11 108.32 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.4 m -87.28 126.78 35.05 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.42 -0.912 . . . . 0.33 110.484 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.018 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.74 117.62 33.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.26 110.162 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.946 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 74.0 t80 -79.13 115.27 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 1.43 112.038 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.776 HD21 HD11 ' A' ' 135' ' ' LEU . 33.9 mt -100.45 104.76 32.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.961 -0.755 . . . . 0.8 108.961 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.683 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.6 Cg_endo -81.94 125.61 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.38 2.053 . . . . 0.42 113.819 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.0 t -140.39 131.25 25.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.833 -1.173 . . . . 1.03 107.833 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 39.4 mttm -140.67 150.59 43.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 1.66 111.183 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 40.6 p90 -140.35 142.04 35.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.642 -0.708 . . . . 1.26 111.133 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -82.3 135.48 35.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.989 -0.551 . . . . 1.33 111.665 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -97.74 140.06 32.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 2.12 111.762 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 2.8 t -159.19 143.21 11.07 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.835 -0.621 . . . . 1.75 109.814 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -41.32 -26.72 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.735 2.29 . . . . 1.61 113.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.82 -50.58 16.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.681 0.277 . . . . 2.18 110.53 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' CG ' ' A' ' 124' ' ' LYS . 4.4 p-10 -74.59 64.25 1.18 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.174 0.512 . . . . 2.41 110.047 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -102.46 2.59 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.479 -0.782 . . . . 1.64 112.556 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.34 169.53 53.11 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.231 -0.985 . . . . 0.55 112.94 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.6 121.96 10.44 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.591 2.194 . . . . 0.85 111.563 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.4 tt -78.29 120.62 23.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.151 -0.477 . . . . 1.9 111.937 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 5.7 m-20 -138.05 103.45 4.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.373 0.606 . . . . 1.78 111.484 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 67.8 mt -98.94 108.45 22.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.103 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' OE2' HD21 ' A' ' 58' ' ' LEU . 85.9 tt0 -100.62 121.17 41.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.765 0.654 . . . . 1.67 112.765 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.901 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.5 m95 -95.33 126.57 40.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.22 109.926 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 88.7 mt -112.9 141.81 46.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.702 -0.481 . . . . 0.41 109.702 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.5 tt -129.99 129.95 65.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.036 0.446 . . . . 0.78 111.793 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.432 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 14.3 m -120.23 102.01 46.35 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 109.015 -0.735 . . . . 1.25 109.015 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.4 Cg_exo -80.02 114.78 3.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.52 2.146 . . . . 0.53 112.92 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.64 73.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.41 110.714 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 86.6 m-20 -86.29 17.2 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 1.82 111.992 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 28.1 m120 -149.86 163.66 37.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.265 0.555 . . . . 1.94 111.68 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.49 -18.84 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.28 -0.873 . . . . 1.66 112.094 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 92.0 mttt -68.51 144.79 54.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.204 -0.453 . . . . 1.74 111.798 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.67 127.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 121.837 0.827 . . . . 0.97 109.636 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 52.88 39.93 29.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.089 -1.414 . . . . 1.77 112.046 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -91.09 145.61 24.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.521 -0.309 . . . . 1.96 110.961 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.6 t -65.91 138.94 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 108.978 -0.749 . . . . 0.77 108.978 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -132.97 -52.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 112.577 0.584 . . . . 1.15 112.577 -176.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.96 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.99 129.95 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.646 -0.872 . . . . 0.29 108.646 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 55' ' ' ILE . 7.7 tp -140.41 157.51 45.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.865 0.364 . . . . 1.3 111.467 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.802 ' CD1' HD13 ' A' ' 79' ' ' ILE . 41.2 t80 -131.3 103.64 6.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 1.3 110.165 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.49 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 41.4 t -144.12 159.78 42.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.661 0.615 . . . . 0.89 112.661 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.13 33.46 5.45 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.838 -0.619 . . . . 0.57 113.26 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t0 70.02 3.26 4.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.604 0.24 . . . . 1.46 111.095 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 21.4 mttm -100.46 116.54 32.65 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.108 -0.331 . . . . 2.41 110.108 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.2 mm -80.71 130.03 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.174 -1.417 . . . . 1.66 107.174 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -117.1 121.59 41.72 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.542 -0.754 . . . . 1.25 110.822 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.5 p-10 -165.82 -52.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.324 -1.361 . . . . 1.2 107.324 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -81.38 -24.14 37.2 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.03 -0.986 . . . . 2.17 109.31 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.93 -26.03 43.66 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.859 -1.064 . . . . 5.05 108.139 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.672 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.8 m-85 -86.37 119.68 71.68 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 114.791 -1.095 . . . . 1.29 110.941 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.2 Cg_endo -50.78 -41.96 52.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.365 1.377 . . . . 0.79 109.93 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' ILE . 63.3 m-20 -67.58 105.6 1.92 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.844 -0.616 . . . . 1.36 110.671 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.862 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.6 mt 68.4 26.79 6.59 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.448 0.907 . . . . 1.62 113.448 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 129.88 43.97 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.78 -0.575 . . . . 2.39 111.477 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.94 17.91 60.53 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.485 -0.864 . . . . 0.37 114.108 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.862 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.7 ptp180 -143.96 -47.92 0.28 Allowed 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 114.448 1.277 . . . . 1.59 114.448 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.96 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.8 81.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 123.109 1.433 . . . . 0.2 107.621 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.526 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.8 m80 -102.07 128.72 48.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 112.15 -2.295 . . . . 0.29 112.363 -175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.112 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.0 m-85 -71.99 120.03 17.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.273 0.559 . . . . 1.23 109.679 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.946 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 22.1 p -70.29 -9.97 57.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.21 -0.904 . . . . 0.46 110.347 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.5 m -89.01 117.42 28.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.775 -0.648 . . . . 1.2 110.625 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -89.95 4.82 48.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.566 0.698 . . . . 2.22 109.798 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' SER . 34.0 p-10 -146.28 66.46 1.19 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.979 -1.119 . . . . 2.14 107.979 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.49 -38.94 82.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.215 -0.902 . . . . 1.49 111.599 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -63.21 0.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.361 0.504 . . . . 2.04 112.361 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 29.3 m -92.97 -1.12 56.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.879 -0.6 . . . . 1.4 110.845 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.497 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.51 -18.75 29.67 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.692 -0.766 . . . . 0.38 113.725 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -99.21 107.95 20.4 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 117.37 0.585 . . . . 1.44 109.829 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.76 23.37 12.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.457 0.91 . . . . 0.43 113.457 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 80.1 p -60.41 147.84 39.43 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.736 1.384 . . . . 1.04 114.736 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.112 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -130.22 133.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 114.53 -1.213 . . . . 0.31 111.015 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.7 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p30 -109.21 144.36 37.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.437 -0.949 . . . . 1.15 108.437 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.95 120.6 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.067 0.461 . . . . 0.27 111.885 -177.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.788 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -81.09 144.43 31.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.316 -0.856 . . . . 0.29 110.721 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.68 54.53 11.03 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.177 -0.465 . . . . 1.52 111.627 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.018 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.8 mt -42.86 90.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.968 1.099 . . . . 1.02 113.968 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.483 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 72.7 mt-30 -59.43 140.6 56.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.909 -0.587 . . . . 2.13 110.829 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.473 HD12 HD12 ' A' ' 115' ' ' ILE . 60.1 tp -60.01 -34.09 72.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.021 -0.733 . . . . 1.7 109.021 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -74.75 -12.43 60.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.271 -0.877 . . . . 1.32 111.338 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.483 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 96.5 m-20 -73.43 -16.56 61.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.755 0.312 . . . . 1.58 110.19 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.37 139.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.314 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.13 162.22 9.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 119.982 -1.104 . . . . 0.24 113.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 71.4 m -59.6 137.77 57.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.141 0.577 . . . . 0.31 112.482 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.678 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 21.0 m-85 -120.02 130.26 54.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.153 -0.684 . . . . 1.24 109.153 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.3 tt0 -121.76 118.63 29.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 1.16 111.29 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 26.5 t -102.4 110.8 22.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 1.03 110.562 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.818 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.5 mtpt -106.62 104.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.82 -0.352 . . . . 1.76 110.23 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.681 ' HA ' HG12 ' A' ' 55' ' ' ILE . 62.8 t -88.07 109.92 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.637 -0.505 . . . . 1.18 109.637 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.9 tttm -96.46 119.5 35.06 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.326 -0.55 . . . . 1.62 112.064 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 49.2 tptt -145.59 101.42 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.648 -0.871 . . . . 2.84 108.648 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 1.033 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.61 134.02 54.78 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 112.455 0.539 . . . . 0.44 112.455 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.7 Cg_endo -99.61 50.47 1.65 Allowed 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.695 -0.96 . . . . 0.56 111.705 -0.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.87 103.2 0.28 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.284 -0.96 . . . . 0.48 113.413 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.4 m -84.51 140.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.607 -0.797 . . . . 1.22 109.802 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -130.09 149.94 51.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.57 111.707 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 45.8 t30 -146.81 142.06 27.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.286 -0.416 . . . . 2.03 111.695 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.761 ' HG2' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -144.61 150.29 37.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 2.95 111.01 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -98.26 140.13 33.02 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.447 0.906 . . . . 2.26 113.447 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.692 HD12 ' CH2' ' A' ' 57' ' ' TRP . 73.8 mt -143.58 113.57 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.266 -0.879 . . . . 0.28 109.339 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 117' ' ' THR . 57.3 m170 -100.45 117.39 34.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.672 -0.411 . . . . 0.55 110.554 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.776 HD11 HD21 ' A' ' 39' ' ' LEU . 12.8 mt -94.41 119.96 33.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.487 0.551 . . . . 1.52 112.487 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 21.6 t -111.93 119.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.146 -1.057 . . . . 0.32 108.146 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 59.5 t -100.47 122.99 53.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.187 0.518 . . . . 1.08 112.181 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.87 162.77 23.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.485 -0.78 . . . . 0.52 109.038 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER -71.65 134.27 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 122.168 0.985 . . . . 1.48 111.75 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.824 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 4.5 mmmt -162.27 174.48 3.63 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 113.404 -1.725 . . . . 2.2 109.659 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.0 Cg_endo -51.52 144.22 33.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.112 1.875 . . . . 1.31 112.15 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.44 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 67.4 m -39.91 -75.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.135 -0.484 . . . . 2.31 112.058 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.97 -60.03 0.76 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.839 -0.696 . . . . 2.52 112.696 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.207 -0.902 . . . . 2.6 111.164 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.484 -0.246 . . . . 3.28 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -79.16 131.5 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 2.43 110.86 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 44' ' ' THR . 53.7 m -75.83 130.04 37.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.251 0.548 . . . . 1.84 111.468 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.618 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.93 133.39 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.833 . . . . 2.15 109.596 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 79.6 p -88.81 150.3 22.99 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.733 0.778 . . . . 1.12 111.914 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.07 82.99 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 114.524 -1.216 . . . . 0.65 111.983 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.1 Cg_endo -78.57 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.675 2.917 . . . . 0.88 112.107 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.32 127.46 32.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.352 -0.981 . . . . 2.06 108.352 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.946 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.6 tt0 -143.94 158.67 43.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.278 1.214 . . . . 1.71 114.278 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 42.0 mtt -139.95 121.86 15.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.5 -1.227 . . . . 1.86 109.13 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.946 HD11 ' OE2' ' A' ' 27' ' ' GLU . 38.9 mm -120.0 122.08 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.39 111.519 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 42.8 mt-10 -112.1 120.06 40.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.472 . . . . 1.19 110.81 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 73.2 mmtt -141.23 150.45 42.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.824 0.345 . . . . 2.52 111.744 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.02 143.74 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.311 -0.404 . . . . 0.39 111.496 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.742 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 43.2 mtmt -42.88 156.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.255 0.55 . . . . 2.35 112.396 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.09 -23.38 0.45 Allowed Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.287 -0.87 . . . . 0.31 114.201 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -79.96 156.2 27.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.544 -0.539 . . . . 2.11 109.544 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.996 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -85.22 134.52 34.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.338 -0.545 . . . . 0.33 109.582 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB3' HG12 ' A' ' 107' ' ' VAL . . . -100.21 110.83 23.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.347 -0.541 . . . . 0.26 111.213 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 94' ' ' THR . 92.7 t80 -79.17 122.2 25.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 1.43 111.618 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.735 HD22 HG21 ' A' ' 133' ' ' ILE . 25.3 mt -118.15 104.34 48.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.429 -0.582 . . . . 0.8 109.429 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.511 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.7 Cg_endo -82.99 133.03 6.47 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.587 2.191 . . . . 0.42 114.778 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.419 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 55.8 m -141.42 104.03 4.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.374 -0.83 . . . . 1.03 110.105 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 10.6 mmtt -102.26 107.71 18.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.224 -0.288 . . . . 1.66 110.224 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 42.5 p90 -93.78 142.72 27.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.355 . . . . 1.26 110.785 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 21' ' ' SER . 9.0 t -79.98 174.24 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.419 0.628 . . . . 1.33 111.627 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 44' ' ' THR . 87.2 mt -142.27 149.8 40.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.924 -1.034 . . . . 2.12 109.96 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.8 t -158.69 147.02 13.92 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.763 0.316 . . . . 1.75 110.886 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.37 -26.67 6.14 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.419 2.079 . . . . 1.61 112.188 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -77.59 -43.85 30.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.417 -0.356 . . . . 2.18 110.694 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 67.6 m-20 -71.98 74.24 0.9 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.435 -0.58 . . . . 2.41 109.435 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -94.04 -5.09 48.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.35 -0.841 . . . . 1.64 111.479 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 159.93 53.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.363 -0.923 . . . . 0.55 112.136 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.43 149.1 31.34 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.526 2.151 . . . . 0.85 112.081 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.949 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.1 tt -77.81 133.47 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 1.9 110.345 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.627 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 10.9 t70 -140.18 152.37 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.454 0.645 . . . . 1.78 112.012 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.71 HD13 ' HB1' ' A' ' 103' ' ' ALA . 31.5 mt -142.8 139.99 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.687 -1.142 . . . . 0.75 109.515 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 1.085 ' HA ' HD22 ' A' ' 73' ' ' LEU . 45.3 mt-10 -140.36 111.66 7.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.337 0.495 . . . . 1.67 112.337 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.9 ' CD2' HD11 ' A' ' 105' ' ' ILE . 77.3 m95 -100.03 119.96 39.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.497 -0.319 . . . . 0.22 111.026 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -106.05 124.33 49.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.597 -0.519 . . . . 0.41 109.597 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.692 HD12 HD11 ' A' ' 87' ' ' LEU . 14.5 tt -109.88 126.34 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.892 0.701 . . . . 0.78 112.892 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 50.2 m -119.98 102.04 46.96 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 108.711 -0.848 . . . . 1.25 108.711 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 96.0 Cg_endo -79.7 117.13 3.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.84 2.36 . . . . 0.53 112.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.76 90.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.861 -0.609 . . . . 0.41 111.496 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.29 -40.0 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.638 . . . . 1.82 112.429 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 13.6 m120 -81.59 161.14 23.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 1.94 112.329 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -69.48 -18.36 63.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.936 -1.029 . . . . 1.66 111.295 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.8 mttp -69.29 151.75 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.741 -0.663 . . . . 1.74 111.125 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.45 135.37 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.55 1.166 . . . . 0.97 110.103 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 43.83 42.39 4.43 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.564 -2.107 . . . . 1.77 112.797 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -96.47 150.87 20.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.653 -0.249 . . . . 1.96 111.158 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 73' ' ' LEU . 20.7 t -66.38 129.43 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 109.696 -0.483 . . . . 0.77 109.696 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.879 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -116.9 -56.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 1.15 112.58 -177.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.963 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.28 128.91 49.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.821 -0.807 . . . . 0.29 108.821 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' GLU . 5.8 mt -134.96 160.0 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.468 0.651 . . . . 1.3 111.701 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.861 ' HD1' HD13 ' A' ' 79' ' ' ILE . 41.3 t80 -135.25 103.33 5.48 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.567 -1.272 . . . . 1.3 107.567 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.523 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 2.3 t -143.15 155.59 44.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.87 -0.604 . . . . 0.89 111.854 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.95 29.47 6.41 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.135 -0.555 . . . . 0.57 113.044 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 73.54 2.94 4.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.508 0.194 . . . . 1.46 111.388 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 118.56 36.65 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.976 -0.379 . . . . 2.41 109.976 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.861 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.79 130.84 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.307 -1.368 . . . . 1.66 107.307 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.632 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -119.92 120.86 37.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.381 -0.827 . . . . 1.25 110.288 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.8 p-10 -165.82 -48.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.663 -1.236 . . . . 1.2 107.663 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.61 -32.09 47.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.019 -0.991 . . . . 2.17 109.185 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -76.18 -28.71 57.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.024 -0.989 . . . . 5.05 108.647 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.3 m-85 -81.01 117.39 67.88 Favored Pre-proline 0 CA--C 1.514 -0.431 0 CA-C-N 114.911 -1.041 . . . . 1.29 110.675 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.7 -40.06 56.41 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.508 1.472 . . . . 0.79 110.117 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.682 ' O ' HG12 ' A' ' 71' ' ' ILE . 5.2 m-20 -67.01 106.37 1.92 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.093 -0.643 . . . . 1.36 110.521 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.5 mt 65.81 28.44 10.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.597 0.962 . . . . 1.62 113.597 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 17.8 pttt -56.58 131.32 48.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.395 -0.522 . . . . 2.39 111.159 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.11 65.07 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.435 -0.888 . . . . 0.37 114.501 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -145.96 -46.25 0.2 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 114.326 1.232 . . . . 1.59 114.326 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.963 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.38 82.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 123.099 1.428 . . . . 0.2 107.274 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.565 ' C ' HG22 ' A' ' 105' ' ' ILE . 7.5 m-70 -103.38 129.83 50.55 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 112.426 -2.17 . . . . 0.29 112.471 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 63.3 m-85 -71.32 120.38 16.82 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.322 -0.622 . . . . 1.23 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.594 HG21 ' HD1' ' A' ' 38' ' ' TYR . 16.6 p -73.03 36.76 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.042 -0.981 . . . . 0.46 113.575 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -149.36 136.0 19.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.388 0.613 . . . . 1.2 111.404 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.04 6.74 46.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 2.22 110.372 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -145.62 65.9 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.444 -0.947 . . . . 2.14 108.444 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 55' ' ' ILE . 8.2 tt -59.47 -38.44 80.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.632 -1.167 . . . . 1.49 111.641 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.5 1.47 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.391 0.515 . . . . 2.04 112.391 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' LEU . 50.6 m -89.99 -0.01 57.34 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 1.4 111.151 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.546 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 108.55 -1.91 32.46 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.844 -0.693 . . . . 0.38 113.023 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 96.5 m-20 -100.26 108.7 20.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.729 0.299 . . . . 1.44 110.672 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.71 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -108.78 5.95 25.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.43 111.558 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 1.3 m -59.68 140.0 56.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.667 1.728 . . . . 1.04 115.667 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.24 135.16 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 114.0 -1.455 . . . . 0.31 109.549 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 41.9 p-10 -113.46 148.95 34.98 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.951 -0.759 . . . . 1.15 108.951 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.03 HG12 ' HB3' ' A' ' 37' ' ' ALA . 7.5 p -95.76 123.79 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 N-CA-C 113.455 0.909 . . . . 0.27 113.455 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.766 ' HA ' HG23 ' A' ' 36' ' ' THR . 1.3 p -84.81 141.65 30.33 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.386 -1.734 . . . . 0.29 111.372 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 53.12 60.56 3.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.486 -0.779 . . . . 1.52 112.668 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 135' ' ' LEU . 10.0 mt -46.19 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.041 0.448 . . . . 1.02 112.059 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 2.9 pt20 -177.24 164.06 2.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.839 -0.618 . . . . 2.13 110.347 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.851 ' HA ' HG11 ' A' ' 137' ' ' VAL . 79.4 mt -59.92 -36.73 77.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.806 0.336 . . . . 1.7 111.531 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.5 p -73.29 -15.85 61.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.388 -0.369 . . . . 1.32 111.97 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 89.1 m-20 -72.99 -20.07 61.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.622 -0.431 . . . . 1.58 110.005 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.903 HD12 HG12 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -47.12 144.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.114 -0.494 . . . . 0.42 110.947 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.84 150.73 5.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.564 -1.303 . . . . 0.24 114.115 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.453 HG23 ' CE1' ' A' ' 134' ' ' HIS . 95.6 m -59.27 129.97 44.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.024 -0.588 . . . . 0.31 111.965 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 87' ' ' LEU . 22.9 m-85 -110.21 129.92 55.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.808 . . . . 1.24 108.82 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.835 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.5 tt0 -114.72 113.04 23.77 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.88 -0.415 . . . . 1.16 109.88 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 7.3 t -100.01 109.36 21.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.965 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 45.0 mttt -120.4 109.97 15.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 1.76 111.836 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 43' ' ' PHE . 45.4 t -94.6 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.18 109.448 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 43.2 tttm -98.67 122.88 42.45 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.994 -0.682 . . . . 1.62 112.732 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 28.5 tttp -144.63 102.36 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.314 -0.625 . . . . 2.84 109.314 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.84 133.32 28.65 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 113.226 0.824 . . . . 0.44 113.226 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.594 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 97.4 Cg_endo -98.43 36.87 6.58 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.439 -1.067 . . . . 0.56 111.753 -1.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.62 102.89 0.43 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-O 122.06 0.811 . . . . 0.48 112.664 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.5 p -90.0 160.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.165 -1.017 . . . . 1.22 109.984 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -139.36 149.32 44.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.336 . . . . 0.57 111.673 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.542 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 37.9 p-10 -146.42 137.25 24.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.286 -0.416 . . . . 2.03 111.862 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.6 ptmt -145.96 155.11 42.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 2.95 110.636 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 24.1 mttt -103.45 140.07 37.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.148 0.796 . . . . 2.26 113.148 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.735 HG21 HD22 ' A' ' 39' ' ' LEU . 87.2 mt -142.22 119.21 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.529 -0.76 . . . . 0.28 109.225 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.453 ' CE1' HG23 ' A' ' 117' ' ' THR . 3.0 m-70 -102.91 119.99 39.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.954 -0.299 . . . . 0.55 110.547 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 110' ' ' LEU . 58.8 tp -89.82 120.03 30.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.428 -0.509 . . . . 1.52 110.936 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 48.6 t -116.28 121.36 67.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.391 -0.822 . . . . 0.32 109.27 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.903 HG12 HD12 ' A' ' 115' ' ' ILE . 14.8 p -94.92 128.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.885 0.374 . . . . 1.08 111.974 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 94.2 mt -83.53 152.8 24.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.525 -0.546 . . . . 0.52 109.525 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.57 134.54 28.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.778 0.799 . . . . 1.48 112.038 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.781 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -165.22 174.86 2.77 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.26 -1.336 . . . . 2.2 108.832 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.781 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 5.9 Cg_endo -48.1 -177.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.924 1.749 . . . . 1.31 111.833 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 141' ' ' PRO . 62.3 m -31.53 -79.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.232 0.456 . . . . 2.31 112.232 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA3' ' CE ' ' A' ' 140' ' ' LYS . . . 43.66 23.52 0.35 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.328 -0.463 . . . . 2.52 113.64 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.294 -0.86 . . . . 2.6 110.99 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' HA3' ' OE2' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.46 -0.256 . . . . 3.28 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -158.92 155.13 27.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.659 0.266 . . . . 2.43 110.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t -159.87 150.5 19.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 1.84 111.537 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.684 HD12 ' O ' ' A' ' 22' ' ' ILE . 2.4 pp -91.54 149.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 2.15 111.144 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.17 158.22 19.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.326 0.584 . . . . 1.12 110.892 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.468 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 44.89 83.82 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.018 -0.992 . . . . 0.65 111.098 -177.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.4 Cg_endo -78.19 -84.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.611 2.874 . . . . 0.88 113.498 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.1 tt0 -77.82 122.13 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.17 -0.612 . . . . 2.06 109.362 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.9 tp10 -143.9 160.65 40.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.418 0.896 . . . . 1.71 113.418 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.1 ttm -134.56 134.33 41.24 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.067 -0.97 . . . . 1.86 109.478 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 28' ' ' MET . 32.8 mm -129.94 129.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.949 -0.569 . . . . 0.39 111.494 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.637 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 98.2 mt-10 -118.36 125.1 49.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.384 -0.371 . . . . 1.19 110.695 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' A' ' 110' ' ' LEU . 61.0 mmtt -141.97 158.05 44.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.638 0.256 . . . . 2.52 111.315 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -77.06 143.38 39.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 0.39 111.69 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 39.6 ttmt -48.51 136.36 13.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 2.35 111.609 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 82.46 -18.42 14.68 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.997 -0.62 . . . . 0.31 113.119 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.9 mm-40 -79.99 158.97 26.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.712 -0.847 . . . . 2.11 108.712 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 m -87.28 129.8 34.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.476 -0.89 . . . . 0.33 109.982 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 114.92 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.807 0.337 . . . . 0.26 110.504 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 94' ' ' THR . 40.8 t80 -79.35 120.77 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.849 -0.614 . . . . 1.43 112.454 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 133' ' ' ILE . 4.4 mp -115.28 104.76 53.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.619 -0.882 . . . . 0.8 108.619 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 88.8 Cg_endo -86.43 104.49 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.328 2.019 . . . . 0.42 114.929 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -98.51 135.51 39.95 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 176.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' HD3' ' OD1' ' A' ' 102' ' ' ASP . 45.5 tptt -140.03 139.99 36.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.741 0.305 . . . . 1.66 110.527 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -140.16 139.76 35.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 1.26 111.413 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.14 126.39 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 1.33 110.775 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD21 ' HE1' ' A' ' 43' ' ' PHE . 84.4 mt -89.09 149.95 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 2.12 110.834 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.8 m -151.32 144.09 16.73 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.486 -0.324 . . . . 1.75 110.133 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.18 -23.57 9.89 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.579 2.186 . . . . 1.61 112.086 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 16.7 pt-20 -77.29 -43.66 32.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.194 -0.457 . . . . 2.18 111.05 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -75.59 76.32 2.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.936 -0.705 . . . . 2.41 109.287 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.51 -3.52 52.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.352 -0.84 . . . . 1.64 111.901 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.03 160.06 53.33 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.691 -0.766 . . . . 0.55 113.024 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.61 136.56 76.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.632 2.222 . . . . 0.85 111.675 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 6.6 mp -78.0 119.05 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.301 -0.409 . . . . 1.9 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -133.01 102.17 5.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.535 0.683 . . . . 1.78 111.033 178.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.881 HG12 HG22 ' A' ' 122' ' ' VAL . 2.6 mp -96.39 105.91 17.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.761 -1.109 . . . . 0.75 110.874 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.646 ' OE2' HD21 ' A' ' 58' ' ' LEU . 86.5 tt0 -100.93 117.66 35.41 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.62 0.6 . . . . 1.67 112.62 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.819 ' CD2' HD11 ' A' ' 105' ' ' ILE . 72.3 m95 -94.06 120.01 33.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.133 -0.321 . . . . 0.22 110.133 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.646 HD21 ' OE2' ' A' ' 56' ' ' GLU . 89.5 mt -105.91 146.86 29.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.866 -0.42 . . . . 0.41 109.866 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 87' ' ' LEU . 12.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.157 0.429 . . . . 0.78 112.157 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.447 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 37.4 m -119.99 102.16 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.631 -0.877 . . . . 1.25 108.631 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.617 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 91.9 Cg_endo -78.96 114.97 3.48 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.775 2.317 . . . . 0.53 113.533 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.18 82.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.352 -0.84 . . . . 0.41 110.614 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 94.4 m-20 -85.93 16.52 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.534 -0.757 . . . . 1.82 112.078 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 28.0 m120 -148.72 161.0 42.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.376 0.608 . . . . 1.94 112.011 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.94 -19.76 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.058 -0.974 . . . . 1.66 112.507 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 43.6 mttt -69.1 153.05 44.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.825 0.345 . . . . 1.74 111.536 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.36 128.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.716 0.77 . . . . 0.97 109.468 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.17 45.18 27.94 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.346 -1.297 . . . . 1.77 112.088 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 136.4 33.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.96 111.089 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.51 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 110.154 -0.313 . . . . 0.77 110.154 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.891 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.5 pp -131.76 -38.85 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.808 0.67 . . . . 1.15 112.808 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.905 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.31 123.85 14.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.175 0.512 . . . . 0.29 110.092 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 8.5 tt -140.38 163.55 32.49 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 116.019 -0.537 . . . . 1.3 109.799 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' ILE . 23.3 t80 -135.31 109.94 8.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.206 0.527 . . . . 1.3 110.477 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.3 t -142.61 159.99 41.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.249 -0.887 . . . . 0.89 111.474 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.32 55.48 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.564 -0.827 . . . . 0.57 112.152 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 74.14 2.83 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.845 -0.178 . . . . 1.46 111.241 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 6.0 mmtm -105.36 118.52 36.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.811 -0.441 . . . . 2.41 109.811 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.73 119.99 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.617 -1.253 . . . . 1.66 107.617 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.839 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -100.01 132.53 45.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.83 -1.077 . . . . 1.25 110.728 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.815 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.8 p-10 -166.32 -58.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.796 -1.557 . . . . 1.2 106.796 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 33.6 p-10 -80.1 -22.01 42.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.565 -1.198 . . . . 2.17 109.731 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.555 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -76.85 -29.8 56.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.85 -1.167 . . . . 5.05 107.85 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.739 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -85.18 118.3 70.54 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 114.452 -1.249 . . . . 1.29 110.263 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -41.0 51.93 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.346 1.364 . . . . 0.79 110.447 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.867 ' HB3' HG22 ' A' ' 71' ' ' ILE . 89.1 m-20 -68.19 104.87 1.92 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.771 -0.65 . . . . 1.36 111.091 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.764 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 34.3 mt 70.4 22.37 5.31 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.295 0.85 . . . . 1.62 113.295 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 21.6 pttp -58.17 136.9 57.34 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.843 -0.536 . . . . 2.39 111.05 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.57 74.81 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.249 -0.977 . . . . 0.37 114.176 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -137.99 -54.61 0.65 Allowed 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 114.754 1.39 . . . . 1.59 114.754 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.905 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -78.28 81.28 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 N-CA-C 107.088 -1.449 . . . . 0.2 107.088 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.501 ' C ' HG22 ' A' ' 105' ' ' ILE . 5.9 m-70 -100.06 129.43 46.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.163 -2.289 . . . . 0.29 112.589 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.093 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -70.37 121.17 17.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 120.231 -0.588 . . . . 1.23 110.054 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.588 HG21 ' CD1' ' A' ' 38' ' ' TYR . 35.0 p -71.4 -10.67 60.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.93 . . . . 0.46 110.099 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 58.1 m -95.15 120.0 34.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.726 -0.67 . . . . 1.2 110.683 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -91.34 6.08 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.927 -0.579 . . . . 2.22 110.189 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -146.25 66.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.551 -0.907 . . . . 2.14 108.551 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.3 -31.29 69.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 1.49 112.21 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -62.86 -4.08 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.142 0.496 . . . . 2.04 111.91 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -0.57 57.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.392 -0.822 . . . . 1.4 110.89 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.507 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 110.07 -20.61 26.03 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.687 -0.768 . . . . 0.38 113.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 82.8 m-20 -92.91 109.01 20.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.964 0.382 . . . . 1.44 111.195 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.29 21.46 16.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.43 111.102 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.728 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 82.5 p -59.98 145.89 44.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 116.03 1.863 . . . . 1.04 116.03 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.093 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.62 133.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 114.246 -1.343 . . . . 0.31 111.27 178.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.678 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.1 p-10 -107.66 147.85 30.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.947 -1.131 . . . . 1.15 107.947 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.75 123.9 52.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.958 0.408 . . . . 0.27 111.79 -178.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.5 p -84.68 142.75 29.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.536 -0.756 . . . . 0.29 110.935 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.9 m-20 49.98 55.69 9.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.996 -0.547 . . . . 1.52 112.133 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.8 mt -46.96 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.577 0.954 . . . . 1.02 113.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 63.7 tt0 -60.03 148.68 34.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.154 -0.475 . . . . 2.13 109.94 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 3.0 tm? -60.02 -39.99 87.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 1.7 110.729 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 74.2 m -72.96 -10.04 59.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.663 . . . . 1.32 111.611 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.95 -18.35 63.35 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.048 -0.352 . . . . 1.58 110.048 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.7 145.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.026 0 CA-C-N 116.113 -0.494 . . . . 0.42 110.397 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 155.79 6.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.984 -1.103 . . . . 0.24 113.887 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.2 m -59.36 139.01 57.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.94 0.496 . . . . 0.31 111.808 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.0 m-85 -119.99 133.68 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.612 -0.514 . . . . 1.24 109.612 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.3 tt0 -123.11 115.22 21.44 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.101 -0.24 . . . . 1.16 110.843 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.485 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.3 t -99.96 112.15 24.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.011 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.847 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 98.4 mttt -110.49 106.51 15.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.627 -0.26 . . . . 1.76 111.577 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.881 HG22 HG12 ' A' ' 55' ' ' ILE . 47.6 t -88.21 110.05 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.75 -0.833 . . . . 1.18 108.75 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.708 ' HG3' HG12 ' A' ' 128' ' ' VAL . 61.1 tttp -96.06 120.3 36.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.869 0.692 . . . . 1.62 112.869 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 11.0 mtmt -144.25 101.64 3.73 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.663 -0.495 . . . . 2.84 109.663 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.22 132.32 51.64 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.45 -0.341 . . . . 0.44 111.751 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 59.7 Cg_endo -100.37 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.808 -0.913 . . . . 0.56 112.366 -0.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 103.18 0.28 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.397 -0.906 . . . . 0.48 113.141 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.708 HG12 ' HG3' ' A' ' 123' ' ' LYS . 13.4 m -87.06 142.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.221 -0.99 . . . . 1.22 109.724 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -136.03 148.11 48.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.979 -0.288 . . . . 0.57 111.642 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.628 ' O ' HD11 ' A' ' 22' ' ' ILE . 47.2 p-10 -146.61 151.67 37.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.466 0.543 . . . . 2.03 112.466 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.916 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.29 153.51 41.36 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.154 -0.475 . . . . 2.95 110.958 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 18.6 tttt -99.59 139.63 34.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.486 0.55 . . . . 2.26 112.486 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.947 HG21 HD23 ' A' ' 39' ' ' LEU . 95.2 mt -143.19 117.79 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.28 109.641 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 117' ' ' THR . 62.6 m170 -100.04 116.16 31.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.008 0.433 . . . . 0.55 111.246 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.889 HD11 HD22 ' A' ' 110' ' ' LEU . 1.8 tm? -89.17 125.18 34.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 1.52 111.479 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 39.2 t -121.22 124.71 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.32 109.939 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.4 t -97.19 120.24 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 1.08 111.51 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.0 mt -80.45 160.02 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.52 109.686 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -77.03 137.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 1.48 111.59 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.795 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -164.93 179.47 1.13 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 114.633 -1.167 . . . . 2.2 109.308 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.795 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 10.7 Cg_endo -53.58 -159.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.062 1.841 . . . . 1.31 112.407 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 141' ' ' PRO . 35.7 t -32.08 -78.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.414 -0.357 . . . . 2.31 111.879 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.46 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 77.49 -43.76 2.13 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.994 -0.622 . . . . 2.52 113.709 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.22 -0.895 . . . . 2.6 111.114 -179.706 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.646 -0.181 . . . . 3.28 112.646 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.9 t -159.67 151.31 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 2.43 110.894 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -160.01 150.01 18.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 1.84 111.024 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.815 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 2.15 110.719 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.688 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.0 p -93.44 156.22 16.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.575 0.702 . . . . 1.12 111.958 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 43.06 82.41 0.23 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.698 -1.137 . . . . 0.65 112.013 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -79.3 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.775 2.983 . . . . 0.88 113.048 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 46.2 mt-10 -78.18 126.58 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.129 -0.693 . . . . 2.06 109.129 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 132' ' ' LYS . 41.8 tt0 -144.11 159.25 42.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 16.5 mtm -140.12 116.43 10.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.629 -1.169 . . . . 1.86 109.376 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.619 ' HB ' HD23 ' A' ' 135' ' ' LEU . 39.2 mm -120.01 130.01 74.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.39 111.553 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.65 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 35.8 mt-10 -120.59 128.06 52.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.572 -0.285 . . . . 1.19 110.711 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 51.3 tptt -142.82 158.48 43.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.687 -0.233 . . . . 2.52 110.552 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.767 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.7 141.91 40.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.788 0.328 . . . . 0.39 111.552 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.661 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 32.1 tttt -47.77 140.98 5.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.0 0.429 . . . . 2.35 111.444 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 83.04 -21.95 7.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.832 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.767 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.05 159.01 26.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.318 -0.993 . . . . 2.11 108.318 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.0 m -88.13 130.0 35.15 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.546 -0.862 . . . . 0.33 110.236 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.933 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.76 113.48 25.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.26 110.617 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.4 t80 -79.26 120.01 23.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 1.43 112.402 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.863 HD23 HG21 ' A' ' 133' ' ' ILE . 4.5 mp -115.68 104.88 52.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.476 -0.935 . . . . 0.8 108.476 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 90.3 Cg_endo -85.48 104.65 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.47 2.114 . . . . 0.42 115.914 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -102.25 131.51 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.467 -0.938 . . . . 1.03 108.467 176.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 23.0 tptm -140.69 105.08 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.042 0.449 . . . . 1.66 110.393 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.895 ' HB3' HG11 ' A' ' 122' ' ' VAL . 38.6 p90 -90.95 141.89 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 1.26 111.647 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 45' ' ' LEU . 25.1 m -79.8 164.14 23.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 1.33 110.483 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' N ' HG22 ' A' ' 44' ' ' THR . 77.4 mt -138.79 149.95 45.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 2.12 111.44 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 m -157.73 148.57 16.28 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.544 -0.753 . . . . 1.75 109.885 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.04 -23.61 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.889 2.392 . . . . 1.61 112.979 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 85.6 tt0 -74.64 -25.92 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.518 -0.31 . . . . 2.18 111.73 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 46' ' ' SER . 55.8 p-10 -63.54 82.69 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 121.534 0.683 . . . . 2.41 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' GLU . 95.1 mt-30 -94.24 0.02 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 1.64 111.822 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.971 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -92.91 170.22 31.75 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.126 -1.035 . . . . 0.55 113.087 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.02 153.03 63.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.913 2.409 . . . . 0.85 111.86 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.681 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.0 tt -78.14 123.99 27.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.306 -0.406 . . . . 1.9 110.613 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 15.3 m-20 -136.34 150.64 48.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.508 0.671 . . . . 1.78 111.494 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 25.1 mt -142.65 139.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.75 109.174 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 99.2 mt-10 -140.68 116.24 10.16 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.185 0.439 . . . . 1.67 112.185 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.843 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.2 m95 -101.79 122.85 44.73 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 121.102 -0.239 . . . . 0.22 110.751 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.8 mt -109.19 139.87 43.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.145 -0.687 . . . . 0.41 109.145 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 tt -130.04 130.0 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.196 0.522 . . . . 0.78 112.245 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.5 m -120.47 102.82 44.9 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.461 -0.79 . . . . 1.25 109.11 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 97.8 Cg_endo -79.11 114.59 3.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.591 2.194 . . . . 0.53 113.28 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.79 80.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.365 -0.834 . . . . 0.41 110.828 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -86.15 20.69 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 1.82 111.919 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 35.1 m120 -151.28 161.98 41.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.288 0.566 . . . . 1.94 111.873 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.32 -19.83 64.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.287 -0.869 . . . . 1.66 112.32 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 90.8 mttt -68.51 146.4 53.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.257 -0.429 . . . . 1.74 111.008 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -155.4 127.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 CA-C-O 121.971 0.891 . . . . 0.97 109.994 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 54.15 39.97 31.22 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.841 -1.527 . . . . 1.77 112.582 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.2 146.81 23.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 1.96 111.137 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 ' OH ' ' A' ' 84' ' ' TYR . 44.6 t -66.58 137.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.905 -0.405 . . . . 0.77 109.905 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.894 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -129.39 -52.41 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 1.15 112.73 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.972 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.52 130.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 107.982 -1.118 . . . . 0.29 107.982 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 159.97 41.02 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 120.833 -0.347 . . . . 1.3 111.704 -176.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.6 t80 -135.81 103.82 5.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.195 -0.669 . . . . 1.3 109.195 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.449 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 20.2 m -142.6 159.99 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.751 0.31 . . . . 0.89 111.582 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.11 25.93 18.95 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.602 -0.809 . . . . 0.57 112.272 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 74.75 1.62 3.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.512 0.196 . . . . 1.46 111.091 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.9 mttt -100.01 115.08 28.89 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 110.034 -0.358 . . . . 2.41 110.034 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.725 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.55 128.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.575 -1.269 . . . . 1.66 107.575 177.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.6 m-85 -113.13 129.33 56.54 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.874 -1.512 . . . . 1.25 110.256 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 21.9 p-10 -166.16 -54.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.654 -1.239 . . . . 1.2 107.654 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -80.13 -20.05 45.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.025 -0.989 . . . . 2.17 109.202 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.43 -26.25 35.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.216 -0.902 . . . . 5.05 108.904 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.532 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -85.3 111.81 39.25 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.073 -0.967 . . . . 1.29 111.057 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.5 -41.9 10.83 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.427 1.418 . . . . 0.79 109.939 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 60.3 t0 -67.89 105.46 1.99 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.64 -0.709 . . . . 1.36 110.266 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.904 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 5.6 mt 68.66 20.03 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.012 1.116 . . . . 1.62 114.012 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 12.2 pttm -54.78 127.06 26.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.336 -0.852 . . . . 2.39 110.84 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.77 12.94 48.75 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.212 -0.994 . . . . 0.37 114.213 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.904 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.5 ptp180 -143.81 -47.6 0.28 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 114.619 1.34 . . . . 1.59 114.619 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.972 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.58 81.15 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.275 1.512 . . . . 0.2 107.544 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -101.58 127.83 48.12 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.044 -2.344 . . . . 0.29 111.856 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.1 ' CD1' HG23 ' A' ' 105' ' ' ILE . 88.1 m-85 -69.59 125.9 28.12 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 119.918 -0.713 . . . . 1.23 110.246 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.713 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.9 p -73.49 29.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.46 111.747 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 93' ' ' PHE . 5.4 m -148.76 127.49 12.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.038 0.447 . . . . 1.2 110.359 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.02 8.17 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.773 -0.649 . . . . 2.22 110.308 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.2 66.2 1.2 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.778 -0.823 . . . . 2.14 108.778 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.618 HD21 ' CG ' ' A' ' 93' ' ' PHE . 6.3 mp -58.36 -23.56 57.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 1.49 111.616 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.54 -3.41 2.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.162 0.506 . . . . 2.04 112.098 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 10.01 25.7 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.466 -0.788 . . . . 1.4 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.577 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 96.54 -10.39 66.86 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.913 -0.66 . . . . 0.38 113.079 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -95.25 110.12 22.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 1.44 111.602 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -110.22 16.06 21.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.43 110.569 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.5 m -59.94 140.38 56.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.229 1.566 . . . . 1.04 115.229 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.1 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.28 136.59 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-N 114.853 -1.067 . . . . 0.31 111.002 178.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.717 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p-10 -112.86 142.98 44.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.33 -0.989 . . . . 1.15 108.33 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.887 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.42 120.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.107 0.48 . . . . 0.27 111.512 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -84.57 141.9 30.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.344 -0.844 . . . . 0.29 110.659 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.514 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 33.8 m120 53.82 52.77 12.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.52 111.346 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.933 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.0 mt -43.08 87.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.558 1.318 . . . . 1.02 114.558 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' ASN . 57.4 mt-30 -58.2 141.93 49.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.055 -0.521 . . . . 2.13 110.593 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.554 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 87.0 mt -59.93 -33.1 71.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.885 0.374 . . . . 1.7 110.487 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.4 m -75.06 -13.13 60.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 1.32 111.213 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.58 -18.59 62.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.87 -0.419 . . . . 1.58 109.87 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.49 141.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 116.044 -0.525 . . . . 0.42 110.535 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.83 162.21 9.01 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.225 -0.988 . . . . 0.24 113.514 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.51 135.77 57.77 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.414 0.524 . . . . 0.31 112.414 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.915 ' CE1' HD12 ' A' ' 135' ' ' LEU . 41.3 m-85 -120.05 129.67 54.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.988 -0.551 . . . . 1.24 109.72 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -121.35 119.97 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.186 -0.206 . . . . 1.16 111.206 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.5 t -99.94 117.42 34.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.096 -0.335 . . . . 1.03 110.096 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 37.3 mtpt -118.07 107.87 14.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 1.76 110.82 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.895 HG11 ' HB3' ' A' ' 43' ' ' PHE . 7.2 p -92.27 106.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.026 -0.361 . . . . 1.18 110.026 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.6 tttm -93.89 115.18 27.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.04 -0.664 . . . . 1.62 112.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -145.86 102.07 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.1 -0.704 . . . . 2.84 109.1 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.971 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.06 134.31 39.73 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 112.369 0.507 . . . . 0.44 112.369 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 77.0 Cg_endo -100.05 46.82 2.29 Favored 'Cis proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.642 -0.982 . . . . 0.56 111.208 -0.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.81 102.93 0.31 Allowed Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.086 -1.054 . . . . 0.48 113.683 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.4 m -93.21 138.21 20.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 113.861 -1.17 . . . . 1.22 109.233 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.815 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -140.76 144.47 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.979 0.363 . . . . 0.57 111.979 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.5 p-10 -146.77 151.45 37.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.482 0.549 . . . . 2.03 112.482 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.0 160.03 41.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 2.95 111.15 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 61.0 mttp -102.53 139.81 37.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 112.422 0.527 . . . . 2.26 112.422 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.863 HG21 HD23 ' A' ' 39' ' ' LEU . 84.9 mt -142.12 114.55 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.959 -0.756 . . . . 0.28 108.959 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.526 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.4 m-70 -99.97 115.55 29.96 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.481 -0.488 . . . . 0.55 110.398 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.915 HD12 ' CE1' ' A' ' 118' ' ' TYR . 46.5 mt -93.68 120.05 33.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.65 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 17.6 t -115.25 120.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.306 -0.998 . . . . 0.32 108.306 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 115' ' ' ILE . 25.4 t -96.26 125.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.814 0.672 . . . . 1.08 112.814 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.85 160.02 22.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.52 109.896 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 139' ' ' VAL . 1.2 p -77.88 142.59 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.987 0.899 . . . . 1.48 112.935 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.661 ' HG3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -162.85 178.83 1.4 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 113.863 -1.517 . . . . 2.2 109.511 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 59.9 Cg_exo -53.07 -145.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.486 2.124 . . . . 1.31 112.699 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.0 m -39.56 -69.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.905 0.383 . . . . 2.31 111.736 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.634 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 59.29 49.89 73.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 2.52 113.355 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.194 -0.908 . . . . 2.6 111.063 179.731 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.541 -0.224 . . . . 3.28 112.541 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 1.9 m -78.5 125.24 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.797 0.332 . . . . 2.43 110.709 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 t -82.58 140.06 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 1.84 111.555 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pp -104.54 136.13 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.666 -0.697 . . . . 2.15 110.401 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -87.15 148.96 24.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.059 0.457 . . . . 1.12 110.344 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.549 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 43.35 83.81 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.393 -0.822 . . . . 0.65 110.549 -177.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.771 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.8 Cg_endo -77.34 -11.04 17.55 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 123.913 3.076 . . . . 0.88 113.864 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 49.2 mp0 -141.36 126.23 18.16 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.182 -0.673 . . . . 2.06 109.182 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.901 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.5 tt0 -144.09 161.19 39.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.731 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.6 ttm -137.11 137.32 39.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.876 -1.057 . . . . 1.86 109.415 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.901 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.1 mm -132.71 139.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.978 -0.555 . . . . 0.39 111.597 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.58 123.07 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 1.19 110.523 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.76 158.91 43.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.52 112.119 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.978 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -77.03 138.6 39.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 0.39 112.021 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.811 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 34.2 mtmt -47.52 144.2 3.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.163 0.506 . . . . 2.35 111.773 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.4 -25.45 3.27 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.31 112.743 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 81.8 mm-40 -80.02 159.97 26.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.148 -0.686 . . . . 2.11 109.148 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 m -84.54 129.31 34.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.078 -0.649 . . . . 0.33 110.639 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.03 114.1 27.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.068 0.461 . . . . 0.26 110.921 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.0 t80 -79.53 121.28 25.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.803 -0.635 . . . . 1.43 112.569 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 105' ' ' ILE . 20.3 mt -110.05 105.27 57.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 108.913 -0.773 . . . . 0.8 108.913 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.772 ' O ' HD11 ' A' ' 133' ' ' ILE . 2.4 Cg_endo -81.06 128.68 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.51 2.14 . . . . 0.42 114.219 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 17.2 t -140.87 131.48 25.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.838 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.48 146.6 38.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.261 -0.427 . . . . 1.66 110.744 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CG ' HG11 ' A' ' 122' ' ' VAL . 44.1 p90 -140.79 141.05 34.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 1.26 111.908 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.3 p -88.02 143.74 26.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 1.33 110.759 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -94.18 113.32 25.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.692 -0.231 . . . . 2.12 110.564 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.8 m -83.97 140.33 40.14 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 110.004 -0.369 . . . . 1.75 110.004 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.76 -34.24 27.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.731 1.621 . . . . 1.61 110.559 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 21.2 pt-20 -79.49 -35.48 40.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.313 -0.858 . . . . 2.18 111.383 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 78.7 m-20 -71.24 73.66 0.68 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.282 0.563 . . . . 2.41 109.952 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -95.51 -1.21 51.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.301 -0.863 . . . . 1.64 111.427 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.05 161.42 53.11 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.485 -0.864 . . . . 0.55 112.259 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.55 144.42 41.71 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.144 1.896 . . . . 0.85 111.488 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.579 HD23 ' HD3' ' A' ' 124' ' ' LYS . 6.8 mt -77.82 129.96 36.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.907 0.384 . . . . 1.9 111.277 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 70.8 m-20 -136.85 153.96 50.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.734 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.617 HG13 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -143.34 140.36 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.75 110.067 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.898 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.5 tt0 -137.35 115.58 11.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.021 0.439 . . . . 1.67 111.79 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.671 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.2 m95 -98.43 119.5 37.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.965 -0.561 . . . . 0.22 110.826 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.86 120.64 42.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.406 -0.59 . . . . 0.41 109.406 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 8.6 tt -108.83 125.84 65.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.305 0.483 . . . . 0.78 112.305 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -112.97 103.26 55.63 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.83 -0.804 . . . . 1.25 108.83 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.8 Cg_exo -78.62 116.75 3.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.83 2.353 . . . . 0.53 112.536 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.49 92.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.41 111.23 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.91 -40.01 61.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.753 -0.658 . . . . 1.82 111.566 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -82.83 158.48 22.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.31 0.576 . . . . 1.94 111.671 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -69.12 -18.02 63.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.294 -0.867 . . . . 1.66 111.872 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 70.7 mttt -69.46 152.43 44.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.939 -0.573 . . . . 1.74 111.853 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.51 127.89 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-O 121.781 0.801 . . . . 0.97 109.229 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.74 40.01 26.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.288 -1.324 . . . . 1.77 111.431 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.59 143.9 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.442 -0.345 . . . . 1.96 111.089 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 73' ' ' LEU . 46.5 t -66.79 138.87 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.841 -0.8 . . . . 0.77 108.841 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -134.27 -54.66 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.741 0.645 . . . . 1.15 112.741 -177.019 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.827 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.92 130.73 49.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.283 -0.636 . . . . 0.29 109.283 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.898 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 2.9 mp -139.77 163.81 31.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.3 111.48 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.89 ' HD1' HD13 ' A' ' 79' ' ' ILE . 34.5 t80 -139.36 103.02 4.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.461 -0.79 . . . . 1.3 109.413 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -144.42 159.82 42.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.072 -0.513 . . . . 0.89 111.954 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.49 28.43 6.61 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.047 -0.597 . . . . 0.57 112.851 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 73.91 1.32 3.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.557 0.206 . . . . 1.46 111.557 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 27.3 mttt -99.87 119.46 38.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 110.004 -0.369 . . . . 2.41 110.004 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.89 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -81.23 130.21 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.004 -1.48 . . . . 1.66 107.004 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.663 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -115.39 117.83 31.52 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.552 -0.749 . . . . 1.25 110.538 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.881 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -166.28 -48.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 1.2 107.345 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD1' ' HA2' ' A' ' 89' ' ' GLY . 10.3 m-20 -77.38 -33.57 55.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 114.72 -1.127 . . . . 2.17 109.024 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -76.61 -28.77 56.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.739 -1.118 . . . . 5.05 108.762 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.536 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -81.93 117.65 69.13 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 114.946 -1.024 . . . . 1.29 110.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.11 -40.33 59.94 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.64 1.56 . . . . 0.79 110.267 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.72 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.7 m-20 -67.82 106.45 2.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.078 -0.649 . . . . 1.36 110.22 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.8 mp 67.7 29.0 7.11 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.307 0.855 . . . . 1.62 113.307 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.881 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 41.7 pttt -58.03 131.33 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.903 -0.498 . . . . 2.39 111.409 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 82' ' ' ASP . . . 80.61 19.41 68.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.642 -0.789 . . . . 0.37 114.142 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.3 ptp180 -145.78 -47.4 0.21 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 114.295 1.22 . . . . 1.59 114.295 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 71' ' ' ILE . 7.2 p -79.53 82.09 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 122.914 1.34 . . . . 0.2 107.624 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.547 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.4 m80 -103.4 131.38 50.54 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 112.287 -2.233 . . . . 0.29 112.25 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.13 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.7 m-85 -73.45 124.51 25.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.251 -0.58 . . . . 1.23 110.393 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.57 HG22 ' ND2' ' A' ' 106' ' ' ASN . 17.3 p -75.72 34.17 0.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.568 -0.742 . . . . 0.46 111.428 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.7 m -149.03 122.57 9.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.052 0.453 . . . . 1.2 110.87 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -91.48 11.61 23.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 2.22 110.207 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -145.56 65.16 1.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.557 -0.905 . . . . 2.14 108.557 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -55.66 -28.03 53.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.835 -1.075 . . . . 1.49 111.249 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.2 mttt -66.21 0.48 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.099 0.476 . . . . 2.04 112.067 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.5 p -89.98 -0.02 57.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 1.4 111.255 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 98.36 -4.55 60.29 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.673 -0.775 . . . . 0.38 113.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -105.42 108.81 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.146 0.473 . . . . 1.44 110.532 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -108.22 19.44 19.9 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 112.101 0.408 . . . . 0.43 112.101 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 9.3 m -60.36 140.84 56.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.02 1.489 . . . . 1.04 115.02 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.13 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.51 130.44 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 114.831 -1.077 . . . . 0.31 110.849 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.698 ' HB2' HG22 ' A' ' 36' ' ' THR . 30.1 p30 -105.65 147.71 28.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.892 -0.781 . . . . 1.15 108.892 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.68 120.02 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.27 111.26 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.18 144.89 29.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.285 -0.87 . . . . 0.29 110.787 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m120 53.21 60.18 3.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.059 -0.519 . . . . 1.52 112.176 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.28 176.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.255 0.55 . . . . 1.02 112.452 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -177.86 164.16 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.504 -0.771 . . . . 2.13 110.073 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.757 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 88.0 mt -60.08 -36.22 76.9 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.749 0.278 . . . . 1.7 111.749 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.5 p -73.68 -10.03 59.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.602 0.239 . . . . 1.32 111.389 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD2' HG11 ' A' ' 107' ' ' VAL . 11.0 t70 -72.92 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.593 -0.521 . . . . 1.58 109.593 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -47.07 142.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 CA-C-N 115.748 -0.66 . . . . 0.42 111.221 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 148.38 5.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.755 -1.212 . . . . 0.24 114.181 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.561 HG23 ' ND1' ' A' ' 134' ' ' HIS . 94.7 m -59.12 130.01 44.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.025 -0.588 . . . . 0.31 111.772 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.676 ' OH ' HD21 ' A' ' 87' ' ' LEU . 45.3 m-85 -112.02 122.58 48.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.268 -0.424 . . . . 1.24 110.017 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.0 tt0 -119.96 118.41 30.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.621 -0.263 . . . . 1.16 110.71 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 29.7 p -101.52 119.65 39.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 1.03 110.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 83.3 mttt -110.65 110.19 20.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 1.76 110.2 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG13 ' A' ' 55' ' ' ILE . 59.8 t -89.99 106.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.18 109.646 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 7.4 ttpm? -91.15 117.35 29.55 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.365 0.506 . . . . 1.62 112.365 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HD3' HD23 ' A' ' 53' ' ' LEU . 7.1 ttpm? -145.3 101.92 3.66 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.502 -0.555 . . . . 2.84 109.502 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.7 129.8 36.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 113.534 0.938 . . . . 0.44 113.534 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 64.3 Cg_endo -101.95 48.84 1.89 Allowed 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 125.026 -0.823 . . . . 0.56 111.988 -0.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -142.01 103.7 0.34 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.577 -0.82 . . . . 0.48 113.634 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -96.88 132.04 42.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.045 -1.078 . . . . 1.22 109.888 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.523 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.82 147.01 32.37 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.282 0.475 . . . . 0.57 112.282 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.616 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 52.8 p-10 -147.51 161.7 40.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.866 0.691 . . . . 2.03 112.866 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.88 ' HE3' ' HA ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -145.27 160.65 41.17 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 2.95 109.929 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -97.19 145.02 26.45 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.731 1.382 . . . . 2.26 114.731 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.772 HD11 ' O ' ' A' ' 40' ' ' PRO . 93.1 mt -143.59 115.11 2.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 114.55 -1.204 . . . . 0.28 108.624 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.561 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.2 m-70 -100.02 120.05 39.22 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.033 -0.417 . . . . 0.55 111.124 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.807 HD21 ' HB1' ' A' ' 37' ' ' ALA . 1.1 tm? -89.48 128.33 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 1.52 111.846 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 135' ' ' LEU . 62.4 t -116.93 130.0 72.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.32 109.818 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 33' ' ' LYS . 16.4 t -95.26 121.22 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.156 0.428 . . . . 1.08 112.156 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.802 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 64.3 mt -88.57 167.17 13.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.052 -0.522 . . . . 0.52 109.811 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.64 140.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.405 0.622 . . . . 1.48 111.784 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.978 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -164.3 175.34 2.7 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.09 -0.959 . . . . 2.2 110.455 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 140' ' ' LYS . 9.5 Cg_endo -50.68 -142.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.164 2.576 . . . . 1.31 113.127 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 141' ' ' PRO . 55.1 m -31.77 -38.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.413 0.523 . . . . 2.31 112.413 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.679 ' HA2' ' HB3' ' A' ' 33' ' ' LYS . . . 102.53 22.68 9.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.453 -0.88 . . . . 2.52 113.513 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 2.6 111.144 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.52 -0.232 . . . . 3.28 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 t -78.61 140.0 38.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 2.43 110.89 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -76.33 150.06 36.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 1.84 111.159 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -140.96 136.0 33.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.744 -0.662 . . . . 2.15 110.304 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -94.94 146.9 23.92 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.57 0.7 . . . . 1.12 111.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.92 83.07 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 114.755 -1.112 . . . . 0.65 111.352 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.04 -85.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.701 2.934 . . . . 0.88 112.676 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 99.2 mt-10 -78.41 120.26 22.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.023 -0.732 . . . . 2.06 109.023 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.485 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.2 tt0 -144.36 160.5 40.93 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.376 1.25 . . . . 1.71 114.376 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.701 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 93.9 mtp -133.49 129.84 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.939 -1.028 . . . . 1.86 109.74 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.485 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.9 mm -122.07 130.69 74.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.39 111.416 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.714 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 72.7 mt-10 -124.39 129.42 50.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.542 -0.299 . . . . 1.19 110.802 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 36' ' ' THR . 54.4 tptt -141.79 160.04 40.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.767 0.317 . . . . 2.52 111.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.15 138.26 40.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.032 0.444 . . . . 0.39 111.74 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 tttp -47.59 136.47 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.777 -0.647 . . . . 2.35 112.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.79 -21.89 10.35 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.647 -0.706 . . . . 0.31 113.515 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.737 ' O ' HD13 ' A' ' 110' ' ' LEU . 79.5 mm-40 -77.69 -147.57 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.795 -1.187 . . . . 2.11 107.795 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 107' ' ' VAL . 81.6 m -139.07 133.68 31.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.01 0.433 . . . . 0.33 110.441 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.556 ' H ' HD11 ' A' ' 110' ' ' LEU . . . -99.83 117.56 34.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 0.26 110.73 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.666 ' CD2' HG21 ' A' ' 94' ' ' THR . 64.7 t80 -79.25 120.29 23.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 1.43 112.195 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 105' ' ' ILE . 21.1 mt -105.42 106.2 55.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.748 -0.834 . . . . 0.8 108.748 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.0 Cg_exo -79.54 123.54 5.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.669 2.246 . . . . 0.42 113.832 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 49.6 t -141.83 123.96 15.48 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.504 -0.771 . . . . 1.03 109.579 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 87.6 mttt -141.56 149.1 40.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.463 -0.79 . . . . 1.66 110.144 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CG ' HG11 ' A' ' 122' ' ' VAL . 34.4 p90 -140.06 140.04 36.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.624 0.601 . . . . 1.26 112.624 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 140.05 29.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.254 -0.885 . . . . 1.33 110.195 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.475 HD21 HD21 ' A' ' 53' ' ' LEU . 9.6 mp -95.99 117.41 30.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 2.12 111.174 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.24 150.37 70.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 1.75 109.822 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.65 -41.88 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.126 1.884 . . . . 1.61 111.06 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -74.7 -36.96 62.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.517 -0.765 . . . . 2.18 110.473 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.646 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 33.6 t0 -70.21 72.51 0.45 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.41 110.47 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -99.75 0.03 40.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 1.64 111.061 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.03 159.96 53.34 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.94 -0.648 . . . . 0.55 112.912 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.42 139.26 55.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.777 2.318 . . . . 0.85 111.97 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 43' ' ' PHE . 86.9 mt -78.22 130.1 35.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.484 . . . . 1.9 111.394 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.5 m-20 -134.88 159.98 39.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.613 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.667 HD13 ' HB1' ' A' ' 103' ' ' ALA . 27.4 mt -141.99 140.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.417 -0.81 . . . . 0.75 110.412 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 1.026 ' HA ' HD22 ' A' ' 73' ' ' LEU . 48.7 mt-10 -139.98 107.46 5.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.779 -0.368 . . . . 1.67 111.394 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.4 m95 -95.12 126.09 40.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.22 111.521 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.581 HD21 HG22 ' A' ' 70' ' ' VAL . 89.8 mt -118.12 140.19 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.149 -0.686 . . . . 0.41 109.149 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.876 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 2.4 tt -130.0 135.57 60.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.78 112.335 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.1 m -114.11 104.05 54.95 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.168 -0.924 . . . . 1.25 108.998 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.9 Cg_exo -78.47 120.43 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.499 2.133 . . . . 0.53 111.907 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.01 83.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.62 -0.718 . . . . 0.41 111.215 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -75.28 -39.96 59.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 1.82 111.459 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 39.5 m-20 -85.41 158.02 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.608 . . . . 1.94 112.186 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.82 -14.59 62.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.103 -0.953 . . . . 1.66 111.265 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 32.8 mttt -66.23 149.21 50.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.441 -0.799 . . . . 1.74 112.303 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -153.63 127.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 121.796 0.808 . . . . 0.97 109.151 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.84 41.5 30.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.28 -1.327 . . . . 1.77 112.186 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -88.12 139.96 29.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 1.96 111.404 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.673 HG13 HD21 ' A' ' 73' ' ' LEU . 65.3 t -69.98 133.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.77 110.372 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 86' ' ' ASP . 1.3 pp -134.75 -39.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.815 0.672 . . . . 1.15 112.815 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 128.17 24.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.378 -0.601 . . . . 0.29 109.378 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.026 HD22 ' HA ' ' A' ' 56' ' ' GLU . 6.9 mt -137.98 162.29 34.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 1.3 111.277 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.704 ' CD1' HD13 ' A' ' 79' ' ' ILE . 35.4 t80 -133.48 102.68 5.61 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.298 -1.371 . . . . 1.3 107.298 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 5.9 t -143.96 157.53 44.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.638 -0.71 . . . . 0.89 111.731 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.99 29.79 3.49 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.256 -0.497 . . . . 0.57 113.405 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.3 t0 73.83 1.0 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.739 0.274 . . . . 1.46 111.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -100.08 118.58 36.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 110.003 -0.369 . . . . 2.41 110.003 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.2 mm -80.02 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 107.214 -1.402 . . . . 1.66 107.214 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.771 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.7 m-85 -120.81 123.83 43.58 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.48 -0.782 . . . . 1.25 110.982 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.851 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.2 p-10 -165.96 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.818 -1.549 . . . . 1.2 106.818 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -79.8 -31.88 40.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.406 -1.27 . . . . 2.17 109.519 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -72.95 -29.65 63.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.501 -1.296 . . . . 5.05 107.501 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.604 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.12 118.72 73.03 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 114.346 -1.297 . . . . 1.29 109.979 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.0 Cg_endo -50.78 -43.2 47.77 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.428 1.418 . . . . 0.79 110.602 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.877 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.4 m-20 -68.42 106.28 2.47 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.047 -0.524 . . . . 1.36 111.145 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.8 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.1 mp 72.33 24.53 3.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.391 0.886 . . . . 1.62 113.391 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.851 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 14.2 pttm -59.17 134.74 57.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.909 -0.494 . . . . 2.39 111.51 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.6 75.61 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.659 -0.781 . . . . 0.37 113.993 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -143.02 -51.02 0.35 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 114.38 1.252 . . . . 1.59 114.38 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.09 81.99 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 123.08 1.419 . . . . 0.2 107.421 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.546 ' C ' HG22 ' A' ' 105' ' ' ILE . 8.8 m-70 -102.17 127.92 48.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.066 -2.333 . . . . 0.29 112.62 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.129 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.7 m-85 -71.61 122.75 21.09 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 120.163 -0.615 . . . . 1.23 109.601 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.666 HG21 ' CD2' ' A' ' 38' ' ' TYR . 2.3 p -75.04 35.89 0.11 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.46 111.214 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 48.1 m -149.09 125.78 11.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.953 0.406 . . . . 1.2 110.396 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.11 6.81 40.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.937 -0.574 . . . . 2.22 110.383 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -145.92 65.12 1.22 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.583 -0.735 . . . . 2.14 109.06 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.2 mp -59.06 -27.16 65.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.173 -0.921 . . . . 1.49 111.958 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -63.46 1.54 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 2.04 112.078 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 98' ' ' LEU . 18.4 t -90.02 0.03 57.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.586 -0.734 . . . . 1.4 110.671 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.25 -8.46 48.8 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.964 -0.636 . . . . 0.38 113.001 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -94.77 114.13 25.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.125 0.488 . . . . 1.44 110.594 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.667 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.55 13.32 24.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.661 -0.699 . . . . 0.43 111.965 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 51.0 m -59.95 139.57 57.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 115.563 1.69 . . . . 1.04 115.563 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.129 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.41 129.7 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 114.343 -1.299 . . . . 0.31 110.294 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.4 p-10 -105.7 146.31 29.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.542 -0.91 . . . . 1.15 108.542 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -95.37 122.8 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.118 0.485 . . . . 0.27 110.746 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -91.08 145.16 24.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.638 -0.71 . . . . 0.29 110.84 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 144' ' ' ALA . 80.8 m-20 66.7 57.06 0.69 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 1.52 111.466 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -53.95 165.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 1.02 112.095 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.653 ' O ' HG21 ' A' ' 137' ' ' VAL . 10.7 pt20 -177.14 167.87 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.664 -0.698 . . . . 2.13 110.996 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.436 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 89.2 mt -59.99 -37.37 79.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.852 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.6 p -73.24 -17.11 61.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.528 -0.305 . . . . 1.32 111.687 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 92.2 m-20 -71.25 -20.01 62.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.723 -0.391 . . . . 1.58 109.974 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -46.51 144.08 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.044 0 CA-C-N 116.179 -0.464 . . . . 0.42 111.055 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 143.89 4.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.904 -1.141 . . . . 0.24 113.834 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 m -59.05 130.6 47.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.143 -0.529 . . . . 0.31 112.009 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.876 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 28.9 m-85 -110.3 137.08 48.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 1.24 109.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.3 tt0 -126.87 122.17 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.638 -0.255 . . . . 1.16 110.579 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.6 t -99.88 119.76 38.71 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.575 0.226 . . . . 1.03 110.679 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 58.0 mttm -115.25 108.69 16.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 1.76 110.849 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.784 HG11 ' CG ' ' A' ' 43' ' ' PHE . 40.9 t -91.3 108.35 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.619 -0.511 . . . . 1.18 109.619 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 72.8 tttt -93.71 112.32 24.17 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.659 0.614 . . . . 1.62 112.659 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.588 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 12.3 pttm -145.74 103.24 3.76 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 109.831 -0.433 . . . . 2.84 109.831 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.59 129.73 13.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 113.158 0.799 . . . . 0.44 113.158 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.646 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 83.0 Cg_endo -102.67 39.93 4.0 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 C-N-CA 125.109 -0.788 . . . . 0.56 111.423 -0.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -131.66 102.87 0.52 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-O 122.365 0.98 . . . . 0.48 113.478 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 123' ' ' LYS . 1.3 m -96.67 135.05 32.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 113.505 -1.347 . . . . 1.22 108.76 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -132.05 154.19 49.65 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.763 -0.375 . . . . 0.57 111.837 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 49.1 p-10 -146.09 149.31 33.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.174 -0.466 . . . . 2.03 111.519 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.35 165.57 28.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 2.95 111.396 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -104.82 140.05 38.69 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 113.028 0.751 . . . . 2.26 113.028 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.7 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 78.5 mt -145.2 112.18 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.375 -0.972 . . . . 0.28 108.375 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.701 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 26.8 m170 -94.69 121.1 35.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.592 -0.443 . . . . 0.55 111.254 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.07 120.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.127 0.489 . . . . 1.52 111.024 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.7 t -122.26 129.11 75.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.258 -0.883 . . . . 0.32 109.089 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 111' ' ' GLN . 47.4 t -109.98 129.34 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.063 0.459 . . . . 1.08 112.052 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.61 160.06 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.739 -0.664 . . . . 0.52 109.504 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.1 t -76.61 134.99 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.372 0.606 . . . . 1.48 110.949 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.561 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -162.47 170.59 7.57 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.855 -1.066 . . . . 2.2 109.792 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 4.3 Cg_endo -45.89 171.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.339 2.026 . . . . 1.31 111.879 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 144' ' ' ALA . 6.4 p -35.54 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.907 0.336 . . . . 2.31 111.907 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.72 -65.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.295 -0.411 . . . . 2.52 113.419 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.153 -0.927 . . . . 2.6 111.426 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.487 -0.245 . . . . 3.28 112.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -78.34 154.41 30.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 2.43 111.08 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 153.51 22.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.671 -0.695 . . . . 1.84 110.38 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.722 HG21 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 pt -112.11 141.43 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.318 -0.401 . . . . 2.15 111.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -93.17 155.05 17.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.64 0.733 . . . . 1.12 111.724 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 45.87 83.14 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 114.574 -1.193 . . . . 0.65 111.981 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 56.9 Cg_endo -78.55 -82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.745 2.964 . . . . 0.88 112.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.48 129.42 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.68 -0.859 . . . . 2.06 108.68 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HB3' HG12 ' A' ' 133' ' ' ILE . 50.6 tp10 -143.76 159.62 42.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.812 1.042 . . . . 1.71 113.812 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 25.5 mtm -139.91 123.77 17.51 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.826 -1.079 . . . . 1.86 109.376 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 133' ' ' ILE . 34.6 mm -120.02 130.04 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.39 111.75 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.717 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.1 mt-10 -127.57 121.83 31.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.395 -0.366 . . . . 1.19 110.413 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 48.0 mmtm -142.23 161.31 38.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.791 0.329 . . . . 2.52 111.44 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.4 136.55 39.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.39 111.189 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.929 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 52.4 tttp -44.51 132.67 6.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 2.35 111.329 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 90.12 -18.94 45.56 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.867 -0.606 . . . . 0.31 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.709 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.03 158.63 26.46 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.582 -0.896 . . . . 2.11 108.582 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 35.0 m -89.08 125.42 35.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.747 -0.781 . . . . 0.33 110.35 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.12 116.31 29.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.26 110.264 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.18 114.97 18.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.795 -0.639 . . . . 1.43 112.088 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 133' ' ' ILE . 31.6 mt -99.13 108.63 50.72 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.811 -0.811 . . . . 0.8 108.811 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.62 122.78 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.555 2.17 . . . . 0.42 113.907 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' HE3' ' A' ' 131' ' ' LYS . 4.3 t -141.0 125.19 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.062 -0.972 . . . . 1.03 109.016 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 83.2 mttt -141.08 148.4 40.09 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.25 0.548 . . . . 1.66 111.706 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 53' ' ' LEU . 40.8 p90 -140.8 142.62 34.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 1.26 111.076 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 139.63 30.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.904 0.383 . . . . 1.33 110.549 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.635 HD23 ' NZ ' ' A' ' 124' ' ' LYS . 32.4 mt -89.03 150.01 22.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 2.12 111.756 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.9 m -150.33 139.88 13.47 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 109.698 -0.482 . . . . 1.75 109.698 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 5.7 Cg_endo -48.55 -25.4 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.544 2.163 . . . . 1.61 112.144 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.667 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 17.5 pt-20 -78.49 -40.22 35.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.354 -0.384 . . . . 2.18 111.473 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.528 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.1 m-20 -72.27 71.54 0.89 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.171 -0.612 . . . . 2.41 109.68 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 47' ' ' PRO . 87.1 mt-30 -97.37 -4.92 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.712 -0.676 . . . . 1.64 112.366 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.864 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.02 159.97 53.33 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.492 -0.861 . . . . 0.55 112.805 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.43 123.77 12.81 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.363 2.042 . . . . 0.85 111.693 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 43' ' ' PHE . 6.4 tt -78.17 110.2 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 1.9 111.297 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 93.4 m-20 -127.83 103.78 7.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.391 0.615 . . . . 1.78 111.877 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 9.4 mt -91.68 113.31 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.974 -1.012 . . . . 0.75 110.04 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.866 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -107.39 120.55 42.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.249 0.833 . . . . 1.67 113.249 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.918 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.3 m95 -97.0 119.99 36.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.22 109.924 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' OE2' ' A' ' 56' ' ' GLU . 92.0 mt -105.69 140.12 39.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.526 -0.546 . . . . 0.41 109.526 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.1 tt -130.04 130.03 65.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.137 0.494 . . . . 0.78 112.306 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 68' ' ' ASP . 26.4 t -119.31 101.89 48.83 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 108.67 -0.863 . . . . 1.25 108.67 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.0 Cg_exo -79.97 111.57 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.603 2.202 . . . . 0.53 112.725 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.61 75.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.395 -0.82 . . . . 0.41 110.864 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 15.9 t0 -85.6 17.88 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 1.82 112.004 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 26.9 m120 -149.64 163.07 38.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.328 0.585 . . . . 1.94 111.677 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.96 -18.89 64.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.209 -0.905 . . . . 1.66 111.868 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 78.9 mttt -69.31 150.38 47.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.114 -0.494 . . . . 1.74 111.46 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.7 135.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.636 1.208 . . . . 0.97 110.047 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 60' ' ' SER . 1.5 p-10 43.63 39.38 2.36 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 112.536 -2.12 . . . . 1.77 112.08 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 1.96 110.869 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 73' ' ' LEU . 20.0 t -66.27 139.28 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.331 -0.618 . . . . 0.77 109.331 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.895 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.17 -53.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.422 0.527 . . . . 1.15 112.422 -177.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.95 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.76 130.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.857 -0.794 . . . . 0.29 108.857 178.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.866 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.0 159.99 40.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.045 0.45 . . . . 1.3 111.487 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.892 ' HD1' HD13 ' A' ' 79' ' ' ILE . 47.3 t80 -134.09 103.61 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.3 110.03 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 47.5 t -143.54 156.15 44.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.555 0.576 . . . . 0.89 112.555 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.02 32.99 9.6 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.953 -0.567 . . . . 0.57 113.074 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 t0 70.13 4.3 4.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.573 0.225 . . . . 1.46 111.248 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.3 mttt -100.01 114.01 27.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.809 -0.441 . . . . 2.41 109.809 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.892 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.83 -1.544 . . . . 1.66 106.83 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -116.61 121.52 41.97 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.45 -0.795 . . . . 1.25 110.625 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.909 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.5 p-10 -165.7 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.747 -1.205 . . . . 1.2 107.747 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -78.9 -31.08 45.24 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.158 -0.928 . . . . 2.17 109.376 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -75.78 -28.3 58.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.185 -1.043 . . . . 5.05 108.185 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.609 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.1 m-85 -81.59 117.83 69.77 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-N 114.777 -1.101 . . . . 1.29 110.554 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.46 -42.8 40.75 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.602 1.535 . . . . 0.79 110.352 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' O ' HG12 ' A' ' 71' ' ' ILE . 11.6 m-20 -67.28 106.18 1.97 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.105 -0.638 . . . . 1.36 110.695 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.838 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 68.08 26.96 7.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.575 0.954 . . . . 1.62 113.575 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.909 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 2.7 pttt -57.14 128.03 34.92 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.73 -0.606 . . . . 2.39 111.616 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.05 18.59 57.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.589 -0.815 . . . . 0.37 114.225 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.6 ptp180 -145.6 -46.27 0.21 Allowed 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 114.336 1.235 . . . . 1.59 114.336 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.99 82.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 123.102 1.429 . . . . 0.2 107.555 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.56 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.6 m80 -102.67 128.44 49.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.235 -2.257 . . . . 0.29 112.331 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.094 ' CD1' HG23 ' A' ' 105' ' ' ILE . 70.2 m-85 -72.25 124.07 24.3 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.338 -0.545 . . . . 1.23 110.075 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.6 HG21 ' CD1' ' A' ' 38' ' ' TYR . 10.8 p -75.13 34.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.4 -0.818 . . . . 0.46 111.116 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 6.9 m -149.07 123.51 9.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.017 0.437 . . . . 1.2 110.856 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -90.95 10.89 24.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.784 -0.643 . . . . 2.22 110.05 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -145.52 65.79 1.23 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.14 108.416 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -56.24 -31.75 63.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 1.49 111.606 -178.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' HD11 ' A' ' 45' ' ' LEU . 71.9 mttt -66.23 1.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.04 111.979 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -89.45 -0.01 57.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.862 -0.608 . . . . 1.4 111.023 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 100.85 -5.68 56.65 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.783 -0.722 . . . . 0.38 113.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 98' ' ' LEU . 95.9 m-20 -101.9 107.18 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.067 0.434 . . . . 1.44 110.427 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -104.63 11.68 33.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.8 0.667 . . . . 0.43 112.8 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 89.8 p -60.03 140.02 57.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.685 1.735 . . . . 1.04 115.685 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.094 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -131.23 130.02 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 114.197 -1.365 . . . . 0.31 110.507 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.703 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.4 p-10 -104.62 146.23 29.21 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.918 -0.771 . . . . 1.15 108.918 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.14 120.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.021 0.439 . . . . 0.27 111.543 -178.212 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.754 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.7 p -82.26 142.77 31.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.39 -0.823 . . . . 0.29 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.431 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 27.9 m120 49.98 55.51 9.32 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.062 -0.517 . . . . 1.52 111.605 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 24.2 mt -44.55 89.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.566 1.321 . . . . 1.02 114.566 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.486 ' HG2' ' H ' ' A' ' 113' ' ' SER . 64.1 tt0 -60.09 145.38 46.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.708 -0.678 . . . . 2.13 109.896 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.555 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -59.98 -40.04 87.74 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.188 0.518 . . . . 1.7 111.223 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 53.1 m -72.24 -9.98 59.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.505 -0.771 . . . . 1.32 111.642 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.99 -19.95 63.32 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.149 -0.315 . . . . 1.58 110.149 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.561 HG13 HG23 ' A' ' 137' ' ' VAL . 2.1 mt -43.33 145.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.42 110.353 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.86 155.08 6.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 0.24 112.808 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.19 138.38 57.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.198 0.444 . . . . 0.31 112.198 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.601 ' OH ' HD11 ' A' ' 87' ' ' LEU . 21.6 m-85 -119.3 135.1 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.58 . . . . 1.24 109.886 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 53.4 tt0 -127.61 119.94 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.184 -0.302 . . . . 1.16 110.184 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 39.1 t -99.98 118.98 37.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.416 . . . . 1.03 110.065 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 82.2 mttt -116.62 104.75 11.71 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 120.982 -0.287 . . . . 1.76 111.418 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 55' ' ' ILE . 22.1 t -87.71 108.66 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.092 -0.707 . . . . 1.18 109.092 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.592 ' HG3' HG12 ' A' ' 128' ' ' VAL . 39.3 ttpt -99.93 113.09 25.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.174 0.805 . . . . 1.62 113.174 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.635 ' NZ ' HD23 ' A' ' 45' ' ' LEU . 6.7 ttpt -145.51 101.9 3.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.477 -0.564 . . . . 2.84 109.477 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.864 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.22 133.13 41.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.683 -0.69 . . . . 0.44 112.714 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 40.0 Cg_endo -97.84 39.82 4.79 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 124.275 -1.135 . . . . 0.56 112.966 -0.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.31 101.96 0.45 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.922 -1.133 . . . . 0.48 113.496 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.7 m -96.82 140.02 18.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.576 -1.312 . . . . 1.22 109.301 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.07 152.0 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 0.57 112.41 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.552 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 35.8 p-10 -146.59 151.7 37.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.248 0.462 . . . . 2.03 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.722 ' NZ ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.08 160.0 42.08 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.904 -0.589 . . . . 2.95 110.779 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.7 mttt -102.34 141.13 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.633 0.975 . . . . 2.26 113.633 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.797 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 97.7 mt -141.75 116.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.28 108.605 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.437 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 2.2 m-70 -100.32 117.91 35.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.463 -0.495 . . . . 0.55 110.752 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 63.5 tp -89.38 122.89 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.227 0.537 . . . . 1.52 112.411 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.717 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 47.7 t -120.02 126.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.423 -0.954 . . . . 0.32 108.423 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 115' ' ' ILE . 46.2 t -109.95 125.66 67.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 112.223 0.453 . . . . 1.08 112.223 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.5 mt -83.4 163.95 20.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.52 109.614 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -75.0 139.67 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.854 0.835 . . . . 1.48 112.124 -178.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 10.1 mmtp -159.83 175.65 3.06 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 113.875 -1.512 . . . . 2.2 109.863 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 45.2 Cg_exo -57.62 -147.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.644 2.229 . . . . 1.31 113.061 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.574 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 50.4 m -41.61 -40.01 1.79 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.006 0.373 . . . . 2.31 112.006 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 64.55 -65.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.193 -0.527 . . . . 2.52 113.621 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.248 -0.882 . . . . 2.6 111.117 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.564 -0.214 . . . . 3.28 112.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.5 p -78.16 155.51 30.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 2.43 110.904 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.1 t -79.68 157.12 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 1.84 111.058 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 129' ' ' ALA . 70.8 mt -143.38 129.1 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 2.15 110.77 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 69.2 p -94.29 153.63 17.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.399 0.618 . . . . 1.12 111.125 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 41.37 82.27 0.23 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 114.782 -1.099 . . . . 0.65 112.347 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 59.9 Cg_endo -79.02 -84.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.83 3.02 . . . . 0.88 112.269 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.0 mt-10 -78.12 129.12 34.8 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.063 -1.088 . . . . 2.06 108.063 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HB3' HG13 ' A' ' 133' ' ' ILE . 50.6 tp10 -144.09 159.21 43.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.414 1.265 . . . . 1.71 114.414 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.6 mtp -140.01 121.7 15.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.303 -1.317 . . . . 1.86 108.913 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 HG12 HG23 ' A' ' 133' ' ' ILE . 37.3 mm -119.77 129.98 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.611 -0.268 . . . . 0.39 111.252 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.8 pt-20 -129.82 126.76 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.355 . . . . 1.19 110.891 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -142.13 162.05 36.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 2.52 110.858 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.08 40.59 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.197 0.444 . . . . 0.39 112.197 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.667 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 87.2 mttt -43.85 141.53 1.57 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.208 -0.451 . . . . 2.35 112.031 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' OXT' ' A' ' 144' ' ' ALA . . . 82.43 -24.99 4.58 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.749 -0.659 . . . . 0.31 113.003 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -80.07 160.58 25.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.214 -0.661 . . . . 2.11 109.214 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.836 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 27.4 m -83.79 133.29 34.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.957 -0.697 . . . . 0.33 110.449 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -95.45 118.43 32.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.989 0.423 . . . . 0.26 110.773 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.991 ' HE1' HG21 ' A' ' 94' ' ' THR . 65.9 t80 -79.33 131.12 36.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.715 -0.675 . . . . 1.43 112.66 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.816 HD12 HD12 ' A' ' 105' ' ' ILE . 15.7 mt -128.32 104.32 19.95 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 108.991 -0.744 . . . . 0.8 108.991 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 95.8 Cg_endo -86.06 126.98 2.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.657 2.238 . . . . 0.42 114.762 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' SG ' ' CE ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -141.93 126.1 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.288 -0.869 . . . . 1.03 109.588 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 27.8 mttp -141.04 117.0 10.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.399 0.619 . . . . 1.66 110.983 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.791 ' CG ' HG11 ' A' ' 122' ' ' VAL . 29.0 p90 -92.84 139.84 30.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.935 -1.03 . . . . 1.26 111.031 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 143.3 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.415 . . . . 1.33 110.91 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.2 mt -100.38 139.76 35.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 2.12 111.525 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.423 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 5.3 m -158.93 147.13 13.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.583 . . . . 1.75 109.899 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.28 -23.73 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.44 2.094 . . . . 1.61 113.082 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -74.47 -43.24 56.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 120.563 0.221 . . . . 2.18 111.014 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 124' ' ' LYS . 1.2 p-10 -73.65 74.51 1.52 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.124 -0.63 . . . . 2.41 109.503 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -90.64 -12.73 35.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 1.64 112.106 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.66 159.95 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.292 -0.956 . . . . 0.55 112.912 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 140.93 97.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.487 2.125 . . . . 0.85 111.385 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.09 104.09 8.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.793 0.33 . . . . 1.9 111.287 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 96.0 m-20 -114.92 103.29 10.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.64 0.734 . . . . 1.78 110.996 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.3 mt -95.07 126.53 47.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.046 -0.979 . . . . 0.75 110.709 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 73' ' ' LEU . 96.5 mt-10 -120.54 117.57 27.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.486 0.55 . . . . 1.67 112.486 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.799 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -96.44 120.04 36.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.072 -0.344 . . . . 0.22 110.072 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.808 HD12 ' OE1' ' A' ' 119' ' ' GLN . 83.1 mt -108.76 140.25 42.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.36 -0.608 . . . . 0.41 109.36 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.651 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.4 tt -129.91 130.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 0.78 112.289 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.6 m -119.99 103.35 45.49 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.01 -0.995 . . . . 1.25 109.142 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 86.2 Cg_endo -78.31 119.11 4.47 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.655 2.237 . . . . 0.53 112.367 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.05 87.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.41 111.55 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD2' ' CD1' ' A' ' 112' ' ' LEU . 81.2 m-20 -76.56 -39.98 51.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.021 -0.536 . . . . 1.82 112.138 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 28.1 m120 -84.43 160.01 20.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.348 0.594 . . . . 1.94 112.214 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -69.84 -17.6 63.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.182 -0.917 . . . . 1.66 111.798 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.7 mttp -65.9 147.14 53.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.849 -0.614 . . . . 1.74 111.02 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.83 127.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 CA-C-O 121.883 0.849 . . . . 0.97 110.187 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 40.02 26.12 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.98 -1.464 . . . . 1.77 112.694 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.4 mt-30 -94.3 143.22 26.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.104 -0.238 . . . . 1.96 111.444 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.584 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.1 t -66.46 132.1 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 108.855 -0.795 . . . . 0.77 108.855 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.939 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -123.48 -51.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.352 0.871 . . . . 1.15 113.352 -176.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.032 HG21 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.81 105.3 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.699 0.761 . . . . 0.29 108.949 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -109.72 155.09 21.99 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.136 -0.938 . . . . 1.3 111.078 -177.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.916 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 22.0 t80 -135.11 104.79 6.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 1.3 110.439 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.439 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 45.2 m -142.57 158.41 43.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.132 0.419 . . . . 0.89 112.132 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.66 30.23 42.62 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.078 -0.582 . . . . 0.57 112.729 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t0 72.62 2.28 4.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.612 0.244 . . . . 1.46 110.903 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 88.0 mttt -99.99 114.8 28.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.634 -0.506 . . . . 2.41 109.634 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.916 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.07 116.99 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.114 -1.069 . . . . 1.66 108.114 178.152 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.715 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 m-85 -100.09 125.93 46.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.914 -1.494 . . . . 1.25 110.46 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.884 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -164.43 -52.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.98 -21.43 43.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.214 -0.903 . . . . 2.17 109.025 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -80.74 -27.42 36.86 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.15 -1.056 . . . . 5.05 108.15 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.65 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.6 m-85 -86.24 116.67 66.71 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.086 . . . . 1.29 110.648 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.1 Cg_endo -47.98 -40.99 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.439 1.426 . . . . 0.79 110.234 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' ILE . 65.5 m-20 -66.97 105.71 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.237 -0.585 . . . . 1.36 110.825 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.821 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.7 mt 66.88 24.82 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.608 0.966 . . . . 1.62 113.608 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 65.3 pttt -57.25 132.93 54.48 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.988 -0.685 . . . . 2.39 111.141 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.79 14.83 62.41 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.417 -0.897 . . . . 0.37 114.015 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.821 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -142.95 -50.85 0.35 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.826 1.417 . . . . 1.59 114.826 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 HG21 ' A' ' 72' ' ' ILE . 7.2 p -79.18 81.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 123.319 1.533 . . . . 0.2 107.363 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.613 ' C ' HG22 ' A' ' 105' ' ' ILE . 8.9 m-70 -100.22 131.55 46.1 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 111.806 -2.452 . . . . 0.29 111.756 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.081 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.1 m-85 -70.78 120.03 15.78 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 121.696 0.76 . . . . 1.23 110.719 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.991 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -70.01 -8.11 46.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.46 110.608 179.34 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 67.9 m -87.09 116.23 25.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.316 -0.402 . . . . 1.2 111.13 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.81 0.07 57.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.225 0.536 . . . . 2.22 109.965 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -146.2 65.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.596 -0.89 . . . . 2.14 108.596 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.702 HD22 ' CE1' ' A' ' 74' ' ' TYR . 6.8 tt -58.15 -32.73 68.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.245 -0.889 . . . . 1.49 111.52 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.52 -8.65 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.293 0.568 . . . . 2.04 111.717 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.6 m -88.52 -0.04 56.81 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.187 -0.915 . . . . 1.4 110.813 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 103.24 -12.32 55.2 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.734 . . . . 0.38 113.749 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 64.9 m-20 -95.06 109.96 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.159 0.48 . . . . 1.44 110.432 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -117.79 24.75 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.653 0.612 . . . . 0.43 112.653 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 10.0 m -61.42 154.6 23.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.27 1.211 . . . . 1.04 114.27 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.081 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -136.45 146.06 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.81 -1.086 . . . . 0.31 111.719 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.617 ' HB2' HG22 ' A' ' 36' ' ' THR . 22.6 p30 -121.73 142.55 50.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.877 -1.157 . . . . 1.15 107.877 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.836 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -97.43 121.84 48.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.065 0.459 . . . . 0.27 111.205 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 145.75 28.71 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.297 -0.865 . . . . 0.29 111.911 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.11 60.92 3.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.877 0.695 . . . . 1.52 112.877 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.721 ' O ' ' HB1' ' A' ' 144' ' ' ALA . 10.2 mt -47.01 172.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.286 0.565 . . . . 1.02 112.397 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -176.6 160.01 1.94 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.997 -1.001 . . . . 2.13 109.601 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 112' ' ' LEU . 1.2 tm? -59.06 -34.13 71.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.454 0.538 . . . . 1.7 112.454 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.38 -12.03 60.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.809 0.3 . . . . 1.32 111.809 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 98.5 m-20 -72.34 -20.95 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.58 109.896 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.3 143.25 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 116.089 -0.505 . . . . 0.42 111.072 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 141.05 147.36 4.91 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.722 -1.227 . . . . 0.24 113.922 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.583 HG23 ' CD2' ' A' ' 134' ' ' HIS . 96.2 m -59.34 130.03 44.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.059 -0.57 . . . . 0.31 111.83 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.651 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 30.5 m-85 -109.81 132.56 54.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.921 -0.581 . . . . 1.24 109.584 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.808 ' OE1' HD12 ' A' ' 58' ' ' LEU . 61.8 tt0 -120.86 110.28 16.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 1.16 110.027 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CE3' ' A' ' 57' ' ' TRP . 1.5 t -100.18 119.68 38.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.87 -0.604 . . . . 1.03 110.066 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.808 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.9 mtpt -122.52 112.97 18.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 1.76 111.172 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 43' ' ' PHE . 20.6 t -93.83 113.15 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.274 -0.639 . . . . 1.18 109.274 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.764 ' HG2' HG12 ' A' ' 128' ' ' VAL . 46.3 mttp -91.54 127.43 36.99 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.201 1.186 . . . . 1.62 114.201 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.718 ' HB3' ' HB2' ' A' ' 49' ' ' ASP . 9.5 mtmp? -145.98 101.88 3.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 2.84 109.326 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.75 132.29 47.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.26 0.467 . . . . 0.44 112.26 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 54.3 Cg_endo -101.44 49.53 1.79 Allowed 'Cis proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.892 -0.879 . . . . 0.56 111.707 -0.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.83 103.84 0.29 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.699 -0.762 . . . . 0.48 112.926 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.764 HG12 ' HG2' ' A' ' 123' ' ' LYS . 26.9 m -83.38 127.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.742 -0.729 . . . . 1.22 110.217 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 22' ' ' ILE . . . -99.46 141.22 32.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.401 0.143 . . . . 0.57 111.239 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.463 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.6 p-10 -145.76 136.47 24.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.068 0.461 . . . . 2.03 111.985 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.639 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.33 157.16 44.1 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.724 -0.671 . . . . 2.95 110.361 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 27' ' ' GLU . 96.8 mttt -104.57 140.08 38.52 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 113.329 0.863 . . . . 2.26 113.329 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.624 HD13 ' CH2' ' A' ' 57' ' ' TRP . 3.2 mt -140.97 120.0 11.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.317 -0.856 . . . . 0.28 109.339 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.583 ' CD2' HG23 ' A' ' 117' ' ' THR . 14.6 m170 -102.58 120.53 40.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.55 110.897 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.517 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -87.92 120.0 28.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.066 0.46 . . . . 1.52 111.124 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 59.1 t -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.373 -0.831 . . . . 0.32 109.316 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 33' ' ' LYS . 18.0 t -100.7 134.08 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.444 0.535 . . . . 1.08 112.444 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 58.7 mt -83.05 150.01 26.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.983 -0.747 . . . . 0.52 108.983 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.36 136.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 122.063 0.935 . . . . 1.48 112.836 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.667 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -165.2 172.2 4.67 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 113.855 -1.52 . . . . 2.2 108.669 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 2.3 Cg_endo -40.12 128.94 2.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.089 1.859 . . . . 1.31 110.84 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.789 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.7 m -33.71 -81.76 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.326 0.491 . . . . 2.31 112.326 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 26.06 -67.37 0.0 OUTLIER Glycine 0 N--CA 1.468 0.782 0 N-CA-C 114.687 0.635 . . . . 2.52 114.687 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.789 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.091 -0.957 . . . . 2.6 109.396 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.473 -0.251 . . . . 3.28 112.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' THR . 38.0 t -77.29 144.24 38.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.29 . . . . 2.43 110.588 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.457 ' H ' ' HB ' ' A' ' 44' ' ' THR . 79.4 p -160.01 159.56 32.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.479 . . . . 1.84 111.154 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.914 HG12 ' HB1' ' A' ' 129' ' ' ALA . 73.1 mt -100.14 117.68 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.382 -0.826 . . . . 2.15 111.189 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' CE ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -92.25 131.41 37.48 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.373 0.606 . . . . 1.12 110.02 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 82.0 0.25 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 122.124 0.964 . . . . 0.65 110.292 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.6 Cg_endo -77.79 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.329 -0.488 0 C-N-CA 123.882 3.055 . . . . 0.88 112.966 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.5 mt-10 -78.48 125.31 29.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 2.06 108.661 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.5 tt0 -143.96 160.02 41.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.855 1.057 . . . . 1.71 113.855 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 29' ' ' ILE . 49.0 ttp -136.74 135.57 38.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.805 -1.089 . . . . 1.86 109.471 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.6 mm -130.03 136.42 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.969 -0.559 . . . . 0.39 111.436 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 83.8 mt-10 -129.86 123.51 31.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.647 0.26 . . . . 1.19 110.925 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' HD11 ' A' ' 110' ' ' LEU . 26.4 mmtt -141.93 153.22 44.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.726 0.298 . . . . 2.52 111.429 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.0 142.35 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 0.39 111.228 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 94.8 mttt -41.28 159.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.373 0.606 . . . . 2.35 112.178 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.63 -24.22 0.13 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.278 -0.874 . . . . 0.31 113.879 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 33' ' ' LYS . 98.9 mt-10 -80.06 160.03 25.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.416 -0.587 . . . . 2.11 109.416 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 40.8 m -86.51 128.93 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.24 -0.584 . . . . 0.33 110.831 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 118.28 36.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.189 0.519 . . . . 0.26 110.254 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.4 t80 -79.19 122.92 26.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.726 -0.67 . . . . 1.43 112.338 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.716 ' HB2' HD12 ' A' ' 105' ' ' ILE . 30.8 mt -110.03 104.67 56.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.39 -0.967 . . . . 0.8 108.39 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' O ' HD11 ' A' ' 133' ' ' ILE . 86.9 Cg_endo -82.12 133.11 7.51 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.508 2.139 . . . . 0.42 115.262 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.93 126.6 19.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.301 -1.318 . . . . 1.03 107.519 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.12 112.32 7.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.329 0.585 . . . . 1.66 111.609 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.715 ' HB3' HG11 ' A' ' 122' ' ' VAL . 41.8 p90 -100.04 139.01 36.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.05 -0.977 . . . . 1.26 111.205 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 20' ' ' SER . 19.5 m -79.93 165.98 22.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.683 -0.488 . . . . 1.33 109.683 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 43' ' ' PHE . 98.0 mt -132.27 148.12 52.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.446 0.641 . . . . 2.12 112.417 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.5 t -160.16 147.92 12.91 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.965 -1.016 . . . . 1.75 109.542 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.57 -21.57 5.44 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.438 2.092 . . . . 1.61 113.236 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.3 pt-20 -76.38 -41.16 48.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 121.177 -0.209 . . . . 2.18 111.194 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -73.03 79.21 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.294 -0.632 . . . . 2.41 109.294 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -100.01 4.99 45.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 1.64 112.076 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.904 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.77 168.87 52.84 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.379 -0.915 . . . . 0.55 113.383 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.0 131.28 23.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.743 2.296 . . . . 0.85 111.562 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 124' ' ' LYS . 7.0 tp -78.51 110.03 13.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 1.9 111.856 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -126.94 103.5 7.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.415 0.626 . . . . 1.78 110.49 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.4 120.06 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.06 -0.973 . . . . 0.75 111.065 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.913 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 97.6 mt-10 -109.75 119.97 41.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.187 0.44 . . . . 1.67 112.187 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.996 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.6 m95 -95.36 119.98 34.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.856 -0.338 . . . . 0.22 110.155 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.98 138.95 40.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.138 -0.69 . . . . 0.41 109.138 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -130.02 130.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.13 0.49 . . . . 0.78 112.264 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.1 m -122.74 102.75 38.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.555 -0.748 . . . . 1.25 109.331 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.602 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 93.8 Cg_endo -79.04 116.0 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.519 2.146 . . . . 0.53 111.902 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.98 87.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.41 111.588 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.61 -40.01 57.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.191 -0.459 . . . . 1.82 111.636 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.3 m120 -84.23 160.04 20.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.293 0.568 . . . . 1.94 112.137 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.72 -18.66 64.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.32 -0.855 . . . . 1.66 111.7 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.602 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 68.0 mttm -67.13 149.03 51.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.022 -0.535 . . . . 1.74 111.186 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.61 127.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-O 121.902 0.858 . . . . 0.97 109.99 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.25 39.96 31.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.58 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.05 144.05 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.553 -0.166 . . . . 1.96 110.553 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' CG1' HD12 ' A' ' 73' ' ' LEU . 23.6 t -66.01 130.0 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.657 -0.417 . . . . 0.77 109.895 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.922 ' CG1' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -117.15 -54.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.753 0.649 . . . . 1.15 112.753 -177.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.861 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.29 131.26 48.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.444 -0.947 . . . . 0.29 108.444 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.913 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.01 158.5 43.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.228 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 79' ' ' ILE . 38.1 t80 -135.58 103.31 5.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 1.3 109.823 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 21.3 t -144.58 160.04 41.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.765 -0.652 . . . . 0.89 112.352 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.95 31.34 5.57 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.093 -0.503 . . . . 0.57 113.017 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 3.14 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.535 0.207 . . . . 1.46 111.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -99.95 115.66 30.2 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.429 -0.582 . . . . 2.41 109.429 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.927 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 107.219 -1.4 . . . . 1.66 107.219 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.722 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 2.8 m-85 -114.92 117.77 31.6 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.397 -0.82 . . . . 1.25 110.065 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 9.7 p-10 -165.94 -49.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.127 -1.434 . . . . 1.2 107.127 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD1' ' CE1' ' A' ' 83' ' ' TYR . 12.1 p-10 -80.13 -26.98 39.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.575 -1.193 . . . . 2.17 108.749 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 36.3 m-85 -80.84 -29.54 35.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.021 -1.103 . . . . 5.05 108.021 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.8 m-85 -82.33 110.32 20.74 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 115.014 -0.994 . . . . 1.29 109.794 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 25.9 Cg_exo -63.1 -28.56 74.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.086 1.857 . . . . 0.79 113.119 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.972 ' O ' HD12 ' A' ' 87' ' ' LEU . 20.1 m-20 -48.71 -33.32 9.93 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.213 -0.595 . . . . 1.36 112.045 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.3 mp -153.06 32.44 0.48 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.03 -0.986 . . . . 1.62 110.186 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 56.1 pttt -53.38 127.63 25.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.475 0.546 . . . . 2.39 112.475 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.52 15.91 57.73 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.487 -0.779 . . . . 0.37 114.639 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.4 ptp180 -145.87 -45.31 0.21 Allowed 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 114.594 1.331 . . . . 1.59 114.594 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.861 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.7 p -79.91 81.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.868 1.318 . . . . 0.2 107.782 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.537 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.0 m80 -102.62 128.88 49.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.654 -2.067 . . . . 0.29 112.684 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.8 m-85 -70.7 122.77 20.43 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 121.227 0.537 . . . . 1.23 110.016 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 38' ' ' TYR . 30.3 p -77.58 34.84 0.18 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.518 -0.765 . . . . 0.46 111.395 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 m -149.05 125.14 10.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.939 0.4 . . . . 1.2 110.275 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -90.0 8.47 32.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.94 -0.573 . . . . 2.22 110.303 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.2 66.53 1.19 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.668 -0.864 . . . . 2.14 108.668 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.62 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.9 mp -58.45 -33.11 69.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.107 -0.951 . . . . 1.49 111.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.27 0.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 2.04 112.166 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 98' ' ' LEU . 52.6 m -89.95 0.02 57.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.625 -0.716 . . . . 1.4 111.18 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.578 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 107.88 -14.59 37.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.69 -0.767 . . . . 0.38 113.295 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.955 0.377 . . . . 1.44 110.735 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.24 20.01 16.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.387 . . . . 0.43 111.998 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.2 p -60.11 144.73 49.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.939 1.459 . . . . 1.04 114.939 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.04 131.84 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 114.588 -1.187 . . . . 0.31 110.581 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -105.51 150.09 25.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.734 -0.839 . . . . 1.15 108.734 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.46 119.84 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.923 0.392 . . . . 0.27 110.652 -179.067 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -84.96 144.66 28.18 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.583 -0.735 . . . . 0.29 111.049 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 54.42 59.98 3.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 1.52 112.121 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.6 mt -45.52 177.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.271 0.558 . . . . 1.02 112.395 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.708 ' O ' HG21 ' A' ' 137' ' ' VAL . 11.5 pt20 -177.24 166.7 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.485 -0.78 . . . . 2.13 110.291 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.61 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 58.8 tp -60.04 -39.93 87.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 1.7 111.577 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 70.2 m -73.22 -10.03 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.393 . . . . 1.32 112.062 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 110' ' ' LEU . 90.7 m-20 -71.85 -22.35 61.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.528 -0.469 . . . . 1.58 109.735 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 142.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.05 -0.523 . . . . 0.42 110.186 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 150.87 5.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.2 -1.0 . . . . 0.24 113.7 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m -59.29 130.64 47.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.137 -0.532 . . . . 0.31 112.375 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 43.8 m-85 -114.49 124.55 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.444 -0.576 . . . . 1.24 109.444 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.0 tt0 -123.37 119.22 29.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.117 -0.233 . . . . 1.16 110.765 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.546 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 15.5 p -105.05 119.91 40.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 1.03 110.362 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 41.2 mtmt -111.77 107.81 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 1.76 110.659 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.7 p -88.0 113.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 1.18 110.033 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.8 tttt -96.55 116.35 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.372 0.508 . . . . 1.62 112.372 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.714 ' HB2' HD12 ' A' ' 53' ' ' LEU . 25.7 tttp -145.65 102.48 3.69 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.402 -0.519 . . . . 2.84 109.849 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.904 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.68 134.0 36.15 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.918 -0.583 . . . . 0.44 111.878 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 93.3 Cg_endo -100.02 49.9 1.73 Allowed 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.627 -0.989 . . . . 0.56 111.606 -0.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.34 103.26 0.27 Allowed Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.147 -1.025 . . . . 0.48 113.939 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.443 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -87.86 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 1.22 108.804 176.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.914 ' HB1' HG12 ' A' ' 22' ' ' ILE . . . -140.96 146.86 37.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.309 0.485 . . . . 0.57 112.309 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.457 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 53.7 p30 -146.73 150.93 36.33 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.198 -0.455 . . . . 2.03 111.374 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.614 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -145.64 159.99 42.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.166 -0.47 . . . . 2.95 110.763 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 66.9 mttm -100.25 140.11 34.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.841 1.052 . . . . 2.26 113.841 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.64 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.7 mt -140.6 113.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.946 -1.025 . . . . 0.28 108.289 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -99.95 119.54 38.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.405 -0.518 . . . . 0.55 110.995 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 110' ' ' LEU . 60.6 tp -91.31 122.52 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.945 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 59.7 t -120.01 127.18 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.826 -0.805 . . . . 0.32 108.826 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.708 HG21 ' O ' ' A' ' 111' ' ' GLN . 33.5 t -98.9 131.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.46 0.541 . . . . 1.08 112.46 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 85.8 mt -82.36 151.3 26.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.824 -0.625 . . . . 0.52 109.824 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.04 139.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.678 0.751 . . . . 1.48 112.387 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HB2' ' CD ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -164.74 -173.75 0.36 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.517 -1.22 . . . . 2.2 109.036 179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' CD ' ' HB2' ' A' ' 140' ' ' LYS . 50.9 Cg_exo -55.24 -143.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.185 1.923 . . . . 1.31 112.244 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 t -38.86 -71.8 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.784 0.326 . . . . 2.31 111.265 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 33' ' ' LYS . . . 68.0 -59.74 0.37 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.957 -0.639 . . . . 2.52 113.59 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.265 -0.874 . . . . 2.6 111.186 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.543 -0.223 . . . . 3.28 112.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 m -77.67 135.55 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 2.43 110.89 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB2' HG21 ' A' ' 44' ' ' THR . 16.5 m -157.11 150.86 24.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 1.84 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -142.86 132.81 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 2.15 110.321 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.21 150.3 22.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.676 0.75 . . . . 1.12 111.725 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER 52.68 81.64 0.26 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.526 -1.215 . . . . 0.65 112.464 -178.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.647 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -78.93 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.656 2.904 . . . . 0.88 111.857 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.57 126.85 31.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 2.06 108.521 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 24' ' ' THR . 2.4 mm-40 -143.61 159.99 41.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.864 1.061 . . . . 1.71 113.864 -176.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.559 ' C ' HD12 ' A' ' 29' ' ' ILE . 49.5 ttp -138.93 132.26 30.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.55 -1.205 . . . . 1.86 108.98 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.116 HD13 HG23 ' A' ' 133' ' ' ILE . 4.3 mp -130.0 139.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.943 -0.571 . . . . 0.39 111.405 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.0 pt-20 -135.13 127.29 29.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.19 111.134 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 56.0 tptt -141.9 157.52 44.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 2.52 110.742 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.5 144.34 39.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.934 0.397 . . . . 0.39 111.746 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HG2' HG21 ' A' ' 137' ' ' VAL . 60.7 mttp -47.2 143.05 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.767 0.655 . . . . 2.35 112.767 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 79.67 -21.8 4.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 114.858 -1.065 . . . . 0.31 113.307 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -81.39 160.65 24.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.708 -0.479 . . . . 2.11 109.708 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.3 m -84.43 129.96 34.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.034 -0.667 . . . . 0.33 110.679 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.899 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.39 117.43 34.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.26 110.628 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.731 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.0 t80 -79.61 119.85 23.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.67 0.619 . . . . 1.43 112.67 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.751 ' HB2' HD12 ' A' ' 105' ' ' ILE . 37.3 mt -106.31 111.58 64.17 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.502 -0.925 . . . . 0.8 108.502 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 85.7 Cg_endo -85.26 131.71 4.26 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.385 2.056 . . . . 0.42 115.648 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.9 t -141.36 130.0 22.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.461 -1.245 . . . . 1.03 108.254 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 33.0 mmtp -141.16 139.99 33.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.394 . . . . 1.66 111.063 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 53.5 p90 -140.0 140.83 36.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 110.75 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 21' ' ' SER . 4.7 p -82.04 138.64 34.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 1.33 111.967 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.24 139.97 33.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 2.12 110.275 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 p -152.49 151.1 26.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.843 0.354 . . . . 1.75 110.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.34 -25.85 25.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.809 2.339 . . . . 1.61 112.39 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 13.4 pt-20 -74.17 -39.99 62.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.494 -0.321 . . . . 2.18 110.251 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.619 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -71.9 75.28 0.89 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.234 -0.654 . . . . 2.41 109.234 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -91.98 -9.51 42.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.405 -0.816 . . . . 1.64 111.691 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.948 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.0 160.0 53.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.324 -0.941 . . . . 0.55 112.317 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.24 148.56 59.77 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.423 2.082 . . . . 0.85 111.619 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 61.5 tp -77.69 131.6 37.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 1.9 110.691 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 26.6 t0 -137.13 146.46 45.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.548 0.69 . . . . 1.78 110.951 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 40.9 mt -142.44 140.01 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.53 -1.214 . . . . 0.75 109.121 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 96.0 mt-10 -140.02 148.81 42.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.944 -0.302 . . . . 1.67 111.187 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.944 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.0 m95 -140.48 119.16 12.4 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.22 110.828 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 70' ' ' VAL . 86.5 mt -109.86 146.33 35.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.728 -0.669 . . . . 0.41 109.314 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.0 136.17 59.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.19 0.519 . . . . 0.78 112.267 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 70.1 m -119.66 103.84 45.7 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 1.25 108.854 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 85.1 Cg_endo -78.31 112.07 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.53 112.613 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.75 87.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.177 -0.92 . . . . 0.41 110.922 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -73.96 -40.48 62.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 1.82 111.416 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 94.3 m-20 -85.12 159.99 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 1.94 111.652 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -69.17 -19.88 64.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.66 111.173 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.542 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 57.7 mttt -70.0 150.63 46.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 1.74 111.298 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.65 127.83 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-O 121.732 0.777 . . . . 0.97 109.249 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 61.14 88.12 0.09 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.366 -1.288 . . . . 1.77 111.969 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' ILE . 11.8 pt20 -140.44 141.84 35.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.794 0.331 . . . . 1.96 111.219 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 58' ' ' LEU . 61.7 t -71.74 129.38 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.77 110.18 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CG1' HD12 ' A' ' 87' ' ' LEU . 1.4 pp -130.3 -38.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.347 0.499 . . . . 1.15 112.347 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.907 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 126.3 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.258 -0.645 . . . . 0.29 109.258 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -140.8 159.98 41.03 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.487 -0.779 . . . . 1.3 110.715 -178.048 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.79 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.2 t80 -134.86 103.75 5.73 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.997 -0.742 . . . . 1.3 108.997 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.452 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 13.0 t -142.7 160.01 41.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.89 111.45 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.52 13.75 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.691 -0.766 . . . . 0.57 112.356 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.29 0.34 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.457 0.17 . . . . 1.46 111.307 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -100.05 114.27 27.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.739 -0.467 . . . . 2.41 109.739 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.61 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -79.4 134.02 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.107 -1.442 . . . . 1.66 107.107 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.722 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -118.8 127.72 53.8 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 1.25 110.208 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.858 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.6 p-10 -165.82 -55.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.15 -1.426 . . . . 1.2 107.15 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 51.8 t0 -82.84 -27.54 30.75 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.785 -1.098 . . . . 2.17 109.0 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.42 -30.04 61.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.7 -1.222 . . . . 5.05 107.7 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.78 110.94 25.63 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.275 -1.33 . . . . 1.29 110.373 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.22 -43.12 13.29 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.843 1.695 . . . . 0.79 111.505 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 71' ' ' ILE . 95.9 m-20 -67.95 103.75 1.56 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.181 -0.463 . . . . 1.36 111.274 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.078 HD13 ' NH2' ' A' ' 90' ' ' ARG . 40.4 mt 73.58 21.48 2.85 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.965 0.728 . . . . 1.62 112.965 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.858 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.8 pttt -56.78 132.24 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.97 -0.456 . . . . 2.39 111.44 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.27 10.74 63.7 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.289 -0.958 . . . . 0.37 114.389 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 1.078 ' NH2' HD13 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -139.56 -49.73 0.49 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 114.781 1.4 . . . . 1.59 114.781 -178.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.907 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.79 81.56 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.981 1.372 . . . . 0.2 107.462 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.422 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.3 m-70 -102.71 129.25 49.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.342 -2.208 . . . . 0.29 112.475 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.3 m-85 -70.34 126.25 29.12 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.084 -0.646 . . . . 1.23 109.577 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.731 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.6 p -74.39 33.41 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.46 112.693 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 t -149.16 140.03 22.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.1 0.476 . . . . 1.2 111.332 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -91.54 0.07 57.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.22 110.648 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.61 67.45 1.17 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.294 0.568 . . . . 2.14 109.506 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.91 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -56.99 -25.88 59.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 1.49 111.229 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HA ' HD22 ' A' ' 53' ' ' LEU . 63.6 mttt -64.93 1.28 0.95 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.165 0.507 . . . . 2.04 112.297 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.7 p -89.99 0.06 57.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.561 -0.745 . . . . 1.4 110.714 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.45 -8.75 32.72 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.38 112.845 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -98.15 111.91 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.329 . . . . 1.44 110.988 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.516 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -110.04 13.02 23.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.31 -0.404 . . . . 0.43 111.424 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 54.5 m -59.98 140.0 57.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.389 1.625 . . . . 1.04 115.389 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.96 129.99 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.753 -1.112 . . . . 0.31 110.511 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.644 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.5 p30 -106.52 154.91 20.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.243 -0.651 . . . . 1.15 109.243 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -98.35 124.31 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 120.966 0.413 . . . . 0.27 111.364 -178.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -88.01 143.59 27.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.702 -0.681 . . . . 0.29 110.92 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.2 m120 50.66 60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 1.52 111.888 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.9 mt -45.37 176.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.445 0.64 . . . . 1.02 112.464 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.405 ' HG2' ' OD2' ' A' ' 114' ' ' ASP . 13.3 pt20 -176.69 163.84 2.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.141 -0.936 . . . . 2.13 110.082 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.775 ' HA ' HG11 ' A' ' 137' ' ' VAL . 2.0 tm? -60.03 -36.42 77.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 1.7 111.937 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -73.81 -14.43 61.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.056 0.391 . . . . 1.32 112.056 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 96.4 m-20 -71.18 -22.02 62.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.408 -0.517 . . . . 1.58 109.698 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.855 ' CD1' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.52 142.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.988 -0.551 . . . . 0.42 110.91 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.05 150.92 5.47 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.704 -1.236 . . . . 0.24 114.218 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.55 HG23 ' CE1' ' A' ' 134' ' ' HIS . 92.0 m -59.78 135.86 57.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.768 -0.716 . . . . 0.31 111.936 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 51.8 m-85 -120.0 139.68 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.24 110.105 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 58.4 tt0 -127.0 120.16 28.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 1.16 109.982 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 48.7 t -98.4 118.21 34.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.055 -0.258 . . . . 1.03 110.684 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 57.4 mttt -115.81 105.22 12.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 1.76 111.008 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 89.5 t -95.34 108.18 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.41 -0.589 . . . . 1.18 109.41 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 61.0 tttm -98.7 115.33 28.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.718 -0.793 . . . . 1.62 112.118 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 50.0 tttm -145.65 102.35 3.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.483 -0.562 . . . . 2.84 109.483 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.948 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.89 131.99 21.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 113.162 0.801 . . . . 0.44 113.162 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.619 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 47.2 Cg_endo -100.07 37.59 5.91 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.625 -0.99 . . . . 0.56 111.627 -0.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.67 102.41 0.53 Allowed Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.313 -0.946 . . . . 0.48 113.345 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.7 m -91.75 141.22 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 113.56 -1.32 . . . . 1.22 109.357 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -138.13 144.02 40.62 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.385 0.513 . . . . 0.57 112.385 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 39.6 p-10 -146.26 140.41 26.49 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.587 . . . . 2.03 110.783 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.9 164.13 32.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.582 -0.281 . . . . 2.95 111.517 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.2 mttt -99.75 140.12 34.41 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.667 0.988 . . . . 2.26 113.667 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.116 HG23 HD13 ' A' ' 29' ' ' ILE . 2.6 mp -140.57 111.91 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.926 -1.034 . . . . 0.28 109.072 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.55 ' CE1' HG23 ' A' ' 117' ' ' THR . 4.6 m-70 -101.03 120.02 39.58 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.596 -0.442 . . . . 0.55 111.235 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 59.5 tp -91.02 123.5 34.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.017 -0.538 . . . . 1.52 111.884 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -119.95 121.45 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.32 109.464 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.855 HG12 ' CD1' ' A' ' 115' ' ' ILE . 12.1 p -93.9 131.3 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 1.08 111.92 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.5 mt -86.55 149.98 24.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.52 109.722 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -78.18 134.82 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.773 0.797 . . . . 1.48 111.709 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.843 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.21 176.55 1.99 Allowed Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.26 -1.336 . . . . 2.2 108.713 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 7.9 Cg_endo -49.38 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.21 1.94 . . . . 1.31 112.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 141' ' ' PRO . 49.1 m -26.89 -76.22 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.993 0.368 . . . . 2.31 111.993 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.547 ' HA3' ' HD2' ' A' ' 140' ' ' LYS . . . 53.93 55.56 25.21 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.846 -0.692 . . . . 2.52 113.757 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.208 -0.901 . . . . 2.6 111.038 179.821 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.644 -0.182 . . . . 3.28 112.644 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 66.8 m -76.84 149.96 36.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 2.43 111.024 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 70.6 m -77.72 133.66 38.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.223 0.535 . . . . 1.84 111.658 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -140.01 140.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.369 -0.832 . . . . 2.15 109.987 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -90.35 149.52 22.27 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.541 0.686 . . . . 1.12 111.365 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.5 83.12 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-N 114.657 -1.156 . . . . 0.65 111.232 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 56.1 Cg_endo -78.21 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.645 2.897 . . . . 0.88 112.278 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.41 127.59 32.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.555 -0.906 . . . . 2.06 108.555 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.911 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -143.85 160.0 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.098 1.147 . . . . 1.71 114.098 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.73 122.8 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.586 -1.188 . . . . 1.86 109.311 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.911 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.4 mm -120.01 123.5 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 0.39 111.607 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.2 mt-10 -113.79 123.78 50.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.339 -0.391 . . . . 1.19 110.421 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.56 154.61 45.56 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.087 0.403 . . . . 2.52 112.087 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.2 143.25 39.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.39 112.219 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' A' ' 140' ' ' LYS . 54.9 mtpt -48.81 143.22 5.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.295 0.569 . . . . 2.35 112.422 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 144' ' ' ALA . . . 79.53 -23.86 3.34 Favored Glycine 0 CA--C 1.516 0.13 0 CA-C-N 115.185 -0.916 . . . . 0.31 113.545 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.2 mm-40 -80.01 160.09 25.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.403 -0.592 . . . . 2.11 109.403 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.1 m -85.72 129.99 34.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.965 -0.694 . . . . 0.33 109.991 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.751 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.73 118.78 35.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.26 110.983 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.986 ' HE1' HG21 ' A' ' 94' ' ' THR . 83.0 t80 -79.53 129.98 34.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.49 -0.777 . . . . 1.43 112.223 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 105' ' ' ILE . 23.5 mt -124.6 104.5 30.91 Favored Pre-proline 0 C--N 1.333 -0.138 0 N-CA-C 108.903 -0.777 . . . . 0.8 108.903 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.76 129.61 8.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.495 2.13 . . . . 0.42 114.658 -177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.544 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 11.6 t -141.37 125.24 17.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.712 -1.131 . . . . 1.03 108.963 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 9.1 mtmm -140.65 144.78 35.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.771 -0.65 . . . . 1.66 109.838 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.916 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.2 p90 -140.03 141.24 36.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.794 -0.639 . . . . 1.26 112.21 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 21' ' ' SER . 1.3 p -88.91 139.86 30.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.654 . . . . 1.33 110.481 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -96.84 110.0 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.621 -0.263 . . . . 2.12 110.744 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -84.52 137.74 38.83 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.843 -0.429 . . . . 1.75 109.843 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -44.89 -34.21 8.38 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.755 1.637 . . . . 1.61 111.035 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.06 -40.03 47.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.403 -0.817 . . . . 2.18 111.014 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 91.7 m-20 -72.76 73.8 1.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.304 -0.558 . . . . 2.41 109.587 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.23 -0.02 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.889 -0.596 . . . . 1.64 112.235 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.07 161.92 52.99 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.55 113.159 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.87 137.86 60.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.695 2.264 . . . . 0.85 112.21 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 43' ' ' PHE . 2.3 mt -78.59 106.8 10.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.9 112.137 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.5 m-20 -119.36 102.41 8.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.519 0.676 . . . . 1.78 110.921 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.868 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 6.7 mt -99.04 111.39 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.873 -1.058 . . . . 0.75 111.029 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 73' ' ' LEU . 84.8 tt0 -107.43 120.69 42.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.278 0.844 . . . . 1.67 113.278 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.946 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -94.82 119.99 34.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.352 -0.385 . . . . 0.22 110.127 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.0 mt -103.82 141.11 36.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.529 -0.545 . . . . 0.41 109.529 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -130.01 138.06 54.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.072 0.767 . . . . 0.78 113.072 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -132.02 102.96 14.37 Favored Pre-proline 0 N--CA 1.455 -0.195 0 CA-C-N 115.199 -0.909 . . . . 1.25 109.503 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 6.3 Cg_exo -80.17 122.06 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.587 2.191 . . . . 0.53 112.38 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.73 73.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.41 110.45 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.76 13.12 7.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.405 -0.816 . . . . 1.82 112.066 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 81.9 m-20 -145.67 160.01 42.32 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.385 0.612 . . . . 1.94 112.04 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -68.96 -19.47 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.008 -0.996 . . . . 1.66 112.316 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.8 mtpt -67.71 140.03 56.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.042 0.448 . . . . 1.74 111.531 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.73 129.08 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 CA-C-O 121.935 0.874 . . . . 0.97 109.546 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 34.71 21.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.031 -1.44 . . . . 1.77 111.858 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.76 142.16 27.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.492 -0.322 . . . . 1.96 110.56 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 6.1 t -66.25 131.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.731 -0.47 . . . . 0.77 109.731 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.903 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.24 -50.58 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.64 0.607 . . . . 1.15 112.64 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.976 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.04 125.79 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.792 -0.818 . . . . 0.29 108.792 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 74' ' ' TYR . 8.6 tt -140.06 159.97 40.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 116.172 -0.467 . . . . 1.3 110.211 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.639 ' CD1' HG23 ' A' ' 79' ' ' ILE . 16.4 t80 -136.34 109.15 7.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 1.3 110.328 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.476 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.6 p -142.86 160.05 41.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.631 -0.713 . . . . 0.89 111.561 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.56 39.22 53.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.728 -0.749 . . . . 0.57 112.477 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.9 t0 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.026 0.441 . . . . 1.46 110.515 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 89.7 mttt -131.33 108.94 10.0 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.41 110.631 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -79.89 118.51 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 107.125 -1.435 . . . . 1.66 107.125 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.747 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.3 m-85 -100.79 136.11 41.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.795 -1.093 . . . . 1.25 110.612 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.81 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 13.9 p-10 -166.37 -55.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.854 -1.165 . . . . 1.2 107.854 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 12.5 t70 -79.26 -18.66 52.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.101 -0.954 . . . . 2.17 109.209 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.35 -28.26 34.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.55 -0.907 . . . . 5.05 108.55 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.571 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -85.8 114.28 55.99 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 114.949 -1.023 . . . . 1.29 111.161 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 88.8 Cg_exo -44.28 -42.36 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.611 1.541 . . . . 0.79 110.595 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.694 ' O ' HG12 ' A' ' 71' ' ' ILE . 3.4 m-20 -66.99 104.88 1.48 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.252 -0.579 . . . . 1.36 110.639 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.819 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 25.9 mt 67.43 23.29 9.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.826 1.047 . . . . 1.62 113.826 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -54.84 128.63 33.97 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.601 -0.687 . . . . 2.39 111.127 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.79 10.59 56.37 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.159 -1.02 . . . . 0.37 114.502 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.819 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -142.1 -46.43 0.35 Allowed 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 114.55 1.315 . . . . 1.59 114.55 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.976 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -79.95 80.89 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-O 123.251 1.501 . . . . 0.2 107.173 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.49 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.5 m80 -98.78 132.06 44.43 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.258 -2.246 . . . . 0.29 111.615 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.103 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.6 m-85 -72.41 121.07 18.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.895 0.855 . . . . 1.23 111.222 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.986 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -69.48 -11.69 61.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.069 -1.423 . . . . 0.46 109.914 178.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.8 m -95.22 120.01 34.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.025 -0.534 . . . . 1.2 110.929 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -90.64 4.82 50.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.422 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -146.19 67.02 1.19 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.802 -0.814 . . . . 2.14 108.802 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.1 mp -59.05 -35.04 72.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.216 -0.902 . . . . 1.49 111.886 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.93 -5.35 4.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 2.04 111.843 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -90.04 0.03 57.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.349 -0.841 . . . . 1.4 110.963 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.01 -20.02 34.17 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.737 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.5 m-20 -96.04 109.34 21.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.361 0.58 . . . . 1.44 110.414 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -114.86 25.58 10.83 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.816 0.673 . . . . 0.43 112.816 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 43.4 t -59.95 146.15 43.47 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.27 1.582 . . . . 1.04 115.27 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.103 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.53 139.97 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 114.217 -1.356 . . . . 0.31 110.788 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.701 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.9 OUTLIER -118.18 148.51 42.29 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.302 -0.999 . . . . 1.15 108.302 177.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.88 121.56 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 120.967 0.413 . . . . 0.27 111.26 -178.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -84.06 145.7 28.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.514 -0.767 . . . . 0.29 111.298 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.64 61.78 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.978 -0.555 . . . . 1.52 112.424 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.7 mt -46.86 173.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.322 0.582 . . . . 1.02 112.336 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.602 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -177.38 163.55 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 2.13 110.137 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.06 -38.29 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.277 -0.419 . . . . 1.7 111.99 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.7 t -73.11 -14.21 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.11 0.411 . . . . 1.32 112.11 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -72.83 -20.09 61.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.699 -0.4 . . . . 1.58 110.183 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.45 146.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.202 -0.454 . . . . 0.42 110.953 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.36 147.0 4.92 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 119.923 -1.132 . . . . 0.24 113.788 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.552 HG23 ' ND1' ' A' ' 134' ' ' HIS . 47.2 m -59.27 138.3 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.378 -0.411 . . . . 0.31 111.755 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.6 m-85 -119.95 131.08 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 1.24 109.792 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.648 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -121.56 119.88 33.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.048 -0.261 . . . . 1.16 110.383 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.458 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.7 t -99.51 111.17 23.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.578 -0.283 . . . . 1.03 110.455 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.868 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 74.3 mttt -106.61 104.74 14.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 1.76 110.812 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 43' ' ' PHE . 24.0 t -89.3 110.12 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 109.212 -0.662 . . . . 1.18 109.212 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 87.8 tttt -95.79 122.92 39.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.309 0.855 . . . . 1.62 113.309 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 3.9 mmtt -141.6 101.43 3.98 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.892 -0.781 . . . . 2.84 108.892 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 1.0 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.34 132.61 61.87 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 112.507 0.558 . . . . 0.44 112.507 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.53 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 81.0 Cg_endo -100.0 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.646 -0.981 . . . . 0.56 112.667 -0.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.3 103.38 0.29 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.696 -0.764 . . . . 0.48 112.971 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 123' ' ' LYS . 2.0 t -90.16 151.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.623 -0.788 . . . . 1.22 110.087 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.86 152.13 43.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.218 . . . . 0.57 111.535 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.517 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 17.6 p30 -146.49 151.9 38.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.05 0.389 . . . . 2.03 112.05 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.15 161.23 40.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.106 -0.497 . . . . 2.95 111.191 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 39.4 mttp -102.82 140.01 37.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.625 0.972 . . . . 2.26 113.625 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.729 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 87.7 mt -143.83 110.66 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.372 -0.973 . . . . 0.28 108.372 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.552 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.7 m-70 -98.46 120.01 38.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.55 111.391 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.415 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.1 tm? -86.87 124.26 32.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 1.52 111.225 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.3 t -119.29 126.93 75.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.582 -0.735 . . . . 0.32 109.433 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 111' ' ' GLN . 18.2 t -96.33 126.76 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.08 112.054 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.2 mt -87.7 145.7 26.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.52 109.078 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER -77.43 134.82 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.249 1.023 . . . . 1.48 112.872 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.711 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.03 169.97 6.9 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.295 -1.775 . . . . 2.2 109.174 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.711 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 2.2 Cg_endo -40.27 167.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.847 2.365 . . . . 1.31 112.535 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 144' ' ' ALA . 0.4 OUTLIER -33.08 -79.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.175 0.435 . . . . 2.31 112.175 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.58 -66.49 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.091 -0.504 . . . . 2.52 113.538 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.407 -0.806 . . . . 2.6 111.812 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 127' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.582 -0.207 . . . . 3.28 112.582 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -159.51 150.02 19.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 2.43 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 44' ' ' THR . 46.8 t -76.98 152.39 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 1.84 111.562 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 131' ' ' LYS . 19.2 tt -139.51 134.99 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 2.15 110.399 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.43 156.91 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.515 0.674 . . . . 1.12 111.706 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.31 83.25 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.576 -1.193 . . . . 0.65 111.695 -178.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 59.3 Cg_endo -78.26 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.404 2.736 . . . . 0.88 112.6 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.59 125.55 29.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.072 -0.714 . . . . 2.06 109.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.7 tt0 -144.33 163.95 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.846 1.054 . . . . 1.71 113.846 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.687 ' O ' HD13 ' A' ' 29' ' ' ILE . 55.4 ttm -138.72 139.4 38.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.72 -1.127 . . . . 1.86 109.117 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.3 mm -132.72 139.37 49.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.214 0.449 . . . . 0.39 112.214 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 21.9 pt-20 -140.23 124.63 17.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 1.19 110.567 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -142.3 163.41 32.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.522 -0.308 . . . . 2.52 111.597 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.731 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.62 139.57 40.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.39 111.467 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 144' ' ' ALA . 86.9 tttt -48.35 130.35 16.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 2.35 111.762 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.79 -19.15 47.02 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.31 112.695 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.731 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -79.99 160.01 26.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.37 -0.974 . . . . 2.11 108.37 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 42.0 m -88.43 128.51 35.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.566 -0.853 . . . . 0.33 110.352 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.987 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.8 113.92 26.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.26 110.522 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.635 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.0 t80 -79.53 129.89 34.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.908 -0.587 . . . . 1.43 112.387 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 133' ' ' ILE . 4.1 mp -120.17 107.64 39.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.424 -0.954 . . . . 0.8 108.424 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.0 Cg_endo -82.8 104.66 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.451 2.101 . . . . 0.42 115.944 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -105.58 126.12 51.77 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.165 -1.05 . . . . 1.03 108.165 175.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mttm -140.72 139.37 34.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.176 0.512 . . . . 1.66 110.992 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.645 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 40.8 p90 -141.11 150.04 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.415 -0.811 . . . . 1.26 111.028 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' SER . 1.7 t -80.1 170.74 16.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.33 111.177 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD21 ' HE2' ' A' ' 43' ' ' PHE . 91.7 mt -138.19 141.19 40.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 2.12 111.03 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 79.5 p -159.99 158.63 26.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.847 -0.615 . . . . 1.75 110.212 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 13.1 Cg_endo -56.24 -17.64 21.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.433 2.089 . . . . 1.61 112.88 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -73.33 -43.72 60.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.685 0.278 . . . . 2.18 110.534 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.46 76.63 1.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.069 -0.715 . . . . 2.41 109.069 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.13 -11.54 43.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 1.64 111.773 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.6 157.59 52.73 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.222 -0.989 . . . . 0.55 112.29 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.81 150.9 27.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.334 2.022 . . . . 0.85 111.321 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.765 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 4.1 mp -77.61 133.06 38.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.893 0.377 . . . . 1.9 110.845 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 21.9 t0 -140.24 146.84 39.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.361 0.6 . . . . 1.78 111.753 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 6.6 mt -143.79 135.0 22.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.422 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.739 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.3 tt0 -140.61 119.9 12.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.668 0.667 . . . . 1.67 112.667 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.889 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.0 m95 -100.2 124.85 46.12 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.174 -0.466 . . . . 0.22 111.377 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -106.87 120.34 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.843 -0.429 . . . . 0.41 109.843 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' A' ' 71' ' ' ILE . 10.3 tt -104.06 124.42 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.506 0.558 . . . . 0.78 112.506 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.8 m -118.33 101.9 50.8 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 98.9 Cg_endo -79.56 115.52 3.41 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.597 2.198 . . . . 0.53 112.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.41 110.944 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.94 -39.96 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 1.82 111.8 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.561 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.4 m120 -85.43 161.87 19.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.39 0.614 . . . . 1.94 112.28 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.63 -18.48 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.091 -0.958 . . . . 1.66 111.741 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -68.49 150.91 47.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.906 -0.588 . . . . 1.74 111.333 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.59 127.69 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.113 0 CA-C-O 121.893 0.854 . . . . 0.97 109.988 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 55.89 40.05 30.57 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 114.074 -1.421 . . . . 1.77 112.727 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.3 mt-30 -94.32 145.05 25.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.192 -0.203 . . . . 1.96 110.75 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG11 ' OH ' ' A' ' 84' ' ' TYR . 18.4 t -66.68 125.95 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.064 0.459 . . . . 0.77 109.883 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -116.21 -53.72 4.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 1.15 111.923 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.73 124.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.2 -1.037 . . . . 0.29 108.2 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.852 HD23 ' N ' ' A' ' 74' ' ' TYR . 6.1 tt -135.32 157.09 47.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.806 -0.633 . . . . 1.3 109.772 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.901 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 12.1 t80 -136.91 104.08 5.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.758 -0.46 . . . . 1.3 109.758 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -143.15 158.26 43.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.89 111.678 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.58 28.58 45.8 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.732 -0.747 . . . . 0.57 112.472 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.53 2.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.545 0.212 . . . . 1.46 111.107 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 68.2 mttm -100.01 113.24 25.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 110.08 -0.341 . . . . 2.41 110.08 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.901 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.87 116.52 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.879 -1.156 . . . . 1.66 107.879 177.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.718 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.2 m-85 -100.03 128.19 46.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.819 -1.537 . . . . 1.25 110.908 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.758 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.2 p-10 -166.14 -53.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.222 -1.029 . . . . 1.2 108.222 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.8 t70 -80.17 -24.33 40.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.09 -0.959 . . . . 2.17 109.371 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.25 -29.1 42.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.118 -0.946 . . . . 5.05 108.5 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -82.35 115.9 60.57 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-N 114.795 -1.093 . . . . 1.29 110.552 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.2 Cg_endo -46.81 -40.99 25.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.729 1.619 . . . . 0.79 110.373 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.721 ' O ' HG12 ' A' ' 71' ' ' ILE . 67.1 m-20 -66.98 105.22 1.57 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.824 -0.626 . . . . 1.36 110.653 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.859 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.2 mt 68.02 24.56 7.82 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.862 1.06 . . . . 1.62 113.862 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttt -55.61 127.5 30.18 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.627 -0.671 . . . . 2.39 111.219 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.63 15.12 54.03 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.385 -0.912 . . . . 0.37 114.451 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.859 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp180 -144.14 -48.03 0.27 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 114.483 1.29 . . . . 1.59 114.483 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.23 81.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.864 1.316 . . . . 0.2 107.725 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.472 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.5 m80 -102.93 129.14 49.55 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.474 -2.148 . . . . 0.29 112.326 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.117 ' CD1' HG23 ' A' ' 105' ' ' ILE . 77.0 m-85 -70.97 120.77 17.03 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 109.097 -0.705 . . . . 1.23 109.097 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.635 HG21 ' CE2' ' A' ' 38' ' ' TYR . 24.6 p -70.43 -10.01 57.97 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.22 -0.9 . . . . 0.46 110.455 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 67.2 m -93.16 121.46 34.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.848 -0.615 . . . . 1.2 110.259 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.11 2.48 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.1 0.476 . . . . 2.22 110.344 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -146.07 66.81 1.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.849 -0.797 . . . . 2.14 108.849 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.598 HD22 ' CD2' ' A' ' 74' ' ' TYR . 5.9 mp -56.74 -28.98 62.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 1.49 111.466 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 55.6 mtmt -62.81 -6.23 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 2.04 111.809 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -87.55 -3.11 59.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.309 -0.86 . . . . 1.4 110.733 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.645 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.57 -12.97 32.93 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.779 -0.724 . . . . 0.38 113.702 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -95.09 110.03 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.192 0.496 . . . . 1.44 110.429 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -108.83 16.38 22.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.294 -0.412 . . . . 0.43 111.916 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 6.0 m -60.16 140.02 57.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 116.104 1.891 . . . . 1.04 116.104 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.117 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.82 135.53 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.291 -1.322 . . . . 0.31 110.587 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.63 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -111.95 145.05 40.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.326 -0.99 . . . . 1.15 108.326 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.03 120.02 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.063 0.459 . . . . 0.27 111.443 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.774 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -83.15 143.96 30.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.369 -0.832 . . . . 0.29 110.64 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 81.3 m-20 49.92 56.52 7.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.156 0.503 . . . . 1.52 111.359 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.987 HD11 ' HB2' ' A' ' 37' ' ' ALA . 21.4 mt -46.38 90.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.986 1.106 . . . . 1.02 113.986 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 47.5 mt-30 -56.58 149.03 18.27 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.948 -0.569 . . . . 2.13 110.468 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.96 -37.05 78.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.28 -0.637 . . . . 1.7 109.28 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.55 -5.63 43.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 1.32 111.542 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 90.0 m-20 -70.08 -19.18 63.28 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.615 -0.513 . . . . 1.58 109.615 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -43.14 137.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 116.001 -0.545 . . . . 0.42 110.452 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 141.04 158.8 7.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.893 -1.146 . . . . 0.24 114.145 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.4 m -60.48 140.0 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.751 -0.724 . . . . 0.31 112.709 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.771 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 32.8 m-85 -125.12 125.38 43.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.023 -0.732 . . . . 1.24 109.023 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.73 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.0 tt0 -120.01 118.96 32.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.943 -0.303 . . . . 1.16 110.727 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.2 t -97.81 118.58 34.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.999 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 31.9 mttm -114.07 106.38 14.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.76 110.858 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 48.9 t -92.18 104.67 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.229 -0.656 . . . . 1.18 109.229 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 85.5 tttt -96.99 120.12 36.75 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.009 -0.676 . . . . 1.62 112.65 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.765 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 10.3 mtmp? -141.81 102.87 4.25 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.693 -0.484 . . . . 2.84 109.693 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.924 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.01 131.96 22.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 0.44 111.654 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 44.1 Cg_endo -101.89 46.83 2.26 Favored 'Cis proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.986 -0.839 . . . . 0.56 111.69 -0.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 19' ' ' GLY . . . -146.07 103.56 0.28 Allowed Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.328 -0.939 . . . . 0.48 113.679 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.33 149.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.691 -0.754 . . . . 1.22 109.666 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -141.79 144.62 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.587 0.232 . . . . 0.57 111.47 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 44.7 p-10 -146.72 148.6 32.16 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.316 0.487 . . . . 2.03 112.316 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.804 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.31 160.72 41.09 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.018 -0.537 . . . . 2.95 110.698 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 99.1 mttt -103.22 136.14 43.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.282 0.845 . . . . 2.26 113.282 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 91.1 mt -145.24 113.47 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 108.708 -0.849 . . . . 0.28 108.708 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -95.4 175.4 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.076 -0.65 . . . . 0.55 109.907 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 110' ' ' LEU . 54.5 tp -144.07 133.05 22.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.864 -0.607 . . . . 1.52 112.255 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.4 t -129.98 129.99 65.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.383 -0.826 . . . . 0.32 109.515 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 33.4 t -97.09 124.84 50.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.915 0.388 . . . . 1.08 111.67 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.87 157.72 25.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.433 -0.58 . . . . 0.52 109.433 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.64 130.53 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 1.48 111.106 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.765 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 10.0 ptmt -165.5 176.96 1.76 Allowed Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 114.691 -1.14 . . . . 2.2 109.418 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.765 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 4.3 Cg_endo -46.66 174.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.094 1.863 . . . . 1.31 112.103 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 p -34.59 -79.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.043 0.386 . . . . 2.31 112.043 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.38 -5.64 2.89 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.027 -0.606 . . . . 2.52 113.748 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.51 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.235 -0.888 . . . . 2.6 111.156 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.768 -0.133 . . . . 3.28 112.768 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -78.45 138.07 38.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 2.43 111.036 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -74.13 149.98 40.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 1.84 110.926 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.56 144.08 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 2.15 110.991 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.48 139.95 34.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.744 0.783 . . . . 1.12 112.025 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.95 81.11 0.27 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.344 -1.298 . . . . 0.65 112.109 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.704 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 76.1 Cg_endo -79.62 -11.03 14.33 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 124.344 3.363 . . . . 0.88 113.338 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -140.67 125.26 17.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.546 -0.909 . . . . 2.06 108.546 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.762 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -144.28 162.87 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 114.595 1.332 . . . . 1.71 114.595 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.713 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.8 ttm -137.92 137.12 37.7 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.491 -1.232 . . . . 1.86 109.197 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.762 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.0 mm -134.5 139.99 46.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.269 -0.423 . . . . 0.39 111.688 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 39.4 mt-10 -137.6 119.28 15.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.368 -0.378 . . . . 1.19 110.295 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 110' ' ' LEU . 31.0 tptt -142.07 158.64 43.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.665 -0.243 . . . . 2.52 110.978 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.739 ' HB1' ' CD ' ' A' ' 140' ' ' LYS . . . -76.89 143.95 39.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.136 0.493 . . . . 0.39 112.242 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 35.2 ttpt -48.93 131.18 18.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.799 -0.637 . . . . 2.35 111.864 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.77 -19.84 38.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.488 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.726 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.7 mt-10 -79.9 158.43 26.68 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.239 -1.023 . . . . 2.11 108.239 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.823 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.0 m -88.4 128.92 35.53 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.511 -0.876 . . . . 0.33 110.976 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 117.7 34.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.26 110.531 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 94' ' ' THR . 31.4 t80 -79.42 112.82 17.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.937 -0.574 . . . . 1.43 111.712 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB2' HD12 ' A' ' 105' ' ' ILE . 40.6 mt -99.09 107.59 44.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.436 -0.95 . . . . 0.8 108.436 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 95.4 Cg_endo -82.69 134.52 7.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.213 1.942 . . . . 0.42 114.4 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 1.8 t -140.42 130.07 24.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.477 -1.238 . . . . 1.03 107.841 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.571 ' O ' HG22 ' A' ' 22' ' ' ILE . 30.3 mmtp -140.42 137.05 33.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.979 0.418 . . . . 1.66 110.94 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HE1' ' HB2' ' A' ' 103' ' ' ALA . 53.2 p90 -140.28 154.25 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 1.26 110.976 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -80.02 169.96 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 1.33 111.835 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.525 HD12 ' OD2' ' A' ' 49' ' ' ASP . 69.0 tp -139.98 132.78 29.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.378 -0.828 . . . . 2.12 110.625 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -157.18 156.09 28.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.75 110.498 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.96 -19.21 31.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.442 2.094 . . . . 1.61 112.529 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 12.6 pt-20 -75.44 -40.61 57.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.718 -0.219 . . . . 2.18 110.84 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.525 ' OD2' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -72.29 75.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.238 -0.585 . . . . 2.41 109.452 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -91.65 -4.47 55.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 1.64 112.292 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.919 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -82.71 146.65 24.6 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 119.814 -1.184 . . . . 0.55 112.292 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.1 131.08 44.25 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.153 1.902 . . . . 0.85 111.393 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.748 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 1.1 pt? -77.64 133.77 38.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 1.9 111.532 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 76.7 m-20 -134.38 102.38 5.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.819 0.819 . . . . 1.78 110.556 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.875 HG12 HG22 ' A' ' 122' ' ' VAL . 4.7 mt -92.36 108.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.225 -1.352 . . . . 0.75 110.564 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' CB ' HD12 ' A' ' 73' ' ' LEU . 85.6 tt0 -106.52 117.56 34.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.409 0.522 . . . . 1.67 112.409 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.935 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -94.66 119.95 34.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.226 -0.287 . . . . 0.22 110.226 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.6 mt -107.69 143.88 35.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.958 -0.386 . . . . 0.41 109.958 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 114' ' ' ASP . 11.1 tt -129.99 130.0 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 0.78 112.05 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.1 m -117.57 102.82 51.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.888 -0.782 . . . . 1.25 108.888 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.677 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 72.0 Cg_endo -78.37 107.68 2.34 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.349 2.032 . . . . 0.53 112.979 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.19 70.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.956 -1.02 . . . . 0.41 110.365 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 5.7 p-10 -87.42 17.27 4.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.644 -0.707 . . . . 1.82 111.204 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -152.86 162.61 41.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.208 0.528 . . . . 1.94 111.837 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -67.19 -19.92 65.64 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.372 -0.831 . . . . 1.66 112.258 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 62.8 mttp -70.06 152.09 44.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.263 -0.426 . . . . 1.74 111.321 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.8 128.67 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 CA-C-O 121.773 0.797 . . . . 0.97 109.614 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.95 44.74 25.18 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.339 -1.301 . . . . 1.77 112.289 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' O ' HG22 ' A' ' 59' ' ' ILE . 90.6 mm-40 -87.29 134.54 33.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 1.96 111.036 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 58' ' ' LEU . 65.6 t -70.8 130.05 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.524 -0.307 . . . . 0.77 110.682 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.843 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -130.15 -37.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.836 0.68 . . . . 1.15 112.836 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.12 122.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.698 -0.482 . . . . 0.29 109.698 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.26 161.71 37.02 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.045 -0.525 . . . . 1.3 110.221 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.659 ' CD1' HG23 ' A' ' 79' ' ' ILE . 47.1 t80 -132.46 111.02 10.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.884 0.373 . . . . 1.3 110.615 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 15.2 t -142.34 158.05 44.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.788 -0.642 . . . . 0.89 111.576 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.69 33.53 42.09 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.827 -0.701 . . . . 0.57 112.324 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER 70.01 10.16 7.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.711 0.291 . . . . 1.46 110.866 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 58.5 mttm -108.84 111.65 23.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.37 -0.377 . . . . 2.41 111.181 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.05 117.84 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.752 -1.574 . . . . 1.66 106.752 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.795 ' O ' HG12 ' A' ' 72' ' ' ILE . 7.2 m-85 -100.05 130.12 46.17 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.839 -1.073 . . . . 1.25 110.648 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.2 p-10 -165.99 -56.81 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.358 -1.719 . . . . 1.2 106.358 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -78.43 -24.52 46.08 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 114.416 -1.266 . . . . 2.17 108.894 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -76.99 -29.97 55.73 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.396 -1.335 . . . . 5.05 107.396 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.619 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 1.2 m-85 -86.24 113.31 51.5 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 114.423 -1.262 . . . . 1.29 109.919 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.04 -36.2 90.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.902 1.735 . . . . 0.79 112.948 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 87' ' ' LEU . 58.2 m-20 -49.99 -29.99 9.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.298 0.851 . . . . 1.36 113.298 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 2.0 mp -151.74 30.19 0.59 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.874 -0.603 . . . . 1.62 111.467 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 40.5 pttt -58.96 137.75 57.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.996 -0.682 . . . . 2.39 111.899 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 13.83 80.2 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.598 -0.728 . . . . 0.37 114.175 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.4 ptm85 -142.23 -56.65 0.45 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 114.922 1.453 . . . . 1.59 114.922 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -78.21 80.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 123.059 1.409 . . . . 0.2 107.358 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.438 ' C ' HG22 ' A' ' 105' ' ' ILE . 7.9 m-70 -98.89 127.07 44.72 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.161 -2.29 . . . . 0.29 112.797 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.113 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.6 m-85 -68.66 125.53 26.83 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 120.1 -0.64 . . . . 1.23 109.298 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.963 HG21 ' CE2' ' A' ' 38' ' ' TYR . 6.6 p -74.15 28.24 0.08 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.514 -0.766 . . . . 0.46 112.644 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 t -148.7 137.64 21.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.13 0.491 . . . . 1.2 110.948 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -92.73 3.72 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.569 -0.741 . . . . 2.22 110.73 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -146.49 66.95 1.17 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.95 -0.759 . . . . 2.14 108.95 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.3 mp -57.87 -24.66 58.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.114 -0.948 . . . . 1.49 111.637 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -64.16 0.59 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.224 0.453 . . . . 2.04 112.224 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -90.02 -0.03 57.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.682 -0.69 . . . . 1.4 110.832 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.73 -13.7 42.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.38 112.557 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -96.14 108.39 20.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.115 -0.328 . . . . 1.44 110.115 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -112.54 15.53 20.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.18 0.437 . . . . 0.43 112.18 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 27.9 p -61.31 147.77 43.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.354 1.613 . . . . 1.04 115.354 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.113 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -134.47 130.33 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.291 -1.322 . . . . 0.31 111.211 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.881 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.3 OUTLIER -103.37 143.58 32.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.602 -0.888 . . . . 1.15 108.602 177.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.68 124.45 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 120.891 0.377 . . . . 0.27 111.637 -178.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.723 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.8 p -85.67 145.14 27.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.29 110.874 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 98.5 m-20 50.57 57.28 6.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.063 0.459 . . . . 1.52 111.878 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 37' ' ' ALA . 25.1 mt -45.66 85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.727 1.38 . . . . 1.02 114.727 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 63.9 tt0 -59.98 147.89 37.27 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.668 -0.696 . . . . 2.13 110.416 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.647 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 94.1 mt -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.054 0.39 . . . . 1.7 112.054 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 23.3 t -70.82 -14.96 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 1.32 111.567 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.726 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -70.16 -19.15 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.384 -0.599 . . . . 1.58 109.384 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 30.2 mt -45.68 138.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.947 -0.57 . . . . 0.42 110.057 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.77 163.68 9.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 119.95 -1.119 . . . . 0.24 113.876 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 87.5 m -59.41 130.02 44.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.599 0.592 . . . . 0.31 112.599 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.596 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.2 m-85 -112.43 130.94 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 1.24 109.687 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -123.24 118.22 27.08 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.057 -0.257 . . . . 1.16 111.027 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 41.9 t -100.54 118.57 36.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 1.03 110.153 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 44.2 mtpt -117.89 106.17 12.7 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.822 -0.351 . . . . 1.76 111.493 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 55' ' ' ILE . 29.9 t -90.04 109.27 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.229 -0.656 . . . . 1.18 109.229 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.7 tttp -100.32 111.77 24.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 1.62 112.327 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 48.6 tttt -142.41 102.84 4.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.3 -0.56 . . . . 2.84 110.189 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.919 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.26 134.01 24.02 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.643 -0.708 . . . . 0.44 112.09 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 65.5 Cg_endo -99.26 47.87 2.08 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.414 -1.078 . . . . 0.56 111.785 -0.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.97 102.95 0.27 Allowed Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.89 -1.147 . . . . 0.48 113.822 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.61 151.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.534 -0.833 . . . . 1.22 109.689 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.49 144.47 34.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.387 0.514 . . . . 0.57 112.387 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.44 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 43.7 p-10 -146.78 139.8 25.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.241 -0.436 . . . . 2.03 111.61 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.704 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.18 161.99 38.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.548 -0.296 . . . . 2.95 111.073 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.4 mttt -106.66 143.44 34.76 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.888 1.07 . . . . 2.26 113.888 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.737 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.3 mt -143.86 114.81 2.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 114.982 -1.008 . . . . 0.28 108.879 176.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -99.44 112.79 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.481 -0.488 . . . . 0.55 110.911 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.7 HD21 HD22 ' A' ' 110' ' ' LEU . 54.6 tp -88.25 131.01 34.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.697 -0.683 . . . . 1.52 112.425 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.0 t -126.42 125.83 68.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.32 109.729 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 27.6 t -99.33 123.09 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.08 111.412 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.6 mt -81.82 157.21 24.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.701 -0.481 . . . . 0.52 109.701 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.65 135.86 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.53 0.681 . . . . 1.48 111.629 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.816 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.1 177.6 1.62 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 114.79 -1.096 . . . . 2.2 109.352 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.816 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 9.6 Cg_endo -54.1 -163.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 121.925 1.75 . . . . 1.31 112.83 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.517 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -30.64 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.981 -0.554 . . . . 2.31 112.492 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.402 ' CA ' ' HA3' ' A' ' 34' ' ' GLY . . . 66.53 -63.23 0.17 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.802 -0.713 . . . . 2.52 113.043 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 2.6 111.139 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.756 -0.138 . . . . 3.28 112.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 t -77.64 129.99 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.599 0.238 . . . . 2.43 110.534 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.8 m -74.82 130.01 38.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 1.84 110.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.748 HG13 ' HB1' ' A' ' 129' ' ' ALA . 42.5 mm -118.73 129.99 74.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 2.15 111.003 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 51.1 p -85.9 146.56 26.66 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.32 0.581 . . . . 1.12 110.598 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.27 83.27 0.21 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.146 -0.934 . . . . 0.65 111.333 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.4 Cg_endo -77.72 -77.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.568 2.845 . . . . 0.88 112.193 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 45.4 mp0 -78.64 123.22 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 2.06 108.958 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 28' ' ' MET . 77.8 tt0 -143.81 159.99 41.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.077 1.14 . . . . 1.71 114.077 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.502 ' C ' HD12 ' A' ' 29' ' ' ILE . 57.5 ttm -134.6 130.01 35.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.536 -1.211 . . . . 1.86 108.284 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.047 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -131.22 138.48 53.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.03 -0.532 . . . . 0.39 112.335 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.764 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 92.2 mt-10 -128.81 126.34 39.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.211 -0.45 . . . . 1.19 110.252 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HB2' HD13 ' A' ' 110' ' ' LEU . 60.3 mmtt -142.09 156.87 45.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.892 0.377 . . . . 2.52 111.846 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -77.29 140.18 39.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.39 111.887 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HD2' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -45.73 141.89 2.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.09 -0.505 . . . . 2.35 111.872 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 79.3 -21.66 4.17 Favored Glycine 0 C--N 1.328 0.132 0 C-N-CA 121.168 -0.539 . . . . 0.31 113.759 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -78.48 155.25 29.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.768 -0.827 . . . . 2.11 108.768 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.835 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.2 m -88.67 121.69 31.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.818 -0.753 . . . . 0.33 110.544 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -95.93 116.1 28.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.275 0.559 . . . . 0.26 110.072 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -79.15 116.22 19.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.558 -0.746 . . . . 1.43 111.632 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 105' ' ' ILE . 29.1 mt -104.37 104.19 43.28 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.383 -0.969 . . . . 0.8 108.383 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 83.1 Cg_endo -83.26 135.58 7.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.685 2.257 . . . . 0.42 114.712 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 86.9 m -141.03 103.32 4.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.273 -0.876 . . . . 1.03 109.831 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 58.2 tptt -100.9 133.86 44.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.962 -0.563 . . . . 1.66 109.53 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.731 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 21.2 p90 -138.31 138.15 38.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.272 0.558 . . . . 1.26 111.395 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -91.5 139.64 30.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.289 -0.869 . . . . 1.33 110.438 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' NZ ' ' A' ' 124' ' ' LYS . 86.0 mt -94.63 109.75 21.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.144 -0.317 . . . . 2.12 110.144 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 m -81.04 139.49 49.44 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 109.942 -0.392 . . . . 1.75 109.942 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.89 -31.27 10.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.558 1.505 . . . . 1.61 110.707 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 82.7 tt0 -75.54 -40.03 57.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.207 -0.906 . . . . 2.18 110.827 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 80.0 m-20 -67.79 79.05 0.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.245 0.545 . . . . 2.41 109.549 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.85 -8.74 33.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.419 -0.81 . . . . 1.64 111.428 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.02 53.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.611 -0.804 . . . . 0.55 112.335 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.18 148.82 47.61 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.255 1.97 . . . . 0.85 111.785 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 45' ' ' LEU . 8.2 mt -78.02 131.1 37.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 1.9 111.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 83.1 m-20 -131.72 149.77 52.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.954 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.696 ' CD1' HD11 ' A' ' 98' ' ' LEU . 23.5 mt -143.57 104.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.226 -0.897 . . . . 0.75 109.538 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 73' ' ' LEU . 86.4 tt0 -104.48 111.04 23.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.491 0.552 . . . . 1.67 112.491 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.693 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.8 m95 -92.98 132.93 36.64 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.923 -0.311 . . . . 0.22 110.437 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.3 mt -119.55 139.99 51.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.465 -0.569 . . . . 0.41 109.465 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 87' ' ' LEU . 8.8 tt -129.97 130.74 66.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.752 0.649 . . . . 0.78 112.752 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.431 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.9 m -125.51 101.39 30.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.306 -0.998 . . . . 1.25 108.306 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.0 Cg_exo -79.76 118.25 3.77 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.534 2.156 . . . . 0.53 112.902 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.75 -39.95 86.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.561 -0.745 . . . . 0.41 110.604 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.847 -0.615 . . . . 1.82 111.749 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 33.7 m120 -85.98 160.51 19.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.365 0.602 . . . . 1.94 112.181 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -69.48 -15.87 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.103 -0.953 . . . . 1.66 111.327 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 48.7 mttt -67.0 151.47 47.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 1.74 111.821 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.02 135.58 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.585 1.183 . . . . 0.97 110.149 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 45.46 40.0 5.19 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 112.609 -2.087 . . . . 1.77 112.858 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.9 145.44 24.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.518 0.199 . . . . 1.96 110.826 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.7 t -67.12 130.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.814 0.34 . . . . 0.77 110.124 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.899 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -109.68 -65.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.908 0.707 . . . . 1.15 112.908 -177.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.824 HG22 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 107.4 9.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.434 -0.95 . . . . 0.29 108.434 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 55' ' ' ILE . 8.0 tp -112.94 157.4 21.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.3 111.042 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.843 ' CD1' HD13 ' A' ' 79' ' ' ILE . 18.1 t80 -132.58 104.72 6.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 1.3 109.921 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.522 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 14.6 t -143.12 159.77 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.427 0.528 . . . . 0.89 112.427 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.45 31.71 14.27 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.875 -0.602 . . . . 0.57 112.73 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t0 70.51 3.3 4.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.666 0.269 . . . . 1.46 111.013 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 50.1 mtpt -100.52 116.5 32.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.876 -0.416 . . . . 2.41 109.876 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.843 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.11 129.44 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 107.543 -1.28 . . . . 1.66 107.543 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.657 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -113.62 121.11 43.17 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.25 -0.886 . . . . 1.25 110.49 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.804 ' HB3' HG12 ' A' ' 72' ' ' ILE . 16.2 p-10 -165.58 -51.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.634 -1.247 . . . . 1.2 107.634 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 50.3 t0 -77.18 -21.73 53.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.157 -0.929 . . . . 2.17 108.88 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.81 -26.46 27.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.925 -1.034 . . . . 5.05 109.268 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.884 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -89.05 111.32 44.19 Favored Pre-proline 0 CA--C 1.512 -0.485 0 CA-C-N 115.25 -0.886 . . . . 1.29 112.155 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.5 -38.72 28.24 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.415 1.41 . . . . 0.79 110.473 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.6 m-20 -64.46 106.07 1.07 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.977 -0.556 . . . . 1.36 111.251 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 59' ' ' ILE . 4.7 mt 59.95 23.08 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.711 1.004 . . . . 1.62 113.711 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 23.2 pttm -58.34 149.01 25.71 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.179 -1.008 . . . . 2.39 111.379 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.83 6.72 88.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.498 -0.858 . . . . 0.37 113.024 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.791 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -142.54 -40.47 0.34 Allowed 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 113.737 1.014 . . . . 1.59 113.737 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.923 ' CG1' HD13 ' A' ' 105' ' ' ILE . 1.6 t -85.29 87.97 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 123.221 1.486 . . . . 0.2 107.525 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 30.2 m-70 -113.16 132.92 55.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 111.258 -2.701 . . . . 0.29 111.86 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.077 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.2 m-85 -75.26 123.96 26.24 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 119.988 -0.685 . . . . 1.23 109.75 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 p -74.69 -4.68 38.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.46 110.916 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . 15.9 p -84.43 113.66 21.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.206 -0.452 . . . . 1.2 110.949 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -88.19 0.01 56.57 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.514 0.673 . . . . 2.22 109.505 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -146.52 68.72 1.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.524 -1.288 . . . . 2.14 107.524 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.696 HD11 ' CD1' ' A' ' 55' ' ' ILE . 9.3 tt -56.11 -38.23 70.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.499 -1.228 . . . . 1.49 112.029 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -63.59 -2.7 1.76 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.137 0.494 . . . . 2.04 112.119 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.2 t -89.62 -0.03 57.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.585 -0.734 . . . . 1.4 111.204 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.731 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.47 -0.18 34.79 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.521 -0.847 . . . . 0.38 113.887 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 95.5 m-20 -99.48 119.95 38.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.005 0.402 . . . . 1.44 110.986 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -118.5 3.7 11.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.21 -0.45 . . . . 0.43 112.087 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 29.9 p -59.99 145.19 47.13 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.508 2.04 . . . . 1.04 116.508 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.93 130.07 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 114.034 -1.439 . . . . 0.31 109.809 177.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p-10 -100.77 142.38 32.33 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.578 -1.267 . . . . 1.15 107.578 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.91 117.83 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 120.746 -0.381 . . . . 0.27 110.716 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -84.55 143.3 29.41 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.743 -0.662 . . . . 0.29 110.759 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 80.8 m-20 49.89 58.55 5.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.52 111.256 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 37' ' ' ALA . 22.1 mt -46.19 90.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.642 0.979 . . . . 1.02 113.642 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.486 HE21 ' NH2' ' A' ' 90' ' ' ARG . 7.1 tt0 -59.64 143.92 49.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.712 -0.676 . . . . 2.13 110.338 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.573 HD12 ' HD2' ' A' ' 33' ' ' LYS . 2.4 tt -60.0 -38.52 82.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.188 0.518 . . . . 1.7 110.67 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 79.3 p -74.12 -6.52 48.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.32 111.42 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 87' ' ' LEU . 95.8 m-20 -69.99 -19.47 63.34 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.346 -0.613 . . . . 1.58 109.346 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -43.08 139.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.632 -0.713 . . . . 0.42 110.256 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.78 162.34 9.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.098 -1.049 . . . . 0.24 113.331 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.4 m -59.71 135.23 57.62 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.31 112.408 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.606 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 19.6 m-85 -119.99 132.1 55.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 1.24 109.618 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.9 mt-30 -120.16 117.5 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.613 0.244 . . . . 1.16 110.401 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.526 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 10.2 t -101.15 106.37 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.92 -0.4 . . . . 1.03 109.92 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.579 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 77.7 mttt -113.26 112.5 23.84 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.522 -0.308 . . . . 1.76 111.501 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 37.8 t -92.96 108.24 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.765 -0.458 . . . . 1.18 109.765 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 82.2 tttt -97.0 119.17 34.97 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.783 0.66 . . . . 1.62 112.783 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.9 tttt -145.82 102.79 3.7 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.646 -0.502 . . . . 2.84 109.646 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.627 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.78 131.59 21.02 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.286 0.847 . . . . 0.44 113.286 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.558 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 63.7 Cg_endo -100.35 40.66 4.13 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.675 -0.969 . . . . 0.56 111.979 -1.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.67 102.27 0.48 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.26 -0.972 . . . . 0.48 113.225 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -91.96 141.76 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 113.629 -1.286 . . . . 1.22 109.879 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -139.87 152.18 46.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.992 -0.283 . . . . 0.57 111.706 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.579 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 41.2 p-10 -146.35 149.64 34.18 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.419 0.526 . . . . 2.03 112.419 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 10.6 ptmt -144.44 157.77 44.08 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.895 -0.593 . . . . 2.95 110.81 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 5.6 ttmm -100.98 139.97 35.93 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.78 0.659 . . . . 2.26 112.78 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.047 HG23 HD13 ' A' ' 29' ' ' ILE . 89.2 mt -142.06 113.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.479 -0.782 . . . . 0.28 109.689 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -100.13 114.75 28.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.728 -0.471 . . . . 0.55 109.728 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 53.8 tp -94.73 123.0 37.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.764 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.8 t -119.93 122.18 67.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.032 -0.729 . . . . 0.32 109.032 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 16.4 t -100.27 127.16 53.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.952 0.406 . . . . 1.08 111.988 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.65 159.42 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.52 109.705 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.51 136.32 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.461 0.648 . . . . 1.48 111.333 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.542 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.05 177.14 1.76 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.868 -1.06 . . . . 2.2 109.718 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 66.7 Cg_exo -51.28 -173.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.995 1.797 . . . . 1.31 111.689 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 p -35.63 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.748 0.309 . . . . 2.31 111.792 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.21 -29.64 1.64 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.99 -0.624 . . . . 2.52 113.59 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 109' ' ' ASN . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.233 -0.889 . . . . 2.6 111.292 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.72 -0.152 . . . . 3.28 112.72 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -77.4 160.0 29.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 2.43 111.151 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -159.22 150.36 20.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.488 . . . . 1.84 110.986 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.933 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 10.9 tt -141.67 144.23 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.776 -0.647 . . . . 2.15 110.482 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.6 p -88.12 152.73 21.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.414 0.626 . . . . 1.12 111.574 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.687 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 37.91 84.75 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.743 -1.117 . . . . 0.65 111.212 -178.185 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.2 Cg_endo -76.8 -11.6 18.26 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 123.417 2.745 . . . . 0.88 112.777 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.9 126.6 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.544 -0.91 . . . . 2.06 108.544 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.0 tt0 -143.93 159.41 42.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.25 1.204 . . . . 1.71 114.25 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 77.9 mtp -139.96 123.89 17.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.678 -1.146 . . . . 1.86 109.781 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.769 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.3 mm -122.47 129.46 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.649 0.261 . . . . 0.39 111.288 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.613 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.3 mt-10 -119.95 124.21 45.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.499 -0.319 . . . . 1.19 110.554 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' A' ' 110' ' ' LEU . 23.6 mmtt -142.22 162.22 36.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 2.52 111.639 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.808 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.56 137.93 39.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.125 -0.489 . . . . 0.39 111.76 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 53.9 tttt -48.33 129.99 16.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.208 -0.451 . . . . 2.35 111.083 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.0 -18.96 45.01 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.118 -0.563 . . . . 0.31 112.349 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 110' ' ' LEU . 82.0 mm-40 -80.09 160.0 25.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.246 -1.02 . . . . 2.11 108.246 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 82.8 m -88.18 128.31 35.45 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.568 -0.853 . . . . 0.33 110.814 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.95 119.98 38.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.26 110.394 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 94' ' ' THR . 30.5 t80 -79.51 113.89 18.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.803 -0.635 . . . . 1.43 111.427 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.766 ' HB2' HD12 ' A' ' 105' ' ' ILE . 47.1 mt -100.96 106.3 43.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.442 -0.948 . . . . 0.8 108.442 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.669 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 4.4 Cg_endo -84.92 126.23 3.3 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.401 2.068 . . . . 0.42 113.361 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 19.7 t -140.59 125.92 18.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.6 -0.889 . . . . 1.03 108.6 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 22' ' ' ILE . 8.4 mtpm? -140.82 148.55 40.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.943 -0.571 . . . . 1.66 111.473 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' CD1' HG11 ' A' ' 122' ' ' VAL . 50.3 p90 -139.99 143.1 36.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.027 -0.988 . . . . 1.26 111.613 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.1 p -83.3 159.96 21.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.814 -0.63 . . . . 1.33 111.093 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.58 122.88 36.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 2.12 110.458 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 15.8 m -76.06 155.97 84.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.599 -0.273 . . . . 1.75 110.404 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.41 -20.1 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.562 2.175 . . . . 1.61 112.399 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 79.5 tt0 -148.19 34.55 0.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.607 -0.27 . . . . 2.18 111.267 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 46' ' ' SER . 34.0 p-10 -69.92 69.94 0.33 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.022 0.439 . . . . 2.41 110.447 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -96.42 -1.4 47.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 1.64 111.679 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.671 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.84 153.95 49.33 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.206 -0.997 . . . . 0.55 112.165 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.68 126.8 23.45 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.235 1.957 . . . . 0.85 111.152 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.874 HD21 ' HD3' ' A' ' 124' ' ' LYS . 1.3 mt -77.94 104.55 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.448 -0.342 . . . . 1.9 111.23 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -116.98 103.42 10.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.535 0.683 . . . . 1.78 110.728 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.1 mt -97.57 121.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.75 110.782 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.932 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -115.41 126.37 54.3 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.34 0.496 . . . . 1.67 112.34 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.732 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.0 m95 -100.52 124.24 45.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.22 110.16 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.513 HD21 ' OE2' ' A' ' 56' ' ' GLU . 86.1 mt -109.52 140.52 43.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.499 -0.556 . . . . 0.41 109.499 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.0 tt -127.77 130.03 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.485 . . . . 0.78 112.259 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 17.8 m -120.18 102.41 46.08 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.892 -0.781 . . . . 1.25 108.892 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.3 Cg_exo -79.4 118.08 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.514 2.143 . . . . 0.53 112.628 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.98 87.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.721 -0.672 . . . . 0.41 110.542 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -75.69 -40.01 56.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 1.82 111.425 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 15.6 t-20 -82.61 158.15 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 1.94 111.731 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -69.18 -20.02 64.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 1.66 111.895 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.75 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 18.5 mtpt -70.59 151.73 44.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 1.74 111.907 -178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.2 m -153.94 129.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.799 0.809 . . . . 0.97 109.106 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 59.5 39.18 22.05 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.231 -1.35 . . . . 1.77 111.785 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 96.0 mm-40 -92.09 153.56 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.356 -0.384 . . . . 1.96 111.415 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.711 HG21 ' CE1' ' A' ' 84' ' ' TYR . 4.2 p -64.34 150.55 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.427 -0.582 . . . . 0.77 109.427 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.914 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -144.21 -57.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.179 -0.608 . . . . 1.15 112.504 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.975 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.56 135.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.626 -0.509 . . . . 0.29 109.626 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.932 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 4.0 mp -140.73 164.06 31.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 1.3 112.207 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.888 ' CD1' HD13 ' A' ' 79' ' ' ILE . 45.3 t80 -137.2 103.27 5.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.337 -0.847 . . . . 1.3 109.195 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.454 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 12.8 t -144.1 159.58 42.39 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.083 -0.508 . . . . 0.89 112.256 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.33 31.02 4.53 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.058 -0.519 . . . . 0.57 113.353 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 72.03 1.95 4.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.446 0.165 . . . . 1.46 111.419 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 87.4 mttt -100.01 117.77 34.99 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.657 -0.497 . . . . 2.41 109.657 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.888 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.4 mm -80.02 130.31 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.436 -1.32 . . . . 1.66 107.436 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.732 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.3 m-85 -117.45 125.17 50.47 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.325 -0.852 . . . . 1.25 110.655 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.885 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.8 p-10 -165.93 -55.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.975 -1.491 . . . . 1.2 106.975 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' N ' ' A' ' 89' ' ' GLY . 51.1 t0 -80.64 -21.51 41.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.864 -1.062 . . . . 2.17 109.047 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -81.56 -25.91 35.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.371 -0.974 . . . . 5.05 108.371 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.729 ' CZ ' HD13 ' A' ' 73' ' ' LEU . 2.2 m-85 -87.11 120.71 71.56 Favored Pre-proline 0 CA--C 1.509 -0.604 0 CA-C-N 115.273 -0.876 . . . . 1.29 110.555 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.9 Cg_endo -48.56 -43.78 32.39 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.391 1.394 . . . . 0.79 110.443 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 71' ' ' ILE . 2.8 m-20 -68.72 107.22 2.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.297 -0.961 . . . . 1.36 111.328 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.813 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.9 mt 68.75 25.9 6.24 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.642 0.979 . . . . 1.62 113.642 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.885 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.2 pttt -56.62 127.53 31.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.025 -0.67 . . . . 2.39 111.431 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 82' ' ' ASP . . . 91.66 16.3 52.48 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.37 114.135 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -144.32 -47.68 0.26 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.707 1.373 . . . . 1.59 114.707 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -80.85 82.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 123.038 1.399 . . . . 0.2 108.119 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.698 ' C ' HG22 ' A' ' 105' ' ' ILE . 20.3 m80 -101.29 130.18 47.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.639 -2.073 . . . . 0.29 111.997 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.1 m-85 -74.09 121.55 21.31 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.551 0.691 . . . . 1.23 109.704 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -69.98 -11.17 60.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.65 -1.159 . . . . 0.46 110.096 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.7 m -93.49 120.02 33.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.971 -0.559 . . . . 1.2 110.738 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -89.56 0.03 57.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.071 0.462 . . . . 2.22 110.26 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -146.19 67.24 1.19 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.764 -0.828 . . . . 2.14 108.764 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 74' ' ' TYR . 5.2 mp -54.61 -23.58 17.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.141 -0.936 . . . . 1.49 111.655 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.26 -4.59 3.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.216 0.532 . . . . 2.04 111.759 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.7 p -88.53 0.02 56.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.305 -0.861 . . . . 1.4 111.072 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 102.86 -14.18 56.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.744 -0.741 . . . . 0.38 113.151 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.18 108.95 21.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.911 0.355 . . . . 1.44 110.69 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.05 16.69 21.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.36 0.504 . . . . 0.43 112.36 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m -60.03 145.78 45.14 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 115.793 1.775 . . . . 1.04 115.793 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.41 136.02 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.082 -1.417 . . . . 0.31 110.783 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 90' ' ' ARG . 49.2 p-10 -107.11 143.52 35.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.528 -0.915 . . . . 1.15 108.528 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.85 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.71 120.7 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.063 0.459 . . . . 0.27 111.655 -178.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 144.54 29.43 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.333 -0.849 . . . . 0.29 111.012 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 29.0 m120 49.84 55.89 8.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.281 -0.418 . . . . 1.52 111.811 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.891 HD22 HD11 ' A' ' 135' ' ' LEU . 21.7 mt -45.45 89.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.699 1.0 . . . . 1.02 113.699 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 52.3 tt0 -60.05 143.82 51.0 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.582 -0.525 . . . . 2.13 109.582 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.96 -40.04 87.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 1.7 110.892 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -73.3 -10.01 59.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.32 111.613 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.2 m-20 -70.56 -17.24 62.92 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.892 -0.41 . . . . 1.58 109.892 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.61 143.76 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 CA-C-N 115.862 -0.608 . . . . 0.42 110.381 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.75 157.09 7.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.155 -1.021 . . . . 0.24 113.201 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.6 m -59.34 138.95 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.339 0.496 . . . . 0.31 112.339 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.552 ' OH ' HD11 ' A' ' 87' ' ' LEU . 9.6 m-85 -120.09 130.91 54.87 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.432 -0.581 . . . . 1.24 109.432 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.6 tt0 -127.47 119.96 27.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.957 -0.297 . . . . 1.16 111.015 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 21.6 p -102.71 119.95 39.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.76 0.314 . . . . 1.03 110.554 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 97.5 mttt -112.75 104.9 12.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 1.76 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.764 HG22 HG12 ' A' ' 55' ' ' ILE . 21.8 t -88.42 117.31 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.325 -0.62 . . . . 1.18 109.325 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.848 ' HG2' HG12 ' A' ' 128' ' ' VAL . 75.8 mttt -113.76 118.31 33.93 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.91 1.078 . . . . 1.62 113.91 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.874 ' HD3' HD21 ' A' ' 53' ' ' LEU . 21.1 pttm -146.94 103.8 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.639 -0.71 . . . . 2.84 110.809 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.671 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -48.34 129.11 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.92 -0.582 . . . . 0.44 111.835 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -104.11 53.79 1.21 Allowed 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 125.207 -0.747 . . . . 0.56 111.802 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 102.98 0.27 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.95 -1.119 . . . . 0.48 113.871 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 123' ' ' LYS . 17.1 m -94.24 134.27 32.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.394 -0.903 . . . . 1.22 109.845 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.933 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -143.55 136.6 27.72 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.13 0.418 . . . . 0.57 112.13 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.605 ' C ' HD13 ' A' ' 22' ' ' ILE . 45.9 p-10 -146.79 150.24 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.219 0.452 . . . . 2.03 112.219 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.758 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.55 163.52 34.51 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 2.95 110.567 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.0 mttt -101.3 145.05 29.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 114.25 1.204 . . . . 2.26 114.25 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.673 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.53 119.36 11.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.63 -1.168 . . . . 0.28 108.654 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.504 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 5.3 m-70 -100.43 119.75 38.95 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.564 -0.455 . . . . 0.55 110.741 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.891 HD11 HD22 ' A' ' 110' ' ' LEU . 1.5 tm? -89.58 120.04 30.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 1.52 111.384 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.613 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.1 t -117.3 120.0 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.653 . . . . 0.32 109.551 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.66 125.34 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.016 0.436 . . . . 1.08 112.035 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 92.9 mt -84.85 170.01 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.52 109.368 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.43 135.18 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 1.48 111.69 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.808 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 5.8 mttt -165.05 176.47 2.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.717 -1.129 . . . . 2.2 110.015 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.472 ' HD2' ' HD3' ' A' ' 140' ' ' LYS . 44.6 Cg_exo -56.87 155.5 27.4 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.302 2.002 . . . . 1.31 112.251 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.443 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 1.1 m -40.05 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.15 -0.477 . . . . 2.31 111.948 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.24 -65.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.99 -0.624 . . . . 2.52 112.854 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.282 -0.866 . . . . 2.6 111.258 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.498 -0.241 . . . . 3.28 112.498 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -78.28 159.96 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 2.43 110.827 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.8 m -157.84 133.9 9.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.84 110.998 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.784 ' CD1' ' HB1' ' A' ' 129' ' ' ALA . 85.6 mt -110.0 129.96 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 2.15 110.558 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 38.1 p -91.44 148.34 22.38 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.191 0.519 . . . . 1.12 110.792 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.62 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 41.38 82.69 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.089 -0.96 . . . . 0.65 111.117 -177.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.46 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 123.971 3.114 . . . . 0.88 112.926 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.27 126.3 30.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.504 -0.925 . . . . 2.06 108.504 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.934 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -143.74 160.02 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.893 1.071 . . . . 1.71 113.893 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.793 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.16 137.21 38.95 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 114.881 -1.054 . . . . 1.86 109.281 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.934 HD11 ' OE2' ' A' ' 27' ' ' GLU . 32.2 mm -134.16 140.02 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.296 0.48 . . . . 0.39 112.296 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt-10 -130.14 123.96 31.54 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.431 -0.581 . . . . 1.19 109.431 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.606 ' HB3' HD13 ' A' ' 110' ' ' LEU . 49.3 tptt -142.07 157.22 45.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.981 -0.287 . . . . 2.52 111.31 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.872 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.8 141.66 40.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.39 112.067 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 142' ' ' SER . 59.5 tttp -48.67 131.48 17.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.884 -0.598 . . . . 2.35 111.872 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 87.38 -17.36 43.92 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.13 -0.557 . . . . 0.31 113.267 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.771 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.1 mt-10 -80.01 159.77 26.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.628 -0.879 . . . . 2.11 108.628 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.863 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.4 m -89.37 128.5 35.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.652 -0.819 . . . . 0.33 110.367 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.966 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.0 112.12 24.33 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.26 110.343 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CD1' HG21 ' A' ' 94' ' ' THR . 77.4 t80 -79.15 117.89 20.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 1.43 111.616 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.831 HD22 HG21 ' A' ' 133' ' ' ILE . 39.9 mt -105.97 104.73 50.71 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.8 109.249 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.37 127.19 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.448 2.099 . . . . 0.42 113.497 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -140.31 130.18 24.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.359 -0.837 . . . . 1.03 109.616 179.02 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 8.9 mptt -140.03 140.34 36.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.053 -0.521 . . . . 1.66 110.003 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CG ' HG11 ' A' ' 122' ' ' VAL . 50.0 p90 -140.23 139.81 35.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.26 111.704 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 p -88.91 147.42 24.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.612 -0.722 . . . . 1.33 111.441 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 124' ' ' LYS . 24.5 tp -99.48 114.38 27.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 2.12 110.903 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -81.87 145.46 53.75 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 110.028 -0.36 . . . . 1.75 110.028 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -49.62 -34.15 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.782 1.654 . . . . 1.61 110.536 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -75.64 -40.02 56.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.282 -0.872 . . . . 2.18 110.641 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.548 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.7 m-20 -69.51 73.58 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.134 0.493 . . . . 2.41 109.759 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -94.29 -4.84 48.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.754 . . . . 1.64 111.621 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.666 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.99 157.33 53.51 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.413 -0.899 . . . . 0.55 112.536 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.45 148.88 10.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.477 2.118 . . . . 0.85 111.858 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.985 HD22 ' HA ' ' A' ' 99' ' ' LYS . 5.6 mp -78.16 135.76 37.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 1.9 111.503 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 9.2 t70 -140.73 153.59 45.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 1.78 111.876 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 21.5 mt -142.49 139.93 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.007 -0.997 . . . . 0.75 109.667 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.621 ' HG2' HD11 ' A' ' 73' ' ' LEU . 98.0 mt-10 -140.23 111.71 7.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.026 0.375 . . . . 1.67 111.748 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.965 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -97.68 119.9 37.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.867 -0.333 . . . . 0.22 110.929 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 119' ' ' GLN . 89.2 mt -104.9 138.84 40.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.014 -0.736 . . . . 0.41 109.014 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.9 tt -129.97 129.98 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.321 0.489 . . . . 0.78 112.321 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.8 m -121.44 102.45 42.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 1.25 109.153 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.8 Cg_exo -81.46 116.19 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.645 2.23 . . . . 0.53 112.716 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -33.25 71.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.71 . . . . 0.41 110.886 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -85.29 12.89 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 1.82 112.148 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 93.9 m-20 -146.99 163.19 37.02 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.37 0.605 . . . . 1.94 111.873 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.06 -18.06 65.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.065 -0.97 . . . . 1.66 111.912 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.676 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 96.2 mttt -67.16 140.01 57.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.117 0.484 . . . . 1.74 111.827 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.0 127.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.852 0.834 . . . . 0.97 109.012 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.82 39.33 29.64 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.098 -1.41 . . . . 1.77 111.796 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -94.72 140.01 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 1.96 110.816 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 43.0 t -69.86 127.1 31.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.987 0.422 . . . . 0.77 110.276 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.925 HG13 HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -112.04 -51.38 5.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.925 -0.58 . . . . 1.15 112.124 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.866 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.92 130.13 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.593 -0.891 . . . . 0.29 108.593 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 74' ' ' TYR . 3.3 tt -140.1 157.03 46.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 1.3 111.271 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 79' ' ' ILE . 36.8 t80 -135.45 104.33 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.345 -0.388 . . . . 1.3 110.076 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 t -144.24 157.26 44.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.416 0.524 . . . . 0.89 112.416 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.22 12.57 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.214 -0.517 . . . . 0.57 113.075 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t0 72.12 3.27 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.497 0.184 . . . . 1.46 111.497 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 114.85 28.46 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.568 -0.53 . . . . 2.41 109.568 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.9 mm -79.81 129.81 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 107.313 -1.366 . . . . 1.66 107.313 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.717 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -115.55 119.2 35.38 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.095 -0.957 . . . . 1.25 110.197 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 10.0 p-10 -166.19 -51.74 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.695 -1.595 . . . . 1.2 106.695 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -80.04 -23.92 41.1 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.352 -1.295 . . . . 2.17 108.49 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -80.82 -27.05 36.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.057 -1.09 . . . . 5.05 108.057 177.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.528 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.6 m-85 -86.57 108.86 19.75 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-N 115.154 -0.93 . . . . 1.29 110.014 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 30.7 Cg_exo -61.47 -28.64 83.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.729 1.619 . . . . 0.79 112.065 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.797 ' O ' HD22 ' A' ' 87' ' ' LEU . 53.2 t0 -44.32 -36.34 2.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.347 0.594 . . . . 1.36 111.762 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.925 HD23 HG13 ' A' ' 71' ' ' ILE . 1.5 mm? -156.48 33.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.751 -1.113 . . . . 1.62 110.56 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 63.3 pttt -52.9 129.98 31.94 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.435 -0.506 . . . . 2.39 111.902 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.14 57.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.506 -0.854 . . . . 0.37 114.818 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.889 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -142.88 -46.6 0.31 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 115.009 1.485 . . . . 1.59 115.009 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.866 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.0 p -80.22 81.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.748 1.261 . . . . 0.2 108.235 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.483 ' C ' HG22 ' A' ' 105' ' ' ILE . 22.3 m80 -103.13 129.69 50.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.892 -1.958 . . . . 0.29 112.521 -175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.115 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.4 m-85 -73.17 122.79 22.44 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 120.002 -0.679 . . . . 1.23 109.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 38' ' ' TYR . 17.9 p -72.16 -9.93 59.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.148 -0.933 . . . . 0.46 110.274 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 1.4 m -89.13 122.05 32.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.658 -0.701 . . . . 1.2 110.5 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -91.34 4.45 52.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.218 0.532 . . . . 2.22 110.396 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -146.57 66.71 1.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.424 -0.807 . . . . 2.14 108.903 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 93' ' ' PHE . 7.9 mp -57.92 -35.04 70.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.254 -0.885 . . . . 1.49 111.434 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.985 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.1 pttt -60.05 -13.78 13.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.701 0.762 . . . . 2.04 111.801 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 t -82.99 0.04 46.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.386 -1.279 . . . . 1.4 110.99 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.86 -2.51 38.65 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.543 -0.836 . . . . 0.38 113.742 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.55 112.65 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.172 0.486 . . . . 1.44 110.976 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -109.83 10.53 24.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.388 0.514 . . . . 0.43 112.388 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.668 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 p -60.06 137.08 58.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.825 1.787 . . . . 1.04 115.825 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.115 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 114.247 -1.342 . . . . 0.31 110.698 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.719 ' OD1' HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -105.21 145.33 30.77 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.527 -0.546 . . . . 1.15 109.527 177.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.863 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.49 118.72 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.142 0.496 . . . . 0.27 111.351 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.19 143.7 30.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.297 -0.865 . . . . 0.29 110.757 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.0 m120 49.95 55.16 9.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.083 0.468 . . . . 1.52 111.508 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.9 mt -45.26 88.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.225 1.194 . . . . 1.02 114.225 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' CG ' ' A' ' 114' ' ' ASP . 14.7 pt20 -59.66 151.45 24.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 2.13 109.756 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.478 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.5 mt -60.12 -28.39 67.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 1.7 110.863 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.3 m -73.93 -5.95 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 1.32 111.424 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.527 ' HB3' HD23 ' A' ' 135' ' ' LEU . 87.9 m-20 -69.92 -23.63 63.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.616 -0.513 . . . . 1.58 109.616 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.87 133.47 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.116 -0.493 . . . . 0.42 110.091 178.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.65 158.71 7.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.034 -1.079 . . . . 0.24 113.386 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.9 m -59.35 133.89 56.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.569 0.581 . . . . 0.31 112.569 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.641 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 25.9 m-85 -118.4 132.83 56.24 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.035 -0.53 . . . . 1.24 109.692 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.5 mt-30 -120.01 119.98 34.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.627 -0.261 . . . . 1.16 111.666 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.574 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 42.7 t -100.04 107.3 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.214 -0.662 . . . . 1.03 109.214 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 8.9 mtpm? -114.19 109.31 18.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.418 -0.355 . . . . 1.76 111.492 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.765 HG11 ' CG ' ' A' ' 43' ' ' PHE . 53.2 t -91.85 108.36 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.652 -0.499 . . . . 1.18 109.652 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 64.7 tttm -93.63 120.37 33.82 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.246 -0.582 . . . . 1.62 112.206 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 4.6 mtpt -144.38 102.2 3.8 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.821 -0.436 . . . . 2.84 109.821 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.666 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.04 130.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 113.44 0.904 . . . . 0.44 113.44 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 88.5 Cg_endo -101.64 42.16 3.3 Favored 'Cis proline' 0 C--N 1.354 0.866 0 C-N-CA 125.094 -0.794 . . . . 0.56 111.811 -1.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.95 103.59 0.46 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 122.006 0.781 . . . . 0.48 112.723 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.584 HG12 ' HG3' ' A' ' 123' ' ' LYS . 23.0 m -82.93 155.73 3.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.086 -1.057 . . . . 1.22 110.433 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.56 0.219 . . . . 0.57 111.397 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 47.9 t30 -146.59 134.59 21.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.121 0.415 . . . . 2.03 112.121 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.684 ' CE ' HD11 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -142.22 158.87 43.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.55 -0.537 . . . . 2.95 109.55 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 43.5 mmtm -109.98 146.68 34.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.659 1.355 . . . . 2.26 114.659 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.831 HG21 HD22 ' A' ' 39' ' ' LEU . 98.9 mt -144.17 122.57 6.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 114.586 -1.188 . . . . 0.28 109.335 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.09 111.6 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.591 -0.443 . . . . 0.55 110.063 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 110' ' ' LEU . 51.6 tp -87.83 135.53 33.35 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.524 0.564 . . . . 1.52 112.524 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.549 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 63.0 t -129.99 130.03 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 0.32 109.491 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 20.4 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.363 . . . . 1.08 111.859 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 87.9 mt -83.81 167.86 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.045 -0.525 . . . . 0.52 109.609 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.89 138.16 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.381 0.61 . . . . 1.48 111.208 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.872 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 5.3 mttt -163.6 170.49 7.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.175 -0.92 . . . . 2.2 110.823 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.2 Cg_endo -50.95 -158.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.98 2.454 . . . . 1.31 112.827 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.518 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 68.3 m -36.78 -40.74 0.28 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.35 -0.387 . . . . 2.31 111.721 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.576 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 34.59 47.35 0.62 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.779 -0.646 . . . . 2.52 114.139 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.212 -0.899 . . . . 2.6 111.083 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.711 -0.156 . . . . 3.28 112.711 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 m -158.93 159.15 34.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.348 . . . . 2.43 110.763 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.55 149.95 19.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 1.84 110.738 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 42' ' ' LYS . 1.9 pt -142.28 143.86 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.0 -0.546 . . . . 2.15 110.869 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 27.5 p -88.58 162.43 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.793 0.806 . . . . 1.12 112.325 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.12 82.78 0.22 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.264 -1.335 . . . . 0.65 112.712 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 63.3 Cg_endo -79.12 -86.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.775 2.984 . . . . 0.88 112.421 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 6.2 pm0 -78.0 122.02 24.99 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.711 -0.848 . . . . 2.06 108.711 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 132' ' ' LYS . 51.3 tp10 -144.22 159.99 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.715 1.006 . . . . 1.71 113.715 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.9 133.01 33.3 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.829 -1.078 . . . . 1.86 109.091 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 28' ' ' MET . 32.0 mm -130.05 140.04 49.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.853 -0.612 . . . . 0.39 111.358 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.1 pt-20 -136.85 127.3 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.455 -0.338 . . . . 1.19 110.687 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 18.3 mmtp -142.31 164.18 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.309 -0.405 . . . . 2.52 111.03 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.888 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.35 137.33 39.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.39 111.269 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 21.0 ttpt -45.79 130.34 9.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 2.35 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 92.23 -18.02 55.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.005 -0.617 . . . . 0.31 112.746 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.7 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 98.9 mt-10 -79.99 156.0 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.704 -0.85 . . . . 2.11 108.704 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 62.6 m -87.98 127.83 35.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.666 -0.814 . . . . 0.33 110.67 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.942 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.9 115.1 28.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.26 110.787 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.702 ' CE2' HG21 ' A' ' 94' ' ' THR . 25.1 t80 -79.37 120.06 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.036 -0.529 . . . . 1.43 111.491 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 105' ' ' ILE . 18.3 mt -109.48 104.78 56.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.093 -0.706 . . . . 0.8 109.093 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.492 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 88.3 Cg_endo -84.76 131.16 4.46 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.818 2.345 . . . . 0.42 115.082 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.415 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 62.6 m -141.34 104.01 4.52 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.623 -0.717 . . . . 1.03 110.251 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 4.4 mptp? -102.96 140.04 37.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 1.66 110.662 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.585 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 50.4 p90 -140.55 146.68 38.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 1.26 110.826 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 82.4 p -80.02 167.1 20.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.86 -0.609 . . . . 1.33 111.65 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.96 142.88 36.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 2.12 111.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 82.0 p -160.02 159.69 27.01 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.474 -0.784 . . . . 1.75 110.003 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 16.4 Cg_endo -57.77 -16.65 26.12 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.197 1.931 . . . . 1.61 112.772 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.0 tt0 -72.21 -41.54 66.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.654 0.264 . . . . 2.18 110.303 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.79 80.4 0.87 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.815 -0.809 . . . . 2.41 108.815 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.61 -11.24 49.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.238 -0.892 . . . . 1.64 111.686 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -78.3 156.82 43.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.217 -0.992 . . . . 0.55 111.916 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.84 148.81 81.97 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.226 1.951 . . . . 0.85 111.435 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 99' ' ' LYS . 92.7 mt -77.5 131.7 38.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.806 0.336 . . . . 1.9 110.288 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -133.83 152.34 51.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.245 0.545 . . . . 1.78 111.093 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.2 mt -143.57 107.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.923 -1.035 . . . . 0.75 109.711 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.745 ' HG2' HD11 ' A' ' 73' ' ' LEU . 97.6 mt-10 -110.25 115.01 28.93 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.191 0.441 . . . . 1.67 112.191 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.828 ' CE2' HD11 ' A' ' 105' ' ' ILE . 76.9 m95 -99.17 120.89 40.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.22 110.612 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 87.7 mt -105.21 140.77 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.41 109.45 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.3 tt -130.0 130.02 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.274 0.559 . . . . 0.78 112.165 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.1 p -119.17 103.06 48.04 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.585 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 88.3 Cg_endo -79.07 114.65 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.51 2.14 . . . . 0.53 113.208 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.03 87.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.41 111.006 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.99 -40.03 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.62 . . . . 1.82 111.437 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.585 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 27.8 m120 -83.85 160.87 21.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 1.94 111.661 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.0 -22.0 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.349 -0.841 . . . . 1.66 112.313 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.575 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -72.64 156.73 38.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.765 0.317 . . . . 1.74 111.789 -178.282 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.35 128.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.906 0.86 . . . . 0.97 109.954 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 39.98 19.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.979 -1.464 . . . . 1.77 112.47 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -88.86 146.84 24.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.666 -0.243 . . . . 1.96 110.578 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.564 HG11 ' OH ' ' A' ' 84' ' ' TYR . 17.2 t -68.87 124.3 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.676 -0.49 . . . . 0.77 109.676 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -112.04 -52.14 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.055 0.761 . . . . 1.15 113.055 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.0 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.06 124.64 26.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.537 -0.912 . . . . 0.29 108.537 179.07 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.745 HD11 ' HG2' ' A' ' 56' ' ' GLU . 3.8 tt -132.24 156.48 46.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 1.3 110.586 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.875 ' CD2' HD22 ' A' ' 98' ' ' LEU . 15.6 t80 -135.14 104.98 6.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.249 -0.432 . . . . 1.3 109.94 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 7.7 t -142.11 158.84 43.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.822 0.344 . . . . 0.89 111.802 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.4 28.7 36.57 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.843 -0.694 . . . . 0.57 112.217 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.6 t0 72.2 3.28 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.24 . . . . 1.46 110.871 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 20.9 mmtp -100.03 112.29 24.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.269 -0.641 . . . . 2.41 109.269 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.84 116.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.171 -1.048 . . . . 1.66 108.171 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.744 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.1 m-85 -99.43 130.55 45.7 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.816 -1.538 . . . . 1.25 110.659 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.864 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.9 p-10 -165.9 -53.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.743 -1.206 . . . . 1.2 107.743 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -79.92 -20.09 46.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.291 -0.868 . . . . 2.17 109.171 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.2 t80 -80.82 -27.0 36.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.352 -0.981 . . . . 5.05 108.352 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.7 m-85 -86.1 113.3 51.2 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.945 -1.025 . . . . 1.29 110.777 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.4 -41.37 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.36 1.373 . . . . 0.79 109.951 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' O ' HG12 ' A' ' 71' ' ' ILE . 46.7 m-20 -67.29 105.16 1.67 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.574 -0.739 . . . . 1.36 110.668 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.886 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.0 mt 67.35 23.41 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.735 1.013 . . . . 1.62 113.735 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.864 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttm -56.08 129.26 39.22 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.517 -0.739 . . . . 2.39 111.08 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.65 15.56 54.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.352 -0.928 . . . . 0.37 114.216 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.886 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.4 ptp180 -144.25 -48.93 0.27 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 114.645 1.35 . . . . 1.59 114.645 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.0 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -79.89 81.9 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 123.157 1.456 . . . . 0.2 107.604 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.491 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.9 m-70 -103.21 129.45 50.14 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.151 -2.295 . . . . 0.29 112.399 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 84.7 m-85 -70.81 125.04 25.73 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.907 -0.717 . . . . 1.23 109.788 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.702 HG21 ' CE2' ' A' ' 38' ' ' TYR . 14.3 p -77.06 36.94 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.923 -1.035 . . . . 0.46 112.931 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.0 m -147.75 136.3 21.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 1.2 111.257 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.85 0.77 57.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.663 . . . . 2.22 110.632 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -146.69 67.81 1.17 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.448 -0.575 . . . . 2.14 109.448 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.875 HD22 ' CD2' ' A' ' 74' ' ' TYR . 7.9 mp -57.15 -27.73 62.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.302 -0.863 . . . . 1.49 111.044 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.73 ' HG2' HD12 ' A' ' 53' ' ' LEU . 37.0 mtmm -64.29 -2.93 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 2.04 112.062 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 0.01 56.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.524 -0.762 . . . . 1.4 110.964 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.585 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 109.93 -7.14 31.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.38 113.234 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.35 119.4 35.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.968 0.413 . . . . 1.44 110.813 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.57 6.48 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.891 -0.595 . . . . 0.43 111.571 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -59.95 140.08 56.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 116.203 1.927 . . . . 1.04 116.203 -177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -129.13 131.94 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.147 -1.388 . . . . 0.31 110.788 177.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -104.08 142.84 33.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.054 -1.091 . . . . 1.15 108.054 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.51 120.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.024 0.44 . . . . 0.27 111.439 -178.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.2 p -84.29 143.86 29.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.444 -0.798 . . . . 0.29 110.851 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 31.0 m120 49.97 55.13 9.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.072 -0.513 . . . . 1.52 111.916 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.942 HD11 ' HB2' ' A' ' 37' ' ' ALA . 27.9 mt -44.19 93.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.456 0.91 . . . . 1.02 113.456 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 56.2 tt0 -59.64 144.47 47.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.7 -0.682 . . . . 2.13 110.136 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 63.9 tp -59.97 -40.07 87.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.193 0.52 . . . . 1.7 110.792 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -73.24 -5.56 40.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.739 -0.664 . . . . 1.32 111.517 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.489 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.96 -19.02 63.38 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.082 -0.34 . . . . 1.58 110.082 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 139.63 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 116.145 -0.479 . . . . 0.42 110.206 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 141.04 159.73 8.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.958 -1.115 . . . . 0.24 113.414 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 63.7 m -59.44 130.69 48.12 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.838 0.681 . . . . 0.31 112.838 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 87' ' ' LEU . 13.3 m-85 -114.27 129.64 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.174 -0.676 . . . . 1.24 109.174 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.61 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 21.1 tt0 -120.9 118.61 30.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 1.16 110.276 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 57' ' ' TRP . 9.7 t -101.01 118.29 36.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 1.03 110.57 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 97.4 mttt -123.66 112.32 17.25 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 116.475 -0.33 . . . . 1.76 111.774 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 61.9 t -92.05 106.46 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.235 -0.654 . . . . 1.18 109.235 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 25.7 ttpp -95.42 117.34 30.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.006 -0.678 . . . . 1.62 112.691 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 44' ' ' THR . 2.7 pttm -146.29 103.14 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.51 -0.476 . . . . 2.84 110.12 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.93 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.92 133.91 21.61 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.44 112.055 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.7 Cg_endo -100.03 46.52 2.37 Favored 'Cis proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.769 -0.929 . . . . 0.56 111.209 -0.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 103.62 0.29 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.257 -0.973 . . . . 0.48 113.674 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.47 153.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.712 -0.744 . . . . 1.22 109.322 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -139.51 144.92 38.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.279 -0.168 . . . . 0.57 111.269 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.538 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 40.0 p-10 -146.57 142.22 27.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.895 0.702 . . . . 2.03 112.895 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.642 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.01 157.78 44.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.784 -0.644 . . . . 2.95 110.39 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 41.2 tttt -101.84 139.98 36.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.216 0.821 . . . . 2.26 113.216 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.697 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 70.9 mt -142.23 119.86 7.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.883 -0.599 . . . . 0.28 109.953 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.443 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 14.8 m170 -100.22 118.37 36.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 0.55 110.381 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 57.0 tp -91.89 123.2 35.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.217 0.451 . . . . 1.52 112.217 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -120.03 119.99 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.32 109.424 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.95 121.71 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.08 111.794 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.2 mt -81.56 164.5 21.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.337 -0.616 . . . . 0.52 109.337 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.1 139.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.399 0.619 . . . . 1.48 111.261 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.888 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -162.25 172.53 5.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.056 -0.975 . . . . 2.2 110.294 -179.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 9.5 Cg_endo -51.91 -157.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.593 2.195 . . . . 1.31 112.363 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -35.12 -59.23 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.972 0.415 . . . . 2.31 111.817 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 69.44 -62.12 0.62 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.062 -0.59 . . . . 2.52 113.127 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.229 -0.891 . . . . 2.6 111.105 -179.826 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.645 -0.182 . . . . 3.28 112.645 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -79.92 168.07 19.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 2.43 110.787 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -158.63 151.06 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 1.84 110.944 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pt -144.29 151.34 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 116.169 -0.469 . . . . 2.15 111.413 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 82.6 p -92.39 161.73 14.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.544 0.687 . . . . 1.12 111.618 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.18 83.55 0.2 Allowed Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.566 -1.197 . . . . 0.65 112.091 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.717 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 65.4 Cg_endo -78.44 -91.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.586 2.857 . . . . 0.88 111.876 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.75 126.93 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.704 -0.85 . . . . 2.06 108.704 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' CG ' HD11 ' A' ' 29' ' ' ILE . 55.3 tt0 -143.69 153.66 42.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.842 1.052 . . . . 1.71 113.842 -176.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 58.5 mtp -135.45 116.45 14.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.62 -1.173 . . . . 1.86 108.511 176.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.065 HD13 HG23 ' A' ' 133' ' ' ILE . 3.7 mp -120.0 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.004 0.431 . . . . 0.39 111.809 -178.076 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 43.9 mt-10 -106.86 126.15 51.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 1.19 110.203 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 49.9 tptt -141.7 157.3 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 2.52 111.081 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.834 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.54 139.68 40.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.39 112.018 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.3 134.02 18.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.995 -0.548 . . . . 2.35 111.546 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.63 -20.39 27.83 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.874 -0.603 . . . . 0.31 112.578 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 79.5 mm-40 -79.94 160.0 26.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.359 -0.978 . . . . 2.11 108.359 178.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.838 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.1 m -89.46 129.97 35.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.658 -0.817 . . . . 0.33 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.851 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.92 115.8 30.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.26 110.217 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 94' ' ' THR . 32.6 t80 -79.25 116.42 19.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.027 -0.533 . . . . 1.43 111.875 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.793 HD12 ' CD1' ' A' ' 105' ' ' ILE . 15.5 mt -101.5 107.62 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.796 -0.816 . . . . 0.8 108.796 177.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.2 Cg_endo -82.67 122.76 3.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.13 . . . . 0.42 113.972 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.3 t -141.46 126.34 18.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.744 -0.662 . . . . 1.03 110.211 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.5 mttm -140.91 149.93 42.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.922 -0.581 . . . . 1.66 109.993 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.803 ' CG ' HG11 ' A' ' 122' ' ' VAL . 36.3 p90 -140.87 139.98 34.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 1.26 112.012 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.43 139.64 30.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.743 . . . . 1.33 110.373 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' CE ' ' A' ' 124' ' ' LYS . 90.0 mt -92.22 107.6 19.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 2.12 110.884 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ASP . 30.4 t -83.54 133.58 46.66 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.529 -0.545 . . . . 1.75 109.529 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -43.0 -33.2 3.11 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.691 1.594 . . . . 1.61 111.04 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 83.4 tt0 -76.72 -39.98 50.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.358 -0.837 . . . . 2.18 111.074 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 77.0 m-20 -68.5 79.19 0.27 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.41 -0.516 . . . . 2.41 109.659 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.99 -5.08 28.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 1.64 111.925 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.757 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.81 53.25 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.894 -0.669 . . . . 0.55 112.689 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.36 138.27 85.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.422 2.082 . . . . 0.85 112.384 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 43' ' ' PHE . 11.3 mt -78.17 120.08 22.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 1.9 111.596 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -133.51 103.05 5.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.548 0.69 . . . . 1.78 111.419 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.849 HG12 HG22 ' A' ' 122' ' ' VAL . 2.7 mp -91.34 122.35 42.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.162 179.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.908 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.3 mt-10 -119.08 114.08 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.449 0.537 . . . . 1.67 112.449 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.92 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.3 m95 -91.7 120.02 32.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 110.078 -0.341 . . . . 0.22 110.078 178.019 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.9 mt -108.69 143.85 37.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.392 . . . . 0.41 109.94 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.611 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 10.3 tt -130.01 132.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.293 0.479 . . . . 0.78 112.293 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.419 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 52.9 m -123.28 101.85 37.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.0 -0.741 . . . . 1.25 109.0 177.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.5 Cg_endo -79.86 116.92 3.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.714 2.276 . . . . 0.53 113.435 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.96 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.61 -0.723 . . . . 0.41 110.632 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -87.42 17.28 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 1.82 112.182 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 42.7 m-20 -148.99 160.02 43.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.41 0.624 . . . . 1.94 112.213 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.08 -18.64 64.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.052 -0.976 . . . . 1.66 111.92 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 61.1 mttp -66.82 150.82 48.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 1.74 111.017 -178.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.77 130.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-O 122.409 1.099 . . . . 0.97 110.299 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.516 ' OD2' HD13 ' A' ' 58' ' ' LEU . 4.9 t0 49.66 39.99 18.77 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 112.932 -1.94 . . . . 1.77 112.542 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -90.24 140.02 30.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 1.96 111.095 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 73' ' ' LEU . 89.7 t -69.65 130.04 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.923 0.392 . . . . 0.77 111.048 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.828 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.3 pp -124.25 -37.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.008 -0.542 . . . . 1.15 111.473 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.918 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 124.58 18.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.685 -0.857 . . . . 0.29 108.685 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.908 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -140.27 157.61 45.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.64 -0.709 . . . . 1.3 110.344 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 60.5 t80 -133.75 103.56 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.018 -0.364 . . . . 1.3 110.018 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 40.0 t -143.03 155.98 44.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.879 0.371 . . . . 0.89 111.925 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.84 30.15 28.43 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.135 -0.555 . . . . 0.57 112.899 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t0 71.72 1.6 3.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.481 0.182 . . . . 1.46 111.118 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.2 mmtt -99.95 107.03 18.9 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.787 -0.82 . . . . 2.41 108.787 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.77 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.76 118.32 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.601 1.191 . . . . 1.66 108.748 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.658 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 1.6 m-85 -100.28 124.9 46.3 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.527 -2.124 . . . . 1.25 111.563 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.833 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.8 p-10 -166.31 -53.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.01 -1.478 . . . . 1.2 107.01 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 55.2 t0 -81.34 -32.59 32.91 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.538 -1.21 . . . . 2.17 109.117 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -71.55 -31.82 67.42 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.332 -1.358 . . . . 5.05 107.332 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -82.49 109.97 19.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.338 -1.301 . . . . 1.29 109.256 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.96 -31.05 77.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.018 1.812 . . . . 0.79 113.031 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.805 ' O ' HD12 ' A' ' 87' ' ' LEU . 83.7 m-20 -49.99 -29.95 9.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 1.36 112.564 -178.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 86' ' ' ASP . 2.0 mp -152.2 27.66 0.59 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.474 -0.785 . . . . 1.62 111.198 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 24.8 pttm -55.63 138.15 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.156 0.503 . . . . 2.39 111.839 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.85 82.89 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.617 -0.801 . . . . 0.37 114.41 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.72 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.35 -52.42 0.36 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 115.07 1.507 . . . . 1.59 115.07 -178.545 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.918 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.3 81.33 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.939 1.352 . . . . 0.2 107.861 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 105' ' ' ILE . 13.8 m-70 -100.64 127.87 46.89 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 112.442 -2.163 . . . . 0.29 112.418 -176.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 78.8 m-85 -72.14 120.57 17.92 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.12 -0.696 . . . . 1.23 109.12 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.615 HG21 ' CE2' ' A' ' 38' ' ' TYR . 28.4 p -71.34 -9.93 58.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.336 -0.847 . . . . 0.46 109.957 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 p -86.94 122.62 31.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.6 -0.727 . . . . 1.2 109.55 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.95 4.66 49.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.144 0.497 . . . . 2.22 110.307 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -146.66 69.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.742 -0.836 . . . . 2.14 108.742 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -56.13 -39.59 72.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.085 -0.961 . . . . 1.49 111.363 -178.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HG3' ' OH ' ' A' ' 74' ' ' TYR . 31.7 mtmm -64.77 -3.07 2.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.118 0.485 . . . . 2.04 112.111 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.7 t -89.56 -0.01 57.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.626 -0.715 . . . . 1.4 111.029 179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.34 -16.16 35.23 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.722 -0.751 . . . . 0.38 113.698 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -97.3 108.82 21.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.203 0.502 . . . . 1.44 110.45 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.902 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.45 19.94 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.43 112.667 -179.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.2 m -61.53 140.0 58.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.857 1.429 . . . . 1.04 114.857 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.15 133.27 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.061 -0.972 . . . . 0.31 111.25 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.4 p-10 -106.66 145.5 31.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.829 -0.804 . . . . 1.15 108.829 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.5 122.09 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.27 111.63 -178.354 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -84.86 144.13 28.61 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.52 -0.764 . . . . 0.29 111.169 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 96.8 m-20 49.96 57.66 6.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 1.52 111.354 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 37' ' ' ALA . 35.6 mt -47.57 92.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.126 1.158 . . . . 1.02 114.126 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 35.0 mt-30 -58.64 142.4 49.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.069 -0.514 . . . . 2.13 110.413 176.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.04 -36.86 78.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.094 0.473 . . . . 1.7 110.185 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 t -74.31 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.646 . . . . 1.32 111.358 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.74 -15.55 62.69 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.009 -0.367 . . . . 1.58 110.009 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 141.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-N 116.238 -0.437 . . . . 0.42 110.096 178.781 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.79 155.2 6.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.879 -1.153 . . . . 0.24 113.759 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.5 m -59.18 129.99 44.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.483 0.549 . . . . 0.31 112.483 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.2 m-85 -111.2 130.2 55.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.291 -0.633 . . . . 1.24 109.291 177.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 62.4 tt0 -121.79 120.05 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.811 -0.356 . . . . 1.16 111.022 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 40.7 t -100.04 123.14 43.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.036 -0.529 . . . . 1.03 109.923 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 96.0 mttt -123.87 105.45 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.69 -0.404 . . . . 1.76 111.978 -179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 55' ' ' ILE . 25.0 t -89.44 111.98 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.476 -0.935 . . . . 1.18 108.476 177.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.709 ' HG3' HG12 ' A' ' 128' ' ' VAL . 77.7 tttt -99.45 120.06 39.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.411 0.893 . . . . 1.62 113.411 -177.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.712 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 14.0 tttp -145.72 102.5 3.68 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.725 -0.472 . . . . 2.84 109.725 176.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.757 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.97 131.36 30.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.548 -0.751 . . . . 0.44 112.934 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.492 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 46.2 Cg_endo -100.76 48.04 2.04 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.696 -0.96 . . . . 0.56 112.527 -0.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.85 102.64 0.31 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.139 -1.029 . . . . 0.48 112.982 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.709 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -88.82 132.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.207 -0.997 . . . . 1.22 109.629 177.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 22' ' ' ILE . . . -121.13 139.05 53.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.773 0.286 . . . . 0.57 111.773 -179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.481 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 52.4 p30 -146.33 146.14 30.58 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.252 0.464 . . . . 2.03 112.252 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.52 160.11 42.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 2.95 110.652 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 44.0 mttp -99.96 140.78 33.68 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.298 0.851 . . . . 2.26 113.298 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.065 HG23 HD13 ' A' ' 29' ' ' ILE . 3.5 mp -139.26 109.13 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.824 -1.08 . . . . 0.28 108.459 176.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.512 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 5.4 m-70 -97.28 118.02 32.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.353 -0.539 . . . . 0.55 110.748 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 110' ' ' LEU . 61.2 tp -92.41 123.3 35.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.883 -0.598 . . . . 1.52 111.669 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 45.3 t -119.93 120.9 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.723 -0.671 . . . . 0.32 109.328 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HB ' HD12 ' A' ' 115' ' ' ILE . 22.1 t -95.49 121.97 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.376 0.51 . . . . 1.08 112.376 -178.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 89.6 mt -84.05 163.77 19.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.717 -0.674 . . . . 0.52 109.224 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.1 t -77.04 133.21 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.401 0.62 . . . . 1.48 111.429 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.834 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -165.08 177.07 1.78 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.797 -1.092 . . . . 2.2 109.675 179.694 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HD2' ' A' ' 140' ' ' LYS . 75.3 Cg_exo -51.1 145.28 26.14 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.073 1.849 . . . . 1.31 112.107 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -37.44 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.025 -0.534 . . . . 2.31 112.251 -179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.84 -63.23 0.91 Allowed Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.767 -0.73 . . . . 2.52 112.355 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.408 -0.806 . . . . 2.6 111.474 179.698 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 127' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 120.418 -0.101 . . . . 3.28 113.092 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -155.19 157.08 36.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.715 0.293 . . . . 2.43 110.473 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 99.5 p -77.37 147.41 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 1.84 111.361 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.665 HD13 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -149.72 149.81 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.711 -0.677 . . . . 2.15 110.934 -179.577 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.15 155.13 17.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 1.12 112.21 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 38.79 82.69 0.22 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.358 -1.292 . . . . 0.65 112.652 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.777 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 53.6 Cg_endo -79.26 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.449 2.766 . . . . 0.88 112.738 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 85.9 tt0 -78.54 127.88 32.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.11 -0.7 . . . . 2.06 109.11 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.641 ' CG ' HD11 ' A' ' 29' ' ' ILE . 44.3 tp10 -143.74 157.02 44.68 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.785 1.032 . . . . 1.71 113.785 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 54.0 ttp -136.92 125.34 23.42 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.665 -1.152 . . . . 1.86 107.934 176.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 133' ' ' ILE . 4.1 mp -130.24 137.52 56.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.703 -0.681 . . . . 0.39 112.362 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 74.9 mt-10 -133.77 127.74 33.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.156 -0.475 . . . . 1.19 110.154 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 10.9 tptm -142.71 161.35 38.32 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.511 0.196 . . . . 2.52 110.754 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.945 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.07 140.59 41.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.39 112.228 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 112' ' ' LEU . 56.5 tttm -47.25 132.3 12.77 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.819 -0.628 . . . . 2.35 111.421 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.64 -20.11 36.91 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.049 -0.596 . . . . 0.31 112.686 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.3 mt-10 -80.04 157.67 26.68 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.767 -0.827 . . . . 2.11 108.767 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.5 m -87.6 126.97 35.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.985 -0.686 . . . . 0.33 110.733 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.56 115.17 28.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.831 0.348 . . . . 0.26 110.367 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.795 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 71.6 t80 -79.46 115.14 18.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 1.43 112.383 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD22 HG21 ' A' ' 133' ' ' ILE . 20.8 mt -100.22 109.83 57.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 108.593 -0.891 . . . . 0.8 108.593 177.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.46 125.35 2.91 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.353 2.035 . . . . 0.42 114.97 -177.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -141.51 122.26 14.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.819 -1.082 . . . . 1.03 108.495 177.591 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -141.32 115.89 9.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 1.66 111.513 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.592 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 25.6 p90 -94.48 139.97 30.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.006 -0.997 . . . . 1.26 111.025 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 141.92 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 1.33 111.042 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 98.6 mt -97.73 139.54 33.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.599 . . . . 2.12 111.527 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.447 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 86.2 p -159.89 145.99 11.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 1.75 109.942 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.62 -21.54 3.54 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.318 2.012 . . . . 1.61 113.084 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.75 -40.06 66.36 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.769 -0.196 . . . . 2.18 111.329 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 3.1 p30 -69.91 79.14 0.47 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.035 -0.666 . . . . 2.41 110.115 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.38 -10.06 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.225 -0.898 . . . . 1.64 111.837 -178.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.981 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.54 154.26 38.01 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.304 -0.951 . . . . 0.55 112.981 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.99 153.71 19.72 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.498 2.132 . . . . 0.85 111.696 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 47.7 tp -78.08 131.56 37.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 1.9 111.337 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -139.5 149.08 43.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.36 0.6 . . . . 1.78 110.722 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 30.5 mt -142.75 135.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.845 -1.07 . . . . 0.75 109.087 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.637 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 40.2 mt-10 -140.13 108.28 5.77 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.278 0.474 . . . . 1.67 112.278 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.974 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.5 m95 -94.51 126.34 39.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.382 -0.372 . . . . 0.22 110.918 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.8 mt -108.87 141.18 41.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.877 -0.786 . . . . 0.41 108.877 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 11.5 tt -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.52 0.563 . . . . 0.78 112.52 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 t -120.36 102.95 45.05 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.228 -0.896 . . . . 1.25 108.932 177.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.1 Cg_endo -78.24 115.63 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.527 2.151 . . . . 0.53 113.028 -178.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.86 -34.47 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.356 -0.838 . . . . 0.41 110.679 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.18 11.53 7.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.637 -0.71 . . . . 1.82 111.818 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 80.8 m-20 -148.93 160.37 43.33 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.279 0.561 . . . . 1.94 111.76 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.75 -18.47 64.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.284 -0.871 . . . . 1.66 112.694 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.68 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.3 mttt -65.79 144.05 57.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.253 -0.431 . . . . 1.74 111.216 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 m -156.39 129.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-O 121.929 0.871 . . . . 0.97 110.019 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.02 40.0 19.23 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.97 -1.468 . . . . 1.77 112.827 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 96.9 mt-30 -95.26 141.1 29.25 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.367 -0.235 . . . . 1.96 110.367 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 84' ' ' TYR . 16.5 t -65.86 120.0 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.175 0.512 . . . . 0.77 109.977 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.901 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.97 -51.97 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.4 -0.818 . . . . 1.15 112.045 -178.135 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.983 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.81 122.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.949 -1.13 . . . . 0.29 107.949 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 1.1 tt -130.98 154.88 47.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.778 -0.646 . . . . 1.3 110.895 -176.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.872 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 25.9 t80 -133.01 104.54 6.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.309 -0.256 . . . . 1.3 110.309 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.453 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 10.0 t -142.64 156.82 45.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.882 0.372 . . . . 0.89 111.98 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.57 29.7 40.55 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.924 -0.655 . . . . 0.57 112.43 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.56 3.14 4.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.583 0.23 . . . . 1.46 110.915 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 34.3 mttm -100.03 112.56 24.85 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.749 -0.463 . . . . 2.41 109.749 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.896 HD13 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -83.85 116.98 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.941 -1.133 . . . . 1.66 107.941 178.136 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.821 ' N ' HD12 ' A' ' 79' ' ' ILE . 4.5 m-85 -99.95 127.74 46.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.282 -1.781 . . . . 1.25 110.589 -178.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.0 p-10 -166.01 -52.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.426 -1.324 . . . . 1.2 107.426 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -80.2 -23.2 41.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.988 -1.006 . . . . 2.17 109.31 177.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -78.68 -28.0 45.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.588 -0.893 . . . . 5.05 108.588 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.549 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.0 m-85 -84.71 119.85 73.28 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 114.942 -1.027 . . . . 1.29 110.668 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.69 -41.75 44.98 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.261 1.307 . . . . 0.79 109.237 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 71' ' ' ILE . 39.1 m-20 -66.98 104.66 1.43 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.365 -0.834 . . . . 1.36 110.657 178.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.935 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.0 mp 68.8 27.35 5.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.101 1.148 . . . . 1.62 114.101 178.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.3 pttt -57.58 129.56 42.41 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.659 -0.65 . . . . 2.39 111.23 177.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.35 58.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.711 -0.757 . . . . 0.37 114.31 178.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.935 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.7 ptm180 -145.89 -48.26 0.21 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.379 1.252 . . . . 1.59 114.379 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.983 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -78.86 81.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.071 -1.455 . . . . 0.2 107.071 -178.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.535 ' C ' HG22 ' A' ' 105' ' ' ILE . 8.4 m-70 -102.8 128.62 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.262 -2.245 . . . . 0.29 112.789 -175.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.12 ' CD1' HG23 ' A' ' 105' ' ' ILE . 73.3 m-85 -70.26 123.76 22.46 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 120.152 -0.619 . . . . 1.23 109.61 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.795 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 15.9 p -73.52 33.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.426 -0.807 . . . . 0.46 111.839 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -149.63 128.81 12.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.2 110.097 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -92.64 7.56 42.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.986 -0.552 . . . . 2.22 110.377 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -146.35 65.72 1.19 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.573 -0.74 . . . . 2.14 109.116 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 74' ' ' TYR . 9.6 mp -56.7 -24.72 51.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.391 -0.822 . . . . 1.49 111.432 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.3 -3.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 2.04 111.996 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -88.73 0.03 56.86 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.48 -0.782 . . . . 1.4 110.94 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 104.31 -9.94 50.12 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.731 -0.747 . . . . 0.38 113.647 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.11 110.04 21.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.963 0.381 . . . . 1.44 111.198 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -107.77 9.48 28.99 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.508 0.559 . . . . 0.43 112.508 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.7 p -59.98 143.45 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.67 1.73 . . . . 1.04 115.67 -178.297 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.12 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.37 132.33 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 114.422 -1.263 . . . . 0.31 110.78 178.17 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p30 -106.41 146.37 30.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.631 -0.878 . . . . 1.15 108.631 177.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 120.02 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 120.826 0.346 . . . . 0.27 111.152 -178.257 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.92 143.7 30.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.824 -0.625 . . . . 0.29 110.928 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 26.4 m120 47.88 58.89 4.6 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.186 -0.461 . . . . 1.52 111.675 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 37' ' ' ALA . 18.8 mt -44.44 88.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.082 1.142 . . . . 1.02 114.082 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.459 ' O ' ' OD2' ' A' ' 114' ' ' ASP . 51.7 tt0 -58.53 147.26 32.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.548 -0.538 . . . . 2.13 109.548 176.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 58.9 tp -60.03 -37.03 78.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.43 . . . . 1.7 111.036 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.8 m -72.03 -9.66 58.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 1.32 112.39 -178.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 111' ' ' GLN . 3.0 p30 -70.47 -18.57 62.98 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.378 -0.529 . . . . 1.58 110.085 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 137.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 CA-C-N 115.988 -0.551 . . . . 0.42 110.265 179.112 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.99 160.51 8.32 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 119.844 -1.17 . . . . 0.24 113.853 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 134' ' ' HIS . 90.9 m -60.04 137.09 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.125 -0.537 . . . . 0.31 112.128 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 25.0 m-85 -120.04 132.15 55.36 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.445 -0.576 . . . . 1.24 109.445 177.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.725 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 49.0 tp60 -120.0 115.06 22.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.073 -0.251 . . . . 1.16 110.708 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 53.0 t -98.35 116.82 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 1.03 110.295 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 88.2 mttt -119.1 106.41 12.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 1.76 111.066 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.4 t -91.34 105.5 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.566 -0.531 . . . . 1.18 109.566 179.01 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.766 ' HG3' HG12 ' A' ' 128' ' ' VAL . 52.2 tttp -90.48 116.11 28.15 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.039 -0.665 . . . . 1.62 111.474 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' CB ' ' A' ' 49' ' ' ASP . 7.2 ttpm? -146.08 102.35 3.62 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.457 -0.571 . . . . 2.84 109.457 178.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.981 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.42 134.39 33.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.44 112.002 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.9 Cg_endo -100.13 48.69 1.92 Allowed 'Cis proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.698 -0.959 . . . . 0.56 111.297 -0.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 19' ' ' GLY . . . -145.8 103.31 0.28 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.188 -1.006 . . . . 0.48 113.591 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.766 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.5 m -87.4 120.0 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.552 -0.824 . . . . 1.22 109.956 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.665 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -101.53 144.77 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.867 0.321 . . . . 0.57 111.867 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.452 ' C ' ' HG3' ' A' ' 131' ' ' LYS . 46.1 t30 -146.28 132.11 19.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 2.03 111.114 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.777 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 4.7 mttp -142.58 160.33 40.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.841 0.353 . . . . 2.95 111.773 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 64.5 mttt -101.77 141.67 34.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.441 0.904 . . . . 2.26 113.441 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 29' ' ' ILE . 3.1 mp -142.58 112.59 2.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.041 -0.982 . . . . 0.28 109.347 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 117' ' ' THR . 60.5 m170 -101.1 114.4 28.3 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.9 -0.5 . . . . 0.55 110.58 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 14.9 mt -96.2 135.58 37.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.698 0.629 . . . . 1.52 112.698 -179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 60.7 t -129.96 130.0 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.355 -0.838 . . . . 0.32 109.198 178.032 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.417 ' H ' HD11 ' A' ' 115' ' ' ILE . 18.9 t -100.46 121.32 51.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.872 0.368 . . . . 1.08 111.96 -179.042 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.7 mt -80.77 163.7 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.353 -0.61 . . . . 0.52 109.353 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.88 136.98 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.462 0.649 . . . . 1.48 111.681 -178.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.945 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.56 173.74 3.96 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 2.2 110.088 179.79 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 46.1 Cg_exo -56.4 -162.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.27 1.98 . . . . 1.31 111.965 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 43.1 p -38.5 -79.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.785 0.326 . . . . 2.31 111.611 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.97 15.2 6.36 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.943 -0.646 . . . . 2.52 113.418 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.242 -0.885 . . . . 2.6 111.132 -179.843 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.557 -0.217 . . . . 3.28 112.557 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 1.9 m -80.17 112.83 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 2.43 111.102 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HD13 ' A' ' 22' ' ' ILE . 43.2 p -80.02 167.61 20.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 1.84 110.666 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.725 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 45.1 mm -140.02 138.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 2.15 110.884 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -86.89 144.91 26.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.12 110.292 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.484 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 45.28 82.61 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 115.179 -0.919 . . . . 0.65 110.39 -177.33 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 57.3 Cg_endo -77.94 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.649 2.899 . . . . 0.88 113.095 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.28 120.66 23.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.571 -0.529 . . . . 2.06 109.571 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 28' ' ' MET . 80.0 tt0 -143.82 160.02 41.51 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.604 0.964 . . . . 1.71 113.604 -177.29 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.556 ' C ' HD12 ' A' ' 29' ' ' ILE . 53.6 ttm -130.95 130.95 44.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.867 -1.06 . . . . 1.86 108.724 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 133' ' ' ILE . 3.5 mp -129.71 131.9 66.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.62 . . . . 0.39 112.122 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 89.7 mt-10 -122.63 127.18 49.04 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.281 -0.418 . . . . 1.19 110.737 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' A' ' 110' ' ' LEU . 47.0 mmtm -142.33 160.03 41.07 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.563 0.221 . . . . 2.52 110.998 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB1' ' CG ' ' A' ' 140' ' ' LYS . . . -76.79 137.0 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.39 112.157 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 60.0 tttt -46.22 129.97 10.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.895 -0.593 . . . . 2.35 110.964 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.74 -19.12 43.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.31 112.275 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 68.1 mm-40 -80.05 160.03 25.97 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.438 -0.949 . . . . 2.11 108.438 178.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.6 m -88.82 129.73 35.52 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.608 -0.837 . . . . 0.33 110.685 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.99 120.0 39.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.895 0.379 . . . . 0.26 110.449 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.955 ' HE1' HG21 ' A' ' 94' ' ' THR . 70.1 t80 -79.1 117.42 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 1.43 111.714 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 133' ' ' ILE . 20.4 mt -109.98 104.4 55.48 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.838 -0.801 . . . . 0.8 108.838 178.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.642 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 89.8 Cg_endo -86.92 128.92 2.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.352 2.035 . . . . 0.42 114.019 -178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 1.8 t -140.8 128.89 22.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.402 -0.817 . . . . 1.03 108.8 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.6 ttpt -140.86 118.62 11.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.241 0.543 . . . . 1.66 110.961 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CG ' HG11 ' A' ' 122' ' ' VAL . 43.9 p90 -101.87 137.63 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.667 -1.151 . . . . 1.26 112.399 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -89.26 140.01 29.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 1.33 109.785 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.812 HD22 ' HE2' ' A' ' 124' ' ' LYS . 90.7 mt -94.46 109.7 21.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.964 -0.294 . . . . 2.12 111.327 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.1 m -83.75 140.0 40.69 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 109.467 -0.568 . . . . 1.75 109.467 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.88 -34.08 21.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.801 1.668 . . . . 1.61 110.775 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.4 pt-20 -81.52 -33.97 31.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.441 -0.799 . . . . 2.18 111.798 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 78.9 m-20 -69.14 77.62 0.35 Allowed 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 120.271 -0.572 . . . . 2.41 110.143 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -101.82 -0.76 33.67 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.502 -0.772 . . . . 1.64 111.548 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.884 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -74.08 162.86 54.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.01 -0.614 . . . . 0.55 113.4 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.12 131.42 44.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.809 2.339 . . . . 0.85 112.168 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 122' ' ' VAL . 13.6 tp -78.12 126.38 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 1.9 111.337 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 6.1 m-20 -139.36 103.09 4.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.564 0.697 . . . . 1.78 111.646 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.9 mt -95.69 118.28 41.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.322 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.561 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.1 tt0 -115.64 120.32 39.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.453 0.538 . . . . 1.67 112.453 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.921 ' CD2' HD11 ' A' ' 105' ' ' ILE . 82.6 m95 -94.18 119.94 33.73 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.194 -0.299 . . . . 0.22 110.194 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.2 mt -108.13 142.45 38.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 0.41 110.185 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 114' ' ' ASP . 5.6 tt -130.0 132.33 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.78 112.043 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 48.7 m -117.71 102.12 51.77 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 108.471 -0.937 . . . . 1.25 108.471 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.639 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 85.4 Cg_endo -79.38 113.49 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.807 2.338 . . . . 0.53 113.031 -178.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.99 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.41 111.257 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.63 -40.08 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 1.82 111.556 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 33.9 m120 -84.58 160.04 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 1.94 111.957 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.81 -18.0 64.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.303 -0.862 . . . . 1.66 111.245 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 42.9 mttt -69.49 154.63 41.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.579 -0.737 . . . . 1.74 111.681 -178.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.72 128.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-O 121.637 0.732 . . . . 0.97 109.072 178.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 57.82 41.82 24.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.631 -1.168 . . . . 1.77 111.724 179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 96.1 mm-40 -87.07 135.09 33.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.797 0.332 . . . . 1.96 111.59 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 58' ' ' LEU . 57.7 t -71.82 132.02 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.77 110.261 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -129.84 -39.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.631 0.604 . . . . 1.15 112.631 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.954 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.43 123.6 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.415 0.626 . . . . 0.29 109.637 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 74' ' ' TYR . 7.3 tt -140.58 160.54 39.78 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.576 -0.738 . . . . 1.3 109.477 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.91 ' N ' HD23 ' A' ' 73' ' ' LEU . 23.9 t80 -134.32 109.15 8.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.218 0.532 . . . . 1.3 110.283 178.264 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.534 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 32.7 t -142.37 160.01 41.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.353 -0.839 . . . . 0.89 111.394 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.31 36.82 53.91 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.822 -0.704 . . . . 0.57 112.608 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 60.63 25.22 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.609 0.242 . . . . 1.46 111.378 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.3 mttp -128.15 111.14 13.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.191 -0.67 . . . . 2.41 109.191 177.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.627 ' CG2' HD22 ' A' ' 98' ' ' LEU . 1.4 pp -76.81 119.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.964 -1.124 . . . . 1.66 107.964 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.796 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -99.97 133.51 44.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.72 -1.127 . . . . 1.25 110.62 -178.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.3 p-10 -166.46 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.977 -1.49 . . . . 1.2 106.977 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HA ' ' CA ' ' A' ' 88' ' ' LYS . 50.9 t0 -80.03 -20.19 45.9 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 114.556 -1.202 . . . . 2.17 109.315 177.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.7 t80 -78.78 -29.81 45.21 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.25 -1.018 . . . . 5.05 108.25 178.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -84.34 112.61 42.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-N 114.436 -1.257 . . . . 1.29 110.872 179.717 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 85.7 Cg_exo -44.09 -42.98 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.501 1.467 . . . . 0.79 110.548 178.471 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.0 m-20 -68.31 104.92 1.98 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.685 -0.688 . . . . 1.36 110.739 178.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.894 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.4 mp 72.71 18.91 4.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.499 0.926 . . . . 1.62 113.499 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.445 -0.784 . . . . 2.39 110.763 178.022 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.56 11.67 60.46 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.273 -0.965 . . . . 0.37 113.917 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.894 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.5 ptp180 -141.27 -53.79 0.47 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 114.574 1.324 . . . . 1.59 114.574 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.954 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -78.73 80.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.11 -1.441 . . . . 0.2 107.11 -178.157 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.636 ' C ' HG22 ' A' ' 105' ' ' ILE . 7.3 m-70 -97.52 128.82 44.57 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.084 -2.326 . . . . 0.29 111.849 -176.148 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.5 m-85 -69.4 121.66 17.39 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.685 0.755 . . . . 1.23 110.684 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.955 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -73.71 34.85 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.471 -1.24 . . . . 0.46 111.732 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -148.81 136.39 20.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.076 0.465 . . . . 1.2 111.683 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.23 0.02 56.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.779 -0.646 . . . . 2.22 110.737 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -146.45 66.76 1.18 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.294 0.569 . . . . 2.14 109.517 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.714 HD21 ' CG ' ' A' ' 93' ' ' PHE . 7.2 mp -59.14 -31.64 69.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.403 -0.817 . . . . 1.49 111.939 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.52 -3.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.152 0.501 . . . . 2.04 112.319 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.8 m -88.5 -0.09 56.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.54 -0.754 . . . . 1.4 111.137 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 111.34 -19.88 23.95 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.748 -0.739 . . . . 0.38 112.915 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.0 m-20 -97.01 107.47 20.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.694 0.283 . . . . 1.44 110.633 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -116.75 24.23 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.891 0.33 . . . . 0.43 111.891 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.4 m -60.92 151.6 29.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 114.425 1.268 . . . . 1.04 114.425 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.035 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -137.03 140.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.682 -1.145 . . . . 0.31 111.545 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.0 p-10 -113.46 142.81 45.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.263 -1.014 . . . . 1.15 108.263 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 122.36 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 120.991 0.424 . . . . 0.27 111.868 -177.866 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.67 143.89 28.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.29 111.16 178.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.595 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 4.0 m-20 50.82 54.35 11.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.08 -0.509 . . . . 1.52 112.304 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 37' ' ' ALA . 34.5 mt -45.9 89.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.441 1.274 . . . . 1.02 114.441 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 60.1 tp60 -59.4 147.72 35.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.767 -0.651 . . . . 2.13 110.399 176.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' CE ' ' A' ' 33' ' ' LYS . 85.4 mt -59.98 -37.35 79.37 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.875 0.369 . . . . 1.7 111.144 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.3 p -72.57 -9.47 58.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.052 -0.522 . . . . 1.32 111.333 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.689 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.0 m-20 -70.0 -19.95 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.91 -0.404 . . . . 1.58 109.91 179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 142.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 115.922 -0.581 . . . . 0.42 110.455 178.999 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.45 155.93 6.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.824 -1.179 . . . . 0.24 113.828 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.6 m -59.33 128.59 37.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 18.6 m-85 -108.84 130.76 55.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 1.24 109.649 177.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.2 tt0 -125.76 119.29 27.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.034 -0.266 . . . . 1.16 110.765 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 20.0 t -99.96 115.82 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.03 110.126 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.82 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 52.3 mtpt -112.53 105.52 13.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.878 -0.329 . . . . 1.76 111.456 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.83 HG11 ' CG ' ' A' ' 43' ' ' PHE . 15.3 t -89.75 110.58 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.747 -0.834 . . . . 1.18 108.747 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 tttm -99.86 120.22 39.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.264 0.839 . . . . 1.62 113.264 -177.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.812 ' HE2' HD22 ' A' ' 45' ' ' LEU . 35.5 tttp -145.09 102.15 3.71 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.388 -0.597 . . . . 2.84 109.388 177.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.884 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.36 133.65 43.01 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.331 -0.85 . . . . 0.44 113.013 -179.106 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 55.0 Cg_endo -98.82 47.68 2.11 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.383 -1.09 . . . . 0.56 112.264 -0.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.16 103.13 0.28 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.2 -1.0 . . . . 0.48 113.142 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 150.2 3.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.36 -0.92 . . . . 1.22 109.587 177.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -142.98 151.54 40.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.975 -0.29 . . . . 0.57 111.683 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 42.5 p-10 -146.41 153.14 40.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.411 -0.359 . . . . 2.03 111.777 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.674 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.35 155.45 43.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.471 -0.331 . . . . 2.95 110.465 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 12.4 tttt -99.99 141.09 33.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.866 1.062 . . . . 2.26 113.866 -177.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.035 HG23 HD13 ' A' ' 29' ' ' ILE . 68.0 mt -143.81 112.03 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.28 109.397 177.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.438 ' CD2' HG23 ' A' ' 117' ' ' THR . 8.3 m170 -97.06 114.38 26.02 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.55 110.284 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.642 HD21 HD22 ' A' ' 110' ' ' LEU . 52.3 tp -93.02 122.53 35.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.477 0.547 . . . . 1.52 112.477 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.1 t -119.99 121.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.762 -0.829 . . . . 0.32 108.762 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 33' ' ' LYS . 11.7 t -98.52 127.03 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 112.656 0.613 . . . . 1.08 112.656 -177.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 81.3 mt -84.51 173.59 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.52 109.443 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -76.52 138.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.358 0.599 . . . . 1.48 112.04 -178.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.931 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 7.4 mmmt -159.87 178.91 1.49 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.897 -1.047 . . . . 2.2 109.605 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.931 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 20.5 Cg_exo -31.59 146.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 123.058 2.505 . . . . 1.31 114.133 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.72 42.57 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.008 1.484 . . . . 2.31 115.008 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 141' ' ' PRO . . . 149.72 55.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.386 -1.388 . . . . 2.52 114.329 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.675 ' H ' ' HE2' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.104 -0.951 . . . . 2.6 111.197 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.551 -0.22 . . . . 3.28 112.551 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -157.22 157.0 33.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 2.43 110.758 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.2 m -158.86 163.68 36.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.84 111.026 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.67 141.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 2.15 110.798 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.2 p -86.58 157.22 19.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.41 0.624 . . . . 1.12 111.399 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.551 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.13 83.21 0.21 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.75 -1.113 . . . . 0.65 111.489 -178.206 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.6 Cg_endo -78.39 -79.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.277 2.651 . . . . 0.88 112.354 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -78.58 128.14 33.1 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.607 -0.886 . . . . 2.06 108.607 178.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.897 ' OE2' HD11 ' A' ' 29' ' ' ILE . 84.0 tt0 -144.03 159.45 42.57 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.038 1.125 . . . . 1.71 114.038 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.45 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 27.4 mtt -139.97 118.93 12.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.802 -1.09 . . . . 1.86 109.584 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.9 mm -120.02 130.93 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.509 -0.314 . . . . 0.39 111.428 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 19.5 pt-20 -128.56 127.8 43.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 1.19 110.775 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 42.4 mmtm -142.28 164.86 29.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.439 . . . . 2.52 110.953 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.022 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.52 135.24 39.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.286 -0.416 . . . . 0.39 111.283 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 71.3 tttt -45.84 130.71 9.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.346 -0.388 . . . . 2.35 111.24 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 91.77 -19.91 45.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 0.31 112.372 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.832 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -80.03 160.01 26.0 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.551 -0.907 . . . . 2.11 108.551 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 31.3 m -88.68 127.34 35.58 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.789 -0.764 . . . . 0.33 110.762 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.008 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 119.97 39.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 0.26 110.829 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 94' ' ' THR . 41.4 t80 -79.37 119.35 22.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 1.43 111.907 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 105' ' ' ILE . 13.1 mt -103.8 105.42 47.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.87 -0.789 . . . . 0.8 108.87 177.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 90.7 Cg_endo -84.6 122.66 2.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.449 2.099 . . . . 0.42 114.589 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.73 127.26 20.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.355 -0.979 . . . . 1.03 108.355 177.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.8 ttpt -140.69 116.56 10.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.393 0.616 . . . . 1.66 110.697 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.754 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 33.2 p90 -93.62 141.43 28.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 1.26 111.885 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 m -80.94 150.48 28.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 1.33 110.774 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.79 141.62 39.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.841 -0.618 . . . . 2.12 111.313 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 m -156.25 153.59 25.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 1.75 110.162 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.4 -20.69 26.82 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.431 2.087 . . . . 1.61 112.467 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.715 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 mt-10 -75.76 -41.42 53.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 111.942 0.349 . . . . 2.18 111.942 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -69.2 74.64 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.836 -0.745 . . . . 2.41 110.244 -179.43 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' GLU . 93.0 mt-30 -90.42 -16.44 29.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.085 -0.961 . . . . 1.64 111.02 -179.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.05 155.8 53.25 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.133 -1.032 . . . . 0.55 112.096 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.23 151.13 9.75 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.125 1.883 . . . . 0.85 111.551 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.754 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -77.67 132.62 38.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.854 0.359 . . . . 1.9 110.946 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 36.1 t0 -140.26 150.5 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.392 0.615 . . . . 1.78 111.895 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.711 HD13 ' HB1' ' A' ' 103' ' ' ALA . 50.4 mt -142.23 137.78 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.682 -1.145 . . . . 0.75 109.619 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.734 ' HG2' HD21 ' A' ' 73' ' ' LEU . 37.0 mt-10 -140.22 111.86 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.79 0.328 . . . . 1.67 111.825 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.6 m95 -98.67 119.99 38.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.22 110.908 178.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.55 146.15 37.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.492 . . . . 0.41 109.67 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.787 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.3 tt -132.5 140.01 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.775 0.657 . . . . 0.78 112.775 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -122.37 102.98 39.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.628 -0.879 . . . . 1.25 108.628 177.149 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.7 Cg_exo -79.08 115.23 3.49 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.725 2.283 . . . . 0.53 113.22 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.32 69.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.41 110.243 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.68 10.22 7.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.614 -0.721 . . . . 1.82 111.491 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 32.7 m120 -145.77 156.01 43.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.061 0.458 . . . . 1.94 111.361 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.91 -22.87 64.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.652 -0.703 . . . . 1.66 111.716 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.707 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 5.6 mttt -73.79 151.23 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 1.74 110.71 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.3 m -152.41 136.29 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 122.502 1.144 . . . . 0.97 110.764 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 61.23 45.05 9.23 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.758 -2.019 . . . . 1.77 112.566 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.12 149.72 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.728 0.299 . . . . 1.96 110.538 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.734 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.9 p -68.26 139.99 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.77 110.09 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.86 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -136.51 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.538 -0.465 . . . . 1.15 111.552 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.946 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.19 133.14 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.009 0.433 . . . . 0.29 109.848 179.384 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HG2' ' A' ' 56' ' ' GLU . 1.6 mp -140.83 158.57 43.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.024 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.867 ' CD1' HD13 ' A' ' 79' ' ' ILE . 51.8 t80 -133.68 104.47 6.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.578 -0.527 . . . . 1.3 109.578 176.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.498 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.1 t -144.02 159.78 42.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.413 0.523 . . . . 0.89 112.413 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.57 30.02 6.05 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.988 -0.551 . . . . 0.57 113.182 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 t0 71.9 3.07 4.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 1.46 111.4 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 22.8 mtpp -100.03 118.05 35.6 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.1 -0.704 . . . . 2.41 109.1 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.867 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.3 mm -79.86 130.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.87 -1.159 . . . . 1.66 107.87 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.77 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.1 m-85 -118.56 125.79 50.59 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.096 -0.956 . . . . 1.25 110.289 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.0 p-10 -166.09 -55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.486 -1.672 . . . . 1.2 106.486 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 34.0 p-10 -82.18 -22.08 36.19 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.311 -1.313 . . . . 2.17 109.202 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.615 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -80.83 -26.52 36.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.736 -1.12 . . . . 5.05 108.556 178.496 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 1.8 m-85 -85.25 118.3 70.51 Favored Pre-proline 0 CA--C 1.51 -0.58 0 CA-C-N 115.374 -0.83 . . . . 1.29 109.868 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.6 Cg_endo -47.04 -43.6 24.54 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.421 1.414 . . . . 0.79 110.49 179.125 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.775 ' HB3' HG22 ' A' ' 71' ' ' ILE . 71.5 m-20 -69.59 106.25 2.96 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.627 -0.829 . . . . 1.36 111.512 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.7 mp 73.12 20.13 3.46 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.186 -0.916 . . . . 1.62 113.453 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 60.2 pttt -54.66 126.07 22.42 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.903 -0.719 . . . . 2.39 111.332 178.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 14.28 45.09 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.323 -0.941 . . . . 0.37 114.402 178.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.7 -47.2 0.24 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 114.656 1.354 . . . . 1.59 114.656 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.946 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.24 81.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.676 1.227 . . . . 0.2 108.109 -178.285 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.595 ' C ' HG22 ' A' ' 105' ' ' ILE . 21.8 m80 -102.73 130.2 49.6 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.081 -1.872 . . . . 0.29 112.313 -176.073 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.119 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.9 m-85 -72.82 121.22 19.57 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.177 -0.675 . . . . 1.23 109.177 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.573 HG22 ' OD1' ' A' ' 106' ' ' ASN . 38.1 p -70.15 -9.78 56.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.188 -0.914 . . . . 0.46 110.805 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 70.5 m -91.09 119.95 31.65 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.987 -0.551 . . . . 1.2 110.449 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.59 4.07 50.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.268 0.556 . . . . 2.22 110.142 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -145.99 67.6 1.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.262 -1.014 . . . . 2.14 108.262 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.466 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.8 mp -55.73 -33.41 64.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.975 -1.011 . . . . 1.49 111.72 -178.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -61.28 -3.59 0.95 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.152 0.501 . . . . 2.04 112.21 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.68 0.07 56.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.546 -0.752 . . . . 1.4 111.187 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.81 -12.31 45.9 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.618 -0.801 . . . . 0.38 113.673 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 96.1 m-20 -94.75 113.76 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.472 . . . . 1.44 111.418 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.36 12.17 24.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.637 . . . . 0.43 111.918 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 72.5 p -60.03 140.05 57.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.64 1.718 . . . . 1.04 115.64 -178.002 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.119 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.07 135.51 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-N 114.104 -1.407 . . . . 0.31 110.871 178.547 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.633 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.7 OUTLIER -105.03 148.21 27.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.039 -0.726 . . . . 1.15 109.039 177.832 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.816 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -101.42 118.89 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.005 0.431 . . . . 0.27 110.999 -179.561 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.1 p -83.26 144.44 29.74 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.537 -0.756 . . . . 0.29 110.53 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 50.58 57.52 6.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.037 0.446 . . . . 1.52 111.549 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.5 mt -46.92 90.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.95 1.092 . . . . 1.02 113.95 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 13.2 mt-30 -59.22 141.47 54.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.864 -0.607 . . . . 2.13 110.702 176.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.06 -37.02 78.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 1.7 110.215 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.58 -9.97 59.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.32 111.48 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.581 ' O ' HD11 ' A' ' 59' ' ' ILE . 92.4 m-20 -72.47 -17.07 61.79 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.938 -0.393 . . . . 1.58 109.938 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.46 141.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 116.198 -0.455 . . . . 0.42 110.346 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.11 158.97 7.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.218 -0.991 . . . . 0.24 113.352 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -59.55 131.04 49.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.685 0.624 . . . . 0.31 112.685 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 20.7 m-85 -111.26 135.38 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.294 -0.632 . . . . 1.24 109.294 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.3 tt0 -127.06 121.5 31.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.971 -0.291 . . . . 1.16 110.717 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 26.0 t -99.98 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.456 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 90.8 mttt -119.81 106.22 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 1.76 111.188 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 50.1 t -93.72 109.92 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.695 -0.483 . . . . 1.18 109.695 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 72.6 tttt -94.13 120.01 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.969 -0.693 . . . . 1.62 112.308 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 5.6 mtmp? -143.73 101.99 3.84 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.202 -0.666 . . . . 2.84 109.202 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.03 131.02 40.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 113.016 0.747 . . . . 0.44 113.016 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 21.2 Cg_endo -102.03 51.92 1.44 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.788 -0.922 . . . . 0.56 111.505 -0.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.49 103.44 0.29 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.183 -1.008 . . . . 0.48 113.993 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.2 m -89.52 139.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.193 -1.004 . . . . 1.22 109.396 177.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -136.73 149.34 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.193 -0.317 . . . . 0.57 111.81 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.6 p-10 -146.41 151.22 37.09 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.381 0.511 . . . . 2.03 112.381 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.625 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.65 155.27 42.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.915 -0.584 . . . . 2.95 110.37 178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.5 mttt -101.25 140.02 36.12 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.504 0.927 . . . . 2.26 113.504 -178.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.8 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.23 119.97 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.28 109.026 176.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 117' ' ' THR . 35.3 m170 -100.25 116.79 33.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.609 -0.436 . . . . 0.55 110.44 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 110' ' ' LEU . 58.8 tp -89.86 120.1 30.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.451 . . . . 1.52 111.657 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 57.7 t -118.14 119.95 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.32 109.418 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 115' ' ' ILE . 39.1 t -99.78 125.81 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.038 0.447 . . . . 1.08 112.174 -178.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 97.8 mt -83.92 170.0 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.734 -0.667 . . . . 0.52 109.545 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.3 t -75.97 138.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 1.48 111.55 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 1.022 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 4.4 mmtt -160.85 171.19 7.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.872 -1.058 . . . . 2.2 109.89 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 11.1 Cg_endo -53.74 -154.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.542 2.161 . . . . 1.31 112.131 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.1 t -36.33 -49.95 0.73 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.916 0.389 . . . . 2.31 111.723 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.504 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 73.32 -60.01 1.91 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.919 -0.657 . . . . 2.52 113.279 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.246 -0.883 . . . . 2.6 111.152 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.619 -0.192 . . . . 3.28 112.619 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 159.32 28.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 2.43 110.848 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 142.6 36.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.84 111.066 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.605 HD12 ' HB1' ' A' ' 129' ' ' ALA . 15.6 tt -142.18 131.3 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 2.15 110.793 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.73 151.75 19.88 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.546 0.689 . . . . 1.12 111.65 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.59 82.96 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.673 -1.149 . . . . 0.65 111.491 -178.287 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.635 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.9 Cg_endo -78.6 -83.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.557 2.838 . . . . 0.88 112.989 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.4 tt0 -77.97 120.22 22.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.221 -0.659 . . . . 2.06 109.221 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.884 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.1 tt0 -144.02 161.03 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.472 0.916 . . . . 1.71 113.472 -176.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.732 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.8 ttm -131.91 139.42 48.74 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.255 -0.884 . . . . 1.86 109.807 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.884 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.5 mm -134.24 140.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.202 -0.454 . . . . 0.39 111.465 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.5 pt-20 -137.84 129.21 27.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.773 0.32 . . . . 1.19 111.086 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 56.8 mmtt -142.33 159.98 41.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.327 -0.397 . . . . 2.52 111.534 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.51 142.51 40.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.089 -0.505 . . . . 0.39 111.844 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 66.4 mttt -46.66 144.13 2.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.888 -0.597 . . . . 2.35 111.933 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.97 -22.81 2.8 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.328 -0.851 . . . . 0.31 113.334 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.99 160.03 26.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.435 -0.58 . . . . 2.11 109.435 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 60.5 m -87.09 129.1 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.182 -0.607 . . . . 0.33 110.712 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 115.34 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.044 0.45 . . . . 0.26 110.631 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.38 120.05 23.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.117 -0.492 . . . . 1.43 112.315 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 105' ' ' ILE . 23.8 mt -104.73 104.86 48.13 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.05 -0.722 . . . . 0.8 109.05 177.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.8 Cg_exo -80.23 130.78 8.36 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.535 2.157 . . . . 0.42 114.257 -177.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.9 t -141.17 130.96 24.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.125 -0.943 . . . . 1.03 108.766 177.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.4 mmtp -140.24 137.54 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.473 -0.33 . . . . 1.66 110.649 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 122' ' ' VAL . 51.3 p90 -140.92 139.97 34.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.488 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 1.33 110.567 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.503 ' O ' HD23 ' A' ' 45' ' ' LEU . 9.6 tt -97.67 108.04 20.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.421 -0.354 . . . . 2.12 110.871 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 t -84.3 136.87 39.96 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.879 -0.415 . . . . 1.75 109.879 179.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.55 -30.73 4.17 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.842 1.694 . . . . 1.61 111.194 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.94 -38.6 45.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.565 -0.743 . . . . 2.18 111.018 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 78.0 m-20 -70.13 73.78 0.47 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.518 -0.473 . . . . 2.41 109.741 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -98.55 0.05 44.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.677 -0.692 . . . . 1.64 111.912 -178.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.908 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.4 171.73 39.75 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.811 -0.709 . . . . 0.55 113.183 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.66 138.69 65.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.816 2.344 . . . . 0.85 112.365 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 2.0 mt -78.54 111.82 14.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 1.9 111.557 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 89.0 m-20 -127.57 102.75 6.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.613 0.721 . . . . 1.78 111.429 178.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.768 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.3 mt -94.01 123.55 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.61 -1.177 . . . . 0.75 109.96 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.682 ' HG2' HD11 ' A' ' 73' ' ' LEU . 95.0 mt-10 -120.01 111.87 18.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.831 0.678 . . . . 1.67 112.831 -178.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.9 m95 -94.33 119.96 33.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.772 -0.371 . . . . 0.22 110.088 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.512 HD12 ' OE1' ' A' ' 119' ' ' GLN . 86.1 mt -105.59 122.67 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.665 0.269 . . . . 0.41 110.329 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.634 ' HB ' HG21 ' A' ' 71' ' ' ILE . 7.3 tt -108.11 131.52 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.459 0.54 . . . . 0.78 112.459 -179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -126.1 102.19 27.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.909 -0.774 . . . . 1.25 108.909 177.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.5 Cg_exo -79.77 118.35 3.79 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.735 2.29 . . . . 0.53 112.389 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.06 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.41 111.024 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.0 -40.03 60.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.869 -0.605 . . . . 1.82 111.845 -179.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 27.5 m120 -83.33 159.95 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.329 0.585 . . . . 1.94 111.988 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -69.36 -16.76 63.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.121 -0.945 . . . . 1.66 111.199 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.67 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.7 mttm -69.15 149.14 48.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.629 -0.714 . . . . 1.74 111.651 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.73 127.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-O 121.942 0.877 . . . . 0.97 109.887 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.65 39.98 27.0 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.51 178.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.04 143.85 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.367 0.127 . . . . 1.96 110.719 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 26.5 t -67.9 119.79 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.77 110.004 179.466 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.23 -55.45 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.622 -0.717 . . . . 1.15 112.328 -178.203 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.825 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.8 124.47 38.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.145 -1.058 . . . . 0.29 108.145 179.119 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.6 tt -137.71 156.17 48.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.928 -0.578 . . . . 1.3 110.786 -176.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.837 ' CD1' HD13 ' A' ' 79' ' ' ILE . 25.2 t80 -132.81 103.71 6.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.198 -0.456 . . . . 1.3 109.879 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.438 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 29.7 t -143.99 156.61 44.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.244 0.461 . . . . 0.89 112.244 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.24 29.3 21.81 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.02 -0.609 . . . . 0.57 112.795 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.6 t0 73.47 2.85 4.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.494 0.188 . . . . 1.46 111.28 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 80.2 mttt -100.01 115.17 29.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 110.148 -0.316 . . . . 2.41 110.148 178.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.837 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.4 mm -80.34 128.33 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 106.927 -1.509 . . . . 1.66 106.927 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.6 m-85 -112.43 117.31 32.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.215 -0.902 . . . . 1.25 110.38 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.855 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.4 p-10 -166.14 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.845 -1.539 . . . . 1.2 106.845 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -76.63 -34.66 58.33 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.37 -1.286 . . . . 2.17 108.563 177.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.52 -29.98 61.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.765 -1.198 . . . . 5.05 107.765 177.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.542 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 m-85 -83.47 110.83 27.01 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 114.833 -1.076 . . . . 1.29 109.938 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.77 -28.14 59.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.063 1.842 . . . . 0.79 112.456 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 1.058 ' O ' HD12 ' A' ' 87' ' ' LEU . 61.1 m-20 -50.05 -32.77 16.31 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.356 -0.538 . . . . 1.36 111.843 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.6 mp -151.42 35.27 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.092 -0.958 . . . . 1.62 110.424 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.855 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.8 pttp -57.26 134.86 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.134 0.492 . . . . 2.39 112.011 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.54 19.84 78.96 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.513 -0.767 . . . . 0.37 113.947 178.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -146.78 -48.71 0.19 Allowed 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.394 1.257 . . . . 1.59 114.394 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.825 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.2 p -80.0 81.48 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.979 1.371 . . . . 0.2 107.721 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.43 ' C ' HG22 ' A' ' 105' ' ' ILE . 11.8 m-70 -101.81 127.68 48.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.355 -2.202 . . . . 0.29 112.366 -175.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.104 ' CD1' HG23 ' A' ' 105' ' ' ILE . 58.6 m-85 -71.86 124.02 23.94 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 120.219 -0.592 . . . . 1.23 109.406 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.669 HG22 ' OD1' ' A' ' 106' ' ' ASN . 30.6 p -73.9 33.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.587 -0.733 . . . . 0.46 112.517 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 m -148.91 136.25 20.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.968 0.413 . . . . 1.2 111.338 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.8 1.01 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 2.22 110.735 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -146.35 65.53 1.19 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.347 0.594 . . . . 2.14 109.583 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.914 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.5 mp -57.67 -30.04 65.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 1.49 111.114 -179.018 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -60.01 -10.96 4.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.619 0.723 . . . . 2.04 112.238 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -83.45 0.05 47.95 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.489 -1.232 . . . . 1.4 111.121 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 112.87 -9.38 25.47 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.627 -0.797 . . . . 0.38 113.433 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.59 116.58 29.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.931 0.366 . . . . 1.44 110.61 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.674 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.75 10.03 15.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.491 -0.322 . . . . 0.43 111.627 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 50.4 m -60.01 139.76 57.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 115.335 1.605 . . . . 1.04 115.335 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.104 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -134.71 127.87 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 114.419 -1.264 . . . . 0.31 110.45 178.375 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.669 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -103.65 150.46 23.98 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.506 -0.553 . . . . 1.15 109.506 178.119 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -101.14 119.98 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.101 0.477 . . . . 0.27 111.114 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -85.56 144.12 28.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.313 -0.858 . . . . 0.29 110.64 178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.15 59.99 3.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.629 0.603 . . . . 1.52 112.629 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.9 mt -46.0 178.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.13 0.49 . . . . 1.02 112.274 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.604 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.1 tt0 -177.55 161.44 1.71 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.817 -0.629 . . . . 2.13 110.25 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.791 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 59.0 tp -59.96 -40.03 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.842 0.353 . . . . 1.7 111.376 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -72.2 -12.33 61.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.127 -0.488 . . . . 1.32 111.683 -178.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.14 -21.31 61.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.791 -0.448 . . . . 1.58 109.791 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -44.94 145.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.877 -0.601 . . . . 0.42 111.06 179.066 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.68 149.91 5.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.768 -1.206 . . . . 0.24 114.229 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.841 HG23 ' CD2' ' A' ' 134' ' ' HIS . 93.8 m -59.81 136.8 58.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.802 -0.699 . . . . 0.31 111.813 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.937 ' CE1' HD12 ' A' ' 135' ' ' LEU . 47.2 m-85 -120.0 132.57 55.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.704 -0.48 . . . . 1.24 109.704 177.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.812 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.7 tt0 -120.29 116.4 25.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.589 -0.278 . . . . 1.16 110.631 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.519 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 53.3 t -100.02 115.57 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 1.03 110.545 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 29.7 mtpp -119.46 105.7 11.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.76 111.125 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.684 HG22 HG12 ' A' ' 55' ' ' ILE . 42.9 t -90.03 117.14 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.349 -0.611 . . . . 1.18 109.349 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 62.9 tttp -98.58 120.29 38.75 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.515 0.931 . . . . 1.62 113.515 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HD3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -143.17 101.04 3.74 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.105 -0.702 . . . . 2.84 109.105 176.44 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.908 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.68 132.56 65.0 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.722 -0.672 . . . . 0.44 112.71 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 51.6 Cg_endo -99.53 48.37 1.98 Allowed 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.68 -0.967 . . . . 0.56 112.432 -0.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.37 103.56 0.29 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.864 -0.684 . . . . 0.48 112.823 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.03 152.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.575 -0.812 . . . . 1.22 110.099 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -131.66 147.46 52.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.485 0.183 . . . . 0.57 111.198 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 49.5 t-20 -146.69 138.59 24.64 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.871 0.322 . . . . 2.03 111.871 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.42 151.7 38.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.49 -0.323 . . . . 2.95 110.824 178.865 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 3.4 tttt -97.98 139.94 33.07 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 113.188 0.81 . . . . 2.26 113.188 -177.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.799 HD11 ' HE2' ' A' ' 131' ' ' LYS . 90.1 mt -145.1 113.7 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.28 109.76 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.841 ' CD2' HG23 ' A' ' 117' ' ' THR . 53.4 m170 -102.95 120.0 39.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.55 111.273 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.937 HD12 ' CE1' ' A' ' 118' ' ' TYR . 13.8 mt -91.09 127.23 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 1.52 112.634 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.417 ' HB ' ' CB ' ' A' ' 30' ' ' GLU . 62.7 t -113.27 127.48 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.098 -0.955 . . . . 0.32 108.939 178.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.857 HG23 HG13 ' A' ' 115' ' ' ILE . 20.7 t -97.88 120.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.579 0.585 . . . . 1.08 112.579 -178.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.763 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 78.4 mt -83.57 160.85 21.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.899 -0.592 . . . . 0.52 109.765 178.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -76.05 139.98 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.384 0.612 . . . . 1.48 112.204 -178.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.81 179.81 1.28 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 114.759 -1.11 . . . . 2.2 109.197 -179.874 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.689 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 88.4 Cg_exo -49.13 -141.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.684 2.256 . . . . 1.31 113.42 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.4 m -34.58 -41.2 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.454 0.539 . . . . 2.31 112.454 -178.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 33' ' ' LYS . . . 123.08 -52.57 0.77 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.454 -0.879 . . . . 2.52 113.331 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.258 -0.877 . . . . 2.6 111.068 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.478 -0.249 . . . . 3.28 112.478 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -78.71 140.4 38.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 2.43 110.742 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -157.79 163.58 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 1.84 111.092 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 129' ' ' ALA . 17.1 tt -139.98 139.37 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 2.15 110.324 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 7.9 p -92.09 153.03 19.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.49 0.662 . . . . 1.12 111.734 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.513 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.41 83.75 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 114.554 -1.203 . . . . 0.65 111.502 -178.358 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.616 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.4 Cg_endo -77.84 -80.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.334 2.689 . . . . 0.88 112.704 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 14.7 pt-20 -78.49 128.11 33.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 2.06 108.783 179.163 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.8 tp10 -144.14 160.01 41.66 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.247 1.203 . . . . 1.71 114.247 -176.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 11.2 mtm -140.26 118.27 11.87 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.464 -1.244 . . . . 1.86 109.126 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.422 HG12 HG23 ' A' ' 133' ' ' ILE . 36.7 mm -120.03 128.65 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.906 0.384 . . . . 0.39 111.561 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.4 mt-10 -120.01 125.35 48.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.19 109.916 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -141.9 160.02 41.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 2.52 111.428 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.794 ' HB1' ' CG ' ' A' ' 140' ' ' LYS . . . -76.77 134.37 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.143 -0.48 . . . . 0.39 111.742 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 84.8 tttt -46.92 134.38 10.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.934 -0.575 . . . . 2.35 111.273 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 90.72 -25.16 14.24 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.992 -0.623 . . . . 0.31 112.66 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -80.0 160.0 26.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.124 -1.065 . . . . 2.11 108.124 178.315 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 59.1 m -87.98 127.04 35.38 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.491 -0.884 . . . . 0.33 110.609 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.52 116.65 30.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.905 0.383 . . . . 0.26 110.169 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.71 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.11 118.54 21.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.873 -0.603 . . . . 1.43 112.259 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 133' ' ' ILE . 38.7 mt -102.9 107.94 56.64 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.142 -0.688 . . . . 0.8 109.142 178.253 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.32 120.63 3.3 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.078 . . . . 0.42 114.312 -178.106 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 2.6 t -141.01 123.93 16.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.777 -0.823 . . . . 1.03 108.777 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 17.1 mttp -141.09 153.77 45.61 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.283 -0.417 . . . . 1.66 110.758 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.494 ' CD1' HG11 ' A' ' 122' ' ' VAL . 33.1 p90 -139.74 145.71 38.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.631 . . . . 1.26 111.479 -178.332 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.07 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.456 -0.793 . . . . 1.33 111.631 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.53 147.46 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.904 -0.589 . . . . 2.12 110.943 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 19.5 p -157.35 139.98 10.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 1.75 110.29 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.27 -27.05 2.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.801 2.334 . . . . 1.61 112.804 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.647 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.08 -28.65 54.69 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.025 0.38 . . . . 2.18 112.025 -179.518 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 44.1 p-10 -67.74 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.453 0.644 . . . . 2.41 111.22 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 65.8 mt-30 -96.98 -6.81 34.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.678 . . . . 1.64 111.763 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.873 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.85 158.24 52.08 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.207 -0.997 . . . . 0.55 113.056 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.83 130.33 39.79 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.85 111.209 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HE2' ' A' ' 74' ' ' TYR . 7.3 tt -77.81 119.96 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.39 . . . . 1.9 110.981 -179.04 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -136.67 102.76 5.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.648 0.737 . . . . 1.78 111.83 179.727 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.8 mt -96.71 111.4 26.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.802 -1.09 . . . . 0.75 110.37 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.762 ' HG2' HD11 ' A' ' 73' ' ' LEU . 79.2 mt-10 -108.91 117.67 34.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.389 0.515 . . . . 1.67 112.389 -179.045 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.947 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.9 m95 -95.43 118.52 32.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.771 -0.455 . . . . 0.22 109.771 177.6 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' CD2' HG22 ' A' ' 70' ' ' VAL . 85.6 mt -109.96 140.02 44.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.599 -0.273 . . . . 0.41 110.294 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.6 tt -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.086 0.402 . . . . 0.78 112.086 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.423 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.8 m -114.63 102.53 54.88 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 108.515 -0.92 . . . . 1.25 108.515 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 81.4 Cg_endo -78.85 111.06 2.91 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.475 2.117 . . . . 0.53 113.151 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.99 72.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.994 -1.003 . . . . 0.41 111.009 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 7.4 p-10 -87.6 17.21 4.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.242 -0.435 . . . . 1.82 111.369 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 63' ' ' ASP . 15.6 m120 -148.34 162.98 38.44 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.408 0.623 . . . . 1.94 111.96 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.3 -19.84 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.946 . . . . 1.66 111.64 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 57.4 mttt -69.68 151.74 45.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.073 -0.512 . . . . 1.74 111.344 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.98 127.93 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-O 121.752 0.787 . . . . 0.97 109.483 178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.48 41.26 31.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.312 -1.313 . . . . 1.77 112.227 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.38 134.89 33.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.96 110.919 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.572 HG22 ' CD2' ' A' ' 58' ' ' LEU . 91.3 t -70.5 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.619 -0.264 . . . . 0.77 110.872 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.5 pp -127.11 -36.7 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.269 0.47 . . . . 1.15 112.269 -179.368 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 123.4 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.29 109.385 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.847 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.2 tt -140.36 155.61 46.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.592 -178.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.847 ' N ' HD23 ' A' ' 73' ' ' LEU . 62.7 t80 -132.45 104.29 6.63 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.658 0.266 . . . . 1.3 110.318 179.15 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.43 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 17.9 t -142.46 157.05 45.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.9 0.381 . . . . 0.89 111.875 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.39 29.45 38.5 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.002 -0.618 . . . . 0.57 112.684 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 71.9 2.43 4.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.601 0.239 . . . . 1.46 110.933 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.0 mttm -100.05 107.36 19.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.991 -0.744 . . . . 2.41 108.991 177.645 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.786 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.95 118.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 122.511 1.148 . . . . 1.66 108.562 178.674 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.68 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -100.19 125.7 46.37 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.767 -2.015 . . . . 1.25 111.663 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.838 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 20.8 p-10 -166.39 -54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.906 -1.516 . . . . 1.2 106.906 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 54.3 t0 -81.7 -30.77 32.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.52 -1.218 . . . . 2.17 108.848 177.23 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -72.48 -31.24 65.23 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 5.05 107.317 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.6 OUTLIER -82.6 111.04 25.71 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.32 -1.309 . . . . 1.29 109.399 178.165 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -34.2 92.91 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.292 1.994 . . . . 0.79 113.581 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 87' ' ' LEU . 51.8 m-20 -49.72 -29.84 8.26 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.129 0.789 . . . . 1.36 113.129 -177.423 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.833 HD22 ' HD2' ' A' ' 90' ' ' ARG . 17.9 mt -153.8 30.29 0.46 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.808 -0.633 . . . . 1.62 111.316 178.024 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 13.5 pttm -55.54 133.41 50.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.309 -0.556 . . . . 2.39 111.847 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.88 11.97 67.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.673 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.833 ' HD2' HD22 ' A' ' 87' ' ' LEU . 6.1 ptp180 -142.57 -51.02 0.37 Allowed 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 114.977 1.473 . . . . 1.59 114.977 -178.353 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.08 80.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-O 122.988 1.375 . . . . 0.2 107.667 -177.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.428 ' C ' HG22 ' A' ' 105' ' ' ILE . 13.4 m-70 -101.2 126.15 47.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 112.248 -2.251 . . . . 0.29 112.388 -175.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.134 ' CD1' HG23 ' A' ' 105' ' ' ILE . 83.3 m-85 -70.76 124.58 24.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 120.036 -0.666 . . . . 1.23 109.715 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 ' CD1' ' A' ' 38' ' ' TYR . 1.7 p -76.18 36.08 0.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.283 -0.871 . . . . 0.46 110.966 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 93' ' ' PHE . 2.9 m -148.93 127.1 12.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.96 0.409 . . . . 1.2 110.127 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.62 8.24 37.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.998 -0.546 . . . . 2.22 110.313 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.53 67.62 1.18 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.518 -0.764 . . . . 2.14 108.998 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.2 mp -57.96 -36.21 72.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.299 -0.864 . . . . 1.49 111.747 -178.591 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.97 2.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.561 0.578 . . . . 2.04 112.561 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 98' ' ' LEU . 15.7 m -90.53 -0.23 57.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.913 -0.585 . . . . 1.4 110.591 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.13 -12.61 37.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.049 -0.596 . . . . 0.38 113.393 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -98.07 110.83 23.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.111 0.456 . . . . 1.44 110.801 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.51 15.43 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.43 112.241 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 23.5 m -60.01 139.98 57.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.338 1.607 . . . . 1.04 115.338 -178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.134 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -132.97 130.1 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 114.844 -1.071 . . . . 0.31 111.078 178.356 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.689 ' HB2' HG22 ' A' ' 36' ' ' THR . 50.8 p30 -105.54 147.88 27.88 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.122 -0.696 . . . . 1.15 109.122 177.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.39 121.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.964 0.411 . . . . 0.27 111.409 -178.268 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -83.06 144.71 29.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.549 -0.751 . . . . 0.29 110.33 178.702 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.98 58.68 5.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.93 0.395 . . . . 1.52 111.139 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.1 mt -46.25 88.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.494 0.924 . . . . 1.02 113.494 -178.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 pt20 -59.51 147.42 36.87 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.896 -0.593 . . . . 2.13 110.441 177.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.94 -35.37 74.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.276 0.56 . . . . 1.7 110.428 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.419 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 24.3 p -72.21 -9.42 58.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.794 . . . . 1.32 111.887 -179.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 6.5 m-20 -70.54 -18.99 62.93 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.682 -0.407 . . . . 1.58 110.209 179.149 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 27.2 mt -44.6 134.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.767 -0.457 . . . . 0.42 109.767 178.233 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.89 156.54 6.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.073 -1.06 . . . . 0.24 113.522 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 85.9 m -59.39 134.67 57.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.797 0.666 . . . . 0.31 112.797 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 14.6 m-85 -113.49 137.88 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 1.24 109.754 177.649 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 32.1 tt0 -129.13 118.14 21.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.666 0.27 . . . . 1.16 110.762 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 13.0 t -104.13 118.79 37.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.4 . . . . 1.03 110.34 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.0 mtpm? -119.97 107.01 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.538 -0.301 . . . . 1.76 111.283 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 t -90.82 110.25 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.311 -0.625 . . . . 1.18 109.311 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.879 ' HG2' HG12 ' A' ' 128' ' ' VAL . 74.3 mttt -96.72 116.53 29.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.942 1.09 . . . . 1.62 113.942 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 49' ' ' ASP . 63.9 tttt -147.21 102.13 3.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 2.84 109.453 176.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.873 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.73 133.17 46.92 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 112.27 0.47 . . . . 0.44 112.27 -179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.6 Cg_endo -100.42 51.56 1.5 Allowed 'Cis proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.716 -0.952 . . . . 0.56 111.9 -0.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 102.83 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.107 -1.044 . . . . 0.48 113.34 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.879 HG12 ' HG2' ' A' ' 123' ' ' LYS . 6.0 m -90.01 119.97 38.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.27 -0.965 . . . . 1.22 110.029 178.202 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -99.68 140.01 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.598 0.222 . . . . 0.57 111.598 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -146.59 133.57 20.27 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.539 -0.301 . . . . 2.03 111.525 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.658 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.54 152.64 40.06 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.571 -0.286 . . . . 2.95 111.239 179.152 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 81.9 mttt -102.16 141.16 35.43 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.282 0.845 . . . . 2.26 113.282 -178.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.774 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 84.1 mt -139.98 120.02 13.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.28 109.417 176.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 15.9 m170 -100.01 114.26 27.43 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.468 -0.493 . . . . 0.55 110.274 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 55.6 tp -90.45 125.02 35.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 1.52 112.35 -178.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 40.7 t -120.88 123.84 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.32 109.634 178.357 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 115' ' ' ILE . 38.2 t -96.87 119.95 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.173 0.434 . . . . 1.08 112.173 -178.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.3 mt -84.46 170.64 13.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.808 -0.633 . . . . 0.52 109.342 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -75.15 138.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.352 0.596 . . . . 1.48 111.538 -178.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.794 ' CG ' ' HB1' ' A' ' 32' ' ' ALA . 18.7 mmtm -160.26 173.93 4.4 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.816 -1.084 . . . . 2.2 109.817 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 16.4 Cg_endo -56.88 -153.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.376 2.051 . . . . 1.31 111.924 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.7 m -36.49 -49.99 0.76 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.969 0.414 . . . . 2.31 111.734 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.502 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 72.22 -61.87 1.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.976 -0.63 . . . . 2.52 113.207 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.191 -0.909 . . . . 2.6 111.151 -179.748 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.556 -0.218 . . . . 3.28 112.556 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -78.21 155.95 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 2.43 110.862 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 29.7 t -78.1 151.72 33.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.071 0.462 . . . . 1.84 111.323 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.888 HG12 ' HB1' ' A' ' 129' ' ' ALA . 3.8 mt -130.01 129.97 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.671 -0.695 . . . . 2.15 110.407 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.738 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -89.09 140.04 29.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.581 . . . . 1.12 110.225 179.072 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 46.04 81.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.039 -0.982 . . . . 0.65 111.096 -177.189 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.0 Cg_endo -78.99 -14.15 13.76 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.854 3.036 . . . . 0.88 113.377 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.8 mt-10 -141.36 126.28 18.21 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.272 -0.64 . . . . 2.06 109.272 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 132' ' ' LYS . 2.1 tt0 -144.06 155.66 44.07 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.534 1.309 . . . . 1.71 114.534 -177.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.458 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 29.1 mtm -140.38 113.99 8.73 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.639 -1.164 . . . . 1.86 109.455 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.885 HD13 HG23 ' A' ' 133' ' ' ILE . 5.3 mp -119.97 120.69 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.646 0.609 . . . . 0.39 112.646 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.6 mt-10 -101.59 126.91 48.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.806 -0.634 . . . . 1.19 109.888 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HB3' HD13 ' A' ' 110' ' ' LEU . 16.7 tptt -142.02 156.0 45.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 121.021 -0.272 . . . . 2.52 111.1 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.93 143.69 39.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.855 0.36 . . . . 0.39 111.919 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 80.8 tttt -48.98 132.47 18.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.283 -0.417 . . . . 2.35 111.621 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 86.98 -15.78 51.21 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.155 -0.545 . . . . 0.31 112.923 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.826 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -79.98 158.76 26.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.95 -0.759 . . . . 2.11 108.95 178.719 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.793 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.7 m -88.77 128.42 35.63 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.058 -0.657 . . . . 0.33 111.033 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 118.88 37.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.26 110.648 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD1' HG21 ' A' ' 94' ' ' THR . 62.8 t80 -79.51 119.13 22.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.037 -0.529 . . . . 1.43 112.062 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.783 HD12 ' CD1' ' A' ' 105' ' ' ILE . 12.0 mt -109.96 104.79 56.28 Favored Pre-proline 0 C--N 1.333 -0.132 0 N-CA-C 108.315 -0.994 . . . . 0.8 108.315 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 96.9 Cg_endo -91.02 104.0 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.218 1.945 . . . . 0.42 115.987 -176.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -100.14 128.7 46.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.438 -1.319 . . . . 1.03 107.438 175.411 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 41.1 mmtm -140.58 107.26 5.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.183 0.516 . . . . 1.66 110.738 -178.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.077 ' HB3' HG11 ' A' ' 122' ' ' VAL . 47.4 p90 -99.3 140.09 33.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.005 -0.998 . . . . 1.26 111.735 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 21' ' ' SER . 0.3 OUTLIER -79.99 139.13 37.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 1.33 110.62 179.492 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 43' ' ' PHE . 97.7 mt -96.23 141.47 29.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 2.12 111.67 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.6 m -150.66 135.86 10.13 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.75 109.303 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -46.81 -25.66 3.96 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.471 2.114 . . . . 1.61 112.238 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.98 -39.99 60.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.373 -0.376 . . . . 2.18 111.199 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 73.7 m-20 -73.27 74.97 1.33 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.017 -0.673 . . . . 2.41 109.638 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.85 -5.31 41.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.423 -0.808 . . . . 1.64 112.148 -178.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.96 166.24 50.02 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.55 112.584 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.22 130.05 29.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.359 2.039 . . . . 0.85 111.756 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 124' ' ' LYS . 8.7 tp -77.98 117.29 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.446 -0.343 . . . . 1.9 110.904 -179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -129.37 103.17 6.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.484 0.659 . . . . 1.78 111.682 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.836 ' O ' HD12 ' A' ' 73' ' ' LEU . 2.6 mp -95.56 109.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.922 -1.035 . . . . 0.75 110.879 179.108 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.921 ' HG2' HD13 ' A' ' 73' ' ' LEU . 18.0 mt-10 -104.7 116.61 32.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.67 111.721 -179.592 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.914 ' CD2' HD11 ' A' ' 105' ' ' ILE . 70.5 m95 -91.28 116.66 29.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.587 -0.445 . . . . 0.22 109.954 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 70' ' ' VAL . 63.0 mt -105.75 138.76 41.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.643 -0.503 . . . . 0.41 109.643 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.628 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.0 tt -129.97 132.76 65.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.615 0.598 . . . . 0.78 112.615 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.08 102.33 40.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 1.25 109.571 177.638 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.71 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 84.6 Cg_endo -79.52 114.9 3.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.566 2.177 . . . . 0.53 113.043 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -29.03 68.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.41 110.373 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.72 10.24 9.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.713 -0.676 . . . . 1.82 111.742 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 67.3 t30 -152.24 160.05 43.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.203 0.525 . . . . 1.94 111.849 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -65.85 -19.01 65.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.386 -0.824 . . . . 1.66 111.941 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.0 ttmt -65.89 142.08 58.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 1.74 111.418 -178.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.79 128.0 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-O 122.015 0.912 . . . . 0.97 110.173 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.53 39.68 21.34 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 113.809 -1.541 . . . . 1.77 112.904 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 93.9 mm-40 -93.37 136.52 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 1.96 110.807 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 58' ' ' LEU . 99.2 t -69.38 130.15 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.77 110.615 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.836 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -126.97 -38.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.23 -0.441 . . . . 1.15 111.658 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.26 120.85 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.089 -0.708 . . . . 0.29 109.089 179.25 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.921 HD13 ' HG2' ' A' ' 56' ' ' GLU . 2.4 tp -140.52 161.12 38.48 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.699 -0.682 . . . . 1.3 109.543 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 79' ' ' ILE . 21.0 t80 -134.66 110.43 9.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.107 0.479 . . . . 1.3 110.307 178.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.533 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.9 t -142.37 160.02 41.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.125 -0.943 . . . . 0.89 111.639 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.65 37.8 42.76 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.805 -0.712 . . . . 0.57 112.137 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t0 59.92 30.04 19.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.075 0.464 . . . . 1.46 110.348 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 44.5 mtmt -129.27 110.82 12.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.704 -0.68 . . . . 2.41 110.344 178.717 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.3 117.49 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.581 -1.266 . . . . 1.66 107.581 177.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.759 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -99.98 132.17 45.5 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.693 -1.139 . . . . 1.25 110.641 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 14.2 p-10 -166.11 -56.34 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.418 -1.327 . . . . 1.2 107.418 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 74.0 m-20 -80.23 -27.41 38.75 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.796 -1.093 . . . . 2.17 109.238 177.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.89 -31.65 61.63 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.226 -1.027 . . . . 5.05 108.226 178.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -81.18 112.73 35.46 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 114.512 -1.222 . . . . 1.29 110.102 179.201 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.25 -42.71 16.98 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.653 1.569 . . . . 0.79 111.208 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.2 m-20 -67.73 104.12 1.57 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.028 -0.533 . . . . 1.36 111.095 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 13.6 mt 73.88 19.91 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.799 1.037 . . . . 1.62 113.799 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.5 pttt -57.19 130.08 44.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.572 -0.705 . . . . 2.39 110.555 177.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 94.21 11.35 57.51 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.165 -1.017 . . . . 0.37 114.186 178.773 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.943 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 12.4 ptp180 -141.96 -52.36 0.42 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 114.24 1.2 . . . . 1.59 114.24 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.24 81.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-O 122.991 1.377 . . . . 0.2 107.322 -178.06 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.434 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.4 m80 -99.0 128.81 45.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.193 -2.276 . . . . 0.29 112.184 -175.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.08 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.1 m-85 -70.53 123.25 21.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.201 0.524 . . . . 1.23 110.79 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -76.21 28.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.412 -0.813 . . . . 0.46 111.926 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.1 m -147.45 129.71 15.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.094 0.473 . . . . 1.2 111.566 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.64 5.73 46.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 2.22 110.361 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -145.77 66.11 1.22 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 2.14 108.959 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.587 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.8 mp -59.92 -37.43 79.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.097 -0.956 . . . . 1.49 112.101 -178.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -62.52 3.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.521 0.563 . . . . 2.04 112.521 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.3 m -90.03 -3.58 57.89 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.813 -0.63 . . . . 1.4 110.259 178.198 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 116.96 -20.51 11.56 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.142 -0.552 . . . . 0.38 113.005 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 3.6 m-20 -100.98 107.81 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.44 111.122 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.91 23.79 13.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.169 -0.468 . . . . 0.43 110.978 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -59.61 147.08 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.881 1.808 . . . . 1.04 115.881 -178.089 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.08 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -135.66 132.0 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 114.455 -1.248 . . . . 0.31 111.016 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -105.35 145.79 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.673 -0.862 . . . . 1.15 108.673 177.216 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.04 122.21 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.87 0.367 . . . . 0.27 111.185 -178.845 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -86.06 143.35 28.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.821 -0.627 . . . . 0.29 110.892 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.7 m-20 49.98 58.17 5.75 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.098 -0.501 . . . . 1.52 111.669 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.7 mt -46.53 89.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.557 0.947 . . . . 1.02 113.557 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.45 ' HG2' ' H ' ' A' ' 113' ' ' SER . 7.5 tt0 -59.97 145.68 45.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.881 -0.599 . . . . 2.13 109.898 177.413 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.445 ' HG ' ' CD ' ' A' ' 33' ' ' LYS . 83.8 mt -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.773 0.321 . . . . 1.7 111.618 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.45 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 79.6 p -73.36 -11.19 60.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.32 111.606 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.3 m-20 -71.7 -17.29 62.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 1.58 109.904 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.4 mt -43.5 141.43 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.42 110.594 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.86 164.71 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.39 -0.91 . . . . 0.24 113.34 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.0 m -59.55 129.99 44.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.625 0.602 . . . . 0.31 112.625 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.628 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 26.9 m-85 -113.89 121.81 45.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.625 -0.88 . . . . 1.24 108.625 177.058 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.0 tt0 -124.34 125.22 43.97 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.778 -0.369 . . . . 1.16 111.021 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.543 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 16.1 p -108.34 119.97 41.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 1.03 110.861 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.2 mttm -113.6 104.09 11.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.157 -0.474 . . . . 1.76 110.935 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 1.077 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.6 p -90.02 112.0 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.084 -0.71 . . . . 1.18 109.084 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.3 tttm -102.61 120.06 39.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.724 1.009 . . . . 1.62 113.724 -177.448 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 53' ' ' LEU . 6.6 ttpp -143.9 102.4 3.89 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.169 0.509 . . . . 2.84 109.756 176.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.796 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.0 131.98 30.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.44 113.051 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.4 Cg_endo -99.96 45.55 2.61 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.686 -0.964 . . . . 0.56 112.198 -0.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.29 103.57 0.32 Allowed Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.422 -0.894 . . . . 0.48 113.044 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.2 p -89.07 158.66 2.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.435 -0.882 . . . . 1.22 109.519 177.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.983 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . . . -144.74 135.64 24.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.376 -0.374 . . . . 0.57 111.554 -179.471 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 19.2 p30 -146.71 139.36 25.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.676 0.621 . . . . 2.03 112.676 -179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.741 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -145.68 161.61 39.46 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.359 -0.382 . . . . 2.95 111.228 178.832 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 68.8 mttm -100.47 143.31 30.79 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.715 1.006 . . . . 2.26 113.715 -178.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 29' ' ' ILE . 96.5 mt -141.32 113.05 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 114.961 -1.018 . . . . 0.28 108.305 176.656 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 7.7 m170 -98.8 117.75 33.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.435 -0.506 . . . . 0.55 110.885 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.956 HD21 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -93.7 118.5 31.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.52 111.946 -179.311 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 58.6 t -111.75 120.01 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.674 -0.862 . . . . 0.32 108.674 178.065 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 115' ' ' ILE . 24.4 t -101.48 122.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.498 0.555 . . . . 1.08 112.498 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.1 mt -84.07 169.27 15.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.971 -0.751 . . . . 0.52 108.971 178.36 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.8 136.7 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.416 0.627 . . . . 1.48 111.496 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.863 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -164.26 173.68 3.82 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.985 -1.007 . . . . 2.2 110.326 179.746 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 71.5 Cg_exo -50.02 169.64 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.455 2.103 . . . . 1.31 112.641 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.461 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 19.4 m -40.1 -69.94 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.945 -0.57 . . . . 2.31 112.348 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.75 -64.98 0.31 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.826 -0.702 . . . . 2.52 112.509 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.208 -0.901 . . . . 2.6 111.442 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.488 -0.245 . . . . 3.28 112.488 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.489 ' OG ' ' HA3' ' A' ' 127' ' ' GLY . 13.2 m -80.09 132.22 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 2.43 110.814 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t -159.95 160.04 32.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 1.84 111.406 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.959 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 19.5 tt -133.65 140.02 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 2.15 110.45 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.757 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.1 p -88.68 154.47 20.27 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.505 0.669 . . . . 1.12 111.867 -179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.52 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 38.39 82.16 0.23 Allowed Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.65 111.953 -178.55 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 77.8 Cg_endo -79.43 -8.62 14.99 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 123.891 3.06 . . . . 0.88 113.032 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -141.3 122.46 14.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.144 -0.687 . . . . 2.06 109.144 178.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.776 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -144.24 156.63 44.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.981 1.104 . . . . 1.71 113.981 -176.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HD13 ' A' ' 29' ' ' ILE . 47.7 mtp -138.82 122.3 17.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.847 -1.07 . . . . 1.86 109.442 177.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.776 HD11 ' OE2' ' A' ' 27' ' ' GLU . 27.1 mm -126.48 134.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 0.39 111.513 -179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 20.4 pt-20 -130.72 127.3 38.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 1.19 110.652 179.622 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 13.3 tptt -142.43 163.48 32.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.39 -0.368 . . . . 2.52 110.945 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.967 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.12 140.29 41.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 0.39 111.704 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 76.6 tttt -47.43 139.71 6.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.095 -0.502 . . . . 2.35 111.715 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 82.5 -20.17 9.55 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.793 -0.639 . . . . 0.31 113.032 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.591 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 80.7 mm-40 -80.07 159.98 25.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.513 -0.921 . . . . 2.11 108.513 178.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.9 m -90.68 127.34 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.785 -0.766 . . . . 0.33 111.222 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.01 119.88 38.96 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.794 0.331 . . . . 0.26 110.529 179.181 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 65.6 t80 -79.64 116.77 20.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.329 -0.396 . . . . 1.43 111.842 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.752 ' HB2' HD12 ' A' ' 105' ' ' ILE . 39.9 mt -100.91 106.15 42.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.999 -0.741 . . . . 0.8 108.999 178.061 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 97.0 Cg_endo -81.98 129.3 6.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.42 114.509 -177.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.6 t -140.91 130.28 23.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.21 -0.905 . . . . 1.03 109.195 177.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.757 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 57.2 tptt -140.02 141.44 36.31 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 1.66 109.514 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.955 ' CG ' HG11 ' A' ' 122' ' ' VAL . 53.1 p90 -139.94 144.82 37.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.242 0.544 . . . . 1.26 112.05 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -80.85 158.37 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.36 -0.836 . . . . 1.33 110.513 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.598 HD11 ' HE2' ' A' ' 124' ' ' LYS . 63.7 tp -140.0 99.98 3.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 2.12 111.422 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.9 t -82.1 142.3 47.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.576 -0.527 . . . . 1.75 109.576 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.34 -29.35 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.931 1.754 . . . . 1.61 111.821 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.89 -33.64 51.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.984 -0.553 . . . . 2.18 111.389 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.585 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.24 79.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.087 -0.645 . . . . 2.41 109.625 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -102.3 7.24 40.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 1.64 112.284 -178.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.959 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.94 164.22 51.77 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.55 112.809 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.57 134.72 59.76 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.3 2.0 . . . . 0.85 111.731 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.611 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 18.7 mt -78.19 104.73 8.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 1.9 111.375 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.1 m-20 -119.55 102.61 8.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.64 0.733 . . . . 1.78 110.905 178.69 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.817 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 8.9 mt -101.38 130.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.765 -1.107 . . . . 0.75 110.004 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.901 ' HG2' HD13 ' A' ' 73' ' ' LEU . 99.3 mt-10 -130.05 125.68 35.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.274 0.842 . . . . 1.67 113.274 -178.605 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.847 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.8 m95 -97.86 119.95 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.935 -0.575 . . . . 0.22 109.514 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.0 mt -105.54 139.98 39.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.372 -0.603 . . . . 0.41 109.372 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.9 tt -128.63 129.56 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.171 0.51 . . . . 0.78 111.46 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.499 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 p -119.91 103.03 46.14 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.954 -0.758 . . . . 1.25 108.954 178.211 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 95.2 Cg_endo -78.78 113.52 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.424 2.082 . . . . 0.53 112.892 -178.629 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.277 -0.874 . . . . 0.41 111.066 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.73 -40.02 63.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.928 -0.578 . . . . 1.82 111.329 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 97.8 m-20 -84.61 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.156 0.503 . . . . 1.94 111.628 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.44 -20.01 63.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.456 -0.793 . . . . 1.66 111.222 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 77.6 mttt -70.3 150.02 46.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 1.74 111.233 -178.425 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.89 128.46 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 121.925 0.869 . . . . 0.97 110.081 178.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.96 40.19 19.23 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 113.94 -1.482 . . . . 1.77 113.229 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.59 144.89 25.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.683 0.277 . . . . 1.96 111.217 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.939 HG13 HD21 ' A' ' 73' ' ' LEU . 31.0 t -66.01 136.56 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.599 -0.889 . . . . 0.77 108.599 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.72 -51.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.839 0.681 . . . . 1.15 112.839 -176.867 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.969 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.42 126.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.309 -0.626 . . . . 0.29 109.309 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 70' ' ' VAL . 3.1 mt -138.09 175.73 9.32 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.412 0.625 . . . . 1.3 111.534 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.718 ' CD1' HG23 ' A' ' 79' ' ' ILE . 45.7 t80 -140.3 104.39 4.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.203 -1.362 . . . . 1.3 107.427 175.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.526 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.9 t -141.54 157.11 45.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.998 -0.546 . . . . 0.89 111.067 -178.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.27 39.25 42.57 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.525 -0.845 . . . . 0.57 112.013 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.01 30.29 19.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 1.46 110.433 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 67.5 mttm -130.8 110.5 11.36 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.768 -0.651 . . . . 2.41 111.231 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -79.98 112.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.253 -1.388 . . . . 1.66 107.253 176.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -100.11 141.5 32.85 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.922 . . . . 1.25 111.198 -178.454 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.4 p-10 -166.83 -54.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.653 -1.24 . . . . 1.2 107.653 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 33.9 m-20 -80.01 -19.9 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.0 -1.0 . . . . 2.17 109.873 177.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.411 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.47 -28.72 46.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.746 -0.835 . . . . 5.05 108.746 178.466 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.682 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.4 m-85 -85.41 119.92 72.7 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 114.931 -1.031 . . . . 1.29 111.189 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 7.5 Cg_endo -48.55 -42.84 34.83 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.388 1.392 . . . . 0.79 109.933 178.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.775 ' O ' HG12 ' A' ' 71' ' ' ILE . 41.3 m-20 -66.31 106.05 1.6 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.747 -0.66 . . . . 1.36 110.702 178.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.7 mt 66.76 21.29 10.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.278 1.214 . . . . 1.62 114.278 178.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 55.6 pttt -56.23 129.95 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.457 -0.897 . . . . 2.39 110.666 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 93.61 14.26 53.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.263 -0.97 . . . . 0.37 113.875 178.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.2 ptp180 -145.16 -48.96 0.24 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.815 1.413 . . . . 1.59 114.815 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.969 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -81.1 81.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-O 123.274 1.511 . . . . 0.2 107.019 -178.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.536 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.2 m-70 -99.03 129.21 45.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.145 -2.298 . . . . 0.29 112.74 -175.399 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.11 ' CD1' HG23 ' A' ' 105' ' ' ILE . 86.1 m-85 -72.31 120.14 17.5 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 120.272 -0.571 . . . . 1.23 109.519 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.448 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 18.8 p -73.37 -7.13 50.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.367 -0.833 . . . . 0.46 110.482 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 17.7 m -86.35 118.77 26.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.939 -0.573 . . . . 1.2 110.895 -179.173 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -90.03 1.38 56.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.858 -0.61 . . . . 2.22 110.014 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -145.99 67.65 1.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.335 -0.987 . . . . 2.14 108.335 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.646 HD22 ' CE2' ' A' ' 74' ' ' TYR . 10.0 tt -58.27 -36.33 73.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.897 -1.047 . . . . 1.49 112.07 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -62.26 -1.08 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 2.04 112.254 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 98' ' ' LEU . 70.5 m -89.64 0.04 57.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 1.4 110.795 178.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 107.13 -15.11 39.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.968 -0.634 . . . . 0.38 113.069 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 42' ' ' LYS . 86.6 m-20 -92.26 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.873 0.337 . . . . 1.44 111.355 -179.754 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.568 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.09 19.85 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.43 111.632 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 5.2 p -60.1 141.2 56.21 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.678 1.733 . . . . 1.04 115.678 -178.399 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.11 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -133.3 130.84 57.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 114.416 -1.266 . . . . 0.31 111.292 178.713 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.2 p30 -102.98 144.98 30.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.396 -0.964 . . . . 1.15 108.396 177.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.87 120.76 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 120.911 0.386 . . . . 0.27 111.971 -177.995 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.704 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -84.44 143.13 29.61 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.516 -0.765 . . . . 0.29 110.832 178.671 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 26.2 m120 49.96 57.84 6.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.142 0.496 . . . . 1.52 111.668 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 37' ' ' ALA . 31.3 mt -46.63 90.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.009 1.114 . . . . 1.02 114.009 -179.051 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 38.9 mt-30 -59.3 141.56 54.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.922 -0.581 . . . . 2.13 110.924 176.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.605 HD23 ' CG1' ' A' ' 137' ' ' VAL . 84.4 mt -60.04 -35.37 74.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.113 0.483 . . . . 1.7 109.995 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.2 p -74.47 -11.63 60.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.698 -0.683 . . . . 1.32 111.435 -179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 99.1 m-20 -71.7 -18.45 62.16 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.033 -0.358 . . . . 1.58 110.033 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -43.36 139.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.202 -0.454 . . . . 0.42 110.22 179.09 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 164.06 9.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.111 -1.042 . . . . 0.24 113.39 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.6 m -59.29 130.22 45.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.012 0.745 . . . . 0.31 113.012 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 15.5 m-85 -114.87 128.87 56.55 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.774 -0.824 . . . . 1.24 108.774 176.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.5 tt0 -127.45 119.03 25.19 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.568 -0.453 . . . . 1.16 111.314 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 35.4 t -100.01 119.4 38.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 1.03 110.611 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.3 mttt -116.57 106.27 13.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.005 -0.278 . . . . 1.76 110.915 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CG ' ' A' ' 43' ' ' PHE . 43.8 t -90.53 112.46 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.363 -0.606 . . . . 1.18 109.363 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 85.9 tttt -99.57 121.88 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.041 0.756 . . . . 1.62 113.041 -178.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 53.9 tptt -145.16 101.39 3.61 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.448 -0.575 . . . . 2.84 109.448 177.111 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.959 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.76 135.83 64.85 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.44 112.335 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.585 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 53.0 Cg_endo -96.94 46.2 2.4 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.336 -1.11 . . . . 0.56 111.631 -0.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.489 ' HA3' ' OG ' ' A' ' 20' ' ' SER . . . -145.28 103.64 0.29 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.434 -0.889 . . . . 0.48 113.399 -179.332 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.64 153.1 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.342 -0.929 . . . . 1.22 109.897 178.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.959 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -138.01 140.4 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.575 0.213 . . . . 0.57 111.575 -179.254 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.472 ' C ' HD13 ' A' ' 22' ' ' ILE . 49.9 p30 -146.74 143.61 28.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.21 0.448 . . . . 2.03 112.21 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.06 159.98 42.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.19 -0.459 . . . . 2.95 110.864 179.056 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 72.1 mmtt -105.61 140.39 38.76 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 112.776 0.658 . . . . 2.26 112.776 -178.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.828 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 64.7 mt -139.97 119.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.28 109.17 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 35.2 m170 -102.72 117.35 34.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.55 110.616 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 40.6 tp -89.35 124.94 34.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 1.52 111.601 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 45.0 t -119.97 120.01 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.797 -0.638 . . . . 0.32 109.293 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 115' ' ' ILE . 40.2 t -99.3 122.69 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.316 0.487 . . . . 1.08 112.316 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.5 mt -84.86 164.95 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.727 -0.67 . . . . 0.52 109.717 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.447 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -77.72 138.42 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 1.48 111.514 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.967 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 1.7 mmtt -159.96 175.22 3.32 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.864 -1.062 . . . . 2.2 109.249 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 18.5 Cg_endo -59.32 -153.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.864 1.709 . . . . 1.31 111.581 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.8 m -34.96 -71.86 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.847 0.356 . . . . 2.31 111.685 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.447 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 69.69 -58.68 0.71 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.995 -0.621 . . . . 2.52 113.082 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.194 -0.907 . . . . 2.6 111.157 -179.718 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.54 -0.224 . . . . 3.28 112.54 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 44' ' ' THR . 47.6 t -158.97 159.06 34.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 2.43 110.642 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.2 t -158.22 144.73 17.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.14 0.495 . . . . 1.84 111.457 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.709 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.8 pp -95.33 143.98 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.478 -0.783 . . . . 2.15 111.5 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -91.12 155.12 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.12 110.361 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.4 OUTLIER 39.44 83.41 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.612 0.72 . . . . 0.65 111.258 -178.069 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.769 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 61.2 Cg_endo -78.24 -8.11 16.27 Favored 'Trans proline' 0 C--N 1.327 -0.582 0 C-N-CA 123.753 2.969 . . . . 0.88 113.477 -178.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.16 121.31 13.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.06 108.893 178.113 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 132' ' ' LYS . 3.3 tt0 -144.48 160.48 41.03 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.86 1.43 . . . . 1.71 114.86 -176.165 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 39.6 mtm -139.98 121.38 15.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.582 -1.19 . . . . 1.86 109.632 177.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.02 126.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.756 0.312 . . . . 0.39 111.659 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 86.3 mt-10 -116.26 125.53 52.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.376 -0.375 . . . . 1.19 110.325 179.166 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.627 ' HB2' HD11 ' A' ' 110' ' ' LEU . 34.5 mmtm -142.07 156.8 45.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.784 0.326 . . . . 2.52 111.502 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.98 137.83 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.39 112.184 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 8.0 ttpt -45.17 142.16 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.854 -0.612 . . . . 2.35 111.707 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.12 -26.9 4.15 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.909 -0.587 . . . . 0.31 112.981 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 110' ' ' LEU . 100.0 mt-10 -80.03 160.02 25.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.889 -0.782 . . . . 2.11 108.889 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 91.6 m -85.49 130.11 34.66 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.018 -0.673 . . . . 0.33 110.737 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.2 117.25 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.126 0.488 . . . . 0.26 110.327 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.545 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.05 120.01 23.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.8 0.667 . . . . 1.43 112.8 -178.397 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' A' ' 105' ' ' ILE . 11.7 mt -107.08 105.67 56.23 Favored Pre-proline 0 CA--C 1.528 0.108 0 N-CA-C 108.533 -0.914 . . . . 0.8 108.533 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.49 ' HD2' HD13 ' A' ' 133' ' ' ILE . 87.6 Cg_endo -83.0 128.88 5.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.45 2.1 . . . . 0.42 115.066 -177.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 9.9 t -141.5 129.89 22.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.043 -0.98 . . . . 1.03 109.637 177.402 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 1.0 OUTLIER -140.31 150.74 44.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.966 -0.561 . . . . 1.66 109.995 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 122' ' ' VAL . 49.7 p90 -140.13 153.26 46.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 1.26 111.021 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 45' ' ' LEU . 20.0 m -79.74 162.81 24.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 1.33 111.047 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 124' ' ' LYS . 47.6 tp -139.83 130.32 25.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.12 110.871 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.01 158.01 25.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.445 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.81 -20.71 23.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 1.61 112.888 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.57 -45.37 59.53 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 110.014 -0.365 . . . . 2.18 110.014 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.556 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -71.88 83.34 0.93 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.595 -0.891 . . . . 2.41 108.595 178.588 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -95.9 -4.36 43.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.56 -0.745 . . . . 1.64 112.361 -177.533 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.848 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -83.15 152.84 30.05 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.169 -1.015 . . . . 0.55 112.779 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.16 139.01 88.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.313 2.009 . . . . 0.85 111.493 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 124' ' ' LYS . 6.5 mt -78.33 104.33 8.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.447 -0.342 . . . . 1.9 111.767 -179.35 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 96.6 m-20 -114.31 102.59 10.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.532 0.682 . . . . 1.78 110.06 178.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 47.1 mt -95.38 139.83 18.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.97 -1.014 . . . . 0.75 110.008 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.91 ' HA ' HD22 ' A' ' 73' ' ' LEU . 98.9 mt-10 -137.6 117.15 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 1.67 112.741 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.961 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.6 m95 -91.25 121.88 33.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.469 178.173 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -107.29 140.02 40.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.555 -0.906 . . . . 0.41 108.555 178.278 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -128.83 133.06 66.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.352 0.596 . . . . 0.78 112.473 -178.426 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -119.85 103.59 45.53 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.112 -0.949 . . . . 1.25 109.216 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.9 Cg_exo -79.33 122.52 5.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.503 2.135 . . . . 0.53 112.075 -179.109 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.98 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.41 110.872 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -74.97 -40.03 60.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 1.82 111.542 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 30.6 m120 -83.64 154.45 23.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.288 0.566 . . . . 1.94 111.912 -179.44 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.72 -16.92 63.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.233 -0.894 . . . . 1.66 111.131 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.673 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 33.2 mttp -68.89 150.02 48.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.484 -0.78 . . . . 1.74 111.449 -178.07 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.44 128.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-O 121.984 0.897 . . . . 0.97 110.14 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.78 39.96 20.13 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.835 -1.53 . . . . 1.77 112.863 178.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -91.14 146.93 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.603 0.239 . . . . 1.96 110.906 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.918 HG13 HD21 ' A' ' 73' ' ' LEU . 15.8 t -65.84 130.01 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.013 -0.736 . . . . 0.77 109.013 178.824 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.9 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.81 -53.21 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.671 0.619 . . . . 1.15 112.671 -177.028 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.012 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.02 129.37 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.163 -0.68 . . . . 0.29 109.163 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 70' ' ' VAL . 3.9 mt -138.76 175.45 9.55 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.57 0.7 . . . . 1.3 111.373 -179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.775 ' CD1' HG23 ' A' ' 79' ' ' ILE . 39.2 t80 -141.36 103.61 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.095 -1.411 . . . . 1.3 107.648 176.141 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 1.8 t -141.6 153.99 45.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.385 -0.371 . . . . 0.89 111.005 -178.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.87 30.1 52.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.527 -0.844 . . . . 0.57 112.146 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.91 3.99 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.618 0.247 . . . . 1.46 110.872 -178.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 65.1 mttm -105.34 110.79 23.28 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.575 -0.284 . . . . 2.41 111.306 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.775 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.2 pp -79.87 113.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.465 -1.68 . . . . 1.66 106.465 176.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.742 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -99.92 140.02 34.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.426 -0.807 . . . . 1.25 111.177 -177.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.2 p-10 -166.55 -52.39 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.864 -1.162 . . . . 1.2 107.864 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 54.5 m-20 -79.92 -25.57 40.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.122 -0.945 . . . . 2.17 109.632 178.061 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.77 -30.47 56.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.546 -0.909 . . . . 5.05 108.546 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.656 ' CE2' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -82.19 114.05 48.22 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 114.952 -1.022 . . . . 1.29 110.679 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.86 -42.17 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.73 1.62 . . . . 0.79 110.31 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.619 ' O ' HG12 ' A' ' 71' ' ' ILE . 58.5 m-20 -67.09 105.24 1.62 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.678 -0.692 . . . . 1.36 110.584 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.797 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 mp 68.98 24.18 6.37 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.892 1.071 . . . . 1.62 113.892 178.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 51.1 pttt -57.02 129.83 43.46 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.571 -0.706 . . . . 2.39 111.016 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.45 15.46 58.52 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.119 178.642 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp85 -143.37 -48.54 0.31 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.383 1.253 . . . . 1.59 114.383 -178.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.012 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.01 81.28 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 123.132 1.444 . . . . 0.2 107.274 -178.54 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.641 ' C ' HG22 ' A' ' 105' ' ' ILE . 3.8 m-70 -98.29 127.84 44.42 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.248 -2.251 . . . . 0.29 112.325 -175.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.036 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.2 m-85 -70.88 121.82 18.79 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.166 0.508 . . . . 1.23 110.434 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 38' ' ' TYR . 5.8 p -77.79 36.0 0.21 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.527 -0.76 . . . . 0.46 111.839 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.1 m -148.32 127.55 12.96 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.128 0.489 . . . . 1.2 111.639 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -90.62 6.16 44.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.593 -0.73 . . . . 2.22 110.211 178.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -145.91 66.03 1.21 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.103 -0.702 . . . . 2.14 109.103 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.469 HD21 ' CG ' ' A' ' 93' ' ' PHE . 4.8 mp -60.08 -39.27 85.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.15 -0.932 . . . . 1.49 111.333 -178.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HE2' ' OH ' ' A' ' 74' ' ' TYR . 25.8 mttm -59.52 -6.73 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.511 . . . . 2.04 112.224 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -81.94 -7.09 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.522 -0.763 . . . . 1.4 110.535 179.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 115.35 -20.02 14.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.852 -0.689 . . . . 0.38 113.227 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -99.91 106.03 17.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.03 0.415 . . . . 1.44 110.516 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -113.03 22.59 14.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.466 0.543 . . . . 0.43 112.466 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 13.9 m -60.02 151.02 27.45 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.963 1.468 . . . . 1.04 114.963 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.036 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -135.11 134.21 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 114.639 -1.164 . . . . 0.31 111.447 179.301 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.658 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.8 p-10 -107.95 148.37 29.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.832 -0.803 . . . . 1.15 108.832 177.438 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.31 123.46 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.943 0.401 . . . . 0.27 111.058 -178.774 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -86.27 144.9 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.689 -0.687 . . . . 0.29 111.262 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.11 61.0 2.92 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.01 -0.541 . . . . 1.52 112.224 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 31' ' ' LYS . 6.6 mt -45.99 169.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 1.02 111.904 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 11.8 pt20 -177.43 161.22 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.701 -0.681 . . . . 2.13 110.572 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.813 ' HA ' HG11 ' A' ' 137' ' ' VAL . 5.1 mp -60.06 -33.01 71.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 1.7 111.465 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -73.74 -19.93 60.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.984 -0.286 . . . . 1.32 111.629 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 95.5 m-20 -72.27 -19.72 61.64 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.923 -0.399 . . . . 1.58 109.923 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -46.03 142.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 116.111 -0.495 . . . . 0.42 111.171 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.46 150.4 5.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.689 -1.243 . . . . 0.24 114.298 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.53 HG23 ' ND1' ' A' ' 134' ' ' HIS . 98.1 m -59.47 139.95 56.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -0.662 . . . . 0.31 112.135 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.8 m-85 -119.98 135.08 55.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 1.24 109.9 178.136 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.1 tt0 -126.77 117.13 22.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.612 -0.267 . . . . 1.16 111.145 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.461 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 50.8 t -99.99 114.73 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 1.03 110.288 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.0 mtpt -109.45 104.77 13.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.574 -0.284 . . . . 1.76 110.801 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 55' ' ' ILE . 42.8 t -90.05 110.69 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.578 -0.527 . . . . 1.18 109.578 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HG3' HG12 ' A' ' 128' ' ' VAL . 26.8 tttp -98.9 115.89 29.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.479 0.548 . . . . 1.62 112.479 -178.758 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.556 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 36.1 tttp -145.77 102.63 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.316 -0.554 . . . . 2.84 109.784 177.643 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.848 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.56 132.1 26.8 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.919 -0.582 . . . . 0.44 111.903 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 63.1 Cg_endo -101.29 51.94 1.44 Allowed 'Cis proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.771 -0.929 . . . . 0.56 111.94 -0.418 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 102.59 0.26 Allowed Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.855 -1.164 . . . . 0.48 113.866 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -93.83 135.78 27.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.391 -0.905 . . . . 1.22 109.293 177.306 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.709 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.44 152.51 40.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.599 -0.44 . . . . 0.57 112.068 -179.183 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 23.6 p-10 -146.42 157.91 43.82 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.217 0.451 . . . . 2.03 112.217 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.769 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.99 166.61 25.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.193 -0.458 . . . . 2.95 111.083 179.009 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' GLU . 68.3 mttm -111.17 140.25 45.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 112.6 0.593 . . . . 2.26 112.6 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.631 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 96.8 mt -141.55 112.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.543 -0.91 . . . . 0.28 108.543 176.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.53 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.7 m-70 -96.89 118.77 34.04 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.425 -0.51 . . . . 0.55 110.984 -178.478 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.2 tm? -88.44 120.0 29.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 1.52 111.69 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 42.3 t -118.96 120.3 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.32 109.197 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 112' ' ' LEU . 10.7 p -94.91 133.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.312 0.486 . . . . 1.08 112.312 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 66.6 mt -80.1 158.18 26.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.944 -0.762 . . . . 0.52 108.944 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' A' ' 140' ' ' LYS . 3.0 p -69.07 150.55 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 122.134 0.968 . . . . 1.48 113.439 -177.185 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.764 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 1.3 mttm -164.24 -174.28 0.39 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 113.538 -1.665 . . . . 2.2 110.303 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 85.8 Cg_exo -49.93 -142.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.85 2.367 . . . . 1.31 113.903 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.0 p -30.42 -59.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.227 0.825 . . . . 2.31 113.227 -178.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.48 ' CA ' ' HD2' ' A' ' 33' ' ' LYS . . . 142.97 27.32 0.15 Allowed Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.333 -0.937 . . . . 2.52 113.342 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.292 -0.861 . . . . 2.6 111.015 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.583 ' N ' ' HG ' ' A' ' 46' ' ' SER . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.582 -0.207 . . . . 3.28 112.582 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -79.53 137.57 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.336 . . . . 2.43 111.063 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -159.96 158.19 30.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 1.84 110.856 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.766 HG13 ' HB1' ' A' ' 129' ' ' ALA . 1.6 pp -91.96 143.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 2.15 111.264 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -89.11 157.75 18.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.775 -0.648 . . . . 1.12 109.891 178.926 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 45.1 85.42 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 121.716 0.769 . . . . 0.65 109.809 -176.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.0 Cg_endo -76.4 -83.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.246 2.631 . . . . 0.88 113.215 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.3 mt-10 -78.54 128.14 33.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.894 -0.722 . . . . 2.06 109.501 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.502 ' CG ' HD11 ' A' ' 29' ' ' ILE . 39.4 tp10 -143.6 156.18 44.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.91 1.078 . . . . 1.71 113.91 -177.317 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 45.0 mtm -137.26 118.24 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.285 -1.325 . . . . 1.86 107.865 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.986 HD13 HG23 ' A' ' 133' ' ' ILE . 5.2 mp -120.03 120.05 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.39 111.894 -177.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 136' ' ' VAL . 51.7 mp0 -105.72 128.53 53.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.821 -0.627 . . . . 1.19 110.939 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB3' HD11 ' A' ' 110' ' ' LEU . 20.9 tptm -141.45 154.73 45.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.854 0.359 . . . . 2.52 111.151 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.681 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . . . -76.65 143.63 40.01 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.615 0.598 . . . . 0.39 112.615 -179.041 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.901 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 75.0 mttt -47.86 143.76 3.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.593 -0.731 . . . . 2.35 112.604 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.36 -23.64 1.48 Allowed Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.31 113.719 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 32' ' ' ALA . 98.7 mt-10 -79.99 159.97 26.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.338 -0.616 . . . . 2.11 109.338 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 55.9 m -86.91 126.31 34.6 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.12 -0.632 . . . . 0.33 110.984 -179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -96.74 118.54 33.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.185 0.516 . . . . 0.26 110.307 179.144 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 94' ' ' THR . 9.9 t80 -79.17 120.53 23.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.887 -0.597 . . . . 1.43 111.932 -178.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.722 ' HB2' HD12 ' A' ' 105' ' ' ILE . 35.7 mt -105.75 104.77 50.34 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 108.428 -0.952 . . . . 0.8 108.428 177.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.8 Cg_endo -82.31 127.49 5.21 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.363 2.042 . . . . 0.42 114.345 -177.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.0 t -141.2 129.98 22.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.072 -0.967 . . . . 1.03 108.859 178.011 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.61 ' O ' HG22 ' A' ' 22' ' ' ILE . 33.3 ttpt -140.73 150.12 43.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.708 -0.678 . . . . 1.66 110.634 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.837 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -139.95 140.42 36.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.897 -178.033 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 138.31 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.694 -0.684 . . . . 1.33 110.507 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.0 107.84 19.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 2.12 111.34 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 19' ' ' GLY . 57.6 m -83.34 148.23 55.24 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 109.355 -0.609 . . . . 1.75 109.355 178.314 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -42.36 -46.75 7.57 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 121.984 1.789 . . . . 1.61 111.594 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 85.6 tt0 -75.94 -38.49 57.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.652 -0.704 . . . . 2.18 110.971 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 13.9 t0 -70.96 80.03 0.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.303 0.573 . . . . 2.41 110.441 -179.439 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -137.25 33.75 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.19 -0.914 . . . . 1.64 111.022 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -97.12 -171.32 33.8 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.541 -0.838 . . . . 0.55 112.717 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.66 113.03 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.644 2.229 . . . . 0.85 111.861 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 47.9 tp -78.7 118.54 20.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.9 111.566 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -134.55 102.95 5.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.524 0.678 . . . . 1.78 111.371 179.08 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.846 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 3.7 mt -96.06 110.01 23.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.75 110.809 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' CB ' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -102.56 117.99 35.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.129 0.788 . . . . 1.67 113.129 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.905 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -93.88 121.7 35.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.22 109.882 176.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.1 mt -106.65 129.94 54.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.035 -0.357 . . . . 0.41 110.035 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.786 HD12 HD11 ' A' ' 87' ' ' LEU . 3.9 tt -119.96 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.203 0.816 . . . . 0.78 113.203 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.538 ' HA ' ' C ' ' A' ' 67' ' ' VAL . 5.4 t -108.11 104.5 53.82 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 108.842 -0.799 . . . . 1.25 108.842 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.701 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 80.6 Cg_endo -78.85 112.74 3.16 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.304 2.003 . . . . 0.53 111.952 -179.107 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.01 87.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.435 -0.802 . . . . 0.41 111.082 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.78 -39.99 63.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.84 -0.618 . . . . 1.82 111.555 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 28.0 m120 -85.28 162.84 18.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.18 0.514 . . . . 1.94 111.942 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.18 -18.05 63.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.4 -0.818 . . . . 1.66 111.942 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -69.46 170.03 11.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.877 -0.601 . . . . 1.74 111.967 -177.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 59' ' ' ILE . 1.3 t -133.47 -154.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 107.753 -1.203 . . . . 0.97 107.753 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 67' ' ' VAL . 78.4 m-20 -67.54 64.54 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.73 0.776 . . . . 1.77 111.564 -177.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -85.76 157.19 20.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.425 -1.261 . . . . 1.96 109.508 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.5 t -66.27 131.4 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.398 -0.521 . . . . 0.77 109.652 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.077 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.56 -50.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.652 0.612 . . . . 1.15 112.652 -176.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.777 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.01 123.1 17.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.067 -0.716 . . . . 0.29 109.067 179.642 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' CB ' ' A' ' 56' ' ' GLU . 7.9 tt -140.0 160.99 38.68 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.793 -0.639 . . . . 1.3 110.156 -177.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.631 ' CD1' HG23 ' A' ' 79' ' ' ILE . 10.2 t80 -135.61 111.64 9.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.997 0.427 . . . . 1.3 110.155 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 6.7 t -142.46 159.98 41.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.89 111.441 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.17 36.2 51.61 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.63 -0.795 . . . . 0.57 111.941 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t0 62.94 22.35 13.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.956 0.408 . . . . 1.46 110.397 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 22.5 mttm -120.68 110.3 16.24 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.922 -0.581 . . . . 2.41 110.677 178.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -80.13 117.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.1 -1.444 . . . . 1.66 107.1 177.313 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.3 m-85 -99.96 136.47 39.83 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.976 -1.011 . . . . 1.25 110.526 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.3 p-10 -166.26 -56.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.402 -0.962 . . . . 1.2 108.402 -179.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' OD1' ' CD2' ' A' ' 83' ' ' TYR . 25.6 p-10 -78.77 -24.01 44.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 2.17 109.787 177.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 80' ' ' TYR . 16.4 m-85 -77.19 -29.17 54.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.285 -1.006 . . . . 5.05 108.285 178.378 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -82.18 115.9 60.38 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-N 114.985 -1.007 . . . . 1.29 110.644 179.368 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.3 -43.95 16.51 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.739 1.626 . . . . 0.79 111.046 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 71' ' ' ILE . 16.6 m-20 -66.93 106.7 1.99 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.106 -0.638 . . . . 1.36 110.808 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.846 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 67.64 22.4 9.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.926 1.084 . . . . 1.62 113.926 178.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 42.6 pttt -54.81 128.75 34.41 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.81 -0.756 . . . . 2.39 111.089 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.35 13.61 55.46 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.344 -0.931 . . . . 0.37 114.422 178.366 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.7 ptp85 -143.63 -48.98 0.3 Allowed 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 114.584 1.327 . . . . 1.59 114.584 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.077 HG11 HD11 ' A' ' 71' ' ' ILE . 5.7 p -80.76 81.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 107.232 -1.395 . . . . 0.2 107.232 -178.299 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.593 ' C ' HG22 ' A' ' 105' ' ' ILE . 6.9 m-70 -100.6 132.89 45.75 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.277 -2.238 . . . . 0.29 112.191 -175.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 1.118 ' CD1' HG23 ' A' ' 105' ' ' ILE . 74.6 m-85 -73.8 120.01 18.81 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-O 121.254 0.55 . . . . 1.23 109.884 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.467 HG21 ' CE2' ' A' ' 38' ' ' TYR . 32.3 p -74.8 -6.14 47.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.46 110.428 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.3 m -90.4 120.17 31.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 1.2 110.754 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -89.93 1.58 56.07 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.299 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -146.16 68.51 1.19 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.751 -0.833 . . . . 2.14 108.751 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 4.3 mp -59.66 -38.38 81.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.962 -1.017 . . . . 1.49 111.696 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -61.62 -6.23 2.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.204 0.526 . . . . 2.04 112.071 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m -86.63 -4.64 59.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.393 -0.821 . . . . 1.4 110.643 178.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.55 -22.7 14.63 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.771 -0.728 . . . . 0.38 113.254 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.4 m-20 -93.7 107.19 19.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.132 0.466 . . . . 1.44 110.489 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -113.9 22.11 14.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.657 0.614 . . . . 0.43 112.657 -178.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.1 m -59.99 148.18 36.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.521 1.675 . . . . 1.04 115.521 -178.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.118 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -132.28 134.31 59.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 114.494 -1.23 . . . . 0.31 111.108 179.199 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.2 p-10 -107.06 150.37 26.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.766 -0.828 . . . . 1.15 108.766 177.516 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.35 121.59 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 120.902 0.382 . . . . 0.27 110.915 -178.938 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.48 144.36 28.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.703 -0.681 . . . . 0.29 111.432 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 54.17 60.32 3.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.638 178.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 37' ' ' ALA . 12.2 mt -46.17 169.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.039 0.447 . . . . 1.02 111.887 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.785 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.0 tt0 -177.99 166.44 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 2.13 109.909 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 87.0 mt -59.97 -33.26 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.903 0.335 . . . . 1.7 111.903 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.9 m -73.36 -19.42 61.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.986 -0.285 . . . . 1.32 111.509 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.44 -20.77 62.06 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.571 -0.529 . . . . 1.58 109.571 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.804 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -49.98 140.33 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-N 115.704 -0.68 . . . . 0.42 111.067 178.796 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.01 153.21 5.91 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 119.71 -1.234 . . . . 0.24 113.705 179.137 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.548 HG23 ' ND1' ' A' ' 134' ' ' HIS . 84.2 m -59.42 135.71 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.298 0.481 . . . . 0.31 112.298 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.9 m-85 -121.17 131.5 54.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.186 -0.672 . . . . 1.24 109.186 177.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.9 tt0 -128.85 120.0 25.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.78 -0.368 . . . . 1.16 110.238 179.233 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.505 ' SG ' ' HG2' ' A' ' 131' ' ' LYS . 16.6 p -102.81 119.59 39.1 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.546 -0.462 . . . . 1.03 110.911 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.846 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.0 mttt -111.21 104.53 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 1.76 110.441 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.837 HG11 ' CG ' ' A' ' 43' ' ' PHE . 21.8 t -88.45 107.44 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.86 -0.422 . . . . 1.18 109.86 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 33.8 mttm -100.1 120.7 40.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.823 1.046 . . . . 1.62 113.823 -178.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 19.1 tttt -145.83 103.32 3.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.211 0.529 . . . . 2.84 109.874 177.171 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.496 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -47.95 130.6 11.89 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.322 -0.853 . . . . 0.44 113.274 -178.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.567 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.9 Cg_endo -102.73 48.72 1.91 Allowed 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 125.008 -0.83 . . . . 0.56 111.621 -0.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 103.5 0.3 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.214 -0.993 . . . . 0.48 113.138 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -92.93 151.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.338 -0.931 . . . . 1.22 109.995 177.918 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -145.63 144.08 30.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.182 -0.463 . . . . 0.57 111.867 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.569 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 50.5 p-10 -147.16 146.66 29.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.559 0.577 . . . . 2.03 112.559 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -144.5 164.67 30.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.395 -0.366 . . . . 2.95 111.299 179.483 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 94.5 mttt -99.68 140.0 34.52 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 113.031 0.752 . . . . 2.26 113.031 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.986 HG23 HD13 ' A' ' 29' ' ' ILE . 71.9 mt -141.08 110.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.939 -1.028 . . . . 0.28 109.248 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.548 ' ND1' HG23 ' A' ' 117' ' ' THR . 5.2 m-70 -100.02 119.98 39.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.55 111.052 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.498 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.3 tm? -89.53 125.54 35.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.933 -0.576 . . . . 1.52 111.42 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 46.9 t -119.95 130.0 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.32 109.496 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.804 HG23 HG13 ' A' ' 115' ' ' ILE . 25.3 t -100.22 122.88 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.156 0.428 . . . . 1.08 112.156 -178.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 72.7 mt -83.5 159.99 21.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.982 -0.554 . . . . 0.52 109.614 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t -72.98 140.77 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 1.48 111.939 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.901 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 4.0 mmtt -161.31 175.88 2.82 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.67 -1.15 . . . . 2.2 109.783 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.64 ' O ' ' O ' ' A' ' 140' ' ' LYS . 4.2 Cg_endo -44.86 -144.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.252 2.635 . . . . 1.31 113.173 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 141' ' ' PRO . 66.5 m -31.8 -44.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.52 0.563 . . . . 2.31 112.52 -179.002 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 33' ' ' LYS . . . 125.14 -57.42 0.68 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.402 -0.904 . . . . 2.52 113.555 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.262 -0.875 . . . . 2.6 110.989 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 22' ' ' ILE . 74.4 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.009 0.433 . . . . 1.8400000000000001 110.631 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 ' HB1' ' A' ' 129' ' ' ALA . 4.6 mt -141.91 138.76 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 2.1499999999999999 110.928 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 21.5 p -93.6 147.86 22.62 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.339 0.59 . . . . 1.1200000000000001 110.714 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.12 82.88 0.22 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.04 -0.982 . . . . 0.65000000000000002 111.8 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 48.3 Cg_endo -78.36 -73.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.706 2.937 . . . . 0.88 112.012 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.48 127.63 32.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.412 -0.959 . . . . 2.0600000000000001 108.412 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.947 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.2 tt0 -143.77 158.34 43.75 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.015 1.117 . . . . 1.71 114.015 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.533 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.41 122.88 17.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.561 -1.199 . . . . 1.8600000000000001 109.031 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.947 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.8 mm -120.01 126.57 75.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.39000000000000001 111.527 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.73 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 87.1 mt-10 -119.19 125.18 48.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.434 . . . . 1.1899999999999999 110.334 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.8 mmtt -141.8 160.02 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 2.52 111.309 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.33 137.56 39.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.39000000000000001 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.68 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 31.2 ttpt -46.59 139.95 4.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.3500000000000001 111.674 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.4 -23.2 7.51 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 116.059 -0.519 . . . . 0.31 113.024 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.581 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.5 mt-10 -80.92 160.0 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.594 -0.521 . . . . 2.1099999999999999 109.594 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.7 m -84.49 130.22 34.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.104 -0.638 . . . . 0.33000000000000002 110.583 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -99.72 113.43 25.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.26000000000000001 110.441 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.35 129.92 34.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 1.4299999999999999 112.24 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.705 HD22 HG21 ' A' ' 133' ' ' ILE . 14.3 mt -121.42 104.33 40.4 Favored Pre-proline 0 CA--C 1.528 0.121 0 N-CA-C 109.132 -0.692 . . . . 0.80000000000000004 109.132 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 92.7 Cg_endo -84.25 134.03 5.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.546 2.164 . . . . 0.41999999999999998 114.889 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.676 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 57.3 m -141.59 112.55 7.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.171 -0.922 . . . . 1.03 109.911 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 8.2 tptt -118.69 109.12 15.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.889 0.376 . . . . 1.6599999999999999 110.663 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.591 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 39.9 p90 -93.82 141.79 28.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.673 -0.694 . . . . 1.26 110.436 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 m -79.46 148.01 32.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 1.3300000000000001 111.238 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.36 144.33 39.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.477 -0.783 . . . . 2.1200000000000001 111.406 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 83.5 p -159.34 145.3 12.08 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.804 -0.634 . . . . 1.75 110.08 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.3 Cg_exo -45.45 -21.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.495 2.13 . . . . 1.6100000000000001 113.107 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 52.6 tp10 -73.67 -38.26 65.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.617 -0.265 . . . . 2.1800000000000002 111.471 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 46' ' ' SER . 51.0 p-10 -65.79 73.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.641 0.734 . . . . 2.4100000000000001 110.753 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 76.8 mm-40 -90.79 -10.02 44.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.308 -0.86 . . . . 1.6399999999999999 111.795 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.941 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -75.57 154.78 46.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.17 -1.014 . . . . 0.55000000000000004 112.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.63 149.0 25.78 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.205 1.937 . . . . 0.84999999999999998 111.578 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.52 131.05 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 1.8999999999999999 110.235 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 19.1 t0 -140.05 150.82 44.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.432 0.634 . . . . 1.78 111.417 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 51.0 mt -141.96 139.99 30.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.919 -1.037 . . . . 0.75 109.747 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.744 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 85.9 tt0 -139.98 148.0 41.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.007 0.432 . . . . 1.6699999999999999 111.835 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.953 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.6 m95 -141.04 119.27 12.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.22 111.004 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.591 HD21 HG22 ' A' ' 70' ' ' VAL . 83.5 mt -110.06 146.3 35.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.40999999999999998 109.192 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.753 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 6.9 tt -129.91 135.59 60.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.685 0.624 . . . . 0.78000000000000003 112.685 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 m -121.52 102.94 41.75 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.26 -0.882 . . . . 1.25 108.646 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 7.1 Cg_exo -78.09 114.09 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.518 2.145 . . . . 0.53000000000000003 112.619 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.98 87.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.101 -0.954 . . . . 0.40999999999999998 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.42 -40.05 62.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 1.8200000000000001 111.253 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 1.2 t30 -85.04 159.77 20.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.227 0.537 . . . . 1.9399999999999999 111.813 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.81 -16.39 63.77 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.343 -0.844 . . . . 1.6599999999999999 111.576 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 93.8 mttt -69.6 151.73 45.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 1.74 111.848 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.12 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-O 121.751 0.786 . . . . 0.96999999999999997 109.496 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 55.66 85.18 0.07 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.276 -1.329 . . . . 1.77 112.304 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -140.04 144.14 36.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.424 . . . . 1.96 111.124 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD21 ' A' ' 58' ' ' LEU . 61.2 t -70.83 131.9 33.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.902 -0.59 . . . . 0.77000000000000002 111.33 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.896 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -130.79 -41.38 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.187 0.44 . . . . 1.1499999999999999 112.187 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.884 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.4 129.89 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.373 0.606 . . . . 0.28999999999999998 110.064 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 160.97 38.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.255 -0.884 . . . . 1.3 109.684 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 24.0 t80 -138.54 103.28 4.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -143.65 153.66 42.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.502 -0.317 . . . . 0.89000000000000001 111.8 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' ASP . . . 58.43 29.49 63.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.624 -0.798 . . . . 0.56999999999999995 111.685 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 10.1 m-20 69.86 4.52 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.619 0.247 . . . . 1.46 111.088 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 97.3 mttt -99.98 112.68 24.95 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.611 -0.514 . . . . 2.4100000000000001 109.611 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -84.28 116.47 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 108.057 -1.09 . . . . 1.6599999999999999 108.057 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.7 m-85 -100.33 126.28 46.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.439 -1.709 . . . . 1.25 110.78 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.87 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.5 p-10 -165.98 -53.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.526 -1.286 . . . . 1.2 107.526 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.0 p-10 -82.93 -26.93 30.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.147 -0.933 . . . . 2.1699999999999999 109.749 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CD1' ' OD1' ' A' ' 82' ' ' ASP . 36.1 m-85 -75.57 -28.58 59.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.4 -1.333 . . . . 5.0499999999999998 107.4 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -83.16 113.19 44.4 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 114.158 -1.383 . . . . 1.29 110.329 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.7 -42.94 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.615 1.544 . . . . 0.79000000000000004 111.226 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.811 ' HB3' HG22 ' A' ' 71' ' ' ILE . 74.6 m-20 -67.99 104.6 1.78 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.012 -0.54 . . . . 1.3600000000000001 111.235 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 32.4 mt 71.27 24.4 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.306 -0.861 . . . . 1.6200000000000001 113.221 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.7 pttt -58.14 135.61 57.08 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.901 -0.499 . . . . 2.3900000000000001 111.63 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.483 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.35 11.31 75.64 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.536 -0.84 . . . . 0.37 114.398 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.6 ptp180 -138.99 -50.97 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.678 1.362 . . . . 1.5900000000000001 114.678 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.896 HG11 ' CD1' ' A' ' 71' ' ' ILE . 7.6 p -78.96 81.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.847 1.308 . . . . 0.20000000000000001 107.53 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 10.6 m80 -102.88 131.55 49.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.451 -2.159 . . . . 0.28999999999999998 112.401 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.142 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.6 m-85 -73.59 120.2 18.86 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 120.024 -0.67 . . . . 1.23 109.312 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 38' ' ' TYR . 18.0 p -70.09 -9.17 54.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.923 -1.035 . . . . 0.46000000000000002 110.807 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 5.3 m -88.32 118.53 28.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.941 -0.572 . . . . 1.2 110.887 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -90.09 0.18 57.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.244 0.545 . . . . 2.2200000000000002 110.168 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -146.41 67.19 1.18 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.487 -0.931 . . . . 2.1400000000000001 108.487 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.594 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.5 mp -57.77 -27.76 63.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.25 -0.886 . . . . 1.49 112.149 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -63.45 -5.04 3.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.187 0.518 . . . . 2.04 112.115 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.6 p -89.85 -0.04 57.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.41 -0.814 . . . . 1.3999999999999999 110.975 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.591 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.21 0.6 38.26 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.645 -0.788 . . . . 0.38 113.218 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.512 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 92.3 m-20 -99.94 118.65 36.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 111.002 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -118.5 10.39 12.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.42999999999999999 111.651 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -60.03 140.43 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.122 1.897 . . . . 1.04 116.122 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.142 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.82 134.61 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 114.543 -1.208 . . . . 0.31 110.486 177.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.3 p-10 -108.88 151.08 26.75 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.673 -0.862 . . . . 1.1499999999999999 108.673 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.78 120.13 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.0 0.429 . . . . 0.27000000000000002 110.903 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -83.9 144.89 28.91 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.506 -0.77 . . . . 0.28999999999999998 111.094 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.82 61.77 3.04 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.963 -0.562 . . . . 1.52 112.328 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.45 176.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.218 0.451 . . . . 1.02 112.218 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.745 ' O ' HG21 ' A' ' 137' ' ' VAL . 62.3 tt0 -176.32 159.99 2.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 2.1299999999999999 110.616 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 95.0 mt -59.93 -40.07 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.525 . . . . 1.7 112.416 -178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.3 m -74.56 -13.98 60.74 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.1 -0.24 . . . . 1.3200000000000001 111.372 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.62 -22.37 62.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 1.5800000000000001 109.271 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.58 HG13 HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.53 144.9 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 115.641 -0.709 . . . . 0.41999999999999998 110.74 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.62 148.79 5.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.234 -0.984 . . . . 0.23999999999999999 113.268 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.887 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.1 m -59.07 135.89 57.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.431 . . . . 0.31 111.771 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.753 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.5 m-85 -116.18 139.99 49.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 1.24 109.867 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.753 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 54.7 tt0 -117.88 117.53 29.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.035 -0.357 . . . . 1.1599999999999999 110.035 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.545 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 18.0 t -100.0 109.62 21.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.101 -0.5 . . . . 1.03 110.687 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 54.4 mtpt -121.35 111.48 17.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 1.76 111.895 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 t -96.28 110.16 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.483 -0.562 . . . . 1.1799999999999999 109.483 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 29.0 tttt -95.02 114.93 26.79 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.879 -0.728 . . . . 1.6200000000000001 112.767 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.99 102.66 3.67 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.262 -0.644 . . . . 2.8399999999999999 109.262 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.941 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.07 133.51 22.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.44 112.29 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 58.6 Cg_endo -101.61 50.04 1.71 Allowed 'Cis proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.745 -0.939 . . . . 0.56000000000000005 111.138 -0.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.98 103.06 0.29 Allowed Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.062 -1.066 . . . . 0.47999999999999998 113.29 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -88.41 119.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.203 -0.999 . . . . 1.22 109.761 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -100.01 140.48 34.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.681 -0.236 . . . . 0.56999999999999995 111.601 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -146.07 131.72 18.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.483 -0.326 . . . . 2.0299999999999998 111.244 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.676 ' HZ3' ' HA ' ' A' ' 41' ' ' CYS . 5.0 ptmt -145.25 158.5 43.81 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.344 -0.389 . . . . 2.9500000000000002 110.676 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.578 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 96.7 mttt -102.79 140.02 37.61 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.065 0.765 . . . . 2.2599999999999998 113.065 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.831 HD13 ' CH2' ' A' ' 57' ' ' TRP . 2.4 mp -141.32 116.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.349 -0.841 . . . . 0.28000000000000003 108.895 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.887 ' CD2' HG23 ' A' ' 117' ' ' THR . 54.0 m170 -101.44 120.04 39.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.55000000000000004 110.845 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.425 HD21 ' CD2' ' A' ' 110' ' ' LEU . 60.8 tp -88.77 121.26 30.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 1.52 111.623 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.8 t -120.0 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.763 -0.653 . . . . 0.32000000000000001 109.513 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG21 ' O ' ' A' ' 111' ' ' GLN . 25.9 t -100.97 125.94 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 1.0800000000000001 112.156 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.26 155.25 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.835 -0.62 . . . . 0.52000000000000002 109.403 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 1.48 111.654 -178.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.942 0.401 . . . . 1.8400000000000001 111.06 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.587 HD13 ' HB1' ' A' ' 129' ' ' ALA . 6.5 pt -99.18 144.89 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 2.1499999999999999 111.182 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.41 159.54 18.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.466 0.65 . . . . 1.1200000000000001 111.614 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.638 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER 41.75 83.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.724 -1.125 . . . . 0.65000000000000002 111.899 -178.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.2 Cg_endo -78.72 -78.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.547 2.832 . . . . 0.88 112.867 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.1 mt-10 -78.96 128.6 33.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.871 -0.418 . . . . 2.0600000000000001 109.871 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.583 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 49.7 tt0 -144.45 159.96 41.87 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.212 1.19 . . . . 1.71 114.212 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' ILE . 31.2 mtt -137.73 117.85 13.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.626 -1.17 . . . . 1.8600000000000001 108.847 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.988 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -119.97 120.6 63.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.371 0.508 . . . . 0.39000000000000001 112.371 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 96.5 mt-10 -106.87 126.25 52.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.059 -0.519 . . . . 1.1899999999999999 109.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 110' ' ' LEU . 27.7 tptt -141.79 150.07 41.23 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.795 -0.362 . . . . 2.52 111.486 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.62 140.26 40.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.39000000000000001 112.134 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 97.6 mttt -44.98 153.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.654 0.613 . . . . 2.3500000000000001 112.654 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.09 -28.53 0.54 Allowed Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.139 -0.937 . . . . 0.31 113.636 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.62 160.07 26.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.236 -0.653 . . . . 2.1099999999999999 109.236 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 79.7 m -85.89 129.87 34.71 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.066 -0.654 . . . . 0.33000000000000002 110.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.83 117.8 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.509 . . . . 0.26000000000000001 110.243 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 94' ' ' THR . 17.6 t80 -79.32 121.11 24.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.722 -0.672 . . . . 1.4299999999999999 112.631 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.843 ' HB2' HD12 ' A' ' 105' ' ' ILE . 22.9 mt -104.29 104.8 46.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.457 -0.942 . . . . 0.80000000000000004 108.457 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.624 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 95.7 Cg_endo -82.95 129.72 5.48 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.235 1.957 . . . . 0.41999999999999998 114.202 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 3.8 t -140.64 134.4 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.183 -1.043 . . . . 1.03 108.183 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' O ' HG22 ' A' ' 22' ' ' ILE . 43.8 mmtm -140.28 143.86 36.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.826 -0.35 . . . . 1.6599999999999999 111.349 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.766 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 47.3 p90 -140.56 140.71 35.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.26 111.26 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -81.88 140.21 34.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.906 -0.588 . . . . 1.3300000000000001 111.899 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.589 HD21 ' HE2' ' A' ' 43' ' ' PHE . 86.1 mt -101.61 141.97 33.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.762 -0.653 . . . . 2.1200000000000001 110.997 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 44.7 m -154.93 154.49 29.03 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 1.75 110.242 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 11.7 Cg_endo -55.42 -21.33 29.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.603 2.202 . . . . 1.6100000000000001 112.909 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.3 tt0 -76.18 -41.49 49.44 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 120.942 -0.303 . . . . 2.1800000000000002 110.952 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -71.48 74.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.357 -0.537 . . . . 2.4100000000000001 109.943 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 62.6 mm-40 -91.38 -8.02 49.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.801 . . . . 1.6399999999999999 111.892 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.938 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.32 159.89 53.54 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.067 -1.064 . . . . 0.55000000000000004 112.259 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 144.04 59.56 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.132 1.888 . . . . 0.84999999999999998 111.348 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.766 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 9.7 tt -77.61 123.66 26.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 1.8999999999999999 110.663 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.2 m-20 -129.46 148.21 51.34 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.508 0.67 . . . . 1.78 111.223 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.807 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 24.3 mt -142.88 141.87 26.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.491 -1.232 . . . . 0.75 109.248 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 40.9 mt-10 -139.97 151.41 45.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.015 -0.274 . . . . 1.6699999999999999 110.953 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.979 ' CD2' HD11 ' A' ' 105' ' ' ILE . 87.4 m95 -140.49 116.12 10.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.22 110.588 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.3 mt -106.31 146.26 30.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.40999999999999998 109.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.568 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.062 0.458 . . . . 0.78000000000000003 111.923 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.454 ' OG ' HG12 ' A' ' 67' ' ' VAL . 28.4 t -115.64 102.88 54.24 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 108.916 -0.772 . . . . 1.25 108.916 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 66' ' ' LYS . 72.4 Cg_endo -78.76 110.29 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.629 2.219 . . . . 0.53000000000000003 112.81 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.79 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.15 -0.932 . . . . 0.40999999999999998 110.901 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 20.1 p-10 -88.24 20.41 3.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 1.8200000000000001 111.642 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -151.46 160.02 43.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.245 0.545 . . . . 1.9399999999999999 111.858 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -68.4 -20.01 64.65 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.394 -0.821 . . . . 1.6599999999999999 112.231 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.609 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 59.4 mttp -67.86 154.19 42.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.945 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.454 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.78 135.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-O 122.751 1.262 . . . . 0.96999999999999997 110.78 178.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 39.98 46.31 1.74 Allowed 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.251 -2.25 . . . . 1.77 113.481 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.33 143.28 26.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.996 -0.282 . . . . 1.96 110.98 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 HD21 ' A' ' 58' ' ' LEU . 94.9 t -68.35 130.03 33.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.77000000000000002 110.525 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.905 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -128.61 -37.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 1.1499999999999999 112.014 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.98 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.67 125.62 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.928 -0.767 . . . . 0.28999999999999998 108.928 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.74 158.29 44.18 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.556 -0.747 . . . . 1.3 110.695 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 14.6 t80 -133.25 103.81 6.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.146 -0.687 . . . . 1.3 109.146 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.444 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 23.5 m -142.74 159.11 42.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.784 0.326 . . . . 0.89000000000000001 111.666 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.19 27.55 23.85 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.797 -0.716 . . . . 0.56999999999999995 112.462 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 74.12 1.83 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.54 0.21 . . . . 1.46 110.989 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.9 mttm -100.01 114.1 27.17 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.954 -0.388 . . . . 2.4100000000000001 109.954 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.24 126.87 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 C-N-CA 118.658 -1.217 . . . . 1.6599999999999999 107.82 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.703 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -111.02 128.06 55.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.635 -1.62 . . . . 1.25 110.631 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.868 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.7 p-10 -166.17 -56.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.081 -1.451 . . . . 1.2 107.081 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.9 t70 -83.09 -26.02 31.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.702 -1.135 . . . . 2.1699999999999999 109.188 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -75.87 -30.2 58.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.921 -1.14 . . . . 5.0499999999999998 107.921 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.55 110.58 22.82 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 114.402 -1.272 . . . . 1.29 110.166 178.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.73 -41.69 11.55 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.67 1.58 . . . . 0.79000000000000004 111.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.818 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.1 m-20 -68.06 104.2 1.71 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.83 -0.623 . . . . 1.3600000000000001 111.188 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.816 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.2 mt 71.74 20.75 4.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.21 0.819 . . . . 1.6200000000000001 113.21 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.868 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.8 pttt -56.23 131.99 49.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.883 -0.511 . . . . 2.3900000000000001 111.269 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.433 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 92.07 10.82 60.74 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.186 -1.007 . . . . 0.37 114.247 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -142.02 -49.26 0.38 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 114.862 1.43 . . . . 1.5900000000000001 114.862 -178.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.98 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.61 81.45 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 CA-C-O 123.339 1.542 . . . . 0.20000000000000001 107.128 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.498 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.6 m80 -102.05 128.9 48.31 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.044 -2.344 . . . . 0.28999999999999998 112.563 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.109 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -72.34 124.74 25.74 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.752 -0.779 . . . . 1.23 109.024 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.464 HG21 ' CD2' ' A' ' 38' ' ' TYR . 12.6 p -76.44 36.03 0.15 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.212 -0.903 . . . . 0.46000000000000002 112.062 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -148.68 133.33 17.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.91 0.386 . . . . 1.2 110.848 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -90.07 5.23 47.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 2.2200000000000002 110.2 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -146.16 65.74 1.2 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.704 -0.68 . . . . 2.1400000000000001 109.429 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.849 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.1 mp -57.32 -29.12 63.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 1.49 110.866 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.5 mttt -65.8 1.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.35 0.5 . . . . 2.04 112.35 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 m -89.99 -0.0 57.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.688 -0.687 . . . . 1.3999999999999999 111.244 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 110.51 -11.02 30.64 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.805 -0.712 . . . . 0.38 113.022 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -100.09 112.69 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 111.135 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -109.65 12.75 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.42999999999999999 111.681 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 21.1 m -60.07 139.15 57.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.459 1.651 . . . . 1.04 115.459 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.109 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.38 130.03 65.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-N 114.347 -1.297 . . . . 0.31 110.735 178.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.629 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.6 p-10 -104.4 146.62 28.58 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.672 -0.862 . . . . 1.1499999999999999 108.672 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.82 121.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.008 0.432 . . . . 0.27000000000000002 110.808 -178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -83.79 145.22 28.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.445 -0.798 . . . . 0.28999999999999998 111.176 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 54.12 63.73 2.07 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.081 -0.509 . . . . 1.52 112.169 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 31' ' ' LYS . 4.5 mt -45.03 175.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.198 0.523 . . . . 1.02 112.299 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.748 ' O ' HG21 ' A' ' 137' ' ' VAL . 14.8 pt20 -177.02 156.83 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 2.1299999999999999 110.888 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 60.5 tp -60.04 -39.71 86.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 1.7 112.11 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.487 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 4.8 t -72.46 -16.11 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.998 0.74 . . . . 1.3200000000000001 112.998 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.2 p30 -74.38 -16.05 60.91 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.888 -0.725 . . . . 1.5800000000000001 109.791 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.839 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -45.17 141.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.41999999999999998 110.185 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 154.05 6.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 119.717 -1.23 . . . . 0.23999999999999999 113.88 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.738 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.88 137.73 57.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.933 -0.633 . . . . 0.31 112.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.6 m-85 -119.97 139.7 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.324 -0.621 . . . . 1.24 109.324 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.1 tt0 -128.39 121.89 30.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.706 0.288 . . . . 1.1599999999999999 110.893 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 56' ' ' GLU . 43.5 t -99.96 117.79 35.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.03 110.632 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 23.0 mttm -115.0 106.1 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.801 -0.359 . . . . 1.76 110.56 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 34.3 t -94.87 105.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.649 -0.5 . . . . 1.1799999999999999 109.649 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.7 tttt -95.27 119.35 33.63 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.898 -0.721 . . . . 1.6200000000000001 112.603 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.526 ' HG2' ' HB2' ' A' ' 49' ' ' ASP . 6.6 ttpm? -146.25 102.98 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 2.8399999999999999 110.111 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.938 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.33 133.25 24.9 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 53.5 Cg_endo -100.68 47.26 2.19 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.742 -0.941 . . . . 0.56000000000000005 111.434 -0.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.94 103.33 0.28 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.146 -1.026 . . . . 0.47999999999999998 113.579 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.73 151.46 3.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -0.811 . . . . 1.22 108.887 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -141.44 151.32 43.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.412 0.523 . . . . 0.56999999999999995 112.412 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 129' ' ' ALA . 1.8 m120 -145.8 141.18 27.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.925 -0.58 . . . . 2.0299999999999998 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.638 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.26 156.31 43.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.689 -0.232 . . . . 2.9500000000000002 110.645 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.3 mttm -101.34 140.53 35.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.631 0.975 . . . . 2.2599999999999998 113.631 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.988 HG23 HD13 ' A' ' 29' ' ' ILE . 33.3 mt -141.96 111.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.28000000000000003 109.233 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.738 ' CD2' HG23 ' A' ' 117' ' ' THR . 41.7 m170 -100.04 118.71 37.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.727 -0.389 . . . . 0.55000000000000004 110.647 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.658 HD11 HD21 ' A' ' 39' ' ' LEU . 10.2 mt -92.94 125.39 37.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.267 0.556 . . . . 1.52 112.035 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.669 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 57.8 t -115.64 123.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.314 -0.857 . . . . 0.32000000000000001 109.109 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.839 HG23 HG13 ' A' ' 115' ' ' ILE . 21.6 t -94.6 120.03 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.062 0.458 . . . . 1.0800000000000001 111.929 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.16 158.63 18.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.52000000000000002 110.505 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.225 0.536 . . . . 1.48 111.057 -179.796 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 1.8400000000000001 111.08 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.87 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 14.9 tt -142.82 147.75 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.596 -0.729 . . . . 2.1499999999999999 110.986 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 53.6 p -88.86 146.3 25.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.28 0.562 . . . . 1.1200000000000001 110.998 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 40.28 82.52 0.22 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.868 -1.06 . . . . 0.65000000000000002 111.384 -178.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.6 Cg_endo -78.15 -11.17 16.34 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 124.008 3.139 . . . . 0.88 113.127 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.56 121.8 13.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.592 -0.892 . . . . 2.0600000000000001 108.592 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.899 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.1 tt0 -143.81 158.99 43.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.765 1.024 . . . . 1.71 113.765 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 29' ' ' ILE . 56.3 ttm -138.52 135.05 34.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.692 -1.14 . . . . 1.8600000000000001 109.138 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.899 HD11 ' OE2' ' A' ' 27' ' ' GLU . 31.9 mm -133.79 139.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.39000000000000001 111.925 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.2 mt-10 -132.61 122.23 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 1.1899999999999999 109.544 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 11.6 tptm -142.1 161.52 37.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.74 -0.384 . . . . 2.52 111.119 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.17 131.69 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.39000000000000001 111.573 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 137' ' ' VAL . 27.7 ttmt -44.89 132.04 6.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.767 -0.651 . . . . 2.3500000000000001 111.345 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.94 -16.56 56.65 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.056 -0.592 . . . . 0.31 112.504 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 66.4 mm-40 -80.32 159.97 25.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.009 -0.737 . . . . 2.1099999999999999 109.009 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.979 HG22 ' OD1' ' A' ' 106' ' ' ASN . 10.1 m -90.84 121.69 32.91 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.001 -0.68 . . . . 0.33000000000000002 110.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.53 119.73 38.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.146 0.498 . . . . 0.26000000000000001 111.451 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.7 t80 -79.24 116.38 19.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 1.4299999999999999 111.638 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.721 HD12 HD12 ' A' ' 105' ' ' ILE . 15.4 mt -99.96 105.05 32.66 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.935 -0.765 . . . . 0.80000000000000004 108.935 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.786 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.0 Cg_endo -82.31 124.92 4.37 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.424 2.083 . . . . 0.41999999999999998 114.09 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.9 t -141.16 132.71 27.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 1.03 109.473 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.579 ' O ' HG13 ' A' ' 22' ' ' ILE . 41.9 mttm -141.08 153.47 45.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.28 -0.418 . . . . 1.6599999999999999 110.538 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.919 ' CE2' HD11 ' A' ' 53' ' ' LEU . 36.3 p90 -140.41 153.02 46.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.567 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -79.89 128.39 33.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 1.3300000000000001 111.299 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 45' ' ' LEU . 3.0 tm? -99.75 131.42 45.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.63 -0.713 . . . . 2.1200000000000001 110.725 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 45' ' ' LEU . 46.0 m -152.24 139.91 13.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 110.223 -0.288 . . . . 1.75 110.223 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.57 -25.69 5.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.398 2.065 . . . . 1.6100000000000001 112.344 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -39.97 67.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.345 -0.388 . . . . 2.1800000000000002 110.53 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -75.93 79.62 2.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.606 -0.887 . . . . 2.4100000000000001 108.606 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.95 -0.23 54.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 112.306 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -71.21 158.96 53.79 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.342 -0.932 . . . . 0.55000000000000004 112.719 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 123' ' ' LYS . 18.6 Cg_endo -59.93 132.5 45.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.472 2.115 . . . . 0.84999999999999998 111.376 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.919 HD11 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -78.2 104.67 8.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.444 -0.344 . . . . 1.8999999999999999 111.698 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.2 m-20 -118.3 103.56 9.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.53 0.681 . . . . 1.78 111.426 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.743 ' CD1' HG13 ' A' ' 122' ' ' VAL . 4.7 mm -89.56 104.44 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.853 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 73' ' ' LEU . 85.9 tt0 -101.73 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.3 m95 -99.99 124.39 45.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.22 110.303 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.618 HD12 ' OE1' ' A' ' 119' ' ' GLN . 92.2 mt -112.23 139.96 47.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.472 -0.566 . . . . 0.40999999999999998 109.472 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.628 HD11 ' O ' ' A' ' 114' ' ' ASP . 3.7 tt -129.59 130.05 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.994 0.426 . . . . 0.78000000000000003 111.675 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 19.6 m -114.3 102.61 54.95 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 115.799 -0.637 . . . . 1.25 109.328 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.7 Cg_exo -78.67 113.79 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.707 2.272 . . . . 0.53000000000000003 112.255 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.98 87.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.29 -0.868 . . . . 0.40999999999999998 111.283 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.73 -40.01 61.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 1.8200000000000001 111.009 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 12.5 t-20 -82.91 159.96 22.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 1.9399999999999999 111.662 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.67 -17.49 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.419 -0.81 . . . . 1.6599999999999999 111.408 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 60.8 mttp -69.76 152.66 44.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.592 -0.731 . . . . 1.74 112.113 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -156.31 126.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-O 121.829 0.823 . . . . 0.96999999999999997 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 56.47 40.04 29.74 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 1.77 111.988 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -89.14 147.71 24.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.628 -0.26 . . . . 1.96 111.158 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG11 ' OH ' ' A' ' 84' ' ' TYR . 22.4 t -67.54 139.74 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.689 -0.486 . . . . 0.77000000000000002 109.689 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 -52.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.1499999999999999 112.912 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.911 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.21 127.04 31.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.076 -0.713 . . . . 0.28999999999999998 109.076 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' HG3' ' A' ' 56' ' ' GLU . 7.4 tt -140.13 160.63 39.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 1.3 110.633 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.925 ' CD1' HD13 ' A' ' 79' ' ' ILE . 20.9 t80 -134.78 104.04 5.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.619 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.473 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 35.6 t -143.61 159.82 41.76 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.475 0.546 . . . . 0.89000000000000001 112.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.14 31.89 8.91 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.862 -0.608 . . . . 0.56999999999999995 113.155 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t0 71.07 2.57 4.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.269 . . . . 1.46 111.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 92.2 mttt -100.18 113.4 26.03 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.979 -0.378 . . . . 2.4100000000000001 109.979 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.925 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.34 128.8 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.063 -1.458 . . . . 1.6599999999999999 107.063 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.725 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -112.59 115.65 28.94 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.241 -0.89 . . . . 1.25 110.328 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.872 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.7 p-10 -166.07 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 106.799 -1.556 . . . . 1.2 106.799 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -79.67 -25.72 41.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.585 -1.189 . . . . 2.1699999999999999 108.491 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -81.32 -28.26 34.64 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.849 -1.167 . . . . 5.0499999999999998 107.849 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 2.7 m-85 -87.65 120.93 71.18 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 114.769 -1.105 . . . . 1.29 110.727 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 84' ' ' TYR . 7.7 Cg_exo -71.47 -28.67 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.033 1.822 . . . . 0.79000000000000004 112.951 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' HD23 ' A' ' 87' ' ' LEU . 28.7 t0 -49.22 -30.01 6.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.228 -0.589 . . . . 1.3600000000000001 112.06 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.946 HD22 ' HD2' ' A' ' 90' ' ' ARG . 29.9 mt -157.56 38.01 0.28 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.121 -0.945 . . . . 1.6200000000000001 110.504 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 23.9 pttm -55.81 134.09 51.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.877 -0.601 . . . . 2.3900000000000001 112.392 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.36 76.0 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.39 -0.823 . . . . 0.37 114.461 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.946 ' HD2' HD22 ' A' ' 87' ' ' LEU . 3.5 ptp180 -145.27 -48.13 0.23 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.701 1.371 . . . . 1.5900000000000001 114.701 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.911 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.22 81.47 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-O 122.992 1.377 . . . . 0.20000000000000001 108.064 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 106' ' ' ASN . 19.8 m80 -102.91 126.98 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.24 -2.254 . . . . 0.28999999999999998 112.343 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.941 ' CD1' HG23 ' A' ' 105' ' ' ILE . 80.5 m-85 -70.01 125.42 26.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 120.168 -0.613 . . . . 1.23 109.701 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.631 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.4 p -76.14 32.94 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.204 -0.907 . . . . 0.46000000000000002 112.027 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.8 m -148.46 132.51 17.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 1.2 111.216 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -91.72 4.9 51.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 2.2200000000000002 110.585 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.04 66.29 1.2 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.135 -0.691 . . . . 2.1400000000000001 109.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.558 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -57.72 -31.76 66.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.888 . . . . 1.49 111.425 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.99 2.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.291 0.478 . . . . 2.04 112.291 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 5.4 t -89.97 -0.03 57.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.761 -0.654 . . . . 1.3999999999999999 110.619 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.89 -14.01 41.28 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.055 -0.593 . . . . 0.38 112.834 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -100.02 108.03 20.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 110.853 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -111.62 19.99 17.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.104 0.409 . . . . 0.42999999999999999 112.104 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.0 m -60.04 143.78 51.11 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.006 1.484 . . . . 1.04 115.006 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.941 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -129.67 133.26 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.735 -1.12 . . . . 0.31 111.252 178.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.979 ' OD1' HG22 ' A' ' 36' ' ' THR . 2.9 t-20 -102.84 157.33 17.04 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.022 -1.103 . . . . 1.1499999999999999 108.022 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.917 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -114.81 117.38 55.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.988 0.423 . . . . 0.27000000000000002 111.456 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.832 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.03 143.01 31.85 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.48 -0.782 . . . . 0.28999999999999998 110.556 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 8.7 t-20 48.88 58.31 5.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.958 -0.565 . . . . 1.52 111.826 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.1 mt -47.27 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.754 1.02 . . . . 1.02 113.754 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.448 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 54.1 tt0 -56.58 145.57 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.983 -0.553 . . . . 2.1299999999999999 110.793 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.584 HD13 ' HE2' ' A' ' 33' ' ' LYS . 62.5 tp -60.03 -40.0 87.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 1.7 111.127 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -73.51 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 111.632 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.628 ' O ' HD11 ' A' ' 59' ' ' ILE . 95.8 m-20 -69.98 -18.08 63.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 1.5800000000000001 109.881 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.74 140.66 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.976 -0.556 . . . . 0.41999999999999998 110.235 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.8 159.14 7.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.9 -1.143 . . . . 0.23999999999999999 113.951 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.8 m -58.99 139.33 56.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.062 -0.569 . . . . 0.31 112.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 29.9 m-85 -119.98 130.87 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.514 . . . . 1.24 109.888 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.618 ' OE1' HD12 ' A' ' 58' ' ' LEU . 57.8 tt0 -122.05 119.83 32.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.148 -0.221 . . . . 1.1599999999999999 110.662 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.557 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 39.5 t -100.15 120.01 39.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.468 -0.333 . . . . 1.03 110.76 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.5 mtpt -114.14 104.83 12.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.377 . . . . 1.76 110.842 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 73.8 t -87.52 108.25 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.197 -1.038 . . . . 1.1799999999999999 108.197 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 83.4 tttt -97.78 110.87 23.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.423 0.897 . . . . 1.6200000000000001 113.423 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.748 ' HD2' HD12 ' A' ' 53' ' ' LEU . 34.8 tttp -145.61 101.56 3.58 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.545 -0.539 . . . . 2.8399999999999999 109.545 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.779 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.79 132.18 47.62 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.44 112.332 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.576 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 60.7 Cg_endo -100.62 49.76 1.75 Allowed 'Cis proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.614 -0.994 . . . . 0.56000000000000005 112.185 -0.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.99 103.3 0.29 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.303 -0.951 . . . . 0.47999999999999998 113.438 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.85 120.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.288 -0.956 . . . . 1.22 110.203 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.006 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -95.45 144.68 25.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 0.56999999999999995 111.359 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 1.4 m-80 -145.72 129.89 17.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.651 0.611 . . . . 2.0299999999999998 112.651 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.786 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.84 159.95 42.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.438 -0.346 . . . . 2.9500000000000002 110.941 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.5 mttt -110.5 146.92 35.14 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.496 0.925 . . . . 2.2599999999999998 113.496 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.748 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 88.7 mt -143.39 118.97 4.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.266 -0.879 . . . . 0.28000000000000003 109.535 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.524 ' CD2' HG23 ' A' ' 117' ' ' THR . 64.2 m170 -100.9 113.22 25.98 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.91 -0.494 . . . . 0.55000000000000004 110.406 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 110' ' ' LEU . 1.9 tm? -91.56 128.91 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.253 0.464 . . . . 1.52 112.253 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.6 t -121.53 129.96 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.689 . . . . 0.32000000000000001 109.297 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 33' ' ' LYS . 26.0 t -103.06 119.96 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.209 0.448 . . . . 1.0800000000000001 112.209 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.2 mt -84.51 172.13 11.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.52000000000000002 109.089 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.63 . . . . 1.48 111.664 -178.498 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.812 0.339 . . . . 1.8400000000000001 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 13.3 tt -130.01 129.93 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 2.1499999999999999 110.558 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -89.39 153.84 20.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.352 0.596 . . . . 1.1200000000000001 111.259 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 44.33 82.96 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.92 -1.037 . . . . 0.65000000000000002 111.004 -177.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.663 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.1 Cg_endo -78.55 -86.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.619 2.879 . . . . 0.88 113.207 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.5 tt0 -77.85 123.09 26.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.222 -0.659 . . . . 2.0600000000000001 109.222 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.8 tp10 -143.91 159.96 41.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.446 0.906 . . . . 1.71 113.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.497 ' O ' HD13 ' A' ' 29' ' ' ILE . 26.0 mtt -132.35 130.01 40.17 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.264 -0.88 . . . . 1.8600000000000001 109.918 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.606 ' HB ' HD23 ' A' ' 135' ' ' LEU . 33.2 mm -127.57 133.82 66.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.643 0.259 . . . . 0.39000000000000001 111.524 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.9 mt-10 -123.77 125.73 45.24 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.498 -0.319 . . . . 1.1899999999999999 110.842 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 110' ' ' LEU . 10.4 mmtp -142.35 160.01 41.1 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.408 . . . . 2.52 111.713 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.82 139.23 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.39000000000000001 111.522 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 112' ' ' LEU . 85.5 tttt -49.24 134.87 17.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.858 0.361 . . . . 2.3500000000000001 111.356 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.52 -21.33 22.44 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.138 -0.553 . . . . 0.31 112.776 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -79.98 159.83 26.13 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.32 -0.993 . . . . 2.1099999999999999 108.32 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.4 m -87.28 126.78 35.05 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.42 -0.912 . . . . 0.33000000000000002 110.484 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.018 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.74 117.62 33.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.26000000000000001 110.162 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.946 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 74.0 t80 -79.13 115.27 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 1.4299999999999999 112.038 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.776 HD21 HD11 ' A' ' 135' ' ' LEU . 33.9 mt -100.45 104.76 32.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.961 -0.755 . . . . 0.80000000000000004 108.961 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.683 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.6 Cg_endo -81.94 125.61 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.38 2.053 . . . . 0.41999999999999998 113.819 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.0 t -140.39 131.25 25.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.833 -1.173 . . . . 1.03 107.833 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 39.4 mttm -140.67 150.59 43.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 1.6599999999999999 111.183 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 40.6 p90 -140.35 142.04 35.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.642 -0.708 . . . . 1.26 111.133 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -82.3 135.48 35.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.989 -0.551 . . . . 1.3300000000000001 111.665 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -97.74 140.06 32.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 2.1200000000000001 111.762 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 2.8 t -159.19 143.21 11.07 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.835 -0.621 . . . . 1.75 109.814 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -41.32 -26.72 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.735 2.29 . . . . 1.6100000000000001 113.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.82 -50.58 16.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.681 0.277 . . . . 2.1800000000000002 110.53 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' CG ' ' A' ' 124' ' ' LYS . 4.4 p-10 -74.59 64.25 1.18 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.174 0.512 . . . . 2.4100000000000001 110.047 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -102.46 2.59 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.479 -0.782 . . . . 1.6399999999999999 112.556 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.34 169.53 53.11 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.231 -0.985 . . . . 0.55000000000000004 112.94 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.6 121.96 10.44 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.591 2.194 . . . . 0.84999999999999998 111.563 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.4 tt -78.29 120.62 23.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.151 -0.477 . . . . 1.8999999999999999 111.937 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 5.7 m-20 -138.05 103.45 4.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.373 0.606 . . . . 1.78 111.484 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 67.8 mt -98.94 108.45 22.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.103 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' OE2' HD21 ' A' ' 58' ' ' LEU . 85.9 tt0 -100.62 121.17 41.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.765 0.654 . . . . 1.6699999999999999 112.765 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.901 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.5 m95 -95.33 126.57 40.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.22 109.926 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 88.7 mt -112.9 141.81 46.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.702 -0.481 . . . . 0.40999999999999998 109.702 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.5 tt -129.99 129.95 65.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.036 0.446 . . . . 0.78000000000000003 111.793 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.432 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 14.3 m -120.23 102.01 46.35 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 109.015 -0.735 . . . . 1.25 109.015 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.4 Cg_exo -80.02 114.78 3.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.52 2.146 . . . . 0.53000000000000003 112.92 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.64 73.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.40999999999999998 110.714 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -86.29 17.2 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 1.8200000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.8 m-20 -149.86 163.66 37.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.265 0.555 . . . . 1.9399999999999999 111.68 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.49 -18.84 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.28 -0.873 . . . . 1.6599999999999999 112.094 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 92.0 mttt -68.51 144.79 54.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.204 -0.453 . . . . 1.74 111.798 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.67 127.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 121.837 0.827 . . . . 0.96999999999999997 109.636 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 52.88 39.93 29.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.089 -1.414 . . . . 1.77 112.046 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -91.09 145.61 24.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.521 -0.309 . . . . 1.96 110.961 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.6 t -65.91 138.94 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 108.978 -0.749 . . . . 0.77000000000000002 108.978 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -132.97 -52.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 112.577 0.584 . . . . 1.1499999999999999 112.577 -176.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.96 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.99 129.95 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.646 -0.872 . . . . 0.28999999999999998 108.646 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 55' ' ' ILE . 7.7 tp -140.41 157.51 45.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.865 0.364 . . . . 1.3 111.467 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.802 ' CD1' HD13 ' A' ' 79' ' ' ILE . 41.2 t80 -131.3 103.64 6.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 1.3 110.165 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.49 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 41.4 t -144.12 159.78 42.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.661 0.615 . . . . 0.89000000000000001 112.661 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.13 33.46 5.45 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.838 -0.619 . . . . 0.56999999999999995 113.26 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t0 70.02 3.26 4.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.604 0.24 . . . . 1.46 111.095 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 21.4 mttm -100.46 116.54 32.65 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.108 -0.331 . . . . 2.4100000000000001 110.108 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.2 mm -80.71 130.03 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.174 -1.417 . . . . 1.6599999999999999 107.174 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -117.1 121.59 41.72 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.542 -0.754 . . . . 1.25 110.822 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.5 p-10 -165.82 -52.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.324 -1.361 . . . . 1.2 107.324 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -81.38 -24.14 37.2 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.03 -0.986 . . . . 2.1699999999999999 109.31 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.93 -26.03 43.66 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.859 -1.064 . . . . 5.0499999999999998 108.139 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.672 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.8 m-85 -86.37 119.68 71.68 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 114.791 -1.095 . . . . 1.29 110.941 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.2 Cg_endo -50.78 -41.96 52.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.365 1.377 . . . . 0.79000000000000004 109.93 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' ILE . 63.3 m-20 -67.58 105.6 1.92 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.844 -0.616 . . . . 1.3600000000000001 110.671 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.862 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.6 mt 68.4 26.79 6.59 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.448 0.907 . . . . 1.6200000000000001 113.448 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 129.88 43.97 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.78 -0.575 . . . . 2.3900000000000001 111.477 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.94 17.91 60.53 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.485 -0.864 . . . . 0.37 114.108 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.862 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.7 ptp180 -143.96 -47.92 0.28 Allowed 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 114.448 1.277 . . . . 1.5900000000000001 114.448 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.96 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.8 81.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 123.109 1.433 . . . . 0.20000000000000001 107.621 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.526 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.8 m80 -102.07 128.72 48.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 112.15 -2.295 . . . . 0.28999999999999998 112.363 -175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.112 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.0 m-85 -71.99 120.03 17.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.273 0.559 . . . . 1.23 109.679 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.946 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 22.1 p -70.29 -9.97 57.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.21 -0.904 . . . . 0.46000000000000002 110.347 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.5 m -89.01 117.42 28.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.775 -0.648 . . . . 1.2 110.625 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -89.95 4.82 48.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.566 0.698 . . . . 2.2200000000000002 109.798 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' SER . 34.0 p-10 -146.28 66.46 1.19 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.979 -1.119 . . . . 2.1400000000000001 107.979 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.49 -38.94 82.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.215 -0.902 . . . . 1.49 111.599 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -63.21 0.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.361 0.504 . . . . 2.04 112.361 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 29.3 m -92.97 -1.12 56.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.879 -0.6 . . . . 1.3999999999999999 110.845 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.497 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.51 -18.75 29.67 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.692 -0.766 . . . . 0.38 113.725 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -99.21 107.95 20.4 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 117.37 0.585 . . . . 1.4399999999999999 109.829 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.76 23.37 12.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.457 0.91 . . . . 0.42999999999999999 113.457 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 80.1 p -60.41 147.84 39.43 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.736 1.384 . . . . 1.04 114.736 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.112 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -130.22 133.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 114.53 -1.213 . . . . 0.31 111.015 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.7 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p30 -109.21 144.36 37.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.437 -0.949 . . . . 1.1499999999999999 108.437 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.95 120.6 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.067 0.461 . . . . 0.27000000000000002 111.885 -177.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.788 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -81.09 144.43 31.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.316 -0.856 . . . . 0.28999999999999998 110.721 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.68 54.53 11.03 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.177 -0.465 . . . . 1.52 111.627 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.018 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.8 mt -42.86 90.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.968 1.099 . . . . 1.02 113.968 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.483 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 72.7 mt-30 -59.43 140.6 56.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.909 -0.587 . . . . 2.1299999999999999 110.829 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.473 HD12 HD12 ' A' ' 115' ' ' ILE . 60.1 tp -60.01 -34.09 72.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.021 -0.733 . . . . 1.7 109.021 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.44 ' HB3' HD21 ' A' ' 64' ' ' ASN . 74.8 m -74.75 -12.43 60.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.271 -0.877 . . . . 1.3200000000000001 111.338 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.483 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 96.5 m-20 -73.43 -16.56 61.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.755 0.312 . . . . 1.5800000000000001 110.19 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.37 139.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 116.137 -0.483 . . . . 0.41999999999999998 110.314 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.13 162.22 9.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 119.982 -1.104 . . . . 0.23999999999999999 113.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 71.4 m -59.6 137.77 57.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.141 0.577 . . . . 0.31 112.482 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.678 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 21.0 m-85 -120.02 130.26 54.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.153 -0.684 . . . . 1.24 109.153 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.6 tt0 -121.76 118.63 29.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 1.1599999999999999 111.29 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 26.5 t -102.4 110.8 22.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 1.03 110.562 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.818 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.5 mtpt -106.62 104.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.82 -0.352 . . . . 1.76 110.23 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.681 ' HA ' HG12 ' A' ' 55' ' ' ILE . 62.8 t -88.07 109.92 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.637 -0.505 . . . . 1.1799999999999999 109.637 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.9 tttm -96.46 119.5 35.06 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.326 -0.55 . . . . 1.6200000000000001 112.064 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 49.2 tptt -145.59 101.42 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.648 -0.871 . . . . 2.8399999999999999 108.648 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 1.033 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.61 134.02 54.78 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 112.455 0.539 . . . . 0.44 112.455 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.7 Cg_endo -99.61 50.47 1.65 Allowed 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.695 -0.96 . . . . 0.56000000000000005 111.705 -0.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.87 103.2 0.28 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.284 -0.96 . . . . 0.47999999999999998 113.413 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.4 m -84.51 140.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.607 -0.797 . . . . 1.22 109.802 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -130.09 149.94 51.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.56999999999999995 111.707 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 45.8 t30 -146.81 142.06 27.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.695 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.761 ' HG2' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -144.61 150.29 37.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 2.9500000000000002 111.01 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -98.26 140.13 33.02 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.447 0.906 . . . . 2.2599999999999998 113.447 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.692 HD12 ' CH2' ' A' ' 57' ' ' TRP . 73.8 mt -143.58 113.57 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.266 -0.879 . . . . 0.28000000000000003 109.339 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 117' ' ' THR . 57.3 m170 -100.45 117.39 34.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.672 -0.411 . . . . 0.55000000000000004 110.554 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.776 HD11 HD21 ' A' ' 39' ' ' LEU . 12.8 mt -94.41 119.96 33.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.487 0.551 . . . . 1.52 112.487 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 21.6 t -111.93 119.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.146 -1.057 . . . . 0.32000000000000001 108.146 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 59.5 t -100.47 122.99 53.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.187 0.518 . . . . 1.0800000000000001 112.181 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.87 162.77 23.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.485 -0.78 . . . . 0.52000000000000002 109.038 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 122.168 0.985 . . . . 1.48 111.75 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 44' ' ' THR . 53.7 m . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.251 0.548 . . . . 1.8400000000000001 111.468 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.618 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.93 133.39 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.833 . . . . 2.1499999999999999 109.596 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 79.6 p -88.81 150.3 22.99 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.733 0.778 . . . . 1.1200000000000001 111.914 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.07 82.99 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 114.524 -1.216 . . . . 0.65000000000000002 111.983 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.1 Cg_endo -78.57 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.675 2.917 . . . . 0.88 112.107 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.32 127.46 32.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.352 -0.981 . . . . 2.0600000000000001 108.352 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.946 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.6 tt0 -143.94 158.67 43.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.278 1.214 . . . . 1.71 114.278 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 42.0 mtt -139.95 121.86 15.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.5 -1.227 . . . . 1.8600000000000001 109.13 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.946 HD11 ' OE2' ' A' ' 27' ' ' GLU . 38.9 mm -120.0 122.08 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.39000000000000001 111.519 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 42.8 mt-10 -112.1 120.06 40.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.472 . . . . 1.1899999999999999 110.81 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 73.2 mmtt -141.23 150.45 42.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.824 0.345 . . . . 2.52 111.744 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.02 143.74 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.311 -0.404 . . . . 0.39000000000000001 111.496 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.742 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 43.2 mtmt -42.88 156.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.255 0.55 . . . . 2.3500000000000001 112.396 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.09 -23.38 0.45 Allowed Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.287 -0.87 . . . . 0.31 114.201 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -79.96 156.2 27.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.544 -0.539 . . . . 2.1099999999999999 109.544 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.996 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -85.22 134.52 34.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.338 -0.545 . . . . 0.33000000000000002 109.582 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB3' HG12 ' A' ' 107' ' ' VAL . . . -100.21 110.83 23.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.347 -0.541 . . . . 0.26000000000000001 111.213 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 94' ' ' THR . 92.7 t80 -79.17 122.2 25.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 1.4299999999999999 111.618 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.735 HD22 HG21 ' A' ' 133' ' ' ILE . 25.3 mt -118.15 104.34 48.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.429 -0.582 . . . . 0.80000000000000004 109.429 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.511 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.7 Cg_endo -82.99 133.03 6.47 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.587 2.191 . . . . 0.41999999999999998 114.778 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.419 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 55.8 m -141.42 104.03 4.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.374 -0.83 . . . . 1.03 110.105 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 10.6 mmtt -102.26 107.71 18.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.224 -0.288 . . . . 1.6599999999999999 110.224 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 42.5 p90 -93.78 142.72 27.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.355 . . . . 1.26 110.785 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 21' ' ' SER . 9.0 t -79.98 174.24 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.419 0.628 . . . . 1.3300000000000001 111.627 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 44' ' ' THR . 87.2 mt -142.27 149.8 40.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.924 -1.034 . . . . 2.1200000000000001 109.96 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.8 t -158.69 147.02 13.92 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.763 0.316 . . . . 1.75 110.886 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.0 Cg_exo -47.37 -26.67 6.14 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.419 2.079 . . . . 1.6100000000000001 112.188 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -77.59 -43.85 30.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.417 -0.356 . . . . 2.1800000000000002 110.694 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 67.6 m-20 -71.98 74.24 0.9 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.435 -0.58 . . . . 2.4100000000000001 109.435 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 55.5 mm-40 -94.04 -5.09 48.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.35 -0.841 . . . . 1.6399999999999999 111.479 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 159.93 53.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.363 -0.923 . . . . 0.55000000000000004 112.136 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.43 149.1 31.34 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.526 2.151 . . . . 0.84999999999999998 112.081 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.949 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.1 tt -77.81 133.47 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 1.8999999999999999 110.345 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.627 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 10.9 t70 -140.18 152.37 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.454 0.645 . . . . 1.78 112.012 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.71 HD13 ' HB1' ' A' ' 103' ' ' ALA . 31.5 mt -142.8 139.99 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.687 -1.142 . . . . 0.75 109.515 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 1.085 ' HA ' HD22 ' A' ' 73' ' ' LEU . 45.3 mt-10 -140.36 111.66 7.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.337 0.495 . . . . 1.6699999999999999 112.337 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.9 ' CD2' HD11 ' A' ' 105' ' ' ILE . 77.3 m95 -100.03 119.96 39.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.497 -0.319 . . . . 0.22 111.026 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -106.05 124.33 49.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.597 -0.519 . . . . 0.40999999999999998 109.597 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.692 HD12 HD11 ' A' ' 87' ' ' LEU . 14.5 tt -109.88 126.34 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.892 0.701 . . . . 0.78000000000000003 112.892 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 50.2 m -119.98 102.04 46.96 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 108.711 -0.848 . . . . 1.25 108.711 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 96.0 Cg_endo -79.7 117.13 3.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.84 2.36 . . . . 0.53000000000000003 112.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.76 90.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.861 -0.609 . . . . 0.40999999999999998 111.496 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.29 -40.0 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.638 . . . . 1.8200000000000001 112.429 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 86.6 m-20 -81.59 161.14 23.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 1.9399999999999999 112.329 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -69.48 -18.36 63.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.936 -1.029 . . . . 1.6599999999999999 111.295 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.8 mttp -69.29 151.75 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.741 -0.663 . . . . 1.74 111.125 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.45 135.37 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.55 1.166 . . . . 0.96999999999999997 110.103 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 43.83 42.39 4.43 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.564 -2.107 . . . . 1.77 112.797 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -96.47 150.87 20.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.653 -0.249 . . . . 1.96 111.158 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 73' ' ' LEU . 20.7 t -66.38 129.43 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 109.696 -0.483 . . . . 0.77000000000000002 109.696 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.879 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -116.9 -56.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 1.1499999999999999 112.58 -177.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.963 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.28 128.91 49.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.821 -0.807 . . . . 0.28999999999999998 108.821 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' GLU . 5.8 mt -134.96 160.0 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.468 0.651 . . . . 1.3 111.701 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.861 ' HD1' HD13 ' A' ' 79' ' ' ILE . 41.3 t80 -135.25 103.33 5.48 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.567 -1.272 . . . . 1.3 107.567 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.523 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 2.3 t -143.15 155.59 44.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.87 -0.604 . . . . 0.89000000000000001 111.854 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.95 29.47 6.41 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 113.044 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 73.54 2.94 4.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.508 0.194 . . . . 1.46 111.388 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 118.56 36.65 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.976 -0.379 . . . . 2.4100000000000001 109.976 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.861 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.79 130.84 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.307 -1.368 . . . . 1.6599999999999999 107.307 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.632 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -119.92 120.86 37.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.381 -0.827 . . . . 1.25 110.288 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.8 p-10 -165.82 -48.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.663 -1.236 . . . . 1.2 107.663 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.61 -32.09 47.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.019 -0.991 . . . . 2.1699999999999999 109.185 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -76.18 -28.71 57.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.024 -0.989 . . . . 5.0499999999999998 108.647 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.3 m-85 -81.01 117.39 67.88 Favored Pre-proline 0 CA--C 1.514 -0.431 0 CA-C-N 114.911 -1.041 . . . . 1.29 110.675 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.7 -40.06 56.41 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.508 1.472 . . . . 0.79000000000000004 110.117 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.682 ' O ' HG12 ' A' ' 71' ' ' ILE . 5.2 m-20 -67.01 106.37 1.92 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.093 -0.643 . . . . 1.3600000000000001 110.521 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.5 mt 65.81 28.44 10.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.597 0.962 . . . . 1.6200000000000001 113.597 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 17.8 pttt -56.58 131.32 48.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.395 -0.522 . . . . 2.3900000000000001 111.159 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 83.39 18.11 65.07 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.435 -0.888 . . . . 0.37 114.501 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -145.96 -46.25 0.2 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.963 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.38 82.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 123.099 1.428 . . . . 0.20000000000000001 107.274 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.565 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.5 m80 -103.38 129.83 50.55 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 112.426 -2.17 . . . . 0.28999999999999998 112.471 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 63.3 m-85 -71.32 120.38 16.82 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.322 -0.622 . . . . 1.23 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.594 HG21 ' HD1' ' A' ' 38' ' ' TYR . 16.6 p -73.03 36.76 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.042 -0.981 . . . . 0.46000000000000002 113.575 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -149.36 136.0 19.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.388 0.613 . . . . 1.2 111.404 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.04 6.74 46.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 2.2200000000000002 110.372 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -145.62 65.9 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.444 -0.947 . . . . 2.1400000000000001 108.444 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 55' ' ' ILE . 8.2 tt -59.47 -38.44 80.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.632 -1.167 . . . . 1.49 111.641 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.5 1.47 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.391 0.515 . . . . 2.04 112.391 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' LEU . 50.6 m -89.99 -0.01 57.34 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 1.3999999999999999 111.151 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.546 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 108.55 -1.91 32.46 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.844 -0.693 . . . . 0.38 113.023 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 96.5 m-20 -100.26 108.7 20.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.729 0.299 . . . . 1.4399999999999999 110.672 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.71 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -108.78 5.95 25.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.42999999999999999 111.558 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 1.3 m -59.68 140.0 56.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.667 1.728 . . . . 1.04 115.667 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.24 135.16 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 114.0 -1.455 . . . . 0.31 109.549 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 41.9 p-10 -113.46 148.95 34.98 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.951 -0.759 . . . . 1.1499999999999999 108.951 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.03 HG12 ' HB3' ' A' ' 37' ' ' ALA . 7.5 p -95.76 123.79 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 N-CA-C 113.455 0.909 . . . . 0.27000000000000002 113.455 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.766 ' HA ' HG23 ' A' ' 36' ' ' THR . 1.3 p -84.81 141.65 30.33 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.386 -1.734 . . . . 0.28999999999999998 111.372 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 53.12 60.56 3.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.486 -0.779 . . . . 1.52 112.668 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 135' ' ' LEU . 10.0 mt -46.19 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.041 0.448 . . . . 1.02 112.059 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HG2' ' OD2' ' A' ' 114' ' ' ASP . 12.0 pt20 -177.24 164.06 2.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.839 -0.618 . . . . 2.1299999999999999 110.347 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.851 ' HA ' HG11 ' A' ' 137' ' ' VAL . 79.4 mt -59.92 -36.73 77.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.806 0.336 . . . . 1.7 111.531 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB2' HD21 ' A' ' 64' ' ' ASN . 70.5 p -73.29 -15.85 61.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.388 -0.369 . . . . 1.3200000000000001 111.97 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 89.1 m-20 -72.99 -20.07 61.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.622 -0.431 . . . . 1.5800000000000001 110.005 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.903 HD12 HG12 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -47.12 144.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.114 -0.494 . . . . 0.41999999999999998 110.947 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.84 150.73 5.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.564 -1.303 . . . . 0.23999999999999999 114.115 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.613 HG23 ' CD2' ' A' ' 134' ' ' HIS . 95.6 m -59.27 129.97 44.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.024 -0.588 . . . . 0.31 111.965 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 87' ' ' LEU . 22.9 m-85 -110.21 129.92 55.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.808 . . . . 1.24 108.82 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.835 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -114.72 113.04 23.77 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.88 -0.415 . . . . 1.1599999999999999 109.88 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 7.3 t -100.01 109.36 21.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.965 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 45.0 mttt -120.4 109.97 15.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 1.76 111.836 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 43' ' ' PHE . 45.4 t -94.6 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.1799999999999999 109.448 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 43.2 tttm -98.67 122.88 42.45 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.994 -0.682 . . . . 1.6200000000000001 112.732 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 28.5 tttp -144.63 102.36 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.314 -0.625 . . . . 2.8399999999999999 109.314 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.84 133.32 28.65 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 113.226 0.824 . . . . 0.44 113.226 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.594 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 97.4 Cg_endo -98.43 36.87 6.58 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.439 -1.067 . . . . 0.56000000000000005 111.753 -1.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.62 102.89 0.43 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-O 122.06 0.811 . . . . 0.47999999999999998 112.664 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.5 p -90.0 160.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.165 -1.017 . . . . 1.22 109.984 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -139.36 149.32 44.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.336 . . . . 0.56999999999999995 111.673 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.542 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 37.9 p-10 -146.42 137.25 24.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.862 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.6 ptmt -145.96 155.11 42.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 2.9500000000000002 110.636 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 24.1 mttt -103.45 140.07 37.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.148 0.796 . . . . 2.2599999999999998 113.148 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.735 HG21 HD22 ' A' ' 39' ' ' LEU . 87.2 mt -142.22 119.21 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.529 -0.76 . . . . 0.28000000000000003 109.225 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.613 ' CD2' HG23 ' A' ' 117' ' ' THR . 59.3 m170 -102.91 119.99 39.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.954 -0.299 . . . . 0.55000000000000004 110.547 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 110' ' ' LEU . 58.8 tp -89.82 120.03 30.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.428 -0.509 . . . . 1.52 110.936 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 48.6 t -116.28 121.36 67.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.391 -0.822 . . . . 0.32000000000000001 109.27 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.903 HG12 HD12 ' A' ' 115' ' ' ILE . 14.8 p -94.92 128.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.885 0.374 . . . . 1.0800000000000001 111.974 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 94.2 mt -83.53 152.8 24.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.525 -0.546 . . . . 0.52000000000000002 109.525 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.778 0.799 . . . . 1.48 112.038 -178.229 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.024 0.44 . . . . 1.8400000000000001 111.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.684 ' O ' HD12 ' A' ' 22' ' ' ILE . 2.4 pp -91.54 149.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 2.1499999999999999 111.144 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.17 158.22 19.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.326 0.584 . . . . 1.1200000000000001 110.892 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.468 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 44.89 83.82 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.018 -0.992 . . . . 0.65000000000000002 111.098 -177.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.4 Cg_endo -78.19 -84.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.611 2.874 . . . . 0.88 113.498 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.1 tt0 -77.82 122.13 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.17 -0.612 . . . . 2.0600000000000001 109.362 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.9 tp10 -143.9 160.65 40.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.418 0.896 . . . . 1.71 113.418 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.1 ttm -134.56 134.33 41.24 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.067 -0.97 . . . . 1.8600000000000001 109.478 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 28' ' ' MET . 32.8 mm -129.94 129.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.949 -0.569 . . . . 0.39000000000000001 111.494 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.637 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 98.2 mt-10 -118.36 125.1 49.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.384 -0.371 . . . . 1.1899999999999999 110.695 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' A' ' 110' ' ' LEU . 61.0 mmtt -141.97 158.05 44.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.638 0.256 . . . . 2.52 111.315 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -77.06 143.38 39.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 0.39000000000000001 111.69 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 39.6 ttmt -48.51 136.36 13.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 2.3500000000000001 111.609 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 82.46 -18.42 14.68 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.997 -0.62 . . . . 0.31 113.119 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.9 mm-40 -79.99 158.97 26.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.712 -0.847 . . . . 2.1099999999999999 108.712 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 m -87.28 129.8 34.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.476 -0.89 . . . . 0.33000000000000002 109.982 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 114.92 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.807 0.337 . . . . 0.26000000000000001 110.504 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 94' ' ' THR . 40.8 t80 -79.35 120.77 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.849 -0.614 . . . . 1.4299999999999999 112.454 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 133' ' ' ILE . 4.4 mp -115.28 104.76 53.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.619 -0.882 . . . . 0.80000000000000004 108.619 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 88.8 Cg_endo -86.43 104.49 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.328 2.019 . . . . 0.41999999999999998 114.929 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -98.51 135.51 39.95 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 176.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' HD3' ' OD1' ' A' ' 102' ' ' ASP . 45.5 tptt -140.03 139.99 36.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.741 0.305 . . . . 1.6599999999999999 110.527 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -140.16 139.76 35.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 1.26 111.413 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.14 126.39 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 1.3300000000000001 110.775 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD21 ' HE1' ' A' ' 43' ' ' PHE . 84.4 mt -89.09 149.95 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 2.1200000000000001 110.834 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.8 m -151.32 144.09 16.73 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.486 -0.324 . . . . 1.75 110.133 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.18 -23.57 9.89 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.579 2.186 . . . . 1.6100000000000001 112.086 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 16.7 pt-20 -77.29 -43.66 32.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.194 -0.457 . . . . 2.1800000000000002 111.05 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -75.59 76.32 2.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.936 -0.705 . . . . 2.4100000000000001 109.287 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.51 -3.52 52.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.352 -0.84 . . . . 1.6399999999999999 111.901 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.03 160.06 53.33 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.691 -0.766 . . . . 0.55000000000000004 113.024 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.61 136.56 76.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.632 2.222 . . . . 0.84999999999999998 111.675 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 6.6 mp -78.0 119.05 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.301 -0.409 . . . . 1.8999999999999999 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -133.01 102.17 5.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.535 0.683 . . . . 1.78 111.033 178.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.881 HG12 HG22 ' A' ' 122' ' ' VAL . 2.6 mp -96.39 105.91 17.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.761 -1.109 . . . . 0.75 110.874 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.646 ' OE2' HD21 ' A' ' 58' ' ' LEU . 86.5 tt0 -100.93 117.66 35.41 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.62 0.6 . . . . 1.6699999999999999 112.62 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.819 ' CD2' HD11 ' A' ' 105' ' ' ILE . 72.3 m95 -94.06 120.01 33.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.133 -0.321 . . . . 0.22 110.133 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.646 HD21 ' OE2' ' A' ' 56' ' ' GLU . 89.5 mt -105.91 146.86 29.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.866 -0.42 . . . . 0.40999999999999998 109.866 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 87' ' ' LEU . 12.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.157 0.429 . . . . 0.78000000000000003 112.157 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.447 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 37.4 m -119.99 102.16 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.631 -0.877 . . . . 1.25 108.631 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.617 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 91.9 Cg_endo -78.96 114.97 3.48 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.775 2.317 . . . . 0.53000000000000003 113.533 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.18 82.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.352 -0.84 . . . . 0.40999999999999998 110.614 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -85.93 16.52 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.534 -0.757 . . . . 1.8200000000000001 112.078 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 81.0 m-20 -148.72 161.0 42.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.376 0.608 . . . . 1.9399999999999999 112.011 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.94 -19.76 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.058 -0.974 . . . . 1.6599999999999999 112.507 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 43.6 mttt -69.1 153.05 44.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.825 0.345 . . . . 1.74 111.536 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.36 128.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.716 0.77 . . . . 0.96999999999999997 109.468 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.17 45.18 27.94 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.346 -1.297 . . . . 1.77 112.088 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 136.4 33.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.96 111.089 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.51 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 110.154 -0.313 . . . . 0.77000000000000002 110.154 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.891 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.5 pp -131.76 -38.85 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.808 0.67 . . . . 1.1499999999999999 112.808 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.905 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.31 123.85 14.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.175 0.512 . . . . 0.28999999999999998 110.092 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 8.5 tt -140.38 163.55 32.49 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 116.019 -0.537 . . . . 1.3 109.799 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' ILE . 23.3 t80 -135.31 109.94 8.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.206 0.527 . . . . 1.3 110.477 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.3 t -142.61 159.99 41.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.249 -0.887 . . . . 0.89000000000000001 111.474 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.32 55.48 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.564 -0.827 . . . . 0.56999999999999995 112.152 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 74.14 2.83 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.845 -0.178 . . . . 1.46 111.241 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 6.0 mmtm -105.36 118.52 36.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.811 -0.441 . . . . 2.4100000000000001 109.811 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.73 119.99 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.617 -1.253 . . . . 1.6599999999999999 107.617 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.839 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -100.01 132.53 45.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.83 -1.077 . . . . 1.25 110.728 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.815 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.8 p-10 -166.32 -58.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.796 -1.557 . . . . 1.2 106.796 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 33.6 p-10 -80.1 -22.01 42.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.565 -1.198 . . . . 2.1699999999999999 109.731 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.555 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -76.85 -29.8 56.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.85 -1.167 . . . . 5.0499999999999998 107.85 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.739 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -85.18 118.3 70.54 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 114.452 -1.249 . . . . 1.29 110.263 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -41.0 51.93 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.346 1.364 . . . . 0.79000000000000004 110.447 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.867 ' HB3' HG22 ' A' ' 71' ' ' ILE . 89.1 m-20 -68.19 104.87 1.92 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.771 -0.65 . . . . 1.3600000000000001 111.091 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.764 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 34.3 mt 70.4 22.37 5.31 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.295 0.85 . . . . 1.6200000000000001 113.295 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 21.6 pttp -58.17 136.9 57.34 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.843 -0.536 . . . . 2.3900000000000001 111.05 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 86.64 9.57 74.81 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.249 -0.977 . . . . 0.37 114.176 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -137.99 -54.61 0.65 Allowed 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 114.754 1.39 . . . . 1.5900000000000001 114.754 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.905 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -78.28 81.28 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 N-CA-C 107.088 -1.449 . . . . 0.20000000000000001 107.088 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.533 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 6.7 m80 -100.06 129.43 46.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.163 -2.289 . . . . 0.28999999999999998 112.589 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.093 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -70.37 121.17 17.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 120.231 -0.588 . . . . 1.23 110.054 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.588 HG21 ' CD1' ' A' ' 38' ' ' TYR . 35.0 p -71.4 -10.67 60.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.93 . . . . 0.46000000000000002 110.099 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 58.1 m -95.15 120.0 34.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.726 -0.67 . . . . 1.2 110.683 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -91.34 6.08 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.927 -0.579 . . . . 2.2200000000000002 110.189 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -146.25 66.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.551 -0.907 . . . . 2.1400000000000001 108.551 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.3 -31.29 69.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 1.49 112.21 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -62.86 -4.08 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.142 0.496 . . . . 2.04 111.91 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -0.57 57.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.392 -0.822 . . . . 1.3999999999999999 110.89 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.507 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 110.07 -20.61 26.03 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.687 -0.768 . . . . 0.38 113.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 82.8 m-20 -92.91 109.01 20.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.964 0.382 . . . . 1.4399999999999999 111.195 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.29 21.46 16.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.42999999999999999 111.102 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.728 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 82.5 p -59.98 145.89 44.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 116.03 1.863 . . . . 1.04 116.03 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.093 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.62 133.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 114.246 -1.343 . . . . 0.31 111.27 178.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.678 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.1 p-10 -107.66 147.85 30.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.947 -1.131 . . . . 1.1499999999999999 107.947 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.75 123.9 52.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.958 0.408 . . . . 0.27000000000000002 111.79 -178.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.5 p -84.68 142.75 29.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.536 -0.756 . . . . 0.28999999999999998 110.935 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.9 m-20 49.98 55.69 9.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.996 -0.547 . . . . 1.52 112.133 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.8 mt -46.96 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.577 0.954 . . . . 1.02 113.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 63.7 tt0 -60.03 148.68 34.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.154 -0.475 . . . . 2.1299999999999999 109.94 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 3.0 tm? -60.02 -39.99 87.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 1.7 110.729 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 74.2 m -72.96 -10.04 59.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.663 . . . . 1.3200000000000001 111.611 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.95 -18.35 63.35 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.048 -0.352 . . . . 1.5800000000000001 110.048 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.7 145.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.026 0 CA-C-N 116.113 -0.494 . . . . 0.41999999999999998 110.397 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 155.79 6.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.984 -1.103 . . . . 0.23999999999999999 113.887 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.2 m -59.36 139.01 57.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.94 0.496 . . . . 0.31 111.808 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.0 m-85 -119.99 133.68 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.612 -0.514 . . . . 1.24 109.612 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.3 tt0 -123.11 115.22 21.44 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.101 -0.24 . . . . 1.1599999999999999 110.843 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.485 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.3 t -99.96 112.15 24.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.011 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.847 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 98.4 mttt -110.49 106.51 15.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.627 -0.26 . . . . 1.76 111.577 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.881 HG22 HG12 ' A' ' 55' ' ' ILE . 47.6 t -88.21 110.05 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.75 -0.833 . . . . 1.1799999999999999 108.75 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.708 ' HG3' HG12 ' A' ' 128' ' ' VAL . 61.1 tttp -96.06 120.3 36.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.869 0.692 . . . . 1.6200000000000001 112.869 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 11.0 mtmt -144.25 101.64 3.73 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.663 -0.495 . . . . 2.8399999999999999 109.663 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.22 132.32 51.64 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.45 -0.341 . . . . 0.44 111.751 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 59.7 Cg_endo -100.37 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.808 -0.913 . . . . 0.56000000000000005 112.366 -0.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 103.18 0.28 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.397 -0.906 . . . . 0.47999999999999998 113.141 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.708 HG12 ' HG3' ' A' ' 123' ' ' LYS . 13.4 m -87.06 142.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.221 -0.99 . . . . 1.22 109.724 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -136.03 148.11 48.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.979 -0.288 . . . . 0.56999999999999995 111.642 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.628 ' O ' HD11 ' A' ' 22' ' ' ILE . 47.2 p-10 -146.61 151.67 37.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.466 0.543 . . . . 2.0299999999999998 112.466 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.916 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.29 153.51 41.36 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.154 -0.475 . . . . 2.9500000000000002 110.958 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 18.6 tttt -99.59 139.63 34.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.486 0.55 . . . . 2.2599999999999998 112.486 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.947 HG21 HD23 ' A' ' 39' ' ' LEU . 95.2 mt -143.19 117.79 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.28000000000000003 109.641 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 117' ' ' THR . 62.6 m170 -100.04 116.16 31.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.008 0.433 . . . . 0.55000000000000004 111.246 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.889 HD11 HD22 ' A' ' 110' ' ' LEU . 1.8 tm? -89.17 125.18 34.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 1.52 111.479 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 39.2 t -121.22 124.71 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.32000000000000001 109.939 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.4 t -97.19 120.24 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 1.0800000000000001 111.51 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.0 mt -80.45 160.02 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.52000000000000002 109.686 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 1.48 111.59 -178.732 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.944 0.402 . . . . 1.8400000000000001 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.815 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 2.1499999999999999 110.719 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.688 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.0 p -93.44 156.22 16.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.575 0.702 . . . . 1.1200000000000001 111.958 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 43.06 82.41 0.23 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.698 -1.137 . . . . 0.65000000000000002 112.013 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -79.3 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.775 2.983 . . . . 0.88 113.048 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 46.2 mt-10 -78.18 126.58 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.129 -0.693 . . . . 2.0600000000000001 109.129 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 132' ' ' LYS . 41.8 tt0 -144.11 159.25 42.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 16.5 mtm -140.12 116.43 10.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.629 -1.169 . . . . 1.8600000000000001 109.376 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.619 ' HB ' HD23 ' A' ' 135' ' ' LEU . 39.2 mm -120.01 130.01 74.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.39000000000000001 111.553 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.65 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 35.8 mt-10 -120.59 128.06 52.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.572 -0.285 . . . . 1.1899999999999999 110.711 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 51.3 tptt -142.82 158.48 43.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.687 -0.233 . . . . 2.52 110.552 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.767 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.7 141.91 40.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.788 0.328 . . . . 0.39000000000000001 111.552 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 32.1 tttt -47.77 140.98 5.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.0 0.429 . . . . 2.3500000000000001 111.444 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 83.04 -21.95 7.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.832 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.767 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.05 159.01 26.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.318 -0.993 . . . . 2.1099999999999999 108.318 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.0 m -88.13 130.0 35.15 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.546 -0.862 . . . . 0.33000000000000002 110.236 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.933 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.76 113.48 25.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.26000000000000001 110.617 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.4 t80 -79.26 120.01 23.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 1.4299999999999999 112.402 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.863 HD23 HG21 ' A' ' 133' ' ' ILE . 4.5 mp -115.68 104.88 52.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.476 -0.935 . . . . 0.80000000000000004 108.476 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 90.3 Cg_endo -85.48 104.65 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.47 2.114 . . . . 0.41999999999999998 115.914 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -102.25 131.51 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.467 -0.938 . . . . 1.03 108.467 176.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 23.0 tptm -140.69 105.08 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.042 0.449 . . . . 1.6599999999999999 110.393 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.895 ' HB3' HG11 ' A' ' 122' ' ' VAL . 38.6 p90 -90.95 141.89 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 1.26 111.647 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 45' ' ' LEU . 25.1 m -79.8 164.14 23.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 1.3300000000000001 110.483 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' N ' HG22 ' A' ' 44' ' ' THR . 77.4 mt -138.79 149.95 45.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 2.1200000000000001 111.44 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 m -157.73 148.57 16.28 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.544 -0.753 . . . . 1.75 109.885 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.04 -23.61 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.889 2.392 . . . . 1.6100000000000001 112.979 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 85.6 tt0 -74.64 -25.92 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.518 -0.31 . . . . 2.1800000000000002 111.73 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 46' ' ' SER . 55.8 p-10 -63.54 82.69 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 121.534 0.683 . . . . 2.4100000000000001 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' GLU . 95.1 mt-30 -94.24 0.02 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 1.6399999999999999 111.822 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.971 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -92.91 170.22 31.75 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.126 -1.035 . . . . 0.55000000000000004 113.087 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.02 153.03 63.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.913 2.409 . . . . 0.84999999999999998 111.86 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.681 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.0 tt -78.14 123.99 27.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.306 -0.406 . . . . 1.8999999999999999 110.613 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 15.3 m-20 -136.34 150.64 48.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.508 0.671 . . . . 1.78 111.494 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 25.1 mt -142.65 139.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.75 109.174 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 99.2 mt-10 -140.68 116.24 10.16 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.843 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.2 m95 -101.79 122.85 44.73 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 121.102 -0.239 . . . . 0.22 110.751 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.8 mt -109.19 139.87 43.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.145 -0.687 . . . . 0.40999999999999998 109.145 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 tt -130.04 130.0 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.196 0.522 . . . . 0.78000000000000003 112.245 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.5 m -120.47 102.82 44.9 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.461 -0.79 . . . . 1.25 109.11 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 97.8 Cg_endo -79.11 114.59 3.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.591 2.194 . . . . 0.53000000000000003 113.28 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.79 80.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.365 -0.834 . . . . 0.40999999999999998 110.828 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -86.15 20.69 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 1.8200000000000001 111.919 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 35.1 m120 -151.28 161.98 41.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.288 0.566 . . . . 1.9399999999999999 111.873 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.32 -19.83 64.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.287 -0.869 . . . . 1.6599999999999999 112.32 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 90.8 mttt -68.51 146.4 53.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.257 -0.429 . . . . 1.74 111.008 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -155.4 127.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 CA-C-O 121.971 0.891 . . . . 0.96999999999999997 109.994 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 54.15 39.97 31.22 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.841 -1.527 . . . . 1.77 112.582 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.441 ' NE2' ' HD3' ' A' ' 66' ' ' LYS . 26.8 mt-30 -94.2 146.81 23.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 1.96 111.137 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 ' OH ' ' A' ' 84' ' ' TYR . 44.6 t -66.58 137.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.905 -0.405 . . . . 0.77000000000000002 109.905 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.894 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -129.39 -52.41 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 1.1499999999999999 112.73 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.972 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.52 130.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 107.982 -1.118 . . . . 0.28999999999999998 107.982 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 159.97 41.02 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 120.833 -0.347 . . . . 1.3 111.704 -176.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.6 t80 -135.81 103.82 5.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.195 -0.669 . . . . 1.3 109.195 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.449 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 20.2 m -142.6 159.99 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.751 0.31 . . . . 0.89000000000000001 111.582 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.11 25.93 18.95 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.602 -0.809 . . . . 0.56999999999999995 112.272 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 74.75 1.62 3.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.512 0.196 . . . . 1.46 111.091 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.9 mttt -100.01 115.08 28.89 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 110.034 -0.358 . . . . 2.4100000000000001 110.034 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.725 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.55 128.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.575 -1.269 . . . . 1.6599999999999999 107.575 177.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.6 m-85 -113.13 129.33 56.54 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.874 -1.512 . . . . 1.25 110.256 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 21.9 p-10 -166.16 -54.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.654 -1.239 . . . . 1.2 107.654 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -80.13 -20.05 45.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.025 -0.989 . . . . 2.1699999999999999 109.202 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.43 -26.25 35.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.216 -0.902 . . . . 5.0499999999999998 108.904 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.532 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -85.3 111.81 39.25 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.073 -0.967 . . . . 1.29 111.057 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.5 -41.9 10.83 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.427 1.418 . . . . 0.79000000000000004 109.939 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 60.3 t0 -67.89 105.46 1.99 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.64 -0.709 . . . . 1.3600000000000001 110.266 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.904 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 5.6 mt 68.66 20.03 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.012 1.116 . . . . 1.6200000000000001 114.012 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 12.2 pttm -54.78 127.06 26.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.336 -0.852 . . . . 2.3900000000000001 110.84 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.77 12.94 48.75 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.212 -0.994 . . . . 0.37 114.213 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.904 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.5 ptp180 -143.81 -47.6 0.28 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 114.619 1.34 . . . . 1.5900000000000001 114.619 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.972 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.58 81.15 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.275 1.512 . . . . 0.20000000000000001 107.544 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -101.58 127.83 48.12 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.044 -2.344 . . . . 0.28999999999999998 111.856 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.1 ' CD1' HG23 ' A' ' 105' ' ' ILE . 88.1 m-85 -69.59 125.9 28.12 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 119.918 -0.713 . . . . 1.23 110.246 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.713 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.9 p -73.49 29.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.46000000000000002 111.747 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 93' ' ' PHE . 5.4 m -148.76 127.49 12.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.038 0.447 . . . . 1.2 110.359 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.02 8.17 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.773 -0.649 . . . . 2.2200000000000002 110.308 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.2 66.2 1.2 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.778 -0.823 . . . . 2.1400000000000001 108.778 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.618 HD21 ' CG ' ' A' ' 93' ' ' PHE . 6.3 mp -58.36 -23.56 57.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 1.49 111.616 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.54 -3.41 2.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.162 0.506 . . . . 2.04 112.098 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 10.01 25.7 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.466 -0.788 . . . . 1.3999999999999999 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.577 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 96.54 -10.39 66.86 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.913 -0.66 . . . . 0.38 113.079 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -95.25 110.12 22.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 1.4399999999999999 111.602 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -110.22 16.06 21.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.42999999999999999 110.569 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.5 m -59.94 140.38 56.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.229 1.566 . . . . 1.04 115.229 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.1 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.28 136.59 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-N 114.853 -1.067 . . . . 0.31 111.002 178.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.717 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p-10 -112.86 142.98 44.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.33 -0.989 . . . . 1.1499999999999999 108.33 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.887 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.42 120.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.107 0.48 . . . . 0.27000000000000002 111.512 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -84.57 141.9 30.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.344 -0.844 . . . . 0.28999999999999998 110.659 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.514 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 33.8 m120 53.82 52.77 12.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.52 111.346 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.933 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.0 mt -43.08 87.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.558 1.318 . . . . 1.02 114.558 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' ASN . 57.4 mt-30 -58.2 141.93 49.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.055 -0.521 . . . . 2.1299999999999999 110.593 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.554 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 87.0 mt -59.93 -33.1 71.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.885 0.374 . . . . 1.7 110.487 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.4 m -75.06 -13.13 60.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 1.3200000000000001 111.213 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.58 -18.59 62.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.87 -0.419 . . . . 1.5800000000000001 109.87 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.49 141.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 116.044 -0.525 . . . . 0.41999999999999998 110.535 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.83 162.21 9.01 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.225 -0.988 . . . . 0.23999999999999999 113.514 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.726 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.51 135.77 57.77 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.414 0.524 . . . . 0.31 112.414 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.915 ' CE1' HD12 ' A' ' 135' ' ' LEU . 41.3 m-85 -120.05 129.67 54.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.988 -0.551 . . . . 1.24 109.72 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -121.35 119.97 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.186 -0.206 . . . . 1.1599999999999999 111.206 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.5 t -99.94 117.42 34.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.096 -0.335 . . . . 1.03 110.096 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 37.3 mtpt -118.07 107.87 14.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 1.76 110.82 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.895 HG11 ' HB3' ' A' ' 43' ' ' PHE . 7.2 p -92.27 106.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.026 -0.361 . . . . 1.1799999999999999 110.026 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.6 tttm -93.89 115.18 27.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.04 -0.664 . . . . 1.6200000000000001 112.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -145.86 102.07 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.1 -0.704 . . . . 2.8399999999999999 109.1 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.971 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.06 134.31 39.73 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 112.369 0.507 . . . . 0.44 112.369 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 77.0 Cg_endo -100.05 46.82 2.29 Favored 'Cis proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.642 -0.982 . . . . 0.56000000000000005 111.208 -0.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.81 102.93 0.31 Allowed Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.086 -1.054 . . . . 0.47999999999999998 113.683 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.4 m -93.21 138.21 20.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 113.861 -1.17 . . . . 1.22 109.233 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.815 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -140.76 144.47 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.979 0.363 . . . . 0.56999999999999995 111.979 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.5 p-10 -146.77 151.45 37.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.482 0.549 . . . . 2.0299999999999998 112.482 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.0 160.03 41.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 2.9500000000000002 111.15 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 61.0 mttp -102.53 139.81 37.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 112.422 0.527 . . . . 2.2599999999999998 112.422 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.863 HG21 HD23 ' A' ' 39' ' ' LEU . 84.9 mt -142.12 114.55 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.959 -0.756 . . . . 0.28000000000000003 108.959 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.726 ' CD2' HG23 ' A' ' 117' ' ' THR . 48.7 m170 -99.97 115.55 29.96 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.481 -0.488 . . . . 0.55000000000000004 110.398 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.915 HD12 ' CE1' ' A' ' 118' ' ' TYR . 46.5 mt -93.68 120.05 33.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.65 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 17.6 t -115.25 120.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.306 -0.998 . . . . 0.32000000000000001 108.306 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 115' ' ' ILE . 25.4 t -96.26 125.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.814 0.672 . . . . 1.0800000000000001 112.814 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.85 160.02 22.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.52000000000000002 109.896 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 139' ' ' VAL . 1.2 p . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 121.987 0.899 . . . . 1.48 112.935 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.083 0.468 . . . . 1.8400000000000001 111.555 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pp -104.54 136.13 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.666 -0.697 . . . . 2.1499999999999999 110.401 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -87.15 148.96 24.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.059 0.457 . . . . 1.1200000000000001 110.344 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.549 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 43.35 83.81 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.393 -0.822 . . . . 0.65000000000000002 110.549 -177.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.771 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.8 Cg_endo -77.34 -11.04 17.55 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 123.913 3.076 . . . . 0.88 113.864 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 49.2 mp0 -141.36 126.23 18.16 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.182 -0.673 . . . . 2.0600000000000001 109.182 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.901 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.5 tt0 -144.09 161.19 39.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.731 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.6 ttm -137.11 137.32 39.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.876 -1.057 . . . . 1.8600000000000001 109.415 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.901 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.1 mm -132.71 139.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.978 -0.555 . . . . 0.39000000000000001 111.597 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.58 123.07 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 1.1899999999999999 110.523 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.76 158.91 43.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.52 112.119 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.802 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.03 138.6 39.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 0.39000000000000001 112.021 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.757 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 34.2 mtmt -47.52 144.2 3.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.163 0.506 . . . . 2.3500000000000001 111.773 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.4 -25.45 3.27 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.31 112.743 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 81.8 mm-40 -80.02 159.97 26.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.148 -0.686 . . . . 2.1099999999999999 109.148 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 m -84.54 129.31 34.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.078 -0.649 . . . . 0.33000000000000002 110.639 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.03 114.1 27.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.068 0.461 . . . . 0.26000000000000001 110.921 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.0 t80 -79.53 121.28 25.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.803 -0.635 . . . . 1.4299999999999999 112.569 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 105' ' ' ILE . 20.3 mt -110.05 105.27 57.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 108.913 -0.773 . . . . 0.80000000000000004 108.913 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.772 ' O ' HD11 ' A' ' 133' ' ' ILE . 2.4 Cg_endo -81.06 128.68 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.51 2.14 . . . . 0.41999999999999998 114.219 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 17.2 t -140.87 131.48 25.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.838 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.48 146.6 38.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.261 -0.427 . . . . 1.6599999999999999 110.744 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CG ' HG11 ' A' ' 122' ' ' VAL . 44.1 p90 -140.79 141.05 34.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 1.26 111.908 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.3 p -88.02 143.74 26.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 1.3300000000000001 110.759 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -94.18 113.32 25.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.692 -0.231 . . . . 2.1200000000000001 110.564 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.8 m -83.97 140.33 40.14 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 110.004 -0.369 . . . . 1.75 110.004 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.76 -34.24 27.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.731 1.621 . . . . 1.6100000000000001 110.559 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 21.2 pt-20 -79.49 -35.48 40.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.313 -0.858 . . . . 2.1800000000000002 111.383 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 78.7 m-20 -71.24 73.66 0.68 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.282 0.563 . . . . 2.4100000000000001 109.952 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -95.51 -1.21 51.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.301 -0.863 . . . . 1.6399999999999999 111.427 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.05 161.42 53.11 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.485 -0.864 . . . . 0.55000000000000004 112.259 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.55 144.42 41.71 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.144 1.896 . . . . 0.84999999999999998 111.488 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.579 HD23 ' HD3' ' A' ' 124' ' ' LYS . 6.8 mt -77.82 129.96 36.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.907 0.384 . . . . 1.8999999999999999 111.277 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 70.8 m-20 -136.85 153.96 50.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.734 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.617 HG13 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -143.34 140.36 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.75 110.067 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.898 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.5 tt0 -137.35 115.58 11.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.021 0.439 . . . . 1.6699999999999999 111.79 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.671 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.2 m95 -98.43 119.5 37.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.965 -0.561 . . . . 0.22 110.826 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.86 120.64 42.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.406 -0.59 . . . . 0.40999999999999998 109.406 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 8.6 tt -108.83 125.84 65.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.305 0.483 . . . . 0.78000000000000003 112.305 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -112.97 103.26 55.63 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.83 -0.804 . . . . 1.25 108.83 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.8 Cg_exo -78.62 116.75 3.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.83 2.353 . . . . 0.53000000000000003 112.536 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.49 92.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.40999999999999998 111.23 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.91 -40.01 61.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.753 -0.658 . . . . 1.8200000000000001 111.566 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -82.83 158.48 22.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.31 0.576 . . . . 1.9399999999999999 111.671 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -69.12 -18.02 63.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.294 -0.867 . . . . 1.6599999999999999 111.872 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 70.7 mttt -69.46 152.43 44.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.939 -0.573 . . . . 1.74 111.853 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.51 127.89 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-O 121.781 0.801 . . . . 0.96999999999999997 109.229 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.74 40.01 26.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.288 -1.324 . . . . 1.77 111.431 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.59 143.9 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.442 -0.345 . . . . 1.96 111.089 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 73' ' ' LEU . 46.5 t -66.79 138.87 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.841 -0.8 . . . . 0.77000000000000002 108.841 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -134.27 -54.66 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.741 0.645 . . . . 1.1499999999999999 112.741 -177.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.827 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.92 130.73 49.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.283 -0.636 . . . . 0.28999999999999998 109.283 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.898 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 2.9 mp -139.77 163.81 31.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.3 111.48 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.89 ' HD1' HD13 ' A' ' 79' ' ' ILE . 34.5 t80 -139.36 103.02 4.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.461 -0.79 . . . . 1.3 109.413 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -144.42 159.82 42.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.072 -0.513 . . . . 0.89000000000000001 111.954 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.49 28.43 6.61 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.047 -0.597 . . . . 0.56999999999999995 112.851 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 73.91 1.32 3.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.557 0.206 . . . . 1.46 111.557 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 27.3 mttt -99.87 119.46 38.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 110.004 -0.369 . . . . 2.4100000000000001 110.004 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.89 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -81.23 130.21 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.004 -1.48 . . . . 1.6599999999999999 107.004 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.663 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -115.39 117.83 31.52 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.552 -0.749 . . . . 1.25 110.538 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.881 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -166.28 -48.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 1.2 107.345 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD1' ' HA2' ' A' ' 89' ' ' GLY . 10.3 m-20 -77.38 -33.57 55.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 114.72 -1.127 . . . . 2.1699999999999999 109.024 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -76.61 -28.77 56.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.739 -1.118 . . . . 5.0499999999999998 108.762 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.536 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -81.93 117.65 69.13 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 114.946 -1.024 . . . . 1.29 110.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.11 -40.33 59.94 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.64 1.56 . . . . 0.79000000000000004 110.267 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.72 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.7 m-20 -67.82 106.45 2.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.078 -0.649 . . . . 1.3600000000000001 110.22 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.8 mp 67.7 29.0 7.11 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.307 0.855 . . . . 1.6200000000000001 113.307 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.881 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 41.7 pttt -58.03 131.33 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.903 -0.498 . . . . 2.3900000000000001 111.409 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 82' ' ' ASP . . . 80.61 19.41 68.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.642 -0.789 . . . . 0.37 114.142 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.3 ptp180 -145.78 -47.4 0.21 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 114.295 1.22 . . . . 1.5900000000000001 114.295 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 71' ' ' ILE . 7.2 p -79.53 82.09 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 122.914 1.34 . . . . 0.20000000000000001 107.624 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.547 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.4 m80 -103.4 131.38 50.54 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 112.287 -2.233 . . . . 0.28999999999999998 112.25 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.13 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.7 m-85 -73.45 124.51 25.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.251 -0.58 . . . . 1.23 110.393 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 38' ' ' TYR . 17.3 p -75.72 34.17 0.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.568 -0.742 . . . . 0.46000000000000002 111.428 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.7 m -149.03 122.57 9.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.052 0.453 . . . . 1.2 110.87 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -91.48 11.61 23.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 2.2200000000000002 110.207 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -145.56 65.16 1.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.557 -0.905 . . . . 2.1400000000000001 108.557 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -55.66 -28.03 53.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.835 -1.075 . . . . 1.49 111.249 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.2 mttt -66.21 0.48 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.099 0.476 . . . . 2.04 112.067 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.5 p -89.98 -0.02 57.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 1.3999999999999999 111.255 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 98.36 -4.55 60.29 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.673 -0.775 . . . . 0.38 113.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -105.42 108.81 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.146 0.473 . . . . 1.4399999999999999 110.532 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -108.22 19.44 19.9 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 112.101 0.408 . . . . 0.42999999999999999 112.101 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 9.3 m -60.36 140.84 56.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.02 1.489 . . . . 1.04 115.02 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.13 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.51 130.44 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 114.831 -1.077 . . . . 0.31 110.849 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.698 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.1 OUTLIER -105.65 147.71 28.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.892 -0.781 . . . . 1.1499999999999999 108.892 177.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.68 120.02 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.27000000000000002 111.26 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.18 144.89 29.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.285 -0.87 . . . . 0.28999999999999998 110.787 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m120 53.21 60.18 3.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.059 -0.519 . . . . 1.52 112.176 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.28 176.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.255 0.55 . . . . 1.02 112.452 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -177.86 164.16 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.504 -0.771 . . . . 2.1299999999999999 110.073 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.757 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 88.0 mt -60.08 -36.22 76.9 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.749 0.278 . . . . 1.7 111.749 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.5 p -73.68 -10.03 59.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.602 0.239 . . . . 1.3200000000000001 111.389 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD2' HG11 ' A' ' 107' ' ' VAL . 11.0 t70 -72.92 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.593 -0.521 . . . . 1.5800000000000001 109.593 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -47.07 142.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 CA-C-N 115.748 -0.66 . . . . 0.41999999999999998 111.221 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 148.38 5.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.755 -1.212 . . . . 0.23999999999999999 114.181 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.759 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.7 m -59.12 130.01 44.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.025 -0.588 . . . . 0.31 111.772 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.676 ' OH ' HD21 ' A' ' 87' ' ' LEU . 45.3 m-85 -112.02 122.58 48.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.268 -0.424 . . . . 1.24 110.017 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.0 tt0 -119.96 118.41 30.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.621 -0.263 . . . . 1.1599999999999999 110.71 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 29.7 p -101.52 119.65 39.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 1.03 110.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 83.3 mttt -110.65 110.19 20.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 1.76 110.2 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG13 ' A' ' 55' ' ' ILE . 59.8 t -89.99 106.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.1799999999999999 109.646 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 7.4 ttpm? -91.15 117.35 29.55 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.365 0.506 . . . . 1.6200000000000001 112.365 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HD3' HD23 ' A' ' 53' ' ' LEU . 7.1 ttpm? -145.3 101.92 3.66 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.502 -0.555 . . . . 2.8399999999999999 109.502 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.7 129.8 36.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 113.534 0.938 . . . . 0.44 113.534 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 64.3 Cg_endo -101.95 48.84 1.89 Allowed 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 125.026 -0.823 . . . . 0.56000000000000005 111.988 -0.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -142.01 103.7 0.34 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.577 -0.82 . . . . 0.47999999999999998 113.634 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -96.88 132.04 42.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.045 -1.078 . . . . 1.22 109.888 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.523 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.82 147.01 32.37 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.282 0.475 . . . . 0.56999999999999995 112.282 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.616 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 52.8 p-10 -147.51 161.7 40.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.866 0.691 . . . . 2.0299999999999998 112.866 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.88 ' HE3' ' HA ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -145.27 160.65 41.17 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 2.9500000000000002 109.929 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -97.19 145.02 26.45 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.731 1.382 . . . . 2.2599999999999998 114.731 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.772 HD11 ' O ' ' A' ' 40' ' ' PRO . 93.1 mt -143.59 115.11 2.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 114.55 -1.204 . . . . 0.28000000000000003 108.624 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.759 ' CD2' HG23 ' A' ' 117' ' ' THR . 52.7 m170 -100.02 120.05 39.22 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.033 -0.417 . . . . 0.55000000000000004 111.124 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.807 HD21 ' HB1' ' A' ' 37' ' ' ALA . 1.1 tm? -89.48 128.33 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 1.52 111.846 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 135' ' ' LEU . 62.4 t -116.93 130.0 72.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.32000000000000001 109.818 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 33' ' ' LYS . 16.4 t -95.26 121.22 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.156 0.428 . . . . 1.0800000000000001 112.156 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.802 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 64.3 mt -88.57 167.17 13.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.052 -0.522 . . . . 0.52000000000000002 109.811 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 121.405 0.622 . . . . 1.48 111.784 -178.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.051 0.453 . . . . 1.8400000000000001 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -140.96 136.0 33.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.744 -0.662 . . . . 2.1499999999999999 110.304 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -94.94 146.9 23.92 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.57 0.7 . . . . 1.1200000000000001 111.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.92 83.07 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 114.755 -1.112 . . . . 0.65000000000000002 111.352 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.04 -85.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.701 2.934 . . . . 0.88 112.676 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 99.2 mt-10 -78.41 120.26 22.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.023 -0.732 . . . . 2.0600000000000001 109.023 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.485 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.2 tt0 -144.36 160.5 40.93 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.376 1.25 . . . . 1.71 114.376 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.701 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 93.9 mtp -133.49 129.84 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.939 -1.028 . . . . 1.8600000000000001 109.74 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.485 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.9 mm -122.07 130.69 74.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.39000000000000001 111.416 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.714 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 72.7 mt-10 -124.39 129.42 50.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.542 -0.299 . . . . 1.1899999999999999 110.802 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 36' ' ' THR . 54.4 tptt -141.79 160.04 40.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.767 0.317 . . . . 2.52 111.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.15 138.26 40.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.032 0.444 . . . . 0.39000000000000001 111.74 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 46.3 tttp -47.59 136.47 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.777 -0.647 . . . . 2.3500000000000001 112.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.79 -21.89 10.35 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.647 -0.706 . . . . 0.31 113.515 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.737 ' O ' HD13 ' A' ' 110' ' ' LEU . 79.5 mm-40 -77.69 -147.57 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.795 -1.187 . . . . 2.1099999999999999 107.795 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 107' ' ' VAL . 81.6 m -139.07 133.68 31.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.01 0.433 . . . . 0.33000000000000002 110.441 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.556 ' H ' HD11 ' A' ' 110' ' ' LEU . . . -99.83 117.56 34.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 0.26000000000000001 110.73 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.666 ' CD2' HG21 ' A' ' 94' ' ' THR . 64.7 t80 -79.25 120.29 23.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 1.4299999999999999 112.195 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 105' ' ' ILE . 21.1 mt -105.42 106.2 55.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.748 -0.834 . . . . 0.80000000000000004 108.748 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.0 Cg_exo -79.54 123.54 5.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.669 2.246 . . . . 0.41999999999999998 113.832 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 49.6 t -141.83 123.96 15.48 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.504 -0.771 . . . . 1.03 109.579 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 87.6 mttt -141.56 149.1 40.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.463 -0.79 . . . . 1.6599999999999999 110.144 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CG ' HG11 ' A' ' 122' ' ' VAL . 34.4 p90 -140.06 140.04 36.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.624 0.601 . . . . 1.26 112.624 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 140.05 29.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.254 -0.885 . . . . 1.3300000000000001 110.195 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.475 HD21 HD21 ' A' ' 53' ' ' LEU . 9.6 mp -95.99 117.41 30.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 2.1200000000000001 111.174 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.24 150.37 70.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 1.75 109.822 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.65 -41.88 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.126 1.884 . . . . 1.6100000000000001 111.06 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -74.7 -36.96 62.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.517 -0.765 . . . . 2.1800000000000002 110.473 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.646 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 33.6 t0 -70.21 72.51 0.45 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.4100000000000001 110.47 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -99.75 0.03 40.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 1.6399999999999999 111.061 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.03 159.96 53.34 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.94 -0.648 . . . . 0.55000000000000004 112.912 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.42 139.26 55.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.777 2.318 . . . . 0.84999999999999998 111.97 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 43' ' ' PHE . 86.9 mt -78.22 130.1 35.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.484 . . . . 1.8999999999999999 111.394 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.5 m-20 -134.88 159.98 39.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.613 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.667 HD13 ' HB1' ' A' ' 103' ' ' ALA . 27.4 mt -141.99 140.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.417 -0.81 . . . . 0.75 110.412 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 1.026 ' HA ' HD22 ' A' ' 73' ' ' LEU . 48.7 mt-10 -139.98 107.46 5.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.779 -0.368 . . . . 1.6699999999999999 111.394 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.4 m95 -95.12 126.09 40.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.22 111.521 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.581 HD21 HG22 ' A' ' 70' ' ' VAL . 89.8 mt -118.12 140.19 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.149 -0.686 . . . . 0.40999999999999998 109.149 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.876 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 2.4 tt -130.0 135.57 60.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.78000000000000003 112.335 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.1 m -114.11 104.05 54.95 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.168 -0.924 . . . . 1.25 108.998 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.9 Cg_exo -78.47 120.43 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.499 2.133 . . . . 0.53000000000000003 111.907 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.01 83.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.62 -0.718 . . . . 0.40999999999999998 111.215 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -75.28 -39.96 59.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 1.8200000000000001 111.459 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 39.5 m-20 -85.41 158.02 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.608 . . . . 1.9399999999999999 112.186 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.82 -14.59 62.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.103 -0.953 . . . . 1.6599999999999999 111.265 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 32.8 mttt -66.23 149.21 50.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.441 -0.799 . . . . 1.74 112.303 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -153.63 127.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 121.796 0.808 . . . . 0.96999999999999997 109.151 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.84 41.5 30.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.28 -1.327 . . . . 1.77 112.186 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -88.12 139.96 29.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 1.96 111.404 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.673 HG13 HD21 ' A' ' 73' ' ' LEU . 65.3 t -69.98 133.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.77000000000000002 110.372 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 86' ' ' ASP . 1.3 pp -134.75 -39.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.815 0.672 . . . . 1.1499999999999999 112.815 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 128.17 24.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.378 -0.601 . . . . 0.28999999999999998 109.378 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.026 HD22 ' HA ' ' A' ' 56' ' ' GLU . 6.9 mt -137.98 162.29 34.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 1.3 111.277 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.704 ' CD1' HD13 ' A' ' 79' ' ' ILE . 35.4 t80 -133.48 102.68 5.61 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.298 -1.371 . . . . 1.3 107.298 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 5.9 t -143.96 157.53 44.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.638 -0.71 . . . . 0.89000000000000001 111.731 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.99 29.79 3.49 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.256 -0.497 . . . . 0.56999999999999995 113.405 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.3 t0 73.83 1.0 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.739 0.274 . . . . 1.46 111.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.557 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -100.08 118.58 36.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 110.003 -0.369 . . . . 2.4100000000000001 110.003 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.2 mm -80.02 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 107.214 -1.402 . . . . 1.6599999999999999 107.214 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.771 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.7 m-85 -120.81 123.83 43.58 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.48 -0.782 . . . . 1.25 110.982 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.851 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.2 p-10 -165.96 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.818 -1.549 . . . . 1.2 106.818 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -79.8 -31.88 40.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.406 -1.27 . . . . 2.1699999999999999 109.519 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -72.95 -29.65 63.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.501 -1.296 . . . . 5.0499999999999998 107.501 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.604 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.12 118.72 73.03 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 114.346 -1.297 . . . . 1.29 109.979 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.0 Cg_endo -50.78 -43.2 47.77 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.428 1.418 . . . . 0.79000000000000004 110.602 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.877 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.4 m-20 -68.42 106.28 2.47 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.047 -0.524 . . . . 1.3600000000000001 111.145 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.8 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.1 mp 72.33 24.53 3.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.391 0.886 . . . . 1.6200000000000001 113.391 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.851 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 14.2 pttm -59.17 134.74 57.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.909 -0.494 . . . . 2.3900000000000001 111.51 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.462 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 80.42 16.6 75.61 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.659 -0.781 . . . . 0.37 113.993 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -143.02 -51.02 0.35 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 114.38 1.252 . . . . 1.5900000000000001 114.38 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.09 81.99 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 123.08 1.419 . . . . 0.20000000000000001 107.421 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.546 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.1 m80 -102.17 127.92 48.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.066 -2.333 . . . . 0.28999999999999998 112.62 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.129 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.7 m-85 -71.61 122.75 21.09 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 120.163 -0.615 . . . . 1.23 109.601 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.666 HG21 ' CD2' ' A' ' 38' ' ' TYR . 2.3 p -75.04 35.89 0.11 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.46000000000000002 111.214 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 48.1 m -149.09 125.78 11.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.953 0.406 . . . . 1.2 110.396 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.11 6.81 40.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.937 -0.574 . . . . 2.2200000000000002 110.383 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -145.92 65.12 1.22 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.583 -0.735 . . . . 2.1400000000000001 109.06 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.2 mp -59.06 -27.16 65.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.173 -0.921 . . . . 1.49 111.958 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -63.46 1.54 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 2.04 112.078 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 98' ' ' LEU . 18.4 t -90.02 0.03 57.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.586 -0.734 . . . . 1.3999999999999999 110.671 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.25 -8.46 48.8 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.964 -0.636 . . . . 0.38 113.001 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -94.77 114.13 25.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.125 0.488 . . . . 1.4399999999999999 110.594 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.667 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.55 13.32 24.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.661 -0.699 . . . . 0.42999999999999999 111.965 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 51.0 m -59.95 139.57 57.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 115.563 1.69 . . . . 1.04 115.563 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.129 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.41 129.7 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 114.343 -1.299 . . . . 0.31 110.294 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.4 p-10 -105.7 146.31 29.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.542 -0.91 . . . . 1.1499999999999999 108.542 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -95.37 122.8 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.118 0.485 . . . . 0.27000000000000002 110.746 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -91.08 145.16 24.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.638 -0.71 . . . . 0.28999999999999998 110.84 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 66.7 57.06 0.69 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 1.52 111.466 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -53.95 165.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 1.02 112.095 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.653 ' O ' HG21 ' A' ' 137' ' ' VAL . 10.7 pt20 -177.14 167.87 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.664 -0.698 . . . . 2.1299999999999999 110.996 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.436 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 89.2 mt -59.99 -37.37 79.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.852 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.6 p -73.24 -17.11 61.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.528 -0.305 . . . . 1.3200000000000001 111.687 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 92.2 m-20 -71.25 -20.01 62.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.723 -0.391 . . . . 1.5800000000000001 109.974 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -46.51 144.08 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.044 0 CA-C-N 116.179 -0.464 . . . . 0.41999999999999998 111.055 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 143.89 4.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.904 -1.141 . . . . 0.23999999999999999 113.834 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 m -59.05 130.6 47.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.143 -0.529 . . . . 0.31 112.009 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.876 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 28.9 m-85 -110.3 137.08 48.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 1.24 109.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.8 tt0 -126.87 122.17 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.638 -0.255 . . . . 1.1599999999999999 110.579 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.6 t -99.88 119.76 38.71 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.575 0.226 . . . . 1.03 110.679 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 58.0 mttm -115.25 108.69 16.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 1.76 110.849 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.784 HG11 ' CG ' ' A' ' 43' ' ' PHE . 40.9 t -91.3 108.35 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.619 -0.511 . . . . 1.1799999999999999 109.619 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 72.8 tttt -93.71 112.32 24.17 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.659 0.614 . . . . 1.6200000000000001 112.659 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.588 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 12.3 pttm -145.74 103.24 3.76 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 109.831 -0.433 . . . . 2.8399999999999999 109.831 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.59 129.73 13.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 113.158 0.799 . . . . 0.44 113.158 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.646 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 83.0 Cg_endo -102.67 39.93 4.0 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 C-N-CA 125.109 -0.788 . . . . 0.56000000000000005 111.423 -0.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -131.66 102.87 0.52 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-O 122.365 0.98 . . . . 0.47999999999999998 113.478 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 123' ' ' LYS . 1.3 m -96.67 135.05 32.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 113.505 -1.347 . . . . 1.22 108.76 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -132.05 154.19 49.65 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.763 -0.375 . . . . 0.56999999999999995 111.837 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 49.1 p-10 -146.09 149.31 33.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 111.519 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.35 165.57 28.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 2.9500000000000002 111.396 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -104.82 140.05 38.69 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 113.028 0.751 . . . . 2.2599999999999998 113.028 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.7 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 78.5 mt -145.2 112.18 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.375 -0.972 . . . . 0.28000000000000003 108.375 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.701 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 26.8 m170 -94.69 121.1 35.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.592 -0.443 . . . . 0.55000000000000004 111.254 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.07 120.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.127 0.489 . . . . 1.52 111.024 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.7 t -122.26 129.11 75.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.258 -0.883 . . . . 0.32000000000000001 109.089 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 111' ' ' GLN . 47.4 t -109.98 129.34 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.063 0.459 . . . . 1.0800000000000001 112.052 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.61 160.06 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.739 -0.664 . . . . 0.52000000000000002 109.504 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.372 0.606 . . . . 1.48 110.949 -179.362 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.805 0.336 . . . . 1.8400000000000001 110.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.722 HG21 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 pt -112.11 141.43 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.318 -0.401 . . . . 2.1499999999999999 111.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -93.17 155.05 17.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.64 0.733 . . . . 1.1200000000000001 111.724 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 45.87 83.14 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 114.574 -1.193 . . . . 0.65000000000000002 111.981 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 56.9 Cg_endo -78.55 -82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.745 2.964 . . . . 0.88 112.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.48 129.42 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.68 -0.859 . . . . 2.0600000000000001 108.68 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HB3' HG12 ' A' ' 133' ' ' ILE . 50.6 tp10 -143.76 159.62 42.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.812 1.042 . . . . 1.71 113.812 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 25.5 mtm -139.91 123.77 17.51 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.826 -1.079 . . . . 1.8600000000000001 109.376 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 133' ' ' ILE . 34.6 mm -120.02 130.04 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.39000000000000001 111.75 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.717 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.1 mt-10 -127.57 121.83 31.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.395 -0.366 . . . . 1.1899999999999999 110.413 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 48.0 mmtm -142.23 161.31 38.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.791 0.329 . . . . 2.52 111.44 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.4 136.55 39.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.39000000000000001 111.189 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 52.4 tttp -44.51 132.67 6.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 2.3500000000000001 111.329 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 90.12 -18.94 45.56 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.867 -0.606 . . . . 0.31 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.709 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.03 158.63 26.46 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.582 -0.896 . . . . 2.1099999999999999 108.582 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 35.0 m -89.08 125.42 35.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.747 -0.781 . . . . 0.33000000000000002 110.35 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.12 116.31 29.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.26000000000000001 110.264 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.18 114.97 18.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.795 -0.639 . . . . 1.4299999999999999 112.088 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 133' ' ' ILE . 31.6 mt -99.13 108.63 50.72 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.811 -0.811 . . . . 0.80000000000000004 108.811 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.62 122.78 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.555 2.17 . . . . 0.41999999999999998 113.907 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' HE3' ' A' ' 131' ' ' LYS . 4.3 t -141.0 125.19 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.062 -0.972 . . . . 1.03 109.016 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 83.2 mttt -141.08 148.4 40.09 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.25 0.548 . . . . 1.6599999999999999 111.706 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 53' ' ' LEU . 40.8 p90 -140.8 142.62 34.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 1.26 111.076 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 139.63 30.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.904 0.383 . . . . 1.3300000000000001 110.549 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.635 HD23 ' NZ ' ' A' ' 124' ' ' LYS . 32.4 mt -89.03 150.01 22.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 2.1200000000000001 111.756 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.9 m -150.33 139.88 13.47 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 109.698 -0.482 . . . . 1.75 109.698 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 5.7 Cg_endo -48.55 -25.4 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.544 2.163 . . . . 1.6100000000000001 112.144 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.667 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 17.5 pt-20 -78.49 -40.22 35.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.354 -0.384 . . . . 2.1800000000000002 111.473 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.528 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.1 m-20 -72.27 71.54 0.89 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.171 -0.612 . . . . 2.4100000000000001 109.68 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 47' ' ' PRO . 87.1 mt-30 -97.37 -4.92 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.712 -0.676 . . . . 1.6399999999999999 112.366 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.864 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.02 159.97 53.33 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.492 -0.861 . . . . 0.55000000000000004 112.805 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.43 123.77 12.81 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.363 2.042 . . . . 0.84999999999999998 111.693 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 43' ' ' PHE . 6.4 tt -78.17 110.2 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 1.8999999999999999 111.297 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 93.4 m-20 -127.83 103.78 7.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.391 0.615 . . . . 1.78 111.877 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 9.4 mt -91.68 113.31 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.974 -1.012 . . . . 0.75 110.04 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.866 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -107.39 120.55 42.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.249 0.833 . . . . 1.6699999999999999 113.249 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.918 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.3 m95 -97.0 119.99 36.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.22 109.924 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' OE2' ' A' ' 56' ' ' GLU . 92.0 mt -105.69 140.12 39.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.526 -0.546 . . . . 0.40999999999999998 109.526 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.1 tt -130.04 130.03 65.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.137 0.494 . . . . 0.78000000000000003 112.306 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 68' ' ' ASP . 26.4 t -119.31 101.89 48.83 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 108.67 -0.863 . . . . 1.25 108.67 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.0 Cg_exo -79.97 111.57 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.603 2.202 . . . . 0.53000000000000003 112.725 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.61 75.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.395 -0.82 . . . . 0.40999999999999998 110.864 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -85.6 17.88 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 1.8200000000000001 112.004 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 79.3 m-20 -149.64 163.07 38.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.328 0.585 . . . . 1.9399999999999999 111.677 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.96 -18.89 64.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.209 -0.905 . . . . 1.6599999999999999 111.868 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 78.9 mttt -69.31 150.38 47.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.114 -0.494 . . . . 1.74 111.46 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.7 135.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.636 1.208 . . . . 0.96999999999999997 110.047 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 60' ' ' SER . 1.5 p-10 43.63 39.38 2.36 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 112.536 -2.12 . . . . 1.77 112.08 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 1.96 110.869 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 73' ' ' LEU . 20.0 t -66.27 139.28 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.331 -0.618 . . . . 0.77000000000000002 109.331 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.895 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.17 -53.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.422 0.527 . . . . 1.1499999999999999 112.422 -177.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.95 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.76 130.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.857 -0.794 . . . . 0.28999999999999998 108.857 178.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.866 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.0 159.99 40.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.045 0.45 . . . . 1.3 111.487 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.892 ' HD1' HD13 ' A' ' 79' ' ' ILE . 47.3 t80 -134.09 103.61 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.3 110.03 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 47.5 t -143.54 156.15 44.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.555 0.576 . . . . 0.89000000000000001 112.555 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.02 32.99 9.6 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.953 -0.567 . . . . 0.56999999999999995 113.074 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 t0 70.13 4.3 4.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.573 0.225 . . . . 1.46 111.248 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.3 mttt -100.01 114.01 27.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.809 -0.441 . . . . 2.4100000000000001 109.809 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.892 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.83 -1.544 . . . . 1.6599999999999999 106.83 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -116.61 121.52 41.97 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.45 -0.795 . . . . 1.25 110.625 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.909 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.5 p-10 -165.7 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.747 -1.205 . . . . 1.2 107.747 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -78.9 -31.08 45.24 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.158 -0.928 . . . . 2.1699999999999999 109.376 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -75.78 -28.3 58.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.185 -1.043 . . . . 5.0499999999999998 108.185 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.609 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.1 m-85 -81.59 117.83 69.77 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-N 114.777 -1.101 . . . . 1.29 110.554 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.46 -42.8 40.75 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.602 1.535 . . . . 0.79000000000000004 110.352 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' O ' HG12 ' A' ' 71' ' ' ILE . 11.6 m-20 -67.28 106.18 1.97 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.105 -0.638 . . . . 1.3600000000000001 110.695 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.838 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 68.08 26.96 7.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.575 0.954 . . . . 1.6200000000000001 113.575 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.909 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 2.7 pttt -57.14 128.03 34.92 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.73 -0.606 . . . . 2.3900000000000001 111.616 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.05 18.59 57.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.589 -0.815 . . . . 0.37 114.225 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.6 ptp180 -145.6 -46.27 0.21 Allowed 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 114.336 1.235 . . . . 1.5900000000000001 114.336 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.99 82.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 123.102 1.429 . . . . 0.20000000000000001 107.555 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.56 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.6 m80 -102.67 128.44 49.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.235 -2.257 . . . . 0.28999999999999998 112.331 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.094 ' CD1' HG23 ' A' ' 105' ' ' ILE . 70.2 m-85 -72.25 124.07 24.3 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.338 -0.545 . . . . 1.23 110.075 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.6 HG21 ' CD1' ' A' ' 38' ' ' TYR . 10.8 p -75.13 34.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.4 -0.818 . . . . 0.46000000000000002 111.116 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 6.9 m -149.07 123.51 9.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.017 0.437 . . . . 1.2 110.856 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -90.95 10.89 24.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.784 -0.643 . . . . 2.2200000000000002 110.05 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -145.52 65.79 1.23 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.1400000000000001 108.416 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -56.24 -31.75 63.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 1.49 111.606 -178.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' HD11 ' A' ' 45' ' ' LEU . 71.9 mttt -66.23 1.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.04 111.979 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -89.45 -0.01 57.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.862 -0.608 . . . . 1.3999999999999999 111.023 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 100.85 -5.68 56.65 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.783 -0.722 . . . . 0.38 113.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 98' ' ' LEU . 95.9 m-20 -101.9 107.18 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.067 0.434 . . . . 1.4399999999999999 110.427 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -104.63 11.68 33.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.8 0.667 . . . . 0.42999999999999999 112.8 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 89.8 p -60.03 140.02 57.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.685 1.735 . . . . 1.04 115.685 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.094 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -131.23 130.02 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 114.197 -1.365 . . . . 0.31 110.507 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.703 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.4 p-10 -104.62 146.23 29.21 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.918 -0.771 . . . . 1.1499999999999999 108.918 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.14 120.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.021 0.439 . . . . 0.27000000000000002 111.543 -178.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.754 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.7 p -82.26 142.77 31.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.39 -0.823 . . . . 0.28999999999999998 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.431 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 27.9 m120 49.98 55.51 9.32 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.062 -0.517 . . . . 1.52 111.605 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 24.2 mt -44.55 89.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.566 1.321 . . . . 1.02 114.566 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.486 ' HG2' ' H ' ' A' ' 113' ' ' SER . 64.1 tt0 -60.09 145.38 46.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.708 -0.678 . . . . 2.1299999999999999 109.896 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.555 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -59.98 -40.04 87.74 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.188 0.518 . . . . 1.7 111.223 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 53.1 m -72.24 -9.98 59.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.505 -0.771 . . . . 1.3200000000000001 111.642 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.99 -19.95 63.32 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.149 -0.315 . . . . 1.5800000000000001 110.149 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.561 HG13 HG23 ' A' ' 137' ' ' VAL . 2.1 mt -43.33 145.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.41999999999999998 110.353 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.86 155.08 6.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 0.23999999999999999 112.808 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.557 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.19 138.38 57.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.198 0.444 . . . . 0.31 112.198 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.601 ' OH ' HD11 ' A' ' 87' ' ' LEU . 21.6 m-85 -119.3 135.1 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.58 . . . . 1.24 109.886 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 53.4 tt0 -127.61 119.94 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.184 -0.302 . . . . 1.1599999999999999 110.184 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 39.1 t -99.98 118.98 37.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.416 . . . . 1.03 110.065 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 82.2 mttt -116.62 104.75 11.71 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 120.982 -0.287 . . . . 1.76 111.418 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 55' ' ' ILE . 22.1 t -87.71 108.66 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.092 -0.707 . . . . 1.1799999999999999 109.092 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.592 ' HG3' HG12 ' A' ' 128' ' ' VAL . 39.3 ttpt -99.93 113.09 25.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.174 0.805 . . . . 1.6200000000000001 113.174 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.635 ' NZ ' HD23 ' A' ' 45' ' ' LEU . 6.7 ttpt -145.51 101.9 3.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.477 -0.564 . . . . 2.8399999999999999 109.477 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.864 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.22 133.13 41.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.683 -0.69 . . . . 0.44 112.714 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 40.0 Cg_endo -97.84 39.82 4.79 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 124.275 -1.135 . . . . 0.56000000000000005 112.966 -0.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.31 101.96 0.45 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.922 -1.133 . . . . 0.47999999999999998 113.496 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.7 m -96.82 140.02 18.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.576 -1.312 . . . . 1.22 109.301 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.07 152.0 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 0.56999999999999995 112.41 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.552 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 35.8 p-10 -146.59 151.7 37.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.248 0.462 . . . . 2.0299999999999998 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.722 ' NZ ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.08 160.0 42.08 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.904 -0.589 . . . . 2.9500000000000002 110.779 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.7 mttt -102.34 141.13 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.633 0.975 . . . . 2.2599999999999998 113.633 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.797 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 97.7 mt -141.75 116.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.28000000000000003 108.605 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 117' ' ' THR . 46.3 m170 -100.32 117.91 35.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.463 -0.495 . . . . 0.55000000000000004 110.752 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 63.5 tp -89.38 122.89 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.227 0.537 . . . . 1.52 112.411 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.717 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 47.7 t -120.02 126.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.423 -0.954 . . . . 0.32000000000000001 108.423 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 115' ' ' ILE . 46.2 t -109.95 125.66 67.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 112.223 0.453 . . . . 1.0800000000000001 112.223 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.5 mt -83.4 163.95 20.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.52000000000000002 109.614 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 139' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.854 0.835 . . . . 1.48 112.124 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.915 0.388 . . . . 1.8400000000000001 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 129' ' ' ALA . 70.8 mt -143.38 129.1 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 110.77 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 69.2 p -94.29 153.63 17.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.399 0.618 . . . . 1.1200000000000001 111.125 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 41.37 82.27 0.23 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 114.782 -1.099 . . . . 0.65000000000000002 112.347 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 59.9 Cg_endo -79.02 -84.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.83 3.02 . . . . 0.88 112.269 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.0 mt-10 -78.12 129.12 34.8 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.063 -1.088 . . . . 2.0600000000000001 108.063 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HB3' HG13 ' A' ' 133' ' ' ILE . 50.6 tp10 -144.09 159.21 43.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.414 1.265 . . . . 1.71 114.414 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.6 mtp -140.01 121.7 15.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.303 -1.317 . . . . 1.8600000000000001 108.913 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 HG12 HG23 ' A' ' 133' ' ' ILE . 37.3 mm -119.77 129.98 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.611 -0.268 . . . . 0.39000000000000001 111.252 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.8 pt-20 -129.82 126.76 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.355 . . . . 1.1899999999999999 110.891 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -142.13 162.05 36.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 2.52 110.858 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.08 40.59 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.197 0.444 . . . . 0.39000000000000001 112.197 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.629 ' HG3' HG12 ' A' ' 137' ' ' VAL . 87.2 mttt -43.85 141.53 1.57 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.208 -0.451 . . . . 2.3500000000000001 112.031 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.43 -24.99 4.58 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.749 -0.659 . . . . 0.31 113.003 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -80.07 160.58 25.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.214 -0.661 . . . . 2.1099999999999999 109.214 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.836 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 27.4 m -83.79 133.29 34.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.957 -0.697 . . . . 0.33000000000000002 110.449 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -95.45 118.43 32.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.989 0.423 . . . . 0.26000000000000001 110.773 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.991 ' HE1' HG21 ' A' ' 94' ' ' THR . 65.9 t80 -79.33 131.12 36.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.715 -0.675 . . . . 1.4299999999999999 112.66 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.816 HD12 HD12 ' A' ' 105' ' ' ILE . 15.7 mt -128.32 104.32 19.95 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 108.991 -0.744 . . . . 0.80000000000000004 108.991 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 95.8 Cg_endo -86.06 126.98 2.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.657 2.238 . . . . 0.41999999999999998 114.762 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.434 ' SG ' ' CE ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -141.93 126.1 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.288 -0.869 . . . . 1.03 109.588 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 27.8 mttp -141.04 117.0 10.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.399 0.619 . . . . 1.6599999999999999 110.983 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.791 ' CG ' HG11 ' A' ' 122' ' ' VAL . 29.0 p90 -92.84 139.84 30.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.935 -1.03 . . . . 1.26 111.031 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 143.3 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.415 . . . . 1.3300000000000001 110.91 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.2 mt -100.38 139.76 35.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 2.1200000000000001 111.525 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.423 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 5.3 m -158.93 147.13 13.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.583 . . . . 1.75 109.899 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.28 -23.73 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.44 2.094 . . . . 1.6100000000000001 113.082 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -74.47 -43.24 56.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 120.563 0.221 . . . . 2.1800000000000002 111.014 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 124' ' ' LYS . 1.2 p-10 -73.65 74.51 1.52 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.124 -0.63 . . . . 2.4100000000000001 109.503 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -90.64 -12.73 35.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 1.6399999999999999 112.106 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.66 159.95 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.292 -0.956 . . . . 0.55000000000000004 112.912 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 140.93 97.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.487 2.125 . . . . 0.84999999999999998 111.385 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.09 104.09 8.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.793 0.33 . . . . 1.8999999999999999 111.287 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 96.0 m-20 -114.92 103.29 10.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.64 0.734 . . . . 1.78 110.996 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.3 mt -95.07 126.53 47.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.046 -0.979 . . . . 0.75 110.709 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 73' ' ' LEU . 96.5 mt-10 -120.54 117.57 27.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.486 0.55 . . . . 1.6699999999999999 112.486 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.799 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -96.44 120.04 36.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.072 -0.344 . . . . 0.22 110.072 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.808 HD12 ' OE1' ' A' ' 119' ' ' GLN . 83.1 mt -108.76 140.25 42.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.36 -0.608 . . . . 0.40999999999999998 109.36 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.651 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.4 tt -129.91 130.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 0.78000000000000003 112.289 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.6 m -119.99 103.35 45.49 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.01 -0.995 . . . . 1.25 109.142 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 86.2 Cg_endo -78.31 119.11 4.47 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.655 2.237 . . . . 0.53000000000000003 112.367 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.05 87.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.40999999999999998 111.55 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD2' ' CD1' ' A' ' 112' ' ' LEU . 81.2 m-20 -76.56 -39.98 51.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.021 -0.536 . . . . 1.8200000000000001 112.138 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -84.43 160.01 20.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.348 0.594 . . . . 1.9399999999999999 112.214 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -69.84 -17.6 63.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.182 -0.917 . . . . 1.6599999999999999 111.798 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.7 mttp -65.9 147.14 53.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.849 -0.614 . . . . 1.74 111.02 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.83 127.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 CA-C-O 121.883 0.849 . . . . 0.96999999999999997 110.187 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 40.02 26.12 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.98 -1.464 . . . . 1.77 112.694 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.4 mt-30 -94.3 143.22 26.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.104 -0.238 . . . . 1.96 111.444 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.584 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.1 t -66.46 132.1 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 108.855 -0.795 . . . . 0.77000000000000002 108.855 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.939 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -123.48 -51.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.352 0.871 . . . . 1.1499999999999999 113.352 -176.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.032 HG21 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.81 105.3 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.699 0.761 . . . . 0.28999999999999998 108.949 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -109.72 155.09 21.99 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.136 -0.938 . . . . 1.3 111.078 -177.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.916 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 22.0 t80 -135.11 104.79 6.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 1.3 110.439 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.439 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 45.2 m -142.57 158.41 43.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.132 0.419 . . . . 0.89000000000000001 112.132 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.66 30.23 42.62 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.078 -0.582 . . . . 0.56999999999999995 112.729 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t0 72.62 2.28 4.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.612 0.244 . . . . 1.46 110.903 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 88.0 mttt -99.99 114.8 28.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.634 -0.506 . . . . 2.4100000000000001 109.634 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.916 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.07 116.99 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.114 -1.069 . . . . 1.6599999999999999 108.114 178.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.715 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 m-85 -100.09 125.93 46.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.914 -1.494 . . . . 1.25 110.46 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.884 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -164.43 -52.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.98 -21.43 43.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.214 -0.903 . . . . 2.1699999999999999 109.025 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -80.74 -27.42 36.86 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.15 -1.056 . . . . 5.0499999999999998 108.15 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.65 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.6 m-85 -86.24 116.67 66.71 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.086 . . . . 1.29 110.648 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.1 Cg_endo -47.98 -40.99 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.439 1.426 . . . . 0.79000000000000004 110.234 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' ILE . 65.5 m-20 -66.97 105.71 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.237 -0.585 . . . . 1.3600000000000001 110.825 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.821 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.7 mt 66.88 24.82 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.608 0.966 . . . . 1.6200000000000001 113.608 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 65.3 pttt -57.25 132.93 54.48 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.988 -0.685 . . . . 2.3900000000000001 111.141 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.415 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 87.79 14.83 62.41 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.417 -0.897 . . . . 0.37 114.015 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.821 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -142.95 -50.85 0.35 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.826 1.417 . . . . 1.5900000000000001 114.826 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 HG21 ' A' ' 72' ' ' ILE . 7.2 p -79.18 81.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 123.319 1.533 . . . . 0.20000000000000001 107.363 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.613 ' C ' HG22 ' A' ' 105' ' ' ILE . 13.5 m80 -100.22 131.55 46.1 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 111.806 -2.452 . . . . 0.28999999999999998 111.756 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.081 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.1 m-85 -70.78 120.03 15.78 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 121.696 0.76 . . . . 1.23 110.719 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.991 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -70.01 -8.11 46.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.46000000000000002 110.608 179.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 67.9 m -87.09 116.23 25.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.316 -0.402 . . . . 1.2 111.13 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.81 0.07 57.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.225 0.536 . . . . 2.2200000000000002 109.965 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -146.2 65.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.596 -0.89 . . . . 2.1400000000000001 108.596 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.702 HD22 ' CE1' ' A' ' 74' ' ' TYR . 6.8 tt -58.15 -32.73 68.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.245 -0.889 . . . . 1.49 111.52 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.52 -8.65 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.293 0.568 . . . . 2.04 111.717 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.6 m -88.52 -0.04 56.81 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.187 -0.915 . . . . 1.3999999999999999 110.813 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 103.24 -12.32 55.2 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.734 . . . . 0.38 113.749 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 64.9 m-20 -95.06 109.96 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.159 0.48 . . . . 1.4399999999999999 110.432 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -117.79 24.75 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.653 0.612 . . . . 0.42999999999999999 112.653 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 10.0 m -61.42 154.6 23.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.27 1.211 . . . . 1.04 114.27 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.081 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -136.45 146.06 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.81 -1.086 . . . . 0.31 111.719 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.617 ' HB2' HG22 ' A' ' 36' ' ' THR . 22.6 p30 -121.73 142.55 50.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.877 -1.157 . . . . 1.1499999999999999 107.877 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.836 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -97.43 121.84 48.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.065 0.459 . . . . 0.27000000000000002 111.205 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 145.75 28.71 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 111.911 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.11 60.92 3.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.877 0.695 . . . . 1.52 112.877 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 31' ' ' LYS . 10.2 mt -47.01 172.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.286 0.565 . . . . 1.02 112.397 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -176.6 160.01 1.94 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.997 -1.001 . . . . 2.1299999999999999 109.601 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.753 HD13 ' O ' ' A' ' 112' ' ' LEU . 1.2 tm? -59.06 -34.13 71.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.454 0.538 . . . . 1.7 112.454 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.38 -12.03 60.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.809 0.3 . . . . 1.3200000000000001 111.809 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 98.5 m-20 -72.34 -20.95 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.5800000000000001 109.896 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.3 143.25 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 116.089 -0.505 . . . . 0.41999999999999998 111.072 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 141.05 147.36 4.91 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.722 -1.227 . . . . 0.23999999999999999 113.922 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.583 HG23 ' CD2' ' A' ' 134' ' ' HIS . 96.2 m -59.34 130.03 44.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.059 -0.57 . . . . 0.31 111.83 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.651 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 30.5 m-85 -109.81 132.56 54.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.921 -0.581 . . . . 1.24 109.584 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.808 ' OE1' HD12 ' A' ' 58' ' ' LEU . 61.8 tt0 -120.86 110.28 16.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 1.1599999999999999 110.027 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CE3' ' A' ' 57' ' ' TRP . 1.5 t -100.18 119.68 38.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.87 -0.604 . . . . 1.03 110.066 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.808 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.9 mtpt -122.52 112.97 18.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 1.76 111.172 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 43' ' ' PHE . 20.6 t -93.83 113.15 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.274 -0.639 . . . . 1.1799999999999999 109.274 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.764 ' HG2' HG12 ' A' ' 128' ' ' VAL . 46.3 mttp -91.54 127.43 36.99 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.201 1.186 . . . . 1.6200000000000001 114.201 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.718 ' HB3' ' HB2' ' A' ' 49' ' ' ASP . 9.5 mtmp? -145.98 101.88 3.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 2.8399999999999999 109.326 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.75 132.29 47.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.26 0.467 . . . . 0.44 112.26 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 54.3 Cg_endo -101.44 49.53 1.79 Allowed 'Cis proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.892 -0.879 . . . . 0.56000000000000005 111.707 -0.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.83 103.84 0.29 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.699 -0.762 . . . . 0.47999999999999998 112.926 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.764 HG12 ' HG2' ' A' ' 123' ' ' LYS . 26.9 m -83.38 127.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.742 -0.729 . . . . 1.22 110.217 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 22' ' ' ILE . . . -99.46 141.22 32.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.401 0.143 . . . . 0.56999999999999995 111.239 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.463 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.6 p-10 -145.76 136.47 24.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.985 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.639 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.33 157.16 44.1 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.724 -0.671 . . . . 2.9500000000000002 110.361 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 27' ' ' GLU . 96.8 mttt -104.57 140.08 38.52 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 113.329 0.863 . . . . 2.2599999999999998 113.329 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.624 HD13 ' CH2' ' A' ' 57' ' ' TRP . 3.2 mt -140.97 120.0 11.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.317 -0.856 . . . . 0.28000000000000003 109.339 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.583 ' CD2' HG23 ' A' ' 117' ' ' THR . 14.6 m170 -102.58 120.53 40.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.55000000000000004 110.897 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.517 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.3 tm? -87.92 120.0 28.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.066 0.46 . . . . 1.52 111.124 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 59.1 t -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.373 -0.831 . . . . 0.32000000000000001 109.316 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 33' ' ' LYS . 18.0 t -100.7 134.08 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.444 0.535 . . . . 1.0800000000000001 112.444 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 58.7 mt -83.05 150.01 26.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.983 -0.747 . . . . 0.52000000000000002 108.983 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 122.063 0.935 . . . . 1.48 112.836 -177.836 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.105 0.479 . . . . 1.8400000000000001 111.154 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.914 HG12 ' HB1' ' A' ' 129' ' ' ALA . 73.1 mt -100.14 117.68 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.382 -0.826 . . . . 2.1499999999999999 111.189 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' CE ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -92.25 131.41 37.48 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.373 0.606 . . . . 1.1200000000000001 110.02 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 82.0 0.25 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 122.124 0.964 . . . . 0.65000000000000002 110.292 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.6 Cg_endo -77.79 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.329 -0.488 0 C-N-CA 123.882 3.055 . . . . 0.88 112.966 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.5 mt-10 -78.48 125.31 29.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 2.0600000000000001 108.661 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.5 tt0 -143.96 160.02 41.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.855 1.057 . . . . 1.71 113.855 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 29' ' ' ILE . 49.0 ttp -136.74 135.57 38.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.805 -1.089 . . . . 1.8600000000000001 109.471 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.6 mm -130.03 136.42 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.969 -0.559 . . . . 0.39000000000000001 111.436 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 83.8 mt-10 -129.86 123.51 31.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.647 0.26 . . . . 1.1899999999999999 110.925 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' HD11 ' A' ' 110' ' ' LEU . 26.4 mmtt -141.93 153.22 44.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.726 0.298 . . . . 2.52 111.429 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.0 142.35 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 0.39000000000000001 111.228 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 94.8 mttt -41.28 159.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.373 0.606 . . . . 2.3500000000000001 112.178 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.63 -24.22 0.13 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.278 -0.874 . . . . 0.31 113.879 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 33' ' ' LYS . 98.9 mt-10 -80.06 160.03 25.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.416 -0.587 . . . . 2.1099999999999999 109.416 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 40.8 m -86.51 128.93 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.24 -0.584 . . . . 0.33000000000000002 110.831 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 118.28 36.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.189 0.519 . . . . 0.26000000000000001 110.254 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.4 t80 -79.19 122.92 26.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.726 -0.67 . . . . 1.4299999999999999 112.338 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.716 ' HB2' HD12 ' A' ' 105' ' ' ILE . 30.8 mt -110.03 104.67 56.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.39 -0.967 . . . . 0.80000000000000004 108.39 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' O ' HD11 ' A' ' 133' ' ' ILE . 86.9 Cg_endo -82.12 133.11 7.51 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.508 2.139 . . . . 0.41999999999999998 115.262 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.93 126.6 19.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.301 -1.318 . . . . 1.03 107.519 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.12 112.32 7.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.329 0.585 . . . . 1.6599999999999999 111.609 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.715 ' HB3' HG11 ' A' ' 122' ' ' VAL . 41.8 p90 -100.04 139.01 36.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.05 -0.977 . . . . 1.26 111.205 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 45' ' ' LEU . 19.5 m -79.93 165.98 22.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.683 -0.488 . . . . 1.3300000000000001 109.683 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 43' ' ' PHE . 98.0 mt -132.27 148.12 52.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.446 0.641 . . . . 2.1200000000000001 112.417 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.5 t -160.16 147.92 12.91 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.965 -1.016 . . . . 1.75 109.542 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.57 -21.57 5.44 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.438 2.092 . . . . 1.6100000000000001 113.236 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.3 pt-20 -76.38 -41.16 48.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 121.177 -0.209 . . . . 2.1800000000000002 111.194 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -73.03 79.21 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.294 -0.632 . . . . 2.4100000000000001 109.294 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -100.01 4.99 45.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 112.076 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.904 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.77 168.87 52.84 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.379 -0.915 . . . . 0.55000000000000004 113.383 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.0 131.28 23.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.743 2.296 . . . . 0.84999999999999998 111.562 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 124' ' ' LYS . 7.0 tp -78.51 110.03 13.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 1.8999999999999999 111.856 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -126.94 103.5 7.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.415 0.626 . . . . 1.78 110.49 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.4 120.06 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.06 -0.973 . . . . 0.75 111.065 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.913 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 97.6 mt-10 -109.75 119.97 41.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.187 0.44 . . . . 1.6699999999999999 112.187 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.996 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.6 m95 -95.36 119.98 34.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.856 -0.338 . . . . 0.22 110.155 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.98 138.95 40.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.138 -0.69 . . . . 0.40999999999999998 109.138 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -130.02 130.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.13 0.49 . . . . 0.78000000000000003 112.264 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.1 m -122.74 102.75 38.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.555 -0.748 . . . . 1.25 109.331 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.602 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 93.8 Cg_endo -79.04 116.0 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.519 2.146 . . . . 0.53000000000000003 111.902 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.98 87.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.40999999999999998 111.588 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.61 -40.01 57.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.191 -0.459 . . . . 1.8200000000000001 111.636 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.3 m120 -84.23 160.04 20.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.293 0.568 . . . . 1.9399999999999999 112.137 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.72 -18.66 64.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.32 -0.855 . . . . 1.6599999999999999 111.7 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.602 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 68.0 mttm -67.13 149.03 51.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.022 -0.535 . . . . 1.74 111.186 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.61 127.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-O 121.902 0.858 . . . . 0.96999999999999997 109.99 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.25 39.96 31.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.58 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.05 144.05 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.553 -0.166 . . . . 1.96 110.553 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' CG1' HD12 ' A' ' 73' ' ' LEU . 23.6 t -66.01 130.0 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.657 -0.417 . . . . 0.77000000000000002 109.895 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.922 ' CG1' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -117.15 -54.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.753 0.649 . . . . 1.1499999999999999 112.753 -177.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.861 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.29 131.26 48.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.444 -0.947 . . . . 0.28999999999999998 108.444 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.913 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.01 158.5 43.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.228 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 79' ' ' ILE . 38.1 t80 -135.58 103.31 5.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 1.3 109.823 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 21.3 t -144.58 160.04 41.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.765 -0.652 . . . . 0.89000000000000001 112.352 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.95 31.34 5.57 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 113.017 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 3.14 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.535 0.207 . . . . 1.46 111.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -99.95 115.66 30.2 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.429 -0.582 . . . . 2.4100000000000001 109.429 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.927 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 107.219 -1.4 . . . . 1.6599999999999999 107.219 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.722 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 2.8 m-85 -114.92 117.77 31.6 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.397 -0.82 . . . . 1.25 110.065 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 9.7 p-10 -165.94 -49.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.127 -1.434 . . . . 1.2 107.127 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD1' ' CE1' ' A' ' 83' ' ' TYR . 12.1 p-10 -80.13 -26.98 39.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.575 -1.193 . . . . 2.1699999999999999 108.749 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 36.3 m-85 -80.84 -29.54 35.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.021 -1.103 . . . . 5.0499999999999998 108.021 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.8 m-85 -82.33 110.32 20.74 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 115.014 -0.994 . . . . 1.29 109.794 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 25.9 Cg_exo -63.1 -28.56 74.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.086 1.857 . . . . 0.79000000000000004 113.119 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.972 ' O ' HD12 ' A' ' 87' ' ' LEU . 20.1 m-20 -48.71 -33.32 9.93 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.213 -0.595 . . . . 1.3600000000000001 112.045 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.3 mp -153.06 32.44 0.48 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.03 -0.986 . . . . 1.6200000000000001 110.186 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 56.1 pttt -53.38 127.63 25.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.475 0.546 . . . . 2.3900000000000001 112.475 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.52 15.91 57.73 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.487 -0.779 . . . . 0.37 114.639 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.4 ptp180 -145.87 -45.31 0.21 Allowed 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 114.594 1.331 . . . . 1.5900000000000001 114.594 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.861 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.7 p -79.91 81.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.868 1.318 . . . . 0.20000000000000001 107.782 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.537 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.0 m80 -102.62 128.88 49.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.654 -2.067 . . . . 0.28999999999999998 112.684 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.8 m-85 -70.7 122.77 20.43 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 121.227 0.537 . . . . 1.23 110.016 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 38' ' ' TYR . 30.3 p -77.58 34.84 0.18 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.518 -0.765 . . . . 0.46000000000000002 111.395 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 m -149.05 125.14 10.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.939 0.4 . . . . 1.2 110.275 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -90.0 8.47 32.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.94 -0.573 . . . . 2.2200000000000002 110.303 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.2 66.53 1.19 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.668 -0.864 . . . . 2.1400000000000001 108.668 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.62 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.9 mp -58.45 -33.11 69.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.107 -0.951 . . . . 1.49 111.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.27 0.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 2.04 112.166 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 98' ' ' LEU . 52.6 m -89.95 0.02 57.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.625 -0.716 . . . . 1.3999999999999999 111.18 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.578 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 107.88 -14.59 37.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.69 -0.767 . . . . 0.38 113.295 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.955 0.377 . . . . 1.4399999999999999 110.735 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.24 20.01 16.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.387 . . . . 0.42999999999999999 111.998 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.2 p -60.11 144.73 49.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.939 1.459 . . . . 1.04 114.939 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.04 131.84 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 114.588 -1.187 . . . . 0.31 110.581 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -105.51 150.09 25.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.734 -0.839 . . . . 1.1499999999999999 108.734 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.46 119.84 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.923 0.392 . . . . 0.27000000000000002 110.652 -179.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -84.96 144.66 28.18 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.583 -0.735 . . . . 0.28999999999999998 111.049 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 54.42 59.98 3.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 1.52 112.121 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.6 mt -45.52 177.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.271 0.558 . . . . 1.02 112.395 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.708 ' O ' HG21 ' A' ' 137' ' ' VAL . 11.5 pt20 -177.24 166.7 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.485 -0.78 . . . . 2.1299999999999999 110.291 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.61 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 58.8 tp -60.04 -39.93 87.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 1.7 111.577 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 70.2 m -73.22 -10.03 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.393 . . . . 1.3200000000000001 112.062 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 110' ' ' LEU . 90.7 m-20 -71.85 -22.35 61.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.528 -0.469 . . . . 1.5800000000000001 109.735 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 142.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 110.186 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 150.87 5.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.2 -1.0 . . . . 0.23999999999999999 113.7 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.586 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.29 130.64 47.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.137 -0.532 . . . . 0.31 112.375 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 43.8 m-85 -114.49 124.55 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.444 -0.576 . . . . 1.24 109.444 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.0 tt0 -123.37 119.22 29.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.117 -0.233 . . . . 1.1599999999999999 110.765 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.546 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 15.5 p -105.05 119.91 40.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 1.03 110.362 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 41.2 mtmt -111.77 107.81 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 1.76 110.659 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.7 p -88.0 113.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 1.1799999999999999 110.033 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.8 tttt -96.55 116.35 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.372 0.508 . . . . 1.6200000000000001 112.372 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.714 ' HB2' HD12 ' A' ' 53' ' ' LEU . 25.7 tttp -145.65 102.48 3.69 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.402 -0.519 . . . . 2.8399999999999999 109.849 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.904 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.68 134.0 36.15 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.918 -0.583 . . . . 0.44 111.878 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 93.3 Cg_endo -100.02 49.9 1.73 Allowed 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.627 -0.989 . . . . 0.56000000000000005 111.606 -0.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.34 103.26 0.27 Allowed Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.147 -1.025 . . . . 0.47999999999999998 113.939 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.443 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -87.86 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 1.22 108.804 176.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.914 ' HB1' HG12 ' A' ' 22' ' ' ILE . . . -140.96 146.86 37.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.309 0.485 . . . . 0.56999999999999995 112.309 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.457 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 53.7 p30 -146.73 150.93 36.33 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.198 -0.455 . . . . 2.0299999999999998 111.374 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.614 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -145.64 159.99 42.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.166 -0.47 . . . . 2.9500000000000002 110.763 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 66.9 mttm -100.25 140.11 34.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.841 1.052 . . . . 2.2599999999999998 113.841 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.64 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.7 mt -140.6 113.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.946 -1.025 . . . . 0.28000000000000003 108.289 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.586 ' CD2' HG23 ' A' ' 117' ' ' THR . 63.0 m170 -99.95 119.54 38.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.405 -0.518 . . . . 0.55000000000000004 110.995 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 110' ' ' LEU . 60.6 tp -91.31 122.52 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.945 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 59.7 t -120.01 127.18 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.826 -0.805 . . . . 0.32000000000000001 108.826 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.708 HG21 ' O ' ' A' ' 111' ' ' GLN . 33.5 t -98.9 131.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.46 0.541 . . . . 1.0800000000000001 112.46 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 85.8 mt -82.36 151.3 26.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.824 -0.625 . . . . 0.52000000000000002 109.824 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 121.678 0.751 . . . . 1.48 112.387 -178.39 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB2' HG21 ' A' ' 44' ' ' THR . 16.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.904 0.383 . . . . 1.8400000000000001 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -142.86 132.81 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 2.1499999999999999 110.321 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.21 150.3 22.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.676 0.75 . . . . 1.1200000000000001 111.725 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER 52.68 81.64 0.26 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.526 -1.215 . . . . 0.65000000000000002 112.464 -178.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.647 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -78.93 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.656 2.904 . . . . 0.88 111.857 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.57 126.85 31.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 2.0600000000000001 108.521 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 24' ' ' THR . 2.4 mm-40 -143.61 159.99 41.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.864 1.061 . . . . 1.71 113.864 -176.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.559 ' C ' HD12 ' A' ' 29' ' ' ILE . 49.5 ttp -138.93 132.26 30.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.55 -1.205 . . . . 1.8600000000000001 108.98 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.116 HD13 HG23 ' A' ' 133' ' ' ILE . 4.3 mp -130.0 139.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.943 -0.571 . . . . 0.39000000000000001 111.405 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.0 pt-20 -135.13 127.29 29.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.1899999999999999 111.134 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 56.0 tptt -141.9 157.52 44.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 2.52 110.742 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.5 144.34 39.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.934 0.397 . . . . 0.39000000000000001 111.746 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HG2' HG21 ' A' ' 137' ' ' VAL . 60.7 mttp -47.2 143.05 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.767 0.655 . . . . 2.3500000000000001 112.767 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 79.67 -21.8 4.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 114.858 -1.065 . . . . 0.31 113.307 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -81.39 160.65 24.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.708 -0.479 . . . . 2.1099999999999999 109.708 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.3 m -84.43 129.96 34.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.034 -0.667 . . . . 0.33000000000000002 110.679 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.899 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.39 117.43 34.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.26000000000000001 110.628 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.731 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.0 t80 -79.61 119.85 23.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.67 0.619 . . . . 1.4299999999999999 112.67 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.751 ' HB2' HD12 ' A' ' 105' ' ' ILE . 37.3 mt -106.31 111.58 64.17 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.502 -0.925 . . . . 0.80000000000000004 108.502 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 85.7 Cg_endo -85.26 131.71 4.26 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.385 2.056 . . . . 0.41999999999999998 115.648 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.9 t -141.36 130.0 22.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.461 -1.245 . . . . 1.03 108.254 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 33.0 mmtp -141.16 139.99 33.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.394 . . . . 1.6599999999999999 111.063 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 53.5 p90 -140.0 140.83 36.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 110.75 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 21' ' ' SER . 4.7 p -82.04 138.64 34.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 1.3300000000000001 111.967 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.24 139.97 33.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 2.1200000000000001 110.275 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 p -152.49 151.1 26.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.843 0.354 . . . . 1.75 110.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.34 -25.85 25.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.809 2.339 . . . . 1.6100000000000001 112.39 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 13.4 pt-20 -74.17 -39.99 62.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.494 -0.321 . . . . 2.1800000000000002 110.251 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.619 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -71.9 75.28 0.89 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.234 -0.654 . . . . 2.4100000000000001 109.234 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -91.98 -9.51 42.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.405 -0.816 . . . . 1.6399999999999999 111.691 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.948 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.0 160.0 53.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.324 -0.941 . . . . 0.55000000000000004 112.317 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.24 148.56 59.77 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.423 2.082 . . . . 0.84999999999999998 111.619 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 61.5 tp -77.69 131.6 37.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 1.8999999999999999 110.691 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 26.6 t0 -137.13 146.46 45.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.548 0.69 . . . . 1.78 110.951 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 40.9 mt -142.44 140.01 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.53 -1.214 . . . . 0.75 109.121 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 96.0 mt-10 -140.02 148.81 42.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.944 -0.302 . . . . 1.6699999999999999 111.187 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.944 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.0 m95 -140.48 119.16 12.4 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.22 110.828 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 70' ' ' VAL . 86.5 mt -109.86 146.33 35.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.728 -0.669 . . . . 0.40999999999999998 109.314 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.0 136.17 59.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.19 0.519 . . . . 0.78000000000000003 112.267 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 70.1 m -119.66 103.84 45.7 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 1.25 108.854 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 85.1 Cg_endo -78.31 112.07 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.53000000000000003 112.613 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.75 87.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.177 -0.92 . . . . 0.40999999999999998 110.922 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -73.96 -40.48 62.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 1.8200000000000001 111.416 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 94.3 m-20 -85.12 159.99 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 1.9399999999999999 111.652 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -69.17 -19.88 64.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.6599999999999999 111.173 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.542 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 57.7 mttt -70.0 150.63 46.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 1.74 111.298 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.65 127.83 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-O 121.732 0.777 . . . . 0.96999999999999997 109.249 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 61.14 88.12 0.09 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.366 -1.288 . . . . 1.77 111.969 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' ILE . 11.8 pt20 -140.44 141.84 35.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.794 0.331 . . . . 1.96 111.219 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 58' ' ' LEU . 61.7 t -71.74 129.38 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.77000000000000002 110.18 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CG1' HD12 ' A' ' 87' ' ' LEU . 1.4 pp -130.3 -38.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.347 0.499 . . . . 1.1499999999999999 112.347 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.907 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 126.3 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.258 -0.645 . . . . 0.28999999999999998 109.258 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -140.8 159.98 41.03 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.487 -0.779 . . . . 1.3 110.715 -178.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.79 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.2 t80 -134.86 103.75 5.73 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.997 -0.742 . . . . 1.3 108.997 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.452 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 13.0 t -142.7 160.01 41.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.89000000000000001 111.45 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.52 13.75 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.691 -0.766 . . . . 0.56999999999999995 112.356 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.29 0.34 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.457 0.17 . . . . 1.46 111.307 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -100.05 114.27 27.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.739 -0.467 . . . . 2.4100000000000001 109.739 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.61 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -79.4 134.02 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.107 -1.442 . . . . 1.6599999999999999 107.107 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.722 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -118.8 127.72 53.8 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 1.25 110.208 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.858 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.6 p-10 -165.82 -55.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.15 -1.426 . . . . 1.2 107.15 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 51.8 t0 -82.84 -27.54 30.75 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.785 -1.098 . . . . 2.1699999999999999 109.0 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.42 -30.04 61.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.7 -1.222 . . . . 5.0499999999999998 107.7 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.78 110.94 25.63 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.275 -1.33 . . . . 1.29 110.373 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.22 -43.12 13.29 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.843 1.695 . . . . 0.79000000000000004 111.505 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 71' ' ' ILE . 95.9 m-20 -67.95 103.75 1.56 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.181 -0.463 . . . . 1.3600000000000001 111.274 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.078 HD13 ' NH2' ' A' ' 90' ' ' ARG . 40.4 mt 73.58 21.48 2.85 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.965 0.728 . . . . 1.6200000000000001 112.965 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.858 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.8 pttt -56.78 132.24 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.97 -0.456 . . . . 2.3900000000000001 111.44 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 90.27 10.74 63.7 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.289 -0.958 . . . . 0.37 114.389 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 1.078 ' NH2' HD13 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -139.56 -49.73 0.49 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 114.781 1.4 . . . . 1.5900000000000001 114.781 -178.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.907 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.79 81.56 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.981 1.372 . . . . 0.20000000000000001 107.462 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.8 m80 -102.71 129.25 49.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.342 -2.208 . . . . 0.28999999999999998 112.475 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.3 m-85 -70.34 126.25 29.12 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.084 -0.646 . . . . 1.23 109.577 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.731 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.6 p -74.39 33.41 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.46000000000000002 112.693 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 t -149.16 140.03 22.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.1 0.476 . . . . 1.2 111.332 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -91.54 0.07 57.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.2200000000000002 110.648 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.61 67.45 1.17 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.294 0.568 . . . . 2.1400000000000001 109.506 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.91 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -56.99 -25.88 59.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 1.49 111.229 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HA ' HD22 ' A' ' 53' ' ' LEU . 63.6 mttt -64.93 1.28 0.95 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.165 0.507 . . . . 2.04 112.297 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.7 p -89.99 0.06 57.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.561 -0.745 . . . . 1.3999999999999999 110.714 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.45 -8.75 32.72 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.38 112.845 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -98.15 111.91 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.329 . . . . 1.4399999999999999 110.988 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.516 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -110.04 13.02 23.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.31 -0.404 . . . . 0.42999999999999999 111.424 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 54.5 m -59.98 140.0 57.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.389 1.625 . . . . 1.04 115.389 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.96 129.99 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.753 -1.112 . . . . 0.31 110.511 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.644 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.5 p30 -106.52 154.91 20.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.243 -0.651 . . . . 1.1499999999999999 109.243 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -98.35 124.31 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 120.966 0.413 . . . . 0.27000000000000002 111.364 -178.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -88.01 143.59 27.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.702 -0.681 . . . . 0.28999999999999998 110.92 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.2 m120 50.66 60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 1.52 111.888 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.9 mt -45.37 176.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.445 0.64 . . . . 1.02 112.464 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.405 ' HG2' ' OD2' ' A' ' 114' ' ' ASP . 13.3 pt20 -176.69 163.84 2.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.141 -0.936 . . . . 2.1299999999999999 110.082 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.775 ' HA ' HG11 ' A' ' 137' ' ' VAL . 2.0 tm? -60.03 -36.42 77.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 1.7 111.937 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -73.81 -14.43 61.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.056 0.391 . . . . 1.3200000000000001 112.056 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 96.4 m-20 -71.18 -22.02 62.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.408 -0.517 . . . . 1.5800000000000001 109.698 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.855 ' CD1' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.52 142.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.988 -0.551 . . . . 0.41999999999999998 110.91 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.05 150.92 5.47 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.704 -1.236 . . . . 0.23999999999999999 114.218 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.707 HG23 ' CD2' ' A' ' 134' ' ' HIS . 92.0 m -59.78 135.86 57.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.768 -0.716 . . . . 0.31 111.936 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 51.8 m-85 -120.0 139.68 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.24 110.105 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 58.4 tt0 -127.0 120.16 28.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 1.1599999999999999 109.982 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 48.7 t -98.4 118.21 34.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.055 -0.258 . . . . 1.03 110.684 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 57.4 mttt -115.81 105.22 12.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 1.76 111.008 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 89.5 t -95.34 108.18 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.41 -0.589 . . . . 1.1799999999999999 109.41 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 61.0 tttm -98.7 115.33 28.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.718 -0.793 . . . . 1.6200000000000001 112.118 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 50.0 tttm -145.65 102.35 3.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.483 -0.562 . . . . 2.8399999999999999 109.483 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.948 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.89 131.99 21.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 113.162 0.801 . . . . 0.44 113.162 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.619 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 47.2 Cg_endo -100.07 37.59 5.91 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.625 -0.99 . . . . 0.56000000000000005 111.627 -0.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.67 102.41 0.53 Allowed Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.313 -0.946 . . . . 0.47999999999999998 113.345 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.7 m -91.75 141.22 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 113.56 -1.32 . . . . 1.22 109.357 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -138.13 144.02 40.62 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.385 0.513 . . . . 0.56999999999999995 112.385 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 39.6 p-10 -146.26 140.41 26.49 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.587 . . . . 2.0299999999999998 110.783 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.9 164.13 32.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.582 -0.281 . . . . 2.9500000000000002 111.517 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.2 mttt -99.75 140.12 34.41 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.667 0.988 . . . . 2.2599999999999998 113.667 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.116 HG23 HD13 ' A' ' 29' ' ' ILE . 2.6 mp -140.57 111.91 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.926 -1.034 . . . . 0.28000000000000003 109.072 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.707 ' CD2' HG23 ' A' ' 117' ' ' THR . 62.9 m170 -101.03 120.02 39.58 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.596 -0.442 . . . . 0.55000000000000004 111.235 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 59.5 tp -91.02 123.5 34.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.017 -0.538 . . . . 1.52 111.884 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -119.95 121.45 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.32000000000000001 109.464 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.855 HG12 ' CD1' ' A' ' 115' ' ' ILE . 12.1 p -93.9 131.3 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 1.0800000000000001 111.92 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.5 mt -86.55 149.98 24.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.52000000000000002 109.722 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 121.773 0.797 . . . . 1.48 111.709 -179.02 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 70.6 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.223 0.535 . . . . 1.8400000000000001 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -140.01 140.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.369 -0.832 . . . . 2.1499999999999999 109.987 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -90.35 149.52 22.27 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.541 0.686 . . . . 1.1200000000000001 111.365 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.5 83.12 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-N 114.657 -1.156 . . . . 0.65000000000000002 111.232 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 56.1 Cg_endo -78.21 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.645 2.897 . . . . 0.88 112.278 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.41 127.59 32.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.555 -0.906 . . . . 2.0600000000000001 108.555 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.911 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -143.85 160.0 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.098 1.147 . . . . 1.71 114.098 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.73 122.8 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.586 -1.188 . . . . 1.8600000000000001 109.311 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.911 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.4 mm -120.01 123.5 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 0.39000000000000001 111.607 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.2 mt-10 -113.79 123.78 50.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.339 -0.391 . . . . 1.1899999999999999 110.421 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.56 154.61 45.56 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.087 0.403 . . . . 2.52 112.087 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.2 143.25 39.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.39000000000000001 112.219 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 137' ' ' VAL . 54.9 mtpt -48.81 143.22 5.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.295 0.569 . . . . 2.3500000000000001 112.422 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 -23.86 3.34 Favored Glycine 0 CA--C 1.516 0.13 0 CA-C-N 115.185 -0.916 . . . . 0.31 113.545 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.2 mm-40 -80.01 160.09 25.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.403 -0.592 . . . . 2.1099999999999999 109.403 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.1 m -85.72 129.99 34.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.965 -0.694 . . . . 0.33000000000000002 109.991 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.751 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.73 118.78 35.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.26000000000000001 110.983 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.986 ' HE1' HG21 ' A' ' 94' ' ' THR . 83.0 t80 -79.53 129.98 34.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.49 -0.777 . . . . 1.4299999999999999 112.223 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 105' ' ' ILE . 23.5 mt -124.6 104.5 30.91 Favored Pre-proline 0 C--N 1.333 -0.138 0 N-CA-C 108.903 -0.777 . . . . 0.80000000000000004 108.903 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.76 129.61 8.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.495 2.13 . . . . 0.41999999999999998 114.658 -177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.544 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 11.6 t -141.37 125.24 17.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.712 -1.131 . . . . 1.03 108.963 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 9.1 mtmm -140.65 144.78 35.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.771 -0.65 . . . . 1.6599999999999999 109.838 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.916 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.2 p90 -140.03 141.24 36.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.794 -0.639 . . . . 1.26 112.21 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 21' ' ' SER . 1.3 p -88.91 139.86 30.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.654 . . . . 1.3300000000000001 110.481 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -96.84 110.0 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.621 -0.263 . . . . 2.1200000000000001 110.744 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -84.52 137.74 38.83 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.843 -0.429 . . . . 1.75 109.843 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -44.89 -34.21 8.38 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.755 1.637 . . . . 1.6100000000000001 111.035 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.06 -40.03 47.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.403 -0.817 . . . . 2.1800000000000002 111.014 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 91.7 m-20 -72.76 73.8 1.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.304 -0.558 . . . . 2.4100000000000001 109.587 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.23 -0.02 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.889 -0.596 . . . . 1.6399999999999999 112.235 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.07 161.92 52.99 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.55000000000000004 113.159 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.87 137.86 60.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.695 2.264 . . . . 0.84999999999999998 112.21 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 43' ' ' PHE . 2.3 mt -78.59 106.8 10.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.8999999999999999 112.137 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.5 m-20 -119.36 102.41 8.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.519 0.676 . . . . 1.78 110.921 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.868 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 6.7 mt -99.04 111.39 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.873 -1.058 . . . . 0.75 111.029 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 73' ' ' LEU . 84.8 tt0 -107.43 120.69 42.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.278 0.844 . . . . 1.6699999999999999 113.278 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.946 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -94.82 119.99 34.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.352 -0.385 . . . . 0.22 110.127 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.0 mt -103.82 141.11 36.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.529 -0.545 . . . . 0.40999999999999998 109.529 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -130.01 138.06 54.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.072 0.767 . . . . 0.78000000000000003 113.072 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -132.02 102.96 14.37 Favored Pre-proline 0 N--CA 1.455 -0.195 0 CA-C-N 115.199 -0.909 . . . . 1.25 109.503 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 6.3 Cg_exo -80.17 122.06 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.587 2.191 . . . . 0.53000000000000003 112.38 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.73 73.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.40999999999999998 110.45 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.76 13.12 7.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.405 -0.816 . . . . 1.8200000000000001 112.066 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 81.9 m-20 -145.67 160.01 42.32 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.385 0.612 . . . . 1.9399999999999999 112.04 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -68.96 -19.47 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.008 -0.996 . . . . 1.6599999999999999 112.316 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.8 mtpt -67.71 140.03 56.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.042 0.448 . . . . 1.74 111.531 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.73 129.08 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 CA-C-O 121.935 0.874 . . . . 0.96999999999999997 109.546 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 34.71 21.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.031 -1.44 . . . . 1.77 111.858 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.76 142.16 27.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.492 -0.322 . . . . 1.96 110.56 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 6.1 t -66.25 131.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.731 -0.47 . . . . 0.77000000000000002 109.731 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.903 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.24 -50.58 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.64 0.607 . . . . 1.1499999999999999 112.64 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.976 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.04 125.79 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.792 -0.818 . . . . 0.28999999999999998 108.792 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 74' ' ' TYR . 8.6 tt -140.06 159.97 40.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 116.172 -0.467 . . . . 1.3 110.211 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.639 ' CD1' HG23 ' A' ' 79' ' ' ILE . 16.4 t80 -136.34 109.15 7.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 1.3 110.328 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.476 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.6 p -142.86 160.05 41.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.631 -0.713 . . . . 0.89000000000000001 111.561 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.56 39.22 53.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.728 -0.749 . . . . 0.56999999999999995 112.477 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.9 t0 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.026 0.441 . . . . 1.46 110.515 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 89.7 mttt -131.33 108.94 10.0 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.4100000000000001 110.631 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -79.89 118.51 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 107.125 -1.435 . . . . 1.6599999999999999 107.125 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.747 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.3 m-85 -100.79 136.11 41.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.795 -1.093 . . . . 1.25 110.612 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.81 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 13.9 p-10 -166.37 -55.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.854 -1.165 . . . . 1.2 107.854 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 12.5 t70 -79.26 -18.66 52.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.101 -0.954 . . . . 2.1699999999999999 109.209 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.35 -28.26 34.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.55 -0.907 . . . . 5.0499999999999998 108.55 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.571 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -85.8 114.28 55.99 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 114.949 -1.023 . . . . 1.29 111.161 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 88.8 Cg_exo -44.28 -42.36 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.611 1.541 . . . . 0.79000000000000004 110.595 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.694 ' O ' HG12 ' A' ' 71' ' ' ILE . 3.4 m-20 -66.99 104.88 1.48 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.252 -0.579 . . . . 1.3600000000000001 110.639 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.819 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 25.9 mt 67.43 23.29 9.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.826 1.047 . . . . 1.6200000000000001 113.826 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -54.84 128.63 33.97 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.601 -0.687 . . . . 2.3900000000000001 111.127 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.79 10.59 56.37 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.159 -1.02 . . . . 0.37 114.502 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.819 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -142.1 -46.43 0.35 Allowed 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 114.55 1.315 . . . . 1.5900000000000001 114.55 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.976 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -79.95 80.89 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-O 123.251 1.501 . . . . 0.20000000000000001 107.173 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.49 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.5 m80 -98.78 132.06 44.43 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.258 -2.246 . . . . 0.28999999999999998 111.615 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.103 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.6 m-85 -72.41 121.07 18.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.895 0.855 . . . . 1.23 111.222 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.986 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -69.48 -11.69 61.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.069 -1.423 . . . . 0.46000000000000002 109.914 178.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.8 m -95.22 120.01 34.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.025 -0.534 . . . . 1.2 110.929 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -90.64 4.82 50.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.034 -0.53 . . . . 2.2200000000000002 110.422 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -146.19 67.02 1.19 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.802 -0.814 . . . . 2.1400000000000001 108.802 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.1 mp -59.05 -35.04 72.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.216 -0.902 . . . . 1.49 111.886 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.93 -5.35 4.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 2.04 111.843 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -90.04 0.03 57.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.349 -0.841 . . . . 1.3999999999999999 110.963 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.01 -20.02 34.17 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.737 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.5 m-20 -96.04 109.34 21.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.361 0.58 . . . . 1.4399999999999999 110.414 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -114.86 25.58 10.83 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.816 0.673 . . . . 0.42999999999999999 112.816 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 43.4 t -59.95 146.15 43.47 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.27 1.582 . . . . 1.04 115.27 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.103 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.53 139.97 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 114.217 -1.356 . . . . 0.31 110.788 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.701 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.9 OUTLIER -118.18 148.51 42.29 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.302 -0.999 . . . . 1.1499999999999999 108.302 177.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.88 121.56 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 120.967 0.413 . . . . 0.27000000000000002 111.26 -178.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -84.06 145.7 28.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.514 -0.767 . . . . 0.28999999999999998 111.298 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.64 61.78 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.978 -0.555 . . . . 1.52 112.424 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.7 mt -46.86 173.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.322 0.582 . . . . 1.02 112.336 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.602 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -177.38 163.55 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 2.1299999999999999 110.137 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.06 -38.29 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.277 -0.419 . . . . 1.7 111.99 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.7 t -73.11 -14.21 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.11 0.411 . . . . 1.3200000000000001 112.11 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -72.83 -20.09 61.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.699 -0.4 . . . . 1.5800000000000001 110.183 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.45 146.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.202 -0.454 . . . . 0.41999999999999998 110.953 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.36 147.0 4.92 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 119.923 -1.132 . . . . 0.23999999999999999 113.788 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.752 HG23 ' CD2' ' A' ' 134' ' ' HIS . 47.2 m -59.27 138.3 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.378 -0.411 . . . . 0.31 111.755 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.6 m-85 -119.95 131.08 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 1.24 109.792 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.648 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -121.56 119.88 33.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.048 -0.261 . . . . 1.1599999999999999 110.383 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.458 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.7 t -99.51 111.17 23.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.578 -0.283 . . . . 1.03 110.455 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.868 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 74.3 mttt -106.61 104.74 14.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 1.76 110.812 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 43' ' ' PHE . 24.0 t -89.3 110.12 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 109.212 -0.662 . . . . 1.1799999999999999 109.212 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 87.8 tttt -95.79 122.92 39.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.309 0.855 . . . . 1.6200000000000001 113.309 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 3.9 mmtt -141.6 101.43 3.98 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.892 -0.781 . . . . 2.8399999999999999 108.892 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 1.0 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.34 132.61 61.87 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 112.507 0.558 . . . . 0.44 112.507 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.53 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 81.0 Cg_endo -100.0 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.646 -0.981 . . . . 0.56000000000000005 112.667 -0.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.3 103.38 0.29 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.696 -0.764 . . . . 0.47999999999999998 112.971 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 123' ' ' LYS . 2.0 t -90.16 151.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.623 -0.788 . . . . 1.22 110.087 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.86 152.13 43.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.218 . . . . 0.56999999999999995 111.535 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.517 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 17.6 p30 -146.49 151.9 38.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.05 0.389 . . . . 2.0299999999999998 112.05 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.15 161.23 40.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.106 -0.497 . . . . 2.9500000000000002 111.191 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 39.4 mttp -102.82 140.01 37.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.625 0.972 . . . . 2.2599999999999998 113.625 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.729 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 87.7 mt -143.83 110.66 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.372 -0.973 . . . . 0.28000000000000003 108.372 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.752 ' CD2' HG23 ' A' ' 117' ' ' THR . 47.4 m170 -98.46 120.01 38.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.55000000000000004 111.391 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.1 tm? -86.87 124.26 32.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 1.52 111.225 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.3 t -119.29 126.93 75.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.582 -0.735 . . . . 0.32000000000000001 109.433 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 111' ' ' GLN . 18.2 t -96.33 126.76 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.0800000000000001 112.054 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.2 mt -87.7 145.7 26.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.52000000000000002 109.078 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 122.249 1.023 . . . . 1.48 112.872 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 44' ' ' THR . 46.8 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.072 0.463 . . . . 1.8400000000000001 111.562 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 131' ' ' LYS . 19.2 tt -139.51 134.99 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 2.1499999999999999 110.399 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.43 156.91 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.515 0.674 . . . . 1.1200000000000001 111.706 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.31 83.25 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.576 -1.193 . . . . 0.65000000000000002 111.695 -178.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 59.3 Cg_endo -78.26 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.404 2.736 . . . . 0.88 112.6 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.59 125.55 29.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.072 -0.714 . . . . 2.0600000000000001 109.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.7 tt0 -144.33 163.95 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.846 1.054 . . . . 1.71 113.846 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.687 ' O ' HD13 ' A' ' 29' ' ' ILE . 55.4 ttm -138.72 139.4 38.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.72 -1.127 . . . . 1.8600000000000001 109.117 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.3 mm -132.72 139.37 49.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.214 0.449 . . . . 0.39000000000000001 112.214 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 21.9 pt-20 -140.23 124.63 17.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 1.1899999999999999 110.567 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -142.3 163.41 32.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.522 -0.308 . . . . 2.52 111.597 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.731 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.62 139.57 40.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.39000000000000001 111.467 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.35 130.35 16.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 2.3500000000000001 111.762 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.79 -19.15 47.02 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.31 112.695 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.731 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -79.99 160.01 26.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.37 -0.974 . . . . 2.1099999999999999 108.37 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 42.0 m -88.43 128.51 35.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.566 -0.853 . . . . 0.33000000000000002 110.352 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.987 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.8 113.92 26.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.26000000000000001 110.522 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.635 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.0 t80 -79.53 129.89 34.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.908 -0.587 . . . . 1.4299999999999999 112.387 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 133' ' ' ILE . 4.1 mp -120.17 107.64 39.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.424 -0.954 . . . . 0.80000000000000004 108.424 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.0 Cg_endo -82.8 104.66 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.451 2.101 . . . . 0.41999999999999998 115.944 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -105.58 126.12 51.77 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.165 -1.05 . . . . 1.03 108.165 175.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mttm -140.72 139.37 34.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.176 0.512 . . . . 1.6599999999999999 110.992 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.645 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 40.8 p90 -141.11 150.04 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.415 -0.811 . . . . 1.26 111.028 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' SER . 1.7 t -80.1 170.74 16.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 111.177 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD21 ' HE2' ' A' ' 43' ' ' PHE . 91.7 mt -138.19 141.19 40.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 2.1200000000000001 111.03 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 79.5 p -159.99 158.63 26.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.847 -0.615 . . . . 1.75 110.212 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 13.1 Cg_endo -56.24 -17.64 21.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.433 2.089 . . . . 1.6100000000000001 112.88 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -73.33 -43.72 60.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.685 0.278 . . . . 2.1800000000000002 110.534 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.46 76.63 1.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.069 -0.715 . . . . 2.4100000000000001 109.069 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.13 -11.54 43.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 1.6399999999999999 111.773 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.6 157.59 52.73 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.222 -0.989 . . . . 0.55000000000000004 112.29 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.81 150.9 27.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.334 2.022 . . . . 0.84999999999999998 111.321 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.765 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 4.1 mp -77.61 133.06 38.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.893 0.377 . . . . 1.8999999999999999 110.845 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 21.9 t0 -140.24 146.84 39.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.361 0.6 . . . . 1.78 111.753 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 6.6 mt -143.79 135.0 22.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.422 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.739 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.3 tt0 -140.61 119.9 12.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.668 0.667 . . . . 1.6699999999999999 112.667 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.889 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.0 m95 -100.2 124.85 46.12 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.174 -0.466 . . . . 0.22 111.377 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -106.87 120.34 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.843 -0.429 . . . . 0.40999999999999998 109.843 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' A' ' 71' ' ' ILE . 10.3 tt -104.06 124.42 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.506 0.558 . . . . 0.78000000000000003 112.506 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.8 m -118.33 101.9 50.8 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.64 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 98.9 Cg_endo -79.56 115.52 3.41 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.597 2.198 . . . . 0.53000000000000003 112.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.40999999999999998 110.944 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.94 -39.96 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 1.8200000000000001 111.8 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.561 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.4 m120 -85.43 161.87 19.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.39 0.614 . . . . 1.9399999999999999 112.28 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.63 -18.48 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.091 -0.958 . . . . 1.6599999999999999 111.741 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -68.49 150.91 47.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.906 -0.588 . . . . 1.74 111.333 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.59 127.69 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.113 0 CA-C-O 121.893 0.854 . . . . 0.96999999999999997 109.988 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 55.89 40.05 30.57 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 114.074 -1.421 . . . . 1.77 112.727 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.3 mt-30 -94.32 145.05 25.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.192 -0.203 . . . . 1.96 110.75 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG11 ' OH ' ' A' ' 84' ' ' TYR . 18.4 t -66.68 125.95 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.064 0.459 . . . . 0.77000000000000002 109.883 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -116.21 -53.72 4.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 1.1499999999999999 111.923 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.73 124.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.2 -1.037 . . . . 0.28999999999999998 108.2 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.852 HD23 ' N ' ' A' ' 74' ' ' TYR . 6.1 tt -135.32 157.09 47.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.806 -0.633 . . . . 1.3 109.772 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.901 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 12.1 t80 -136.91 104.08 5.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.758 -0.46 . . . . 1.3 109.758 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -143.15 158.26 43.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.89000000000000001 111.678 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.58 28.58 45.8 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.732 -0.747 . . . . 0.56999999999999995 112.472 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.53 2.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.545 0.212 . . . . 1.46 111.107 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 68.2 mttm -100.01 113.24 25.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 110.08 -0.341 . . . . 2.4100000000000001 110.08 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.901 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.87 116.52 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.879 -1.156 . . . . 1.6599999999999999 107.879 177.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.718 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.2 m-85 -100.03 128.19 46.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.819 -1.537 . . . . 1.25 110.908 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.758 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.2 p-10 -166.14 -53.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.222 -1.029 . . . . 1.2 108.222 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.8 t70 -80.17 -24.33 40.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.09 -0.959 . . . . 2.1699999999999999 109.371 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.25 -29.1 42.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.118 -0.946 . . . . 5.0499999999999998 108.5 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -82.35 115.9 60.57 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-N 114.795 -1.093 . . . . 1.29 110.552 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.2 Cg_endo -46.81 -40.99 25.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.729 1.619 . . . . 0.79000000000000004 110.373 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.721 ' O ' HG12 ' A' ' 71' ' ' ILE . 67.1 m-20 -66.98 105.22 1.57 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.824 -0.626 . . . . 1.3600000000000001 110.653 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.859 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.2 mt 68.02 24.56 7.82 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.862 1.06 . . . . 1.6200000000000001 113.862 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttt -55.61 127.5 30.18 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.627 -0.671 . . . . 2.3900000000000001 111.219 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.63 15.12 54.03 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.385 -0.912 . . . . 0.37 114.451 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.859 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp180 -144.14 -48.03 0.27 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 114.483 1.29 . . . . 1.5900000000000001 114.483 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.23 81.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.864 1.316 . . . . 0.20000000000000001 107.725 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.472 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.5 m80 -102.93 129.14 49.55 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.474 -2.148 . . . . 0.28999999999999998 112.326 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.117 ' CD1' HG23 ' A' ' 105' ' ' ILE . 77.0 m-85 -70.97 120.77 17.03 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 109.097 -0.705 . . . . 1.23 109.097 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.635 HG21 ' CE2' ' A' ' 38' ' ' TYR . 24.6 p -70.43 -10.01 57.97 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.22 -0.9 . . . . 0.46000000000000002 110.455 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 67.2 m -93.16 121.46 34.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.848 -0.615 . . . . 1.2 110.259 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.11 2.48 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.1 0.476 . . . . 2.2200000000000002 110.344 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -146.07 66.81 1.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.849 -0.797 . . . . 2.1400000000000001 108.849 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.598 HD22 ' CD2' ' A' ' 74' ' ' TYR . 5.9 mp -56.74 -28.98 62.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 1.49 111.466 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 55.6 mtmt -62.81 -6.23 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 2.04 111.809 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -87.55 -3.11 59.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.309 -0.86 . . . . 1.3999999999999999 110.733 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.645 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.57 -12.97 32.93 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.779 -0.724 . . . . 0.38 113.702 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -95.09 110.03 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.192 0.496 . . . . 1.4399999999999999 110.429 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -108.83 16.38 22.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.294 -0.412 . . . . 0.42999999999999999 111.916 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 6.0 m -60.16 140.02 57.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 116.104 1.891 . . . . 1.04 116.104 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.117 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.82 135.53 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.291 -1.322 . . . . 0.31 110.587 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.63 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -111.95 145.05 40.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.326 -0.99 . . . . 1.1499999999999999 108.326 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.03 120.02 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.063 0.459 . . . . 0.27000000000000002 111.443 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.774 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -83.15 143.96 30.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.369 -0.832 . . . . 0.28999999999999998 110.64 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 81.3 m-20 49.92 56.52 7.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.156 0.503 . . . . 1.52 111.359 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.987 HD11 ' HB2' ' A' ' 37' ' ' ALA . 21.4 mt -46.38 90.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.986 1.106 . . . . 1.02 113.986 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 47.5 mt-30 -56.58 149.03 18.27 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.948 -0.569 . . . . 2.1299999999999999 110.468 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.96 -37.05 78.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.28 -0.637 . . . . 1.7 109.28 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.55 -5.63 43.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 1.3200000000000001 111.542 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 90.0 m-20 -70.08 -19.18 63.28 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.615 -0.513 . . . . 1.5800000000000001 109.615 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -43.14 137.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 116.001 -0.545 . . . . 0.41999999999999998 110.452 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 141.04 158.8 7.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.893 -1.146 . . . . 0.23999999999999999 114.145 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.4 m -60.48 140.0 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.751 -0.724 . . . . 0.31 112.709 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.771 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 32.8 m-85 -125.12 125.38 43.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.023 -0.732 . . . . 1.24 109.023 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.73 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 24.6 tt0 -120.01 118.96 32.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.943 -0.303 . . . . 1.1599999999999999 110.727 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.2 t -97.81 118.58 34.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.999 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 31.9 mttm -114.07 106.38 14.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.76 110.858 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 48.9 t -92.18 104.67 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.229 -0.656 . . . . 1.1799999999999999 109.229 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 85.5 tttt -96.99 120.12 36.75 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.009 -0.676 . . . . 1.6200000000000001 112.65 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.765 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 10.3 mtmp? -141.81 102.87 4.25 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.693 -0.484 . . . . 2.8399999999999999 109.693 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.924 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.01 131.96 22.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 0.44 111.654 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 44.1 Cg_endo -101.89 46.83 2.26 Favored 'Cis proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.986 -0.839 . . . . 0.56000000000000005 111.69 -0.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.07 103.56 0.28 Allowed Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.328 -0.939 . . . . 0.47999999999999998 113.679 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.33 149.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.691 -0.754 . . . . 1.22 109.666 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -141.79 144.62 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.587 0.232 . . . . 0.56999999999999995 111.47 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 44.7 p-10 -146.72 148.6 32.16 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.316 0.487 . . . . 2.0299999999999998 112.316 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.804 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.31 160.72 41.09 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.018 -0.537 . . . . 2.9500000000000002 110.698 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 99.1 mttt -103.22 136.14 43.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.282 0.845 . . . . 2.2599999999999998 113.282 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 91.1 mt -145.24 113.47 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 108.708 -0.849 . . . . 0.28000000000000003 108.708 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -95.4 175.4 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.076 -0.65 . . . . 0.55000000000000004 109.907 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 110' ' ' LEU . 54.5 tp -144.07 133.05 22.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.864 -0.607 . . . . 1.52 112.255 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.4 t -129.98 129.99 65.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.383 -0.826 . . . . 0.32000000000000001 109.515 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 33.4 t -97.09 124.84 50.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.915 0.388 . . . . 1.0800000000000001 111.67 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.87 157.72 25.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.433 -0.58 . . . . 0.52000000000000002 109.433 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 1.48 111.106 -179.173 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.938 0.399 . . . . 1.8400000000000001 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.56 144.08 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 2.1499999999999999 110.991 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.48 139.95 34.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.744 0.783 . . . . 1.1200000000000001 112.025 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.95 81.11 0.27 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.344 -1.298 . . . . 0.65000000000000002 112.109 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.704 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 76.1 Cg_endo -79.62 -11.03 14.33 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 124.344 3.363 . . . . 0.88 113.338 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -140.67 125.26 17.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.546 -0.909 . . . . 2.0600000000000001 108.546 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.762 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -144.28 162.87 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 114.595 1.332 . . . . 1.71 114.595 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.713 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.8 ttm -137.92 137.12 37.7 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.491 -1.232 . . . . 1.8600000000000001 109.197 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.762 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.0 mm -134.5 139.99 46.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.269 -0.423 . . . . 0.39000000000000001 111.688 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 39.4 mt-10 -137.6 119.28 15.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.368 -0.378 . . . . 1.1899999999999999 110.295 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 110' ' ' LEU . 31.0 tptt -142.07 158.64 43.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.665 -0.243 . . . . 2.52 110.978 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.89 143.95 39.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.136 0.493 . . . . 0.39000000000000001 112.242 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 35.2 ttpt -48.93 131.18 18.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.799 -0.637 . . . . 2.3500000000000001 111.864 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.77 -19.84 38.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.488 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.726 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.7 mt-10 -79.9 158.43 26.68 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.239 -1.023 . . . . 2.1099999999999999 108.239 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.823 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.0 m -88.4 128.92 35.53 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.511 -0.876 . . . . 0.33000000000000002 110.976 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 117.7 34.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.26000000000000001 110.531 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 94' ' ' THR . 31.4 t80 -79.42 112.82 17.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.937 -0.574 . . . . 1.4299999999999999 111.712 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB2' HD12 ' A' ' 105' ' ' ILE . 40.6 mt -99.09 107.59 44.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.436 -0.95 . . . . 0.80000000000000004 108.436 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 95.4 Cg_endo -82.69 134.52 7.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.213 1.942 . . . . 0.41999999999999998 114.4 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 1.8 t -140.42 130.07 24.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.477 -1.238 . . . . 1.03 107.841 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.571 ' O ' HG22 ' A' ' 22' ' ' ILE . 30.3 mmtp -140.42 137.05 33.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.979 0.418 . . . . 1.6599999999999999 110.94 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HE1' ' HB2' ' A' ' 103' ' ' ALA . 53.2 p90 -140.28 154.25 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 1.26 110.976 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -80.02 169.96 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 1.3300000000000001 111.835 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.525 HD12 ' OD2' ' A' ' 49' ' ' ASP . 69.0 tp -139.98 132.78 29.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.378 -0.828 . . . . 2.1200000000000001 110.625 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -157.18 156.09 28.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.75 110.498 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.96 -19.21 31.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.442 2.094 . . . . 1.6100000000000001 112.529 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 12.6 pt-20 -75.44 -40.61 57.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.718 -0.219 . . . . 2.1800000000000002 110.84 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' OD2' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -72.29 75.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.238 -0.585 . . . . 2.4100000000000001 109.452 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -91.65 -4.47 55.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 1.6399999999999999 112.292 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.919 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -82.71 146.65 24.6 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 119.814 -1.184 . . . . 0.55000000000000004 112.292 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.1 131.08 44.25 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.153 1.902 . . . . 0.84999999999999998 111.393 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.748 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 1.1 pt? -77.64 133.77 38.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 1.8999999999999999 111.532 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 76.7 m-20 -134.38 102.38 5.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.819 0.819 . . . . 1.78 110.556 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.875 HG12 HG22 ' A' ' 122' ' ' VAL . 4.7 mt -92.36 108.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.225 -1.352 . . . . 0.75 110.564 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' CB ' HD12 ' A' ' 73' ' ' LEU . 85.6 tt0 -106.52 117.56 34.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.409 0.522 . . . . 1.6699999999999999 112.409 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.935 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -94.66 119.95 34.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.226 -0.287 . . . . 0.22 110.226 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.6 mt -107.69 143.88 35.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.958 -0.386 . . . . 0.40999999999999998 109.958 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 114' ' ' ASP . 11.1 tt -129.99 130.0 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 0.78000000000000003 112.05 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.1 m -117.57 102.82 51.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.888 -0.782 . . . . 1.25 108.888 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.677 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 72.0 Cg_endo -78.37 107.68 2.34 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.349 2.032 . . . . 0.53000000000000003 112.979 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.19 70.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.956 -1.02 . . . . 0.40999999999999998 110.365 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 5.7 p-10 -87.42 17.27 4.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.644 -0.707 . . . . 1.8200000000000001 111.204 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -152.86 162.61 41.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.208 0.528 . . . . 1.9399999999999999 111.837 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -67.19 -19.92 65.64 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.372 -0.831 . . . . 1.6599999999999999 112.258 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 62.8 mttp -70.06 152.09 44.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.263 -0.426 . . . . 1.74 111.321 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.8 128.67 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 CA-C-O 121.773 0.797 . . . . 0.96999999999999997 109.614 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.95 44.74 25.18 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.339 -1.301 . . . . 1.77 112.289 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' O ' HG22 ' A' ' 59' ' ' ILE . 90.6 mm-40 -87.29 134.54 33.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 1.96 111.036 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 58' ' ' LEU . 65.6 t -70.8 130.05 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.524 -0.307 . . . . 0.77000000000000002 110.682 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.843 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -130.15 -37.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.836 0.68 . . . . 1.1499999999999999 112.836 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.12 122.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.698 -0.482 . . . . 0.28999999999999998 109.698 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.26 161.71 37.02 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.045 -0.525 . . . . 1.3 110.221 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.659 ' CD1' HG23 ' A' ' 79' ' ' ILE . 47.1 t80 -132.46 111.02 10.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.884 0.373 . . . . 1.3 110.615 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 15.2 t -142.34 158.05 44.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.788 -0.642 . . . . 0.89000000000000001 111.576 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.69 33.53 42.09 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.827 -0.701 . . . . 0.56999999999999995 112.324 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER 70.01 10.16 7.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.711 0.291 . . . . 1.46 110.866 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 58.5 mttm -108.84 111.65 23.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.37 -0.377 . . . . 2.4100000000000001 111.181 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.05 117.84 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.752 -1.574 . . . . 1.6599999999999999 106.752 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.795 ' O ' HG12 ' A' ' 72' ' ' ILE . 7.2 m-85 -100.05 130.12 46.17 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.839 -1.073 . . . . 1.25 110.648 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.2 p-10 -165.99 -56.81 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.358 -1.719 . . . . 1.2 106.358 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -78.43 -24.52 46.08 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 114.416 -1.266 . . . . 2.1699999999999999 108.894 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -76.99 -29.97 55.73 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.396 -1.335 . . . . 5.0499999999999998 107.396 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.619 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 1.2 m-85 -86.24 113.31 51.5 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 114.423 -1.262 . . . . 1.29 109.919 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.04 -36.2 90.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.902 1.735 . . . . 0.79000000000000004 112.948 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 87' ' ' LEU . 58.2 m-20 -49.99 -29.99 9.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.298 0.851 . . . . 1.3600000000000001 113.298 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 2.0 mp -151.74 30.19 0.59 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.874 -0.603 . . . . 1.6200000000000001 111.467 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 40.5 pttt -58.96 137.75 57.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.996 -0.682 . . . . 2.3900000000000001 111.899 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.471 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 81.15 13.83 80.2 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.598 -0.728 . . . . 0.37 114.175 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.4 ptm85 -142.23 -56.65 0.45 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 114.922 1.453 . . . . 1.5900000000000001 114.922 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -78.21 80.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 123.059 1.409 . . . . 0.20000000000000001 107.358 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.471 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 8.0 m80 -98.89 127.07 44.72 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.161 -2.29 . . . . 0.28999999999999998 112.797 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.113 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.6 m-85 -68.66 125.53 26.83 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 120.1 -0.64 . . . . 1.23 109.298 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.963 HG21 ' CE2' ' A' ' 38' ' ' TYR . 6.6 p -74.15 28.24 0.08 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.514 -0.766 . . . . 0.46000000000000002 112.644 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 t -148.7 137.64 21.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.13 0.491 . . . . 1.2 110.948 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -92.73 3.72 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.569 -0.741 . . . . 2.2200000000000002 110.73 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -146.49 66.95 1.17 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.95 -0.759 . . . . 2.1400000000000001 108.95 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.3 mp -57.87 -24.66 58.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.114 -0.948 . . . . 1.49 111.637 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -64.16 0.59 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.224 0.453 . . . . 2.04 112.224 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -90.02 -0.03 57.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.682 -0.69 . . . . 1.3999999999999999 110.832 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.73 -13.7 42.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.38 112.557 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -96.14 108.39 20.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.115 -0.328 . . . . 1.4399999999999999 110.115 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -112.54 15.53 20.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.18 0.437 . . . . 0.42999999999999999 112.18 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 27.9 p -61.31 147.77 43.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.354 1.613 . . . . 1.04 115.354 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.113 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -134.47 130.33 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.291 -1.322 . . . . 0.31 111.211 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.881 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.3 OUTLIER -103.37 143.58 32.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.602 -0.888 . . . . 1.1499999999999999 108.602 177.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.68 124.45 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 120.891 0.377 . . . . 0.27000000000000002 111.637 -178.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.723 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.8 p -85.67 145.14 27.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.28999999999999998 110.874 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 98.5 m-20 50.57 57.28 6.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.063 0.459 . . . . 1.52 111.878 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 37' ' ' ALA . 25.1 mt -45.66 85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.727 1.38 . . . . 1.02 114.727 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 63.9 tt0 -59.98 147.89 37.27 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.668 -0.696 . . . . 2.1299999999999999 110.416 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.647 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 94.1 mt -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.054 0.39 . . . . 1.7 112.054 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 23.3 t -70.82 -14.96 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 1.3200000000000001 111.567 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.726 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -70.16 -19.15 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.384 -0.599 . . . . 1.5800000000000001 109.384 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 30.2 mt -45.68 138.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.947 -0.57 . . . . 0.41999999999999998 110.057 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.77 163.68 9.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 119.95 -1.119 . . . . 0.23999999999999999 113.876 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.499 HG23 ' CD2' ' A' ' 134' ' ' HIS . 87.5 m -59.41 130.02 44.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.599 0.592 . . . . 0.31 112.599 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.596 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.2 m-85 -112.43 130.94 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 1.24 109.687 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -123.24 118.22 27.08 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.057 -0.257 . . . . 1.1599999999999999 111.027 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 41.9 t -100.54 118.57 36.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 1.03 110.153 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 44.2 mtpt -117.89 106.17 12.7 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.822 -0.351 . . . . 1.76 111.493 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 55' ' ' ILE . 29.9 t -90.04 109.27 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.229 -0.656 . . . . 1.1799999999999999 109.229 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.7 tttp -100.32 111.77 24.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 1.6200000000000001 112.327 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 48.6 tttt -142.41 102.84 4.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.3 -0.56 . . . . 2.8399999999999999 110.189 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.919 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.26 134.01 24.02 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.643 -0.708 . . . . 0.44 112.09 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 65.5 Cg_endo -99.26 47.87 2.08 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.414 -1.078 . . . . 0.56000000000000005 111.785 -0.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.97 102.95 0.27 Allowed Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.89 -1.147 . . . . 0.47999999999999998 113.822 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.61 151.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.534 -0.833 . . . . 1.22 109.689 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.49 144.47 34.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.387 0.514 . . . . 0.56999999999999995 112.387 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.44 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 43.7 p-10 -146.78 139.8 25.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 111.61 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.704 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.18 161.99 38.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.548 -0.296 . . . . 2.9500000000000002 111.073 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.4 mttt -106.66 143.44 34.76 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.888 1.07 . . . . 2.2599999999999998 113.888 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.737 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.3 mt -143.86 114.81 2.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 114.982 -1.008 . . . . 0.28000000000000003 108.879 176.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 117' ' ' THR . 58.8 m170 -99.44 112.79 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.481 -0.488 . . . . 0.55000000000000004 110.911 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.7 HD21 HD22 ' A' ' 110' ' ' LEU . 54.6 tp -88.25 131.01 34.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.697 -0.683 . . . . 1.52 112.425 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.0 t -126.42 125.83 68.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.32000000000000001 109.729 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 27.6 t -99.33 123.09 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.0800000000000001 111.412 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.6 mt -81.82 157.21 24.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.701 -0.481 . . . . 0.52000000000000002 109.701 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.53 0.681 . . . . 1.48 111.629 -178.926 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.971 0.415 . . . . 1.8400000000000001 110.371 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.748 HG13 ' HB1' ' A' ' 129' ' ' ALA . 42.5 mm -118.73 129.99 74.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 2.1499999999999999 111.003 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 51.1 p -85.9 146.56 26.66 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.32 0.581 . . . . 1.1200000000000001 110.598 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.27 83.27 0.21 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.146 -0.934 . . . . 0.65000000000000002 111.333 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.4 Cg_endo -77.72 -77.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.568 2.845 . . . . 0.88 112.193 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 45.4 mp0 -78.64 123.22 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 2.0600000000000001 108.958 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 28' ' ' MET . 77.8 tt0 -143.81 159.99 41.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.077 1.14 . . . . 1.71 114.077 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.502 ' C ' HD12 ' A' ' 29' ' ' ILE . 57.5 ttm -134.6 130.01 35.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.536 -1.211 . . . . 1.8600000000000001 108.284 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.047 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -131.22 138.48 53.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.03 -0.532 . . . . 0.39000000000000001 112.335 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.764 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 92.2 mt-10 -128.81 126.34 39.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.211 -0.45 . . . . 1.1899999999999999 110.252 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HB2' HD13 ' A' ' 110' ' ' LEU . 60.3 mmtt -142.09 156.87 45.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.892 0.377 . . . . 2.52 111.846 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -77.29 140.18 39.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.39000000000000001 111.887 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HD2' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -45.73 141.89 2.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.09 -0.505 . . . . 2.3500000000000001 111.872 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 79.3 -21.66 4.17 Favored Glycine 0 C--N 1.328 0.132 0 C-N-CA 121.168 -0.539 . . . . 0.31 113.759 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -78.48 155.25 29.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.835 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.2 m -88.67 121.69 31.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.818 -0.753 . . . . 0.33000000000000002 110.544 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -95.93 116.1 28.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.275 0.559 . . . . 0.26000000000000001 110.072 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -79.15 116.22 19.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.558 -0.746 . . . . 1.4299999999999999 111.632 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 105' ' ' ILE . 29.1 mt -104.37 104.19 43.28 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.383 -0.969 . . . . 0.80000000000000004 108.383 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 83.1 Cg_endo -83.26 135.58 7.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.685 2.257 . . . . 0.41999999999999998 114.712 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 86.9 m -141.03 103.32 4.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.273 -0.876 . . . . 1.03 109.831 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 58.2 tptt -100.9 133.86 44.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.962 -0.563 . . . . 1.6599999999999999 109.53 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.731 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 21.2 p90 -138.31 138.15 38.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.272 0.558 . . . . 1.26 111.395 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -91.5 139.64 30.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.289 -0.869 . . . . 1.3300000000000001 110.438 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' NZ ' ' A' ' 124' ' ' LYS . 86.0 mt -94.63 109.75 21.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.144 -0.317 . . . . 2.1200000000000001 110.144 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 m -81.04 139.49 49.44 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 109.942 -0.392 . . . . 1.75 109.942 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.89 -31.27 10.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.558 1.505 . . . . 1.6100000000000001 110.707 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 82.7 tt0 -75.54 -40.03 57.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.207 -0.906 . . . . 2.1800000000000002 110.827 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 80.0 m-20 -67.79 79.05 0.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.245 0.545 . . . . 2.4100000000000001 109.549 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.85 -8.74 33.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.419 -0.81 . . . . 1.6399999999999999 111.428 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.02 53.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.611 -0.804 . . . . 0.55000000000000004 112.335 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.18 148.82 47.61 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.255 1.97 . . . . 0.84999999999999998 111.785 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 45' ' ' LEU . 8.2 mt -78.02 131.1 37.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 1.8999999999999999 111.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 83.1 m-20 -131.72 149.77 52.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.954 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.696 ' CD1' HD11 ' A' ' 98' ' ' LEU . 23.5 mt -143.57 104.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.226 -0.897 . . . . 0.75 109.538 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 73' ' ' LEU . 86.4 tt0 -104.48 111.04 23.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.491 0.552 . . . . 1.6699999999999999 112.491 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.693 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.8 m95 -92.98 132.93 36.64 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.923 -0.311 . . . . 0.22 110.437 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.3 mt -119.55 139.99 51.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.465 -0.569 . . . . 0.40999999999999998 109.465 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 87' ' ' LEU . 8.8 tt -129.97 130.74 66.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.752 0.649 . . . . 0.78000000000000003 112.752 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.431 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.9 m -125.51 101.39 30.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.306 -0.998 . . . . 1.25 108.306 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.0 Cg_exo -79.76 118.25 3.77 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.534 2.156 . . . . 0.53000000000000003 112.902 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.75 -39.95 86.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.561 -0.745 . . . . 0.40999999999999998 110.604 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.847 -0.615 . . . . 1.8200000000000001 111.749 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 33.7 m120 -85.98 160.51 19.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.365 0.602 . . . . 1.9399999999999999 112.181 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -69.48 -15.87 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.103 -0.953 . . . . 1.6599999999999999 111.327 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 48.7 mttt -67.0 151.47 47.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 1.74 111.821 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.02 135.58 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.585 1.183 . . . . 0.96999999999999997 110.149 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 45.46 40.0 5.19 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 112.609 -2.087 . . . . 1.77 112.858 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.9 145.44 24.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.518 0.199 . . . . 1.96 110.826 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.7 t -67.12 130.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.814 0.34 . . . . 0.77000000000000002 110.124 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.899 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -109.68 -65.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.908 0.707 . . . . 1.1499999999999999 112.908 -177.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.824 HG22 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 107.4 9.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.434 -0.95 . . . . 0.28999999999999998 108.434 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 55' ' ' ILE . 8.0 tp -112.94 157.4 21.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.3 111.042 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.843 ' CD1' HD13 ' A' ' 79' ' ' ILE . 18.1 t80 -132.58 104.72 6.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 1.3 109.921 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.522 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 14.6 t -143.12 159.77 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.427 0.528 . . . . 0.89000000000000001 112.427 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.45 31.71 14.27 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.875 -0.602 . . . . 0.56999999999999995 112.73 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t0 70.51 3.3 4.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.666 0.269 . . . . 1.46 111.013 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 50.1 mtpt -100.52 116.5 32.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.876 -0.416 . . . . 2.4100000000000001 109.876 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.843 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.11 129.44 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 107.543 -1.28 . . . . 1.6599999999999999 107.543 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.657 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -113.62 121.11 43.17 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.25 -0.886 . . . . 1.25 110.49 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.804 ' HB3' HG12 ' A' ' 72' ' ' ILE . 16.2 p-10 -165.58 -51.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.634 -1.247 . . . . 1.2 107.634 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 50.3 t0 -77.18 -21.73 53.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.157 -0.929 . . . . 2.1699999999999999 108.88 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.81 -26.46 27.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.925 -1.034 . . . . 5.0499999999999998 109.268 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.884 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -89.05 111.32 44.19 Favored Pre-proline 0 CA--C 1.512 -0.485 0 CA-C-N 115.25 -0.886 . . . . 1.29 112.155 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.5 -38.72 28.24 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.415 1.41 . . . . 0.79000000000000004 110.473 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.6 m-20 -64.46 106.07 1.07 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.977 -0.556 . . . . 1.3600000000000001 111.251 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 59' ' ' ILE . 4.7 mt 59.95 23.08 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.711 1.004 . . . . 1.6200000000000001 113.711 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 23.2 pttm -58.34 149.01 25.71 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.179 -1.008 . . . . 2.3900000000000001 111.379 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.83 6.72 88.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.498 -0.858 . . . . 0.37 113.024 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.791 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -142.54 -40.47 0.34 Allowed 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 113.737 1.014 . . . . 1.5900000000000001 113.737 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.923 ' CG1' HD13 ' A' ' 105' ' ' ILE . 1.6 t -85.29 87.97 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 123.221 1.486 . . . . 0.20000000000000001 107.525 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 20.6 m80 -113.16 132.92 55.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 111.258 -2.701 . . . . 0.28999999999999998 111.86 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.077 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.2 m-85 -75.26 123.96 26.24 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 119.988 -0.685 . . . . 1.23 109.75 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 p -74.69 -4.68 38.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.46000000000000002 110.916 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . 15.9 p -84.43 113.66 21.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.206 -0.452 . . . . 1.2 110.949 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -88.19 0.01 56.57 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.514 0.673 . . . . 2.2200000000000002 109.505 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -146.52 68.72 1.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.524 -1.288 . . . . 2.1400000000000001 107.524 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.696 HD11 ' CD1' ' A' ' 55' ' ' ILE . 9.3 tt -56.11 -38.23 70.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.499 -1.228 . . . . 1.49 112.029 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -63.59 -2.7 1.76 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.137 0.494 . . . . 2.04 112.119 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.2 t -89.62 -0.03 57.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.585 -0.734 . . . . 1.3999999999999999 111.204 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.731 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.47 -0.18 34.79 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.521 -0.847 . . . . 0.38 113.887 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 95.5 m-20 -99.48 119.95 38.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.005 0.402 . . . . 1.4399999999999999 110.986 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -118.5 3.7 11.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.21 -0.45 . . . . 0.42999999999999999 112.087 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 29.9 p -59.99 145.19 47.13 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.508 2.04 . . . . 1.04 116.508 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.93 130.07 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 114.034 -1.439 . . . . 0.31 109.809 177.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p-10 -100.77 142.38 32.33 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.578 -1.267 . . . . 1.1499999999999999 107.578 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.91 117.83 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 120.746 -0.381 . . . . 0.27000000000000002 110.716 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -84.55 143.3 29.41 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.743 -0.662 . . . . 0.28999999999999998 110.759 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 80.8 m-20 49.89 58.55 5.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.52 111.256 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 37' ' ' ALA . 22.1 mt -46.19 90.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.642 0.979 . . . . 1.02 113.642 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 53.8 tt0 -59.64 143.92 49.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.712 -0.676 . . . . 2.1299999999999999 110.338 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.573 HD12 ' HD2' ' A' ' 33' ' ' LYS . 2.4 tt -60.0 -38.52 82.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.188 0.518 . . . . 1.7 110.67 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 79.3 p -74.12 -6.52 48.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.3200000000000001 111.42 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 87' ' ' LEU . 95.8 m-20 -69.99 -19.47 63.34 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.346 -0.613 . . . . 1.5800000000000001 109.346 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -43.08 139.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.632 -0.713 . . . . 0.41999999999999998 110.256 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.78 162.34 9.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.098 -1.049 . . . . 0.23999999999999999 113.331 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.4 m -59.71 135.23 57.62 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.31 112.408 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.606 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 19.6 m-85 -119.99 132.1 55.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 1.24 109.618 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.9 mt-30 -120.16 117.5 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.613 0.244 . . . . 1.1599999999999999 110.401 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.526 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 10.2 t -101.15 106.37 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.92 -0.4 . . . . 1.03 109.92 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.579 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 77.7 mttt -113.26 112.5 23.84 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.522 -0.308 . . . . 1.76 111.501 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 37.8 t -92.96 108.24 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.765 -0.458 . . . . 1.1799999999999999 109.765 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 82.2 tttt -97.0 119.17 34.97 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.783 0.66 . . . . 1.6200000000000001 112.783 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.9 tttt -145.82 102.79 3.7 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.646 -0.502 . . . . 2.8399999999999999 109.646 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.627 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.78 131.59 21.02 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.286 0.847 . . . . 0.44 113.286 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.558 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 63.7 Cg_endo -100.35 40.66 4.13 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.675 -0.969 . . . . 0.56000000000000005 111.979 -1.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.67 102.27 0.48 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.26 -0.972 . . . . 0.47999999999999998 113.225 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -91.96 141.76 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 113.629 -1.286 . . . . 1.22 109.879 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -139.87 152.18 46.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.992 -0.283 . . . . 0.56999999999999995 111.706 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.579 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 41.2 p-10 -146.35 149.64 34.18 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.419 0.526 . . . . 2.0299999999999998 112.419 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 10.6 ptmt -144.44 157.77 44.08 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.895 -0.593 . . . . 2.9500000000000002 110.81 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 5.6 ttmm -100.98 139.97 35.93 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.78 0.659 . . . . 2.2599999999999998 112.78 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.047 HG23 HD13 ' A' ' 29' ' ' ILE . 89.2 mt -142.06 113.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.479 -0.782 . . . . 0.28000000000000003 109.689 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -100.13 114.75 28.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.728 -0.471 . . . . 0.55000000000000004 109.728 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 53.8 tp -94.73 123.0 37.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.764 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.8 t -119.93 122.18 67.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.032 -0.729 . . . . 0.32000000000000001 109.032 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 16.4 t -100.27 127.16 53.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.952 0.406 . . . . 1.0800000000000001 111.988 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.65 159.42 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.52000000000000002 109.705 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.461 0.648 . . . . 1.48 111.333 -179.136 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.038 0.447 . . . . 1.8400000000000001 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.933 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 10.9 tt -141.67 144.23 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.776 -0.647 . . . . 2.1499999999999999 110.482 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.6 p -88.12 152.73 21.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.414 0.626 . . . . 1.1200000000000001 111.574 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.687 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 37.91 84.75 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.743 -1.117 . . . . 0.65000000000000002 111.212 -178.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.2 Cg_endo -76.8 -11.6 18.26 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 123.417 2.745 . . . . 0.88 112.777 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.9 126.6 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.544 -0.91 . . . . 2.0600000000000001 108.544 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.0 tt0 -143.93 159.41 42.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.25 1.204 . . . . 1.71 114.25 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 77.9 mtp -139.96 123.89 17.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.678 -1.146 . . . . 1.8600000000000001 109.781 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.769 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.3 mm -122.47 129.46 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.649 0.261 . . . . 0.39000000000000001 111.288 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.613 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.3 mt-10 -119.95 124.21 45.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.499 -0.319 . . . . 1.1899999999999999 110.554 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' A' ' 110' ' ' LEU . 23.6 mmtt -142.22 162.22 36.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 2.52 111.639 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -76.56 137.93 39.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.125 -0.489 . . . . 0.39000000000000001 111.76 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 tttt -48.33 129.99 16.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.208 -0.451 . . . . 2.3500000000000001 111.083 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.0 -18.96 45.01 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.118 -0.563 . . . . 0.31 112.349 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 110' ' ' LEU . 82.0 mm-40 -80.09 160.0 25.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.246 -1.02 . . . . 2.1099999999999999 108.246 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 82.8 m -88.18 128.31 35.45 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.568 -0.853 . . . . 0.33000000000000002 110.814 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.95 119.98 38.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.26000000000000001 110.394 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 94' ' ' THR . 30.5 t80 -79.51 113.89 18.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.803 -0.635 . . . . 1.4299999999999999 111.427 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.766 ' HB2' HD12 ' A' ' 105' ' ' ILE . 47.1 mt -100.96 106.3 43.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.442 -0.948 . . . . 0.80000000000000004 108.442 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.669 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 4.4 Cg_endo -84.92 126.23 3.3 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.401 2.068 . . . . 0.41999999999999998 113.361 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 19.7 t -140.59 125.92 18.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.6 -0.889 . . . . 1.03 108.6 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 22' ' ' ILE . 8.4 mtpm? -140.82 148.55 40.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.943 -0.571 . . . . 1.6599999999999999 111.473 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' CD1' HG11 ' A' ' 122' ' ' VAL . 50.3 p90 -139.99 143.1 36.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.027 -0.988 . . . . 1.26 111.613 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.1 p -83.3 159.96 21.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.814 -0.63 . . . . 1.3300000000000001 111.093 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.58 122.88 36.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 2.1200000000000001 110.458 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 15.8 m -76.06 155.97 84.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.599 -0.273 . . . . 1.75 110.404 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.41 -20.1 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.562 2.175 . . . . 1.6100000000000001 112.399 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 79.5 tt0 -148.19 34.55 0.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.607 -0.27 . . . . 2.1800000000000002 111.267 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 46' ' ' SER . 34.0 p-10 -69.92 69.94 0.33 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.022 0.439 . . . . 2.4100000000000001 110.447 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -96.42 -1.4 47.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 1.6399999999999999 111.679 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.671 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.84 153.95 49.33 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.206 -0.997 . . . . 0.55000000000000004 112.165 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.68 126.8 23.45 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.235 1.957 . . . . 0.84999999999999998 111.152 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.874 HD21 ' HD3' ' A' ' 124' ' ' LYS . 1.3 mt -77.94 104.55 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.448 -0.342 . . . . 1.8999999999999999 111.23 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -116.98 103.42 10.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.535 0.683 . . . . 1.78 110.728 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.1 mt -97.57 121.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.75 110.782 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.932 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -115.41 126.37 54.3 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.34 0.496 . . . . 1.6699999999999999 112.34 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.732 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.0 m95 -100.52 124.24 45.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.22 110.16 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.513 HD21 ' OE2' ' A' ' 56' ' ' GLU . 86.1 mt -109.52 140.52 43.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.499 -0.556 . . . . 0.40999999999999998 109.499 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.0 tt -127.77 130.03 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.485 . . . . 0.78000000000000003 112.259 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 17.8 m -120.18 102.41 46.08 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.892 -0.781 . . . . 1.25 108.892 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.3 Cg_exo -79.4 118.08 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.514 2.143 . . . . 0.53000000000000003 112.628 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.98 87.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.721 -0.672 . . . . 0.40999999999999998 110.542 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -75.69 -40.01 56.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 1.8200000000000001 111.425 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 15.6 t-20 -82.61 158.15 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 1.9399999999999999 111.731 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -69.18 -20.02 64.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 1.6599999999999999 111.895 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.75 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 18.5 mtpt -70.59 151.73 44.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 1.74 111.907 -178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.2 m -153.94 129.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.799 0.809 . . . . 0.96999999999999997 109.106 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 59.5 39.18 22.05 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.231 -1.35 . . . . 1.77 111.785 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 96.0 mm-40 -92.09 153.56 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.356 -0.384 . . . . 1.96 111.415 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.711 HG21 ' CE1' ' A' ' 84' ' ' TYR . 4.2 p -64.34 150.55 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.427 -0.582 . . . . 0.77000000000000002 109.427 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.914 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -144.21 -57.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.179 -0.608 . . . . 1.1499999999999999 112.504 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.975 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.56 135.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.626 -0.509 . . . . 0.28999999999999998 109.626 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.932 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 4.0 mp -140.73 164.06 31.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 1.3 112.207 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.888 ' CD1' HD13 ' A' ' 79' ' ' ILE . 45.3 t80 -137.2 103.27 5.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.337 -0.847 . . . . 1.3 109.195 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.454 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 12.8 t -144.1 159.58 42.39 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.083 -0.508 . . . . 0.89000000000000001 112.256 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.33 31.02 4.53 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.058 -0.519 . . . . 0.56999999999999995 113.353 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 72.03 1.95 4.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.446 0.165 . . . . 1.46 111.419 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 87.4 mttt -100.01 117.77 34.99 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.657 -0.497 . . . . 2.4100000000000001 109.657 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.888 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.4 mm -80.02 130.31 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.436 -1.32 . . . . 1.6599999999999999 107.436 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.732 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.3 m-85 -117.45 125.17 50.47 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.325 -0.852 . . . . 1.25 110.655 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.885 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.8 p-10 -165.93 -55.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.975 -1.491 . . . . 1.2 106.975 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' N ' ' A' ' 89' ' ' GLY . 51.1 t0 -80.64 -21.51 41.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.864 -1.062 . . . . 2.1699999999999999 109.047 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -81.56 -25.91 35.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.371 -0.974 . . . . 5.0499999999999998 108.371 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.729 ' CZ ' HD13 ' A' ' 73' ' ' LEU . 2.2 m-85 -87.11 120.71 71.56 Favored Pre-proline 0 CA--C 1.509 -0.604 0 CA-C-N 115.273 -0.876 . . . . 1.29 110.555 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.9 Cg_endo -48.56 -43.78 32.39 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.391 1.394 . . . . 0.79000000000000004 110.443 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 71' ' ' ILE . 2.8 m-20 -68.72 107.22 2.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.297 -0.961 . . . . 1.3600000000000001 111.328 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.813 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.9 mt 68.75 25.9 6.24 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.642 0.979 . . . . 1.6200000000000001 113.642 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.885 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.2 pttt -56.62 127.53 31.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.025 -0.67 . . . . 2.3900000000000001 111.431 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 82' ' ' ASP . . . 91.66 16.3 52.48 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.37 114.135 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -144.32 -47.68 0.26 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.707 1.373 . . . . 1.5900000000000001 114.707 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -80.85 82.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 123.038 1.399 . . . . 0.20000000000000001 108.119 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.698 ' C ' HG22 ' A' ' 105' ' ' ILE . 20.3 m80 -101.29 130.18 47.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.639 -2.073 . . . . 0.28999999999999998 111.997 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.1 m-85 -74.09 121.55 21.31 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.551 0.691 . . . . 1.23 109.704 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -69.98 -11.17 60.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.65 -1.159 . . . . 0.46000000000000002 110.096 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.7 m -93.49 120.02 33.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.971 -0.559 . . . . 1.2 110.738 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -89.56 0.03 57.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.071 0.462 . . . . 2.2200000000000002 110.26 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -146.19 67.24 1.19 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.764 -0.828 . . . . 2.1400000000000001 108.764 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 74' ' ' TYR . 5.2 mp -54.61 -23.58 17.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.141 -0.936 . . . . 1.49 111.655 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.26 -4.59 3.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.216 0.532 . . . . 2.04 111.759 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.7 p -88.53 0.02 56.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.305 -0.861 . . . . 1.3999999999999999 111.072 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 102.86 -14.18 56.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.744 -0.741 . . . . 0.38 113.151 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.18 108.95 21.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.911 0.355 . . . . 1.4399999999999999 110.69 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.05 16.69 21.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.36 0.504 . . . . 0.42999999999999999 112.36 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m -60.03 145.78 45.14 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 115.793 1.775 . . . . 1.04 115.793 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.41 136.02 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.082 -1.417 . . . . 0.31 110.783 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 90' ' ' ARG . 49.2 p-10 -107.11 143.52 35.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.528 -0.915 . . . . 1.1499999999999999 108.528 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.85 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.71 120.7 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.063 0.459 . . . . 0.27000000000000002 111.655 -178.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 144.54 29.43 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.333 -0.849 . . . . 0.28999999999999998 111.012 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 29.0 m120 49.84 55.89 8.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.281 -0.418 . . . . 1.52 111.811 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.891 HD22 HD11 ' A' ' 135' ' ' LEU . 21.7 mt -45.45 89.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.699 1.0 . . . . 1.02 113.699 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 52.3 tt0 -60.05 143.82 51.0 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.582 -0.525 . . . . 2.1299999999999999 109.582 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.96 -40.04 87.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 1.7 110.892 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -73.3 -10.01 59.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.3200000000000001 111.613 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.2 m-20 -70.56 -17.24 62.92 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.892 -0.41 . . . . 1.5800000000000001 109.892 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.61 143.76 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 CA-C-N 115.862 -0.608 . . . . 0.41999999999999998 110.381 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.75 157.09 7.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.155 -1.021 . . . . 0.23999999999999999 113.201 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.597 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.6 m -59.34 138.95 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.339 0.496 . . . . 0.31 112.339 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.552 ' OH ' HD11 ' A' ' 87' ' ' LEU . 9.6 m-85 -120.09 130.91 54.87 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.432 -0.581 . . . . 1.24 109.432 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 66.7 tt0 -127.47 119.96 27.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.957 -0.297 . . . . 1.1599999999999999 111.015 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 21.6 p -102.71 119.95 39.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.76 0.314 . . . . 1.03 110.554 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 97.5 mttt -112.75 104.9 12.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 1.76 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.764 HG22 HG12 ' A' ' 55' ' ' ILE . 21.8 t -88.42 117.31 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.325 -0.62 . . . . 1.1799999999999999 109.325 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.848 ' HG2' HG12 ' A' ' 128' ' ' VAL . 75.8 mttt -113.76 118.31 33.93 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.91 1.078 . . . . 1.6200000000000001 113.91 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.874 ' HD3' HD21 ' A' ' 53' ' ' LEU . 21.1 pttm -146.94 103.8 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.639 -0.71 . . . . 2.8399999999999999 110.809 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.671 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -48.34 129.11 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.92 -0.582 . . . . 0.44 111.835 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -104.11 53.79 1.21 Allowed 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 125.207 -0.747 . . . . 0.56000000000000005 111.802 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 102.98 0.27 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.95 -1.119 . . . . 0.47999999999999998 113.871 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 123' ' ' LYS . 17.1 m -94.24 134.27 32.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.394 -0.903 . . . . 1.22 109.845 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.933 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -143.55 136.6 27.72 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.13 0.418 . . . . 0.56999999999999995 112.13 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.605 ' C ' HD13 ' A' ' 22' ' ' ILE . 45.9 p-10 -146.79 150.24 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.219 0.452 . . . . 2.0299999999999998 112.219 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.758 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.55 163.52 34.51 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 2.9500000000000002 110.567 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.0 mttt -101.3 145.05 29.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 114.25 1.204 . . . . 2.2599999999999998 114.25 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.673 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.53 119.36 11.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.63 -1.168 . . . . 0.28000000000000003 108.654 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.597 ' CD2' HG23 ' A' ' 117' ' ' THR . 52.4 m170 -100.43 119.75 38.95 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.564 -0.455 . . . . 0.55000000000000004 110.741 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.891 HD11 HD22 ' A' ' 110' ' ' LEU . 1.5 tm? -89.58 120.04 30.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 1.52 111.384 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.613 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.1 t -117.3 120.0 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.653 . . . . 0.32000000000000001 109.551 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.66 125.34 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.016 0.436 . . . . 1.0800000000000001 112.035 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 92.9 mt -84.85 170.01 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.52000000000000002 109.368 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 1.48 111.69 -178.643 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.938 0.399 . . . . 1.8400000000000001 110.998 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.784 ' CD1' ' HB1' ' A' ' 129' ' ' ALA . 85.6 mt -110.0 129.96 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 2.1499999999999999 110.558 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 38.1 p -91.44 148.34 22.38 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.191 0.519 . . . . 1.1200000000000001 110.792 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.62 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 41.38 82.69 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.089 -0.96 . . . . 0.65000000000000002 111.117 -177.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.46 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 123.971 3.114 . . . . 0.88 112.926 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.27 126.3 30.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.504 -0.925 . . . . 2.0600000000000001 108.504 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.934 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -143.74 160.02 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.893 1.071 . . . . 1.71 113.893 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.793 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.16 137.21 38.95 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 114.881 -1.054 . . . . 1.8600000000000001 109.281 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.934 HD11 ' OE2' ' A' ' 27' ' ' GLU . 32.2 mm -134.16 140.02 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.296 0.48 . . . . 0.39000000000000001 112.296 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt-10 -130.14 123.96 31.54 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.431 -0.581 . . . . 1.1899999999999999 109.431 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.606 ' HB3' HD13 ' A' ' 110' ' ' LEU . 49.3 tptt -142.07 157.22 45.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.981 -0.287 . . . . 2.52 111.31 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.8 141.66 40.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.39000000000000001 112.067 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HD2' ' HG ' ' A' ' 112' ' ' LEU . 59.5 tttp -48.67 131.48 17.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.884 -0.598 . . . . 2.3500000000000001 111.872 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.38 -17.36 43.92 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.13 -0.557 . . . . 0.31 113.267 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.771 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.1 mt-10 -80.01 159.77 26.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.628 -0.879 . . . . 2.1099999999999999 108.628 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.863 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.4 m -89.37 128.5 35.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.652 -0.819 . . . . 0.33000000000000002 110.367 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.966 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.0 112.12 24.33 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.26000000000000001 110.343 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CD1' HG21 ' A' ' 94' ' ' THR . 77.4 t80 -79.15 117.89 20.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 111.616 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.831 HD22 HG21 ' A' ' 133' ' ' ILE . 39.9 mt -105.97 104.73 50.71 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.80000000000000004 109.249 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.37 127.19 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.448 2.099 . . . . 0.41999999999999998 113.497 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -140.31 130.18 24.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.359 -0.837 . . . . 1.03 109.616 179.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 8.9 mptt -140.03 140.34 36.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 110.003 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CG ' HG11 ' A' ' 122' ' ' VAL . 50.0 p90 -140.23 139.81 35.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.26 111.704 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 p -88.91 147.42 24.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.612 -0.722 . . . . 1.3300000000000001 111.441 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 124' ' ' LYS . 24.5 tp -99.48 114.38 27.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 2.1200000000000001 110.903 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -81.87 145.46 53.75 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 110.028 -0.36 . . . . 1.75 110.028 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -49.62 -34.15 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.782 1.654 . . . . 1.6100000000000001 110.536 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -75.64 -40.02 56.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.282 -0.872 . . . . 2.1800000000000002 110.641 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.548 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.7 m-20 -69.51 73.58 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.134 0.493 . . . . 2.4100000000000001 109.759 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -94.29 -4.84 48.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.754 . . . . 1.6399999999999999 111.621 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.666 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.99 157.33 53.51 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.413 -0.899 . . . . 0.55000000000000004 112.536 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.45 148.88 10.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.477 2.118 . . . . 0.84999999999999998 111.858 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.985 HD22 ' HA ' ' A' ' 99' ' ' LYS . 5.6 mp -78.16 135.76 37.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 1.8999999999999999 111.503 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 9.2 t70 -140.73 153.59 45.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 1.78 111.876 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 21.5 mt -142.49 139.93 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.007 -0.997 . . . . 0.75 109.667 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.621 ' HG2' HD11 ' A' ' 73' ' ' LEU . 98.0 mt-10 -140.23 111.71 7.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.026 0.375 . . . . 1.6699999999999999 111.748 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.965 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -97.68 119.9 37.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.867 -0.333 . . . . 0.22 110.929 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 119' ' ' GLN . 89.2 mt -104.9 138.84 40.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.014 -0.736 . . . . 0.40999999999999998 109.014 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.9 tt -129.97 129.98 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.321 0.489 . . . . 0.78000000000000003 112.321 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.8 m -121.44 102.45 42.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 1.25 109.153 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.8 Cg_exo -81.46 116.19 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.645 2.23 . . . . 0.53000000000000003 112.716 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -33.25 71.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.71 . . . . 0.40999999999999998 110.886 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -85.29 12.89 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 1.8200000000000001 112.148 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 93.9 m-20 -146.99 163.19 37.02 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.37 0.605 . . . . 1.9399999999999999 111.873 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.06 -18.06 65.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.065 -0.97 . . . . 1.6599999999999999 111.912 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.676 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 96.2 mttt -67.16 140.01 57.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.117 0.484 . . . . 1.74 111.827 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.0 127.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.852 0.834 . . . . 0.96999999999999997 109.012 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.82 39.33 29.64 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.098 -1.41 . . . . 1.77 111.796 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -94.72 140.01 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 1.96 110.816 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 43.0 t -69.86 127.1 31.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.987 0.422 . . . . 0.77000000000000002 110.276 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.925 HG13 HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -112.04 -51.38 5.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.925 -0.58 . . . . 1.1499999999999999 112.124 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.866 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.92 130.13 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.593 -0.891 . . . . 0.28999999999999998 108.593 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 74' ' ' TYR . 3.3 tt -140.1 157.03 46.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 1.3 111.271 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 79' ' ' ILE . 36.8 t80 -135.45 104.33 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.345 -0.388 . . . . 1.3 110.076 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 t -144.24 157.26 44.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.416 0.524 . . . . 0.89000000000000001 112.416 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.22 12.57 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.214 -0.517 . . . . 0.56999999999999995 113.075 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t0 72.12 3.27 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.497 0.184 . . . . 1.46 111.497 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 114.85 28.46 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.568 -0.53 . . . . 2.4100000000000001 109.568 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.9 mm -79.81 129.81 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 107.313 -1.366 . . . . 1.6599999999999999 107.313 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.717 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -115.55 119.2 35.38 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.095 -0.957 . . . . 1.25 110.197 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 10.0 p-10 -166.19 -51.74 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.695 -1.595 . . . . 1.2 106.695 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -80.04 -23.92 41.1 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.352 -1.295 . . . . 2.1699999999999999 108.49 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -80.82 -27.05 36.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.057 -1.09 . . . . 5.0499999999999998 108.057 177.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.528 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.6 m-85 -86.57 108.86 19.75 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-N 115.154 -0.93 . . . . 1.29 110.014 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 30.7 Cg_exo -61.47 -28.64 83.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.729 1.619 . . . . 0.79000000000000004 112.065 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.797 ' O ' HD22 ' A' ' 87' ' ' LEU . 53.2 t0 -44.32 -36.34 2.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.347 0.594 . . . . 1.3600000000000001 111.762 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.925 HD23 HG13 ' A' ' 71' ' ' ILE . 1.5 mm? -156.48 33.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.751 -1.113 . . . . 1.6200000000000001 110.56 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 63.3 pttt -52.9 129.98 31.94 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.435 -0.506 . . . . 2.3900000000000001 111.902 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.14 57.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.506 -0.854 . . . . 0.37 114.818 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.889 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -142.88 -46.6 0.31 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 115.009 1.485 . . . . 1.5900000000000001 115.009 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.866 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.0 p -80.22 81.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.748 1.261 . . . . 0.20000000000000001 108.235 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.483 ' C ' HG22 ' A' ' 105' ' ' ILE . 22.3 m80 -103.13 129.69 50.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.892 -1.958 . . . . 0.28999999999999998 112.521 -175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.115 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.4 m-85 -73.17 122.79 22.44 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 120.002 -0.679 . . . . 1.23 109.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 38' ' ' TYR . 17.9 p -72.16 -9.93 59.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.148 -0.933 . . . . 0.46000000000000002 110.274 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 1.4 m -89.13 122.05 32.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.658 -0.701 . . . . 1.2 110.5 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -91.34 4.45 52.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.218 0.532 . . . . 2.2200000000000002 110.396 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -146.57 66.71 1.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.424 -0.807 . . . . 2.1400000000000001 108.903 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 93' ' ' PHE . 7.9 mp -57.92 -35.04 70.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.254 -0.885 . . . . 1.49 111.434 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.985 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.1 pttt -60.05 -13.78 13.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.701 0.762 . . . . 2.04 111.801 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 t -82.99 0.04 46.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.386 -1.279 . . . . 1.3999999999999999 110.99 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.86 -2.51 38.65 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.543 -0.836 . . . . 0.38 113.742 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.55 112.65 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.172 0.486 . . . . 1.4399999999999999 110.976 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -109.83 10.53 24.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.388 0.514 . . . . 0.42999999999999999 112.388 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.668 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 p -60.06 137.08 58.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.825 1.787 . . . . 1.04 115.825 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.115 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 114.247 -1.342 . . . . 0.31 110.698 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.719 ' OD1' HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -105.21 145.33 30.77 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.527 -0.546 . . . . 1.1499999999999999 109.527 177.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.863 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.49 118.72 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.142 0.496 . . . . 0.27000000000000002 111.351 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.19 143.7 30.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 110.757 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.0 m120 49.95 55.16 9.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.083 0.468 . . . . 1.52 111.508 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.9 mt -45.26 88.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.225 1.194 . . . . 1.02 114.225 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' CG ' ' A' ' 114' ' ' ASP . 14.7 pt20 -59.66 151.45 24.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 2.1299999999999999 109.756 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.478 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.5 mt -60.12 -28.39 67.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 1.7 110.863 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.3 m -73.93 -5.95 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 1.3200000000000001 111.424 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.527 ' HB3' HD23 ' A' ' 135' ' ' LEU . 87.9 m-20 -69.92 -23.63 63.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.616 -0.513 . . . . 1.5800000000000001 109.616 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.87 133.47 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.116 -0.493 . . . . 0.41999999999999998 110.091 178.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.65 158.71 7.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.034 -1.079 . . . . 0.23999999999999999 113.386 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.9 m -59.35 133.89 56.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.569 0.581 . . . . 0.31 112.569 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.641 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 25.9 m-85 -118.4 132.83 56.24 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.035 -0.53 . . . . 1.24 109.692 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.5 mt-30 -120.01 119.98 34.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.627 -0.261 . . . . 1.1599999999999999 111.666 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.574 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 42.7 t -100.04 107.3 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.214 -0.662 . . . . 1.03 109.214 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 8.9 mtpm? -114.19 109.31 18.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.418 -0.355 . . . . 1.76 111.492 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.765 HG11 ' CG ' ' A' ' 43' ' ' PHE . 53.2 t -91.85 108.36 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.652 -0.499 . . . . 1.1799999999999999 109.652 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 64.7 tttm -93.63 120.37 33.82 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.246 -0.582 . . . . 1.6200000000000001 112.206 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 4.6 mtpt -144.38 102.2 3.8 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.821 -0.436 . . . . 2.8399999999999999 109.821 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.666 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.04 130.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 113.44 0.904 . . . . 0.44 113.44 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 88.5 Cg_endo -101.64 42.16 3.3 Favored 'Cis proline' 0 C--N 1.354 0.866 0 C-N-CA 125.094 -0.794 . . . . 0.56000000000000005 111.811 -1.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.95 103.59 0.46 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 122.006 0.781 . . . . 0.47999999999999998 112.723 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.584 HG12 ' HG3' ' A' ' 123' ' ' LYS . 23.0 m -82.93 155.73 3.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.086 -1.057 . . . . 1.22 110.433 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.56 0.219 . . . . 0.56999999999999995 111.397 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 47.9 t30 -146.59 134.59 21.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.121 0.415 . . . . 2.0299999999999998 112.121 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.684 ' CE ' HD11 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -142.22 158.87 43.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.55 -0.537 . . . . 2.9500000000000002 109.55 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 43.5 mmtm -109.98 146.68 34.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.659 1.355 . . . . 2.2599999999999998 114.659 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.831 HG21 HD22 ' A' ' 39' ' ' LEU . 98.9 mt -144.17 122.57 6.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 114.586 -1.188 . . . . 0.28000000000000003 109.335 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.09 111.6 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.591 -0.443 . . . . 0.55000000000000004 110.063 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 110' ' ' LEU . 51.6 tp -87.83 135.53 33.35 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.524 0.564 . . . . 1.52 112.524 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.549 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 63.0 t -129.99 130.03 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 0.32000000000000001 109.491 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 20.4 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.363 . . . . 1.0800000000000001 111.859 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 87.9 mt -83.81 167.86 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.045 -0.525 . . . . 0.52000000000000002 109.609 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.381 0.61 . . . . 1.48 111.208 -178.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.897 0.38 . . . . 1.8400000000000001 110.738 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 42' ' ' LYS . 1.9 pt -142.28 143.86 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.0 -0.546 . . . . 2.1499999999999999 110.869 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 27.5 p -88.58 162.43 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.793 0.806 . . . . 1.1200000000000001 112.325 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.12 82.78 0.22 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.264 -1.335 . . . . 0.65000000000000002 112.712 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 63.3 Cg_endo -79.12 -86.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.775 2.984 . . . . 0.88 112.421 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 6.2 pm0 -78.0 122.02 24.99 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.711 -0.848 . . . . 2.0600000000000001 108.711 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 132' ' ' LYS . 51.3 tp10 -144.22 159.99 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.715 1.006 . . . . 1.71 113.715 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.9 133.01 33.3 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.829 -1.078 . . . . 1.8600000000000001 109.091 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 28' ' ' MET . 32.0 mm -130.05 140.04 49.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.853 -0.612 . . . . 0.39000000000000001 111.358 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.1 pt-20 -136.85 127.3 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.455 -0.338 . . . . 1.1899999999999999 110.687 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 18.3 mmtp -142.31 164.18 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.309 -0.405 . . . . 2.52 111.03 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.7 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.35 137.33 39.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.39000000000000001 111.269 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 112' ' ' LEU . 21.0 ttpt -45.79 130.34 9.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 2.3500000000000001 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 92.23 -18.02 55.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.005 -0.617 . . . . 0.31 112.746 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.7 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 98.9 mt-10 -79.99 156.0 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.704 -0.85 . . . . 2.1099999999999999 108.704 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 62.6 m -87.98 127.83 35.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.666 -0.814 . . . . 0.33000000000000002 110.67 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.942 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.9 115.1 28.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.26000000000000001 110.787 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.702 ' CE2' HG21 ' A' ' 94' ' ' THR . 25.1 t80 -79.37 120.06 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.036 -0.529 . . . . 1.4299999999999999 111.491 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 105' ' ' ILE . 18.3 mt -109.48 104.78 56.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.093 -0.706 . . . . 0.80000000000000004 109.093 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.492 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 88.3 Cg_endo -84.76 131.16 4.46 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.818 2.345 . . . . 0.41999999999999998 115.082 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.415 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 62.6 m -141.34 104.01 4.52 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.623 -0.717 . . . . 1.03 110.251 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 4.4 mptp? -102.96 140.04 37.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 1.6599999999999999 110.662 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.585 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 50.4 p90 -140.55 146.68 38.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 1.26 110.826 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 82.4 p -80.02 167.1 20.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 111.65 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.96 142.88 36.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 2.1200000000000001 111.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 82.0 p -160.02 159.69 27.01 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.474 -0.784 . . . . 1.75 110.003 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 16.4 Cg_endo -57.77 -16.65 26.12 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.197 1.931 . . . . 1.6100000000000001 112.772 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.0 tt0 -72.21 -41.54 66.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.654 0.264 . . . . 2.1800000000000002 110.303 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.79 80.4 0.87 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.815 -0.809 . . . . 2.4100000000000001 108.815 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.61 -11.24 49.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.238 -0.892 . . . . 1.6399999999999999 111.686 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -78.3 156.82 43.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.217 -0.992 . . . . 0.55000000000000004 111.916 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.84 148.81 81.97 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.226 1.951 . . . . 0.84999999999999998 111.435 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 99' ' ' LYS . 92.7 mt -77.5 131.7 38.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.806 0.336 . . . . 1.8999999999999999 110.288 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -133.83 152.34 51.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.245 0.545 . . . . 1.78 111.093 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.2 mt -143.57 107.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.923 -1.035 . . . . 0.75 109.711 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.745 ' HG2' HD11 ' A' ' 73' ' ' LEU . 97.6 mt-10 -110.25 115.01 28.93 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.191 0.441 . . . . 1.6699999999999999 112.191 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.828 ' CE2' HD11 ' A' ' 105' ' ' ILE . 76.9 m95 -99.17 120.89 40.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.22 110.612 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 87.7 mt -105.21 140.77 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.40999999999999998 109.45 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.3 tt -130.0 130.02 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.274 0.559 . . . . 0.78000000000000003 112.165 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.1 p -119.17 103.06 48.04 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.585 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 88.3 Cg_endo -79.07 114.65 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.51 2.14 . . . . 0.53000000000000003 113.208 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.03 87.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.40999999999999998 111.006 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.99 -40.03 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.62 . . . . 1.8200000000000001 111.437 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.585 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.85 160.87 21.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 1.9399999999999999 111.661 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.0 -22.0 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.349 -0.841 . . . . 1.6599999999999999 112.313 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.575 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -72.64 156.73 38.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.765 0.317 . . . . 1.74 111.789 -178.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.35 128.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.906 0.86 . . . . 0.96999999999999997 109.954 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 39.98 19.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.979 -1.464 . . . . 1.77 112.47 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -88.86 146.84 24.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.666 -0.243 . . . . 1.96 110.578 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.564 HG11 ' OH ' ' A' ' 84' ' ' TYR . 17.2 t -68.87 124.3 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.676 -0.49 . . . . 0.77000000000000002 109.676 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -112.04 -52.14 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.055 0.761 . . . . 1.1499999999999999 113.055 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.0 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.06 124.64 26.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.537 -0.912 . . . . 0.28999999999999998 108.537 179.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.745 HD11 ' HG2' ' A' ' 56' ' ' GLU . 3.8 tt -132.24 156.48 46.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 1.3 110.586 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.875 ' CD2' HD22 ' A' ' 98' ' ' LEU . 15.6 t80 -135.14 104.98 6.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.249 -0.432 . . . . 1.3 109.94 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 7.7 t -142.11 158.84 43.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.822 0.344 . . . . 0.89000000000000001 111.802 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.4 28.7 36.57 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.843 -0.694 . . . . 0.56999999999999995 112.217 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.6 t0 72.2 3.28 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.24 . . . . 1.46 110.871 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 20.9 mmtp -100.03 112.29 24.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.269 -0.641 . . . . 2.4100000000000001 109.269 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.84 116.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.171 -1.048 . . . . 1.6599999999999999 108.171 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.744 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.1 m-85 -99.43 130.55 45.7 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.816 -1.538 . . . . 1.25 110.659 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.864 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.9 p-10 -165.9 -53.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.743 -1.206 . . . . 1.2 107.743 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -79.92 -20.09 46.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.291 -0.868 . . . . 2.1699999999999999 109.171 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.2 t80 -80.82 -27.0 36.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.352 -0.981 . . . . 5.0499999999999998 108.352 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.7 m-85 -86.1 113.3 51.2 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.945 -1.025 . . . . 1.29 110.777 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.4 -41.37 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.36 1.373 . . . . 0.79000000000000004 109.951 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' O ' HG12 ' A' ' 71' ' ' ILE . 46.7 m-20 -67.29 105.16 1.67 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.574 -0.739 . . . . 1.3600000000000001 110.668 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.886 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.0 mt 67.35 23.41 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.735 1.013 . . . . 1.6200000000000001 113.735 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.864 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttm -56.08 129.26 39.22 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.517 -0.739 . . . . 2.3900000000000001 111.08 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 91.65 15.56 54.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.352 -0.928 . . . . 0.37 114.216 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.886 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.4 ptp180 -144.25 -48.93 0.27 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 114.645 1.35 . . . . 1.5900000000000001 114.645 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.0 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -79.89 81.9 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 123.157 1.456 . . . . 0.20000000000000001 107.604 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.491 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.9 m80 -103.21 129.45 50.14 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.151 -2.295 . . . . 0.28999999999999998 112.399 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 84.7 m-85 -70.81 125.04 25.73 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.907 -0.717 . . . . 1.23 109.788 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.702 HG21 ' CE2' ' A' ' 38' ' ' TYR . 14.3 p -77.06 36.94 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.923 -1.035 . . . . 0.46000000000000002 112.931 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.0 m -147.75 136.3 21.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 1.2 111.257 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.85 0.77 57.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.663 . . . . 2.2200000000000002 110.632 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -146.69 67.81 1.17 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.448 -0.575 . . . . 2.1400000000000001 109.448 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.875 HD22 ' CD2' ' A' ' 74' ' ' TYR . 7.9 mp -57.15 -27.73 62.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.302 -0.863 . . . . 1.49 111.044 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.73 ' HG2' HD12 ' A' ' 53' ' ' LEU . 37.0 mtmm -64.29 -2.93 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 2.04 112.062 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 0.01 56.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.524 -0.762 . . . . 1.3999999999999999 110.964 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.585 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 109.93 -7.14 31.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.38 113.234 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.35 119.4 35.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.968 0.413 . . . . 1.4399999999999999 110.813 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.57 6.48 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.891 -0.595 . . . . 0.42999999999999999 111.571 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -59.95 140.08 56.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 116.203 1.927 . . . . 1.04 116.203 -177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -129.13 131.94 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.147 -1.388 . . . . 0.31 110.788 177.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -104.08 142.84 33.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.054 -1.091 . . . . 1.1499999999999999 108.054 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.51 120.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.024 0.44 . . . . 0.27000000000000002 111.439 -178.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.2 p -84.29 143.86 29.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.444 -0.798 . . . . 0.28999999999999998 110.851 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 31.0 m120 49.97 55.13 9.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.072 -0.513 . . . . 1.52 111.916 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.942 HD11 ' HB2' ' A' ' 37' ' ' ALA . 27.9 mt -44.19 93.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.456 0.91 . . . . 1.02 113.456 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 56.2 tt0 -59.64 144.47 47.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.7 -0.682 . . . . 2.1299999999999999 110.136 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 63.9 tp -59.97 -40.07 87.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.193 0.52 . . . . 1.7 110.792 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -73.24 -5.56 40.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.739 -0.664 . . . . 1.3200000000000001 111.517 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.489 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.96 -19.02 63.38 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.082 -0.34 . . . . 1.5800000000000001 110.082 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 139.63 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 116.145 -0.479 . . . . 0.41999999999999998 110.206 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 141.04 159.73 8.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.958 -1.115 . . . . 0.23999999999999999 113.414 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 63.7 m -59.44 130.69 48.12 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.838 0.681 . . . . 0.31 112.838 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 87' ' ' LEU . 13.3 m-85 -114.27 129.64 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.174 -0.676 . . . . 1.24 109.174 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.61 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 12.1 tt0 -120.9 118.61 30.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 1.1599999999999999 110.276 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 57' ' ' TRP . 9.7 t -101.01 118.29 36.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 1.03 110.57 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 97.4 mttt -123.66 112.32 17.25 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 116.475 -0.33 . . . . 1.76 111.774 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 61.9 t -92.05 106.46 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.235 -0.654 . . . . 1.1799999999999999 109.235 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 25.7 ttpp -95.42 117.34 30.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.006 -0.678 . . . . 1.6200000000000001 112.691 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 44' ' ' THR . 2.7 pttm -146.29 103.14 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.51 -0.476 . . . . 2.8399999999999999 110.12 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.93 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.92 133.91 21.61 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.44 112.055 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.7 Cg_endo -100.03 46.52 2.37 Favored 'Cis proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.769 -0.929 . . . . 0.56000000000000005 111.209 -0.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 103.62 0.29 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.257 -0.973 . . . . 0.47999999999999998 113.674 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.47 153.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.712 -0.744 . . . . 1.22 109.322 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -139.51 144.92 38.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.279 -0.168 . . . . 0.56999999999999995 111.269 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.538 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 40.0 p-10 -146.57 142.22 27.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.895 0.702 . . . . 2.0299999999999998 112.895 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.642 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.01 157.78 44.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.784 -0.644 . . . . 2.9500000000000002 110.39 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 41.2 tttt -101.84 139.98 36.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.216 0.821 . . . . 2.2599999999999998 113.216 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.697 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 70.9 mt -142.23 119.86 7.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.883 -0.599 . . . . 0.28000000000000003 109.953 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.443 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 14.8 m170 -100.22 118.37 36.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 0.55000000000000004 110.381 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 57.0 tp -91.89 123.2 35.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.217 0.451 . . . . 1.52 112.217 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -120.03 119.99 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.32000000000000001 109.424 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.95 121.71 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0800000000000001 111.794 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.2 mt -81.56 164.5 21.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.337 -0.616 . . . . 0.52000000000000002 109.337 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.399 0.619 . . . . 1.48 111.261 -178.831 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.807 0.337 . . . . 1.8400000000000001 110.944 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pt -144.29 151.34 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 116.169 -0.469 . . . . 2.1499999999999999 111.413 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 82.6 p -92.39 161.73 14.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.544 0.687 . . . . 1.1200000000000001 111.618 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.18 83.55 0.2 Allowed Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.566 -1.197 . . . . 0.65000000000000002 112.091 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.717 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 65.4 Cg_endo -78.44 -91.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.586 2.857 . . . . 0.88 111.876 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.75 126.93 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.704 -0.85 . . . . 2.0600000000000001 108.704 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' CG ' HD11 ' A' ' 29' ' ' ILE . 55.3 tt0 -143.69 153.66 42.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.842 1.052 . . . . 1.71 113.842 -176.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 58.5 mtp -135.45 116.45 14.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.62 -1.173 . . . . 1.8600000000000001 108.511 176.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.065 HD13 HG23 ' A' ' 133' ' ' ILE . 3.7 mp -120.0 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.004 0.431 . . . . 0.39000000000000001 111.809 -178.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 43.9 mt-10 -106.86 126.15 51.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 1.1899999999999999 110.203 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 49.9 tptt -141.7 157.3 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 2.52 111.081 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -76.54 139.68 40.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.39000000000000001 112.018 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.3 134.02 18.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.995 -0.548 . . . . 2.3500000000000001 111.546 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.63 -20.39 27.83 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.874 -0.603 . . . . 0.31 112.578 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 79.5 mm-40 -79.94 160.0 26.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 178.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.838 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.1 m -89.46 129.97 35.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.658 -0.817 . . . . 0.33000000000000002 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.851 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.92 115.8 30.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.26000000000000001 110.217 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 94' ' ' THR . 32.6 t80 -79.25 116.42 19.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.027 -0.533 . . . . 1.4299999999999999 111.875 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.793 HD12 ' CD1' ' A' ' 105' ' ' ILE . 15.5 mt -101.5 107.62 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.796 -0.816 . . . . 0.80000000000000004 108.796 177.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.2 Cg_endo -82.67 122.76 3.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.13 . . . . 0.41999999999999998 113.972 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.3 t -141.46 126.34 18.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.744 -0.662 . . . . 1.03 110.211 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.5 mttm -140.91 149.93 42.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.922 -0.581 . . . . 1.6599999999999999 109.993 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.803 ' CG ' HG11 ' A' ' 122' ' ' VAL . 36.3 p90 -140.87 139.98 34.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 1.26 112.012 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.43 139.64 30.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.743 . . . . 1.3300000000000001 110.373 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' CE ' ' A' ' 124' ' ' LYS . 90.0 mt -92.22 107.6 19.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 2.1200000000000001 110.884 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ASP . 30.4 t -83.54 133.58 46.66 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.529 -0.545 . . . . 1.75 109.529 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -43.0 -33.2 3.11 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.691 1.594 . . . . 1.6100000000000001 111.04 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 83.4 tt0 -76.72 -39.98 50.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.358 -0.837 . . . . 2.1800000000000002 111.074 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 77.0 m-20 -68.5 79.19 0.27 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.41 -0.516 . . . . 2.4100000000000001 109.659 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.99 -5.08 28.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 1.6399999999999999 111.925 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.757 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.81 53.25 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.894 -0.669 . . . . 0.55000000000000004 112.689 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.36 138.27 85.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.422 2.082 . . . . 0.84999999999999998 112.384 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 43' ' ' PHE . 11.3 mt -78.17 120.08 22.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 1.8999999999999999 111.596 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -133.51 103.05 5.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.548 0.69 . . . . 1.78 111.419 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.849 HG12 HG22 ' A' ' 122' ' ' VAL . 2.7 mp -91.34 122.35 42.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.162 179.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.908 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.3 mt-10 -119.08 114.08 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.449 0.537 . . . . 1.6699999999999999 112.449 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.92 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.3 m95 -91.7 120.02 32.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 110.078 -0.341 . . . . 0.22 110.078 178.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.9 mt -108.69 143.85 37.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.392 . . . . 0.40999999999999998 109.94 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.611 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 10.3 tt -130.01 132.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.293 0.479 . . . . 0.78000000000000003 112.293 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.419 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 52.9 m -123.28 101.85 37.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.0 -0.741 . . . . 1.25 109.0 177.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.5 Cg_endo -79.86 116.92 3.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.714 2.276 . . . . 0.53000000000000003 113.435 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.96 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.61 -0.723 . . . . 0.40999999999999998 110.632 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -87.42 17.28 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 1.8200000000000001 112.182 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 42.7 m-20 -148.99 160.02 43.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.41 0.624 . . . . 1.9399999999999999 112.213 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.08 -18.64 64.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.052 -0.976 . . . . 1.6599999999999999 111.92 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 61.1 mttp -66.82 150.82 48.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 1.74 111.017 -178.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.77 130.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-O 122.409 1.099 . . . . 0.96999999999999997 110.299 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.516 ' OD2' HD13 ' A' ' 58' ' ' LEU . 4.9 t0 49.66 39.99 18.77 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 112.932 -1.94 . . . . 1.77 112.542 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -90.24 140.02 30.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 1.96 111.095 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 73' ' ' LEU . 89.7 t -69.65 130.04 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.923 0.392 . . . . 0.77000000000000002 111.048 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.828 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.3 pp -124.25 -37.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.008 -0.542 . . . . 1.1499999999999999 111.473 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.918 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 124.58 18.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.685 -0.857 . . . . 0.28999999999999998 108.685 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.908 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -140.27 157.61 45.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.64 -0.709 . . . . 1.3 110.344 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.494 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 60.5 t80 -133.75 103.56 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.018 -0.364 . . . . 1.3 110.018 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 40.0 t -143.03 155.98 44.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.879 0.371 . . . . 0.89000000000000001 111.925 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.84 30.15 28.43 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 112.899 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t0 71.72 1.6 3.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.481 0.182 . . . . 1.46 111.118 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.2 mmtt -99.95 107.03 18.9 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.787 -0.82 . . . . 2.4100000000000001 108.787 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.77 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.76 118.32 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.601 1.191 . . . . 1.6599999999999999 108.748 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.658 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 1.6 m-85 -100.28 124.9 46.3 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.527 -2.124 . . . . 1.25 111.563 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.833 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.8 p-10 -166.31 -53.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.01 -1.478 . . . . 1.2 107.01 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 55.2 t0 -81.34 -32.59 32.91 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.538 -1.21 . . . . 2.1699999999999999 109.117 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -71.55 -31.82 67.42 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.332 -1.358 . . . . 5.0499999999999998 107.332 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -82.49 109.97 19.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.338 -1.301 . . . . 1.29 109.256 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.96 -31.05 77.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.018 1.812 . . . . 0.79000000000000004 113.031 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.805 ' O ' HD12 ' A' ' 87' ' ' LEU . 83.7 m-20 -49.99 -29.95 9.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 1.3600000000000001 112.564 -178.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 86' ' ' ASP . 2.0 mp -152.2 27.66 0.59 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.474 -0.785 . . . . 1.6200000000000001 111.198 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 24.8 pttm -55.63 138.15 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.156 0.503 . . . . 2.3900000000000001 111.839 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 80.03 12.85 82.89 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.617 -0.801 . . . . 0.37 114.41 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.72 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.35 -52.42 0.36 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 115.07 1.507 . . . . 1.5900000000000001 115.07 -178.545 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.918 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.3 81.33 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.939 1.352 . . . . 0.20000000000000001 107.861 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.4 m80 -100.64 127.87 46.89 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 112.442 -2.163 . . . . 0.28999999999999998 112.418 -176.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 78.8 m-85 -72.14 120.57 17.92 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.12 -0.696 . . . . 1.23 109.12 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.615 HG21 ' CE2' ' A' ' 38' ' ' TYR . 28.4 p -71.34 -9.93 58.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.336 -0.847 . . . . 0.46000000000000002 109.957 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 p -86.94 122.62 31.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.6 -0.727 . . . . 1.2 109.55 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.95 4.66 49.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.144 0.497 . . . . 2.2200000000000002 110.307 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -146.66 69.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.742 -0.836 . . . . 2.1400000000000001 108.742 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -56.13 -39.59 72.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.085 -0.961 . . . . 1.49 111.363 -178.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HG3' ' OH ' ' A' ' 74' ' ' TYR . 31.7 mtmm -64.77 -3.07 2.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.118 0.485 . . . . 2.04 112.111 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.7 t -89.56 -0.01 57.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.626 -0.715 . . . . 1.3999999999999999 111.029 179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.34 -16.16 35.23 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.722 -0.751 . . . . 0.38 113.698 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -97.3 108.82 21.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.203 0.502 . . . . 1.4399999999999999 110.45 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.902 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.45 19.94 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.42999999999999999 112.667 -179.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.2 m -61.53 140.0 58.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.857 1.429 . . . . 1.04 114.857 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.15 133.27 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.061 -0.972 . . . . 0.31 111.25 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.4 p-10 -106.66 145.5 31.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.829 -0.804 . . . . 1.1499999999999999 108.829 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.5 122.09 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.27000000000000002 111.63 -178.354 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -84.86 144.13 28.61 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.52 -0.764 . . . . 0.28999999999999998 111.169 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 96.8 m-20 49.96 57.66 6.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 1.52 111.354 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 37' ' ' ALA . 35.6 mt -47.57 92.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.126 1.158 . . . . 1.02 114.126 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 35.0 mt-30 -58.64 142.4 49.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.069 -0.514 . . . . 2.1299999999999999 110.413 176.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.04 -36.86 78.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.094 0.473 . . . . 1.7 110.185 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 t -74.31 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.646 . . . . 1.3200000000000001 111.358 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.74 -15.55 62.69 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.009 -0.367 . . . . 1.5800000000000001 110.009 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 141.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-N 116.238 -0.437 . . . . 0.41999999999999998 110.096 178.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.79 155.2 6.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.879 -1.153 . . . . 0.23999999999999999 113.759 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.675 HG23 ' CD2' ' A' ' 134' ' ' HIS . 93.5 m -59.18 129.99 44.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.483 0.549 . . . . 0.31 112.483 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.2 m-85 -111.2 130.2 55.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.291 -0.633 . . . . 1.24 109.291 177.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 62.4 tt0 -121.79 120.05 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.811 -0.356 . . . . 1.1599999999999999 111.022 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 40.7 t -100.04 123.14 43.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.036 -0.529 . . . . 1.03 109.923 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 96.0 mttt -123.87 105.45 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.69 -0.404 . . . . 1.76 111.978 -179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 55' ' ' ILE . 25.0 t -89.44 111.98 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.476 -0.935 . . . . 1.1799999999999999 108.476 177.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.709 ' HG3' HG12 ' A' ' 128' ' ' VAL . 77.7 tttt -99.45 120.06 39.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.411 0.893 . . . . 1.6200000000000001 113.411 -177.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.712 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 14.0 tttp -145.72 102.5 3.68 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.725 -0.472 . . . . 2.8399999999999999 109.725 176.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.757 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.97 131.36 30.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.548 -0.751 . . . . 0.44 112.934 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.492 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 46.2 Cg_endo -100.76 48.04 2.04 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.696 -0.96 . . . . 0.56000000000000005 112.527 -0.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.85 102.64 0.31 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.139 -1.029 . . . . 0.47999999999999998 112.982 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.709 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -88.82 132.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.207 -0.997 . . . . 1.22 109.629 177.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 22' ' ' ILE . . . -121.13 139.05 53.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.773 0.286 . . . . 0.56999999999999995 111.773 -179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.481 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 52.4 p30 -146.33 146.14 30.58 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.252 0.464 . . . . 2.0299999999999998 112.252 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.52 160.11 42.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 2.9500000000000002 110.652 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 44.0 mttp -99.96 140.78 33.68 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.298 0.851 . . . . 2.2599999999999998 113.298 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.065 HG23 HD13 ' A' ' 29' ' ' ILE . 3.5 mp -139.26 109.13 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.824 -1.08 . . . . 0.28000000000000003 108.459 176.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.675 ' CD2' HG23 ' A' ' 117' ' ' THR . 54.0 m170 -97.28 118.02 32.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.353 -0.539 . . . . 0.55000000000000004 110.748 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 110' ' ' LEU . 61.2 tp -92.41 123.3 35.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.883 -0.598 . . . . 1.52 111.669 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 45.3 t -119.93 120.9 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.723 -0.671 . . . . 0.32000000000000001 109.328 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HB ' HD12 ' A' ' 115' ' ' ILE . 22.1 t -95.49 121.97 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.376 0.51 . . . . 1.0800000000000001 112.376 -178.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 89.6 mt -84.05 163.77 19.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.717 -0.674 . . . . 0.52000000000000002 109.224 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.401 0.62 . . . . 1.48 111.429 -178.912 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.081 0.467 . . . . 1.8400000000000001 111.361 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.665 HD13 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -149.72 149.81 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.711 -0.677 . . . . 2.1499999999999999 110.934 -179.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.15 155.13 17.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 1.1200000000000001 112.21 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 38.79 82.69 0.22 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.358 -1.292 . . . . 0.65000000000000002 112.652 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.777 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 53.6 Cg_endo -79.26 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.449 2.766 . . . . 0.88 112.738 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 85.9 tt0 -78.54 127.88 32.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.11 -0.7 . . . . 2.0600000000000001 109.11 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.641 ' CG ' HD11 ' A' ' 29' ' ' ILE . 44.3 tp10 -143.74 157.02 44.68 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.785 1.032 . . . . 1.71 113.785 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 54.0 ttp -136.92 125.34 23.42 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.665 -1.152 . . . . 1.8600000000000001 107.934 176.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 133' ' ' ILE . 4.1 mp -130.24 137.52 56.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.703 -0.681 . . . . 0.39000000000000001 112.362 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 74.9 mt-10 -133.77 127.74 33.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.156 -0.475 . . . . 1.1899999999999999 110.154 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 10.9 tptm -142.71 161.35 38.32 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.511 0.196 . . . . 2.52 110.754 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.07 140.59 41.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.39000000000000001 112.228 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 112' ' ' LEU . 56.5 tttm -47.25 132.3 12.77 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.819 -0.628 . . . . 2.3500000000000001 111.421 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.64 -20.11 36.91 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.049 -0.596 . . . . 0.31 112.686 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.3 mt-10 -80.04 157.67 26.68 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.767 -0.827 . . . . 2.1099999999999999 108.767 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.5 m -87.6 126.97 35.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.985 -0.686 . . . . 0.33000000000000002 110.733 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.56 115.17 28.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.831 0.348 . . . . 0.26000000000000001 110.367 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.795 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 71.6 t80 -79.46 115.14 18.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 1.4299999999999999 112.383 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD22 HG21 ' A' ' 133' ' ' ILE . 20.8 mt -100.22 109.83 57.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 108.593 -0.891 . . . . 0.80000000000000004 108.593 177.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.46 125.35 2.91 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.353 2.035 . . . . 0.41999999999999998 114.97 -177.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -141.51 122.26 14.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.819 -1.082 . . . . 1.03 108.495 177.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -141.32 115.89 9.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 1.6599999999999999 111.513 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.592 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 25.6 p90 -94.48 139.97 30.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.006 -0.997 . . . . 1.26 111.025 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 141.92 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 1.3300000000000001 111.042 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 98.6 mt -97.73 139.54 33.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.599 . . . . 2.1200000000000001 111.527 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.447 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 86.2 p -159.89 145.99 11.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 1.75 109.942 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.62 -21.54 3.54 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.318 2.012 . . . . 1.6100000000000001 113.084 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.75 -40.06 66.36 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.769 -0.196 . . . . 2.1800000000000002 111.329 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 3.1 p30 -69.91 79.14 0.47 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.035 -0.666 . . . . 2.4100000000000001 110.115 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.38 -10.06 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.225 -0.898 . . . . 1.6399999999999999 111.837 -178.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.981 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.54 154.26 38.01 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.304 -0.951 . . . . 0.55000000000000004 112.981 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.99 153.71 19.72 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.498 2.132 . . . . 0.84999999999999998 111.696 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 47.7 tp -78.08 131.56 37.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 1.8999999999999999 111.337 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -139.5 149.08 43.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.36 0.6 . . . . 1.78 110.722 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 30.5 mt -142.75 135.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.845 -1.07 . . . . 0.75 109.087 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.637 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 40.2 mt-10 -140.13 108.28 5.77 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.278 0.474 . . . . 1.6699999999999999 112.278 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.974 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.5 m95 -94.51 126.34 39.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.382 -0.372 . . . . 0.22 110.918 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.8 mt -108.87 141.18 41.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.877 -0.786 . . . . 0.40999999999999998 108.877 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 11.5 tt -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.52 0.563 . . . . 0.78000000000000003 112.52 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 t -120.36 102.95 45.05 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.228 -0.896 . . . . 1.25 108.932 177.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.1 Cg_endo -78.24 115.63 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.527 2.151 . . . . 0.53000000000000003 113.028 -178.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.86 -34.47 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.356 -0.838 . . . . 0.40999999999999998 110.679 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.18 11.53 7.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.637 -0.71 . . . . 1.8200000000000001 111.818 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 80.8 m-20 -148.93 160.37 43.33 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.279 0.561 . . . . 1.9399999999999999 111.76 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.75 -18.47 64.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.284 -0.871 . . . . 1.6599999999999999 112.694 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.68 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.3 mttt -65.79 144.05 57.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.253 -0.431 . . . . 1.74 111.216 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 m -156.39 129.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-O 121.929 0.871 . . . . 0.96999999999999997 110.019 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.02 40.0 19.23 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.97 -1.468 . . . . 1.77 112.827 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 96.9 mt-30 -95.26 141.1 29.25 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.367 -0.235 . . . . 1.96 110.367 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 84' ' ' TYR . 16.5 t -65.86 120.0 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.175 0.512 . . . . 0.77000000000000002 109.977 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.901 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.97 -51.97 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.4 -0.818 . . . . 1.1499999999999999 112.045 -178.135 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.983 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.81 122.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.949 -1.13 . . . . 0.28999999999999998 107.949 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 1.1 tt -130.98 154.88 47.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.778 -0.646 . . . . 1.3 110.895 -176.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.872 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 25.9 t80 -133.01 104.54 6.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.309 -0.256 . . . . 1.3 110.309 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.453 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 10.0 t -142.64 156.82 45.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.882 0.372 . . . . 0.89000000000000001 111.98 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.57 29.7 40.55 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.924 -0.655 . . . . 0.56999999999999995 112.43 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.56 3.14 4.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.583 0.23 . . . . 1.46 110.915 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 34.3 mttm -100.03 112.56 24.85 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.749 -0.463 . . . . 2.4100000000000001 109.749 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.896 HD13 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -83.85 116.98 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.941 -1.133 . . . . 1.6599999999999999 107.941 178.136 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.821 ' N ' HD12 ' A' ' 79' ' ' ILE . 4.5 m-85 -99.95 127.74 46.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.282 -1.781 . . . . 1.25 110.589 -178.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.0 p-10 -166.01 -52.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.426 -1.324 . . . . 1.2 107.426 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -80.2 -23.2 41.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.988 -1.006 . . . . 2.1699999999999999 109.31 177.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -78.68 -28.0 45.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.588 -0.893 . . . . 5.0499999999999998 108.588 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.549 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.0 m-85 -84.71 119.85 73.28 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 114.942 -1.027 . . . . 1.29 110.668 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.69 -41.75 44.98 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.261 1.307 . . . . 0.79000000000000004 109.237 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 71' ' ' ILE . 39.1 m-20 -66.98 104.66 1.43 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.365 -0.834 . . . . 1.3600000000000001 110.657 178.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.935 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.0 mp 68.8 27.35 5.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.101 1.148 . . . . 1.6200000000000001 114.101 178.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.3 pttt -57.58 129.56 42.41 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.659 -0.65 . . . . 2.3900000000000001 111.23 177.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.43 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.37 19.35 58.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.711 -0.757 . . . . 0.37 114.31 178.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.935 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.7 ptm180 -145.89 -48.26 0.21 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.379 1.252 . . . . 1.5900000000000001 114.379 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.983 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -78.86 81.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.071 -1.455 . . . . 0.20000000000000001 107.071 -178.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.535 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.7 m80 -102.8 128.62 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.262 -2.245 . . . . 0.28999999999999998 112.789 -175.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.12 ' CD1' HG23 ' A' ' 105' ' ' ILE . 73.3 m-85 -70.26 123.76 22.46 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 120.152 -0.619 . . . . 1.23 109.61 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.795 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 15.9 p -73.52 33.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.426 -0.807 . . . . 0.46000000000000002 111.839 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -149.63 128.81 12.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.2 110.097 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -92.64 7.56 42.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.986 -0.552 . . . . 2.2200000000000002 110.377 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -146.35 65.72 1.19 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 109.116 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 74' ' ' TYR . 9.6 mp -56.7 -24.72 51.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.391 -0.822 . . . . 1.49 111.432 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.3 -3.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 2.04 111.996 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -88.73 0.03 56.86 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.48 -0.782 . . . . 1.3999999999999999 110.94 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 104.31 -9.94 50.12 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.731 -0.747 . . . . 0.38 113.647 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.11 110.04 21.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.963 0.381 . . . . 1.4399999999999999 111.198 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -107.77 9.48 28.99 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.508 0.559 . . . . 0.42999999999999999 112.508 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.7 p -59.98 143.45 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.67 1.73 . . . . 1.04 115.67 -178.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.12 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.37 132.33 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 114.422 -1.263 . . . . 0.31 110.78 178.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p30 -106.41 146.37 30.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.631 -0.878 . . . . 1.1499999999999999 108.631 177.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 120.02 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 120.826 0.346 . . . . 0.27000000000000002 111.152 -178.257 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.92 143.7 30.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.824 -0.625 . . . . 0.28999999999999998 110.928 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 26.4 m120 47.88 58.89 4.6 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.186 -0.461 . . . . 1.52 111.675 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 37' ' ' ALA . 18.8 mt -44.44 88.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.082 1.142 . . . . 1.02 114.082 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.459 ' O ' ' OD2' ' A' ' 114' ' ' ASP . 51.7 tt0 -58.53 147.26 32.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.548 -0.538 . . . . 2.1299999999999999 109.548 176.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.403 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 58.9 tp -60.03 -37.03 78.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.43 . . . . 1.7 111.036 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.8 m -72.03 -9.66 58.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 1.3200000000000001 112.39 -178.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 111' ' ' GLN . 3.0 p30 -70.47 -18.57 62.98 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.378 -0.529 . . . . 1.5800000000000001 110.085 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 137.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 CA-C-N 115.988 -0.551 . . . . 0.41999999999999998 110.265 179.112 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.99 160.51 8.32 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 119.844 -1.17 . . . . 0.23999999999999999 113.853 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 134' ' ' HIS . 90.9 m -60.04 137.09 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.125 -0.537 . . . . 0.31 112.128 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 25.0 m-85 -120.04 132.15 55.36 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.445 -0.576 . . . . 1.24 109.445 177.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.725 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 49.0 tp60 -120.0 115.06 22.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.073 -0.251 . . . . 1.1599999999999999 110.708 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 53.0 t -98.35 116.82 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 1.03 110.295 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 88.2 mttt -119.1 106.41 12.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 1.76 111.066 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.4 t -91.34 105.5 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.566 -0.531 . . . . 1.1799999999999999 109.566 179.01 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.766 ' HG3' HG12 ' A' ' 128' ' ' VAL . 52.2 tttp -90.48 116.11 28.15 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.039 -0.665 . . . . 1.6200000000000001 111.474 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' CB ' ' A' ' 49' ' ' ASP . 7.2 ttpm? -146.08 102.35 3.62 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.457 -0.571 . . . . 2.8399999999999999 109.457 178.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.981 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.42 134.39 33.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.44 112.002 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.9 Cg_endo -100.13 48.69 1.92 Allowed 'Cis proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.698 -0.959 . . . . 0.56000000000000005 111.297 -0.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 103.31 0.28 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.188 -1.006 . . . . 0.47999999999999998 113.591 -179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.766 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.5 m -87.4 120.0 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.552 -0.824 . . . . 1.22 109.956 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.665 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -101.53 144.77 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.867 0.321 . . . . 0.56999999999999995 111.867 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.452 ' C ' ' HG3' ' A' ' 131' ' ' LYS . 46.1 t30 -146.28 132.11 19.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 2.0299999999999998 111.114 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.777 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 4.7 mttp -142.58 160.33 40.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.841 0.353 . . . . 2.9500000000000002 111.773 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 64.5 mttt -101.77 141.67 34.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.441 0.904 . . . . 2.2599999999999998 113.441 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 29' ' ' ILE . 3.1 mp -142.58 112.59 2.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.041 -0.982 . . . . 0.28000000000000003 109.347 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 117' ' ' THR . 60.5 m170 -101.1 114.4 28.3 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.9 -0.5 . . . . 0.55000000000000004 110.58 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 14.9 mt -96.2 135.58 37.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.698 0.629 . . . . 1.52 112.698 -179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 60.7 t -129.96 130.0 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.355 -0.838 . . . . 0.32000000000000001 109.198 178.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.417 ' H ' HD11 ' A' ' 115' ' ' ILE . 18.9 t -100.46 121.32 51.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.872 0.368 . . . . 1.0800000000000001 111.96 -179.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.7 mt -80.77 163.7 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.353 -0.61 . . . . 0.52000000000000002 109.353 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.462 0.649 . . . . 1.48 111.681 -178.522 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HD13 ' A' ' 22' ' ' ILE . 43.2 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.781 0.324 . . . . 1.8400000000000001 110.666 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.725 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 45.1 mm -140.02 138.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 2.1499999999999999 110.884 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -86.89 144.91 26.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.1200000000000001 110.292 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.484 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 45.28 82.61 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 115.179 -0.919 . . . . 0.65000000000000002 110.39 -177.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 57.3 Cg_endo -77.94 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.649 2.899 . . . . 0.88 113.095 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.28 120.66 23.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.571 -0.529 . . . . 2.0600000000000001 109.571 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 28' ' ' MET . 80.0 tt0 -143.82 160.02 41.51 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.604 0.964 . . . . 1.71 113.604 -177.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.556 ' C ' HD12 ' A' ' 29' ' ' ILE . 53.6 ttm -130.95 130.95 44.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.867 -1.06 . . . . 1.8600000000000001 108.724 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 133' ' ' ILE . 3.5 mp -129.71 131.9 66.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.62 . . . . 0.39000000000000001 112.122 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 89.7 mt-10 -122.63 127.18 49.04 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.281 -0.418 . . . . 1.1899999999999999 110.737 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' A' ' 110' ' ' LEU . 47.0 mmtm -142.33 160.03 41.07 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.563 0.221 . . . . 2.52 110.998 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.79 137.0 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.39000000000000001 112.157 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' CE ' ' HG ' ' A' ' 112' ' ' LEU . 60.0 tttt -46.22 129.97 10.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.895 -0.593 . . . . 2.3500000000000001 110.964 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.74 -19.12 43.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.31 112.275 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 68.1 mm-40 -80.05 160.03 25.97 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.438 -0.949 . . . . 2.1099999999999999 108.438 178.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.6 m -88.82 129.73 35.52 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.608 -0.837 . . . . 0.33000000000000002 110.685 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.99 120.0 39.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.895 0.379 . . . . 0.26000000000000001 110.449 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.955 ' HE1' HG21 ' A' ' 94' ' ' THR . 70.1 t80 -79.1 117.42 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 1.4299999999999999 111.714 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 133' ' ' ILE . 20.4 mt -109.98 104.4 55.48 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.838 -0.801 . . . . 0.80000000000000004 108.838 178.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.642 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 89.8 Cg_endo -86.92 128.92 2.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.352 2.035 . . . . 0.41999999999999998 114.019 -178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 1.8 t -140.8 128.89 22.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.402 -0.817 . . . . 1.03 108.8 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.6 ttpt -140.86 118.62 11.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.241 0.543 . . . . 1.6599999999999999 110.961 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CG ' HG11 ' A' ' 122' ' ' VAL . 43.9 p90 -101.87 137.63 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.667 -1.151 . . . . 1.26 112.399 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -89.26 140.01 29.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 1.3300000000000001 109.785 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.812 HD22 ' HE2' ' A' ' 124' ' ' LYS . 90.7 mt -94.46 109.7 21.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.964 -0.294 . . . . 2.1200000000000001 111.327 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.1 m -83.75 140.0 40.69 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 109.467 -0.568 . . . . 1.75 109.467 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.88 -34.08 21.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.801 1.668 . . . . 1.6100000000000001 110.775 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.4 pt-20 -81.52 -33.97 31.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.441 -0.799 . . . . 2.1800000000000002 111.798 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 78.9 m-20 -69.14 77.62 0.35 Allowed 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 120.271 -0.572 . . . . 2.4100000000000001 110.143 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -101.82 -0.76 33.67 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.502 -0.772 . . . . 1.6399999999999999 111.548 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.884 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -74.08 162.86 54.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.01 -0.614 . . . . 0.55000000000000004 113.4 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.12 131.42 44.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.809 2.339 . . . . 0.84999999999999998 112.168 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 122' ' ' VAL . 13.6 tp -78.12 126.38 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 1.8999999999999999 111.337 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 6.1 m-20 -139.36 103.09 4.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.564 0.697 . . . . 1.78 111.646 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.9 mt -95.69 118.28 41.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.322 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.561 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.1 tt0 -115.64 120.32 39.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.453 0.538 . . . . 1.6699999999999999 112.453 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.921 ' CD2' HD11 ' A' ' 105' ' ' ILE . 82.6 m95 -94.18 119.94 33.73 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.194 -0.299 . . . . 0.22 110.194 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.2 mt -108.13 142.45 38.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 0.40999999999999998 110.185 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 114' ' ' ASP . 5.6 tt -130.0 132.33 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.78000000000000003 112.043 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 48.7 m -117.71 102.12 51.77 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 108.471 -0.937 . . . . 1.25 108.471 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.639 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 85.4 Cg_endo -79.38 113.49 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.807 2.338 . . . . 0.53000000000000003 113.031 -178.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.99 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.40999999999999998 111.257 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.63 -40.08 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 1.8200000000000001 111.556 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 33.9 m120 -84.58 160.04 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 1.9399999999999999 111.957 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.81 -18.0 64.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.303 -0.862 . . . . 1.6599999999999999 111.245 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 42.9 mttt -69.49 154.63 41.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.579 -0.737 . . . . 1.74 111.681 -178.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.72 128.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-O 121.637 0.732 . . . . 0.96999999999999997 109.072 178.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 57.82 41.82 24.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.631 -1.168 . . . . 1.77 111.724 179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 96.1 mm-40 -87.07 135.09 33.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.797 0.332 . . . . 1.96 111.59 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 58' ' ' LEU . 57.7 t -71.82 132.02 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.77000000000000002 110.261 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -129.84 -39.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.631 0.604 . . . . 1.1499999999999999 112.631 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.954 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.43 123.6 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.415 0.626 . . . . 0.28999999999999998 109.637 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 74' ' ' TYR . 7.3 tt -140.58 160.54 39.78 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.576 -0.738 . . . . 1.3 109.477 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.91 ' N ' HD23 ' A' ' 73' ' ' LEU . 23.9 t80 -134.32 109.15 8.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.218 0.532 . . . . 1.3 110.283 178.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.534 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 32.7 t -142.37 160.01 41.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.353 -0.839 . . . . 0.89000000000000001 111.394 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.31 36.82 53.91 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.822 -0.704 . . . . 0.56999999999999995 112.608 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 60.63 25.22 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.609 0.242 . . . . 1.46 111.378 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.3 mttp -128.15 111.14 13.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.191 -0.67 . . . . 2.4100000000000001 109.191 177.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.627 ' CG2' HD22 ' A' ' 98' ' ' LEU . 1.4 pp -76.81 119.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.964 -1.124 . . . . 1.6599999999999999 107.964 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.796 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -99.97 133.51 44.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.72 -1.127 . . . . 1.25 110.62 -178.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.3 p-10 -166.46 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.977 -1.49 . . . . 1.2 106.977 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HA ' ' CA ' ' A' ' 88' ' ' LYS . 50.9 t0 -80.03 -20.19 45.9 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 114.556 -1.202 . . . . 2.1699999999999999 109.315 177.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.7 t80 -78.78 -29.81 45.21 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.25 -1.018 . . . . 5.0499999999999998 108.25 178.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -84.34 112.61 42.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-N 114.436 -1.257 . . . . 1.29 110.872 179.717 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 85.7 Cg_exo -44.09 -42.98 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.501 1.467 . . . . 0.79000000000000004 110.548 178.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.0 m-20 -68.31 104.92 1.98 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.685 -0.688 . . . . 1.3600000000000001 110.739 178.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.894 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.4 mp 72.71 18.91 4.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.499 0.926 . . . . 1.6200000000000001 113.499 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.445 -0.784 . . . . 2.3900000000000001 110.763 178.022 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 91.56 11.67 60.46 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.273 -0.965 . . . . 0.37 113.917 178.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.894 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.5 ptp180 -141.27 -53.79 0.47 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 114.574 1.324 . . . . 1.5900000000000001 114.574 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.954 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -78.73 80.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.11 -1.441 . . . . 0.20000000000000001 107.11 -178.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.636 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.3 m80 -97.52 128.82 44.57 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.084 -2.326 . . . . 0.28999999999999998 111.849 -176.148 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.5 m-85 -69.4 121.66 17.39 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.685 0.755 . . . . 1.23 110.684 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.955 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -73.71 34.85 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.471 -1.24 . . . . 0.46000000000000002 111.732 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -148.81 136.39 20.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.076 0.465 . . . . 1.2 111.683 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.23 0.02 56.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.779 -0.646 . . . . 2.2200000000000002 110.737 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -146.45 66.76 1.18 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.294 0.569 . . . . 2.1400000000000001 109.517 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.714 HD21 ' CG ' ' A' ' 93' ' ' PHE . 7.2 mp -59.14 -31.64 69.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.403 -0.817 . . . . 1.49 111.939 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.52 -3.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.152 0.501 . . . . 2.04 112.319 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.8 m -88.5 -0.09 56.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.54 -0.754 . . . . 1.3999999999999999 111.137 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 111.34 -19.88 23.95 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.748 -0.739 . . . . 0.38 112.915 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.0 m-20 -97.01 107.47 20.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.694 0.283 . . . . 1.4399999999999999 110.633 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -116.75 24.23 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.891 0.33 . . . . 0.42999999999999999 111.891 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.4 m -60.92 151.6 29.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 114.425 1.268 . . . . 1.04 114.425 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.035 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -137.03 140.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.682 -1.145 . . . . 0.31 111.545 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.0 p-10 -113.46 142.81 45.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.263 -1.014 . . . . 1.1499999999999999 108.263 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 122.36 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 120.991 0.424 . . . . 0.27000000000000002 111.868 -177.866 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.67 143.89 28.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.28999999999999998 111.16 178.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.482 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.9 OUTLIER 50.82 54.35 11.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.08 -0.509 . . . . 1.52 112.304 178.537 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 37' ' ' ALA . 34.5 mt -45.9 89.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.441 1.274 . . . . 1.02 114.441 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 60.1 tp60 -59.4 147.72 35.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.767 -0.651 . . . . 2.1299999999999999 110.399 176.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' CE ' ' A' ' 33' ' ' LYS . 85.4 mt -59.98 -37.35 79.37 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.875 0.369 . . . . 1.7 111.144 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.3 p -72.57 -9.47 58.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.052 -0.522 . . . . 1.3200000000000001 111.333 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.689 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.0 m-20 -70.0 -19.95 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.91 -0.404 . . . . 1.5800000000000001 109.91 179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 142.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 115.922 -0.581 . . . . 0.41999999999999998 110.455 178.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.45 155.93 6.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.824 -1.179 . . . . 0.23999999999999999 113.828 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.6 m -59.33 128.59 37.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 18.6 m-85 -108.84 130.76 55.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 1.24 109.649 177.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -125.76 119.29 27.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.034 -0.266 . . . . 1.1599999999999999 110.765 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 20.0 t -99.96 115.82 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.03 110.126 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.82 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 52.3 mtpt -112.53 105.52 13.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.878 -0.329 . . . . 1.76 111.456 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.83 HG11 ' CG ' ' A' ' 43' ' ' PHE . 15.3 t -89.75 110.58 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.747 -0.834 . . . . 1.1799999999999999 108.747 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 tttm -99.86 120.22 39.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.264 0.839 . . . . 1.6200000000000001 113.264 -177.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.812 ' HE2' HD22 ' A' ' 45' ' ' LEU . 35.5 tttp -145.09 102.15 3.71 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.388 -0.597 . . . . 2.8399999999999999 109.388 177.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.884 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.36 133.65 43.01 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.331 -0.85 . . . . 0.44 113.013 -179.106 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 55.0 Cg_endo -98.82 47.68 2.11 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.383 -1.09 . . . . 0.56000000000000005 112.264 -0.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.16 103.13 0.28 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.2 -1.0 . . . . 0.47999999999999998 113.142 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 150.2 3.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.36 -0.92 . . . . 1.22 109.587 177.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -142.98 151.54 40.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.975 -0.29 . . . . 0.56999999999999995 111.683 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 42.5 p-10 -146.41 153.14 40.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.411 -0.359 . . . . 2.0299999999999998 111.777 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.674 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.35 155.45 43.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.471 -0.331 . . . . 2.9500000000000002 110.465 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 12.4 tttt -99.99 141.09 33.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.866 1.062 . . . . 2.2599999999999998 113.866 -177.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.035 HG23 HD13 ' A' ' 29' ' ' ILE . 68.0 mt -143.81 112.03 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.28000000000000003 109.397 177.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.438 ' CD2' HG23 ' A' ' 117' ' ' THR . 8.3 m170 -97.06 114.38 26.02 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.55000000000000004 110.284 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.642 HD21 HD22 ' A' ' 110' ' ' LEU . 52.3 tp -93.02 122.53 35.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.477 0.547 . . . . 1.52 112.477 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.1 t -119.99 121.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.762 -0.829 . . . . 0.32000000000000001 108.762 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 33' ' ' LYS . 11.7 t -98.52 127.03 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 112.656 0.613 . . . . 1.0800000000000001 112.656 -177.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 81.3 mt -84.51 173.59 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.52000000000000002 109.443 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.358 0.599 . . . . 1.48 112.04 -178.639 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.2 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.961 0.41 . . . . 1.8400000000000001 111.026 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.67 141.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 2.1499999999999999 110.798 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.2 p -86.58 157.22 19.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.41 0.624 . . . . 1.1200000000000001 111.399 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.551 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.13 83.21 0.21 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.75 -1.113 . . . . 0.65000000000000002 111.489 -178.206 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.6 Cg_endo -78.39 -79.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.277 2.651 . . . . 0.88 112.354 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -78.58 128.14 33.1 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.607 -0.886 . . . . 2.0600000000000001 108.607 178.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.897 ' OE2' HD11 ' A' ' 29' ' ' ILE . 84.0 tt0 -144.03 159.45 42.57 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.038 1.125 . . . . 1.71 114.038 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.45 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 27.4 mtt -139.97 118.93 12.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.802 -1.09 . . . . 1.8600000000000001 109.584 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.9 mm -120.02 130.93 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.509 -0.314 . . . . 0.39000000000000001 111.428 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 19.5 pt-20 -128.56 127.8 43.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 1.1899999999999999 110.775 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 42.4 mmtm -142.28 164.86 29.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.439 . . . . 2.52 110.953 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.832 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.52 135.24 39.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.286 -0.416 . . . . 0.39000000000000001 111.283 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -45.84 130.71 9.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.346 -0.388 . . . . 2.3500000000000001 111.24 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.77 -19.91 45.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 0.31 112.372 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.832 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -80.03 160.01 26.0 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.551 -0.907 . . . . 2.1099999999999999 108.551 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 31.3 m -88.68 127.34 35.58 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.789 -0.764 . . . . 0.33000000000000002 110.762 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.008 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 119.97 39.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 0.26000000000000001 110.829 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 94' ' ' THR . 41.4 t80 -79.37 119.35 22.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 1.4299999999999999 111.907 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 105' ' ' ILE . 13.1 mt -103.8 105.42 47.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.87 -0.789 . . . . 0.80000000000000004 108.87 177.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 90.7 Cg_endo -84.6 122.66 2.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.449 2.099 . . . . 0.41999999999999998 114.589 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.73 127.26 20.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.355 -0.979 . . . . 1.03 108.355 177.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.8 ttpt -140.69 116.56 10.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.393 0.616 . . . . 1.6599999999999999 110.697 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.754 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 33.2 p90 -93.62 141.43 28.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 1.26 111.885 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 m -80.94 150.48 28.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 1.3300000000000001 110.774 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.79 141.62 39.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.841 -0.618 . . . . 2.1200000000000001 111.313 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 m -156.25 153.59 25.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 1.75 110.162 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.4 -20.69 26.82 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.431 2.087 . . . . 1.6100000000000001 112.467 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.715 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 mt-10 -75.76 -41.42 53.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 111.942 0.349 . . . . 2.1800000000000002 111.942 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -69.2 74.64 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.836 -0.745 . . . . 2.4100000000000001 110.244 -179.43 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' GLU . 93.0 mt-30 -90.42 -16.44 29.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.085 -0.961 . . . . 1.6399999999999999 111.02 -179.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.05 155.8 53.25 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.133 -1.032 . . . . 0.55000000000000004 112.096 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.23 151.13 9.75 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.125 1.883 . . . . 0.84999999999999998 111.551 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.754 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -77.67 132.62 38.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.854 0.359 . . . . 1.8999999999999999 110.946 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 36.1 t0 -140.26 150.5 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.392 0.615 . . . . 1.78 111.895 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.711 HD13 ' HB1' ' A' ' 103' ' ' ALA . 50.4 mt -142.23 137.78 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.682 -1.145 . . . . 0.75 109.619 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.734 ' HG2' HD21 ' A' ' 73' ' ' LEU . 37.0 mt-10 -140.22 111.86 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.79 0.328 . . . . 1.6699999999999999 111.825 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.6 m95 -98.67 119.99 38.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.22 110.908 178.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.55 146.15 37.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.492 . . . . 0.40999999999999998 109.67 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.787 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.3 tt -132.5 140.01 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.775 0.657 . . . . 0.78000000000000003 112.775 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -122.37 102.98 39.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.628 -0.879 . . . . 1.25 108.628 177.149 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.7 Cg_exo -79.08 115.23 3.49 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.725 2.283 . . . . 0.53000000000000003 113.22 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.32 69.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.40999999999999998 110.243 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.68 10.22 7.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.614 -0.721 . . . . 1.8200000000000001 111.491 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 32.7 m120 -145.77 156.01 43.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.061 0.458 . . . . 1.9399999999999999 111.361 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.91 -22.87 64.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.652 -0.703 . . . . 1.6599999999999999 111.716 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.707 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 5.6 mttt -73.79 151.23 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 1.74 110.71 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.3 m -152.41 136.29 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 122.502 1.144 . . . . 0.96999999999999997 110.764 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 61.23 45.05 9.23 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.758 -2.019 . . . . 1.77 112.566 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -87.12 149.72 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.728 0.299 . . . . 1.96 110.538 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.734 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.9 p -68.26 139.99 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.77000000000000002 110.09 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.86 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -136.51 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.538 -0.465 . . . . 1.1499999999999999 111.552 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.946 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.19 133.14 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.009 0.433 . . . . 0.28999999999999998 109.848 179.384 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HG2' ' A' ' 56' ' ' GLU . 1.6 mp -140.83 158.57 43.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.024 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.867 ' CD1' HD13 ' A' ' 79' ' ' ILE . 51.8 t80 -133.68 104.47 6.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.578 -0.527 . . . . 1.3 109.578 176.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.498 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.1 t -144.02 159.78 42.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.413 0.523 . . . . 0.89000000000000001 112.413 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.57 30.02 6.05 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.988 -0.551 . . . . 0.56999999999999995 113.182 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 t0 71.9 3.07 4.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 1.46 111.4 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 22.8 mtpp -100.03 118.05 35.6 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.1 -0.704 . . . . 2.4100000000000001 109.1 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.867 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.3 mm -79.86 130.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.87 -1.159 . . . . 1.6599999999999999 107.87 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.77 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.1 m-85 -118.56 125.79 50.59 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.096 -0.956 . . . . 1.25 110.289 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.0 p-10 -166.09 -55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.486 -1.672 . . . . 1.2 106.486 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 34.0 p-10 -82.18 -22.08 36.19 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.311 -1.313 . . . . 2.1699999999999999 109.202 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.615 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -80.83 -26.52 36.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.736 -1.12 . . . . 5.0499999999999998 108.556 178.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 1.8 m-85 -85.25 118.3 70.51 Favored Pre-proline 0 CA--C 1.51 -0.58 0 CA-C-N 115.374 -0.83 . . . . 1.29 109.868 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.6 Cg_endo -47.04 -43.6 24.54 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.421 1.414 . . . . 0.79000000000000004 110.49 179.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.775 ' HB3' HG22 ' A' ' 71' ' ' ILE . 71.5 m-20 -69.59 106.25 2.96 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.627 -0.829 . . . . 1.3600000000000001 111.512 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.7 mp 73.12 20.13 3.46 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.186 -0.916 . . . . 1.6200000000000001 113.453 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 60.2 pttt -54.66 126.07 22.42 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.903 -0.719 . . . . 2.3900000000000001 111.332 178.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 14.28 45.09 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.323 -0.941 . . . . 0.37 114.402 178.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.7 -47.2 0.24 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 114.656 1.354 . . . . 1.5900000000000001 114.656 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.946 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.24 81.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.676 1.227 . . . . 0.20000000000000001 108.109 -178.285 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.595 ' C ' HG22 ' A' ' 105' ' ' ILE . 21.8 m80 -102.73 130.2 49.6 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.081 -1.872 . . . . 0.28999999999999998 112.313 -176.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.119 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.9 m-85 -72.82 121.22 19.57 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.177 -0.675 . . . . 1.23 109.177 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.573 HG22 ' OD1' ' A' ' 106' ' ' ASN . 38.1 p -70.15 -9.78 56.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.188 -0.914 . . . . 0.46000000000000002 110.805 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 70.5 m -91.09 119.95 31.65 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.987 -0.551 . . . . 1.2 110.449 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.59 4.07 50.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.268 0.556 . . . . 2.2200000000000002 110.142 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -145.99 67.6 1.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.262 -1.014 . . . . 2.1400000000000001 108.262 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.466 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.8 mp -55.73 -33.41 64.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.975 -1.011 . . . . 1.49 111.72 -178.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -61.28 -3.59 0.95 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.152 0.501 . . . . 2.04 112.21 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.68 0.07 56.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.546 -0.752 . . . . 1.3999999999999999 111.187 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.81 -12.31 45.9 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.618 -0.801 . . . . 0.38 113.673 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 96.1 m-20 -94.75 113.76 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.472 . . . . 1.4399999999999999 111.418 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.36 12.17 24.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.637 . . . . 0.42999999999999999 111.918 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 72.5 p -60.03 140.05 57.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.64 1.718 . . . . 1.04 115.64 -178.002 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.119 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.07 135.51 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-N 114.104 -1.407 . . . . 0.31 110.871 178.547 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.633 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.7 OUTLIER -105.03 148.21 27.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.039 -0.726 . . . . 1.1499999999999999 109.039 177.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.816 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -101.42 118.89 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.005 0.431 . . . . 0.27000000000000002 110.999 -179.561 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.1 p -83.26 144.44 29.74 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.537 -0.756 . . . . 0.28999999999999998 110.53 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 50.58 57.52 6.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.037 0.446 . . . . 1.52 111.549 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.5 mt -46.92 90.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.95 1.092 . . . . 1.02 113.95 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 33.7 mt-30 -59.22 141.47 54.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.864 -0.607 . . . . 2.1299999999999999 110.702 176.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.06 -37.02 78.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 1.7 110.215 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.58 -9.97 59.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.3200000000000001 111.48 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.581 ' O ' HD11 ' A' ' 59' ' ' ILE . 92.4 m-20 -72.47 -17.07 61.79 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.938 -0.393 . . . . 1.5800000000000001 109.938 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.46 141.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 116.198 -0.455 . . . . 0.41999999999999998 110.346 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.11 158.97 7.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.218 -0.991 . . . . 0.23999999999999999 113.352 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -59.55 131.04 49.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.685 0.624 . . . . 0.31 112.685 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 20.7 m-85 -111.26 135.38 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.294 -0.632 . . . . 1.24 109.294 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 59.2 tt0 -127.06 121.5 31.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.971 -0.291 . . . . 1.1599999999999999 110.717 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 26.0 t -99.98 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.456 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 90.8 mttt -119.81 106.22 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 1.76 111.188 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 50.1 t -93.72 109.92 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.695 -0.483 . . . . 1.1799999999999999 109.695 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 72.6 tttt -94.13 120.01 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.969 -0.693 . . . . 1.6200000000000001 112.308 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 5.6 mtmp? -143.73 101.99 3.84 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.202 -0.666 . . . . 2.8399999999999999 109.202 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.03 131.02 40.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 113.016 0.747 . . . . 0.44 113.016 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 21.2 Cg_endo -102.03 51.92 1.44 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.788 -0.922 . . . . 0.56000000000000005 111.505 -0.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.49 103.44 0.29 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.183 -1.008 . . . . 0.47999999999999998 113.993 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.2 m -89.52 139.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.193 -1.004 . . . . 1.22 109.396 177.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -136.73 149.34 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.193 -0.317 . . . . 0.56999999999999995 111.81 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.6 p-10 -146.41 151.22 37.09 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.381 0.511 . . . . 2.0299999999999998 112.381 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.625 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.65 155.27 42.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.915 -0.584 . . . . 2.9500000000000002 110.37 178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.5 mttt -101.25 140.02 36.12 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.504 0.927 . . . . 2.2599999999999998 113.504 -178.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.8 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.23 119.97 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.28000000000000003 109.026 176.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 117' ' ' THR . 35.3 m170 -100.25 116.79 33.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.609 -0.436 . . . . 0.55000000000000004 110.44 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 110' ' ' LEU . 58.8 tp -89.86 120.1 30.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.451 . . . . 1.52 111.657 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 57.7 t -118.14 119.95 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.32000000000000001 109.418 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 115' ' ' ILE . 39.1 t -99.78 125.81 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.038 0.447 . . . . 1.0800000000000001 112.174 -178.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 97.8 mt -83.92 170.0 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.734 -0.667 . . . . 0.52000000000000002 109.545 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 1.48 111.55 -178.813 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.823 0.344 . . . . 1.8400000000000001 111.066 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.605 HD12 ' HB1' ' A' ' 129' ' ' ALA . 15.6 tt -142.18 131.3 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 110.793 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.73 151.75 19.88 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.546 0.689 . . . . 1.1200000000000001 111.65 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.59 82.96 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.673 -1.149 . . . . 0.65000000000000002 111.491 -178.287 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.635 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.9 Cg_endo -78.6 -83.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.557 2.838 . . . . 0.88 112.989 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.4 tt0 -77.97 120.22 22.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.221 -0.659 . . . . 2.0600000000000001 109.221 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.884 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.1 tt0 -144.02 161.03 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.472 0.916 . . . . 1.71 113.472 -176.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.732 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.8 ttm -131.91 139.42 48.74 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.255 -0.884 . . . . 1.8600000000000001 109.807 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.884 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.5 mm -134.24 140.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.202 -0.454 . . . . 0.39000000000000001 111.465 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.5 pt-20 -137.84 129.21 27.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.773 0.32 . . . . 1.1899999999999999 111.086 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 56.8 mmtt -142.33 159.98 41.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.327 -0.397 . . . . 2.52 111.534 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.51 142.51 40.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.089 -0.505 . . . . 0.39000000000000001 111.844 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.791 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 66.4 mttt -46.66 144.13 2.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.888 -0.597 . . . . 2.3500000000000001 111.933 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.97 -22.81 2.8 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.328 -0.851 . . . . 0.31 113.334 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.99 160.03 26.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.435 -0.58 . . . . 2.1099999999999999 109.435 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 60.5 m -87.09 129.1 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.182 -0.607 . . . . 0.33000000000000002 110.712 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 115.34 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.044 0.45 . . . . 0.26000000000000001 110.631 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.38 120.05 23.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.117 -0.492 . . . . 1.4299999999999999 112.315 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 105' ' ' ILE . 23.8 mt -104.73 104.86 48.13 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.05 -0.722 . . . . 0.80000000000000004 109.05 177.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.8 Cg_exo -80.23 130.78 8.36 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.535 2.157 . . . . 0.41999999999999998 114.257 -177.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.9 t -141.17 130.96 24.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.125 -0.943 . . . . 1.03 108.766 177.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.4 mmtp -140.24 137.54 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.473 -0.33 . . . . 1.6599999999999999 110.649 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 122' ' ' VAL . 51.3 p90 -140.92 139.97 34.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.488 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 1.3300000000000001 110.567 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 45' ' ' LEU . 9.6 tt -97.67 108.04 20.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.421 -0.354 . . . . 2.1200000000000001 110.871 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 t -84.3 136.87 39.96 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.879 -0.415 . . . . 1.75 109.879 179.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.55 -30.73 4.17 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.842 1.694 . . . . 1.6100000000000001 111.194 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.94 -38.6 45.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.565 -0.743 . . . . 2.1800000000000002 111.018 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 78.0 m-20 -70.13 73.78 0.47 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.518 -0.473 . . . . 2.4100000000000001 109.741 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -98.55 0.05 44.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.677 -0.692 . . . . 1.6399999999999999 111.912 -178.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.908 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.4 171.73 39.75 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.811 -0.709 . . . . 0.55000000000000004 113.183 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.66 138.69 65.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.816 2.344 . . . . 0.84999999999999998 112.365 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 2.0 mt -78.54 111.82 14.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 1.8999999999999999 111.557 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 89.0 m-20 -127.57 102.75 6.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.613 0.721 . . . . 1.78 111.429 178.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.768 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.3 mt -94.01 123.55 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.61 -1.177 . . . . 0.75 109.96 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.682 ' HG2' HD11 ' A' ' 73' ' ' LEU . 95.0 mt-10 -120.01 111.87 18.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.831 0.678 . . . . 1.6699999999999999 112.831 -178.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.9 m95 -94.33 119.96 33.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.772 -0.371 . . . . 0.22 110.088 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.512 HD12 ' OE1' ' A' ' 119' ' ' GLN . 86.1 mt -105.59 122.67 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.665 0.269 . . . . 0.40999999999999998 110.329 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.634 ' HB ' HG21 ' A' ' 71' ' ' ILE . 7.3 tt -108.11 131.52 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.459 0.54 . . . . 0.78000000000000003 112.459 -179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -126.1 102.19 27.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.909 -0.774 . . . . 1.25 108.909 177.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.5 Cg_exo -79.77 118.35 3.79 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.735 2.29 . . . . 0.53000000000000003 112.389 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.06 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.40999999999999998 111.024 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.0 -40.03 60.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.869 -0.605 . . . . 1.8200000000000001 111.845 -179.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.33 159.95 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.329 0.585 . . . . 1.9399999999999999 111.988 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -69.36 -16.76 63.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.121 -0.945 . . . . 1.6599999999999999 111.199 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.67 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.7 mttm -69.15 149.14 48.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.629 -0.714 . . . . 1.74 111.651 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.73 127.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-O 121.942 0.877 . . . . 0.96999999999999997 109.887 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.65 39.98 27.0 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.51 178.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.04 143.85 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.367 0.127 . . . . 1.96 110.719 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 26.5 t -67.9 119.79 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.77000000000000002 110.004 179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.23 -55.45 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.622 -0.717 . . . . 1.1499999999999999 112.328 -178.203 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.825 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.8 124.47 38.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.145 -1.058 . . . . 0.28999999999999998 108.145 179.119 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.6 tt -137.71 156.17 48.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.928 -0.578 . . . . 1.3 110.786 -176.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.837 ' CD1' HD13 ' A' ' 79' ' ' ILE . 25.2 t80 -132.81 103.71 6.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.198 -0.456 . . . . 1.3 109.879 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.438 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 29.7 t -143.99 156.61 44.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.244 0.461 . . . . 0.89000000000000001 112.244 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.24 29.3 21.81 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.02 -0.609 . . . . 0.56999999999999995 112.795 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.6 t0 73.47 2.85 4.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.494 0.188 . . . . 1.46 111.28 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 80.2 mttt -100.01 115.17 29.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 110.148 -0.316 . . . . 2.4100000000000001 110.148 178.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.837 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.4 mm -80.34 128.33 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 106.927 -1.509 . . . . 1.6599999999999999 106.927 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.6 m-85 -112.43 117.31 32.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.215 -0.902 . . . . 1.25 110.38 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.855 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.4 p-10 -166.14 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.845 -1.539 . . . . 1.2 106.845 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -76.63 -34.66 58.33 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.37 -1.286 . . . . 2.1699999999999999 108.563 177.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.52 -29.98 61.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.765 -1.198 . . . . 5.0499999999999998 107.765 177.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.542 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 m-85 -83.47 110.83 27.01 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 114.833 -1.076 . . . . 1.29 109.938 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.77 -28.14 59.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.063 1.842 . . . . 0.79000000000000004 112.456 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 1.058 ' O ' HD12 ' A' ' 87' ' ' LEU . 61.1 m-20 -50.05 -32.77 16.31 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.356 -0.538 . . . . 1.3600000000000001 111.843 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.6 mp -151.42 35.27 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.092 -0.958 . . . . 1.6200000000000001 110.424 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.855 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.8 pttp -57.26 134.86 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.134 0.492 . . . . 2.3900000000000001 112.011 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 75.54 19.84 78.96 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.513 -0.767 . . . . 0.37 113.947 178.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -146.78 -48.71 0.19 Allowed 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.394 1.257 . . . . 1.5900000000000001 114.394 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.825 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.2 p -80.0 81.48 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.979 1.371 . . . . 0.20000000000000001 107.721 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.43 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.6 m80 -101.81 127.68 48.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.355 -2.202 . . . . 0.28999999999999998 112.366 -175.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.104 ' CD1' HG23 ' A' ' 105' ' ' ILE . 58.6 m-85 -71.86 124.02 23.94 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 120.219 -0.592 . . . . 1.23 109.406 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.669 HG22 ' OD1' ' A' ' 106' ' ' ASN . 30.6 p -73.9 33.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.587 -0.733 . . . . 0.46000000000000002 112.517 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 m -148.91 136.25 20.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.968 0.413 . . . . 1.2 111.338 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.8 1.01 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 2.2200000000000002 110.735 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -146.35 65.53 1.19 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.347 0.594 . . . . 2.1400000000000001 109.583 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.914 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.5 mp -57.67 -30.04 65.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 1.49 111.114 -179.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -60.01 -10.96 4.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.619 0.723 . . . . 2.04 112.238 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -83.45 0.05 47.95 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.489 -1.232 . . . . 1.3999999999999999 111.121 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 112.87 -9.38 25.47 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.627 -0.797 . . . . 0.38 113.433 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.59 116.58 29.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.931 0.366 . . . . 1.4399999999999999 110.61 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.674 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.75 10.03 15.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.491 -0.322 . . . . 0.42999999999999999 111.627 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 50.4 m -60.01 139.76 57.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 115.335 1.605 . . . . 1.04 115.335 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.104 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -134.71 127.87 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 114.419 -1.264 . . . . 0.31 110.45 178.375 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.669 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -103.65 150.46 23.98 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.506 -0.553 . . . . 1.1499999999999999 109.506 178.119 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -101.14 119.98 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.101 0.477 . . . . 0.27000000000000002 111.114 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -85.56 144.12 28.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.313 -0.858 . . . . 0.28999999999999998 110.64 178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.15 59.99 3.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.629 0.603 . . . . 1.52 112.629 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.9 mt -46.0 178.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.13 0.49 . . . . 1.02 112.274 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.604 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.1 tt0 -177.55 161.44 1.71 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.817 -0.629 . . . . 2.1299999999999999 110.25 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.791 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 59.0 tp -59.96 -40.03 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.842 0.353 . . . . 1.7 111.376 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -72.2 -12.33 61.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.127 -0.488 . . . . 1.3200000000000001 111.683 -178.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.14 -21.31 61.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.791 -0.448 . . . . 1.5800000000000001 109.791 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -44.94 145.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.877 -0.601 . . . . 0.41999999999999998 111.06 179.066 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.68 149.91 5.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.768 -1.206 . . . . 0.23999999999999999 114.229 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.841 HG23 ' CD2' ' A' ' 134' ' ' HIS . 93.8 m -59.81 136.8 58.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.802 -0.699 . . . . 0.31 111.813 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.937 ' CE1' HD12 ' A' ' 135' ' ' LEU . 47.2 m-85 -120.0 132.57 55.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.704 -0.48 . . . . 1.24 109.704 177.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.812 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.7 tt0 -120.29 116.4 25.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.589 -0.278 . . . . 1.1599999999999999 110.631 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.519 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 53.3 t -100.02 115.57 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 1.03 110.545 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 29.7 mtpp -119.46 105.7 11.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.76 111.125 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.684 HG22 HG12 ' A' ' 55' ' ' ILE . 42.9 t -90.03 117.14 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.349 -0.611 . . . . 1.1799999999999999 109.349 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 62.9 tttp -98.58 120.29 38.75 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.515 0.931 . . . . 1.6200000000000001 113.515 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HD3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -143.17 101.04 3.74 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.105 -0.702 . . . . 2.8399999999999999 109.105 176.44 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.908 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.68 132.56 65.0 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.722 -0.672 . . . . 0.44 112.71 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 51.6 Cg_endo -99.53 48.37 1.98 Allowed 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.68 -0.967 . . . . 0.56000000000000005 112.432 -0.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.37 103.56 0.29 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.864 -0.684 . . . . 0.47999999999999998 112.823 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.03 152.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.575 -0.812 . . . . 1.22 110.099 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -131.66 147.46 52.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.485 0.183 . . . . 0.56999999999999995 111.198 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 49.5 t-20 -146.69 138.59 24.64 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.871 0.322 . . . . 2.0299999999999998 111.871 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.42 151.7 38.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.49 -0.323 . . . . 2.9500000000000002 110.824 178.865 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 3.4 tttt -97.98 139.94 33.07 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 113.188 0.81 . . . . 2.2599999999999998 113.188 -177.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.799 HD11 ' HE2' ' A' ' 131' ' ' LYS . 90.1 mt -145.1 113.7 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.28000000000000003 109.76 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.841 ' CD2' HG23 ' A' ' 117' ' ' THR . 53.4 m170 -102.95 120.0 39.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.55000000000000004 111.273 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.937 HD12 ' CE1' ' A' ' 118' ' ' TYR . 13.8 mt -91.09 127.23 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 1.52 112.634 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.417 ' HB ' ' CB ' ' A' ' 30' ' ' GLU . 62.7 t -113.27 127.48 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.098 -0.955 . . . . 0.32000000000000001 108.939 178.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.857 HG23 HG13 ' A' ' 115' ' ' ILE . 20.7 t -97.88 120.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.579 0.585 . . . . 1.0800000000000001 112.579 -178.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.763 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 78.4 mt -83.57 160.85 21.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.899 -0.592 . . . . 0.52000000000000002 109.765 178.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.384 0.612 . . . . 1.48 112.204 -178.5 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 1.8400000000000001 111.092 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 129' ' ' ALA . 17.1 tt -139.98 139.37 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 2.1499999999999999 110.324 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 7.9 p -92.09 153.03 19.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.49 0.662 . . . . 1.1200000000000001 111.734 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.513 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.41 83.75 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 114.554 -1.203 . . . . 0.65000000000000002 111.502 -178.358 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.616 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.4 Cg_endo -77.84 -80.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.334 2.689 . . . . 0.88 112.704 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 14.7 pt-20 -78.49 128.11 33.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 179.163 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.8 tp10 -144.14 160.01 41.66 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.247 1.203 . . . . 1.71 114.247 -176.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 11.2 mtm -140.26 118.27 11.87 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.464 -1.244 . . . . 1.8600000000000001 109.126 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.422 HG12 HG23 ' A' ' 133' ' ' ILE . 36.7 mm -120.03 128.65 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.906 0.384 . . . . 0.39000000000000001 111.561 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.4 mt-10 -120.01 125.35 48.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.1899999999999999 109.916 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -141.9 160.02 41.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 2.52 111.428 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.77 134.37 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.143 -0.48 . . . . 0.39000000000000001 111.742 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 84.8 tttt -46.92 134.38 10.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.934 -0.575 . . . . 2.3500000000000001 111.273 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.72 -25.16 14.24 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.992 -0.623 . . . . 0.31 112.66 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -80.0 160.0 26.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.124 -1.065 . . . . 2.1099999999999999 108.124 178.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 59.1 m -87.98 127.04 35.38 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.491 -0.884 . . . . 0.33000000000000002 110.609 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.52 116.65 30.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.905 0.383 . . . . 0.26000000000000001 110.169 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.71 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.11 118.54 21.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.873 -0.603 . . . . 1.4299999999999999 112.259 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 133' ' ' ILE . 38.7 mt -102.9 107.94 56.64 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.142 -0.688 . . . . 0.80000000000000004 109.142 178.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.32 120.63 3.3 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.078 . . . . 0.41999999999999998 114.312 -178.106 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 2.6 t -141.01 123.93 16.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.777 -0.823 . . . . 1.03 108.777 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 17.1 mttp -141.09 153.77 45.61 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.283 -0.417 . . . . 1.6599999999999999 110.758 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.494 ' CD1' HG11 ' A' ' 122' ' ' VAL . 33.1 p90 -139.74 145.71 38.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.631 . . . . 1.26 111.479 -178.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.07 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.456 -0.793 . . . . 1.3300000000000001 111.631 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.53 147.46 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.904 -0.589 . . . . 2.1200000000000001 110.943 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 19.5 p -157.35 139.98 10.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 1.75 110.29 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.27 -27.05 2.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.801 2.334 . . . . 1.6100000000000001 112.804 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.647 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.08 -28.65 54.69 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.025 0.38 . . . . 2.1800000000000002 112.025 -179.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 44.1 p-10 -67.74 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.453 0.644 . . . . 2.4100000000000001 111.22 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 65.8 mt-30 -96.98 -6.81 34.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.678 . . . . 1.6399999999999999 111.763 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.873 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.85 158.24 52.08 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.207 -0.997 . . . . 0.55000000000000004 113.056 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.83 130.33 39.79 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.84999999999999998 111.209 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HE2' ' A' ' 74' ' ' TYR . 7.3 tt -77.81 119.96 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.39 . . . . 1.8999999999999999 110.981 -179.04 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -136.67 102.76 5.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.648 0.737 . . . . 1.78 111.83 179.727 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.8 mt -96.71 111.4 26.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.802 -1.09 . . . . 0.75 110.37 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.762 ' HG2' HD11 ' A' ' 73' ' ' LEU . 79.2 mt-10 -108.91 117.67 34.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.389 0.515 . . . . 1.6699999999999999 112.389 -179.045 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.947 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.9 m95 -95.43 118.52 32.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.771 -0.455 . . . . 0.22 109.771 177.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' CD2' HG22 ' A' ' 70' ' ' VAL . 85.6 mt -109.96 140.02 44.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.599 -0.273 . . . . 0.40999999999999998 110.294 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.6 tt -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.086 0.402 . . . . 0.78000000000000003 112.086 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.423 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.8 m -114.63 102.53 54.88 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 108.515 -0.92 . . . . 1.25 108.515 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 81.4 Cg_endo -78.85 111.06 2.91 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.475 2.117 . . . . 0.53000000000000003 113.151 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.99 72.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.994 -1.003 . . . . 0.40999999999999998 111.009 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 7.4 p-10 -87.6 17.21 4.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.242 -0.435 . . . . 1.8200000000000001 111.369 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.6 HD21 ' HB2' ' A' ' 113' ' ' SER . 91.8 m-20 -148.34 162.98 38.44 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.408 0.623 . . . . 1.9399999999999999 111.96 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.3 -19.84 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.946 . . . . 1.6599999999999999 111.64 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 57.4 mttt -69.68 151.74 45.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.073 -0.512 . . . . 1.74 111.344 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.98 127.93 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-O 121.752 0.787 . . . . 0.96999999999999997 109.483 178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.48 41.26 31.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.312 -1.313 . . . . 1.77 112.227 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.38 134.89 33.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.96 110.919 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.572 HG22 ' CD2' ' A' ' 58' ' ' LEU . 91.3 t -70.5 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.619 -0.264 . . . . 0.77000000000000002 110.872 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.5 pp -127.11 -36.7 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.269 0.47 . . . . 1.1499999999999999 112.269 -179.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 123.4 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.28999999999999998 109.385 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.847 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.2 tt -140.36 155.61 46.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.592 -178.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.847 ' N ' HD23 ' A' ' 73' ' ' LEU . 62.7 t80 -132.45 104.29 6.63 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.658 0.266 . . . . 1.3 110.318 179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.43 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 17.9 t -142.46 157.05 45.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.9 0.381 . . . . 0.89000000000000001 111.875 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.39 29.45 38.5 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.002 -0.618 . . . . 0.56999999999999995 112.684 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 71.9 2.43 4.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.601 0.239 . . . . 1.46 110.933 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.0 mttm -100.05 107.36 19.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.991 -0.744 . . . . 2.4100000000000001 108.991 177.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.786 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.95 118.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 122.511 1.148 . . . . 1.6599999999999999 108.562 178.674 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.68 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -100.19 125.7 46.37 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.767 -2.015 . . . . 1.25 111.663 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.838 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 20.8 p-10 -166.39 -54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.906 -1.516 . . . . 1.2 106.906 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 54.3 t0 -81.7 -30.77 32.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.52 -1.218 . . . . 2.1699999999999999 108.848 177.23 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -72.48 -31.24 65.23 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 5.0499999999999998 107.317 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.6 OUTLIER -82.6 111.04 25.71 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.32 -1.309 . . . . 1.29 109.399 178.165 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -34.2 92.91 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.292 1.994 . . . . 0.79000000000000004 113.581 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 87' ' ' LEU . 51.8 m-20 -49.72 -29.84 8.26 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.129 0.789 . . . . 1.3600000000000001 113.129 -177.423 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.833 HD22 ' HD2' ' A' ' 90' ' ' ARG . 17.9 mt -153.8 30.29 0.46 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.808 -0.633 . . . . 1.6200000000000001 111.316 178.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 13.5 pttm -55.54 133.41 50.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.309 -0.556 . . . . 2.3900000000000001 111.847 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 87.88 11.97 67.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.673 177.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.833 ' HD2' HD22 ' A' ' 87' ' ' LEU . 6.1 ptp180 -142.57 -51.02 0.37 Allowed 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 114.977 1.473 . . . . 1.5900000000000001 114.977 -178.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.08 80.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-O 122.988 1.375 . . . . 0.20000000000000001 107.667 -177.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.428 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.5 m80 -101.2 126.15 47.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 112.248 -2.251 . . . . 0.28999999999999998 112.388 -175.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.134 ' CD1' HG23 ' A' ' 105' ' ' ILE . 83.3 m-85 -70.76 124.58 24.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 120.036 -0.666 . . . . 1.23 109.715 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 ' CD1' ' A' ' 38' ' ' TYR . 1.7 p -76.18 36.08 0.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.283 -0.871 . . . . 0.46000000000000002 110.966 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 93' ' ' PHE . 2.9 m -148.93 127.1 12.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.96 0.409 . . . . 1.2 110.127 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.62 8.24 37.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.998 -0.546 . . . . 2.2200000000000002 110.313 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.53 67.62 1.18 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.518 -0.764 . . . . 2.1400000000000001 108.998 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.2 mp -57.96 -36.21 72.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.299 -0.864 . . . . 1.49 111.747 -178.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.97 2.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.561 0.578 . . . . 2.04 112.561 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 98' ' ' LEU . 15.7 m -90.53 -0.23 57.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.913 -0.585 . . . . 1.3999999999999999 110.591 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.13 -12.61 37.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.049 -0.596 . . . . 0.38 113.393 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -98.07 110.83 23.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.111 0.456 . . . . 1.4399999999999999 110.801 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.51 15.43 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.42999999999999999 112.241 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 23.5 m -60.01 139.98 57.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.338 1.607 . . . . 1.04 115.338 -178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.134 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -132.97 130.1 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 114.844 -1.071 . . . . 0.31 111.078 178.356 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.689 ' HB2' HG22 ' A' ' 36' ' ' THR . 50.8 p30 -105.54 147.88 27.88 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.122 -0.696 . . . . 1.1499999999999999 109.122 177.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.39 121.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.964 0.411 . . . . 0.27000000000000002 111.409 -178.268 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -83.06 144.71 29.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.549 -0.751 . . . . 0.28999999999999998 110.33 178.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.98 58.68 5.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.93 0.395 . . . . 1.52 111.139 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.1 mt -46.25 88.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.494 0.924 . . . . 1.02 113.494 -178.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 pt20 -59.51 147.42 36.87 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.896 -0.593 . . . . 2.1299999999999999 110.441 177.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.94 -35.37 74.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.276 0.56 . . . . 1.7 110.428 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.6 ' HB2' HD21 ' A' ' 64' ' ' ASN . 24.3 p -72.21 -9.42 58.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.794 . . . . 1.3200000000000001 111.887 -179.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 6.5 m-20 -70.54 -18.99 62.93 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.682 -0.407 . . . . 1.5800000000000001 110.209 179.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 27.2 mt -44.6 134.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.767 -0.457 . . . . 0.41999999999999998 109.767 178.233 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.89 156.54 6.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.073 -1.06 . . . . 0.23999999999999999 113.522 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 85.9 m -59.39 134.67 57.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.797 0.666 . . . . 0.31 112.797 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 14.6 m-85 -113.49 137.88 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 1.24 109.754 177.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 32.1 tt0 -129.13 118.14 21.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.666 0.27 . . . . 1.1599999999999999 110.762 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 13.0 t -104.13 118.79 37.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.4 . . . . 1.03 110.34 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.0 mtpm? -119.97 107.01 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.538 -0.301 . . . . 1.76 111.283 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 t -90.82 110.25 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.311 -0.625 . . . . 1.1799999999999999 109.311 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.879 ' HG2' HG12 ' A' ' 128' ' ' VAL . 74.3 mttt -96.72 116.53 29.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.942 1.09 . . . . 1.6200000000000001 113.942 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 49' ' ' ASP . 63.9 tttt -147.21 102.13 3.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 2.8399999999999999 109.453 176.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.873 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.73 133.17 46.92 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 112.27 0.47 . . . . 0.44 112.27 -179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.6 Cg_endo -100.42 51.56 1.5 Allowed 'Cis proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.716 -0.952 . . . . 0.56000000000000005 111.9 -0.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 102.83 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.107 -1.044 . . . . 0.47999999999999998 113.34 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.879 HG12 ' HG2' ' A' ' 123' ' ' LYS . 6.0 m -90.01 119.97 38.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.27 -0.965 . . . . 1.22 110.029 178.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -99.68 140.01 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.598 0.222 . . . . 0.56999999999999995 111.598 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -146.59 133.57 20.27 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.539 -0.301 . . . . 2.0299999999999998 111.525 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.658 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.54 152.64 40.06 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.571 -0.286 . . . . 2.9500000000000002 111.239 179.152 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 81.9 mttt -102.16 141.16 35.43 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.282 0.845 . . . . 2.2599999999999998 113.282 -178.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.774 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 84.1 mt -139.98 120.02 13.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.28000000000000003 109.417 176.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 15.9 m170 -100.01 114.26 27.43 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.468 -0.493 . . . . 0.55000000000000004 110.274 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 55.6 tp -90.45 125.02 35.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 1.52 112.35 -178.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 40.7 t -120.88 123.84 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.32000000000000001 109.634 178.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 115' ' ' ILE . 38.2 t -96.87 119.95 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.173 0.434 . . . . 1.0800000000000001 112.173 -178.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.3 mt -84.46 170.64 13.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.808 -0.633 . . . . 0.52000000000000002 109.342 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.352 0.596 . . . . 1.48 111.538 -178.817 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 29.7 t . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.071 0.462 . . . . 1.8400000000000001 111.323 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.888 HG12 ' HB1' ' A' ' 129' ' ' ALA . 3.8 mt -130.01 129.97 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.671 -0.695 . . . . 2.1499999999999999 110.407 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.738 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -89.09 140.04 29.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.581 . . . . 1.1200000000000001 110.225 179.072 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 46.04 81.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.039 -0.982 . . . . 0.65000000000000002 111.096 -177.189 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.0 Cg_endo -78.99 -14.15 13.76 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.854 3.036 . . . . 0.88 113.377 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.8 mt-10 -141.36 126.28 18.21 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.272 -0.64 . . . . 2.0600000000000001 109.272 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 132' ' ' LYS . 2.1 tt0 -144.06 155.66 44.07 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.534 1.309 . . . . 1.71 114.534 -177.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.458 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 29.1 mtm -140.38 113.99 8.73 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.639 -1.164 . . . . 1.8600000000000001 109.455 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.885 HD13 HG23 ' A' ' 133' ' ' ILE . 5.3 mp -119.97 120.69 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.646 0.609 . . . . 0.39000000000000001 112.646 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.6 mt-10 -101.59 126.91 48.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.806 -0.634 . . . . 1.1899999999999999 109.888 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HB3' HD13 ' A' ' 110' ' ' LEU . 16.7 tptt -142.02 156.0 45.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 121.021 -0.272 . . . . 2.52 111.1 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.826 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.93 143.69 39.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.855 0.36 . . . . 0.39000000000000001 111.919 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' CD ' ' HG ' ' A' ' 112' ' ' LEU . 80.8 tttt -48.98 132.47 18.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.283 -0.417 . . . . 2.3500000000000001 111.621 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 86.98 -15.78 51.21 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.155 -0.545 . . . . 0.31 112.923 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.826 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -79.98 158.76 26.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.95 -0.759 . . . . 2.1099999999999999 108.95 178.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.793 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.7 m -88.77 128.42 35.63 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.058 -0.657 . . . . 0.33000000000000002 111.033 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 118.88 37.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.26000000000000001 110.648 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD1' HG21 ' A' ' 94' ' ' THR . 62.8 t80 -79.51 119.13 22.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.037 -0.529 . . . . 1.4299999999999999 112.062 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.783 HD12 ' CD1' ' A' ' 105' ' ' ILE . 12.0 mt -109.96 104.79 56.28 Favored Pre-proline 0 C--N 1.333 -0.132 0 N-CA-C 108.315 -0.994 . . . . 0.80000000000000004 108.315 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 96.9 Cg_endo -91.02 104.0 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.218 1.945 . . . . 0.41999999999999998 115.987 -176.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -100.14 128.7 46.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.438 -1.319 . . . . 1.03 107.438 175.411 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 41.1 mmtm -140.58 107.26 5.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.183 0.516 . . . . 1.6599999999999999 110.738 -178.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.077 ' HB3' HG11 ' A' ' 122' ' ' VAL . 47.4 p90 -99.3 140.09 33.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.005 -0.998 . . . . 1.26 111.735 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 21' ' ' SER . 0.3 OUTLIER -79.99 139.13 37.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 1.3300000000000001 110.62 179.492 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 43' ' ' PHE . 97.7 mt -96.23 141.47 29.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 2.1200000000000001 111.67 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.6 m -150.66 135.86 10.13 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.75 109.303 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -46.81 -25.66 3.96 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.471 2.114 . . . . 1.6100000000000001 112.238 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.98 -39.99 60.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.373 -0.376 . . . . 2.1800000000000002 111.199 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 73.7 m-20 -73.27 74.97 1.33 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.017 -0.673 . . . . 2.4100000000000001 109.638 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.85 -5.31 41.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.423 -0.808 . . . . 1.6399999999999999 112.148 -178.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.96 166.24 50.02 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.55000000000000004 112.584 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.22 130.05 29.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.359 2.039 . . . . 0.84999999999999998 111.756 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 124' ' ' LYS . 8.7 tp -77.98 117.29 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.446 -0.343 . . . . 1.8999999999999999 110.904 -179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -129.37 103.17 6.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.484 0.659 . . . . 1.78 111.682 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.836 ' O ' HD12 ' A' ' 73' ' ' LEU . 2.6 mp -95.56 109.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.922 -1.035 . . . . 0.75 110.879 179.108 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.921 ' HG2' HD13 ' A' ' 73' ' ' LEU . 18.0 mt-10 -104.7 116.61 32.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.6699999999999999 111.721 -179.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.914 ' CD2' HD11 ' A' ' 105' ' ' ILE . 70.5 m95 -91.28 116.66 29.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.587 -0.445 . . . . 0.22 109.954 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 70' ' ' VAL . 63.0 mt -105.75 138.76 41.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.643 -0.503 . . . . 0.40999999999999998 109.643 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.628 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.0 tt -129.97 132.76 65.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.615 0.598 . . . . 0.78000000000000003 112.615 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.08 102.33 40.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 1.25 109.571 177.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.71 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 84.6 Cg_endo -79.52 114.9 3.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.566 2.177 . . . . 0.53000000000000003 113.043 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -29.03 68.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.40999999999999998 110.373 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.72 10.24 9.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.713 -0.676 . . . . 1.8200000000000001 111.742 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 67.3 t30 -152.24 160.05 43.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.203 0.525 . . . . 1.9399999999999999 111.849 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -65.85 -19.01 65.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.386 -0.824 . . . . 1.6599999999999999 111.941 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.0 ttmt -65.89 142.08 58.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 1.74 111.418 -178.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.79 128.0 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-O 122.015 0.912 . . . . 0.96999999999999997 110.173 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.53 39.68 21.34 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 113.809 -1.541 . . . . 1.77 112.904 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 93.9 mm-40 -93.37 136.52 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 1.96 110.807 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 58' ' ' LEU . 99.2 t -69.38 130.15 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.77000000000000002 110.615 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.836 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -126.97 -38.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.23 -0.441 . . . . 1.1499999999999999 111.658 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.26 120.85 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.089 -0.708 . . . . 0.28999999999999998 109.089 179.25 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.921 HD13 ' HG2' ' A' ' 56' ' ' GLU . 2.4 tp -140.52 161.12 38.48 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.699 -0.682 . . . . 1.3 109.543 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 79' ' ' ILE . 21.0 t80 -134.66 110.43 9.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.107 0.479 . . . . 1.3 110.307 178.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.533 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.9 t -142.37 160.02 41.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.125 -0.943 . . . . 0.89000000000000001 111.639 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.65 37.8 42.76 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.805 -0.712 . . . . 0.56999999999999995 112.137 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t0 59.92 30.04 19.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.075 0.464 . . . . 1.46 110.348 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 44.5 mtmt -129.27 110.82 12.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.704 -0.68 . . . . 2.4100000000000001 110.344 178.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.3 117.49 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.581 -1.266 . . . . 1.6599999999999999 107.581 177.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.759 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -99.98 132.17 45.5 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.693 -1.139 . . . . 1.25 110.641 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 14.2 p-10 -166.11 -56.34 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.418 -1.327 . . . . 1.2 107.418 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.421 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 74.0 m-20 -80.23 -27.41 38.75 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.796 -1.093 . . . . 2.1699999999999999 109.238 177.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.89 -31.65 61.63 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.226 -1.027 . . . . 5.0499999999999998 108.226 178.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -81.18 112.73 35.46 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 114.512 -1.222 . . . . 1.29 110.102 179.201 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.25 -42.71 16.98 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.653 1.569 . . . . 0.79000000000000004 111.208 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.2 m-20 -67.73 104.12 1.57 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.028 -0.533 . . . . 1.3600000000000001 111.095 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 13.6 mt 73.88 19.91 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.799 1.037 . . . . 1.6200000000000001 113.799 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.5 pttt -57.19 130.08 44.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.572 -0.705 . . . . 2.3900000000000001 110.555 177.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 94.21 11.35 57.51 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.165 -1.017 . . . . 0.37 114.186 178.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.943 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 12.4 ptp180 -141.96 -52.36 0.42 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 114.24 1.2 . . . . 1.5900000000000001 114.24 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.24 81.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-O 122.991 1.377 . . . . 0.20000000000000001 107.322 -178.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.434 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.4 m80 -99.0 128.81 45.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.193 -2.276 . . . . 0.28999999999999998 112.184 -175.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.08 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.1 m-85 -70.53 123.25 21.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.201 0.524 . . . . 1.23 110.79 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -76.21 28.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.412 -0.813 . . . . 0.46000000000000002 111.926 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.1 m -147.45 129.71 15.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.094 0.473 . . . . 1.2 111.566 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.64 5.73 46.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 2.2200000000000002 110.361 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -145.77 66.11 1.22 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 2.1400000000000001 108.959 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.587 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.8 mp -59.92 -37.43 79.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.097 -0.956 . . . . 1.49 112.101 -178.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -62.52 3.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.521 0.563 . . . . 2.04 112.521 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.3 m -90.03 -3.58 57.89 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.813 -0.63 . . . . 1.3999999999999999 110.259 178.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 116.96 -20.51 11.56 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.142 -0.552 . . . . 0.38 113.005 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 3.6 m-20 -100.98 107.81 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.4399999999999999 111.122 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.91 23.79 13.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.169 -0.468 . . . . 0.42999999999999999 110.978 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -59.61 147.08 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.881 1.808 . . . . 1.04 115.881 -178.089 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.08 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -135.66 132.0 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 114.455 -1.248 . . . . 0.31 111.016 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -105.35 145.79 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.673 -0.862 . . . . 1.1499999999999999 108.673 177.216 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.04 122.21 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.87 0.367 . . . . 0.27000000000000002 111.185 -178.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -86.06 143.35 28.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.821 -0.627 . . . . 0.28999999999999998 110.892 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.7 m-20 49.98 58.17 5.75 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.098 -0.501 . . . . 1.52 111.669 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.7 mt -46.53 89.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.557 0.947 . . . . 1.02 113.557 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.45 ' HG2' ' H ' ' A' ' 113' ' ' SER . 62.9 tt0 -59.97 145.68 45.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.881 -0.599 . . . . 2.1299999999999999 109.898 177.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.445 ' HG ' ' CD ' ' A' ' 33' ' ' LYS . 83.8 mt -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.773 0.321 . . . . 1.7 111.618 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.45 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 79.6 p -73.36 -11.19 60.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.3200000000000001 111.606 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.3 m-20 -71.7 -17.29 62.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 1.5800000000000001 109.904 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.4 mt -43.5 141.43 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.41999999999999998 110.594 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.86 164.71 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.39 -0.91 . . . . 0.23999999999999999 113.34 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.0 m -59.55 129.99 44.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.625 0.602 . . . . 0.31 112.625 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.628 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 26.9 m-85 -113.89 121.81 45.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.625 -0.88 . . . . 1.24 108.625 177.058 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.0 tt0 -124.34 125.22 43.97 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.778 -0.369 . . . . 1.1599999999999999 111.021 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.543 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 16.1 p -108.34 119.97 41.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 1.03 110.861 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.2 mttm -113.6 104.09 11.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.157 -0.474 . . . . 1.76 110.935 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 1.077 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.6 p -90.02 112.0 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.084 -0.71 . . . . 1.1799999999999999 109.084 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.3 tttm -102.61 120.06 39.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.724 1.009 . . . . 1.6200000000000001 113.724 -177.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 53' ' ' LEU . 6.6 ttpp -143.9 102.4 3.89 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.169 0.509 . . . . 2.8399999999999999 109.756 176.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.796 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.0 131.98 30.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.44 113.051 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.4 Cg_endo -99.96 45.55 2.61 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.686 -0.964 . . . . 0.56000000000000005 112.198 -0.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.29 103.57 0.32 Allowed Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.422 -0.894 . . . . 0.47999999999999998 113.044 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.2 p -89.07 158.66 2.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.435 -0.882 . . . . 1.22 109.519 177.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.983 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . . . -144.74 135.64 24.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.376 -0.374 . . . . 0.56999999999999995 111.554 -179.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 19.2 p30 -146.71 139.36 25.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.676 0.621 . . . . 2.0299999999999998 112.676 -179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.741 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -145.68 161.61 39.46 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.359 -0.382 . . . . 2.9500000000000002 111.228 178.832 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 68.8 mttm -100.47 143.31 30.79 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.715 1.006 . . . . 2.2599999999999998 113.715 -178.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 29' ' ' ILE . 96.5 mt -141.32 113.05 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 114.961 -1.018 . . . . 0.28000000000000003 108.305 176.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 7.7 m170 -98.8 117.75 33.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.435 -0.506 . . . . 0.55000000000000004 110.885 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.956 HD21 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -93.7 118.5 31.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.52 111.946 -179.311 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 58.6 t -111.75 120.01 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.674 -0.862 . . . . 0.32000000000000001 108.674 178.065 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 115' ' ' ILE . 24.4 t -101.48 122.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.498 0.555 . . . . 1.0800000000000001 112.498 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.1 mt -84.07 169.27 15.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.971 -0.751 . . . . 0.52000000000000002 108.971 178.36 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.416 0.627 . . . . 1.48 111.496 -178.884 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.018 0.437 . . . . 1.8400000000000001 111.406 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.959 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 19.5 tt -133.65 140.02 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 2.1499999999999999 110.45 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.757 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.1 p -88.68 154.47 20.27 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.505 0.669 . . . . 1.1200000000000001 111.867 -179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.52 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 38.39 82.16 0.23 Allowed Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.65000000000000002 111.953 -178.55 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 77.8 Cg_endo -79.43 -8.62 14.99 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 123.891 3.06 . . . . 0.88 113.032 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -141.3 122.46 14.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.144 -0.687 . . . . 2.0600000000000001 109.144 178.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.776 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -144.24 156.63 44.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.981 1.104 . . . . 1.71 113.981 -176.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HD13 ' A' ' 29' ' ' ILE . 47.7 mtp -138.82 122.3 17.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.847 -1.07 . . . . 1.8600000000000001 109.442 177.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.776 HD11 ' OE2' ' A' ' 27' ' ' GLU . 27.1 mm -126.48 134.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 0.39000000000000001 111.513 -179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 20.4 pt-20 -130.72 127.3 38.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 1.1899999999999999 110.652 179.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 13.3 tptt -142.43 163.48 32.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.39 -0.368 . . . . 2.52 110.945 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.492 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.12 140.29 41.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 0.39000000000000001 111.704 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CD ' ' HG ' ' A' ' 112' ' ' LEU . 76.6 tttt -47.43 139.71 6.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.095 -0.502 . . . . 2.3500000000000001 111.715 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 82.5 -20.17 9.55 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.793 -0.639 . . . . 0.31 113.032 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.591 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 80.7 mm-40 -80.07 159.98 25.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.513 -0.921 . . . . 2.1099999999999999 108.513 178.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.9 m -90.68 127.34 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.785 -0.766 . . . . 0.33000000000000002 111.222 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.01 119.88 38.96 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.794 0.331 . . . . 0.26000000000000001 110.529 179.181 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 65.6 t80 -79.64 116.77 20.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.329 -0.396 . . . . 1.4299999999999999 111.842 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.752 ' HB2' HD12 ' A' ' 105' ' ' ILE . 39.9 mt -100.91 106.15 42.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.999 -0.741 . . . . 0.80000000000000004 108.999 178.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 97.0 Cg_endo -81.98 129.3 6.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.41999999999999998 114.509 -177.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.6 t -140.91 130.28 23.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.21 -0.905 . . . . 1.03 109.195 177.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.757 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 57.2 tptt -140.02 141.44 36.31 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 1.6599999999999999 109.514 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.955 ' CG ' HG11 ' A' ' 122' ' ' VAL . 53.1 p90 -139.94 144.82 37.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.242 0.544 . . . . 1.26 112.05 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -80.85 158.37 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.36 -0.836 . . . . 1.3300000000000001 110.513 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.598 HD11 ' HE2' ' A' ' 124' ' ' LYS . 63.7 tp -140.0 99.98 3.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 2.1200000000000001 111.422 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.9 t -82.1 142.3 47.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.576 -0.527 . . . . 1.75 109.576 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.34 -29.35 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.931 1.754 . . . . 1.6100000000000001 111.821 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.89 -33.64 51.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.984 -0.553 . . . . 2.1800000000000002 111.389 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.585 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.24 79.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.087 -0.645 . . . . 2.4100000000000001 109.625 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -102.3 7.24 40.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 1.6399999999999999 112.284 -178.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.959 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.94 164.22 51.77 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.55000000000000004 112.809 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.57 134.72 59.76 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.3 2.0 . . . . 0.84999999999999998 111.731 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.611 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 18.7 mt -78.19 104.73 8.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 1.8999999999999999 111.375 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.1 m-20 -119.55 102.61 8.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.64 0.733 . . . . 1.78 110.905 178.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.817 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 8.9 mt -101.38 130.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.765 -1.107 . . . . 0.75 110.004 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.901 ' HG2' HD13 ' A' ' 73' ' ' LEU . 99.3 mt-10 -130.05 125.68 35.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.274 0.842 . . . . 1.6699999999999999 113.274 -178.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.847 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.8 m95 -97.86 119.95 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.935 -0.575 . . . . 0.22 109.514 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.0 mt -105.54 139.98 39.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.372 -0.603 . . . . 0.40999999999999998 109.372 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.9 tt -128.63 129.56 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.171 0.51 . . . . 0.78000000000000003 111.46 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.499 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 p -119.91 103.03 46.14 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.954 -0.758 . . . . 1.25 108.954 178.211 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 95.2 Cg_endo -78.78 113.52 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.424 2.082 . . . . 0.53000000000000003 112.892 -178.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.277 -0.874 . . . . 0.40999999999999998 111.066 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.73 -40.02 63.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.928 -0.578 . . . . 1.8200000000000001 111.329 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 97.8 m-20 -84.61 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.156 0.503 . . . . 1.9399999999999999 111.628 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.44 -20.01 63.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.456 -0.793 . . . . 1.6599999999999999 111.222 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 77.6 mttt -70.3 150.02 46.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 1.74 111.233 -178.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.89 128.46 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 121.925 0.869 . . . . 0.96999999999999997 110.081 178.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.96 40.19 19.23 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 113.94 -1.482 . . . . 1.77 113.229 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.59 144.89 25.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.683 0.277 . . . . 1.96 111.217 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.939 HG13 HD21 ' A' ' 73' ' ' LEU . 31.0 t -66.01 136.56 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.599 -0.889 . . . . 0.77000000000000002 108.599 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.72 -51.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.839 0.681 . . . . 1.1499999999999999 112.839 -176.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.969 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.42 126.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.309 -0.626 . . . . 0.28999999999999998 109.309 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 70' ' ' VAL . 3.1 mt -138.09 175.73 9.32 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.412 0.625 . . . . 1.3 111.534 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.718 ' CD1' HG23 ' A' ' 79' ' ' ILE . 45.7 t80 -140.3 104.39 4.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.203 -1.362 . . . . 1.3 107.427 175.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.526 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.9 t -141.54 157.11 45.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.998 -0.546 . . . . 0.89000000000000001 111.067 -178.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.27 39.25 42.57 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.525 -0.845 . . . . 0.56999999999999995 112.013 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.01 30.29 19.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 1.46 110.433 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 67.5 mttm -130.8 110.5 11.36 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.768 -0.651 . . . . 2.4100000000000001 111.231 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -79.98 112.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.253 -1.388 . . . . 1.6599999999999999 107.253 176.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -100.11 141.5 32.85 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.922 . . . . 1.25 111.198 -178.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.4 p-10 -166.83 -54.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.653 -1.24 . . . . 1.2 107.653 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.457 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 33.9 m-20 -80.01 -19.9 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.0 -1.0 . . . . 2.1699999999999999 109.873 177.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.411 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.47 -28.72 46.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.746 -0.835 . . . . 5.0499999999999998 108.746 178.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.682 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.4 m-85 -85.41 119.92 72.7 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 114.931 -1.031 . . . . 1.29 111.189 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 7.5 Cg_endo -48.55 -42.84 34.83 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.388 1.392 . . . . 0.79000000000000004 109.933 178.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.775 ' O ' HG12 ' A' ' 71' ' ' ILE . 41.3 m-20 -66.31 106.05 1.6 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.747 -0.66 . . . . 1.3600000000000001 110.702 178.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.7 mt 66.76 21.29 10.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.278 1.214 . . . . 1.6200000000000001 114.278 178.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 55.6 pttt -56.23 129.95 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.457 -0.897 . . . . 2.3900000000000001 110.666 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.61 14.26 53.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.263 -0.97 . . . . 0.37 113.875 178.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.2 ptp180 -145.16 -48.96 0.24 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.815 1.413 . . . . 1.5900000000000001 114.815 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.969 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -81.1 81.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-O 123.274 1.511 . . . . 0.20000000000000001 107.019 -178.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.536 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.9 m80 -99.03 129.21 45.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.145 -2.298 . . . . 0.28999999999999998 112.74 -175.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.11 ' CD1' HG23 ' A' ' 105' ' ' ILE . 86.1 m-85 -72.31 120.14 17.5 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 120.272 -0.571 . . . . 1.23 109.519 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.448 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 18.8 p -73.37 -7.13 50.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.367 -0.833 . . . . 0.46000000000000002 110.482 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 17.7 m -86.35 118.77 26.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.939 -0.573 . . . . 1.2 110.895 -179.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -90.03 1.38 56.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.858 -0.61 . . . . 2.2200000000000002 110.014 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -145.99 67.65 1.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.335 -0.987 . . . . 2.1400000000000001 108.335 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.646 HD22 ' CE2' ' A' ' 74' ' ' TYR . 10.0 tt -58.27 -36.33 73.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.897 -1.047 . . . . 1.49 112.07 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -62.26 -1.08 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 2.04 112.254 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 98' ' ' LEU . 70.5 m -89.64 0.04 57.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 1.3999999999999999 110.795 178.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 107.13 -15.11 39.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.968 -0.634 . . . . 0.38 113.069 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 42' ' ' LYS . 86.6 m-20 -92.26 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.873 0.337 . . . . 1.4399999999999999 111.355 -179.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.568 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.09 19.85 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.42999999999999999 111.632 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 5.2 p -60.1 141.2 56.21 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.678 1.733 . . . . 1.04 115.678 -178.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.11 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -133.3 130.84 57.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 114.416 -1.266 . . . . 0.31 111.292 178.713 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.2 p30 -102.98 144.98 30.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.396 -0.964 . . . . 1.1499999999999999 108.396 177.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.87 120.76 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 120.911 0.386 . . . . 0.27000000000000002 111.971 -177.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.704 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -84.44 143.13 29.61 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.516 -0.765 . . . . 0.28999999999999998 110.832 178.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 26.2 m120 49.96 57.84 6.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.142 0.496 . . . . 1.52 111.668 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 37' ' ' ALA . 31.3 mt -46.63 90.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.009 1.114 . . . . 1.02 114.009 -179.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 38.9 mt-30 -59.3 141.56 54.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.922 -0.581 . . . . 2.1299999999999999 110.924 176.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.605 HD23 ' CG1' ' A' ' 137' ' ' VAL . 84.4 mt -60.04 -35.37 74.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.113 0.483 . . . . 1.7 109.995 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.2 p -74.47 -11.63 60.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.698 -0.683 . . . . 1.3200000000000001 111.435 -179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 99.1 m-20 -71.7 -18.45 62.16 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.033 -0.358 . . . . 1.5800000000000001 110.033 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -43.36 139.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.202 -0.454 . . . . 0.41999999999999998 110.22 179.09 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 164.06 9.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.111 -1.042 . . . . 0.23999999999999999 113.39 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.6 m -59.29 130.22 45.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.012 0.745 . . . . 0.31 113.012 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 15.5 m-85 -114.87 128.87 56.55 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.774 -0.824 . . . . 1.24 108.774 176.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.5 tt0 -127.45 119.03 25.19 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.568 -0.453 . . . . 1.1599999999999999 111.314 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 35.4 t -100.01 119.4 38.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 1.03 110.611 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.3 mttt -116.57 106.27 13.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.005 -0.278 . . . . 1.76 110.915 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CG ' ' A' ' 43' ' ' PHE . 43.8 t -90.53 112.46 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.363 -0.606 . . . . 1.1799999999999999 109.363 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 85.9 tttt -99.57 121.88 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.041 0.756 . . . . 1.6200000000000001 113.041 -178.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 53.9 tptt -145.16 101.39 3.61 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.448 -0.575 . . . . 2.8399999999999999 109.448 177.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.959 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.76 135.83 64.85 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.44 112.335 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.585 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 53.0 Cg_endo -96.94 46.2 2.4 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.336 -1.11 . . . . 0.56000000000000005 111.631 -0.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.28 103.64 0.29 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.434 -0.889 . . . . 0.47999999999999998 113.399 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.64 153.1 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.342 -0.929 . . . . 1.22 109.897 178.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.959 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -138.01 140.4 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.575 0.213 . . . . 0.56999999999999995 111.575 -179.254 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.472 ' C ' HD13 ' A' ' 22' ' ' ILE . 49.9 p30 -146.74 143.61 28.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.21 0.448 . . . . 2.0299999999999998 112.21 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.06 159.98 42.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.19 -0.459 . . . . 2.9500000000000002 110.864 179.056 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 72.1 mmtt -105.61 140.39 38.76 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 112.776 0.658 . . . . 2.2599999999999998 112.776 -178.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.828 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 64.7 mt -139.97 119.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.28000000000000003 109.17 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 35.2 m170 -102.72 117.35 34.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.55000000000000004 110.616 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 40.6 tp -89.35 124.94 34.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 1.52 111.601 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 45.0 t -119.97 120.01 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.797 -0.638 . . . . 0.32000000000000001 109.293 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 115' ' ' ILE . 40.2 t -99.3 122.69 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.316 0.487 . . . . 1.0800000000000001 112.316 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.5 mt -84.86 164.95 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.727 -0.67 . . . . 0.52000000000000002 109.717 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 1.48 111.514 -179.117 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.14 0.495 . . . . 1.8400000000000001 111.457 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.709 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.8 pp -95.33 143.98 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.478 -0.783 . . . . 2.1499999999999999 111.5 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -91.12 155.12 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.1200000000000001 110.361 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.4 OUTLIER 39.44 83.41 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.612 0.72 . . . . 0.65000000000000002 111.258 -178.069 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.769 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 61.2 Cg_endo -78.24 -8.11 16.27 Favored 'Trans proline' 0 C--N 1.327 -0.582 0 C-N-CA 123.753 2.969 . . . . 0.88 113.477 -178.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.16 121.31 13.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.0600000000000001 108.893 178.113 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 132' ' ' LYS . 3.3 tt0 -144.48 160.48 41.03 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.86 1.43 . . . . 1.71 114.86 -176.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 39.6 mtm -139.98 121.38 15.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.582 -1.19 . . . . 1.8600000000000001 109.632 177.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.02 126.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.756 0.312 . . . . 0.39000000000000001 111.659 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 86.3 mt-10 -116.26 125.53 52.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.376 -0.375 . . . . 1.1899999999999999 110.325 179.166 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.627 ' HB2' HD11 ' A' ' 110' ' ' LEU . 34.5 mmtm -142.07 156.8 45.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.784 0.326 . . . . 2.52 111.502 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.98 137.83 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.39000000000000001 112.184 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 8.0 ttpt -45.17 142.16 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.854 -0.612 . . . . 2.3500000000000001 111.707 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.12 -26.9 4.15 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.909 -0.587 . . . . 0.31 112.981 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 110' ' ' LEU . 100.0 mt-10 -80.03 160.02 25.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.889 -0.782 . . . . 2.1099999999999999 108.889 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 91.6 m -85.49 130.11 34.66 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.018 -0.673 . . . . 0.33000000000000002 110.737 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.2 117.25 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.126 0.488 . . . . 0.26000000000000001 110.327 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.545 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.05 120.01 23.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.8 0.667 . . . . 1.4299999999999999 112.8 -178.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' A' ' 105' ' ' ILE . 11.7 mt -107.08 105.67 56.23 Favored Pre-proline 0 CA--C 1.528 0.108 0 N-CA-C 108.533 -0.914 . . . . 0.80000000000000004 108.533 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.49 ' HD2' HD13 ' A' ' 133' ' ' ILE . 87.6 Cg_endo -83.0 128.88 5.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.45 2.1 . . . . 0.41999999999999998 115.066 -177.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 9.9 t -141.5 129.89 22.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.043 -0.98 . . . . 1.03 109.637 177.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 1.0 OUTLIER -140.31 150.74 44.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.966 -0.561 . . . . 1.6599999999999999 109.995 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 122' ' ' VAL . 49.7 p90 -140.13 153.26 46.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 1.26 111.021 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 45' ' ' LEU . 20.0 m -79.74 162.81 24.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 1.3300000000000001 111.047 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 124' ' ' LYS . 47.6 tp -139.83 130.32 25.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.1200000000000001 110.871 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.01 158.01 25.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.445 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.81 -20.71 23.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 1.6100000000000001 112.888 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.57 -45.37 59.53 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 110.014 -0.365 . . . . 2.1800000000000002 110.014 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.556 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -71.88 83.34 0.93 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.595 -0.891 . . . . 2.4100000000000001 108.595 178.588 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -95.9 -4.36 43.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.56 -0.745 . . . . 1.6399999999999999 112.361 -177.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.848 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -83.15 152.84 30.05 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.169 -1.015 . . . . 0.55000000000000004 112.779 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.16 139.01 88.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.313 2.009 . . . . 0.84999999999999998 111.493 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 124' ' ' LYS . 6.5 mt -78.33 104.33 8.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.447 -0.342 . . . . 1.8999999999999999 111.767 -179.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 96.6 m-20 -114.31 102.59 10.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.532 0.682 . . . . 1.78 110.06 178.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 47.1 mt -95.38 139.83 18.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.97 -1.014 . . . . 0.75 110.008 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.91 ' HA ' HD22 ' A' ' 73' ' ' LEU . 98.9 mt-10 -137.6 117.15 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 1.6699999999999999 112.741 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.961 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.6 m95 -91.25 121.88 33.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.469 178.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -107.29 140.02 40.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.555 -0.906 . . . . 0.40999999999999998 108.555 178.278 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -128.83 133.06 66.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.352 0.596 . . . . 0.78000000000000003 112.473 -178.426 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -119.85 103.59 45.53 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.112 -0.949 . . . . 1.25 109.216 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.9 Cg_exo -79.33 122.52 5.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.503 2.135 . . . . 0.53000000000000003 112.075 -179.109 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.98 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.40999999999999998 110.872 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -74.97 -40.03 60.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 1.8200000000000001 111.542 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 30.6 m120 -83.64 154.45 23.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.288 0.566 . . . . 1.9399999999999999 111.912 -179.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.72 -16.92 63.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.233 -0.894 . . . . 1.6599999999999999 111.131 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.673 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 33.2 mttp -68.89 150.02 48.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.484 -0.78 . . . . 1.74 111.449 -178.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.44 128.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-O 121.984 0.897 . . . . 0.96999999999999997 110.14 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.78 39.96 20.13 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.835 -1.53 . . . . 1.77 112.863 178.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -91.14 146.93 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.603 0.239 . . . . 1.96 110.906 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.918 HG13 HD21 ' A' ' 73' ' ' LEU . 15.8 t -65.84 130.01 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.013 -0.736 . . . . 0.77000000000000002 109.013 178.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.9 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.81 -53.21 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.671 0.619 . . . . 1.1499999999999999 112.671 -177.028 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.012 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.02 129.37 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.163 -0.68 . . . . 0.28999999999999998 109.163 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 70' ' ' VAL . 3.9 mt -138.76 175.45 9.55 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.57 0.7 . . . . 1.3 111.373 -179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.775 ' CD1' HG23 ' A' ' 79' ' ' ILE . 39.2 t80 -141.36 103.61 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.095 -1.411 . . . . 1.3 107.648 176.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 1.8 t -141.6 153.99 45.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.385 -0.371 . . . . 0.89000000000000001 111.005 -178.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.87 30.1 52.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.527 -0.844 . . . . 0.56999999999999995 112.146 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.91 3.99 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.618 0.247 . . . . 1.46 110.872 -178.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 65.1 mttm -105.34 110.79 23.28 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.575 -0.284 . . . . 2.4100000000000001 111.306 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.775 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.2 pp -79.87 113.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.465 -1.68 . . . . 1.6599999999999999 106.465 176.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.742 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -99.92 140.02 34.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.426 -0.807 . . . . 1.25 111.177 -177.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.2 p-10 -166.55 -52.39 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.864 -1.162 . . . . 1.2 107.864 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 54.5 m-20 -79.92 -25.57 40.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.122 -0.945 . . . . 2.1699999999999999 109.632 178.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.77 -30.47 56.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.546 -0.909 . . . . 5.0499999999999998 108.546 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.656 ' CE2' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -82.19 114.05 48.22 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 114.952 -1.022 . . . . 1.29 110.679 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.86 -42.17 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.73 1.62 . . . . 0.79000000000000004 110.31 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.619 ' O ' HG12 ' A' ' 71' ' ' ILE . 58.5 m-20 -67.09 105.24 1.62 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.678 -0.692 . . . . 1.3600000000000001 110.584 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.797 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 mp 68.98 24.18 6.37 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.892 1.071 . . . . 1.6200000000000001 113.892 178.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 51.1 pttt -57.02 129.83 43.46 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.571 -0.706 . . . . 2.3900000000000001 111.016 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.418 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 89.45 15.46 58.52 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.119 178.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp85 -143.37 -48.54 0.31 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.383 1.253 . . . . 1.5900000000000001 114.383 -178.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.012 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.01 81.28 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 123.132 1.444 . . . . 0.20000000000000001 107.274 -178.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.641 ' C ' HG22 ' A' ' 105' ' ' ILE . 11.3 m80 -98.29 127.84 44.42 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.248 -2.251 . . . . 0.28999999999999998 112.325 -175.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.036 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.2 m-85 -70.88 121.82 18.79 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.166 0.508 . . . . 1.23 110.434 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 38' ' ' TYR . 5.8 p -77.79 36.0 0.21 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.527 -0.76 . . . . 0.46000000000000002 111.839 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.1 m -148.32 127.55 12.96 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.128 0.489 . . . . 1.2 111.639 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -90.62 6.16 44.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.593 -0.73 . . . . 2.2200000000000002 110.211 178.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -145.91 66.03 1.21 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.103 -0.702 . . . . 2.1400000000000001 109.103 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.469 HD21 ' CG ' ' A' ' 93' ' ' PHE . 4.8 mp -60.08 -39.27 85.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.15 -0.932 . . . . 1.49 111.333 -178.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HE2' ' OH ' ' A' ' 74' ' ' TYR . 25.8 mttm -59.52 -6.73 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.511 . . . . 2.04 112.224 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -81.94 -7.09 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 110.535 179.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 115.35 -20.02 14.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.852 -0.689 . . . . 0.38 113.227 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -99.91 106.03 17.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.03 0.415 . . . . 1.4399999999999999 110.516 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -113.03 22.59 14.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.466 0.543 . . . . 0.42999999999999999 112.466 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 13.9 m -60.02 151.02 27.45 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.963 1.468 . . . . 1.04 114.963 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.036 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -135.11 134.21 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 114.639 -1.164 . . . . 0.31 111.447 179.301 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.658 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.8 p-10 -107.95 148.37 29.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.832 -0.803 . . . . 1.1499999999999999 108.832 177.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.31 123.46 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.943 0.401 . . . . 0.27000000000000002 111.058 -178.774 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -86.27 144.9 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.689 -0.687 . . . . 0.28999999999999998 111.262 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.11 61.0 2.92 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.01 -0.541 . . . . 1.52 112.224 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 31' ' ' LYS . 6.6 mt -45.99 169.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 1.02 111.904 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' HG3' ' A' ' 33' ' ' LYS . 11.8 pt20 -177.43 161.22 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.701 -0.681 . . . . 2.1299999999999999 110.572 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.813 ' HA ' HG11 ' A' ' 137' ' ' VAL . 5.1 mp -60.06 -33.01 71.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 1.7 111.465 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -73.74 -19.93 60.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.984 -0.286 . . . . 1.3200000000000001 111.629 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 95.5 m-20 -72.27 -19.72 61.64 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.923 -0.399 . . . . 1.5800000000000001 109.923 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -46.03 142.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 116.111 -0.495 . . . . 0.41999999999999998 111.171 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.46 150.4 5.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.689 -1.243 . . . . 0.23999999999999999 114.298 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.73 HG23 ' CD2' ' A' ' 134' ' ' HIS . 98.1 m -59.47 139.95 56.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -0.662 . . . . 0.31 112.135 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.8 m-85 -119.98 135.08 55.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 1.24 109.9 178.136 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.8 tt0 -126.77 117.13 22.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.612 -0.267 . . . . 1.1599999999999999 111.145 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.461 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 50.8 t -99.99 114.73 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 1.03 110.288 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.0 mtpt -109.45 104.77 13.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.574 -0.284 . . . . 1.76 110.801 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 55' ' ' ILE . 42.8 t -90.05 110.69 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.578 -0.527 . . . . 1.1799999999999999 109.578 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HG3' HG12 ' A' ' 128' ' ' VAL . 26.8 tttp -98.9 115.89 29.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.479 0.548 . . . . 1.6200000000000001 112.479 -178.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.556 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 36.1 tttp -145.77 102.63 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.316 -0.554 . . . . 2.8399999999999999 109.784 177.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.848 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.56 132.1 26.8 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.919 -0.582 . . . . 0.44 111.903 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 63.1 Cg_endo -101.29 51.94 1.44 Allowed 'Cis proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.771 -0.929 . . . . 0.56000000000000005 111.94 -0.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 102.59 0.26 Allowed Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.855 -1.164 . . . . 0.47999999999999998 113.866 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -93.83 135.78 27.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.391 -0.905 . . . . 1.22 109.293 177.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.709 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.44 152.51 40.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.599 -0.44 . . . . 0.56999999999999995 112.068 -179.183 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 23.6 p-10 -146.42 157.91 43.82 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.217 0.451 . . . . 2.0299999999999998 112.217 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.769 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.99 166.61 25.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 111.083 179.009 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' GLU . 68.3 mttm -111.17 140.25 45.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 112.6 0.593 . . . . 2.2599999999999998 112.6 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.631 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 96.8 mt -141.55 112.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.543 -0.91 . . . . 0.28000000000000003 108.543 176.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.73 ' CD2' HG23 ' A' ' 117' ' ' THR . 49.5 m170 -96.89 118.77 34.04 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.425 -0.51 . . . . 0.55000000000000004 110.984 -178.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.2 tm? -88.44 120.0 29.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 1.52 111.69 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 42.3 t -118.96 120.3 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.32000000000000001 109.197 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 112' ' ' LEU . 10.7 p -94.91 133.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.312 0.486 . . . . 1.0800000000000001 112.312 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 66.6 mt -80.1 158.18 26.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.944 -0.762 . . . . 0.52000000000000002 108.944 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 122.134 0.968 . . . . 1.48 113.439 -177.185 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.706 0.288 . . . . 1.8400000000000001 110.856 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.766 HG13 ' HB1' ' A' ' 129' ' ' ALA . 1.6 pp -91.96 143.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 2.1499999999999999 111.264 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -89.11 157.75 18.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 109.891 178.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 45.1 85.42 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 121.716 0.769 . . . . 0.65000000000000002 109.809 -176.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.0 Cg_endo -76.4 -83.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.246 2.631 . . . . 0.88 113.215 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.3 mt-10 -78.54 128.14 33.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.894 -0.722 . . . . 2.0600000000000001 109.501 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.502 ' CG ' HD11 ' A' ' 29' ' ' ILE . 39.4 tp10 -143.6 156.18 44.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.91 1.078 . . . . 1.71 113.91 -177.317 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 45.0 mtm -137.26 118.24 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.285 -1.325 . . . . 1.8600000000000001 107.865 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.986 HD13 HG23 ' A' ' 133' ' ' ILE . 5.2 mp -120.03 120.05 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.39000000000000001 111.894 -177.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 136' ' ' VAL . 51.7 mp0 -105.72 128.53 53.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.821 -0.627 . . . . 1.1899999999999999 110.939 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB3' HD11 ' A' ' 110' ' ' LEU . 20.9 tptm -141.45 154.73 45.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.854 0.359 . . . . 2.52 111.151 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.681 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . . . -76.65 143.63 40.01 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.615 0.598 . . . . 0.39000000000000001 112.615 -179.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.618 ' HG3' HG12 ' A' ' 137' ' ' VAL . 75.0 mttt -47.86 143.76 3.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.593 -0.731 . . . . 2.3500000000000001 112.604 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.36 -23.64 1.48 Allowed Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.31 113.719 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 32' ' ' ALA . 98.7 mt-10 -79.99 159.97 26.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.338 -0.616 . . . . 2.1099999999999999 109.338 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 55.9 m -86.91 126.31 34.6 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.12 -0.632 . . . . 0.33000000000000002 110.984 -179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -96.74 118.54 33.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.185 0.516 . . . . 0.26000000000000001 110.307 179.144 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 94' ' ' THR . 9.9 t80 -79.17 120.53 23.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.887 -0.597 . . . . 1.4299999999999999 111.932 -178.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.722 ' HB2' HD12 ' A' ' 105' ' ' ILE . 35.7 mt -105.75 104.77 50.34 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 108.428 -0.952 . . . . 0.80000000000000004 108.428 177.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.8 Cg_endo -82.31 127.49 5.21 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.363 2.042 . . . . 0.41999999999999998 114.345 -177.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.0 t -141.2 129.98 22.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.072 -0.967 . . . . 1.03 108.859 178.011 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.61 ' O ' HG22 ' A' ' 22' ' ' ILE . 33.3 ttpt -140.73 150.12 43.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.708 -0.678 . . . . 1.6599999999999999 110.634 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.837 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -139.95 140.42 36.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.897 -178.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 138.31 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.694 -0.684 . . . . 1.3300000000000001 110.507 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.0 107.84 19.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 2.1200000000000001 111.34 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 57.6 m -83.34 148.23 55.24 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 109.355 -0.609 . . . . 1.75 109.355 178.314 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -42.36 -46.75 7.57 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 121.984 1.789 . . . . 1.6100000000000001 111.594 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 85.6 tt0 -75.94 -38.49 57.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.652 -0.704 . . . . 2.1800000000000002 110.971 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 13.9 t0 -70.96 80.03 0.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.303 0.573 . . . . 2.4100000000000001 110.441 -179.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -137.25 33.75 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.19 -0.914 . . . . 1.6399999999999999 111.022 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -97.12 -171.32 33.8 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.541 -0.838 . . . . 0.55000000000000004 112.717 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.66 113.03 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.644 2.229 . . . . 0.84999999999999998 111.861 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 47.9 tp -78.7 118.54 20.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.8999999999999999 111.566 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -134.55 102.95 5.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.524 0.678 . . . . 1.78 111.371 179.08 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.846 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 3.7 mt -96.06 110.01 23.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.75 110.809 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' CB ' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -102.56 117.99 35.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.129 0.788 . . . . 1.6699999999999999 113.129 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.905 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -93.88 121.7 35.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.22 109.882 176.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.1 mt -106.65 129.94 54.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.035 -0.357 . . . . 0.40999999999999998 110.035 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.786 HD12 HD11 ' A' ' 87' ' ' LEU . 3.9 tt -119.96 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.203 0.816 . . . . 0.78000000000000003 113.203 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.538 ' HA ' ' C ' ' A' ' 67' ' ' VAL . 5.4 t -108.11 104.5 53.82 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 108.842 -0.799 . . . . 1.25 108.842 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.701 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 80.6 Cg_endo -78.85 112.74 3.16 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.304 2.003 . . . . 0.53000000000000003 111.952 -179.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.01 87.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.435 -0.802 . . . . 0.40999999999999998 111.082 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.78 -39.99 63.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.84 -0.618 . . . . 1.8200000000000001 111.555 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -85.28 162.84 18.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.18 0.514 . . . . 1.9399999999999999 111.942 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.18 -18.05 63.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.4 -0.818 . . . . 1.6599999999999999 111.942 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -69.46 170.03 11.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.877 -0.601 . . . . 1.74 111.967 -177.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 59' ' ' ILE . 1.3 t -133.47 -154.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 107.753 -1.203 . . . . 0.96999999999999997 107.753 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 67' ' ' VAL . 78.4 m-20 -67.54 64.54 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.73 0.776 . . . . 1.77 111.564 -177.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -85.76 157.19 20.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.425 -1.261 . . . . 1.96 109.508 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.5 t -66.27 131.4 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.398 -0.521 . . . . 0.77000000000000002 109.652 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.077 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.56 -50.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.652 0.612 . . . . 1.1499999999999999 112.652 -176.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.777 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.01 123.1 17.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.067 -0.716 . . . . 0.28999999999999998 109.067 179.642 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' CB ' ' A' ' 56' ' ' GLU . 7.9 tt -140.0 160.99 38.68 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.793 -0.639 . . . . 1.3 110.156 -177.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.631 ' CD1' HG23 ' A' ' 79' ' ' ILE . 10.2 t80 -135.61 111.64 9.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.997 0.427 . . . . 1.3 110.155 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 6.7 t -142.46 159.98 41.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.89000000000000001 111.441 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.17 36.2 51.61 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.63 -0.795 . . . . 0.56999999999999995 111.941 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t0 62.94 22.35 13.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.956 0.408 . . . . 1.46 110.397 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 22.5 mttm -120.68 110.3 16.24 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.922 -0.581 . . . . 2.4100000000000001 110.677 178.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -80.13 117.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.1 -1.444 . . . . 1.6599999999999999 107.1 177.313 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.3 m-85 -99.96 136.47 39.83 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.976 -1.011 . . . . 1.25 110.526 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.3 p-10 -166.26 -56.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.402 -0.962 . . . . 1.2 108.402 -179.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' OD1' ' CD2' ' A' ' 83' ' ' TYR . 25.6 p-10 -78.77 -24.01 44.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 2.1699999999999999 109.787 177.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 80' ' ' TYR . 16.4 m-85 -77.19 -29.17 54.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.285 -1.006 . . . . 5.0499999999999998 108.285 178.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -82.18 115.9 60.38 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-N 114.985 -1.007 . . . . 1.29 110.644 179.368 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.3 -43.95 16.51 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.739 1.626 . . . . 0.79000000000000004 111.046 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 71' ' ' ILE . 16.6 m-20 -66.93 106.7 1.99 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.106 -0.638 . . . . 1.3600000000000001 110.808 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.846 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 67.64 22.4 9.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.926 1.084 . . . . 1.6200000000000001 113.926 178.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 42.6 pttt -54.81 128.75 34.41 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.81 -0.756 . . . . 2.3900000000000001 111.089 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.35 13.61 55.46 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.344 -0.931 . . . . 0.37 114.422 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.7 ptp85 -143.63 -48.98 0.3 Allowed 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 114.584 1.327 . . . . 1.5900000000000001 114.584 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.077 HG11 HD11 ' A' ' 71' ' ' ILE . 5.7 p -80.76 81.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 107.232 -1.395 . . . . 0.20000000000000001 107.232 -178.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.593 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.6 m80 -100.6 132.89 45.75 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.277 -2.238 . . . . 0.28999999999999998 112.191 -175.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 1.118 ' CD1' HG23 ' A' ' 105' ' ' ILE . 74.6 m-85 -73.8 120.01 18.81 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-O 121.254 0.55 . . . . 1.23 109.884 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.467 HG21 ' CE2' ' A' ' 38' ' ' TYR . 32.3 p -74.8 -6.14 47.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.46000000000000002 110.428 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.3 m -90.4 120.17 31.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 1.2 110.754 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -89.93 1.58 56.07 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.034 -0.53 . . . . 2.2200000000000002 110.299 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -146.16 68.51 1.19 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 4.3 mp -59.66 -38.38 81.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.962 -1.017 . . . . 1.49 111.696 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -61.62 -6.23 2.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.204 0.526 . . . . 2.04 112.071 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m -86.63 -4.64 59.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.393 -0.821 . . . . 1.3999999999999999 110.643 178.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.55 -22.7 14.63 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.771 -0.728 . . . . 0.38 113.254 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.4 m-20 -93.7 107.19 19.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.132 0.466 . . . . 1.4399999999999999 110.489 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -113.9 22.11 14.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.657 0.614 . . . . 0.42999999999999999 112.657 -178.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.1 m -59.99 148.18 36.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.521 1.675 . . . . 1.04 115.521 -178.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.118 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -132.28 134.31 59.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 114.494 -1.23 . . . . 0.31 111.108 179.199 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.2 p-10 -107.06 150.37 26.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.766 -0.828 . . . . 1.1499999999999999 108.766 177.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.35 121.59 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 120.902 0.382 . . . . 0.27000000000000002 110.915 -178.938 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.48 144.36 28.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.703 -0.681 . . . . 0.28999999999999998 111.432 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 54.17 60.32 3.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.638 178.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 37' ' ' ALA . 12.2 mt -46.17 169.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.039 0.447 . . . . 1.02 111.887 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.785 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.0 tt0 -177.99 166.44 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 2.1299999999999999 109.909 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 87.0 mt -59.97 -33.26 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.903 0.335 . . . . 1.7 111.903 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.9 m -73.36 -19.42 61.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.986 -0.285 . . . . 1.3200000000000001 111.509 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.44 -20.77 62.06 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.571 -0.529 . . . . 1.5800000000000001 109.571 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.804 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -49.98 140.33 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-N 115.704 -0.68 . . . . 0.41999999999999998 111.067 178.796 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.01 153.21 5.91 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 119.71 -1.234 . . . . 0.23999999999999999 113.705 179.137 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.749 HG23 ' CD2' ' A' ' 134' ' ' HIS . 84.2 m -59.42 135.71 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.298 0.481 . . . . 0.31 112.298 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.9 m-85 -121.17 131.5 54.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.186 -0.672 . . . . 1.24 109.186 177.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.9 tt0 -128.85 120.0 25.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.78 -0.368 . . . . 1.1599999999999999 110.238 179.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.505 ' SG ' ' HG2' ' A' ' 131' ' ' LYS . 16.6 p -102.81 119.59 39.1 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.546 -0.462 . . . . 1.03 110.911 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.846 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.0 mttt -111.21 104.53 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 1.76 110.441 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.837 HG11 ' CG ' ' A' ' 43' ' ' PHE . 21.8 t -88.45 107.44 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.86 -0.422 . . . . 1.1799999999999999 109.86 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 33.8 mttm -100.1 120.7 40.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.823 1.046 . . . . 1.6200000000000001 113.823 -178.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 19.1 tttt -145.83 103.32 3.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.211 0.529 . . . . 2.8399999999999999 109.874 177.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.496 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -47.95 130.6 11.89 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.322 -0.853 . . . . 0.44 113.274 -178.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.567 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.9 Cg_endo -102.73 48.72 1.91 Allowed 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 125.008 -0.83 . . . . 0.56000000000000005 111.621 -0.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 103.5 0.3 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.214 -0.993 . . . . 0.47999999999999998 113.138 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -92.93 151.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.338 -0.931 . . . . 1.22 109.995 177.918 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -145.63 144.08 30.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.867 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.569 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 50.5 p-10 -147.16 146.66 29.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.559 0.577 . . . . 2.0299999999999998 112.559 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -144.5 164.67 30.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.395 -0.366 . . . . 2.9500000000000002 111.299 179.483 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 94.5 mttt -99.68 140.0 34.52 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 113.031 0.752 . . . . 2.2599999999999998 113.031 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.986 HG23 HD13 ' A' ' 29' ' ' ILE . 71.9 mt -141.08 110.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.939 -1.028 . . . . 0.28000000000000003 109.248 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.749 ' CD2' HG23 ' A' ' 117' ' ' THR . 53.3 m170 -100.02 119.98 39.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.55000000000000004 111.052 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.3 tm? -89.53 125.54 35.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.933 -0.576 . . . . 1.52 111.42 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 46.9 t -119.95 130.0 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.32000000000000001 109.496 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.804 HG23 HG13 ' A' ' 115' ' ' ILE . 25.3 t -100.22 122.88 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.156 0.428 . . . . 1.0800000000000001 112.156 -178.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 72.7 mt -83.5 159.99 21.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.982 -0.554 . . . . 0.52000000000000002 109.614 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 1.48 111.939 -178.626 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.462 -0.255 . . . . 3.2799999999999998 112.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -79.97 169.99 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 2.4300000000000002 110.91 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 22' ' ' ILE . 74.4 m -153.82 116.03 4.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.009 0.433 . . . . 1.8400000000000001 110.631 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 ' HB1' ' A' ' 129' ' ' ALA . 4.6 mt -141.91 138.76 31.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 2.1499999999999999 110.928 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 21.5 p -93.6 147.86 22.62 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.339 0.59 . . . . 1.1200000000000001 110.714 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.12 82.88 0.22 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.04 -0.982 . . . . 0.65000000000000002 111.8 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 48.3 Cg_endo -78.36 -73.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.706 2.937 . . . . 0.88 112.012 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.48 127.63 32.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.412 -0.959 . . . . 2.0600000000000001 108.412 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.947 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.2 tt0 -143.77 158.34 43.75 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.015 1.117 . . . . 1.71 114.015 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.533 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.41 122.88 17.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.561 -1.199 . . . . 1.8600000000000001 109.031 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.947 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.8 mm -120.01 126.57 75.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.39000000000000001 111.527 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.73 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 87.1 mt-10 -119.19 125.18 48.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.434 . . . . 1.1899999999999999 110.334 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 74.8 mmtt -141.8 160.02 41.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 2.52 111.309 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.33 137.56 39.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.39000000000000001 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.68 ' HG3' ' HA ' ' A' ' 111' ' ' GLN . 31.2 ttpt -46.59 139.95 4.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.3500000000000001 111.674 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.4 -23.2 7.51 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 116.059 -0.519 . . . . 0.31 113.024 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.5 mt-10 -80.92 160.0 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.594 -0.521 . . . . 2.1099999999999999 109.594 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.792 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.7 m -84.49 130.22 34.78 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.104 -0.638 . . . . 0.33000000000000002 110.583 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.774 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -99.72 113.43 25.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.012 0.434 . . . . 0.26000000000000001 110.441 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.35 129.92 34.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 1.4299999999999999 112.24 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.705 HD22 HG21 ' A' ' 133' ' ' ILE . 14.3 mt -121.42 104.33 40.4 Favored Pre-proline 0 CA--C 1.528 0.121 0 N-CA-C 109.132 -0.692 . . . . 0.80000000000000004 109.132 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 92.7 Cg_endo -84.25 134.03 5.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.546 2.164 . . . . 0.41999999999999998 114.889 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.676 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 57.3 m -141.59 112.55 7.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.171 -0.922 . . . . 1.03 109.911 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 8.2 tptt -118.69 109.12 15.73 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.889 0.376 . . . . 1.6599999999999999 110.663 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.591 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 39.9 p90 -93.82 141.79 28.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.673 -0.694 . . . . 1.26 110.436 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 m -79.46 148.01 32.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 1.3300000000000001 111.238 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.36 144.33 39.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.477 -0.783 . . . . 2.1200000000000001 111.406 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 83.5 p -159.34 145.3 12.08 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.804 -0.634 . . . . 1.75 110.08 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.3 Cg_exo -45.45 -21.36 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.495 2.13 . . . . 1.6100000000000001 113.107 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 52.6 tp10 -73.67 -38.26 65.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.617 -0.265 . . . . 2.1800000000000002 111.471 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 46' ' ' SER . 51.0 p-10 -65.79 73.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.641 0.734 . . . . 2.4100000000000001 110.753 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 76.8 mm-40 -90.79 -10.02 44.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.308 -0.86 . . . . 1.6399999999999999 111.795 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.941 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -75.57 154.78 46.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.17 -1.014 . . . . 0.55000000000000004 112.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.63 149.0 25.78 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.205 1.937 . . . . 0.84999999999999998 111.578 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -77.52 131.05 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 1.8999999999999999 110.235 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 19.1 t0 -140.05 150.82 44.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.432 0.634 . . . . 1.78 111.417 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 51.0 mt -141.96 139.99 30.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.919 -1.037 . . . . 0.75 109.747 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.744 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 85.9 tt0 -139.98 148.0 41.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.007 0.432 . . . . 1.6699999999999999 111.835 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.953 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.6 m95 -141.04 119.27 12.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.22 111.004 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.591 HD21 HG22 ' A' ' 70' ' ' VAL . 83.5 mt -110.06 146.3 35.61 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.192 -0.67 . . . . 0.40999999999999998 109.192 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.753 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 6.9 tt -129.91 135.59 60.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.685 0.624 . . . . 0.78000000000000003 112.685 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 m -121.52 102.94 41.75 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 115.26 -0.882 . . . . 1.25 108.646 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 7.1 Cg_exo -78.09 114.09 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.518 2.145 . . . . 0.53000000000000003 112.619 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.98 87.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.101 -0.954 . . . . 0.40999999999999998 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.42 -40.05 62.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 1.8200000000000001 111.253 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 1.2 t30 -85.04 159.77 20.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.227 0.537 . . . . 1.9399999999999999 111.813 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.81 -16.39 63.77 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.343 -0.844 . . . . 1.6599999999999999 111.576 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 93.8 mttt -69.6 151.73 45.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 1.74 111.848 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.12 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.258 0 CA-C-O 121.751 0.786 . . . . 0.96999999999999997 109.496 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 55.66 85.18 0.07 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.276 -1.329 . . . . 1.77 112.304 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -140.04 144.14 36.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.424 . . . . 1.96 111.124 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD21 ' A' ' 58' ' ' LEU . 61.2 t -70.83 131.9 33.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.902 -0.59 . . . . 0.77000000000000002 111.33 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.896 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -130.79 -41.38 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.187 0.44 . . . . 1.1499999999999999 112.187 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.884 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.4 129.89 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.373 0.606 . . . . 0.28999999999999998 110.064 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD23 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 160.97 38.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.255 -0.884 . . . . 1.3 109.684 -179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.847 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 24.0 t80 -138.54 103.28 4.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -143.65 153.66 42.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.502 -0.317 . . . . 0.89000000000000001 111.8 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' ASP . . . 58.43 29.49 63.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.624 -0.798 . . . . 0.56999999999999995 111.685 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 10.1 m-20 69.86 4.52 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.619 0.247 . . . . 1.46 111.088 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 97.3 mttt -99.98 112.68 24.95 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.611 -0.514 . . . . 2.4100000000000001 109.611 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.871 HD12 ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -84.28 116.47 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 108.057 -1.09 . . . . 1.6599999999999999 108.057 178.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.7 m-85 -100.33 126.28 46.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.439 -1.709 . . . . 1.25 110.78 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.87 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.5 p-10 -165.98 -53.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.526 -1.286 . . . . 1.2 107.526 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.0 p-10 -82.93 -26.93 30.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.147 -0.933 . . . . 2.1699999999999999 109.749 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CD1' ' OD1' ' A' ' 82' ' ' ASP . 36.1 m-85 -75.57 -28.58 59.04 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.4 -1.333 . . . . 5.0499999999999998 107.4 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -83.16 113.19 44.4 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 114.158 -1.383 . . . . 1.29 110.329 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.7 -42.94 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.615 1.544 . . . . 0.79000000000000004 111.226 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.811 ' HB3' HG22 ' A' ' 71' ' ' ILE . 74.6 m-20 -67.99 104.6 1.78 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.012 -0.54 . . . . 1.3600000000000001 111.235 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.83 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 32.4 mt 71.27 24.4 3.79 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.306 -0.861 . . . . 1.6200000000000001 113.221 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.7 pttt -58.14 135.61 57.08 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.901 -0.499 . . . . 2.3900000000000001 111.63 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.483 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.35 11.31 75.64 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.536 -0.84 . . . . 0.37 114.398 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.83 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.6 ptp180 -138.99 -50.97 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.678 1.362 . . . . 1.5900000000000001 114.678 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.896 HG11 ' CD1' ' A' ' 71' ' ' ILE . 7.6 p -78.96 81.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.847 1.308 . . . . 0.20000000000000001 107.53 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 10.6 m80 -102.88 131.55 49.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.451 -2.159 . . . . 0.28999999999999998 112.401 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.142 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.6 m-85 -73.59 120.2 18.86 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 120.024 -0.67 . . . . 1.23 109.312 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 38' ' ' TYR . 18.0 p -70.09 -9.17 54.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.923 -1.035 . . . . 0.46000000000000002 110.807 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 5.3 m -88.32 118.53 28.0 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.941 -0.572 . . . . 1.2 110.887 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -90.09 0.18 57.27 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.244 0.545 . . . . 2.2200000000000002 110.168 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -146.41 67.19 1.18 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.487 -0.931 . . . . 2.1400000000000001 108.487 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.594 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.5 mp -57.77 -27.76 63.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.25 -0.886 . . . . 1.49 112.149 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -63.45 -5.04 3.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.187 0.518 . . . . 2.04 112.115 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.6 p -89.85 -0.04 57.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.41 -0.814 . . . . 1.3999999999999999 110.975 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.591 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.21 0.6 38.26 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.645 -0.788 . . . . 0.38 113.218 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.512 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 92.3 m-20 -99.94 118.65 36.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 111.002 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -118.5 10.39 12.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.42999999999999999 111.651 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -60.03 140.43 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.122 1.897 . . . . 1.04 116.122 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.142 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.82 134.61 59.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 114.543 -1.208 . . . . 0.31 110.486 177.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.3 p-10 -108.88 151.08 26.75 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.673 -0.862 . . . . 1.1499999999999999 108.673 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.792 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.78 120.13 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.0 0.429 . . . . 0.27000000000000002 110.903 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -83.9 144.89 28.91 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.506 -0.77 . . . . 0.28999999999999998 111.094 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.43 ' HB3' ' OXT' ' A' ' 144' ' ' ALA . 98.6 m-20 51.82 61.77 3.04 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.963 -0.562 . . . . 1.52 112.328 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.45 176.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.218 0.451 . . . . 1.02 112.218 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.745 ' O ' HG21 ' A' ' 137' ' ' VAL . 62.3 tt0 -176.32 159.99 2.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 2.1299999999999999 110.616 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 95.0 mt -59.93 -40.07 87.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.525 . . . . 1.7 112.416 -178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.3 m -74.56 -13.98 60.74 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.1 -0.24 . . . . 1.3200000000000001 111.372 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.62 -22.37 62.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 1.5800000000000001 109.271 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.58 HG13 HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.53 144.9 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 115.641 -0.709 . . . . 0.41999999999999998 110.74 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.62 148.79 5.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.234 -0.984 . . . . 0.23999999999999999 113.268 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.887 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.1 m -59.07 135.89 57.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.339 -0.431 . . . . 0.31 111.771 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.753 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.5 m-85 -116.18 139.99 49.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 1.24 109.867 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.753 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 54.7 tt0 -117.88 117.53 29.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.035 -0.357 . . . . 1.1599999999999999 110.035 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.545 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 18.0 t -100.0 109.62 21.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.101 -0.5 . . . . 1.03 110.687 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 54.4 mtpt -121.35 111.48 17.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 1.76 111.895 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 t -96.28 110.16 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.483 -0.562 . . . . 1.1799999999999999 109.483 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 29.0 tttt -95.02 114.93 26.79 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.879 -0.728 . . . . 1.6200000000000001 112.767 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.99 102.66 3.67 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.262 -0.644 . . . . 2.8399999999999999 109.262 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.941 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.07 133.51 22.87 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.44 112.29 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 58.6 Cg_endo -101.61 50.04 1.71 Allowed 'Cis proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.745 -0.939 . . . . 0.56000000000000005 111.138 -0.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.98 103.06 0.29 Allowed Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.062 -1.066 . . . . 0.47999999999999998 113.29 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -88.41 119.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.203 -0.999 . . . . 1.22 109.761 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -100.01 140.48 34.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.681 -0.236 . . . . 0.56999999999999995 111.601 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -146.07 131.72 18.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.483 -0.326 . . . . 2.0299999999999998 111.244 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.676 ' HZ3' ' HA ' ' A' ' 41' ' ' CYS . 5.0 ptmt -145.25 158.5 43.81 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.344 -0.389 . . . . 2.9500000000000002 110.676 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.578 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 96.7 mttt -102.79 140.02 37.61 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.065 0.765 . . . . 2.2599999999999998 113.065 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.831 HD13 ' CH2' ' A' ' 57' ' ' TRP . 2.4 mp -141.32 116.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.349 -0.841 . . . . 0.28000000000000003 108.895 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.887 ' CD2' HG23 ' A' ' 117' ' ' THR . 54.0 m170 -101.44 120.04 39.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.55000000000000004 110.845 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.425 HD21 ' CD2' ' A' ' 110' ' ' LEU . 60.8 tp -88.77 121.26 30.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 1.52 111.623 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.73 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.8 t -120.0 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.763 -0.653 . . . . 0.32000000000000001 109.513 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG21 ' O ' ' A' ' 111' ' ' GLN . 25.9 t -100.97 125.94 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 1.0800000000000001 112.156 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.26 155.25 22.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.835 -0.62 . . . . 0.52000000000000002 109.403 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -77.9 134.73 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.699 0.762 . . . . 1.48 111.654 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.749 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.14 173.57 3.64 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.431 -1.259 . . . . 2.2000000000000002 108.953 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.749 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 5.4 Cg_endo -46.85 164.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.876 1.717 . . . . 1.3100000000000001 111.583 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 144' ' ' ALA . 0.4 OUTLIER -35.62 -79.59 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.348 0.499 . . . . 2.3100000000000001 112.348 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.19 -66.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.215 -0.448 . . . . 2.52 112.956 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.449 -0.786 . . . . 2.6000000000000001 111.789 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 112.51 -0.236 . . . . 3.2799999999999998 112.51 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -80.04 138.69 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 2.4300000000000002 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -157.25 134.29 10.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 1.8400000000000001 111.06 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.587 HD13 ' HB1' ' A' ' 129' ' ' ALA . 6.5 pt -99.18 144.89 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 2.1499999999999999 111.182 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.41 159.54 18.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.466 0.65 . . . . 1.1200000000000001 111.614 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.638 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.7 OUTLIER 41.75 83.24 0.21 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.724 -1.125 . . . . 0.65000000000000002 111.899 -178.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.2 Cg_endo -78.72 -78.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.547 2.832 . . . . 0.88 112.867 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.1 mt-10 -78.96 128.6 33.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.871 -0.418 . . . . 2.0600000000000001 109.871 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.583 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 49.7 tt0 -144.45 159.96 41.87 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.212 1.19 . . . . 1.71 114.212 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.425 ' C ' HD12 ' A' ' 29' ' ' ILE . 31.2 mtt -137.73 117.85 13.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.626 -1.17 . . . . 1.8600000000000001 108.847 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.988 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -119.97 120.6 63.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.371 0.508 . . . . 0.39000000000000001 112.371 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.669 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 96.5 mt-10 -106.87 126.25 52.07 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.059 -0.519 . . . . 1.1899999999999999 109.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 110' ' ' LEU . 27.7 tptt -141.79 150.07 41.23 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.795 -0.362 . . . . 2.52 111.486 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.62 140.26 40.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.39000000000000001 112.134 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.599 ' HB2' ' CG ' ' A' ' 140' ' ' LYS . 97.6 mttt -44.98 153.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.654 0.613 . . . . 2.3500000000000001 112.654 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.09 -28.53 0.54 Allowed Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.139 -0.937 . . . . 0.31 113.636 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.62 160.07 26.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.236 -0.653 . . . . 2.1099999999999999 109.236 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 79.7 m -85.89 129.87 34.71 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.066 -0.654 . . . . 0.33000000000000002 110.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.553 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.83 117.8 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.509 . . . . 0.26000000000000001 110.243 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 94' ' ' THR . 17.6 t80 -79.32 121.11 24.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.722 -0.672 . . . . 1.4299999999999999 112.631 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.843 ' HB2' HD12 ' A' ' 105' ' ' ILE . 22.9 mt -104.29 104.8 46.39 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.457 -0.942 . . . . 0.80000000000000004 108.457 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 95.7 Cg_endo -82.95 129.72 5.48 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.235 1.957 . . . . 0.41999999999999998 114.202 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 3.8 t -140.64 134.4 30.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.183 -1.043 . . . . 1.03 108.183 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' O ' HG22 ' A' ' 22' ' ' ILE . 43.8 mmtm -140.28 143.86 36.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.826 -0.35 . . . . 1.6599999999999999 111.349 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.766 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 47.3 p90 -140.56 140.71 35.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 1.26 111.26 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -81.88 140.21 34.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.906 -0.588 . . . . 1.3300000000000001 111.899 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.589 HD21 ' HE2' ' A' ' 43' ' ' PHE . 86.1 mt -101.61 141.97 33.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.762 -0.653 . . . . 2.1200000000000001 110.997 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 44.7 m -154.93 154.49 29.03 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 1.75 110.242 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 11.7 Cg_endo -55.42 -21.33 29.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.603 2.202 . . . . 1.6100000000000001 112.909 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.3 tt0 -76.18 -41.49 49.44 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 120.942 -0.303 . . . . 2.1800000000000002 110.952 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -71.48 74.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.357 -0.537 . . . . 2.4100000000000001 109.943 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 62.6 mm-40 -91.38 -8.02 49.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.801 . . . . 1.6399999999999999 111.892 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.938 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.32 159.89 53.54 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.067 -1.064 . . . . 0.55000000000000004 112.259 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.07 144.04 59.56 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.132 1.888 . . . . 0.84999999999999998 111.348 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.766 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 9.7 tt -77.61 123.66 26.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 1.8999999999999999 110.663 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.2 m-20 -129.46 148.21 51.34 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.508 0.67 . . . . 1.78 111.223 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.807 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 24.3 mt -142.88 141.87 26.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.491 -1.232 . . . . 0.75 109.248 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 40.9 mt-10 -139.97 151.41 45.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.015 -0.274 . . . . 1.6699999999999999 110.953 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.979 ' CD2' HD11 ' A' ' 105' ' ' ILE . 87.4 m95 -140.49 116.12 10.18 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.22 110.588 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.3 mt -106.31 146.26 30.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.40999999999999998 109.609 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.568 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.062 0.458 . . . . 0.78000000000000003 111.923 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.454 ' OG ' HG12 ' A' ' 67' ' ' VAL . 28.4 t -115.64 102.88 54.24 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 108.916 -0.772 . . . . 1.25 108.916 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 66' ' ' LYS . 72.4 Cg_endo -78.76 110.29 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.629 2.219 . . . . 0.53000000000000003 112.81 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.79 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.15 -0.932 . . . . 0.40999999999999998 110.901 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 20.1 p-10 -88.24 20.41 3.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.83 -0.623 . . . . 1.8200000000000001 111.642 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -151.46 160.02 43.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.245 0.545 . . . . 1.9399999999999999 111.858 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -68.4 -20.01 64.65 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.394 -0.821 . . . . 1.6599999999999999 112.231 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.609 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 59.4 mttp -67.86 154.19 42.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.945 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.454 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.78 135.24 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-O 122.751 1.262 . . . . 0.96999999999999997 110.78 178.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 39.98 46.31 1.74 Allowed 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.251 -2.25 . . . . 1.77 113.481 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -91.33 143.28 26.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.996 -0.282 . . . . 1.96 110.98 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 HD21 ' A' ' 58' ' ' LEU . 94.9 t -68.35 130.03 33.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.815 0.34 . . . . 0.77000000000000002 110.525 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.905 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -128.61 -37.94 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 1.1499999999999999 112.014 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.98 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.67 125.62 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.928 -0.767 . . . . 0.28999999999999998 108.928 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.74 158.29 44.18 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.556 -0.747 . . . . 1.3 110.695 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 14.6 t80 -133.25 103.81 6.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.146 -0.687 . . . . 1.3 109.146 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.444 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 23.5 m -142.74 159.11 42.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.784 0.326 . . . . 0.89000000000000001 111.666 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.19 27.55 23.85 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.797 -0.716 . . . . 0.56999999999999995 112.462 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 74.12 1.83 3.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.54 0.21 . . . . 1.46 110.989 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.9 mttm -100.01 114.1 27.17 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.954 -0.388 . . . . 2.4100000000000001 109.954 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.24 126.87 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 C-N-CA 118.658 -1.217 . . . . 1.6599999999999999 107.82 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.703 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -111.02 128.06 55.73 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.635 -1.62 . . . . 1.25 110.631 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.868 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.7 p-10 -166.17 -56.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.081 -1.451 . . . . 1.2 107.081 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.9 t70 -83.09 -26.02 31.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.702 -1.135 . . . . 2.1699999999999999 109.188 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -75.87 -30.2 58.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.921 -1.14 . . . . 5.0499999999999998 107.921 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.55 110.58 22.82 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 114.402 -1.272 . . . . 1.29 110.166 178.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.73 -41.69 11.55 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.67 1.58 . . . . 0.79000000000000004 111.102 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.818 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.1 m-20 -68.06 104.2 1.71 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.83 -0.623 . . . . 1.3600000000000001 111.188 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.816 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.2 mt 71.74 20.75 4.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.21 0.819 . . . . 1.6200000000000001 113.21 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.868 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 64.8 pttt -56.23 131.99 49.42 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.883 -0.511 . . . . 2.3900000000000001 111.269 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.433 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 92.07 10.82 60.74 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.186 -1.007 . . . . 0.37 114.247 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.816 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -142.02 -49.26 0.38 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 114.862 1.43 . . . . 1.5900000000000001 114.862 -178.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.98 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.61 81.45 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 CA-C-O 123.339 1.542 . . . . 0.20000000000000001 107.128 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.498 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.6 m80 -102.05 128.9 48.31 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 112.044 -2.344 . . . . 0.28999999999999998 112.563 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.109 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -72.34 124.74 25.74 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.752 -0.779 . . . . 1.23 109.024 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.464 HG21 ' CD2' ' A' ' 38' ' ' TYR . 12.6 p -76.44 36.03 0.15 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.212 -0.903 . . . . 0.46000000000000002 112.062 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -148.68 133.33 17.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.91 0.386 . . . . 1.2 110.848 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -90.07 5.23 47.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 2.2200000000000002 110.2 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -146.16 65.74 1.2 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.704 -0.68 . . . . 2.1400000000000001 109.429 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.849 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.1 mp -57.32 -29.12 63.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 1.49 110.866 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.5 mttt -65.8 1.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.35 0.5 . . . . 2.04 112.35 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 m -89.99 -0.0 57.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.688 -0.687 . . . . 1.3999999999999999 111.244 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 110.51 -11.02 30.64 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.805 -0.712 . . . . 0.38 113.022 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -100.09 112.69 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 111.135 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -109.65 12.75 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 0.42999999999999999 111.681 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 21.1 m -60.07 139.15 57.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.459 1.651 . . . . 1.04 115.459 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.109 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.38 130.03 65.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-N 114.347 -1.297 . . . . 0.31 110.735 178.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.629 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.6 p-10 -104.4 146.62 28.58 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.672 -0.862 . . . . 1.1499999999999999 108.672 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.82 121.09 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.008 0.432 . . . . 0.27000000000000002 110.808 -178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -83.79 145.22 28.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.445 -0.798 . . . . 0.28999999999999998 111.176 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 54.12 63.73 2.07 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.081 -0.509 . . . . 1.52 112.169 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 31' ' ' LYS . 4.5 mt -45.03 175.84 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.198 0.523 . . . . 1.02 112.299 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.748 ' O ' HG21 ' A' ' 137' ' ' VAL . 14.8 pt20 -177.02 156.83 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 2.1299999999999999 110.888 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 60.5 tp -60.04 -39.71 86.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.038 -0.528 . . . . 1.7 112.11 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.487 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 4.8 t -72.46 -16.11 61.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.998 0.74 . . . . 1.3200000000000001 112.998 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.6 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.2 p30 -74.38 -16.05 60.91 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.888 -0.725 . . . . 1.5800000000000001 109.791 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.839 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -45.17 141.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.41999999999999998 110.185 178.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 154.05 6.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 119.717 -1.23 . . . . 0.23999999999999999 113.88 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.738 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.88 137.73 57.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.933 -0.633 . . . . 0.31 112.089 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.6 m-85 -119.97 139.7 52.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.324 -0.621 . . . . 1.24 109.324 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.1 tt0 -128.39 121.89 30.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.706 0.288 . . . . 1.1599999999999999 110.893 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 56' ' ' GLU . 43.5 t -99.96 117.79 35.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.03 110.632 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 23.0 mttm -115.0 106.1 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.801 -0.359 . . . . 1.76 110.56 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 34.3 t -94.87 105.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.649 -0.5 . . . . 1.1799999999999999 109.649 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.7 tttt -95.27 119.35 33.63 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 119.898 -0.721 . . . . 1.6200000000000001 112.603 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.526 ' HG2' ' HB2' ' A' ' 49' ' ' ASP . 6.6 ttpm? -146.25 102.98 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 2.8399999999999999 110.111 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.938 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.33 133.25 24.9 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 53.5 Cg_endo -100.68 47.26 2.19 Favored 'Cis proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.742 -0.941 . . . . 0.56000000000000005 111.434 -0.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.94 103.33 0.28 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.146 -1.026 . . . . 0.47999999999999998 113.579 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.73 151.46 3.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -0.811 . . . . 1.22 108.887 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -141.44 151.32 43.31 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.412 0.523 . . . . 0.56999999999999995 112.412 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 129' ' ' ALA . 1.8 m120 -145.8 141.18 27.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.925 -0.58 . . . . 2.0299999999999998 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.638 ' HE2' ' O ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -145.26 156.31 43.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.689 -0.232 . . . . 2.9500000000000002 110.645 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.3 mttm -101.34 140.53 35.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.631 0.975 . . . . 2.2599999999999998 113.631 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.988 HG23 HD13 ' A' ' 29' ' ' ILE . 33.3 mt -141.96 111.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.958 -1.019 . . . . 0.28000000000000003 109.233 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.738 ' CD2' HG23 ' A' ' 117' ' ' THR . 41.7 m170 -100.04 118.71 37.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.727 -0.389 . . . . 0.55000000000000004 110.647 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.658 HD11 HD21 ' A' ' 39' ' ' LEU . 10.2 mt -92.94 125.39 37.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.267 0.556 . . . . 1.52 112.035 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.669 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 57.8 t -115.64 123.54 71.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.314 -0.857 . . . . 0.32000000000000001 109.109 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.839 HG23 HG13 ' A' ' 115' ' ' ILE . 21.6 t -94.6 120.03 43.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.062 0.458 . . . . 1.0800000000000001 111.929 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.16 158.63 18.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.52000000000000002 110.505 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.1 142.02 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.225 0.536 . . . . 1.48 111.057 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.873 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -159.63 175.89 2.93 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.47 -0.786 . . . . 2.2000000000000002 110.031 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.873 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 72.2 Cg_exo -14.72 -140.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.545 4.163 . . . . 1.3100000000000001 115.769 179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 141' ' ' PRO . 7.5 t -22.77 -51.87 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.193 0.812 . . . . 2.3100000000000001 113.193 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 144' ' ' ALA . . . 113.83 56.05 0.41 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.163 -1.018 . . . . 2.52 113.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.495 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.292 -0.861 . . . . 2.6000000000000001 110.977 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.492 -0.243 . . . . 3.2799999999999998 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.451 ' HB3' ' HA2' ' A' ' 127' ' ' GLY . 78.9 p -78.65 158.55 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 2.4300000000000002 110.934 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 m -159.9 149.24 17.86 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.043 0.449 . . . . 1.8400000000000001 111.08 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.87 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 14.9 tt -142.82 147.75 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.596 -0.729 . . . . 2.1499999999999999 110.986 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 53.6 p -88.86 146.3 25.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.28 0.562 . . . . 1.1200000000000001 110.998 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 40.28 82.52 0.22 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.868 -1.06 . . . . 0.65000000000000002 111.384 -178.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.715 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.6 Cg_endo -78.15 -11.17 16.34 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 124.008 3.139 . . . . 0.88 113.127 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.56 121.8 13.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.592 -0.892 . . . . 2.0600000000000001 108.592 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.899 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.1 tt0 -143.81 158.99 43.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.765 1.024 . . . . 1.71 113.765 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.797 ' O ' HD13 ' A' ' 29' ' ' ILE . 56.3 ttm -138.52 135.05 34.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.692 -1.14 . . . . 1.8600000000000001 109.138 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.899 HD11 ' OE2' ' A' ' 27' ' ' GLU . 31.9 mm -133.79 139.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.39000000000000001 111.925 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.2 mt-10 -132.61 122.23 24.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.869 -0.605 . . . . 1.1899999999999999 109.544 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 11.6 tptm -142.1 161.52 37.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.74 -0.384 . . . . 2.52 111.119 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.003 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.17 131.69 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.39000000000000001 111.573 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.617 ' HG3' HG11 ' A' ' 137' ' ' VAL . 27.7 ttmt -44.89 132.04 6.89 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.767 -0.651 . . . . 2.3500000000000001 111.345 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.94 -16.56 56.65 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.056 -0.592 . . . . 0.31 112.504 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 66.4 mm-40 -80.32 159.97 25.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.009 -0.737 . . . . 2.1099999999999999 109.009 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.979 HG22 ' OD1' ' A' ' 106' ' ' ASN . 10.1 m -90.84 121.69 32.91 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.001 -0.68 . . . . 0.33000000000000002 110.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.53 119.73 38.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.146 0.498 . . . . 0.26000000000000001 111.451 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.631 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.7 t80 -79.24 116.38 19.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 1.4299999999999999 111.638 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.721 HD12 HD12 ' A' ' 105' ' ' ILE . 15.4 mt -99.96 105.05 32.66 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.935 -0.765 . . . . 0.80000000000000004 108.935 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.786 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.0 Cg_endo -82.31 124.92 4.37 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.424 2.083 . . . . 0.41999999999999998 114.09 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.9 t -141.16 132.71 27.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 1.03 109.473 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.579 ' O ' HG13 ' A' ' 22' ' ' ILE . 41.9 mttm -141.08 153.47 45.47 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.28 -0.418 . . . . 1.6599999999999999 110.538 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.919 ' CE2' HD11 ' A' ' 53' ' ' LEU . 36.3 p90 -140.41 153.02 46.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.567 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -79.89 128.39 33.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 1.3300000000000001 111.299 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 45' ' ' LEU . 3.0 tm? -99.75 131.42 45.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.63 -0.713 . . . . 2.1200000000000001 110.725 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 45' ' ' LEU . 46.0 m -152.24 139.91 13.0 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 110.223 -0.288 . . . . 1.75 110.223 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.57 -25.69 5.65 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.398 2.065 . . . . 1.6100000000000001 112.344 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -39.97 67.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.345 -0.388 . . . . 2.1800000000000002 110.53 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -75.93 79.62 2.82 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.606 -0.887 . . . . 2.4100000000000001 108.606 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -94.95 -0.23 54.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 112.306 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -71.21 158.96 53.79 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.342 -0.932 . . . . 0.55000000000000004 112.719 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 123' ' ' LYS . 18.6 Cg_endo -59.93 132.5 45.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.472 2.115 . . . . 0.84999999999999998 111.376 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.919 HD11 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -78.2 104.67 8.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.444 -0.344 . . . . 1.8999999999999999 111.698 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.2 m-20 -118.3 103.56 9.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.53 0.681 . . . . 1.78 111.426 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.743 ' CD1' HG13 ' A' ' 122' ' ' VAL . 4.7 mm -89.56 104.44 15.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.853 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 73' ' ' LEU . 85.9 tt0 -101.73 119.4 38.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.3 m95 -99.99 124.39 45.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.22 110.303 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.618 HD12 ' OE1' ' A' ' 119' ' ' GLN . 92.2 mt -112.23 139.96 47.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.472 -0.566 . . . . 0.40999999999999998 109.472 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.628 HD11 ' O ' ' A' ' 114' ' ' ASP . 3.7 tt -129.59 130.05 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.994 0.426 . . . . 0.78000000000000003 111.675 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 19.6 m -114.3 102.61 54.95 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 115.799 -0.637 . . . . 1.25 109.328 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.7 Cg_exo -78.67 113.79 3.36 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.707 2.272 . . . . 0.53000000000000003 112.255 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.98 87.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.29 -0.868 . . . . 0.40999999999999998 111.283 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -74.73 -40.01 61.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 1.8200000000000001 111.009 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 12.5 t-20 -82.91 159.96 22.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 1.9399999999999999 111.662 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.67 -17.49 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.419 -0.81 . . . . 1.6599999999999999 111.408 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 60.8 mttp -69.76 152.66 44.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.592 -0.731 . . . . 1.74 112.113 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -156.31 126.4 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-O 121.829 0.823 . . . . 0.96999999999999997 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 56.47 40.04 29.74 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 1.77 111.988 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -89.14 147.71 24.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.628 -0.26 . . . . 1.96 111.158 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG11 ' OH ' ' A' ' 84' ' ' TYR . 22.4 t -67.54 139.74 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.689 -0.486 . . . . 0.77000000000000002 109.689 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 -52.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.1499999999999999 112.912 -177.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.911 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.21 127.04 31.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.076 -0.713 . . . . 0.28999999999999998 109.076 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' HG3' ' A' ' 56' ' ' GLU . 7.4 tt -140.13 160.63 39.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 1.3 110.633 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.925 ' CD1' HD13 ' A' ' 79' ' ' ILE . 20.9 t80 -134.78 104.04 5.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.619 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.473 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 35.6 t -143.61 159.82 41.76 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.475 0.546 . . . . 0.89000000000000001 112.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.14 31.89 8.91 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.862 -0.608 . . . . 0.56999999999999995 113.155 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t0 71.07 2.57 4.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.269 . . . . 1.46 111.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 92.2 mttt -100.18 113.4 26.03 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.979 -0.378 . . . . 2.4100000000000001 109.979 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.925 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.34 128.8 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.063 -1.458 . . . . 1.6599999999999999 107.063 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.725 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.4 m-85 -112.59 115.65 28.94 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.241 -0.89 . . . . 1.25 110.328 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.872 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.7 p-10 -166.07 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 106.799 -1.556 . . . . 1.2 106.799 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -79.67 -25.72 41.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.585 -1.189 . . . . 2.1699999999999999 108.491 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -81.32 -28.26 34.64 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.849 -1.167 . . . . 5.0499999999999998 107.849 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.613 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 2.7 m-85 -87.65 120.93 71.18 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 114.769 -1.105 . . . . 1.29 110.727 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 84' ' ' TYR . 7.7 Cg_exo -71.47 -28.67 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.033 1.822 . . . . 0.79000000000000004 112.951 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' HD23 ' A' ' 87' ' ' LEU . 28.7 t0 -49.22 -30.01 6.49 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.228 -0.589 . . . . 1.3600000000000001 112.06 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.946 HD22 ' HD2' ' A' ' 90' ' ' ARG . 29.9 mt -157.56 38.01 0.28 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.121 -0.945 . . . . 1.6200000000000001 110.504 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.872 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 23.9 pttm -55.81 134.09 51.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.877 -0.601 . . . . 2.3900000000000001 112.392 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.36 76.0 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.39 -0.823 . . . . 0.37 114.461 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.946 ' HD2' HD22 ' A' ' 87' ' ' LEU . 3.5 ptp180 -145.27 -48.13 0.23 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.701 1.371 . . . . 1.5900000000000001 114.701 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.911 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.22 81.47 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 CA-C-O 122.992 1.377 . . . . 0.20000000000000001 108.064 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 106' ' ' ASN . 19.8 m80 -102.91 126.98 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.24 -2.254 . . . . 0.28999999999999998 112.343 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.941 ' CD1' HG23 ' A' ' 105' ' ' ILE . 80.5 m-85 -70.01 125.42 26.71 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 120.168 -0.613 . . . . 1.23 109.701 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.631 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.4 p -76.14 32.94 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.204 -0.907 . . . . 0.46000000000000002 112.027 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.8 m -148.46 132.51 17.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 1.2 111.216 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -91.72 4.9 51.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 2.2200000000000002 110.585 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.04 66.29 1.2 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.135 -0.691 . . . . 2.1400000000000001 109.135 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.558 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -57.72 -31.76 66.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.245 -0.888 . . . . 1.49 111.425 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.99 2.42 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.291 0.478 . . . . 2.04 112.291 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 98' ' ' LEU . 5.4 t -89.97 -0.03 57.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.761 -0.654 . . . . 1.3999999999999999 110.619 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.89 -14.01 41.28 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.055 -0.593 . . . . 0.38 112.834 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -100.02 108.03 20.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 1.4399999999999999 110.853 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -111.62 19.99 17.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.104 0.409 . . . . 0.42999999999999999 112.104 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.0 m -60.04 143.78 51.11 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.006 1.484 . . . . 1.04 115.006 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.941 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -129.67 133.26 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.735 -1.12 . . . . 0.31 111.252 178.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.979 ' OD1' HG22 ' A' ' 36' ' ' THR . 2.9 t-20 -102.84 157.33 17.04 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 108.022 -1.103 . . . . 1.1499999999999999 108.022 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.917 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -114.81 117.38 55.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.988 0.423 . . . . 0.27000000000000002 111.456 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.832 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.03 143.01 31.85 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.48 -0.782 . . . . 0.28999999999999998 110.556 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.772 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 8.7 t-20 48.88 58.31 5.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.958 -0.565 . . . . 1.52 111.826 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.1 mt -47.27 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.754 1.02 . . . . 1.02 113.754 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.742 ' HA ' ' HB3' ' A' ' 144' ' ' ALA . 54.1 tt0 -56.58 145.57 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.983 -0.553 . . . . 2.1299999999999999 110.793 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.584 HD13 ' HE2' ' A' ' 33' ' ' LYS . 62.5 tp -60.03 -40.0 87.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.001 0.429 . . . . 1.7 111.127 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.2 m -73.51 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 111.632 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.628 ' O ' HD11 ' A' ' 59' ' ' ILE . 95.8 m-20 -69.98 -18.08 63.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 1.5800000000000001 109.881 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.74 140.66 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.976 -0.556 . . . . 0.41999999999999998 110.235 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.8 159.14 7.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.9 -1.143 . . . . 0.23999999999999999 113.951 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.8 m -58.99 139.33 56.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.062 -0.569 . . . . 0.31 112.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 29.9 m-85 -119.98 130.87 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.514 . . . . 1.24 109.888 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.618 ' OE1' HD12 ' A' ' 58' ' ' LEU . 57.8 tt0 -122.05 119.83 32.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.148 -0.221 . . . . 1.1599999999999999 110.662 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.557 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 39.5 t -100.15 120.01 39.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.468 -0.333 . . . . 1.03 110.76 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.5 mtpt -114.14 104.83 12.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.372 -0.377 . . . . 1.76 110.842 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 73.8 t -87.52 108.25 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.197 -1.038 . . . . 1.1799999999999999 108.197 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 83.4 tttt -97.78 110.87 23.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.423 0.897 . . . . 1.6200000000000001 113.423 -177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.748 ' HD2' HD12 ' A' ' 53' ' ' LEU . 34.8 tttp -145.61 101.56 3.58 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.545 -0.539 . . . . 2.8399999999999999 109.545 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.779 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.79 132.18 47.62 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.941 -0.572 . . . . 0.44 112.332 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.576 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 60.7 Cg_endo -100.62 49.76 1.75 Allowed 'Cis proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.614 -0.994 . . . . 0.56000000000000005 112.185 -0.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 20' ' ' SER . . . -144.99 103.3 0.29 Allowed Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.303 -0.951 . . . . 0.47999999999999998 113.438 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -92.85 120.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.288 -0.956 . . . . 1.22 110.203 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.006 ' HB3' ' HB ' ' A' ' 122' ' ' VAL . . . -95.45 144.68 25.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.61 -0.268 . . . . 0.56999999999999995 111.359 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 1.4 m-80 -145.72 129.89 17.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.651 0.611 . . . . 2.0299999999999998 112.651 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.786 ' HE3' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -145.84 159.95 42.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.438 -0.346 . . . . 2.9500000000000002 110.941 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.5 mttt -110.5 146.92 35.14 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.496 0.925 . . . . 2.2599999999999998 113.496 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.748 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 88.7 mt -143.39 118.97 4.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.266 -0.879 . . . . 0.28000000000000003 109.535 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.524 ' CD2' HG23 ' A' ' 117' ' ' THR . 64.2 m170 -100.9 113.22 25.98 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.91 -0.494 . . . . 0.55000000000000004 110.406 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 110' ' ' LEU . 1.9 tm? -91.56 128.91 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.253 0.464 . . . . 1.52 112.253 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.6 t -121.53 129.96 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.689 . . . . 0.32000000000000001 109.297 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 33' ' ' LYS . 26.0 t -103.06 119.96 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.209 0.448 . . . . 1.0800000000000001 112.209 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.2 mt -84.51 172.13 11.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.52000000000000002 109.089 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.87 139.24 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.63 . . . . 1.48 111.664 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.003 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -162.69 172.56 5.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.017 -0.992 . . . . 2.2000000000000002 110.708 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.9 Cg_endo -51.52 -142.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.071 2.514 . . . . 1.3100000000000001 112.39 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 141' ' ' PRO . 10.7 t -34.16 -49.87 0.38 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.757 0.313 . . . . 2.3100000000000001 111.82 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 144' ' ' ALA . . . 53.18 55.91 21.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.789 . . . . 2.52 113.261 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 109' ' ' ASN . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 2.6000000000000001 111.247 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.481 -0.248 . . . . 3.2799999999999998 112.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.7 p -79.88 140.06 36.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.357 . . . . 2.4300000000000002 110.859 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -160.05 160.43 33.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.8400000000000001 110.843 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 13.3 tt -130.01 129.93 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 2.1499999999999999 110.558 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -89.39 153.84 20.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.352 0.596 . . . . 1.1200000000000001 111.259 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 44.33 82.96 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.92 -1.037 . . . . 0.65000000000000002 111.004 -177.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.663 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 60.1 Cg_endo -78.55 -86.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.619 2.879 . . . . 0.88 113.207 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.5 tt0 -77.85 123.09 26.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.222 -0.659 . . . . 2.0600000000000001 109.222 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.8 tp10 -143.91 159.96 41.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.446 0.906 . . . . 1.71 113.446 -176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.497 ' O ' HD13 ' A' ' 29' ' ' ILE . 26.0 mtt -132.35 130.01 40.17 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.264 -0.88 . . . . 1.8600000000000001 109.918 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.606 ' HB ' HD23 ' A' ' 135' ' ' LEU . 33.2 mm -127.57 133.82 66.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.643 0.259 . . . . 0.39000000000000001 111.524 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.9 mt-10 -123.77 125.73 45.24 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.498 -0.319 . . . . 1.1899999999999999 110.842 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 110' ' ' LEU . 10.4 mmtp -142.35 160.01 41.1 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.408 . . . . 2.52 111.713 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.824 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.82 139.23 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.39000000000000001 111.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 85.5 tttt -49.24 134.87 17.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.858 0.361 . . . . 2.3500000000000001 111.356 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.52 -21.33 22.44 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.138 -0.553 . . . . 0.31 112.776 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -79.98 159.83 26.13 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.32 -0.993 . . . . 2.1099999999999999 108.32 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.4 m -87.28 126.78 35.05 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.42 -0.912 . . . . 0.33000000000000002 110.484 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.018 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.74 117.62 33.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.26000000000000001 110.162 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.946 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 74.0 t80 -79.13 115.27 18.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 1.4299999999999999 112.038 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.776 HD21 HD11 ' A' ' 135' ' ' LEU . 33.9 mt -100.45 104.76 32.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 108.961 -0.755 . . . . 0.80000000000000004 108.961 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.683 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 85.6 Cg_endo -81.94 125.61 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.38 2.053 . . . . 0.41999999999999998 113.819 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 4.0 t -140.39 131.25 25.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.833 -1.173 . . . . 1.03 107.833 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.544 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 39.4 mttm -140.67 150.59 43.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.12 0.486 . . . . 1.6599999999999999 111.183 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 40.6 p90 -140.35 142.04 35.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.642 -0.708 . . . . 1.26 111.133 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -82.3 135.48 35.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.989 -0.551 . . . . 1.3300000000000001 111.665 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -97.74 140.06 32.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.904 -0.589 . . . . 2.1200000000000001 111.762 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 2.8 t -159.19 143.21 11.07 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.835 -0.621 . . . . 1.75 109.814 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -41.32 -26.72 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.735 2.29 . . . . 1.6100000000000001 113.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.561 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.82 -50.58 16.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.681 0.277 . . . . 2.1800000000000002 110.53 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' HB2' ' CG ' ' A' ' 124' ' ' LYS . 4.4 p-10 -74.59 64.25 1.18 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.174 0.512 . . . . 2.4100000000000001 110.047 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -102.46 2.59 36.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.479 -0.782 . . . . 1.6399999999999999 112.556 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.34 169.53 53.11 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.231 -0.985 . . . . 0.55000000000000004 112.94 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.6 121.96 10.44 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.591 2.194 . . . . 0.84999999999999998 111.563 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 7.4 tt -78.29 120.62 23.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.151 -0.477 . . . . 1.8999999999999999 111.937 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 5.7 m-20 -138.05 103.45 4.96 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.373 0.606 . . . . 1.78 111.484 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.818 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 67.8 mt -98.94 108.45 22.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.103 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' OE2' HD21 ' A' ' 58' ' ' LEU . 85.9 tt0 -100.62 121.17 41.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.765 0.654 . . . . 1.6699999999999999 112.765 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.901 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.5 m95 -95.33 126.57 40.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.399 . . . . 0.22 109.926 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 88.7 mt -112.9 141.81 46.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.702 -0.481 . . . . 0.40999999999999998 109.702 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.5 tt -129.99 129.95 65.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.036 0.446 . . . . 0.78000000000000003 111.793 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.432 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 14.3 m -120.23 102.01 46.35 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 109.015 -0.735 . . . . 1.25 109.015 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 4.4 Cg_exo -80.02 114.78 3.18 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.52 2.146 . . . . 0.53000000000000003 112.92 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.64 73.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.40999999999999998 110.714 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -86.29 17.2 3.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 1.8200000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.8 m-20 -149.86 163.66 37.43 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.265 0.555 . . . . 1.9399999999999999 111.68 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.49 -18.84 65.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.28 -0.873 . . . . 1.6599999999999999 112.094 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 92.0 mttt -68.51 144.79 54.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.204 -0.453 . . . . 1.74 111.798 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.67 127.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-O 121.837 0.827 . . . . 0.96999999999999997 109.636 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 52.88 39.93 29.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.089 -1.414 . . . . 1.77 112.046 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -91.09 145.61 24.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.521 -0.309 . . . . 1.96 110.961 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.6 t -65.91 138.94 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 108.978 -0.749 . . . . 0.77000000000000002 108.978 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -132.97 -52.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 112.577 0.584 . . . . 1.1499999999999999 112.577 -176.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.96 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.99 129.95 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.646 -0.872 . . . . 0.28999999999999998 108.646 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 55' ' ' ILE . 7.7 tp -140.41 157.51 45.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.865 0.364 . . . . 1.3 111.467 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.802 ' CD1' HD13 ' A' ' 79' ' ' ILE . 41.2 t80 -131.3 103.64 6.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 1.3 110.165 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.49 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 41.4 t -144.12 159.78 42.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.661 0.615 . . . . 0.89000000000000001 112.661 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.13 33.46 5.45 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.838 -0.619 . . . . 0.56999999999999995 113.26 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t0 70.02 3.26 4.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.604 0.24 . . . . 1.46 111.095 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 21.4 mttm -100.46 116.54 32.65 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.108 -0.331 . . . . 2.4100000000000001 110.108 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.2 mm -80.71 130.03 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 107.174 -1.417 . . . . 1.6599999999999999 107.174 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.737 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -117.1 121.59 41.72 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.542 -0.754 . . . . 1.25 110.822 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.5 p-10 -165.82 -52.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.324 -1.361 . . . . 1.2 107.324 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -81.38 -24.14 37.2 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.03 -0.986 . . . . 2.1699999999999999 109.31 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.93 -26.03 43.66 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.859 -1.064 . . . . 5.0499999999999998 108.139 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.672 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.8 m-85 -86.37 119.68 71.68 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 114.791 -1.095 . . . . 1.29 110.941 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.2 Cg_endo -50.78 -41.96 52.8 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.365 1.377 . . . . 0.79000000000000004 109.93 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.702 ' O ' HG12 ' A' ' 71' ' ' ILE . 63.3 m-20 -67.58 105.6 1.92 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.844 -0.616 . . . . 1.3600000000000001 110.671 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.862 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.6 mt 68.4 26.79 6.59 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.448 0.907 . . . . 1.6200000000000001 113.448 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 129.88 43.97 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.78 -0.575 . . . . 2.3900000000000001 111.477 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.94 17.91 60.53 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.485 -0.864 . . . . 0.37 114.108 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.862 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.7 ptp180 -143.96 -47.92 0.28 Allowed 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 114.448 1.277 . . . . 1.5900000000000001 114.448 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.96 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.8 81.87 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 123.109 1.433 . . . . 0.20000000000000001 107.621 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.526 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.8 m80 -102.07 128.72 48.41 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 112.15 -2.295 . . . . 0.28999999999999998 112.363 -175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.112 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.0 m-85 -71.99 120.03 17.01 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.273 0.559 . . . . 1.23 109.679 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.946 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 22.1 p -70.29 -9.97 57.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.21 -0.904 . . . . 0.46000000000000002 110.347 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.5 m -89.01 117.42 28.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.775 -0.648 . . . . 1.2 110.625 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -89.95 4.82 48.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.566 0.698 . . . . 2.2200000000000002 109.798 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' SER . 34.0 p-10 -146.28 66.46 1.19 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.979 -1.119 . . . . 2.1400000000000001 107.979 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.49 -38.94 82.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.215 -0.902 . . . . 1.49 111.599 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -63.21 0.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.361 0.504 . . . . 2.04 112.361 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 97' ' ' ASP . 29.3 m -92.97 -1.12 56.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.879 -0.6 . . . . 1.3999999999999999 110.845 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.497 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.51 -18.75 29.67 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.692 -0.766 . . . . 0.38 113.725 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -99.21 107.95 20.4 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 117.37 0.585 . . . . 1.4399999999999999 109.829 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.76 23.37 12.35 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.457 0.91 . . . . 0.42999999999999999 113.457 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 80.1 p -60.41 147.84 39.43 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.736 1.384 . . . . 1.04 114.736 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.112 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -130.22 133.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 114.53 -1.213 . . . . 0.31 111.015 178.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.7 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p30 -109.21 144.36 37.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.437 -0.949 . . . . 1.1499999999999999 108.437 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.95 120.6 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.067 0.461 . . . . 0.27000000000000002 111.885 -177.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.788 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -81.09 144.43 31.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.316 -0.856 . . . . 0.28999999999999998 110.721 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.68 54.53 11.03 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.177 -0.465 . . . . 1.52 111.627 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.018 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.8 mt -42.86 90.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.968 1.099 . . . . 1.02 113.968 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.483 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 72.7 mt-30 -59.43 140.6 56.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.909 -0.587 . . . . 2.1299999999999999 110.829 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.473 HD12 HD12 ' A' ' 115' ' ' ILE . 60.1 tp -60.01 -34.09 72.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.021 -0.733 . . . . 1.7 109.021 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.44 ' HB3' HD21 ' A' ' 64' ' ' ASN . 74.8 m -74.75 -12.43 60.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.271 -0.877 . . . . 1.3200000000000001 111.338 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.483 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 96.5 m-20 -73.43 -16.56 61.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.755 0.312 . . . . 1.5800000000000001 110.19 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.37 139.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 116.137 -0.483 . . . . 0.41999999999999998 110.314 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.13 162.22 9.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 119.982 -1.104 . . . . 0.23999999999999999 113.736 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 71.4 m -59.6 137.77 57.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.141 0.577 . . . . 0.31 112.482 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.678 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 21.0 m-85 -120.02 130.26 54.64 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.153 -0.684 . . . . 1.24 109.153 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.6 tt0 -121.76 118.63 29.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 1.1599999999999999 111.29 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.498 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 26.5 t -102.4 110.8 22.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 1.03 110.562 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.818 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.5 mtpt -106.62 104.97 14.78 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.82 -0.352 . . . . 1.76 110.23 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.681 ' HA ' HG12 ' A' ' 55' ' ' ILE . 62.8 t -88.07 109.92 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.637 -0.505 . . . . 1.1799999999999999 109.637 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.9 tttm -96.46 119.5 35.06 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.326 -0.55 . . . . 1.6200000000000001 112.064 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 49.2 tptt -145.59 101.42 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.648 -0.871 . . . . 2.8399999999999999 108.648 177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 1.033 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.61 134.02 54.78 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 112.455 0.539 . . . . 0.44 112.455 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.7 Cg_endo -99.61 50.47 1.65 Allowed 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.695 -0.96 . . . . 0.56000000000000005 111.705 -0.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -145.87 103.2 0.28 Allowed Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.284 -0.96 . . . . 0.47999999999999998 113.413 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.4 m -84.51 140.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.607 -0.797 . . . . 1.22 109.802 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -130.09 149.94 51.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.686 0.279 . . . . 0.56999999999999995 111.707 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 45.8 t30 -146.81 142.06 27.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.695 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.761 ' HG2' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -144.61 150.29 37.19 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.902 0.382 . . . . 2.9500000000000002 111.01 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -98.26 140.13 33.02 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.447 0.906 . . . . 2.2599999999999998 113.447 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.692 HD12 ' CH2' ' A' ' 57' ' ' TRP . 73.8 mt -143.58 113.57 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.266 -0.879 . . . . 0.28000000000000003 109.339 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 117' ' ' THR . 57.3 m170 -100.45 117.39 34.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.672 -0.411 . . . . 0.55000000000000004 110.554 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.776 HD11 HD21 ' A' ' 39' ' ' LEU . 12.8 mt -94.41 119.96 33.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.487 0.551 . . . . 1.52 112.487 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 21.6 t -111.93 119.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.146 -1.057 . . . . 0.32000000000000001 108.146 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 59.5 t -100.47 122.99 53.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.187 0.518 . . . . 1.0800000000000001 112.181 -177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.87 162.77 23.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.485 -0.78 . . . . 0.52000000000000002 109.038 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER -71.65 134.27 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 122.168 0.985 . . . . 1.48 111.75 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.824 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 4.5 mmmt -162.27 174.48 3.63 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 113.404 -1.725 . . . . 2.2000000000000002 109.659 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.0 Cg_endo -51.52 144.22 33.23 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.112 1.875 . . . . 1.3100000000000001 112.15 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.44 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 67.4 m -39.91 -75.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.135 -0.484 . . . . 2.3100000000000001 112.058 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.97 -60.03 0.76 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.839 -0.696 . . . . 2.52 112.696 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.207 -0.902 . . . . 2.6000000000000001 111.164 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.484 -0.246 . . . . 3.2799999999999998 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -79.16 131.5 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 2.4300000000000002 110.86 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 44' ' ' THR . 53.7 m -75.83 130.04 37.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.251 0.548 . . . . 1.8400000000000001 111.468 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.618 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.93 133.39 11.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.833 . . . . 2.1499999999999999 109.596 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 79.6 p -88.81 150.3 22.99 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.733 0.778 . . . . 1.1200000000000001 111.914 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.07 82.99 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 114.524 -1.216 . . . . 0.65000000000000002 111.983 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.1 Cg_endo -78.57 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.675 2.917 . . . . 0.88 112.107 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.32 127.46 32.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.352 -0.981 . . . . 2.0600000000000001 108.352 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.946 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.6 tt0 -143.94 158.67 43.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.278 1.214 . . . . 1.71 114.278 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 42.0 mtt -139.95 121.86 15.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.5 -1.227 . . . . 1.8600000000000001 109.13 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.946 HD11 ' OE2' ' A' ' 27' ' ' GLU . 38.9 mm -120.0 122.08 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.842 0.353 . . . . 0.39000000000000001 111.519 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 42.8 mt-10 -112.1 120.06 40.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.163 -0.472 . . . . 1.1899999999999999 110.81 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 73.2 mmtt -141.23 150.45 42.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.824 0.345 . . . . 2.52 111.744 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.02 143.74 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.311 -0.404 . . . . 0.39000000000000001 111.496 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.742 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 43.2 mtmt -42.88 156.83 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.255 0.55 . . . . 2.3500000000000001 112.396 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.09 -23.38 0.45 Allowed Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.287 -0.87 . . . . 0.31 114.201 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -79.96 156.2 27.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.544 -0.539 . . . . 2.1099999999999999 109.544 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.996 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -85.22 134.52 34.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.338 -0.545 . . . . 0.33000000000000002 109.582 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB3' HG12 ' A' ' 107' ' ' VAL . . . -100.21 110.83 23.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.347 -0.541 . . . . 0.26000000000000001 111.213 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 94' ' ' THR . 92.7 t80 -79.17 122.2 25.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 1.4299999999999999 111.618 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.735 HD22 HG21 ' A' ' 133' ' ' ILE . 25.3 mt -118.15 104.34 48.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.429 -0.582 . . . . 0.80000000000000004 109.429 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.511 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.7 Cg_endo -82.99 133.03 6.47 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.587 2.191 . . . . 0.41999999999999998 114.778 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.419 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 55.8 m -141.42 104.03 4.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.374 -0.83 . . . . 1.03 110.105 178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 10.6 mmtt -102.26 107.71 18.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.224 -0.288 . . . . 1.6599999999999999 110.224 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.949 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 42.5 p90 -93.78 142.72 27.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.355 . . . . 1.26 110.785 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 21' ' ' SER . 9.0 t -79.98 174.24 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.419 0.628 . . . . 1.3300000000000001 111.627 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 44' ' ' THR . 87.2 mt -142.27 149.8 40.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.924 -1.034 . . . . 2.1200000000000001 109.96 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.8 t -158.69 147.02 13.92 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.763 0.316 . . . . 1.75 110.886 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 83.0 Cg_exo -47.37 -26.67 6.14 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.419 2.079 . . . . 1.6100000000000001 112.188 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -77.59 -43.85 30.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.417 -0.356 . . . . 2.1800000000000002 110.694 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 67.6 m-20 -71.98 74.24 0.9 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.435 -0.58 . . . . 2.4100000000000001 109.435 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 47' ' ' PRO . 55.5 mm-40 -94.04 -5.09 48.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.35 -0.841 . . . . 1.6399999999999999 111.479 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.737 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 159.93 53.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.363 -0.923 . . . . 0.55000000000000004 112.136 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.43 149.1 31.34 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.526 2.151 . . . . 0.84999999999999998 112.081 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.949 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.1 tt -77.81 133.47 38.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 1.8999999999999999 110.345 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.627 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 10.9 t70 -140.18 152.37 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.454 0.645 . . . . 1.78 112.012 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.71 HD13 ' HB1' ' A' ' 103' ' ' ALA . 31.5 mt -142.8 139.99 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.687 -1.142 . . . . 0.75 109.515 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 1.085 ' HA ' HD22 ' A' ' 73' ' ' LEU . 45.3 mt-10 -140.36 111.66 7.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.337 0.495 . . . . 1.6699999999999999 112.337 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.9 ' CD2' HD11 ' A' ' 105' ' ' ILE . 77.3 m95 -100.03 119.96 39.09 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.497 -0.319 . . . . 0.22 111.026 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -106.05 124.33 49.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.597 -0.519 . . . . 0.40999999999999998 109.597 178.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.692 HD12 HD11 ' A' ' 87' ' ' LEU . 14.5 tt -109.88 126.34 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.892 0.701 . . . . 0.78000000000000003 112.892 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 50.2 m -119.98 102.04 46.96 Favored Pre-proline 0 N--CA 1.449 -0.515 0 N-CA-C 108.711 -0.848 . . . . 1.25 108.711 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 96.0 Cg_endo -79.7 117.13 3.6 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.84 2.36 . . . . 0.53000000000000003 112.752 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.76 90.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.861 -0.609 . . . . 0.40999999999999998 111.496 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.29 -40.0 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.795 -0.638 . . . . 1.8200000000000001 112.429 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 86.6 m-20 -81.59 161.14 23.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 1.9399999999999999 112.329 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -69.48 -18.36 63.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.936 -1.029 . . . . 1.6599999999999999 111.295 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.8 mttp -69.29 151.75 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.741 -0.663 . . . . 1.74 111.125 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.45 135.37 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.55 1.166 . . . . 0.96999999999999997 110.103 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 43.83 42.39 4.43 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.564 -2.107 . . . . 1.77 112.797 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -96.47 150.87 20.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.653 -0.249 . . . . 1.96 111.158 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 73' ' ' LEU . 20.7 t -66.38 129.43 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 109.696 -0.483 . . . . 0.77000000000000002 109.696 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.879 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -116.9 -56.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.863 -0.608 . . . . 1.1499999999999999 112.58 -177.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.963 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.28 128.91 49.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.821 -0.807 . . . . 0.28999999999999998 108.821 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 56' ' ' GLU . 5.8 mt -134.96 160.0 39.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.468 0.651 . . . . 1.3 111.701 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.861 ' HD1' HD13 ' A' ' 79' ' ' ILE . 41.3 t80 -135.25 103.33 5.48 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.567 -1.272 . . . . 1.3 107.567 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.523 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 2.3 t -143.15 155.59 44.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.87 -0.604 . . . . 0.89000000000000001 111.854 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.95 29.47 6.41 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 113.044 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t0 73.54 2.94 4.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.508 0.194 . . . . 1.46 111.388 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 118.56 36.65 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.976 -0.379 . . . . 2.4100000000000001 109.976 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.861 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.79 130.84 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.307 -1.368 . . . . 1.6599999999999999 107.307 177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.632 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.6 m-85 -119.92 120.86 37.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.381 -0.827 . . . . 1.25 110.288 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.8 p-10 -165.82 -48.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.663 -1.236 . . . . 1.2 107.663 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.61 -32.09 47.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.019 -0.991 . . . . 2.1699999999999999 109.185 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -76.18 -28.71 57.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.024 -0.989 . . . . 5.0499999999999998 108.647 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.3 m-85 -81.01 117.39 67.88 Favored Pre-proline 0 CA--C 1.514 -0.431 0 CA-C-N 114.911 -1.041 . . . . 1.29 110.675 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.7 -40.06 56.41 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.508 1.472 . . . . 0.79000000000000004 110.117 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.682 ' O ' HG12 ' A' ' 71' ' ' ILE . 5.2 m-20 -67.01 106.37 1.92 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.093 -0.643 . . . . 1.3600000000000001 110.521 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.5 mt 65.81 28.44 10.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.597 0.962 . . . . 1.6200000000000001 113.597 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 17.8 pttt -56.58 131.32 48.47 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.395 -0.522 . . . . 2.3900000000000001 111.159 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 83.39 18.11 65.07 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.435 -0.888 . . . . 0.37 114.501 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -145.96 -46.25 0.2 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -178.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.963 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.38 82.14 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 123.099 1.428 . . . . 0.20000000000000001 107.274 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.565 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.5 m80 -103.38 129.83 50.55 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 112.426 -2.17 . . . . 0.28999999999999998 112.471 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 63.3 m-85 -71.32 120.38 16.82 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.322 -0.622 . . . . 1.23 109.322 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.594 HG21 ' HD1' ' A' ' 38' ' ' TYR . 16.6 p -73.03 36.76 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.042 -0.981 . . . . 0.46000000000000002 113.575 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -149.36 136.0 19.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.388 0.613 . . . . 1.2 111.404 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.04 6.74 46.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 2.2200000000000002 110.372 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -145.62 65.9 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.444 -0.947 . . . . 2.1400000000000001 108.444 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 55' ' ' ILE . 8.2 tt -59.47 -38.44 80.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.632 -1.167 . . . . 1.49 111.641 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.5 1.47 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.391 0.515 . . . . 2.04 112.391 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' LEU . 50.6 m -89.99 -0.01 57.34 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.717 -0.674 . . . . 1.3999999999999999 111.151 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.546 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 108.55 -1.91 32.46 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.844 -0.693 . . . . 0.38 113.023 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 96.5 m-20 -100.26 108.7 20.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.729 0.299 . . . . 1.4399999999999999 110.672 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.71 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -108.78 5.95 25.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.42999999999999999 111.558 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 1.3 m -59.68 140.0 56.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.667 1.728 . . . . 1.04 115.667 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.24 135.16 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-N 114.0 -1.455 . . . . 0.31 109.549 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 41.9 p-10 -113.46 148.95 34.98 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.951 -0.759 . . . . 1.1499999999999999 108.951 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.03 HG12 ' HB3' ' A' ' 37' ' ' ALA . 7.5 p -95.76 123.79 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.526 0 N-CA-C 113.455 0.909 . . . . 0.27000000000000002 113.455 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.766 ' HA ' HG23 ' A' ' 36' ' ' THR . 1.3 p -84.81 141.65 30.33 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.386 -1.734 . . . . 0.28999999999999998 111.372 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 53.12 60.56 3.68 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.486 -0.779 . . . . 1.52 112.668 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 135' ' ' LEU . 10.0 mt -46.19 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.041 0.448 . . . . 1.02 112.059 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 12.0 pt20 -177.24 164.06 2.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.839 -0.618 . . . . 2.1299999999999999 110.347 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.851 ' HA ' HG11 ' A' ' 137' ' ' VAL . 79.4 mt -59.92 -36.73 77.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.806 0.336 . . . . 1.7 111.531 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB2' HD21 ' A' ' 64' ' ' ASN . 70.5 p -73.29 -15.85 61.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.388 -0.369 . . . . 1.3200000000000001 111.97 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 89.1 m-20 -72.99 -20.07 61.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.622 -0.431 . . . . 1.5800000000000001 110.005 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.903 HD12 HG12 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -47.12 144.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 116.114 -0.494 . . . . 0.41999999999999998 110.947 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.84 150.73 5.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.564 -1.303 . . . . 0.23999999999999999 114.115 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.613 HG23 ' CD2' ' A' ' 134' ' ' HIS . 95.6 m -59.27 129.97 44.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.024 -0.588 . . . . 0.31 111.965 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 87' ' ' LEU . 22.9 m-85 -110.21 129.92 55.63 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.808 . . . . 1.24 108.82 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.835 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -114.72 113.04 23.77 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.88 -0.415 . . . . 1.1599999999999999 109.88 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 7.3 t -100.01 109.36 21.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.965 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 45.0 mttt -120.4 109.97 15.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 1.76 111.836 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 43' ' ' PHE . 45.4 t -94.6 109.76 22.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.1799999999999999 109.448 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 43.2 tttm -98.67 122.88 42.45 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.994 -0.682 . . . . 1.6200000000000001 112.732 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 28.5 tttp -144.63 102.36 3.8 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.314 -0.625 . . . . 2.8399999999999999 109.314 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.84 133.32 28.65 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 113.226 0.824 . . . . 0.44 113.226 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.594 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 97.4 Cg_endo -98.43 36.87 6.58 Favored 'Cis proline' 0 N--CA 1.452 -0.956 0 C-N-CA 124.439 -1.067 . . . . 0.56000000000000005 111.753 -1.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.62 102.89 0.43 Allowed Glycine 0 N--CA 1.435 -1.42 0 CA-C-O 122.06 0.811 . . . . 0.47999999999999998 112.664 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.5 p -90.0 160.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.165 -1.017 . . . . 1.22 109.984 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -139.36 149.32 44.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.46 -0.336 . . . . 0.56999999999999995 111.673 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.542 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 37.9 p-10 -146.42 137.25 24.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.286 -0.416 . . . . 2.0299999999999998 111.862 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.6 ptmt -145.96 155.11 42.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 2.9500000000000002 110.636 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 24.1 mttt -103.45 140.07 37.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.148 0.796 . . . . 2.2599999999999998 113.148 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.735 HG21 HD22 ' A' ' 39' ' ' LEU . 87.2 mt -142.22 119.21 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.529 -0.76 . . . . 0.28000000000000003 109.225 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.613 ' CD2' HG23 ' A' ' 117' ' ' THR . 59.3 m170 -102.91 119.99 39.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.954 -0.299 . . . . 0.55000000000000004 110.547 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.464 HD21 HD21 ' A' ' 110' ' ' LEU . 58.8 tp -89.82 120.03 30.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.428 -0.509 . . . . 1.52 110.936 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 48.6 t -116.28 121.36 67.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.391 -0.822 . . . . 0.32000000000000001 109.27 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.903 HG12 HD12 ' A' ' 115' ' ' ILE . 14.8 p -94.92 128.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.885 0.374 . . . . 1.0800000000000001 111.974 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 94.2 mt -83.53 152.8 24.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.525 -0.546 . . . . 0.52000000000000002 109.525 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.57 134.54 28.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.778 0.799 . . . . 1.48 112.038 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.781 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -165.22 174.86 2.77 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.26 -1.336 . . . . 2.2000000000000002 108.832 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.781 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 5.9 Cg_endo -48.1 -177.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.924 1.749 . . . . 1.3100000000000001 111.833 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 141' ' ' PRO . 62.3 m -31.53 -79.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.232 0.456 . . . . 2.3100000000000001 112.232 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA3' ' CE ' ' A' ' 140' ' ' LYS . . . 43.66 23.52 0.35 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.328 -0.463 . . . . 2.52 113.64 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.294 -0.86 . . . . 2.6000000000000001 110.99 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' HA3' ' OE2' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.46 -0.256 . . . . 3.2799999999999998 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -158.92 155.13 27.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.659 0.266 . . . . 2.4300000000000002 110.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.8 t -159.87 150.5 19.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 1.8400000000000001 111.537 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.684 ' O ' HD12 ' A' ' 22' ' ' ILE . 2.4 pp -91.54 149.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 2.1499999999999999 111.144 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -87.17 158.22 19.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.326 0.584 . . . . 1.1200000000000001 110.892 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.468 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 44.89 83.82 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.018 -0.992 . . . . 0.65000000000000002 111.098 -177.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.4 Cg_endo -78.19 -84.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.611 2.874 . . . . 0.88 113.498 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.1 tt0 -77.82 122.13 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.17 -0.612 . . . . 2.0600000000000001 109.362 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' LYS . 52.9 tp10 -143.9 160.65 40.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.418 0.896 . . . . 1.71 113.418 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.583 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.1 ttm -134.56 134.33 41.24 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.067 -0.97 . . . . 1.8600000000000001 109.478 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 28' ' ' MET . 32.8 mm -129.94 129.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.949 -0.569 . . . . 0.39000000000000001 111.494 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.637 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 98.2 mt-10 -118.36 125.1 49.32 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.384 -0.371 . . . . 1.1899999999999999 110.695 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' A' ' 110' ' ' LEU . 61.0 mmtt -141.97 158.05 44.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.638 0.256 . . . . 2.52 111.315 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 35' ' ' GLU . . . -77.06 143.38 39.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 0.39000000000000001 111.69 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 39.6 ttmt -48.51 136.36 13.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 2.3500000000000001 111.609 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 82.46 -18.42 14.68 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.997 -0.62 . . . . 0.31 113.119 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.9 mm-40 -79.99 158.97 26.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.712 -0.847 . . . . 2.1099999999999999 108.712 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.1 m -87.28 129.8 34.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.476 -0.89 . . . . 0.33000000000000002 109.982 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 114.92 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.807 0.337 . . . . 0.26000000000000001 110.504 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 94' ' ' THR . 40.8 t80 -79.35 120.77 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.849 -0.614 . . . . 1.4299999999999999 112.454 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 133' ' ' ILE . 4.4 mp -115.28 104.76 53.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.619 -0.882 . . . . 0.80000000000000004 108.619 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 88.8 Cg_endo -86.43 104.49 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.328 2.019 . . . . 0.41999999999999998 114.929 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -98.51 135.51 39.95 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 176.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' HD3' ' OD1' ' A' ' 102' ' ' ASP . 45.5 tptt -140.03 139.99 36.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.741 0.305 . . . . 1.6599999999999999 110.527 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -140.16 139.76 35.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 1.26 111.413 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.14 126.39 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 1.3300000000000001 110.775 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD21 ' HE1' ' A' ' 43' ' ' PHE . 84.4 mt -89.09 149.95 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 2.1200000000000001 110.834 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.8 m -151.32 144.09 16.73 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 116.486 -0.324 . . . . 1.75 110.133 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.18 -23.57 9.89 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.579 2.186 . . . . 1.6100000000000001 112.086 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 16.7 pt-20 -77.29 -43.66 32.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.194 -0.457 . . . . 2.1800000000000002 111.05 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -75.59 76.32 2.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.936 -0.705 . . . . 2.4100000000000001 109.287 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.51 -3.52 52.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.352 -0.84 . . . . 1.6399999999999999 111.901 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.03 160.06 53.33 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.691 -0.766 . . . . 0.55000000000000004 113.024 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.61 136.56 76.68 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.632 2.222 . . . . 0.84999999999999998 111.675 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 6.6 mp -78.0 119.05 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.301 -0.409 . . . . 1.8999999999999999 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -133.01 102.17 5.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.535 0.683 . . . . 1.78 111.033 178.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.881 HG12 HG22 ' A' ' 122' ' ' VAL . 2.6 mp -96.39 105.91 17.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.761 -1.109 . . . . 0.75 110.874 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.646 ' OE2' HD21 ' A' ' 58' ' ' LEU . 86.5 tt0 -100.93 117.66 35.41 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.62 0.6 . . . . 1.6699999999999999 112.62 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.819 ' CD2' HD11 ' A' ' 105' ' ' ILE . 72.3 m95 -94.06 120.01 33.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.133 -0.321 . . . . 0.22 110.133 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.646 HD21 ' OE2' ' A' ' 56' ' ' GLU . 89.5 mt -105.91 146.86 29.44 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.866 -0.42 . . . . 0.40999999999999998 109.866 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 87' ' ' LEU . 12.7 tt -130.02 130.02 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.157 0.429 . . . . 0.78000000000000003 112.157 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.447 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 37.4 m -119.99 102.16 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.631 -0.877 . . . . 1.25 108.631 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.617 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 91.9 Cg_endo -78.96 114.97 3.48 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.775 2.317 . . . . 0.53000000000000003 113.533 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.18 82.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.352 -0.84 . . . . 0.40999999999999998 110.614 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -85.93 16.52 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.534 -0.757 . . . . 1.8200000000000001 112.078 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 81.0 m-20 -148.72 161.0 42.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.376 0.608 . . . . 1.9399999999999999 112.011 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.94 -19.76 65.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.058 -0.974 . . . . 1.6599999999999999 112.507 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 43.6 mttt -69.1 153.05 44.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.825 0.345 . . . . 1.74 111.536 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.36 128.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.716 0.77 . . . . 0.96999999999999997 109.468 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 54.17 45.18 27.94 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.346 -1.297 . . . . 1.77 112.088 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 136.4 33.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.96 111.089 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.51 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 110.154 -0.313 . . . . 0.77000000000000002 110.154 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.891 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.5 pp -131.76 -38.85 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.808 0.67 . . . . 1.1499999999999999 112.808 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.905 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.31 123.85 14.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.175 0.512 . . . . 0.28999999999999998 110.092 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 8.5 tt -140.38 163.55 32.49 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 116.019 -0.537 . . . . 1.3 109.799 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' ILE . 23.3 t80 -135.31 109.94 8.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.206 0.527 . . . . 1.3 110.477 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.3 t -142.61 159.99 41.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.249 -0.887 . . . . 0.89000000000000001 111.474 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.32 55.48 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.564 -0.827 . . . . 0.56999999999999995 112.152 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 74.14 2.83 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.845 -0.178 . . . . 1.46 111.241 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 6.0 mmtm -105.36 118.52 36.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 109.811 -0.441 . . . . 2.4100000000000001 109.811 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.626 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.73 119.99 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.617 -1.253 . . . . 1.6599999999999999 107.617 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.839 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -100.01 132.53 45.31 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.83 -1.077 . . . . 1.25 110.728 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.815 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.8 p-10 -166.32 -58.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.796 -1.557 . . . . 1.2 106.796 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 33.6 p-10 -80.1 -22.01 42.66 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.565 -1.198 . . . . 2.1699999999999999 109.731 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.555 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -76.85 -29.8 56.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.85 -1.167 . . . . 5.0499999999999998 107.85 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.739 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.1 m-85 -85.18 118.3 70.54 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 114.452 -1.249 . . . . 1.29 110.263 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -41.0 51.93 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.346 1.364 . . . . 0.79000000000000004 110.447 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.867 ' HB3' HG22 ' A' ' 71' ' ' ILE . 89.1 m-20 -68.19 104.87 1.92 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.771 -0.65 . . . . 1.3600000000000001 111.091 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.764 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 34.3 mt 70.4 22.37 5.31 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.295 0.85 . . . . 1.6200000000000001 113.295 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 21.6 pttp -58.17 136.9 57.34 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.843 -0.536 . . . . 2.3900000000000001 111.05 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 86.64 9.57 74.81 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.249 -0.977 . . . . 0.37 114.176 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -137.99 -54.61 0.65 Allowed 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 114.754 1.39 . . . . 1.5900000000000001 114.754 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.905 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -78.28 81.28 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 N-CA-C 107.088 -1.449 . . . . 0.20000000000000001 107.088 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.533 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 6.7 m80 -100.06 129.43 46.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.163 -2.289 . . . . 0.28999999999999998 112.589 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.093 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.3 m-85 -70.37 121.17 17.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 120.231 -0.588 . . . . 1.23 110.054 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.588 HG21 ' CD1' ' A' ' 38' ' ' TYR . 35.0 p -71.4 -10.67 60.13 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.93 . . . . 0.46000000000000002 110.099 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 58.1 m -95.15 120.0 34.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.726 -0.67 . . . . 1.2 110.683 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -91.34 6.08 46.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.927 -0.579 . . . . 2.2200000000000002 110.189 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -146.25 66.3 1.19 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.551 -0.907 . . . . 2.1400000000000001 108.551 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.7 mp -59.3 -31.29 69.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 1.49 112.21 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -62.86 -4.08 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.142 0.496 . . . . 2.04 111.91 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.65 -0.57 57.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.392 -0.822 . . . . 1.3999999999999999 110.89 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.507 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 110.07 -20.61 26.03 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.687 -0.768 . . . . 0.38 113.186 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 82.8 m-20 -92.91 109.01 20.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.964 0.382 . . . . 1.4399999999999999 111.195 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.29 21.46 16.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.42999999999999999 111.102 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.728 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 82.5 p -59.98 145.89 44.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 116.03 1.863 . . . . 1.04 116.03 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.093 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.62 133.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 114.246 -1.343 . . . . 0.31 111.27 178.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.678 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.1 p-10 -107.66 147.85 30.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.947 -1.131 . . . . 1.1499999999999999 107.947 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.75 123.9 52.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.958 0.408 . . . . 0.27000000000000002 111.79 -178.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.5 p -84.68 142.75 29.67 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.536 -0.756 . . . . 0.28999999999999998 110.935 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.9 m-20 49.98 55.69 9.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.996 -0.547 . . . . 1.52 112.133 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 37' ' ' ALA . 19.8 mt -46.96 89.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.577 0.954 . . . . 1.02 113.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 63.7 tt0 -60.03 148.68 34.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.154 -0.475 . . . . 2.1299999999999999 109.94 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 3.0 tm? -60.02 -39.99 87.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 1.7 110.729 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 74.2 m -72.96 -10.04 59.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.74 -0.663 . . . . 1.3200000000000001 111.611 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.95 -18.35 63.35 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.048 -0.352 . . . . 1.5800000000000001 110.048 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.7 145.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.526 0.026 0 CA-C-N 116.113 -0.494 . . . . 0.41999999999999998 110.397 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 155.79 6.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.984 -1.103 . . . . 0.23999999999999999 113.887 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.2 m -59.36 139.01 57.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.94 0.496 . . . . 0.31 111.808 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 29.0 m-85 -119.99 133.68 55.47 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.612 -0.514 . . . . 1.24 109.612 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.3 tt0 -123.11 115.22 21.44 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.101 -0.24 . . . . 1.1599999999999999 110.843 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.485 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.3 t -99.96 112.15 24.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.371 -0.377 . . . . 1.03 110.011 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.847 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 98.4 mttt -110.49 106.51 15.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.627 -0.26 . . . . 1.76 111.577 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.881 HG22 HG12 ' A' ' 55' ' ' ILE . 47.6 t -88.21 110.05 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 108.75 -0.833 . . . . 1.1799999999999999 108.75 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.708 ' HG3' HG12 ' A' ' 128' ' ' VAL . 61.1 tttp -96.06 120.3 36.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.869 0.692 . . . . 1.6200000000000001 112.869 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 11.0 mtmt -144.25 101.64 3.73 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.663 -0.495 . . . . 2.8399999999999999 109.663 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -53.22 132.32 51.64 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.45 -0.341 . . . . 0.44 111.751 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 59.7 Cg_endo -100.37 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 124.808 -0.913 . . . . 0.56000000000000005 112.366 -0.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 103.18 0.28 Allowed Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.397 -0.906 . . . . 0.47999999999999998 113.141 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.708 HG12 ' HG3' ' A' ' 123' ' ' LYS . 13.4 m -87.06 142.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.221 -0.99 . . . . 1.22 109.724 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -136.03 148.11 48.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.979 -0.288 . . . . 0.56999999999999995 111.642 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.628 ' O ' HD11 ' A' ' 22' ' ' ILE . 47.2 p-10 -146.61 151.67 37.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.466 0.543 . . . . 2.0299999999999998 112.466 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.916 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.29 153.51 41.36 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.154 -0.475 . . . . 2.9500000000000002 110.958 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 18.6 tttt -99.59 139.63 34.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.486 0.55 . . . . 2.2599999999999998 112.486 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.947 HG21 HD23 ' A' ' 39' ' ' LEU . 95.2 mt -143.19 117.79 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.28000000000000003 109.641 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.515 ' CD2' HG23 ' A' ' 117' ' ' THR . 62.6 m170 -100.04 116.16 31.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.008 0.433 . . . . 0.55000000000000004 111.246 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.889 HD11 HD22 ' A' ' 110' ' ' LEU . 1.8 tm? -89.17 125.18 34.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.946 -0.57 . . . . 1.52 111.479 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 39.2 t -121.22 124.71 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.805 -0.634 . . . . 0.32000000000000001 109.939 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.4 t -97.19 120.24 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 1.0800000000000001 111.51 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.0 mt -80.45 160.02 25.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 0.52000000000000002 109.686 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -77.03 137.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.642 0.734 . . . . 1.48 111.59 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.795 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -164.93 179.47 1.13 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 114.633 -1.167 . . . . 2.2000000000000002 109.308 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.795 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 10.7 Cg_endo -53.58 -159.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.062 1.841 . . . . 1.3100000000000001 112.407 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 141' ' ' PRO . 35.7 t -32.08 -78.32 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.414 -0.357 . . . . 2.3100000000000001 111.879 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.46 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 77.49 -43.76 2.13 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.994 -0.622 . . . . 2.52 113.709 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.22 -0.895 . . . . 2.6000000000000001 111.114 -179.706 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.646 -0.181 . . . . 3.2799999999999998 112.646 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.9 t -159.67 151.31 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 2.4300000000000002 110.894 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -160.01 150.01 18.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 1.8400000000000001 111.024 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.815 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -147.88 134.24 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 2.1499999999999999 110.719 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.688 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.0 p -93.44 156.22 16.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.575 0.702 . . . . 1.1200000000000001 111.958 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 43.06 82.41 0.23 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.698 -1.137 . . . . 0.65000000000000002 112.013 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -79.3 -86.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.775 2.983 . . . . 0.88 113.048 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 46.2 mt-10 -78.18 126.58 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.129 -0.693 . . . . 2.0600000000000001 109.129 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 132' ' ' LYS . 41.8 tt0 -144.11 159.25 42.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.449 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 16.5 mtm -140.12 116.43 10.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.629 -1.169 . . . . 1.8600000000000001 109.376 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.619 ' HB ' HD23 ' A' ' 135' ' ' LEU . 39.2 mm -120.01 130.01 74.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.39000000000000001 111.553 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.65 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 35.8 mt-10 -120.59 128.06 52.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.572 -0.285 . . . . 1.1899999999999999 110.711 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 51.3 tptt -142.82 158.48 43.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.687 -0.233 . . . . 2.52 110.552 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.767 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.7 141.91 40.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.788 0.328 . . . . 0.39000000000000001 111.552 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.661 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 32.1 tttt -47.77 140.98 5.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.0 0.429 . . . . 2.3500000000000001 111.444 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 83.04 -21.95 7.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.832 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.767 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.05 159.01 26.33 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.318 -0.993 . . . . 2.1099999999999999 108.318 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.0 m -88.13 130.0 35.15 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.546 -0.862 . . . . 0.33000000000000002 110.236 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.933 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.76 113.48 25.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.26000000000000001 110.617 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.4 t80 -79.26 120.01 23.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 1.4299999999999999 112.402 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.863 HD23 HG21 ' A' ' 133' ' ' ILE . 4.5 mp -115.68 104.88 52.53 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 108.476 -0.935 . . . . 0.80000000000000004 108.476 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 90.3 Cg_endo -85.48 104.65 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.47 2.114 . . . . 0.41999999999999998 115.914 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -102.25 131.51 48.77 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.467 -0.938 . . . . 1.03 108.467 176.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.65 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 23.0 tptm -140.69 105.08 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.042 0.449 . . . . 1.6599999999999999 110.393 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.895 ' HB3' HG11 ' A' ' 122' ' ' VAL . 38.6 p90 -90.95 141.89 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 1.26 111.647 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 45' ' ' LEU . 25.1 m -79.8 164.14 23.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.735 -0.666 . . . . 1.3300000000000001 110.483 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' N ' HG22 ' A' ' 44' ' ' THR . 77.4 mt -138.79 149.95 45.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.141 0.496 . . . . 2.1200000000000001 111.44 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 53.3 m -157.73 148.57 16.28 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.544 -0.753 . . . . 1.75 109.885 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.04 -23.61 1.04 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.889 2.392 . . . . 1.6100000000000001 112.979 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 85.6 tt0 -74.64 -25.92 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.518 -0.31 . . . . 2.1800000000000002 111.73 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 46' ' ' SER . 55.8 p-10 -63.54 82.69 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 121.534 0.683 . . . . 2.4100000000000001 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' GLU . 95.1 mt-30 -94.24 0.02 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 1.6399999999999999 111.822 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.971 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -92.91 170.22 31.75 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.126 -1.035 . . . . 0.55000000000000004 113.087 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.02 153.03 63.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.913 2.409 . . . . 0.84999999999999998 111.86 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.681 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.0 tt -78.14 123.99 27.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.306 -0.406 . . . . 1.8999999999999999 110.613 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 15.3 m-20 -136.34 150.64 48.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.508 0.671 . . . . 1.78 111.494 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 25.1 mt -142.65 139.66 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.75 109.174 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 99.2 mt-10 -140.68 116.24 10.16 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.185 0.439 . . . . 1.6699999999999999 112.185 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.843 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.2 m95 -101.79 122.85 44.73 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 121.102 -0.239 . . . . 0.22 110.751 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 90.8 mt -109.19 139.87 43.53 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.145 -0.687 . . . . 0.40999999999999998 109.145 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 tt -130.04 130.0 65.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.196 0.522 . . . . 0.78000000000000003 112.245 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.5 m -120.47 102.82 44.9 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.461 -0.79 . . . . 1.25 109.11 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 97.8 Cg_endo -79.11 114.59 3.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.591 2.194 . . . . 0.53000000000000003 113.28 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.79 80.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.365 -0.834 . . . . 0.40999999999999998 110.828 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -86.15 20.69 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 1.8200000000000001 111.919 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 35.1 m120 -151.28 161.98 41.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.288 0.566 . . . . 1.9399999999999999 111.873 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.32 -19.83 64.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.287 -0.869 . . . . 1.6599999999999999 112.32 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 90.8 mttt -68.51 146.4 53.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.257 -0.429 . . . . 1.74 111.008 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -155.4 127.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 CA-C-O 121.971 0.891 . . . . 0.96999999999999997 109.994 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 54.15 39.97 31.22 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.841 -1.527 . . . . 1.77 112.582 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.441 ' NE2' ' HD3' ' A' ' 66' ' ' LYS . 26.8 mt-30 -94.2 146.81 23.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.629 0.252 . . . . 1.96 111.137 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 ' OH ' ' A' ' 84' ' ' TYR . 44.6 t -66.58 137.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.905 -0.405 . . . . 0.77000000000000002 109.905 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.894 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -129.39 -52.41 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 1.1499999999999999 112.73 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.972 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.52 130.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 107.982 -1.118 . . . . 0.28999999999999998 107.982 178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -140.41 159.97 41.02 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 120.833 -0.347 . . . . 1.3 111.704 -176.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.6 t80 -135.81 103.82 5.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.195 -0.669 . . . . 1.3 109.195 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.449 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 20.2 m -142.6 159.99 41.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.751 0.31 . . . . 0.89000000000000001 111.582 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.11 25.93 18.95 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.602 -0.809 . . . . 0.56999999999999995 112.272 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t0 74.75 1.62 3.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.512 0.196 . . . . 1.46 111.091 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.9 mttt -100.01 115.08 28.89 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 110.034 -0.358 . . . . 2.4100000000000001 110.034 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.725 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.55 128.85 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.575 -1.269 . . . . 1.6599999999999999 107.575 177.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.6 m-85 -113.13 129.33 56.54 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.874 -1.512 . . . . 1.25 110.256 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.793 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 21.9 p-10 -166.16 -54.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.654 -1.239 . . . . 1.2 107.654 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -80.13 -20.05 45.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.025 -0.989 . . . . 2.1699999999999999 109.202 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.43 -26.25 35.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.216 -0.902 . . . . 5.0499999999999998 108.904 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.532 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -85.3 111.81 39.25 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.073 -0.967 . . . . 1.29 111.057 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.5 -41.9 10.83 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.427 1.418 . . . . 0.79000000000000004 109.939 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.707 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . 60.3 t0 -67.89 105.46 1.99 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.64 -0.709 . . . . 1.3600000000000001 110.266 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.904 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 5.6 mt 68.66 20.03 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.012 1.116 . . . . 1.6200000000000001 114.012 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 12.2 pttm -54.78 127.06 26.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.336 -0.852 . . . . 2.3900000000000001 110.84 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.77 12.94 48.75 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.212 -0.994 . . . . 0.37 114.213 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.904 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.5 ptp180 -143.81 -47.6 0.28 Allowed 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 114.619 1.34 . . . . 1.5900000000000001 114.619 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.972 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.58 81.15 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-O 123.275 1.512 . . . . 0.20000000000000001 107.544 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -101.58 127.83 48.12 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.044 -2.344 . . . . 0.28999999999999998 111.856 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.1 ' CD1' HG23 ' A' ' 105' ' ' ILE . 88.1 m-85 -69.59 125.9 28.12 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 119.918 -0.713 . . . . 1.23 110.246 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.713 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.9 p -73.49 29.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.46000000000000002 111.747 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 93' ' ' PHE . 5.4 m -148.76 127.49 12.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.038 0.447 . . . . 1.2 110.359 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.02 8.17 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.773 -0.649 . . . . 2.2200000000000002 110.308 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -146.2 66.2 1.2 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.778 -0.823 . . . . 2.1400000000000001 108.778 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.618 HD21 ' CG ' ' A' ' 93' ' ' PHE . 6.3 mp -58.36 -23.56 57.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.185 -0.916 . . . . 1.49 111.616 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.54 -3.41 2.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.162 0.506 . . . . 2.04 112.098 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 10.01 25.7 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.466 -0.788 . . . . 1.3999999999999999 111.048 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.577 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 96.54 -10.39 66.86 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.913 -0.66 . . . . 0.38 113.079 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -95.25 110.12 22.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 1.4399999999999999 111.602 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -110.22 16.06 21.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.025 -0.534 . . . . 0.42999999999999999 110.569 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.5 m -59.94 140.38 56.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 115.229 1.566 . . . . 1.04 115.229 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.1 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.28 136.59 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-N 114.853 -1.067 . . . . 0.31 111.002 178.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.717 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.5 p-10 -112.86 142.98 44.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.33 -0.989 . . . . 1.1499999999999999 108.33 177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.887 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.42 120.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.107 0.48 . . . . 0.27000000000000002 111.512 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -84.57 141.9 30.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.344 -0.844 . . . . 0.28999999999999998 110.659 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.514 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 33.8 m120 53.82 52.77 12.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.52 111.346 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.933 HD11 ' HB2' ' A' ' 37' ' ' ALA . 16.0 mt -43.08 87.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.558 1.318 . . . . 1.02 114.558 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' ASN . 57.4 mt-30 -58.2 141.93 49.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.055 -0.521 . . . . 2.1299999999999999 110.593 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.554 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 87.0 mt -59.93 -33.1 71.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.885 0.374 . . . . 1.7 110.487 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.4 m -75.06 -13.13 60.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 1.3200000000000001 111.213 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.58 -18.59 62.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.87 -0.419 . . . . 1.5800000000000001 109.87 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -43.49 141.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 116.044 -0.525 . . . . 0.41999999999999998 110.535 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.83 162.21 9.01 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.225 -0.988 . . . . 0.23999999999999999 113.514 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.726 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.51 135.77 57.77 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.414 0.524 . . . . 0.31 112.414 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.915 ' CE1' HD12 ' A' ' 135' ' ' LEU . 41.3 m-85 -120.05 129.67 54.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.988 -0.551 . . . . 1.24 109.72 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -121.35 119.97 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.186 -0.206 . . . . 1.1599999999999999 111.206 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.5 t -99.94 117.42 34.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.096 -0.335 . . . . 1.03 110.096 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.646 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 37.3 mtpt -118.07 107.87 14.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 1.76 110.82 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.895 HG11 ' HB3' ' A' ' 43' ' ' PHE . 7.2 p -92.27 106.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.026 -0.361 . . . . 1.1799999999999999 110.026 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 63.6 tttm -93.89 115.18 27.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.04 -0.664 . . . . 1.6200000000000001 112.087 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -145.86 102.07 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.1 -0.704 . . . . 2.8399999999999999 109.1 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.971 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.06 134.31 39.73 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 112.369 0.507 . . . . 0.44 112.369 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 77.0 Cg_endo -100.05 46.82 2.29 Favored 'Cis proline' 0 N--CA 1.45 -1.059 0 C-N-CA 124.642 -0.982 . . . . 0.56000000000000005 111.208 -0.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.81 102.93 0.31 Allowed Glycine 0 N--CA 1.435 -1.433 0 C-N-CA 120.086 -1.054 . . . . 0.47999999999999998 113.683 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.4 m -93.21 138.21 20.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 113.861 -1.17 . . . . 1.22 109.233 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.815 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -140.76 144.47 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.979 0.363 . . . . 0.56999999999999995 111.979 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.5 p-10 -146.77 151.45 37.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.482 0.549 . . . . 2.0299999999999998 112.482 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.0 160.03 41.56 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 2.9500000000000002 111.15 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 61.0 mttp -102.53 139.81 37.64 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 112.422 0.527 . . . . 2.2599999999999998 112.422 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.863 HG21 HD23 ' A' ' 39' ' ' LEU . 84.9 mt -142.12 114.55 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.959 -0.756 . . . . 0.28000000000000003 108.959 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.726 ' CD2' HG23 ' A' ' 117' ' ' THR . 48.7 m170 -99.97 115.55 29.96 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.481 -0.488 . . . . 0.55000000000000004 110.398 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.915 HD12 ' CE1' ' A' ' 118' ' ' TYR . 46.5 mt -93.68 120.05 33.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.65 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 17.6 t -115.25 120.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.306 -0.998 . . . . 0.32000000000000001 108.306 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 115' ' ' ILE . 25.4 t -96.26 125.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.814 0.672 . . . . 1.0800000000000001 112.814 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -82.85 160.02 22.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.537 -0.756 . . . . 0.52000000000000002 109.896 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 139' ' ' VAL . 1.2 p -77.88 142.59 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.987 0.899 . . . . 1.48 112.935 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.661 ' HG3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -162.85 178.83 1.4 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 113.863 -1.517 . . . . 2.2000000000000002 109.511 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 59.9 Cg_exo -53.07 -145.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.486 2.124 . . . . 1.3100000000000001 112.699 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.0 m -39.56 -69.98 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.905 0.383 . . . . 2.3100000000000001 111.736 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.634 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 59.29 49.89 73.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 2.52 113.355 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.194 -0.908 . . . . 2.6000000000000001 111.063 179.731 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.541 -0.224 . . . . 3.2799999999999998 112.541 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 1.9 m -78.5 125.24 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.797 0.332 . . . . 2.4300000000000002 110.709 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 t -82.58 140.06 33.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 1.8400000000000001 111.555 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pp -104.54 136.13 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.666 -0.697 . . . . 2.1499999999999999 110.401 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -87.15 148.96 24.97 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.059 0.457 . . . . 1.1200000000000001 110.344 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.549 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 43.35 83.81 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.393 -0.822 . . . . 0.65000000000000002 110.549 -177.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.771 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.8 Cg_endo -77.34 -11.04 17.55 Favored 'Trans proline' 0 C--N 1.331 -0.394 0 C-N-CA 123.913 3.076 . . . . 0.88 113.864 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 49.2 mp0 -141.36 126.23 18.16 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.182 -0.673 . . . . 2.0600000000000001 109.182 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.901 ' OE2' HD11 ' A' ' 29' ' ' ILE . 85.5 tt0 -144.09 161.19 39.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.731 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.6 ttm -137.11 137.32 39.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.876 -1.057 . . . . 1.8600000000000001 109.415 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.901 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.1 mm -132.71 139.94 48.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.978 -0.555 . . . . 0.39000000000000001 111.597 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.58 123.07 19.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 1.1899999999999999 110.523 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.76 158.91 43.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.52 112.119 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.978 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -77.03 138.6 39.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 0.39000000000000001 112.021 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.811 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 34.2 mtmt -47.52 144.2 3.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.163 0.506 . . . . 2.3500000000000001 111.773 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.4 -25.45 3.27 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.491 -0.777 . . . . 0.31 112.743 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 81.8 mm-40 -80.02 159.97 26.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.148 -0.686 . . . . 2.1099999999999999 109.148 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 21.6 m -84.54 129.31 34.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.078 -0.649 . . . . 0.33000000000000002 110.639 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.03 114.1 27.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.068 0.461 . . . . 0.26000000000000001 110.921 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CD1' HG21 ' A' ' 94' ' ' THR . 82.0 t80 -79.53 121.28 25.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.803 -0.635 . . . . 1.4299999999999999 112.569 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 105' ' ' ILE . 20.3 mt -110.05 105.27 57.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 N-CA-C 108.913 -0.773 . . . . 0.80000000000000004 108.913 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.772 ' O ' HD11 ' A' ' 133' ' ' ILE . 2.4 Cg_endo -81.06 128.68 6.56 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.51 2.14 . . . . 0.41999999999999998 114.219 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 131' ' ' LYS . 17.2 t -140.87 131.48 25.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.028 -0.987 . . . . 1.03 108.838 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.48 146.6 38.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.261 -0.427 . . . . 1.6599999999999999 110.744 -179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CG ' HG11 ' A' ' 122' ' ' VAL . 44.1 p90 -140.79 141.05 34.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 1.26 111.908 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.3 p -88.02 143.74 26.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 1.3300000000000001 110.759 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -94.18 113.32 25.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.692 -0.231 . . . . 2.1200000000000001 110.564 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.8 m -83.97 140.33 40.14 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 110.004 -0.369 . . . . 1.75 110.004 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.76 -34.24 27.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.731 1.621 . . . . 1.6100000000000001 110.559 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 21.2 pt-20 -79.49 -35.48 40.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.313 -0.858 . . . . 2.1800000000000002 111.383 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 78.7 m-20 -71.24 73.66 0.68 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.282 0.563 . . . . 2.4100000000000001 109.952 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -95.51 -1.21 51.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.301 -0.863 . . . . 1.6399999999999999 111.427 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -70.05 161.42 53.11 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.485 -0.864 . . . . 0.55000000000000004 112.259 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.55 144.42 41.71 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.144 1.896 . . . . 0.84999999999999998 111.488 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.579 HD23 ' HD3' ' A' ' 124' ' ' LYS . 6.8 mt -77.82 129.96 36.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.907 0.384 . . . . 1.8999999999999999 111.277 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 70.8 m-20 -136.85 153.96 50.64 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.734 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.617 HG13 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -143.34 140.36 26.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.405 -0.816 . . . . 0.75 110.067 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.898 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.5 tt0 -137.35 115.58 11.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.021 0.439 . . . . 1.6699999999999999 111.79 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.671 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.2 m95 -98.43 119.5 37.23 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.965 -0.561 . . . . 0.22 110.826 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.1 mt -106.86 120.64 42.57 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.406 -0.59 . . . . 0.40999999999999998 109.406 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 8.6 tt -108.83 125.84 65.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.305 0.483 . . . . 0.78000000000000003 112.305 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 m -112.97 103.26 55.63 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.83 -0.804 . . . . 1.25 108.83 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.8 Cg_exo -78.62 116.75 3.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.83 2.353 . . . . 0.53000000000000003 112.536 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.49 92.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.40999999999999998 111.23 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.91 -40.01 61.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.753 -0.658 . . . . 1.8200000000000001 111.566 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -82.83 158.48 22.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.31 0.576 . . . . 1.9399999999999999 111.671 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -69.12 -18.02 63.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.294 -0.867 . . . . 1.6599999999999999 111.872 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.661 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 70.7 mttt -69.46 152.43 44.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.939 -0.573 . . . . 1.74 111.853 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.51 127.89 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-O 121.781 0.801 . . . . 0.96999999999999997 109.229 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.74 40.01 26.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.288 -1.324 . . . . 1.77 111.431 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.59 143.9 26.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.442 -0.345 . . . . 1.96 111.089 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 73' ' ' LEU . 46.5 t -66.79 138.87 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.841 -0.8 . . . . 0.77000000000000002 108.841 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -134.27 -54.66 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.741 0.645 . . . . 1.1499999999999999 112.741 -177.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.827 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.92 130.73 49.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.283 -0.636 . . . . 0.28999999999999998 109.283 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.898 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 2.9 mp -139.77 163.81 31.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.3 111.48 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.89 ' HD1' HD13 ' A' ' 79' ' ' ILE . 34.5 t80 -139.36 103.02 4.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.461 -0.79 . . . . 1.3 109.413 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -144.42 159.82 42.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.072 -0.513 . . . . 0.89000000000000001 111.954 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.49 28.43 6.61 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 121.047 -0.597 . . . . 0.56999999999999995 112.851 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 73.91 1.32 3.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.557 0.206 . . . . 1.46 111.557 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 27.3 mttt -99.87 119.46 38.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 110.004 -0.369 . . . . 2.4100000000000001 110.004 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.89 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -81.23 130.21 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.004 -1.48 . . . . 1.6599999999999999 107.004 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.663 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.8 m-85 -115.39 117.83 31.52 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.552 -0.749 . . . . 1.25 110.538 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.881 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -166.28 -48.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 1.2 107.345 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD1' ' HA2' ' A' ' 89' ' ' GLY . 10.3 m-20 -77.38 -33.57 55.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 114.72 -1.127 . . . . 2.1699999999999999 109.024 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -76.61 -28.77 56.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.739 -1.118 . . . . 5.0499999999999998 108.762 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.536 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.5 m-85 -81.93 117.65 69.13 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 114.946 -1.024 . . . . 1.29 110.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.11 -40.33 59.94 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.64 1.56 . . . . 0.79000000000000004 110.267 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.72 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.7 m-20 -67.82 106.45 2.28 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.078 -0.649 . . . . 1.3600000000000001 110.22 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.8 mp 67.7 29.0 7.11 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.307 0.855 . . . . 1.6200000000000001 113.307 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.881 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 41.7 pttt -58.03 131.33 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.903 -0.498 . . . . 2.3900000000000001 111.409 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 82' ' ' ASP . . . 80.61 19.41 68.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.642 -0.789 . . . . 0.37 114.142 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 8.3 ptp180 -145.78 -47.4 0.21 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 114.295 1.22 . . . . 1.5900000000000001 114.295 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 71' ' ' ILE . 7.2 p -79.53 82.09 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 122.914 1.34 . . . . 0.20000000000000001 107.624 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.547 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.4 m80 -103.4 131.38 50.54 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 112.287 -2.233 . . . . 0.28999999999999998 112.25 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.13 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.7 m-85 -73.45 124.51 25.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.251 -0.58 . . . . 1.23 110.393 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 38' ' ' TYR . 17.3 p -75.72 34.17 0.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.568 -0.742 . . . . 0.46000000000000002 111.428 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.7 m -149.03 122.57 9.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.052 0.453 . . . . 1.2 110.87 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -91.48 11.61 23.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 2.2200000000000002 110.207 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -145.56 65.16 1.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.557 -0.905 . . . . 2.1400000000000001 108.557 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -55.66 -28.03 53.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.835 -1.075 . . . . 1.49 111.249 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.555 ' HA ' HD13 ' A' ' 53' ' ' LEU . 96.2 mttt -66.21 0.48 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.099 0.476 . . . . 2.04 112.067 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.5 p -89.98 -0.02 57.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.621 -0.718 . . . . 1.3999999999999999 111.255 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 98.36 -4.55 60.29 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.673 -0.775 . . . . 0.38 113.641 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -105.42 108.81 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.146 0.473 . . . . 1.4399999999999999 110.532 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -108.22 19.44 19.9 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 112.101 0.408 . . . . 0.42999999999999999 112.101 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 9.3 m -60.36 140.84 56.95 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.02 1.489 . . . . 1.04 115.02 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.13 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -130.51 130.44 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 114.831 -1.077 . . . . 0.31 110.849 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.698 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.1 OUTLIER -105.65 147.71 28.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.892 -0.781 . . . . 1.1499999999999999 108.892 177.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.68 120.02 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.27000000000000002 111.26 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.746 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.18 144.89 29.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.285 -0.87 . . . . 0.28999999999999998 110.787 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m120 53.21 60.18 3.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.059 -0.519 . . . . 1.52 112.176 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.4 mt -45.28 176.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.255 0.55 . . . . 1.02 112.452 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -177.86 164.16 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.504 -0.771 . . . . 2.1299999999999999 110.073 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.757 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 88.0 mt -60.08 -36.22 76.9 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.749 0.278 . . . . 1.7 111.749 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.5 p -73.68 -10.03 59.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.602 0.239 . . . . 1.3200000000000001 111.389 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD2' HG11 ' A' ' 107' ' ' VAL . 11.0 t70 -72.92 -23.73 60.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.593 -0.521 . . . . 1.5800000000000001 109.593 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -47.07 142.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 CA-C-N 115.748 -0.66 . . . . 0.41999999999999998 111.221 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.55 148.38 5.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.755 -1.212 . . . . 0.23999999999999999 114.181 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.759 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.7 m -59.12 130.01 44.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.025 -0.588 . . . . 0.31 111.772 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.676 ' OH ' HD21 ' A' ' 87' ' ' LEU . 45.3 m-85 -112.02 122.58 48.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.268 -0.424 . . . . 1.24 110.017 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.0 tt0 -119.96 118.41 30.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.621 -0.263 . . . . 1.1599999999999999 110.71 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 29.7 p -101.52 119.65 39.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 1.03 110.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 83.3 mttt -110.65 110.19 20.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 1.76 110.2 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG13 ' A' ' 55' ' ' ILE . 59.8 t -89.99 106.05 16.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.1799999999999999 109.646 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 7.4 ttpm? -91.15 117.35 29.55 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.365 0.506 . . . . 1.6200000000000001 112.365 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.579 ' HD3' HD23 ' A' ' 53' ' ' LEU . 7.1 ttpm? -145.3 101.92 3.66 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.502 -0.555 . . . . 2.8399999999999999 109.502 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -51.7 129.8 36.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 113.534 0.938 . . . . 0.44 113.534 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 64.3 Cg_endo -101.95 48.84 1.89 Allowed 'Cis proline' 0 C--N 1.355 0.869 0 C-N-CA 125.026 -0.823 . . . . 0.56000000000000005 111.988 -0.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -142.01 103.7 0.34 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.577 -0.82 . . . . 0.47999999999999998 113.634 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -96.88 132.04 42.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.045 -1.078 . . . . 1.22 109.888 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.523 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.82 147.01 32.37 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.282 0.475 . . . . 0.56999999999999995 112.282 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.616 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 52.8 p-10 -147.51 161.7 40.55 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.866 0.691 . . . . 2.0299999999999998 112.866 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.88 ' HE3' ' HA ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -145.27 160.65 41.17 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 2.9500000000000002 109.929 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -97.19 145.02 26.45 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.731 1.382 . . . . 2.2599999999999998 114.731 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.772 HD11 ' O ' ' A' ' 40' ' ' PRO . 93.1 mt -143.59 115.11 2.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 114.55 -1.204 . . . . 0.28000000000000003 108.624 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.759 ' CD2' HG23 ' A' ' 117' ' ' THR . 52.7 m170 -100.02 120.05 39.22 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.033 -0.417 . . . . 0.55000000000000004 111.124 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.807 HD21 ' HB1' ' A' ' 37' ' ' ALA . 1.1 tm? -89.48 128.33 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 1.52 111.846 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 135' ' ' LEU . 62.4 t -116.93 130.0 72.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.32000000000000001 109.818 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.565 HG12 ' HG3' ' A' ' 33' ' ' LYS . 16.4 t -95.26 121.22 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.156 0.428 . . . . 1.0800000000000001 112.156 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.802 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 64.3 mt -88.57 167.17 13.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.052 -0.522 . . . . 0.52000000000000002 109.811 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.64 140.12 18.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.405 0.622 . . . . 1.48 111.784 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.978 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -164.3 175.34 2.7 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.09 -0.959 . . . . 2.2000000000000002 110.455 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 140' ' ' LYS . 9.5 Cg_endo -50.68 -142.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.164 2.576 . . . . 1.3100000000000001 113.127 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 141' ' ' PRO . 55.1 m -31.77 -38.95 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.413 0.523 . . . . 2.3100000000000001 112.413 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.679 ' HA2' ' HB3' ' A' ' 33' ' ' LYS . . . 102.53 22.68 9.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.453 -0.88 . . . . 2.52 113.513 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 2.6000000000000001 111.144 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.52 -0.232 . . . . 3.2799999999999998 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.5 t -78.61 140.0 38.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 2.4300000000000002 110.89 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -76.33 150.06 36.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 1.8400000000000001 111.159 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -140.96 136.0 33.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.744 -0.662 . . . . 2.1499999999999999 110.304 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -94.94 146.9 23.92 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.57 0.7 . . . . 1.1200000000000001 111.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.92 83.07 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 114.755 -1.112 . . . . 0.65000000000000002 111.352 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.04 -85.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.701 2.934 . . . . 0.88 112.676 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 99.2 mt-10 -78.41 120.26 22.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.023 -0.732 . . . . 2.0600000000000001 109.023 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.485 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.2 tt0 -144.36 160.5 40.93 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.376 1.25 . . . . 1.71 114.376 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.701 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 93.9 mtp -133.49 129.84 37.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.939 -1.028 . . . . 1.8600000000000001 109.74 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.485 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.9 mm -122.07 130.69 74.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.626 -0.261 . . . . 0.39000000000000001 111.416 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.714 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 72.7 mt-10 -124.39 129.42 50.65 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.542 -0.299 . . . . 1.1899999999999999 110.802 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 36' ' ' THR . 54.4 tptt -141.79 160.04 40.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.767 0.317 . . . . 2.52 111.307 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.15 138.26 40.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.032 0.444 . . . . 0.39000000000000001 111.74 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 46.3 tttp -47.59 136.47 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.777 -0.647 . . . . 2.3500000000000001 112.455 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.79 -21.89 10.35 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.647 -0.706 . . . . 0.31 113.515 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.737 ' O ' HD13 ' A' ' 110' ' ' LEU . 79.5 mm-40 -77.69 -147.57 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.795 -1.187 . . . . 2.1099999999999999 107.795 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 107' ' ' VAL . 81.6 m -139.07 133.68 31.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.01 0.433 . . . . 0.33000000000000002 110.441 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.556 ' H ' HD11 ' A' ' 110' ' ' LEU . . . -99.83 117.56 34.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.776 -0.647 . . . . 0.26000000000000001 110.73 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.666 ' CD2' HG21 ' A' ' 94' ' ' THR . 64.7 t80 -79.25 120.29 23.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.722 -0.672 . . . . 1.4299999999999999 112.195 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.643 ' HB2' HD12 ' A' ' 105' ' ' ILE . 21.1 mt -105.42 106.2 55.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.748 -0.834 . . . . 0.80000000000000004 108.748 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.0 Cg_exo -79.54 123.54 5.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.669 2.246 . . . . 0.41999999999999998 113.832 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 49.6 t -141.83 123.96 15.48 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.504 -0.771 . . . . 1.03 109.579 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 87.6 mttt -141.56 149.1 40.35 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.463 -0.79 . . . . 1.6599999999999999 110.144 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.784 ' CG ' HG11 ' A' ' 122' ' ' VAL . 34.4 p90 -140.06 140.04 36.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.624 0.601 . . . . 1.26 112.624 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.29 140.05 29.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.254 -0.885 . . . . 1.3300000000000001 110.195 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.475 HD21 HD21 ' A' ' 53' ' ' LEU . 9.6 mp -95.99 117.41 30.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 2.1200000000000001 111.174 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.24 150.37 70.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.822 -0.436 . . . . 1.75 109.822 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -46.65 -41.88 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.126 1.884 . . . . 1.6100000000000001 111.06 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -74.7 -36.96 62.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.517 -0.765 . . . . 2.1800000000000002 110.473 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.646 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 33.6 t0 -70.21 72.51 0.45 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.4100000000000001 110.47 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -99.75 0.03 40.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 1.6399999999999999 111.061 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.03 159.96 53.34 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.94 -0.648 . . . . 0.55000000000000004 112.912 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.42 139.26 55.87 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.777 2.318 . . . . 0.84999999999999998 111.97 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 43' ' ' PHE . 86.9 mt -78.22 130.1 35.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.484 . . . . 1.8999999999999999 111.394 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 78.5 m-20 -134.88 159.98 39.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.613 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.667 HD13 ' HB1' ' A' ' 103' ' ' ALA . 27.4 mt -141.99 140.09 30.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.417 -0.81 . . . . 0.75 110.412 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 1.026 ' HA ' HD22 ' A' ' 73' ' ' LEU . 48.7 mt-10 -139.98 107.46 5.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.779 -0.368 . . . . 1.6699999999999999 111.394 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 81.4 m95 -95.12 126.09 40.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.22 111.521 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.581 HD21 HG22 ' A' ' 70' ' ' VAL . 89.8 mt -118.12 140.19 50.15 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.149 -0.686 . . . . 0.40999999999999998 109.149 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.876 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 2.4 tt -130.0 135.57 60.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.78000000000000003 112.335 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 65.1 m -114.11 104.05 54.95 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.168 -0.924 . . . . 1.25 108.998 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.9 Cg_exo -78.47 120.43 4.83 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.499 2.133 . . . . 0.53000000000000003 111.907 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.01 83.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.62 -0.718 . . . . 0.40999999999999998 111.215 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -75.28 -39.96 59.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 1.8200000000000001 111.459 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 39.5 m-20 -85.41 158.02 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.608 . . . . 1.9399999999999999 112.186 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.82 -14.59 62.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.103 -0.953 . . . . 1.6599999999999999 111.265 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 32.8 mttt -66.23 149.21 50.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.441 -0.799 . . . . 1.74 112.303 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -153.63 127.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 121.796 0.808 . . . . 0.96999999999999997 109.151 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 55.84 41.5 30.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.28 -1.327 . . . . 1.77 112.186 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -88.12 139.96 29.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 1.96 111.404 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.673 HG13 HD21 ' A' ' 73' ' ' LEU . 65.3 t -69.98 133.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.224 -0.444 . . . . 0.77000000000000002 110.372 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 86' ' ' ASP . 1.3 pp -134.75 -39.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.815 0.672 . . . . 1.1499999999999999 112.815 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 128.17 24.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.378 -0.601 . . . . 0.28999999999999998 109.378 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.026 HD22 ' HA ' ' A' ' 56' ' ' GLU . 6.9 mt -137.98 162.29 34.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 1.3 111.277 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.704 ' CD1' HD13 ' A' ' 79' ' ' ILE . 35.4 t80 -133.48 102.68 5.61 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.298 -1.371 . . . . 1.3 107.298 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 5.9 t -143.96 157.53 44.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.638 -0.71 . . . . 0.89000000000000001 111.731 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 45.99 29.79 3.49 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.256 -0.497 . . . . 0.56999999999999995 113.405 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.3 t0 73.83 1.0 3.8 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.739 0.274 . . . . 1.46 111.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -100.08 118.58 36.74 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 110.003 -0.369 . . . . 2.4100000000000001 110.003 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.2 mm -80.02 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 107.214 -1.402 . . . . 1.6599999999999999 107.214 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.771 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.7 m-85 -120.81 123.83 43.58 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.48 -0.782 . . . . 1.25 110.982 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.851 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.2 p-10 -165.96 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.818 -1.549 . . . . 1.2 106.818 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -79.8 -31.88 40.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.406 -1.27 . . . . 2.1699999999999999 109.519 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -72.95 -29.65 63.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.501 -1.296 . . . . 5.0499999999999998 107.501 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.604 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -82.12 118.72 73.03 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 114.346 -1.297 . . . . 1.29 109.979 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 10.0 Cg_endo -50.78 -43.2 47.77 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.428 1.418 . . . . 0.79000000000000004 110.602 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.877 ' HB3' HG22 ' A' ' 71' ' ' ILE . 86.4 m-20 -68.42 106.28 2.47 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.047 -0.524 . . . . 1.3600000000000001 111.145 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.8 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.1 mp 72.33 24.53 3.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.391 0.886 . . . . 1.6200000000000001 113.391 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.851 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 14.2 pttm -59.17 134.74 57.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.909 -0.494 . . . . 2.3900000000000001 111.51 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.462 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 80.42 16.6 75.61 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.659 -0.781 . . . . 0.37 113.993 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -143.02 -51.02 0.35 Allowed 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 114.38 1.252 . . . . 1.5900000000000001 114.38 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.936 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.09 81.99 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 123.08 1.419 . . . . 0.20000000000000001 107.421 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.546 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.1 m80 -102.17 127.92 48.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.066 -2.333 . . . . 0.28999999999999998 112.62 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.129 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.7 m-85 -71.61 122.75 21.09 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 120.163 -0.615 . . . . 1.23 109.601 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.666 HG21 ' CD2' ' A' ' 38' ' ' TYR . 2.3 p -75.04 35.89 0.11 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.46000000000000002 111.214 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 48.1 m -149.09 125.78 11.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.953 0.406 . . . . 1.2 110.396 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.11 6.81 40.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.937 -0.574 . . . . 2.2200000000000002 110.383 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -145.92 65.12 1.22 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.583 -0.735 . . . . 2.1400000000000001 109.06 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.2 mp -59.06 -27.16 65.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.173 -0.921 . . . . 1.49 111.958 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -63.46 1.54 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 2.04 112.078 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 98' ' ' LEU . 18.4 t -90.02 0.03 57.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.586 -0.734 . . . . 1.3999999999999999 110.671 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.25 -8.46 48.8 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.964 -0.636 . . . . 0.38 113.001 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -94.77 114.13 25.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.125 0.488 . . . . 1.4399999999999999 110.594 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.667 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.55 13.32 24.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.661 -0.699 . . . . 0.42999999999999999 111.965 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 51.0 m -59.95 139.57 57.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 115.563 1.69 . . . . 1.04 115.563 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.129 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -136.41 129.7 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-N 114.343 -1.299 . . . . 0.31 110.294 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.583 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.4 p-10 -105.7 146.31 29.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.542 -0.91 . . . . 1.1499999999999999 108.542 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -95.37 122.8 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.118 0.485 . . . . 0.27000000000000002 110.746 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.707 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -91.08 145.16 24.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.638 -0.71 . . . . 0.28999999999999998 110.84 179.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 144' ' ' ALA . 80.8 m-20 66.7 57.06 0.69 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 1.52 111.466 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -53.95 165.8 0.43 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 1.02 112.095 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.653 ' O ' HG21 ' A' ' 137' ' ' VAL . 10.7 pt20 -177.14 167.87 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.664 -0.698 . . . . 2.1299999999999999 110.996 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.436 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 89.2 mt -59.99 -37.37 79.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.852 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.6 p -73.24 -17.11 61.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.528 -0.305 . . . . 1.3200000000000001 111.687 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 92.2 m-20 -71.25 -20.01 62.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.723 -0.391 . . . . 1.5800000000000001 109.974 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -46.51 144.08 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.044 0 CA-C-N 116.179 -0.464 . . . . 0.41999999999999998 111.055 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 143.89 4.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.904 -1.141 . . . . 0.23999999999999999 113.834 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 m -59.05 130.6 47.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.143 -0.529 . . . . 0.31 112.009 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.876 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 28.9 m-85 -110.3 137.08 48.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 1.24 109.798 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.8 tt0 -126.87 122.17 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.638 -0.255 . . . . 1.1599999999999999 110.579 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 42.6 t -99.88 119.76 38.71 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.575 0.226 . . . . 1.03 110.679 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 58.0 mttm -115.25 108.69 16.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 1.76 110.849 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.784 HG11 ' CG ' ' A' ' 43' ' ' PHE . 40.9 t -91.3 108.35 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.619 -0.511 . . . . 1.1799999999999999 109.619 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 72.8 tttt -93.71 112.32 24.17 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.659 0.614 . . . . 1.6200000000000001 112.659 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.588 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 12.3 pttm -145.74 103.24 3.76 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 109.831 -0.433 . . . . 2.8399999999999999 109.831 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . . . -48.59 129.73 13.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 113.158 0.799 . . . . 0.44 113.158 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.646 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 83.0 Cg_endo -102.67 39.93 4.0 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 C-N-CA 125.109 -0.788 . . . . 0.56000000000000005 111.423 -0.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 124' ' ' LYS . . . -131.66 102.87 0.52 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-O 122.365 0.98 . . . . 0.47999999999999998 113.478 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 123' ' ' LYS . 1.3 m -96.67 135.05 32.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 113.505 -1.347 . . . . 1.22 108.76 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -132.05 154.19 49.65 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.763 -0.375 . . . . 0.56999999999999995 111.837 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 49.1 p-10 -146.09 149.31 33.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 111.519 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.35 165.57 28.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.246 -0.434 . . . . 2.9500000000000002 111.396 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -104.82 140.05 38.69 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 113.028 0.751 . . . . 2.2599999999999998 113.028 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.7 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 78.5 mt -145.2 112.18 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.375 -0.972 . . . . 0.28000000000000003 108.375 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.701 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 26.8 m170 -94.69 121.1 35.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.592 -0.443 . . . . 0.55000000000000004 111.254 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.5 tp -89.07 120.0 30.08 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.127 0.489 . . . . 1.52 111.024 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 43.7 t -122.26 129.11 75.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.258 -0.883 . . . . 0.32000000000000001 109.089 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 111' ' ' GLN . 47.4 t -109.98 129.34 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.063 0.459 . . . . 1.0800000000000001 112.052 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.61 160.06 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.739 -0.664 . . . . 0.52000000000000002 109.504 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.1 t -76.61 134.99 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.372 0.606 . . . . 1.48 110.949 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.561 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -162.47 170.59 7.57 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.855 -1.066 . . . . 2.2000000000000002 109.792 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 4.3 Cg_endo -45.89 171.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.339 2.026 . . . . 1.3100000000000001 111.879 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 144' ' ' ALA . 6.4 p -35.54 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.907 0.336 . . . . 2.3100000000000001 111.907 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.72 -65.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.295 -0.411 . . . . 2.52 113.419 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.153 -0.927 . . . . 2.6000000000000001 111.426 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.487 -0.245 . . . . 3.2799999999999998 112.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.7 p -78.34 154.41 30.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 2.4300000000000002 111.08 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 153.51 22.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.671 -0.695 . . . . 1.8400000000000001 110.38 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.722 HG21 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 pt -112.11 141.43 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.318 -0.401 . . . . 2.1499999999999999 111.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -93.17 155.05 17.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.64 0.733 . . . . 1.1200000000000001 111.724 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 45.87 83.14 0.22 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 114.574 -1.193 . . . . 0.65000000000000002 111.981 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 56.9 Cg_endo -78.55 -82.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.745 2.964 . . . . 0.88 112.541 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.48 129.42 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.68 -0.859 . . . . 2.0600000000000001 108.68 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HB3' HG12 ' A' ' 133' ' ' ILE . 50.6 tp10 -143.76 159.62 42.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.812 1.042 . . . . 1.71 113.812 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 25.5 mtm -139.91 123.77 17.51 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.826 -1.079 . . . . 1.8600000000000001 109.376 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 133' ' ' ILE . 34.6 mm -120.02 130.04 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.39000000000000001 111.75 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.717 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.1 mt-10 -127.57 121.83 31.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.395 -0.366 . . . . 1.1899999999999999 110.413 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 48.0 mmtm -142.23 161.31 38.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.791 0.329 . . . . 2.52 111.44 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.4 136.55 39.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.39000000000000001 111.189 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.929 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 52.4 tttp -44.51 132.67 6.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 2.3500000000000001 111.329 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 90.12 -18.94 45.56 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.867 -0.606 . . . . 0.31 112.526 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.709 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.9 mt-10 -80.03 158.63 26.46 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.582 -0.896 . . . . 2.1099999999999999 108.582 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 35.0 m -89.08 125.42 35.01 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.747 -0.781 . . . . 0.33000000000000002 110.35 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.12 116.31 29.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.26000000000000001 110.264 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.18 114.97 18.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.795 -0.639 . . . . 1.4299999999999999 112.088 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 133' ' ' ILE . 31.6 mt -99.13 108.63 50.72 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.811 -0.811 . . . . 0.80000000000000004 108.811 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.62 122.78 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.555 2.17 . . . . 0.41999999999999998 113.907 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' HE3' ' A' ' 131' ' ' LYS . 4.3 t -141.0 125.19 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.062 -0.972 . . . . 1.03 109.016 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 83.2 mttt -141.08 148.4 40.09 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.25 0.548 . . . . 1.6599999999999999 111.706 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 53' ' ' LEU . 40.8 p90 -140.8 142.62 34.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 1.26 111.076 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 139.63 30.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.904 0.383 . . . . 1.3300000000000001 110.549 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.635 HD23 ' NZ ' ' A' ' 124' ' ' LYS . 32.4 mt -89.03 150.01 22.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 2.1200000000000001 111.756 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.9 m -150.33 139.88 13.47 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 109.698 -0.482 . . . . 1.75 109.698 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 5.7 Cg_endo -48.55 -25.4 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.544 2.163 . . . . 1.6100000000000001 112.144 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.667 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 17.5 pt-20 -78.49 -40.22 35.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.354 -0.384 . . . . 2.1800000000000002 111.473 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.528 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.1 m-20 -72.27 71.54 0.89 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.171 -0.612 . . . . 2.4100000000000001 109.68 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 47' ' ' PRO . 87.1 mt-30 -97.37 -4.92 37.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.712 -0.676 . . . . 1.6399999999999999 112.366 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.864 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.02 159.97 53.33 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.492 -0.861 . . . . 0.55000000000000004 112.805 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.43 123.77 12.81 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.363 2.042 . . . . 0.84999999999999998 111.693 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 43' ' ' PHE . 6.4 tt -78.17 110.2 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 1.8999999999999999 111.297 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 93.4 m-20 -127.83 103.78 7.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.391 0.615 . . . . 1.78 111.877 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 9.4 mt -91.68 113.31 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.974 -1.012 . . . . 0.75 110.04 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.866 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -107.39 120.55 42.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.249 0.833 . . . . 1.6699999999999999 113.249 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.918 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.3 m95 -97.0 119.99 36.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.84 -0.618 . . . . 0.22 109.924 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD21 ' OE2' ' A' ' 56' ' ' GLU . 92.0 mt -105.69 140.12 39.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.526 -0.546 . . . . 0.40999999999999998 109.526 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.1 tt -130.04 130.03 65.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.137 0.494 . . . . 0.78000000000000003 112.306 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 68' ' ' ASP . 26.4 t -119.31 101.89 48.83 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 108.67 -0.863 . . . . 1.25 108.67 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.0 Cg_exo -79.97 111.57 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.603 2.202 . . . . 0.53000000000000003 112.725 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.61 75.41 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.395 -0.82 . . . . 0.40999999999999998 110.864 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -85.6 17.88 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 1.8200000000000001 112.004 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 79.3 m-20 -149.64 163.07 38.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.328 0.585 . . . . 1.9399999999999999 111.677 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.96 -18.89 64.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.209 -0.905 . . . . 1.6599999999999999 111.868 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 78.9 mttt -69.31 150.38 47.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.114 -0.494 . . . . 1.74 111.46 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -156.7 135.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 CA-C-O 122.636 1.208 . . . . 0.96999999999999997 110.047 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 60' ' ' SER . 1.5 p-10 43.63 39.38 2.36 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 112.536 -2.12 . . . . 1.77 112.08 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 1.96 110.869 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 73' ' ' LEU . 20.0 t -66.27 139.28 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.331 -0.618 . . . . 0.77000000000000002 109.331 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.895 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.17 -53.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.422 0.527 . . . . 1.1499999999999999 112.422 -177.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.95 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -137.76 130.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.857 -0.794 . . . . 0.28999999999999998 108.857 178.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.866 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.0 159.99 40.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.045 0.45 . . . . 1.3 111.487 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.892 ' HD1' HD13 ' A' ' 79' ' ' ILE . 47.3 t80 -134.09 103.61 5.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.3 110.03 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 47.5 t -143.54 156.15 44.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.555 0.576 . . . . 0.89000000000000001 112.555 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 48.02 32.99 9.6 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.953 -0.567 . . . . 0.56999999999999995 113.074 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 t0 70.13 4.3 4.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.573 0.225 . . . . 1.46 111.248 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 88.3 mttt -100.01 114.01 27.01 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.809 -0.441 . . . . 2.4100000000000001 109.809 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.892 HD13 ' HD1' ' A' ' 74' ' ' TYR . 2.8 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.83 -1.544 . . . . 1.6599999999999999 106.83 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.2 m-85 -116.61 121.52 41.97 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.45 -0.795 . . . . 1.25 110.625 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.909 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.5 p-10 -165.7 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.747 -1.205 . . . . 1.2 107.747 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -78.9 -31.08 45.24 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.158 -0.928 . . . . 2.1699999999999999 109.376 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -75.78 -28.3 58.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.185 -1.043 . . . . 5.0499999999999998 108.185 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.609 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.1 m-85 -81.59 117.83 69.77 Favored Pre-proline 0 CA--C 1.515 -0.389 0 CA-C-N 114.777 -1.101 . . . . 1.29 110.554 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -49.46 -42.8 40.75 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.602 1.535 . . . . 0.79000000000000004 110.352 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' O ' HG12 ' A' ' 71' ' ' ILE . 11.6 m-20 -67.28 106.18 1.97 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.105 -0.638 . . . . 1.3600000000000001 110.695 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.838 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 68.08 26.96 7.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.575 0.954 . . . . 1.6200000000000001 113.575 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.909 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 2.7 pttt -57.14 128.03 34.92 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.73 -0.606 . . . . 2.3900000000000001 111.616 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.05 18.59 57.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.589 -0.815 . . . . 0.37 114.225 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.838 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.6 ptp180 -145.6 -46.27 0.21 Allowed 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 114.336 1.235 . . . . 1.5900000000000001 114.336 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.99 82.04 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 123.102 1.429 . . . . 0.20000000000000001 107.555 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.56 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.6 m80 -102.67 128.44 49.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.235 -2.257 . . . . 0.28999999999999998 112.331 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.094 ' CD1' HG23 ' A' ' 105' ' ' ILE . 70.2 m-85 -72.25 124.07 24.3 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.338 -0.545 . . . . 1.23 110.075 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.6 HG21 ' CD1' ' A' ' 38' ' ' TYR . 10.8 p -75.13 34.57 0.11 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.4 -0.818 . . . . 0.46000000000000002 111.116 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' PHE . 6.9 m -149.07 123.51 9.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.017 0.437 . . . . 1.2 110.856 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -90.95 10.89 24.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.784 -0.643 . . . . 2.2200000000000002 110.05 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -145.52 65.79 1.23 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.1400000000000001 108.416 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -56.24 -31.75 63.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 1.49 111.606 -178.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' HD11 ' A' ' 45' ' ' LEU . 71.9 mttt -66.23 1.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.04 111.979 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -89.45 -0.01 57.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.862 -0.608 . . . . 1.3999999999999999 111.023 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 100.85 -5.68 56.65 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.783 -0.722 . . . . 0.38 113.355 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 98' ' ' LEU . 95.9 m-20 -101.9 107.18 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.067 0.434 . . . . 1.4399999999999999 110.427 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -104.63 11.68 33.86 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.8 0.667 . . . . 0.42999999999999999 112.8 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.622 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 89.8 p -60.03 140.02 57.08 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 115.685 1.735 . . . . 1.04 115.685 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.094 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -131.23 130.02 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-N 114.197 -1.365 . . . . 0.31 110.507 178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.703 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.4 p-10 -104.62 146.23 29.21 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.918 -0.771 . . . . 1.1499999999999999 108.918 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.14 120.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.021 0.439 . . . . 0.27000000000000002 111.543 -178.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.754 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.7 p -82.26 142.77 31.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.39 -0.823 . . . . 0.28999999999999998 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.431 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 27.9 m120 49.98 55.51 9.32 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.062 -0.517 . . . . 1.52 111.605 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 24.2 mt -44.55 89.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.566 1.321 . . . . 1.02 114.566 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.486 ' HG2' ' H ' ' A' ' 113' ' ' SER . 64.1 tt0 -60.09 145.38 46.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.708 -0.678 . . . . 2.1299999999999999 109.896 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.555 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.4 mt -59.98 -40.04 87.74 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.188 0.518 . . . . 1.7 111.223 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 53.1 m -72.24 -9.98 59.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.505 -0.771 . . . . 1.3200000000000001 111.642 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.1 m-20 -69.99 -19.95 63.32 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.149 -0.315 . . . . 1.5800000000000001 110.149 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.561 HG13 HG23 ' A' ' 137' ' ' VAL . 2.1 mt -43.33 145.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.41999999999999998 110.353 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.86 155.08 6.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 0.23999999999999999 112.808 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.557 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.19 138.38 57.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.198 0.444 . . . . 0.31 112.198 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.601 ' OH ' HD11 ' A' ' 87' ' ' LEU . 21.6 m-85 -119.3 135.1 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.58 . . . . 1.24 109.886 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 53.4 tt0 -127.61 119.94 27.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.184 -0.302 . . . . 1.1599999999999999 110.184 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 39.1 t -99.98 118.98 37.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.284 -0.416 . . . . 1.03 110.065 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 82.2 mttt -116.62 104.75 11.71 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 120.982 -0.287 . . . . 1.76 111.418 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 55' ' ' ILE . 22.1 t -87.71 108.66 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.092 -0.707 . . . . 1.1799999999999999 109.092 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.592 ' HG3' HG12 ' A' ' 128' ' ' VAL . 39.3 ttpt -99.93 113.09 25.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.174 0.805 . . . . 1.6200000000000001 113.174 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.635 ' NZ ' HD23 ' A' ' 45' ' ' LEU . 6.7 ttpt -145.51 101.9 3.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.477 -0.564 . . . . 2.8399999999999999 109.477 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.864 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.22 133.13 41.92 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.683 -0.69 . . . . 0.44 112.714 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 40.0 Cg_endo -97.84 39.82 4.79 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 124.275 -1.135 . . . . 0.56000000000000005 112.966 -0.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.31 101.96 0.45 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.922 -1.133 . . . . 0.47999999999999998 113.496 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 123' ' ' LYS . 2.7 m -96.82 140.02 18.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.576 -1.312 . . . . 1.22 109.301 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.07 152.0 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.41 0.522 . . . . 0.56999999999999995 112.41 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.552 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 35.8 p-10 -146.59 151.7 37.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.248 0.462 . . . . 2.0299999999999998 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.722 ' NZ ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.08 160.0 42.08 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.904 -0.589 . . . . 2.9500000000000002 110.779 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.7 mttt -102.34 141.13 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.633 0.975 . . . . 2.2599999999999998 113.633 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.797 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 97.7 mt -141.75 116.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.28000000000000003 108.605 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 117' ' ' THR . 46.3 m170 -100.32 117.91 35.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.463 -0.495 . . . . 0.55000000000000004 110.752 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 63.5 tp -89.38 122.89 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.227 0.537 . . . . 1.52 112.411 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.717 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 47.7 t -120.02 126.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.423 -0.954 . . . . 0.32000000000000001 108.423 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 115' ' ' ILE . 46.2 t -109.95 125.66 67.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 112.223 0.453 . . . . 1.0800000000000001 112.223 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.5 mt -83.4 163.95 20.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.52000000000000002 109.614 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -75.0 139.67 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-O 121.854 0.835 . . . . 1.48 112.124 -178.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 10.1 mmtp -159.83 175.65 3.06 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 113.875 -1.512 . . . . 2.2000000000000002 109.863 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 45.2 Cg_exo -57.62 -147.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.644 2.229 . . . . 1.3100000000000001 113.061 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.574 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 50.4 m -41.61 -40.01 1.79 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.006 0.373 . . . . 2.3100000000000001 112.006 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 64.55 -65.12 0.06 OUTLIER Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.193 -0.527 . . . . 2.52 113.621 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.248 -0.882 . . . . 2.6000000000000001 111.117 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.564 -0.214 . . . . 3.2799999999999998 112.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.5 p -78.16 155.51 30.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 2.4300000000000002 110.904 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.1 t -79.68 157.12 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 1.8400000000000001 111.058 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 129' ' ' ALA . 70.8 mt -143.38 129.1 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 110.77 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 69.2 p -94.29 153.63 17.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.399 0.618 . . . . 1.1200000000000001 111.125 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 41.37 82.27 0.23 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 114.782 -1.099 . . . . 0.65000000000000002 112.347 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 59.9 Cg_endo -79.02 -84.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.83 3.02 . . . . 0.88 112.269 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.0 mt-10 -78.12 129.12 34.8 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.063 -1.088 . . . . 2.0600000000000001 108.063 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HB3' HG13 ' A' ' 133' ' ' ILE . 50.6 tp10 -144.09 159.21 43.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.414 1.265 . . . . 1.71 114.414 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.6 mtp -140.01 121.7 15.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.303 -1.317 . . . . 1.8600000000000001 108.913 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 HG12 HG23 ' A' ' 133' ' ' ILE . 37.3 mm -119.77 129.98 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.611 -0.268 . . . . 0.39000000000000001 111.252 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 13.8 pt-20 -129.82 126.76 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.355 . . . . 1.1899999999999999 110.891 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -142.13 162.05 36.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 2.52 110.858 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.54 139.08 40.59 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.197 0.444 . . . . 0.39000000000000001 112.197 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.667 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 87.2 mttt -43.85 141.53 1.57 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.208 -0.451 . . . . 2.3500000000000001 112.031 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' N ' ' OXT' ' A' ' 144' ' ' ALA . . . 82.43 -24.99 4.58 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.749 -0.659 . . . . 0.31 113.003 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -80.07 160.58 25.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.214 -0.661 . . . . 2.1099999999999999 109.214 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.836 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 27.4 m -83.79 133.29 34.77 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.957 -0.697 . . . . 0.33000000000000002 110.449 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -95.45 118.43 32.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.989 0.423 . . . . 0.26000000000000001 110.773 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.991 ' HE1' HG21 ' A' ' 94' ' ' THR . 65.9 t80 -79.33 131.12 36.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.715 -0.675 . . . . 1.4299999999999999 112.66 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.816 HD12 HD12 ' A' ' 105' ' ' ILE . 15.7 mt -128.32 104.32 19.95 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 108.991 -0.744 . . . . 0.80000000000000004 108.991 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 95.8 Cg_endo -86.06 126.98 2.92 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.657 2.238 . . . . 0.41999999999999998 114.762 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.434 ' SG ' ' CE ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -141.93 126.1 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.288 -0.869 . . . . 1.03 109.588 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 27.8 mttp -141.04 117.0 10.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.399 0.619 . . . . 1.6599999999999999 110.983 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.791 ' CG ' HG11 ' A' ' 122' ' ' VAL . 29.0 p90 -92.84 139.84 30.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.935 -1.03 . . . . 1.26 111.031 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 143.3 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.415 . . . . 1.3300000000000001 110.91 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 99.2 mt -100.38 139.76 35.6 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 2.1200000000000001 111.525 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.423 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . 5.3 m -158.93 147.13 13.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.583 . . . . 1.75 109.899 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.28 -23.73 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.44 2.094 . . . . 1.6100000000000001 113.082 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -74.47 -43.24 56.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 120.563 0.221 . . . . 2.1800000000000002 111.014 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 124' ' ' LYS . 1.2 p-10 -73.65 74.51 1.52 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.124 -0.63 . . . . 2.4100000000000001 109.503 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -90.64 -12.73 35.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 1.6399999999999999 112.106 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.66 159.95 53.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.292 -0.956 . . . . 0.55000000000000004 112.912 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 140.93 97.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.487 2.125 . . . . 0.84999999999999998 111.385 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -78.09 104.09 8.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.793 0.33 . . . . 1.8999999999999999 111.287 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 96.0 m-20 -114.92 103.29 10.78 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.64 0.734 . . . . 1.78 110.996 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.3 mt -95.07 126.53 47.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.046 -0.979 . . . . 0.75 110.709 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 73' ' ' LEU . 96.5 mt-10 -120.54 117.57 27.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.486 0.55 . . . . 1.6699999999999999 112.486 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.799 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -96.44 120.04 36.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.072 -0.344 . . . . 0.22 110.072 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.808 HD12 ' OE1' ' A' ' 119' ' ' GLN . 83.1 mt -108.76 140.25 42.45 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.36 -0.608 . . . . 0.40999999999999998 109.36 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.651 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.4 tt -129.91 130.16 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.368 0.604 . . . . 0.78000000000000003 112.289 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 52.6 m -119.99 103.35 45.49 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.01 -0.995 . . . . 1.25 109.142 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 86.2 Cg_endo -78.31 119.11 4.47 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.655 2.237 . . . . 0.53000000000000003 112.367 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.05 87.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.72 -0.673 . . . . 0.40999999999999998 111.55 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD2' ' CD1' ' A' ' 112' ' ' LEU . 81.2 m-20 -76.56 -39.98 51.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.021 -0.536 . . . . 1.8200000000000001 112.138 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -84.43 160.01 20.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.348 0.594 . . . . 1.9399999999999999 112.214 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -69.84 -17.6 63.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.182 -0.917 . . . . 1.6599999999999999 111.798 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 61.7 mttp -65.9 147.14 53.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.849 -0.614 . . . . 1.74 111.02 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.83 127.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.15 0 CA-C-O 121.883 0.849 . . . . 0.96999999999999997 110.187 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 40.02 26.12 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.98 -1.464 . . . . 1.77 112.694 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.4 mt-30 -94.3 143.22 26.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.104 -0.238 . . . . 1.96 111.444 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.584 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.1 t -66.46 132.1 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 108.855 -0.795 . . . . 0.77000000000000002 108.855 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.939 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -123.48 -51.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.352 0.871 . . . . 1.1499999999999999 113.352 -176.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.032 HG21 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.81 105.3 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.699 0.761 . . . . 0.28999999999999998 108.949 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -109.72 155.09 21.99 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.136 -0.938 . . . . 1.3 111.078 -177.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.916 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 22.0 t80 -135.11 104.79 6.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.787 0.327 . . . . 1.3 110.439 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.439 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 45.2 m -142.57 158.41 43.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.132 0.419 . . . . 0.89000000000000001 112.132 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.66 30.23 42.62 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.078 -0.582 . . . . 0.56999999999999995 112.729 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t0 72.62 2.28 4.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.612 0.244 . . . . 1.46 110.903 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 88.0 mttt -99.99 114.8 28.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.634 -0.506 . . . . 2.4100000000000001 109.634 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.916 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.07 116.99 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 108.114 -1.069 . . . . 1.6599999999999999 108.114 178.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.715 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 m-85 -100.09 125.93 46.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.914 -1.494 . . . . 1.25 110.46 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.884 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.6 p-10 -164.43 -52.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -79.98 -21.43 43.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.214 -0.903 . . . . 2.1699999999999999 109.025 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -80.74 -27.42 36.86 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.15 -1.056 . . . . 5.0499999999999998 108.15 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.65 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.6 m-85 -86.24 116.67 66.71 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 114.812 -1.086 . . . . 1.29 110.648 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.1 Cg_endo -47.98 -40.99 33.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.439 1.426 . . . . 0.79000000000000004 110.234 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.738 ' O ' HG12 ' A' ' 71' ' ' ILE . 65.5 m-20 -66.97 105.71 1.71 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.237 -0.585 . . . . 1.3600000000000001 110.825 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.821 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 14.7 mt 66.88 24.82 9.63 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.608 0.966 . . . . 1.6200000000000001 113.608 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 65.3 pttt -57.25 132.93 54.48 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.988 -0.685 . . . . 2.3900000000000001 111.141 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.415 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 87.79 14.83 62.41 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.417 -0.897 . . . . 0.37 114.015 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.821 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -142.95 -50.85 0.35 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.826 1.417 . . . . 1.5900000000000001 114.826 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG21 HG21 ' A' ' 72' ' ' ILE . 7.2 p -79.18 81.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 123.319 1.533 . . . . 0.20000000000000001 107.363 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.613 ' C ' HG22 ' A' ' 105' ' ' ILE . 13.5 m80 -100.22 131.55 46.1 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 111.806 -2.452 . . . . 0.28999999999999998 111.756 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.081 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.1 m-85 -70.78 120.03 15.78 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-O 121.696 0.76 . . . . 1.23 110.719 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.991 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -70.01 -8.11 46.47 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.46000000000000002 110.608 179.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 67.9 m -87.09 116.23 25.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.316 -0.402 . . . . 1.2 111.13 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.81 0.07 57.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.225 0.536 . . . . 2.2200000000000002 109.965 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -146.2 65.6 1.2 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.596 -0.89 . . . . 2.1400000000000001 108.596 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.702 HD22 ' CE1' ' A' ' 74' ' ' TYR . 6.8 tt -58.15 -32.73 68.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.245 -0.889 . . . . 1.49 111.52 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.52 -8.65 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.293 0.568 . . . . 2.04 111.717 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.6 m -88.52 -0.04 56.81 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.187 -0.915 . . . . 1.3999999999999999 110.813 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 103.24 -12.32 55.2 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.734 . . . . 0.38 113.749 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 64.9 m-20 -95.06 109.96 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.159 0.48 . . . . 1.4399999999999999 110.432 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -117.79 24.75 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.653 0.612 . . . . 0.42999999999999999 112.653 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 10.0 m -61.42 154.6 23.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.27 1.211 . . . . 1.04 114.27 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.081 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -136.45 146.06 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.81 -1.086 . . . . 0.31 111.719 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.617 ' HB2' HG22 ' A' ' 36' ' ' THR . 22.6 p30 -121.73 142.55 50.07 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.877 -1.157 . . . . 1.1499999999999999 107.877 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.836 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -97.43 121.84 48.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.065 0.459 . . . . 0.27000000000000002 111.205 -178.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 145.75 28.71 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 111.911 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 55.11 60.92 3.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.877 0.695 . . . . 1.52 112.877 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.721 ' O ' ' HB1' ' A' ' 144' ' ' ALA . 10.2 mt -47.01 172.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.286 0.565 . . . . 1.02 112.397 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -176.6 160.01 1.94 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.997 -1.001 . . . . 2.1299999999999999 109.601 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.753 HD13 ' O ' ' A' ' 112' ' ' LEU . 1.2 tm? -59.06 -34.13 71.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.454 0.538 . . . . 1.7 112.454 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.38 -12.03 60.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.809 0.3 . . . . 1.3200000000000001 111.809 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 98.5 m-20 -72.34 -20.95 61.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.5800000000000001 109.896 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.3 143.25 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 116.089 -0.505 . . . . 0.41999999999999998 111.072 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 141.05 147.36 4.91 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.722 -1.227 . . . . 0.23999999999999999 113.922 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.583 HG23 ' CD2' ' A' ' 134' ' ' HIS . 96.2 m -59.34 130.03 44.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.059 -0.57 . . . . 0.31 111.83 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.651 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 30.5 m-85 -109.81 132.56 54.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.921 -0.581 . . . . 1.24 109.584 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.808 ' OE1' HD12 ' A' ' 58' ' ' LEU . 61.8 tt0 -120.86 110.28 16.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 1.1599999999999999 110.027 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CE3' ' A' ' 57' ' ' TRP . 1.5 t -100.18 119.68 38.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.87 -0.604 . . . . 1.03 110.066 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.808 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.9 mtpt -122.52 112.97 18.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 1.76 111.172 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 43' ' ' PHE . 20.6 t -93.83 113.15 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.274 -0.639 . . . . 1.1799999999999999 109.274 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.764 ' HG2' HG12 ' A' ' 128' ' ' VAL . 46.3 mttp -91.54 127.43 36.99 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.201 1.186 . . . . 1.6200000000000001 114.201 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.718 ' HB3' ' HB2' ' A' ' 49' ' ' ASP . 9.5 mtmp? -145.98 101.88 3.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 2.8399999999999999 109.326 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.75 132.29 47.21 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.26 0.467 . . . . 0.44 112.26 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 54.3 Cg_endo -101.44 49.53 1.79 Allowed 'Cis proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.892 -0.879 . . . . 0.56000000000000005 111.707 -0.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.83 103.84 0.29 Allowed Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.699 -0.762 . . . . 0.47999999999999998 112.926 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.764 HG12 ' HG2' ' A' ' 123' ' ' LYS . 26.9 m -83.38 127.89 39.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.742 -0.729 . . . . 1.22 110.217 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 22' ' ' ILE . . . -99.46 141.22 32.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.401 0.143 . . . . 0.56999999999999995 111.239 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.463 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 45.6 p-10 -145.76 136.47 24.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.068 0.461 . . . . 2.0299999999999998 111.985 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.639 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.33 157.16 44.1 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.724 -0.671 . . . . 2.9500000000000002 110.361 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 27' ' ' GLU . 96.8 mttt -104.57 140.08 38.52 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 113.329 0.863 . . . . 2.2599999999999998 113.329 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.624 HD13 ' CH2' ' A' ' 57' ' ' TRP . 3.2 mt -140.97 120.0 11.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.317 -0.856 . . . . 0.28000000000000003 109.339 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.583 ' CD2' HG23 ' A' ' 117' ' ' THR . 14.6 m170 -102.58 120.53 40.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.742 0.306 . . . . 0.55000000000000004 110.897 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.517 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.3 tm? -87.92 120.0 28.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.066 0.46 . . . . 1.52 111.124 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 59.1 t -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.373 -0.831 . . . . 0.32000000000000001 109.316 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 33' ' ' LYS . 18.0 t -100.7 134.08 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.444 0.535 . . . . 1.0800000000000001 112.444 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 58.7 mt -83.05 150.01 26.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.983 -0.747 . . . . 0.52000000000000002 108.983 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.36 136.49 25.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 122.063 0.935 . . . . 1.48 112.836 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.667 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -165.2 172.2 4.67 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 113.855 -1.52 . . . . 2.2000000000000002 108.669 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 2.3 Cg_endo -40.12 128.94 2.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.089 1.859 . . . . 1.3100000000000001 110.84 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.789 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.7 m -33.71 -81.76 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.326 0.491 . . . . 2.3100000000000001 112.326 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 26.06 -67.37 0.0 OUTLIER Glycine 0 N--CA 1.468 0.782 0 N-CA-C 114.687 0.635 . . . . 2.52 114.687 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.789 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.091 -0.957 . . . . 2.6000000000000001 109.396 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.473 -0.251 . . . . 3.2799999999999998 112.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' THR . 38.0 t -77.29 144.24 38.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.29 . . . . 2.4300000000000002 110.588 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.457 ' H ' ' HB ' ' A' ' 44' ' ' THR . 79.4 p -160.01 159.56 32.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.479 . . . . 1.8400000000000001 111.154 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.914 HG12 ' HB1' ' A' ' 129' ' ' ALA . 73.1 mt -100.14 117.68 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.382 -0.826 . . . . 2.1499999999999999 111.189 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' CE ' ' A' ' 131' ' ' LYS . 0.6 OUTLIER -92.25 131.41 37.48 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.373 0.606 . . . . 1.1200000000000001 110.02 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 82.0 0.25 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 122.124 0.964 . . . . 0.65000000000000002 110.292 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 54.6 Cg_endo -77.79 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.329 -0.488 0 C-N-CA 123.882 3.055 . . . . 0.88 112.966 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.5 mt-10 -78.48 125.31 29.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.661 -0.866 . . . . 2.0600000000000001 108.661 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.5 tt0 -143.96 160.02 41.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.855 1.057 . . . . 1.71 113.855 -176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 29' ' ' ILE . 49.0 ttp -136.74 135.57 38.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.805 -1.089 . . . . 1.8600000000000001 109.471 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.6 mm -130.03 136.42 58.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.969 -0.559 . . . . 0.39000000000000001 111.436 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 83.8 mt-10 -129.86 123.51 31.0 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.647 0.26 . . . . 1.1899999999999999 110.925 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HB2' HD11 ' A' ' 110' ' ' LEU . 26.4 mmtt -141.93 153.22 44.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.726 0.298 . . . . 2.52 111.429 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.0 142.35 39.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 0.39000000000000001 111.228 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 112' ' ' LEU . 94.8 mttt -41.28 159.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.373 0.606 . . . . 2.3500000000000001 112.178 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.63 -24.22 0.13 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.278 -0.874 . . . . 0.31 113.879 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 33' ' ' LYS . 98.9 mt-10 -80.06 160.03 25.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.416 -0.587 . . . . 2.1099999999999999 109.416 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 40.8 m -86.51 128.93 35.01 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.24 -0.584 . . . . 0.33000000000000002 110.831 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 118.28 36.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.189 0.519 . . . . 0.26000000000000001 110.254 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.4 t80 -79.19 122.92 26.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.726 -0.67 . . . . 1.4299999999999999 112.338 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.716 ' HB2' HD12 ' A' ' 105' ' ' ILE . 30.8 mt -110.03 104.67 56.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 108.39 -0.967 . . . . 0.80000000000000004 108.39 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' O ' HD11 ' A' ' 133' ' ' ILE . 86.9 Cg_endo -82.12 133.11 7.51 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.508 2.139 . . . . 0.41999999999999998 115.262 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.93 126.6 19.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.301 -1.318 . . . . 1.03 107.519 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.12 112.32 7.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.329 0.585 . . . . 1.6599999999999999 111.609 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.715 ' HB3' HG11 ' A' ' 122' ' ' VAL . 41.8 p90 -100.04 139.01 36.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.05 -0.977 . . . . 1.26 111.205 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 20' ' ' SER . 19.5 m -79.93 165.98 22.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.683 -0.488 . . . . 1.3300000000000001 109.683 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 43' ' ' PHE . 98.0 mt -132.27 148.12 52.43 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.446 0.641 . . . . 2.1200000000000001 112.417 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.5 t -160.16 147.92 12.91 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.965 -1.016 . . . . 1.75 109.542 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.57 -21.57 5.44 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.438 2.092 . . . . 1.6100000000000001 113.236 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.3 pt-20 -76.38 -41.16 48.95 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 121.177 -0.209 . . . . 2.1800000000000002 111.194 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -73.03 79.21 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.294 -0.632 . . . . 2.4100000000000001 109.294 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -100.01 4.99 45.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 112.076 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.904 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.77 168.87 52.84 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.379 -0.915 . . . . 0.55000000000000004 113.383 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.0 131.28 23.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.743 2.296 . . . . 0.84999999999999998 111.562 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 124' ' ' LYS . 7.0 tp -78.51 110.03 13.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 1.8999999999999999 111.856 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -126.94 103.5 7.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.415 0.626 . . . . 1.78 110.49 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.83 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.6 mp -96.4 120.06 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.06 -0.973 . . . . 0.75 111.065 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.913 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 97.6 mt-10 -109.75 119.97 41.01 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.187 0.44 . . . . 1.6699999999999999 112.187 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.996 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.6 m95 -95.36 119.98 34.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.856 -0.338 . . . . 0.22 110.155 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.98 138.95 40.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.138 -0.69 . . . . 0.40999999999999998 109.138 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -130.02 130.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.13 0.49 . . . . 0.78000000000000003 112.264 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.1 m -122.74 102.75 38.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 115.555 -0.748 . . . . 1.25 109.331 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.602 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 93.8 Cg_endo -79.04 116.0 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.519 2.146 . . . . 0.53000000000000003 111.902 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.98 87.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.657 -0.701 . . . . 0.40999999999999998 111.588 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.61 -40.01 57.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.191 -0.459 . . . . 1.8200000000000001 111.636 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.3 m120 -84.23 160.04 20.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.293 0.568 . . . . 1.9399999999999999 112.137 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -68.72 -18.66 64.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.32 -0.855 . . . . 1.6599999999999999 111.7 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.602 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 68.0 mttm -67.13 149.03 51.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.022 -0.535 . . . . 1.74 111.186 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -156.61 127.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-O 121.902 0.858 . . . . 0.96999999999999997 109.99 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 55.25 39.96 31.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.58 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -94.05 144.05 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.553 -0.166 . . . . 1.96 110.553 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' CG1' HD12 ' A' ' 73' ' ' LEU . 23.6 t -66.01 130.0 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 120.657 -0.417 . . . . 0.77000000000000002 109.895 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.922 ' CG1' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -117.15 -54.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.753 0.649 . . . . 1.1499999999999999 112.753 -177.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.861 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.29 131.26 48.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.444 -0.947 . . . . 0.28999999999999998 108.444 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.913 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -140.01 158.5 43.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.228 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 79' ' ' ILE . 38.1 t80 -135.58 103.31 5.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.076 -0.511 . . . . 1.3 109.823 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 21.3 t -144.58 160.04 41.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.765 -0.652 . . . . 0.89000000000000001 112.352 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.95 31.34 5.57 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 113.017 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 3.14 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.535 0.207 . . . . 1.46 111.478 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 30.6 mttt -99.95 115.66 30.2 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.429 -0.582 . . . . 2.4100000000000001 109.429 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.927 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.1 mm -79.53 130.02 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 107.219 -1.4 . . . . 1.6599999999999999 107.219 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.722 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 2.8 m-85 -114.92 117.77 31.6 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.397 -0.82 . . . . 1.25 110.065 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.873 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 9.7 p-10 -165.94 -49.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.127 -1.434 . . . . 1.2 107.127 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' OD1' ' CE1' ' A' ' 83' ' ' TYR . 12.1 p-10 -80.13 -26.98 39.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 114.575 -1.193 . . . . 2.1699999999999999 108.749 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 36.3 m-85 -80.84 -29.54 35.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.021 -1.103 . . . . 5.0499999999999998 108.021 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.8 m-85 -82.33 110.32 20.74 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-N 115.014 -0.994 . . . . 1.29 109.794 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 25.9 Cg_exo -63.1 -28.56 74.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.086 1.857 . . . . 0.79000000000000004 113.119 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.972 ' O ' HD12 ' A' ' 87' ' ' LEU . 20.1 m-20 -48.71 -33.32 9.93 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.213 -0.595 . . . . 1.3600000000000001 112.045 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.3 mp -153.06 32.44 0.48 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.03 -0.986 . . . . 1.6200000000000001 110.186 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.873 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 56.1 pttt -53.38 127.63 25.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.475 0.546 . . . . 2.3900000000000001 112.475 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.52 15.91 57.73 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.487 -0.779 . . . . 0.37 114.639 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.4 ptp180 -145.87 -45.31 0.21 Allowed 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 114.594 1.331 . . . . 1.5900000000000001 114.594 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.861 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.7 p -79.91 81.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-O 122.868 1.318 . . . . 0.20000000000000001 107.782 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.537 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.0 m80 -102.62 128.88 49.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.654 -2.067 . . . . 0.28999999999999998 112.684 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.139 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.8 m-85 -70.7 122.77 20.43 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 121.227 0.537 . . . . 1.23 110.016 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 38' ' ' TYR . 30.3 p -77.58 34.84 0.18 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.518 -0.765 . . . . 0.46000000000000002 111.395 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 m -149.05 125.14 10.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.939 0.4 . . . . 1.2 110.275 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -90.0 8.47 32.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.94 -0.573 . . . . 2.2200000000000002 110.303 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.2 66.53 1.19 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.668 -0.864 . . . . 2.1400000000000001 108.668 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.62 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.9 mp -58.45 -33.11 69.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.107 -0.951 . . . . 1.49 111.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.27 0.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.051 0.453 . . . . 2.04 112.166 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 98' ' ' LEU . 52.6 m -89.95 0.02 57.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.625 -0.716 . . . . 1.3999999999999999 111.18 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.578 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 107.88 -14.59 37.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.69 -0.767 . . . . 0.38 113.295 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.955 0.377 . . . . 1.4399999999999999 110.735 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -113.24 20.01 16.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.35 -0.387 . . . . 0.42999999999999999 111.998 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.2 p -60.11 144.73 49.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.939 1.459 . . . . 1.04 114.939 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.139 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -130.04 131.84 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 114.588 -1.187 . . . . 0.31 110.581 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.634 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -105.51 150.09 25.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.734 -0.839 . . . . 1.1499999999999999 108.734 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -97.46 119.84 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 120.923 0.392 . . . . 0.27000000000000002 110.652 -179.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -84.96 144.66 28.18 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.583 -0.735 . . . . 0.28999999999999998 111.049 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 54.42 59.98 3.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 1.52 112.121 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.6 mt -45.52 177.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.271 0.558 . . . . 1.02 112.395 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.708 ' O ' HG21 ' A' ' 137' ' ' VAL . 11.5 pt20 -177.24 166.7 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.485 -0.78 . . . . 2.1299999999999999 110.291 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.61 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 58.8 tp -60.04 -39.93 87.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 1.7 111.577 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 70.2 m -73.22 -10.03 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.062 0.393 . . . . 1.3200000000000001 112.062 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.455 ' OD2' ' HA ' ' A' ' 110' ' ' LEU . 90.7 m-20 -71.85 -22.35 61.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.528 -0.469 . . . . 1.5800000000000001 109.735 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 142.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 110.186 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.74 150.87 5.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.2 -1.0 . . . . 0.23999999999999999 113.7 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.586 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.4 m -59.29 130.64 47.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.137 -0.532 . . . . 0.31 112.375 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 43.8 m-85 -114.49 124.55 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.444 -0.576 . . . . 1.24 109.444 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.0 tt0 -123.37 119.22 29.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.117 -0.233 . . . . 1.1599999999999999 110.765 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.546 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 15.5 p -105.05 119.91 40.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 1.03 110.362 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 41.2 mtmt -111.77 107.81 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 1.76 110.659 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.7 p -88.0 113.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 1.1799999999999999 110.033 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.8 tttt -96.55 116.35 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.372 0.508 . . . . 1.6200000000000001 112.372 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.714 ' HB2' HD12 ' A' ' 53' ' ' LEU . 25.7 tttp -145.65 102.48 3.69 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.402 -0.519 . . . . 2.8399999999999999 109.849 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.904 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.68 134.0 36.15 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.918 -0.583 . . . . 0.44 111.878 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 93.3 Cg_endo -100.02 49.9 1.73 Allowed 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.627 -0.989 . . . . 0.56000000000000005 111.606 -0.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.34 103.26 0.27 Allowed Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 120.147 -1.025 . . . . 0.47999999999999998 113.939 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.443 HG12 ' HG3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -87.86 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 1.22 108.804 176.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.914 ' HB1' HG12 ' A' ' 22' ' ' ILE . . . -140.96 146.86 37.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.309 0.485 . . . . 0.56999999999999995 112.309 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.457 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 53.7 p30 -146.73 150.93 36.33 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.198 -0.455 . . . . 2.0299999999999998 111.374 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.614 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -145.64 159.99 42.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.166 -0.47 . . . . 2.9500000000000002 110.763 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 66.9 mttm -100.25 140.11 34.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.841 1.052 . . . . 2.2599999999999998 113.841 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.64 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.7 mt -140.6 113.81 5.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.946 -1.025 . . . . 0.28000000000000003 108.289 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.586 ' CD2' HG23 ' A' ' 117' ' ' THR . 63.0 m170 -99.95 119.54 38.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.405 -0.518 . . . . 0.55000000000000004 110.995 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.513 HD21 HD21 ' A' ' 110' ' ' LEU . 60.6 tp -91.31 122.52 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 1.52 111.945 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 59.7 t -120.01 127.18 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.826 -0.805 . . . . 0.32000000000000001 108.826 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.708 HG21 ' O ' ' A' ' 111' ' ' GLN . 33.5 t -98.9 131.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.46 0.541 . . . . 1.0800000000000001 112.46 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 85.8 mt -82.36 151.3 26.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.824 -0.625 . . . . 0.52000000000000002 109.824 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.04 139.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.678 0.751 . . . . 1.48 112.387 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.617 ' HB2' ' CD ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -164.74 -173.75 0.36 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.517 -1.22 . . . . 2.2000000000000002 109.036 179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' CD ' ' HB2' ' A' ' 140' ' ' LYS . 50.9 Cg_exo -55.24 -143.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.185 1.923 . . . . 1.3100000000000001 112.244 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 t -38.86 -71.8 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.784 0.326 . . . . 2.3100000000000001 111.265 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 33' ' ' LYS . . . 68.0 -59.74 0.37 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.957 -0.639 . . . . 2.52 113.59 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.265 -0.874 . . . . 2.6000000000000001 111.186 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.543 -0.223 . . . . 3.2799999999999998 112.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 m -77.67 135.55 38.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 2.4300000000000002 110.89 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB2' HG21 ' A' ' 44' ' ' THR . 16.5 m -157.11 150.86 24.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 1.8400000000000001 110.883 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -142.86 132.81 22.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 2.1499999999999999 110.321 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.21 150.3 22.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.676 0.75 . . . . 1.1200000000000001 111.725 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER 52.68 81.64 0.26 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.526 -1.215 . . . . 0.65000000000000002 112.464 -178.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.647 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 60.6 Cg_endo -78.93 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.656 2.904 . . . . 0.88 111.857 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.57 126.85 31.32 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 2.0600000000000001 108.521 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 24' ' ' THR . 2.4 mm-40 -143.61 159.99 41.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.864 1.061 . . . . 1.71 113.864 -176.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.559 ' C ' HD12 ' A' ' 29' ' ' ILE . 49.5 ttp -138.93 132.26 30.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.55 -1.205 . . . . 1.8600000000000001 108.98 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.116 HD13 HG23 ' A' ' 133' ' ' ILE . 4.3 mp -130.0 139.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.943 -0.571 . . . . 0.39000000000000001 111.405 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 22.0 pt-20 -135.13 127.29 29.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 1.1899999999999999 111.134 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 56.0 tptt -141.9 157.52 44.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 2.52 110.742 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.5 144.34 39.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.934 0.397 . . . . 0.39000000000000001 111.746 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HG2' HG21 ' A' ' 137' ' ' VAL . 60.7 mttp -47.2 143.05 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.767 0.655 . . . . 2.3500000000000001 112.767 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 79.67 -21.8 4.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 114.858 -1.065 . . . . 0.31 113.307 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' O ' HD12 ' A' ' 110' ' ' LEU . 80.7 mm-40 -81.39 160.65 24.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.708 -0.479 . . . . 2.1099999999999999 109.708 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.3 m -84.43 129.96 34.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.034 -0.667 . . . . 0.33000000000000002 110.679 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.899 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.39 117.43 34.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.833 0.349 . . . . 0.26000000000000001 110.628 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.731 ' CD1' HG21 ' A' ' 94' ' ' THR . 80.0 t80 -79.61 119.85 23.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.67 0.619 . . . . 1.4299999999999999 112.67 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.751 ' HB2' HD12 ' A' ' 105' ' ' ILE . 37.3 mt -106.31 111.58 64.17 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.502 -0.925 . . . . 0.80000000000000004 108.502 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 85.7 Cg_endo -85.26 131.71 4.26 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.385 2.056 . . . . 0.41999999999999998 115.648 -176.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.9 t -141.36 130.0 22.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.461 -1.245 . . . . 1.03 108.254 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 33.0 mmtp -141.16 139.99 33.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.394 . . . . 1.6599999999999999 111.063 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.66 ' CZ ' HD11 ' A' ' 53' ' ' LEU . 53.5 p90 -140.0 140.83 36.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 1.26 110.75 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 21' ' ' SER . 4.7 p -82.04 138.64 34.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 1.3300000000000001 111.967 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.4 tp -98.24 139.97 33.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 2.1200000000000001 110.275 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 p -152.49 151.1 26.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.843 0.354 . . . . 1.75 110.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.34 -25.85 25.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.809 2.339 . . . . 1.6100000000000001 112.39 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.566 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 13.4 pt-20 -74.17 -39.99 62.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.494 -0.321 . . . . 2.1800000000000002 110.251 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.619 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.2 OUTLIER -71.9 75.28 0.89 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.234 -0.654 . . . . 2.4100000000000001 109.234 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -91.98 -9.51 42.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.405 -0.816 . . . . 1.6399999999999999 111.691 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.948 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.0 160.0 53.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.324 -0.941 . . . . 0.55000000000000004 112.317 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.24 148.56 59.77 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.423 2.082 . . . . 0.84999999999999998 111.619 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.66 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 61.5 tp -77.69 131.6 37.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 1.8999999999999999 110.691 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.753 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 26.6 t0 -137.13 146.46 45.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.548 0.69 . . . . 1.78 110.951 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 40.9 mt -142.44 140.01 28.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.53 -1.214 . . . . 0.75 109.121 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' A' ' 121' ' ' LYS . 96.0 mt-10 -140.02 148.81 42.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.944 -0.302 . . . . 1.6699999999999999 111.187 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.944 ' CD2' HD11 ' A' ' 105' ' ' ILE . 79.0 m95 -140.48 119.16 12.4 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.22 110.828 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 70' ' ' VAL . 86.5 mt -109.86 146.33 35.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.728 -0.669 . . . . 0.40999999999999998 109.314 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.7 tt -130.0 136.17 59.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.19 0.519 . . . . 0.78000000000000003 112.267 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 70.1 m -119.66 103.84 45.7 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 1.25 108.854 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 85.1 Cg_endo -78.31 112.07 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.53000000000000003 112.613 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.75 87.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.177 -0.92 . . . . 0.40999999999999998 110.922 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -73.96 -40.48 62.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 1.8200000000000001 111.416 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 94.3 m-20 -85.12 159.99 20.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 1.9399999999999999 111.652 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -69.17 -19.88 64.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.539 -0.755 . . . . 1.6599999999999999 111.173 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.542 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 57.7 mttt -70.0 150.63 46.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 1.74 111.298 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.65 127.83 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-O 121.732 0.777 . . . . 0.96999999999999997 109.249 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 61.14 88.12 0.09 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.366 -1.288 . . . . 1.77 111.969 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' ILE . 11.8 pt20 -140.44 141.84 35.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.794 0.331 . . . . 1.96 111.219 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 58' ' ' LEU . 61.7 t -71.74 129.38 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.77000000000000002 110.18 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CG1' HD12 ' A' ' 87' ' ' LEU . 1.4 pp -130.3 -38.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.347 0.499 . . . . 1.1499999999999999 112.347 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.907 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 126.3 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.258 -0.645 . . . . 0.28999999999999998 109.258 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -140.8 159.98 41.03 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.487 -0.779 . . . . 1.3 110.715 -178.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.79 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 20.2 t80 -134.86 103.75 5.73 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.997 -0.742 . . . . 1.3 108.997 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.452 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 13.0 t -142.7 160.01 41.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.89000000000000001 111.45 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.52 13.75 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.691 -0.766 . . . . 0.56999999999999995 112.356 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.29 0.34 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.457 0.17 . . . . 1.46 111.307 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -100.05 114.27 27.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.739 -0.467 . . . . 2.4100000000000001 109.739 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.61 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -79.4 134.02 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 N-CA-C 107.107 -1.442 . . . . 1.6599999999999999 107.107 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.722 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -118.8 127.72 53.8 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.321 -1.309 . . . . 1.25 110.208 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.858 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 19.6 p-10 -165.82 -55.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.15 -1.426 . . . . 1.2 107.15 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 51.8 t0 -82.84 -27.54 30.75 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.785 -1.098 . . . . 2.1699999999999999 109.0 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -74.42 -30.04 61.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.7 -1.222 . . . . 5.0499999999999998 107.7 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -82.78 110.94 25.63 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 114.275 -1.33 . . . . 1.29 110.373 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.22 -43.12 13.29 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.843 1.695 . . . . 0.79000000000000004 111.505 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 71' ' ' ILE . 95.9 m-20 -67.95 103.75 1.56 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.181 -0.463 . . . . 1.3600000000000001 111.274 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.078 HD13 ' NH2' ' A' ' 90' ' ' ARG . 40.4 mt 73.58 21.48 2.85 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.965 0.728 . . . . 1.6200000000000001 112.965 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.858 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.8 pttt -56.78 132.24 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.97 -0.456 . . . . 2.3900000000000001 111.44 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 90.27 10.74 63.7 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.289 -0.958 . . . . 0.37 114.389 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 1.078 ' NH2' HD13 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -139.56 -49.73 0.49 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 114.781 1.4 . . . . 1.5900000000000001 114.781 -178.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.907 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.79 81.56 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-O 122.981 1.372 . . . . 0.20000000000000001 107.462 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 9.8 m80 -102.71 129.25 49.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.342 -2.208 . . . . 0.28999999999999998 112.475 -175.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.3 m-85 -70.34 126.25 29.12 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.084 -0.646 . . . . 1.23 109.577 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.731 HG21 ' CD1' ' A' ' 38' ' ' TYR . 2.6 p -74.39 33.41 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.46000000000000002 112.693 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 t -149.16 140.03 22.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.1 0.476 . . . . 1.2 111.332 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -91.54 0.07 57.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 2.2200000000000002 110.648 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.61 67.45 1.17 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.294 0.568 . . . . 2.1400000000000001 109.506 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.91 HD21 ' CG ' ' A' ' 93' ' ' PHE . 8.5 mp -56.99 -25.88 59.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 1.49 111.229 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HA ' HD22 ' A' ' 53' ' ' LEU . 63.6 mttt -64.93 1.28 0.95 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.165 0.507 . . . . 2.04 112.297 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 79.7 p -89.99 0.06 57.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.561 -0.745 . . . . 1.3999999999999999 110.714 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.45 -8.75 32.72 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.38 112.845 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -98.15 111.91 24.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.329 . . . . 1.4399999999999999 110.988 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.516 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -110.04 13.02 23.44 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.31 -0.404 . . . . 0.42999999999999999 111.424 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 54.5 m -59.98 140.0 57.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.389 1.625 . . . . 1.04 115.389 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -131.96 129.99 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.753 -1.112 . . . . 0.31 110.511 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.644 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.5 p30 -106.52 154.91 20.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.243 -0.651 . . . . 1.1499999999999999 109.243 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -98.35 124.31 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 120.966 0.413 . . . . 0.27000000000000002 111.364 -178.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.6 p -88.01 143.59 27.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.702 -0.681 . . . . 0.28999999999999998 110.92 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.2 m120 50.66 60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 1.52 111.888 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.9 mt -45.37 176.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.445 0.64 . . . . 1.02 112.464 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.405 ' HG2' ' OD2' ' A' ' 114' ' ' ASP . 13.3 pt20 -176.69 163.84 2.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.141 -0.936 . . . . 2.1299999999999999 110.082 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.775 ' HA ' HG11 ' A' ' 137' ' ' VAL . 2.0 tm? -60.03 -36.42 77.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 1.7 111.937 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -73.81 -14.43 61.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.056 0.391 . . . . 1.3200000000000001 112.056 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 96.4 m-20 -71.18 -22.02 62.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.408 -0.517 . . . . 1.5800000000000001 109.698 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.855 ' CD1' HG12 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -46.52 142.72 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.988 -0.551 . . . . 0.41999999999999998 110.91 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.05 150.92 5.47 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.704 -1.236 . . . . 0.23999999999999999 114.218 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.707 HG23 ' CD2' ' A' ' 134' ' ' HIS . 92.0 m -59.78 135.86 57.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.768 -0.716 . . . . 0.31 111.936 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 51.8 m-85 -120.0 139.68 52.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 1.24 110.105 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 58.4 tt0 -127.0 120.16 28.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 1.1599999999999999 109.982 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 48.7 t -98.4 118.21 34.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.055 -0.258 . . . . 1.03 110.684 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 57.4 mttt -115.81 105.22 12.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 1.76 111.008 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 89.5 t -95.34 108.18 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.41 -0.589 . . . . 1.1799999999999999 109.41 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 61.0 tttm -98.7 115.33 28.47 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.718 -0.793 . . . . 1.6200000000000001 112.118 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 50.0 tttm -145.65 102.35 3.67 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.483 -0.562 . . . . 2.8399999999999999 109.483 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.948 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.89 131.99 21.8 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 113.162 0.801 . . . . 0.44 113.162 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.619 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 47.2 Cg_endo -100.07 37.59 5.91 Favored 'Cis proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.625 -0.99 . . . . 0.56000000000000005 111.627 -0.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.67 102.41 0.53 Allowed Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.313 -0.946 . . . . 0.47999999999999998 113.345 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' A' ' 123' ' ' LYS . 5.7 m -91.75 141.22 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 113.56 -1.32 . . . . 1.22 109.357 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 22' ' ' ILE . . . -138.13 144.02 40.62 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.385 0.513 . . . . 0.56999999999999995 112.385 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 39.6 p-10 -146.26 140.41 26.49 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.587 . . . . 2.0299999999999998 110.783 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.9 164.13 32.93 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.582 -0.281 . . . . 2.9500000000000002 111.517 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 87.2 mttt -99.75 140.12 34.41 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.667 0.988 . . . . 2.2599999999999998 113.667 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.116 HG23 HD13 ' A' ' 29' ' ' ILE . 2.6 mp -140.57 111.91 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.926 -1.034 . . . . 0.28000000000000003 109.072 177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.707 ' CD2' HG23 ' A' ' 117' ' ' THR . 62.9 m170 -101.03 120.02 39.58 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.596 -0.442 . . . . 0.55000000000000004 111.235 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HB3' ' HE1' ' A' ' 118' ' ' TYR . 59.5 tp -91.02 123.5 34.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.017 -0.538 . . . . 1.52 111.884 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -119.95 121.45 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.32000000000000001 109.464 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.855 HG12 ' CD1' ' A' ' 115' ' ' ILE . 12.1 p -93.9 131.3 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 1.0800000000000001 111.92 -178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.5 mt -86.55 149.98 24.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.52000000000000002 109.722 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -78.18 134.82 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.773 0.797 . . . . 1.48 111.709 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.843 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.21 176.55 1.99 Allowed Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 114.26 -1.336 . . . . 2.2000000000000002 108.713 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 7.9 Cg_endo -49.38 -155.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.21 1.94 . . . . 1.3100000000000001 112.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 141' ' ' PRO . 49.1 m -26.89 -76.22 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.993 0.368 . . . . 2.3100000000000001 111.993 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.547 ' HA3' ' HD2' ' A' ' 140' ' ' LYS . . . 53.93 55.56 25.21 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.846 -0.692 . . . . 2.52 113.757 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.208 -0.901 . . . . 2.6000000000000001 111.038 179.821 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.644 -0.182 . . . . 3.2799999999999998 112.644 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 66.8 m -76.84 149.96 36.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 2.4300000000000002 111.024 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 70.6 m -77.72 133.66 38.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.223 0.535 . . . . 1.8400000000000001 111.658 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -140.01 140.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.369 -0.832 . . . . 2.1499999999999999 109.987 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -90.35 149.52 22.27 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.541 0.686 . . . . 1.1200000000000001 111.365 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.5 83.12 0.22 Allowed Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-N 114.657 -1.156 . . . . 0.65000000000000002 111.232 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 56.1 Cg_endo -78.21 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.645 2.897 . . . . 0.88 112.278 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.41 127.59 32.41 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.555 -0.906 . . . . 2.0600000000000001 108.555 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.911 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -143.85 160.0 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.098 1.147 . . . . 1.71 114.098 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 43.0 mtt -139.73 122.8 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.586 -1.188 . . . . 1.8600000000000001 109.311 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.911 HD11 ' OE2' ' A' ' 27' ' ' GLU . 40.4 mm -120.01 123.5 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 0.39000000000000001 111.607 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 90.2 mt-10 -113.79 123.78 50.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.339 -0.391 . . . . 1.1899999999999999 110.421 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 37' ' ' ALA . 74.4 mmtt -141.56 154.61 45.56 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.087 0.403 . . . . 2.52 112.087 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -77.2 143.25 39.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.987 -0.551 . . . . 0.39000000000000001 112.219 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB2' ' HG3' ' A' ' 140' ' ' LYS . 54.9 mtpt -48.81 143.22 5.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.295 0.569 . . . . 2.3500000000000001 112.422 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 144' ' ' ALA . . . 79.53 -23.86 3.34 Favored Glycine 0 CA--C 1.516 0.13 0 CA-C-N 115.185 -0.916 . . . . 0.31 113.545 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 110' ' ' LEU . 7.2 mm-40 -80.01 160.09 25.99 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.403 -0.592 . . . . 2.1099999999999999 109.403 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.1 m -85.72 129.99 34.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.965 -0.694 . . . . 0.33000000000000002 109.991 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.751 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.73 118.78 35.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.26000000000000001 110.983 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.986 ' HE1' HG21 ' A' ' 94' ' ' THR . 83.0 t80 -79.53 129.98 34.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.49 -0.777 . . . . 1.4299999999999999 112.223 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 105' ' ' ILE . 23.5 mt -124.6 104.5 30.91 Favored Pre-proline 0 C--N 1.333 -0.138 0 N-CA-C 108.903 -0.777 . . . . 0.80000000000000004 108.903 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.76 129.61 8.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.495 2.13 . . . . 0.41999999999999998 114.658 -177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.544 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 11.6 t -141.37 125.24 17.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.712 -1.131 . . . . 1.03 108.963 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 9.1 mtmm -140.65 144.78 35.89 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.771 -0.65 . . . . 1.6599999999999999 109.838 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.916 ' CG ' HG11 ' A' ' 122' ' ' VAL . 51.2 p90 -140.03 141.24 36.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.794 -0.639 . . . . 1.26 112.21 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 21' ' ' SER . 1.3 p -88.91 139.86 30.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.654 . . . . 1.3300000000000001 110.481 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -96.84 110.0 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.621 -0.263 . . . . 2.1200000000000001 110.744 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -84.52 137.74 38.83 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.843 -0.429 . . . . 1.75 109.843 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -44.89 -34.21 8.38 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.755 1.637 . . . . 1.6100000000000001 111.035 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.06 -40.03 47.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.403 -0.817 . . . . 2.1800000000000002 111.014 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 91.7 m-20 -72.76 73.8 1.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.304 -0.558 . . . . 2.4100000000000001 109.587 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.23 -0.02 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.889 -0.596 . . . . 1.6399999999999999 112.235 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.07 161.92 52.99 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.55000000000000004 113.159 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.87 137.86 60.76 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.695 2.264 . . . . 0.84999999999999998 112.21 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 43' ' ' PHE . 2.3 mt -78.59 106.8 10.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.8999999999999999 112.137 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.5 m-20 -119.36 102.41 8.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.519 0.676 . . . . 1.78 110.921 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.868 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 6.7 mt -99.04 111.39 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.873 -1.058 . . . . 0.75 111.029 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 73' ' ' LEU . 84.8 tt0 -107.43 120.69 42.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.278 0.844 . . . . 1.6699999999999999 113.278 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.946 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.0 m95 -94.82 119.99 34.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.352 -0.385 . . . . 0.22 110.127 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 85.0 mt -103.82 141.11 36.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.529 -0.545 . . . . 0.40999999999999998 109.529 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 87' ' ' LEU . 7.6 tt -130.01 138.06 54.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.072 0.767 . . . . 0.78000000000000003 113.072 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -132.02 102.96 14.37 Favored Pre-proline 0 N--CA 1.455 -0.195 0 CA-C-N 115.199 -0.909 . . . . 1.25 109.503 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 6.3 Cg_exo -80.17 122.06 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.587 2.191 . . . . 0.53000000000000003 112.38 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.73 73.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.40999999999999998 110.45 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.76 13.12 7.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.405 -0.816 . . . . 1.8200000000000001 112.066 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 81.9 m-20 -145.67 160.01 42.32 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.385 0.612 . . . . 1.9399999999999999 112.04 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -68.96 -19.47 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.008 -0.996 . . . . 1.6599999999999999 112.316 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.8 mtpt -67.71 140.03 56.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.042 0.448 . . . . 1.74 111.531 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.73 129.08 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 CA-C-O 121.935 0.874 . . . . 0.96999999999999997 109.546 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.03 34.71 21.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.031 -1.44 . . . . 1.77 111.858 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.76 142.16 27.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.492 -0.322 . . . . 1.96 110.56 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 6.1 t -66.25 131.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.731 -0.47 . . . . 0.77000000000000002 109.731 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.903 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.24 -50.58 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.64 0.607 . . . . 1.1499999999999999 112.64 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.976 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.04 125.79 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.792 -0.818 . . . . 0.28999999999999998 108.792 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 74' ' ' TYR . 8.6 tt -140.06 159.97 40.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 116.172 -0.467 . . . . 1.3 110.211 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.639 ' CD1' HG23 ' A' ' 79' ' ' ILE . 16.4 t80 -136.34 109.15 7.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 1.3 110.328 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.476 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.6 p -142.86 160.05 41.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.631 -0.713 . . . . 0.89000000000000001 111.561 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.56 39.22 53.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.728 -0.749 . . . . 0.56999999999999995 112.477 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.9 t0 60.0 30.01 19.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.026 0.441 . . . . 1.46 110.515 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 89.7 mttt -131.33 108.94 10.0 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.4100000000000001 110.631 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -79.89 118.51 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 107.125 -1.435 . . . . 1.6599999999999999 107.125 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.747 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.3 m-85 -100.79 136.11 41.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.795 -1.093 . . . . 1.25 110.612 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.81 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 13.9 p-10 -166.37 -55.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.854 -1.165 . . . . 1.2 107.854 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 12.5 t70 -79.26 -18.66 52.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.101 -0.954 . . . . 2.1699999999999999 109.209 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.35 -28.26 34.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.55 -0.907 . . . . 5.0499999999999998 108.55 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.571 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.3 m-85 -85.8 114.28 55.99 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 114.949 -1.023 . . . . 1.29 111.161 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 88.8 Cg_exo -44.28 -42.36 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.611 1.541 . . . . 0.79000000000000004 110.595 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.694 ' O ' HG12 ' A' ' 71' ' ' ILE . 3.4 m-20 -66.99 104.88 1.48 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.252 -0.579 . . . . 1.3600000000000001 110.639 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.819 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 25.9 mt 67.43 23.29 9.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.826 1.047 . . . . 1.6200000000000001 113.826 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -54.84 128.63 33.97 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.601 -0.687 . . . . 2.3900000000000001 111.127 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.79 10.59 56.37 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.159 -1.02 . . . . 0.37 114.502 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.819 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -142.1 -46.43 0.35 Allowed 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 114.55 1.315 . . . . 1.5900000000000001 114.55 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.976 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -79.95 80.89 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-O 123.251 1.501 . . . . 0.20000000000000001 107.173 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.49 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.5 m80 -98.78 132.06 44.43 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.258 -2.246 . . . . 0.28999999999999998 111.615 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.103 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.6 m-85 -72.41 121.07 18.93 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.895 0.855 . . . . 1.23 111.222 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.986 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -69.48 -11.69 61.04 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.069 -1.423 . . . . 0.46000000000000002 109.914 178.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.8 m -95.22 120.01 34.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.025 -0.534 . . . . 1.2 110.929 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -90.64 4.82 50.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.034 -0.53 . . . . 2.2200000000000002 110.422 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -146.19 67.02 1.19 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.802 -0.814 . . . . 2.1400000000000001 108.802 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 5.1 mp -59.05 -35.04 72.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.216 -0.902 . . . . 1.49 111.886 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.93 -5.35 4.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 2.04 111.843 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -90.04 0.03 57.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.349 -0.841 . . . . 1.3999999999999999 110.963 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.01 -20.02 34.17 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.737 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.5 m-20 -96.04 109.34 21.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.361 0.58 . . . . 1.4399999999999999 110.414 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -114.86 25.58 10.83 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.816 0.673 . . . . 0.42999999999999999 112.816 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 43.4 t -59.95 146.15 43.47 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.27 1.582 . . . . 1.04 115.27 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.103 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.53 139.97 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 114.217 -1.356 . . . . 0.31 110.788 178.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.701 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.9 OUTLIER -118.18 148.51 42.29 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.302 -0.999 . . . . 1.1499999999999999 108.302 177.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -96.88 121.56 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 120.967 0.413 . . . . 0.27000000000000002 111.26 -178.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -84.06 145.7 28.32 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.514 -0.767 . . . . 0.28999999999999998 111.298 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.64 61.78 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.978 -0.555 . . . . 1.52 112.424 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 37' ' ' ALA . 9.7 mt -46.86 173.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.322 0.582 . . . . 1.02 112.336 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.602 ' O ' HG21 ' A' ' 137' ' ' VAL . 13.7 pt20 -177.38 163.55 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.262 -0.881 . . . . 2.1299999999999999 110.137 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.06 -38.29 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.277 -0.419 . . . . 1.7 111.99 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.7 t -73.11 -14.21 61.34 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.11 0.411 . . . . 1.3200000000000001 112.11 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -72.83 -20.09 61.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.699 -0.4 . . . . 1.5800000000000001 110.183 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -46.45 146.63 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.202 -0.454 . . . . 0.41999999999999998 110.953 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.36 147.0 4.92 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 119.923 -1.132 . . . . 0.23999999999999999 113.788 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.752 HG23 ' CD2' ' A' ' 134' ' ' HIS . 47.2 m -59.27 138.3 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.378 -0.411 . . . . 0.31 111.755 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 47.6 m-85 -119.95 131.08 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 1.24 109.792 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.648 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 57.8 tt0 -121.56 119.88 33.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.048 -0.261 . . . . 1.1599999999999999 110.383 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.458 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.7 t -99.51 111.17 23.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.578 -0.283 . . . . 1.03 110.455 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.868 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 74.3 mttt -106.61 104.74 14.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.848 -0.341 . . . . 1.76 110.812 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 43' ' ' PHE . 24.0 t -89.3 110.12 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 109.212 -0.662 . . . . 1.1799999999999999 109.212 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 87.8 tttt -95.79 122.92 39.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.309 0.855 . . . . 1.6200000000000001 113.309 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 3.9 mmtt -141.6 101.43 3.98 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.892 -0.781 . . . . 2.8399999999999999 108.892 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 1.0 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.34 132.61 61.87 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 112.507 0.558 . . . . 0.44 112.507 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.53 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 81.0 Cg_endo -100.0 47.65 2.12 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.646 -0.981 . . . . 0.56000000000000005 112.667 -0.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.3 103.38 0.29 Allowed Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.696 -0.764 . . . . 0.47999999999999998 112.971 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 123' ' ' LYS . 2.0 t -90.16 151.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.623 -0.788 . . . . 1.22 110.087 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.86 152.13 43.35 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.218 . . . . 0.56999999999999995 111.535 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.517 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 17.6 p30 -146.49 151.9 38.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.05 0.389 . . . . 2.0299999999999998 112.05 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -146.15 161.23 40.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.106 -0.497 . . . . 2.9500000000000002 111.191 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 39.4 mttp -102.82 140.01 37.65 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.625 0.972 . . . . 2.2599999999999998 113.625 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.729 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 87.7 mt -143.83 110.66 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.372 -0.973 . . . . 0.28000000000000003 108.372 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.752 ' CD2' HG23 ' A' ' 117' ' ' THR . 47.4 m170 -98.46 120.01 38.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.55000000000000004 111.391 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.1 tm? -86.87 124.26 32.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 1.52 111.225 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.3 t -119.29 126.93 75.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.582 -0.735 . . . . 0.32000000000000001 109.433 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 111' ' ' GLN . 18.2 t -96.33 126.76 48.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.0800000000000001 112.054 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 71.2 mt -87.7 145.7 26.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.52000000000000002 109.078 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 139' ' ' VAL . 0.8 OUTLIER -77.43 134.82 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.249 1.023 . . . . 1.48 112.872 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.711 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.03 169.97 6.9 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.295 -1.775 . . . . 2.2000000000000002 109.174 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.711 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 2.2 Cg_endo -40.27 167.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.847 2.365 . . . . 1.3100000000000001 112.535 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 144' ' ' ALA . 0.4 OUTLIER -33.08 -79.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.175 0.435 . . . . 2.3100000000000001 112.175 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.58 -66.49 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.091 -0.504 . . . . 2.52 113.538 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.407 -0.806 . . . . 2.6000000000000001 111.812 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 127' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.582 -0.207 . . . . 3.2799999999999998 112.582 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.8 p -159.51 150.02 19.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 2.4300000000000002 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 44' ' ' THR . 46.8 t -76.98 152.39 35.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 1.8400000000000001 111.562 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 131' ' ' LYS . 19.2 tt -139.51 134.99 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 2.1499999999999999 110.399 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.43 156.91 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.515 0.674 . . . . 1.1200000000000001 111.706 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.31 83.25 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.576 -1.193 . . . . 0.65000000000000002 111.695 -178.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 59.3 Cg_endo -78.26 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.404 2.736 . . . . 0.88 112.6 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.59 125.55 29.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.072 -0.714 . . . . 2.0600000000000001 109.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.709 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.7 tt0 -144.33 163.95 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.846 1.054 . . . . 1.71 113.846 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.687 ' O ' HD13 ' A' ' 29' ' ' ILE . 55.4 ttm -138.72 139.4 38.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.72 -1.127 . . . . 1.8600000000000001 109.117 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.709 HD11 ' OE2' ' A' ' 27' ' ' GLU . 34.3 mm -132.72 139.37 49.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.214 0.449 . . . . 0.39000000000000001 112.214 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 21.9 pt-20 -140.23 124.63 17.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.225 -0.443 . . . . 1.1899999999999999 110.567 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -142.3 163.41 32.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.522 -0.308 . . . . 2.52 111.597 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.731 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -76.62 139.57 40.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.39000000000000001 111.467 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 144' ' ' ALA . 86.9 tttt -48.35 130.35 16.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.128 -0.487 . . . . 2.3500000000000001 111.762 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.79 -19.15 47.02 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.31 112.695 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.731 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -79.99 160.01 26.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.37 -0.974 . . . . 2.1099999999999999 108.37 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 42.0 m -88.43 128.51 35.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.566 -0.853 . . . . 0.33000000000000002 110.352 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.987 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.8 113.92 26.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.26000000000000001 110.522 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.635 ' CE2' HG21 ' A' ' 94' ' ' THR . 29.0 t80 -79.53 129.89 34.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.908 -0.587 . . . . 1.4299999999999999 112.387 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.619 HD23 ' CG2' ' A' ' 133' ' ' ILE . 4.1 mp -120.17 107.64 39.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.424 -0.954 . . . . 0.80000000000000004 108.424 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.572 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 89.0 Cg_endo -82.8 104.66 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.451 2.101 . . . . 0.41999999999999998 115.944 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -105.58 126.12 51.77 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.165 -1.05 . . . . 1.03 108.165 175.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.0 mttm -140.72 139.37 34.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.176 0.512 . . . . 1.6599999999999999 110.992 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.645 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 40.8 p90 -141.11 150.04 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.415 -0.811 . . . . 1.26 111.028 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' SER . 1.7 t -80.1 170.74 16.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 111.177 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD21 ' HE2' ' A' ' 43' ' ' PHE . 91.7 mt -138.19 141.19 40.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 2.1200000000000001 111.03 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 79.5 p -159.99 158.63 26.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.847 -0.615 . . . . 1.75 110.212 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 13.1 Cg_endo -56.24 -17.64 21.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.433 2.089 . . . . 1.6100000000000001 112.88 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -73.33 -43.72 60.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 120.685 0.278 . . . . 2.1800000000000002 110.534 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.46 76.63 1.05 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.069 -0.715 . . . . 2.4100000000000001 109.069 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -89.13 -11.54 43.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.366 -0.834 . . . . 1.6399999999999999 111.773 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.6 157.59 52.73 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.222 -0.989 . . . . 0.55000000000000004 112.29 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.81 150.9 27.88 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.334 2.022 . . . . 0.84999999999999998 111.321 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.765 ' HA ' ' HG2' ' A' ' 124' ' ' LYS . 4.1 mp -77.61 133.06 38.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.893 0.377 . . . . 1.8999999999999999 110.845 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 21.9 t0 -140.24 146.84 39.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.361 0.6 . . . . 1.78 111.753 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 6.6 mt -143.79 135.0 22.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.774 -1.103 . . . . 0.75 109.422 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.739 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.3 tt0 -140.61 119.9 12.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.668 0.667 . . . . 1.6699999999999999 112.667 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.889 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.0 m95 -100.2 124.85 46.12 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.174 -0.466 . . . . 0.22 111.377 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -106.87 120.34 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.843 -0.429 . . . . 0.40999999999999998 109.843 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' A' ' 71' ' ' ILE . 10.3 tt -104.06 124.42 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.506 0.558 . . . . 0.78000000000000003 112.506 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.8 m -118.33 101.9 50.8 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.64 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 98.9 Cg_endo -79.56 115.52 3.41 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.597 2.198 . . . . 0.53000000000000003 112.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.40999999999999998 110.944 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.94 -39.96 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 1.8200000000000001 111.8 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.561 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 32.4 m120 -85.43 161.87 19.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.39 0.614 . . . . 1.9399999999999999 112.28 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.63 -18.48 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.091 -0.958 . . . . 1.6599999999999999 111.741 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -68.49 150.91 47.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.906 -0.588 . . . . 1.74 111.333 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.59 127.69 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.113 0 CA-C-O 121.893 0.854 . . . . 0.96999999999999997 109.988 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 55.89 40.05 30.57 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 114.074 -1.421 . . . . 1.77 112.727 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 91.3 mt-30 -94.32 145.05 25.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.192 -0.203 . . . . 1.96 110.75 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG11 ' OH ' ' A' ' 84' ' ' TYR . 18.4 t -66.68 125.95 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.064 0.459 . . . . 0.77000000000000002 109.883 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -116.21 -53.72 4.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.628 -0.715 . . . . 1.1499999999999999 111.923 -177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.73 124.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.2 -1.037 . . . . 0.28999999999999998 108.2 178.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.852 HD23 ' N ' ' A' ' 74' ' ' TYR . 6.1 tt -135.32 157.09 47.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.806 -0.633 . . . . 1.3 109.772 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.901 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 12.1 t80 -136.91 104.08 5.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.758 -0.46 . . . . 1.3 109.758 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -143.15 158.26 43.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.89000000000000001 111.678 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.58 28.58 45.8 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.732 -0.747 . . . . 0.56999999999999995 112.472 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t0 73.53 2.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.545 0.212 . . . . 1.46 111.107 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 68.2 mttm -100.01 113.24 25.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 110.08 -0.341 . . . . 2.4100000000000001 110.08 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.901 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -84.87 116.52 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 107.879 -1.156 . . . . 1.6599999999999999 107.879 177.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.718 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.2 m-85 -100.03 128.19 46.14 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.819 -1.537 . . . . 1.25 110.908 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.758 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 24.2 p-10 -166.14 -53.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.222 -1.029 . . . . 1.2 108.222 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 10.8 t70 -80.17 -24.33 40.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.09 -0.959 . . . . 2.1699999999999999 109.371 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.25 -29.1 42.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.118 -0.946 . . . . 5.0499999999999998 108.5 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -82.35 115.9 60.57 Favored Pre-proline 0 CA--C 1.515 -0.369 0 CA-C-N 114.795 -1.093 . . . . 1.29 110.552 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.2 Cg_endo -46.81 -40.99 25.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.729 1.619 . . . . 0.79000000000000004 110.373 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.721 ' O ' HG12 ' A' ' 71' ' ' ILE . 67.1 m-20 -66.98 105.22 1.57 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.824 -0.626 . . . . 1.3600000000000001 110.653 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.859 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.2 mt 68.02 24.56 7.82 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.862 1.06 . . . . 1.6200000000000001 113.862 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttt -55.61 127.5 30.18 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.627 -0.671 . . . . 2.3900000000000001 111.219 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.63 15.12 54.03 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.385 -0.912 . . . . 0.37 114.451 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.859 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp180 -144.14 -48.03 0.27 Allowed 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 114.483 1.29 . . . . 1.5900000000000001 114.483 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.23 81.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 122.864 1.316 . . . . 0.20000000000000001 107.725 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.472 ' C ' HG22 ' A' ' 105' ' ' ILE . 17.5 m80 -102.93 129.14 49.55 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.474 -2.148 . . . . 0.28999999999999998 112.326 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.117 ' CD1' HG23 ' A' ' 105' ' ' ILE . 77.0 m-85 -70.97 120.77 17.03 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 109.097 -0.705 . . . . 1.23 109.097 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.635 HG21 ' CE2' ' A' ' 38' ' ' TYR . 24.6 p -70.43 -10.01 57.97 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.22 -0.9 . . . . 0.46000000000000002 110.455 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 67.2 m -93.16 121.46 34.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.848 -0.615 . . . . 1.2 110.259 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.11 2.48 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.1 0.476 . . . . 2.2200000000000002 110.344 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -146.07 66.81 1.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.849 -0.797 . . . . 2.1400000000000001 108.849 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.598 HD22 ' CD2' ' A' ' 74' ' ' TYR . 5.9 mp -56.74 -28.98 62.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 1.49 111.466 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 55.6 mtmt -62.81 -6.23 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.211 0.529 . . . . 2.04 111.809 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -87.55 -3.11 59.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.309 -0.86 . . . . 1.3999999999999999 110.733 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.645 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 109.57 -12.97 32.93 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.779 -0.724 . . . . 0.38 113.702 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -95.09 110.03 22.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.192 0.496 . . . . 1.4399999999999999 110.429 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -108.83 16.38 22.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.294 -0.412 . . . . 0.42999999999999999 111.916 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 6.0 m -60.16 140.02 57.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 116.104 1.891 . . . . 1.04 116.104 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.117 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.82 135.53 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.291 -1.322 . . . . 0.31 110.587 178.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.63 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.0 p-10 -111.95 145.05 40.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.326 -0.99 . . . . 1.1499999999999999 108.326 177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.03 120.02 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-O 121.063 0.459 . . . . 0.27000000000000002 111.443 -178.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.774 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -83.15 143.96 30.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.369 -0.832 . . . . 0.28999999999999998 110.64 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 81.3 m-20 49.92 56.52 7.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.156 0.503 . . . . 1.52 111.359 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.987 HD11 ' HB2' ' A' ' 37' ' ' ALA . 21.4 mt -46.38 90.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.986 1.106 . . . . 1.02 113.986 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 47.5 mt-30 -56.58 149.03 18.27 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.948 -0.569 . . . . 2.1299999999999999 110.468 176.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.96 -37.05 78.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.28 -0.637 . . . . 1.7 109.28 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.55 -5.63 43.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 1.3200000000000001 111.542 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 90.0 m-20 -70.08 -19.18 63.28 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.615 -0.513 . . . . 1.5800000000000001 109.615 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -43.14 137.98 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 116.001 -0.545 . . . . 0.41999999999999998 110.452 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 141.04 158.8 7.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.893 -1.146 . . . . 0.23999999999999999 114.145 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.4 m -60.48 140.0 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.751 -0.724 . . . . 0.31 112.709 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.771 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 32.8 m-85 -125.12 125.38 43.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.023 -0.732 . . . . 1.24 109.023 176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.73 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 24.6 tt0 -120.01 118.96 32.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.943 -0.303 . . . . 1.1599999999999999 110.727 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 42.2 t -97.81 118.58 34.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.999 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 130' ' ' ASN . 31.9 mttm -114.07 106.38 14.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.76 110.858 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 48.9 t -92.18 104.67 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.229 -0.656 . . . . 1.1799999999999999 109.229 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 85.5 tttt -96.99 120.12 36.75 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.009 -0.676 . . . . 1.6200000000000001 112.65 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.765 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 10.3 mtmp? -141.81 102.87 4.25 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.693 -0.484 . . . . 2.8399999999999999 109.693 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.924 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.01 131.96 22.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.634 -0.257 . . . . 0.44 111.654 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 44.1 Cg_endo -101.89 46.83 2.26 Favored 'Cis proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.986 -0.839 . . . . 0.56000000000000005 111.69 -0.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 19' ' ' GLY . . . -146.07 103.56 0.28 Allowed Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.328 -0.939 . . . . 0.47999999999999998 113.679 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.33 149.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 114.691 -0.754 . . . . 1.22 109.666 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 122' ' ' VAL . . . -141.79 144.62 34.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.587 0.232 . . . . 0.56999999999999995 111.47 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 44.7 p-10 -146.72 148.6 32.16 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.316 0.487 . . . . 2.0299999999999998 112.316 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.804 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.31 160.72 41.09 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.018 -0.537 . . . . 2.9500000000000002 110.698 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 99.1 mttt -103.22 136.14 43.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.282 0.845 . . . . 2.2599999999999998 113.282 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 118' ' ' TYR . 91.1 mt -145.24 113.47 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 N-CA-C 108.708 -0.849 . . . . 0.28000000000000003 108.708 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -95.4 175.4 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.076 -0.65 . . . . 0.55000000000000004 109.907 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.669 HD21 HD22 ' A' ' 110' ' ' LEU . 54.5 tp -144.07 133.05 22.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.864 -0.607 . . . . 1.52 112.255 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.4 t -129.98 129.99 65.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.383 -0.826 . . . . 0.32000000000000001 109.515 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 33.4 t -97.09 124.84 50.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.915 0.388 . . . . 1.0800000000000001 111.67 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.87 157.72 25.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.433 -0.58 . . . . 0.52000000000000002 109.433 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.64 130.53 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 1.48 111.106 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.765 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 10.0 ptmt -165.5 176.96 1.76 Allowed Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 114.691 -1.14 . . . . 2.2000000000000002 109.418 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.765 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 4.3 Cg_endo -46.66 174.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.094 1.863 . . . . 1.3100000000000001 112.103 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 p -34.59 -79.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.043 0.386 . . . . 2.3100000000000001 112.043 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.38 -5.64 2.89 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.027 -0.606 . . . . 2.52 113.748 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.51 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.235 -0.888 . . . . 2.6000000000000001 111.156 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.768 -0.133 . . . . 3.2799999999999998 112.768 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -78.45 138.07 38.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 2.4300000000000002 111.036 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -74.13 149.98 40.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 1.8400000000000001 110.926 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -144.56 144.08 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 2.1499999999999999 110.991 -179.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -99.48 139.95 34.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.744 0.783 . . . . 1.1200000000000001 112.025 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.95 81.11 0.27 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.344 -1.298 . . . . 0.65000000000000002 112.109 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.704 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 76.1 Cg_endo -79.62 -11.03 14.33 Favored 'Trans proline' 0 C--N 1.33 -0.427 0 C-N-CA 124.344 3.363 . . . . 0.88 113.338 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -140.67 125.26 17.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.546 -0.909 . . . . 2.0600000000000001 108.546 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.762 ' OE2' HD11 ' A' ' 29' ' ' ILE . 83.4 tt0 -144.28 162.87 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 114.595 1.332 . . . . 1.71 114.595 -176.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.713 ' O ' HD13 ' A' ' 29' ' ' ILE . 54.8 ttm -137.92 137.12 37.7 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.491 -1.232 . . . . 1.8600000000000001 109.197 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.762 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.0 mm -134.5 139.99 46.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.269 -0.423 . . . . 0.39000000000000001 111.688 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 39.4 mt-10 -137.6 119.28 15.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.368 -0.378 . . . . 1.1899999999999999 110.295 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 110' ' ' LEU . 31.0 tptt -142.07 158.64 43.53 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.665 -0.243 . . . . 2.52 110.978 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.739 ' HB1' ' CD ' ' A' ' 140' ' ' LYS . . . -76.89 143.95 39.28 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.136 0.493 . . . . 0.39000000000000001 112.242 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HD3' ' HG ' ' A' ' 112' ' ' LEU . 35.2 ttpt -48.93 131.18 18.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.799 -0.637 . . . . 2.3500000000000001 111.864 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.77 -19.84 38.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.31 112.488 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.726 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.7 mt-10 -79.9 158.43 26.68 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.239 -1.023 . . . . 2.1099999999999999 108.239 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.823 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.0 m -88.4 128.92 35.53 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.511 -0.876 . . . . 0.33000000000000002 110.976 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.979 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 117.7 34.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.26000000000000001 110.531 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 94' ' ' THR . 31.4 t80 -79.42 112.82 17.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.937 -0.574 . . . . 1.4299999999999999 111.712 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB2' HD12 ' A' ' 105' ' ' ILE . 40.6 mt -99.09 107.59 44.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.436 -0.95 . . . . 0.80000000000000004 108.436 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HG2' ' OE1' ' A' ' 27' ' ' GLU . 95.4 Cg_endo -82.69 134.52 7.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.213 1.942 . . . . 0.41999999999999998 114.4 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' ' 131' ' ' LYS . 1.8 t -140.42 130.07 24.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.477 -1.238 . . . . 1.03 107.841 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.571 ' O ' HG22 ' A' ' 22' ' ' ILE . 30.3 mmtp -140.42 137.05 33.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.979 0.418 . . . . 1.6599999999999999 110.94 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HE1' ' HB2' ' A' ' 103' ' ' ALA . 53.2 p90 -140.28 154.25 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.585 -0.734 . . . . 1.26 110.976 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 t -80.02 169.96 17.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 1.3300000000000001 111.835 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.525 HD12 ' OD2' ' A' ' 49' ' ' ASP . 69.0 tp -139.98 132.78 29.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.378 -0.828 . . . . 2.1200000000000001 110.625 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.0 m -157.18 156.09 28.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.75 110.498 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.96 -19.21 31.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.442 2.094 . . . . 1.6100000000000001 112.529 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 12.6 pt-20 -75.44 -40.61 57.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.718 -0.219 . . . . 2.1800000000000002 110.84 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.525 ' OD2' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -72.29 75.94 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.238 -0.585 . . . . 2.4100000000000001 109.452 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -91.65 -4.47 55.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 1.6399999999999999 112.292 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.919 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -82.71 146.65 24.6 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 119.814 -1.184 . . . . 0.55000000000000004 112.292 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.1 131.08 44.25 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.153 1.902 . . . . 0.84999999999999998 111.393 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.748 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 1.1 pt? -77.64 133.77 38.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 1.8999999999999999 111.532 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 76.7 m-20 -134.38 102.38 5.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.819 0.819 . . . . 1.78 110.556 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.875 HG12 HG22 ' A' ' 122' ' ' VAL . 4.7 mt -92.36 108.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.225 -1.352 . . . . 0.75 110.564 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' CB ' HD12 ' A' ' 73' ' ' LEU . 85.6 tt0 -106.52 117.56 34.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.409 0.522 . . . . 1.6699999999999999 112.409 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.935 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -94.66 119.95 34.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.226 -0.287 . . . . 0.22 110.226 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.6 mt -107.69 143.88 35.56 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.958 -0.386 . . . . 0.40999999999999998 109.958 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 114' ' ' ASP . 11.1 tt -129.99 130.0 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 0.78000000000000003 112.05 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.1 m -117.57 102.82 51.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.888 -0.782 . . . . 1.25 108.888 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.677 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 72.0 Cg_endo -78.37 107.68 2.34 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.349 2.032 . . . . 0.53000000000000003 112.979 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.19 70.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.956 -1.02 . . . . 0.40999999999999998 110.365 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 5.7 p-10 -87.42 17.27 4.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.644 -0.707 . . . . 1.8200000000000001 111.204 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -152.86 162.61 41.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.208 0.528 . . . . 1.9399999999999999 111.837 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -67.19 -19.92 65.64 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.372 -0.831 . . . . 1.6599999999999999 112.258 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 62.8 mttp -70.06 152.09 44.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.263 -0.426 . . . . 1.74 111.321 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.8 128.67 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 CA-C-O 121.773 0.797 . . . . 0.96999999999999997 109.614 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.95 44.74 25.18 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.339 -1.301 . . . . 1.77 112.289 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' O ' HG22 ' A' ' 59' ' ' ILE . 90.6 mm-40 -87.29 134.54 33.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 1.96 111.036 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 58' ' ' LEU . 65.6 t -70.8 130.05 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 116.524 -0.307 . . . . 0.77000000000000002 110.682 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.843 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -130.15 -37.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.836 0.68 . . . . 1.1499999999999999 112.836 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.932 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.12 122.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.698 -0.482 . . . . 0.28999999999999998 109.698 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 80' ' ' TYR . 8.6 tt -140.26 161.71 37.02 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 116.045 -0.525 . . . . 1.3 110.221 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.659 ' CD1' HG23 ' A' ' 79' ' ' ILE . 47.1 t80 -132.46 111.02 10.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.884 0.373 . . . . 1.3 110.615 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.527 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 15.2 t -142.34 158.05 44.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.788 -0.642 . . . . 0.89000000000000001 111.576 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 52.69 33.53 42.09 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.827 -0.701 . . . . 0.56999999999999995 112.324 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HA ' ' OH ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER 70.01 10.16 7.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.711 0.291 . . . . 1.46 110.866 -179.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 58.5 mttm -108.84 111.65 23.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.37 -0.377 . . . . 2.4100000000000001 111.181 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.659 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.05 117.84 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.752 -1.574 . . . . 1.6599999999999999 106.752 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.795 ' O ' HG12 ' A' ' 72' ' ' ILE . 7.2 m-85 -100.05 130.12 46.17 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.839 -1.073 . . . . 1.25 110.648 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.2 p-10 -165.99 -56.81 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.358 -1.719 . . . . 1.2 106.358 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 51.7 t0 -78.43 -24.52 46.08 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 114.416 -1.266 . . . . 2.1699999999999999 108.894 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -76.99 -29.97 55.73 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.396 -1.335 . . . . 5.0499999999999998 107.396 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.619 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 1.2 m-85 -86.24 113.31 51.5 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 114.423 -1.262 . . . . 1.29 109.919 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.04 -36.2 90.28 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.902 1.735 . . . . 0.79000000000000004 112.948 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 87' ' ' LEU . 58.2 m-20 -49.99 -29.99 9.68 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.298 0.851 . . . . 1.3600000000000001 113.298 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 2.0 mp -151.74 30.19 0.59 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.874 -0.603 . . . . 1.6200000000000001 111.467 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 40.5 pttt -58.96 137.75 57.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.996 -0.682 . . . . 2.3900000000000001 111.899 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.471 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 81.15 13.83 80.2 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.598 -0.728 . . . . 0.37 114.175 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.4 ptm85 -142.23 -56.65 0.45 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 114.922 1.453 . . . . 1.5900000000000001 114.922 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.932 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -78.21 80.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 123.059 1.409 . . . . 0.20000000000000001 107.358 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.471 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 8.0 m80 -98.89 127.07 44.72 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.161 -2.29 . . . . 0.28999999999999998 112.797 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.113 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.6 m-85 -68.66 125.53 26.83 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 120.1 -0.64 . . . . 1.23 109.298 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.963 HG21 ' CE2' ' A' ' 38' ' ' TYR . 6.6 p -74.15 28.24 0.08 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.514 -0.766 . . . . 0.46000000000000002 112.644 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 t -148.7 137.64 21.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.13 0.491 . . . . 1.2 110.948 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -92.73 3.72 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.569 -0.741 . . . . 2.2200000000000002 110.73 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -146.49 66.95 1.17 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.95 -0.759 . . . . 2.1400000000000001 108.95 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.3 mp -57.87 -24.66 58.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.114 -0.948 . . . . 1.49 111.637 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -64.16 0.59 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.224 0.453 . . . . 2.04 112.224 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -90.02 -0.03 57.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.682 -0.69 . . . . 1.3999999999999999 110.832 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 106.73 -13.7 42.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.38 112.557 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -96.14 108.39 20.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.115 -0.328 . . . . 1.4399999999999999 110.115 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -112.54 15.53 20.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.18 0.437 . . . . 0.42999999999999999 112.18 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 27.9 p -61.31 147.77 43.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.354 1.613 . . . . 1.04 115.354 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.113 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -134.47 130.33 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.291 -1.322 . . . . 0.31 111.211 179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.881 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.3 OUTLIER -103.37 143.58 32.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.602 -0.888 . . . . 1.1499999999999999 108.602 177.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.68 124.45 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 120.891 0.377 . . . . 0.27000000000000002 111.637 -178.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.723 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.8 p -85.67 145.14 27.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 0.28999999999999998 110.874 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 98.5 m-20 50.57 57.28 6.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.063 0.459 . . . . 1.52 111.878 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.979 HD11 ' HB2' ' A' ' 37' ' ' ALA . 25.1 mt -45.66 85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.727 1.38 . . . . 1.02 114.727 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 63.9 tt0 -59.98 147.89 37.27 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.668 -0.696 . . . . 2.1299999999999999 110.416 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.647 ' HG ' ' HD3' ' A' ' 33' ' ' LYS . 94.1 mt -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.054 0.39 . . . . 1.7 112.054 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 23.3 t -70.82 -14.96 62.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 1.3200000000000001 111.567 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.726 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -70.16 -19.15 63.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.384 -0.599 . . . . 1.5800000000000001 109.384 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 30.2 mt -45.68 138.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.947 -0.57 . . . . 0.41999999999999998 110.057 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.77 163.68 9.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 119.95 -1.119 . . . . 0.23999999999999999 113.876 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.499 HG23 ' CD2' ' A' ' 134' ' ' HIS . 87.5 m -59.41 130.02 44.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.599 0.592 . . . . 0.31 112.599 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.596 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 31.2 m-85 -112.43 130.94 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 1.24 109.687 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 64.1 tt0 -123.24 118.22 27.08 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.057 -0.257 . . . . 1.1599999999999999 111.027 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 41.9 t -100.54 118.57 36.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 1.03 110.153 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 44.2 mtpt -117.89 106.17 12.7 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.822 -0.351 . . . . 1.76 111.493 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.875 HG22 HG12 ' A' ' 55' ' ' ILE . 29.9 t -90.04 109.27 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.229 -0.656 . . . . 1.1799999999999999 109.229 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 56.7 tttp -100.32 111.77 24.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 1.6200000000000001 112.327 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 48.6 tttt -142.41 102.84 4.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.3 -0.56 . . . . 2.8399999999999999 110.189 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.919 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.26 134.01 24.02 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.643 -0.708 . . . . 0.44 112.09 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 65.5 Cg_endo -99.26 47.87 2.08 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.414 -1.078 . . . . 0.56000000000000005 111.785 -0.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.97 102.95 0.27 Allowed Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 119.89 -1.147 . . . . 0.47999999999999998 113.822 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.61 151.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.534 -0.833 . . . . 1.22 109.689 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -141.49 144.47 34.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.387 0.514 . . . . 0.56999999999999995 112.387 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.44 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 43.7 p-10 -146.78 139.8 25.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 111.61 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.704 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.18 161.99 38.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.548 -0.296 . . . . 2.9500000000000002 111.073 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.4 mttt -106.66 143.44 34.76 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.888 1.07 . . . . 2.2599999999999998 113.888 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.737 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 86.3 mt -143.86 114.81 2.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-N 114.982 -1.008 . . . . 0.28000000000000003 108.879 176.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.499 ' CD2' HG23 ' A' ' 117' ' ' THR . 58.8 m170 -99.44 112.79 24.93 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.481 -0.488 . . . . 0.55000000000000004 110.911 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.7 HD21 HD22 ' A' ' 110' ' ' LEU . 54.6 tp -88.25 131.01 34.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.697 -0.683 . . . . 1.52 112.425 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 51.0 t -126.42 125.83 68.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.768 -0.651 . . . . 0.32000000000000001 109.729 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 27.6 t -99.33 123.09 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.0800000000000001 111.412 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.6 mt -81.82 157.21 24.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.701 -0.481 . . . . 0.52000000000000002 109.701 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.65 135.86 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.53 0.681 . . . . 1.48 111.629 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.816 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.1 177.6 1.62 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 114.79 -1.096 . . . . 2.2000000000000002 109.352 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.816 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 9.6 Cg_endo -54.1 -163.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 121.925 1.75 . . . . 1.3100000000000001 112.83 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.517 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -30.64 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.981 -0.554 . . . . 2.3100000000000001 112.492 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.402 ' CA ' ' HA3' ' A' ' 34' ' ' GLY . . . 66.53 -63.23 0.17 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.802 -0.713 . . . . 2.52 113.043 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 2.6000000000000001 111.139 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.756 -0.138 . . . . 3.2799999999999998 112.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 t -77.64 129.99 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.599 0.238 . . . . 2.4300000000000002 110.534 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.8 m -74.82 130.01 38.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 1.8400000000000001 110.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.748 HG13 ' HB1' ' A' ' 129' ' ' ALA . 42.5 mm -118.73 129.99 74.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 2.1499999999999999 111.003 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 51.1 p -85.9 146.56 26.66 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.32 0.581 . . . . 1.1200000000000001 110.598 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 43.27 83.27 0.21 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.146 -0.934 . . . . 0.65000000000000002 111.333 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.4 Cg_endo -77.72 -77.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.568 2.845 . . . . 0.88 112.193 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 45.4 mp0 -78.64 123.22 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 2.0600000000000001 108.958 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 28' ' ' MET . 77.8 tt0 -143.81 159.99 41.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.077 1.14 . . . . 1.71 114.077 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.502 ' C ' HD12 ' A' ' 29' ' ' ILE . 57.5 ttm -134.6 130.01 35.82 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.536 -1.211 . . . . 1.8600000000000001 108.284 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.047 HD13 HG23 ' A' ' 133' ' ' ILE . 3.6 mp -131.22 138.48 53.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.03 -0.532 . . . . 0.39000000000000001 112.335 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.764 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 92.2 mt-10 -128.81 126.34 39.68 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.211 -0.45 . . . . 1.1899999999999999 110.252 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HB2' HD13 ' A' ' 110' ' ' LEU . 60.3 mmtt -142.09 156.87 45.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.892 0.377 . . . . 2.52 111.846 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB3' ' CD ' ' A' ' 35' ' ' GLU . . . -77.29 140.18 39.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.39000000000000001 111.887 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HD2' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -45.73 141.89 2.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.09 -0.505 . . . . 2.3500000000000001 111.872 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 79.3 -21.66 4.17 Favored Glycine 0 C--N 1.328 0.132 0 C-N-CA 121.168 -0.539 . . . . 0.31 113.759 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -78.48 155.25 29.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.835 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.2 m -88.67 121.69 31.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.818 -0.753 . . . . 0.33000000000000002 110.544 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -95.93 116.1 28.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.275 0.559 . . . . 0.26000000000000001 110.072 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -79.15 116.22 19.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.558 -0.746 . . . . 1.4299999999999999 111.632 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 105' ' ' ILE . 29.1 mt -104.37 104.19 43.28 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.383 -0.969 . . . . 0.80000000000000004 108.383 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 104' ' ' SER . 83.1 Cg_endo -83.26 135.58 7.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.685 2.257 . . . . 0.41999999999999998 114.712 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HZ3' ' A' ' 131' ' ' LYS . 86.9 m -141.03 103.32 4.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.273 -0.876 . . . . 1.03 109.831 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 58.2 tptt -100.9 133.86 44.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.962 -0.563 . . . . 1.6599999999999999 109.53 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.731 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 21.2 p90 -138.31 138.15 38.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.272 0.558 . . . . 1.26 111.395 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -91.5 139.64 30.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.289 -0.869 . . . . 1.3300000000000001 110.438 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' NZ ' ' A' ' 124' ' ' LYS . 86.0 mt -94.63 109.75 21.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.144 -0.317 . . . . 2.1200000000000001 110.144 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 m -81.04 139.49 49.44 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 109.942 -0.392 . . . . 1.75 109.942 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.89 -31.27 10.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.558 1.505 . . . . 1.6100000000000001 110.707 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 82.7 tt0 -75.54 -40.03 57.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.207 -0.906 . . . . 2.1800000000000002 110.827 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 80.0 m-20 -67.79 79.05 0.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.245 0.545 . . . . 2.4100000000000001 109.549 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.85 -8.74 33.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.419 -0.81 . . . . 1.6399999999999999 111.428 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.02 53.33 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.611 -0.804 . . . . 0.55000000000000004 112.335 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.18 148.82 47.61 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.255 1.97 . . . . 0.84999999999999998 111.785 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 45' ' ' LEU . 8.2 mt -78.02 131.1 37.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 1.8999999999999999 111.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.718 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 83.1 m-20 -131.72 149.77 52.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.954 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.696 ' CD1' HD11 ' A' ' 98' ' ' LEU . 23.5 mt -143.57 104.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.226 -0.897 . . . . 0.75 109.538 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 73' ' ' LEU . 86.4 tt0 -104.48 111.04 23.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.491 0.552 . . . . 1.6699999999999999 112.491 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.693 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.8 m95 -92.98 132.93 36.64 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.923 -0.311 . . . . 0.22 110.437 177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 92.3 mt -119.55 139.99 51.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.465 -0.569 . . . . 0.40999999999999998 109.465 179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.962 HD12 HD11 ' A' ' 87' ' ' LEU . 8.8 tt -129.97 130.74 66.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.752 0.649 . . . . 0.78000000000000003 112.752 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.431 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 16.9 m -125.51 101.39 30.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.306 -0.998 . . . . 1.25 108.306 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 3.0 Cg_exo -79.76 118.25 3.77 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.534 2.156 . . . . 0.53000000000000003 112.902 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.75 -39.95 86.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.561 -0.745 . . . . 0.40999999999999998 110.604 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -74.58 -40.01 61.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.847 -0.615 . . . . 1.8200000000000001 111.749 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 33.7 m120 -85.98 160.51 19.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.365 0.602 . . . . 1.9399999999999999 112.181 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -69.48 -15.87 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.103 -0.953 . . . . 1.6599999999999999 111.327 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.651 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 48.7 mttt -67.0 151.47 47.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.612 -0.722 . . . . 1.74 111.821 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.02 135.58 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 122.585 1.183 . . . . 0.96999999999999997 110.149 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 45.46 40.0 5.19 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 112.609 -2.087 . . . . 1.77 112.858 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.9 145.44 24.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.518 0.199 . . . . 1.96 110.826 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG11 ' OH ' ' A' ' 84' ' ' TYR . 21.7 t -67.12 130.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.814 0.34 . . . . 0.77000000000000002 110.124 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.899 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -109.68 -65.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.908 0.707 . . . . 1.1499999999999999 112.908 -177.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.824 HG22 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -134.06 107.4 9.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.434 -0.95 . . . . 0.28999999999999998 108.434 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 55' ' ' ILE . 8.0 tp -112.94 157.4 21.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.3 111.042 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.843 ' CD1' HD13 ' A' ' 79' ' ' ILE . 18.1 t80 -132.58 104.72 6.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 1.3 109.921 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.522 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 14.6 t -143.12 159.77 41.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.427 0.528 . . . . 0.89000000000000001 112.427 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.45 31.71 14.27 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.875 -0.602 . . . . 0.56999999999999995 112.73 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 t0 70.51 3.3 4.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.666 0.269 . . . . 1.46 111.013 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 50.1 mtpt -100.52 116.5 32.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.876 -0.416 . . . . 2.4100000000000001 109.876 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.843 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.8 mm -80.11 129.44 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 107.543 -1.28 . . . . 1.6599999999999999 107.543 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.657 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.5 m-85 -113.62 121.11 43.17 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.25 -0.886 . . . . 1.25 110.49 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.804 ' HB3' HG12 ' A' ' 72' ' ' ILE . 16.2 p-10 -165.58 -51.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.634 -1.247 . . . . 1.2 107.634 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 50.3 t0 -77.18 -21.73 53.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.157 -0.929 . . . . 2.1699999999999999 108.88 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.81 -26.46 27.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.925 -1.034 . . . . 5.0499999999999998 109.268 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.884 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 2.2 m-85 -89.05 111.32 44.19 Favored Pre-proline 0 CA--C 1.512 -0.485 0 CA-C-N 115.25 -0.886 . . . . 1.29 112.155 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.5 -38.72 28.24 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.415 1.41 . . . . 0.79000000000000004 110.473 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.744 ' O ' HG12 ' A' ' 71' ' ' ILE . 68.6 m-20 -64.46 106.07 1.07 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.977 -0.556 . . . . 1.3600000000000001 111.251 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.962 HD11 HD12 ' A' ' 59' ' ' ILE . 4.7 mt 59.95 23.08 12.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.711 1.004 . . . . 1.6200000000000001 113.711 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.884 ' HB3' ' O ' ' A' ' 84' ' ' TYR . 23.2 pttm -58.34 149.01 25.71 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.179 -1.008 . . . . 2.3900000000000001 111.379 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.83 6.72 88.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.498 -0.858 . . . . 0.37 113.024 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.791 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -142.54 -40.47 0.34 Allowed 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 113.737 1.014 . . . . 1.5900000000000001 113.737 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.923 ' CG1' HD13 ' A' ' 105' ' ' ILE . 1.6 t -85.29 87.97 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 123.221 1.486 . . . . 0.20000000000000001 107.525 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' C ' HG22 ' A' ' 105' ' ' ILE . 20.6 m80 -113.16 132.92 55.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 111.258 -2.701 . . . . 0.28999999999999998 111.86 -174.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.077 ' CD1' HG23 ' A' ' 105' ' ' ILE . 82.2 m-85 -75.26 123.96 26.24 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 119.988 -0.685 . . . . 1.23 109.75 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 p -74.69 -4.68 38.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.308 -0.86 . . . . 0.46000000000000002 110.916 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 102' ' ' ASP . 15.9 p -84.43 113.66 21.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.206 -0.452 . . . . 1.2 110.949 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -88.19 0.01 56.57 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.514 0.673 . . . . 2.2200000000000002 109.505 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -146.52 68.72 1.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.524 -1.288 . . . . 2.1400000000000001 107.524 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.696 HD11 ' CD1' ' A' ' 55' ' ' ILE . 9.3 tt -56.11 -38.23 70.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.499 -1.228 . . . . 1.49 112.029 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -63.59 -2.7 1.76 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.137 0.494 . . . . 2.04 112.119 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.2 t -89.62 -0.03 57.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.585 -0.734 . . . . 1.3999999999999999 111.204 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.731 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 107.47 -0.18 34.79 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.521 -0.847 . . . . 0.38 113.887 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 95.5 m-20 -99.48 119.95 38.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.005 0.402 . . . . 1.4399999999999999 110.986 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -118.5 3.7 11.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.21 -0.45 . . . . 0.42999999999999999 112.087 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.659 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 29.9 p -59.99 145.19 47.13 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.508 2.04 . . . . 1.04 116.508 -177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -129.93 130.07 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 114.034 -1.439 . . . . 0.31 109.809 177.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p-10 -100.77 142.38 32.33 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.578 -1.267 . . . . 1.1499999999999999 107.578 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -96.91 117.83 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 120.746 -0.381 . . . . 0.27000000000000002 110.716 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -84.55 143.3 29.41 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.743 -0.662 . . . . 0.28999999999999998 110.759 179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 80.8 m-20 49.89 58.55 5.33 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.52 111.256 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 37' ' ' ALA . 22.1 mt -46.19 90.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.642 0.979 . . . . 1.02 113.642 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 53.8 tt0 -59.64 143.92 49.23 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.712 -0.676 . . . . 2.1299999999999999 110.338 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.573 HD12 ' HD2' ' A' ' 33' ' ' LYS . 2.4 tt -60.0 -38.52 82.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.188 0.518 . . . . 1.7 110.67 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 79.3 p -74.12 -6.52 48.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.3200000000000001 111.42 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' OD1' HD22 ' A' ' 87' ' ' LEU . 95.8 m-20 -69.99 -19.47 63.34 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.346 -0.613 . . . . 1.5800000000000001 109.346 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -43.08 139.24 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 CA-C-N 115.632 -0.713 . . . . 0.41999999999999998 110.256 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.78 162.34 9.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.098 -1.049 . . . . 0.23999999999999999 113.331 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.4 m -59.71 135.23 57.62 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.408 0.521 . . . . 0.31 112.408 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.606 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 19.6 m-85 -119.99 132.1 55.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 1.24 109.618 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 7.9 mt-30 -120.16 117.5 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.613 0.244 . . . . 1.1599999999999999 110.401 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.526 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 10.2 t -101.15 106.37 17.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.92 -0.4 . . . . 1.03 109.92 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.579 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 77.7 mttt -113.26 112.5 23.84 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.522 -0.308 . . . . 1.76 111.501 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 37.8 t -92.96 108.24 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.765 -0.458 . . . . 1.1799999999999999 109.765 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 82.2 tttt -97.0 119.17 34.97 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.783 0.66 . . . . 1.6200000000000001 112.783 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.9 tttt -145.82 102.79 3.7 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.646 -0.502 . . . . 2.8399999999999999 109.646 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.627 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.78 131.59 21.02 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.286 0.847 . . . . 0.44 113.286 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.558 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 63.7 Cg_endo -100.35 40.66 4.13 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.675 -0.969 . . . . 0.56000000000000005 111.979 -1.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.67 102.27 0.48 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.26 -0.972 . . . . 0.47999999999999998 113.225 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.58 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.0 m -91.96 141.76 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 113.629 -1.286 . . . . 1.22 109.879 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -139.87 152.18 46.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.992 -0.283 . . . . 0.56999999999999995 111.706 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.579 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 41.2 p-10 -146.35 149.64 34.18 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.419 0.526 . . . . 2.0299999999999998 112.419 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 10.6 ptmt -144.44 157.77 44.08 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.895 -0.593 . . . . 2.9500000000000002 110.81 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 5.6 ttmm -100.98 139.97 35.93 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.78 0.659 . . . . 2.2599999999999998 112.78 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.047 HG23 HD13 ' A' ' 29' ' ' ILE . 89.2 mt -142.06 113.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.479 -0.782 . . . . 0.28000000000000003 109.689 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -100.13 114.75 28.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.728 -0.471 . . . . 0.55000000000000004 109.728 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 53.8 tp -94.73 123.0 37.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.609 0.596 . . . . 1.52 112.609 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.764 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.8 t -119.93 122.18 67.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.032 -0.729 . . . . 0.32000000000000001 109.032 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 16.4 t -100.27 127.16 53.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.952 0.406 . . . . 1.0800000000000001 111.988 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.65 159.42 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.52000000000000002 109.705 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.51 136.32 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.461 0.648 . . . . 1.48 111.333 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.542 ' HB2' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -165.05 177.14 1.76 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.868 -1.06 . . . . 2.2000000000000002 109.718 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 140' ' ' LYS . 66.7 Cg_exo -51.28 -173.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.995 1.797 . . . . 1.3100000000000001 111.689 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 p -35.63 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.748 0.309 . . . . 2.3100000000000001 111.792 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.21 -29.64 1.64 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.99 -0.624 . . . . 2.52 113.59 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 109' ' ' ASN . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.233 -0.889 . . . . 2.6000000000000001 111.292 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.72 -0.152 . . . . 3.2799999999999998 112.72 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -77.4 160.0 29.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.892 0.377 . . . . 2.4300000000000002 111.151 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -159.22 150.36 20.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.488 . . . . 1.8400000000000001 110.986 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.933 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 10.9 tt -141.67 144.23 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.776 -0.647 . . . . 2.1499999999999999 110.482 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.6 p -88.12 152.73 21.79 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.414 0.626 . . . . 1.1200000000000001 111.574 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.687 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 37.91 84.75 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.743 -1.117 . . . . 0.65000000000000002 111.212 -178.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.2 Cg_endo -76.8 -11.6 18.26 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 123.417 2.745 . . . . 0.88 112.777 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.9 126.6 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.544 -0.91 . . . . 2.0600000000000001 108.544 177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HD11 ' A' ' 29' ' ' ILE . 81.0 tt0 -143.93 159.41 42.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.25 1.204 . . . . 1.71 114.25 -176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 77.9 mtp -139.96 123.89 17.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.678 -1.146 . . . . 1.8600000000000001 109.781 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.769 HD11 ' OE2' ' A' ' 27' ' ' GLU . 36.3 mm -122.47 129.46 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.649 0.261 . . . . 0.39000000000000001 111.288 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.613 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.3 mt-10 -119.95 124.21 45.43 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.499 -0.319 . . . . 1.1899999999999999 110.554 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' A' ' 110' ' ' LEU . 23.6 mmtt -142.22 162.22 36.01 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 2.52 111.639 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.808 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.56 137.93 39.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.125 -0.489 . . . . 0.39000000000000001 111.76 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 53.9 tttt -48.33 129.99 16.02 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.208 -0.451 . . . . 2.3500000000000001 111.083 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 90.0 -18.96 45.01 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.118 -0.563 . . . . 0.31 112.349 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.594 ' O ' HD12 ' A' ' 110' ' ' LEU . 82.0 mm-40 -80.09 160.0 25.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.246 -1.02 . . . . 2.1099999999999999 108.246 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 82.8 m -88.18 128.31 35.45 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.568 -0.853 . . . . 0.33000000000000002 110.814 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -98.95 119.98 38.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.115 0.483 . . . . 0.26000000000000001 110.394 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 94' ' ' THR . 30.5 t80 -79.51 113.89 18.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.803 -0.635 . . . . 1.4299999999999999 111.427 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.766 ' HB2' HD12 ' A' ' 105' ' ' ILE . 47.1 mt -100.96 106.3 43.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.442 -0.948 . . . . 0.80000000000000004 108.442 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.669 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 4.4 Cg_endo -84.92 126.23 3.3 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.401 2.068 . . . . 0.41999999999999998 113.361 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 19.7 t -140.59 125.92 18.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.6 -0.889 . . . . 1.03 108.6 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 22' ' ' ILE . 8.4 mtpm? -140.82 148.55 40.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.943 -0.571 . . . . 1.6599999999999999 111.473 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' CD1' HG11 ' A' ' 122' ' ' VAL . 50.3 p90 -139.99 143.1 36.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.027 -0.988 . . . . 1.26 111.613 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.1 p -83.3 159.96 21.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.814 -0.63 . . . . 1.3300000000000001 111.093 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.58 122.88 36.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 2.1200000000000001 110.458 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 15.8 m -76.06 155.97 84.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.599 -0.273 . . . . 1.75 110.404 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.41 -20.1 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.562 2.175 . . . . 1.6100000000000001 112.399 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 79.5 tt0 -148.19 34.55 0.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.607 -0.27 . . . . 2.1800000000000002 111.267 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 46' ' ' SER . 34.0 p-10 -69.92 69.94 0.33 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.022 0.439 . . . . 2.4100000000000001 110.447 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -96.42 -1.4 47.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 1.6399999999999999 111.679 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.671 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -72.84 153.95 49.33 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.206 -0.997 . . . . 0.55000000000000004 112.165 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.68 126.8 23.45 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.235 1.957 . . . . 0.84999999999999998 111.152 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.874 HD21 ' HD3' ' A' ' 124' ' ' LYS . 1.3 mt -77.94 104.55 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.448 -0.342 . . . . 1.8999999999999999 111.23 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -116.98 103.42 10.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.535 0.683 . . . . 1.78 110.728 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 5.1 mt -97.57 121.27 47.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.75 110.782 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.932 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 86.3 tt0 -115.41 126.37 54.3 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.34 0.496 . . . . 1.6699999999999999 112.34 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.732 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.0 m95 -100.52 124.24 45.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.22 110.16 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.513 HD21 ' OE2' ' A' ' 56' ' ' GLU . 86.1 mt -109.52 140.52 43.19 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.499 -0.556 . . . . 0.40999999999999998 109.499 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 6.0 tt -127.77 130.03 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.485 . . . . 0.78000000000000003 112.259 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 17.8 m -120.18 102.41 46.08 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.892 -0.781 . . . . 1.25 108.892 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.3 Cg_exo -79.4 118.08 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.514 2.143 . . . . 0.53000000000000003 112.628 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.98 87.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.721 -0.672 . . . . 0.40999999999999998 110.542 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -75.69 -40.01 56.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 1.8200000000000001 111.425 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' CB ' ' HB2' ' A' ' 61' ' ' PRO . 15.6 t-20 -82.61 158.15 23.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.521 . . . . 1.9399999999999999 111.731 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -69.18 -20.02 64.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 1.6599999999999999 111.895 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.75 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 18.5 mtpt -70.59 151.73 44.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.138 -0.483 . . . . 1.74 111.907 -178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.2 m -153.94 129.06 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.799 0.809 . . . . 0.96999999999999997 109.106 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 59.5 39.18 22.05 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.231 -1.35 . . . . 1.77 111.785 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 66' ' ' LYS . 96.0 mm-40 -92.09 153.56 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.356 -0.384 . . . . 1.96 111.415 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.711 HG21 ' CE1' ' A' ' 84' ' ' TYR . 4.2 p -64.34 150.55 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.427 -0.582 . . . . 0.77000000000000002 109.427 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.914 ' CD1' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -144.21 -57.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.179 -0.608 . . . . 1.1499999999999999 112.504 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.975 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.56 135.12 34.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.626 -0.509 . . . . 0.28999999999999998 109.626 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.932 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 4.0 mp -140.73 164.06 31.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 1.3 112.207 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.888 ' CD1' HD13 ' A' ' 79' ' ' ILE . 45.3 t80 -137.2 103.27 5.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.337 -0.847 . . . . 1.3 109.195 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.454 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 12.8 t -144.1 159.58 42.39 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.083 -0.508 . . . . 0.89000000000000001 112.256 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.33 31.02 4.53 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.058 -0.519 . . . . 0.56999999999999995 113.353 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 72.03 1.95 4.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.446 0.165 . . . . 1.46 111.419 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 87.4 mttt -100.01 117.77 34.99 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.657 -0.497 . . . . 2.4100000000000001 109.657 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.888 HD13 ' CD1' ' A' ' 74' ' ' TYR . 3.4 mm -80.02 130.31 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.436 -1.32 . . . . 1.6599999999999999 107.436 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.732 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.3 m-85 -117.45 125.17 50.47 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.325 -0.852 . . . . 1.25 110.655 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.885 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.8 p-10 -165.93 -55.1 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.975 -1.491 . . . . 1.2 106.975 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HA ' ' N ' ' A' ' 89' ' ' GLY . 51.1 t0 -80.64 -21.51 41.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.864 -1.062 . . . . 2.1699999999999999 109.047 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.3 t80 -81.56 -25.91 35.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.371 -0.974 . . . . 5.0499999999999998 108.371 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.729 ' CZ ' HD13 ' A' ' 73' ' ' LEU . 2.2 m-85 -87.11 120.71 71.56 Favored Pre-proline 0 CA--C 1.509 -0.604 0 CA-C-N 115.273 -0.876 . . . . 1.29 110.555 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 6.9 Cg_endo -48.56 -43.78 32.39 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.391 1.394 . . . . 0.79000000000000004 110.443 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.573 ' O ' HG12 ' A' ' 71' ' ' ILE . 2.8 m-20 -68.72 107.22 2.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.297 -0.961 . . . . 1.3600000000000001 111.328 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.813 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 15.9 mt 68.75 25.9 6.24 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.642 0.979 . . . . 1.6200000000000001 113.642 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.885 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.2 pttt -56.62 127.53 31.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.025 -0.67 . . . . 2.3900000000000001 111.431 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 82' ' ' ASP . . . 91.66 16.3 52.48 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.433 -0.889 . . . . 0.37 114.135 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.813 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 3.3 ptp180 -144.32 -47.68 0.26 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.707 1.373 . . . . 1.5900000000000001 114.707 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.6 p -80.85 82.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 123.038 1.399 . . . . 0.20000000000000001 108.119 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.698 ' C ' HG22 ' A' ' 105' ' ' ILE . 20.3 m80 -101.29 130.18 47.39 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.639 -2.073 . . . . 0.28999999999999998 111.997 -176.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.121 ' CD1' HG23 ' A' ' 105' ' ' ILE . 71.1 m-85 -74.09 121.55 21.31 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.551 0.691 . . . . 1.23 109.704 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -69.98 -11.17 60.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.65 -1.159 . . . . 0.46000000000000002 110.096 179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.7 m -93.49 120.02 33.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.971 -0.559 . . . . 1.2 110.738 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -89.56 0.03 57.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.071 0.462 . . . . 2.2200000000000002 110.26 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -146.19 67.24 1.19 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.764 -0.828 . . . . 2.1400000000000001 108.764 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 74' ' ' TYR . 5.2 mp -54.61 -23.58 17.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.141 -0.936 . . . . 1.49 111.655 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.26 -4.59 3.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.216 0.532 . . . . 2.04 111.759 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 81.7 p -88.53 0.02 56.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.305 -0.861 . . . . 1.3999999999999999 111.072 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 102.86 -14.18 56.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.744 -0.741 . . . . 0.38 113.151 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.18 108.95 21.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.911 0.355 . . . . 1.4399999999999999 110.69 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -110.05 16.69 21.7 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.36 0.504 . . . . 0.42999999999999999 112.36 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m -60.03 145.78 45.14 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 115.793 1.775 . . . . 1.04 115.793 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.121 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.41 136.02 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 114.082 -1.417 . . . . 0.31 110.783 178.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 90' ' ' ARG . 49.2 p-10 -107.11 143.52 35.15 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.528 -0.915 . . . . 1.1499999999999999 108.528 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.85 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.71 120.7 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.063 0.459 . . . . 0.27000000000000002 111.655 -178.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.55 144.54 29.43 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.333 -0.849 . . . . 0.28999999999999998 111.012 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 29.0 m120 49.84 55.89 8.71 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.281 -0.418 . . . . 1.52 111.811 178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.891 HD22 HD11 ' A' ' 135' ' ' LEU . 21.7 mt -45.45 89.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.699 1.0 . . . . 1.02 113.699 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 52.3 tt0 -60.05 143.82 51.0 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.582 -0.525 . . . . 2.1299999999999999 109.582 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.96 -40.04 87.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.927 0.394 . . . . 1.7 110.892 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -73.3 -10.01 59.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.3200000000000001 111.613 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 96.2 m-20 -70.56 -17.24 62.92 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.892 -0.41 . . . . 1.5800000000000001 109.892 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.61 143.76 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 CA-C-N 115.862 -0.608 . . . . 0.41999999999999998 110.381 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.75 157.09 7.07 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.155 -1.021 . . . . 0.23999999999999999 113.201 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.597 HG23 ' CD2' ' A' ' 134' ' ' HIS . 94.6 m -59.34 138.95 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.339 0.496 . . . . 0.31 112.339 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.552 ' OH ' HD11 ' A' ' 87' ' ' LEU . 9.6 m-85 -120.09 130.91 54.87 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.432 -0.581 . . . . 1.24 109.432 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 66.7 tt0 -127.47 119.96 27.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.957 -0.297 . . . . 1.1599999999999999 111.015 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 21.6 p -102.71 119.95 39.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.76 0.314 . . . . 1.03 110.554 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 97.5 mttt -112.75 104.9 12.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 1.76 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.764 HG22 HG12 ' A' ' 55' ' ' ILE . 21.8 t -88.42 117.31 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.325 -0.62 . . . . 1.1799999999999999 109.325 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.848 ' HG2' HG12 ' A' ' 128' ' ' VAL . 75.8 mttt -113.76 118.31 33.93 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.91 1.078 . . . . 1.6200000000000001 113.91 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.874 ' HD3' HD21 ' A' ' 53' ' ' LEU . 21.1 pttm -146.94 103.8 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.639 -0.71 . . . . 2.8399999999999999 110.809 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.671 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -48.34 129.11 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.92 -0.582 . . . . 0.44 111.835 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -104.11 53.79 1.21 Allowed 'Cis proline' 0 N--CA 1.453 -0.886 0 C-N-CA 125.207 -0.747 . . . . 0.56000000000000005 111.802 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.8 102.98 0.27 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.95 -1.119 . . . . 0.47999999999999998 113.871 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 123' ' ' LYS . 17.1 m -94.24 134.27 32.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.394 -0.903 . . . . 1.22 109.845 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.933 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -143.55 136.6 27.72 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.13 0.418 . . . . 0.56999999999999995 112.13 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.605 ' C ' HD13 ' A' ' 22' ' ' ILE . 45.9 p-10 -146.79 150.24 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.219 0.452 . . . . 2.0299999999999998 112.219 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.758 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.55 163.52 34.51 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 2.9500000000000002 110.567 179.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 98.0 mttt -101.3 145.05 29.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 114.25 1.204 . . . . 2.2599999999999998 114.25 -177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.673 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.53 119.36 11.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.63 -1.168 . . . . 0.28000000000000003 108.654 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.597 ' CD2' HG23 ' A' ' 117' ' ' THR . 52.4 m170 -100.43 119.75 38.95 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.564 -0.455 . . . . 0.55000000000000004 110.741 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.891 HD11 HD22 ' A' ' 110' ' ' LEU . 1.5 tm? -89.58 120.04 30.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 1.52 111.384 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.613 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 49.1 t -117.3 120.0 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.762 -0.653 . . . . 0.32000000000000001 109.551 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.66 125.34 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.016 0.436 . . . . 1.0800000000000001 112.035 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 92.9 mt -84.85 170.01 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.52000000000000002 109.368 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.43 135.18 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 1.48 111.69 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.808 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 5.8 mttt -165.05 176.47 2.05 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.717 -1.129 . . . . 2.2000000000000002 110.015 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.472 ' HD2' ' HD3' ' A' ' 140' ' ' LYS . 44.6 Cg_exo -56.87 155.5 27.4 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.302 2.002 . . . . 1.3100000000000001 112.251 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.443 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 1.1 m -40.05 -74.03 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.15 -0.477 . . . . 2.3100000000000001 111.948 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.24 -65.26 0.09 OUTLIER Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.99 -0.624 . . . . 2.52 112.854 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.282 -0.866 . . . . 2.6000000000000001 111.258 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.498 -0.241 . . . . 3.2799999999999998 112.498 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.2 p -78.28 159.96 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.824 0.345 . . . . 2.4300000000000002 110.827 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.8 m -157.84 133.9 9.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.8400000000000001 110.998 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.784 ' CD1' ' HB1' ' A' ' 129' ' ' ALA . 85.6 mt -110.0 129.96 64.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 2.1499999999999999 110.558 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 38.1 p -91.44 148.34 22.38 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.191 0.519 . . . . 1.1200000000000001 110.792 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.62 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 41.38 82.69 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 115.089 -0.96 . . . . 0.65000000000000002 111.117 -177.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 58.1 Cg_endo -78.46 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.33 -0.414 0 C-N-CA 123.971 3.114 . . . . 0.88 112.926 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -78.27 126.3 30.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.504 -0.925 . . . . 2.0600000000000001 108.504 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.934 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -143.74 160.02 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.893 1.071 . . . . 1.71 113.893 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.793 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.16 137.21 38.95 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 114.881 -1.054 . . . . 1.8600000000000001 109.281 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.934 HD11 ' OE2' ' A' ' 27' ' ' GLU . 32.2 mm -134.16 140.02 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.296 0.48 . . . . 0.39000000000000001 112.296 -178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt-10 -130.14 123.96 31.54 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.431 -0.581 . . . . 1.1899999999999999 109.431 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.606 ' HB3' HD13 ' A' ' 110' ' ' LEU . 49.3 tptt -142.07 157.22 45.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.981 -0.287 . . . . 2.52 111.31 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.872 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.8 141.66 40.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.39000000000000001 112.067 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 142' ' ' SER . 59.5 tttp -48.67 131.48 17.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.884 -0.598 . . . . 2.3500000000000001 111.872 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 87.38 -17.36 43.92 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.13 -0.557 . . . . 0.31 113.267 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.771 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.1 mt-10 -80.01 159.77 26.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.628 -0.879 . . . . 2.1099999999999999 108.628 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.863 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 90.4 m -89.37 128.5 35.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.652 -0.819 . . . . 0.33000000000000002 110.367 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.966 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.0 112.12 24.33 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.26000000000000001 110.343 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CD1' HG21 ' A' ' 94' ' ' THR . 77.4 t80 -79.15 117.89 20.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 111.616 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.831 HD22 HG21 ' A' ' 133' ' ' ILE . 39.9 mt -105.97 104.73 50.71 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.249 -0.649 . . . . 0.80000000000000004 109.249 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.37 127.19 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.448 2.099 . . . . 0.41999999999999998 113.497 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -140.31 130.18 24.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.359 -0.837 . . . . 1.03 109.616 179.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 8.9 mptt -140.03 140.34 36.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 110.003 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CG ' HG11 ' A' ' 122' ' ' VAL . 50.0 p90 -140.23 139.81 35.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.26 111.704 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 p -88.91 147.42 24.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.612 -0.722 . . . . 1.3300000000000001 111.441 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 124' ' ' LYS . 24.5 tp -99.48 114.38 27.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 2.1200000000000001 110.903 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -81.87 145.46 53.75 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 110.028 -0.36 . . . . 1.75 110.028 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -49.62 -34.15 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.782 1.654 . . . . 1.6100000000000001 110.536 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -75.64 -40.02 56.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.282 -0.872 . . . . 2.1800000000000002 110.641 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.548 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 90.7 m-20 -69.51 73.58 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.134 0.493 . . . . 2.4100000000000001 109.759 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -94.29 -4.84 48.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.542 -0.754 . . . . 1.6399999999999999 111.621 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.666 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.99 157.33 53.51 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.413 -0.899 . . . . 0.55000000000000004 112.536 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.45 148.88 10.4 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.477 2.118 . . . . 0.84999999999999998 111.858 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.985 HD22 ' HA ' ' A' ' 99' ' ' LYS . 5.6 mp -78.16 135.76 37.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.02 0.438 . . . . 1.8999999999999999 111.503 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 9.2 t70 -140.73 153.59 45.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 1.78 111.876 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 21.5 mt -142.49 139.93 28.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.007 -0.997 . . . . 0.75 109.667 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.621 ' HG2' HD11 ' A' ' 73' ' ' LEU . 98.0 mt-10 -140.23 111.71 7.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.026 0.375 . . . . 1.6699999999999999 111.748 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.965 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -97.68 119.9 37.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.867 -0.333 . . . . 0.22 110.929 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 119' ' ' GLN . 89.2 mt -104.9 138.84 40.52 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.014 -0.736 . . . . 0.40999999999999998 109.014 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.9 tt -129.97 129.98 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.321 0.489 . . . . 0.78000000000000003 112.321 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.8 m -121.44 102.45 42.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 1.25 109.153 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.8 Cg_exo -81.46 116.19 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.645 2.23 . . . . 0.53000000000000003 112.716 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.99 -33.25 71.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.71 . . . . 0.40999999999999998 110.886 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -85.29 12.89 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 1.8200000000000001 112.148 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 93.9 m-20 -146.99 163.19 37.02 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.37 0.605 . . . . 1.9399999999999999 111.873 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.06 -18.06 65.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.065 -0.97 . . . . 1.6599999999999999 111.912 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.676 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 96.2 mttt -67.16 140.01 57.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.117 0.484 . . . . 1.74 111.827 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.0 127.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.852 0.834 . . . . 0.96999999999999997 109.012 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.82 39.33 29.64 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.098 -1.41 . . . . 1.77 111.796 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -94.72 140.01 30.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 1.96 110.816 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' OH ' ' A' ' 84' ' ' TYR . 43.0 t -69.86 127.1 31.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.987 0.422 . . . . 0.77000000000000002 110.276 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.925 HG13 HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -112.04 -51.38 5.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.925 -0.58 . . . . 1.1499999999999999 112.124 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.866 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -136.92 130.13 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.593 -0.891 . . . . 0.28999999999999998 108.593 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 74' ' ' TYR . 3.3 tt -140.1 157.03 46.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 1.3 111.271 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.905 ' CD1' HD13 ' A' ' 79' ' ' ILE . 36.8 t80 -135.45 104.33 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.345 -0.388 . . . . 1.3 110.076 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.7 t -144.24 157.26 44.39 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.416 0.524 . . . . 0.89000000000000001 112.416 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.22 12.57 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.214 -0.517 . . . . 0.56999999999999995 113.075 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t0 72.12 3.27 4.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.497 0.184 . . . . 1.46 111.497 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 81.8 mttt -100.02 114.85 28.46 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.568 -0.53 . . . . 2.4100000000000001 109.568 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.905 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.9 mm -79.81 129.81 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 107.313 -1.366 . . . . 1.6599999999999999 107.313 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.717 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -115.55 119.2 35.38 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.095 -0.957 . . . . 1.25 110.197 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.803 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 10.0 p-10 -166.19 -51.74 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.695 -1.595 . . . . 1.2 106.695 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -80.04 -23.92 41.1 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.352 -1.295 . . . . 2.1699999999999999 108.49 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.542 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 0.7 OUTLIER -80.82 -27.05 36.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.057 -1.09 . . . . 5.0499999999999998 108.057 177.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.528 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.6 m-85 -86.57 108.86 19.75 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-N 115.154 -0.93 . . . . 1.29 110.014 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 83' ' ' TYR . 30.7 Cg_exo -61.47 -28.64 83.82 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.729 1.619 . . . . 0.79000000000000004 112.065 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.797 ' O ' HD22 ' A' ' 87' ' ' LEU . 53.2 t0 -44.32 -36.34 2.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.347 0.594 . . . . 1.3600000000000001 111.762 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.925 HD23 HG13 ' A' ' 71' ' ' ILE . 1.5 mm? -156.48 33.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.751 -1.113 . . . . 1.6200000000000001 110.56 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.803 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 63.3 pttt -52.9 129.98 31.94 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.435 -0.506 . . . . 2.3900000000000001 111.902 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.14 57.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.506 -0.854 . . . . 0.37 114.818 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.889 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 7.3 ptp180 -142.88 -46.6 0.31 Allowed 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 115.009 1.485 . . . . 1.5900000000000001 115.009 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.866 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.0 p -80.22 81.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.748 1.261 . . . . 0.20000000000000001 108.235 -177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.483 ' C ' HG22 ' A' ' 105' ' ' ILE . 22.3 m80 -103.13 129.69 50.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.892 -1.958 . . . . 0.28999999999999998 112.521 -175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.115 ' CD1' HG23 ' A' ' 105' ' ' ILE . 75.4 m-85 -73.17 122.79 22.44 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 120.002 -0.679 . . . . 1.23 109.245 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.534 HG21 ' CD1' ' A' ' 38' ' ' TYR . 17.9 p -72.16 -9.93 59.1 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.148 -0.933 . . . . 0.46000000000000002 110.274 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 1.4 m -89.13 122.05 32.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.658 -0.701 . . . . 1.2 110.5 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -91.34 4.45 52.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.218 0.532 . . . . 2.2200000000000002 110.396 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -146.57 66.71 1.17 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.424 -0.807 . . . . 2.1400000000000001 108.903 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 93' ' ' PHE . 7.9 mp -57.92 -35.04 70.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.254 -0.885 . . . . 1.49 111.434 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.985 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.1 pttt -60.05 -13.78 13.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.701 0.762 . . . . 2.04 111.801 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.0 t -82.99 0.04 46.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.386 -1.279 . . . . 1.3999999999999999 110.99 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.86 -2.51 38.65 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.543 -0.836 . . . . 0.38 113.742 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.55 112.65 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.172 0.486 . . . . 1.4399999999999999 110.976 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' CYS . . . -109.83 10.53 24.52 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.388 0.514 . . . . 0.42999999999999999 112.388 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.668 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 p -60.06 137.08 58.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.825 1.787 . . . . 1.04 115.825 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.115 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -133.98 129.99 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 114.247 -1.342 . . . . 0.31 110.698 178.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.719 ' OD1' HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -105.21 145.33 30.77 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.527 -0.546 . . . . 1.1499999999999999 109.527 177.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.863 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.49 118.72 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.142 0.496 . . . . 0.27000000000000002 111.351 -178.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -83.19 143.7 30.3 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 110.757 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 28.0 m120 49.95 55.16 9.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.083 0.468 . . . . 1.52 111.508 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.966 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.9 mt -45.26 88.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.225 1.194 . . . . 1.02 114.225 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' CG ' ' A' ' 114' ' ' ASP . 14.7 pt20 -59.66 151.45 24.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 2.1299999999999999 109.756 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.478 ' HG ' ' HD2' ' A' ' 33' ' ' LYS . 84.5 mt -60.12 -28.39 67.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 1.7 110.863 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.3 m -73.93 -5.95 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 1.3200000000000001 111.424 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.527 ' HB3' HD23 ' A' ' 135' ' ' LEU . 87.9 m-20 -69.92 -23.63 63.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.616 -0.513 . . . . 1.5800000000000001 109.616 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -44.87 133.47 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-N 116.116 -0.493 . . . . 0.41999999999999998 110.091 178.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.65 158.71 7.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.034 -1.079 . . . . 0.23999999999999999 113.386 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 95.9 m -59.35 133.89 56.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.569 0.581 . . . . 0.31 112.569 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.641 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 25.9 m-85 -118.4 132.83 56.24 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.035 -0.53 . . . . 1.24 109.692 177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 9.5 mt-30 -120.01 119.98 34.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.627 -0.261 . . . . 1.1599999999999999 111.666 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.574 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 42.7 t -100.04 107.3 19.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.214 -0.662 . . . . 1.03 109.214 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 8.9 mtpm? -114.19 109.31 18.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.418 -0.355 . . . . 1.76 111.492 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.765 HG11 ' CG ' ' A' ' 43' ' ' PHE . 53.2 t -91.85 108.36 19.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.652 -0.499 . . . . 1.1799999999999999 109.652 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 64.7 tttm -93.63 120.37 33.82 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.246 -0.582 . . . . 1.6200000000000001 112.206 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 4.6 mtpt -144.38 102.2 3.8 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.821 -0.436 . . . . 2.8399999999999999 109.821 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.666 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.04 130.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 113.44 0.904 . . . . 0.44 113.44 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 88.5 Cg_endo -101.64 42.16 3.3 Favored 'Cis proline' 0 C--N 1.354 0.866 0 C-N-CA 125.094 -0.794 . . . . 0.56000000000000005 111.811 -1.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.95 103.59 0.46 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 122.006 0.781 . . . . 0.47999999999999998 112.723 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.584 HG12 ' HG3' ' A' ' 123' ' ' LYS . 23.0 m -82.93 155.73 3.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.086 -1.057 . . . . 1.22 110.433 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.784 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -137.84 143.19 40.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.56 0.219 . . . . 0.56999999999999995 111.397 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 47.9 t30 -146.59 134.59 21.45 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.121 0.415 . . . . 2.0299999999999998 112.121 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.684 ' CE ' HD11 ' A' ' 133' ' ' ILE . 0.1 OUTLIER -142.22 158.87 43.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.55 -0.537 . . . . 2.9500000000000002 109.55 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 43.5 mmtm -109.98 146.68 34.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.659 1.355 . . . . 2.2599999999999998 114.659 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.831 HG21 HD22 ' A' ' 39' ' ' LEU . 98.9 mt -144.17 122.57 6.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-N 114.586 -1.188 . . . . 0.28000000000000003 109.335 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.09 111.6 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.591 -0.443 . . . . 0.55000000000000004 110.063 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.543 HD21 HD22 ' A' ' 110' ' ' LEU . 51.6 tp -87.83 135.53 33.35 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.524 0.564 . . . . 1.52 112.524 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.549 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 63.0 t -129.99 130.03 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 0.32000000000000001 109.491 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 20.4 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.363 . . . . 1.0800000000000001 111.859 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 87.9 mt -83.81 167.86 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.045 -0.525 . . . . 0.52000000000000002 109.609 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 t -75.89 138.16 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.381 0.61 . . . . 1.48 111.208 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.872 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 5.3 mttt -163.6 170.49 7.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.175 -0.92 . . . . 2.2000000000000002 110.823 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 10.2 Cg_endo -50.95 -158.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.98 2.454 . . . . 1.3100000000000001 112.827 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.518 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 68.3 m -36.78 -40.74 0.28 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.35 -0.387 . . . . 2.3100000000000001 111.721 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.576 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 34.59 47.35 0.62 Allowed Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.779 -0.646 . . . . 2.52 114.139 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.212 -0.899 . . . . 2.6000000000000001 111.083 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.711 -0.156 . . . . 3.2799999999999998 112.711 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 m -158.93 159.15 34.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.348 . . . . 2.4300000000000002 110.763 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.55 149.95 19.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 1.8400000000000001 110.738 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 42' ' ' LYS . 1.9 pt -142.28 143.86 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.0 -0.546 . . . . 2.1499999999999999 110.869 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 27.5 p -88.58 162.43 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.793 0.806 . . . . 1.1200000000000001 112.325 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.12 82.78 0.22 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.264 -1.335 . . . . 0.65000000000000002 112.712 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 63.3 Cg_endo -79.12 -86.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.775 2.984 . . . . 0.88 112.421 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 6.2 pm0 -78.0 122.02 24.99 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.711 -0.848 . . . . 2.0600000000000001 108.711 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 132' ' ' LYS . 51.3 tp10 -144.22 159.99 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.715 1.006 . . . . 1.71 113.715 -176.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 29' ' ' ILE . 57.7 ttm -137.9 133.01 33.3 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.829 -1.078 . . . . 1.8600000000000001 109.091 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 28' ' ' MET . 32.0 mm -130.05 140.04 49.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.853 -0.612 . . . . 0.39000000000000001 111.358 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 17.1 pt-20 -136.85 127.3 26.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.455 -0.338 . . . . 1.1899999999999999 110.687 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 18.3 mmtp -142.31 164.18 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.309 -0.405 . . . . 2.52 111.03 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.888 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.35 137.33 39.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.39000000000000001 111.269 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 21.0 ttpt -45.79 130.34 9.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 2.3500000000000001 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 92.23 -18.02 55.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.005 -0.617 . . . . 0.31 112.746 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.7 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 98.9 mt-10 -79.99 156.0 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.704 -0.85 . . . . 2.1099999999999999 108.704 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 62.6 m -87.98 127.83 35.38 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.666 -0.814 . . . . 0.33000000000000002 110.67 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.942 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.9 115.1 28.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.26000000000000001 110.787 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.702 ' CE2' HG21 ' A' ' 94' ' ' THR . 25.1 t80 -79.37 120.06 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.036 -0.529 . . . . 1.4299999999999999 111.491 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 105' ' ' ILE . 18.3 mt -109.48 104.78 56.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.093 -0.706 . . . . 0.80000000000000004 109.093 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.492 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 88.3 Cg_endo -84.76 131.16 4.46 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.818 2.345 . . . . 0.41999999999999998 115.082 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.415 ' SG ' ' CZ2' ' A' ' 57' ' ' TRP . 62.6 m -141.34 104.01 4.52 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.623 -0.717 . . . . 1.03 110.251 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.494 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 4.4 mptp? -102.96 140.04 37.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 1.6599999999999999 110.662 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.585 ' CE1' ' HA2' ' A' ' 101' ' ' GLY . 50.4 p90 -140.55 146.68 38.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 1.26 110.826 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 82.4 p -80.02 167.1 20.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 111.65 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.96 142.88 36.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 2.1200000000000001 111.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 82.0 p -160.02 159.69 27.01 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.474 -0.784 . . . . 1.75 110.003 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 16.4 Cg_endo -57.77 -16.65 26.12 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.197 1.931 . . . . 1.6100000000000001 112.772 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.0 tt0 -72.21 -41.54 66.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.654 0.264 . . . . 2.1800000000000002 110.303 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.79 80.4 0.87 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.815 -0.809 . . . . 2.4100000000000001 108.815 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.61 -11.24 49.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.238 -0.892 . . . . 1.6399999999999999 111.686 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -78.3 156.82 43.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.217 -0.992 . . . . 0.55000000000000004 111.916 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.84 148.81 81.97 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.226 1.951 . . . . 0.84999999999999998 111.435 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 99' ' ' LYS . 92.7 mt -77.5 131.7 38.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.806 0.336 . . . . 1.8999999999999999 110.288 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -133.83 152.34 51.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.245 0.545 . . . . 1.78 111.093 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 27.2 mt -143.57 107.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.923 -1.035 . . . . 0.75 109.711 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.745 ' HG2' HD11 ' A' ' 73' ' ' LEU . 97.6 mt-10 -110.25 115.01 28.93 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.191 0.441 . . . . 1.6699999999999999 112.191 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.828 ' CE2' HD11 ' A' ' 105' ' ' ILE . 76.9 m95 -99.17 120.89 40.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.22 110.612 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 87.7 mt -105.21 140.77 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.40999999999999998 109.45 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 117' ' ' THR . 12.3 tt -130.0 130.02 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.274 0.559 . . . . 0.78000000000000003 112.165 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.1 p -119.17 103.06 48.04 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.585 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 88.3 Cg_endo -79.07 114.65 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.51 2.14 . . . . 0.53000000000000003 113.208 -178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.03 87.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.497 -0.774 . . . . 0.40999999999999998 111.006 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.99 -40.03 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.835 -0.62 . . . . 1.8200000000000001 111.437 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.585 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.85 160.87 21.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 1.9399999999999999 111.661 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.0 -22.0 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.349 -0.841 . . . . 1.6599999999999999 112.313 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.575 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -72.64 156.73 38.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.765 0.317 . . . . 1.74 111.789 -178.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.35 128.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.13 0 CA-C-O 121.906 0.86 . . . . 0.96999999999999997 109.954 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.99 39.98 19.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.979 -1.464 . . . . 1.77 112.47 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -88.86 146.84 24.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.666 -0.243 . . . . 1.96 110.578 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.564 HG11 ' OH ' ' A' ' 84' ' ' TYR . 17.2 t -68.87 124.3 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 109.676 -0.49 . . . . 0.77000000000000002 109.676 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -112.04 -52.14 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 113.055 0.761 . . . . 1.1499999999999999 113.055 -177.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.0 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.06 124.64 26.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 108.537 -0.912 . . . . 0.28999999999999998 108.537 179.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.745 HD11 ' HG2' ' A' ' 56' ' ' GLU . 3.8 tt -132.24 156.48 46.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 1.3 110.586 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.875 ' CD2' HD22 ' A' ' 98' ' ' LEU . 15.6 t80 -135.14 104.98 6.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.249 -0.432 . . . . 1.3 109.94 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 7.7 t -142.11 158.84 43.29 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.822 0.344 . . . . 0.89000000000000001 111.802 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.4 28.7 36.57 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.843 -0.694 . . . . 0.56999999999999995 112.217 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.6 t0 72.2 3.28 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.24 . . . . 1.46 110.871 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 20.9 mmtp -100.03 112.29 24.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.269 -0.641 . . . . 2.4100000000000001 109.269 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' ' HD2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.84 116.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.171 -1.048 . . . . 1.6599999999999999 108.171 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.744 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.1 m-85 -99.43 130.55 45.7 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.816 -1.538 . . . . 1.25 110.659 -177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.864 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.9 p-10 -165.9 -53.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.743 -1.206 . . . . 1.2 107.743 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -79.92 -20.09 46.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.291 -0.868 . . . . 2.1699999999999999 109.171 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.2 t80 -80.82 -27.0 36.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.352 -0.981 . . . . 5.0499999999999998 108.352 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' OH ' HG11 ' A' ' 70' ' ' VAL . 1.7 m-85 -86.1 113.3 51.2 Favored Pre-proline 0 N--CA 1.447 -0.586 0 CA-C-N 114.945 -1.025 . . . . 1.29 110.777 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.4 -41.37 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.36 1.373 . . . . 0.79000000000000004 109.951 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' O ' HG12 ' A' ' 71' ' ' ILE . 46.7 m-20 -67.29 105.16 1.67 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.574 -0.739 . . . . 1.3600000000000001 110.668 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.886 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.0 mt 67.35 23.41 9.24 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.735 1.013 . . . . 1.6200000000000001 113.735 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.864 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 15.0 pttm -56.08 129.26 39.22 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.517 -0.739 . . . . 2.3900000000000001 111.08 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 91.65 15.56 54.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.352 -0.928 . . . . 0.37 114.216 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.886 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.4 ptp180 -144.25 -48.93 0.27 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 114.645 1.35 . . . . 1.5900000000000001 114.645 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.0 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -79.89 81.9 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 123.157 1.456 . . . . 0.20000000000000001 107.604 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.491 ' C ' HG22 ' A' ' 105' ' ' ILE . 16.9 m80 -103.21 129.45 50.14 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 112.151 -2.295 . . . . 0.28999999999999998 112.399 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 84.7 m-85 -70.81 125.04 25.73 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 119.907 -0.717 . . . . 1.23 109.788 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.702 HG21 ' CE2' ' A' ' 38' ' ' TYR . 14.3 p -77.06 36.94 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.923 -1.035 . . . . 0.46000000000000002 112.931 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.0 m -147.75 136.3 21.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 1.2 111.257 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -90.85 0.77 57.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.663 . . . . 2.2200000000000002 110.632 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -146.69 67.81 1.17 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.448 -0.575 . . . . 2.1400000000000001 109.448 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.875 HD22 ' CD2' ' A' ' 74' ' ' TYR . 7.9 mp -57.15 -27.73 62.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.302 -0.863 . . . . 1.49 111.044 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.73 ' HG2' HD12 ' A' ' 53' ' ' LEU . 37.0 mtmm -64.29 -2.93 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 2.04 112.062 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 0.01 56.02 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.524 -0.762 . . . . 1.3999999999999999 110.964 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.585 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 109.93 -7.14 31.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.889 -0.672 . . . . 0.38 113.234 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -97.35 119.4 35.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.968 0.413 . . . . 1.4399999999999999 110.813 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -115.57 6.48 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.891 -0.595 . . . . 0.42999999999999999 111.571 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 2.0 m -59.95 140.08 56.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 116.203 1.927 . . . . 1.04 116.203 -177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -129.13 131.94 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 114.147 -1.388 . . . . 0.31 110.788 177.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.589 ' O ' ' O ' ' A' ' 90' ' ' ARG . 52.2 p-10 -104.08 142.84 33.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.054 -1.091 . . . . 1.1499999999999999 108.054 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.51 120.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.024 0.44 . . . . 0.27000000000000002 111.439 -178.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.758 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.2 p -84.29 143.86 29.27 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.444 -0.798 . . . . 0.28999999999999998 110.851 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.416 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 31.0 m120 49.97 55.13 9.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.072 -0.513 . . . . 1.52 111.916 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.942 HD11 ' HB2' ' A' ' 37' ' ' ALA . 27.9 mt -44.19 93.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.456 0.91 . . . . 1.02 113.456 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' HB3' ' CG ' ' A' ' 114' ' ' ASP . 56.2 tt0 -59.64 144.47 47.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.7 -0.682 . . . . 2.1299999999999999 110.136 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 63.9 tp -59.97 -40.07 87.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.193 0.52 . . . . 1.7 110.792 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m -73.24 -5.56 40.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.739 -0.664 . . . . 1.3200000000000001 111.517 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.489 ' CG ' ' HB3' ' A' ' 111' ' ' GLN . 95.8 m-20 -69.96 -19.02 63.38 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.082 -0.34 . . . . 1.5800000000000001 110.082 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 139.63 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 116.145 -0.479 . . . . 0.41999999999999998 110.206 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 141.04 159.73 8.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.958 -1.115 . . . . 0.23999999999999999 113.414 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 63.7 m -59.44 130.69 48.12 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.838 0.681 . . . . 0.31 112.838 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.605 ' OH ' HD11 ' A' ' 87' ' ' LEU . 13.3 m-85 -114.27 129.64 56.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.174 -0.676 . . . . 1.24 109.174 177.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.61 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 12.1 tt0 -120.9 118.61 30.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 1.1599999999999999 110.276 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.636 ' HB2' ' CZ3' ' A' ' 57' ' ' TRP . 9.7 t -101.01 118.29 36.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 1.03 110.57 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 130' ' ' ASN . 97.4 mttt -123.66 112.32 17.25 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 116.475 -0.33 . . . . 1.76 111.774 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 61.9 t -92.05 106.46 17.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.235 -0.654 . . . . 1.1799999999999999 109.235 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 25.7 ttpp -95.42 117.34 30.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.006 -0.678 . . . . 1.6200000000000001 112.691 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 44' ' ' THR . 2.7 pttm -146.29 103.14 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.51 -0.476 . . . . 2.8399999999999999 110.12 177.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.93 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -49.92 133.91 21.61 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.44 112.055 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.436 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.7 Cg_endo -100.03 46.52 2.37 Favored 'Cis proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.769 -0.929 . . . . 0.56000000000000005 111.209 -0.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 103.62 0.29 Allowed Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 120.257 -0.973 . . . . 0.47999999999999998 113.674 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.47 153.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.712 -0.744 . . . . 1.22 109.322 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -139.51 144.92 38.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.279 -0.168 . . . . 0.56999999999999995 111.269 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.538 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 40.0 p-10 -146.57 142.22 27.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.895 0.702 . . . . 2.0299999999999998 112.895 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.642 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -144.01 157.78 44.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.784 -0.644 . . . . 2.9500000000000002 110.39 178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 41.2 tttt -101.84 139.98 36.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.216 0.821 . . . . 2.2599999999999998 113.216 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.697 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 70.9 mt -142.23 119.86 7.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.883 -0.599 . . . . 0.28000000000000003 109.953 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.443 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 14.8 m170 -100.22 118.37 36.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 0.55000000000000004 110.381 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 57.0 tp -91.89 123.2 35.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.217 0.451 . . . . 1.52 112.217 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 62.1 t -120.03 119.99 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.85 -0.614 . . . . 0.32000000000000001 109.424 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.95 121.71 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0800000000000001 111.794 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 75.2 mt -81.56 164.5 21.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.337 -0.616 . . . . 0.52000000000000002 109.337 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 t -75.1 139.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.399 0.619 . . . . 1.48 111.261 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.888 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -162.25 172.53 5.39 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.056 -0.975 . . . . 2.2000000000000002 110.294 -179.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 9.5 Cg_endo -51.91 -157.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.593 2.195 . . . . 1.3100000000000001 112.363 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -35.12 -59.23 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.972 0.415 . . . . 2.3100000000000001 111.817 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 69.44 -62.12 0.62 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.062 -0.59 . . . . 2.52 113.127 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.229 -0.891 . . . . 2.6000000000000001 111.105 -179.826 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.645 -0.182 . . . . 3.2799999999999998 112.645 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -79.92 168.07 19.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 2.4300000000000002 110.787 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.6 t -158.63 151.06 21.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 1.8400000000000001 110.944 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' CG2' ' HB1' ' A' ' 129' ' ' ALA . 1.1 pt -144.29 151.34 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 116.169 -0.469 . . . . 2.1499999999999999 111.413 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 82.6 p -92.39 161.73 14.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.544 0.687 . . . . 1.1200000000000001 111.618 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.18 83.55 0.2 Allowed Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.566 -1.197 . . . . 0.65000000000000002 112.091 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.717 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 65.4 Cg_endo -78.44 -91.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.586 2.857 . . . . 0.88 111.876 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -78.75 126.93 31.39 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.704 -0.85 . . . . 2.0600000000000001 108.704 178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' CG ' HD11 ' A' ' 29' ' ' ILE . 55.3 tt0 -143.69 153.66 42.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.842 1.052 . . . . 1.71 113.842 -176.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 58.5 mtp -135.45 116.45 14.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.62 -1.173 . . . . 1.8600000000000001 108.511 176.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.065 HD13 HG23 ' A' ' 133' ' ' ILE . 3.7 mp -120.0 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.004 0.431 . . . . 0.39000000000000001 111.809 -178.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 43.9 mt-10 -106.86 126.15 51.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 1.1899999999999999 110.203 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HG3' ' HB2' ' A' ' 35' ' ' GLU . 49.9 tptt -141.7 157.3 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 2.52 111.081 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.834 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.54 139.68 40.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.39000000000000001 112.018 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.3 134.02 18.9 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.995 -0.548 . . . . 2.3500000000000001 111.546 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 87.63 -20.39 27.83 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.874 -0.603 . . . . 0.31 112.578 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 79.5 mm-40 -79.94 160.0 26.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 178.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.838 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 30.1 m -89.46 129.97 35.87 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.658 -0.817 . . . . 0.33000000000000002 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.851 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.92 115.8 30.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.861 0.362 . . . . 0.26000000000000001 110.217 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 94' ' ' THR . 32.6 t80 -79.25 116.42 19.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.027 -0.533 . . . . 1.4299999999999999 111.875 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.793 HD12 ' CD1' ' A' ' 105' ' ' ILE . 15.5 mt -101.5 107.62 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.796 -0.816 . . . . 0.80000000000000004 108.796 177.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.2 Cg_endo -82.67 122.76 3.57 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.13 . . . . 0.41999999999999998 113.972 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 57' ' ' TRP . 1.3 t -141.46 126.34 18.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.744 -0.662 . . . . 1.03 110.211 178.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 54.5 mttm -140.91 149.93 42.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.922 -0.581 . . . . 1.6599999999999999 109.993 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.803 ' CG ' HG11 ' A' ' 122' ' ' VAL . 36.3 p90 -140.87 139.98 34.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 1.26 112.012 -178.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.43 139.64 30.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.743 . . . . 1.3300000000000001 110.373 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' CE ' ' A' ' 124' ' ' LYS . 90.0 mt -92.22 107.6 19.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 2.1200000000000001 110.884 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' ASP . 30.4 t -83.54 133.58 46.66 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.529 -0.545 . . . . 1.75 109.529 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -43.0 -33.2 3.11 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.691 1.594 . . . . 1.6100000000000001 111.04 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 83.4 tt0 -76.72 -39.98 50.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.358 -0.837 . . . . 2.1800000000000002 111.074 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 77.0 m-20 -68.5 79.19 0.27 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.41 -0.516 . . . . 2.4100000000000001 109.659 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -99.99 -5.08 28.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 1.6399999999999999 111.925 -178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.757 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.04 160.81 53.25 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.894 -0.669 . . . . 0.55000000000000004 112.689 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.36 138.27 85.41 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.422 2.082 . . . . 0.84999999999999998 112.384 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 43' ' ' PHE . 11.3 mt -78.17 120.08 22.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 1.8999999999999999 111.596 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.593 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 77.6 m-20 -133.51 103.05 5.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.548 0.69 . . . . 1.78 111.419 178.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.849 HG12 HG22 ' A' ' 122' ' ' VAL . 2.7 mp -91.34 122.35 42.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.162 179.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.908 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 79.3 mt-10 -119.08 114.08 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.449 0.537 . . . . 1.6699999999999999 112.449 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.92 ' CD2' HD11 ' A' ' 105' ' ' ILE . 76.3 m95 -91.7 120.02 32.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 110.078 -0.341 . . . . 0.22 110.078 178.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.9 mt -108.69 143.85 37.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.392 . . . . 0.40999999999999998 109.94 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.611 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 10.3 tt -130.01 132.97 65.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.293 0.479 . . . . 0.78000000000000003 112.293 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.419 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 52.9 m -123.28 101.85 37.46 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.0 -0.741 . . . . 1.25 109.0 177.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.5 Cg_endo -79.86 116.92 3.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.714 2.276 . . . . 0.53000000000000003 113.435 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.96 76.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.61 -0.723 . . . . 0.40999999999999998 110.632 179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -87.42 17.28 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 1.8200000000000001 112.182 -179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 42.7 m-20 -148.99 160.02 43.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.41 0.624 . . . . 1.9399999999999999 112.213 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.08 -18.64 64.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.052 -0.976 . . . . 1.6599999999999999 111.92 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 61.1 mttp -66.82 150.82 48.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 1.74 111.017 -178.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.77 130.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-O 122.409 1.099 . . . . 0.96999999999999997 110.299 178.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.516 ' OD2' HD13 ' A' ' 58' ' ' LEU . 4.9 t0 49.66 39.99 18.77 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 112.932 -1.94 . . . . 1.77 112.542 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -90.24 140.02 30.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 1.96 111.095 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 73' ' ' LEU . 89.7 t -69.65 130.04 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.923 0.392 . . . . 0.77000000000000002 111.048 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.828 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.3 pp -124.25 -37.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.008 -0.542 . . . . 1.1499999999999999 111.473 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.918 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.24 124.58 18.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.685 -0.857 . . . . 0.28999999999999998 108.685 178.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.908 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -140.27 157.61 45.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.64 -0.709 . . . . 1.3 110.344 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' HD1' ' HB ' ' A' ' 79' ' ' ILE . 60.5 t80 -133.75 103.56 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.018 -0.364 . . . . 1.3 110.018 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 40.0 t -143.03 155.98 44.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.879 0.371 . . . . 0.89000000000000001 111.925 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.84 30.15 28.43 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.135 -0.555 . . . . 0.56999999999999995 112.899 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t0 71.72 1.6 3.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.481 0.182 . . . . 1.46 111.118 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.556 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.2 mmtt -99.95 107.03 18.9 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.787 -0.82 . . . . 2.4100000000000001 108.787 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.77 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -82.76 118.32 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.601 1.191 . . . . 1.6599999999999999 108.748 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.658 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 1.6 m-85 -100.28 124.9 46.3 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 112.527 -2.124 . . . . 1.25 111.563 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.833 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.8 p-10 -166.31 -53.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.01 -1.478 . . . . 1.2 107.01 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 55.2 t0 -81.34 -32.59 32.91 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.538 -1.21 . . . . 2.1699999999999999 109.117 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -71.55 -31.82 67.42 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.332 -1.358 . . . . 5.0499999999999998 107.332 178.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -82.49 109.97 19.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.338 -1.301 . . . . 1.29 109.256 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.96 -31.05 77.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.018 1.812 . . . . 0.79000000000000004 113.031 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.805 ' O ' HD12 ' A' ' 87' ' ' LEU . 83.7 m-20 -49.99 -29.95 9.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 1.3600000000000001 112.564 -178.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 86' ' ' ASP . 2.0 mp -152.2 27.66 0.59 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.474 -0.785 . . . . 1.6200000000000001 111.198 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 24.8 pttm -55.63 138.15 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.156 0.503 . . . . 2.3900000000000001 111.839 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 80.03 12.85 82.89 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.617 -0.801 . . . . 0.37 114.41 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.72 ' HA ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -143.35 -52.42 0.36 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 115.07 1.507 . . . . 1.5900000000000001 115.07 -178.545 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.918 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -79.3 81.33 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 122.939 1.352 . . . . 0.20000000000000001 107.861 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.4 m80 -100.64 127.87 46.89 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 112.442 -2.163 . . . . 0.28999999999999998 112.418 -176.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.124 ' CD1' HG23 ' A' ' 105' ' ' ILE . 78.8 m-85 -72.14 120.57 17.92 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.12 -0.696 . . . . 1.23 109.12 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.615 HG21 ' CE2' ' A' ' 38' ' ' TYR . 28.4 p -71.34 -9.93 58.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.336 -0.847 . . . . 0.46000000000000002 109.957 179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 p -86.94 122.62 31.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.6 -0.727 . . . . 1.2 109.55 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.95 4.66 49.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.144 0.497 . . . . 2.2200000000000002 110.307 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -146.66 69.35 1.18 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.742 -0.836 . . . . 2.1400000000000001 108.742 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.902 HD23 ' HA ' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -56.13 -39.59 72.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.085 -0.961 . . . . 1.49 111.363 -178.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HG3' ' OH ' ' A' ' 74' ' ' TYR . 31.7 mtmm -64.77 -3.07 2.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.118 0.485 . . . . 2.04 112.111 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.7 t -89.56 -0.01 57.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.626 -0.715 . . . . 1.3999999999999999 111.029 179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.34 -16.16 35.23 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.722 -0.751 . . . . 0.38 113.698 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.8 m-20 -97.3 108.82 21.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.203 0.502 . . . . 1.4399999999999999 110.45 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.902 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.45 19.94 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.667 0.617 . . . . 0.42999999999999999 112.667 -179.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.2 m -61.53 140.0 58.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.857 1.429 . . . . 1.04 114.857 -179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.124 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.15 133.27 62.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.061 -0.972 . . . . 0.31 111.25 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.4 p-10 -106.66 145.5 31.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.829 -0.804 . . . . 1.1499999999999999 108.829 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.5 122.09 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.27000000000000002 111.63 -178.354 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -84.86 144.13 28.61 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.52 -0.764 . . . . 0.28999999999999998 111.169 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 96.8 m-20 49.96 57.66 6.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.15 0.5 . . . . 1.52 111.354 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 37' ' ' ALA . 35.6 mt -47.57 92.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.126 1.158 . . . . 1.02 114.126 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 35.0 mt-30 -58.64 142.4 49.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.069 -0.514 . . . . 2.1299999999999999 110.413 176.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.04 -36.86 78.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.094 0.473 . . . . 1.7 110.185 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 t -74.31 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.646 . . . . 1.3200000000000001 111.358 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.74 -15.55 62.69 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.009 -0.367 . . . . 1.5800000000000001 110.009 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.76 141.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-N 116.238 -0.437 . . . . 0.41999999999999998 110.096 178.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.79 155.2 6.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.879 -1.153 . . . . 0.23999999999999999 113.759 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.675 HG23 ' CD2' ' A' ' 134' ' ' HIS . 93.5 m -59.18 129.99 44.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.483 0.549 . . . . 0.31 112.483 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.2 m-85 -111.2 130.2 55.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.291 -0.633 . . . . 1.24 109.291 177.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 62.4 tt0 -121.79 120.05 33.47 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.811 -0.356 . . . . 1.1599999999999999 111.022 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 40.7 t -100.04 123.14 43.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.036 -0.529 . . . . 1.03 109.923 179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 96.0 mttt -123.87 105.45 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.69 -0.404 . . . . 1.76 111.978 -179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 55' ' ' ILE . 25.0 t -89.44 111.98 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.476 -0.935 . . . . 1.1799999999999999 108.476 177.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.709 ' HG3' HG12 ' A' ' 128' ' ' VAL . 77.7 tttt -99.45 120.06 39.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.411 0.893 . . . . 1.6200000000000001 113.411 -177.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.712 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 14.0 tttp -145.72 102.5 3.68 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.725 -0.472 . . . . 2.8399999999999999 109.725 176.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.757 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.97 131.36 30.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.548 -0.751 . . . . 0.44 112.934 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.492 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 46.2 Cg_endo -100.76 48.04 2.04 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.696 -0.96 . . . . 0.56000000000000005 112.527 -0.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -141.85 102.64 0.31 Allowed Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.139 -1.029 . . . . 0.47999999999999998 112.982 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.709 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -88.82 132.22 34.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.207 -0.997 . . . . 1.22 109.629 177.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 22' ' ' ILE . . . -121.13 139.05 53.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.773 0.286 . . . . 0.56999999999999995 111.773 -179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.481 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 52.4 p30 -146.33 146.14 30.58 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.252 0.464 . . . . 2.0299999999999998 112.252 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.717 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.52 160.11 42.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 2.9500000000000002 110.652 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 44.0 mttp -99.96 140.78 33.68 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.298 0.851 . . . . 2.2599999999999998 113.298 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.065 HG23 HD13 ' A' ' 29' ' ' ILE . 3.5 mp -139.26 109.13 4.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.824 -1.08 . . . . 0.28000000000000003 108.459 176.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.675 ' CD2' HG23 ' A' ' 117' ' ' THR . 54.0 m170 -97.28 118.02 32.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.353 -0.539 . . . . 0.55000000000000004 110.748 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.716 HD21 HD22 ' A' ' 110' ' ' LEU . 61.2 tp -92.41 123.3 35.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.883 -0.598 . . . . 1.52 111.669 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 45.3 t -119.93 120.9 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.723 -0.671 . . . . 0.32000000000000001 109.328 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HB ' HD12 ' A' ' 115' ' ' ILE . 22.1 t -95.49 121.97 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.376 0.51 . . . . 1.0800000000000001 112.376 -178.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 89.6 mt -84.05 163.77 19.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.717 -0.674 . . . . 0.52000000000000002 109.224 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.1 t -77.04 133.21 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.401 0.62 . . . . 1.48 111.429 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.834 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -165.08 177.07 1.78 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.797 -1.092 . . . . 2.2000000000000002 109.675 179.694 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HD2' ' A' ' 140' ' ' LYS . 75.3 Cg_exo -51.1 145.28 26.14 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.073 1.849 . . . . 1.3100000000000001 112.107 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 p -37.44 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.025 -0.534 . . . . 2.3100000000000001 112.251 -179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.84 -63.23 0.91 Allowed Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.767 -0.73 . . . . 2.52 112.355 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.408 -0.806 . . . . 2.6000000000000001 111.474 179.698 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 127' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 120.418 -0.101 . . . . 3.2799999999999998 113.092 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -155.19 157.08 36.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.715 0.293 . . . . 2.4300000000000002 110.473 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 99.5 p -77.37 147.41 36.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 1.8400000000000001 111.361 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.665 HD13 ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -149.72 149.81 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.711 -0.677 . . . . 2.1499999999999999 110.934 -179.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.15 155.13 17.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 1.1200000000000001 112.21 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 38.79 82.69 0.22 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.358 -1.292 . . . . 0.65000000000000002 112.652 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.777 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 53.6 Cg_endo -79.26 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.449 2.766 . . . . 0.88 112.738 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 85.9 tt0 -78.54 127.88 32.76 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.11 -0.7 . . . . 2.0600000000000001 109.11 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.641 ' CG ' HD11 ' A' ' 29' ' ' ILE . 44.3 tp10 -143.74 157.02 44.68 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.785 1.032 . . . . 1.71 113.785 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 54.0 ttp -136.92 125.34 23.42 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.665 -1.152 . . . . 1.8600000000000001 107.934 176.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.031 HD13 HG23 ' A' ' 133' ' ' ILE . 4.1 mp -130.24 137.52 56.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.703 -0.681 . . . . 0.39000000000000001 112.362 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.602 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 74.9 mt-10 -133.77 127.74 33.36 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.156 -0.475 . . . . 1.1899999999999999 110.154 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 10.9 tptm -142.71 161.35 38.32 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.511 0.196 . . . . 2.52 110.754 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.945 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.07 140.59 41.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.39000000000000001 112.228 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 112' ' ' LEU . 56.5 tttm -47.25 132.3 12.77 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.819 -0.628 . . . . 2.3500000000000001 111.421 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 89.64 -20.11 36.91 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.049 -0.596 . . . . 0.31 112.686 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.3 mt-10 -80.04 157.67 26.68 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.767 -0.827 . . . . 2.1099999999999999 108.767 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.5 m -87.6 126.97 35.25 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.985 -0.686 . . . . 0.33000000000000002 110.733 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.56 115.17 28.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.831 0.348 . . . . 0.26000000000000001 110.367 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.795 ' HE1' ' HG1' ' A' ' 94' ' ' THR . 71.6 t80 -79.46 115.14 18.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 1.4299999999999999 112.383 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD22 HG21 ' A' ' 133' ' ' ILE . 20.8 mt -100.22 109.83 57.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 108.593 -0.891 . . . . 0.80000000000000004 108.593 177.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.46 125.35 2.91 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.353 2.035 . . . . 0.41999999999999998 114.97 -177.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -141.51 122.26 14.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.819 -1.082 . . . . 1.03 108.495 177.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -141.32 115.89 9.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 1.6599999999999999 111.513 -179.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.592 ' CE2' ' HA2' ' A' ' 101' ' ' GLY . 25.6 p90 -94.48 139.97 30.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.006 -0.997 . . . . 1.26 111.025 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 141.92 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 1.3300000000000001 111.042 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 98.6 mt -97.73 139.54 33.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.599 . . . . 2.1200000000000001 111.527 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.447 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 86.2 p -159.89 145.99 11.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 1.75 109.942 179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.62 -21.54 3.54 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.318 2.012 . . . . 1.6100000000000001 113.084 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.75 -40.06 66.36 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.769 -0.196 . . . . 2.1800000000000002 111.329 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 3.1 p30 -69.91 79.14 0.47 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.035 -0.666 . . . . 2.4100000000000001 110.115 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -90.38 -10.06 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.225 -0.898 . . . . 1.6399999999999999 111.837 -178.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.981 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -79.54 154.26 38.01 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.304 -0.951 . . . . 0.55000000000000004 112.981 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.99 153.71 19.72 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.498 2.132 . . . . 0.84999999999999998 111.696 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 47.7 tp -78.08 131.56 37.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 1.8999999999999999 111.337 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -139.5 149.08 43.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.36 0.6 . . . . 1.78 110.722 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 74' ' ' TYR . 30.5 mt -142.75 135.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.845 -1.07 . . . . 0.75 109.087 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.637 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 40.2 mt-10 -140.13 108.28 5.77 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.278 0.474 . . . . 1.6699999999999999 112.278 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.974 ' CD2' HD11 ' A' ' 105' ' ' ILE . 78.5 m95 -94.51 126.34 39.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.382 -0.372 . . . . 0.22 110.918 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 89.8 mt -108.87 141.18 41.3 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.877 -0.786 . . . . 0.40999999999999998 108.877 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 11.5 tt -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.52 0.563 . . . . 0.78000000000000003 112.52 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.3 t -120.36 102.95 45.05 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.228 -0.896 . . . . 1.25 108.932 177.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 88.1 Cg_endo -78.24 115.63 3.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.527 2.151 . . . . 0.53000000000000003 113.028 -178.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.86 -34.47 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.356 -0.838 . . . . 0.40999999999999998 110.679 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.18 11.53 7.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.637 -0.71 . . . . 1.8200000000000001 111.818 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 80.8 m-20 -148.93 160.37 43.33 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.279 0.561 . . . . 1.9399999999999999 111.76 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -67.75 -18.47 64.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.284 -0.871 . . . . 1.6599999999999999 112.694 -179.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.68 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.3 mttt -65.79 144.05 57.1 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.253 -0.431 . . . . 1.74 111.216 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 m -156.39 129.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 CA-C-O 121.929 0.871 . . . . 0.96999999999999997 110.019 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.02 40.0 19.23 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 113.97 -1.468 . . . . 1.77 112.827 177.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 66' ' ' LYS . 96.9 mt-30 -95.26 141.1 29.25 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.367 -0.235 . . . . 1.96 110.367 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 84' ' ' TYR . 16.5 t -65.86 120.0 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.175 0.512 . . . . 0.77000000000000002 109.977 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.901 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.97 -51.97 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.4 -0.818 . . . . 1.1499999999999999 112.045 -178.135 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.983 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -138.81 122.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.949 -1.13 . . . . 0.28999999999999998 107.949 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 56' ' ' GLU . 1.1 tt -130.98 154.88 47.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.778 -0.646 . . . . 1.3 110.895 -176.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.872 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 25.9 t80 -133.01 104.54 6.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.309 -0.256 . . . . 1.3 110.309 179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.453 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 10.0 t -142.64 156.82 45.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.882 0.372 . . . . 0.89000000000000001 111.98 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.57 29.7 40.55 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.924 -0.655 . . . . 0.56999999999999995 112.43 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.56 3.14 4.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.583 0.23 . . . . 1.46 110.915 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 34.3 mttm -100.03 112.56 24.85 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.749 -0.463 . . . . 2.4100000000000001 109.749 178.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.896 HD13 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -83.85 116.98 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 107.941 -1.133 . . . . 1.6599999999999999 107.941 178.136 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.821 ' N ' HD12 ' A' ' 79' ' ' ILE . 4.5 m-85 -99.95 127.74 46.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.282 -1.781 . . . . 1.25 110.589 -178.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.0 p-10 -166.01 -52.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.426 -1.324 . . . . 1.2 107.426 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -80.2 -23.2 41.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.988 -1.006 . . . . 2.1699999999999999 109.31 177.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.1 t80 -78.68 -28.0 45.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.588 -0.893 . . . . 5.0499999999999998 108.588 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.549 ' OH ' HG11 ' A' ' 70' ' ' VAL . 2.0 m-85 -84.71 119.85 73.28 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 114.942 -1.027 . . . . 1.29 110.668 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.69 -41.75 44.98 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.261 1.307 . . . . 0.79000000000000004 109.237 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 71' ' ' ILE . 39.1 m-20 -66.98 104.66 1.43 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.365 -0.834 . . . . 1.3600000000000001 110.657 178.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.935 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.0 mp 68.8 27.35 5.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.101 1.148 . . . . 1.6200000000000001 114.101 178.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 58.3 pttt -57.58 129.56 42.41 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.659 -0.65 . . . . 2.3900000000000001 111.23 177.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 85.37 19.35 58.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.711 -0.757 . . . . 0.37 114.31 178.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.935 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.7 ptm180 -145.89 -48.26 0.21 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.379 1.252 . . . . 1.5900000000000001 114.379 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.983 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.5 p -78.86 81.71 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.071 -1.455 . . . . 0.20000000000000001 107.071 -178.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.535 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.7 m80 -102.8 128.62 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.262 -2.245 . . . . 0.28999999999999998 112.789 -175.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.12 ' CD1' HG23 ' A' ' 105' ' ' ILE . 73.3 m-85 -70.26 123.76 22.46 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 120.152 -0.619 . . . . 1.23 109.61 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.795 ' HG1' ' HE1' ' A' ' 38' ' ' TYR . 15.9 p -73.52 33.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.426 -0.807 . . . . 0.46000000000000002 111.839 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -149.63 128.81 12.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.2 110.097 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -92.64 7.56 42.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.986 -0.552 . . . . 2.2200000000000002 110.377 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -146.35 65.72 1.19 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 109.116 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.861 HD22 ' CD2' ' A' ' 74' ' ' TYR . 9.6 mp -56.7 -24.72 51.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.391 -0.822 . . . . 1.49 111.432 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.3 -3.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 2.04 111.996 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -88.73 0.03 56.86 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.48 -0.782 . . . . 1.3999999999999999 110.94 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 104.31 -9.94 50.12 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.731 -0.747 . . . . 0.38 113.647 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.11 110.04 21.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.963 0.381 . . . . 1.4399999999999999 111.198 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -107.77 9.48 28.99 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.508 0.559 . . . . 0.42999999999999999 112.508 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.7 p -59.98 143.45 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.67 1.73 . . . . 1.04 115.67 -178.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.12 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -132.37 132.33 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-N 114.422 -1.263 . . . . 0.31 110.78 178.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HB2' HG22 ' A' ' 36' ' ' THR . 53.2 p30 -106.41 146.37 30.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.631 -0.878 . . . . 1.1499999999999999 108.631 177.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 120.02 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 120.826 0.346 . . . . 0.27000000000000002 111.152 -178.257 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.753 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.4 p -82.92 143.7 30.53 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.824 -0.625 . . . . 0.28999999999999998 110.928 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 26.4 m120 47.88 58.89 4.6 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.186 -0.461 . . . . 1.52 111.675 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.936 HD11 ' HB2' ' A' ' 37' ' ' ALA . 18.8 mt -44.44 88.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.082 1.142 . . . . 1.02 114.082 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.459 ' O ' ' OD2' ' A' ' 114' ' ' ASP . 51.7 tt0 -58.53 147.26 32.67 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.548 -0.538 . . . . 2.1299999999999999 109.548 176.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 58.9 tp -60.03 -37.03 78.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.43 . . . . 1.7 111.036 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.8 m -72.03 -9.66 58.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 1.3200000000000001 112.39 -178.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 111' ' ' GLN . 3.0 p30 -70.47 -18.57 62.98 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.378 -0.529 . . . . 1.5800000000000001 110.085 179.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 137.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 CA-C-N 115.988 -0.551 . . . . 0.41999999999999998 110.265 179.112 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.99 160.51 8.32 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 119.844 -1.17 . . . . 0.23999999999999999 113.853 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.567 HG23 ' CD2' ' A' ' 134' ' ' HIS . 90.9 m -60.04 137.09 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.125 -0.537 . . . . 0.31 112.128 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.659 ' CZ ' HD12 ' A' ' 135' ' ' LEU . 25.0 m-85 -120.04 132.15 55.36 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.445 -0.576 . . . . 1.24 109.445 177.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.725 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 49.0 tp60 -120.0 115.06 22.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.073 -0.251 . . . . 1.1599999999999999 110.708 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 53.0 t -98.35 116.82 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 1.03 110.295 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 129' ' ' ALA . 88.2 mttt -119.1 106.41 12.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 1.76 111.066 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.4 t -91.34 105.5 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.566 -0.531 . . . . 1.1799999999999999 109.566 179.01 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.766 ' HG3' HG12 ' A' ' 128' ' ' VAL . 52.2 tttp -90.48 116.11 28.15 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.039 -0.665 . . . . 1.6200000000000001 111.474 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' CB ' ' A' ' 49' ' ' ASP . 7.2 ttpm? -146.08 102.35 3.62 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.457 -0.571 . . . . 2.8399999999999999 109.457 178.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.981 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.42 134.39 33.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.44 112.002 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 62.9 Cg_endo -100.13 48.69 1.92 Allowed 'Cis proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.698 -0.959 . . . . 0.56000000000000005 111.297 -0.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 19' ' ' GLY . . . -145.8 103.31 0.28 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.188 -1.006 . . . . 0.47999999999999998 113.591 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.766 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.5 m -87.4 120.0 35.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.552 -0.824 . . . . 1.22 109.956 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.665 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -101.53 144.77 29.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.867 0.321 . . . . 0.56999999999999995 111.867 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.452 ' C ' ' HG3' ' A' ' 131' ' ' LYS . 46.1 t30 -146.28 132.11 19.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 2.0299999999999998 111.114 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.777 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 4.7 mttp -142.58 160.33 40.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.841 0.353 . . . . 2.9500000000000002 111.773 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 64.5 mttt -101.77 141.67 34.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.441 0.904 . . . . 2.2599999999999998 113.441 -179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 29' ' ' ILE . 3.1 mp -142.58 112.59 2.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.041 -0.982 . . . . 0.28000000000000003 109.347 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 117' ' ' THR . 60.5 m170 -101.1 114.4 28.3 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.9 -0.5 . . . . 0.55000000000000004 110.58 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.659 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 14.9 mt -96.2 135.58 37.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.698 0.629 . . . . 1.52 112.698 -179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 60.7 t -129.96 130.0 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.355 -0.838 . . . . 0.32000000000000001 109.198 178.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.417 ' H ' HD11 ' A' ' 115' ' ' ILE . 18.9 t -100.46 121.32 51.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.872 0.368 . . . . 1.0800000000000001 111.96 -179.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.7 mt -80.77 163.7 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.353 -0.61 . . . . 0.52000000000000002 109.353 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.88 136.98 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.462 0.649 . . . . 1.48 111.681 -178.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.945 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.56 173.74 3.96 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 2.2000000000000002 110.088 179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 46.1 Cg_exo -56.4 -162.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.27 1.98 . . . . 1.3100000000000001 111.965 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 43.1 p -38.5 -79.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.785 0.326 . . . . 2.3100000000000001 111.611 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.97 15.2 6.36 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.943 -0.646 . . . . 2.52 113.418 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.242 -0.885 . . . . 2.6000000000000001 111.132 -179.843 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.557 -0.217 . . . . 3.2799999999999998 112.557 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 1.9 m -80.17 112.83 17.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 2.4300000000000002 111.102 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HD13 ' A' ' 22' ' ' ILE . 43.2 p -80.02 167.61 20.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 1.8400000000000001 110.666 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.725 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 45.1 mm -140.02 138.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 2.1499999999999999 110.884 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.2 OUTLIER -86.89 144.91 26.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.219 0.533 . . . . 1.1200000000000001 110.292 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.484 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 45.28 82.61 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 115.179 -0.919 . . . . 0.65000000000000002 110.39 -177.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 57.3 Cg_endo -77.94 -84.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.649 2.899 . . . . 0.88 113.095 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 86.4 tt0 -78.28 120.66 23.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.571 -0.529 . . . . 2.0600000000000001 109.571 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 28' ' ' MET . 80.0 tt0 -143.82 160.02 41.51 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.604 0.964 . . . . 1.71 113.604 -177.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.556 ' C ' HD12 ' A' ' 29' ' ' ILE . 53.6 ttm -130.95 130.95 44.08 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.867 -1.06 . . . . 1.8600000000000001 108.724 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.035 HD13 HG23 ' A' ' 133' ' ' ILE . 3.5 mp -129.71 131.9 66.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.62 . . . . 0.39000000000000001 112.122 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 89.7 mt-10 -122.63 127.18 49.04 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.281 -0.418 . . . . 1.1899999999999999 110.737 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' A' ' 110' ' ' LEU . 47.0 mmtm -142.33 160.03 41.07 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.563 0.221 . . . . 2.52 110.998 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.728 ' HB1' ' CG ' ' A' ' 140' ' ' LYS . . . -76.79 137.0 38.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.059 0.457 . . . . 0.39000000000000001 112.157 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 60.0 tttt -46.22 129.97 10.31 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.895 -0.593 . . . . 2.3500000000000001 110.964 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 89.74 -19.12 43.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.31 112.275 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 68.1 mm-40 -80.05 160.03 25.97 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.438 -0.949 . . . . 2.1099999999999999 108.438 178.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 28.6 m -88.82 129.73 35.52 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.608 -0.837 . . . . 0.33000000000000002 110.685 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.99 120.0 39.13 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.895 0.379 . . . . 0.26000000000000001 110.449 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.955 ' HE1' HG21 ' A' ' 94' ' ' THR . 70.1 t80 -79.1 117.42 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 1.4299999999999999 111.714 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 133' ' ' ILE . 20.4 mt -109.98 104.4 55.48 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.838 -0.801 . . . . 0.80000000000000004 108.838 178.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.642 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 89.8 Cg_endo -86.92 128.92 2.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.352 2.035 . . . . 0.41999999999999998 114.019 -178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 131' ' ' LYS . 1.8 t -140.8 128.89 22.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.402 -0.817 . . . . 1.03 108.8 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.6 ttpt -140.86 118.62 11.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.241 0.543 . . . . 1.6599999999999999 110.961 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CG ' HG11 ' A' ' 122' ' ' VAL . 43.9 p90 -101.87 137.63 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.667 -1.151 . . . . 1.26 112.399 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -89.26 140.01 29.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 1.3300000000000001 109.785 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.812 HD22 ' HE2' ' A' ' 124' ' ' LYS . 90.7 mt -94.46 109.7 21.55 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.964 -0.294 . . . . 2.1200000000000001 111.327 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.1 m -83.75 140.0 40.69 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 109.467 -0.568 . . . . 1.75 109.467 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.88 -34.08 21.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.801 1.668 . . . . 1.6100000000000001 110.775 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 20.4 pt-20 -81.52 -33.97 31.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.441 -0.799 . . . . 2.1800000000000002 111.798 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 78.9 m-20 -69.14 77.62 0.35 Allowed 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 120.271 -0.572 . . . . 2.4100000000000001 110.143 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -101.82 -0.76 33.67 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.502 -0.772 . . . . 1.6399999999999999 111.548 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.884 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -74.08 162.86 54.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.01 -0.614 . . . . 0.55000000000000004 113.4 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.12 131.42 44.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.809 2.339 . . . . 0.84999999999999998 112.168 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.619 HD11 ' CG1' ' A' ' 122' ' ' VAL . 13.6 tp -78.12 126.38 30.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 1.8999999999999999 111.337 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 6.1 m-20 -139.36 103.09 4.64 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.564 0.697 . . . . 1.78 111.646 179.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 2.9 mt -95.69 118.28 41.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.745 -1.116 . . . . 0.75 110.322 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.561 ' HG3' HD12 ' A' ' 73' ' ' LEU . 86.1 tt0 -115.64 120.32 39.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.453 0.538 . . . . 1.6699999999999999 112.453 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.921 ' CD2' HD11 ' A' ' 105' ' ' ILE . 82.6 m95 -94.18 119.94 33.73 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.194 -0.299 . . . . 0.22 110.194 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.2 mt -108.13 142.45 38.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 0.40999999999999998 110.185 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.689 HD11 ' O ' ' A' ' 114' ' ' ASP . 5.6 tt -130.0 132.33 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.78000000000000003 112.043 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.403 ' O ' ' CA ' ' A' ' 116' ' ' GLY . 48.7 m -117.71 102.12 51.77 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 108.471 -0.937 . . . . 1.25 108.471 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.639 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 85.4 Cg_endo -79.38 113.49 3.15 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.807 2.338 . . . . 0.53000000000000003 113.031 -178.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.99 87.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.40999999999999998 111.257 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.63 -40.08 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 1.8200000000000001 111.556 -179.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 33.9 m120 -84.58 160.04 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 1.9399999999999999 111.957 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.81 -18.0 64.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.303 -0.862 . . . . 1.6599999999999999 111.245 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 42.9 mttt -69.49 154.63 41.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.579 -0.737 . . . . 1.74 111.681 -178.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.72 128.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-O 121.637 0.732 . . . . 0.96999999999999997 109.072 178.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 57.82 41.82 24.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.631 -1.168 . . . . 1.77 111.724 179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 96.1 mm-40 -87.07 135.09 33.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.797 0.332 . . . . 1.96 111.59 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 58' ' ' LEU . 57.7 t -71.82 132.02 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.307 -0.406 . . . . 0.77000000000000002 110.261 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.854 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.3 pp -129.84 -39.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.631 0.604 . . . . 1.1499999999999999 112.631 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.954 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.43 123.6 16.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.415 0.626 . . . . 0.28999999999999998 109.637 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 74' ' ' TYR . 7.3 tt -140.58 160.54 39.78 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.576 -0.738 . . . . 1.3 109.477 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.91 ' N ' HD23 ' A' ' 73' ' ' LEU . 23.9 t80 -134.32 109.15 8.63 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.218 0.532 . . . . 1.3 110.283 178.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.534 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 32.7 t -142.37 160.01 41.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.353 -0.839 . . . . 0.89000000000000001 111.394 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.31 36.82 53.91 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.822 -0.704 . . . . 0.56999999999999995 112.608 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t0 60.63 25.22 14.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.609 0.242 . . . . 1.46 111.378 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.3 mttp -128.15 111.14 13.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.191 -0.67 . . . . 2.4100000000000001 109.191 177.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.627 ' CG2' HD22 ' A' ' 98' ' ' LEU . 1.4 pp -76.81 119.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.964 -1.124 . . . . 1.6599999999999999 107.964 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.796 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.7 m-85 -99.97 133.51 44.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.72 -1.127 . . . . 1.25 110.62 -178.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 1.3 p-10 -166.46 -59.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.977 -1.49 . . . . 1.2 106.977 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HA ' ' CA ' ' A' ' 88' ' ' LYS . 50.9 t0 -80.03 -20.19 45.9 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 114.556 -1.202 . . . . 2.1699999999999999 109.315 177.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.7 t80 -78.78 -29.81 45.21 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.25 -1.018 . . . . 5.0499999999999998 108.25 178.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.8 OUTLIER -84.34 112.61 42.92 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-N 114.436 -1.257 . . . . 1.29 110.872 179.717 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 85.7 Cg_exo -44.09 -42.98 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.501 1.467 . . . . 0.79000000000000004 110.548 178.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.0 m-20 -68.31 104.92 1.98 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.685 -0.688 . . . . 1.3600000000000001 110.739 178.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.894 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 7.4 mp 72.71 18.91 4.12 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.499 0.926 . . . . 1.6200000000000001 113.499 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.5 pttp -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.445 -0.784 . . . . 2.3900000000000001 110.763 178.022 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 91.56 11.67 60.46 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.273 -0.965 . . . . 0.37 113.917 178.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.894 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.5 ptp180 -141.27 -53.79 0.47 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 114.574 1.324 . . . . 1.5900000000000001 114.574 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.954 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -78.73 80.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.11 -1.441 . . . . 0.20000000000000001 107.11 -178.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.636 ' C ' HG22 ' A' ' 105' ' ' ILE . 9.3 m80 -97.52 128.82 44.57 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.084 -2.326 . . . . 0.28999999999999998 111.849 -176.148 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 105' ' ' ILE . 60.5 m-85 -69.4 121.66 17.39 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.685 0.755 . . . . 1.23 110.684 -179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.955 HG21 ' HE1' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -73.71 34.85 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.471 -1.24 . . . . 0.46000000000000002 111.732 179.875 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -148.81 136.39 20.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.076 0.465 . . . . 1.2 111.683 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.23 0.02 56.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.779 -0.646 . . . . 2.2200000000000002 110.737 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -146.45 66.76 1.18 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.294 0.569 . . . . 2.1400000000000001 109.517 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.714 HD21 ' CG ' ' A' ' 93' ' ' PHE . 7.2 mp -59.14 -31.64 69.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.403 -0.817 . . . . 1.49 111.939 -178.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.52 -3.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.152 0.501 . . . . 2.04 112.319 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.8 m -88.5 -0.09 56.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.54 -0.754 . . . . 1.3999999999999999 111.137 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 111.34 -19.88 23.95 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.748 -0.739 . . . . 0.38 112.915 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 95.0 m-20 -97.01 107.47 20.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.694 0.283 . . . . 1.4399999999999999 110.633 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 93' ' ' PHE . . . -116.75 24.23 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.891 0.33 . . . . 0.42999999999999999 111.891 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 16.4 m -60.92 151.6 29.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 114.425 1.268 . . . . 1.04 114.425 -178.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.035 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -137.03 140.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.682 -1.145 . . . . 0.31 111.545 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.0 p-10 -113.46 142.81 45.47 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.263 -1.014 . . . . 1.1499999999999999 108.263 177.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.36 122.36 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 120.991 0.424 . . . . 0.27000000000000002 111.868 -177.866 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.725 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.67 143.89 28.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.28999999999999998 111.16 178.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.595 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 0.9 OUTLIER 50.82 54.35 11.37 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.08 -0.509 . . . . 1.52 112.304 178.537 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 37' ' ' ALA . 34.5 mt -45.9 89.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.441 1.274 . . . . 1.02 114.441 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 60.1 tp60 -59.4 147.72 35.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.767 -0.651 . . . . 2.1299999999999999 110.399 176.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' CE ' ' A' ' 33' ' ' LYS . 85.4 mt -59.98 -37.35 79.37 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.875 0.369 . . . . 1.7 111.144 178.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.3 p -72.57 -9.47 58.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.052 -0.522 . . . . 1.3200000000000001 111.333 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.689 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.0 m-20 -70.0 -19.95 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.91 -0.404 . . . . 1.5800000000000001 109.91 179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -42.87 142.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 115.922 -0.581 . . . . 0.41999999999999998 110.455 178.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 60' ' ' SER . . . 140.45 155.93 6.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.824 -1.179 . . . . 0.23999999999999999 113.828 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 97.6 m -59.33 128.59 37.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 18.6 m-85 -108.84 130.76 55.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.049 -0.523 . . . . 1.24 109.649 177.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 30.1 tt0 -125.76 119.29 27.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.034 -0.266 . . . . 1.1599999999999999 110.765 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 20.0 t -99.96 115.82 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.474 -0.33 . . . . 1.03 110.126 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.82 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 52.3 mtpt -112.53 105.52 13.76 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.878 -0.329 . . . . 1.76 111.456 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.83 HG11 ' CG ' ' A' ' 43' ' ' PHE . 15.3 t -89.75 110.58 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.747 -0.834 . . . . 1.1799999999999999 108.747 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 tttm -99.86 120.22 39.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.264 0.839 . . . . 1.6200000000000001 113.264 -177.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.812 ' HE2' HD22 ' A' ' 45' ' ' LEU . 35.5 tttp -145.09 102.15 3.71 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.388 -0.597 . . . . 2.8399999999999999 109.388 177.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.884 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.36 133.65 43.01 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.331 -0.85 . . . . 0.44 113.013 -179.106 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 55.0 Cg_endo -98.82 47.68 2.11 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.383 -1.09 . . . . 0.56000000000000005 112.264 -0.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.16 103.13 0.28 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.2 -1.0 . . . . 0.47999999999999998 113.142 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 150.2 3.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.36 -0.92 . . . . 1.22 109.587 177.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.725 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -142.98 151.54 40.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.975 -0.29 . . . . 0.56999999999999995 111.683 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 42.5 p-10 -146.41 153.14 40.13 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.411 -0.359 . . . . 2.0299999999999998 111.777 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.674 ' HG2' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.35 155.45 43.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.471 -0.331 . . . . 2.9500000000000002 110.465 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 12.4 tttt -99.99 141.09 33.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.866 1.062 . . . . 2.2599999999999998 113.866 -177.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.035 HG23 HD13 ' A' ' 29' ' ' ILE . 68.0 mt -143.81 112.03 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.28000000000000003 109.397 177.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.438 ' CD2' HG23 ' A' ' 117' ' ' THR . 8.3 m170 -97.06 114.38 26.02 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.55000000000000004 110.284 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.642 HD21 HD22 ' A' ' 110' ' ' LEU . 52.3 tp -93.02 122.53 35.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.477 0.547 . . . . 1.52 112.477 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.668 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 61.1 t -119.99 121.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.762 -0.829 . . . . 0.32000000000000001 108.762 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 33' ' ' LYS . 11.7 t -98.52 127.03 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 112.656 0.613 . . . . 1.0800000000000001 112.656 -177.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.726 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 81.3 mt -84.51 173.59 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.663 -0.699 . . . . 0.52000000000000002 109.443 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -76.52 138.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.358 0.599 . . . . 1.48 112.04 -178.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.931 ' HB3' ' HD2' ' A' ' 141' ' ' PRO . 7.4 mmmt -159.87 178.91 1.49 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.897 -1.047 . . . . 2.2000000000000002 109.605 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.931 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 20.5 Cg_exo -31.59 146.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 123.058 2.505 . . . . 1.3100000000000001 114.133 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.72 42.57 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.008 1.484 . . . . 2.3100000000000001 115.008 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 141' ' ' PRO . . . 149.72 55.52 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.386 -1.388 . . . . 2.52 114.329 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.675 ' H ' ' HE2' ' A' ' 33' ' ' LYS . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.104 -0.951 . . . . 2.6000000000000001 111.197 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.551 -0.22 . . . . 3.2799999999999998 112.551 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -157.22 157.0 33.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 2.4300000000000002 110.758 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.2 m -158.86 163.68 36.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.8400000000000001 111.026 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.67 141.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.001 -0.545 . . . . 2.1499999999999999 110.798 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.2 p -86.58 157.22 19.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.41 0.624 . . . . 1.1200000000000001 111.399 -179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.551 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.13 83.21 0.21 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.75 -1.113 . . . . 0.65000000000000002 111.489 -178.206 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.6 Cg_endo -78.39 -79.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.277 2.651 . . . . 0.88 112.354 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -78.58 128.14 33.1 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.607 -0.886 . . . . 2.0600000000000001 108.607 178.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.897 ' OE2' HD11 ' A' ' 29' ' ' ILE . 84.0 tt0 -144.03 159.45 42.57 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.038 1.125 . . . . 1.71 114.038 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.45 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 27.4 mtt -139.97 118.93 12.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.802 -1.09 . . . . 1.8600000000000001 109.584 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.9 mm -120.02 130.93 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.509 -0.314 . . . . 0.39000000000000001 111.428 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 19.5 pt-20 -128.56 127.8 43.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 1.1899999999999999 110.775 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 110' ' ' LEU . 42.4 mmtm -142.28 164.86 29.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.235 -0.439 . . . . 2.52 110.953 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.022 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.52 135.24 39.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.286 -0.416 . . . . 0.39000000000000001 111.283 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 71.3 tttt -45.84 130.71 9.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.346 -0.388 . . . . 2.3500000000000001 111.24 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 91.77 -19.91 45.36 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.084 -0.579 . . . . 0.31 112.372 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.832 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.2 mt-10 -80.03 160.01 26.0 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.551 -0.907 . . . . 2.1099999999999999 108.551 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 31.3 m -88.68 127.34 35.58 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.789 -0.764 . . . . 0.33000000000000002 110.762 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.008 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.04 119.97 39.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 0.26000000000000001 110.829 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 94' ' ' THR . 41.4 t80 -79.37 119.35 22.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 1.4299999999999999 111.907 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 105' ' ' ILE . 13.1 mt -103.8 105.42 47.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.87 -0.789 . . . . 0.80000000000000004 108.87 177.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 90.7 Cg_endo -84.6 122.66 2.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.449 2.099 . . . . 0.41999999999999998 114.589 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.8 t -140.73 127.26 20.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.355 -0.979 . . . . 1.03 108.355 177.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 29.8 ttpt -140.69 116.56 10.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.393 0.616 . . . . 1.6599999999999999 110.697 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.754 ' CZ ' HD21 ' A' ' 53' ' ' LEU . 33.2 p90 -93.62 141.43 28.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 1.26 111.885 -179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 m -80.94 150.48 28.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 1.3300000000000001 110.774 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.79 141.62 39.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.841 -0.618 . . . . 2.1200000000000001 111.313 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 m -156.25 153.59 25.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 1.75 110.162 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.4 -20.69 26.82 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.431 2.087 . . . . 1.6100000000000001 112.467 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.715 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 43.9 mt-10 -75.76 -41.42 53.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 111.942 0.349 . . . . 2.1800000000000002 111.942 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -69.2 74.64 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.836 -0.745 . . . . 2.4100000000000001 110.244 -179.43 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 48' ' ' GLU . 93.0 mt-30 -90.42 -16.44 29.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.085 -0.961 . . . . 1.6399999999999999 111.02 -179.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -70.05 155.8 53.25 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.133 -1.032 . . . . 0.55000000000000004 112.096 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.23 151.13 9.75 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.125 1.883 . . . . 0.84999999999999998 111.551 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.754 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -77.67 132.62 38.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.854 0.359 . . . . 1.8999999999999999 110.946 -179.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 123' ' ' LYS . 36.1 t0 -140.26 150.5 44.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.392 0.615 . . . . 1.78 111.895 -179.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.711 HD13 ' HB1' ' A' ' 103' ' ' ALA . 50.4 mt -142.23 137.78 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.682 -1.145 . . . . 0.75 109.619 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.734 ' HG2' HD21 ' A' ' 73' ' ' LEU . 37.0 mt-10 -140.22 111.86 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.79 0.328 . . . . 1.6699999999999999 111.825 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.932 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.6 m95 -98.67 119.99 38.34 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.22 110.908 178.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.55 146.15 37.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.67 -0.492 . . . . 0.40999999999999998 109.67 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.787 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 7.3 tt -132.5 140.01 48.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.775 0.657 . . . . 0.78000000000000003 112.775 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -122.37 102.98 39.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 108.628 -0.879 . . . . 1.25 108.628 177.149 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 2.7 Cg_exo -79.08 115.23 3.49 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.725 2.283 . . . . 0.53000000000000003 113.22 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.32 69.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.528 -0.76 . . . . 0.40999999999999998 110.243 178.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.68 10.22 7.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.614 -0.721 . . . . 1.8200000000000001 111.491 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 32.7 m120 -145.77 156.01 43.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.061 0.458 . . . . 1.9399999999999999 111.361 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.91 -22.87 64.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.652 -0.703 . . . . 1.6599999999999999 111.716 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.707 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 5.6 mttt -73.79 151.23 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.221 -0.445 . . . . 1.74 110.71 -179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.3 m -152.41 136.29 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.655 0 CA-C-O 122.502 1.144 . . . . 0.96999999999999997 110.764 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 61.23 45.05 9.23 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.758 -2.019 . . . . 1.77 112.566 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -87.12 149.72 24.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.728 0.299 . . . . 1.96 110.538 179.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.734 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 5.9 p -68.26 139.99 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.77000000000000002 110.09 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.86 ' CD1' HG11 ' A' ' 91' ' ' VAL . 1.1 pp -136.51 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.538 -0.465 . . . . 1.1499999999999999 111.552 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.946 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -141.19 133.14 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.009 0.433 . . . . 0.28999999999999998 109.848 179.384 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HG2' ' A' ' 56' ' ' GLU . 1.6 mp -140.83 158.57 43.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 1.3 111.024 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.867 ' CD1' HD13 ' A' ' 79' ' ' ILE . 51.8 t80 -133.68 104.47 6.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.578 -0.527 . . . . 1.3 109.578 176.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.498 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 8.1 t -144.02 159.78 42.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.413 0.523 . . . . 0.89000000000000001 112.413 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 47.57 30.02 6.05 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.988 -0.551 . . . . 0.56999999999999995 113.182 178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.1 t0 71.9 3.07 4.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 1.46 111.4 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 22.8 mtpp -100.03 118.05 35.6 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.1 -0.704 . . . . 2.4100000000000001 109.1 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.867 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.3 mm -79.86 130.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.87 -1.159 . . . . 1.6599999999999999 107.87 178.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.77 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.1 m-85 -118.56 125.79 50.59 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.096 -0.956 . . . . 1.25 110.289 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.844 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.0 p-10 -166.09 -55.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.486 -1.672 . . . . 1.2 106.486 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 34.0 p-10 -82.18 -22.08 36.19 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.311 -1.313 . . . . 2.1699999999999999 109.202 176.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.615 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.6 t80 -80.83 -26.52 36.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.736 -1.12 . . . . 5.0499999999999998 108.556 178.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 1.8 m-85 -85.25 118.3 70.51 Favored Pre-proline 0 CA--C 1.51 -0.58 0 CA-C-N 115.374 -0.83 . . . . 1.29 109.868 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 4.6 Cg_endo -47.04 -43.6 24.54 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.421 1.414 . . . . 0.79000000000000004 110.49 179.125 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.775 ' HB3' HG22 ' A' ' 71' ' ' ILE . 71.5 m-20 -69.59 106.25 2.96 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 119.627 -0.829 . . . . 1.3600000000000001 111.512 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.858 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 8.7 mp 73.12 20.13 3.46 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.186 -0.916 . . . . 1.6200000000000001 113.453 178.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 60.2 pttt -54.66 126.07 22.42 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.903 -0.719 . . . . 2.3900000000000001 111.332 178.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 14.28 45.09 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.323 -0.941 . . . . 0.37 114.402 178.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.858 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -144.7 -47.2 0.24 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 114.656 1.354 . . . . 1.5900000000000001 114.656 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.946 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.24 81.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.676 1.227 . . . . 0.20000000000000001 108.109 -178.285 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.595 ' C ' HG22 ' A' ' 105' ' ' ILE . 21.8 m80 -102.73 130.2 49.6 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.081 -1.872 . . . . 0.28999999999999998 112.313 -176.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.119 ' CD1' HG23 ' A' ' 105' ' ' ILE . 68.9 m-85 -72.82 121.22 19.57 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.177 -0.675 . . . . 1.23 109.177 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.573 HG22 ' OD1' ' A' ' 106' ' ' ASN . 38.1 p -70.15 -9.78 56.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.188 -0.914 . . . . 0.46000000000000002 110.805 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 70.5 m -91.09 119.95 31.65 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.987 -0.551 . . . . 1.2 110.449 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -89.59 4.07 50.55 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.268 0.556 . . . . 2.2200000000000002 110.142 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -145.99 67.6 1.2 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.262 -1.014 . . . . 2.1400000000000001 108.262 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.466 HD23 ' CD1' ' A' ' 55' ' ' ILE . 6.8 mp -55.73 -33.41 64.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.975 -1.011 . . . . 1.49 111.72 -178.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -61.28 -3.59 0.95 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.152 0.501 . . . . 2.04 112.21 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.68 0.07 56.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.546 -0.752 . . . . 1.3999999999999999 111.187 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 105.81 -12.31 45.9 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.618 -0.801 . . . . 0.38 113.673 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 96.1 m-20 -94.75 113.76 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.472 . . . . 1.4399999999999999 111.418 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.36 12.17 24.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.8 -0.637 . . . . 0.42999999999999999 111.918 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 72.5 p -60.03 140.05 57.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.64 1.718 . . . . 1.04 115.64 -178.002 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.119 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -131.07 135.51 59.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-N 114.104 -1.407 . . . . 0.31 110.871 178.547 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.633 ' HB2' HG22 ' A' ' 36' ' ' THR . 0.7 OUTLIER -105.03 148.21 27.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.039 -0.726 . . . . 1.1499999999999999 109.039 177.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.816 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -101.42 118.89 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.005 0.431 . . . . 0.27000000000000002 110.999 -179.561 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.1 p -83.26 144.44 29.74 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.537 -0.756 . . . . 0.28999999999999998 110.53 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 50.58 57.52 6.52 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.037 0.446 . . . . 1.52 111.549 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 37' ' ' ALA . 23.5 mt -46.92 90.09 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.95 1.092 . . . . 1.02 113.95 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 33.7 mt-30 -59.22 141.47 54.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.864 -0.607 . . . . 2.1299999999999999 110.702 176.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.06 -37.02 78.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 1.7 110.215 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.4 p -74.58 -9.97 59.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.3200000000000001 111.48 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.581 ' O ' HD11 ' A' ' 59' ' ' ILE . 92.4 m-20 -72.47 -17.07 61.79 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.938 -0.393 . . . . 1.5800000000000001 109.938 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -43.46 141.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 116.198 -0.455 . . . . 0.41999999999999998 110.346 178.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.11 158.97 7.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.218 -0.991 . . . . 0.23999999999999999 113.352 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 90.9 m -59.55 131.04 49.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.685 0.624 . . . . 0.31 112.685 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 20.7 m-85 -111.26 135.38 51.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.294 -0.632 . . . . 1.24 109.294 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 59.2 tt0 -127.06 121.5 31.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.971 -0.291 . . . . 1.1599999999999999 110.717 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 130' ' ' ASN . 26.0 t -99.98 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 1.03 110.456 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 90.8 mttt -119.81 106.22 11.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 1.76 111.188 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 50.1 t -93.72 109.92 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.695 -0.483 . . . . 1.1799999999999999 109.695 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 72.6 tttt -94.13 120.01 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.969 -0.693 . . . . 1.6200000000000001 112.308 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HG2' ' HA ' ' A' ' 53' ' ' LEU . 5.6 mtmp? -143.73 101.99 3.84 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.202 -0.666 . . . . 2.8399999999999999 109.202 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.939 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.03 131.02 40.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 113.016 0.747 . . . . 0.44 113.016 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 21.2 Cg_endo -102.03 51.92 1.44 Allowed 'Cis proline' 0 C--N 1.354 0.837 0 C-N-CA 124.788 -0.922 . . . . 0.56000000000000005 111.505 -0.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.49 103.44 0.29 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.183 -1.008 . . . . 0.47999999999999998 113.993 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.2 m -89.52 139.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.193 -1.004 . . . . 1.22 109.396 177.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' LYS . . . -136.73 149.34 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.193 -0.317 . . . . 0.56999999999999995 111.81 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 120' ' ' CYS . 51.6 p-10 -146.41 151.22 37.09 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.381 0.511 . . . . 2.0299999999999998 112.381 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.625 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.65 155.27 42.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.915 -0.584 . . . . 2.9500000000000002 110.37 178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 97.5 mttt -101.25 140.02 36.12 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.504 0.927 . . . . 2.2599999999999998 113.504 -178.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.8 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 85.6 mt -140.23 119.97 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.28000000000000003 109.026 176.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 117' ' ' THR . 35.3 m170 -100.25 116.79 33.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.609 -0.436 . . . . 0.55000000000000004 110.44 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 110' ' ' LEU . 58.8 tp -89.86 120.1 30.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.451 . . . . 1.52 111.657 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 57.7 t -118.14 119.95 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.32000000000000001 109.418 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 115' ' ' ILE . 39.1 t -99.78 125.81 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.038 0.447 . . . . 1.0800000000000001 112.174 -178.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 97.8 mt -83.92 170.0 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.734 -0.667 . . . . 0.52000000000000002 109.545 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.3 t -75.97 138.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 1.48 111.55 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 1.022 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 4.4 mmtt -160.85 171.19 7.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.872 -1.058 . . . . 2.2000000000000002 109.89 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 11.1 Cg_endo -53.74 -154.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.542 2.161 . . . . 1.3100000000000001 112.131 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.1 t -36.33 -49.95 0.73 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.916 0.389 . . . . 2.3100000000000001 111.723 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.504 ' HA3' ' HG2' ' A' ' 33' ' ' LYS . . . 73.32 -60.01 1.91 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.919 -0.657 . . . . 2.52 113.279 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.246 -0.883 . . . . 2.6000000000000001 111.152 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.619 -0.192 . . . . 3.2799999999999998 112.619 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 159.32 28.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 2.4300000000000002 110.848 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -78.82 142.6 36.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.8400000000000001 111.066 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.605 HD12 ' HB1' ' A' ' 129' ' ' ALA . 15.6 tt -142.18 131.3 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 110.793 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.73 151.75 19.88 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.546 0.689 . . . . 1.1200000000000001 111.65 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER 42.59 82.96 0.21 Allowed Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.673 -1.149 . . . . 0.65000000000000002 111.491 -178.287 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.635 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 58.9 Cg_endo -78.6 -83.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.557 2.838 . . . . 0.88 112.989 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 86.4 tt0 -77.97 120.22 22.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.221 -0.659 . . . . 2.0600000000000001 109.221 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.884 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.1 tt0 -144.02 161.03 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.472 0.916 . . . . 1.71 113.472 -176.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.732 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.8 ttm -131.91 139.42 48.74 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.255 -0.884 . . . . 1.8600000000000001 109.807 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.884 HD11 ' OE2' ' A' ' 27' ' ' GLU . 33.5 mm -134.24 140.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.202 -0.454 . . . . 0.39000000000000001 111.465 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.5 pt-20 -137.84 129.21 27.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.773 0.32 . . . . 1.1899999999999999 111.086 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 110' ' ' LEU . 56.8 mmtt -142.33 159.98 41.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.327 -0.397 . . . . 2.52 111.534 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.51 142.51 40.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.089 -0.505 . . . . 0.39000000000000001 111.844 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 66.4 mttt -46.66 144.13 2.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.888 -0.597 . . . . 2.3500000000000001 111.933 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.97 -22.81 2.8 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.328 -0.851 . . . . 0.31 113.334 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 110' ' ' LEU . 99.4 mt-10 -79.99 160.03 26.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.435 -0.58 . . . . 2.1099999999999999 109.435 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 60.5 m -87.09 129.1 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.182 -0.607 . . . . 0.33000000000000002 110.712 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.0 115.34 29.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.044 0.45 . . . . 0.26000000000000001 110.631 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.38 120.05 23.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.117 -0.492 . . . . 1.4299999999999999 112.315 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 105' ' ' ILE . 23.8 mt -104.73 104.86 48.13 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.05 -0.722 . . . . 0.80000000000000004 109.05 177.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 5.8 Cg_exo -80.23 130.78 8.36 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.535 2.157 . . . . 0.41999999999999998 114.257 -177.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 1.9 t -141.17 130.96 24.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.125 -0.943 . . . . 1.03 108.766 177.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.4 mmtp -140.24 137.54 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.473 -0.33 . . . . 1.6599999999999999 110.649 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 122' ' ' VAL . 51.3 p90 -140.92 139.97 34.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.488 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 1.3300000000000001 110.567 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 45' ' ' LEU . 9.6 tt -97.67 108.04 20.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.421 -0.354 . . . . 2.1200000000000001 110.871 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 t -84.3 136.87 39.96 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.879 -0.415 . . . . 1.75 109.879 179.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.55 -30.73 4.17 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.842 1.694 . . . . 1.6100000000000001 111.194 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.94 -38.6 45.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.565 -0.743 . . . . 2.1800000000000002 111.018 179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 78.0 m-20 -70.13 73.78 0.47 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 120.518 -0.473 . . . . 2.4100000000000001 109.741 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -98.55 0.05 44.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.677 -0.692 . . . . 1.6399999999999999 111.912 -178.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.908 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.4 171.73 39.75 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.811 -0.709 . . . . 0.55000000000000004 113.183 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.66 138.69 65.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.816 2.344 . . . . 0.84999999999999998 112.365 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 2.0 mt -78.54 111.82 14.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 1.8999999999999999 111.557 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.789 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 89.0 m-20 -127.57 102.75 6.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.613 0.721 . . . . 1.78 111.429 178.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.768 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.3 mt -94.01 123.55 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.61 -1.177 . . . . 0.75 109.96 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.682 ' HG2' HD11 ' A' ' 73' ' ' LEU . 95.0 mt-10 -120.01 111.87 18.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.831 0.678 . . . . 1.6699999999999999 112.831 -178.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.938 ' CD2' HD11 ' A' ' 105' ' ' ILE . 69.9 m95 -94.33 119.96 33.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.772 -0.371 . . . . 0.22 110.088 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.512 HD12 ' OE1' ' A' ' 119' ' ' GLN . 86.1 mt -105.59 122.67 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.665 0.269 . . . . 0.40999999999999998 110.329 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.634 ' HB ' HG21 ' A' ' 71' ' ' ILE . 7.3 tt -108.11 131.52 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.459 0.54 . . . . 0.78000000000000003 112.459 -179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -126.1 102.19 27.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.909 -0.774 . . . . 1.25 108.909 177.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 5.5 Cg_exo -79.77 118.35 3.79 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.735 2.29 . . . . 0.53000000000000003 112.389 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.06 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.86 -0.609 . . . . 0.40999999999999998 111.024 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -75.0 -40.03 60.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.869 -0.605 . . . . 1.8200000000000001 111.845 -179.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 80.7 m-20 -83.33 159.95 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.329 0.585 . . . . 1.9399999999999999 111.988 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -69.36 -16.76 63.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.121 -0.945 . . . . 1.6599999999999999 111.199 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.67 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.7 mttm -69.15 149.14 48.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.629 -0.714 . . . . 1.74 111.651 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -156.73 127.87 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-O 121.942 0.877 . . . . 0.96999999999999997 109.887 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.65 39.98 27.0 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 113.959 -1.473 . . . . 1.77 112.51 178.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.04 143.85 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.367 0.127 . . . . 1.96 110.719 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' CG1' ' CZ ' ' A' ' 84' ' ' TYR . 26.5 t -67.9 119.79 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.77000000000000002 110.004 179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.896 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -105.23 -55.45 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.622 -0.717 . . . . 1.1499999999999999 112.328 -178.203 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.825 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -135.8 124.47 38.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.145 -1.058 . . . . 0.28999999999999998 108.145 179.119 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.811 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.6 tt -137.71 156.17 48.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.928 -0.578 . . . . 1.3 110.786 -176.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.837 ' CD1' HD13 ' A' ' 79' ' ' ILE . 25.2 t80 -132.81 103.71 6.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.198 -0.456 . . . . 1.3 109.879 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.438 ' HB3' ' HE2' ' A' ' 80' ' ' TYR . 29.7 t -143.99 156.61 44.47 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.244 0.461 . . . . 0.89000000000000001 112.244 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.24 29.3 21.81 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.02 -0.609 . . . . 0.56999999999999995 112.795 178.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.6 t0 73.47 2.85 4.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.494 0.188 . . . . 1.46 111.28 -179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 80.2 mttt -100.01 115.17 29.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 110.148 -0.316 . . . . 2.4100000000000001 110.148 178.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.837 HD13 ' CD1' ' A' ' 74' ' ' TYR . 2.4 mm -80.34 128.33 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 106.927 -1.509 . . . . 1.6599999999999999 106.927 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.6 m-85 -112.43 117.31 32.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.215 -0.902 . . . . 1.25 110.38 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.855 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 2.4 p-10 -166.14 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.845 -1.539 . . . . 1.2 106.845 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -76.63 -34.66 58.33 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.37 -1.286 . . . . 2.1699999999999999 108.563 177.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.52 -29.98 61.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.765 -1.198 . . . . 5.0499999999999998 107.765 177.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.542 ' CZ ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 m-85 -83.47 110.83 27.01 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 114.833 -1.076 . . . . 1.29 109.938 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.77 -28.14 59.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.063 1.842 . . . . 0.79000000000000004 112.456 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 1.058 ' O ' HD12 ' A' ' 87' ' ' LEU . 61.1 m-20 -50.05 -32.77 16.31 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.356 -0.538 . . . . 1.3600000000000001 111.843 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 86' ' ' ASP . 7.6 mp -151.42 35.27 0.57 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.092 -0.958 . . . . 1.6200000000000001 110.424 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.855 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 18.8 pttp -57.26 134.86 56.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.134 0.492 . . . . 2.3900000000000001 112.011 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 75.54 19.84 78.96 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.513 -0.767 . . . . 0.37 113.947 178.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.851 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.6 ptp180 -146.78 -48.71 0.19 Allowed 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.394 1.257 . . . . 1.5900000000000001 114.394 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.825 HG11 ' HB ' ' A' ' 72' ' ' ILE . 8.2 p -80.0 81.48 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.979 1.371 . . . . 0.20000000000000001 107.721 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.43 ' C ' HG22 ' A' ' 105' ' ' ILE . 15.6 m80 -101.81 127.68 48.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 112.355 -2.202 . . . . 0.28999999999999998 112.366 -175.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.104 ' CD1' HG23 ' A' ' 105' ' ' ILE . 58.6 m-85 -71.86 124.02 23.94 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 120.219 -0.592 . . . . 1.23 109.406 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.669 HG22 ' OD1' ' A' ' 106' ' ' ASN . 30.6 p -73.9 33.09 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.587 -0.733 . . . . 0.46000000000000002 112.517 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 m -148.91 136.25 20.21 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.968 0.413 . . . . 1.2 111.338 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.8 1.01 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 2.2200000000000002 110.735 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -146.35 65.53 1.19 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.347 0.594 . . . . 2.1400000000000001 109.583 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.914 HD21 ' CG ' ' A' ' 93' ' ' PHE . 9.5 mp -57.67 -30.04 65.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.297 -0.865 . . . . 1.49 111.114 -179.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -60.01 -10.96 4.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.619 0.723 . . . . 2.04 112.238 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -83.45 0.05 47.95 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.489 -1.232 . . . . 1.3999999999999999 111.121 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 112.87 -9.38 25.47 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.627 -0.797 . . . . 0.38 113.433 179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.0 m-20 -96.59 116.58 29.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.931 0.366 . . . . 1.4399999999999999 110.61 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.674 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.75 10.03 15.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.491 -0.322 . . . . 0.42999999999999999 111.627 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 50.4 m -60.01 139.76 57.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 115.335 1.605 . . . . 1.04 115.335 -178.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.104 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -134.71 127.87 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-N 114.419 -1.264 . . . . 0.31 110.45 178.375 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.669 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -103.65 150.46 23.98 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.506 -0.553 . . . . 1.1499999999999999 109.506 178.119 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -101.14 119.98 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.101 0.477 . . . . 0.27000000000000002 111.114 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.3 p -85.56 144.12 28.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.313 -0.858 . . . . 0.28999999999999998 110.64 178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.15 59.99 3.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.629 0.603 . . . . 1.52 112.629 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 37' ' ' ALA . 8.9 mt -46.0 178.26 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.13 0.49 . . . . 1.02 112.274 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.604 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.1 tt0 -177.55 161.44 1.71 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.817 -0.629 . . . . 2.1299999999999999 110.25 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.791 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 59.0 tp -59.96 -40.03 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.842 0.353 . . . . 1.7 111.376 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -72.2 -12.33 61.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.127 -0.488 . . . . 1.3200000000000001 111.683 -178.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.14 -21.31 61.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.791 -0.448 . . . . 1.5800000000000001 109.791 178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 HG23 ' A' ' 137' ' ' VAL . 0.1 OUTLIER -44.94 145.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.877 -0.601 . . . . 0.41999999999999998 111.06 179.066 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.68 149.91 5.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.768 -1.206 . . . . 0.23999999999999999 114.229 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.841 HG23 ' CD2' ' A' ' 134' ' ' HIS . 93.8 m -59.81 136.8 58.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.802 -0.699 . . . . 0.31 111.813 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.937 ' CE1' HD12 ' A' ' 135' ' ' LEU . 47.2 m-85 -120.0 132.57 55.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.704 -0.48 . . . . 1.24 109.704 177.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.812 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 36.7 tt0 -120.29 116.4 25.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.589 -0.278 . . . . 1.1599999999999999 110.631 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.519 ' HB3' ' CD ' ' A' ' 131' ' ' LYS . 53.3 t -100.02 115.57 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.692 0.282 . . . . 1.03 110.545 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 29.7 mtpp -119.46 105.7 11.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 1.76 111.125 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.684 HG22 HG12 ' A' ' 55' ' ' ILE . 42.9 t -90.03 117.14 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.349 -0.611 . . . . 1.1799999999999999 109.349 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 62.9 tttp -98.58 120.29 38.75 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.515 0.931 . . . . 1.6200000000000001 113.515 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HD3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -143.17 101.04 3.74 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 109.105 -0.702 . . . . 2.8399999999999999 109.105 176.44 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.908 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.68 132.56 65.0 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.722 -0.672 . . . . 0.44 112.71 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HD2' ' OD1' ' A' ' 49' ' ' ASP . 51.6 Cg_endo -99.53 48.37 1.98 Allowed 'Cis proline' 0 C--N 1.353 0.79 0 C-N-CA 124.68 -0.967 . . . . 0.56000000000000005 112.432 -0.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.37 103.56 0.29 Allowed Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.864 -0.684 . . . . 0.47999999999999998 112.823 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.03 152.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.575 -0.812 . . . . 1.22 110.099 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.605 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -131.66 147.46 52.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.485 0.183 . . . . 0.56999999999999995 111.198 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 49.5 t-20 -146.69 138.59 24.64 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.871 0.322 . . . . 2.0299999999999998 111.871 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.799 ' HE2' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.42 151.7 38.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.49 -0.323 . . . . 2.9500000000000002 110.824 178.865 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' GLU . 3.4 tttt -97.98 139.94 33.07 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 113.188 0.81 . . . . 2.2599999999999998 113.188 -177.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.799 HD11 ' HE2' ' A' ' 131' ' ' LYS . 90.1 mt -145.1 113.7 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.28000000000000003 109.76 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.841 ' CD2' HG23 ' A' ' 117' ' ' THR . 53.4 m170 -102.95 120.0 39.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.55000000000000004 111.273 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.937 HD12 ' CE1' ' A' ' 118' ' ' TYR . 13.8 mt -91.09 127.23 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 1.52 112.634 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.417 ' HB ' ' CB ' ' A' ' 30' ' ' GLU . 62.7 t -113.27 127.48 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.098 -0.955 . . . . 0.32000000000000001 108.939 178.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.857 HG23 HG13 ' A' ' 115' ' ' ILE . 20.7 t -97.88 120.65 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.579 0.585 . . . . 1.0800000000000001 112.579 -178.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.763 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 78.4 mt -83.57 160.85 21.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.899 -0.592 . . . . 0.52000000000000002 109.765 178.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -76.05 139.98 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.384 0.612 . . . . 1.48 112.204 -178.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.998 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -158.81 179.81 1.28 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 114.759 -1.11 . . . . 2.2000000000000002 109.197 -179.874 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.689 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 88.4 Cg_exo -49.13 -141.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.684 2.256 . . . . 1.3100000000000001 113.42 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.4 m -34.58 -41.2 0.12 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.454 0.539 . . . . 2.3100000000000001 112.454 -178.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 33' ' ' LYS . . . 123.08 -52.57 0.77 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.454 -0.879 . . . . 2.52 113.331 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.258 -0.877 . . . . 2.6000000000000001 111.068 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.478 -0.249 . . . . 3.2799999999999998 112.478 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -78.71 140.4 38.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 2.4300000000000002 110.742 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -157.79 163.58 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 1.8400000000000001 111.092 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 129' ' ' ALA . 17.1 tt -139.98 139.37 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 2.1499999999999999 110.324 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 7.9 p -92.09 153.03 19.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.49 0.662 . . . . 1.1200000000000001 111.734 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.513 ' O ' ' HE2' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 39.41 83.75 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 114.554 -1.203 . . . . 0.65000000000000002 111.502 -178.358 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.616 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 55.4 Cg_endo -77.84 -80.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.334 2.689 . . . . 0.88 112.704 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 14.7 pt-20 -78.49 128.11 33.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.783 -0.821 . . . . 2.0600000000000001 108.783 179.163 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 132' ' ' LYS . 50.8 tp10 -144.14 160.01 41.66 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.247 1.203 . . . . 1.71 114.247 -176.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 11.2 mtm -140.26 118.27 11.87 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 114.464 -1.244 . . . . 1.8600000000000001 109.126 177.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.422 HG12 HG23 ' A' ' 133' ' ' ILE . 36.7 mm -120.03 128.65 75.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.906 0.384 . . . . 0.39000000000000001 111.561 -178.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 91.4 mt-10 -120.01 125.35 48.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.1899999999999999 109.916 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HB2' HD13 ' A' ' 110' ' ' LEU . 74.5 mmtt -141.9 160.02 41.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 2.52 111.428 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.794 ' HB1' ' CG ' ' A' ' 140' ' ' LYS . . . -76.77 134.37 39.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.143 -0.48 . . . . 0.39000000000000001 111.742 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 84.8 tttt -46.92 134.38 10.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.934 -0.575 . . . . 2.3500000000000001 111.273 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA3' ' HA2' ' A' ' 143' ' ' GLY . . . 90.72 -25.16 14.24 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.992 -0.623 . . . . 0.31 112.66 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 110' ' ' LEU . 98.9 mt-10 -80.0 160.0 26.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.124 -1.065 . . . . 2.1099999999999999 108.124 178.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 59.1 m -87.98 127.04 35.38 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.491 -0.884 . . . . 0.33000000000000002 110.609 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -97.52 116.65 30.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.905 0.383 . . . . 0.26000000000000001 110.169 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.71 ' CD1' HG21 ' A' ' 94' ' ' THR . 74.5 t80 -79.11 118.54 21.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.873 -0.603 . . . . 1.4299999999999999 112.259 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 133' ' ' ILE . 38.7 mt -102.9 107.94 56.64 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.142 -0.688 . . . . 0.80000000000000004 109.142 178.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 96.2 Cg_endo -82.32 120.63 3.3 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.078 . . . . 0.41999999999999998 114.312 -178.106 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 2.6 t -141.01 123.93 16.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.777 -0.823 . . . . 1.03 108.777 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.655 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 17.1 mttp -141.09 153.77 45.61 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.283 -0.417 . . . . 1.6599999999999999 110.758 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.494 ' CD1' HG11 ' A' ' 122' ' ' VAL . 33.1 p90 -139.74 145.71 38.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.631 . . . . 1.26 111.479 -178.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.07 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.456 -0.793 . . . . 1.3300000000000001 111.631 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.53 147.46 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.904 -0.589 . . . . 2.1200000000000001 110.943 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 19.5 p -157.35 139.98 10.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 1.75 110.29 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.27 -27.05 2.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.801 2.334 . . . . 1.6100000000000001 112.804 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.647 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.0 pt-20 -77.08 -28.65 54.69 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.025 0.38 . . . . 2.1800000000000002 112.025 -179.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 44.1 p-10 -67.74 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.453 0.644 . . . . 2.4100000000000001 111.22 -178.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' GLU . 65.8 mt-30 -96.98 -6.81 34.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.678 . . . . 1.6399999999999999 111.763 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.873 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -73.85 158.24 52.08 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.207 -0.997 . . . . 0.55000000000000004 113.056 -179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.83 130.33 39.79 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.84999999999999998 111.209 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HE2' ' A' ' 74' ' ' TYR . 7.3 tt -77.81 119.96 22.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.39 . . . . 1.8999999999999999 110.981 -179.04 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -136.67 102.76 5.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 121.648 0.737 . . . . 1.78 111.83 179.727 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 20.8 mt -96.71 111.4 26.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.802 -1.09 . . . . 0.75 110.37 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.762 ' HG2' HD11 ' A' ' 73' ' ' LEU . 79.2 mt-10 -108.91 117.67 34.79 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.389 0.515 . . . . 1.6699999999999999 112.389 -179.045 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.947 ' CD2' HD11 ' A' ' 105' ' ' ILE . 73.9 m95 -95.43 118.52 32.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.771 -0.455 . . . . 0.22 109.771 177.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' CD2' HG22 ' A' ' 70' ' ' VAL . 85.6 mt -109.96 140.02 44.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.599 -0.273 . . . . 0.40999999999999998 110.294 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 117' ' ' THR . 2.6 tt -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.086 0.402 . . . . 0.78000000000000003 112.086 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.423 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 48.8 m -114.63 102.53 54.88 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 108.515 -0.92 . . . . 1.25 108.515 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 81.4 Cg_endo -78.85 111.06 2.91 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.475 2.117 . . . . 0.53000000000000003 113.151 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.02 -33.99 72.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.994 -1.003 . . . . 0.40999999999999998 111.009 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 113' ' ' SER . 7.4 p-10 -87.6 17.21 4.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.242 -0.435 . . . . 1.8200000000000001 111.369 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.6 HD21 ' HB2' ' A' ' 113' ' ' SER . 91.8 m-20 -148.34 162.98 38.44 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.408 0.623 . . . . 1.9399999999999999 111.96 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.3 -19.84 63.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.946 . . . . 1.6599999999999999 111.64 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 57.4 mttt -69.68 151.74 45.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.073 -0.512 . . . . 1.74 111.344 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -155.98 127.93 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 CA-C-O 121.752 0.787 . . . . 0.96999999999999997 109.483 178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 55.48 41.26 31.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.312 -1.313 . . . . 1.77 112.227 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.38 134.89 33.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.96 110.919 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.572 HG22 ' CD2' ' A' ' 58' ' ' LEU . 91.3 t -70.5 129.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.619 -0.264 . . . . 0.77000000000000002 110.872 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.863 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.5 pp -127.11 -36.7 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.269 0.47 . . . . 1.1499999999999999 112.269 -179.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -139.99 123.4 17.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.53 0.681 . . . . 0.28999999999999998 109.385 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.847 HD23 ' N ' ' A' ' 74' ' ' TYR . 5.2 tt -140.36 155.61 46.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.592 -178.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.847 ' N ' HD23 ' A' ' 73' ' ' LEU . 62.7 t80 -132.45 104.29 6.63 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.658 0.266 . . . . 1.3 110.318 179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.43 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 17.9 t -142.46 157.05 45.17 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.9 0.381 . . . . 0.89000000000000001 111.875 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.39 29.45 38.5 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.002 -0.618 . . . . 0.56999999999999995 112.684 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t0 71.9 2.43 4.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.601 0.239 . . . . 1.46 110.933 -179.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 41.0 mttm -100.05 107.36 19.27 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.991 -0.744 . . . . 2.4100000000000001 108.991 177.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.786 HG13 ' CD2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -81.95 118.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 122.511 1.148 . . . . 1.6599999999999999 108.562 178.674 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.68 ' O ' HG12 ' A' ' 72' ' ' ILE . 2.9 m-85 -100.19 125.7 46.37 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 112.767 -2.015 . . . . 1.25 111.663 -177.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.838 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 20.8 p-10 -166.39 -54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.906 -1.516 . . . . 1.2 106.906 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' LYS . 54.3 t0 -81.7 -30.77 32.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.52 -1.218 . . . . 2.1699999999999999 108.848 177.23 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -72.48 -31.24 65.23 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.317 -1.364 . . . . 5.0499999999999998 107.317 177.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 71' ' ' ILE . 0.6 OUTLIER -82.6 111.04 25.71 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.32 -1.309 . . . . 1.29 109.399 178.165 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -34.2 92.91 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.292 1.994 . . . . 0.79000000000000004 113.581 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.778 ' O ' HD23 ' A' ' 87' ' ' LEU . 51.8 m-20 -49.72 -29.84 8.26 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.129 0.789 . . . . 1.3600000000000001 113.129 -177.423 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.833 HD22 ' HD2' ' A' ' 90' ' ' ARG . 17.9 mt -153.8 30.29 0.46 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.808 -0.633 . . . . 1.6200000000000001 111.316 178.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 13.5 pttm -55.54 133.41 50.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.309 -0.556 . . . . 2.3900000000000001 111.847 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 87.88 11.97 67.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.673 177.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.833 ' HD2' HD22 ' A' ' 87' ' ' LEU . 6.1 ptp180 -142.57 -51.02 0.37 Allowed 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 114.977 1.473 . . . . 1.5900000000000001 114.977 -178.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.3 p -79.08 80.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 CA-C-O 122.988 1.375 . . . . 0.20000000000000001 107.667 -177.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.428 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.5 m80 -101.2 126.15 47.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 112.248 -2.251 . . . . 0.28999999999999998 112.388 -175.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.134 ' CD1' HG23 ' A' ' 105' ' ' ILE . 83.3 m-85 -70.76 124.58 24.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 120.036 -0.666 . . . . 1.23 109.715 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.71 HG21 ' CD1' ' A' ' 38' ' ' TYR . 1.7 p -76.18 36.08 0.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.283 -0.871 . . . . 0.46000000000000002 110.966 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 93' ' ' PHE . 2.9 m -148.93 127.1 12.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.96 0.409 . . . . 1.2 110.127 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.62 8.24 37.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.998 -0.546 . . . . 2.2200000000000002 110.313 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -146.53 67.62 1.18 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.518 -0.764 . . . . 2.1400000000000001 108.998 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 93' ' ' PHE . 6.2 mp -57.96 -36.21 72.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.299 -0.864 . . . . 1.49 111.747 -178.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.97 2.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.561 0.578 . . . . 2.04 112.561 -178.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 98' ' ' LEU . 15.7 m -90.53 -0.23 57.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.913 -0.585 . . . . 1.3999999999999999 110.591 178.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 108.13 -12.61 37.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.049 -0.596 . . . . 0.38 113.393 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . 96.0 m-20 -98.07 110.83 23.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.111 0.456 . . . . 1.4399999999999999 110.801 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -109.51 15.43 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.42999999999999999 112.241 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 23.5 m -60.01 139.98 57.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.338 1.607 . . . . 1.04 115.338 -178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.134 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -132.97 130.1 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 114.844 -1.071 . . . . 0.31 111.078 178.356 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.689 ' HB2' HG22 ' A' ' 36' ' ' THR . 50.8 p30 -105.54 147.88 27.88 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.122 -0.696 . . . . 1.1499999999999999 109.122 177.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -99.39 121.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.964 0.411 . . . . 0.27000000000000002 111.409 -178.268 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.2 p -83.06 144.71 29.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.549 -0.751 . . . . 0.28999999999999998 110.33 178.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.8 m-20 50.98 58.68 5.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.93 0.395 . . . . 1.52 111.139 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.1 mt -46.25 88.9 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.494 0.924 . . . . 1.02 113.494 -178.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.2 pt20 -59.51 147.42 36.87 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.896 -0.593 . . . . 2.1299999999999999 110.441 177.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.94 -35.37 74.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.276 0.56 . . . . 1.7 110.428 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.6 ' HB2' HD21 ' A' ' 64' ' ' ASN . 24.3 p -72.21 -9.42 58.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.794 . . . . 1.3200000000000001 111.887 -179.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 6.5 m-20 -70.54 -18.99 62.93 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.682 -0.407 . . . . 1.5800000000000001 110.209 179.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 27.2 mt -44.6 134.97 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.767 -0.457 . . . . 0.41999999999999998 109.767 178.233 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.89 156.54 6.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.073 -1.06 . . . . 0.23999999999999999 113.522 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 85.9 m -59.39 134.67 57.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.797 0.666 . . . . 0.31 112.797 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 14.6 m-85 -113.49 137.88 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.875 -0.602 . . . . 1.24 109.754 177.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 32.1 tt0 -129.13 118.14 21.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.666 0.27 . . . . 1.1599999999999999 110.762 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 13.0 t -104.13 118.79 37.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.4 . . . . 1.03 110.34 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 10.0 mtpm? -119.97 107.01 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.538 -0.301 . . . . 1.76 111.283 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 t -90.82 110.25 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.311 -0.625 . . . . 1.1799999999999999 109.311 178.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.879 ' HG2' HG12 ' A' ' 128' ' ' VAL . 74.3 mttt -96.72 116.53 29.29 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.942 1.09 . . . . 1.6200000000000001 113.942 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 49' ' ' ASP . 63.9 tttt -147.21 102.13 3.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 2.8399999999999999 109.453 176.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.873 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -52.73 133.17 46.92 Favored Pre-proline 0 N--CA 1.463 0.209 0 N-CA-C 112.27 0.47 . . . . 0.44 112.27 -179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.6 Cg_endo -100.42 51.56 1.5 Allowed 'Cis proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.716 -0.952 . . . . 0.56000000000000005 111.9 -0.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.11 102.83 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.107 -1.044 . . . . 0.47999999999999998 113.34 -179.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.879 HG12 ' HG2' ' A' ' 123' ' ' LYS . 6.0 m -90.01 119.97 38.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.27 -0.965 . . . . 1.22 110.029 178.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 22' ' ' ILE . . . -99.68 140.01 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.598 0.222 . . . . 0.56999999999999995 111.598 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -146.59 133.57 20.27 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.539 -0.301 . . . . 2.0299999999999998 111.525 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.658 ' HE3' HD11 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -145.54 152.64 40.06 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.571 -0.286 . . . . 2.9500000000000002 111.239 179.152 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 81.9 mttt -102.16 141.16 35.43 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.282 0.845 . . . . 2.2599999999999998 113.282 -178.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.774 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 84.1 mt -139.98 120.02 13.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.28000000000000003 109.417 176.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.514 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 15.9 m170 -100.01 114.26 27.43 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.468 -0.493 . . . . 0.55000000000000004 110.274 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 55.6 tp -90.45 125.02 35.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.088 -0.506 . . . . 1.52 112.35 -178.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 40.7 t -120.88 123.84 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.779 -0.646 . . . . 0.32000000000000001 109.634 178.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.514 HG23 HG13 ' A' ' 115' ' ' ILE . 38.2 t -96.87 119.95 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.173 0.434 . . . . 1.0800000000000001 112.173 -178.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 88.3 mt -84.46 170.64 13.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.808 -0.633 . . . . 0.52000000000000002 109.342 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -75.15 138.23 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.352 0.596 . . . . 1.48 111.538 -178.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.794 ' CG ' ' HB1' ' A' ' 32' ' ' ALA . 18.7 mmtm -160.26 173.93 4.4 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.816 -1.084 . . . . 2.2000000000000002 109.817 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 16.4 Cg_endo -56.88 -153.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.376 2.051 . . . . 1.3100000000000001 111.924 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.7 m -36.49 -49.99 0.76 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.969 0.414 . . . . 2.3100000000000001 111.734 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.502 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 72.22 -61.87 1.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.976 -0.63 . . . . 2.52 113.207 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.191 -0.909 . . . . 2.6000000000000001 111.151 -179.748 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.556 -0.218 . . . . 3.2799999999999998 112.556 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -78.21 155.95 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.76 0.314 . . . . 2.4300000000000002 110.862 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 29.7 t -78.1 151.72 33.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.071 0.462 . . . . 1.8400000000000001 111.323 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.888 HG12 ' HB1' ' A' ' 129' ' ' ALA . 3.8 mt -130.01 129.97 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.671 -0.695 . . . . 2.1499999999999999 110.407 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.738 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -89.09 140.04 29.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.581 . . . . 1.1200000000000001 110.225 179.072 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 46.04 81.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.039 -0.982 . . . . 0.65000000000000002 111.096 -177.189 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 73.0 Cg_endo -78.99 -14.15 13.76 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.854 3.036 . . . . 0.88 113.377 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.8 mt-10 -141.36 126.28 18.21 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.272 -0.64 . . . . 2.0600000000000001 109.272 178.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 132' ' ' LYS . 2.1 tt0 -144.06 155.66 44.07 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.534 1.309 . . . . 1.71 114.534 -177.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.458 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 29.1 mtm -140.38 113.99 8.73 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.639 -1.164 . . . . 1.8600000000000001 109.455 177.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.885 HD13 HG23 ' A' ' 133' ' ' ILE . 5.3 mp -119.97 120.69 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 112.646 0.609 . . . . 0.39000000000000001 112.646 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 97.6 mt-10 -101.59 126.91 48.49 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.806 -0.634 . . . . 1.1899999999999999 109.888 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HB3' HD13 ' A' ' 110' ' ' LEU . 16.7 tptt -142.02 156.0 45.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 121.021 -0.272 . . . . 2.52 111.1 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.93 143.69 39.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.855 0.36 . . . . 0.39000000000000001 111.919 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 80.8 tttt -48.98 132.47 18.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.283 -0.417 . . . . 2.3500000000000001 111.621 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . 86.98 -15.78 51.21 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.155 -0.545 . . . . 0.31 112.923 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.826 ' CD ' ' HB3' ' A' ' 32' ' ' ALA . 99.4 mt-10 -79.98 158.76 26.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.95 -0.759 . . . . 2.1099999999999999 108.95 178.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.793 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 26.7 m -88.77 128.42 35.63 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.058 -0.657 . . . . 0.33000000000000002 111.033 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.993 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -99.98 118.88 37.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.26000000000000001 110.648 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD1' HG21 ' A' ' 94' ' ' THR . 62.8 t80 -79.51 119.13 22.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.037 -0.529 . . . . 1.4299999999999999 112.062 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.783 HD12 ' CD1' ' A' ' 105' ' ' ILE . 12.0 mt -109.96 104.79 56.28 Favored Pre-proline 0 C--N 1.333 -0.132 0 N-CA-C 108.315 -0.994 . . . . 0.80000000000000004 108.315 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 96.9 Cg_endo -91.02 104.0 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.218 1.945 . . . . 0.41999999999999998 115.987 -176.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 1.0 OUTLIER -100.14 128.7 46.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.438 -1.319 . . . . 1.03 107.438 175.411 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.738 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 41.1 mmtm -140.58 107.26 5.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.183 0.516 . . . . 1.6599999999999999 110.738 -178.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.077 ' HB3' HG11 ' A' ' 122' ' ' VAL . 47.4 p90 -99.3 140.09 33.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.005 -0.998 . . . . 1.26 111.735 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 21' ' ' SER . 0.3 OUTLIER -79.99 139.13 37.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 1.3300000000000001 110.62 179.492 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 43' ' ' PHE . 97.7 mt -96.23 141.47 29.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 2.1200000000000001 111.67 -179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.6 m -150.66 135.86 10.13 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.75 109.303 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -46.81 -25.66 3.96 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.471 2.114 . . . . 1.6100000000000001 112.238 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.4 tt0 -74.98 -39.99 60.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.373 -0.376 . . . . 2.1800000000000002 111.199 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' OD1' ' HD2' ' A' ' 126' ' ' PRO . 73.7 m-20 -73.27 74.97 1.33 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.017 -0.673 . . . . 2.4100000000000001 109.638 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.85 -5.31 41.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.423 -0.808 . . . . 1.6399999999999999 112.148 -178.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.96 166.24 50.02 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.55000000000000004 112.584 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.22 130.05 29.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.359 2.039 . . . . 0.84999999999999998 111.756 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 124' ' ' LYS . 8.7 tp -77.98 117.29 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.446 -0.343 . . . . 1.8999999999999999 110.904 -179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -129.37 103.17 6.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.484 0.659 . . . . 1.78 111.682 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.836 ' O ' HD12 ' A' ' 73' ' ' LEU . 2.6 mp -95.56 109.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.922 -1.035 . . . . 0.75 110.879 179.108 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.921 ' HG2' HD13 ' A' ' 73' ' ' LEU . 18.0 mt-10 -104.7 116.61 32.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.6699999999999999 111.721 -179.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.914 ' CD2' HD11 ' A' ' 105' ' ' ILE . 70.5 m95 -91.28 116.66 29.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.587 -0.445 . . . . 0.22 109.954 177.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 70' ' ' VAL . 63.0 mt -105.75 138.76 41.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.643 -0.503 . . . . 0.40999999999999998 109.643 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.628 HD12 ' CZ ' ' A' ' 118' ' ' TYR . 9.0 tt -129.97 132.76 65.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.615 0.598 . . . . 0.78000000000000003 112.615 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.08 102.33 40.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 1.25 109.571 177.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.71 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 84.6 Cg_endo -79.52 114.9 3.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.566 2.177 . . . . 0.53000000000000003 113.043 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -29.03 68.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.40999999999999998 110.373 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.72 10.24 9.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.713 -0.676 . . . . 1.8200000000000001 111.742 -179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 67.3 t30 -152.24 160.05 43.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.203 0.525 . . . . 1.9399999999999999 111.849 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -65.85 -19.01 65.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.386 -0.824 . . . . 1.6599999999999999 111.941 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.0 ttmt -65.89 142.08 58.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.115 -0.493 . . . . 1.74 111.418 -178.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.79 128.0 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-O 122.015 0.912 . . . . 0.96999999999999997 110.173 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.53 39.68 21.34 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 113.809 -1.541 . . . . 1.77 112.904 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.525 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 93.9 mm-40 -93.37 136.52 33.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 1.96 110.807 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 58' ' ' LEU . 99.2 t -69.38 130.15 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.77000000000000002 110.615 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.836 HD12 ' HB ' ' A' ' 72' ' ' ILE . 1.4 pp -126.97 -38.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.23 -0.441 . . . . 1.1499999999999999 111.658 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.921 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.26 120.85 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.089 -0.708 . . . . 0.28999999999999998 109.089 179.25 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.921 HD13 ' HG2' ' A' ' 56' ' ' GLU . 2.4 tp -140.52 161.12 38.48 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.699 -0.682 . . . . 1.3 109.543 -178.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 79' ' ' ILE . 21.0 t80 -134.66 110.43 9.28 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.107 0.479 . . . . 1.3 110.307 178.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.533 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 19.9 t -142.37 160.02 41.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.125 -0.943 . . . . 0.89000000000000001 111.639 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.65 37.8 42.76 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.805 -0.712 . . . . 0.56999999999999995 112.137 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t0 59.92 30.04 19.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.075 0.464 . . . . 1.46 110.348 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 44.5 mtmt -129.27 110.82 12.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.704 -0.68 . . . . 2.4100000000000001 110.344 178.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -80.3 117.49 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.581 -1.266 . . . . 1.6599999999999999 107.581 177.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.759 ' O ' HG12 ' A' ' 72' ' ' ILE . 4.9 m-85 -99.98 132.17 45.5 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.693 -1.139 . . . . 1.25 110.641 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 14.2 p-10 -166.11 -56.34 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.418 -1.327 . . . . 1.2 107.418 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 74.0 m-20 -80.23 -27.41 38.75 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.796 -1.093 . . . . 2.1699999999999999 109.238 177.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -74.89 -31.65 61.63 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.226 -1.027 . . . . 5.0499999999999998 108.226 178.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -81.18 112.73 35.46 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 114.512 -1.222 . . . . 1.29 110.102 179.201 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.25 -42.71 16.98 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.653 1.569 . . . . 0.79000000000000004 111.208 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' A' ' 71' ' ' ILE . 96.2 m-20 -67.73 104.12 1.57 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.028 -0.533 . . . . 1.3600000000000001 111.095 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.943 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 13.6 mt 73.88 19.91 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.799 1.037 . . . . 1.6200000000000001 113.799 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 44.5 pttt -57.19 130.08 44.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.572 -0.705 . . . . 2.3900000000000001 110.555 177.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 94.21 11.35 57.51 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.165 -1.017 . . . . 0.37 114.186 178.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.943 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 12.4 ptp180 -141.96 -52.36 0.42 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 114.24 1.2 . . . . 1.5900000000000001 114.24 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.1 p -79.24 81.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 CA-C-O 122.991 1.377 . . . . 0.20000000000000001 107.322 -178.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.434 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 10.4 m80 -99.0 128.81 45.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.193 -2.276 . . . . 0.28999999999999998 112.184 -175.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.08 ' CD1' HG23 ' A' ' 105' ' ' ILE . 66.1 m-85 -70.53 123.25 21.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.201 0.524 . . . . 1.23 110.79 -179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 106' ' ' ASN . 2.7 p -76.21 28.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.412 -0.813 . . . . 0.46000000000000002 111.926 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.1 m -147.45 129.71 15.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.094 0.473 . . . . 1.2 111.566 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.64 5.73 46.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 2.2200000000000002 110.361 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -145.77 66.11 1.22 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 2.1400000000000001 108.959 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.587 HD21 ' CG ' ' A' ' 93' ' ' PHE . 5.8 mp -59.92 -37.43 79.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.097 -0.956 . . . . 1.49 112.101 -178.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -62.52 3.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.521 0.563 . . . . 2.04 112.521 -179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 98' ' ' LEU . 57.3 m -90.03 -3.58 57.89 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.813 -0.63 . . . . 1.3999999999999999 110.259 178.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 43' ' ' PHE . . . 116.96 -20.51 11.56 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.142 -0.552 . . . . 0.38 113.005 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 3.6 m-20 -100.98 107.81 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.4399999999999999 111.122 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.565 ' HA ' HD23 ' A' ' 98' ' ' LEU . . . -110.91 23.79 13.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.169 -0.468 . . . . 0.42999999999999999 110.978 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -59.61 147.08 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.881 1.808 . . . . 1.04 115.881 -178.089 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.08 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -135.66 132.0 51.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 114.455 -1.248 . . . . 0.31 111.016 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.662 ' OD1' HG22 ' A' ' 94' ' ' THR . 0.8 OUTLIER -105.35 145.79 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.673 -0.862 . . . . 1.1499999999999999 108.673 177.216 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.04 122.21 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.87 0.367 . . . . 0.27000000000000002 111.185 -178.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.735 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.5 p -86.06 143.35 28.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.821 -0.627 . . . . 0.28999999999999998 110.892 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 80.7 m-20 49.98 58.17 5.75 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.098 -0.501 . . . . 1.52 111.669 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 37' ' ' ALA . 20.7 mt -46.53 89.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.557 0.947 . . . . 1.02 113.557 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.45 ' HG2' ' H ' ' A' ' 113' ' ' SER . 62.9 tt0 -59.97 145.68 45.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.881 -0.599 . . . . 2.1299999999999999 109.898 177.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.445 ' HG ' ' CD ' ' A' ' 33' ' ' LYS . 83.8 mt -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.773 0.321 . . . . 1.7 111.618 -179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.45 ' H ' ' HG2' ' A' ' 111' ' ' GLN . 79.6 p -73.36 -11.19 60.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.3200000000000001 111.606 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 59' ' ' ILE . 96.3 m-20 -71.7 -17.29 62.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.904 -0.406 . . . . 1.5800000000000001 109.904 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.4 mt -43.5 141.43 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.41999999999999998 110.594 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 140.86 164.71 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.39 -0.91 . . . . 0.23999999999999999 113.34 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 94.0 m -59.55 129.99 44.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.625 0.602 . . . . 0.31 112.625 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.628 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 26.9 m-85 -113.89 121.81 45.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.625 -0.88 . . . . 1.24 108.625 177.058 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.0 tt0 -124.34 125.22 43.97 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.778 -0.369 . . . . 1.1599999999999999 111.021 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.543 ' HB3' ' CE2' ' A' ' 57' ' ' TRP . 16.1 p -108.34 119.97 41.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.843 0.354 . . . . 1.03 110.861 179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 59.2 mttm -113.6 104.09 11.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.157 -0.474 . . . . 1.76 110.935 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 1.077 HG11 ' HB3' ' A' ' 43' ' ' PHE . 5.6 p -90.02 112.0 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.084 -0.71 . . . . 1.1799999999999999 109.084 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 62.3 tttm -102.61 120.06 39.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.724 1.009 . . . . 1.6200000000000001 113.724 -177.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 53' ' ' LEU . 6.6 ttpp -143.9 102.4 3.89 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-O 121.169 0.509 . . . . 2.8399999999999999 109.756 176.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.796 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -51.0 131.98 30.13 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.44 113.051 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 42.4 Cg_endo -99.96 45.55 2.61 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.686 -0.964 . . . . 0.56000000000000005 112.198 -0.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -143.29 103.57 0.32 Allowed Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.422 -0.894 . . . . 0.47999999999999998 113.044 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 1.2 p -89.07 158.66 2.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.435 -0.882 . . . . 1.22 109.519 177.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.983 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . . . -144.74 135.64 24.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.376 -0.374 . . . . 0.56999999999999995 111.554 -179.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 19.2 p30 -146.71 139.36 25.12 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.676 0.621 . . . . 2.0299999999999998 112.676 -179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.741 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -145.68 161.61 39.46 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.359 -0.382 . . . . 2.9500000000000002 111.228 178.832 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 68.8 mttm -100.47 143.31 30.79 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.715 1.006 . . . . 2.2599999999999998 113.715 -178.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 29' ' ' ILE . 96.5 mt -141.32 113.05 3.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 114.961 -1.018 . . . . 0.28000000000000003 108.305 176.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 7.7 m170 -98.8 117.75 33.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.435 -0.506 . . . . 0.55000000000000004 110.885 -178.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.956 HD21 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -93.7 118.5 31.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.52 111.946 -179.311 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 58.6 t -111.75 120.01 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.674 -0.862 . . . . 0.32000000000000001 108.674 178.065 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 115' ' ' ILE . 24.4 t -101.48 122.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.498 0.555 . . . . 1.0800000000000001 112.498 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 90.1 mt -84.07 169.27 15.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.971 -0.751 . . . . 0.52000000000000002 108.971 178.36 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 t -76.8 136.7 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.416 0.627 . . . . 1.48 111.496 -178.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.863 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -164.26 173.68 3.82 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.985 -1.007 . . . . 2.2000000000000002 110.326 179.746 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 71.5 Cg_exo -50.02 169.64 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.455 2.103 . . . . 1.3100000000000001 112.641 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.461 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 19.4 m -40.1 -69.94 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.945 -0.57 . . . . 2.3100000000000001 112.348 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.75 -64.98 0.31 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.826 -0.702 . . . . 2.52 112.509 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.208 -0.901 . . . . 2.6000000000000001 111.442 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.488 -0.245 . . . . 3.2799999999999998 112.488 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.489 ' OG ' ' HA3' ' A' ' 127' ' ' GLY . 13.2 m -80.09 132.22 35.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 2.4300000000000002 110.814 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t -159.95 160.04 32.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 1.8400000000000001 111.406 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.959 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 19.5 tt -133.65 140.02 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 2.1499999999999999 110.45 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.757 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 2.1 p -88.68 154.47 20.27 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.505 0.669 . . . . 1.1200000000000001 111.867 -179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.52 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER 38.39 82.16 0.23 Allowed Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.65000000000000002 111.953 -178.55 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 131' ' ' LYS . 77.8 Cg_endo -79.43 -8.62 14.99 Favored 'Trans proline' 0 C--N 1.326 -0.655 0 C-N-CA 123.891 3.06 . . . . 0.88 113.032 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 86.5 tt0 -141.3 122.46 14.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.144 -0.687 . . . . 2.0600000000000001 109.144 178.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.776 ' OE2' HD11 ' A' ' 29' ' ' ILE . 86.0 tt0 -144.24 156.63 44.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.981 1.104 . . . . 1.71 113.981 -176.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.69 ' O ' HD13 ' A' ' 29' ' ' ILE . 47.7 mtp -138.82 122.3 17.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.847 -1.07 . . . . 1.8600000000000001 109.442 177.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.776 HD11 ' OE2' ' A' ' 27' ' ' GLU . 27.1 mm -126.48 134.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 0.39000000000000001 111.513 -179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 20.4 pt-20 -130.72 127.3 38.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.344 -0.389 . . . . 1.1899999999999999 110.652 179.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 13.3 tptt -142.43 163.48 32.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.39 -0.368 . . . . 2.52 110.945 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.967 ' HB1' ' HG3' ' A' ' 140' ' ' LYS . . . -76.12 140.29 41.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.907 0.384 . . . . 0.39000000000000001 111.704 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 76.6 tttt -47.43 139.71 6.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.095 -0.502 . . . . 2.3500000000000001 111.715 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 109' ' ' ASN . . . 82.5 -20.17 9.55 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.793 -0.639 . . . . 0.31 113.032 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.591 ' HB3' ' HE3' ' A' ' 31' ' ' LYS . 80.7 mm-40 -80.07 159.98 25.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.513 -0.921 . . . . 2.1099999999999999 108.513 178.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 32.9 m -90.68 127.34 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.785 -0.766 . . . . 0.33000000000000002 111.222 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -100.01 119.88 38.96 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.794 0.331 . . . . 0.26000000000000001 110.529 179.181 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 40' ' ' PRO . 65.6 t80 -79.64 116.77 20.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.329 -0.396 . . . . 1.4299999999999999 111.842 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.752 ' HB2' HD12 ' A' ' 105' ' ' ILE . 39.9 mt -100.91 106.15 42.45 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.999 -0.741 . . . . 0.80000000000000004 108.999 178.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HE2' ' A' ' 38' ' ' TYR . 97.0 Cg_endo -81.98 129.3 6.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.549 2.166 . . . . 0.41999999999999998 114.509 -177.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 1.6 t -140.91 130.28 23.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.21 -0.905 . . . . 1.03 109.195 177.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.757 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 57.2 tptt -140.02 141.44 36.31 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.514 -0.55 . . . . 1.6599999999999999 109.514 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.955 ' CG ' HG11 ' A' ' 122' ' ' VAL . 53.1 p90 -139.94 144.82 37.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.242 0.544 . . . . 1.26 112.05 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -80.85 158.37 25.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.36 -0.836 . . . . 1.3300000000000001 110.513 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.598 HD11 ' HE2' ' A' ' 124' ' ' LYS . 63.7 tp -140.0 99.98 3.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 2.1200000000000001 111.422 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.9 t -82.1 142.3 47.68 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.576 -0.527 . . . . 1.75 109.576 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -45.34 -29.35 4.51 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.931 1.754 . . . . 1.6100000000000001 111.821 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.89 -33.64 51.91 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.984 -0.553 . . . . 2.1800000000000002 111.389 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.585 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -71.24 79.96 0.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.087 -0.645 . . . . 2.4100000000000001 109.625 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -102.3 7.24 40.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 1.6399999999999999 112.284 -178.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.959 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -69.94 164.22 51.77 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.55000000000000004 112.809 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.57 134.72 59.76 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.3 2.0 . . . . 0.84999999999999998 111.731 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.611 ' HG ' ' HD3' ' A' ' 124' ' ' LYS . 18.7 mt -78.19 104.73 8.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.656 -0.247 . . . . 1.8999999999999999 111.375 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 92.1 m-20 -119.55 102.61 8.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.64 0.733 . . . . 1.78 110.905 178.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.817 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 8.9 mt -101.38 130.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.765 -1.107 . . . . 0.75 110.004 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.901 ' HG2' HD13 ' A' ' 73' ' ' LEU . 99.3 mt-10 -130.05 125.68 35.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.274 0.842 . . . . 1.6699999999999999 113.274 -178.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.847 ' CD2' HD11 ' A' ' 105' ' ' ILE . 80.8 m95 -97.86 119.95 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.935 -0.575 . . . . 0.22 109.514 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 86.0 mt -105.54 139.98 39.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.372 -0.603 . . . . 0.40999999999999998 109.372 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 117' ' ' THR . 4.9 tt -128.63 129.56 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.171 0.51 . . . . 0.78000000000000003 111.46 -179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.499 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 1.7 p -119.91 103.03 46.14 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 108.954 -0.758 . . . . 1.25 108.954 178.211 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 95.2 Cg_endo -78.78 113.52 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.424 2.082 . . . . 0.53000000000000003 112.892 -178.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.277 -0.874 . . . . 0.40999999999999998 111.066 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.73 -40.02 63.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.928 -0.578 . . . . 1.8200000000000001 111.329 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 97.8 m-20 -84.61 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.156 0.503 . . . . 1.9399999999999999 111.628 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.44 -20.01 63.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.456 -0.793 . . . . 1.6599999999999999 111.222 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 77.6 mttt -70.3 150.02 46.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 1.74 111.233 -178.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.89 128.46 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.065 0 CA-C-O 121.925 0.869 . . . . 0.96999999999999997 110.081 178.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 59.96 40.19 19.23 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 113.94 -1.482 . . . . 1.77 113.229 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -90.59 144.89 25.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.683 0.277 . . . . 1.96 111.217 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.939 HG13 HD21 ' A' ' 73' ' ' LEU . 31.0 t -66.01 136.56 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 108.599 -0.889 . . . . 0.77000000000000002 108.599 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.932 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -130.72 -51.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.839 0.681 . . . . 1.1499999999999999 112.839 -176.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.969 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.42 126.56 21.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.309 -0.626 . . . . 0.28999999999999998 109.309 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 70' ' ' VAL . 3.1 mt -138.09 175.73 9.32 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.412 0.625 . . . . 1.3 111.534 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.718 ' CD1' HG23 ' A' ' 79' ' ' ILE . 45.7 t80 -140.3 104.39 4.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.203 -1.362 . . . . 1.3 107.427 175.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.526 ' O ' ' OH ' ' A' ' 80' ' ' TYR . 1.9 t -141.54 157.11 45.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.998 -0.546 . . . . 0.89000000000000001 111.067 -178.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.27 39.25 42.57 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.525 -0.845 . . . . 0.56999999999999995 112.013 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.01 30.29 19.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 1.46 110.433 -179.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 67.5 mttm -130.8 110.5 11.36 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.768 -0.651 . . . . 2.4100000000000001 111.231 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.718 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.3 pp -79.98 112.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.253 -1.388 . . . . 1.6599999999999999 107.253 176.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -100.11 141.5 32.85 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.922 . . . . 1.25 111.198 -178.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 22.4 p-10 -166.83 -54.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.653 -1.24 . . . . 1.2 107.653 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.457 ' OD1' ' CE1' ' A' ' 92' ' ' HIS . 33.9 m-20 -80.01 -19.9 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.0 -1.0 . . . . 2.1699999999999999 109.873 177.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.411 ' HD2' ' HB3' ' A' ' 80' ' ' TYR . 1.5 t80 -78.47 -28.72 46.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.746 -0.835 . . . . 5.0499999999999998 108.746 178.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.682 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 1.4 m-85 -85.41 119.92 72.7 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 114.931 -1.031 . . . . 1.29 111.189 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 84' ' ' TYR . 7.5 Cg_endo -48.55 -42.84 34.83 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.388 1.392 . . . . 0.79000000000000004 109.933 178.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.775 ' O ' HG12 ' A' ' 71' ' ' ILE . 41.3 m-20 -66.31 106.05 1.6 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.747 -0.66 . . . . 1.3600000000000001 110.702 178.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.898 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 21.7 mt 66.76 21.29 10.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.278 1.214 . . . . 1.6200000000000001 114.278 178.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 55.6 pttt -56.23 129.95 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.457 -0.897 . . . . 2.3900000000000001 110.666 177.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.61 14.26 53.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.263 -0.97 . . . . 0.37 113.875 178.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.898 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.2 ptp180 -145.16 -48.96 0.24 Allowed 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 114.815 1.413 . . . . 1.5900000000000001 114.815 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.969 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.2 p -81.1 81.22 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 CA-C-O 123.274 1.511 . . . . 0.20000000000000001 107.019 -178.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.536 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.9 m80 -99.03 129.21 45.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.145 -2.298 . . . . 0.28999999999999998 112.74 -175.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.11 ' CD1' HG23 ' A' ' 105' ' ' ILE . 86.1 m-85 -72.31 120.14 17.5 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 120.272 -0.571 . . . . 1.23 109.519 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.448 ' OG1' ' HE1' ' A' ' 38' ' ' TYR . 18.8 p -73.37 -7.13 50.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.367 -0.833 . . . . 0.46000000000000002 110.482 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 102' ' ' ASP . 17.7 m -86.35 118.77 26.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.939 -0.573 . . . . 1.2 110.895 -179.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -90.03 1.38 56.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.858 -0.61 . . . . 2.2200000000000002 110.014 179.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -145.99 67.65 1.2 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.335 -0.987 . . . . 2.1400000000000001 108.335 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.646 HD22 ' CE2' ' A' ' 74' ' ' TYR . 10.0 tt -58.27 -36.33 73.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.897 -1.047 . . . . 1.49 112.07 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -62.26 -1.08 0.65 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 2.04 112.254 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 98' ' ' LEU . 70.5 m -89.64 0.04 57.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.618 -0.719 . . . . 1.3999999999999999 110.795 178.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 43' ' ' PHE . . . 107.13 -15.11 39.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.968 -0.634 . . . . 0.38 113.069 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 42' ' ' LYS . 86.6 m-20 -92.26 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.873 0.337 . . . . 1.4399999999999999 111.355 -179.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.568 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -115.09 19.85 15.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.42999999999999999 111.632 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 5.2 p -60.1 141.2 56.21 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.678 1.733 . . . . 1.04 115.678 -178.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.11 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -133.3 130.84 57.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 114.416 -1.266 . . . . 0.31 111.292 178.713 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.573 ' O ' ' O ' ' A' ' 90' ' ' ARG . 51.2 p30 -102.98 144.98 30.56 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.396 -0.964 . . . . 1.1499999999999999 108.396 177.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.87 120.76 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 120.911 0.386 . . . . 0.27000000000000002 111.971 -177.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.704 HG23 ' HA ' ' A' ' 90' ' ' ARG . 2.7 p -84.44 143.13 29.61 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.516 -0.765 . . . . 0.28999999999999998 110.832 178.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 26.2 m120 49.96 57.84 6.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.142 0.496 . . . . 1.52 111.668 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 37' ' ' ALA . 31.3 mt -46.63 90.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.009 1.114 . . . . 1.02 114.009 -179.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 114' ' ' ASP . 38.9 mt-30 -59.3 141.56 54.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.922 -0.581 . . . . 2.1299999999999999 110.924 176.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.605 HD23 ' CG1' ' A' ' 137' ' ' VAL . 84.4 mt -60.04 -35.37 74.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.113 0.483 . . . . 1.7 109.995 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.2 p -74.47 -11.63 60.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.698 -0.683 . . . . 1.3200000000000001 111.435 -179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 111' ' ' GLN . 99.1 m-20 -71.7 -18.45 62.16 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.033 -0.358 . . . . 1.5800000000000001 110.033 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.696 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -43.36 139.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.202 -0.454 . . . . 0.41999999999999998 110.22 179.09 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 60' ' ' SER . . . 140.96 164.06 9.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.111 -1.042 . . . . 0.23999999999999999 113.39 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 93.6 m -59.29 130.22 45.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.012 0.745 . . . . 0.31 113.012 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 15.5 m-85 -114.87 128.87 56.55 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.774 -0.824 . . . . 1.24 108.774 176.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 60.5 tt0 -127.45 119.03 25.19 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.568 -0.453 . . . . 1.1599999999999999 111.314 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' CH2' ' A' ' 57' ' ' TRP . 35.4 t -100.01 119.4 38.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 1.03 110.611 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.817 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.3 mttt -116.57 106.27 13.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.005 -0.278 . . . . 1.76 110.915 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CG ' ' A' ' 43' ' ' PHE . 43.8 t -90.53 112.46 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.363 -0.606 . . . . 1.1799999999999999 109.363 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 85.9 tttt -99.57 121.88 41.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.041 0.756 . . . . 1.6200000000000001 113.041 -178.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 53.9 tptt -145.16 101.39 3.61 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.448 -0.575 . . . . 2.8399999999999999 109.448 177.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.959 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -54.76 135.83 64.85 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.44 112.335 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.585 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 53.0 Cg_endo -96.94 46.2 2.4 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.336 -1.11 . . . . 0.56000000000000005 111.631 -0.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.489 ' HA3' ' OG ' ' A' ' 20' ' ' SER . . . -145.28 103.64 0.29 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.434 -0.889 . . . . 0.47999999999999998 113.399 -179.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.64 153.1 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.342 -0.929 . . . . 1.22 109.897 178.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.959 ' HB1' ' HB ' ' A' ' 22' ' ' ILE . . . -138.01 140.4 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.575 0.213 . . . . 0.56999999999999995 111.575 -179.254 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.472 ' C ' HD13 ' A' ' 22' ' ' ILE . 49.9 p30 -146.74 143.61 28.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.21 0.448 . . . . 2.0299999999999998 112.21 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -146.06 159.98 42.53 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.19 -0.459 . . . . 2.9500000000000002 110.864 179.056 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 72.1 mmtt -105.61 140.39 38.76 Favored 'General case' 0 C--N 1.34 0.192 0 N-CA-C 112.776 0.658 . . . . 2.2599999999999998 112.776 -178.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.828 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 64.7 mt -139.97 119.98 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.28000000000000003 109.17 176.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 28' ' ' MET . 35.2 m170 -102.72 117.35 34.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.55000000000000004 110.616 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.463 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 40.6 tp -89.35 124.94 34.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 1.52 111.601 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 45.0 t -119.97 120.01 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.797 -0.638 . . . . 0.32000000000000001 109.293 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 HG13 ' A' ' 115' ' ' ILE . 40.2 t -99.3 122.69 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.316 0.487 . . . . 1.0800000000000001 112.316 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 86.5 mt -84.86 164.95 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.727 -0.67 . . . . 0.52000000000000002 109.717 178.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.447 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 1.2 t -77.72 138.42 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 1.48 111.514 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.967 ' HG3' ' HB1' ' A' ' 32' ' ' ALA . 1.7 mmtt -159.96 175.22 3.32 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.864 -1.062 . . . . 2.2000000000000002 109.249 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.669 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 18.5 Cg_endo -59.32 -153.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.864 1.709 . . . . 1.3100000000000001 111.581 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 65.8 m -34.96 -71.86 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.847 0.356 . . . . 2.3100000000000001 111.685 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.447 ' HA2' ' HA3' ' A' ' 34' ' ' GLY . . . 69.69 -58.68 0.71 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.995 -0.621 . . . . 2.52 113.082 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.194 -0.907 . . . . 2.6000000000000001 111.157 -179.718 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.54 -0.224 . . . . 3.2799999999999998 112.54 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 44' ' ' THR . 47.6 t -158.97 159.06 34.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 2.4300000000000002 110.642 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.2 t -158.22 144.73 17.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.14 0.495 . . . . 1.8400000000000001 111.457 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.709 ' CG1' ' HB1' ' A' ' 129' ' ' ALA . 1.8 pp -95.33 143.98 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.478 -0.783 . . . . 2.1499999999999999 111.5 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 42' ' ' LYS . 1.2 p -91.12 155.12 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.212 -0.449 . . . . 1.1200000000000001 110.361 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.4 OUTLIER 39.44 83.41 0.2 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.612 0.72 . . . . 0.65000000000000002 111.258 -178.069 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.769 ' HA ' ' CB ' ' A' ' 131' ' ' LYS . 61.2 Cg_endo -78.24 -8.11 16.27 Favored 'Trans proline' 0 C--N 1.327 -0.582 0 C-N-CA 123.753 2.969 . . . . 0.88 113.477 -178.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 98.9 mt-10 -141.16 121.31 13.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.0600000000000001 108.893 178.113 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 132' ' ' LYS . 3.3 tt0 -144.48 160.48 41.03 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.86 1.43 . . . . 1.71 114.86 -176.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 39.6 mtm -139.98 121.38 15.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.582 -1.19 . . . . 1.8600000000000001 109.632 177.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.02 126.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.756 0.312 . . . . 0.39000000000000001 111.659 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 136' ' ' VAL . 86.3 mt-10 -116.26 125.53 52.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.376 -0.375 . . . . 1.1899999999999999 110.325 179.166 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.627 ' HB2' HD11 ' A' ' 110' ' ' LEU . 34.5 mmtm -142.07 156.8 45.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.784 0.326 . . . . 2.52 111.502 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.819 ' HA ' ' HB2' ' A' ' 138' ' ' LEU . . . -76.98 137.83 39.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.39000000000000001 112.184 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 8.0 ttpt -45.17 142.16 2.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.854 -0.612 . . . . 2.3500000000000001 111.707 179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.12 -26.9 4.15 Favored Glycine 0 C--N 1.33 0.221 0 CA-C-N 115.909 -0.587 . . . . 0.31 112.981 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 110' ' ' LEU . 100.0 mt-10 -80.03 160.02 25.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.889 -0.782 . . . . 2.1099999999999999 108.889 178.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 91.6 m -85.49 130.11 34.66 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.018 -0.673 . . . . 0.33000000000000002 110.737 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 107' ' ' VAL . . . -97.2 117.25 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.126 0.488 . . . . 0.26000000000000001 110.327 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.545 ' CD1' HG21 ' A' ' 94' ' ' THR . 89.1 t80 -79.05 120.01 23.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.8 0.667 . . . . 1.4299999999999999 112.8 -178.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' A' ' 105' ' ' ILE . 11.7 mt -107.08 105.67 56.23 Favored Pre-proline 0 CA--C 1.528 0.108 0 N-CA-C 108.533 -0.914 . . . . 0.80000000000000004 108.533 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.49 ' HD2' HD13 ' A' ' 133' ' ' ILE . 87.6 Cg_endo -83.0 128.88 5.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.45 2.1 . . . . 0.41999999999999998 115.066 -177.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 57' ' ' TRP . 9.9 t -141.5 129.89 22.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.043 -0.98 . . . . 1.03 109.637 177.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 1.0 OUTLIER -140.31 150.74 44.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.966 -0.561 . . . . 1.6599999999999999 109.995 179.717 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 122' ' ' VAL . 49.7 p90 -140.13 153.26 46.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.515 -0.766 . . . . 1.26 111.021 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 45' ' ' LEU . 20.0 m -79.74 162.81 24.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 1.3300000000000001 111.047 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 124' ' ' LYS . 47.6 tp -139.83 130.32 25.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 2.1200000000000001 110.871 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.01 158.01 25.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.445 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.81 -20.71 23.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 1.6100000000000001 112.888 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.522 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 86.5 tt0 -72.57 -45.37 59.53 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 110.014 -0.365 . . . . 2.1800000000000002 110.014 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.556 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -71.88 83.34 0.93 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.595 -0.891 . . . . 2.4100000000000001 108.595 178.588 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -95.9 -4.36 43.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.56 -0.745 . . . . 1.6399999999999999 112.361 -177.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.848 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -83.15 152.84 30.05 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.169 -1.015 . . . . 0.55000000000000004 112.779 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.16 139.01 88.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.313 2.009 . . . . 0.84999999999999998 111.493 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 124' ' ' LYS . 6.5 mt -78.33 104.33 8.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.447 -0.342 . . . . 1.8999999999999999 111.767 -179.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 96.6 m-20 -114.31 102.59 10.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.532 0.682 . . . . 1.78 110.06 178.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 47.1 mt -95.38 139.83 18.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.97 -1.014 . . . . 0.75 110.008 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.91 ' HA ' HD22 ' A' ' 73' ' ' LEU . 98.9 mt-10 -137.6 117.15 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 1.6699999999999999 112.741 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.961 ' CD2' HD11 ' A' ' 105' ' ' ILE . 83.6 m95 -91.25 121.88 33.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.428 -0.351 . . . . 0.22 110.469 178.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 119' ' ' GLN . 90.0 mt -107.29 140.02 40.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.555 -0.906 . . . . 0.40999999999999998 108.555 178.278 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' THR . 7.2 tt -128.83 133.06 66.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.352 0.596 . . . . 0.78000000000000003 112.473 -178.426 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -119.85 103.59 45.53 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.112 -0.949 . . . . 1.25 109.216 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 4.9 Cg_exo -79.33 122.52 5.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.503 2.135 . . . . 0.53000000000000003 112.075 -179.109 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.98 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.826 -0.625 . . . . 0.40999999999999998 110.872 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -74.97 -40.03 60.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 1.8200000000000001 111.542 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 30.6 m120 -83.64 154.45 23.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.288 0.566 . . . . 1.9399999999999999 111.912 -179.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.72 -16.92 63.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.233 -0.894 . . . . 1.6599999999999999 111.131 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.673 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 33.2 mttp -68.89 150.02 48.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.484 -0.78 . . . . 1.74 111.449 -178.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 m -155.44 128.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-O 121.984 0.897 . . . . 0.96999999999999997 110.14 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.78 39.96 20.13 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.835 -1.53 . . . . 1.77 112.863 178.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -91.14 146.93 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.603 0.239 . . . . 1.96 110.906 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.918 HG13 HD21 ' A' ' 73' ' ' LEU . 15.8 t -65.84 130.01 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.013 -0.736 . . . . 0.77000000000000002 109.013 178.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.9 HD13 ' C ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -124.81 -53.21 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.671 0.619 . . . . 1.1499999999999999 112.671 -177.028 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.012 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.02 129.37 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 109.163 -0.68 . . . . 0.28999999999999998 109.163 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 70' ' ' VAL . 3.9 mt -138.76 175.45 9.55 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.57 0.7 . . . . 1.3 111.373 -179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.775 ' CD1' HG23 ' A' ' 79' ' ' ILE . 39.2 t80 -141.36 103.61 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.095 -1.411 . . . . 1.3 107.648 176.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HE2' ' A' ' 80' ' ' TYR . 1.8 t -141.6 153.99 45.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.385 -0.371 . . . . 0.89000000000000001 111.005 -178.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.87 30.1 52.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.527 -0.844 . . . . 0.56999999999999995 112.146 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.91 3.99 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.618 0.247 . . . . 1.46 110.872 -178.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 65.1 mttm -105.34 110.79 23.28 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 116.575 -0.284 . . . . 2.4100000000000001 111.306 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.775 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.2 pp -79.87 113.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 106.465 -1.68 . . . . 1.6599999999999999 106.465 176.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.742 ' O ' HG12 ' A' ' 72' ' ' ILE . 1.9 m-85 -99.92 140.02 34.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.426 -0.807 . . . . 1.25 111.177 -177.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.814 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 23.2 p-10 -166.55 -52.39 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.864 -1.162 . . . . 1.2 107.864 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 54.5 m-20 -79.92 -25.57 40.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.122 -0.945 . . . . 2.1699999999999999 109.632 178.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -76.77 -30.47 56.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.546 -0.909 . . . . 5.0499999999999998 108.546 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.656 ' CE2' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -82.19 114.05 48.22 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 114.952 -1.022 . . . . 1.29 110.679 179.43 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.86 -42.17 15.3 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.73 1.62 . . . . 0.79000000000000004 110.31 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.619 ' O ' HG12 ' A' ' 71' ' ' ILE . 58.5 m-20 -67.09 105.24 1.62 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.678 -0.692 . . . . 1.3600000000000001 110.584 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.797 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 9.9 mp 68.98 24.18 6.37 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.892 1.071 . . . . 1.6200000000000001 113.892 178.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 51.1 pttt -57.02 129.83 43.46 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.571 -0.706 . . . . 2.3900000000000001 111.016 178.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.418 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 89.45 15.46 58.52 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.515 -0.85 . . . . 0.37 114.119 178.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 5.9 ptp85 -143.37 -48.54 0.31 Allowed 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 114.383 1.253 . . . . 1.5900000000000001 114.383 -178.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.012 HG11 ' HB ' ' A' ' 72' ' ' ILE . 7.4 p -80.01 81.28 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 123.132 1.444 . . . . 0.20000000000000001 107.274 -178.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.641 ' C ' HG22 ' A' ' 105' ' ' ILE . 11.3 m80 -98.29 127.84 44.42 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.248 -2.251 . . . . 0.28999999999999998 112.325 -175.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.036 ' CD1' HG23 ' A' ' 105' ' ' ILE . 67.2 m-85 -70.88 121.82 18.79 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.166 0.508 . . . . 1.23 110.434 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.545 HG21 ' CD1' ' A' ' 38' ' ' TYR . 5.8 p -77.79 36.0 0.21 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.527 -0.76 . . . . 0.46000000000000002 111.839 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.1 m -148.32 127.55 12.96 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.128 0.489 . . . . 1.2 111.639 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -90.62 6.16 44.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.593 -0.73 . . . . 2.2200000000000002 110.211 178.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -145.91 66.03 1.21 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.103 -0.702 . . . . 2.1400000000000001 109.103 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.469 HD21 ' CG ' ' A' ' 93' ' ' PHE . 4.8 mp -60.08 -39.27 85.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.15 -0.932 . . . . 1.49 111.333 -178.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HE2' ' OH ' ' A' ' 74' ' ' TYR . 25.8 mttm -59.52 -6.73 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.511 . . . . 2.04 112.224 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -81.94 -7.09 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 110.535 179.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 43' ' ' PHE . . . 115.35 -20.02 14.28 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.852 -0.689 . . . . 0.38 113.227 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.2 m-20 -99.91 106.03 17.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.03 0.415 . . . . 1.4399999999999999 110.516 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -113.03 22.59 14.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.466 0.543 . . . . 0.42999999999999999 112.466 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 13.9 m -60.02 151.02 27.45 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.963 1.468 . . . . 1.04 114.963 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.036 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -135.11 134.21 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 114.639 -1.164 . . . . 0.31 111.447 179.301 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.658 ' HB2' HG22 ' A' ' 36' ' ' THR . 51.8 p-10 -107.95 148.37 29.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.832 -0.803 . . . . 1.1499999999999999 108.832 177.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -96.31 123.46 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.943 0.401 . . . . 0.27000000000000002 111.058 -178.774 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -86.27 144.9 27.17 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.689 -0.687 . . . . 0.28999999999999998 111.262 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.7 t30 56.11 61.0 2.92 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.01 -0.541 . . . . 1.52 112.224 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 31' ' ' LYS . 6.6 mt -45.99 169.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 1.02 111.904 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . 11.8 pt20 -177.43 161.22 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.701 -0.681 . . . . 2.1299999999999999 110.572 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.813 ' HA ' HG11 ' A' ' 137' ' ' VAL . 5.1 mp -60.06 -33.01 71.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 1.7 111.465 -179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -73.74 -19.93 60.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.984 -0.286 . . . . 1.3200000000000001 111.629 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 111' ' ' GLN . 95.5 m-20 -72.27 -19.72 61.64 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.923 -0.399 . . . . 1.5800000000000001 109.923 178.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -46.03 142.12 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 116.111 -0.495 . . . . 0.41999999999999998 111.171 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 140.46 150.4 5.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.689 -1.243 . . . . 0.23999999999999999 114.298 179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.73 HG23 ' CD2' ' A' ' 134' ' ' HIS . 98.1 m -59.47 139.95 56.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.875 -0.662 . . . . 0.31 112.135 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 27.8 m-85 -119.98 135.08 55.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 1.24 109.9 178.136 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.692 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.8 tt0 -126.77 117.13 22.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.612 -0.267 . . . . 1.1599999999999999 111.145 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.461 ' HB3' ' HD3' ' A' ' 131' ' ' LYS . 50.8 t -99.99 114.73 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 1.03 110.288 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 60.0 mtpt -109.45 104.77 13.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.574 -0.284 . . . . 1.76 110.801 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 55' ' ' ILE . 42.8 t -90.05 110.69 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.578 -0.527 . . . . 1.1799999999999999 109.578 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HG3' HG12 ' A' ' 128' ' ' VAL . 26.8 tttp -98.9 115.89 29.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.479 0.548 . . . . 1.6200000000000001 112.479 -178.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.556 ' HE3' ' O ' ' A' ' 49' ' ' ASP . 36.1 tttp -145.77 102.63 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.316 -0.554 . . . . 2.8399999999999999 109.784 177.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.848 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -50.56 132.1 26.8 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.919 -0.582 . . . . 0.44 111.903 -179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 48' ' ' GLU . 63.1 Cg_endo -101.29 51.94 1.44 Allowed 'Cis proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.771 -0.929 . . . . 0.56000000000000005 111.94 -0.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.02 102.59 0.26 Allowed Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 119.855 -1.164 . . . . 0.47999999999999998 113.866 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.598 HG12 ' HG3' ' A' ' 123' ' ' LYS . 3.4 m -93.83 135.78 27.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.391 -0.905 . . . . 1.22 109.293 177.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.709 ' HB1' ' CG1' ' A' ' 22' ' ' ILE . . . -144.44 152.51 40.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.599 -0.44 . . . . 0.56999999999999995 112.068 -179.183 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.639 ' HB3' ' HG2' ' A' ' 121' ' ' LYS . 23.6 p-10 -146.42 157.91 43.82 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.217 0.451 . . . . 2.0299999999999998 112.217 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.769 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -145.99 166.61 25.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.193 -0.458 . . . . 2.9500000000000002 111.083 179.009 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' GLU . 68.3 mttm -111.17 140.25 45.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 112.6 0.593 . . . . 2.2599999999999998 112.6 -179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.631 HD12 ' CZ3' ' A' ' 57' ' ' TRP . 96.8 mt -141.55 112.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.543 -0.91 . . . . 0.28000000000000003 108.543 176.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.73 ' CD2' HG23 ' A' ' 117' ' ' THR . 49.5 m170 -96.89 118.77 34.04 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.425 -0.51 . . . . 0.55000000000000004 110.984 -178.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.2 tm? -88.44 120.0 29.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 1.52 111.69 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 30' ' ' GLU . 42.3 t -118.96 120.3 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.32000000000000001 109.197 178.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 112' ' ' LEU . 10.7 p -94.91 133.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.312 0.486 . . . . 1.0800000000000001 112.312 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 66.6 mt -80.1 158.18 26.47 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.944 -0.762 . . . . 0.52000000000000002 108.944 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' N ' ' A' ' 140' ' ' LYS . 3.0 p -69.07 150.55 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 122.134 0.968 . . . . 1.48 113.439 -177.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.764 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 1.3 mttm -164.24 -174.28 0.39 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 113.538 -1.665 . . . . 2.2000000000000002 110.303 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 140' ' ' LYS . 85.8 Cg_exo -49.93 -142.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.85 2.367 . . . . 1.3100000000000001 113.903 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.0 p -30.42 -59.87 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.227 0.825 . . . . 2.3100000000000001 113.227 -178.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.48 ' CA ' ' HD2' ' A' ' 33' ' ' LYS . . . 142.97 27.32 0.15 Allowed Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.333 -0.937 . . . . 2.52 113.342 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.292 -0.861 . . . . 2.6000000000000001 111.015 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.583 ' N ' ' HG ' ' A' ' 46' ' ' SER . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.582 -0.207 . . . . 3.2799999999999998 112.582 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -79.53 137.57 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.336 . . . . 2.4300000000000002 111.063 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -159.96 158.19 30.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 1.8400000000000001 110.856 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.766 HG13 ' HB1' ' A' ' 129' ' ' ALA . 1.6 pp -91.96 143.63 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.089 0.471 . . . . 2.1499999999999999 111.264 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -89.11 157.75 18.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.775 -0.648 . . . . 1.1200000000000001 109.891 178.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 45.1 85.42 0.17 Allowed Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 121.716 0.769 . . . . 0.65000000000000002 109.809 -176.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HA ' ' HB2' ' A' ' 131' ' ' LYS . 44.0 Cg_endo -76.4 -83.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.246 2.631 . . . . 0.88 113.215 -177.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 132' ' ' LYS . 99.3 mt-10 -78.54 128.14 33.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.894 -0.722 . . . . 2.0600000000000001 109.501 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.502 ' CG ' HD11 ' A' ' 29' ' ' ILE . 39.4 tp10 -143.6 156.18 44.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.91 1.078 . . . . 1.71 113.91 -177.317 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HG2' ' HB2' ' A' ' 134' ' ' HIS . 45.0 mtm -137.26 118.24 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.285 -1.325 . . . . 1.8600000000000001 107.865 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.986 HD13 HG23 ' A' ' 133' ' ' ILE . 5.2 mp -120.03 120.05 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.989 0.423 . . . . 0.39000000000000001 111.894 -177.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 136' ' ' VAL . 51.7 mp0 -105.72 128.53 53.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.821 -0.627 . . . . 1.1899999999999999 110.939 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HB3' HD11 ' A' ' 110' ' ' LEU . 20.9 tptm -141.45 154.73 45.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.854 0.359 . . . . 2.52 111.151 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.681 ' HB3' ' OE1' ' A' ' 35' ' ' GLU . . . -76.65 143.63 40.01 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.615 0.598 . . . . 0.39000000000000001 112.615 -179.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.901 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 75.0 mttt -47.86 143.76 3.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.593 -0.731 . . . . 2.3500000000000001 112.604 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.36 -23.64 1.48 Allowed Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.31 113.719 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 32' ' ' ALA . 98.7 mt-10 -79.99 159.97 26.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.338 -0.616 . . . . 2.1099999999999999 109.338 179.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.796 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 55.9 m -86.91 126.31 34.6 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.12 -0.632 . . . . 0.33000000000000002 110.984 -179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD11 ' A' ' 110' ' ' LEU . . . -96.74 118.54 33.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.185 0.516 . . . . 0.26000000000000001 110.307 179.144 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 94' ' ' THR . 9.9 t80 -79.17 120.53 23.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.887 -0.597 . . . . 1.4299999999999999 111.932 -178.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.722 ' HB2' HD12 ' A' ' 105' ' ' ILE . 35.7 mt -105.75 104.77 50.34 Favored Pre-proline 0 N--CA 1.456 -0.168 0 N-CA-C 108.428 -0.952 . . . . 0.80000000000000004 108.428 177.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 87.8 Cg_endo -82.31 127.49 5.21 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.363 2.042 . . . . 0.41999999999999998 114.345 -177.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.0 t -141.2 129.98 22.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.072 -0.967 . . . . 1.03 108.859 178.011 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.61 ' O ' HG22 ' A' ' 22' ' ' ILE . 33.3 ttpt -140.73 150.12 43.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.708 -0.678 . . . . 1.6599999999999999 110.634 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.837 ' CG ' HG11 ' A' ' 122' ' ' VAL . 47.0 p90 -139.95 140.42 36.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.897 -178.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.01 138.31 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.694 -0.684 . . . . 1.3300000000000001 110.507 179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.0 107.84 19.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 2.1200000000000001 111.34 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 19' ' ' GLY . 57.6 m -83.34 148.23 55.24 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 109.355 -0.609 . . . . 1.75 109.355 178.314 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -42.36 -46.75 7.57 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 121.984 1.789 . . . . 1.6100000000000001 111.594 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 85.6 tt0 -75.94 -38.49 57.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.652 -0.704 . . . . 2.1800000000000002 110.971 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HA ' ' CD ' ' A' ' 126' ' ' PRO . 13.9 t0 -70.96 80.03 0.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.303 0.573 . . . . 2.4100000000000001 110.441 -179.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -137.25 33.75 2.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.19 -0.914 . . . . 1.6399999999999999 111.022 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 125' ' ' ALA . . . -97.12 -171.32 33.8 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.541 -0.838 . . . . 0.55000000000000004 112.717 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.66 113.03 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.644 2.229 . . . . 0.84999999999999998 111.861 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 47.9 tp -78.7 118.54 20.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.8999999999999999 111.566 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -134.55 102.95 5.48 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.524 0.678 . . . . 1.78 111.371 179.08 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.846 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 3.7 mt -96.06 110.01 23.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.011 -0.995 . . . . 0.75 110.809 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' CB ' HD12 ' A' ' 73' ' ' LEU . 86.5 tt0 -102.56 117.99 35.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.129 0.788 . . . . 1.6699999999999999 113.129 -178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.905 ' CD2' HD11 ' A' ' 105' ' ' ILE . 74.3 m95 -93.88 121.7 35.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.22 109.882 176.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 87.1 mt -106.65 129.94 54.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.035 -0.357 . . . . 0.40999999999999998 110.035 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.786 HD12 HD11 ' A' ' 87' ' ' LEU . 3.9 tt -119.96 120.05 61.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.203 0.816 . . . . 0.78000000000000003 113.203 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.538 ' HA ' ' C ' ' A' ' 67' ' ' VAL . 5.4 t -108.11 104.5 53.82 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 108.842 -0.799 . . . . 1.25 108.842 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.701 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 80.6 Cg_endo -78.85 112.74 3.16 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.304 2.003 . . . . 0.53000000000000003 111.952 -179.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.01 87.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.435 -0.802 . . . . 0.40999999999999998 111.082 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.78 -39.99 63.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.84 -0.618 . . . . 1.8200000000000001 111.555 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 80.8 m-20 -85.28 162.84 18.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.18 0.514 . . . . 1.9399999999999999 111.942 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -69.18 -18.05 63.87 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.4 -0.818 . . . . 1.6599999999999999 111.942 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HB2' ' CG ' ' A' ' 61' ' ' PRO . 67.5 mttm -69.46 170.03 11.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.877 -0.601 . . . . 1.74 111.967 -177.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.619 ' O ' ' O ' ' A' ' 59' ' ' ILE . 1.3 t -133.47 -154.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 107.753 -1.203 . . . . 0.96999999999999997 107.753 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 67' ' ' VAL . 78.4 m-20 -67.54 64.54 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.73 0.776 . . . . 1.77 111.564 -177.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -85.76 157.19 20.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.425 -1.261 . . . . 1.96 109.508 178.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' OH ' ' A' ' 84' ' ' TYR . 11.5 t -66.27 131.4 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.398 -0.521 . . . . 0.77000000000000002 109.652 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.077 HD11 HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.56 -50.77 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.652 0.612 . . . . 1.1499999999999999 112.652 -176.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.777 ' HB ' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -140.01 123.1 17.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.067 -0.716 . . . . 0.28999999999999998 109.067 179.642 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' CB ' ' A' ' 56' ' ' GLU . 7.9 tt -140.0 160.99 38.68 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.793 -0.639 . . . . 1.3 110.156 -177.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.631 ' CD1' HG23 ' A' ' 79' ' ' ILE . 10.2 t80 -135.61 111.64 9.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.997 0.427 . . . . 1.3 110.155 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' ' CE2' ' A' ' 80' ' ' TYR . 6.7 t -142.46 159.98 41.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.554 -0.748 . . . . 0.89000000000000001 111.441 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 53.17 36.2 51.61 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.63 -0.795 . . . . 0.56999999999999995 111.941 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.5 t0 62.94 22.35 13.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.956 0.408 . . . . 1.46 110.397 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' CB ' ' CE1' ' A' ' 80' ' ' TYR . 22.5 mttm -120.68 110.3 16.24 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.922 -0.581 . . . . 2.4100000000000001 110.677 178.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.631 HG23 ' CD1' ' A' ' 74' ' ' TYR . 1.4 pp -80.13 117.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.1 -1.444 . . . . 1.6599999999999999 107.1 177.313 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 72' ' ' ILE . 5.3 m-85 -99.96 136.47 39.83 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.976 -1.011 . . . . 1.25 110.526 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.749 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.3 p-10 -166.26 -56.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.402 -0.962 . . . . 1.2 108.402 -179.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' OD1' ' CD2' ' A' ' 83' ' ' TYR . 25.6 p-10 -78.77 -24.01 44.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.554 -0.748 . . . . 2.1699999999999999 109.787 177.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' HD2' ' HA ' ' A' ' 80' ' ' TYR . 16.4 m-85 -77.19 -29.17 54.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.285 -1.006 . . . . 5.0499999999999998 108.285 178.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -82.18 115.9 60.38 Favored Pre-proline 0 CA--C 1.517 -0.301 0 CA-C-N 114.985 -1.007 . . . . 1.29 110.644 179.368 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.3 -43.95 16.51 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.739 1.626 . . . . 0.79000000000000004 111.046 178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.763 ' O ' HG12 ' A' ' 71' ' ' ILE . 16.6 m-20 -66.93 106.7 1.99 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.106 -0.638 . . . . 1.3600000000000001 110.808 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.846 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 17.4 mt 67.64 22.4 9.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.926 1.084 . . . . 1.6200000000000001 113.926 178.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HA ' ' O ' ' A' ' 81' ' ' ASP . 42.6 pttt -54.81 128.75 34.41 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.81 -0.756 . . . . 2.3900000000000001 111.089 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA2' ' HE1' ' A' ' 92' ' ' HIS . . . 93.35 13.61 55.46 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.344 -0.931 . . . . 0.37 114.422 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.846 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.7 ptp85 -143.63 -48.98 0.3 Allowed 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 114.584 1.327 . . . . 1.5900000000000001 114.584 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.077 HG11 HD11 ' A' ' 71' ' ' ILE . 5.7 p -80.76 81.5 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 107.232 -1.395 . . . . 0.20000000000000001 107.232 -178.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.593 ' C ' HG22 ' A' ' 105' ' ' ILE . 12.6 m80 -100.6 132.89 45.75 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 112.277 -2.238 . . . . 0.28999999999999998 112.191 -175.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 1.118 ' CD1' HG23 ' A' ' 105' ' ' ILE . 74.6 m-85 -73.8 120.01 18.81 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-O 121.254 0.55 . . . . 1.23 109.884 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.467 HG21 ' CE2' ' A' ' 38' ' ' TYR . 32.3 p -74.8 -6.14 47.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.319 -0.855 . . . . 0.46000000000000002 110.428 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.3 m -90.4 120.17 31.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 1.2 110.754 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -89.93 1.58 56.07 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.034 -0.53 . . . . 2.2200000000000002 110.299 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -146.16 68.51 1.19 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 4.3 mp -59.66 -38.38 81.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.962 -1.017 . . . . 1.49 111.696 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -61.62 -6.23 2.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.204 0.526 . . . . 2.04 112.071 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m -86.63 -4.64 59.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.393 -0.821 . . . . 1.3999999999999999 110.643 178.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.55 -22.7 14.63 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.771 -0.728 . . . . 0.38 113.254 179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 98' ' ' LEU . 96.4 m-20 -93.7 107.19 19.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.132 0.466 . . . . 1.4399999999999999 110.489 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -113.9 22.11 14.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.657 0.614 . . . . 0.42999999999999999 112.657 -178.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 15.1 m -59.99 148.18 36.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.521 1.675 . . . . 1.04 115.521 -178.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.118 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -132.28 134.31 59.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 114.494 -1.23 . . . . 0.31 111.108 179.199 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' HB2' HG22 ' A' ' 36' ' ' THR . 52.2 p-10 -107.06 150.37 26.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.766 -0.828 . . . . 1.1499999999999999 108.766 177.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -98.35 121.59 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 120.902 0.382 . . . . 0.27000000000000002 110.915 -178.938 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.687 HG23 ' HA ' ' A' ' 90' ' ' ARG . 1.8 p -85.48 144.36 28.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.703 -0.681 . . . . 0.28999999999999998 111.432 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 54.17 60.32 3.66 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.638 178.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 37' ' ' ALA . 12.2 mt -46.17 169.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.039 0.447 . . . . 1.02 111.887 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.785 ' O ' HG21 ' A' ' 137' ' ' VAL . 64.0 tt0 -177.99 166.44 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.711 -0.677 . . . . 2.1299999999999999 109.909 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 87.0 mt -59.97 -33.26 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.903 0.335 . . . . 1.7 111.903 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 52.9 m -73.36 -19.42 61.01 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.986 -0.285 . . . . 1.3200000000000001 111.509 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -71.44 -20.77 62.06 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.571 -0.529 . . . . 1.5800000000000001 109.571 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.804 HG13 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -49.98 140.33 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 CA-C-N 115.704 -0.68 . . . . 0.41999999999999998 111.067 178.796 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . 141.01 153.21 5.91 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 119.71 -1.234 . . . . 0.23999999999999999 113.705 179.137 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.749 HG23 ' CD2' ' A' ' 134' ' ' HIS . 84.2 m -59.42 135.71 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.298 0.481 . . . . 0.31 112.298 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 21.9 m-85 -121.17 131.5 54.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.186 -0.672 . . . . 1.24 109.186 177.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 57' ' ' TRP . 61.9 tt0 -128.85 120.0 25.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.78 -0.368 . . . . 1.1599999999999999 110.238 179.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.505 ' SG ' ' HG2' ' A' ' 131' ' ' LYS . 16.6 p -102.81 119.59 39.1 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.546 -0.462 . . . . 1.03 110.911 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.846 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 94.0 mttt -111.21 104.53 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 1.76 110.441 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.837 HG11 ' CG ' ' A' ' 43' ' ' PHE . 21.8 t -88.45 107.44 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 109.86 -0.422 . . . . 1.1799999999999999 109.86 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 33.8 mttm -100.1 120.7 40.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.823 1.046 . . . . 1.6200000000000001 113.823 -178.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 19.1 tttt -145.83 103.32 3.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.211 0.529 . . . . 2.8399999999999999 109.874 177.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.496 ' HB3' ' HA3' ' A' ' 51' ' ' GLY . . . -47.95 130.6 11.89 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.322 -0.853 . . . . 0.44 113.274 -178.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.567 ' CD ' ' HA ' ' A' ' 49' ' ' ASP . 62.9 Cg_endo -102.73 48.72 1.91 Allowed 'Cis proline' 0 N--CA 1.452 -0.92 0 C-N-CA 125.008 -0.83 . . . . 0.56000000000000005 111.621 -0.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 103.5 0.3 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.214 -0.993 . . . . 0.47999999999999998 113.138 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -92.93 151.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.338 -0.931 . . . . 1.22 109.995 177.918 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 22' ' ' ILE . . . -145.63 144.08 30.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.867 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.569 ' CB ' ' HG2' ' A' ' 121' ' ' LYS . 50.5 p-10 -147.16 146.66 29.95 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.559 0.577 . . . . 2.0299999999999998 112.559 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.836 ' HB2' ' HA ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -144.5 164.67 30.19 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.395 -0.366 . . . . 2.9500000000000002 111.299 179.483 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' GLU . 94.5 mttt -99.68 140.0 34.52 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 113.031 0.752 . . . . 2.2599999999999998 113.031 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.986 HG23 HD13 ' A' ' 29' ' ' ILE . 71.9 mt -141.08 110.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.939 -1.028 . . . . 0.28000000000000003 109.248 177.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.749 ' CD2' HG23 ' A' ' 117' ' ' THR . 53.3 m170 -100.02 119.98 39.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.55000000000000004 111.052 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.3 tm? -89.53 125.54 35.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.933 -0.576 . . . . 1.52 111.42 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 46.9 t -119.95 130.0 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.32000000000000001 109.496 178.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.804 HG23 HG13 ' A' ' 115' ' ' ILE . 25.3 t -100.22 122.88 52.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.156 0.428 . . . . 1.0800000000000001 112.156 -178.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 72.7 mt -83.5 159.99 21.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.982 -0.554 . . . . 0.52000000000000002 109.614 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.5 t -72.98 140.77 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 1.48 111.939 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.901 ' HB2' ' HB2' ' A' ' 33' ' ' LYS . 4.0 mmtt -161.31 175.88 2.82 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.67 -1.15 . . . . 2.2000000000000002 109.783 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.64 ' O ' ' O ' ' A' ' 140' ' ' LYS . 4.2 Cg_endo -44.86 -144.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.252 2.635 . . . . 1.3100000000000001 113.173 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 141' ' ' PRO . 66.5 m -31.8 -44.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.52 0.563 . . . . 2.3100000000000001 112.52 -179.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 33' ' ' LYS . . . 125.14 -57.42 0.68 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.402 -0.904 . . . . 2.52 113.555 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 110' ' ' LEU . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.262 -0.875 . . . . 2.6000000000000001 110.989 -179.481 . . . . . . . . 1 1 . 1 stop_ save_